data_2kn5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kn5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.463 ' HE1' ' HB2' ' A' ' 63' ' ' LYS . 82.0 mtp . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.993 -1.114 . . . . 50.51 107.993 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -84.43 140.22 31.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 126.976 2.673 . . . . 50.55 109.692 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.4 pt -133.64 159.58 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-O 115.982 -1.961 . . . . 50.51 107.126 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -117.16 135.69 53.58 Favored 'General case' 0 N--CA 1.512 2.639 1 O-C-N 130.48 4.863 . . . . 50.51 110.963 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.532 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 69.9 t -114.87 108.28 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 113.436 -3.173 . . . . 50.51 110.719 175.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.472 ' CD ' HG23 ' A' ' 12' ' ' THR . 35.1 mmtp -88.2 122.94 32.33 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.303 4.127 . . . . 50.51 111.031 -178.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.9 p -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.354 -2.091 . . . . 50.51 105.354 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -112.64 6.62 18.38 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.067 0.854 . . . . 50.51 112.102 -177.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -106.67 -27.84 10.57 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.702 -2.399 . . . . 50.51 106.563 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.2 0.65 2.11 Favored Glycine 0 C--N 1.296 -1.641 0 O-C-N 119.78 -1.825 . . . . 50.51 115.343 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -73.92 152.29 40.17 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.852 -1.547 . . . . 50.51 115.111 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.472 HG23 ' CD ' ' A' ' 6' ' ' LYS . 44.3 p -121.26 156.72 31.88 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 126.654 2.471 . . . . 50.51 108.939 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 62.7 mt -127.96 142.09 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.396 2.935 . . . . 50.51 111.49 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -111.92 134.28 53.57 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.163 -1.792 . . . . 50.51 106.163 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.571 HD21 ' HE2' ' A' ' 33' ' ' LYS . 96.0 mt -127.15 134.06 50.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.412 2.375 . . . . 50.51 117.412 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.55 96.16 7.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 128.807 3.817 . . . . 50.62 111.345 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -121.86 -175.02 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.267 0 O-C-N 127.603 3.064 . . . . 50.51 115.619 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CD ' ' OG ' ' A' ' 20' ' ' SER . 14.7 pt-20 -151.91 154.73 33.12 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.227 -2.26 . . . . 50.62 108.206 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.3 Cg_exo -54.94 -24.51 39.61 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.575 2.184 . . . . 50.51 111.985 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.46 ' OG ' ' CD ' ' A' ' 18' ' ' GLU . 92.8 p -63.79 -30.86 71.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.142 -0.932 . . . . 50.51 111.755 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -69.62 149.63 47.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.357 -1.737 . . . . 50.62 115.373 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 HG23 ' A' ' 55' ' ' THR . 33.0 p -93.58 169.62 10.2 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.827 -0.624 . . . . 50.51 109.549 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.476 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 42.3 mm -58.99 -25.6 30.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 O-C-N 127.189 2.806 . . . . 50.51 112.352 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -70.89 -46.41 62.64 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.047 2.24 . . . . 50.62 117.047 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -66.6 -50.34 63.37 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 124.31 1.044 . . . . 50.55 110.626 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.41 -31.39 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.932 1.395 . . . . 50.51 112.353 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 92.1 mttt -81.65 -19.97 40.63 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 105.184 -2.154 . . . . 50.51 105.184 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.33 -14.97 34.5 Favored 'General case' 0 C--O 1.278 2.58 0 N-CA-C 112.47 0.544 . . . . 50.51 112.47 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -90.15 -35.2 15.53 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.338 -1.476 . . . . 50.51 107.719 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 61.0 mt -60.41 -29.4 44.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.53 -0.868 . . . . 50.51 112.135 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' ILE . 61.9 tt0 -49.94 -51.94 37.32 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 125.627 2.632 . . . . 50.55 104.767 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -46.96 -41.37 16.06 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.619 -1.628 . . . . 50.62 112.33 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HE2' HD21 ' A' ' 15' ' ' LEU . 12.3 mptt -73.68 -41.77 62.19 Favored 'General case' 0 C--O 1.279 2.645 0 C-N-CA 116.464 -2.094 . . . . 50.51 114.312 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' OE2' HD12 ' A' ' 13' ' ' ILE . 30.1 mt-10 -113.98 -62.79 1.54 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 123.06 2.664 . . . . 50.62 109.956 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.82 -16.68 1.98 Allowed Glycine 0 CA--C 1.477 -2.288 0 CA-C-O 120.017 -0.324 . . . . 50.51 112.919 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.502 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.9 mm -58.06 128.86 82.04 Favored Pre-proline 0 C--O 1.244 0.768 0 N-CA-C 117.582 2.438 . . . . 50.51 117.582 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 77.9 Cg_exo -56.98 136.97 79.83 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.147 2.565 . . . . 50.51 110.869 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -57.21 -32.09 92.54 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.861 0.927 . . . . 50.51 113.45 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.33 -26.89 67.5 Favored 'General case' 0 C--O 1.262 1.743 0 O-C-N 119.981 -1.699 . . . . 50.62 108.101 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.0 3.5 55.1 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.555 -1.341 . . . . 50.55 113.535 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 86.7 mt-30 -101.49 140.5 35.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 124.355 2.026 . . . . 50.55 109.8 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -134.88 148.66 50.15 Favored 'General case' 0 C--O 1.296 3.506 0 CA-C-O 116.696 -1.621 . . . . 50.64 107.468 172.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.0 mt -129.83 125.13 34.96 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.638 -1.245 . . . . 50.51 107.638 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.6 133.68 61.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 125.08 1.488 . . . . 50.51 112.789 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.57 110.91 5.81 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 107.086 -1.45 . . . . 50.51 107.086 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.02 30.76 4.36 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.254 -2.248 . . . . 50.51 115.498 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.93 -7.46 82.07 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 128.424 2.916 . . . . 50.51 116.734 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -80.43 119.52 23.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.047 0.924 . . . . 50.51 112.719 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -81.6 106.18 13.34 Favored 'General case' 0 C--O 1.259 1.583 0 O-C-N 123.936 0.773 . . . . 50.55 111.918 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.07 154.23 4.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 114.268 1.21 . . . . 50.51 114.268 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.5 132.35 51.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.144 2.275 . . . . 50.62 117.144 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -56.31 -5.02 0.16 Allowed 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.927 2.936 . . . . 50.62 118.927 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 9.3 22.67 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 105.382 -3.087 . . . . 50.51 105.382 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.17 156.77 16.25 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 119.961 -1.905 . . . . 50.64 109.981 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.576 HG23 HG23 ' A' ' 22' ' ' THR . 41.5 p -109.56 144.4 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.187 -1.412 . . . . 50.51 107.187 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -40.96 -25.47 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.145 0.903 . . . . 50.51 109.021 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' THR . 91.0 p -74.0 -27.41 60.95 Favored 'General case' 0 C--O 1.268 2.076 0 N-CA-C 115.809 1.781 . . . . 50.51 115.809 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -65.86 -26.95 67.88 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.461 1.124 . . . . 50.62 110.413 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.86 5.95 26.92 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 117.781 -1.104 . . . . 50.51 111.333 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 41.36 29.38 0.09 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.474 1.943 . . . . 50.55 113.378 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -51.44 107.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.267 1.975 0 N-CA-C 104.064 -2.569 . . . . 50.51 104.064 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 63' ' ' LYS . 16.6 pt20 -107.0 -169.04 1.48 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 126.092 2.12 . . . . 50.55 112.791 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.49 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 36.1 ttpt -73.32 136.06 44.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.184 1.469 . . . . 50.51 114.36 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 41.3 mt-10 71.85 8.9 6.13 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 117.217 2.302 . . . . 50.62 117.217 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 t -74.77 142.3 44.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 104.636 -2.357 . . . . 50.51 104.636 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -106.41 133.81 50.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.39 -0.967 . . . . 50.51 108.39 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.54 162.17 13.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.681 -2.581 . . . . 50.51 109.154 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -116.01 121.92 43.69 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 127.406 2.941 . . . . 50.51 111.196 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.1 tp -79.83 140.41 36.83 Favored 'General case' 0 C--O 1.283 2.822 0 N-CA-C 115.5 1.667 . . . . 50.51 115.5 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.74 138.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.634 1.106 . . . . 50.51 112.603 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.5 tp -103.91 107.78 18.81 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.47 0.915 . . . . 50.51 113.47 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.5 79.85 2.0 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 113.349 -3.215 . . . . 50.64 115.252 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -58.0 148.23 26.74 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 117.843 2.534 . . . . 50.51 117.843 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 70.6 ttp85 -95.34 55.03 1.69 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 115.389 1.625 . . . . 50.64 115.389 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.22 -170.86 39.59 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.594 -3.402 . . . . 50.51 104.594 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.453 0 CA-C-O 116.337 -2.369 . . . . 50.51 111.883 179.197 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.606 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 118.86 -0.591 . . . . 50.51 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -88.0 142.49 27.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 126.954 2.659 . . . . 50.55 109.499 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 17' ' ' VAL . 24.3 pt -141.77 160.76 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 116.036 -1.935 . . . . 50.51 107.472 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 66' ' ' THR . 83.1 m-85 -113.78 132.34 55.89 Favored 'General case' 0 N--CA 1.511 2.582 1 O-C-N 130.381 4.801 . . . . 50.51 113.364 179.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.99 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 113.348 -3.215 . . . . 50.51 106.321 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG2' ' OG1' ' A' ' 12' ' ' THR . 92.5 mttt -111.88 135.51 52.4 Favored 'General case' 0 N--CA 1.503 2.207 1 O-C-N 129.388 4.18 . . . . 50.51 117.046 -178.112 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 154.78 31.92 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 107.609 -1.256 . . . . 50.51 107.609 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.26 -12.97 23.45 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.177 0.923 . . . . 50.51 110.549 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -66.06 -22.46 66.42 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 115.705 -2.398 . . . . 50.51 113.759 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.39 10.55 35.81 Favored Glycine 0 C--N 1.297 -1.598 0 O-C-N 120.106 -1.621 . . . . 50.51 112.437 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -101.28 134.84 43.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 116.82 -1.562 . . . . 50.51 112.252 174.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 6' ' ' LYS . 52.4 m -127.51 149.29 50.2 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.707 2.505 . . . . 50.51 115.581 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -134.07 157.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 115.266 -2.574 . . . . 50.51 106.314 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -121.38 144.41 48.67 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.248 -1.781 . . . . 50.51 113.515 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD23 ' HB3' ' A' ' 29' ' ' LYS . 77.5 mt -120.1 167.37 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.445 -2.216 . . . . 50.51 109.959 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -129.47 92.96 3.44 Favored 'General case' 0 N--CA 1.5 2.041 1 O-C-N 129.131 4.019 . . . . 50.62 106.104 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.606 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 m -105.34 173.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.779 3.174 . . . . 50.51 111.764 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 84.0 mt-10 -106.44 145.13 30.4 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.164 -2.289 . . . . 50.62 111.14 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.3 Cg_exo -54.9 -24.57 39.62 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.637 2.224 . . . . 50.51 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 p -88.23 -9.0 54.4 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 115.2 1.556 . . . . 50.51 115.2 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 46.2 m-20 -65.27 148.79 51.07 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 117.412 -1.715 . . . . 50.62 110.448 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -78.94 170.94 15.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.865 -0.607 . . . . 50.51 110.503 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.24 -29.33 46.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 O-C-N 127.103 2.752 . . . . 50.51 108.04 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -70.93 -15.1 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 119.915 3.302 . . . . 50.62 119.915 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.467 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 23.0 t-20 -81.82 -50.63 9.0 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.366 1.066 . . . . 50.55 110.51 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -54.7 -44.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 125.045 1.466 . . . . 50.51 108.146 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -54.39 -35.46 62.87 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 107.989 -1.115 . . . . 50.51 107.989 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -67.2 -49.62 63.94 Favored 'General case' 0 C--O 1.278 2.597 0 N-CA-C 109.695 -0.483 . . . . 50.51 109.695 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.567 ' HB3' HD23 ' A' ' 15' ' ' LEU . 46.8 mmtm -50.89 -37.09 41.66 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 120.374 -1.454 . . . . 50.51 114.823 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.82 -42.11 28.51 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 104.617 -2.364 . . . . 50.51 104.617 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -53.6 -42.36 67.6 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 125.628 2.632 . . . . 50.55 112.14 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.9 -41.73 78.62 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 120.716 3.599 . . . . 50.62 120.716 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -106.76 -15.08 14.83 Favored 'General case' 0 C--O 1.279 2.633 0 C-N-CA 116.434 -2.106 . . . . 50.51 113.39 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.18 -11.11 11.37 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 118.616 2.821 . . . . 50.62 118.616 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 28.74 45.78 Favored Glycine 0 CA--C 1.478 -2.25 0 N-CA-C 114.94 0.736 . . . . 50.51 114.94 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.486 HD11 HD22 ' A' ' 71' ' ' LEU . 71.5 mt -107.46 119.64 50.05 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 114.984 1.476 . . . . 50.51 114.984 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.07 137.0 79.94 Favored 'Trans proline' 0 C--O 1.258 1.515 0 C-N-CA 123.116 2.544 . . . . 50.51 110.883 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -57.14 -32.28 92.9 Favored 'Trans proline' 0 C--O 1.261 1.663 0 C-N-CA 120.711 0.941 . . . . 50.51 113.379 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -73.27 0.15 12.76 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.948 -1.72 . . . . 50.62 110.64 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -112.4 1.69 16.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.572 -1.33 . . . . 50.55 109.356 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.04 128.55 47.03 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.419 2.057 . . . . 50.55 111.985 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' HD2' ' HB2' ' A' ' 72' ' ' ARG . 70.3 mtp180 -112.21 127.35 55.93 Favored 'General case' 0 C--O 1.297 3.555 0 N-CA-C 105.903 -1.888 . . . . 50.64 105.903 172.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -109.65 136.13 49.49 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 102.88 -3.007 . . . . 50.51 102.88 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -132.4 121.32 45.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 O-C-N 125.223 1.577 . . . . 50.51 111.755 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.53 90.81 3.4 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 106.998 -1.482 . . . . 50.51 106.998 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.07 76.54 0.33 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.219 -2.264 . . . . 50.51 112.337 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.03 32.07 0.35 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 128.405 2.907 . . . . 50.51 113.437 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -121.85 112.63 18.58 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 102.62 -3.104 . . . . 50.51 102.62 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -70.62 123.59 22.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.887 0.742 . . . . 50.55 111.637 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 mt -78.04 139.39 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 117.756 -1.116 . . . . 50.51 113.743 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -86.58 115.25 23.93 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.95 1.406 . . . . 50.62 114.529 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -40.42 -21.16 0.01 OUTLIER 'General case' 0 C--O 1.264 1.834 0 N-CA-C 117.809 2.522 . . . . 50.62 117.809 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.96 2.74 51.85 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 118.398 2.119 . . . . 50.51 118.398 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 mmp_? -96.99 -177.77 3.98 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 120.031 -1.864 . . . . 50.64 109.983 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -108.66 174.73 5.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.062 0.945 . . . . 50.51 110.315 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.5 mt -74.8 -13.95 60.64 Favored 'General case' 0 C--O 1.201 -1.482 0 CA-C-O 118.382 -0.818 . . . . 50.51 111.156 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -85.83 -40.85 15.56 Favored 'General case' 0 C--O 1.268 2.057 0 N-CA-C 117.598 2.444 . . . . 50.51 117.598 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -47.51 -37.27 11.67 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.497 1.141 . . . . 50.62 108.843 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 9.72 9.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 117.328 2.344 . . . . 50.51 117.328 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 62' ' ' GLN . 87.2 m-20 53.97 16.08 1.02 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-N 121.526 1.966 . . . . 50.55 115.744 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.649 HG23 ' HG ' ' A' ' 65' ' ' SER . 27.2 mm -52.1 90.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.265 1.913 0 CA-C-O 115.207 -2.33 . . . . 50.51 110.741 175.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 60' ' ' ASN . 77.0 mt-30 -78.21 -175.73 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 125.588 1.805 . . . . 50.55 114.506 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -70.64 141.94 51.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.622 -1.992 . . . . 50.51 105.622 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 67.6 31.17 6.25 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.437 -2.165 . . . . 50.62 112.362 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.649 ' HG ' HG23 ' A' ' 61' ' ' ILE . 32.3 t -77.91 135.98 37.95 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.792 -1.094 . . . . 50.51 108.596 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.5 HG23 ' HB2' ' A' ' 4' ' ' PHE . 16.9 p -93.35 142.87 26.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 118.313 -0.851 . . . . 50.51 110.594 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.6 mt -122.09 122.58 39.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.78 -2.533 . . . . 50.51 105.6 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -83.64 151.25 25.4 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 102.87 -3.011 . . . . 50.51 102.87 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -123.3 109.76 14.34 Favored 'General case' 0 C--O 1.283 2.822 0 CA-C-O 117.608 -1.187 . . . . 50.51 110.481 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.09 133.01 49.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.502 -2.036 . . . . 50.51 105.502 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.486 HD22 HD11 ' A' ' 36' ' ' ILE . 35.1 mt -82.67 152.09 25.99 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 118.77 2.878 . . . . 50.51 118.77 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.467 ' HB2' ' HD2' ' A' ' 42' ' ' ARG . 36.3 ttm180 -123.76 89.77 3.15 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 113.308 -3.234 . . . . 50.64 111.62 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.59 156.19 29.26 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 125.904 2.002 . . . . 50.51 111.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -106.16 77.61 1.24 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 115.821 1.785 . . . . 50.64 115.821 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.23 124.6 2.83 Favored Glycine 0 C--O 1.242 0.643 0 CA-C-N 114.646 -1.161 . . . . 50.51 113.593 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 N-CA-C 104.406 -3.478 . . . . 50.51 104.406 179.279 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.528 ' SD ' ' HE2' ' A' ' 63' ' ' LYS . 18.4 mmt . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 112.576 0.584 . . . . 50.51 112.576 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -88.21 150.95 23.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.907 2.629 . . . . 50.55 106.822 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -148.42 145.7 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 104.972 -2.232 . . . . 50.51 104.972 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.66 134.98 54.65 Favored 'General case' 0 N--CA 1.511 2.597 1 O-C-N 130.409 4.818 . . . . 50.51 110.476 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -119.55 128.01 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 113.399 -3.191 . . . . 50.51 116.944 175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -94.14 119.36 32.86 Favored 'General case' 0 N--CA 1.504 2.239 1 O-C-N 129.254 4.097 . . . . 50.51 113.065 -178.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.513 HG23 HD21 ' A' ' 69' ' ' LEU . 69.0 p -95.27 177.59 5.8 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.793 -1.098 . . . . 50.51 109.48 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.6 mt -83.79 -12.85 55.09 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.138 0.899 . . . . 50.51 110.752 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -95.09 -17.46 21.82 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.76 -2.376 . . . . 50.51 113.426 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.16 -23.04 7.38 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 119.034 2.374 . . . . 50.51 119.034 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.66 107.09 0.76 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 117.134 2.272 . . . . 50.51 117.134 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -82.07 128.41 34.08 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.595 2.434 . . . . 50.51 107.848 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.01 144.92 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 127.591 3.057 . . . . 50.51 114.268 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -113.68 123.52 50.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.264 -1.774 . . . . 50.51 112.454 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.0 mt -116.92 145.92 43.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 120.933 3.679 . . . . 50.51 120.933 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.17 114.22 28.31 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 128.413 3.571 . . . . 50.62 112.676 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.51 163.05 35.8 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 O-C-N 127.831 3.207 . . . . 50.51 117.228 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 40.3 mt-10 -99.18 151.24 37.32 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 117.604 2.446 . . . . 50.62 117.604 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.1 Cg_exo -54.9 -24.52 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.586 2.191 . . . . 50.51 111.928 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -93.12 -19.48 21.46 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 116.547 2.054 . . . . 50.51 116.547 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.58 151.23 17.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.404 -1.718 . . . . 50.62 107.183 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.444 ' HG1' ' HB2' ' A' ' 24' ' ' GLU . 33.1 p -87.45 167.67 13.79 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.858 -0.61 . . . . 50.51 109.445 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.413 HD11 ' HH ' ' A' ' 59' ' ' TYR . 23.8 pt -61.58 -34.93 64.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 127.193 2.808 . . . . 50.51 103.875 175.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HB2' ' HG1' ' A' ' 22' ' ' THR . 43.8 mt-10 -56.55 -49.41 74.89 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 114.048 1.129 . . . . 50.62 114.048 176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -55.97 -32.13 63.6 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.307 1.043 . . . . 50.55 111.959 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -41.94 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.975 1.422 . . . . 50.51 111.264 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.25 -40.31 45.25 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 116.391 1.997 . . . . 50.51 116.391 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.32 83.38 Favored 'General case' 0 C--O 1.278 2.576 0 CA-C-N 117.984 0.356 . . . . 50.51 111.524 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -55.15 -55.95 25.4 Favored 'General case' 0 C--O 1.255 1.351 0 N-CA-C 104.776 -2.305 . . . . 50.51 104.776 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -54.77 -36.1 35.64 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.47 -0.892 . . . . 50.51 113.053 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.1 -32.85 16.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 125.625 2.631 . . . . 50.55 113.307 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.72 -44.71 20.27 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 113.592 -1.64 . . . . 50.62 113.123 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -87.72 -29.52 21.02 Favored 'General case' 0 C--O 1.279 2.637 0 N-CA-C 116.89 2.182 . . . . 50.51 116.89 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -115.58 -23.13 8.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 123.07 2.668 . . . . 50.62 109.5 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.21 -34.54 4.64 Favored Glycine 0 CA--C 1.477 -2.342 0 N-CA-C 116.477 1.351 . . . . 50.51 116.477 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.6 mt -40.69 113.7 1.03 Allowed Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 115.063 1.505 . . . . 50.51 115.063 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.182 2.588 . . . . 50.51 110.888 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -57.18 -32.22 92.83 Favored 'Trans proline' 0 C--O 1.262 1.684 0 C-N-CA 120.671 0.914 . . . . 50.51 113.444 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.41 -12.79 15.87 Favored 'General case' 0 C--O 1.262 1.741 0 O-C-N 119.921 -1.737 . . . . 50.62 112.028 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.43 -12.42 17.19 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.515 -1.366 . . . . 50.55 111.808 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -93.11 125.27 37.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.345 2.021 . . . . 50.55 115.244 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -121.15 134.7 55.23 Favored 'General case' 0 C--O 1.295 3.458 0 CA-C-O 116.691 -1.623 . . . . 50.64 108.961 172.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.587 ' HB2' HD23 ' A' ' 50' ' ' LEU . 60.3 mt -119.17 120.33 36.78 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 102.08 -3.304 . . . . 50.51 102.08 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.34 129.47 71.54 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 O-C-N 125.15 1.531 . . . . 50.51 112.727 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.97 121.81 15.48 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 117.973 2.583 . . . . 50.51 117.973 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.38 9.53 6.51 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.206 -2.27 . . . . 50.51 108.435 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.62 37.35 8.09 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.481 2.943 . . . . 50.51 109.469 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' O ' ' C ' ' A' ' 49' ' ' GLN . 36.1 ttpt -126.63 85.39 2.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.098 0.949 . . . . 50.51 112.39 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.511 ' C ' ' O ' ' A' ' 48' ' ' LYS . 6.9 tt0 -36.93 128.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.926 -1.879 . . . . 50.55 105.926 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD23 ' HB2' ' A' ' 43' ' ' LEU . 2.1 mp -60.03 120.78 10.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 117.695 -1.145 . . . . 50.51 111.417 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -88.95 131.87 34.96 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.018 1.449 . . . . 50.62 109.345 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -50.82 -47.1 60.1 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.171 1.788 . . . . 50.62 111.497 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.82 21.44 2.56 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 119.051 2.38 . . . . 50.51 119.051 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -111.26 158.2 19.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.006 -1.879 . . . . 50.64 111.509 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 p -93.88 167.02 11.89 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.105 0.962 . . . . 50.51 110.491 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 56' ' ' LEU . 26.8 mt -56.53 -28.56 60.32 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 116.618 2.081 . . . . 50.51 116.618 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -87.82 -20.87 25.48 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.362 -1.735 . . . . 50.51 112.767 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.99 -36.46 62.95 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.225 -1.768 . . . . 50.62 106.225 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.471 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 77.8 m-85 -81.7 -31.91 31.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.777 -1.106 . . . . 50.51 109.354 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 26.2 m120 76.54 36.74 0.36 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 121.451 1.932 . . . . 50.55 114.554 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.57 108.91 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.981 0 CA-C-O 115.165 -2.35 . . . . 50.51 113.679 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -104.88 -176.31 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.898 -2.63 . . . . 50.55 103.898 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.528 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 35.4 mmtp -67.07 162.4 22.33 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 102.841 -3.022 . . . . 50.51 102.841 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 51.34 44.75 28.72 Favored 'General case' 0 C--O 1.257 1.485 0 CA-C-N 112.443 -2.162 . . . . 50.62 114.696 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 t -109.23 137.78 46.58 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.23 1.196 . . . . 50.51 114.23 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 m -118.46 117.09 28.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 114.463 1.283 . . . . 50.51 114.463 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.34 153.04 20.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 114.738 -2.553 . . . . 50.51 110.766 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -95.57 146.54 24.38 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 127.371 2.919 . . . . 50.51 113.483 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 7' ' ' THR . 29.3 tp -107.42 101.83 11.16 Favored 'General case' 0 C--O 1.283 2.827 0 CA-C-O 117.647 -1.168 . . . . 50.51 110.412 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.51 121.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 119.602 1.092 . . . . 50.51 111.027 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.5 mt -74.33 133.62 42.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.369 2.729 . . . . 50.51 118.369 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -113.59 131.43 56.11 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 113.368 -3.206 . . . . 50.64 105.614 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.94 -178.7 3.74 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.867 1.979 . . . . 50.51 111.226 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -126.04 67.89 1.19 Allowed 'General case' 0 C--O 1.245 0.831 0 N-CA-C 104.342 -2.466 . . . . 50.64 104.342 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.28 146.13 8.82 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 114.63 -1.168 . . . . 50.51 115.838 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.831 -3.307 . . . . 50.51 104.831 179.255 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 116.342 1.978 . . . . 50.51 116.342 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -82.88 149.76 26.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 126.882 2.613 . . . . 50.55 107.781 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 15' ' ' LEU . 18.5 tt -163.46 136.5 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 115.981 -1.961 . . . . 50.51 106.277 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' THR . 42.4 m-85 -104.39 143.52 32.89 Favored 'General case' 0 N--CA 1.512 2.634 1 O-C-N 130.259 4.724 . . . . 50.51 113.453 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 70.0 t -109.65 105.52 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.391 -3.195 . . . . 50.51 107.296 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -99.77 109.72 22.13 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.347 4.154 . . . . 50.51 110.385 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.532 HG21 ' H ' ' A' ' 9' ' ' THR . 9.7 t -89.78 -171.51 3.2 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 115.324 1.602 . . . . 50.51 115.324 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' N ' ' OG1' ' A' ' 7' ' ' THR . 65.6 mt -90.12 6.68 41.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.756 1.021 . . . . 50.51 113.756 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.532 ' H ' HG21 ' A' ' 7' ' ' THR . 55.5 p -104.55 0.53 28.79 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 115.715 -2.394 . . . . 50.51 114.853 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.88 37.04 7.46 Favored Glycine 0 C--N 1.298 -1.558 0 N-CA-C 103.411 -3.875 . . . . 50.51 103.411 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -113.59 159.14 19.93 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 119.455 3.131 . . . . 50.51 119.455 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.2 m -135.27 123.8 23.51 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 120.337 3.458 . . . . 50.51 120.337 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 96.7 mt -108.33 136.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.521 3.013 . . . . 50.51 107.483 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 m -117.16 117.54 29.86 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 117.329 -1.749 . . . . 50.51 112.395 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 3' ' ' ILE . 46.0 tp -128.69 135.49 49.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 120.168 3.395 . . . . 50.51 120.168 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -79.79 139.91 37.07 Favored 'General case' 0 N--CA 1.5 2.046 1 O-C-N 129.176 4.048 . . . . 50.62 114.764 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.76 175.18 6.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 O-C-N 127.758 3.161 . . . . 50.51 114.114 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.7 mt-10 -124.81 142.65 41.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 112.197 -2.274 . . . . 50.62 108.835 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.7 Cg_exo -54.97 -24.54 39.98 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 122.549 2.166 . . . . 50.51 111.943 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -86.35 -0.16 55.3 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.655 1.724 . . . . 50.51 115.655 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -79.13 160.08 27.17 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.421 -1.712 . . . . 50.62 107.471 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.407 ' H ' HD21 ' A' ' 25' ' ' ASN . 52.3 p -107.62 153.68 22.54 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 103.753 -2.684 . . . . 50.51 103.753 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 25.6 mm -56.67 -23.03 16.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 O-C-N 127.011 2.694 . . . . 50.51 116.481 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 23.7 tt0 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 103.248 -2.871 . . . . 50.62 103.248 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.407 HD21 ' H ' ' A' ' 22' ' ' THR . 57.8 m-80 -68.11 -43.17 79.04 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 124.383 1.073 . . . . 50.55 112.305 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.17 -38.57 77.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.046 1.466 . . . . 50.51 113.289 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -74.57 -30.31 61.67 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 106.784 -1.561 . . . . 50.51 106.784 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.13 82.73 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 114.364 1.246 . . . . 50.51 114.364 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.11 -31.99 73.47 Favored 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.373 -1.454 . . . . 50.51 114.549 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.73 -45.08 67.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 119.551 -0.859 . . . . 50.51 113.077 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -52.08 -34.19 42.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.431 3.123 . . . . 50.55 119.431 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.05 -60.57 3.4 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 113.59 -1.641 . . . . 50.62 113.321 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.03 -55.97 4.24 Favored 'General case' 0 C--O 1.28 2.683 0 N-CA-C 119.806 3.262 . . . . 50.51 119.806 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.43 -60.11 4.01 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.143 2.702 . . . . 50.62 104.818 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.56 8.56 3.13 Favored Glycine 0 CA--C 1.478 -2.269 0 CA-C-O 120.033 -0.315 . . . . 50.51 113.398 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 84.8 mt -89.89 125.6 60.23 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 119.843 3.275 . . . . 50.51 119.843 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.0 136.97 79.9 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.111 2.541 . . . . 50.51 110.917 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -57.17 -32.15 92.61 Favored 'Trans proline' 0 C--O 1.261 1.629 0 O-C-N 122.919 0.958 . . . . 50.51 113.442 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -56.72 -17.17 8.01 Favored 'General case' 0 C--O 1.263 1.781 0 O-C-N 120.045 -1.659 . . . . 50.62 114.713 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -91.8 -7.48 49.41 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.471 1.656 . . . . 50.55 115.471 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -90.66 137.56 32.26 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 116.787 2.144 . . . . 50.55 116.787 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -125.1 120.63 31.96 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 104.591 -2.374 . . . . 50.64 104.591 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 35.2 mt -102.89 138.07 40.26 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 103.596 -2.742 . . . . 50.51 103.596 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.31 129.23 36.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 119.972 3.323 . . . . 50.51 119.972 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -137.67 117.99 13.68 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 116.377 1.992 . . . . 50.51 116.377 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.83 16.25 4.58 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 103.752 -2.684 . . . . 50.51 103.752 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.41 44.68 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 128.379 2.895 . . . . 50.51 107.135 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -108.85 114.7 28.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 104.653 -2.351 . . . . 50.51 104.653 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 43' ' ' LEU . 32.2 tt0 -68.98 129.77 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.325 0.861 . . . . 50.55 113.325 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.7 mp -78.2 150.39 33.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 117.726 -1.13 . . . . 50.51 109.67 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 73.7 mt-10 -115.98 158.98 22.25 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.959 1.412 . . . . 50.62 112.276 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -83.37 -9.71 58.88 Favored 'General case' 0 C--O 1.263 1.795 0 N-CA-C 117.204 2.298 . . . . 50.62 117.204 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.87 -2.68 34.35 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 110.178 -1.169 . . . . 50.51 110.178 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -107.5 143.32 36.04 Favored 'General case' 0 C--O 1.248 1.023 0 O-C-N 119.944 -1.915 . . . . 50.64 107.174 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -69.98 140.95 53.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 116.718 2.118 . . . . 50.51 116.718 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.452 HD12 HD13 ' A' ' 61' ' ' ILE . 38.0 tp -48.19 -26.49 1.95 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.108 0.88 . . . . 50.51 112.08 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 p -90.47 -0.53 57.7 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.307 -1.757 . . . . 50.51 114.191 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -97.56 15.01 24.59 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 50.62 107.679 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 92.7 m-85 -113.85 -6.24 13.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 117.812 -1.09 . . . . 50.51 110.264 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 14.5 m120 73.42 18.67 3.6 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 121.457 1.935 . . . . 50.55 107.551 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.452 HD13 HD12 ' A' ' 56' ' ' LEU . 68.5 mt -75.22 108.59 7.19 Favored 'Isoleucine or valine' 0 C--O 1.267 2.007 0 CA-C-O 115.188 -2.339 . . . . 50.51 112.792 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -110.82 -175.68 2.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.117 2.135 . . . . 50.55 112.41 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 80.7 tttt -53.67 141.87 24.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 116.569 2.063 . . . . 50.51 116.569 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.467 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 97.2 mt-10 52.71 42.93 31.82 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-N 112.554 -2.112 . . . . 50.62 114.585 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 152.59 18.98 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.494 2.035 . . . . 50.51 116.494 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 40.4 m -111.83 119.65 39.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 116.502 2.038 . . . . 50.51 116.502 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.88 140.02 32.05 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.723 -2.56 . . . . 50.51 108.086 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -89.96 132.38 35.37 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.199 2.812 . . . . 50.51 113.377 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.435 ' C ' HD21 ' A' ' 69' ' ' LEU . 10.2 tt -103.95 109.22 20.9 Favored 'General case' 0 C--O 1.282 2.768 0 N-CA-C 116.271 1.952 . . . . 50.51 116.271 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -94.1 145.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 119.604 1.093 . . . . 50.51 110.916 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 48.8 tp -99.29 86.78 3.48 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 119.437 3.125 . . . . 50.51 119.437 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 71' ' ' LEU . 59.8 ttt85 -53.36 130.98 36.94 Favored 'General case' 0 C--N 1.281 -2.383 1 O-C-N 110.816 -7.427 . . . . 50.64 113.779 177.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.49 147.44 24.24 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 120.858 1.663 . . . . 50.51 114.259 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -81.37 56.26 2.85 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.665 -1.605 . . . . 50.64 106.665 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.43 -155.71 16.87 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.586 -1.188 . . . . 50.51 113.999 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.682 -3.367 . . . . 50.51 104.682 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.814 -0.612 . . . . 50.51 109.802 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -101.27 131.68 47.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 126.973 2.671 . . . . 50.55 109.517 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 pt -132.19 149.8 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 N-CA-C 103.595 -2.743 . . . . 50.51 103.595 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -110.34 157.93 18.98 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.398 4.811 . . . . 50.51 112.095 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.6 t -141.36 121.02 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 113.383 -3.199 . . . . 50.51 112.24 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -90.59 136.05 33.31 Favored 'General case' 0 N--CA 1.504 2.261 1 O-C-N 129.37 4.169 . . . . 50.51 105.1 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -112.44 142.46 44.95 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 105.03 -2.211 . . . . 50.51 105.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -44.84 -35.97 3.04 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.052 0.845 . . . . 50.51 109.198 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.6 m -52.3 -32.69 38.8 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 118.631 2.826 . . . . 50.51 118.631 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.11 4.79 11.05 Favored Glycine 0 C--N 1.296 -1.671 0 O-C-N 120.142 -1.599 . . . . 50.51 111.756 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -83.89 152.82 24.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.847 -1.549 . . . . 50.51 114.26 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -125.86 112.56 16.13 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.701 2.501 . . . . 50.51 106.849 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 pt -102.3 147.69 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 118.583 2.808 . . . . 50.51 118.583 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -104.32 123.72 47.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 117.263 -1.775 . . . . 50.51 113.436 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.678 HD23 ' CG ' ' A' ' 29' ' ' LYS . 68.5 mt -109.73 132.31 54.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 117.591 2.441 . . . . 50.51 117.591 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.28 110.26 22.41 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 129.244 4.09 . . . . 50.62 109.888 174.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.405 HG22 HD22 ' A' ' 56' ' ' LEU . 35.0 m -130.82 173.59 14.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 O-C-N 127.672 3.107 . . . . 50.51 108.589 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 68.8 mm-40 -116.87 141.95 29.04 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 112.157 -2.292 . . . . 50.62 108.862 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HA ' ' HB3' ' A' ' 56' ' ' LEU . 85.4 Cg_exo -54.88 -24.58 39.54 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.617 2.211 . . . . 50.51 111.964 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -78.23 -23.13 47.54 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.818 -1.549 . . . . 50.51 106.818 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 81.0 m-20 -62.39 139.18 58.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 104.308 -2.478 . . . . 50.62 104.308 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 48.1 p -78.23 165.17 24.22 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.326 -0.99 . . . . 50.51 108.326 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.543 HD13 HD21 ' A' ' 50' ' ' LEU . 24.5 mm -58.81 -35.21 54.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 O-C-N 127.244 2.84 . . . . 50.51 111.816 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.7 -45.34 81.88 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.211 -2.144 . . . . 50.62 105.211 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 85.8 m-20 -56.56 -46.03 80.94 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.365 1.066 . . . . 50.55 112.181 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 56' ' ' LEU . 40.5 t -61.58 -41.38 90.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 125.168 1.543 . . . . 50.51 113.192 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.86 -22.71 60.73 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 106.824 -1.547 . . . . 50.51 106.824 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -68.35 -61.41 1.85 Allowed 'General case' 0 C--O 1.278 2.561 0 N-CA-C 105.049 -2.204 . . . . 50.51 105.049 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.678 ' CG ' HD23 ' A' ' 15' ' ' LEU . 17.0 tppt? -42.5 -41.6 3.03 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 115.679 1.733 . . . . 50.51 115.679 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.513 HG21 HD11 ' A' ' 69' ' ' LEU . 73.4 mt -68.19 -23.86 29.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 C-N-CA 119.493 -0.883 . . . . 50.51 108.68 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -82.25 -55.45 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 125.57 2.605 . . . . 50.55 105.565 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -35.32 -51.37 0.58 Allowed 'General case' 0 C--O 1.252 1.228 0 N-CA-C 118.513 2.782 . . . . 50.62 118.513 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.13 -59.99 1.62 Allowed 'General case' 0 C--O 1.28 2.677 0 C-N-CA 116.459 -2.096 . . . . 50.51 108.82 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -57.99 -43.76 86.75 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 123.158 2.708 . . . . 50.62 116.743 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.16 23.35 7.73 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 108.763 -1.735 . . . . 50.51 108.763 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.3 mt -100.58 117.31 63.06 Favored Pre-proline 0 C--O 1.243 0.73 0 C-N-CA 118.79 -1.164 . . . . 50.51 108.501 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.0 Cg_exo -56.93 136.93 79.52 Favored 'Trans proline' 0 C--O 1.261 1.634 0 C-N-CA 123.185 2.59 . . . . 50.51 110.916 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.19 -32.15 92.66 Favored 'Trans proline' 0 C--O 1.262 1.691 0 C-N-CA 120.682 0.922 . . . . 50.51 113.429 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -62.56 -15.21 49.82 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.948 -1.72 . . . . 50.62 109.985 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -102.92 16.05 27.67 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.532 -1.355 . . . . 50.55 112.104 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -110.85 114.08 27.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 117.295 2.332 . . . . 50.55 117.295 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -111.39 108.49 18.09 Favored 'General case' 0 C--O 1.296 3.523 0 N-CA-C 105.502 -2.036 . . . . 50.64 105.502 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.458 ' CD2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mt -101.99 132.76 47.63 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.501 1.046 . . . . 50.51 110.488 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.63 136.77 50.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 O-C-N 125.227 1.58 . . . . 50.51 115.167 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -133.75 112.06 11.06 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.543 -1.208 . . . . 50.51 110.483 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.45 49.7 6.2 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.268 -2.242 . . . . 50.51 113.311 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.47 1.71 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 120.894 3.118 . . . . 50.51 120.894 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -71.7 166.19 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 116.334 1.975 . . . . 50.51 116.334 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -102.26 140.86 35.98 Favored 'General case' 0 C--O 1.259 1.592 0 O-C-N 124.008 0.818 . . . . 50.55 112.008 174.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.543 HD21 HD13 ' A' ' 23' ' ' ILE . 2.1 mp -78.14 143.17 37.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.285 -1.746 . . . . 50.51 106.285 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -120.21 135.15 55.08 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.883 1.364 . . . . 50.62 109.464 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.56 -33.41 1.14 Allowed 'General case' 0 C--O 1.262 1.748 0 C-N-CA 126.165 1.786 . . . . 50.62 114.951 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.73 63.5 Favored Glycine 0 C--O 1.254 1.345 0 C-N-CA 124.339 0.971 . . . . 50.51 113.5 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -111.73 155.12 23.99 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 101.889 -3.374 . . . . 50.64 101.889 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -99.72 174.12 6.38 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.048 0.939 . . . . 50.51 111.483 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -67.54 -38.54 84.33 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 106.349 -1.723 . . . . 50.51 106.349 177.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -67.94 -22.61 65.04 Favored 'General case' 0 C--O 1.268 2.029 0 N-CA-C 117.75 2.5 . . . . 50.51 117.75 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -64.45 -40.17 95.22 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.664 2.098 . . . . 50.62 116.664 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -83.26 5.02 24.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 115.986 1.847 . . . . 50.51 115.986 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 59.08 38.44 23.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.493 1.951 . . . . 50.55 107.054 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -73.48 117.79 17.81 Favored 'Isoleucine or valine' 0 C--O 1.267 2.012 0 CA-C-O 115.223 -2.322 . . . . 50.51 108.388 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -94.15 -175.82 3.8 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.707 2.114 . . . . 50.55 116.707 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.03 142.72 49.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 123.144 1.449 . . . . 50.51 107.314 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 46.4 26.19 0.46 Allowed 'General case' 0 C--O 1.257 1.496 0 N-CA-C 117.592 2.441 . . . . 50.62 117.592 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -72.53 153.18 41.45 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.512 -1.662 . . . . 50.51 106.512 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.43 ' O ' HD21 ' A' ' 67' ' ' LEU . 40.6 m -108.16 146.09 33.22 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.225 -0.893 . . . . 50.51 111.084 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD21 ' O ' ' A' ' 66' ' ' THR . 26.8 mt -116.96 156.78 26.86 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 114.688 -2.577 . . . . 50.51 109.959 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -93.61 141.66 28.22 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 127.246 2.841 . . . . 50.51 106.202 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 30' ' ' ILE . 5.3 tt -119.79 109.88 16.12 Favored 'General case' 0 C--O 1.282 2.8 0 N-CA-C 106.356 -1.72 . . . . 50.51 106.356 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -98.35 145.1 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.391 -2.078 . . . . 50.51 105.391 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.99 132.5 43.5 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.964 -0.754 . . . . 50.51 108.964 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -97.44 126.18 42.54 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-O 113.322 -3.228 . . . . 50.64 107.33 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.89 152.09 23.81 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.901 2.001 . . . . 50.51 111.862 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -83.15 55.42 3.12 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 113.726 -1.579 . . . . 50.64 108.051 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.15 156.33 18.08 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 109.56 -1.416 . . . . 50.51 109.56 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 1 N-CA-C 102.519 -4.233 . . . . 50.51 102.519 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 107.894 -1.151 . . . . 50.51 107.894 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -101.03 133.44 45.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.911 2.632 . . . . 50.55 110.278 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.35 159.89 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 117.083 -3.51 . . . . 50.51 107.703 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -114.67 137.31 52.06 Favored 'General case' 0 N--CA 1.512 2.648 1 O-C-N 130.429 4.831 . . . . 50.51 107.911 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 87.6 t -110.54 121.34 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 113.431 -3.176 . . . . 50.51 104.019 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -107.08 131.81 53.68 Favored 'General case' 0 N--CA 1.503 2.195 1 O-C-N 129.295 4.122 . . . . 50.51 113.336 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -91.38 -177.33 4.81 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.87 2.544 . . . . 50.51 117.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.26 -5.59 23.93 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.164 0.915 . . . . 50.51 109.792 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.7 p -114.69 9.01 16.36 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.726 2.862 . . . . 50.51 118.726 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.32 62.29 Favored Glycine 0 C--N 1.298 -1.565 0 O-C-N 120.072 -1.642 . . . . 50.51 115.164 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -65.23 140.22 58.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 116.888 -1.53 . . . . 50.51 113.033 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -131.53 164.46 25.76 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 126.613 2.446 . . . . 50.51 108.573 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.35 170.64 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 127.551 3.032 . . . . 50.51 110.215 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -111.41 128.33 55.95 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.266 -1.773 . . . . 50.51 110.41 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -126.53 135.71 51.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 115.488 -2.196 . . . . 50.51 116.567 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.27 100.41 7.16 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 128.315 3.509 . . . . 50.62 112.505 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -103.18 172.99 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.209 0 O-C-N 127.762 3.164 . . . . 50.51 116.324 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 94.1 mt-10 -110.65 153.45 43.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 112.157 -2.292 . . . . 50.62 112.521 174.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.2 Cg_exo -54.89 -24.57 39.5 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.603 2.202 . . . . 50.51 111.909 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 m -82.92 -26.52 31.38 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 114.954 1.465 . . . . 50.51 114.954 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -53.34 138.95 31.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 117.398 -1.721 . . . . 50.62 114.311 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -95.1 172.46 8.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 102.156 -3.276 . . . . 50.51 102.156 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 54' ' ' ARG . 23.2 mm -53.89 -45.49 63.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 O-C-N 127.095 2.747 . . . . 50.51 110.439 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -54.11 -46.83 72.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.723 1.379 . . . . 50.62 114.723 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -57.54 -39.64 77.08 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.265 1.026 . . . . 50.55 111.757 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 -50.11 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 125.045 1.466 . . . . 50.51 111.73 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HE3' ' CG2' ' A' ' 23' ' ' ILE . 94.5 mttt -56.87 -29.93 63.38 Favored 'General case' 0 C--O 1.257 1.485 0 N-CA-C 104.583 -2.377 . . . . 50.51 104.583 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.06 -27.61 48.69 Favored 'General case' 0 C--O 1.278 2.599 0 CA-C-N 118.031 0.378 . . . . 50.51 111.567 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -71.76 -36.32 70.36 Favored 'General case' 0 C--O 1.255 1.342 0 N-CA-C 106.606 -1.627 . . . . 50.51 106.606 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.43 -34.55 65.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 106.863 -1.532 . . . . 50.51 106.863 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -51.49 -59.51 4.17 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.567 2.603 . . . . 50.55 112.225 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -51.76 -40.83 60.98 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 115.817 1.784 . . . . 50.62 115.817 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 31.1 mmmt -76.65 -32.5 58.01 Favored 'General case' 0 C--O 1.279 2.647 0 C-N-CA 116.464 -2.095 . . . . 50.51 113.853 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -119.33 -39.47 2.89 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.018 2.644 . . . . 50.62 115.061 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.32 8.77 8.32 Favored Glycine 0 CA--C 1.478 -2.271 0 CA-C-O 119.947 -0.363 . . . . 50.51 112.46 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.513 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 93.5 mt -84.62 128.21 62.24 Favored Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 116.76 2.134 . . . . 50.51 116.76 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.94 136.99 79.85 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.116 2.544 . . . . 50.51 110.92 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -57.2 -32.13 92.64 Favored 'Trans proline' 0 C--O 1.261 1.649 0 O-C-N 122.91 0.952 . . . . 50.51 113.405 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -75.29 -15.78 60.48 Favored 'General case' 0 C--O 1.262 1.745 0 O-C-N 119.915 -1.74 . . . . 50.62 112.375 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -97.34 9.0 43.46 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.568 -1.332 . . . . 50.55 110.692 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.97 132.98 53.57 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 103.437 -2.801 . . . . 50.55 103.437 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -119.48 108.52 14.63 Favored 'General case' 0 C--O 1.297 3.562 0 N-CA-C 105.462 -2.051 . . . . 50.64 105.462 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.78 121.97 44.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.49 1.041 . . . . 50.51 113.414 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 120.456 3.502 . . . . 50.51 120.456 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.427 ' HB3' HD22 ' A' ' 50' ' ' LEU . 17.8 t80 -110.18 130.17 55.59 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 114.811 1.411 . . . . 50.51 114.811 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.21 32.11 15.39 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.192 -2.276 . . . . 50.51 111.994 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.67 2.7 85.97 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 128.4 2.905 . . . . 50.51 113.269 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -94.51 115.77 27.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 116.32 1.97 . . . . 50.51 116.32 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -50.53 120.24 4.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.94 0.775 . . . . 50.55 111.744 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 45' ' ' PHE . 56.1 mt -83.51 127.55 33.81 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.7 -1.143 . . . . 50.51 111.984 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 88.7 tt0 -77.0 145.23 38.17 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 119.173 3.027 . . . . 50.62 119.173 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -38.6 -48.08 1.4 Allowed 'General case' 0 C--O 1.264 1.833 0 N-CA-C 118.526 2.788 . . . . 50.62 118.526 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 23.01 32.27 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 116.384 1.314 . . . . 50.51 116.384 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' O ' HG12 ' A' ' 23' ' ' ILE . 37.1 mmt180 -93.34 155.53 17.34 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 119.892 -1.946 . . . . 50.64 111.151 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -108.53 176.93 4.94 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.979 0.912 . . . . 50.51 109.466 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.413 ' HG ' ' HB ' ' A' ' 61' ' ' ILE . 7.2 mp -59.1 -32.69 70.04 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 119.177 3.028 . . . . 50.51 119.177 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -81.11 -23.34 38.45 Favored 'General case' 0 C--O 1.267 2.024 0 C-N-CA 117.325 -1.75 . . . . 50.51 112.258 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -53.54 -30.9 44.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.918 -2.253 . . . . 50.62 104.918 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.25 6.92 19.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 116.468 2.025 . . . . 50.51 116.468 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.37 32.49 20.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-N 121.461 1.937 . . . . 50.55 111.036 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' CD2' ' A' ' 45' ' ' PHE . 93.2 mt -73.53 104.86 2.59 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.188 -2.339 . . . . 50.51 109.353 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -97.23 -165.86 1.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 126.137 2.148 . . . . 50.55 115.028 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -70.16 142.76 52.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.159 1.457 . . . . 50.51 110.688 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 58.73 36.29 24.79 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.471 -2.15 . . . . 50.62 110.721 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -78.02 152.5 33.01 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.802 -1.09 . . . . 50.51 110.915 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.443 ' O ' HD21 ' A' ' 67' ' ' LEU . 60.4 p -103.64 140.13 37.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 118.216 -0.897 . . . . 50.51 110.182 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 59.5 mt -123.95 134.82 53.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 101.65 -3.463 . . . . 50.51 101.65 175.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -95.45 136.93 35.2 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 127.375 2.922 . . . . 50.51 108.264 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 tp -105.56 136.02 45.89 Favored 'General case' 0 C--O 1.282 2.802 0 CA-C-O 117.641 -1.171 . . . . 50.51 113.203 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -116.02 126.06 73.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 105.847 -1.909 . . . . 50.51 105.847 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -79.04 105.55 10.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.782 2.512 . . . . 50.51 117.782 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -92.96 102.21 14.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.279 -3.248 . . . . 50.64 114.666 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.64 177.58 7.01 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 125.715 1.884 . . . . 50.51 110.047 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -100.7 97.65 8.28 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 115.972 1.842 . . . . 50.64 115.972 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.46 158.67 6.18 Favored Glycine 0 C--O 1.243 0.668 0 CA-C-N 114.619 -1.173 . . . . 50.51 110.562 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 1 N-CA-C 102.073 -4.411 . . . . 50.51 102.073 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 106.871 -1.529 . . . . 50.51 106.871 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -117.73 119.43 34.92 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.923 2.64 . . . . 50.55 104.846 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 tt -121.73 149.4 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 115.952 -1.975 . . . . 50.51 110.13 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.84 123.88 50.88 Favored 'General case' 0 N--CA 1.511 2.599 1 O-C-N 130.372 4.795 . . . . 50.51 114.524 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.34 104.86 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.42 -3.181 . . . . 50.51 109.571 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -85.02 121.2 27.45 Favored 'General case' 0 N--CA 1.504 2.237 1 O-C-N 129.394 4.184 . . . . 50.51 109.412 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.412 HG23 HD21 ' A' ' 69' ' ' LEU . 69.7 p -85.95 -177.05 6.22 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 116.322 1.971 . . . . 50.51 116.322 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.511 HD11 HG13 ' A' ' 70' ' ' VAL . 67.5 mt -82.01 -6.08 58.86 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.788 1.773 . . . . 50.51 115.788 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -90.07 -8.04 52.41 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 115.715 -2.394 . . . . 50.51 106.592 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 15.79 37.73 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 107.727 -2.149 . . . . 50.51 107.727 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.52 111.02 21.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 116.549 2.055 . . . . 50.51 116.549 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.9 m -87.37 125.44 34.26 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 126.65 2.469 . . . . 50.51 113.203 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -111.9 174.08 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 127.53 3.019 . . . . 50.51 113.725 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 m -124.37 140.97 52.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.011 -2.218 . . . . 50.51 105.011 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.7 mt -130.66 141.7 50.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 115.487 -2.197 . . . . 50.51 108.05 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.87 100.25 9.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 129.009 3.943 . . . . 50.62 109.281 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -100.27 171.12 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.253 0 O-C-N 127.796 3.185 . . . . 50.51 107.938 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -124.28 160.51 52.32 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 112.24 -2.254 . . . . 50.62 116.147 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.01 -24.45 39.92 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 122.586 2.191 . . . . 50.51 111.966 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -99.82 -28.82 12.95 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 116.031 1.863 . . . . 50.51 116.031 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -38.82 136.88 0.7 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.331 -1.748 . . . . 50.62 114.825 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' ASN . 70.7 p -88.7 138.17 31.66 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 103.109 -2.922 . . . . 50.51 103.109 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 52' ' ' ASP . 7.4 tp -47.52 -19.19 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.729 0 O-C-N 127.183 2.802 . . . . 50.51 114.02 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.57 -44.31 62.25 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 102.991 -2.966 . . . . 50.62 102.991 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' THR . 9.3 t-20 -70.78 -17.28 62.79 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 114.957 1.465 . . . . 50.55 114.957 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.12 -45.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.999 -1.482 . . . . 50.51 106.999 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 97.2 mttt -64.26 -42.87 96.28 Favored 'General case' 0 C--O 1.256 1.433 0 N-CA-C 108.04 -1.096 . . . . 50.51 108.04 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -59.14 -25.19 63.66 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 112.511 0.559 . . . . 50.51 112.511 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 58.2 mttm -64.75 -30.78 71.8 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 106.327 -1.731 . . . . 50.51 106.327 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 30' ' ' ILE . 95.7 mt -82.66 2.86 2.93 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 N-CA-C 105.535 -2.024 . . . . 50.51 105.535 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 50.7 tt0 -87.12 -57.43 2.97 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.592 2.615 . . . . 50.55 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -69.05 -36.23 77.45 Favored 'General case' 0 C--O 1.253 1.264 0 CA-C-N 113.616 -1.629 . . . . 50.62 113.278 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.2 -32.71 24.41 Favored 'General case' 0 C--O 1.279 2.623 0 C-N-CA 116.427 -2.109 . . . . 50.51 112.667 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -108.99 -17.04 14.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 119.315 3.08 . . . . 50.62 119.315 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.82 37.54 10.23 Favored Glycine 0 CA--C 1.479 -2.199 0 N-CA-C 107.607 -2.197 . . . . 50.51 107.607 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.5 mt -121.4 117.74 30.21 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 106.939 -1.504 . . . . 50.51 106.939 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -56.97 136.89 79.36 Favored 'Trans proline' 0 C--O 1.259 1.562 0 C-N-CA 123.185 2.59 . . . . 50.51 110.924 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -57.11 -32.15 92.48 Favored 'Trans proline' 0 C--O 1.261 1.667 0 O-C-N 122.948 0.973 . . . . 50.51 113.471 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.96 -2.02 8.8 Favored 'General case' 0 C--O 1.262 1.731 0 O-C-N 119.976 -1.703 . . . . 50.62 111.592 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -114.77 15.58 17.48 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.617 -1.302 . . . . 50.55 114.13 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -115.76 122.26 44.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.366 2.031 . . . . 50.55 111.203 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -115.83 121.56 42.77 Favored 'General case' 0 C--O 1.296 3.507 0 CA-C-O 116.657 -1.639 . . . . 50.64 111.265 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 76.6 mt -104.59 139.93 38.74 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 119.397 0.999 . . . . 50.51 108.897 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.36 134.13 64.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 O-C-N 125.129 1.518 . . . . 50.51 108.377 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 50.5 t80 -160.17 113.15 2.1 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.561 -1.199 . . . . 50.51 110.926 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 45' ' ' PHE . . . 78.39 28.62 0.46 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.259 -2.246 . . . . 50.51 116.087 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.14 -8.95 35.36 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 128.44 2.924 . . . . 50.51 117.04 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -101.48 138.33 38.63 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 114.211 1.189 . . . . 50.51 114.211 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.06 121.01 15.23 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.994 0.809 . . . . 50.55 110.234 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.649 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 11.1 mp -78.58 150.26 32.8 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.096 -2.187 . . . . 50.51 105.096 -175.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -110.19 143.72 39.89 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.939 1.4 . . . . 50.62 113.769 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' CG2' ' A' ' 23' ' ' ILE . 34.9 m-20 -38.33 -46.22 1.08 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 120.332 3.456 . . . . 50.62 120.332 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.71 -3.68 73.76 Favored Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 121.177 3.231 . . . . 50.51 121.177 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -83.72 159.13 21.55 Favored 'General case' 0 C--O 1.249 1.046 0 O-C-N 117.464 -3.374 . . . . 50.64 115.453 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.3 p -99.99 172.18 7.37 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.018 0.927 . . . . 50.51 109.143 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -70.54 -23.78 62.68 Favored 'General case' 0 C--O 1.201 -1.46 0 O-C-N 124.164 0.915 . . . . 50.51 109.268 177.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.8 p -77.52 -30.44 52.88 Favored 'General case' 0 C--O 1.269 2.102 0 C-N-CA 117.338 -1.745 . . . . 50.51 111.28 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.17 -42.87 70.13 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.423 1.106 . . . . 50.62 111.21 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.649 ' CZ ' ' HG ' ' A' ' 50' ' ' LEU . 92.9 m-85 -93.48 17.75 11.0 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.773 -1.108 . . . . 50.51 113.765 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.68 40.34 31.83 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 121.516 1.962 . . . . 50.55 116.273 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.57 112.95 2.45 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-O 115.183 -2.341 . . . . 50.51 116.634 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -118.16 174.24 6.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 126.141 2.15 . . . . 50.55 112.497 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.558 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 79.4 tttt -57.61 138.6 55.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 123.193 1.473 . . . . 50.51 111.378 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.558 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 29.5 mt-10 65.31 43.27 3.58 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.458 -2.155 . . . . 50.62 115.755 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -82.91 137.9 34.06 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.664 -1.606 . . . . 50.51 106.664 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -113.59 123.22 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.253 -1.017 . . . . 50.51 108.253 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -117.84 153.52 33.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 114.663 -2.589 . . . . 50.51 107.188 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -109.35 133.07 53.51 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 127.451 2.97 . . . . 50.51 103.358 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.412 HD21 HG23 ' A' ' 7' ' ' THR . 44.4 tp -101.52 107.14 18.34 Favored 'General case' 0 C--O 1.282 2.806 0 N-CA-C 118.914 2.931 . . . . 50.51 118.914 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.511 HG13 HD11 ' A' ' 8' ' ' LEU . 61.9 t -92.03 117.16 34.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 119.564 1.075 . . . . 50.51 112.995 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.99 159.81 33.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.146 0.498 . . . . 50.51 110.435 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -119.52 109.87 16.22 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 113.298 -3.239 . . . . 50.64 103.744 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 2.0 mp -86.08 140.82 29.9 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 125.826 1.953 . . . . 50.51 116.206 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -68.85 122.31 18.34 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.01 -1.848 . . . . 50.64 106.01 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.01 -176.82 52.0 Favored Glycine 0 C--O 1.243 0.695 0 CA-C-N 114.63 -1.168 . . . . 50.51 115.431 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.445 0 N-CA-C 119.479 2.552 . . . . 50.51 119.479 179.25 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.51 109.784 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.55 110.888 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.51 104.776 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.51 116.515 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.51 113.74 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.51 108.059 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.51 111.299 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.51 113.264 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.51 109.711 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.51 118.139 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.51 115.485 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.51 112.444 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.51 104.287 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.51 112.3 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.51 121.099 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.62 110.491 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.51 108.724 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.62 111.398 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.51 111.977 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.51 114.356 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.62 114.483 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.51 107.854 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.51 119.713 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.62 107.589 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.55 116.179 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.51 107.144 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.51 106.178 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.51 113.884 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.51 110.545 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.426 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.51 115.565 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.55 108.505 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.62 115.994 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.51 109.748 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.62 110.609 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.51 106.674 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.51 113.426 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.51 110.966 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.51 113.447 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.62 115.85 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.55 110.579 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.55 112.07 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.64 108.703 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.543 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.51 118.456 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.51 111.752 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.51 118.653 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.51 114.688 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.51 116.218 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.51 102.92 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.55 109.69 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.51 113.209 -175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.62 106.192 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.62 118.695 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.51 114.117 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.64 110.918 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.51 113.601 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.51 119.947 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.51 115.529 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.62 114.759 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.51 110.366 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.55 113.715 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.51 106.035 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.55 104.072 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.51 118.355 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.62 118.736 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.51 106.228 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.51 112.755 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.51 109.784 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.51 108.847 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.51 104.275 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.51 102.101 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.51 111.016 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.64 109.31 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.51 112.756 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.64 102.16 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.51 109.351 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.51 108.526 179.194 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.51 109.784 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.55 110.888 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.51 104.776 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.51 116.515 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.51 113.74 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.51 108.059 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.51 111.299 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.51 113.264 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.51 109.711 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.51 118.139 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.51 115.485 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.51 112.444 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.51 104.287 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.51 112.3 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.51 121.099 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.62 110.491 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.51 108.724 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.62 111.398 174.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.51 111.977 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.51 114.356 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.62 114.483 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.51 107.854 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.51 119.713 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.62 107.589 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.55 116.179 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.51 107.144 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.51 106.178 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.51 113.884 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.51 110.545 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.426 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.51 115.565 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.55 108.505 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.62 115.994 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.51 109.748 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.62 110.609 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.51 106.674 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.51 113.426 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.51 110.966 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.51 113.447 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.62 115.85 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.55 110.579 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.55 112.07 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.64 108.703 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.543 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.51 118.456 -177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.51 111.752 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.51 118.653 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.51 114.688 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.51 116.218 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.51 102.92 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.55 109.69 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.51 113.209 -175.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.62 106.192 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.62 118.695 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.51 114.117 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.64 110.918 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.51 113.601 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.51 119.947 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.51 115.529 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.62 114.759 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.51 110.366 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.55 113.715 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.51 106.035 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.55 104.072 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.51 118.355 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.62 118.736 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.51 106.228 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.51 112.755 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.51 109.784 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.51 108.847 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.51 104.275 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.51 102.101 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.51 111.016 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.64 109.31 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.51 112.756 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.64 102.16 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.51 109.351 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.51 108.526 179.194 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.51 106.676 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.55 106.021 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.51 104.709 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HB2' HG23 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.51 113.954 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG22 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.51 102.923 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.51 112.316 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.51 106.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.51 115.548 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.51 108.113 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.51 106.107 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.51 120.071 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.51 110.493 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.51 109.559 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.51 114.838 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG22 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.51 106.275 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.62 113.422 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.51 109.333 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.62 106.827 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.51 111.928 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.51 121.083 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.62 111.205 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.51 110.198 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.51 109.42 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.62 111.997 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.55 112.41 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.51 109.295 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.51 112.034 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.51 108.289 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.51 110.474 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.51 112.329 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.55 110.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.62 107.396 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.51 117.751 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.62 110.115 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.51 107.221 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.51 111.423 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.51 110.839 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.51 113.43 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.62 110.786 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.55 113.905 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.55 108.396 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.64 106.438 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.51 111.107 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.51 108.499 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.51 110.923 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.51 110.976 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.51 110.394 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.51 113.046 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.55 105.007 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.51 110.654 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.62 113.026 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.62 118.034 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.51 115.926 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.64 104.585 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.51 116.28 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.51 114.766 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.51 108.201 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.62 110.796 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.535 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.51 109.666 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.55 108.723 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.51 106.728 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.55 120.811 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.51 108.884 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.62 119.75 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.51 111.035 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.51 110.83 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.51 107.516 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.51 114.067 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.51 113.384 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.51 112.182 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.51 107.317 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.64 106.699 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.51 116.896 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.64 110.974 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.51 113.009 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.51 117.514 179.235 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.51 106.676 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.55 106.021 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.51 104.709 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HB2' HG23 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.51 113.954 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG22 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.51 102.923 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.51 112.316 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.51 106.004 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.51 115.548 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.51 108.113 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.51 106.107 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.51 120.071 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.51 110.493 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.51 109.559 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.51 114.838 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG22 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.51 106.275 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.62 113.422 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.51 109.333 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.62 106.827 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.51 111.928 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.51 121.083 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.62 111.205 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.51 110.198 175.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.51 109.42 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.62 111.997 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.55 112.41 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.51 109.295 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.51 112.034 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.51 108.289 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.51 110.474 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.51 112.329 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.55 110.082 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.62 107.396 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.51 117.751 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.62 110.115 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.51 107.221 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.51 111.423 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.51 110.839 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.51 113.43 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.62 110.786 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.55 113.905 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.55 108.396 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.64 106.438 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.51 111.107 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.51 108.499 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.51 110.923 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.51 110.976 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.51 110.394 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.51 113.046 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.55 105.007 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.51 110.654 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.62 113.026 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.62 118.034 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.51 115.926 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.64 104.585 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.51 116.28 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.51 114.766 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.51 108.201 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.62 110.796 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.535 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.51 109.666 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.55 108.723 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.51 106.728 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.55 120.811 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.51 108.884 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.62 119.75 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.51 111.035 174.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.51 110.83 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.51 107.516 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.51 114.067 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.51 113.384 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.51 112.182 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.51 107.317 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.64 106.699 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.51 116.896 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.64 110.974 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.51 113.009 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.51 117.514 179.235 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.868 0 N-CA-C 104.835 -2.283 . . . . 50.51 104.835 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -88.49 154.45 20.35 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 102.339 -3.208 . . . . 50.55 102.339 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 3' ' ' ILE . 19.7 tt -150.21 128.91 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 115.963 -1.97 . . . . 50.51 108.004 173.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' THR . 82.5 m-85 -92.92 141.96 27.84 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.328 4.767 . . . . 50.51 112.03 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.79 99.23 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 113.439 -3.172 . . . . 50.51 111.052 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -68.65 136.07 52.38 Favored 'General case' 0 N--CA 1.504 2.235 1 O-C-N 129.254 4.096 . . . . 50.51 114.159 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 11' ' ' LYS . 24.6 p -112.87 149.23 33.43 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 104.91 -2.256 . . . . 50.51 104.91 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.44 -6.85 0.5 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.799 2.888 . . . . 50.51 118.799 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -115.91 19.46 15.1 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 120.312 3.449 . . . . 50.51 120.312 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.26 -13.69 66.4 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 117.483 1.753 . . . . 50.51 117.483 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 98.8 mttt -60.41 155.41 18.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 116.871 -1.538 . . . . 50.51 111.77 174.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -148.98 149.77 31.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 126.656 2.472 . . . . 50.51 109.639 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -143.62 146.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.497 2.998 . . . . 50.51 110.559 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.456 ' O ' HD21 ' A' ' 15' ' ' LEU . 20.9 p -102.87 130.4 49.89 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.315 -1.754 . . . . 50.51 112.746 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.456 HD21 ' O ' ' A' ' 14' ' ' THR . 48.0 mt -124.95 149.79 47.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 115.37 -2.253 . . . . 50.51 113.511 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -107.4 142.43 37.23 Favored 'General case' 0 N--CA 1.5 2.025 1 O-C-N 129.114 4.009 . . . . 50.62 104.294 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -144.08 167.18 12.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 O-C-N 126.091 2.119 . . . . 50.51 105.692 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 68.9 mm-40 -122.0 157.66 57.15 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 112.209 -2.269 . . . . 50.62 112.202 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.2 Cg_exo -54.96 -24.47 39.58 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 122.662 2.241 . . . . 50.51 111.904 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -96.78 -8.78 30.31 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 118.158 -0.925 . . . . 50.51 112.674 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 30.4 m-20 -66.3 124.44 22.71 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.308 -1.757 . . . . 50.62 106.485 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.483 HG23 HG23 ' A' ' 55' ' ' THR . 33.3 p -79.09 155.79 28.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.808 -0.633 . . . . 50.51 112.51 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.569 HD11 ' HB3' ' A' ' 50' ' ' LEU . 76.6 mt -52.18 -45.87 43.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 O-C-N 127.176 2.798 . . . . 50.51 108.374 175.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.05 -51.01 18.58 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.45 -0.781 . . . . 50.62 110.645 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -65.19 -43.05 92.87 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 118.735 2.865 . . . . 50.55 118.735 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.22 -42.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.123 -1.399 . . . . 50.51 110.285 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.26 -38.25 90.38 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 108.12 -1.066 . . . . 50.51 108.12 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.7 -40.02 63.94 Favored 'General case' 0 C--O 1.277 2.543 0 N-CA-C 114.709 1.374 . . . . 50.51 114.709 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -58.05 -29.19 65.17 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 120.398 -1.439 . . . . 50.51 112.966 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.416 HG12 HD11 ' A' ' 15' ' ' LEU . 74.6 mt -77.58 -29.86 16.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 N-CA-C 106.695 -1.595 . . . . 50.51 106.695 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -58.08 -41.71 84.0 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 125.614 2.626 . . . . 50.55 108.18 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -73.48 10.92 0.89 Allowed 'General case' 0 C--O 1.253 1.289 0 CA-C-N 113.6 -1.636 . . . . 50.62 113.765 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -139.26 -30.1 0.74 Allowed 'General case' 0 C--O 1.279 2.647 0 N-CA-C 104.592 -2.373 . . . . 50.51 104.592 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -110.18 -61.57 1.64 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 123.081 2.673 . . . . 50.62 109.578 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.51 20.29 0.9 Allowed Glycine 0 CA--C 1.477 -2.327 0 N-CA-C 108.891 -1.683 . . . . 50.51 108.891 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.2 mt -103.03 122.26 46.14 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 116.526 2.047 . . . . 50.51 116.526 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.0 Cg_exo -57.01 136.91 79.55 Favored 'Trans proline' 0 C--O 1.259 1.545 0 C-N-CA 123.104 2.536 . . . . 50.51 110.937 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -57.18 -32.12 92.55 Favored 'Trans proline' 0 C--O 1.262 1.685 0 O-C-N 122.912 0.953 . . . . 50.51 113.388 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -59.91 -27.91 67.14 Favored 'General case' 0 C--O 1.261 1.702 0 O-C-N 119.897 -1.752 . . . . 50.62 114.427 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -87.97 -15.63 35.97 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.593 -1.317 . . . . 50.55 113.857 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -87.3 117.7 26.25 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 118.3 2.704 . . . . 50.55 118.3 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.32 131.99 53.62 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 105.937 -1.875 . . . . 50.64 105.937 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 mt -107.67 133.38 52.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 101.965 -3.346 . . . . 50.51 101.965 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 70' ' ' VAL . 3.3 mp -124.31 135.87 62.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 O-C-N 125.201 1.563 . . . . 50.51 114.334 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -140.14 113.03 8.14 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 105.719 -1.956 . . . . 50.51 105.719 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.93 41.42 31.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.26 -2.245 . . . . 50.51 108.716 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.66 3.54 59.15 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 128.432 2.92 . . . . 50.51 116.134 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.1 125.5 29.45 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.714 1.376 . . . . 50.51 114.714 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -75.24 127.91 34.24 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 107.68 -1.23 . . . . 50.55 107.68 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.569 ' HB3' HD11 ' A' ' 23' ' ' ILE . 2.9 mp -95.51 124.59 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 117.72 -1.133 . . . . 50.51 112.665 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -104.37 135.97 44.83 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.368 1.988 . . . . 50.62 116.368 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -42.62 -36.23 1.33 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 121.197 3.777 . . . . 50.62 121.197 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.56 -33.61 87.7 Favored Glycine 0 CA--C 1.493 -1.294 0 C-N-CA 124.438 1.018 . . . . 50.51 113.72 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -88.69 136.45 32.99 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 119.766 -2.02 . . . . 50.64 112.614 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.483 HG23 HG23 ' A' ' 22' ' ' THR . 57.0 p -77.68 171.54 14.79 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.015 0.926 . . . . 50.51 111.465 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.69 -39.24 83.87 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 117.381 2.363 . . . . 50.51 117.381 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -64.41 -37.67 88.33 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.332 -1.747 . . . . 50.51 110.815 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -50.01 -43.57 50.68 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 116.888 2.181 . . . . 50.62 116.888 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 63.4 m-85 -74.57 -6.85 50.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 117.815 -1.088 . . . . 50.51 110.416 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 71.52 40.67 0.79 Allowed 'General case' 0 C--O 1.247 0.957 0 CA-C-N 121.429 1.922 . . . . 50.55 115.239 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.439 HG23 ' HG ' ' A' ' 65' ' ' SER . 20.7 mm -71.03 110.41 3.96 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.182 -2.342 . . . . 50.51 110.428 175.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 174.35 7.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.056 2.097 . . . . 50.55 114.79 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 26.7 ttpp -61.35 114.27 3.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 123.159 1.457 . . . . 50.51 112.848 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.554 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 45.6 mm-40 80.31 44.18 0.04 OUTLIER 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.575 -2.102 . . . . 50.62 111.989 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.439 ' HG ' HG23 ' A' ' 61' ' ' ILE . 35.2 t -82.64 140.71 33.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.785 -1.098 . . . . 50.51 108.832 174.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 45.7 m -109.28 146.65 33.94 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 102.454 -3.165 . . . . 50.51 102.454 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.2 147.28 41.59 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.739 -2.553 . . . . 50.51 109.193 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -88.89 137.98 31.83 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 127.149 2.78 . . . . 50.51 111.373 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.5 109.17 18.59 Favored 'General case' 0 C--O 1.283 2.86 0 CA-C-O 117.662 -1.161 . . . . 50.51 113.737 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.419 HG21 HD11 ' A' ' 44' ' ' ILE . 45.6 t -111.69 128.48 68.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 119.614 1.097 . . . . 50.51 108.452 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.07 139.05 32.73 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 116.296 1.962 . . . . 50.51 116.296 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -98.08 116.7 30.84 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.337 -3.22 . . . . 50.64 108.684 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mp -85.76 138.4 32.12 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.795 1.934 . . . . 50.51 106.421 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -99.56 73.93 1.86 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.763 -1.562 . . . . 50.64 109.118 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.55 145.04 6.7 Favored Glycine 0 C--O 1.244 0.735 0 N-CA-C 106.293 -2.723 . . . . 50.51 106.293 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.416 0 N-CA-C 106.551 -2.62 . . . . 50.51 106.551 179.239 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 97.6 mmm . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.819 -1.178 . . . . 50.51 107.819 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -113.54 139.66 48.8 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 103.575 -2.75 . . . . 50.55 103.575 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.522 ' C ' HD13 ' A' ' 3' ' ' ILE . 2.0 pp -144.78 162.55 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 104.75 -2.315 . . . . 50.51 104.75 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 148.02 40.27 Favored 'General case' 0 N--CA 1.511 2.604 1 O-C-N 130.46 4.85 . . . . 50.51 109.434 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.9 t -130.22 100.05 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 113.406 -3.188 . . . . 50.51 105.245 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -65.4 131.11 45.61 Favored 'General case' 0 N--CA 1.504 2.275 1 O-C-N 129.266 4.103 . . . . 50.51 112.832 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.547 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 41.5 p -93.22 -169.39 2.14 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 107.672 -1.233 . . . . 50.51 107.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.06 34.87 4.75 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.851 -1.537 . . . . 50.51 106.851 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.1 p -134.13 -15.09 2.29 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 115.706 -2.398 . . . . 50.51 114.646 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.63 13.14 10.7 Favored Glycine 0 C--N 1.296 -1.645 0 O-C-N 120.227 -1.546 . . . . 50.51 112.654 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -119.87 120.31 36.08 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 116.834 -1.555 . . . . 50.51 111.126 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -85.77 144.75 27.58 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 126.647 2.467 . . . . 50.51 110.942 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -116.75 142.74 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 127.582 3.052 . . . . 50.51 110.391 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -122.33 128.92 51.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.249 -1.78 . . . . 50.51 113.007 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.462 HD11 HD12 ' A' ' 30' ' ' ILE . 5.4 mp -118.64 151.7 37.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 115.39 -2.243 . . . . 50.51 107.28 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 1' ' ' MET . 40.1 mt-10 -117.22 126.18 52.35 Favored 'General case' 0 N--CA 1.5 2.028 1 O-C-N 129.176 4.048 . . . . 50.62 102.984 173.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.493 HG12 ' HE3' ' A' ' 29' ' ' LYS . 35.3 m -146.31 170.83 4.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 126.241 2.213 . . . . 50.51 108.46 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 96.0 mt-10 -108.52 154.84 41.33 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.163 -2.29 . . . . 50.62 114.645 174.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -55.03 -24.51 40.35 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 122.624 2.216 . . . . 50.51 111.918 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -75.08 -14.74 60.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 118.067 -0.968 . . . . 50.51 112.467 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.0 140.91 56.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 117.355 -1.738 . . . . 50.62 109.344 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.0 p -80.93 133.51 35.55 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 105.809 -1.923 . . . . 50.51 105.809 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 54' ' ' ARG . 24.4 mm -37.69 -35.64 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.212 2.82 . . . . 50.51 110.364 175.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -58.5 -45.17 89.29 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.543 2.423 . . . . 50.62 117.543 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.09 -26.59 66.79 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.874 2.175 . . . . 50.55 116.874 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.74 -43.08 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 125.118 1.511 . . . . 50.51 112.842 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.7 -34.34 71.19 Favored 'General case' 0 C--O 1.256 1.402 0 CA-C-N 115.767 -0.651 . . . . 50.51 110.009 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -66.42 -44.82 81.88 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 117.872 2.545 . . . . 50.51 117.872 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HE3' HG12 ' A' ' 17' ' ' VAL . 62.0 mttm -46.65 -32.66 3.66 Favored 'General case' 0 C--O 1.255 1.395 0 O-C-N 120.422 -1.424 . . . . 50.51 108.56 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.462 HD12 HD11 ' A' ' 15' ' ' LEU . 22.6 mm -68.97 -40.69 81.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.199 0 N-CA-C 106.363 -1.717 . . . . 50.51 106.363 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 26.0 tt0 -39.92 -38.62 0.72 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 118.359 2.726 . . . . 50.55 118.359 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.11 -12.4 61.48 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 115.605 1.706 . . . . 50.62 115.605 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -105.18 -43.47 5.01 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.459 -2.096 . . . . 50.51 115.246 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -110.57 -43.46 3.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 123.067 2.667 . . . . 50.62 108.205 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 35.39 1.88 Allowed Glycine 0 CA--C 1.477 -2.33 0 N-CA-C 108.188 -1.965 . . . . 50.51 108.188 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.9 mm -98.73 123.41 49.81 Favored Pre-proline 0 C--O 1.243 0.739 0 C-N-CA 118.851 -1.139 . . . . 50.51 108.703 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.92 136.98 79.77 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.1 2.533 . . . . 50.51 110.943 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HA ' HE21 ' A' ' 41' ' ' GLN . 86.7 Cg_exo -57.18 -32.23 92.87 Favored 'Trans proline' 0 C--O 1.261 1.663 0 O-C-N 122.904 0.949 . . . . 50.51 113.436 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.45 -15.99 63.39 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 120.023 -1.673 . . . . 50.62 114.309 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -104.63 17.57 23.88 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.555 -1.341 . . . . 50.55 113.991 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 38' ' ' PRO . 54.7 mt-30 -114.35 146.11 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 124.422 2.058 . . . . 50.55 106.636 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.627 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 21.5 mtp-105 -128.7 105.19 8.09 Favored 'General case' 0 C--O 1.295 3.488 0 CA-C-O 116.632 -1.651 . . . . 50.64 113.386 172.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.41 117.58 29.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.459 1.027 . . . . 50.51 110.701 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -107.8 122.07 61.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 N-CA-C 119.051 2.982 . . . . 50.51 119.051 -177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -128.38 128.92 45.42 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 106.791 -1.559 . . . . 50.51 106.791 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.11 25.91 15.88 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.221 -2.263 . . . . 50.51 108.701 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.57 16.52 61.06 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.438 2.923 . . . . 50.51 108.69 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.47 142.01 33.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 118.037 0.918 . . . . 50.51 110.062 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -75.92 156.7 34.0 Favored 'General case' 0 C--O 1.26 1.607 0 O-C-N 123.981 0.801 . . . . 50.55 111.969 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -107.9 146.81 31.85 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.344 -1.725 . . . . 50.51 106.344 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -92.01 140.15 29.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 103.767 -2.679 . . . . 50.62 103.767 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -53.52 -52.18 60.46 Favored 'General case' 0 C--O 1.264 1.836 0 C-N-CA 126.206 1.802 . . . . 50.62 113.646 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.72 28.46 5.91 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 119.658 2.623 . . . . 50.51 119.658 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 23' ' ' ILE . 20.7 mmm180 -117.35 169.49 9.45 Favored 'General case' 0 C--O 1.248 1.006 0 O-C-N 120.047 -1.854 . . . . 50.64 112.33 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.95 149.36 28.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.091 0.956 . . . . 50.51 113.485 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.8 mt -50.47 -36.0 31.57 Favored 'General case' 0 C--O 1.201 -1.475 0 O-C-N 124.196 0.935 . . . . 50.51 109.023 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -68.79 -15.01 63.38 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.319 -1.752 . . . . 50.51 112.086 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.391 1.091 . . . . 50.62 109.894 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -121.88 11.2 10.33 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.778 -1.106 . . . . 50.51 113.333 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t30 51.45 39.79 25.27 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 121.442 1.928 . . . . 50.55 110.203 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mm -56.54 116.26 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.959 0 CA-C-O 115.215 -2.326 . . . . 50.51 109.473 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.404 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 76.3 mt-30 -79.98 -171.03 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.638 2.458 . . . . 50.55 117.638 -176.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.404 ' H ' ' HB3' ' A' ' 62' ' ' GLN . 98.7 mttt -72.27 143.68 48.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.229 1.49 . . . . 50.51 108.827 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 34.42 39.58 0.03 OUTLIER 'General case' 0 C--O 1.256 1.447 0 N-CA-C 117.905 2.557 . . . . 50.62 117.905 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -65.89 146.68 54.44 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.83 -1.077 . . . . 50.51 111.949 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 p -104.54 144.15 32.08 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 118.299 -0.857 . . . . 50.51 110.926 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 60.0 mt -110.66 156.04 21.56 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 114.756 -2.545 . . . . 50.51 108.625 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -118.94 144.94 46.16 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 127.408 2.942 . . . . 50.51 110.475 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 49.2 tp -96.09 129.88 43.26 Favored 'General case' 0 C--O 1.282 2.803 0 CA-C-O 117.696 -1.145 . . . . 50.51 111.668 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.627 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 61.8 t -116.11 137.06 51.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 102.392 -3.188 . . . . 50.51 102.392 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.87 127.86 46.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.102 0.477 . . . . 50.51 110.42 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -114.27 111.83 22.14 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.374 -3.203 . . . . 50.64 112.494 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.05 143.9 28.12 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.837 1.961 . . . . 50.51 108.097 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -98.09 89.28 4.47 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 106.662 -1.607 . . . . 50.64 106.662 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.7 -162.65 26.99 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 104.643 -3.383 . . . . 50.51 104.643 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 CA-C-O 116.355 -2.358 . . . . 50.51 108.044 179.25 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 118.768 -0.634 . . . . 50.51 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 10.9 mm-40 -109.09 127.67 54.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 127.001 2.688 . . . . 50.55 109.026 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -133.16 146.55 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 116.024 -1.941 . . . . 50.51 107.717 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -106.56 135.89 47.28 Favored 'General case' 0 N--CA 1.512 2.645 1 O-C-N 130.446 4.841 . . . . 50.51 113.486 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.8 t -108.05 136.63 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.417 -3.182 . . . . 50.51 103.898 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -126.24 119.7 28.12 Favored 'General case' 0 N--CA 1.503 2.219 1 O-C-N 129.277 4.111 . . . . 50.51 114.834 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.563 HG23 HD21 ' A' ' 69' ' ' LEU . 43.9 p -67.44 -172.27 0.23 Allowed 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.869 -1.063 . . . . 50.51 110.337 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.89 -18.97 26.46 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.116 -0.698 . . . . 50.51 109.116 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -106.36 16.08 25.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 119.87 3.285 . . . . 50.51 119.87 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.86 55.67 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 120.952 3.141 . . . . 50.51 120.952 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -84.16 123.35 30.0 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.227 -1.768 . . . . 50.51 106.227 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -113.03 134.1 54.67 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 126.585 2.428 . . . . 50.51 111.872 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.44 HG13 ' HB ' ' A' ' 5' ' ' VAL . 28.0 pt -115.92 153.81 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 127.533 3.02 . . . . 50.51 114.0 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -110.58 142.99 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 117.301 -1.76 . . . . 50.51 115.021 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' A' ' 30' ' ' ILE . 76.4 mt -135.46 139.78 44.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 115.459 -2.21 . . . . 50.51 113.54 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -101.85 107.19 18.3 Favored 'General case' 0 N--CA 1.5 2.069 1 O-C-N 129.128 4.018 . . . . 50.62 113.926 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -128.17 154.63 39.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.671 3.107 . . . . 50.51 114.443 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.67 159.02 30.65 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 118.256 2.688 . . . . 50.62 118.256 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.0 -24.49 40.0 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.581 2.187 . . . . 50.51 111.948 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -103.34 34.33 2.97 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 117.806 2.521 . . . . 50.51 117.806 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -114.15 130.75 56.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.374 -1.731 . . . . 50.62 112.166 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.444 ' O ' HG21 ' A' ' 26' ' ' VAL . 41.3 p -57.93 155.54 10.5 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.598 1.332 . . . . 50.51 114.598 175.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 54' ' ' ARG . 15.3 mm -60.45 -42.06 89.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 127.205 2.816 . . . . 50.51 110.955 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.07 -59.05 5.88 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.941 . . . . 50.62 108.458 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 44.5 t30 -47.85 -43.54 28.36 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 124.399 1.08 . . . . 50.55 111.145 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG22 HD11 ' A' ' 56' ' ' LEU . 42.1 t -63.38 -34.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.97 1.419 . . . . 50.51 109.707 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -76.16 -30.44 58.12 Favored 'General case' 0 C--O 1.257 1.451 0 N-CA-C 108.816 -0.809 . . . . 50.51 108.816 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.88 70.02 Favored 'General case' 0 C--O 1.279 2.616 0 N-CA-C 105.517 -2.031 . . . . 50.51 105.517 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 75.3 mmtt -58.93 -63.2 1.38 Allowed 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.397 -1.439 . . . . 50.51 107.994 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.499 ' CG1' HD11 ' A' ' 15' ' ' LEU . 70.3 mt -47.97 -37.75 6.8 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.486 -0.886 . . . . 50.51 109.105 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -54.45 -50.73 66.99 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 125.568 2.604 . . . . 50.55 112.849 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -49.0 -60.99 2.3 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 113.644 -1.616 . . . . 50.62 110.273 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -84.13 -40.33 18.36 Favored 'General case' 0 C--O 1.279 2.654 0 N-CA-C 119.617 3.191 . . . . 50.51 119.617 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HG3' HG13 ' A' ' 36' ' ' ILE . 42.5 tp10 -76.19 -31.37 58.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 123.082 2.674 . . . . 50.62 108.162 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.42 2.36 76.75 Favored Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.458 -1.057 . . . . 50.51 110.458 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -87.81 136.39 32.67 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 118.812 -1.155 . . . . 50.51 110.999 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.0 Cg_exo -57.07 137.0 79.97 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.159 2.572 . . . . 50.51 110.875 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -57.19 -32.16 92.68 Favored 'Trans proline' 0 C--O 1.262 1.709 0 O-C-N 122.89 0.942 . . . . 50.51 113.436 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.513 ' OD1' ' HG3' ' A' ' 40' ' ' GLN . 35.6 p30 -69.4 -14.1 62.72 Favored 'General case' 0 C--O 1.262 1.733 0 O-C-N 119.893 -1.754 . . . . 50.62 113.83 -177.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.513 ' HG3' ' OD1' ' A' ' 39' ' ' ASP . 88.2 mt-30 -102.81 6.84 39.49 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.544 -1.347 . . . . 50.55 109.891 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -103.41 130.94 50.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 124.362 2.029 . . . . 50.55 110.796 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -120.98 122.12 39.47 Favored 'General case' 0 C--O 1.296 3.544 0 CA-C-O 116.625 -1.655 . . . . 50.64 110.828 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.451 ' CB ' HD12 ' A' ' 50' ' ' LEU . 60.2 mt -108.14 126.16 52.44 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.509 1.05 . . . . 50.51 109.839 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 67.5 mt -111.14 138.86 37.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 O-C-N 125.223 1.577 . . . . 50.51 108.147 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -150.55 120.63 7.2 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 114.488 -1.233 . . . . 50.51 110.913 177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.34 38.66 7.69 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.208 -2.269 . . . . 50.51 112.284 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 3.42 68.08 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.346 2.879 . . . . 50.51 115.863 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -113.76 146.78 39.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 114.978 1.473 . . . . 50.51 114.978 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -70.51 153.96 42.38 Favored 'General case' 0 C--O 1.259 1.58 0 N-CA-C 108.2 -1.037 . . . . 50.55 108.2 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.451 HD12 ' CB ' ' A' ' 43' ' ' LEU . 63.5 mt -96.94 135.01 39.55 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 117.666 -1.159 . . . . 50.51 110.312 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -99.06 128.1 45.13 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.933 1.395 . . . . 50.62 112.737 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.11 -57.82 3.63 Favored 'General case' 0 C--O 1.264 1.844 0 C-N-CA 126.133 1.773 . . . . 50.62 115.216 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.26 -26.68 29.85 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 124.415 1.007 . . . . 50.51 113.886 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.499 ' O ' HG12 ' A' ' 23' ' ' ILE . 29.5 mmt180 -83.6 161.04 21.27 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 120.025 -1.868 . . . . 50.64 112.109 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -103.93 172.68 6.67 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 124.065 0.946 . . . . 50.51 110.218 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD11 HG22 ' A' ' 26' ' ' VAL . 47.5 mt -58.07 -33.19 68.79 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 116.49 2.033 . . . . 50.51 116.49 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -86.38 -5.66 59.12 Favored 'General case' 0 C--O 1.267 2.0 0 C-N-CA 117.372 -1.731 . . . . 50.51 111.167 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -79.81 -0.79 36.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.809 -1.182 . . . . 50.62 107.809 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -123.95 11.98 9.01 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 117.755 -1.117 . . . . 50.51 110.542 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.61 28.61 12.2 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 121.545 1.975 . . . . 50.55 111.595 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.2 103.0 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.969 0 CA-C-O 115.17 -2.348 . . . . 50.51 108.827 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -98.84 164.62 12.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.112 2.133 . . . . 50.55 112.435 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -51.04 135.89 24.27 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.513 2.042 . . . . 50.51 116.513 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 73.09 37.93 0.73 Allowed 'General case' 0 C--O 1.255 1.393 0 CA-C-N 112.497 -2.138 . . . . 50.62 111.07 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 p -78.07 156.56 29.96 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 107.537 -1.283 . . . . 50.51 107.537 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.5 m -122.05 117.97 27.63 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.834 -3.024 . . . . 50.51 102.834 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.65 170.09 9.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 114.695 -2.574 . . . . 50.51 112.545 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.699 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -110.32 127.62 55.12 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.361 2.913 . . . . 50.51 108.73 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.563 HD21 HG23 ' A' ' 7' ' ' THR . 48.0 tp -103.07 101.87 11.87 Favored 'General case' 0 C--O 1.283 2.823 0 CA-C-O 117.649 -1.167 . . . . 50.51 113.194 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.38 137.11 25.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.583 1.083 . . . . 50.51 112.149 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 tp -96.03 115.73 27.88 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.318 -0.623 . . . . 50.51 109.318 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -109.04 108.18 18.79 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.305 -3.236 . . . . 50.64 114.166 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.86 165.16 15.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 125.859 1.974 . . . . 50.51 114.664 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -115.35 61.45 0.69 Allowed 'General case' 0 C--O 1.244 0.812 0 CA-C-N 113.742 -1.572 . . . . 50.64 108.472 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.75 138.82 2.55 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 107.298 -2.321 . . . . 50.51 107.298 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.444 0 CA-C-O 116.356 -2.358 . . . . 50.51 109.038 179.217 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 106.917 -1.512 . . . . 50.51 106.917 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -120.19 135.71 54.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 101.557 -3.498 . . . . 50.55 101.557 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -137.89 159.36 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.94 -1.981 . . . . 50.51 106.941 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -114.24 143.91 44.08 Favored 'General case' 0 N--CA 1.512 2.628 1 O-C-N 130.446 4.842 . . . . 50.51 111.395 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -118.97 109.87 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.404 -3.189 . . . . 50.51 106.121 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -84.3 150.37 25.46 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.306 4.129 . . . . 50.51 117.362 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -126.78 164.23 21.81 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 117.826 -1.083 . . . . 50.51 110.137 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.54 -43.36 65.12 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.999 2.592 . . . . 50.51 117.999 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.6 p -68.64 -26.52 65.37 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 115.726 -2.39 . . . . 50.51 107.455 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.73 -5.93 18.42 Favored Glycine 0 C--N 1.297 -1.6 0 O-C-N 120.258 -1.526 . . . . 50.51 115.438 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -54.66 130.88 41.96 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.88 -1.533 . . . . 50.51 109.889 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -112.86 119.58 38.47 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 126.624 2.453 . . . . 50.51 117.221 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -88.48 145.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.571 3.044 . . . . 50.51 108.329 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -104.58 141.93 35.53 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 117.287 -1.765 . . . . 50.51 110.584 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -134.13 137.48 44.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 118.195 2.665 . . . . 50.51 118.195 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -103.61 111.18 23.54 Favored 'General case' 0 N--CA 1.501 2.104 1 O-C-N 129.242 4.089 . . . . 50.62 112.35 174.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -98.24 166.74 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.197 0 O-C-N 127.508 3.005 . . . . 50.51 112.548 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 53.9 mm-40 -115.72 148.66 41.63 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.197 -2.274 . . . . 50.62 112.58 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.5 Cg_exo -54.95 -24.49 39.57 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.581 2.188 . . . . 50.51 112.003 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -103.14 13.75 33.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 118.043 2.608 . . . . 50.51 118.043 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -92.74 148.6 21.91 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 117.349 -1.74 . . . . 50.62 110.986 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -99.09 157.42 16.37 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.836 -0.62 . . . . 50.51 109.716 175.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -45.01 -43.86 2.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 O-C-N 127.238 2.836 . . . . 50.51 113.015 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -57.39 -46.68 83.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.456 -0.778 . . . . 50.62 110.305 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -59.51 -39.88 85.3 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.287 1.035 . . . . 50.55 110.653 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.63 -46.73 95.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.022 -1.473 . . . . 50.51 107.022 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 93.4 mttt -55.0 -59.38 4.83 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-N 115.814 -0.63 . . . . 50.51 111.336 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.02 -40.59 76.99 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 113.887 1.069 . . . . 50.51 113.887 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -50.8 -44.38 58.97 Favored 'General case' 0 C--O 1.255 1.39 0 N-CA-C 106.367 -1.716 . . . . 50.51 106.367 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 31' ' ' GLN . 72.3 mt -64.26 -42.2 94.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.281 0 C-N-CA 119.51 -0.876 . . . . 50.51 108.669 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' C ' ' A' ' 32' ' ' ASP . 35.4 tt0 -43.87 -58.34 2.8 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.623 2.63 . . . . 50.55 108.844 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 31' ' ' GLN . 98.1 m-20 -34.57 -35.79 0.04 OUTLIER 'General case' 0 C--O 1.253 1.26 0 CA-C-N 113.645 -1.616 . . . . 50.62 110.833 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 31' ' ' GLN . 33.7 mmtp -112.46 -1.22 15.05 Favored 'General case' 0 C--O 1.28 2.703 0 N-CA-C 120.15 3.389 . . . . 50.51 120.15 -175.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -129.81 -38.07 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 123.147 2.703 . . . . 50.62 108.399 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 11.98 31.98 Favored Glycine 0 CA--C 1.477 -2.333 0 N-CA-C 115.177 0.831 . . . . 50.51 115.177 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.6 mt -97.51 136.72 21.18 Favored Pre-proline 0 C--O 1.245 0.83 0 C-N-CA 118.836 -1.146 . . . . 50.51 112.149 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.565 0 C-N-CA 123.152 2.568 . . . . 50.51 110.88 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 Cg_exo -57.24 -32.18 92.86 Favored 'Trans proline' 0 C--O 1.26 1.621 0 O-C-N 122.903 0.949 . . . . 50.51 113.38 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -72.82 5.17 3.39 Favored 'General case' 0 C--O 1.262 1.757 0 O-C-N 120.022 -1.674 . . . . 50.62 113.573 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.579 HE21 ' HG3' ' A' ' 74' ' ' ARG . 62.8 mt-30 -111.2 -6.71 14.53 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.541 -1.349 . . . . 50.55 112.632 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.433 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 8.8 mt-30 -102.79 130.59 49.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.412 2.053 . . . . 50.55 112.686 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -111.54 119.68 39.57 Favored 'General case' 0 C--O 1.297 3.566 0 CA-C-O 116.672 -1.632 . . . . 50.64 108.368 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.4 mt -100.97 158.72 15.79 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 105.595 -2.002 . . . . 50.51 105.595 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 67' ' ' LEU . 60.8 mt -137.35 135.78 46.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 118.835 2.902 . . . . 50.51 118.835 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -128.05 112.62 14.81 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 115.063 1.505 . . . . 50.51 115.063 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.92 30.92 20.42 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.19 -2.277 . . . . 50.51 109.525 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.09 19.34 72.63 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 128.486 2.945 . . . . 50.51 117.187 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -111.02 151.72 27.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 118.162 -0.923 . . . . 50.51 112.078 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.05 154.17 42.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.986 1.106 . . . . 50.55 113.986 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.09 140.22 49.77 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 117.796 -1.097 . . . . 50.51 109.169 -175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -103.32 136.03 43.85 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.864 1.352 . . . . 50.62 114.31 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -57.33 -55.73 31.01 Favored 'General case' 0 C--O 1.263 1.793 0 C-N-CA 126.177 1.791 . . . . 50.62 114.019 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.16 11.66 4.76 Favored Glycine 0 C--O 1.254 1.368 0 C-N-CA 124.464 1.03 . . . . 50.51 115.389 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -106.96 166.7 10.41 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 119.963 -1.904 . . . . 50.64 110.538 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -90.22 158.67 17.1 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 124.014 0.926 . . . . 50.51 113.308 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -70.62 -28.82 65.14 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 124.071 0.857 . . . . 50.51 110.085 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -69.31 -21.71 63.83 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.31 -1.756 . . . . 50.51 113.535 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.29 -5.35 51.78 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.63 2.085 . . . . 50.62 116.63 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -111.75 14.32 21.11 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 114.791 1.404 . . . . 50.51 114.791 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 51.4 28.1 4.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 121.571 1.987 . . . . 50.55 114.397 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.85 100.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.973 0 CA-C-O 115.192 -2.337 . . . . 50.51 106.878 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -98.9 162.76 12.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 126.159 2.162 . . . . 50.55 111.333 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 58.4 pttt -52.93 118.32 3.62 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 116.501 2.038 . . . . 50.51 116.501 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 71.69 46.87 0.36 Allowed 'General case' 0 C--O 1.257 1.453 0 CA-C-N 112.53 -2.123 . . . . 50.62 112.764 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.3 p -102.0 151.86 21.63 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 101.515 -3.513 . . . . 50.51 101.515 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.1 p -94.29 139.55 30.92 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 117.729 2.492 . . . . 50.51 117.729 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 46.6 mt -109.36 151.73 26.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 103.166 -2.902 . . . . 50.51 103.166 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 55.5 m80 -108.75 124.95 51.37 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 127.472 2.982 . . . . 50.51 104.565 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.4 tp -99.42 117.56 34.11 Favored 'General case' 0 C--O 1.283 2.841 0 CA-C-O 117.63 -1.176 . . . . 50.51 111.172 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -103.84 145.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 119.558 1.072 . . . . 50.51 108.765 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -115.23 120.55 40.08 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.859 2.17 . . . . 50.51 116.859 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -119.13 90.06 3.25 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 113.371 -3.204 . . . . 50.64 111.138 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.24 163.38 1.65 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.795 1.935 . . . . 50.51 109.209 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.579 ' HG3' HE21 ' A' ' 40' ' ' GLN . 93.8 mtt-85 -87.62 94.01 9.6 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 113.706 -1.588 . . . . 50.64 113.065 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.66 171.34 18.3 Favored Glycine 0 C--O 1.243 0.705 0 N-CA-C 109.663 -1.375 . . . . 50.51 109.663 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.472 0 N-CA-C 106.215 -2.754 . . . . 50.51 106.215 179.22 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 118.753 -0.641 . . . . 50.51 111.148 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.52 ' OE1' HG22 ' A' ' 14' ' ' THR . 48.9 mt-30 -86.22 125.11 33.31 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.96 2.663 . . . . 50.55 116.662 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.3 pt -119.87 162.65 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 115.983 -1.96 . . . . 50.51 109.392 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -112.02 136.28 51.58 Favored 'General case' 0 N--CA 1.513 2.69 1 O-C-N 130.504 4.877 . . . . 50.51 118.459 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -105.85 111.63 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.438 -3.172 . . . . 50.51 111.728 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -81.22 129.44 34.59 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.309 4.131 . . . . 50.51 109.318 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 69.2 p -97.67 -176.77 3.57 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 114.576 1.324 . . . . 50.51 114.576 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.2 mt -86.91 -28.68 22.64 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.784 1.031 . . . . 50.51 113.784 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 p -93.97 -22.37 18.61 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.713 -2.395 . . . . 50.51 111.12 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.2 3.9 2.39 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 117.726 1.85 . . . . 50.51 117.726 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' N ' ' OG1' ' A' ' 7' ' ' THR . 95.4 mttt -71.7 137.65 47.96 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 116.868 -1.539 . . . . 50.51 112.323 174.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.1 m -122.15 106.73 11.42 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.678 2.486 . . . . 50.51 110.809 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 15' ' ' LEU . 62.5 mt -84.87 153.09 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 127.244 2.84 . . . . 50.51 111.427 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.52 HG22 ' OE1' ' A' ' 2' ' ' GLN . 42.6 m -119.76 132.1 55.53 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 102.538 -3.134 . . . . 50.51 102.538 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 13' ' ' ILE . 1.5 mp -118.05 142.6 47.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 117.3 2.333 . . . . 50.51 117.3 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.71 107.39 19.87 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 128.944 3.902 . . . . 50.62 109.902 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.58 166.71 10.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 O-C-N 127.782 3.176 . . . . 50.51 106.046 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -132.67 157.77 77.46 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 112.234 -2.257 . . . . 50.62 106.446 174.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.92 -24.5 39.38 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.56 2.173 . . . . 50.51 112.014 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -75.81 -13.0 60.28 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 115.451 1.648 . . . . 50.51 115.451 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -84.65 131.27 34.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 118.379 2.733 . . . . 50.62 118.379 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -83.61 179.92 7.49 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 103.948 -2.612 . . . . 50.51 103.948 175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' GLU . 24.6 mm -65.41 -39.56 85.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 O-C-N 127.206 2.816 . . . . 50.51 110.824 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 29.7 tt0 -46.84 -59.23 3.2 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.275 -2.12 . . . . 50.62 105.275 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 24.6 m-80 -53.12 -46.37 68.73 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 118.123 2.638 . . . . 50.55 118.123 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.41 -39.6 81.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 117.777 2.51 . . . . 50.51 117.777 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -72.27 -30.08 64.5 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 103.231 -2.877 . . . . 50.51 103.231 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -30.86 71.18 Favored 'General case' 0 C--O 1.279 2.608 0 N-CA-C 109.146 -0.687 . . . . 50.51 109.146 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.6 mttt -71.79 -19.18 62.04 Favored 'General case' 0 C--O 1.256 1.422 0 O-C-N 120.316 -1.49 . . . . 50.51 111.058 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 30' ' ' ILE . 95.7 mt -88.94 -11.25 10.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 C-N-CA 119.538 -0.865 . . . . 50.51 109.491 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -91.67 -19.64 22.45 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 125.63 2.633 . . . . 50.55 113.161 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.26 -52.77 20.5 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.572 -1.649 . . . . 50.62 110.606 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -80.28 -75.93 0.24 Allowed 'General case' 0 C--O 1.278 2.598 0 C-N-CA 116.468 -2.093 . . . . 50.51 108.175 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -55.18 -70.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.05 2.659 . . . . 50.62 114.812 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.69 20.33 0.88 Allowed Glycine 0 CA--C 1.478 -2.27 0 CA-C-O 120.012 -0.327 . . . . 50.51 113.223 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.524 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -89.28 125.86 60.51 Favored Pre-proline 0 C--O 1.244 0.776 0 N-CA-C 116.77 2.137 . . . . 50.51 116.77 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -57.01 136.98 79.95 Favored 'Trans proline' 0 C--O 1.258 1.523 0 C-N-CA 123.159 2.572 . . . . 50.51 110.903 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -57.17 -32.19 92.72 Favored 'Trans proline' 0 C--O 1.261 1.653 0 C-N-CA 120.671 0.914 . . . . 50.51 113.377 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.04 -9.71 58.9 Favored 'General case' 0 C--O 1.262 1.738 0 O-C-N 119.949 -1.719 . . . . 50.62 112.854 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.685 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 79.8 mt-30 -103.32 -1.89 27.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.488 -1.382 . . . . 50.55 107.656 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.22 138.1 31.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 124.447 2.07 . . . . 50.55 105.745 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.11 114.4 15.7 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.646 -1.645 . . . . 50.64 106.831 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.511 ' HB3' HD23 ' A' ' 50' ' ' LEU . 35.2 mt -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 119.537 1.062 . . . . 50.51 110.285 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -129.06 123.87 59.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 O-C-N 125.102 1.501 . . . . 50.51 111.849 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -140.1 117.19 11.16 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 114.539 -1.21 . . . . 50.51 109.948 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.7 29.0 13.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 112.241 -2.254 . . . . 50.51 114.706 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 37.54 45.29 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 128.379 2.895 . . . . 50.51 114.393 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -133.95 150.23 51.28 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 118.317 2.71 . . . . 50.51 118.317 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.08 135.18 42.97 Favored 'General case' 0 C--O 1.26 1.635 0 O-C-N 123.953 0.783 . . . . 50.55 110.33 174.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 43' ' ' LEU . 2.1 mp -87.79 129.18 35.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 114.637 1.347 . . . . 50.51 114.637 -175.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' HG2' ' HH ' ' A' ' 59' ' ' TYR . 61.8 mm-40 -89.5 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 120.377 3.473 . . . . 50.62 120.377 -177.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -51.07 -55.97 14.95 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 119.74 3.237 . . . . 50.62 119.74 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.96 7.85 78.69 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.387 0.994 . . . . 50.51 114.189 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.51 144.55 28.48 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 119.951 -1.911 . . . . 50.64 109.276 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -87.4 155.84 19.85 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.062 0.945 . . . . 50.51 108.581 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -46.93 -32.26 3.71 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 113.869 1.063 . . . . 50.51 113.869 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.58 -20.38 65.38 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 115.759 1.763 . . . . 50.51 115.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -62.24 -43.84 97.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.452 1.12 . . . . 50.62 110.603 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.523 ' HH ' ' HG2' ' A' ' 51' ' ' GLU . 59.7 m-85 -84.66 17.11 2.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 115.609 1.707 . . . . 50.51 115.609 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 t30 60.31 33.13 20.88 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 121.536 1.971 . . . . 50.55 113.59 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.534 HG23 ' OG ' ' A' ' 65' ' ' SER . 56.9 mt -85.47 83.71 2.08 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 CA-C-O 115.169 -2.348 . . . . 50.51 113.65 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -82.97 179.06 7.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 125.717 1.885 . . . . 50.55 116.027 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -53.2 124.21 13.91 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 123.179 1.466 . . . . 50.51 111.394 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 61.1 40.42 14.98 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 118.528 2.788 . . . . 50.62 118.528 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.534 ' OG ' HG23 ' A' ' 61' ' ' ILE . 94.2 p -86.91 152.35 22.51 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.164 -1.421 . . . . 50.51 107.164 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 m -91.47 123.3 34.78 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 116.667 2.099 . . . . 50.51 116.667 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.01 138.58 41.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 114.735 -2.555 . . . . 50.51 105.291 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 49.0 m80 -81.6 168.04 18.59 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 127.038 2.711 . . . . 50.51 106.612 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -131.24 120.47 23.28 Favored 'General case' 0 C--O 1.282 2.789 0 N-CA-C 104.664 -2.346 . . . . 50.51 104.664 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.5 t -118.8 149.93 21.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 102.585 -3.117 . . . . 50.51 102.585 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.11 152.33 18.64 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.536 0.569 . . . . 50.51 112.536 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.685 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 74.9 ttt180 -122.12 97.73 5.61 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 113.413 -3.184 . . . . 50.64 106.789 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.0 mt -85.83 134.6 33.91 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 125.757 1.911 . . . . 50.51 113.369 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.84 81.49 8.75 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.703 -1.59 . . . . 50.64 112.88 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.94 -175.34 16.6 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 107.596 -2.201 . . . . 50.51 107.596 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.464 0 N-CA-C 105.24 -3.144 . . . . 50.51 105.24 179.213 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' VAL . 63.0 mtp . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 102.042 -3.318 . . . . 50.51 102.042 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -112.52 135.05 53.69 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 103.497 -2.779 . . . . 50.55 103.497 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -124.77 173.12 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 CA-C-O 116.074 -1.917 . . . . 50.51 107.004 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.8 141.98 38.55 Favored 'General case' 0 N--CA 1.511 2.609 1 O-C-N 130.343 4.777 . . . . 50.51 115.954 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.34 110.58 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.454 -3.165 . . . . 50.51 104.585 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -90.47 143.94 26.27 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.204 4.065 . . . . 50.51 105.472 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 24.8 p -117.39 177.2 4.82 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.8 -1.095 . . . . 50.51 112.878 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.05 -24.76 67.83 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.082 0.864 . . . . 50.51 112.65 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -101.23 25.79 7.83 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 115.748 -2.381 . . . . 50.51 110.799 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.56 31.34 74.44 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 107.559 -2.216 . . . . 50.51 107.559 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 29.3 ttpt -84.97 124.7 31.98 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 103.735 -2.691 . . . . 50.51 103.735 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 p -103.31 137.72 41.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.664 2.477 . . . . 50.51 105.851 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 13' ' ' ILE . 16.6 tt -144.74 112.13 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 101.735 -3.432 . . . . 50.51 101.735 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.9 p -81.52 155.07 25.94 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.302 -1.759 . . . . 50.51 114.975 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -114.22 167.63 10.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.446 -2.216 . . . . 50.51 110.928 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.6 104.06 12.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 129.025 3.953 . . . . 50.62 106.427 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 1' ' ' MET . 19.7 m -107.41 148.62 11.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 O-C-N 127.62 3.075 . . . . 50.51 114.912 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 38.0 mt-10 -116.0 149.47 43.4 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.208 -2.269 . . . . 50.62 112.131 174.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.5 Cg_exo -54.87 -24.53 39.18 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.535 2.157 . . . . 50.51 111.971 177.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -87.31 -2.54 58.7 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 118.146 -0.931 . . . . 50.51 111.135 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.43 131.8 37.05 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 115.949 1.833 . . . . 50.62 115.949 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.98 148.58 24.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.808 -0.633 . . . . 50.51 111.04 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 51' ' ' GLU . 73.2 mt -48.6 -29.87 2.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.147 2.779 . . . . 50.51 114.907 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 78.5 tt0 -56.25 -63.82 1.06 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 105.021 -2.215 . . . . 50.62 105.021 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -50.42 -40.71 51.01 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 118.97 2.952 . . . . 50.55 118.97 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.13 -23.15 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.129 -1.396 . . . . 50.51 107.518 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 64.5 mttm -88.73 -26.68 21.65 Favored 'General case' 0 C--O 1.257 1.474 0 N-CA-C 118.272 2.693 . . . . 50.51 118.272 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -23.7 24.29 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.901 -0.407 . . . . 50.51 109.901 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.87 -49.69 73.84 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 120.333 -1.48 . . . . 50.51 111.41 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.42 -36.96 48.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 108.575 -0.898 . . . . 50.51 108.575 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.47 -45.19 73.13 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.578 2.608 . . . . 50.55 115.682 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -52.64 -29.55 26.83 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 106.387 -1.709 . . . . 50.62 106.387 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.72 -45.48 11.61 Favored 'General case' 0 C--O 1.279 2.656 0 C-N-CA 116.433 -2.107 . . . . 50.51 113.243 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -116.78 -36.67 3.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 123.107 2.685 . . . . 50.62 112.321 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.86 31.32 2.74 Favored Glycine 0 CA--C 1.477 -2.291 0 N-CA-C 110.512 -1.035 . . . . 50.51 110.512 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 68.0 mt -83.09 122.92 77.89 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 105.273 -2.121 . . . . 50.51 105.273 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 77.4 Cg_exo -57.0 136.93 79.63 Favored 'Trans proline' 0 C--O 1.258 1.514 0 C-N-CA 123.228 2.618 . . . . 50.51 110.838 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -57.18 -32.19 92.77 Favored 'Trans proline' 0 C--O 1.262 1.688 0 O-C-N 122.885 0.939 . . . . 50.51 113.418 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -89.25 27.57 1.39 Allowed 'General case' 0 C--O 1.262 1.75 0 O-C-N 119.981 -1.699 . . . . 50.62 115.06 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -137.8 14.03 2.91 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 104.384 -2.45 . . . . 50.55 104.384 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -110.39 137.79 47.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.948 -2.242 . . . . 50.55 104.948 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -131.62 108.88 9.82 Favored 'General case' 0 C--O 1.296 3.537 0 CA-C-O 116.676 -1.63 . . . . 50.64 112.564 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.0 mt -90.42 131.22 36.31 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 116.63 2.085 . . . . 50.51 116.63 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.715 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -107.0 137.9 35.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.51 113.524 -177.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -149.4 112.39 4.87 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 114.55 -1.204 . . . . 50.51 113.78 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 46.05 27.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.215 -2.266 . . . . 50.51 113.31 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.93 -6.07 56.63 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 128.384 2.897 . . . . 50.51 114.763 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -97.47 158.9 15.24 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 117.412 2.375 . . . . 50.51 117.412 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -96.17 139.96 31.57 Favored 'General case' 0 C--O 1.259 1.554 0 N-CA-C 105.644 -1.984 . . . . 50.55 105.644 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -95.84 127.79 42.16 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 117.72 -1.133 . . . . 50.51 112.554 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 23' ' ' ILE . 57.5 mt-10 -85.55 139.39 31.49 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.891 1.369 . . . . 50.62 113.79 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -53.88 -50.21 66.82 Favored 'General case' 0 C--O 1.264 1.86 0 C-N-CA 126.171 1.788 . . . . 50.62 114.38 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.3 -4.58 44.66 Favored Glycine 0 CA--C 1.493 -1.321 0 C-N-CA 124.457 1.027 . . . . 50.51 113.999 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.99 150.0 21.63 Favored 'General case' 0 C--O 1.249 1.072 0 O-C-N 119.858 -1.966 . . . . 50.64 108.92 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -83.47 -179.19 7.29 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.08 0.952 . . . . 50.51 110.398 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.38 -29.12 31.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.821 -1.548 . . . . 50.51 106.821 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 59' ' ' TYR . 73.3 m -73.78 -37.37 65.0 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.282 -1.767 . . . . 50.51 106.904 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -46.92 -16.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.334 1.064 . . . . 50.62 112.88 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' H ' ' C ' ' A' ' 57' ' ' SER . 91.1 m-85 -121.71 -6.12 9.14 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 117.795 -1.098 . . . . 50.51 113.613 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 66.31 41.65 3.29 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 117.569 2.433 . . . . 50.55 117.569 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.595 HG23 ' HG ' ' A' ' 65' ' ' SER . 71.8 mt -82.14 124.41 39.15 Favored 'Isoleucine or valine' 0 C--O 1.267 1.978 0 CA-C-O 115.287 -2.292 . . . . 50.51 110.174 175.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.67 168.68 9.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 126.018 2.073 . . . . 50.55 115.893 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -36.54 146.2 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 123.277 1.513 . . . . 50.51 113.569 -176.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 50.31 34.93 9.63 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-N 112.469 -2.15 . . . . 50.62 115.885 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.595 ' HG ' HG23 ' A' ' 61' ' ' ILE . 28.3 t -76.8 154.07 34.29 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.802 -1.09 . . . . 50.51 108.659 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 m -119.99 123.6 43.89 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.734 -1.209 . . . . 50.51 107.734 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.7 mt -94.85 147.88 22.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.696 -2.573 . . . . 50.51 111.47 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.715 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.0 m-70 -95.93 119.28 34.13 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 127.454 2.971 . . . . 50.51 108.781 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -98.51 110.53 23.11 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 107.08 -1.452 . . . . 50.51 107.08 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.476 HG22 HD12 ' A' ' 44' ' ' ILE . 45.6 t -93.81 165.17 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 101.499 -3.519 . . . . 50.51 101.499 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.3 mt -117.21 139.98 50.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.884 -0.784 . . . . 50.51 108.884 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -131.33 91.67 3.06 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-O 113.405 -3.188 . . . . 50.64 107.094 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -85.15 157.23 20.72 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 125.778 1.924 . . . . 50.51 110.066 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -90.53 113.2 25.13 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 105.543 -2.021 . . . . 50.64 105.543 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.65 155.81 14.52 Favored Glycine 0 C--O 1.243 0.682 0 CA-C-N 114.662 -1.154 . . . . 50.51 113.581 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.323 -2.376 . . . . 50.51 113.473 179.214 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 106.471 -1.678 . . . . 50.51 106.471 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.548 ' HG2' ' HG2' ' A' ' 16' ' ' GLU . 82.1 mt-30 -102.5 131.82 48.96 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 126.952 2.658 . . . . 50.55 108.424 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.73 163.95 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 CA-C-O 115.961 -1.971 . . . . 50.51 112.534 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' A' ' 14' ' ' THR . 79.0 m-85 -108.44 141.51 40.19 Favored 'General case' 0 N--CA 1.511 2.608 1 O-C-N 130.49 4.869 . . . . 50.51 116.756 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -116.72 120.16 64.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 113.356 -3.212 . . . . 50.51 106.065 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.32 117.38 34.0 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.326 4.141 . . . . 50.51 112.825 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 69.4 p -84.54 -174.46 5.28 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 117.774 -1.108 . . . . 50.51 108.723 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.74 -8.9 58.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.516 2.784 . . . . 50.51 118.516 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -122.65 22.86 9.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 115.74 -2.384 . . . . 50.51 116.791 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.03 22.16 21.03 Favored Glycine 0 C--N 1.297 -1.609 0 O-C-N 119.225 -2.172 . . . . 50.51 118.183 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 80.0 tttt -100.54 124.13 45.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 116.823 -1.56 . . . . 50.51 108.417 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.47 135.29 53.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 126.668 2.48 . . . . 50.51 106.369 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.3 pt -123.31 153.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 127.565 3.04 . . . . 50.51 103.594 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.406 HG23 ' CD1' ' A' ' 4' ' ' PHE . 70.2 p -117.1 139.04 51.2 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 117.266 -1.774 . . . . 50.51 107.862 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -126.3 137.96 53.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 115.454 -2.212 . . . . 50.51 107.446 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.548 ' HG2' ' HG2' ' A' ' 2' ' ' GLN . 46.8 mt-10 -96.24 133.14 40.95 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.231 4.082 . . . . 50.62 109.407 173.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HZ3' ' A' ' 29' ' ' LYS . 35.0 m -130.42 170.62 19.03 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.631 3.082 . . . . 50.51 113.57 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 8.8 mp0 -124.09 153.5 68.03 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.215 -2.266 . . . . 50.62 111.165 174.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.6 Cg_exo -55.01 -24.5 40.1 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 122.623 2.215 . . . . 50.51 111.906 177.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.0 p -89.01 8.32 30.27 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 117.243 2.312 . . . . 50.51 117.243 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.84 137.73 32.99 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 118.648 2.833 . . . . 50.62 118.648 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 25' ' ' ASN . 32.8 p -86.89 137.17 32.61 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.834 -0.621 . . . . 50.51 111.95 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -42.6 -35.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.26 2.85 . . . . 50.51 112.932 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.47 -11.79 58.73 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.488 -0.757 . . . . 50.62 111.077 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' THR . 31.3 t30 -108.56 -14.48 14.63 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.251 1.02 . . . . 50.55 109.814 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.1 t -81.47 -44.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 103.701 -2.703 . . . . 50.51 103.701 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 50.9 mtmt -66.88 -33.54 75.81 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.769 -0.65 . . . . 50.51 110.203 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.04 73.88 Favored 'General case' 0 C--O 1.279 2.627 0 N-CA-C 108.324 -0.991 . . . . 50.51 108.324 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.1 mttt -47.16 -28.35 1.79 Allowed 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.368 -1.458 . . . . 50.51 113.826 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -80.23 -49.76 18.45 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 C-N-CA 119.496 -0.882 . . . . 50.51 109.861 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' ILE . 18.0 tm0? -38.63 -51.14 1.64 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 125.572 2.605 . . . . 50.55 112.061 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -54.69 -39.17 67.87 Favored 'General case' 0 C--O 1.253 1.24 0 N-CA-C 117.499 2.407 . . . . 50.62 117.499 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -109.59 -7.88 15.06 Favored 'General case' 0 C--O 1.279 2.653 0 C-N-CA 116.425 -2.11 . . . . 50.51 111.687 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' HG3' HG12 ' A' ' 36' ' ' ILE . 32.3 tp10 -108.6 -31.54 7.73 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 123.108 2.686 . . . . 50.62 107.77 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.99 7.4 85.52 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 109.488 -1.445 . . . . 50.51 109.488 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.487 HG12 ' HG3' ' A' ' 34' ' ' GLU . 30.4 mm -101.65 131.86 22.42 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 102.233 -3.247 . . . . 50.51 102.233 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.02 136.93 79.62 Favored 'Trans proline' 0 C--O 1.26 1.604 0 C-N-CA 123.192 2.595 . . . . 50.51 110.908 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' CG ' ' HB2' ' A' ' 31' ' ' GLN . 87.7 Cg_exo -57.15 -32.16 92.6 Favored 'Trans proline' 0 C--O 1.262 1.677 0 O-C-N 122.846 0.919 . . . . 50.51 113.44 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.09 2.82 3.22 Favored 'General case' 0 C--O 1.261 1.7 0 O-C-N 119.909 -1.744 . . . . 50.62 112.957 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -127.58 35.97 4.44 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.59 -1.319 . . . . 50.55 113.765 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.22 134.71 55.2 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 124.447 2.07 . . . . 50.55 111.514 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.579 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 54.8 ttm-85 -99.94 124.04 44.84 Favored 'General case' 0 C--O 1.298 3.613 0 CA-C-O 116.635 -1.65 . . . . 50.64 110.22 172.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.23 121.44 42.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.504 1.047 . . . . 50.51 110.749 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.13 123.39 60.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 125.174 1.546 . . . . 50.51 113.674 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.77 112.21 17.05 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 114.616 -1.175 . . . . 50.51 110.196 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.68 27.8 7.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 112.24 -2.254 . . . . 50.51 110.586 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.97 33.26 59.9 Favored Glycine 0 C--N 1.3 -1.453 0 C-N-CA 128.411 2.91 . . . . 50.51 117.476 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -119.03 148.88 42.53 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 104.741 -2.318 . . . . 50.51 104.741 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -88.04 135.75 33.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 119.797 3.258 . . . . 50.55 119.797 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.38 155.5 16.71 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 101.484 -3.525 . . . . 50.51 101.484 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -130.71 157.19 43.47 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 125.02 1.45 . . . . 50.62 108.242 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.01 -34.92 77.41 Favored 'General case' 0 C--O 1.264 1.833 0 C-N-CA 126.19 1.796 . . . . 50.62 109.38 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.39 9.21 4.58 Favored Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 124.426 1.013 . . . . 50.51 113.156 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -124.29 162.56 23.49 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 120.941 3.682 . . . . 50.64 120.941 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -80.43 173.76 12.28 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.028 0.931 . . . . 50.51 109.419 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 tp -88.85 -20.14 25.01 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.04 -1.096 . . . . 50.51 108.04 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 m -79.56 -36.69 37.87 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.362 -1.735 . . . . 50.51 112.665 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -53.13 -17.26 1.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 117.082 2.253 . . . . 50.62 117.082 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -93.38 12.0 26.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.823 -1.084 . . . . 50.51 110.836 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.37 33.08 3.59 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 116.533 2.049 . . . . 50.55 116.533 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -82.26 114.8 23.71 Favored 'Isoleucine or valine' 0 C--O 1.265 1.907 0 CA-C-O 115.268 -2.301 . . . . 50.51 112.346 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -110.33 -166.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.125 2.141 . . . . 50.55 111.126 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.434 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 78.7 tttt -74.16 134.65 42.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.177 1.465 . . . . 50.51 108.792 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.434 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 53.0 mt-10 67.55 44.23 1.75 Allowed 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.537 -2.12 . . . . 50.62 114.35 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -88.21 167.28 13.72 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 105.464 -2.05 . . . . 50.51 105.464 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -121.35 112.31 18.41 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 118.253 -0.879 . . . . 50.51 110.982 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.3 mt -99.7 141.68 32.18 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.729 -2.558 . . . . 50.51 109.56 175.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -95.1 134.81 37.4 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.347 2.905 . . . . 50.51 111.788 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -105.31 114.98 29.49 Favored 'General case' 0 C--O 1.283 2.861 0 CA-C-O 117.611 -1.185 . . . . 50.51 110.902 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.7 t -104.83 137.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.171 -1.788 . . . . 50.51 106.171 175.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.0 tp -79.86 128.68 33.74 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.252 0.549 . . . . 50.51 110.331 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 -103.28 107.41 18.22 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-O 113.428 -3.177 . . . . 50.64 110.041 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.92 143.1 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 125.791 1.932 . . . . 50.51 109.533 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -105.51 59.95 0.67 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.743 -1.571 . . . . 50.64 110.21 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.96 153.21 5.84 Favored Glycine 0 C--O 1.243 0.707 0 N-CA-C 107.926 -2.069 . . . . 50.51 107.926 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 CA-C-O 116.349 -2.362 . . . . 50.51 107.227 179.226 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 101.783 -3.414 . . . . 50.51 101.783 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -110.85 138.34 47.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 126.95 2.656 . . . . 50.55 105.433 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -133.07 155.69 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 115.928 -1.987 . . . . 50.51 113.867 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -93.63 144.41 25.41 Favored 'General case' 0 N--CA 1.512 2.663 1 O-C-N 130.442 4.839 . . . . 50.51 118.789 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.792 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.6 t -132.53 101.96 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.364 -3.208 . . . . 50.51 110.123 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.92 117.99 21.28 Favored 'General case' 0 N--CA 1.504 2.231 1 O-C-N 129.362 4.164 . . . . 50.51 117.225 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 11' ' ' LYS . 41.7 p -70.83 -172.72 0.69 Allowed 'General case' 0 C--N 1.351 0.673 0 N-CA-C 114.893 1.442 . . . . 50.51 114.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.78 11.78 38.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.854 -1.906 . . . . 50.51 105.854 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -122.45 -3.22 8.89 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 115.737 -2.385 . . . . 50.51 114.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 6.76 22.04 Favored Glycine 0 C--N 1.296 -1.665 0 O-C-N 120.103 -1.623 . . . . 50.51 113.617 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 45.0 mtmt -92.66 166.73 12.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 118.445 2.758 . . . . 50.51 118.445 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.0 p -125.15 158.69 33.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 126.658 2.474 . . . . 50.51 105.676 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.792 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 72.3 mt -131.27 111.18 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 127.415 2.947 . . . . 50.51 104.716 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -90.75 110.97 22.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.809 1.781 . . . . 50.51 115.809 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.3 mt -105.77 155.55 19.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 115.483 -2.198 . . . . 50.51 112.153 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.05 112.33 23.88 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 128.9 3.875 . . . . 50.62 112.23 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -117.25 169.45 7.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 O-C-N 127.743 3.152 . . . . 50.51 113.998 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -126.58 158.33 67.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 112.156 -2.293 . . . . 50.62 108.288 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 57' ' ' SER . 85.1 Cg_exo -54.93 -24.56 39.81 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.54 2.16 . . . . 50.51 111.969 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -87.09 -18.39 30.63 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 116.415 2.005 . . . . 50.51 116.415 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -70.86 135.73 48.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.898 1.814 . . . . 50.62 115.898 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.591 HG23 HG23 ' A' ' 55' ' ' THR . 72.3 p -78.85 168.42 19.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.947 1.832 . . . . 50.51 115.947 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 33.8 mm -62.69 -40.62 89.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 O-C-N 127.239 2.837 . . . . 50.51 109.34 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.94 -27.87 46.73 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 50.62 112.809 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.4 -27.85 20.15 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 114.84 1.422 . . . . 50.55 114.84 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.7 -41.63 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.024 1.453 . . . . 50.51 107.155 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -64.62 -28.0 69.32 Favored 'General case' 0 C--O 1.258 1.524 0 CA-C-N 115.845 -0.616 . . . . 50.51 111.524 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -29.6 59.73 Favored 'General case' 0 C--O 1.279 2.637 0 CA-C-N 118.088 0.404 . . . . 50.51 111.599 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.37 -31.34 69.67 Favored 'General case' 0 C--O 1.256 1.401 0 O-C-N 120.319 -1.488 . . . . 50.51 108.493 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.0 -34.67 71.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 107.091 -1.448 . . . . 50.51 107.091 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -56.36 -53.56 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 125.579 2.609 . . . . 50.55 117.578 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.28 -34.27 70.35 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 113.622 -1.626 . . . . 50.62 111.243 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.17 -28.57 21.13 Favored 'General case' 0 C--O 1.278 2.593 0 C-N-CA 116.434 -2.106 . . . . 50.51 109.737 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -117.22 -77.26 0.57 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 123.035 2.652 . . . . 50.62 109.059 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.09 23.51 0.48 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.572 -1.811 . . . . 50.51 108.572 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.498 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.7 mt -79.4 133.5 59.94 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.81 -1.156 . . . . 50.51 112.335 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.03 136.93 79.61 Favored 'Trans proline' 0 C--O 1.26 1.592 0 C-N-CA 123.152 2.568 . . . . 50.51 110.914 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -57.2 -32.1 92.53 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.857 0.925 . . . . 50.51 113.449 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -76.71 -9.23 58.53 Favored 'General case' 0 C--O 1.262 1.746 0 O-C-N 119.94 -1.725 . . . . 50.62 109.297 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -103.01 19.06 20.22 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.422 1.638 . . . . 50.55 115.422 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -127.93 102.04 6.59 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 116.638 2.088 . . . . 50.55 116.638 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -99.35 132.51 44.63 Favored 'General case' 0 C--O 1.296 3.531 0 CA-C-O 116.742 -1.599 . . . . 50.64 109.381 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 mp -103.94 154.75 19.29 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.287 -2.486 . . . . 50.51 104.287 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.07 142.1 35.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.51 111.087 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -142.66 91.3 2.3 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 114.534 -1.212 . . . . 50.51 113.345 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.9 45.6 26.18 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 104.461 -2.422 . . . . 50.51 104.461 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 -18.13 6.99 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 128.386 2.898 . . . . 50.51 113.034 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -76.59 135.75 39.22 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 118.102 0.951 . . . . 50.51 111.418 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.85 129.22 35.14 Favored 'General case' 0 C--O 1.259 1.558 0 O-C-N 123.957 0.785 . . . . 50.55 110.968 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.8 mt -78.65 145.65 34.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 101.906 -3.368 . . . . 50.51 101.906 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -97.99 135.88 39.05 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.939 1.399 . . . . 50.62 108.538 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.5 m-20 -53.66 -49.59 67.63 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 126.151 1.78 . . . . 50.62 111.919 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.93 19.46 5.21 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.4 1.0 . . . . 50.51 113.9 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -113.0 156.69 22.61 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 103.069 -2.937 . . . . 50.64 103.069 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.591 HG23 HG23 ' A' ' 22' ' ' THR . 81.0 p -95.67 168.51 10.63 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.606 0.965 . . . . 50.51 113.606 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.16 -32.19 70.03 Favored 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.15 0.907 . . . . 50.51 109.358 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 90.9 p -74.13 -29.08 61.64 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.271 -1.772 . . . . 50.51 112.149 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' H ' ' HG1' ' A' ' 55' ' ' THR . 97.7 m-20 -61.71 -29.33 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.431 1.11 . . . . 50.62 108.676 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -94.19 -5.21 47.54 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.809 -1.091 . . . . 50.51 112.291 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 53.93 51.33 14.94 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 121.552 1.978 . . . . 50.55 113.882 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -95.53 119.2 43.26 Favored 'Isoleucine or valine' 0 C--O 1.266 1.952 0 N-CA-C 102.218 -3.253 . . . . 50.51 102.218 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 -168.83 2.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.019 2.075 . . . . 50.55 111.213 -176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.65 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 84.2 tttt -79.07 143.76 35.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.185 1.469 . . . . 50.51 107.558 -176.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.65 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 69.66 37.56 1.87 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.559 -2.109 . . . . 50.62 113.62 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -92.42 155.48 17.84 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.809 -1.087 . . . . 50.51 111.994 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -110.27 126.49 54.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 118.199 -0.905 . . . . 50.51 112.717 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.11 155.52 21.8 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 114.679 -2.581 . . . . 50.51 104.356 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -98.0 149.88 21.97 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 127.177 2.798 . . . . 50.51 112.998 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -102.2 126.68 49.25 Favored 'General case' 0 C--O 1.283 2.849 0 N-CA-C 104.9 -2.259 . . . . 50.51 104.9 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.63 146.24 28.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 105.861 -1.903 . . . . 50.51 105.861 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -114.09 107.57 15.83 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 119.869 3.285 . . . . 50.51 119.869 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -92.07 111.1 22.52 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.324 -3.227 . . . . 50.64 104.249 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.52 167.66 14.41 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 125.576 1.798 . . . . 50.51 110.907 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.0 mtm105 -102.85 86.42 2.73 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.72 -1.582 . . . . 50.64 108.321 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.95 147.51 22.78 Favored Glycine 0 C--O 1.244 0.726 0 CA-C-N 114.678 -1.146 . . . . 50.51 114.436 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.457 0 N-CA-C 106.023 -2.831 . . . . 50.51 106.023 179.232 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.547 0.86 0 CA-C-O 118.822 -0.609 . . . . 50.51 111.147 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -96.39 128.69 43.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 126.959 2.662 . . . . 50.55 113.368 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.67 152.44 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 115.972 -1.966 . . . . 50.51 107.561 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.441 ' CD1' HG23 ' A' ' 14' ' ' THR . 97.3 m-85 -109.53 143.06 39.71 Favored 'General case' 0 N--CA 1.512 2.658 1 O-C-N 130.215 4.697 . . . . 50.51 115.202 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.12 98.18 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-O 113.425 -3.179 . . . . 50.51 113.771 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -72.86 114.92 11.54 Favored 'General case' 0 N--CA 1.503 2.224 1 O-C-N 129.297 4.123 . . . . 50.51 109.929 -178.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' HD21 ' A' ' 69' ' ' LEU . 68.7 p -72.04 -169.8 0.52 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-O 117.829 -1.081 . . . . 50.51 113.236 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.34 -47.1 7.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.756 -1.201 . . . . 50.51 107.756 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -70.59 2.17 4.37 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 115.732 -2.387 . . . . 50.51 115.586 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.81 -40.67 2.38 Favored Glycine 0 C--N 1.298 -1.541 0 N-CA-C 120.892 3.117 . . . . 50.51 120.892 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' A' ' 7' ' ' THR . 27.1 tptp -42.09 131.33 3.48 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 116.902 -1.523 . . . . 50.51 108.125 174.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.0 p -101.59 138.15 38.97 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 126.623 2.452 . . . . 50.51 112.184 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 pt -120.16 146.79 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 127.507 3.004 . . . . 50.51 109.399 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.441 HG23 ' CD1' ' A' ' 4' ' ' PHE . 80.8 p -120.6 128.03 52.66 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.249 -1.78 . . . . 50.51 109.583 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 29' ' ' LYS . 50.0 mt -103.8 148.48 26.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 115.542 -2.171 . . . . 50.51 110.37 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -106.41 103.2 12.61 Favored 'General case' 0 N--CA 1.501 2.089 1 O-C-N 129.28 4.112 . . . . 50.62 104.954 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 1' ' ' MET . 33.7 m -101.65 164.54 2.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.69 3.119 . . . . 50.51 112.915 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 6.4 pt-20 -137.33 151.33 71.23 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.164 -2.289 . . . . 50.62 112.798 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.5 Cg_exo -54.97 -24.5 39.77 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 122.587 2.191 . . . . 50.51 111.949 177.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -98.38 21.85 10.51 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 118.208 -0.901 . . . . 50.51 110.829 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -94.57 125.42 39.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 117.354 -1.738 . . . . 50.62 111.189 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.3 p -82.82 135.01 35.09 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.865 -0.607 . . . . 50.51 110.908 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.474 HG21 ' HA ' ' A' ' 52' ' ' ASP . 55.6 mt -37.56 -30.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.137 2.773 . . . . 50.51 117.552 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.21 -27.85 69.34 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.422 -0.798 . . . . 50.62 112.203 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.63 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 57.4 m-80 -86.08 -13.14 48.18 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.309 1.044 . . . . 50.55 112.4 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -78.18 -51.99 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.041 1.463 . . . . 50.51 110.256 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.04 -23.67 55.31 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.174 -0.676 . . . . 50.51 109.174 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.06 -34.79 17.84 Favored 'General case' 0 C--O 1.278 2.598 0 N-CA-C 107.478 -1.305 . . . . 50.51 107.478 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 57.9 mttm -52.26 -38.62 58.72 Favored 'General case' 0 C--O 1.257 1.459 0 N-CA-C 106.291 -1.744 . . . . 50.51 106.291 175.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.9 -33.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 107.56 -1.274 . . . . 50.51 107.56 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 125.583 2.611 . . . . 50.55 113.525 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -58.36 -25.57 62.15 Favored 'General case' 0 C--O 1.254 1.322 0 N-CA-C 119.087 2.995 . . . . 50.62 119.087 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -108.81 -27.25 9.86 Favored 'General case' 0 C--O 1.28 2.659 0 C-N-CA 116.385 -2.126 . . . . 50.51 113.917 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -108.75 -29.15 8.83 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.056 2.662 . . . . 50.62 113.529 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.94 42.88 4.59 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 111.247 -0.741 . . . . 50.51 111.247 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 94.4 mt -117.95 125.2 28.15 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.597 -1.261 . . . . 50.51 107.597 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 77.9 Cg_exo -57.05 136.97 79.82 Favored 'Trans proline' 0 C--O 1.259 1.559 0 C-N-CA 123.106 2.537 . . . . 50.51 110.95 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.17 -32.07 92.37 Favored 'Trans proline' 0 C--O 1.26 1.619 0 O-C-N 122.828 0.909 . . . . 50.51 113.51 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.26 -20.35 64.16 Favored 'General case' 0 C--O 1.262 1.756 0 O-C-N 119.982 -1.699 . . . . 50.62 109.542 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -94.89 7.48 45.85 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.526 -1.358 . . . . 50.55 113.45 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -115.87 119.32 35.58 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 124.42 2.057 . . . . 50.55 110.925 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.466 HH11 ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp85 -106.33 138.18 42.97 Favored 'General case' 0 C--O 1.295 3.486 0 CA-C-O 116.651 -1.642 . . . . 50.64 107.716 172.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.9 mt -115.2 105.97 13.53 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.987 1.847 . . . . 50.51 115.987 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 61.5 mt -110.55 130.37 63.98 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 O-C-N 125.254 1.596 . . . . 50.51 111.633 -177.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -145.83 126.01 13.82 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 115.293 1.59 . . . . 50.51 115.293 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.11 28.24 17.02 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.261 -2.245 . . . . 50.51 107.43 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.7 30.41 77.25 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 128.37 2.89 . . . . 50.51 111.595 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.48 135.6 53.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.455 -2.054 . . . . 50.51 105.455 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.35 113.9 9.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.946 0.779 . . . . 50.55 111.186 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 59' ' ' TYR . 37.5 mt -75.49 113.84 13.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 117.722 -1.132 . . . . 50.51 112.296 -175.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -89.53 126.08 35.45 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.822 1.326 . . . . 50.62 109.598 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.474 ' HA ' HG21 ' A' ' 23' ' ' ILE . 27.7 p-10 -45.36 -38.93 6.28 Favored 'General case' 0 C--O 1.263 1.805 0 C-N-CA 126.14 1.776 . . . . 50.62 111.549 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.52 37.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 108.655 -1.778 . . . . 50.51 108.655 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -94.64 165.67 12.39 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 119.949 -1.912 . . . . 50.64 115.838 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -99.87 166.08 11.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.152 -1.055 . . . . 50.51 108.152 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -86.43 -39.72 16.07 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 104.193 -2.521 . . . . 50.51 104.193 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -52.64 -53.04 52.47 Favored 'General case' 0 C--O 1.268 2.058 0 C-N-CA 117.356 -1.738 . . . . 50.51 113.979 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.42 -28.28 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 120.635 3.568 . . . . 50.62 120.635 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CE2' HD23 ' A' ' 50' ' ' LEU . 42.2 m-85 -82.1 13.1 3.61 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.764 -1.112 . . . . 50.51 109.511 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.57 32.26 20.38 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 121.442 1.928 . . . . 50.55 108.95 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.71 133.1 30.14 Favored 'Isoleucine or valine' 0 C--O 1.267 1.989 0 CA-C-O 115.146 -2.359 . . . . 50.51 113.362 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.426 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 57.7 mt-30 -134.81 -159.34 0.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 125.856 1.972 . . . . 50.55 110.636 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.612 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 63.2 tttm -69.15 149.88 48.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.257 1.503 . . . . 50.51 109.628 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.612 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 47.67 65.48 1.27 Allowed 'General case' 0 C--O 1.257 1.45 0 CA-C-N 112.42 -2.173 . . . . 50.62 113.981 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -122.97 125.57 45.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.921 -1.141 . . . . 50.51 107.921 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -81.67 133.68 35.39 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 117.186 2.291 . . . . 50.51 117.186 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.32 135.88 48.08 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 114.688 -2.577 . . . . 50.51 114.45 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -71.55 133.0 45.48 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 127.365 2.915 . . . . 50.51 115.619 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.483 HD21 ' HA ' ' A' ' 7' ' ' THR . 30.6 tp -104.95 96.99 6.92 Favored 'General case' 0 C--O 1.282 2.809 0 N-CA-C 115.792 1.775 . . . . 50.51 115.792 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.53 123.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.857 -1.164 . . . . 50.51 107.857 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt -73.12 159.23 33.87 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.946 1.091 . . . . 50.51 113.946 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.466 ' HD2' HH11 ' A' ' 42' ' ' ARG . 77.8 ttt-85 -136.96 77.19 1.63 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 113.404 -3.188 . . . . 50.64 111.964 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.42 155.34 15.09 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 116.795 2.146 . . . . 50.51 116.795 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -110.39 85.53 2.13 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.714 -1.585 . . . . 50.64 107.073 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.26 160.9 13.61 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 107.691 -2.164 . . . . 50.51 107.691 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 CA-C-O 116.308 -2.385 . . . . 50.51 110.446 179.174 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.51 107.478 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.55 105.792 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.51 105.226 173.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.51 111.097 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.51 110.321 175.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.51 108.6 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.437 ' HG1' ' HB2' ' A' ' 11' ' ' LYS . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.51 113.379 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.51 115.964 -177.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.51 111.276 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.51 114.048 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.437 ' HB2' ' HG1' ' A' ' 7' ' ' THR . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.51 102.065 174.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.51 107.975 176.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.51 108.441 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.51 110.2 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.416 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.51 118.562 -179.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.62 108.62 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.51 114.132 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.62 106.711 174.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.51 111.935 177.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.51 116.813 -177.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.62 109.138 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG21 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.51 107.045 175.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.51 110.561 175.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.62 113.229 177.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.55 110.044 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.51 107.759 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.51 106.412 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.51 109.249 176.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.657 ' HE3' ' HZ2' ' A' ' 33' ' ' LYS . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.51 111.346 176.077 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.416 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.51 110.973 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.55 112.509 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.62 116.389 179.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.657 ' HZ2' ' HE3' ' A' ' 29' ' ' LYS . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.51 111.864 -175.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.62 117.592 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.51 114.888 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.484 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.51 109.747 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.51 110.864 178.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.51 113.394 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.62 114.605 -177.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.55 107.838 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.55 119.467 -177.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.64 109.52 172.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.51 115.444 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.51 113.347 -177.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.51 111.83 177.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.51 113.518 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.51 115.209 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.51 114.25 177.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.55 117.72 174.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.51 119.412 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.62 106.675 -177.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.62 118.064 -175.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.51 112.981 -177.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.64 112.921 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.51 106.383 177.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.51 114.586 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.51 111.793 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.62 114.68 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.51 113.892 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.55 110.922 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.51 112.515 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.408 ' O ' ' OG ' ' A' ' 65' ' ' SER . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.55 116.774 -176.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.671 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.51 113.522 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.671 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.62 110.901 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.51 110.249 174.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.51 105.297 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.51 101.589 175.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.51 106.251 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.51 111.961 176.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.51 104.421 175.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.51 115.767 178.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.64 106.516 177.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.51 105.632 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.64 107.378 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.51 119.036 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.51 104.312 179.258 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.51 107.478 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.55 105.792 178.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.51 105.226 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.51 111.097 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.51 110.321 175.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.51 108.6 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.437 ' HG1' ' HB2' ' A' ' 11' ' ' LYS . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.51 113.379 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.51 115.964 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.51 111.276 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.51 114.048 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.437 ' HB2' ' HG1' ' A' ' 7' ' ' THR . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.51 102.065 174.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.51 107.975 176.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.51 108.441 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.51 110.2 178.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.416 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.51 118.562 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.62 108.62 174.005 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.51 114.132 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.62 106.711 174.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.51 111.935 177.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.51 116.813 -177.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.62 109.138 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG21 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.51 107.045 175.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.51 110.561 175.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.62 113.229 177.002 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.55 110.044 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.51 107.759 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.51 106.412 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.51 109.249 176.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.657 ' HE3' ' HZ2' ' A' ' 33' ' ' LYS . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.51 111.346 176.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.416 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.51 110.973 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.55 112.509 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.62 116.389 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.657 ' HZ2' ' HE3' ' A' ' 29' ' ' LYS . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.51 111.864 -175.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.62 117.592 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.51 114.888 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.484 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.51 109.747 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.51 110.864 178.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.51 113.394 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.62 114.605 -177.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.55 107.838 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.55 119.467 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.64 109.52 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.51 115.444 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.51 113.347 -177.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.51 111.83 177.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.51 113.518 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.51 115.209 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.51 114.25 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.55 117.72 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.51 119.412 -175.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.62 106.675 -177.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.62 118.064 -175.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.51 112.981 -177.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.64 112.921 176.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.51 106.383 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.51 114.586 177.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.51 111.793 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.62 114.68 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.51 113.892 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.55 110.922 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.51 112.515 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.408 ' O ' ' OG ' ' A' ' 65' ' ' SER . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.55 116.774 -176.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.671 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.51 113.522 -176.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.671 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.62 110.901 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.51 110.249 174.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.51 105.297 176.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.51 101.589 175.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.51 106.251 177.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.51 111.961 176.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.51 104.421 175.142 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.51 115.767 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.64 106.516 177.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.51 105.632 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.64 107.378 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.51 119.036 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.51 104.312 179.258 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.0 mtp . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 115.228 1.566 . . . . 50.51 115.228 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 12.5 mm-40 -88.72 118.09 28.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 126.99 2.681 . . . . 50.55 117.707 178.275 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.523 HD12 HD23 ' A' ' 67' ' ' LEU . 14.7 tt -122.01 161.57 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 115.935 -1.983 . . . . 50.51 109.47 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.432 ' N ' HG12 ' A' ' 3' ' ' ILE . 79.1 m-85 -130.3 128.98 42.63 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 129.667 4.354 . . . . 50.51 113.461 179.548 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -108.91 109.82 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 113.419 -3.182 . . . . 50.51 112.584 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -87.2 134.28 33.55 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.371 4.169 . . . . 50.51 106.23 -178.055 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.1 p -99.77 -168.47 1.61 Allowed 'General case' 0 C--N 1.351 0.651 0 N-CA-C 114.385 1.254 . . . . 50.51 114.385 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 mt -90.15 24.27 2.56 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.125 0.891 . . . . 50.51 111.979 -178.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -139.79 10.95 2.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 115.747 -2.381 . . . . 50.51 110.231 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.83 12.66 81.04 Favored Glycine 0 C--N 1.297 -1.604 0 O-C-N 119.303 -2.123 . . . . 50.51 114.738 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.64 139.47 30.66 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.533 -2.025 . . . . 50.51 105.533 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -120.9 119.62 33.14 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 126.586 2.429 . . . . 50.51 112.064 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.411 HD13 HD11 ' A' ' 15' ' ' LEU . 17.1 pt -94.75 144.3 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.346 2.904 . . . . 50.51 116.312 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -100.32 128.79 46.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.313 -1.755 . . . . 50.51 114.569 178.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD11 HD13 ' A' ' 13' ' ' ILE . 1.5 mp -114.24 145.23 42.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 115.463 -2.208 . . . . 50.51 116.629 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.15 89.58 3.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 129.065 3.978 . . . . 50.62 116.324 173.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.442 HG11 HG23 ' A' ' 26' ' ' VAL . 35.0 m -120.79 148.17 24.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 N-CA-C 120.095 3.368 . . . . 50.51 120.095 -177.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 96.5 mt-10 -98.65 151.47 37.46 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 112.198 -2.274 . . . . 50.62 111.017 174.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.6 Cg_exo -54.89 -24.55 39.49 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.562 2.175 . . . . 50.51 111.962 177.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -73.23 -13.09 61.08 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.487 -2.042 . . . . 50.51 105.487 -177.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.511 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 75.6 m-20 -68.64 138.49 55.05 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 117.323 -1.751 . . . . 50.62 115.301 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -106.3 174.16 6.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.853 -0.612 . . . . 50.51 109.689 175.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -51.18 -46.66 32.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 O-C-N 127.138 2.774 . . . . 50.51 111.886 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -51.8 -38.13 54.43 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.802 -0.814 . . . . 50.62 108.802 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -79.53 -41.47 27.25 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 120.185 3.402 . . . . 50.55 120.185 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.442 HG23 HG11 ' A' ' 17' ' ' VAL . 40.6 t -72.71 -44.32 59.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.085 1.491 . . . . 50.51 114.531 178.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.87 -29.94 68.35 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 107.787 -1.19 . . . . 50.51 107.787 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -49.2 77.73 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 108.517 -0.919 . . . . 50.51 108.517 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -44.95 -53.77 7.28 Favored 'General case' 0 C--O 1.255 1.361 0 O-C-N 120.396 -1.44 . . . . 50.51 109.322 176.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -57.96 -25.23 25.4 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 116.219 1.933 . . . . 50.51 116.219 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.9 tt0 -75.47 -19.66 59.29 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 125.587 2.613 . . . . 50.55 111.862 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.51 -45.28 8.2 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 113.589 -1.641 . . . . 50.62 113.724 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.93 -51.04 10.19 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.476 -2.09 . . . . 50.51 107.665 -175.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -91.97 -56.33 3.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.131 2.696 . . . . 50.62 110.814 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 120.17 4.21 11.33 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 111.616 -0.594 . . . . 50.51 111.616 176.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mm -69.44 123.05 87.61 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 118.852 -1.139 . . . . 50.51 109.38 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -57.02 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.539 0 C-N-CA 123.203 2.602 . . . . 50.51 110.846 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -57.21 -32.09 92.53 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.914 0.955 . . . . 50.51 113.422 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -73.67 2.26 8.53 Favored 'General case' 0 C--O 1.261 1.675 0 N-CA-C 118.375 2.731 . . . . 50.62 118.375 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -115.69 -9.23 11.98 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.536 -1.352 . . . . 50.55 108.153 178.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -81.25 143.28 32.4 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 124.384 2.04 . . . . 50.55 115.24 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -131.95 114.78 15.03 Favored 'General case' 0 C--O 1.296 3.506 0 N-CA-C 105.833 -1.914 . . . . 50.64 105.833 172.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.32 123.89 49.0 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.539 1.063 . . . . 50.51 111.324 -177.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.08 132.63 61.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 O-C-N 125.174 1.546 . . . . 50.51 112.57 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.549 ' CE2' HG12 ' A' ' 61' ' ' ILE . 45.2 t80 -142.33 112.61 7.1 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 114.575 -1.193 . . . . 50.51 108.987 177.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 45' ' ' PHE . . . 75.64 18.64 2.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 112.227 -2.26 . . . . 50.51 108.501 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.3 -2.01 85.84 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.431 2.92 . . . . 50.51 110.513 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -85.66 121.55 28.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 118.045 0.923 . . . . 50.51 111.156 177.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -61.93 137.71 58.28 Favored 'General case' 0 C--O 1.26 1.61 0 N-CA-C 108.169 -1.049 . . . . 50.55 108.169 174.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.5 mt -75.4 149.19 38.65 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.543 -1.28 . . . . 50.51 107.543 -175.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.15 150.89 28.83 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.996 1.435 . . . . 50.62 112.497 -177.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.99 -41.26 78.11 Favored 'General case' 0 C--O 1.264 1.826 0 N-CA-C 118.347 2.721 . . . . 50.62 118.347 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.41 5.0 67.34 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 120.212 2.845 . . . . 50.51 120.212 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.47 154.37 19.69 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 120.089 3.366 . . . . 50.64 120.089 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 41.5 p -93.09 151.9 19.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.39 -3.189 . . . . 50.51 102.39 177.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.4 mt -56.28 -36.58 68.77 Favored 'General case' 0 C--O 1.202 -1.425 0 O-C-N 124.19 0.931 . . . . 50.51 108.894 177.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -62.04 -31.07 71.44 Favored 'General case' 0 C--O 1.268 2.065 0 C-N-CA 117.331 -1.747 . . . . 50.51 109.04 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 55' ' ' THR . 88.7 m-20 -60.42 -10.17 4.54 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.405 1.098 . . . . 50.62 111.684 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -114.16 -14.9 12.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.094 -1.817 . . . . 50.51 106.094 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 48.44 56.77 7.03 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 121.522 1.965 . . . . 50.55 110.701 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.549 HG12 ' CE2' ' A' ' 45' ' ' PHE . 74.1 mt -78.33 105.95 8.25 Favored 'Isoleucine or valine' 0 C--O 1.267 1.997 0 N-CA-C 102.936 -2.987 . . . . 50.51 102.936 175.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.77 176.21 3.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 126.1 2.125 . . . . 50.55 107.713 -176.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -70.73 147.1 49.39 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 123.205 1.478 . . . . 50.51 110.572 -176.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 54.02 44.84 28.72 Favored 'General case' 0 C--O 1.258 1.526 0 CA-C-N 112.521 -2.127 . . . . 50.62 112.894 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -106.87 142.26 36.79 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.157 -1.794 . . . . 50.51 106.157 174.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.0 m -101.25 130.24 47.35 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 120.454 3.501 . . . . 50.51 120.454 175.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.523 HD23 HD12 ' A' ' 3' ' ' ILE . 2.7 mp -95.38 149.7 21.08 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.68 -2.581 . . . . 50.51 114.761 175.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -102.31 132.93 47.97 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 126.969 2.668 . . . . 50.51 114.743 177.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -104.48 122.35 45.35 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.685 -1.15 . . . . 50.51 111.321 176.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -113.09 135.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.571 -1.641 . . . . 50.51 106.571 175.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.8 tp -93.83 100.11 12.36 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.497 1.666 . . . . 50.51 115.497 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -74.84 138.56 42.61 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 113.316 -3.231 . . . . 50.64 108.215 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 mt -111.86 139.2 47.54 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.804 1.94 . . . . 50.51 113.237 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -96.15 68.19 2.65 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 113.69 -1.596 . . . . 50.64 106.907 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.65 148.17 4.85 Favored Glycine 0 C--O 1.244 0.76 0 N-CA-C 107.145 -2.382 . . . . 50.51 107.145 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 116.361 -2.355 . . . . 50.51 110.4 179.246 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.883 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 61.2 mtm . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 105.248 -2.13 . . . . 50.51 105.248 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -70.42 144.62 51.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 127.003 2.689 . . . . 50.55 108.922 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.456 HD13 HD13 ' A' ' 67' ' ' LEU . 21.7 pt -132.24 164.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 N-CA-C 104.099 -2.556 . . . . 50.51 104.099 173.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.25 156.01 22.11 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.473 4.858 . . . . 50.51 109.296 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.0 t -138.52 122.18 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.37 -3.205 . . . . 50.51 109.203 175.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 79.1 tttt -94.94 128.6 41.86 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.403 4.19 . . . . 50.51 114.904 -178.047 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.08 179.23 4.68 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-O 117.809 -1.091 . . . . 50.51 108.425 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.7 -12.19 58.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.93 2.937 . . . . 50.51 118.93 -177.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -90.48 -24.98 20.53 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 115.705 -2.398 . . . . 50.51 105.345 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.23 23.78 3.73 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 107.538 -2.225 . . . . 50.51 107.538 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -86.06 144.22 27.67 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.568 -2.012 . . . . 50.51 105.568 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.2 m -128.44 117.77 21.95 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 126.629 2.456 . . . . 50.51 110.992 176.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.7 pt -98.57 164.85 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 127.469 2.981 . . . . 50.51 113.557 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.6 p -121.59 144.1 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.256 -1.778 . . . . 50.51 108.483 178.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.425 HD23 ' HG3' ' A' ' 29' ' ' LYS . 78.4 mt -132.38 142.62 49.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 103.047 -2.946 . . . . 50.51 103.047 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.93 109.1 17.12 Favored 'General case' 0 N--CA 1.499 2.003 1 O-C-N 129.275 4.109 . . . . 50.62 102.972 173.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.74 156.22 31.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.74 3.15 . . . . 50.51 114.401 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -88.37 139.81 30.18 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.175 -2.284 . . . . 50.62 107.746 174.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.502 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 85.5 Cg_exo -54.83 -24.57 39.11 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 122.552 2.168 . . . . 50.51 111.976 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -61.56 -26.06 67.71 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.241 -1.392 . . . . 50.51 107.241 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -59.76 136.52 58.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.353 -1.739 . . . . 50.62 114.831 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.6 p -79.11 171.59 14.99 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 117.834 -3.041 . . . . 50.51 110.062 175.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.19 -35.25 62.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 O-C-N 127.196 2.81 . . . . 50.51 109.281 175.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.3 -41.77 80.46 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.457 -0.777 . . . . 50.62 112.473 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -76.92 -50.23 13.77 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 115.099 1.518 . . . . 50.55 115.099 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 22' ' ' THR . 54.9 t -51.68 -39.31 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.958 1.411 . . . . 50.51 109.701 178.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -61.71 -36.1 79.97 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 115.833 -0.621 . . . . 50.51 110.368 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.35 86.29 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 109.691 -0.485 . . . . 50.51 109.691 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HG3' HD23 ' A' ' 15' ' ' LEU . 50.9 tptt -57.97 -41.29 82.6 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.191 -1.781 . . . . 50.51 106.191 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.81 -49.17 81.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.54 -0.864 . . . . 50.51 111.674 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.58 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 22.0 tm0? -53.26 -56.83 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 125.554 2.597 . . . . 50.55 117.944 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -46.32 -54.23 9.34 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 118.38 2.733 . . . . 50.62 118.38 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -81.16 -41.8 21.84 Favored 'General case' 0 C--O 1.279 2.638 0 C-N-CA 116.464 -2.095 . . . . 50.51 112.313 -175.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -86.75 -55.43 3.86 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.075 2.67 . . . . 50.62 110.958 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.88 -23.1 5.05 Favored Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 112.031 -0.428 . . . . 50.51 112.031 176.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 mm -53.68 113.86 5.48 Favored Pre-proline 0 C--O 1.245 0.854 0 C-N-CA 118.815 -1.154 . . . . 50.51 109.665 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.553 0 C-N-CA 123.181 2.588 . . . . 50.51 110.925 178.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 88.4 Cg_exo -57.32 -32.03 92.62 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.9 0.947 . . . . 50.51 113.407 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -57.96 -18.12 21.49 Favored 'General case' 0 C--O 1.263 1.8 0 O-C-N 120.008 -1.683 . . . . 50.62 111.655 -177.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -113.53 11.34 18.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 120.631 3.567 . . . . 50.55 120.631 178.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -95.44 129.17 42.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 124.388 2.042 . . . . 50.55 111.987 -177.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 36.6 ttm180 -119.98 110.49 16.76 Favored 'General case' 0 C--O 1.295 3.477 0 N-CA-C 105.776 -1.935 . . . . 50.64 105.776 172.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' HB2' HD12 ' A' ' 50' ' ' LEU . 94.4 mt -101.62 129.7 47.8 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.441 1.019 . . . . 50.51 108.444 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.8 140.51 29.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.054 1.471 . . . . 50.51 111.994 -177.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -138.73 116.81 11.74 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.084 -2.191 . . . . 50.51 105.084 177.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.48 17.8 10.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.193 -2.276 . . . . 50.51 115.981 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.65 8.31 67.87 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 128.443 2.925 . . . . 50.51 109.279 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -100.36 112.81 25.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 118.071 0.936 . . . . 50.51 109.925 177.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -55.43 139.41 43.48 Favored 'General case' 0 C--O 1.259 1.581 0 N-CA-C 108.513 -0.921 . . . . 50.55 108.513 174.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 43' ' ' LEU . 80.9 mt -85.05 141.47 30.25 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.857 1.429 . . . . 50.51 114.857 -175.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -84.65 126.8 33.68 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.923 1.389 . . . . 50.62 111.892 -177.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -50.9 -42.27 59.11 Favored 'General case' 0 C--O 1.264 1.818 0 C-N-CA 126.178 1.791 . . . . 50.62 109.743 -175.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.49 25.1 9.81 Favored Glycine 0 C--O 1.254 1.366 0 C-N-CA 124.442 1.02 . . . . 50.51 114.211 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -116.33 164.69 14.15 Favored 'General case' 0 C--O 1.249 1.048 0 O-C-N 119.915 -1.932 . . . . 50.64 113.457 176.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 41.6 p -101.81 -178.74 3.81 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.111 0.965 . . . . 50.51 110.223 177.102 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 59.3 mt -79.94 -20.5 45.49 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.366 -0.975 . . . . 50.51 108.366 177.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.7 p -88.92 12.95 13.9 Favored 'General case' 0 C--O 1.268 2.077 0 C-N-CA 117.307 -1.757 . . . . 50.51 112.115 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -94.66 -36.24 11.85 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.449 1.119 . . . . 50.62 113.343 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.83 23.88 13.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 120.87 3.656 . . . . 50.51 120.87 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 56.08 46.64 21.26 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 121.515 1.961 . . . . 50.55 111.377 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 61' ' ' ILE . 73.4 mt -101.01 85.54 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.009 0 CA-C-O 115.201 -2.333 . . . . 50.51 106.033 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 65' ' ' SER . 97.8 mm-40 -92.43 -177.07 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.099 2.124 . . . . 50.55 114.683 -176.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.883 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 60.3 pttt -57.76 143.55 41.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.18 1.467 . . . . 50.51 112.192 -176.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 65.78 31.55 9.47 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.502 -2.135 . . . . 50.62 109.887 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 95.7 p -80.23 164.34 23.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.813 -1.18 . . . . 50.51 107.813 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -123.58 131.9 53.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.268 -0.872 . . . . 50.51 108.791 175.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.456 HD13 HD13 ' A' ' 3' ' ' ILE . 7.1 mp -105.38 137.71 42.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.649 -2.595 . . . . 50.51 108.854 175.111 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -98.54 108.48 21.19 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 127.427 2.954 . . . . 50.51 107.195 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 33.2 tp -72.97 147.01 45.62 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.316 1.228 . . . . 50.51 114.316 176.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 63.4 t -138.42 142.85 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 102.787 -3.042 . . . . 50.51 102.787 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 mt -98.29 100.59 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.608 1.336 . . . . 50.51 114.608 178.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -69.95 104.1 2.43 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 113.338 -3.22 . . . . 50.64 112.11 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -83.56 165.07 19.38 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.767 1.917 . . . . 50.51 108.472 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -131.82 45.39 2.79 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.76 -1.564 . . . . 50.64 109.369 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.35 151.14 6.15 Favored Glycine 0 C--O 1.242 0.633 0 N-CA-C 108.027 -2.029 . . . . 50.51 108.027 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.463 0 N-CA-C 106.51 -2.636 . . . . 50.51 106.51 179.226 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 107.734 -1.21 . . . . 50.51 107.734 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -111.06 133.8 53.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 126.915 2.634 . . . . 50.55 105.701 178.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.73 162.13 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 115.921 -1.99 . . . . 50.51 108.41 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -113.0 123.55 50.57 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.518 4.886 . . . . 50.51 110.598 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.28 112.02 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 113.427 -3.178 . . . . 50.51 118.975 175.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.64 133.97 34.81 Favored 'General case' 0 N--CA 1.504 2.252 1 O-C-N 129.363 4.164 . . . . 50.51 105.515 -178.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -115.08 171.63 7.55 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 117.781 -1.104 . . . . 50.51 109.466 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -65.05 -31.81 73.22 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.159 0.912 . . . . 50.51 109.949 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -74.84 -1.95 24.56 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 115.72 -2.392 . . . . 50.51 114.656 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.28 2.52 87.7 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.917 -1.673 . . . . 50.51 108.917 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.01 143.8 41.24 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.507 -1.584 . . . . 50.51 107.443 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -113.93 112.02 22.63 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 126.693 2.495 . . . . 50.51 110.434 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -97.91 143.14 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.561 3.038 . . . . 50.51 113.765 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -108.18 144.73 35.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.267 -1.773 . . . . 50.51 111.923 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -140.7 129.27 22.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.466 -2.207 . . . . 50.51 109.002 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.83 144.12 41.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 128.947 3.904 . . . . 50.62 108.482 174.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -149.39 174.08 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 127.742 3.152 . . . . 50.51 112.14 -177.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 57.3 mm-40 -139.21 150.08 63.23 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.254 -2.248 . . . . 50.62 111.055 174.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -54.88 -24.6 39.64 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.634 2.223 . . . . 50.51 111.957 177.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.4 p -66.87 -38.74 86.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 105.985 -1.857 . . . . 50.51 105.985 -177.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 55' ' ' THR . 84.9 m-20 -44.92 155.21 0.11 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.981 2.215 . . . . 50.62 116.981 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 25' ' ' ASN . 33.1 p -119.01 138.18 53.01 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.252 -3.611 . . . . 50.51 101.252 175.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.664 HD12 HD21 ' A' ' 50' ' ' LEU . 25.5 mm -32.0 -42.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.123 2.764 . . . . 50.51 114.867 175.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -60.83 -34.15 74.11 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 50.62 111.08 176.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' THR . 91.3 m-20 -74.39 -28.93 61.32 Favored 'General case' 0 C--O 1.249 1.053 0 C-N-CA 124.321 1.048 . . . . 50.55 110.31 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -72.51 -51.88 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 125.039 1.462 . . . . 50.51 108.5 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.3 -36.66 84.77 Favored 'General case' 0 C--O 1.257 1.447 0 CA-C-N 115.717 -0.674 . . . . 50.51 109.342 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.61 79.44 Favored 'General case' 0 C--O 1.278 2.584 0 N-CA-C 121.133 3.753 . . . . 50.51 121.133 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -59.49 -41.63 90.3 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 120.404 -1.435 . . . . 50.51 107.679 176.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 60.4 mt -64.22 -20.7 27.41 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 113.375 0.88 . . . . 50.51 113.375 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.461 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 33.4 tt0 -50.19 -41.41 49.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.546 2.593 . . . . 50.55 107.228 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 33' ' ' LYS . 29.3 t70 -81.78 -46.05 14.75 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 116.683 2.105 . . . . 50.62 116.683 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 32' ' ' ASP . 48.5 mmtm -51.27 -64.15 0.9 Allowed 'General case' 0 C--O 1.279 2.631 0 C-N-CA 116.501 -2.079 . . . . 50.51 108.394 -175.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -93.09 -41.33 10.02 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.048 2.658 . . . . 50.62 117.926 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 119.34 17.25 4.91 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 111.083 -0.807 . . . . 50.51 111.083 176.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 24.7 mm -94.9 117.79 66.81 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 118.73 -1.188 . . . . 50.51 110.546 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.0 136.98 79.92 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.154 2.569 . . . . 50.51 110.909 178.341 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -57.26 -32.16 92.86 Favored 'Trans proline' 0 C--O 1.261 1.665 0 O-C-N 122.89 0.942 . . . . 50.51 113.371 -179.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -67.33 -14.44 62.92 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 120.002 -1.686 . . . . 50.62 111.758 -177.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.451 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 58.9 mt-30 -98.64 11.41 38.55 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.54 -1.35 . . . . 50.55 113.001 178.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -113.47 119.1 36.42 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 117.22 2.304 . . . . 50.55 117.22 -177.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.412 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.2 mtm180 -107.41 137.49 45.35 Favored 'General case' 0 C--O 1.296 3.543 0 CA-C-O 116.669 -1.634 . . . . 50.64 111.851 172.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.2 mt -120.94 115.23 22.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.522 1.056 . . . . 50.51 111.809 -177.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.44 114.95 35.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 O-C-N 125.218 1.574 . . . . 50.51 113.496 -177.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' A' ' 50' ' ' LEU . 39.9 t80 -140.76 117.05 10.67 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 114.555 -1.202 . . . . 50.51 109.983 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.36 23.97 13.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.16 -2.291 . . . . 50.51 113.03 177.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.59 0.27 89.87 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 128.379 2.895 . . . . 50.51 110.603 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -103.99 108.28 19.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 116.09 1.885 . . . . 50.51 116.09 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -45.75 129.17 9.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.222 -1.029 . . . . 50.55 108.222 174.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.664 HD21 HD12 ' A' ' 23' ' ' ILE . 5.8 mp -69.9 144.23 52.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 117.742 -1.123 . . . . 50.51 109.544 -175.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.435 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 42.6 mt-10 -94.47 145.44 24.79 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.886 1.366 . . . . 50.62 108.617 -177.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.6 -36.39 83.65 Favored 'General case' 0 C--O 1.263 1.805 0 N-CA-C 117.982 2.586 . . . . 50.62 117.982 -175.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.21 -26.05 49.52 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.411 1.005 . . . . 50.51 112.821 -177.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 22' ' ' THR . 25.6 mmm180 -59.71 173.76 0.53 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 119.957 -1.908 . . . . 50.64 111.275 176.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 21' ' ' ASP . 41.5 p -117.7 172.47 7.34 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 103.117 -2.92 . . . . 50.51 103.117 177.135 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.83 -26.84 64.42 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 106.117 -1.808 . . . . 50.51 106.117 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.1 p -67.3 -25.15 65.9 Favored 'General case' 0 C--O 1.268 2.062 0 C-N-CA 117.324 -1.751 . . . . 50.51 110.745 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 54' ' ' ARG . 47.0 m-20 -66.01 -36.8 84.27 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 118.883 2.92 . . . . 50.62 118.883 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.21 9.34 43.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 117.758 -1.115 . . . . 50.51 112.701 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 57.63 65.42 1.34 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 121.543 1.974 . . . . 50.55 115.113 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.19 93.35 4.21 Favored 'Isoleucine or valine' 0 C--O 1.266 1.967 0 CA-C-O 115.284 -2.293 . . . . 50.51 111.444 175.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.503 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 8.5 mm-40 -99.01 167.07 10.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 126.073 2.108 . . . . 50.55 111.963 -176.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 64.8 mttm -51.99 133.83 32.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 119.673 3.212 . . . . 50.51 119.673 -176.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 64.7 mm-40 77.35 23.48 0.88 Allowed 'General case' 0 C--O 1.256 1.427 0 CA-C-N 112.498 -2.137 . . . . 50.62 111.019 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.0 m -82.38 144.19 30.7 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.787 -1.097 . . . . 50.51 113.336 174.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 p -101.78 131.67 47.96 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 118.252 -0.88 . . . . 50.51 113.348 175.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.0 tp -100.96 139.11 37.11 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 114.647 -2.597 . . . . 50.51 105.642 175.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -100.06 117.84 35.18 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 127.463 2.977 . . . . 50.51 114.223 177.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.0 tp -91.26 106.18 18.32 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 115.187 1.551 . . . . 50.51 115.187 176.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 29.7 t -108.62 136.82 43.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 119.601 1.091 . . . . 50.51 112.155 175.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.2 mt -67.14 155.84 37.72 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 118.226 2.676 . . . . 50.51 118.226 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.451 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 29.2 tpt180 -136.4 77.79 1.67 Allowed 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.32 -3.229 . . . . 50.64 107.103 177.253 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -74.35 140.09 44.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.644 2.091 . . . . 50.51 116.644 -179.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.41 82.94 8.1 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.756 -1.566 . . . . 50.64 108.388 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.39 155.0 20.89 Favored Glycine 0 C--O 1.243 0.712 0 N-CA-C 116.527 1.371 . . . . 50.51 116.527 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 CA-C-O 116.294 -2.392 . . . . 50.51 107.282 179.258 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.51 104.333 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.55 104.738 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.51 102.29 173.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.51 112.145 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.51 111.786 175.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.51 109.252 -178.064 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.51 109.62 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.51 107.743 -178.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.51 114.468 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.51 111.28 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.51 116.256 174.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.51 110.602 176.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.465 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.51 109.027 179.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD21 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.51 113.571 178.077 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.51 114.99 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.62 109.559 173.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.51 121.09 -177.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.62 112.333 174.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.51 111.966 177.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.51 111.757 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.62 111.666 -179.019 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.51 101.444 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.51 119.584 175.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.62 112.675 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.55 114.628 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.51 109.898 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.51 115.72 -179.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.51 107.477 176.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 28' ' ' ALA . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.51 106.496 176.04 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.51 114.209 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.55 108.968 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.62 111.037 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.51 110.301 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.62 120.858 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.51 106.1 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.51 105.672 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.51 110.944 178.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.51 113.447 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.62 108.594 -177.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.55 115.056 178.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.55 109.719 -177.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.64 117.817 172.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.672 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.51 115.168 -177.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.51 112.637 -177.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.51 112.285 177.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.51 110.997 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.51 114.91 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.51 115.839 177.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.483 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.55 106.456 174.564 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.51 105.88 -175.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.62 110.154 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.62 111.365 -175.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.51 116.277 -177.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.64 116.133 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.51 113.461 177.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.51 117.407 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.51 109.337 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.62 110.015 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.51 107.531 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.55 112.093 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.51 107.161 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.55 114.939 -176.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.51 105.716 -176.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.62 117.312 179.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.51 112.232 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.51 108.905 175.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.51 107.573 175.074 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.51 103.336 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.51 105.765 176.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.51 109.836 175.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.51 116.358 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.64 107.244 177.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.51 116.283 -179.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.64 107.429 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.51 109.356 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.51 113.24 179.152 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.51 104.333 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.55 104.738 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.51 102.29 173.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.51 112.145 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.51 111.786 175.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.51 109.252 -178.064 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.51 109.62 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.51 107.743 -178.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.51 114.468 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.51 111.28 179.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.51 116.256 174.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.51 110.602 176.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.465 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.51 109.027 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD21 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.51 113.571 178.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.51 114.99 -179.243 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.62 109.559 173.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.51 121.09 -177.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.62 112.333 174.619 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.51 111.966 177.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.51 111.757 -177.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.62 111.666 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.51 101.444 175.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.51 119.584 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.62 112.675 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.55 114.628 -179.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.51 109.898 178.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.51 115.72 -179.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.51 107.477 176.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 28' ' ' ALA . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.51 106.496 176.04 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.51 114.209 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.55 108.968 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.62 111.037 179.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.51 110.301 -175.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.62 120.858 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.51 106.1 176.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.51 105.672 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.51 110.944 178.284 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.51 113.447 -179.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.62 108.594 -177.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.55 115.056 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.55 109.719 -177.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.64 117.817 172.109 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.672 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.51 115.168 -177.449 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.51 112.637 -177.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.51 112.285 177.562 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.51 110.997 177.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.51 114.91 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.51 115.839 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.483 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.55 106.456 174.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.51 105.88 -175.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.62 110.154 -177.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.62 111.365 -175.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.51 116.277 -177.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.64 116.133 176.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.51 113.461 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.51 117.407 177.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.51 109.337 -179.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.62 110.015 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.51 107.531 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.55 112.093 179.98 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.51 107.161 175.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.55 114.939 -176.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.51 105.716 -176.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.62 117.312 179.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.51 112.232 174.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.51 108.905 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.51 107.573 175.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.51 103.336 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.51 105.765 176.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.51 109.836 175.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.51 116.358 178.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.64 107.244 177.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.51 116.283 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.64 107.429 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.51 109.356 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.51 113.24 179.152 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.51 104.333 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.55 104.738 178.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.51 102.29 173.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.51 112.145 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.51 111.786 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.51 109.252 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.51 109.62 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.51 107.743 -178.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.51 114.468 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.51 111.28 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.51 116.256 174.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.51 110.602 176.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.465 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.51 109.027 179.705 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD21 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.51 113.571 178.077 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.51 114.99 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.62 109.559 173.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.51 121.09 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.62 112.333 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.51 111.966 177.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.51 111.757 -177.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.62 111.666 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.51 101.444 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.51 119.584 175.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.62 112.675 177.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.55 114.628 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.51 109.898 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.51 115.72 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.51 107.477 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 28' ' ' ALA . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.51 106.496 176.04 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.51 114.209 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.55 108.968 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.62 111.037 179.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.51 110.301 -175.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.62 120.858 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.51 106.1 176.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.51 105.672 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.51 110.944 178.284 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.51 113.447 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.62 108.594 -177.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.55 115.056 178.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.55 109.719 -177.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.64 117.817 172.109 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.672 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.51 115.168 -177.449 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.51 112.637 -177.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.51 112.285 177.562 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.51 110.997 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.51 114.91 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.51 115.839 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.483 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.55 106.456 174.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.51 105.88 -175.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.62 110.154 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.62 111.365 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.51 116.277 -177.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.64 116.133 176.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.51 113.461 177.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.51 117.407 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.51 109.337 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.62 110.015 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.51 107.531 179.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.55 112.093 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.51 107.161 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.55 114.939 -176.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.51 105.716 -176.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.62 117.312 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.51 112.232 174.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.51 108.905 175.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.51 107.573 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.51 103.336 177.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.51 105.765 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.51 109.836 175.091 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.51 116.358 178.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.64 107.244 177.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.51 116.283 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.64 107.429 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.51 109.356 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.51 113.24 179.152 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.51 110.493 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.55 104.893 178.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.51 102.837 173.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.41 ' HD2' HG22 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.51 117.134 179.556 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.51 116.317 175.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.51 112.121 -178.081 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.51 109.624 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.51 116.025 -177.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.51 106.536 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.51 112.921 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.51 113.028 175.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.41 HG22 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.51 111.926 176.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.51 102.234 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.51 107.977 178.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.51 113.269 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.62 114.947 174.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 1' ' ' MET . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.51 115.789 -177.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.62 107.53 174.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.51 111.949 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.51 109.308 -177.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.62 108.196 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.51 111.912 175.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 50' ' ' LEU . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.51 112.556 175.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.62 115.475 176.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 55.5 t-20 -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.55 106.23 -179.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.51 107.58 178.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.51 111.113 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.51 109.947 176.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.51 115.455 175.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.51 104.372 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.55 109.548 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.62 110.423 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.51 113.197 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.62 117.619 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.51 109.26 176.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.514 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.51 113.852 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.51 110.907 178.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.51 113.412 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.62 115.136 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.409 HE21 HD11 ' A' ' 71' ' ' LEU . 19.5 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.55 103.57 178.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.55 113.647 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.64 112.495 172.132 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.51 118.018 -177.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.51 117.708 -177.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.61 ' HB3' HD22 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.51 116.78 177.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.51 113.302 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.51 114.896 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.51 114.931 177.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.55 107.727 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.51 107.986 -175.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.62 112.944 -177.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.62 118.065 -175.824 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.51 108.537 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.64 104.693 176.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.51 107.733 177.174 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.51 103.779 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.51 109.455 -179.438 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.62 111.805 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.51 115.046 179.177 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.55 109.887 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.596 HD13 HD22 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.51 106.554 175.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.55 119.305 -176.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.51 112.625 -176.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.62 109.925 179.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.51 105.936 174.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.51 114.003 175.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD22 HD13 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.51 101.726 175.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.508 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 7.7 m170 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.51 105.529 177.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.51 108.662 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.51 109.301 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD11 HE21 ' A' ' 40' ' ' GLN . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.51 105.818 178.446 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.64 109.263 177.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.51 120.492 -179.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.64 113.699 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.51 105.703 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.51 108.344 179.318 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.51 110.493 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.55 104.893 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.51 102.837 173.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.41 ' HD2' HG22 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.51 117.134 179.556 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.51 116.317 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.51 112.121 -178.081 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.51 109.624 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.51 116.025 -177.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.51 106.536 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.51 112.921 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.51 113.028 175.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.41 HG22 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.51 111.926 176.101 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.51 102.234 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.51 107.977 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.51 113.269 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.62 114.947 174.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 1' ' ' MET . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.51 115.789 -177.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.62 107.53 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.51 111.949 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.51 109.308 -177.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.62 108.196 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.51 111.912 175.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 50' ' ' LEU . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.51 112.556 175.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.62 115.475 176.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 55.5 t-20 -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.55 106.23 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.51 107.58 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.51 111.113 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.51 109.947 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.51 115.455 175.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.51 104.372 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.55 109.548 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.62 110.423 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.51 113.197 -175.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.62 117.619 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.51 109.26 176.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.514 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.51 113.852 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.51 110.907 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.51 113.412 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.62 115.136 -177.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.409 HE21 HD11 ' A' ' 71' ' ' LEU . 19.5 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.55 103.57 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.55 113.647 -177.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.64 112.495 172.132 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.51 118.018 -177.498 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.51 117.708 -177.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.61 ' HB3' HD22 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.51 116.78 177.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.51 113.302 177.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.51 114.896 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.51 114.931 177.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.55 107.727 174.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.51 107.986 -175.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.62 112.944 -177.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.62 118.065 -175.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.51 108.537 -177.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.64 104.693 176.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.51 107.733 177.174 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.51 103.779 177.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.51 109.455 -179.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.62 111.805 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.51 115.046 179.177 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.55 109.887 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.596 HD13 HD22 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.51 106.554 175.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.55 119.305 -176.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.51 112.625 -176.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.62 109.925 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.51 105.936 174.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.51 114.003 175.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD22 HD13 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.51 101.726 175.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.508 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 7.7 m170 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.51 105.529 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.51 108.662 176.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.51 109.301 175.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD11 HE21 ' A' ' 40' ' ' GLN . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.51 105.818 178.446 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.64 109.263 177.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.51 120.492 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.64 113.699 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.51 105.703 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.51 108.344 179.318 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 107.349 -1.352 . . . . 50.51 107.349 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -87.51 137.75 32.07 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.946 2.654 . . . . 50.55 110.199 178.218 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -135.32 161.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.022 -1.942 . . . . 50.51 106.638 173.313 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -94.91 148.05 22.73 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.467 4.854 . . . . 50.51 119.097 179.532 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.44 116.74 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.395 -3.193 . . . . 50.51 106.384 175.822 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.19 106.45 17.68 Favored 'General case' 0 N--CA 1.504 2.253 1 O-C-N 129.388 4.18 . . . . 50.51 115.234 -178.118 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -82.79 178.88 7.97 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 117.759 -1.115 . . . . 50.51 109.653 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -70.56 -34.07 71.81 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 120.19 3.404 . . . . 50.51 120.19 -178.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 p -96.57 -9.09 30.21 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 115.706 -2.397 . . . . 50.51 116.356 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.64 38.41 0.72 Allowed Glycine 0 C--N 1.297 -1.617 0 N-CA-C 120.575 2.99 . . . . 50.51 120.575 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -94.61 135.64 35.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.848 -1.548 . . . . 50.51 111.047 175.018 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -109.51 117.76 34.83 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 126.702 2.501 . . . . 50.51 110.113 176.149 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.6 mt -117.72 132.05 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 127.609 3.068 . . . . 50.51 106.754 179.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.3 p -104.75 134.54 47.73 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.298 -1.761 . . . . 50.51 113.776 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.5 mt -118.39 155.87 29.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.435 -2.221 . . . . 50.51 116.029 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -93.7 119.16 32.35 Favored 'General case' 0 N--CA 1.501 2.084 1 O-C-N 129.227 4.08 . . . . 50.62 107.368 173.938 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.23 164.19 28.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 O-C-N 127.739 3.15 . . . . 50.51 111.114 -177.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.8 mt-10 -135.66 145.94 55.27 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 112.215 -2.266 . . . . 50.62 109.52 174.661 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.1 Cg_exo -54.94 -24.49 39.51 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.559 2.172 . . . . 50.51 111.956 177.732 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -78.58 -34.48 46.83 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.947 -1.501 . . . . 50.51 106.947 -177.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.1 145.63 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.37 -1.732 . . . . 50.62 114.434 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -96.83 156.41 16.36 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.874 -0.603 . . . . 50.51 109.555 175.657 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.647 HD11 ' HB3' ' A' ' 50' ' ' LEU . 55.5 mt -50.69 -40.13 19.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 O-C-N 127.094 2.746 . . . . 50.51 108.977 175.774 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 29.3 tt0 -47.65 -57.78 5.08 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.031 -1.1 . . . . 50.62 108.031 177.015 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -53.84 -40.87 66.83 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 115.74 1.756 . . . . 50.55 115.74 -179.633 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.71 -22.3 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 125.086 1.491 . . . . 50.51 110.299 178.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 94.9 mttt -82.78 -38.17 23.53 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 104.744 -2.317 . . . . 50.51 104.744 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.41 -28.45 61.08 Favored 'General case' 0 C--O 1.278 2.605 0 CA-C-N 117.982 0.355 . . . . 50.51 111.845 176.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -66.27 -36.51 83.17 Favored 'General case' 0 C--O 1.256 1.435 0 O-C-N 120.355 -1.466 . . . . 50.51 110.144 175.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.2 -29.29 27.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.529 -0.868 . . . . 50.51 108.661 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.24 -35.61 67.58 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 125.666 2.651 . . . . 50.55 111.019 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -63.75 -27.88 69.5 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 120.947 3.684 . . . . 50.62 120.947 179.132 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -108.83 -20.29 13.11 Favored 'General case' 0 C--O 1.279 2.65 0 O-C-N 119.27 -2.143 . . . . 50.51 113.539 -175.638 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -123.69 -26.57 4.13 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 123.061 2.664 . . . . 50.62 111.205 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.47 12.04 57.58 Favored Glycine 0 CA--C 1.477 -2.303 0 CA-C-O 120.049 -0.306 . . . . 50.51 113.122 176.55 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.5 126.3 84.86 Favored Pre-proline 0 C--O 1.245 0.822 0 N-CA-C 104.66 -2.348 . . . . 50.51 104.66 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.97 136.95 79.69 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.166 2.578 . . . . 50.51 110.914 178.309 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.07 -32.3 92.8 Favored 'Trans proline' 0 C--O 1.262 1.688 0 C-N-CA 120.701 0.934 . . . . 50.51 113.436 -179.321 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -80.12 12.04 3.08 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.864 -1.772 . . . . 50.62 114.954 -177.406 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.23 9.14 11.0 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.467 -1.395 . . . . 50.55 107.358 178.663 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -103.05 125.13 49.65 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.407 2.051 . . . . 50.55 112.999 -177.583 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -111.79 114.54 27.58 Favored 'General case' 0 C--O 1.295 3.478 0 CA-C-O 116.711 -1.614 . . . . 50.64 114.898 172.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.557 HD12 HG23 ' A' ' 23' ' ' ILE . 23.1 mt -98.62 122.34 41.71 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 119.431 1.014 . . . . 50.51 111.832 -177.442 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.81 117.99 56.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 O-C-N 124.545 1.153 . . . . 50.51 111.016 -177.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.692 ' HB3' HD22 ' A' ' 50' ' ' LEU . 57.9 t80 -140.92 143.4 34.58 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.121 -1.437 . . . . 50.51 107.121 177.52 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 45.38 34.98 1.68 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.254 -2.248 . . . . 50.51 106.798 177.434 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.87 -7.39 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.445 2.926 . . . . 50.51 113.263 -179.499 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 46' ' ' ALA . 75.2 mmtt -77.04 148.07 36.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 118.099 0.949 . . . . 50.51 113.402 177.662 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.5 116.09 11.43 Favored 'General case' 0 C--O 1.259 1.573 0 O-C-N 123.953 0.783 . . . . 50.55 109.485 174.559 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.692 HD22 ' HB3' ' A' ' 45' ' ' PHE . 64.8 mt -78.84 145.68 34.1 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 101.394 -3.558 . . . . 50.51 101.394 -175.866 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' O ' HD13 ' A' ' 23' ' ' ILE . 4.2 mm-40 -116.72 148.66 40.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.975 1.472 . . . . 50.62 114.975 -177.661 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.25 -47.9 71.76 Favored 'General case' 0 C--O 1.264 1.838 0 C-N-CA 126.141 1.776 . . . . 50.62 114.572 -175.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 4.42 57.12 Favored Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 124.408 1.004 . . . . 50.51 112.921 -177.25 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.438 ' HD2' ' OH ' ' A' ' 59' ' ' TYR . 89.3 mtt-85 -93.01 143.52 26.15 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 119.997 -1.884 . . . . 50.64 112.3 176.451 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.2 p -86.25 162.05 18.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.036 0.935 . . . . 50.51 112.019 177.087 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.57 -27.31 65.95 Favored 'General case' 0 C--O 1.201 -1.495 0 N-CA-C 102.205 -3.257 . . . . 50.51 102.205 177.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -71.67 -36.03 70.52 Favored 'General case' 0 C--O 1.267 2.022 0 C-N-CA 117.326 -1.749 . . . . 50.51 113.078 -179.387 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -49.86 -38.64 36.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.501 1.143 . . . . 50.62 113.718 179.765 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.438 ' OH ' ' HD2' ' A' ' 54' ' ' ARG . 58.1 m-85 -91.58 -10.72 39.51 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.759 -1.115 . . . . 50.51 113.584 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 70.31 41.58 1.01 Allowed 'General case' 0 C--O 1.248 0.989 0 CA-C-N 121.52 1.964 . . . . 50.55 108.684 179.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.72 118.07 14.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.93 0 CA-C-O 115.184 -2.341 . . . . 50.51 107.126 175.872 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -97.3 177.86 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.556 1.785 . . . . 50.55 110.196 -176.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -58.15 146.94 31.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.198 1.475 . . . . 50.51 107.658 -176.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 39.74 61.31 1.46 Allowed 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.537 -2.12 . . . . 50.62 112.614 179.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 m -98.26 151.07 20.85 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 104.729 -2.323 . . . . 50.51 104.729 174.743 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 p -95.96 140.26 30.96 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 118.287 -0.863 . . . . 50.51 111.879 175.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -122.64 136.92 55.01 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 114.641 -2.599 . . . . 50.51 104.479 175.088 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.15 116.92 29.2 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 127.427 2.954 . . . . 50.51 108.517 177.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.25 130.92 34.96 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.623 -1.179 . . . . 50.51 111.098 176.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -128.56 141.78 45.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 104.004 -2.591 . . . . 50.51 104.004 174.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.4 ' HA ' HD21 ' A' ' 71' ' ' LEU . 35.5 mt -97.55 123.54 41.46 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.639 0.607 . . . . 50.51 112.639 178.438 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -104.28 86.76 2.59 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.336 -3.221 . . . . 50.64 112.841 177.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.7 mt -73.32 167.77 20.55 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.954 . . . . 50.51 107.815 -179.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -120.59 86.5 2.58 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.714 -1.585 . . . . 50.64 107.247 -179.624 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.23 131.74 3.36 Favored Glycine 0 C--O 1.244 0.743 0 O-C-N 124.645 1.216 . . . . 50.51 113.081 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.47 1 O-C-N 115.118 -4.754 . . . . 50.51 103.707 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.51 111.053 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.55 116.588 178.321 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.51 108.408 173.351 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.51 119.91 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.51 113.866 175.785 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.51 109.83 -178.037 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.51 114.27 179.956 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.51 106.823 -177.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.51 106.406 179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.51 115.847 179.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.51 113.185 174.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.51 106.82 176.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.51 110.632 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.51 110.788 178.084 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.51 115.167 -179.282 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.62 107.469 173.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.51 111.54 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.62 109.116 174.729 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.51 111.942 177.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.51 110.261 -177.489 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.62 110.438 -179.014 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.51 102.814 175.665 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.51 108.219 175.869 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.62 110.915 177.063 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.55 110.953 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.51 113.215 178.571 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.51 108.802 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.51 103.321 176.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.51 108.74 176.075 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.51 114.446 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.555 HE21 ' HA ' ' A' ' 37' ' ' PRO . 33.4 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.55 111.108 179.417 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.62 106.799 179.153 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.51 117.415 -175.737 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.62 108.973 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.51 108.229 176.498 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.51 107.149 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.555 ' HA ' HE21 ' A' ' 31' ' ' GLN . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.51 110.835 178.328 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.51 113.479 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.62 113.097 -177.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.55 107.358 178.748 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.55 116.575 -177.483 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.605 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.64 106.18 172.202 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' HB3' HD12 ' A' ' 50' ' ' LEU . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.51 109.103 -177.516 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.51 114.506 -177.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.494 ' HB3' HD22 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.51 114.578 177.624 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.51 108.335 177.409 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.51 113.694 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.51 108.927 177.678 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.55 107.079 174.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.51 107.602 -175.891 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.62 112.193 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.62 116.528 -175.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.51 116.292 -177.256 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.64 108.919 176.463 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.51 113.355 177.121 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.51 108.481 177.184 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.51 116.691 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.62 119.838 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.51 110.142 179.286 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.55 113.734 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.51 105.625 175.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.55 108.806 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.581 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.51 116.225 -176.896 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.62 117.221 179.545 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.51 103.824 174.726 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.51 115.599 175.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.51 106.66 175.091 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.51 108.183 177.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.51 108.516 176.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.51 105.118 175.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.51 116.356 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.605 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.64 113.39 177.176 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.51 111.184 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.64 111.505 -179.621 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.51 104.884 179.378 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.51 116.938 179.231 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.51 111.053 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.55 116.588 178.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.51 108.408 173.351 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.51 119.91 179.541 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.51 113.866 175.785 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.51 109.83 -178.037 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.51 114.27 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.51 106.823 -177.969 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.51 106.406 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.51 115.847 179.804 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.51 113.185 174.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.51 106.82 176.229 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.51 110.632 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.51 110.788 178.084 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.51 115.167 -179.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.62 107.469 173.999 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.51 111.54 -177.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.62 109.116 174.729 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.51 111.942 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.51 110.261 -177.489 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.62 110.438 -179.014 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.51 102.814 175.665 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.51 108.219 175.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.62 110.915 177.063 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.55 110.953 -179.579 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.51 113.215 178.571 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.51 108.802 -179.798 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.51 103.321 176.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.51 108.74 176.075 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.51 114.446 179.874 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.555 HE21 ' HA ' ' A' ' 37' ' ' PRO . 33.4 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.55 111.108 179.417 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.62 106.799 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.51 117.415 -175.737 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.62 108.973 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.51 108.229 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.51 107.149 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.555 ' HA ' HE21 ' A' ' 31' ' ' GLN . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.51 110.835 178.328 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.51 113.479 -179.365 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.62 113.097 -177.452 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.55 107.358 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.55 116.575 -177.483 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.605 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.64 106.18 172.202 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' HB3' HD12 ' A' ' 50' ' ' LEU . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.51 109.103 -177.516 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.51 114.506 -177.616 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.494 ' HB3' HD22 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.51 114.578 177.624 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.51 108.335 177.409 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.51 113.694 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.51 108.927 177.678 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.55 107.079 174.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.51 107.602 -175.891 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.62 112.193 -177.677 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.62 116.528 -175.761 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.51 116.292 -177.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.64 108.919 176.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.51 113.355 177.121 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.51 108.481 177.184 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.51 116.691 -179.453 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.62 119.838 179.741 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.51 110.142 179.286 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.55 113.734 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.51 105.625 175.863 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.55 108.806 -176.835 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.581 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.51 116.225 -176.896 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.62 117.221 179.545 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.51 103.824 174.726 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.51 115.599 175.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.51 106.66 175.091 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.51 108.183 177.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.51 108.516 176.581 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.51 105.118 175.096 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.51 116.356 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.605 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.64 113.39 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.51 111.184 -179.342 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.64 111.505 -179.621 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.51 104.884 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.51 116.938 179.231 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.51 110.518 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.55 111.931 178.254 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.51 109.629 173.36 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.51 110.788 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.51 109.267 175.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.51 112.054 -178.082 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.51 109.558 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.51 115.426 -177.96 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.51 110.359 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.51 109.262 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.51 111.702 175.031 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.51 120.495 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.51 104.467 179.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.51 119.511 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.51 111.182 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.62 105.523 173.97 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.51 120.87 -177.968 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.62 113.88 174.624 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.51 111.907 177.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.51 110.539 -177.503 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.62 116.041 -179.054 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.51 113.13 175.663 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.51 106.643 175.794 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.62 109.013 176.992 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.55 120.754 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.51 109.974 178.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.51 103.034 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.51 114.005 176.947 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.51 108.149 175.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.51 112.731 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.55 116.636 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.62 110.424 179.144 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.51 117.298 -175.651 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.62 114.698 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.51 108.03 176.505 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.51 103.399 179.696 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.51 110.927 178.325 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.51 113.487 -179.297 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.62 115.612 -177.478 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.55 108.548 178.699 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.55 111.184 -177.606 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.64 102.446 172.198 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.51 113.857 -177.541 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.51 112.916 -177.592 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.51 108.783 177.641 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 45' ' ' PHE . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.51 104.079 177.365 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.51 117.886 -179.581 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.51 111.909 177.62 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.55 106.814 174.54 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.51 110.278 -175.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.62 111.58 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.62 111.456 -175.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.51 112.985 -177.227 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.64 115.651 176.557 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.51 116.995 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD23 HD13 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.51 105.494 177.211 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.51 113.975 -179.481 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.62 113.595 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.51 108.268 179.243 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 57' ' ' SER . 17.4 m120 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.55 112.768 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.594 HD13 HD23 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.51 112.67 175.785 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.55 105.766 -176.791 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.51 107.365 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.62 116.2 179.519 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.51 107.156 174.815 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.51 106.777 175.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.51 107.127 175.12 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.51 114.104 177.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.51 109.856 176.533 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.51 106.088 175.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.51 118.655 178.372 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.64 107.592 177.293 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.51 112.686 -179.374 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.64 111.255 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.51 104.302 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.51 116.097 179.25 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.51 110.518 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.55 111.931 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.51 109.629 173.36 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.51 110.788 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.51 109.267 175.855 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.51 112.054 -178.082 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.51 109.558 179.941 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.51 115.426 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.51 110.359 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.51 109.262 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.51 111.702 175.031 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.51 120.495 176.137 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.51 104.467 179.69 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.51 119.511 178.086 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.51 111.182 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.62 105.523 173.97 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.51 120.87 -177.968 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.62 113.88 174.624 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.51 111.907 177.796 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.51 110.539 -177.503 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.62 116.041 -179.054 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.51 113.13 175.663 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.51 106.643 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.62 109.013 176.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.55 120.754 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.51 109.974 178.629 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.51 103.034 -179.722 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.51 114.005 176.947 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.51 108.149 175.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.51 112.731 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.55 116.636 179.47 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.62 110.424 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.51 117.298 -175.651 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.62 114.698 179.824 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.51 108.03 176.505 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.51 103.399 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.51 110.927 178.325 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.51 113.487 -179.297 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.62 115.612 -177.478 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.55 108.548 178.699 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.55 111.184 -177.606 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.64 102.446 172.198 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.51 113.857 -177.541 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.51 112.916 -177.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.51 108.783 177.641 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 45' ' ' PHE . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.51 104.079 177.365 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.51 117.886 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.51 111.909 177.62 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.55 106.814 174.54 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.51 110.278 -175.89 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.62 111.58 -177.608 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.62 111.456 -175.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.51 112.985 -177.227 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.64 115.651 176.557 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.51 116.995 177.093 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD23 HD13 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.51 105.494 177.211 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.51 113.975 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.62 113.595 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.51 108.268 179.243 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 57' ' ' SER . 17.4 m120 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.55 112.768 179.934 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.594 HD13 HD23 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.51 112.67 175.785 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.55 105.766 -176.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.51 107.365 -176.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.62 116.2 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.51 107.156 174.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.51 106.777 175.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.51 107.127 175.12 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.51 114.104 177.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.51 109.856 176.533 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.51 106.088 175.043 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.51 118.655 178.372 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.64 107.592 177.293 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.51 112.686 -179.374 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.64 111.255 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.51 104.302 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.51 116.097 179.25 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.51 109.216 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.55 103.603 178.265 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.51 102.846 173.404 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.51 110.328 179.525 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.51 108.503 175.797 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.51 111.281 -178.135 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.51 107.142 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.51 113.219 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.51 118.548 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.51 113.235 179.813 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.51 110.483 175.053 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.51 109.006 176.163 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.51 111.867 179.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.51 112.051 178.17 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.51 111.304 -179.259 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.62 111.542 173.996 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.51 113.859 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.62 109.383 174.688 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' CB ' ' HB3' ' A' ' 57' ' ' SER . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.51 111.93 177.744 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.51 109.656 -177.521 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.62 105.534 -178.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.51 104.641 175.636 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.51 102.724 175.8 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.62 112.597 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.55 113.205 -179.62 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.51 106.768 178.591 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.51 104.533 -179.657 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.51 115.722 176.905 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.51 109.212 176.022 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.51 108.658 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.55 111.06 179.442 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.62 114.416 179.161 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.51 113.454 -175.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.62 118.939 179.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.51 116.117 176.531 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.51 115.529 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.51 110.941 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.51 113.474 -179.286 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.62 110.618 -177.477 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.55 116.484 178.705 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.55 110.86 -177.585 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.64 113.393 172.104 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.51 110.243 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.51 110.981 -177.61 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD21 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.51 108.01 177.633 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.51 113.133 177.447 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.51 117.508 -179.574 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.51 101.956 177.664 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.55 110.798 174.602 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.51 119.732 -175.918 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.62 112.76 -177.687 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.62 106.458 -175.812 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.51 113.468 -177.236 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.64 110.824 176.396 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.51 113.774 177.098 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 26' ' ' VAL . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.51 108.835 177.218 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.51 111.441 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.62 112.841 179.711 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.51 112.857 179.26 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.55 107.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.51 106.658 175.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.55 117.509 -176.826 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.51 120.0 -176.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.62 112.075 179.492 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.51 105.232 174.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.51 116.272 175.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.51 110.944 175.058 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.51 108.741 177.914 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.51 111.13 176.573 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.51 106.129 175.073 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.51 117.402 178.462 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.64 102.12 177.214 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.51 112.404 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.64 110.368 -179.564 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.51 110.56 179.331 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.51 115.967 179.282 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.51 109.216 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.55 103.603 178.265 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.51 102.846 173.404 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.51 110.328 179.525 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.51 108.503 175.797 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.51 111.281 -178.135 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.51 107.142 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.51 113.219 -177.941 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.51 118.548 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.51 113.235 179.813 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.51 110.483 175.053 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.51 109.006 176.163 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.51 111.867 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.51 112.051 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.51 111.304 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.62 111.542 173.996 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.51 113.859 -177.904 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.62 109.383 174.688 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' CB ' ' HB3' ' A' ' 57' ' ' SER . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.51 111.93 177.744 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.51 109.656 -177.521 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.62 105.534 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.51 104.641 175.636 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.51 102.724 175.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.62 112.597 176.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.55 113.205 -179.62 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.51 106.768 178.591 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.51 104.533 -179.657 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.51 115.722 176.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.51 109.212 176.022 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.51 108.658 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.55 111.06 179.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.62 114.416 179.161 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.51 113.454 -175.681 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.62 118.939 179.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.51 116.117 176.531 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.51 115.529 179.717 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.51 110.941 178.286 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.51 113.474 -179.286 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.62 110.618 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.55 116.484 178.705 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.55 110.86 -177.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.64 113.393 172.104 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.51 110.243 -177.466 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.51 110.981 -177.61 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD21 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.51 108.01 177.633 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.51 113.133 177.447 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.51 117.508 -179.574 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.51 101.956 177.664 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.55 110.798 174.602 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.51 119.732 -175.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.62 112.76 -177.687 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.62 106.458 -175.812 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.51 113.468 -177.236 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.64 110.824 176.396 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.51 113.774 177.098 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 26' ' ' VAL . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.51 108.835 177.218 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.51 111.441 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.62 112.841 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.51 112.857 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.55 107.075 179.86 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.51 106.658 175.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.55 117.509 -176.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.51 120.0 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.62 112.075 179.492 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.51 105.232 174.788 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.51 116.272 175.958 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.51 110.944 175.058 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.51 108.741 177.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.51 111.13 176.573 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.51 106.129 175.073 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.51 117.402 178.462 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.64 102.12 177.214 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.51 112.404 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.64 110.368 -179.564 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.51 110.56 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.51 115.967 179.282 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.51 109.216 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.55 103.603 178.265 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.51 102.846 173.404 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.51 110.328 179.525 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.51 108.503 175.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.51 111.281 -178.135 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.51 107.142 179.927 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.51 113.219 -177.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.51 118.548 179.928 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.51 113.235 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.51 110.483 175.053 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.51 109.006 176.163 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.51 111.867 179.742 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.51 112.051 178.17 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.51 111.304 -179.259 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.62 111.542 173.996 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.51 113.859 -177.904 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.62 109.383 174.688 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' CB ' ' HB3' ' A' ' 57' ' ' SER . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.51 111.93 177.744 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.51 109.656 -177.521 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.62 105.534 -178.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.51 104.641 175.636 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.51 102.724 175.8 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.62 112.597 176.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.55 113.205 -179.62 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.51 106.768 178.591 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.51 104.533 -179.657 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.51 115.722 176.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.51 109.212 176.022 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.51 108.658 179.937 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.55 111.06 179.442 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.62 114.416 179.161 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.51 113.454 -175.681 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.62 118.939 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.51 116.117 176.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.51 115.529 179.717 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.51 110.941 178.286 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.51 113.474 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.62 110.618 -177.477 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.55 116.484 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.55 110.86 -177.585 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.64 113.393 172.104 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.51 110.243 -177.466 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.51 110.981 -177.61 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD21 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.51 108.01 177.633 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.51 113.133 177.447 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.51 117.508 -179.574 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.51 101.956 177.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.55 110.798 174.602 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.51 119.732 -175.918 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.62 112.76 -177.687 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.62 106.458 -175.812 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.51 113.468 -177.236 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.64 110.824 176.396 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.51 113.774 177.098 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 26' ' ' VAL . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.51 108.835 177.218 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.51 111.441 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.62 112.841 179.711 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.51 112.857 179.26 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.55 107.075 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.51 106.658 175.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.55 117.509 -176.826 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.51 120.0 -176.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.62 112.075 179.492 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.51 105.232 174.788 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.51 116.272 175.958 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.51 110.944 175.058 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.51 108.741 177.914 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.51 111.13 176.573 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.51 106.129 175.073 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.51 117.402 178.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.64 102.12 177.214 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.51 112.404 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.64 110.368 -179.564 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.51 110.56 179.331 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.51 115.967 179.282 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.51 109.216 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.55 103.603 178.265 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.51 102.846 173.404 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.51 110.328 179.525 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.51 108.503 175.797 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.51 111.281 -178.135 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.51 107.142 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.51 113.219 -177.941 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.51 118.548 179.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.51 113.235 179.813 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.51 110.483 175.053 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.51 109.006 176.163 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.51 111.867 179.742 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.51 112.051 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.51 111.304 -179.259 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.62 111.542 173.996 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.51 113.859 -177.904 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.62 109.383 174.688 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' CB ' ' HB3' ' A' ' 57' ' ' SER . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.51 111.93 177.744 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.51 109.656 -177.521 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.62 105.534 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.51 104.641 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.51 102.724 175.8 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.62 112.597 176.987 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.55 113.205 -179.62 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.51 106.768 178.591 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.51 104.533 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.51 115.722 176.905 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.51 109.212 176.022 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.51 108.658 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.55 111.06 179.442 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.62 114.416 179.161 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.51 113.454 -175.681 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.62 118.939 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.51 116.117 176.531 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.51 115.529 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.51 110.941 178.286 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.51 113.474 -179.286 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.62 110.618 -177.477 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.55 116.484 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.55 110.86 -177.585 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.64 113.393 172.104 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.51 110.243 -177.466 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.51 110.981 -177.61 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD21 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.51 108.01 177.633 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.51 113.133 177.447 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.51 117.508 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.51 101.956 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.55 110.798 174.602 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.51 119.732 -175.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.62 112.76 -177.687 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.62 106.458 -175.812 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.51 113.468 -177.236 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.64 110.824 176.396 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.51 113.774 177.098 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 26' ' ' VAL . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.51 108.835 177.218 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.51 111.441 -179.44 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.62 112.841 179.711 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.51 112.857 179.26 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.55 107.075 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.51 106.658 175.859 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.55 117.509 -176.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.51 120.0 -176.981 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.62 112.075 179.492 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.51 105.232 174.788 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.51 116.272 175.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.51 110.944 175.058 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.51 108.741 177.914 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.51 111.13 176.573 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.51 106.129 175.073 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.51 117.402 178.462 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.64 102.12 177.214 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.51 112.404 -179.306 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.64 110.368 -179.564 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.51 110.56 179.331 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.51 115.967 179.282 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.992 0.738 . . . . 50.51 112.992 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.58 106.94 9.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 126.973 2.671 . . . . 50.55 111.748 178.306 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -114.26 155.73 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 CA-C-O 115.983 -1.96 . . . . 50.51 113.24 173.276 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -119.93 132.41 55.51 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.523 4.889 . . . . 50.51 112.064 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.481 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 70.8 t -108.49 134.02 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 113.412 -3.185 . . . . 50.51 112.244 175.773 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -94.46 118.68 32.02 Favored 'General case' 0 N--CA 1.503 2.22 1 O-C-N 129.329 4.143 . . . . 50.51 106.07 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -98.48 161.28 13.76 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 117.753 -1.117 . . . . 50.51 110.633 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -54.82 -33.43 61.6 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.877 1.436 . . . . 50.51 114.877 -177.95 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 9' ' ' THR . 54.0 m -71.16 -20.77 62.26 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 115.689 -2.404 . . . . 50.51 113.117 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.56 -10.97 38.99 Favored Glycine 0 C--N 1.297 -1.602 0 O-C-N 120.144 -1.598 . . . . 50.51 116.312 179.843 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -69.22 117.6 11.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 116.868 -1.539 . . . . 50.51 110.608 174.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.2 m -73.51 126.55 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.659 2.475 . . . . 50.51 111.716 176.201 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.481 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 14.1 pt -104.58 142.4 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 127.432 2.958 . . . . 50.51 112.531 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -106.34 142.04 36.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 117.294 -1.763 . . . . 50.51 112.363 178.112 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -131.01 133.8 46.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 115.49 -2.195 . . . . 50.51 113.451 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -100.57 139.88 35.63 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 129.163 4.04 . . . . 50.62 106.417 173.974 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.94 170.76 18.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 O-C-N 127.728 3.143 . . . . 50.51 117.344 -177.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 28.4 mt-10 -115.27 138.13 23.43 Favored Pre-proline 0 C--N 1.315 -0.926 0 N-CA-C 103.36 -2.83 . . . . 50.62 103.36 174.642 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.6 Cg_exo -55.02 -24.46 40.01 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 122.535 2.157 . . . . 50.51 111.957 177.706 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -79.01 -6.42 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.128 -0.939 . . . . 50.51 109.326 -177.611 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -72.55 122.55 21.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.092 2.627 . . . . 50.62 118.092 -178.954 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.456 ' O ' HG21 ' A' ' 26' ' ' VAL . 66.8 p -67.66 155.54 38.95 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.423 -1.325 . . . . 50.51 107.423 175.71 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 54' ' ' ARG . 25.6 mm -58.12 -23.74 22.31 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 127.191 2.807 . . . . 50.51 107.383 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.34 -39.99 67.72 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.471 -0.768 . . . . 50.62 110.918 177.097 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -70.7 -20.67 62.65 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.292 1.037 . . . . 50.55 108.258 -179.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 22' ' ' THR . 90.6 t -71.35 -57.52 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 101.293 -3.595 . . . . 50.51 101.293 178.579 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HG2' ' OE1' ' A' ' 41' ' ' GLN . 93.6 mttt -52.14 -38.47 57.65 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 114.456 1.28 . . . . 50.51 114.456 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.08 90.84 Favored 'General case' 0 C--O 1.278 2.591 0 CA-C-N 118.007 0.367 . . . . 50.51 110.322 176.869 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -60.61 -13.47 14.53 Favored 'General case' 0 C--O 1.254 1.309 0 N-CA-C 118.576 2.806 . . . . 50.51 118.576 176.028 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -90.99 -40.41 12.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 C-N-CA 119.565 -0.854 . . . . 50.51 110.04 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.567 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 31.3 tt0 -54.15 -31.98 54.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 125.656 2.646 . . . . 50.55 116.229 179.474 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.04 -72.14 0.1 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.627 -1.624 . . . . 50.62 109.717 179.092 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.94 -39.99 33.09 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.404 -2.119 . . . . 50.51 114.829 -175.745 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -88.19 -22.14 24.18 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 123.037 2.653 . . . . 50.62 114.028 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 71.31 27.13 72.16 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 109.332 -1.507 . . . . 50.51 109.332 176.571 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.8 mt -96.66 118.62 64.99 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.856 -1.138 . . . . 50.51 107.968 179.711 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.8 Cg_exo -57.02 136.99 80.0 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 123.149 2.566 . . . . 50.51 110.865 178.296 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.5 Cg_exo -57.25 -32.16 92.81 Favored 'Trans proline' 0 C--O 1.261 1.657 0 O-C-N 122.873 0.933 . . . . 50.51 113.391 -179.268 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -69.76 -21.8 63.4 Favored 'General case' 0 C--O 1.262 1.736 0 O-C-N 119.985 -1.697 . . . . 50.62 110.39 -177.443 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -93.91 18.16 10.97 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.52 -1.363 . . . . 50.55 110.421 178.662 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.515 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 71.7 mt-30 -111.49 139.57 46.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.3 2.0 . . . . 50.55 112.116 -177.584 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.702 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 37.5 ttm180 -119.97 126.61 51.28 Favored 'General case' 0 C--O 1.296 3.529 0 CA-C-O 116.708 -1.615 . . . . 50.64 108.393 172.147 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.3 mt -118.91 89.25 3.09 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.452 1.024 . . . . 50.51 112.257 -177.553 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.539 HD12 ' HD3' ' A' ' 42' ' ' ARG . 60.5 mt -98.51 128.85 49.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 O-C-N 125.255 1.597 . . . . 50.51 107.084 -177.63 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.671 ' CE2' HG12 ' A' ' 61' ' ' ILE . 87.3 t80 -136.33 124.6 23.21 Favored 'General case' 0 C--N 1.36 1.025 0 CA-C-N 114.498 -1.228 . . . . 50.51 110.627 177.646 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 36.84 20.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 112.221 -2.263 . . . . 50.51 113.255 177.332 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 25.15 63.84 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 128.455 2.931 . . . . 50.51 115.916 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.17 136.55 40.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 118.036 0.918 . . . . 50.51 110.82 177.621 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -73.45 128.24 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.05 0.844 . . . . 50.55 112.456 174.624 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 43' ' ' LEU . 78.2 mt -77.4 149.15 35.19 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 105.514 -2.032 . . . . 50.51 105.514 -175.903 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 82.5 tt0 -105.72 144.53 32.34 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.929 1.393 . . . . 50.62 113.456 -177.693 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 37.5 p30 -61.19 -35.51 77.35 Favored 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.099 1.76 . . . . 50.62 109.198 -175.749 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.481 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -91.48 20.94 38.03 Favored Glycine 0 CA--C 1.492 -1.403 0 C-N-CA 124.383 0.992 . . . . 50.51 115.55 -177.296 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.6 ' O ' HG12 ' A' ' 23' ' ' ILE . 86.5 mmt-85 -128.69 168.3 16.0 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 101.878 -3.378 . . . . 50.64 101.878 176.488 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -108.57 152.67 24.44 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.003 0.921 . . . . 50.51 108.842 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.7 mt -47.36 -39.42 15.06 Favored 'General case' 0 C--O 1.201 -1.462 0 O-C-N 124.087 0.867 . . . . 50.51 108.791 177.239 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -70.79 -27.71 64.11 Favored 'General case' 0 C--O 1.268 2.051 0 N-CA-C 116.35 1.981 . . . . 50.51 116.35 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -57.46 -27.18 62.24 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.496 1.141 . . . . 50.62 109.733 179.789 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 59.0 m-85 -87.06 -5.73 58.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 118.284 2.698 . . . . 50.51 118.284 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 54.3 m-20 74.28 32.1 1.02 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.524 1.965 . . . . 50.55 111.521 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.671 HG12 ' CE2' ' A' ' 45' ' ' PHE . 69.5 mt -81.0 103.8 8.57 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.206 -2.33 . . . . 50.51 110.464 175.849 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 77.0 mt-30 -103.84 -171.1 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 119.241 3.052 . . . . 50.55 119.241 -176.853 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 65.5 tttm -52.72 138.36 29.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.245 -2.131 . . . . 50.51 105.245 -176.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.456 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 46.6 mt-10 61.95 68.15 0.71 Allowed 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.492 -2.14 . . . . 50.62 115.36 179.549 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.412 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 51.0 m -136.06 138.82 42.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.786 -1.097 . . . . 50.51 109.749 174.813 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -114.39 132.31 56.27 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 118.841 -2.412 . . . . 50.51 113.919 175.886 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.0 mt -90.06 145.96 24.68 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.64 -2.6 . . . . 50.51 111.595 175.091 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -96.78 140.64 31.06 Favored 'General case' 0 C--N 1.284 -2.258 0 O-C-N 127.295 2.872 . . . . 50.51 106.937 177.89 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -106.07 116.0 31.18 Favored 'General case' 0 C--O 1.282 2.81 0 CA-C-O 117.656 -1.164 . . . . 50.51 113.338 176.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -120.28 138.33 51.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 119.533 1.06 . . . . 50.51 112.217 175.072 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.36 114.53 28.71 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.405 0.52 . . . . 50.51 112.405 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -89.08 111.63 22.42 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 113.365 -3.207 . . . . 50.64 104.738 177.198 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.59 131.62 36.2 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.819 1.949 . . . . 50.51 112.438 -179.359 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -88.07 77.62 8.33 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 113.757 -1.565 . . . . 50.64 113.193 -179.544 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.67 -147.62 16.67 Favored Glycine 0 C--O 1.242 0.597 0 N-CA-C 106.325 -2.71 . . . . 50.51 106.325 179.372 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 CA-C-O 116.329 -2.373 . . . . 50.51 109.025 179.196 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 118.833 -0.603 . . . . 50.51 110.318 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -105.25 112.49 25.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 126.937 2.648 . . . . 50.55 112.805 178.264 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.9 pt -114.42 139.79 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-O 115.984 -1.96 . . . . 50.51 112.339 173.288 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.416 ' HB2' ' HG1' ' A' ' 66' ' ' THR . 75.7 m-85 -96.2 145.78 25.25 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 130.43 4.831 . . . . 50.51 111.845 179.503 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 70.6 t -133.87 105.18 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.328 -3.225 . . . . 50.51 113.923 175.748 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -91.08 139.72 30.49 Favored 'General case' 0 N--CA 1.504 2.265 1 O-C-N 129.388 4.18 . . . . 50.51 120.678 -178.121 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -113.79 -168.87 1.41 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 115.052 1.501 . . . . 50.51 115.052 179.956 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -107.9 7.98 28.31 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 124.109 0.88 . . . . 50.51 111.005 -177.925 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -92.24 -14.88 28.27 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 102.41 -3.181 . . . . 50.51 102.41 179.975 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.89 10.72 29.87 Favored Glycine 0 C--N 1.297 -1.603 0 O-C-N 120.188 -1.57 . . . . 50.51 110.048 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.649 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 43.0 mtpt -90.8 154.51 19.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.86 -1.543 . . . . 50.51 113.116 175.003 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -126.8 122.63 35.33 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.706 2.504 . . . . 50.51 107.466 176.19 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.521 HG22 ' HG ' ' A' ' 15' ' ' LEU . 62.5 mt -99.11 136.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 115.182 -2.607 . . . . 50.51 108.76 179.775 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.9 m -127.24 104.18 7.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 104.209 -2.515 . . . . 50.51 104.209 178.092 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' HG ' HG22 ' A' ' 13' ' ' ILE . 46.2 mt -106.75 175.23 5.57 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.536 -2.173 . . . . 50.51 110.936 -179.197 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -125.64 137.95 53.89 Favored 'General case' 0 N--CA 1.5 2.058 1 O-C-N 129.164 4.04 . . . . 50.62 108.038 173.961 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -139.69 165.9 21.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 O-C-N 126.599 2.437 . . . . 50.51 110.623 -177.891 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.29 158.65 31.58 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 119.381 3.104 . . . . 50.62 119.381 174.647 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.88 -24.56 39.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.629 2.219 . . . . 50.51 111.91 177.686 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -110.42 25.71 11.49 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 119.98 3.326 . . . . 50.51 119.98 -177.543 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -94.62 149.22 21.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 117.305 -1.758 . . . . 50.62 107.26 -179.038 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -92.97 148.46 21.98 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.799 -0.637 . . . . 50.51 109.688 175.752 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -44.94 -39.6 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.155 2.784 . . . . 50.51 115.021 175.785 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.87 -36.73 77.53 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.407 -0.808 . . . . 50.62 111.367 177.009 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -67.35 -34.07 76.56 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.358 1.063 . . . . 50.55 110.821 -179.589 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -71.16 -46.11 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 125.048 1.467 . . . . 50.51 112.878 178.571 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HG2' ' OE1' ' A' ' 41' ' ' GLN . 53.7 mtmt -62.84 -32.1 73.26 Favored 'General case' 0 C--O 1.255 1.352 0 N-CA-C 107.084 -1.45 . . . . 50.51 107.084 -179.753 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -56.75 17.61 Favored 'General case' 0 C--O 1.279 2.615 0 N-CA-C 114.575 1.324 . . . . 50.51 114.575 176.828 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -46.24 -49.18 17.58 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 120.387 -1.445 . . . . 50.51 109.911 176.054 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.84 -42.5 63.01 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 118.32 2.711 . . . . 50.51 118.32 179.896 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.406 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.8 tt0 -57.96 -45.51 86.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 125.662 2.648 . . . . 50.55 104.618 179.446 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.74 -25.13 61.93 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 116.353 1.982 . . . . 50.62 116.353 179.164 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -89.63 -58.61 2.46 Favored 'General case' 0 C--O 1.279 2.64 0 O-C-N 119.325 -2.109 . . . . 50.51 113.879 -175.683 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.649 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 74.2 mm-40 -103.93 -24.91 13.21 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 123.058 2.663 . . . . 50.62 110.631 179.868 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 105.52 20.11 9.85 Favored Glycine 0 CA--C 1.478 -2.274 0 N-CA-C 120.393 2.917 . . . . 50.51 120.393 176.52 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.9 mt -86.18 134.41 38.75 Favored Pre-proline 0 C--O 1.244 0.792 0 C-N-CA 118.854 -1.138 . . . . 50.51 110.05 179.738 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -57.07 136.99 79.88 Favored 'Trans proline' 0 C--O 1.26 1.603 0 C-N-CA 123.194 2.596 . . . . 50.51 110.877 178.361 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -57.13 -32.26 92.83 Favored 'Trans proline' 0 C--O 1.261 1.645 0 C-N-CA 120.731 0.954 . . . . 50.51 113.411 -179.306 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.79 -27.04 60.15 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 116.268 1.951 . . . . 50.62 116.268 -177.429 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 80.1 mt-30 -73.65 -21.59 60.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.567 -1.333 . . . . 50.55 109.995 178.686 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.615 ' HB3' HD11 ' A' ' 69' ' ' LEU . 71.8 mt-30 -70.56 118.28 13.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.36 2.028 . . . . 50.55 115.678 -177.613 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -113.81 121.4 43.92 Favored 'General case' 0 C--O 1.295 3.498 0 CA-C-O 116.621 -1.657 . . . . 50.64 109.303 172.098 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -96.49 127.49 42.53 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 119.447 1.021 . . . . 50.51 112.907 -177.422 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.51 119.3 57.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 115.056 1.502 . . . . 50.51 115.056 -177.623 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -145.35 121.44 10.76 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 104.741 -2.318 . . . . 50.51 104.741 177.608 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.0 39.8 3.12 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.208 -2.269 . . . . 50.51 107.961 177.41 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.47 11.24 4.99 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 128.417 2.913 . . . . 50.51 115.701 -179.606 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -115.92 126.67 54.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 119.27 3.063 . . . . 50.51 119.27 177.633 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -41.56 120.82 1.55 Allowed 'General case' 0 C--O 1.259 1.597 0 N-CA-C 120.047 3.351 . . . . 50.55 120.047 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 2.1 mp -82.35 123.59 29.24 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 117.751 -1.118 . . . . 50.51 109.737 -175.936 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.15 140.06 48.63 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.62 1.711 . . . . 50.62 115.62 -177.645 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -54.51 -53.02 59.94 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.148 1.779 . . . . 50.62 110.458 -175.776 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.17 -7.74 60.48 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 116.531 1.373 . . . . 50.51 116.531 -177.229 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -76.45 176.48 8.21 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 116.466 2.024 . . . . 50.64 116.466 176.538 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.6 p -112.44 164.83 12.81 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.055 -1.831 . . . . 50.51 106.055 177.148 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.414 HD23 ' CD1' ' A' ' 61' ' ' ILE . 65.5 mt -68.64 -36.17 78.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 106.573 -1.64 . . . . 50.51 106.573 177.279 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -65.51 -31.48 72.58 Favored 'General case' 0 C--O 1.267 1.995 0 C-N-CA 117.34 -1.744 . . . . 50.51 112.392 -179.491 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -47.37 -37.48 11.27 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.515 1.15 . . . . 50.62 111.902 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.501 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 92.5 m-85 -96.12 -11.32 26.42 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 117.757 -1.116 . . . . 50.51 113.147 179.216 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 32.5 t30 78.58 47.46 0.04 OUTLIER 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.464 1.938 . . . . 50.55 113.949 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CD1' HD23 ' A' ' 56' ' ' LEU . 73.8 mt -85.07 112.49 22.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.965 0 CA-C-O 115.243 -2.313 . . . . 50.51 109.183 175.873 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -114.69 -171.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 126.059 2.099 . . . . 50.55 108.661 -176.869 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.1 tttp -59.59 145.2 45.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.255 1.502 . . . . 50.51 110.307 -176.948 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 34.6 mt-10 66.36 10.22 7.07 Favored 'General case' 0 C--O 1.258 1.507 0 N-CA-C 118.578 2.807 . . . . 50.62 118.578 179.57 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -74.32 138.05 43.25 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.845 -1.071 . . . . 50.51 112.668 174.796 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.416 ' HG1' ' HB2' ' A' ' 4' ' ' PHE . 97.9 m -112.05 128.47 56.2 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 115.14 1.533 . . . . 50.51 115.14 175.934 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 94.5 mt -103.47 138.93 39.51 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 114.635 -2.602 . . . . 50.51 107.85 175.072 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -96.33 143.56 27.29 Favored 'General case' 0 C--N 1.284 -2.273 0 O-C-N 127.374 2.921 . . . . 50.51 106.491 177.885 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 41' ' ' GLN . 37.7 tp -110.86 115.86 30.25 Favored 'General case' 0 C--O 1.282 2.779 0 CA-C-O 117.733 -1.127 . . . . 50.51 112.625 176.572 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.62 143.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 119.541 1.064 . . . . 50.51 110.495 175.066 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 54.9 mt -101.61 102.85 13.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 117.019 2.229 . . . . 50.51 117.019 178.522 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -73.76 101.54 3.73 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 113.34 -3.219 . . . . 50.64 110.824 177.207 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.9 163.5 3.41 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.891 1.995 . . . . 50.51 112.581 -179.274 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.97 74.39 1.53 Allowed 'General case' 0 C--O 1.244 0.804 0 N-CA-C 105.945 -1.872 . . . . 50.64 105.945 -179.614 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.27 131.56 3.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 106.202 -2.759 . . . . 50.51 106.202 179.389 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.497 0 CA-C-O 116.331 -2.372 . . . . 50.51 116.984 179.311 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.51 111.006 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.55 116.688 178.266 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.51 111.74 173.324 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.51 115.113 179.52 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.51 107.106 175.824 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.51 103.747 -178.117 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.51 107.547 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.51 105.417 -177.96 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.51 110.637 179.919 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.51 119.029 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.51 114.413 174.998 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.51 113.052 176.185 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.534 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.51 114.549 179.78 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.51 111.59 178.086 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.51 110.023 -179.207 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.62 111.711 173.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.51 110.993 -177.951 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.62 108.19 174.632 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.51 111.964 177.711 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.51 113.164 -177.552 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.62 108.919 -179.0 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.51 108.06 175.711 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.51 117.251 175.811 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.62 111.876 176.964 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.55 110.173 -179.603 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.51 109.312 178.599 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.51 106.896 -179.77 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.51 114.569 176.92 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.51 103.094 176.011 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.419 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.51 104.805 179.898 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 40.0 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.55 111.202 179.415 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.62 113.082 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.51 116.338 -175.645 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.62 113.877 179.862 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.51 105.347 176.537 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.51 107.204 179.761 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.51 110.872 178.293 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.415 ' CG ' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.51 113.407 -179.303 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.62 115.506 -177.444 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.55 113.269 178.741 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.617 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.55 109.19 -177.64 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.561 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.64 104.765 172.138 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.635 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.51 109.582 -177.498 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.51 112.344 -177.583 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.51 107.281 177.627 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.51 104.493 177.379 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.51 118.709 -179.624 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.51 114.674 177.718 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.55 109.652 174.548 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.51 110.096 -175.862 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.62 111.682 -177.729 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.62 118.573 -175.763 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.51 109.54 -177.249 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.64 110.879 176.534 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.51 116.693 177.156 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.428 HD12 HD13 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.51 110.756 177.237 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.51 119.247 -179.485 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.62 116.794 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.51 117.56 179.269 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 59' ' ' TYR . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.55 116.376 179.895 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.44 HG23 ' HG ' ' A' ' 65' ' ' SER . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.51 115.487 175.861 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.55 107.756 -176.828 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.51 114.348 -176.929 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.62 107.384 179.576 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.44 ' HG ' HG23 ' A' ' 61' ' ' ILE . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.51 106.402 174.815 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.51 110.362 175.94 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.51 107.602 175.106 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.51 109.96 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.51 108.197 176.547 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.51 102.361 175.117 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.51 113.908 178.441 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.64 110.488 177.138 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.51 104.971 -179.332 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.64 109.517 -179.572 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.51 111.861 179.397 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.51 108.119 179.238 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.51 111.006 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.55 116.688 178.266 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.51 111.74 173.324 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.51 115.113 179.52 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.51 107.106 175.824 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.51 103.747 -178.117 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.51 107.547 179.921 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.51 105.417 -177.96 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.51 110.637 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.51 119.029 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.51 114.413 174.998 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.51 113.052 176.185 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.534 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.51 114.549 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.51 111.59 178.086 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.51 110.023 -179.207 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.62 111.711 173.943 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.51 110.993 -177.951 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.62 108.19 174.632 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.51 111.964 177.711 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.51 113.164 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.62 108.919 -179.0 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.51 108.06 175.711 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.51 117.251 175.811 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.62 111.876 176.964 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.55 110.173 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.51 109.312 178.599 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.51 106.896 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.51 114.569 176.92 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.51 103.094 176.011 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.419 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.51 104.805 179.898 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 40.0 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.55 111.202 179.415 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.62 113.082 179.182 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.51 116.338 -175.645 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.62 113.877 179.862 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.51 105.347 176.537 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.51 107.204 179.761 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.51 110.872 178.293 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.415 ' CG ' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.51 113.407 -179.303 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.62 115.506 -177.444 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.55 113.269 178.741 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.617 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.55 109.19 -177.64 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.561 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.64 104.765 172.138 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.635 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.51 109.582 -177.498 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.51 112.344 -177.583 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.51 107.281 177.627 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.51 104.493 177.379 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.51 118.709 -179.624 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.51 114.674 177.718 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.55 109.652 174.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.51 110.096 -175.862 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.62 111.682 -177.729 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.62 118.573 -175.763 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.51 109.54 -177.249 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.64 110.879 176.534 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.51 116.693 177.156 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.428 HD12 HD13 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.51 110.756 177.237 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.51 119.247 -179.485 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.62 116.794 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.51 117.56 179.269 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 59' ' ' TYR . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.55 116.376 179.895 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.44 HG23 ' HG ' ' A' ' 65' ' ' SER . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.51 115.487 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.55 107.756 -176.828 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.51 114.348 -176.929 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.62 107.384 179.576 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.44 ' HG ' HG23 ' A' ' 61' ' ' ILE . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.51 106.402 174.815 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.51 110.362 175.94 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.51 107.602 175.106 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.51 109.96 177.938 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.51 108.197 176.547 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.51 102.361 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.51 113.908 178.441 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.64 110.488 177.138 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.51 104.971 -179.332 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.64 109.517 -179.572 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.51 111.861 179.397 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.51 108.119 179.238 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 108.426 -0.953 . . . . 50.51 108.426 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -94.3 140.95 29.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 126.951 2.657 . . . . 50.55 106.368 178.272 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -126.22 -179.35 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-O 116.017 -1.944 . . . . 50.51 109.918 173.348 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.91 101.28 5.78 Favored 'General case' 0 N--CA 1.512 2.626 1 O-C-N 130.414 4.821 . . . . 50.51 114.319 179.567 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.25 123.7 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.488 -3.149 . . . . 50.51 110.223 175.79 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -117.24 118.42 32.23 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.291 4.119 . . . . 50.51 112.111 -178.079 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.49 HG21 ' H ' ' A' ' 9' ' ' THR . 5.1 t -104.0 167.38 9.8 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 116.911 2.189 . . . . 50.51 116.911 179.982 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.97 -17.79 63.98 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.807 1.78 . . . . 50.51 115.807 -178.008 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.49 ' H ' HG21 ' A' ' 7' ' ' THR . 53.3 p -89.25 1.7 55.33 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 115.767 -2.373 . . . . 50.51 109.718 179.889 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 -4.28 85.63 Favored Glycine 0 C--N 1.296 -1.655 0 O-C-N 120.115 -1.616 . . . . 50.51 117.096 179.84 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -67.5 110.0 3.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.825 -1.56 . . . . 50.51 109.337 174.976 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -81.38 133.74 35.46 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.665 2.478 . . . . 50.51 114.41 176.175 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.87 138.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 127.38 2.925 . . . . 50.51 118.105 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.3 m -106.96 130.0 54.68 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.222 -1.791 . . . . 50.51 111.438 178.138 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.439 ' HG ' HG13 ' A' ' 17' ' ' VAL . 49.3 tp -115.74 152.19 33.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 115.479 -2.201 . . . . 50.51 114.636 -179.279 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -115.01 107.48 15.42 Favored 'General case' 0 N--CA 1.5 2.04 1 O-C-N 129.273 4.108 . . . . 50.62 114.466 173.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.439 HG13 ' HG ' ' A' ' 15' ' ' LEU . 21.0 m -126.55 150.58 32.38 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 127.849 3.218 . . . . 50.51 118.53 -177.869 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 76.3 mt-10 -87.31 152.12 52.13 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 117.776 2.51 . . . . 50.62 117.776 174.655 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.46 39.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.556 2.171 . . . . 50.51 111.946 177.715 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -107.6 37.77 2.33 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 116.229 1.937 . . . . 50.51 116.229 -177.54 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -105.01 148.54 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 117.321 -1.751 . . . . 50.62 109.822 -178.965 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -92.88 159.57 15.3 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.087 -1.449 . . . . 50.51 107.087 175.728 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.12 -40.58 74.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 O-C-N 127.234 2.834 . . . . 50.51 108.203 175.801 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -54.08 -13.49 0.82 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.301 1.222 . . . . 50.62 114.301 177.015 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.35 -18.87 10.37 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.062 1.505 . . . . 50.55 115.062 -179.608 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.85 -57.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 101.545 -3.502 . . . . 50.51 101.545 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -57.09 -24.68 55.72 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 115.77 -0.65 . . . . 50.51 111.547 -179.775 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.68 -6.61 57.52 Favored 'General case' 0 C--O 1.278 2.553 0 N-CA-C 117.612 2.449 . . . . 50.51 117.612 176.862 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.427 ' CB ' HD11 ' A' ' 15' ' ' LEU . 63.3 mttp -91.9 -30.25 16.24 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 102.818 -3.03 . . . . 50.51 102.818 176.037 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.97 -45.0 98.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 103.108 -2.923 . . . . 50.51 103.108 179.858 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -52.09 -50.84 60.81 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 125.608 2.623 . . . . 50.55 108.453 179.419 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -56.66 -14.46 3.27 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 113.612 -1.631 . . . . 50.62 115.384 179.062 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 31.2 mmmt -117.46 -50.09 2.55 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.465 -2.094 . . . . 50.51 111.468 -175.688 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -94.93 -8.46 37.0 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.62 111.17 179.853 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.05 29.25 69.16 Favored Glycine 0 CA--C 1.477 -2.313 0 N-CA-C 107.777 -2.129 . . . . 50.51 107.777 176.518 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.61 122.74 45.09 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 105.386 -2.079 . . . . 50.51 105.386 179.75 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -56.95 136.96 79.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 123.177 2.584 . . . . 50.51 110.913 178.328 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.14 -32.19 92.67 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 120.713 0.942 . . . . 50.51 113.428 -179.347 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.38 -14.42 27.57 Favored 'General case' 0 C--O 1.262 1.723 0 N-CA-C 115.691 1.737 . . . . 50.62 115.691 -177.383 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -100.66 13.38 34.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.416 1.636 . . . . 50.55 115.416 178.788 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -116.42 133.12 56.38 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.363 2.03 . . . . 50.55 114.944 -177.592 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -116.97 124.77 50.17 Favored 'General case' 0 C--O 1.296 3.516 0 N-CA-C 105.245 -2.132 . . . . 50.64 105.245 172.145 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.83 133.86 49.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.735 -1.95 . . . . 50.51 105.735 -177.582 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -121.55 123.47 69.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.159 1.537 . . . . 50.51 111.155 -177.615 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -134.58 127.78 31.95 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 114.477 -1.238 . . . . 50.51 111.214 177.625 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.28 20.31 5.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.292 -2.231 . . . . 50.51 114.468 177.354 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.2 -8.25 67.13 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 120.673 3.029 . . . . 50.51 120.673 -179.589 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -98.67 144.68 27.68 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 118.052 0.926 . . . . 50.51 109.91 177.61 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -80.12 129.87 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.346 -2.835 . . . . 50.55 103.346 174.587 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.71 157.96 31.34 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 117.701 -1.142 . . . . 50.51 113.902 -175.911 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -100.66 154.23 18.76 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.131 -1.433 . . . . 50.62 107.131 -177.603 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -72.02 -44.89 62.68 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 126.116 1.766 . . . . 50.62 111.718 -175.841 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.13 61.31 Favored Glycine 0 C--O 1.253 1.295 0 N-CA-C 120.191 2.836 . . . . 50.51 120.191 -177.249 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -95.87 169.05 10.26 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 120.066 -1.843 . . . . 50.64 112.669 176.524 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -100.41 153.92 18.94 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 114.167 1.173 . . . . 50.51 114.167 177.082 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.8 mt -55.28 -30.84 60.92 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.238 0.962 . . . . 50.51 112.059 177.254 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -75.23 -28.89 60.08 Favored 'General case' 0 C--O 1.268 2.039 0 C-N-CA 117.375 -1.73 . . . . 50.51 109.422 -179.434 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -53.44 -42.38 67.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.457 1.123 . . . . 50.62 112.401 179.836 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -91.18 20.15 5.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 117.779 -1.105 . . . . 50.51 113.266 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 m120 44.71 24.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 120.024 3.342 . . . . 50.55 120.024 179.976 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.19 127.92 34.63 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 N-CA-C 101.628 -3.471 . . . . 50.51 101.628 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' LYS . 44.8 mt-30 -132.37 159.98 37.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 125.946 2.029 . . . . 50.55 106.699 -176.795 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 62' ' ' GLN . 34.3 ttpt -43.09 146.61 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.707 -1.96 . . . . 50.51 105.707 -177.019 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 66.4 50.5 1.29 Allowed 'General case' 0 C--O 1.257 1.477 0 CA-C-N 112.5 -2.136 . . . . 50.62 114.734 179.558 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -124.91 142.97 51.11 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.827 -1.079 . . . . 50.51 108.436 174.847 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -91.91 135.52 33.87 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.276 -0.868 . . . . 50.51 109.119 175.87 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.77 136.76 53.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 114.669 -2.586 . . . . 50.51 105.323 175.11 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -95.23 128.3 41.96 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 127.453 2.971 . . . . 50.51 112.17 177.899 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.45 119.26 32.89 Favored 'General case' 0 C--O 1.282 2.764 0 CA-C-O 117.71 -1.138 . . . . 50.51 113.789 176.557 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.07 140.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.676 -2.713 . . . . 50.51 103.676 175.084 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -111.39 135.12 52.39 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.023 1.12 . . . . 50.51 114.023 178.462 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -116.29 115.97 26.91 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 113.324 -3.227 . . . . 50.64 107.894 177.265 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -99.75 168.17 10.09 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 117.876 2.547 . . . . 50.51 117.876 -179.334 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -77.26 123.36 26.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 113.739 -1.573 . . . . 50.64 109.597 -179.602 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 154.42 5.85 Favored Glycine 0 C--O 1.244 0.724 0 CA-C-N 114.605 -1.179 . . . . 50.51 114.458 179.37 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 CA-C-O 116.37 -2.35 . . . . 50.51 118.366 179.233 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtp . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 104.905 -2.257 . . . . 50.51 104.905 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -87.34 142.13 28.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.957 2.66 . . . . 50.55 109.191 178.32 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.86 174.03 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 116.012 -1.947 . . . . 50.51 105.937 173.324 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 66' ' ' THR . 77.5 m-85 -122.88 126.47 47.37 Favored 'General case' 0 N--CA 1.513 2.688 1 O-C-N 129.858 4.474 . . . . 50.51 113.505 179.558 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 114.86 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 113.373 -3.203 . . . . 50.51 115.835 175.753 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -79.76 121.1 24.93 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.346 4.154 . . . . 50.51 118.167 -178.045 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.68 HG23 HD21 ' A' ' 69' ' ' LEU . 24.7 p -96.64 177.16 5.75 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 120.831 3.641 . . . . 50.51 120.831 179.917 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.84 17.73 4.62 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.072 0.858 . . . . 50.51 109.674 -178.014 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -124.18 14.49 9.06 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 115.741 -2.384 . . . . 50.51 112.587 179.929 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.09 14.95 81.29 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 107.75 -2.14 . . . . 50.51 107.75 179.807 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -104.91 147.1 28.12 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 116.831 -1.557 . . . . 50.51 112.915 174.977 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -119.01 134.8 54.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 126.637 2.461 . . . . 50.51 106.354 176.113 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.1 mt -97.37 147.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.477 2.986 . . . . 50.51 112.74 179.706 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 m -109.99 125.13 52.56 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.287 -1.765 . . . . 50.51 106.692 178.136 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -126.12 141.89 51.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.875 -2.268 . . . . 50.51 104.875 -179.27 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -116.45 112.51 21.54 Favored 'General case' 0 N--CA 1.5 2.034 1 O-C-N 129.243 4.089 . . . . 50.62 109.392 173.962 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 56' ' ' LEU . 33.8 m -106.97 171.42 2.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.214 0 O-C-N 127.694 3.121 . . . . 50.51 114.6 -177.943 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 75.9 tt0 -111.3 143.15 27.84 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 112.21 -2.268 . . . . 50.62 106.057 174.556 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.2 Cg_exo -55.0 -24.44 39.78 Favored 'Trans proline' 0 C--N 1.32 -0.933 0 C-N-CA 122.564 2.176 . . . . 50.51 111.953 177.737 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -82.13 -17.8 45.14 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 114.348 1.24 . . . . 50.51 114.348 -177.537 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.93 163.42 27.49 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.451 -1.7 . . . . 50.62 112.123 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.597 ' O ' HG21 ' A' ' 26' ' ' VAL . 33.3 p -95.62 -165.48 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.876 -0.602 . . . . 50.51 111.085 175.7 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -87.01 -40.86 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 127.171 2.794 . . . . 50.51 108.181 175.716 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 16.8 tp10 -52.46 -42.56 64.31 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 107.534 -1.284 . . . . 50.62 107.534 177.021 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.17 -49.77 72.97 Favored 'General case' 0 C--O 1.249 1.038 0 C-N-CA 124.352 1.061 . . . . 50.55 113.405 -179.656 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 22' ' ' THR . 91.1 t -57.78 -42.65 82.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.999 1.437 . . . . 50.51 111.95 178.645 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 93.3 mttt -65.95 -37.06 85.03 Favored 'General case' 0 C--O 1.257 1.481 0 N-CA-C 106.535 -1.654 . . . . 50.51 106.535 -179.693 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 31' ' ' GLN . . . -63.88 -45.19 90.53 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 113.186 0.809 . . . . 50.51 113.186 176.911 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -44.18 -36.7 2.77 Favored 'General case' 0 C--O 1.255 1.348 0 O-C-N 120.375 -1.453 . . . . 50.51 108.8 175.973 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 HG21 HE22 ' A' ' 41' ' ' GLN . 58.8 mt -72.88 -33.44 43.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.487 -0.885 . . . . 50.51 110.492 179.895 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 28' ' ' ALA . 55.4 tt0 -54.95 -41.61 71.29 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.581 2.61 . . . . 50.55 108.434 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.73 -20.53 57.03 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 113.631 -1.622 . . . . 50.62 115.104 179.173 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 31.0 mmmt -110.37 -36.15 5.87 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.413 -2.115 . . . . 50.51 110.828 -175.703 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.55 -54.79 3.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 123.121 2.691 . . . . 50.62 108.627 179.861 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 18.77 4.06 Favored Glycine 0 CA--C 1.477 -2.288 0 N-CA-C 103.565 -3.814 . . . . 50.51 103.565 176.55 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.474 HG23 ' HD2' ' A' ' 37' ' ' PRO . 73.5 mt -103.74 135.89 19.29 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 116.785 2.143 . . . . 50.51 116.785 179.637 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 36' ' ' ILE . 78.2 Cg_exo -56.98 137.02 80.12 Favored 'Trans proline' 0 C--O 1.259 1.546 0 C-N-CA 123.084 2.523 . . . . 50.51 110.919 178.317 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -57.23 -32.14 92.72 Favored 'Trans proline' 0 C--O 1.262 1.687 0 O-C-N 122.914 0.955 . . . . 50.51 113.391 -179.298 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -64.71 -18.68 65.22 Favored 'General case' 0 C--O 1.263 1.767 0 N-CA-C 117.422 2.379 . . . . 50.62 117.422 -177.401 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -81.45 -15.61 54.55 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.573 -1.33 . . . . 50.55 109.072 178.719 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.44 HE22 HG21 ' A' ' 30' ' ' ILE . 61.9 mt-30 -100.71 130.09 46.7 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 124.48 2.086 . . . . 50.55 112.444 -177.6 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -111.65 137.61 49.29 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.648 -1.644 . . . . 50.64 110.507 172.14 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.603 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 35.2 mt -116.24 129.45 56.29 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.904 1.446 . . . . 50.51 114.904 -177.456 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -114.77 127.15 72.42 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 O-C-N 125.085 1.491 . . . . 50.51 111.278 -177.6 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -139.81 107.06 5.5 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 106.99 -1.485 . . . . 50.51 106.99 177.652 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.43 41.73 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.228 -2.26 . . . . 50.51 105.53 177.383 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.96 -51.51 2.0 Allowed Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 128.434 2.921 . . . . 50.51 116.588 -179.605 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -40.2 148.32 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 116.747 2.128 . . . . 50.51 116.747 177.718 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -82.42 146.08 29.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.042 -2.207 . . . . 50.55 105.042 174.598 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 43' ' ' LEU . 32.1 mt -100.03 142.35 31.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.102 -1.444 . . . . 50.51 107.102 -175.888 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.04 156.55 17.85 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.106 -1.442 . . . . 50.62 107.106 -177.72 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 74.8 m-20 -82.99 -39.1 21.75 Favored 'General case' 0 C--O 1.264 1.837 0 C-N-CA 126.159 1.784 . . . . 50.62 108.242 -175.8 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.41 2.07 87.74 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 116.288 1.275 . . . . 50.51 116.288 -177.201 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -95.73 161.01 14.21 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 119.91 -1.935 . . . . 50.64 106.027 176.515 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 22.8 p -98.37 170.29 8.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.403 -0.962 . . . . 50.51 108.403 177.129 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' CD2' HG22 ' A' ' 17' ' ' VAL . 4.1 mp -65.31 -16.91 64.07 Favored 'General case' 0 C--O 1.201 -1.498 0 N-CA-C 107.767 -1.198 . . . . 50.51 107.767 177.255 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 p -70.71 -23.66 62.51 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 116.47 2.026 . . . . 50.51 116.47 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.21 -37.66 80.96 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.107 2.262 . . . . 50.62 117.107 179.773 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -101.19 4.52 42.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 117.765 -1.112 . . . . 50.51 109.716 179.299 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 56.39 54.93 7.05 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 103.862 -2.644 . . . . 50.55 103.862 179.869 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.17 132.76 31.62 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 115.224 -2.322 . . . . 50.51 105.818 175.86 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -117.3 172.94 6.97 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.771 2.508 . . . . 50.55 117.771 -176.815 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -68.08 133.09 48.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 123.187 1.47 . . . . 50.51 113.737 -176.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.12 42.97 30.28 Favored 'General case' 0 C--O 1.256 1.436 0 N-CA-C 116.855 2.168 . . . . 50.62 116.855 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.6 p -85.46 166.27 16.48 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 104.315 -2.476 . . . . 50.51 104.315 174.796 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 46.9 p -114.94 132.72 56.47 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.816 -1.55 . . . . 50.51 106.816 175.975 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.6 mp -108.37 160.33 15.95 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 114.7 -2.572 . . . . 50.51 112.396 175.012 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.67 132.07 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.383 2.927 . . . . 50.51 109.765 177.947 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.68 HD21 HG23 ' A' ' 7' ' ' THR . 30.3 tp -112.78 125.37 54.26 Favored 'General case' 0 C--O 1.282 2.78 0 CA-C-O 117.657 -1.163 . . . . 50.51 109.467 176.525 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.84 139.97 39.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 105.165 -2.161 . . . . 50.51 105.165 175.087 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.2 mt -100.42 130.0 46.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.573 -2.01 . . . . 50.51 105.573 178.397 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -122.89 113.07 18.62 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 101.358 -3.571 . . . . 50.64 101.358 177.175 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.81 166.31 11.69 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.78 1.925 . . . . 50.51 111.032 -179.287 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.07 96.73 9.96 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 118.874 2.916 . . . . 50.64 118.874 -179.592 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.24 -168.62 12.63 Favored Glycine 0 C--O 1.243 0.679 0 N-CA-C 107.136 -2.385 . . . . 50.51 107.136 179.361 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.477 0 CA-C-O 116.31 -2.383 . . . . 50.51 110.028 179.212 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.495 ' CE ' ' HD2' ' A' ' 63' ' ' LYS . 81.4 mmm . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.081 0.771 . . . . 50.51 113.081 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -95.5 124.07 39.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.902 2.626 . . . . 50.55 115.59 178.29 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.39 152.72 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.984 -1.96 . . . . 50.51 109.264 173.317 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.557 ' CE2' ' OG1' ' A' ' 14' ' ' THR . 53.6 m-85 -106.52 141.71 37.36 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.386 4.804 . . . . 50.51 116.464 179.533 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' HB ' HG12 ' A' ' 13' ' ' ILE . 85.9 t -113.13 110.4 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 113.435 -3.174 . . . . 50.51 110.211 175.719 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -83.34 130.74 35.07 Favored 'General case' 0 N--CA 1.505 2.276 1 O-C-N 129.353 4.158 . . . . 50.51 106.732 -178.064 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.66 -173.65 2.52 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 117.846 -1.073 . . . . 50.51 108.973 179.928 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -90.34 -16.81 28.46 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.854 1.427 . . . . 50.51 114.854 -177.959 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -101.33 -3.14 29.38 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 115.695 -2.402 . . . . 50.51 116.879 179.962 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.41 1.38 Allowed Glycine 0 C--N 1.297 -1.614 0 N-CA-C 117.366 1.706 . . . . 50.51 117.366 179.781 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -54.9 143.02 27.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 116.069 1.877 . . . . 50.51 116.069 175.013 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -124.14 136.45 54.22 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 126.619 2.449 . . . . 50.51 112.919 176.11 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.47 HG12 ' HB ' ' A' ' 5' ' ' VAL . 17.3 pt -106.67 125.18 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.464 2.978 . . . . 50.51 107.182 179.774 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.557 ' OG1' ' CE2' ' A' ' 4' ' ' PHE . 43.7 m -98.65 134.98 40.81 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.294 -1.762 . . . . 50.51 112.953 178.123 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -117.01 154.73 30.42 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 115.492 -2.194 . . . . 50.51 114.072 -179.29 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.7 tt0 -114.94 99.3 7.37 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 129.172 4.045 . . . . 50.62 109.17 174.005 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.88 155.46 15.07 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.781 3.175 . . . . 50.51 116.308 -177.967 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -107.3 135.33 19.67 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 104.518 -2.401 . . . . 50.62 104.518 174.63 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 57' ' ' SER . 84.3 Cg_exo -54.95 -24.52 39.72 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 122.54 2.16 . . . . 50.51 111.931 177.765 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -76.99 -0.23 23.63 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 118.102 -0.952 . . . . 50.51 109.269 -177.585 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.533 ' O ' ' HB ' ' A' ' 55' ' ' THR . 92.1 m-20 -72.76 178.21 4.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 117.378 -1.729 . . . . 50.62 109.31 -179.01 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 26' ' ' VAL . 33.1 p -106.3 167.44 9.83 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 103.074 -2.936 . . . . 50.51 103.074 175.741 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -67.34 -45.99 84.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 O-C-N 126.975 2.672 . . . . 50.51 107.788 175.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -54.71 -48.41 72.52 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.42 -0.8 . . . . 50.62 112.376 177.017 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -48.61 -49.23 37.91 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.468 -1.308 . . . . 50.55 107.468 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 22' ' ' THR . 95.8 t -52.07 -52.65 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 125.069 1.481 . . . . 50.51 113.436 178.528 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -72.81 -23.05 60.73 Favored 'General case' 0 C--O 1.257 1.486 0 CA-C-N 115.755 -0.657 . . . . 50.51 109.356 -179.745 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.3 95.04 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.334 -2.099 . . . . 50.51 105.334 176.973 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.38 -48.81 60.04 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 114.995 1.48 . . . . 50.51 114.995 175.933 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -56.32 -52.6 49.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 103.796 -2.668 . . . . 50.51 103.796 179.871 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.501 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.6 tt0 -38.32 -73.56 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 125.567 2.603 . . . . 50.55 110.301 179.391 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -39.76 -59.13 1.22 Allowed 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.671 -1.604 . . . . 50.62 114.382 179.098 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -82.43 -42.66 18.28 Favored 'General case' 0 C--O 1.279 2.623 0 N-CA-C 119.941 3.312 . . . . 50.51 119.941 -175.677 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.18 -30.97 22.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 123.058 2.663 . . . . 50.62 105.776 179.828 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.63 22.76 23.08 Favored Glycine 0 CA--C 1.477 -2.31 0 N-CA-C 118.867 2.307 . . . . 50.51 118.867 176.564 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 59.2 mt -105.14 122.23 43.75 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 118.753 -1.179 . . . . 50.51 110.216 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.4 Cg_exo -56.97 136.94 79.64 Favored 'Trans proline' 0 C--O 1.259 1.537 0 C-N-CA 123.207 2.605 . . . . 50.51 110.879 178.348 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -57.15 -32.17 92.62 Favored 'Trans proline' 0 C--O 1.261 1.661 0 O-C-N 122.926 0.961 . . . . 50.51 113.486 -179.376 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.45 -0.33 1.88 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 119.973 -1.705 . . . . 50.62 115.303 -177.448 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -126.91 18.74 7.2 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.5 -1.375 . . . . 50.55 113.503 178.709 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -110.3 141.47 43.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.299 2.0 . . . . 50.55 110.246 -177.582 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -128.62 136.67 50.99 Favored 'General case' 0 C--O 1.297 3.557 0 CA-C-O 116.726 -1.607 . . . . 50.64 107.496 172.157 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 69' ' ' LEU . 60.3 mt -135.94 124.45 23.56 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.464 1.029 . . . . 50.51 110.586 -177.538 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -122.62 122.53 66.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.121 1.513 . . . . 50.51 108.685 -177.589 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -143.06 139.03 30.34 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 114.514 -1.221 . . . . 50.51 112.103 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 20.48 10.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 112.271 -2.24 . . . . 50.51 114.865 177.398 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -21.76 27.32 Favored Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 128.493 2.949 . . . . 50.51 109.173 -179.654 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.74 177.79 7.89 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 118.087 0.943 . . . . 50.51 111.707 177.65 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -109.59 149.59 29.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 123.99 0.806 . . . . 50.55 109.481 174.579 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.81 101.71 10.35 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 104.918 -2.253 . . . . 50.51 104.918 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -101.91 153.23 20.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.916 1.385 . . . . 50.62 113.765 -177.66 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.45 -44.55 96.15 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 115.969 1.84 . . . . 50.62 115.969 -175.795 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.99 -15.21 3.23 Favored Glycine 0 C--O 1.253 1.333 0 N-CA-C 116.118 1.207 . . . . 50.51 116.118 -177.226 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -131.37 145.78 51.99 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 118.838 2.903 . . . . 50.64 118.838 176.506 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 21' ' ' ASP . 70.7 p -68.94 172.35 6.74 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 115.279 1.585 . . . . 50.51 115.279 177.189 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.543 HD23 HG13 ' A' ' 61' ' ' ILE . 35.5 mt -59.47 -49.39 77.98 Favored 'General case' 0 C--O 1.201 -1.477 0 O-C-N 124.156 0.91 . . . . 50.51 108.789 177.188 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' PRO . 9.4 t -47.52 -47.87 27.66 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 117.298 -1.761 . . . . 50.51 112.454 -179.444 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -48.45 -26.36 2.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.236 1.569 . . . . 50.62 115.236 179.767 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CD2' ' O ' ' A' ' 55' ' ' THR . 66.9 m-85 -95.01 5.8 50.88 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 117.793 2.516 . . . . 50.51 117.793 179.222 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.518 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 63.4 m-20 68.81 9.71 7.52 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 121.534 1.97 . . . . 50.55 114.52 179.909 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.543 HG13 HD23 ' A' ' 56' ' ' LEU . 26.6 mm -50.97 117.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.99 0 CA-C-O 115.141 -2.361 . . . . 50.51 109.155 175.776 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 72.2 mt-30 -123.93 179.53 4.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 126.147 2.155 . . . . 50.55 105.837 -176.811 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.495 ' HD2' ' CE ' ' A' ' 1' ' ' MET . 82.9 tttt -68.2 146.52 53.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.202 1.477 . . . . 50.51 108.35 -176.921 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 46.8 67.4 0.79 Allowed 'General case' 0 C--O 1.256 1.429 0 N-CA-C 120.868 3.655 . . . . 50.62 120.868 179.538 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.5 p -121.04 172.07 8.21 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 106.966 -1.494 . . . . 50.51 106.966 174.798 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 p -111.96 118.17 34.73 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 115.604 1.705 . . . . 50.51 115.604 175.982 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.05 138.03 34.27 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 114.647 -2.596 . . . . 50.51 107.617 175.08 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -97.96 122.48 41.14 Favored 'General case' 0 C--N 1.285 -2.236 0 O-C-N 127.383 2.927 . . . . 50.51 112.859 177.886 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HA ' HD21 ' A' ' 43' ' ' LEU . 42.1 tp -90.14 131.91 35.73 Favored 'General case' 0 C--O 1.283 2.83 0 N-CA-C 115.551 1.686 . . . . 50.51 115.551 176.519 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -120.9 129.28 75.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 103.253 -2.869 . . . . 50.51 103.253 175.109 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.55 123.93 44.28 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.178 0.513 . . . . 50.51 110.13 178.424 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -112.19 91.44 3.66 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.41 -3.186 . . . . 50.64 110.839 177.247 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.87 163.0 28.61 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.811 1.945 . . . . 50.51 108.282 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.9 ttm105 -87.16 107.35 18.42 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 116.366 1.987 . . . . 50.64 116.366 -179.544 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.84 151.94 23.58 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 114.66 -1.154 . . . . 50.51 114.59 179.394 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.336 -2.369 . . . . 50.51 113.943 179.22 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 36.7 mmt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 105.584 -2.006 . . . . 50.51 105.584 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -100.73 135.85 41.53 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.965 2.666 . . . . 50.55 107.301 178.239 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.464 ' C ' HD13 ' A' ' 3' ' ' ILE . 2.8 pp -137.29 154.93 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 115.961 -1.971 . . . . 50.51 108.392 173.316 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.39 149.49 23.12 Favored 'General case' 0 N--CA 1.511 2.602 1 O-C-N 130.475 4.86 . . . . 50.51 115.331 179.558 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.52 122.11 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 101.949 -3.352 . . . . 50.51 101.949 175.73 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.503 2.198 1 O-C-N 129.322 4.139 . . . . 50.51 105.737 -178.074 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -87.31 -171.97 3.72 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 117.746 -1.121 . . . . 50.51 111.573 179.983 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.94 19.73 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.085 0.866 . . . . 50.51 112.175 -177.974 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -130.8 -14.49 3.56 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 115.706 -2.398 . . . . 50.51 115.874 179.921 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.83 29.21 4.45 Favored Glycine 0 C--N 1.296 -1.672 0 O-C-N 120.006 -1.684 . . . . 50.51 109.105 179.833 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.67 123.0 47.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 116.891 -1.528 . . . . 50.51 111.611 174.997 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p -109.21 131.94 54.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 118.001 2.593 . . . . 50.51 118.001 176.14 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -113.07 157.4 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 127.209 2.818 . . . . 50.51 106.143 179.741 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -112.83 140.13 47.88 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.274 -1.77 . . . . 50.51 109.73 178.131 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 mt -122.1 171.16 9.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 115.488 -2.196 . . . . 50.51 113.214 -179.293 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' H ' ' HE2' ' A' ' 29' ' ' LYS . 71.7 tt0 -128.94 109.85 11.59 Favored 'General case' 0 N--CA 1.5 2.032 1 O-C-N 129.104 4.003 . . . . 50.62 112.573 173.976 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.22 172.36 8.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.722 3.139 . . . . 50.51 114.387 -177.939 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 42.6 mt-10 -129.75 150.33 75.49 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 112.224 -2.262 . . . . 50.62 108.179 174.638 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.9 -24.53 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.562 2.174 . . . . 50.51 111.887 177.744 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -81.36 -19.96 41.63 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 118.154 -0.926 . . . . 50.51 109.737 -177.52 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.63 139.59 58.78 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.352 -1.739 . . . . 50.62 108.165 -179.053 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 156.03 18.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 105.125 -2.176 . . . . 50.51 105.125 175.691 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -49.24 -33.66 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 O-C-N 127.201 2.813 . . . . 50.51 112.734 175.787 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -72.37 -16.61 61.86 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 113.917 1.08 . . . . 50.62 113.917 177.034 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 25' ' ' ASN . 64.4 t-20 -98.7 -9.0 25.22 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.305 1.042 . . . . 50.55 109.217 -179.663 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -91.32 -43.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 104.981 -2.229 . . . . 50.51 104.981 178.588 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 30' ' ' ILE . 53.8 mtmt -64.38 -58.41 6.56 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 113.294 0.85 . . . . 50.51 113.294 -179.806 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.8 -34.11 3.51 Favored 'General case' 0 C--O 1.279 2.608 0 CA-C-N 117.984 0.356 . . . . 50.51 110.058 176.851 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' HE2' ' H ' ' A' ' 16' ' ' GLU . 66.1 tttp -62.84 -31.89 73.0 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.383 -1.448 . . . . 50.51 109.787 175.95 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' LYS . 70.0 mt -77.42 -35.03 21.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 105.709 -1.96 . . . . 50.51 105.709 179.903 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.444 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 17.8 tm0? -47.11 -36.72 8.69 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 125.564 2.602 . . . . 50.55 115.246 179.46 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -69.58 -32.24 70.89 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 113.664 -1.607 . . . . 50.62 113.743 179.131 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -99.77 -7.21 25.8 Favored 'General case' 0 C--O 1.279 2.641 0 C-N-CA 116.473 -2.091 . . . . 50.51 115.925 -175.671 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -121.97 -32.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 123.063 2.665 . . . . 50.62 110.136 179.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.55 12.57 60.88 Favored Glycine 0 CA--C 1.478 -2.222 0 N-CA-C 104.703 -3.359 . . . . 50.51 104.703 176.543 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 21.9 mm -98.3 125.64 42.63 Favored Pre-proline 0 C--O 1.245 0.818 0 N-CA-C 104.462 -2.422 . . . . 50.51 104.462 179.653 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.2 Cg_exo -57.04 136.94 79.66 Favored 'Trans proline' 0 C--O 1.259 1.528 0 C-N-CA 123.154 2.569 . . . . 50.51 110.922 178.353 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' CG ' ' A' ' 31' ' ' GLN . 87.4 Cg_exo -57.18 -32.17 92.7 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.918 0.957 . . . . 50.51 113.398 -179.268 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.45 -18.75 65.54 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 119.918 -1.739 . . . . 50.62 106.65 -177.489 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.36 -1.29 56.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.23 1.937 . . . . 50.55 116.23 178.724 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.415 HE22 ' HB ' ' A' ' 30' ' ' ILE . 57.6 mt-30 -86.74 151.48 23.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.363 2.03 . . . . 50.55 110.256 -177.575 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.583 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 75.3 ttt180 -133.54 106.96 7.72 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.671 -1.633 . . . . 50.64 109.224 172.151 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 50' ' ' LEU . 6.7 mp -98.05 136.33 38.46 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.483 1.038 . . . . 50.51 113.488 -177.472 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.75 124.97 57.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 O-C-N 125.111 1.507 . . . . 50.51 113.16 -177.608 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -138.35 118.08 13.15 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 114.472 1.286 . . . . 50.51 114.472 177.673 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 35.57 18.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.291 -2.232 . . . . 50.51 106.186 177.349 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 8.0 84.69 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 128.437 2.922 . . . . 50.51 116.237 -179.596 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -101.87 141.45 34.7 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 118.058 0.929 . . . . 50.51 113.213 177.665 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -84.46 120.73 26.65 Favored 'General case' 0 C--O 1.259 1.599 0 O-C-N 123.977 0.798 . . . . 50.55 109.235 174.599 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 43' ' ' LEU . 44.9 mt -60.98 126.23 26.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 117.726 -1.13 . . . . 50.51 110.757 -175.883 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.16 132.14 40.42 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.973 1.42 . . . . 50.62 114.002 -177.713 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.82 -58.31 5.01 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 103.631 -2.729 . . . . 50.62 103.631 -175.871 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.72 1.66 28.65 Favored Glycine 0 CA--C 1.493 -1.297 0 N-CA-C 118.34 2.096 . . . . 50.51 118.34 -177.174 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -109.81 144.96 37.52 Favored 'General case' 0 C--O 1.249 1.034 0 O-C-N 119.696 -2.061 . . . . 50.64 106.479 176.425 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -91.31 162.49 14.59 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 117.183 2.29 . . . . 50.51 117.183 177.109 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.732 ' HG ' ' HB ' ' A' ' 61' ' ' ILE . 2.7 mp -46.84 -25.92 0.86 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.14 0.9 . . . . 50.51 109.5 177.187 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.9 p -71.84 -36.91 70.3 Favored 'General case' 0 C--O 1.269 2.096 0 C-N-CA 117.314 -1.755 . . . . 50.51 114.309 -179.468 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.2 -25.29 67.71 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.472 1.13 . . . . 50.62 113.699 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.46 24.09 11.59 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 117.805 -1.093 . . . . 50.51 112.609 179.193 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 t30 37.16 54.18 1.25 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 118.865 2.913 . . . . 50.55 118.865 179.896 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.732 ' HB ' ' HG ' ' A' ' 56' ' ' LEU . 40.9 mm -88.82 100.15 10.2 Favored 'Isoleucine or valine' 0 C--O 1.267 2.017 0 CA-C-O 115.144 -2.36 . . . . 50.51 112.488 175.861 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -108.85 -178.58 3.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.155 2.16 . . . . 50.55 111.715 -176.864 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 64.0 tttm -67.63 144.62 55.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.094 -2.928 . . . . 50.51 103.094 -176.935 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 67.43 21.82 9.55 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 118.641 2.83 . . . . 50.62 118.641 179.559 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -73.96 174.24 8.85 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.15 1.907 . . . . 50.51 116.15 174.857 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -117.2 110.56 18.29 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.472 1.656 . . . . 50.51 115.472 175.981 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.7 113.83 27.04 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 114.655 -2.593 . . . . 50.51 115.949 175.042 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.35 136.89 37.12 Favored 'General case' 0 C--N 1.285 -2.216 0 O-C-N 127.457 2.973 . . . . 50.51 115.542 177.905 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -106.95 114.68 28.91 Favored 'General case' 0 C--O 1.281 2.763 0 N-CA-C 115.546 1.684 . . . . 50.51 115.546 176.578 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.583 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -111.75 137.91 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 104.908 -2.256 . . . . 50.51 104.908 175.121 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.92 157.57 28.21 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.403 0.89 . . . . 50.51 113.403 178.467 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 ttm105 -132.03 77.31 1.75 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 101.997 -3.335 . . . . 50.64 101.997 177.184 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -84.24 114.39 21.79 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 125.803 1.939 . . . . 50.51 111.716 -179.306 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -70.31 108.67 4.31 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.709 -1.587 . . . . 50.64 112.725 -179.635 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 -170.9 13.48 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 107.962 -2.055 . . . . 50.51 107.962 179.407 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 106.944 -2.462 . . . . 50.51 106.944 179.161 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.487 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 23.9 mmt . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 118.802 -0.618 . . . . 50.51 111.202 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -92.41 147.35 22.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.941 2.65 . . . . 50.55 106.999 178.287 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.528 HD11 HG22 ' A' ' 17' ' ' VAL . 35.1 pt -145.94 151.47 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.453 -2.054 . . . . 50.51 105.453 173.347 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 14' ' ' THR . 97.4 m-85 -103.19 143.52 32.52 Favored 'General case' 0 N--CA 1.512 2.671 1 O-C-N 130.502 4.876 . . . . 50.51 112.212 179.503 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.96 116.17 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 113.36 -3.21 . . . . 50.51 110.554 175.797 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HD3' HG23 ' A' ' 12' ' ' THR . 25.1 mmtp -73.39 160.74 31.34 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.363 4.165 . . . . 50.51 112.885 -178.08 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -134.49 -165.44 1.66 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.491 -1.3 . . . . 50.51 107.491 179.942 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.7 mt -94.73 -33.83 12.77 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.297 -2.112 . . . . 50.51 105.297 -177.965 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -75.68 -9.26 58.44 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 115.744 -2.383 . . . . 50.51 117.254 179.914 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.57 4.22 58.22 Favored Glycine 0 C--N 1.296 -1.642 0 O-C-N 120.194 -1.566 . . . . 50.51 116.153 179.748 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HE3' HG22 ' A' ' 13' ' ' ILE . 50.6 tptt -76.08 129.01 36.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 116.838 -1.553 . . . . 50.51 109.37 175.061 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.504 HG23 ' HD3' ' A' ' 6' ' ' LYS . 33.9 p -111.93 107.91 17.07 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 126.686 2.491 . . . . 50.51 107.119 176.215 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.459 HG22 ' HE3' ' A' ' 11' ' ' LYS . 26.9 pt -97.17 147.87 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 127.352 2.907 . . . . 50.51 114.29 179.643 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' CE1' ' A' ' 4' ' ' PHE . 20.7 p -94.13 153.75 17.94 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 101.438 -3.542 . . . . 50.51 101.438 178.164 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.33 149.27 49.69 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.64 -2.356 . . . . 50.51 104.64 -179.303 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -100.33 120.56 40.12 Favored 'General case' 0 N--CA 1.499 2.009 1 O-C-N 129.266 4.104 . . . . 50.62 109.741 173.955 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.528 HG22 HD11 ' A' ' 3' ' ' ILE . 18.8 m -131.7 166.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.673 3.108 . . . . 50.51 107.743 -177.987 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -125.86 143.49 45.46 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 112.185 -2.28 . . . . 50.62 106.18 174.733 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.94 -24.62 40.14 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.606 2.204 . . . . 50.51 111.905 177.702 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -69.87 -44.9 68.85 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 117.536 2.421 . . . . 50.51 117.536 -177.512 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.7 154.07 34.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 117.393 -1.723 . . . . 50.62 113.773 -178.992 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.416 ' C ' ' N ' ' A' ' 24' ' ' GLU . 44.9 p -84.5 157.79 21.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.834 1.05 . . . . 50.51 113.834 175.642 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -49.13 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 O-C-N 127.18 2.8 . . . . 50.51 105.858 175.793 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.507 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 41.2 tt0 -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 120.388 3.477 . . . . 50.62 120.388 177.05 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 73.1 m-80 -98.69 -38.02 9.27 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 102.963 -2.977 . . . . 50.55 102.963 -179.562 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.56 -59.0 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 125.069 1.481 . . . . 50.51 113.507 178.681 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 24' ' ' GLU . 54.8 pttt -53.11 -45.82 68.43 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 109.241 -0.652 . . . . 50.51 109.241 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.35 75.56 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 119.665 3.209 . . . . 50.51 119.665 176.797 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 94.1 mttt -52.92 -40.95 63.99 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.384 -1.447 . . . . 50.51 107.303 176.033 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . 87.1 mt -67.59 -21.94 28.0 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 N-CA-C 113.406 0.891 . . . . 50.51 113.406 179.882 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -58.57 -33.96 70.53 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.586 2.612 . . . . 50.55 106.395 179.473 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.06 -27.86 67.72 Favored 'General case' 0 C--O 1.253 1.271 0 N-CA-C 116.411 2.004 . . . . 50.62 116.411 179.16 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -107.08 -26.14 11.26 Favored 'General case' 0 C--O 1.279 2.643 0 C-N-CA 116.473 -2.091 . . . . 50.51 113.955 -175.669 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -109.22 -46.74 3.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.074 2.67 . . . . 50.62 110.337 179.869 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 10.1 20.56 Favored Glycine 0 CA--C 1.477 -2.292 0 N-CA-C 110.097 -1.201 . . . . 50.51 110.097 176.575 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 36.9 mm -83.42 124.21 75.98 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 106.671 -1.603 . . . . 50.51 106.671 179.693 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.4 Cg_exo -57.05 136.92 79.54 Favored 'Trans proline' 0 C--O 1.259 1.554 0 C-N-CA 123.159 2.573 . . . . 50.51 110.883 178.327 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -57.17 -32.19 92.71 Favored 'Trans proline' 0 C--O 1.261 1.64 0 O-C-N 122.886 0.94 . . . . 50.51 113.363 -179.265 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.99 -15.48 63.04 Favored 'General case' 0 C--O 1.262 1.722 0 O-C-N 119.92 -1.737 . . . . 50.62 108.114 -177.41 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.4 12.92 35.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.971 1.471 . . . . 50.55 114.971 178.758 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -114.94 119.67 37.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.428 2.061 . . . . 50.55 110.587 -177.705 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -119.92 116.9 26.74 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.694 -1.622 . . . . 50.64 107.394 172.178 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.02 133.4 44.47 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.153 1.538 . . . . 50.51 115.153 -177.548 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -115.83 124.87 72.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 N-CA-C 117.106 2.261 . . . . 50.51 117.106 -177.6 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -126.13 118.2 24.74 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.573 -1.194 . . . . 50.51 112.605 177.617 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.69 40.68 29.09 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.276 -2.238 . . . . 50.51 111.591 177.391 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 6.6 42.62 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 128.391 2.9 . . . . 50.51 112.91 -179.584 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -91.22 127.06 36.51 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.284 -1.376 . . . . 50.51 107.284 177.699 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -76.64 122.19 24.31 Favored 'General case' 0 C--O 1.26 1.611 0 O-C-N 123.971 0.794 . . . . 50.55 109.141 174.621 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 mt -81.03 155.51 26.32 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 116.588 2.07 . . . . 50.51 116.588 -175.884 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 41.3 tp10 -106.01 142.11 36.27 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 125.024 1.452 . . . . 50.62 113.709 -177.755 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -59.96 -32.2 70.59 Favored 'General case' 0 C--O 1.263 1.794 0 C-N-CA 126.131 1.772 . . . . 50.62 111.404 -175.75 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.438 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -101.06 38.25 3.23 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 124.334 0.969 . . . . 50.51 113.772 -177.235 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -134.2 159.04 42.12 Favored 'General case' 0 C--O 1.248 1.009 0 O-C-N 118.037 -3.037 . . . . 50.64 105.106 176.464 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -91.02 172.07 8.83 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.022 0.929 . . . . 50.51 112.063 177.091 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.98 -37.87 66.87 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.193 0.933 . . . . 50.51 108.486 177.225 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -64.11 -39.0 93.1 Favored 'General case' 0 C--O 1.268 2.04 0 N-CA-C 116.601 2.074 . . . . 50.51 116.601 -179.401 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -55.55 -23.84 28.94 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.418 1.104 . . . . 50.62 111.692 179.773 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -97.52 -0.18 46.43 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 117.722 -1.133 . . . . 50.51 113.931 179.234 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.5 t30 69.89 21.34 6.35 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.36 1.985 . . . . 50.55 116.36 179.892 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.73 96.86 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.976 0 CA-C-O 115.206 -2.33 . . . . 50.51 112.232 175.858 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.54 ' O ' ' OG ' ' A' ' 65' ' ' SER . 21.7 pt20 -88.18 160.34 17.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 126.074 2.109 . . . . 50.55 111.758 -176.813 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 88.4 tttt -43.23 149.36 0.24 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.426 -2.065 . . . . 50.51 105.426 -177.034 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 97.6 mt-10 52.64 74.28 0.29 Allowed 'General case' 0 C--O 1.257 1.493 0 CA-C-N 112.522 -2.127 . . . . 50.62 107.909 179.633 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.54 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 69.1 m -119.45 132.39 55.79 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.743 -1.117 . . . . 50.51 111.249 174.801 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.3 m -81.43 121.37 26.17 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 118.187 -0.911 . . . . 50.51 113.287 175.94 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -111.56 143.93 41.62 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.707 -2.568 . . . . 50.51 111.404 175.06 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -94.79 136.66 34.83 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 126.809 2.568 . . . . 50.51 108.367 177.914 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' CB ' ' O ' ' A' ' 6' ' ' LYS . 65.9 tp -93.09 118.96 31.8 Favored 'General case' 0 C--O 1.282 2.794 0 CA-C-O 117.609 -1.186 . . . . 50.51 110.624 176.517 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.9 121.96 66.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.558 -1.275 . . . . 50.51 107.558 175.071 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.8 mt -96.01 128.18 42.67 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.674 0.62 . . . . 50.51 112.674 178.403 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.564 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 60.8 ttt85 -113.69 69.62 0.71 Allowed 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 120.313 3.449 . . . . 50.64 120.313 177.305 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.57 142.23 28.6 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 125.872 1.982 . . . . 50.51 114.841 -179.382 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -91.21 85.94 6.02 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.773 -1.558 . . . . 50.64 111.801 -179.629 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.3 -161.7 28.35 Favored Glycine 0 C--O 1.243 0.699 0 N-CA-C 108.705 -1.758 . . . . 50.51 108.705 179.339 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 116.322 -2.376 . . . . 50.51 111.287 179.257 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mmt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 101.467 -3.531 . . . . 50.51 101.467 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -103.85 129.51 51.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 126.961 2.663 . . . . 50.55 107.932 178.256 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 pt -119.72 157.49 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 116.04 -1.933 . . . . 50.51 110.386 173.353 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -106.23 139.21 41.1 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.407 4.817 . . . . 50.51 112.035 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -113.86 101.58 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.359 -3.21 . . . . 50.51 108.884 175.81 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -66.76 147.0 53.84 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.463 4.227 . . . . 50.51 112.322 -178.097 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.512 HG23 HD21 ' A' ' 69' ' ' LEU . 41.6 p -135.64 170.39 16.03 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.768 -1.111 . . . . 50.51 108.494 179.959 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -91.4 29.96 1.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.967 0.792 . . . . 50.51 112.414 -177.966 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.3 p -130.55 18.67 5.25 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 115.677 -2.409 . . . . 50.51 117.199 179.904 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.92 51.15 25.47 Favored Glycine 0 C--N 1.297 -1.591 0 O-C-N 120.109 -1.619 . . . . 50.51 111.271 179.763 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -160.2 123.69 3.55 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 115.225 1.565 . . . . 50.51 115.225 175.02 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -83.89 135.15 34.6 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 126.666 2.479 . . . . 50.51 114.566 176.137 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 mm -108.51 133.79 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.562 3.039 . . . . 50.51 106.079 179.717 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.8 p -104.27 154.31 19.95 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.553 2.057 . . . . 50.51 116.553 178.073 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.5 mt -140.62 139.65 34.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.49 -2.195 . . . . 50.51 113.33 -179.261 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.61 113.52 25.6 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 128.66 3.725 . . . . 50.62 103.548 173.988 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.24 -166.26 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.271 0 O-C-N 127.518 3.011 . . . . 50.51 105.312 -177.911 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -150.56 156.87 36.66 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.256 -2.247 . . . . 50.62 109.062 174.621 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.96 -24.53 39.89 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.622 2.215 . . . . 50.51 111.953 177.754 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.5 p -93.52 -7.36 44.47 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 115.541 1.682 . . . . 50.51 115.541 -177.546 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.21 135.6 52.28 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.29 -1.764 . . . . 50.62 114.821 -179.017 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -77.43 160.34 28.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.851 -0.613 . . . . 50.51 110.904 175.78 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -55.3 -40.03 54.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.153 2.783 . . . . 50.51 109.387 175.808 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -61.64 -40.77 96.09 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.422 -0.798 . . . . 50.62 111.568 176.95 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -64.05 -45.44 88.79 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 124.377 1.071 . . . . 50.55 112.781 -179.613 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 56' ' ' LEU . 91.5 t -55.83 -55.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.344 -1.724 . . . . 50.51 106.344 178.613 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -48.2 -30.12 4.37 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 113.072 0.768 . . . . 50.51 113.072 -179.813 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -35.88 74.5 Favored 'General case' 0 C--O 1.278 2.6 0 N-CA-C 114.379 1.251 . . . . 50.51 114.379 176.846 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -58.38 -43.36 88.45 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 104.256 -2.498 . . . . 50.51 104.256 176.03 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.77 -35.05 53.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.287 0 N-CA-C 115.219 1.563 . . . . 50.51 115.219 179.93 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -60.64 -32.07 71.25 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 125.593 2.616 . . . . 50.55 112.391 179.427 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -71.7 -52.1 19.53 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-N 113.568 -1.651 . . . . 50.62 109.803 179.131 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -78.82 -47.44 16.67 Favored 'General case' 0 C--O 1.279 2.616 0 C-N-CA 116.465 -2.094 . . . . 50.51 116.073 -175.656 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.79 -14.26 40.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 123.079 2.672 . . . . 50.62 117.047 179.819 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 13.02 83.97 Favored Glycine 0 CA--C 1.477 -2.32 0 CA-C-O 120.065 -0.297 . . . . 50.51 112.612 176.539 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 68.0 mt -91.33 123.47 64.0 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 115.554 1.687 . . . . 50.51 115.554 179.7 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.9 Cg_exo -56.93 136.9 79.33 Favored 'Trans proline' 0 C--O 1.26 1.617 0 C-N-CA 123.109 2.539 . . . . 50.51 111.006 178.268 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -57.2 -32.07 92.45 Favored 'Trans proline' 0 C--O 1.261 1.651 0 O-C-N 122.83 0.911 . . . . 50.51 113.45 -179.249 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -59.61 -12.49 6.81 Favored 'General case' 0 C--O 1.262 1.729 0 N-CA-C 117.768 2.507 . . . . 50.62 117.768 -177.463 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.517 ' O ' HD21 ' A' ' 71' ' ' LEU . 79.2 mt-30 -112.23 14.71 20.57 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.519 -1.363 . . . . 50.55 113.661 178.718 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -107.46 131.67 54.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.4 2.048 . . . . 50.55 115.36 -177.612 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.589 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 33.1 ttm180 -115.58 113.85 24.15 Favored 'General case' 0 C--O 1.296 3.524 0 CA-C-O 116.592 -1.671 . . . . 50.64 112.565 172.148 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.92 130.08 46.06 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 104.507 -2.405 . . . . 50.51 104.507 -177.501 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.549 HD12 ' HD3' ' A' ' 42' ' ' ARG . 89.4 mt -125.95 130.97 72.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.078 1.486 . . . . 50.51 112.746 -177.565 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.89 103.38 8.02 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 114.505 -1.225 . . . . 50.51 111.211 177.572 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.09 48.39 22.4 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.211 -2.268 . . . . 50.51 108.317 177.368 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.37 72.16 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 128.445 2.926 . . . . 50.51 115.154 -179.539 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -99.28 138.32 36.54 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.328 -0.99 . . . . 50.51 108.328 177.6 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -88.78 114.78 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.02 0.825 . . . . 50.55 112.617 174.616 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.36 128.18 35.67 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 117.679 -1.153 . . . . 50.51 113.899 -175.919 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -92.88 137.46 32.34 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.956 1.41 . . . . 50.62 107.43 -177.593 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.04 -44.14 67.15 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 118.367 2.728 . . . . 50.62 118.367 -175.784 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.38 -22.32 77.62 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 119.54 2.576 . . . . 50.51 119.54 -177.225 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -82.99 158.99 22.31 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 119.716 -2.049 . . . . 50.64 112.849 176.485 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -88.03 160.7 17.74 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 117.629 2.455 . . . . 50.51 117.629 177.044 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.522 HD11 HG22 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -55.61 -31.01 61.91 Favored 'General case' 0 C--O 1.2 -1.526 0 CA-C-N 115.473 -0.785 . . . . 50.51 110.912 177.243 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -71.62 -27.2 62.95 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.301 -1.76 . . . . 50.51 112.059 -179.485 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.96 -13.95 62.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.461 1.282 . . . . 50.62 114.461 179.769 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.585 ' HB2' HG12 ' A' ' 61' ' ' ILE . 53.5 m-85 -103.19 14.39 31.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 115.497 1.665 . . . . 50.51 115.497 179.25 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.9 t30 64.78 19.81 11.94 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 121.48 1.946 . . . . 50.55 109.459 179.855 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 59' ' ' TYR . 34.8 mm -81.23 99.69 4.76 Favored 'Isoleucine or valine' 0 C--O 1.267 2.026 0 CA-C-O 115.209 -2.329 . . . . 50.51 113.777 175.847 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -124.27 -115.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.101 2.125 . . . . 50.55 112.77 -176.851 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.77 128.72 35.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.259 1.504 . . . . 50.51 111.915 -176.95 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 51.65 39.23 24.68 Favored 'General case' 0 C--O 1.257 1.47 0 CA-C-N 112.516 -2.129 . . . . 50.62 115.775 179.52 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -71.27 148.27 47.33 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.842 -1.072 . . . . 50.51 110.018 174.8 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.9 m -127.51 116.05 19.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 118.26 -0.876 . . . . 50.51 112.222 175.938 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.42 142.45 27.41 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.76 -2.543 . . . . 50.51 111.856 175.043 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -88.78 138.29 31.55 Favored 'General case' 0 C--N 1.286 -2.182 0 O-C-N 126.818 2.574 . . . . 50.51 107.324 177.925 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.512 HD21 HG23 ' A' ' 7' ' ' THR . 68.0 tp -106.98 123.55 48.35 Favored 'General case' 0 C--O 1.283 2.852 0 CA-C-O 117.632 -1.175 . . . . 50.51 109.246 176.544 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.589 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.6 t -135.22 126.99 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 119.596 1.089 . . . . 50.51 110.346 175.059 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 71.2 mt -70.21 139.9 52.36 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 120.417 3.488 . . . . 50.51 120.417 178.446 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -118.27 106.46 12.82 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.327 -3.225 . . . . 50.64 102.491 177.314 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' CD1' ' HB3' ' A' ' 71' ' ' LEU . 6.4 mp -104.75 127.81 52.66 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.955 . . . . 50.51 115.508 -179.314 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -90.02 84.37 6.16 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.751 -1.568 . . . . 50.64 107.806 -179.648 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.21 157.04 7.21 Favored Glycine 0 C--O 1.244 0.744 1 N-CA-C 102.525 -4.23 . . . . 50.51 102.525 179.367 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 N-CA-C 105.58 -3.008 . . . . 50.51 105.58 179.227 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 108.225 -1.028 . . . . 50.51 108.225 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -102.06 133.53 46.75 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 126.889 2.618 . . . . 50.55 107.185 178.29 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.35 169.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 N-CA-C 104.745 -2.317 . . . . 50.51 104.745 173.37 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.97 123.73 40.51 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.427 4.829 . . . . 50.51 111.603 179.588 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.18 110.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 113.349 -3.215 . . . . 50.51 109.404 175.788 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -99.18 146.85 25.72 Favored 'General case' 0 N--CA 1.504 2.271 1 O-C-N 129.367 4.167 . . . . 50.51 112.42 -178.085 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -112.87 178.97 4.1 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.046 -2.946 . . . . 50.51 103.046 179.993 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.6 mt -91.53 3.7 54.35 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.111 0.882 . . . . 50.51 111.028 -178.036 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -91.96 -24.83 19.13 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 115.673 -2.411 . . . . 50.51 114.467 179.956 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.76 14.65 2.28 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 106.022 -2.831 . . . . 50.51 106.022 179.735 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -95.33 120.12 35.01 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 115.247 1.573 . . . . 50.51 115.247 174.971 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -119.53 108.56 14.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 126.679 2.487 . . . . 50.51 105.48 176.143 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 tt -103.19 146.02 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.442 2.964 . . . . 50.51 114.156 179.721 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 15' ' ' LEU . 98.5 m -97.93 155.76 16.93 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 117.27 -1.772 . . . . 50.51 111.194 178.092 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.464 ' N ' HG23 ' A' ' 14' ' ' THR . 12.6 tp -138.11 140.02 39.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 115.485 -2.198 . . . . 50.51 111.804 -179.239 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -103.11 115.05 29.85 Favored 'General case' 0 N--CA 1.5 2.042 1 O-C-N 129.187 4.055 . . . . 50.62 111.421 173.972 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.58 178.09 2.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 O-C-N 127.888 3.243 . . . . 50.51 113.093 -177.93 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 25.7 tt0 -102.01 149.97 37.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 112.196 -2.274 . . . . 50.62 106.082 174.622 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.93 -24.5 39.52 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.6 2.2 . . . . 50.51 111.948 177.691 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.6 p -120.14 22.07 11.55 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 119.795 3.257 . . . . 50.51 119.795 -177.528 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.0 152.19 42.65 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.44 -1.704 . . . . 50.62 108.547 -179.026 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.407 HG23 HG23 ' A' ' 55' ' ' THR . 71.6 p -97.27 145.92 25.62 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.895 -0.593 . . . . 50.51 109.499 175.649 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.592 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 50.5 mm -42.64 -36.77 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 O-C-N 127.126 2.766 . . . . 50.51 113.586 175.789 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -44.53 -55.66 4.94 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.364 -0.835 . . . . 50.62 112.729 176.96 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -72.14 -46.02 58.19 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.361 1.064 . . . . 50.55 108.18 -179.645 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.509 ' HB ' ' HA ' ' A' ' 23' ' ' ILE . 90.8 t -40.69 -62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.003 1.439 . . . . 50.51 108.535 178.54 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 53.3 mtmt -67.7 -16.32 64.08 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 115.288 1.588 . . . . 50.51 115.288 -179.74 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.69 -33.08 25.25 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.84 -0.43 . . . . 50.51 109.84 176.87 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -69.0 -46.77 67.19 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 103.278 -2.86 . . . . 50.51 103.278 176.025 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -55.78 -28.69 24.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.491 -0.883 . . . . 50.51 111.724 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -63.56 -35.55 80.85 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 125.604 2.621 . . . . 50.55 108.384 179.465 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -68.93 -55.07 12.12 Favored 'General case' 0 C--O 1.254 1.303 0 N-CA-C 117.122 2.267 . . . . 50.62 117.122 179.08 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -80.47 -42.47 22.52 Favored 'General case' 0 C--O 1.28 2.71 0 C-N-CA 116.447 -2.101 . . . . 50.51 111.603 -175.687 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -86.82 -50.12 6.95 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 123.096 2.68 . . . . 50.62 115.667 179.881 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 18.59 7.84 Favored Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 107.886 -2.086 . . . . 50.51 107.886 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.455 HG21 ' HG2' ' A' ' 41' ' ' GLN . 31.0 mm -98.62 120.63 58.62 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.794 -1.162 . . . . 50.51 112.326 179.689 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.0 Cg_exo -56.99 136.9 79.49 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.202 2.601 . . . . 50.51 110.901 178.29 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HA ' HE21 ' A' ' 41' ' ' GLN . 86.5 Cg_exo -57.15 -32.14 92.54 Favored 'Trans proline' 0 C--O 1.262 1.697 0 C-N-CA 120.682 0.921 . . . . 50.51 113.449 -179.336 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.11 -11.7 59.85 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 119.931 -1.731 . . . . 50.62 109.084 -177.42 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -98.78 2.92 47.35 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.462 -1.399 . . . . 50.55 110.585 178.764 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 38' ' ' PRO . 54.8 mt-30 -102.27 118.77 37.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 124.348 2.023 . . . . 50.55 114.652 -177.588 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.548 ' HD2' ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp180 -102.17 118.5 37.02 Favored 'General case' 0 C--O 1.295 3.497 0 CA-C-O 116.732 -1.604 . . . . 50.64 107.566 172.165 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.555 ' HB3' HD12 ' A' ' 50' ' ' LEU . 51.5 mt -109.72 119.77 40.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 50.51 112.721 -177.425 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.41 132.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 O-C-N 125.046 1.467 . . . . 50.51 113.525 -177.65 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.14 100.71 7.0 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 103.543 -2.762 . . . . 50.51 103.543 177.556 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 33.63 11.68 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.152 -2.294 . . . . 50.51 114.779 177.448 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.62 10.27 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 128.513 2.959 . . . . 50.51 113.266 -179.546 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -124.55 112.24 16.61 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 115.11 1.522 . . . . 50.51 115.11 177.713 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -58.12 113.61 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.135 2.272 . . . . 50.55 117.135 174.574 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 43' ' ' LEU . 55.1 mt -65.15 150.05 48.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 117.802 -1.094 . . . . 50.51 112.936 -175.917 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.47 ' HB3' ' HH ' ' A' ' 59' ' ' TYR . 74.5 tt0 -108.04 135.09 49.99 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.544 1.153 . . . . 50.62 110.984 -177.684 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -53.02 -63.91 0.99 Allowed 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.115 1.766 . . . . 50.62 112.088 -175.806 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 -8.04 66.87 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 117.496 1.759 . . . . 50.51 117.496 -177.274 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.535 ' HB2' ' HH ' ' A' ' 59' ' ' TYR . 16.8 mmp_? -82.37 -173.1 4.37 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 120.037 -1.861 . . . . 50.64 107.531 176.492 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.407 HG23 HG23 ' A' ' 22' ' ' THR . 38.9 p -127.59 158.2 38.14 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.549 1.315 . . . . 50.51 114.549 177.07 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.87 -39.82 69.08 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 106.456 -1.683 . . . . 50.51 106.456 177.242 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' TYR . 73.3 m -61.49 -43.84 98.15 Favored 'General case' 0 C--O 1.269 2.086 0 C-N-CA 117.299 -1.76 . . . . 50.51 108.829 -179.493 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.29 -4.26 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.214 1.19 . . . . 50.62 114.214 179.685 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.535 ' HH ' ' HB2' ' A' ' 54' ' ' ARG . 83.7 m-85 -122.94 9.7 9.42 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 116.44 2.015 . . . . 50.51 116.44 179.26 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 61.22 23.25 13.48 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 121.446 1.93 . . . . 50.55 113.53 179.944 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 61' ' ' ILE . 73.4 mt -73.93 94.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.198 -2.335 . . . . 50.51 116.274 175.836 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -87.7 159.23 18.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 126.031 2.082 . . . . 50.55 112.994 -176.81 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.469 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 79.5 tttt -54.64 154.34 5.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 123.235 1.493 . . . . 50.51 108.135 -176.958 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' OE2' ' HE2' ' A' ' 63' ' ' LYS . 42.6 mm-40 57.8 69.31 0.75 Allowed 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.476 -2.147 . . . . 50.62 106.143 179.613 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -143.08 129.82 20.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.775 -1.102 . . . . 50.51 112.761 174.823 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -72.78 130.16 39.84 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 118.121 2.637 . . . . 50.51 118.121 175.92 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.3 138.02 45.29 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.673 -2.584 . . . . 50.51 107.445 175.079 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -91.95 123.07 35.04 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 127.389 2.93 . . . . 50.51 113.659 177.848 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -105.84 103.06 12.48 Favored 'General case' 0 C--O 1.282 2.792 0 CA-C-O 117.657 -1.163 . . . . 50.51 113.918 176.511 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.5 138.9 33.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 119.538 1.063 . . . . 50.51 109.262 175.174 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.26 148.11 39.71 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 117.33 2.344 . . . . 50.51 117.33 178.479 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.548 ' HD2' ' HD2' ' A' ' 42' ' ' ARG . 76.5 ttt-85 -132.41 87.36 2.42 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 113.375 -3.202 . . . . 50.64 104.574 177.22 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -79.2 167.47 20.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.814 1.946 . . . . 50.51 106.928 -179.344 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.39 63.58 1.12 Allowed 'General case' 0 C--O 1.244 0.772 0 N-CA-C 118.105 2.632 . . . . 50.64 118.105 -179.643 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.24 178.06 38.14 Favored Glycine 0 C--O 1.242 0.651 0 O-C-N 124.617 1.198 . . . . 50.51 112.85 179.403 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 CA-C-O 116.338 -2.368 . . . . 50.51 115.437 179.204 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' HE1' ' HB2' ' A' ' 63' ' ' LYS . 82.0 mtp . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.993 -1.114 . . . . 50.51 107.993 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -84.43 140.22 31.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 126.976 2.673 . . . . 50.55 109.692 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.4 pt -133.64 159.58 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-O 115.982 -1.961 . . . . 50.51 107.126 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -117.16 135.69 53.58 Favored 'General case' 0 N--CA 1.512 2.639 1 O-C-N 130.48 4.863 . . . . 50.51 110.963 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.532 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 69.9 t -114.87 108.28 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 113.436 -3.173 . . . . 50.51 110.719 175.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' CD ' HG23 ' A' ' 12' ' ' THR . 35.1 mmtp -88.2 122.94 32.33 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.303 4.127 . . . . 50.51 111.031 -178.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.9 p -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.354 -2.091 . . . . 50.51 105.354 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -112.64 6.62 18.38 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.067 0.854 . . . . 50.51 112.102 -177.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -106.67 -27.84 10.57 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.702 -2.399 . . . . 50.51 106.563 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.2 0.65 2.11 Favored Glycine 0 C--N 1.296 -1.641 0 O-C-N 119.78 -1.825 . . . . 50.51 115.343 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -73.92 152.29 40.17 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.852 -1.547 . . . . 50.51 115.111 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.472 HG23 ' CD ' ' A' ' 6' ' ' LYS . 44.3 p -121.26 156.72 31.88 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 126.654 2.471 . . . . 50.51 108.939 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 62.7 mt -127.96 142.09 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.396 2.935 . . . . 50.51 111.49 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -111.92 134.28 53.57 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.163 -1.792 . . . . 50.51 106.163 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.571 HD21 ' HE2' ' A' ' 33' ' ' LYS . 96.0 mt -127.15 134.06 50.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.412 2.375 . . . . 50.51 117.412 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.55 96.16 7.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 128.807 3.817 . . . . 50.62 111.345 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -121.86 -175.02 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.267 0 O-C-N 127.603 3.064 . . . . 50.51 115.619 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CD ' ' OG ' ' A' ' 20' ' ' SER . 14.7 pt-20 -151.91 154.73 33.12 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.227 -2.26 . . . . 50.62 108.206 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.3 Cg_exo -54.94 -24.51 39.61 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.575 2.184 . . . . 50.51 111.985 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.46 ' OG ' ' CD ' ' A' ' 18' ' ' GLU . 92.8 p -63.79 -30.86 71.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.142 -0.932 . . . . 50.51 111.755 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -69.62 149.63 47.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.357 -1.737 . . . . 50.62 115.373 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 HG23 ' A' ' 55' ' ' THR . 33.0 p -93.58 169.62 10.2 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.827 -0.624 . . . . 50.51 109.549 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.476 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 42.3 mm -58.99 -25.6 30.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 O-C-N 127.189 2.806 . . . . 50.51 112.352 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -70.89 -46.41 62.64 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.047 2.24 . . . . 50.62 117.047 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -66.6 -50.34 63.37 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 124.31 1.044 . . . . 50.55 110.626 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.41 -31.39 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.932 1.395 . . . . 50.51 112.353 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 92.1 mttt -81.65 -19.97 40.63 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 105.184 -2.154 . . . . 50.51 105.184 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.33 -14.97 34.5 Favored 'General case' 0 C--O 1.278 2.58 0 N-CA-C 112.47 0.544 . . . . 50.51 112.47 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -90.15 -35.2 15.53 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.338 -1.476 . . . . 50.51 107.719 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 61.0 mt -60.41 -29.4 44.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.53 -0.868 . . . . 50.51 112.135 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' ILE . 61.9 tt0 -49.94 -51.94 37.32 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 125.627 2.632 . . . . 50.55 104.767 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -46.96 -41.37 16.06 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.619 -1.628 . . . . 50.62 112.33 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HE2' HD21 ' A' ' 15' ' ' LEU . 12.3 mptt -73.68 -41.77 62.19 Favored 'General case' 0 C--O 1.279 2.645 0 C-N-CA 116.464 -2.094 . . . . 50.51 114.312 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' OE2' HD12 ' A' ' 13' ' ' ILE . 30.1 mt-10 -113.98 -62.79 1.54 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 123.06 2.664 . . . . 50.62 109.956 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.82 -16.68 1.98 Allowed Glycine 0 CA--C 1.477 -2.288 0 CA-C-O 120.017 -0.324 . . . . 50.51 112.919 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.502 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.9 mm -58.06 128.86 82.04 Favored Pre-proline 0 C--O 1.244 0.768 0 N-CA-C 117.582 2.438 . . . . 50.51 117.582 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 77.9 Cg_exo -56.98 136.97 79.83 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.147 2.565 . . . . 50.51 110.869 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -57.21 -32.09 92.54 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.861 0.927 . . . . 50.51 113.45 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.33 -26.89 67.5 Favored 'General case' 0 C--O 1.262 1.743 0 O-C-N 119.981 -1.699 . . . . 50.62 108.101 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.0 3.5 55.1 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.555 -1.341 . . . . 50.55 113.535 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 86.7 mt-30 -101.49 140.5 35.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 124.355 2.026 . . . . 50.55 109.8 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -134.88 148.66 50.15 Favored 'General case' 0 C--O 1.296 3.506 0 CA-C-O 116.696 -1.621 . . . . 50.64 107.468 172.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.0 mt -129.83 125.13 34.96 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.638 -1.245 . . . . 50.51 107.638 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.6 133.68 61.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 125.08 1.488 . . . . 50.51 112.789 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.57 110.91 5.81 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 107.086 -1.45 . . . . 50.51 107.086 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.02 30.76 4.36 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.254 -2.248 . . . . 50.51 115.498 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.93 -7.46 82.07 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 128.424 2.916 . . . . 50.51 116.734 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -80.43 119.52 23.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.047 0.924 . . . . 50.51 112.719 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -81.6 106.18 13.34 Favored 'General case' 0 C--O 1.259 1.583 0 O-C-N 123.936 0.773 . . . . 50.55 111.918 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.07 154.23 4.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 114.268 1.21 . . . . 50.51 114.268 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.5 132.35 51.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.144 2.275 . . . . 50.62 117.144 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -56.31 -5.02 0.16 Allowed 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.927 2.936 . . . . 50.62 118.927 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 9.3 22.67 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 105.382 -3.087 . . . . 50.51 105.382 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.17 156.77 16.25 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 119.961 -1.905 . . . . 50.64 109.981 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.576 HG23 HG23 ' A' ' 22' ' ' THR . 41.5 p -109.56 144.4 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.187 -1.412 . . . . 50.51 107.187 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -40.96 -25.47 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.145 0.903 . . . . 50.51 109.021 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' THR . 91.0 p -74.0 -27.41 60.95 Favored 'General case' 0 C--O 1.268 2.076 0 N-CA-C 115.809 1.781 . . . . 50.51 115.809 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -65.86 -26.95 67.88 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.461 1.124 . . . . 50.62 110.413 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.86 5.95 26.92 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 117.781 -1.104 . . . . 50.51 111.333 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 41.36 29.38 0.09 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.474 1.943 . . . . 50.55 113.378 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -51.44 107.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.267 1.975 0 N-CA-C 104.064 -2.569 . . . . 50.51 104.064 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 63' ' ' LYS . 16.6 pt20 -107.0 -169.04 1.48 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 126.092 2.12 . . . . 50.55 112.791 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.49 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 36.1 ttpt -73.32 136.06 44.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.184 1.469 . . . . 50.51 114.36 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 41.3 mt-10 71.85 8.9 6.13 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 117.217 2.302 . . . . 50.62 117.217 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 t -74.77 142.3 44.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 104.636 -2.357 . . . . 50.51 104.636 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -106.41 133.81 50.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.39 -0.967 . . . . 50.51 108.39 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.54 162.17 13.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.681 -2.581 . . . . 50.51 109.154 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -116.01 121.92 43.69 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 127.406 2.941 . . . . 50.51 111.196 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.1 tp -79.83 140.41 36.83 Favored 'General case' 0 C--O 1.283 2.822 0 N-CA-C 115.5 1.667 . . . . 50.51 115.5 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.74 138.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.634 1.106 . . . . 50.51 112.603 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.5 tp -103.91 107.78 18.81 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.47 0.915 . . . . 50.51 113.47 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.5 79.85 2.0 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 113.349 -3.215 . . . . 50.64 115.252 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -58.0 148.23 26.74 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 117.843 2.534 . . . . 50.51 117.843 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 70.6 ttp85 -95.34 55.03 1.69 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 115.389 1.625 . . . . 50.64 115.389 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.22 -170.86 39.59 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.594 -3.402 . . . . 50.51 104.594 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.453 0 CA-C-O 116.337 -2.369 . . . . 50.51 111.883 179.197 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.606 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 118.86 -0.591 . . . . 50.51 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -88.0 142.49 27.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 126.954 2.659 . . . . 50.55 109.499 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 17' ' ' VAL . 24.3 pt -141.77 160.76 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 116.036 -1.935 . . . . 50.51 107.472 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 66' ' ' THR . 83.1 m-85 -113.78 132.34 55.89 Favored 'General case' 0 N--CA 1.511 2.582 1 O-C-N 130.381 4.801 . . . . 50.51 113.364 179.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.99 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 113.348 -3.215 . . . . 50.51 106.321 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG2' ' OG1' ' A' ' 12' ' ' THR . 92.5 mttt -111.88 135.51 52.4 Favored 'General case' 0 N--CA 1.503 2.207 1 O-C-N 129.388 4.18 . . . . 50.51 117.046 -178.112 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 154.78 31.92 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 107.609 -1.256 . . . . 50.51 107.609 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.26 -12.97 23.45 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.177 0.923 . . . . 50.51 110.549 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -66.06 -22.46 66.42 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 115.705 -2.398 . . . . 50.51 113.759 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.39 10.55 35.81 Favored Glycine 0 C--N 1.297 -1.598 0 O-C-N 120.106 -1.621 . . . . 50.51 112.437 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -101.28 134.84 43.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 116.82 -1.562 . . . . 50.51 112.252 174.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 6' ' ' LYS . 52.4 m -127.51 149.29 50.2 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.707 2.505 . . . . 50.51 115.581 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -134.07 157.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 115.266 -2.574 . . . . 50.51 106.314 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -121.38 144.41 48.67 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.248 -1.781 . . . . 50.51 113.515 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD23 ' HB3' ' A' ' 29' ' ' LYS . 77.5 mt -120.1 167.37 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.445 -2.216 . . . . 50.51 109.959 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -129.47 92.96 3.44 Favored 'General case' 0 N--CA 1.5 2.041 1 O-C-N 129.131 4.019 . . . . 50.62 106.104 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.606 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 m -105.34 173.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.779 3.174 . . . . 50.51 111.764 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 84.0 mt-10 -106.44 145.13 30.4 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.164 -2.289 . . . . 50.62 111.14 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.3 Cg_exo -54.9 -24.57 39.62 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.637 2.224 . . . . 50.51 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 p -88.23 -9.0 54.4 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 115.2 1.556 . . . . 50.51 115.2 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 46.2 m-20 -65.27 148.79 51.07 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 117.412 -1.715 . . . . 50.62 110.448 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -78.94 170.94 15.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.865 -0.607 . . . . 50.51 110.503 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.24 -29.33 46.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 O-C-N 127.103 2.752 . . . . 50.51 108.04 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -70.93 -15.1 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 119.915 3.302 . . . . 50.62 119.915 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.467 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 23.0 t-20 -81.82 -50.63 9.0 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.366 1.066 . . . . 50.55 110.51 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -54.7 -44.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 125.045 1.466 . . . . 50.51 108.146 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -54.39 -35.46 62.87 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 107.989 -1.115 . . . . 50.51 107.989 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -67.2 -49.62 63.94 Favored 'General case' 0 C--O 1.278 2.597 0 N-CA-C 109.695 -0.483 . . . . 50.51 109.695 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.567 ' HB3' HD23 ' A' ' 15' ' ' LEU . 46.8 mmtm -50.89 -37.09 41.66 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 120.374 -1.454 . . . . 50.51 114.823 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.82 -42.11 28.51 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 104.617 -2.364 . . . . 50.51 104.617 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -53.6 -42.36 67.6 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 125.628 2.632 . . . . 50.55 112.14 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.9 -41.73 78.62 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 120.716 3.599 . . . . 50.62 120.716 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -106.76 -15.08 14.83 Favored 'General case' 0 C--O 1.279 2.633 0 C-N-CA 116.434 -2.106 . . . . 50.51 113.39 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.18 -11.11 11.37 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 118.616 2.821 . . . . 50.62 118.616 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 28.74 45.78 Favored Glycine 0 CA--C 1.478 -2.25 0 N-CA-C 114.94 0.736 . . . . 50.51 114.94 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.486 HD11 HD22 ' A' ' 71' ' ' LEU . 71.5 mt -107.46 119.64 50.05 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 114.984 1.476 . . . . 50.51 114.984 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.07 137.0 79.94 Favored 'Trans proline' 0 C--O 1.258 1.515 0 C-N-CA 123.116 2.544 . . . . 50.51 110.883 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -57.14 -32.28 92.9 Favored 'Trans proline' 0 C--O 1.261 1.663 0 C-N-CA 120.711 0.941 . . . . 50.51 113.379 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -73.27 0.15 12.76 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.948 -1.72 . . . . 50.62 110.64 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -112.4 1.69 16.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.572 -1.33 . . . . 50.55 109.356 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.04 128.55 47.03 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.419 2.057 . . . . 50.55 111.985 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' HD2' ' HB2' ' A' ' 72' ' ' ARG . 70.3 mtp180 -112.21 127.35 55.93 Favored 'General case' 0 C--O 1.297 3.555 0 N-CA-C 105.903 -1.888 . . . . 50.64 105.903 172.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -109.65 136.13 49.49 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 102.88 -3.007 . . . . 50.51 102.88 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -132.4 121.32 45.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 O-C-N 125.223 1.577 . . . . 50.51 111.755 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.53 90.81 3.4 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 106.998 -1.482 . . . . 50.51 106.998 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.07 76.54 0.33 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.219 -2.264 . . . . 50.51 112.337 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.03 32.07 0.35 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 128.405 2.907 . . . . 50.51 113.437 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -121.85 112.63 18.58 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 102.62 -3.104 . . . . 50.51 102.62 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -70.62 123.59 22.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.887 0.742 . . . . 50.55 111.637 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 mt -78.04 139.39 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 117.756 -1.116 . . . . 50.51 113.743 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -86.58 115.25 23.93 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.95 1.406 . . . . 50.62 114.529 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -40.42 -21.16 0.01 OUTLIER 'General case' 0 C--O 1.264 1.834 0 N-CA-C 117.809 2.522 . . . . 50.62 117.809 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.96 2.74 51.85 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 118.398 2.119 . . . . 50.51 118.398 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 mmp_? -96.99 -177.77 3.98 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 120.031 -1.864 . . . . 50.64 109.983 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -108.66 174.73 5.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.062 0.945 . . . . 50.51 110.315 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.5 mt -74.8 -13.95 60.64 Favored 'General case' 0 C--O 1.201 -1.482 0 CA-C-O 118.382 -0.818 . . . . 50.51 111.156 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -85.83 -40.85 15.56 Favored 'General case' 0 C--O 1.268 2.057 0 N-CA-C 117.598 2.444 . . . . 50.51 117.598 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -47.51 -37.27 11.67 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.497 1.141 . . . . 50.62 108.843 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 9.72 9.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 117.328 2.344 . . . . 50.51 117.328 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 62' ' ' GLN . 87.2 m-20 53.97 16.08 1.02 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-N 121.526 1.966 . . . . 50.55 115.744 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.649 HG23 ' HG ' ' A' ' 65' ' ' SER . 27.2 mm -52.1 90.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.265 1.913 0 CA-C-O 115.207 -2.33 . . . . 50.51 110.741 175.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 60' ' ' ASN . 77.0 mt-30 -78.21 -175.73 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 125.588 1.805 . . . . 50.55 114.506 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -70.64 141.94 51.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.622 -1.992 . . . . 50.51 105.622 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 67.6 31.17 6.25 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.437 -2.165 . . . . 50.62 112.362 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.649 ' HG ' HG23 ' A' ' 61' ' ' ILE . 32.3 t -77.91 135.98 37.95 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.792 -1.094 . . . . 50.51 108.596 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.5 HG23 ' HB2' ' A' ' 4' ' ' PHE . 16.9 p -93.35 142.87 26.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 118.313 -0.851 . . . . 50.51 110.594 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.6 mt -122.09 122.58 39.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.78 -2.533 . . . . 50.51 105.6 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -83.64 151.25 25.4 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 102.87 -3.011 . . . . 50.51 102.87 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -123.3 109.76 14.34 Favored 'General case' 0 C--O 1.283 2.822 0 CA-C-O 117.608 -1.187 . . . . 50.51 110.481 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.09 133.01 49.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.502 -2.036 . . . . 50.51 105.502 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.486 HD22 HD11 ' A' ' 36' ' ' ILE . 35.1 mt -82.67 152.09 25.99 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 118.77 2.878 . . . . 50.51 118.77 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.467 ' HB2' ' HD2' ' A' ' 42' ' ' ARG . 36.3 ttm180 -123.76 89.77 3.15 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 113.308 -3.234 . . . . 50.64 111.62 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.59 156.19 29.26 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 125.904 2.002 . . . . 50.51 111.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -106.16 77.61 1.24 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 115.821 1.785 . . . . 50.64 115.821 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.23 124.6 2.83 Favored Glycine 0 C--O 1.242 0.643 0 CA-C-N 114.646 -1.161 . . . . 50.51 113.593 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 N-CA-C 104.406 -3.478 . . . . 50.51 104.406 179.279 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.528 ' SD ' ' HE2' ' A' ' 63' ' ' LYS . 18.4 mmt . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 112.576 0.584 . . . . 50.51 112.576 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -88.21 150.95 23.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.907 2.629 . . . . 50.55 106.822 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -148.42 145.7 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 104.972 -2.232 . . . . 50.51 104.972 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.66 134.98 54.65 Favored 'General case' 0 N--CA 1.511 2.597 1 O-C-N 130.409 4.818 . . . . 50.51 110.476 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -119.55 128.01 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 113.399 -3.191 . . . . 50.51 116.944 175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -94.14 119.36 32.86 Favored 'General case' 0 N--CA 1.504 2.239 1 O-C-N 129.254 4.097 . . . . 50.51 113.065 -178.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.513 HG23 HD21 ' A' ' 69' ' ' LEU . 69.0 p -95.27 177.59 5.8 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.793 -1.098 . . . . 50.51 109.48 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.6 mt -83.79 -12.85 55.09 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.138 0.899 . . . . 50.51 110.752 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -95.09 -17.46 21.82 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.76 -2.376 . . . . 50.51 113.426 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.16 -23.04 7.38 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 119.034 2.374 . . . . 50.51 119.034 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.66 107.09 0.76 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 117.134 2.272 . . . . 50.51 117.134 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -82.07 128.41 34.08 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.595 2.434 . . . . 50.51 107.848 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.01 144.92 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 127.591 3.057 . . . . 50.51 114.268 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -113.68 123.52 50.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.264 -1.774 . . . . 50.51 112.454 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.0 mt -116.92 145.92 43.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 120.933 3.679 . . . . 50.51 120.933 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.17 114.22 28.31 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 128.413 3.571 . . . . 50.62 112.676 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.51 163.05 35.8 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 O-C-N 127.831 3.207 . . . . 50.51 117.228 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 40.3 mt-10 -99.18 151.24 37.32 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 117.604 2.446 . . . . 50.62 117.604 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.1 Cg_exo -54.9 -24.52 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.586 2.191 . . . . 50.51 111.928 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -93.12 -19.48 21.46 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 116.547 2.054 . . . . 50.51 116.547 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.58 151.23 17.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.404 -1.718 . . . . 50.62 107.183 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.444 ' HG1' ' HB2' ' A' ' 24' ' ' GLU . 33.1 p -87.45 167.67 13.79 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.858 -0.61 . . . . 50.51 109.445 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.413 HD11 ' HH ' ' A' ' 59' ' ' TYR . 23.8 pt -61.58 -34.93 64.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 127.193 2.808 . . . . 50.51 103.875 175.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HB2' ' HG1' ' A' ' 22' ' ' THR . 43.8 mt-10 -56.55 -49.41 74.89 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 114.048 1.129 . . . . 50.62 114.048 176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -55.97 -32.13 63.6 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.307 1.043 . . . . 50.55 111.959 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -41.94 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.975 1.422 . . . . 50.51 111.264 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.25 -40.31 45.25 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 116.391 1.997 . . . . 50.51 116.391 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.32 83.38 Favored 'General case' 0 C--O 1.278 2.576 0 CA-C-N 117.984 0.356 . . . . 50.51 111.524 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -55.15 -55.95 25.4 Favored 'General case' 0 C--O 1.255 1.351 0 N-CA-C 104.776 -2.305 . . . . 50.51 104.776 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -54.77 -36.1 35.64 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.47 -0.892 . . . . 50.51 113.053 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.1 -32.85 16.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 125.625 2.631 . . . . 50.55 113.307 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.72 -44.71 20.27 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 113.592 -1.64 . . . . 50.62 113.123 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -87.72 -29.52 21.02 Favored 'General case' 0 C--O 1.279 2.637 0 N-CA-C 116.89 2.182 . . . . 50.51 116.89 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -115.58 -23.13 8.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 123.07 2.668 . . . . 50.62 109.5 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.21 -34.54 4.64 Favored Glycine 0 CA--C 1.477 -2.342 0 N-CA-C 116.477 1.351 . . . . 50.51 116.477 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.6 mt -40.69 113.7 1.03 Allowed Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 115.063 1.505 . . . . 50.51 115.063 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.182 2.588 . . . . 50.51 110.888 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -57.18 -32.22 92.83 Favored 'Trans proline' 0 C--O 1.262 1.684 0 C-N-CA 120.671 0.914 . . . . 50.51 113.444 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.41 -12.79 15.87 Favored 'General case' 0 C--O 1.262 1.741 0 O-C-N 119.921 -1.737 . . . . 50.62 112.028 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.43 -12.42 17.19 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.515 -1.366 . . . . 50.55 111.808 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -93.11 125.27 37.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.345 2.021 . . . . 50.55 115.244 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -121.15 134.7 55.23 Favored 'General case' 0 C--O 1.295 3.458 0 CA-C-O 116.691 -1.623 . . . . 50.64 108.961 172.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.587 ' HB2' HD23 ' A' ' 50' ' ' LEU . 60.3 mt -119.17 120.33 36.78 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 102.08 -3.304 . . . . 50.51 102.08 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.34 129.47 71.54 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 O-C-N 125.15 1.531 . . . . 50.51 112.727 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.97 121.81 15.48 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 117.973 2.583 . . . . 50.51 117.973 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.38 9.53 6.51 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.206 -2.27 . . . . 50.51 108.435 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.62 37.35 8.09 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.481 2.943 . . . . 50.51 109.469 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' O ' ' C ' ' A' ' 49' ' ' GLN . 36.1 ttpt -126.63 85.39 2.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.098 0.949 . . . . 50.51 112.39 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.511 ' C ' ' O ' ' A' ' 48' ' ' LYS . 6.9 tt0 -36.93 128.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.926 -1.879 . . . . 50.55 105.926 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD23 ' HB2' ' A' ' 43' ' ' LEU . 2.1 mp -60.03 120.78 10.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 117.695 -1.145 . . . . 50.51 111.417 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -88.95 131.87 34.96 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.018 1.449 . . . . 50.62 109.345 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -50.82 -47.1 60.1 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.171 1.788 . . . . 50.62 111.497 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.82 21.44 2.56 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 119.051 2.38 . . . . 50.51 119.051 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -111.26 158.2 19.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.006 -1.879 . . . . 50.64 111.509 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 p -93.88 167.02 11.89 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.105 0.962 . . . . 50.51 110.491 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 56' ' ' LEU . 26.8 mt -56.53 -28.56 60.32 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 116.618 2.081 . . . . 50.51 116.618 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -87.82 -20.87 25.48 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.362 -1.735 . . . . 50.51 112.767 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.99 -36.46 62.95 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.225 -1.768 . . . . 50.62 106.225 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.471 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 77.8 m-85 -81.7 -31.91 31.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.777 -1.106 . . . . 50.51 109.354 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 26.2 m120 76.54 36.74 0.36 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 121.451 1.932 . . . . 50.55 114.554 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.57 108.91 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.981 0 CA-C-O 115.165 -2.35 . . . . 50.51 113.679 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -104.88 -176.31 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.898 -2.63 . . . . 50.55 103.898 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.528 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 35.4 mmtp -67.07 162.4 22.33 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 102.841 -3.022 . . . . 50.51 102.841 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 51.34 44.75 28.72 Favored 'General case' 0 C--O 1.257 1.485 0 CA-C-N 112.443 -2.162 . . . . 50.62 114.696 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 t -109.23 137.78 46.58 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.23 1.196 . . . . 50.51 114.23 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 m -118.46 117.09 28.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 114.463 1.283 . . . . 50.51 114.463 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.34 153.04 20.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 114.738 -2.553 . . . . 50.51 110.766 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -95.57 146.54 24.38 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 127.371 2.919 . . . . 50.51 113.483 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 7' ' ' THR . 29.3 tp -107.42 101.83 11.16 Favored 'General case' 0 C--O 1.283 2.827 0 CA-C-O 117.647 -1.168 . . . . 50.51 110.412 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.51 121.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 119.602 1.092 . . . . 50.51 111.027 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.5 mt -74.33 133.62 42.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.369 2.729 . . . . 50.51 118.369 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -113.59 131.43 56.11 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 113.368 -3.206 . . . . 50.64 105.614 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.94 -178.7 3.74 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.867 1.979 . . . . 50.51 111.226 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -126.04 67.89 1.19 Allowed 'General case' 0 C--O 1.245 0.831 0 N-CA-C 104.342 -2.466 . . . . 50.64 104.342 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.28 146.13 8.82 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 114.63 -1.168 . . . . 50.51 115.838 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.831 -3.307 . . . . 50.51 104.831 179.255 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 116.342 1.978 . . . . 50.51 116.342 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -82.88 149.76 26.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 126.882 2.613 . . . . 50.55 107.781 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 15' ' ' LEU . 18.5 tt -163.46 136.5 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 115.981 -1.961 . . . . 50.51 106.277 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' THR . 42.4 m-85 -104.39 143.52 32.89 Favored 'General case' 0 N--CA 1.512 2.634 1 O-C-N 130.259 4.724 . . . . 50.51 113.453 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 70.0 t -109.65 105.52 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.391 -3.195 . . . . 50.51 107.296 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -99.77 109.72 22.13 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.347 4.154 . . . . 50.51 110.385 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.532 HG21 ' H ' ' A' ' 9' ' ' THR . 9.7 t -89.78 -171.51 3.2 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 115.324 1.602 . . . . 50.51 115.324 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' N ' ' OG1' ' A' ' 7' ' ' THR . 65.6 mt -90.12 6.68 41.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.756 1.021 . . . . 50.51 113.756 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.532 ' H ' HG21 ' A' ' 7' ' ' THR . 55.5 p -104.55 0.53 28.79 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 115.715 -2.394 . . . . 50.51 114.853 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.88 37.04 7.46 Favored Glycine 0 C--N 1.298 -1.558 0 N-CA-C 103.411 -3.875 . . . . 50.51 103.411 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -113.59 159.14 19.93 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 119.455 3.131 . . . . 50.51 119.455 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.2 m -135.27 123.8 23.51 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 120.337 3.458 . . . . 50.51 120.337 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 96.7 mt -108.33 136.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.521 3.013 . . . . 50.51 107.483 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 m -117.16 117.54 29.86 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 117.329 -1.749 . . . . 50.51 112.395 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 3' ' ' ILE . 46.0 tp -128.69 135.49 49.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 120.168 3.395 . . . . 50.51 120.168 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -79.79 139.91 37.07 Favored 'General case' 0 N--CA 1.5 2.046 1 O-C-N 129.176 4.048 . . . . 50.62 114.764 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.76 175.18 6.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 O-C-N 127.758 3.161 . . . . 50.51 114.114 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.7 mt-10 -124.81 142.65 41.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 112.197 -2.274 . . . . 50.62 108.835 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.7 Cg_exo -54.97 -24.54 39.98 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 122.549 2.166 . . . . 50.51 111.943 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -86.35 -0.16 55.3 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.655 1.724 . . . . 50.51 115.655 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -79.13 160.08 27.17 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.421 -1.712 . . . . 50.62 107.471 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.407 ' H ' HD21 ' A' ' 25' ' ' ASN . 52.3 p -107.62 153.68 22.54 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 103.753 -2.684 . . . . 50.51 103.753 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 25.6 mm -56.67 -23.03 16.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 O-C-N 127.011 2.694 . . . . 50.51 116.481 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 23.7 tt0 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 103.248 -2.871 . . . . 50.62 103.248 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.407 HD21 ' H ' ' A' ' 22' ' ' THR . 57.8 m-80 -68.11 -43.17 79.04 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 124.383 1.073 . . . . 50.55 112.305 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.17 -38.57 77.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.046 1.466 . . . . 50.51 113.289 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -74.57 -30.31 61.67 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 106.784 -1.561 . . . . 50.51 106.784 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.13 82.73 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 114.364 1.246 . . . . 50.51 114.364 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.11 -31.99 73.47 Favored 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.373 -1.454 . . . . 50.51 114.549 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.73 -45.08 67.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 119.551 -0.859 . . . . 50.51 113.077 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -52.08 -34.19 42.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.431 3.123 . . . . 50.55 119.431 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.05 -60.57 3.4 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 113.59 -1.641 . . . . 50.62 113.321 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.03 -55.97 4.24 Favored 'General case' 0 C--O 1.28 2.683 0 N-CA-C 119.806 3.262 . . . . 50.51 119.806 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.43 -60.11 4.01 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.143 2.702 . . . . 50.62 104.818 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.56 8.56 3.13 Favored Glycine 0 CA--C 1.478 -2.269 0 CA-C-O 120.033 -0.315 . . . . 50.51 113.398 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 84.8 mt -89.89 125.6 60.23 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 119.843 3.275 . . . . 50.51 119.843 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.0 136.97 79.9 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.111 2.541 . . . . 50.51 110.917 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -57.17 -32.15 92.61 Favored 'Trans proline' 0 C--O 1.261 1.629 0 O-C-N 122.919 0.958 . . . . 50.51 113.442 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -56.72 -17.17 8.01 Favored 'General case' 0 C--O 1.263 1.781 0 O-C-N 120.045 -1.659 . . . . 50.62 114.713 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -91.8 -7.48 49.41 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.471 1.656 . . . . 50.55 115.471 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -90.66 137.56 32.26 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 116.787 2.144 . . . . 50.55 116.787 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -125.1 120.63 31.96 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 104.591 -2.374 . . . . 50.64 104.591 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 35.2 mt -102.89 138.07 40.26 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 103.596 -2.742 . . . . 50.51 103.596 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.31 129.23 36.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 119.972 3.323 . . . . 50.51 119.972 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -137.67 117.99 13.68 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 116.377 1.992 . . . . 50.51 116.377 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.83 16.25 4.58 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 103.752 -2.684 . . . . 50.51 103.752 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.41 44.68 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 128.379 2.895 . . . . 50.51 107.135 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -108.85 114.7 28.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 104.653 -2.351 . . . . 50.51 104.653 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 43' ' ' LEU . 32.2 tt0 -68.98 129.77 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.325 0.861 . . . . 50.55 113.325 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.7 mp -78.2 150.39 33.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 117.726 -1.13 . . . . 50.51 109.67 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 73.7 mt-10 -115.98 158.98 22.25 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.959 1.412 . . . . 50.62 112.276 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -83.37 -9.71 58.88 Favored 'General case' 0 C--O 1.263 1.795 0 N-CA-C 117.204 2.298 . . . . 50.62 117.204 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.87 -2.68 34.35 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 110.178 -1.169 . . . . 50.51 110.178 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -107.5 143.32 36.04 Favored 'General case' 0 C--O 1.248 1.023 0 O-C-N 119.944 -1.915 . . . . 50.64 107.174 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -69.98 140.95 53.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 116.718 2.118 . . . . 50.51 116.718 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.452 HD12 HD13 ' A' ' 61' ' ' ILE . 38.0 tp -48.19 -26.49 1.95 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.108 0.88 . . . . 50.51 112.08 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 p -90.47 -0.53 57.7 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.307 -1.757 . . . . 50.51 114.191 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -97.56 15.01 24.59 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 50.62 107.679 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 92.7 m-85 -113.85 -6.24 13.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 117.812 -1.09 . . . . 50.51 110.264 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 14.5 m120 73.42 18.67 3.6 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 121.457 1.935 . . . . 50.55 107.551 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.452 HD13 HD12 ' A' ' 56' ' ' LEU . 68.5 mt -75.22 108.59 7.19 Favored 'Isoleucine or valine' 0 C--O 1.267 2.007 0 CA-C-O 115.188 -2.339 . . . . 50.51 112.792 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -110.82 -175.68 2.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.117 2.135 . . . . 50.55 112.41 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 80.7 tttt -53.67 141.87 24.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 116.569 2.063 . . . . 50.51 116.569 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 97.2 mt-10 52.71 42.93 31.82 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-N 112.554 -2.112 . . . . 50.62 114.585 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 152.59 18.98 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.494 2.035 . . . . 50.51 116.494 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 40.4 m -111.83 119.65 39.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 116.502 2.038 . . . . 50.51 116.502 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.88 140.02 32.05 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.723 -2.56 . . . . 50.51 108.086 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -89.96 132.38 35.37 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.199 2.812 . . . . 50.51 113.377 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.435 ' C ' HD21 ' A' ' 69' ' ' LEU . 10.2 tt -103.95 109.22 20.9 Favored 'General case' 0 C--O 1.282 2.768 0 N-CA-C 116.271 1.952 . . . . 50.51 116.271 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -94.1 145.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 119.604 1.093 . . . . 50.51 110.916 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 48.8 tp -99.29 86.78 3.48 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 119.437 3.125 . . . . 50.51 119.437 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 71' ' ' LEU . 59.8 ttt85 -53.36 130.98 36.94 Favored 'General case' 0 C--N 1.281 -2.383 1 O-C-N 110.816 -7.427 . . . . 50.64 113.779 177.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.49 147.44 24.24 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 120.858 1.663 . . . . 50.51 114.259 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -81.37 56.26 2.85 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.665 -1.605 . . . . 50.64 106.665 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.43 -155.71 16.87 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.586 -1.188 . . . . 50.51 113.999 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.682 -3.367 . . . . 50.51 104.682 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.814 -0.612 . . . . 50.51 109.802 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -101.27 131.68 47.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 126.973 2.671 . . . . 50.55 109.517 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 pt -132.19 149.8 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 N-CA-C 103.595 -2.743 . . . . 50.51 103.595 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -110.34 157.93 18.98 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.398 4.811 . . . . 50.51 112.095 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.6 t -141.36 121.02 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 113.383 -3.199 . . . . 50.51 112.24 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -90.59 136.05 33.31 Favored 'General case' 0 N--CA 1.504 2.261 1 O-C-N 129.37 4.169 . . . . 50.51 105.1 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -112.44 142.46 44.95 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 105.03 -2.211 . . . . 50.51 105.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -44.84 -35.97 3.04 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.052 0.845 . . . . 50.51 109.198 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.6 m -52.3 -32.69 38.8 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 118.631 2.826 . . . . 50.51 118.631 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.11 4.79 11.05 Favored Glycine 0 C--N 1.296 -1.671 0 O-C-N 120.142 -1.599 . . . . 50.51 111.756 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -83.89 152.82 24.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.847 -1.549 . . . . 50.51 114.26 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -125.86 112.56 16.13 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.701 2.501 . . . . 50.51 106.849 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 pt -102.3 147.69 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 118.583 2.808 . . . . 50.51 118.583 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -104.32 123.72 47.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 117.263 -1.775 . . . . 50.51 113.436 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.678 HD23 ' CG ' ' A' ' 29' ' ' LYS . 68.5 mt -109.73 132.31 54.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 117.591 2.441 . . . . 50.51 117.591 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.28 110.26 22.41 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 129.244 4.09 . . . . 50.62 109.888 174.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.405 HG22 HD22 ' A' ' 56' ' ' LEU . 35.0 m -130.82 173.59 14.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 O-C-N 127.672 3.107 . . . . 50.51 108.589 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 68.8 mm-40 -116.87 141.95 29.04 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 112.157 -2.292 . . . . 50.62 108.862 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HA ' ' HB3' ' A' ' 56' ' ' LEU . 85.4 Cg_exo -54.88 -24.58 39.54 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.617 2.211 . . . . 50.51 111.964 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -78.23 -23.13 47.54 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.818 -1.549 . . . . 50.51 106.818 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 81.0 m-20 -62.39 139.18 58.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 104.308 -2.478 . . . . 50.62 104.308 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 48.1 p -78.23 165.17 24.22 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.326 -0.99 . . . . 50.51 108.326 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.543 HD13 HD21 ' A' ' 50' ' ' LEU . 24.5 mm -58.81 -35.21 54.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 O-C-N 127.244 2.84 . . . . 50.51 111.816 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.7 -45.34 81.88 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.211 -2.144 . . . . 50.62 105.211 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 85.8 m-20 -56.56 -46.03 80.94 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.365 1.066 . . . . 50.55 112.181 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 56' ' ' LEU . 40.5 t -61.58 -41.38 90.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 125.168 1.543 . . . . 50.51 113.192 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.86 -22.71 60.73 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 106.824 -1.547 . . . . 50.51 106.824 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -68.35 -61.41 1.85 Allowed 'General case' 0 C--O 1.278 2.561 0 N-CA-C 105.049 -2.204 . . . . 50.51 105.049 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.678 ' CG ' HD23 ' A' ' 15' ' ' LEU . 17.0 tppt? -42.5 -41.6 3.03 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 115.679 1.733 . . . . 50.51 115.679 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.513 HG21 HD11 ' A' ' 69' ' ' LEU . 73.4 mt -68.19 -23.86 29.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 C-N-CA 119.493 -0.883 . . . . 50.51 108.68 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -82.25 -55.45 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 125.57 2.605 . . . . 50.55 105.565 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -35.32 -51.37 0.58 Allowed 'General case' 0 C--O 1.252 1.228 0 N-CA-C 118.513 2.782 . . . . 50.62 118.513 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.13 -59.99 1.62 Allowed 'General case' 0 C--O 1.28 2.677 0 C-N-CA 116.459 -2.096 . . . . 50.51 108.82 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -57.99 -43.76 86.75 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 123.158 2.708 . . . . 50.62 116.743 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.16 23.35 7.73 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 108.763 -1.735 . . . . 50.51 108.763 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.3 mt -100.58 117.31 63.06 Favored Pre-proline 0 C--O 1.243 0.73 0 C-N-CA 118.79 -1.164 . . . . 50.51 108.501 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.0 Cg_exo -56.93 136.93 79.52 Favored 'Trans proline' 0 C--O 1.261 1.634 0 C-N-CA 123.185 2.59 . . . . 50.51 110.916 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.19 -32.15 92.66 Favored 'Trans proline' 0 C--O 1.262 1.691 0 C-N-CA 120.682 0.922 . . . . 50.51 113.429 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -62.56 -15.21 49.82 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.948 -1.72 . . . . 50.62 109.985 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -102.92 16.05 27.67 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.532 -1.355 . . . . 50.55 112.104 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -110.85 114.08 27.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 117.295 2.332 . . . . 50.55 117.295 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -111.39 108.49 18.09 Favored 'General case' 0 C--O 1.296 3.523 0 N-CA-C 105.502 -2.036 . . . . 50.64 105.502 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.458 ' CD2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mt -101.99 132.76 47.63 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.501 1.046 . . . . 50.51 110.488 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.63 136.77 50.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 O-C-N 125.227 1.58 . . . . 50.51 115.167 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -133.75 112.06 11.06 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.543 -1.208 . . . . 50.51 110.483 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.45 49.7 6.2 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.268 -2.242 . . . . 50.51 113.311 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.47 1.71 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 120.894 3.118 . . . . 50.51 120.894 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -71.7 166.19 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 116.334 1.975 . . . . 50.51 116.334 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -102.26 140.86 35.98 Favored 'General case' 0 C--O 1.259 1.592 0 O-C-N 124.008 0.818 . . . . 50.55 112.008 174.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.543 HD21 HD13 ' A' ' 23' ' ' ILE . 2.1 mp -78.14 143.17 37.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.285 -1.746 . . . . 50.51 106.285 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -120.21 135.15 55.08 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.883 1.364 . . . . 50.62 109.464 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.56 -33.41 1.14 Allowed 'General case' 0 C--O 1.262 1.748 0 C-N-CA 126.165 1.786 . . . . 50.62 114.951 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.73 63.5 Favored Glycine 0 C--O 1.254 1.345 0 C-N-CA 124.339 0.971 . . . . 50.51 113.5 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -111.73 155.12 23.99 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 101.889 -3.374 . . . . 50.64 101.889 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -99.72 174.12 6.38 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.048 0.939 . . . . 50.51 111.483 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -67.54 -38.54 84.33 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 106.349 -1.723 . . . . 50.51 106.349 177.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -67.94 -22.61 65.04 Favored 'General case' 0 C--O 1.268 2.029 0 N-CA-C 117.75 2.5 . . . . 50.51 117.75 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -64.45 -40.17 95.22 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.664 2.098 . . . . 50.62 116.664 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -83.26 5.02 24.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 115.986 1.847 . . . . 50.51 115.986 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 59.08 38.44 23.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.493 1.951 . . . . 50.55 107.054 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -73.48 117.79 17.81 Favored 'Isoleucine or valine' 0 C--O 1.267 2.012 0 CA-C-O 115.223 -2.322 . . . . 50.51 108.388 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -94.15 -175.82 3.8 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.707 2.114 . . . . 50.55 116.707 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.03 142.72 49.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 123.144 1.449 . . . . 50.51 107.314 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 46.4 26.19 0.46 Allowed 'General case' 0 C--O 1.257 1.496 0 N-CA-C 117.592 2.441 . . . . 50.62 117.592 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -72.53 153.18 41.45 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.512 -1.662 . . . . 50.51 106.512 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.43 ' O ' HD21 ' A' ' 67' ' ' LEU . 40.6 m -108.16 146.09 33.22 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.225 -0.893 . . . . 50.51 111.084 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD21 ' O ' ' A' ' 66' ' ' THR . 26.8 mt -116.96 156.78 26.86 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 114.688 -2.577 . . . . 50.51 109.959 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -93.61 141.66 28.22 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 127.246 2.841 . . . . 50.51 106.202 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 30' ' ' ILE . 5.3 tt -119.79 109.88 16.12 Favored 'General case' 0 C--O 1.282 2.8 0 N-CA-C 106.356 -1.72 . . . . 50.51 106.356 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -98.35 145.1 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.391 -2.078 . . . . 50.51 105.391 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.99 132.5 43.5 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.964 -0.754 . . . . 50.51 108.964 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -97.44 126.18 42.54 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-O 113.322 -3.228 . . . . 50.64 107.33 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.89 152.09 23.81 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.901 2.001 . . . . 50.51 111.862 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -83.15 55.42 3.12 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 113.726 -1.579 . . . . 50.64 108.051 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.15 156.33 18.08 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 109.56 -1.416 . . . . 50.51 109.56 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 1 N-CA-C 102.519 -4.233 . . . . 50.51 102.519 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 107.894 -1.151 . . . . 50.51 107.894 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -101.03 133.44 45.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.911 2.632 . . . . 50.55 110.278 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.35 159.89 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 117.083 -3.51 . . . . 50.51 107.703 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -114.67 137.31 52.06 Favored 'General case' 0 N--CA 1.512 2.648 1 O-C-N 130.429 4.831 . . . . 50.51 107.911 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 87.6 t -110.54 121.34 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 113.431 -3.176 . . . . 50.51 104.019 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -107.08 131.81 53.68 Favored 'General case' 0 N--CA 1.503 2.195 1 O-C-N 129.295 4.122 . . . . 50.51 113.336 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -91.38 -177.33 4.81 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.87 2.544 . . . . 50.51 117.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.26 -5.59 23.93 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.164 0.915 . . . . 50.51 109.792 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.7 p -114.69 9.01 16.36 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.726 2.862 . . . . 50.51 118.726 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.32 62.29 Favored Glycine 0 C--N 1.298 -1.565 0 O-C-N 120.072 -1.642 . . . . 50.51 115.164 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -65.23 140.22 58.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 116.888 -1.53 . . . . 50.51 113.033 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -131.53 164.46 25.76 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 126.613 2.446 . . . . 50.51 108.573 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.35 170.64 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 127.551 3.032 . . . . 50.51 110.215 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -111.41 128.33 55.95 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.266 -1.773 . . . . 50.51 110.41 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -126.53 135.71 51.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 115.488 -2.196 . . . . 50.51 116.567 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.27 100.41 7.16 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 128.315 3.509 . . . . 50.62 112.505 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -103.18 172.99 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.209 0 O-C-N 127.762 3.164 . . . . 50.51 116.324 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 94.1 mt-10 -110.65 153.45 43.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 112.157 -2.292 . . . . 50.62 112.521 174.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.2 Cg_exo -54.89 -24.57 39.5 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.603 2.202 . . . . 50.51 111.909 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 m -82.92 -26.52 31.38 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 114.954 1.465 . . . . 50.51 114.954 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -53.34 138.95 31.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 117.398 -1.721 . . . . 50.62 114.311 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -95.1 172.46 8.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 102.156 -3.276 . . . . 50.51 102.156 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 54' ' ' ARG . 23.2 mm -53.89 -45.49 63.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 O-C-N 127.095 2.747 . . . . 50.51 110.439 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -54.11 -46.83 72.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.723 1.379 . . . . 50.62 114.723 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -57.54 -39.64 77.08 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.265 1.026 . . . . 50.55 111.757 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 -50.11 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 125.045 1.466 . . . . 50.51 111.73 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HE3' ' CG2' ' A' ' 23' ' ' ILE . 94.5 mttt -56.87 -29.93 63.38 Favored 'General case' 0 C--O 1.257 1.485 0 N-CA-C 104.583 -2.377 . . . . 50.51 104.583 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.06 -27.61 48.69 Favored 'General case' 0 C--O 1.278 2.599 0 CA-C-N 118.031 0.378 . . . . 50.51 111.567 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -71.76 -36.32 70.36 Favored 'General case' 0 C--O 1.255 1.342 0 N-CA-C 106.606 -1.627 . . . . 50.51 106.606 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.43 -34.55 65.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 106.863 -1.532 . . . . 50.51 106.863 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -51.49 -59.51 4.17 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.567 2.603 . . . . 50.55 112.225 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -51.76 -40.83 60.98 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 115.817 1.784 . . . . 50.62 115.817 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 31.1 mmmt -76.65 -32.5 58.01 Favored 'General case' 0 C--O 1.279 2.647 0 C-N-CA 116.464 -2.095 . . . . 50.51 113.853 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -119.33 -39.47 2.89 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.018 2.644 . . . . 50.62 115.061 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.32 8.77 8.32 Favored Glycine 0 CA--C 1.478 -2.271 0 CA-C-O 119.947 -0.363 . . . . 50.51 112.46 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.513 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 93.5 mt -84.62 128.21 62.24 Favored Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 116.76 2.134 . . . . 50.51 116.76 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.94 136.99 79.85 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.116 2.544 . . . . 50.51 110.92 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -57.2 -32.13 92.64 Favored 'Trans proline' 0 C--O 1.261 1.649 0 O-C-N 122.91 0.952 . . . . 50.51 113.405 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -75.29 -15.78 60.48 Favored 'General case' 0 C--O 1.262 1.745 0 O-C-N 119.915 -1.74 . . . . 50.62 112.375 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -97.34 9.0 43.46 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.568 -1.332 . . . . 50.55 110.692 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.97 132.98 53.57 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 103.437 -2.801 . . . . 50.55 103.437 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -119.48 108.52 14.63 Favored 'General case' 0 C--O 1.297 3.562 0 N-CA-C 105.462 -2.051 . . . . 50.64 105.462 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.78 121.97 44.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.49 1.041 . . . . 50.51 113.414 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 120.456 3.502 . . . . 50.51 120.456 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' HB3' HD22 ' A' ' 50' ' ' LEU . 17.8 t80 -110.18 130.17 55.59 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 114.811 1.411 . . . . 50.51 114.811 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.21 32.11 15.39 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.192 -2.276 . . . . 50.51 111.994 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.67 2.7 85.97 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 128.4 2.905 . . . . 50.51 113.269 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -94.51 115.77 27.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 116.32 1.97 . . . . 50.51 116.32 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -50.53 120.24 4.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.94 0.775 . . . . 50.55 111.744 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 45' ' ' PHE . 56.1 mt -83.51 127.55 33.81 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.7 -1.143 . . . . 50.51 111.984 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 88.7 tt0 -77.0 145.23 38.17 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 119.173 3.027 . . . . 50.62 119.173 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -38.6 -48.08 1.4 Allowed 'General case' 0 C--O 1.264 1.833 0 N-CA-C 118.526 2.788 . . . . 50.62 118.526 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 23.01 32.27 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 116.384 1.314 . . . . 50.51 116.384 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' O ' HG12 ' A' ' 23' ' ' ILE . 37.1 mmt180 -93.34 155.53 17.34 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 119.892 -1.946 . . . . 50.64 111.151 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -108.53 176.93 4.94 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.979 0.912 . . . . 50.51 109.466 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.413 ' HG ' ' HB ' ' A' ' 61' ' ' ILE . 7.2 mp -59.1 -32.69 70.04 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 119.177 3.028 . . . . 50.51 119.177 177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -81.11 -23.34 38.45 Favored 'General case' 0 C--O 1.267 2.024 0 C-N-CA 117.325 -1.75 . . . . 50.51 112.258 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -53.54 -30.9 44.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.918 -2.253 . . . . 50.62 104.918 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.25 6.92 19.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 116.468 2.025 . . . . 50.51 116.468 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.37 32.49 20.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-N 121.461 1.937 . . . . 50.55 111.036 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' CD2' ' A' ' 45' ' ' PHE . 93.2 mt -73.53 104.86 2.59 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.188 -2.339 . . . . 50.51 109.353 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -97.23 -165.86 1.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 126.137 2.148 . . . . 50.55 115.028 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -70.16 142.76 52.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.159 1.457 . . . . 50.51 110.688 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 58.73 36.29 24.79 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.471 -2.15 . . . . 50.62 110.721 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -78.02 152.5 33.01 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.802 -1.09 . . . . 50.51 110.915 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.443 ' O ' HD21 ' A' ' 67' ' ' LEU . 60.4 p -103.64 140.13 37.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 118.216 -0.897 . . . . 50.51 110.182 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 59.5 mt -123.95 134.82 53.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 101.65 -3.463 . . . . 50.51 101.65 175.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -95.45 136.93 35.2 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 127.375 2.922 . . . . 50.51 108.264 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 tp -105.56 136.02 45.89 Favored 'General case' 0 C--O 1.282 2.802 0 CA-C-O 117.641 -1.171 . . . . 50.51 113.203 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -116.02 126.06 73.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 105.847 -1.909 . . . . 50.51 105.847 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -79.04 105.55 10.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.782 2.512 . . . . 50.51 117.782 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -92.96 102.21 14.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.279 -3.248 . . . . 50.64 114.666 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.64 177.58 7.01 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 125.715 1.884 . . . . 50.51 110.047 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -100.7 97.65 8.28 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 115.972 1.842 . . . . 50.64 115.972 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.46 158.67 6.18 Favored Glycine 0 C--O 1.243 0.668 0 CA-C-N 114.619 -1.173 . . . . 50.51 110.562 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 1 N-CA-C 102.073 -4.411 . . . . 50.51 102.073 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 106.871 -1.529 . . . . 50.51 106.871 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -117.73 119.43 34.92 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.923 2.64 . . . . 50.55 104.846 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 tt -121.73 149.4 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 115.952 -1.975 . . . . 50.51 110.13 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.84 123.88 50.88 Favored 'General case' 0 N--CA 1.511 2.599 1 O-C-N 130.372 4.795 . . . . 50.51 114.524 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.34 104.86 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.42 -3.181 . . . . 50.51 109.571 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -85.02 121.2 27.45 Favored 'General case' 0 N--CA 1.504 2.237 1 O-C-N 129.394 4.184 . . . . 50.51 109.412 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.412 HG23 HD21 ' A' ' 69' ' ' LEU . 69.7 p -85.95 -177.05 6.22 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 116.322 1.971 . . . . 50.51 116.322 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.511 HD11 HG13 ' A' ' 70' ' ' VAL . 67.5 mt -82.01 -6.08 58.86 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.788 1.773 . . . . 50.51 115.788 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -90.07 -8.04 52.41 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 115.715 -2.394 . . . . 50.51 106.592 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 15.79 37.73 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 107.727 -2.149 . . . . 50.51 107.727 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.52 111.02 21.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 116.549 2.055 . . . . 50.51 116.549 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.9 m -87.37 125.44 34.26 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 126.65 2.469 . . . . 50.51 113.203 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -111.9 174.08 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 127.53 3.019 . . . . 50.51 113.725 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 m -124.37 140.97 52.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.011 -2.218 . . . . 50.51 105.011 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.7 mt -130.66 141.7 50.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 115.487 -2.197 . . . . 50.51 108.05 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.87 100.25 9.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 129.009 3.943 . . . . 50.62 109.281 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -100.27 171.12 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.253 0 O-C-N 127.796 3.185 . . . . 50.51 107.938 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -124.28 160.51 52.32 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 112.24 -2.254 . . . . 50.62 116.147 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.01 -24.45 39.92 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 122.586 2.191 . . . . 50.51 111.966 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -99.82 -28.82 12.95 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 116.031 1.863 . . . . 50.51 116.031 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -38.82 136.88 0.7 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.331 -1.748 . . . . 50.62 114.825 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' ASN . 70.7 p -88.7 138.17 31.66 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 103.109 -2.922 . . . . 50.51 103.109 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 52' ' ' ASP . 7.4 tp -47.52 -19.19 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.729 0 O-C-N 127.183 2.802 . . . . 50.51 114.02 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.57 -44.31 62.25 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 102.991 -2.966 . . . . 50.62 102.991 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' THR . 9.3 t-20 -70.78 -17.28 62.79 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 114.957 1.465 . . . . 50.55 114.957 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.12 -45.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.999 -1.482 . . . . 50.51 106.999 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 97.2 mttt -64.26 -42.87 96.28 Favored 'General case' 0 C--O 1.256 1.433 0 N-CA-C 108.04 -1.096 . . . . 50.51 108.04 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -59.14 -25.19 63.66 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 112.511 0.559 . . . . 50.51 112.511 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 58.2 mttm -64.75 -30.78 71.8 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 106.327 -1.731 . . . . 50.51 106.327 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 30' ' ' ILE . 95.7 mt -82.66 2.86 2.93 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 N-CA-C 105.535 -2.024 . . . . 50.51 105.535 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 50.7 tt0 -87.12 -57.43 2.97 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.592 2.615 . . . . 50.55 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -69.05 -36.23 77.45 Favored 'General case' 0 C--O 1.253 1.264 0 CA-C-N 113.616 -1.629 . . . . 50.62 113.278 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.2 -32.71 24.41 Favored 'General case' 0 C--O 1.279 2.623 0 C-N-CA 116.427 -2.109 . . . . 50.51 112.667 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -108.99 -17.04 14.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 119.315 3.08 . . . . 50.62 119.315 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.82 37.54 10.23 Favored Glycine 0 CA--C 1.479 -2.199 0 N-CA-C 107.607 -2.197 . . . . 50.51 107.607 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.5 mt -121.4 117.74 30.21 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 106.939 -1.504 . . . . 50.51 106.939 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -56.97 136.89 79.36 Favored 'Trans proline' 0 C--O 1.259 1.562 0 C-N-CA 123.185 2.59 . . . . 50.51 110.924 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -57.11 -32.15 92.48 Favored 'Trans proline' 0 C--O 1.261 1.667 0 O-C-N 122.948 0.973 . . . . 50.51 113.471 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.96 -2.02 8.8 Favored 'General case' 0 C--O 1.262 1.731 0 O-C-N 119.976 -1.703 . . . . 50.62 111.592 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -114.77 15.58 17.48 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.617 -1.302 . . . . 50.55 114.13 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -115.76 122.26 44.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.366 2.031 . . . . 50.55 111.203 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -115.83 121.56 42.77 Favored 'General case' 0 C--O 1.296 3.507 0 CA-C-O 116.657 -1.639 . . . . 50.64 111.265 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 76.6 mt -104.59 139.93 38.74 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 119.397 0.999 . . . . 50.51 108.897 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.36 134.13 64.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 O-C-N 125.129 1.518 . . . . 50.51 108.377 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 50.5 t80 -160.17 113.15 2.1 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.561 -1.199 . . . . 50.51 110.926 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 45' ' ' PHE . . . 78.39 28.62 0.46 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.259 -2.246 . . . . 50.51 116.087 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.14 -8.95 35.36 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 128.44 2.924 . . . . 50.51 117.04 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -101.48 138.33 38.63 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 114.211 1.189 . . . . 50.51 114.211 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.06 121.01 15.23 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.994 0.809 . . . . 50.55 110.234 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.649 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 11.1 mp -78.58 150.26 32.8 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.096 -2.187 . . . . 50.51 105.096 -175.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -110.19 143.72 39.89 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.939 1.4 . . . . 50.62 113.769 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' CG2' ' A' ' 23' ' ' ILE . 34.9 m-20 -38.33 -46.22 1.08 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 120.332 3.456 . . . . 50.62 120.332 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.71 -3.68 73.76 Favored Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 121.177 3.231 . . . . 50.51 121.177 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -83.72 159.13 21.55 Favored 'General case' 0 C--O 1.249 1.046 0 O-C-N 117.464 -3.374 . . . . 50.64 115.453 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.3 p -99.99 172.18 7.37 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.018 0.927 . . . . 50.51 109.143 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -70.54 -23.78 62.68 Favored 'General case' 0 C--O 1.201 -1.46 0 O-C-N 124.164 0.915 . . . . 50.51 109.268 177.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.8 p -77.52 -30.44 52.88 Favored 'General case' 0 C--O 1.269 2.102 0 C-N-CA 117.338 -1.745 . . . . 50.51 111.28 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.17 -42.87 70.13 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.423 1.106 . . . . 50.62 111.21 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.649 ' CZ ' ' HG ' ' A' ' 50' ' ' LEU . 92.9 m-85 -93.48 17.75 11.0 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.773 -1.108 . . . . 50.51 113.765 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.68 40.34 31.83 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 121.516 1.962 . . . . 50.55 116.273 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.57 112.95 2.45 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-O 115.183 -2.341 . . . . 50.51 116.634 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -118.16 174.24 6.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 126.141 2.15 . . . . 50.55 112.497 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.558 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 79.4 tttt -57.61 138.6 55.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 123.193 1.473 . . . . 50.51 111.378 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.558 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 29.5 mt-10 65.31 43.27 3.58 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.458 -2.155 . . . . 50.62 115.755 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -82.91 137.9 34.06 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.664 -1.606 . . . . 50.51 106.664 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -113.59 123.22 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.253 -1.017 . . . . 50.51 108.253 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -117.84 153.52 33.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 114.663 -2.589 . . . . 50.51 107.188 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -109.35 133.07 53.51 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 127.451 2.97 . . . . 50.51 103.358 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.412 HD21 HG23 ' A' ' 7' ' ' THR . 44.4 tp -101.52 107.14 18.34 Favored 'General case' 0 C--O 1.282 2.806 0 N-CA-C 118.914 2.931 . . . . 50.51 118.914 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.511 HG13 HD11 ' A' ' 8' ' ' LEU . 61.9 t -92.03 117.16 34.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 119.564 1.075 . . . . 50.51 112.995 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.99 159.81 33.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.146 0.498 . . . . 50.51 110.435 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -119.52 109.87 16.22 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 113.298 -3.239 . . . . 50.64 103.744 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 2.0 mp -86.08 140.82 29.9 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 125.826 1.953 . . . . 50.51 116.206 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -68.85 122.31 18.34 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.01 -1.848 . . . . 50.64 106.01 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.01 -176.82 52.0 Favored Glycine 0 C--O 1.243 0.695 0 CA-C-N 114.63 -1.168 . . . . 50.51 115.431 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.445 0 N-CA-C 119.479 2.552 . . . . 50.51 119.479 179.25 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.51 109.784 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.55 110.888 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.51 104.776 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.51 116.515 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.51 113.74 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.51 108.059 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.51 111.299 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.51 113.264 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.51 109.711 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.51 118.139 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.51 115.485 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.51 112.444 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.51 104.287 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.51 112.3 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.51 121.099 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.62 110.491 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.51 108.724 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.62 111.398 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.51 111.977 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.51 114.356 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.62 114.483 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.51 107.854 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.51 119.713 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.62 107.589 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.55 116.179 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.51 107.144 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.51 106.178 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.51 113.884 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.51 110.545 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.426 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.51 115.565 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.55 108.505 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.62 115.994 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.51 109.748 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.62 110.609 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.51 106.674 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.51 113.426 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.51 110.966 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.51 113.447 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.62 115.85 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.55 110.579 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.55 112.07 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.64 108.703 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.543 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.51 118.456 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.51 111.752 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.51 118.653 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.51 114.688 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.51 116.218 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.51 102.92 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.55 109.69 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.51 113.209 -175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.62 106.192 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.62 118.695 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.51 114.117 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.64 110.918 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.51 113.601 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.51 119.947 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.51 115.529 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.62 114.759 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.51 110.366 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.55 113.715 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.51 106.035 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.55 104.072 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.51 118.355 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.62 118.736 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.51 106.228 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.51 112.755 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.51 109.784 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.51 108.847 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.51 104.275 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.51 102.101 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.51 111.016 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.64 109.31 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.51 112.756 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.64 102.16 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.51 109.351 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.51 108.526 179.194 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.51 109.784 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.55 110.888 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.51 104.776 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.51 116.515 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.51 113.74 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.51 108.059 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.51 111.299 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.51 113.264 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.51 109.711 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.51 118.139 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.51 115.485 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.51 112.444 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.51 104.287 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.51 112.3 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.51 121.099 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.62 110.491 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.51 108.724 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.62 111.398 174.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.51 111.977 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.51 114.356 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.62 114.483 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.51 107.854 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.51 119.713 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.62 107.589 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.55 116.179 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.51 107.144 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.51 106.178 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.51 113.884 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.51 110.545 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.426 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.51 115.565 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.55 108.505 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.62 115.994 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.51 109.748 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.62 110.609 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.51 106.674 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.51 113.426 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.51 110.966 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.51 113.447 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.62 115.85 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.55 110.579 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.55 112.07 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.64 108.703 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.543 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.51 118.456 -177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.51 111.752 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.51 118.653 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.51 114.688 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.51 116.218 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.51 102.92 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.55 109.69 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.51 113.209 -175.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.62 106.192 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.62 118.695 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.51 114.117 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.64 110.918 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.51 113.601 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.51 119.947 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.51 115.529 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.62 114.759 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.51 110.366 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.55 113.715 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.51 106.035 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.55 104.072 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.51 118.355 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.62 118.736 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.51 106.228 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.51 112.755 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.51 109.784 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.51 108.847 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.51 104.275 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.51 102.101 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.51 111.016 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.64 109.31 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.51 112.756 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.64 102.16 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.51 109.351 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.51 108.526 179.194 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.51 106.676 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.55 106.021 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.51 104.709 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HB2' HG23 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.51 113.954 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG22 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.51 102.923 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.51 112.316 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.51 106.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.51 115.548 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.51 108.113 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.51 106.107 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.51 120.071 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.51 110.493 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.51 109.559 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.51 114.838 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG22 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.51 106.275 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.62 113.422 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.51 109.333 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.62 106.827 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.51 111.928 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.51 121.083 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.62 111.205 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.51 110.198 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.51 109.42 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.62 111.997 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.55 112.41 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.51 109.295 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.51 112.034 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.51 108.289 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.51 110.474 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.51 112.329 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.55 110.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.62 107.396 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.51 117.751 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.62 110.115 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.51 107.221 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.51 111.423 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.51 110.839 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.51 113.43 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.62 110.786 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.55 113.905 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.55 108.396 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.64 106.438 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.51 111.107 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.51 108.499 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.51 110.923 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.51 110.976 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.51 110.394 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.51 113.046 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.55 105.007 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.51 110.654 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.62 113.026 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.62 118.034 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.51 115.926 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.64 104.585 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.51 116.28 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.51 114.766 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.51 108.201 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.62 110.796 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.51 109.666 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.55 108.723 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.51 106.728 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.55 120.811 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.51 108.884 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.62 119.75 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.51 111.035 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.51 110.83 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.51 107.516 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.51 114.067 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.51 113.384 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.51 112.182 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.51 107.317 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.64 106.699 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.51 116.896 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.64 110.974 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.51 113.009 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.51 117.514 179.235 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.51 106.676 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.55 106.021 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.51 104.709 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HB2' HG23 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.51 113.954 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG22 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.51 102.923 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.51 112.316 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.51 106.004 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.51 115.548 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.51 108.113 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.51 106.107 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.51 120.071 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.51 110.493 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.51 109.559 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.51 114.838 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG22 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.51 106.275 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.62 113.422 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.51 109.333 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.62 106.827 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.51 111.928 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.51 121.083 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.62 111.205 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.51 110.198 175.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.51 109.42 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.62 111.997 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.55 112.41 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.51 109.295 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.51 112.034 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.51 108.289 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.51 110.474 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.51 112.329 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.55 110.082 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.62 107.396 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.51 117.751 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.62 110.115 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.51 107.221 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.51 111.423 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.51 110.839 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.51 113.43 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.62 110.786 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.55 113.905 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.55 108.396 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.64 106.438 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.51 111.107 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.51 108.499 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.51 110.923 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.51 110.976 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.51 110.394 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.51 113.046 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.55 105.007 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.51 110.654 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.62 113.026 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.62 118.034 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.51 115.926 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.64 104.585 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.51 116.28 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.51 114.766 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.51 108.201 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.62 110.796 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.51 109.666 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.55 108.723 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.51 106.728 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.55 120.811 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.51 108.884 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.62 119.75 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.51 111.035 174.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.51 110.83 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.51 107.516 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.51 114.067 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.51 113.384 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.51 112.182 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.51 107.317 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.64 106.699 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.51 116.896 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.64 110.974 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.51 113.009 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.51 117.514 179.235 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.868 0 N-CA-C 104.835 -2.283 . . . . 50.51 104.835 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -88.49 154.45 20.35 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 102.339 -3.208 . . . . 50.55 102.339 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 3' ' ' ILE . 19.7 tt -150.21 128.91 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 115.963 -1.97 . . . . 50.51 108.004 173.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' THR . 82.5 m-85 -92.92 141.96 27.84 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.328 4.767 . . . . 50.51 112.03 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.79 99.23 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 113.439 -3.172 . . . . 50.51 111.052 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -68.65 136.07 52.38 Favored 'General case' 0 N--CA 1.504 2.235 1 O-C-N 129.254 4.096 . . . . 50.51 114.159 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 11' ' ' LYS . 24.6 p -112.87 149.23 33.43 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 104.91 -2.256 . . . . 50.51 104.91 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.44 -6.85 0.5 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.799 2.888 . . . . 50.51 118.799 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -115.91 19.46 15.1 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 120.312 3.449 . . . . 50.51 120.312 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.26 -13.69 66.4 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 117.483 1.753 . . . . 50.51 117.483 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 98.8 mttt -60.41 155.41 18.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 116.871 -1.538 . . . . 50.51 111.77 174.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -148.98 149.77 31.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 126.656 2.472 . . . . 50.51 109.639 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -143.62 146.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.497 2.998 . . . . 50.51 110.559 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.456 ' O ' HD21 ' A' ' 15' ' ' LEU . 20.9 p -102.87 130.4 49.89 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.315 -1.754 . . . . 50.51 112.746 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.456 HD21 ' O ' ' A' ' 14' ' ' THR . 48.0 mt -124.95 149.79 47.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 115.37 -2.253 . . . . 50.51 113.511 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -107.4 142.43 37.23 Favored 'General case' 0 N--CA 1.5 2.025 1 O-C-N 129.114 4.009 . . . . 50.62 104.294 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -144.08 167.18 12.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 O-C-N 126.091 2.119 . . . . 50.51 105.692 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 68.9 mm-40 -122.0 157.66 57.15 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 112.209 -2.269 . . . . 50.62 112.202 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.2 Cg_exo -54.96 -24.47 39.58 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 122.662 2.241 . . . . 50.51 111.904 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -96.78 -8.78 30.31 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 118.158 -0.925 . . . . 50.51 112.674 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 30.4 m-20 -66.3 124.44 22.71 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.308 -1.757 . . . . 50.62 106.485 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.483 HG23 HG23 ' A' ' 55' ' ' THR . 33.3 p -79.09 155.79 28.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.808 -0.633 . . . . 50.51 112.51 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.569 HD11 ' HB3' ' A' ' 50' ' ' LEU . 76.6 mt -52.18 -45.87 43.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 O-C-N 127.176 2.798 . . . . 50.51 108.374 175.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.05 -51.01 18.58 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.45 -0.781 . . . . 50.62 110.645 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -65.19 -43.05 92.87 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 118.735 2.865 . . . . 50.55 118.735 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.22 -42.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.123 -1.399 . . . . 50.51 110.285 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.26 -38.25 90.38 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 108.12 -1.066 . . . . 50.51 108.12 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.7 -40.02 63.94 Favored 'General case' 0 C--O 1.277 2.543 0 N-CA-C 114.709 1.374 . . . . 50.51 114.709 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -58.05 -29.19 65.17 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 120.398 -1.439 . . . . 50.51 112.966 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.416 HG12 HD11 ' A' ' 15' ' ' LEU . 74.6 mt -77.58 -29.86 16.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 N-CA-C 106.695 -1.595 . . . . 50.51 106.695 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -58.08 -41.71 84.0 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 125.614 2.626 . . . . 50.55 108.18 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -73.48 10.92 0.89 Allowed 'General case' 0 C--O 1.253 1.289 0 CA-C-N 113.6 -1.636 . . . . 50.62 113.765 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -139.26 -30.1 0.74 Allowed 'General case' 0 C--O 1.279 2.647 0 N-CA-C 104.592 -2.373 . . . . 50.51 104.592 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -110.18 -61.57 1.64 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 123.081 2.673 . . . . 50.62 109.578 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.51 20.29 0.9 Allowed Glycine 0 CA--C 1.477 -2.327 0 N-CA-C 108.891 -1.683 . . . . 50.51 108.891 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.2 mt -103.03 122.26 46.14 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 116.526 2.047 . . . . 50.51 116.526 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.0 Cg_exo -57.01 136.91 79.55 Favored 'Trans proline' 0 C--O 1.259 1.545 0 C-N-CA 123.104 2.536 . . . . 50.51 110.937 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -57.18 -32.12 92.55 Favored 'Trans proline' 0 C--O 1.262 1.685 0 O-C-N 122.912 0.953 . . . . 50.51 113.388 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -59.91 -27.91 67.14 Favored 'General case' 0 C--O 1.261 1.702 0 O-C-N 119.897 -1.752 . . . . 50.62 114.427 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -87.97 -15.63 35.97 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.593 -1.317 . . . . 50.55 113.857 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -87.3 117.7 26.25 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 118.3 2.704 . . . . 50.55 118.3 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.32 131.99 53.62 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 105.937 -1.875 . . . . 50.64 105.937 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 mt -107.67 133.38 52.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 101.965 -3.346 . . . . 50.51 101.965 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 70' ' ' VAL . 3.3 mp -124.31 135.87 62.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 O-C-N 125.201 1.563 . . . . 50.51 114.334 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -140.14 113.03 8.14 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 105.719 -1.956 . . . . 50.51 105.719 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.93 41.42 31.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.26 -2.245 . . . . 50.51 108.716 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.66 3.54 59.15 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 128.432 2.92 . . . . 50.51 116.134 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.1 125.5 29.45 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.714 1.376 . . . . 50.51 114.714 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -75.24 127.91 34.24 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 107.68 -1.23 . . . . 50.55 107.68 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.569 ' HB3' HD11 ' A' ' 23' ' ' ILE . 2.9 mp -95.51 124.59 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 117.72 -1.133 . . . . 50.51 112.665 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -104.37 135.97 44.83 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.368 1.988 . . . . 50.62 116.368 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -42.62 -36.23 1.33 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 121.197 3.777 . . . . 50.62 121.197 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.56 -33.61 87.7 Favored Glycine 0 CA--C 1.493 -1.294 0 C-N-CA 124.438 1.018 . . . . 50.51 113.72 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -88.69 136.45 32.99 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 119.766 -2.02 . . . . 50.64 112.614 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.483 HG23 HG23 ' A' ' 22' ' ' THR . 57.0 p -77.68 171.54 14.79 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.015 0.926 . . . . 50.51 111.465 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.69 -39.24 83.87 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 117.381 2.363 . . . . 50.51 117.381 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -64.41 -37.67 88.33 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.332 -1.747 . . . . 50.51 110.815 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -50.01 -43.57 50.68 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 116.888 2.181 . . . . 50.62 116.888 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 63.4 m-85 -74.57 -6.85 50.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 117.815 -1.088 . . . . 50.51 110.416 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 71.52 40.67 0.79 Allowed 'General case' 0 C--O 1.247 0.957 0 CA-C-N 121.429 1.922 . . . . 50.55 115.239 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.439 HG23 ' HG ' ' A' ' 65' ' ' SER . 20.7 mm -71.03 110.41 3.96 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.182 -2.342 . . . . 50.51 110.428 175.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 174.35 7.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.056 2.097 . . . . 50.55 114.79 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 26.7 ttpp -61.35 114.27 3.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 123.159 1.457 . . . . 50.51 112.848 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.554 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 45.6 mm-40 80.31 44.18 0.04 OUTLIER 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.575 -2.102 . . . . 50.62 111.989 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.439 ' HG ' HG23 ' A' ' 61' ' ' ILE . 35.2 t -82.64 140.71 33.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.785 -1.098 . . . . 50.51 108.832 174.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 45.7 m -109.28 146.65 33.94 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 102.454 -3.165 . . . . 50.51 102.454 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.2 147.28 41.59 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.739 -2.553 . . . . 50.51 109.193 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -88.89 137.98 31.83 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 127.149 2.78 . . . . 50.51 111.373 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.5 109.17 18.59 Favored 'General case' 0 C--O 1.283 2.86 0 CA-C-O 117.662 -1.161 . . . . 50.51 113.737 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.419 HG21 HD11 ' A' ' 44' ' ' ILE . 45.6 t -111.69 128.48 68.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 119.614 1.097 . . . . 50.51 108.452 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.07 139.05 32.73 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 116.296 1.962 . . . . 50.51 116.296 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -98.08 116.7 30.84 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.337 -3.22 . . . . 50.64 108.684 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mp -85.76 138.4 32.12 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.795 1.934 . . . . 50.51 106.421 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -99.56 73.93 1.86 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.763 -1.562 . . . . 50.64 109.118 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.55 145.04 6.7 Favored Glycine 0 C--O 1.244 0.735 0 N-CA-C 106.293 -2.723 . . . . 50.51 106.293 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.416 0 N-CA-C 106.551 -2.62 . . . . 50.51 106.551 179.239 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 97.6 mmm . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.819 -1.178 . . . . 50.51 107.819 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -113.54 139.66 48.8 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 103.575 -2.75 . . . . 50.55 103.575 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.522 ' C ' HD13 ' A' ' 3' ' ' ILE . 2.0 pp -144.78 162.55 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 104.75 -2.315 . . . . 50.51 104.75 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 148.02 40.27 Favored 'General case' 0 N--CA 1.511 2.604 1 O-C-N 130.46 4.85 . . . . 50.51 109.434 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.9 t -130.22 100.05 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 113.406 -3.188 . . . . 50.51 105.245 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -65.4 131.11 45.61 Favored 'General case' 0 N--CA 1.504 2.275 1 O-C-N 129.266 4.103 . . . . 50.51 112.832 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.547 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 41.5 p -93.22 -169.39 2.14 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 107.672 -1.233 . . . . 50.51 107.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.06 34.87 4.75 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.851 -1.537 . . . . 50.51 106.851 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.1 p -134.13 -15.09 2.29 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 115.706 -2.398 . . . . 50.51 114.646 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.63 13.14 10.7 Favored Glycine 0 C--N 1.296 -1.645 0 O-C-N 120.227 -1.546 . . . . 50.51 112.654 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -119.87 120.31 36.08 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 116.834 -1.555 . . . . 50.51 111.126 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -85.77 144.75 27.58 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 126.647 2.467 . . . . 50.51 110.942 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -116.75 142.74 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 127.582 3.052 . . . . 50.51 110.391 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -122.33 128.92 51.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.249 -1.78 . . . . 50.51 113.007 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.462 HD11 HD12 ' A' ' 30' ' ' ILE . 5.4 mp -118.64 151.7 37.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 115.39 -2.243 . . . . 50.51 107.28 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 1' ' ' MET . 40.1 mt-10 -117.22 126.18 52.35 Favored 'General case' 0 N--CA 1.5 2.028 1 O-C-N 129.176 4.048 . . . . 50.62 102.984 173.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.493 HG12 ' HE3' ' A' ' 29' ' ' LYS . 35.3 m -146.31 170.83 4.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 126.241 2.213 . . . . 50.51 108.46 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 96.0 mt-10 -108.52 154.84 41.33 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.163 -2.29 . . . . 50.62 114.645 174.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -55.03 -24.51 40.35 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 122.624 2.216 . . . . 50.51 111.918 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -75.08 -14.74 60.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 118.067 -0.968 . . . . 50.51 112.467 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.0 140.91 56.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 117.355 -1.738 . . . . 50.62 109.344 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.0 p -80.93 133.51 35.55 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 105.809 -1.923 . . . . 50.51 105.809 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 54' ' ' ARG . 24.4 mm -37.69 -35.64 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.212 2.82 . . . . 50.51 110.364 175.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -58.5 -45.17 89.29 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.543 2.423 . . . . 50.62 117.543 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.09 -26.59 66.79 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.874 2.175 . . . . 50.55 116.874 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.74 -43.08 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 125.118 1.511 . . . . 50.51 112.842 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.7 -34.34 71.19 Favored 'General case' 0 C--O 1.256 1.402 0 CA-C-N 115.767 -0.651 . . . . 50.51 110.009 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -66.42 -44.82 81.88 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 117.872 2.545 . . . . 50.51 117.872 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HE3' HG12 ' A' ' 17' ' ' VAL . 62.0 mttm -46.65 -32.66 3.66 Favored 'General case' 0 C--O 1.255 1.395 0 O-C-N 120.422 -1.424 . . . . 50.51 108.56 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.462 HD12 HD11 ' A' ' 15' ' ' LEU . 22.6 mm -68.97 -40.69 81.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.199 0 N-CA-C 106.363 -1.717 . . . . 50.51 106.363 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 26.0 tt0 -39.92 -38.62 0.72 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 118.359 2.726 . . . . 50.55 118.359 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.11 -12.4 61.48 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 115.605 1.706 . . . . 50.62 115.605 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -105.18 -43.47 5.01 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.459 -2.096 . . . . 50.51 115.246 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -110.57 -43.46 3.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 123.067 2.667 . . . . 50.62 108.205 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 35.39 1.88 Allowed Glycine 0 CA--C 1.477 -2.33 0 N-CA-C 108.188 -1.965 . . . . 50.51 108.188 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.9 mm -98.73 123.41 49.81 Favored Pre-proline 0 C--O 1.243 0.739 0 C-N-CA 118.851 -1.139 . . . . 50.51 108.703 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.92 136.98 79.77 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.1 2.533 . . . . 50.51 110.943 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HA ' HE21 ' A' ' 41' ' ' GLN . 86.7 Cg_exo -57.18 -32.23 92.87 Favored 'Trans proline' 0 C--O 1.261 1.663 0 O-C-N 122.904 0.949 . . . . 50.51 113.436 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.45 -15.99 63.39 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 120.023 -1.673 . . . . 50.62 114.309 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -104.63 17.57 23.88 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.555 -1.341 . . . . 50.55 113.991 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 38' ' ' PRO . 54.7 mt-30 -114.35 146.11 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 124.422 2.058 . . . . 50.55 106.636 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.627 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 21.5 mtp-105 -128.7 105.19 8.09 Favored 'General case' 0 C--O 1.295 3.488 0 CA-C-O 116.632 -1.651 . . . . 50.64 113.386 172.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.41 117.58 29.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.459 1.027 . . . . 50.51 110.701 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -107.8 122.07 61.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 N-CA-C 119.051 2.982 . . . . 50.51 119.051 -177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -128.38 128.92 45.42 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 106.791 -1.559 . . . . 50.51 106.791 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.11 25.91 15.88 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.221 -2.263 . . . . 50.51 108.701 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.57 16.52 61.06 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.438 2.923 . . . . 50.51 108.69 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.47 142.01 33.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 118.037 0.918 . . . . 50.51 110.062 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -75.92 156.7 34.0 Favored 'General case' 0 C--O 1.26 1.607 0 O-C-N 123.981 0.801 . . . . 50.55 111.969 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -107.9 146.81 31.85 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.344 -1.725 . . . . 50.51 106.344 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -92.01 140.15 29.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 103.767 -2.679 . . . . 50.62 103.767 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -53.52 -52.18 60.46 Favored 'General case' 0 C--O 1.264 1.836 0 C-N-CA 126.206 1.802 . . . . 50.62 113.646 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.72 28.46 5.91 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 119.658 2.623 . . . . 50.51 119.658 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 23' ' ' ILE . 20.7 mmm180 -117.35 169.49 9.45 Favored 'General case' 0 C--O 1.248 1.006 0 O-C-N 120.047 -1.854 . . . . 50.64 112.33 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.95 149.36 28.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.091 0.956 . . . . 50.51 113.485 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.8 mt -50.47 -36.0 31.57 Favored 'General case' 0 C--O 1.201 -1.475 0 O-C-N 124.196 0.935 . . . . 50.51 109.023 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -68.79 -15.01 63.38 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.319 -1.752 . . . . 50.51 112.086 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.391 1.091 . . . . 50.62 109.894 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -121.88 11.2 10.33 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.778 -1.106 . . . . 50.51 113.333 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t30 51.45 39.79 25.27 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 121.442 1.928 . . . . 50.55 110.203 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mm -56.54 116.26 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.959 0 CA-C-O 115.215 -2.326 . . . . 50.51 109.473 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.404 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 76.3 mt-30 -79.98 -171.03 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.638 2.458 . . . . 50.55 117.638 -176.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' H ' ' HB3' ' A' ' 62' ' ' GLN . 98.7 mttt -72.27 143.68 48.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.229 1.49 . . . . 50.51 108.827 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 34.42 39.58 0.03 OUTLIER 'General case' 0 C--O 1.256 1.447 0 N-CA-C 117.905 2.557 . . . . 50.62 117.905 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -65.89 146.68 54.44 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.83 -1.077 . . . . 50.51 111.949 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 p -104.54 144.15 32.08 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 118.299 -0.857 . . . . 50.51 110.926 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 60.0 mt -110.66 156.04 21.56 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 114.756 -2.545 . . . . 50.51 108.625 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -118.94 144.94 46.16 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 127.408 2.942 . . . . 50.51 110.475 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 49.2 tp -96.09 129.88 43.26 Favored 'General case' 0 C--O 1.282 2.803 0 CA-C-O 117.696 -1.145 . . . . 50.51 111.668 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.627 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 61.8 t -116.11 137.06 51.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 102.392 -3.188 . . . . 50.51 102.392 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.87 127.86 46.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.102 0.477 . . . . 50.51 110.42 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -114.27 111.83 22.14 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.374 -3.203 . . . . 50.64 112.494 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.05 143.9 28.12 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.837 1.961 . . . . 50.51 108.097 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -98.09 89.28 4.47 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 106.662 -1.607 . . . . 50.64 106.662 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.7 -162.65 26.99 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 104.643 -3.383 . . . . 50.51 104.643 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 CA-C-O 116.355 -2.358 . . . . 50.51 108.044 179.25 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 118.768 -0.634 . . . . 50.51 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 10.9 mm-40 -109.09 127.67 54.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 127.001 2.688 . . . . 50.55 109.026 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -133.16 146.55 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 116.024 -1.941 . . . . 50.51 107.717 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -106.56 135.89 47.28 Favored 'General case' 0 N--CA 1.512 2.645 1 O-C-N 130.446 4.841 . . . . 50.51 113.486 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.8 t -108.05 136.63 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.417 -3.182 . . . . 50.51 103.898 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -126.24 119.7 28.12 Favored 'General case' 0 N--CA 1.503 2.219 1 O-C-N 129.277 4.111 . . . . 50.51 114.834 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.563 HG23 HD21 ' A' ' 69' ' ' LEU . 43.9 p -67.44 -172.27 0.23 Allowed 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.869 -1.063 . . . . 50.51 110.337 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.89 -18.97 26.46 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.116 -0.698 . . . . 50.51 109.116 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -106.36 16.08 25.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 119.87 3.285 . . . . 50.51 119.87 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.86 55.67 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 120.952 3.141 . . . . 50.51 120.952 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -84.16 123.35 30.0 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.227 -1.768 . . . . 50.51 106.227 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -113.03 134.1 54.67 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 126.585 2.428 . . . . 50.51 111.872 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.44 HG13 ' HB ' ' A' ' 5' ' ' VAL . 28.0 pt -115.92 153.81 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 127.533 3.02 . . . . 50.51 114.0 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -110.58 142.99 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 117.301 -1.76 . . . . 50.51 115.021 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' A' ' 30' ' ' ILE . 76.4 mt -135.46 139.78 44.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 115.459 -2.21 . . . . 50.51 113.54 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -101.85 107.19 18.3 Favored 'General case' 0 N--CA 1.5 2.069 1 O-C-N 129.128 4.018 . . . . 50.62 113.926 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -128.17 154.63 39.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.671 3.107 . . . . 50.51 114.443 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.67 159.02 30.65 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 118.256 2.688 . . . . 50.62 118.256 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.0 -24.49 40.0 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.581 2.187 . . . . 50.51 111.948 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -103.34 34.33 2.97 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 117.806 2.521 . . . . 50.51 117.806 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -114.15 130.75 56.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.374 -1.731 . . . . 50.62 112.166 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.444 ' O ' HG21 ' A' ' 26' ' ' VAL . 41.3 p -57.93 155.54 10.5 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.598 1.332 . . . . 50.51 114.598 175.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 54' ' ' ARG . 15.3 mm -60.45 -42.06 89.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 127.205 2.816 . . . . 50.51 110.955 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.07 -59.05 5.88 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.941 . . . . 50.62 108.458 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 44.5 t30 -47.85 -43.54 28.36 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 124.399 1.08 . . . . 50.55 111.145 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG22 HD11 ' A' ' 56' ' ' LEU . 42.1 t -63.38 -34.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.97 1.419 . . . . 50.51 109.707 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -76.16 -30.44 58.12 Favored 'General case' 0 C--O 1.257 1.451 0 N-CA-C 108.816 -0.809 . . . . 50.51 108.816 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.88 70.02 Favored 'General case' 0 C--O 1.279 2.616 0 N-CA-C 105.517 -2.031 . . . . 50.51 105.517 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 75.3 mmtt -58.93 -63.2 1.38 Allowed 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.397 -1.439 . . . . 50.51 107.994 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.499 ' CG1' HD11 ' A' ' 15' ' ' LEU . 70.3 mt -47.97 -37.75 6.8 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.486 -0.886 . . . . 50.51 109.105 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -54.45 -50.73 66.99 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 125.568 2.604 . . . . 50.55 112.849 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -49.0 -60.99 2.3 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 113.644 -1.616 . . . . 50.62 110.273 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -84.13 -40.33 18.36 Favored 'General case' 0 C--O 1.279 2.654 0 N-CA-C 119.617 3.191 . . . . 50.51 119.617 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HG3' HG13 ' A' ' 36' ' ' ILE . 42.5 tp10 -76.19 -31.37 58.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 123.082 2.674 . . . . 50.62 108.162 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.42 2.36 76.75 Favored Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.458 -1.057 . . . . 50.51 110.458 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -87.81 136.39 32.67 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 118.812 -1.155 . . . . 50.51 110.999 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.0 Cg_exo -57.07 137.0 79.97 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.159 2.572 . . . . 50.51 110.875 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -57.19 -32.16 92.68 Favored 'Trans proline' 0 C--O 1.262 1.709 0 O-C-N 122.89 0.942 . . . . 50.51 113.436 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.513 ' OD1' ' HG3' ' A' ' 40' ' ' GLN . 35.6 p30 -69.4 -14.1 62.72 Favored 'General case' 0 C--O 1.262 1.733 0 O-C-N 119.893 -1.754 . . . . 50.62 113.83 -177.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.513 ' HG3' ' OD1' ' A' ' 39' ' ' ASP . 88.2 mt-30 -102.81 6.84 39.49 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.544 -1.347 . . . . 50.55 109.891 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -103.41 130.94 50.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 124.362 2.029 . . . . 50.55 110.796 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -120.98 122.12 39.47 Favored 'General case' 0 C--O 1.296 3.544 0 CA-C-O 116.625 -1.655 . . . . 50.64 110.828 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.451 ' CB ' HD12 ' A' ' 50' ' ' LEU . 60.2 mt -108.14 126.16 52.44 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.509 1.05 . . . . 50.51 109.839 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 67.5 mt -111.14 138.86 37.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 O-C-N 125.223 1.577 . . . . 50.51 108.147 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -150.55 120.63 7.2 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 114.488 -1.233 . . . . 50.51 110.913 177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.34 38.66 7.69 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.208 -2.269 . . . . 50.51 112.284 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 3.42 68.08 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.346 2.879 . . . . 50.51 115.863 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -113.76 146.78 39.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 114.978 1.473 . . . . 50.51 114.978 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -70.51 153.96 42.38 Favored 'General case' 0 C--O 1.259 1.58 0 N-CA-C 108.2 -1.037 . . . . 50.55 108.2 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.451 HD12 ' CB ' ' A' ' 43' ' ' LEU . 63.5 mt -96.94 135.01 39.55 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 117.666 -1.159 . . . . 50.51 110.312 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -99.06 128.1 45.13 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.933 1.395 . . . . 50.62 112.737 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.11 -57.82 3.63 Favored 'General case' 0 C--O 1.264 1.844 0 C-N-CA 126.133 1.773 . . . . 50.62 115.216 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.26 -26.68 29.85 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 124.415 1.007 . . . . 50.51 113.886 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' O ' HG12 ' A' ' 23' ' ' ILE . 29.5 mmt180 -83.6 161.04 21.27 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 120.025 -1.868 . . . . 50.64 112.109 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -103.93 172.68 6.67 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 124.065 0.946 . . . . 50.51 110.218 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD11 HG22 ' A' ' 26' ' ' VAL . 47.5 mt -58.07 -33.19 68.79 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 116.49 2.033 . . . . 50.51 116.49 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -86.38 -5.66 59.12 Favored 'General case' 0 C--O 1.267 2.0 0 C-N-CA 117.372 -1.731 . . . . 50.51 111.167 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -79.81 -0.79 36.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.809 -1.182 . . . . 50.62 107.809 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -123.95 11.98 9.01 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 117.755 -1.117 . . . . 50.51 110.542 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.61 28.61 12.2 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 121.545 1.975 . . . . 50.55 111.595 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.2 103.0 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.969 0 CA-C-O 115.17 -2.348 . . . . 50.51 108.827 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -98.84 164.62 12.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.112 2.133 . . . . 50.55 112.435 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -51.04 135.89 24.27 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.513 2.042 . . . . 50.51 116.513 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 73.09 37.93 0.73 Allowed 'General case' 0 C--O 1.255 1.393 0 CA-C-N 112.497 -2.138 . . . . 50.62 111.07 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 p -78.07 156.56 29.96 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 107.537 -1.283 . . . . 50.51 107.537 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.5 m -122.05 117.97 27.63 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.834 -3.024 . . . . 50.51 102.834 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.65 170.09 9.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 114.695 -2.574 . . . . 50.51 112.545 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.699 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -110.32 127.62 55.12 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.361 2.913 . . . . 50.51 108.73 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.563 HD21 HG23 ' A' ' 7' ' ' THR . 48.0 tp -103.07 101.87 11.87 Favored 'General case' 0 C--O 1.283 2.823 0 CA-C-O 117.649 -1.167 . . . . 50.51 113.194 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.38 137.11 25.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.583 1.083 . . . . 50.51 112.149 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 tp -96.03 115.73 27.88 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.318 -0.623 . . . . 50.51 109.318 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -109.04 108.18 18.79 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.305 -3.236 . . . . 50.64 114.166 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.86 165.16 15.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 125.859 1.974 . . . . 50.51 114.664 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -115.35 61.45 0.69 Allowed 'General case' 0 C--O 1.244 0.812 0 CA-C-N 113.742 -1.572 . . . . 50.64 108.472 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.75 138.82 2.55 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 107.298 -2.321 . . . . 50.51 107.298 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.444 0 CA-C-O 116.356 -2.358 . . . . 50.51 109.038 179.217 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 106.917 -1.512 . . . . 50.51 106.917 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -120.19 135.71 54.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 101.557 -3.498 . . . . 50.55 101.557 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -137.89 159.36 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.94 -1.981 . . . . 50.51 106.941 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -114.24 143.91 44.08 Favored 'General case' 0 N--CA 1.512 2.628 1 O-C-N 130.446 4.842 . . . . 50.51 111.395 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -118.97 109.87 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.404 -3.189 . . . . 50.51 106.121 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -84.3 150.37 25.46 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.306 4.129 . . . . 50.51 117.362 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -126.78 164.23 21.81 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 117.826 -1.083 . . . . 50.51 110.137 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.54 -43.36 65.12 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.999 2.592 . . . . 50.51 117.999 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.6 p -68.64 -26.52 65.37 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 115.726 -2.39 . . . . 50.51 107.455 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.73 -5.93 18.42 Favored Glycine 0 C--N 1.297 -1.6 0 O-C-N 120.258 -1.526 . . . . 50.51 115.438 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -54.66 130.88 41.96 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.88 -1.533 . . . . 50.51 109.889 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -112.86 119.58 38.47 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 126.624 2.453 . . . . 50.51 117.221 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -88.48 145.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.571 3.044 . . . . 50.51 108.329 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -104.58 141.93 35.53 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 117.287 -1.765 . . . . 50.51 110.584 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -134.13 137.48 44.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 118.195 2.665 . . . . 50.51 118.195 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -103.61 111.18 23.54 Favored 'General case' 0 N--CA 1.501 2.104 1 O-C-N 129.242 4.089 . . . . 50.62 112.35 174.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -98.24 166.74 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.197 0 O-C-N 127.508 3.005 . . . . 50.51 112.548 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 53.9 mm-40 -115.72 148.66 41.63 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.197 -2.274 . . . . 50.62 112.58 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.5 Cg_exo -54.95 -24.49 39.57 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.581 2.188 . . . . 50.51 112.003 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -103.14 13.75 33.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 118.043 2.608 . . . . 50.51 118.043 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -92.74 148.6 21.91 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 117.349 -1.74 . . . . 50.62 110.986 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -99.09 157.42 16.37 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.836 -0.62 . . . . 50.51 109.716 175.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -45.01 -43.86 2.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 O-C-N 127.238 2.836 . . . . 50.51 113.015 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -57.39 -46.68 83.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.456 -0.778 . . . . 50.62 110.305 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -59.51 -39.88 85.3 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.287 1.035 . . . . 50.55 110.653 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.63 -46.73 95.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.022 -1.473 . . . . 50.51 107.022 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 93.4 mttt -55.0 -59.38 4.83 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-N 115.814 -0.63 . . . . 50.51 111.336 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.02 -40.59 76.99 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 113.887 1.069 . . . . 50.51 113.887 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -50.8 -44.38 58.97 Favored 'General case' 0 C--O 1.255 1.39 0 N-CA-C 106.367 -1.716 . . . . 50.51 106.367 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 31' ' ' GLN . 72.3 mt -64.26 -42.2 94.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.281 0 C-N-CA 119.51 -0.876 . . . . 50.51 108.669 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' C ' ' A' ' 32' ' ' ASP . 35.4 tt0 -43.87 -58.34 2.8 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.623 2.63 . . . . 50.55 108.844 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 31' ' ' GLN . 98.1 m-20 -34.57 -35.79 0.04 OUTLIER 'General case' 0 C--O 1.253 1.26 0 CA-C-N 113.645 -1.616 . . . . 50.62 110.833 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 31' ' ' GLN . 33.7 mmtp -112.46 -1.22 15.05 Favored 'General case' 0 C--O 1.28 2.703 0 N-CA-C 120.15 3.389 . . . . 50.51 120.15 -175.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -129.81 -38.07 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 123.147 2.703 . . . . 50.62 108.399 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 11.98 31.98 Favored Glycine 0 CA--C 1.477 -2.333 0 N-CA-C 115.177 0.831 . . . . 50.51 115.177 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.6 mt -97.51 136.72 21.18 Favored Pre-proline 0 C--O 1.245 0.83 0 C-N-CA 118.836 -1.146 . . . . 50.51 112.149 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.565 0 C-N-CA 123.152 2.568 . . . . 50.51 110.88 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 Cg_exo -57.24 -32.18 92.86 Favored 'Trans proline' 0 C--O 1.26 1.621 0 O-C-N 122.903 0.949 . . . . 50.51 113.38 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -72.82 5.17 3.39 Favored 'General case' 0 C--O 1.262 1.757 0 O-C-N 120.022 -1.674 . . . . 50.62 113.573 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.579 HE21 ' HG3' ' A' ' 74' ' ' ARG . 62.8 mt-30 -111.2 -6.71 14.53 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.541 -1.349 . . . . 50.55 112.632 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.433 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 8.8 mt-30 -102.79 130.59 49.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.412 2.053 . . . . 50.55 112.686 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -111.54 119.68 39.57 Favored 'General case' 0 C--O 1.297 3.566 0 CA-C-O 116.672 -1.632 . . . . 50.64 108.368 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.4 mt -100.97 158.72 15.79 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 105.595 -2.002 . . . . 50.51 105.595 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 67' ' ' LEU . 60.8 mt -137.35 135.78 46.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 118.835 2.902 . . . . 50.51 118.835 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -128.05 112.62 14.81 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 115.063 1.505 . . . . 50.51 115.063 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.92 30.92 20.42 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.19 -2.277 . . . . 50.51 109.525 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.09 19.34 72.63 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 128.486 2.945 . . . . 50.51 117.187 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -111.02 151.72 27.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 118.162 -0.923 . . . . 50.51 112.078 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.05 154.17 42.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.986 1.106 . . . . 50.55 113.986 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.09 140.22 49.77 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 117.796 -1.097 . . . . 50.51 109.169 -175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -103.32 136.03 43.85 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.864 1.352 . . . . 50.62 114.31 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -57.33 -55.73 31.01 Favored 'General case' 0 C--O 1.263 1.793 0 C-N-CA 126.177 1.791 . . . . 50.62 114.019 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.16 11.66 4.76 Favored Glycine 0 C--O 1.254 1.368 0 C-N-CA 124.464 1.03 . . . . 50.51 115.389 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -106.96 166.7 10.41 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 119.963 -1.904 . . . . 50.64 110.538 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -90.22 158.67 17.1 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 124.014 0.926 . . . . 50.51 113.308 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -70.62 -28.82 65.14 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 124.071 0.857 . . . . 50.51 110.085 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -69.31 -21.71 63.83 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.31 -1.756 . . . . 50.51 113.535 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.29 -5.35 51.78 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.63 2.085 . . . . 50.62 116.63 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -111.75 14.32 21.11 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 114.791 1.404 . . . . 50.51 114.791 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 51.4 28.1 4.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 121.571 1.987 . . . . 50.55 114.397 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.85 100.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.973 0 CA-C-O 115.192 -2.337 . . . . 50.51 106.878 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -98.9 162.76 12.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 126.159 2.162 . . . . 50.55 111.333 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 58.4 pttt -52.93 118.32 3.62 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 116.501 2.038 . . . . 50.51 116.501 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 71.69 46.87 0.36 Allowed 'General case' 0 C--O 1.257 1.453 0 CA-C-N 112.53 -2.123 . . . . 50.62 112.764 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.3 p -102.0 151.86 21.63 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 101.515 -3.513 . . . . 50.51 101.515 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.1 p -94.29 139.55 30.92 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 117.729 2.492 . . . . 50.51 117.729 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 46.6 mt -109.36 151.73 26.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 103.166 -2.902 . . . . 50.51 103.166 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 55.5 m80 -108.75 124.95 51.37 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 127.472 2.982 . . . . 50.51 104.565 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.4 tp -99.42 117.56 34.11 Favored 'General case' 0 C--O 1.283 2.841 0 CA-C-O 117.63 -1.176 . . . . 50.51 111.172 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -103.84 145.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 119.558 1.072 . . . . 50.51 108.765 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -115.23 120.55 40.08 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.859 2.17 . . . . 50.51 116.859 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -119.13 90.06 3.25 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 113.371 -3.204 . . . . 50.64 111.138 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.24 163.38 1.65 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.795 1.935 . . . . 50.51 109.209 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.579 ' HG3' HE21 ' A' ' 40' ' ' GLN . 93.8 mtt-85 -87.62 94.01 9.6 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 113.706 -1.588 . . . . 50.64 113.065 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.66 171.34 18.3 Favored Glycine 0 C--O 1.243 0.705 0 N-CA-C 109.663 -1.375 . . . . 50.51 109.663 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.472 0 N-CA-C 106.215 -2.754 . . . . 50.51 106.215 179.22 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 118.753 -0.641 . . . . 50.51 111.148 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' OE1' HG22 ' A' ' 14' ' ' THR . 48.9 mt-30 -86.22 125.11 33.31 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.96 2.663 . . . . 50.55 116.662 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.3 pt -119.87 162.65 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 115.983 -1.96 . . . . 50.51 109.392 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -112.02 136.28 51.58 Favored 'General case' 0 N--CA 1.513 2.69 1 O-C-N 130.504 4.877 . . . . 50.51 118.459 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -105.85 111.63 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.438 -3.172 . . . . 50.51 111.728 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -81.22 129.44 34.59 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.309 4.131 . . . . 50.51 109.318 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 69.2 p -97.67 -176.77 3.57 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 114.576 1.324 . . . . 50.51 114.576 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.2 mt -86.91 -28.68 22.64 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.784 1.031 . . . . 50.51 113.784 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 p -93.97 -22.37 18.61 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.713 -2.395 . . . . 50.51 111.12 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.2 3.9 2.39 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 117.726 1.85 . . . . 50.51 117.726 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' N ' ' OG1' ' A' ' 7' ' ' THR . 95.4 mttt -71.7 137.65 47.96 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 116.868 -1.539 . . . . 50.51 112.323 174.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.1 m -122.15 106.73 11.42 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.678 2.486 . . . . 50.51 110.809 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 15' ' ' LEU . 62.5 mt -84.87 153.09 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 127.244 2.84 . . . . 50.51 111.427 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.52 HG22 ' OE1' ' A' ' 2' ' ' GLN . 42.6 m -119.76 132.1 55.53 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 102.538 -3.134 . . . . 50.51 102.538 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 13' ' ' ILE . 1.5 mp -118.05 142.6 47.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 117.3 2.333 . . . . 50.51 117.3 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.71 107.39 19.87 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 128.944 3.902 . . . . 50.62 109.902 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.58 166.71 10.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 O-C-N 127.782 3.176 . . . . 50.51 106.046 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -132.67 157.77 77.46 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 112.234 -2.257 . . . . 50.62 106.446 174.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.92 -24.5 39.38 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.56 2.173 . . . . 50.51 112.014 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -75.81 -13.0 60.28 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 115.451 1.648 . . . . 50.51 115.451 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -84.65 131.27 34.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 118.379 2.733 . . . . 50.62 118.379 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -83.61 179.92 7.49 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 103.948 -2.612 . . . . 50.51 103.948 175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' GLU . 24.6 mm -65.41 -39.56 85.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 O-C-N 127.206 2.816 . . . . 50.51 110.824 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 29.7 tt0 -46.84 -59.23 3.2 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.275 -2.12 . . . . 50.62 105.275 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 24.6 m-80 -53.12 -46.37 68.73 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 118.123 2.638 . . . . 50.55 118.123 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.41 -39.6 81.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 117.777 2.51 . . . . 50.51 117.777 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -72.27 -30.08 64.5 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 103.231 -2.877 . . . . 50.51 103.231 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -30.86 71.18 Favored 'General case' 0 C--O 1.279 2.608 0 N-CA-C 109.146 -0.687 . . . . 50.51 109.146 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.6 mttt -71.79 -19.18 62.04 Favored 'General case' 0 C--O 1.256 1.422 0 O-C-N 120.316 -1.49 . . . . 50.51 111.058 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 30' ' ' ILE . 95.7 mt -88.94 -11.25 10.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 C-N-CA 119.538 -0.865 . . . . 50.51 109.491 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -91.67 -19.64 22.45 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 125.63 2.633 . . . . 50.55 113.161 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.26 -52.77 20.5 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.572 -1.649 . . . . 50.62 110.606 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -80.28 -75.93 0.24 Allowed 'General case' 0 C--O 1.278 2.598 0 C-N-CA 116.468 -2.093 . . . . 50.51 108.175 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -55.18 -70.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.05 2.659 . . . . 50.62 114.812 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.69 20.33 0.88 Allowed Glycine 0 CA--C 1.478 -2.27 0 CA-C-O 120.012 -0.327 . . . . 50.51 113.223 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.524 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -89.28 125.86 60.51 Favored Pre-proline 0 C--O 1.244 0.776 0 N-CA-C 116.77 2.137 . . . . 50.51 116.77 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -57.01 136.98 79.95 Favored 'Trans proline' 0 C--O 1.258 1.523 0 C-N-CA 123.159 2.572 . . . . 50.51 110.903 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -57.17 -32.19 92.72 Favored 'Trans proline' 0 C--O 1.261 1.653 0 C-N-CA 120.671 0.914 . . . . 50.51 113.377 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.04 -9.71 58.9 Favored 'General case' 0 C--O 1.262 1.738 0 O-C-N 119.949 -1.719 . . . . 50.62 112.854 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.685 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 79.8 mt-30 -103.32 -1.89 27.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.488 -1.382 . . . . 50.55 107.656 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.22 138.1 31.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 124.447 2.07 . . . . 50.55 105.745 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.11 114.4 15.7 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.646 -1.645 . . . . 50.64 106.831 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.511 ' HB3' HD23 ' A' ' 50' ' ' LEU . 35.2 mt -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 119.537 1.062 . . . . 50.51 110.285 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -129.06 123.87 59.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 O-C-N 125.102 1.501 . . . . 50.51 111.849 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -140.1 117.19 11.16 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 114.539 -1.21 . . . . 50.51 109.948 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.7 29.0 13.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 112.241 -2.254 . . . . 50.51 114.706 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 37.54 45.29 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 128.379 2.895 . . . . 50.51 114.393 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -133.95 150.23 51.28 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 118.317 2.71 . . . . 50.51 118.317 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.08 135.18 42.97 Favored 'General case' 0 C--O 1.26 1.635 0 O-C-N 123.953 0.783 . . . . 50.55 110.33 174.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 43' ' ' LEU . 2.1 mp -87.79 129.18 35.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 114.637 1.347 . . . . 50.51 114.637 -175.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' HG2' ' HH ' ' A' ' 59' ' ' TYR . 61.8 mm-40 -89.5 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 120.377 3.473 . . . . 50.62 120.377 -177.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -51.07 -55.97 14.95 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 119.74 3.237 . . . . 50.62 119.74 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.96 7.85 78.69 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.387 0.994 . . . . 50.51 114.189 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.51 144.55 28.48 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 119.951 -1.911 . . . . 50.64 109.276 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -87.4 155.84 19.85 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.062 0.945 . . . . 50.51 108.581 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -46.93 -32.26 3.71 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 113.869 1.063 . . . . 50.51 113.869 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.58 -20.38 65.38 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 115.759 1.763 . . . . 50.51 115.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -62.24 -43.84 97.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.452 1.12 . . . . 50.62 110.603 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.523 ' HH ' ' HG2' ' A' ' 51' ' ' GLU . 59.7 m-85 -84.66 17.11 2.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 115.609 1.707 . . . . 50.51 115.609 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 t30 60.31 33.13 20.88 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 121.536 1.971 . . . . 50.55 113.59 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.534 HG23 ' OG ' ' A' ' 65' ' ' SER . 56.9 mt -85.47 83.71 2.08 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 CA-C-O 115.169 -2.348 . . . . 50.51 113.65 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -82.97 179.06 7.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 125.717 1.885 . . . . 50.55 116.027 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -53.2 124.21 13.91 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 123.179 1.466 . . . . 50.51 111.394 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 61.1 40.42 14.98 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 118.528 2.788 . . . . 50.62 118.528 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.534 ' OG ' HG23 ' A' ' 61' ' ' ILE . 94.2 p -86.91 152.35 22.51 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.164 -1.421 . . . . 50.51 107.164 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 m -91.47 123.3 34.78 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 116.667 2.099 . . . . 50.51 116.667 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.01 138.58 41.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 114.735 -2.555 . . . . 50.51 105.291 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 49.0 m80 -81.6 168.04 18.59 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 127.038 2.711 . . . . 50.51 106.612 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -131.24 120.47 23.28 Favored 'General case' 0 C--O 1.282 2.789 0 N-CA-C 104.664 -2.346 . . . . 50.51 104.664 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.5 t -118.8 149.93 21.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 102.585 -3.117 . . . . 50.51 102.585 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.11 152.33 18.64 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.536 0.569 . . . . 50.51 112.536 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.685 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 74.9 ttt180 -122.12 97.73 5.61 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 113.413 -3.184 . . . . 50.64 106.789 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.0 mt -85.83 134.6 33.91 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 125.757 1.911 . . . . 50.51 113.369 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.84 81.49 8.75 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.703 -1.59 . . . . 50.64 112.88 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.94 -175.34 16.6 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 107.596 -2.201 . . . . 50.51 107.596 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.464 0 N-CA-C 105.24 -3.144 . . . . 50.51 105.24 179.213 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' VAL . 63.0 mtp . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 102.042 -3.318 . . . . 50.51 102.042 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -112.52 135.05 53.69 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 103.497 -2.779 . . . . 50.55 103.497 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -124.77 173.12 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 CA-C-O 116.074 -1.917 . . . . 50.51 107.004 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.8 141.98 38.55 Favored 'General case' 0 N--CA 1.511 2.609 1 O-C-N 130.343 4.777 . . . . 50.51 115.954 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.34 110.58 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.454 -3.165 . . . . 50.51 104.585 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -90.47 143.94 26.27 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.204 4.065 . . . . 50.51 105.472 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 24.8 p -117.39 177.2 4.82 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.8 -1.095 . . . . 50.51 112.878 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.05 -24.76 67.83 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.082 0.864 . . . . 50.51 112.65 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -101.23 25.79 7.83 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 115.748 -2.381 . . . . 50.51 110.799 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.56 31.34 74.44 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 107.559 -2.216 . . . . 50.51 107.559 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 29.3 ttpt -84.97 124.7 31.98 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 103.735 -2.691 . . . . 50.51 103.735 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 p -103.31 137.72 41.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.664 2.477 . . . . 50.51 105.851 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 13' ' ' ILE . 16.6 tt -144.74 112.13 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 101.735 -3.432 . . . . 50.51 101.735 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.9 p -81.52 155.07 25.94 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.302 -1.759 . . . . 50.51 114.975 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -114.22 167.63 10.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.446 -2.216 . . . . 50.51 110.928 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.6 104.06 12.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 129.025 3.953 . . . . 50.62 106.427 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 1' ' ' MET . 19.7 m -107.41 148.62 11.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 O-C-N 127.62 3.075 . . . . 50.51 114.912 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 38.0 mt-10 -116.0 149.47 43.4 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.208 -2.269 . . . . 50.62 112.131 174.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.5 Cg_exo -54.87 -24.53 39.18 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.535 2.157 . . . . 50.51 111.971 177.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -87.31 -2.54 58.7 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 118.146 -0.931 . . . . 50.51 111.135 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.43 131.8 37.05 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 115.949 1.833 . . . . 50.62 115.949 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.98 148.58 24.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.808 -0.633 . . . . 50.51 111.04 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 51' ' ' GLU . 73.2 mt -48.6 -29.87 2.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.147 2.779 . . . . 50.51 114.907 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 78.5 tt0 -56.25 -63.82 1.06 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 105.021 -2.215 . . . . 50.62 105.021 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -50.42 -40.71 51.01 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 118.97 2.952 . . . . 50.55 118.97 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.13 -23.15 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.129 -1.396 . . . . 50.51 107.518 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 64.5 mttm -88.73 -26.68 21.65 Favored 'General case' 0 C--O 1.257 1.474 0 N-CA-C 118.272 2.693 . . . . 50.51 118.272 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -23.7 24.29 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.901 -0.407 . . . . 50.51 109.901 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.87 -49.69 73.84 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 120.333 -1.48 . . . . 50.51 111.41 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.42 -36.96 48.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 108.575 -0.898 . . . . 50.51 108.575 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.47 -45.19 73.13 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.578 2.608 . . . . 50.55 115.682 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -52.64 -29.55 26.83 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 106.387 -1.709 . . . . 50.62 106.387 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.72 -45.48 11.61 Favored 'General case' 0 C--O 1.279 2.656 0 C-N-CA 116.433 -2.107 . . . . 50.51 113.243 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -116.78 -36.67 3.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 123.107 2.685 . . . . 50.62 112.321 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.86 31.32 2.74 Favored Glycine 0 CA--C 1.477 -2.291 0 N-CA-C 110.512 -1.035 . . . . 50.51 110.512 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 68.0 mt -83.09 122.92 77.89 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 105.273 -2.121 . . . . 50.51 105.273 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 77.4 Cg_exo -57.0 136.93 79.63 Favored 'Trans proline' 0 C--O 1.258 1.514 0 C-N-CA 123.228 2.618 . . . . 50.51 110.838 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -57.18 -32.19 92.77 Favored 'Trans proline' 0 C--O 1.262 1.688 0 O-C-N 122.885 0.939 . . . . 50.51 113.418 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -89.25 27.57 1.39 Allowed 'General case' 0 C--O 1.262 1.75 0 O-C-N 119.981 -1.699 . . . . 50.62 115.06 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -137.8 14.03 2.91 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 104.384 -2.45 . . . . 50.55 104.384 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -110.39 137.79 47.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.948 -2.242 . . . . 50.55 104.948 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -131.62 108.88 9.82 Favored 'General case' 0 C--O 1.296 3.537 0 CA-C-O 116.676 -1.63 . . . . 50.64 112.564 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.0 mt -90.42 131.22 36.31 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 116.63 2.085 . . . . 50.51 116.63 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.715 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -107.0 137.9 35.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.51 113.524 -177.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -149.4 112.39 4.87 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 114.55 -1.204 . . . . 50.51 113.78 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 46.05 27.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.215 -2.266 . . . . 50.51 113.31 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.93 -6.07 56.63 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 128.384 2.897 . . . . 50.51 114.763 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -97.47 158.9 15.24 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 117.412 2.375 . . . . 50.51 117.412 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -96.17 139.96 31.57 Favored 'General case' 0 C--O 1.259 1.554 0 N-CA-C 105.644 -1.984 . . . . 50.55 105.644 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -95.84 127.79 42.16 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 117.72 -1.133 . . . . 50.51 112.554 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 23' ' ' ILE . 57.5 mt-10 -85.55 139.39 31.49 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.891 1.369 . . . . 50.62 113.79 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -53.88 -50.21 66.82 Favored 'General case' 0 C--O 1.264 1.86 0 C-N-CA 126.171 1.788 . . . . 50.62 114.38 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.3 -4.58 44.66 Favored Glycine 0 CA--C 1.493 -1.321 0 C-N-CA 124.457 1.027 . . . . 50.51 113.999 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.99 150.0 21.63 Favored 'General case' 0 C--O 1.249 1.072 0 O-C-N 119.858 -1.966 . . . . 50.64 108.92 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -83.47 -179.19 7.29 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.08 0.952 . . . . 50.51 110.398 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.38 -29.12 31.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.821 -1.548 . . . . 50.51 106.821 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 59' ' ' TYR . 73.3 m -73.78 -37.37 65.0 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.282 -1.767 . . . . 50.51 106.904 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -46.92 -16.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.334 1.064 . . . . 50.62 112.88 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' H ' ' C ' ' A' ' 57' ' ' SER . 91.1 m-85 -121.71 -6.12 9.14 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 117.795 -1.098 . . . . 50.51 113.613 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 66.31 41.65 3.29 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 117.569 2.433 . . . . 50.55 117.569 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.595 HG23 ' HG ' ' A' ' 65' ' ' SER . 71.8 mt -82.14 124.41 39.15 Favored 'Isoleucine or valine' 0 C--O 1.267 1.978 0 CA-C-O 115.287 -2.292 . . . . 50.51 110.174 175.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.67 168.68 9.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 126.018 2.073 . . . . 50.55 115.893 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -36.54 146.2 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 123.277 1.513 . . . . 50.51 113.569 -176.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 50.31 34.93 9.63 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-N 112.469 -2.15 . . . . 50.62 115.885 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.595 ' HG ' HG23 ' A' ' 61' ' ' ILE . 28.3 t -76.8 154.07 34.29 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.802 -1.09 . . . . 50.51 108.659 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 m -119.99 123.6 43.89 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.734 -1.209 . . . . 50.51 107.734 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.7 mt -94.85 147.88 22.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.696 -2.573 . . . . 50.51 111.47 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.715 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.0 m-70 -95.93 119.28 34.13 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 127.454 2.971 . . . . 50.51 108.781 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -98.51 110.53 23.11 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 107.08 -1.452 . . . . 50.51 107.08 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.476 HG22 HD12 ' A' ' 44' ' ' ILE . 45.6 t -93.81 165.17 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 101.499 -3.519 . . . . 50.51 101.499 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.3 mt -117.21 139.98 50.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.884 -0.784 . . . . 50.51 108.884 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -131.33 91.67 3.06 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-O 113.405 -3.188 . . . . 50.64 107.094 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -85.15 157.23 20.72 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 125.778 1.924 . . . . 50.51 110.066 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -90.53 113.2 25.13 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 105.543 -2.021 . . . . 50.64 105.543 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.65 155.81 14.52 Favored Glycine 0 C--O 1.243 0.682 0 CA-C-N 114.662 -1.154 . . . . 50.51 113.581 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.323 -2.376 . . . . 50.51 113.473 179.214 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 106.471 -1.678 . . . . 50.51 106.471 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.548 ' HG2' ' HG2' ' A' ' 16' ' ' GLU . 82.1 mt-30 -102.5 131.82 48.96 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 126.952 2.658 . . . . 50.55 108.424 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.73 163.95 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 CA-C-O 115.961 -1.971 . . . . 50.51 112.534 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' A' ' 14' ' ' THR . 79.0 m-85 -108.44 141.51 40.19 Favored 'General case' 0 N--CA 1.511 2.608 1 O-C-N 130.49 4.869 . . . . 50.51 116.756 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -116.72 120.16 64.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 113.356 -3.212 . . . . 50.51 106.065 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.32 117.38 34.0 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.326 4.141 . . . . 50.51 112.825 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 69.4 p -84.54 -174.46 5.28 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 117.774 -1.108 . . . . 50.51 108.723 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.74 -8.9 58.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.516 2.784 . . . . 50.51 118.516 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -122.65 22.86 9.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 115.74 -2.384 . . . . 50.51 116.791 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.03 22.16 21.03 Favored Glycine 0 C--N 1.297 -1.609 0 O-C-N 119.225 -2.172 . . . . 50.51 118.183 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 80.0 tttt -100.54 124.13 45.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 116.823 -1.56 . . . . 50.51 108.417 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.47 135.29 53.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 126.668 2.48 . . . . 50.51 106.369 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.3 pt -123.31 153.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 127.565 3.04 . . . . 50.51 103.594 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.406 HG23 ' CD1' ' A' ' 4' ' ' PHE . 70.2 p -117.1 139.04 51.2 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 117.266 -1.774 . . . . 50.51 107.862 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -126.3 137.96 53.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 115.454 -2.212 . . . . 50.51 107.446 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.548 ' HG2' ' HG2' ' A' ' 2' ' ' GLN . 46.8 mt-10 -96.24 133.14 40.95 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.231 4.082 . . . . 50.62 109.407 173.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HZ3' ' A' ' 29' ' ' LYS . 35.0 m -130.42 170.62 19.03 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.631 3.082 . . . . 50.51 113.57 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 8.8 mp0 -124.09 153.5 68.03 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.215 -2.266 . . . . 50.62 111.165 174.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.6 Cg_exo -55.01 -24.5 40.1 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 122.623 2.215 . . . . 50.51 111.906 177.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.0 p -89.01 8.32 30.27 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 117.243 2.312 . . . . 50.51 117.243 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.84 137.73 32.99 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 118.648 2.833 . . . . 50.62 118.648 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 25' ' ' ASN . 32.8 p -86.89 137.17 32.61 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.834 -0.621 . . . . 50.51 111.95 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -42.6 -35.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.26 2.85 . . . . 50.51 112.932 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.47 -11.79 58.73 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.488 -0.757 . . . . 50.62 111.077 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' THR . 31.3 t30 -108.56 -14.48 14.63 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.251 1.02 . . . . 50.55 109.814 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.1 t -81.47 -44.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 103.701 -2.703 . . . . 50.51 103.701 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 50.9 mtmt -66.88 -33.54 75.81 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.769 -0.65 . . . . 50.51 110.203 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.04 73.88 Favored 'General case' 0 C--O 1.279 2.627 0 N-CA-C 108.324 -0.991 . . . . 50.51 108.324 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.1 mttt -47.16 -28.35 1.79 Allowed 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.368 -1.458 . . . . 50.51 113.826 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -80.23 -49.76 18.45 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 C-N-CA 119.496 -0.882 . . . . 50.51 109.861 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' ILE . 18.0 tm0? -38.63 -51.14 1.64 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 125.572 2.605 . . . . 50.55 112.061 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -54.69 -39.17 67.87 Favored 'General case' 0 C--O 1.253 1.24 0 N-CA-C 117.499 2.407 . . . . 50.62 117.499 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -109.59 -7.88 15.06 Favored 'General case' 0 C--O 1.279 2.653 0 C-N-CA 116.425 -2.11 . . . . 50.51 111.687 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' HG3' HG12 ' A' ' 36' ' ' ILE . 32.3 tp10 -108.6 -31.54 7.73 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 123.108 2.686 . . . . 50.62 107.77 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.99 7.4 85.52 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 109.488 -1.445 . . . . 50.51 109.488 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.487 HG12 ' HG3' ' A' ' 34' ' ' GLU . 30.4 mm -101.65 131.86 22.42 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 102.233 -3.247 . . . . 50.51 102.233 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.02 136.93 79.62 Favored 'Trans proline' 0 C--O 1.26 1.604 0 C-N-CA 123.192 2.595 . . . . 50.51 110.908 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' CG ' ' HB2' ' A' ' 31' ' ' GLN . 87.7 Cg_exo -57.15 -32.16 92.6 Favored 'Trans proline' 0 C--O 1.262 1.677 0 O-C-N 122.846 0.919 . . . . 50.51 113.44 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.09 2.82 3.22 Favored 'General case' 0 C--O 1.261 1.7 0 O-C-N 119.909 -1.744 . . . . 50.62 112.957 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -127.58 35.97 4.44 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.59 -1.319 . . . . 50.55 113.765 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.22 134.71 55.2 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 124.447 2.07 . . . . 50.55 111.514 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.579 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 54.8 ttm-85 -99.94 124.04 44.84 Favored 'General case' 0 C--O 1.298 3.613 0 CA-C-O 116.635 -1.65 . . . . 50.64 110.22 172.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.23 121.44 42.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.504 1.047 . . . . 50.51 110.749 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.13 123.39 60.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 125.174 1.546 . . . . 50.51 113.674 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.77 112.21 17.05 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 114.616 -1.175 . . . . 50.51 110.196 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.68 27.8 7.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 112.24 -2.254 . . . . 50.51 110.586 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.97 33.26 59.9 Favored Glycine 0 C--N 1.3 -1.453 0 C-N-CA 128.411 2.91 . . . . 50.51 117.476 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -119.03 148.88 42.53 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 104.741 -2.318 . . . . 50.51 104.741 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -88.04 135.75 33.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 119.797 3.258 . . . . 50.55 119.797 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.38 155.5 16.71 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 101.484 -3.525 . . . . 50.51 101.484 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -130.71 157.19 43.47 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 125.02 1.45 . . . . 50.62 108.242 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.01 -34.92 77.41 Favored 'General case' 0 C--O 1.264 1.833 0 C-N-CA 126.19 1.796 . . . . 50.62 109.38 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.39 9.21 4.58 Favored Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 124.426 1.013 . . . . 50.51 113.156 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -124.29 162.56 23.49 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 120.941 3.682 . . . . 50.64 120.941 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -80.43 173.76 12.28 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.028 0.931 . . . . 50.51 109.419 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 tp -88.85 -20.14 25.01 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.04 -1.096 . . . . 50.51 108.04 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 m -79.56 -36.69 37.87 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.362 -1.735 . . . . 50.51 112.665 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -53.13 -17.26 1.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 117.082 2.253 . . . . 50.62 117.082 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -93.38 12.0 26.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.823 -1.084 . . . . 50.51 110.836 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.37 33.08 3.59 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 116.533 2.049 . . . . 50.55 116.533 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -82.26 114.8 23.71 Favored 'Isoleucine or valine' 0 C--O 1.265 1.907 0 CA-C-O 115.268 -2.301 . . . . 50.51 112.346 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -110.33 -166.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.125 2.141 . . . . 50.55 111.126 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.434 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 78.7 tttt -74.16 134.65 42.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.177 1.465 . . . . 50.51 108.792 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.434 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 53.0 mt-10 67.55 44.23 1.75 Allowed 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.537 -2.12 . . . . 50.62 114.35 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -88.21 167.28 13.72 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 105.464 -2.05 . . . . 50.51 105.464 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -121.35 112.31 18.41 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 118.253 -0.879 . . . . 50.51 110.982 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.3 mt -99.7 141.68 32.18 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.729 -2.558 . . . . 50.51 109.56 175.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -95.1 134.81 37.4 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.347 2.905 . . . . 50.51 111.788 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -105.31 114.98 29.49 Favored 'General case' 0 C--O 1.283 2.861 0 CA-C-O 117.611 -1.185 . . . . 50.51 110.902 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.7 t -104.83 137.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.171 -1.788 . . . . 50.51 106.171 175.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.0 tp -79.86 128.68 33.74 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.252 0.549 . . . . 50.51 110.331 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 -103.28 107.41 18.22 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-O 113.428 -3.177 . . . . 50.64 110.041 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.92 143.1 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 125.791 1.932 . . . . 50.51 109.533 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -105.51 59.95 0.67 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.743 -1.571 . . . . 50.64 110.21 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.96 153.21 5.84 Favored Glycine 0 C--O 1.243 0.707 0 N-CA-C 107.926 -2.069 . . . . 50.51 107.926 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 CA-C-O 116.349 -2.362 . . . . 50.51 107.227 179.226 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 101.783 -3.414 . . . . 50.51 101.783 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -110.85 138.34 47.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 126.95 2.656 . . . . 50.55 105.433 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -133.07 155.69 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 115.928 -1.987 . . . . 50.51 113.867 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -93.63 144.41 25.41 Favored 'General case' 0 N--CA 1.512 2.663 1 O-C-N 130.442 4.839 . . . . 50.51 118.789 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.792 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.6 t -132.53 101.96 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.364 -3.208 . . . . 50.51 110.123 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.92 117.99 21.28 Favored 'General case' 0 N--CA 1.504 2.231 1 O-C-N 129.362 4.164 . . . . 50.51 117.225 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 11' ' ' LYS . 41.7 p -70.83 -172.72 0.69 Allowed 'General case' 0 C--N 1.351 0.673 0 N-CA-C 114.893 1.442 . . . . 50.51 114.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.78 11.78 38.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.854 -1.906 . . . . 50.51 105.854 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -122.45 -3.22 8.89 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 115.737 -2.385 . . . . 50.51 114.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 6.76 22.04 Favored Glycine 0 C--N 1.296 -1.665 0 O-C-N 120.103 -1.623 . . . . 50.51 113.617 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 45.0 mtmt -92.66 166.73 12.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 118.445 2.758 . . . . 50.51 118.445 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.0 p -125.15 158.69 33.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 126.658 2.474 . . . . 50.51 105.676 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.792 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 72.3 mt -131.27 111.18 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 127.415 2.947 . . . . 50.51 104.716 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -90.75 110.97 22.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.809 1.781 . . . . 50.51 115.809 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.3 mt -105.77 155.55 19.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 115.483 -2.198 . . . . 50.51 112.153 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.05 112.33 23.88 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 128.9 3.875 . . . . 50.62 112.23 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -117.25 169.45 7.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 O-C-N 127.743 3.152 . . . . 50.51 113.998 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -126.58 158.33 67.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 112.156 -2.293 . . . . 50.62 108.288 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 57' ' ' SER . 85.1 Cg_exo -54.93 -24.56 39.81 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.54 2.16 . . . . 50.51 111.969 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -87.09 -18.39 30.63 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 116.415 2.005 . . . . 50.51 116.415 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -70.86 135.73 48.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.898 1.814 . . . . 50.62 115.898 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.591 HG23 HG23 ' A' ' 55' ' ' THR . 72.3 p -78.85 168.42 19.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.947 1.832 . . . . 50.51 115.947 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 33.8 mm -62.69 -40.62 89.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 O-C-N 127.239 2.837 . . . . 50.51 109.34 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.94 -27.87 46.73 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 50.62 112.809 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.4 -27.85 20.15 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 114.84 1.422 . . . . 50.55 114.84 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.7 -41.63 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.024 1.453 . . . . 50.51 107.155 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -64.62 -28.0 69.32 Favored 'General case' 0 C--O 1.258 1.524 0 CA-C-N 115.845 -0.616 . . . . 50.51 111.524 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -29.6 59.73 Favored 'General case' 0 C--O 1.279 2.637 0 CA-C-N 118.088 0.404 . . . . 50.51 111.599 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.37 -31.34 69.67 Favored 'General case' 0 C--O 1.256 1.401 0 O-C-N 120.319 -1.488 . . . . 50.51 108.493 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.0 -34.67 71.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 107.091 -1.448 . . . . 50.51 107.091 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -56.36 -53.56 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 125.579 2.609 . . . . 50.55 117.578 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.28 -34.27 70.35 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 113.622 -1.626 . . . . 50.62 111.243 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.17 -28.57 21.13 Favored 'General case' 0 C--O 1.278 2.593 0 C-N-CA 116.434 -2.106 . . . . 50.51 109.737 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -117.22 -77.26 0.57 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 123.035 2.652 . . . . 50.62 109.059 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.09 23.51 0.48 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.572 -1.811 . . . . 50.51 108.572 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.498 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.7 mt -79.4 133.5 59.94 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.81 -1.156 . . . . 50.51 112.335 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.03 136.93 79.61 Favored 'Trans proline' 0 C--O 1.26 1.592 0 C-N-CA 123.152 2.568 . . . . 50.51 110.914 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -57.2 -32.1 92.53 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.857 0.925 . . . . 50.51 113.449 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -76.71 -9.23 58.53 Favored 'General case' 0 C--O 1.262 1.746 0 O-C-N 119.94 -1.725 . . . . 50.62 109.297 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -103.01 19.06 20.22 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.422 1.638 . . . . 50.55 115.422 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -127.93 102.04 6.59 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 116.638 2.088 . . . . 50.55 116.638 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -99.35 132.51 44.63 Favored 'General case' 0 C--O 1.296 3.531 0 CA-C-O 116.742 -1.599 . . . . 50.64 109.381 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 mp -103.94 154.75 19.29 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.287 -2.486 . . . . 50.51 104.287 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.07 142.1 35.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.51 111.087 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -142.66 91.3 2.3 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 114.534 -1.212 . . . . 50.51 113.345 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.9 45.6 26.18 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 104.461 -2.422 . . . . 50.51 104.461 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 -18.13 6.99 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 128.386 2.898 . . . . 50.51 113.034 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -76.59 135.75 39.22 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 118.102 0.951 . . . . 50.51 111.418 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.85 129.22 35.14 Favored 'General case' 0 C--O 1.259 1.558 0 O-C-N 123.957 0.785 . . . . 50.55 110.968 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.8 mt -78.65 145.65 34.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 101.906 -3.368 . . . . 50.51 101.906 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -97.99 135.88 39.05 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.939 1.399 . . . . 50.62 108.538 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.5 m-20 -53.66 -49.59 67.63 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 126.151 1.78 . . . . 50.62 111.919 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.93 19.46 5.21 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.4 1.0 . . . . 50.51 113.9 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -113.0 156.69 22.61 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 103.069 -2.937 . . . . 50.64 103.069 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.591 HG23 HG23 ' A' ' 22' ' ' THR . 81.0 p -95.67 168.51 10.63 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.606 0.965 . . . . 50.51 113.606 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.16 -32.19 70.03 Favored 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.15 0.907 . . . . 50.51 109.358 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 90.9 p -74.13 -29.08 61.64 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.271 -1.772 . . . . 50.51 112.149 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' H ' ' HG1' ' A' ' 55' ' ' THR . 97.7 m-20 -61.71 -29.33 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.431 1.11 . . . . 50.62 108.676 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -94.19 -5.21 47.54 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.809 -1.091 . . . . 50.51 112.291 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 53.93 51.33 14.94 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 121.552 1.978 . . . . 50.55 113.882 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -95.53 119.2 43.26 Favored 'Isoleucine or valine' 0 C--O 1.266 1.952 0 N-CA-C 102.218 -3.253 . . . . 50.51 102.218 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 -168.83 2.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.019 2.075 . . . . 50.55 111.213 -176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.65 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 84.2 tttt -79.07 143.76 35.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.185 1.469 . . . . 50.51 107.558 -176.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.65 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 69.66 37.56 1.87 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.559 -2.109 . . . . 50.62 113.62 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -92.42 155.48 17.84 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.809 -1.087 . . . . 50.51 111.994 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -110.27 126.49 54.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 118.199 -0.905 . . . . 50.51 112.717 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.11 155.52 21.8 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 114.679 -2.581 . . . . 50.51 104.356 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -98.0 149.88 21.97 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 127.177 2.798 . . . . 50.51 112.998 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -102.2 126.68 49.25 Favored 'General case' 0 C--O 1.283 2.849 0 N-CA-C 104.9 -2.259 . . . . 50.51 104.9 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.63 146.24 28.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 105.861 -1.903 . . . . 50.51 105.861 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -114.09 107.57 15.83 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 119.869 3.285 . . . . 50.51 119.869 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -92.07 111.1 22.52 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.324 -3.227 . . . . 50.64 104.249 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.52 167.66 14.41 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 125.576 1.798 . . . . 50.51 110.907 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.0 mtm105 -102.85 86.42 2.73 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.72 -1.582 . . . . 50.64 108.321 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.95 147.51 22.78 Favored Glycine 0 C--O 1.244 0.726 0 CA-C-N 114.678 -1.146 . . . . 50.51 114.436 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.457 0 N-CA-C 106.023 -2.831 . . . . 50.51 106.023 179.232 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.547 0.86 0 CA-C-O 118.822 -0.609 . . . . 50.51 111.147 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -96.39 128.69 43.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 126.959 2.662 . . . . 50.55 113.368 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.67 152.44 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 115.972 -1.966 . . . . 50.51 107.561 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.441 ' CD1' HG23 ' A' ' 14' ' ' THR . 97.3 m-85 -109.53 143.06 39.71 Favored 'General case' 0 N--CA 1.512 2.658 1 O-C-N 130.215 4.697 . . . . 50.51 115.202 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.12 98.18 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-O 113.425 -3.179 . . . . 50.51 113.771 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -72.86 114.92 11.54 Favored 'General case' 0 N--CA 1.503 2.224 1 O-C-N 129.297 4.123 . . . . 50.51 109.929 -178.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' HD21 ' A' ' 69' ' ' LEU . 68.7 p -72.04 -169.8 0.52 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-O 117.829 -1.081 . . . . 50.51 113.236 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.34 -47.1 7.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.756 -1.201 . . . . 50.51 107.756 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -70.59 2.17 4.37 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 115.732 -2.387 . . . . 50.51 115.586 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.81 -40.67 2.38 Favored Glycine 0 C--N 1.298 -1.541 0 N-CA-C 120.892 3.117 . . . . 50.51 120.892 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' A' ' 7' ' ' THR . 27.1 tptp -42.09 131.33 3.48 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 116.902 -1.523 . . . . 50.51 108.125 174.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.0 p -101.59 138.15 38.97 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 126.623 2.452 . . . . 50.51 112.184 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 pt -120.16 146.79 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 127.507 3.004 . . . . 50.51 109.399 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.441 HG23 ' CD1' ' A' ' 4' ' ' PHE . 80.8 p -120.6 128.03 52.66 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.249 -1.78 . . . . 50.51 109.583 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 29' ' ' LYS . 50.0 mt -103.8 148.48 26.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 115.542 -2.171 . . . . 50.51 110.37 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -106.41 103.2 12.61 Favored 'General case' 0 N--CA 1.501 2.089 1 O-C-N 129.28 4.112 . . . . 50.62 104.954 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 1' ' ' MET . 33.7 m -101.65 164.54 2.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.69 3.119 . . . . 50.51 112.915 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 6.4 pt-20 -137.33 151.33 71.23 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.164 -2.289 . . . . 50.62 112.798 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.5 Cg_exo -54.97 -24.5 39.77 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 122.587 2.191 . . . . 50.51 111.949 177.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -98.38 21.85 10.51 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 118.208 -0.901 . . . . 50.51 110.829 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -94.57 125.42 39.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 117.354 -1.738 . . . . 50.62 111.189 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.3 p -82.82 135.01 35.09 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.865 -0.607 . . . . 50.51 110.908 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.474 HG21 ' HA ' ' A' ' 52' ' ' ASP . 55.6 mt -37.56 -30.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.137 2.773 . . . . 50.51 117.552 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.21 -27.85 69.34 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.422 -0.798 . . . . 50.62 112.203 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.63 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 57.4 m-80 -86.08 -13.14 48.18 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.309 1.044 . . . . 50.55 112.4 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -78.18 -51.99 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.041 1.463 . . . . 50.51 110.256 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.04 -23.67 55.31 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.174 -0.676 . . . . 50.51 109.174 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.06 -34.79 17.84 Favored 'General case' 0 C--O 1.278 2.598 0 N-CA-C 107.478 -1.305 . . . . 50.51 107.478 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 57.9 mttm -52.26 -38.62 58.72 Favored 'General case' 0 C--O 1.257 1.459 0 N-CA-C 106.291 -1.744 . . . . 50.51 106.291 175.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.9 -33.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 107.56 -1.274 . . . . 50.51 107.56 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 125.583 2.611 . . . . 50.55 113.525 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -58.36 -25.57 62.15 Favored 'General case' 0 C--O 1.254 1.322 0 N-CA-C 119.087 2.995 . . . . 50.62 119.087 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -108.81 -27.25 9.86 Favored 'General case' 0 C--O 1.28 2.659 0 C-N-CA 116.385 -2.126 . . . . 50.51 113.917 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -108.75 -29.15 8.83 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.056 2.662 . . . . 50.62 113.529 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.94 42.88 4.59 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 111.247 -0.741 . . . . 50.51 111.247 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 94.4 mt -117.95 125.2 28.15 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.597 -1.261 . . . . 50.51 107.597 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 77.9 Cg_exo -57.05 136.97 79.82 Favored 'Trans proline' 0 C--O 1.259 1.559 0 C-N-CA 123.106 2.537 . . . . 50.51 110.95 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.17 -32.07 92.37 Favored 'Trans proline' 0 C--O 1.26 1.619 0 O-C-N 122.828 0.909 . . . . 50.51 113.51 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.26 -20.35 64.16 Favored 'General case' 0 C--O 1.262 1.756 0 O-C-N 119.982 -1.699 . . . . 50.62 109.542 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -94.89 7.48 45.85 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.526 -1.358 . . . . 50.55 113.45 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -115.87 119.32 35.58 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 124.42 2.057 . . . . 50.55 110.925 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.466 HH11 ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp85 -106.33 138.18 42.97 Favored 'General case' 0 C--O 1.295 3.486 0 CA-C-O 116.651 -1.642 . . . . 50.64 107.716 172.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.9 mt -115.2 105.97 13.53 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.987 1.847 . . . . 50.51 115.987 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 61.5 mt -110.55 130.37 63.98 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 O-C-N 125.254 1.596 . . . . 50.51 111.633 -177.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -145.83 126.01 13.82 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 115.293 1.59 . . . . 50.51 115.293 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.11 28.24 17.02 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.261 -2.245 . . . . 50.51 107.43 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.7 30.41 77.25 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 128.37 2.89 . . . . 50.51 111.595 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.48 135.6 53.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.455 -2.054 . . . . 50.51 105.455 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.35 113.9 9.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.946 0.779 . . . . 50.55 111.186 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 59' ' ' TYR . 37.5 mt -75.49 113.84 13.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 117.722 -1.132 . . . . 50.51 112.296 -175.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -89.53 126.08 35.45 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.822 1.326 . . . . 50.62 109.598 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.474 ' HA ' HG21 ' A' ' 23' ' ' ILE . 27.7 p-10 -45.36 -38.93 6.28 Favored 'General case' 0 C--O 1.263 1.805 0 C-N-CA 126.14 1.776 . . . . 50.62 111.549 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.52 37.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 108.655 -1.778 . . . . 50.51 108.655 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -94.64 165.67 12.39 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 119.949 -1.912 . . . . 50.64 115.838 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -99.87 166.08 11.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.152 -1.055 . . . . 50.51 108.152 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -86.43 -39.72 16.07 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 104.193 -2.521 . . . . 50.51 104.193 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -52.64 -53.04 52.47 Favored 'General case' 0 C--O 1.268 2.058 0 C-N-CA 117.356 -1.738 . . . . 50.51 113.979 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.42 -28.28 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 120.635 3.568 . . . . 50.62 120.635 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CE2' HD23 ' A' ' 50' ' ' LEU . 42.2 m-85 -82.1 13.1 3.61 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.764 -1.112 . . . . 50.51 109.511 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.57 32.26 20.38 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 121.442 1.928 . . . . 50.55 108.95 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.71 133.1 30.14 Favored 'Isoleucine or valine' 0 C--O 1.267 1.989 0 CA-C-O 115.146 -2.359 . . . . 50.51 113.362 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.426 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 57.7 mt-30 -134.81 -159.34 0.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 125.856 1.972 . . . . 50.55 110.636 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.612 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 63.2 tttm -69.15 149.88 48.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.257 1.503 . . . . 50.51 109.628 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.612 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 47.67 65.48 1.27 Allowed 'General case' 0 C--O 1.257 1.45 0 CA-C-N 112.42 -2.173 . . . . 50.62 113.981 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -122.97 125.57 45.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.921 -1.141 . . . . 50.51 107.921 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -81.67 133.68 35.39 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 117.186 2.291 . . . . 50.51 117.186 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.32 135.88 48.08 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 114.688 -2.577 . . . . 50.51 114.45 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -71.55 133.0 45.48 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 127.365 2.915 . . . . 50.51 115.619 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.483 HD21 ' HA ' ' A' ' 7' ' ' THR . 30.6 tp -104.95 96.99 6.92 Favored 'General case' 0 C--O 1.282 2.809 0 N-CA-C 115.792 1.775 . . . . 50.51 115.792 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.53 123.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.857 -1.164 . . . . 50.51 107.857 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt -73.12 159.23 33.87 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.946 1.091 . . . . 50.51 113.946 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.466 ' HD2' HH11 ' A' ' 42' ' ' ARG . 77.8 ttt-85 -136.96 77.19 1.63 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 113.404 -3.188 . . . . 50.64 111.964 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.42 155.34 15.09 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 116.795 2.146 . . . . 50.51 116.795 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -110.39 85.53 2.13 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.714 -1.585 . . . . 50.64 107.073 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.26 160.9 13.61 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 107.691 -2.164 . . . . 50.51 107.691 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 CA-C-O 116.308 -2.385 . . . . 50.51 110.446 179.174 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.51 107.478 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.55 105.792 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.51 105.226 173.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.51 111.097 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.51 110.321 175.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.51 108.6 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.437 ' HG1' ' HB2' ' A' ' 11' ' ' LYS . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.51 113.379 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.51 115.964 -177.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.51 111.276 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.51 114.048 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' HB2' ' HG1' ' A' ' 7' ' ' THR . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.51 102.065 174.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.51 107.975 176.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.51 108.441 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.51 110.2 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.51 118.562 -179.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.62 108.62 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.51 114.132 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.62 106.711 174.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.51 111.935 177.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.51 116.813 -177.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.62 109.138 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG21 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.51 107.045 175.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.51 110.561 175.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.62 113.229 177.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.55 110.044 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.51 107.759 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.51 106.412 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.51 109.249 176.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.657 ' HE3' ' HZ2' ' A' ' 33' ' ' LYS . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.51 111.346 176.077 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.416 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.51 110.973 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.55 112.509 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.62 116.389 179.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.657 ' HZ2' ' HE3' ' A' ' 29' ' ' LYS . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.51 111.864 -175.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.62 117.592 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.51 114.888 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.484 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.51 109.747 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.51 110.864 178.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.51 113.394 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.62 114.605 -177.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.55 107.838 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.55 119.467 -177.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.64 109.52 172.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.51 115.444 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.51 113.347 -177.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.51 111.83 177.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.51 113.518 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.51 115.209 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.51 114.25 177.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.55 117.72 174.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.51 119.412 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.62 106.675 -177.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.62 118.064 -175.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.51 112.981 -177.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.64 112.921 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.51 106.383 177.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.51 114.586 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.51 111.793 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.62 114.68 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.51 113.892 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.55 110.922 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.51 112.515 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' O ' ' OG ' ' A' ' 65' ' ' SER . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.55 116.774 -176.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.671 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.51 113.522 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.671 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.62 110.901 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.51 110.249 174.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.51 105.297 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.51 101.589 175.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.51 106.251 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.51 111.961 176.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.51 104.421 175.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.51 115.767 178.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.64 106.516 177.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.51 105.632 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.64 107.378 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.51 119.036 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.51 104.312 179.258 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.51 107.478 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.55 105.792 178.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.51 105.226 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.51 111.097 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.51 110.321 175.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.51 108.6 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.437 ' HG1' ' HB2' ' A' ' 11' ' ' LYS . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.51 113.379 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.51 115.964 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.51 111.276 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.51 114.048 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' HB2' ' HG1' ' A' ' 7' ' ' THR . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.51 102.065 174.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.51 107.975 176.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.51 108.441 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.51 110.2 178.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.51 118.562 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.62 108.62 174.005 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.51 114.132 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.62 106.711 174.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.51 111.935 177.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.51 116.813 -177.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.62 109.138 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG21 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.51 107.045 175.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.51 110.561 175.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.62 113.229 177.002 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.55 110.044 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.51 107.759 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.51 106.412 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.51 109.249 176.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.657 ' HE3' ' HZ2' ' A' ' 33' ' ' LYS . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.51 111.346 176.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.416 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.51 110.973 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.55 112.509 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.62 116.389 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.657 ' HZ2' ' HE3' ' A' ' 29' ' ' LYS . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.51 111.864 -175.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.62 117.592 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.51 114.888 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.484 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.51 109.747 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.51 110.864 178.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.51 113.394 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.62 114.605 -177.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.55 107.838 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.55 119.467 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.64 109.52 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.51 115.444 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.51 113.347 -177.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.51 111.83 177.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.51 113.518 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.51 115.209 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.51 114.25 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.55 117.72 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.51 119.412 -175.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.62 106.675 -177.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.62 118.064 -175.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.51 112.981 -177.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.64 112.921 176.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.51 106.383 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.51 114.586 177.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.51 111.793 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.62 114.68 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.51 113.892 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.55 110.922 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.51 112.515 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' O ' ' OG ' ' A' ' 65' ' ' SER . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.55 116.774 -176.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.671 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.51 113.522 -176.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.671 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.62 110.901 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.51 110.249 174.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.51 105.297 176.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.51 101.589 175.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.51 106.251 177.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.51 111.961 176.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.51 104.421 175.142 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.51 115.767 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.64 106.516 177.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.51 105.632 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.64 107.378 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.51 119.036 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.51 104.312 179.258 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.0 mtp . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 115.228 1.566 . . . . 50.51 115.228 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 12.5 mm-40 -88.72 118.09 28.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 126.99 2.681 . . . . 50.55 117.707 178.275 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.523 HD12 HD23 ' A' ' 67' ' ' LEU . 14.7 tt -122.01 161.57 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 115.935 -1.983 . . . . 50.51 109.47 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' N ' HG12 ' A' ' 3' ' ' ILE . 79.1 m-85 -130.3 128.98 42.63 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 129.667 4.354 . . . . 50.51 113.461 179.548 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -108.91 109.82 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 113.419 -3.182 . . . . 50.51 112.584 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -87.2 134.28 33.55 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.371 4.169 . . . . 50.51 106.23 -178.055 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.1 p -99.77 -168.47 1.61 Allowed 'General case' 0 C--N 1.351 0.651 0 N-CA-C 114.385 1.254 . . . . 50.51 114.385 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 mt -90.15 24.27 2.56 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.125 0.891 . . . . 50.51 111.979 -178.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -139.79 10.95 2.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 115.747 -2.381 . . . . 50.51 110.231 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.83 12.66 81.04 Favored Glycine 0 C--N 1.297 -1.604 0 O-C-N 119.303 -2.123 . . . . 50.51 114.738 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.64 139.47 30.66 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.533 -2.025 . . . . 50.51 105.533 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -120.9 119.62 33.14 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 126.586 2.429 . . . . 50.51 112.064 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.411 HD13 HD11 ' A' ' 15' ' ' LEU . 17.1 pt -94.75 144.3 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.346 2.904 . . . . 50.51 116.312 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -100.32 128.79 46.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.313 -1.755 . . . . 50.51 114.569 178.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD11 HD13 ' A' ' 13' ' ' ILE . 1.5 mp -114.24 145.23 42.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 115.463 -2.208 . . . . 50.51 116.629 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.15 89.58 3.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 129.065 3.978 . . . . 50.62 116.324 173.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.442 HG11 HG23 ' A' ' 26' ' ' VAL . 35.0 m -120.79 148.17 24.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 N-CA-C 120.095 3.368 . . . . 50.51 120.095 -177.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 96.5 mt-10 -98.65 151.47 37.46 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 112.198 -2.274 . . . . 50.62 111.017 174.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.6 Cg_exo -54.89 -24.55 39.49 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.562 2.175 . . . . 50.51 111.962 177.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -73.23 -13.09 61.08 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.487 -2.042 . . . . 50.51 105.487 -177.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.511 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 75.6 m-20 -68.64 138.49 55.05 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 117.323 -1.751 . . . . 50.62 115.301 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -106.3 174.16 6.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.853 -0.612 . . . . 50.51 109.689 175.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -51.18 -46.66 32.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 O-C-N 127.138 2.774 . . . . 50.51 111.886 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -51.8 -38.13 54.43 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.802 -0.814 . . . . 50.62 108.802 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -79.53 -41.47 27.25 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 120.185 3.402 . . . . 50.55 120.185 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.442 HG23 HG11 ' A' ' 17' ' ' VAL . 40.6 t -72.71 -44.32 59.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.085 1.491 . . . . 50.51 114.531 178.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.87 -29.94 68.35 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 107.787 -1.19 . . . . 50.51 107.787 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -49.2 77.73 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 108.517 -0.919 . . . . 50.51 108.517 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -44.95 -53.77 7.28 Favored 'General case' 0 C--O 1.255 1.361 0 O-C-N 120.396 -1.44 . . . . 50.51 109.322 176.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -57.96 -25.23 25.4 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 116.219 1.933 . . . . 50.51 116.219 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.9 tt0 -75.47 -19.66 59.29 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 125.587 2.613 . . . . 50.55 111.862 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.51 -45.28 8.2 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 113.589 -1.641 . . . . 50.62 113.724 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.93 -51.04 10.19 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.476 -2.09 . . . . 50.51 107.665 -175.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -91.97 -56.33 3.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.131 2.696 . . . . 50.62 110.814 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 120.17 4.21 11.33 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 111.616 -0.594 . . . . 50.51 111.616 176.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mm -69.44 123.05 87.61 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 118.852 -1.139 . . . . 50.51 109.38 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -57.02 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.539 0 C-N-CA 123.203 2.602 . . . . 50.51 110.846 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -57.21 -32.09 92.53 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.914 0.955 . . . . 50.51 113.422 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -73.67 2.26 8.53 Favored 'General case' 0 C--O 1.261 1.675 0 N-CA-C 118.375 2.731 . . . . 50.62 118.375 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -115.69 -9.23 11.98 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.536 -1.352 . . . . 50.55 108.153 178.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -81.25 143.28 32.4 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 124.384 2.04 . . . . 50.55 115.24 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -131.95 114.78 15.03 Favored 'General case' 0 C--O 1.296 3.506 0 N-CA-C 105.833 -1.914 . . . . 50.64 105.833 172.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.32 123.89 49.0 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.539 1.063 . . . . 50.51 111.324 -177.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.08 132.63 61.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 O-C-N 125.174 1.546 . . . . 50.51 112.57 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.549 ' CE2' HG12 ' A' ' 61' ' ' ILE . 45.2 t80 -142.33 112.61 7.1 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 114.575 -1.193 . . . . 50.51 108.987 177.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 45' ' ' PHE . . . 75.64 18.64 2.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 112.227 -2.26 . . . . 50.51 108.501 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.3 -2.01 85.84 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.431 2.92 . . . . 50.51 110.513 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -85.66 121.55 28.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 118.045 0.923 . . . . 50.51 111.156 177.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -61.93 137.71 58.28 Favored 'General case' 0 C--O 1.26 1.61 0 N-CA-C 108.169 -1.049 . . . . 50.55 108.169 174.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.5 mt -75.4 149.19 38.65 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.543 -1.28 . . . . 50.51 107.543 -175.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.15 150.89 28.83 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.996 1.435 . . . . 50.62 112.497 -177.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.99 -41.26 78.11 Favored 'General case' 0 C--O 1.264 1.826 0 N-CA-C 118.347 2.721 . . . . 50.62 118.347 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.41 5.0 67.34 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 120.212 2.845 . . . . 50.51 120.212 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.47 154.37 19.69 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 120.089 3.366 . . . . 50.64 120.089 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 41.5 p -93.09 151.9 19.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.39 -3.189 . . . . 50.51 102.39 177.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.4 mt -56.28 -36.58 68.77 Favored 'General case' 0 C--O 1.202 -1.425 0 O-C-N 124.19 0.931 . . . . 50.51 108.894 177.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -62.04 -31.07 71.44 Favored 'General case' 0 C--O 1.268 2.065 0 C-N-CA 117.331 -1.747 . . . . 50.51 109.04 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 55' ' ' THR . 88.7 m-20 -60.42 -10.17 4.54 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.405 1.098 . . . . 50.62 111.684 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -114.16 -14.9 12.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.094 -1.817 . . . . 50.51 106.094 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 48.44 56.77 7.03 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 121.522 1.965 . . . . 50.55 110.701 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.549 HG12 ' CE2' ' A' ' 45' ' ' PHE . 74.1 mt -78.33 105.95 8.25 Favored 'Isoleucine or valine' 0 C--O 1.267 1.997 0 N-CA-C 102.936 -2.987 . . . . 50.51 102.936 175.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.77 176.21 3.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 126.1 2.125 . . . . 50.55 107.713 -176.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -70.73 147.1 49.39 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 123.205 1.478 . . . . 50.51 110.572 -176.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 54.02 44.84 28.72 Favored 'General case' 0 C--O 1.258 1.526 0 CA-C-N 112.521 -2.127 . . . . 50.62 112.894 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -106.87 142.26 36.79 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.157 -1.794 . . . . 50.51 106.157 174.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.0 m -101.25 130.24 47.35 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 120.454 3.501 . . . . 50.51 120.454 175.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.523 HD23 HD12 ' A' ' 3' ' ' ILE . 2.7 mp -95.38 149.7 21.08 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.68 -2.581 . . . . 50.51 114.761 175.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -102.31 132.93 47.97 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 126.969 2.668 . . . . 50.51 114.743 177.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -104.48 122.35 45.35 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.685 -1.15 . . . . 50.51 111.321 176.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -113.09 135.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.571 -1.641 . . . . 50.51 106.571 175.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.8 tp -93.83 100.11 12.36 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.497 1.666 . . . . 50.51 115.497 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -74.84 138.56 42.61 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 113.316 -3.231 . . . . 50.64 108.215 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 mt -111.86 139.2 47.54 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.804 1.94 . . . . 50.51 113.237 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -96.15 68.19 2.65 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 113.69 -1.596 . . . . 50.64 106.907 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.65 148.17 4.85 Favored Glycine 0 C--O 1.244 0.76 0 N-CA-C 107.145 -2.382 . . . . 50.51 107.145 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 116.361 -2.355 . . . . 50.51 110.4 179.246 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.883 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 61.2 mtm . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 105.248 -2.13 . . . . 50.51 105.248 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -70.42 144.62 51.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 127.003 2.689 . . . . 50.55 108.922 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.456 HD13 HD13 ' A' ' 67' ' ' LEU . 21.7 pt -132.24 164.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 N-CA-C 104.099 -2.556 . . . . 50.51 104.099 173.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.25 156.01 22.11 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.473 4.858 . . . . 50.51 109.296 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.0 t -138.52 122.18 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.37 -3.205 . . . . 50.51 109.203 175.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 79.1 tttt -94.94 128.6 41.86 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.403 4.19 . . . . 50.51 114.904 -178.047 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.08 179.23 4.68 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-O 117.809 -1.091 . . . . 50.51 108.425 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.7 -12.19 58.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.93 2.937 . . . . 50.51 118.93 -177.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -90.48 -24.98 20.53 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 115.705 -2.398 . . . . 50.51 105.345 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.23 23.78 3.73 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 107.538 -2.225 . . . . 50.51 107.538 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -86.06 144.22 27.67 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.568 -2.012 . . . . 50.51 105.568 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.2 m -128.44 117.77 21.95 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 126.629 2.456 . . . . 50.51 110.992 176.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.7 pt -98.57 164.85 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 127.469 2.981 . . . . 50.51 113.557 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.6 p -121.59 144.1 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.256 -1.778 . . . . 50.51 108.483 178.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.425 HD23 ' HG3' ' A' ' 29' ' ' LYS . 78.4 mt -132.38 142.62 49.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 103.047 -2.946 . . . . 50.51 103.047 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.93 109.1 17.12 Favored 'General case' 0 N--CA 1.499 2.003 1 O-C-N 129.275 4.109 . . . . 50.62 102.972 173.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.74 156.22 31.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.74 3.15 . . . . 50.51 114.401 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -88.37 139.81 30.18 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.175 -2.284 . . . . 50.62 107.746 174.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.502 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 85.5 Cg_exo -54.83 -24.57 39.11 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 122.552 2.168 . . . . 50.51 111.976 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -61.56 -26.06 67.71 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.241 -1.392 . . . . 50.51 107.241 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -59.76 136.52 58.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.353 -1.739 . . . . 50.62 114.831 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.6 p -79.11 171.59 14.99 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 117.834 -3.041 . . . . 50.51 110.062 175.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.19 -35.25 62.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 O-C-N 127.196 2.81 . . . . 50.51 109.281 175.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.3 -41.77 80.46 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.457 -0.777 . . . . 50.62 112.473 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -76.92 -50.23 13.77 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 115.099 1.518 . . . . 50.55 115.099 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 22' ' ' THR . 54.9 t -51.68 -39.31 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.958 1.411 . . . . 50.51 109.701 178.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -61.71 -36.1 79.97 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 115.833 -0.621 . . . . 50.51 110.368 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.35 86.29 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 109.691 -0.485 . . . . 50.51 109.691 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HG3' HD23 ' A' ' 15' ' ' LEU . 50.9 tptt -57.97 -41.29 82.6 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.191 -1.781 . . . . 50.51 106.191 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.81 -49.17 81.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.54 -0.864 . . . . 50.51 111.674 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.58 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 22.0 tm0? -53.26 -56.83 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 125.554 2.597 . . . . 50.55 117.944 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -46.32 -54.23 9.34 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 118.38 2.733 . . . . 50.62 118.38 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -81.16 -41.8 21.84 Favored 'General case' 0 C--O 1.279 2.638 0 C-N-CA 116.464 -2.095 . . . . 50.51 112.313 -175.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -86.75 -55.43 3.86 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.075 2.67 . . . . 50.62 110.958 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.88 -23.1 5.05 Favored Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 112.031 -0.428 . . . . 50.51 112.031 176.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 mm -53.68 113.86 5.48 Favored Pre-proline 0 C--O 1.245 0.854 0 C-N-CA 118.815 -1.154 . . . . 50.51 109.665 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.553 0 C-N-CA 123.181 2.588 . . . . 50.51 110.925 178.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 88.4 Cg_exo -57.32 -32.03 92.62 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.9 0.947 . . . . 50.51 113.407 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -57.96 -18.12 21.49 Favored 'General case' 0 C--O 1.263 1.8 0 O-C-N 120.008 -1.683 . . . . 50.62 111.655 -177.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -113.53 11.34 18.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 120.631 3.567 . . . . 50.55 120.631 178.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -95.44 129.17 42.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 124.388 2.042 . . . . 50.55 111.987 -177.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 36.6 ttm180 -119.98 110.49 16.76 Favored 'General case' 0 C--O 1.295 3.477 0 N-CA-C 105.776 -1.935 . . . . 50.64 105.776 172.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' HB2' HD12 ' A' ' 50' ' ' LEU . 94.4 mt -101.62 129.7 47.8 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.441 1.019 . . . . 50.51 108.444 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.8 140.51 29.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.054 1.471 . . . . 50.51 111.994 -177.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -138.73 116.81 11.74 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.084 -2.191 . . . . 50.51 105.084 177.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.48 17.8 10.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.193 -2.276 . . . . 50.51 115.981 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.65 8.31 67.87 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 128.443 2.925 . . . . 50.51 109.279 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -100.36 112.81 25.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 118.071 0.936 . . . . 50.51 109.925 177.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -55.43 139.41 43.48 Favored 'General case' 0 C--O 1.259 1.581 0 N-CA-C 108.513 -0.921 . . . . 50.55 108.513 174.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 43' ' ' LEU . 80.9 mt -85.05 141.47 30.25 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.857 1.429 . . . . 50.51 114.857 -175.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -84.65 126.8 33.68 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.923 1.389 . . . . 50.62 111.892 -177.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -50.9 -42.27 59.11 Favored 'General case' 0 C--O 1.264 1.818 0 C-N-CA 126.178 1.791 . . . . 50.62 109.743 -175.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.49 25.1 9.81 Favored Glycine 0 C--O 1.254 1.366 0 C-N-CA 124.442 1.02 . . . . 50.51 114.211 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -116.33 164.69 14.15 Favored 'General case' 0 C--O 1.249 1.048 0 O-C-N 119.915 -1.932 . . . . 50.64 113.457 176.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 41.6 p -101.81 -178.74 3.81 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.111 0.965 . . . . 50.51 110.223 177.102 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 59.3 mt -79.94 -20.5 45.49 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.366 -0.975 . . . . 50.51 108.366 177.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.7 p -88.92 12.95 13.9 Favored 'General case' 0 C--O 1.268 2.077 0 C-N-CA 117.307 -1.757 . . . . 50.51 112.115 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -94.66 -36.24 11.85 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.449 1.119 . . . . 50.62 113.343 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.83 23.88 13.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 120.87 3.656 . . . . 50.51 120.87 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 56.08 46.64 21.26 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 121.515 1.961 . . . . 50.55 111.377 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 61' ' ' ILE . 73.4 mt -101.01 85.54 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.009 0 CA-C-O 115.201 -2.333 . . . . 50.51 106.033 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 65' ' ' SER . 97.8 mm-40 -92.43 -177.07 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.099 2.124 . . . . 50.55 114.683 -176.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.883 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 60.3 pttt -57.76 143.55 41.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.18 1.467 . . . . 50.51 112.192 -176.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 65.78 31.55 9.47 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.502 -2.135 . . . . 50.62 109.887 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 95.7 p -80.23 164.34 23.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.813 -1.18 . . . . 50.51 107.813 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -123.58 131.9 53.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.268 -0.872 . . . . 50.51 108.791 175.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.456 HD13 HD13 ' A' ' 3' ' ' ILE . 7.1 mp -105.38 137.71 42.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.649 -2.595 . . . . 50.51 108.854 175.111 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -98.54 108.48 21.19 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 127.427 2.954 . . . . 50.51 107.195 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 33.2 tp -72.97 147.01 45.62 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.316 1.228 . . . . 50.51 114.316 176.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 63.4 t -138.42 142.85 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 102.787 -3.042 . . . . 50.51 102.787 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 mt -98.29 100.59 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.608 1.336 . . . . 50.51 114.608 178.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -69.95 104.1 2.43 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 113.338 -3.22 . . . . 50.64 112.11 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -83.56 165.07 19.38 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.767 1.917 . . . . 50.51 108.472 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -131.82 45.39 2.79 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.76 -1.564 . . . . 50.64 109.369 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.35 151.14 6.15 Favored Glycine 0 C--O 1.242 0.633 0 N-CA-C 108.027 -2.029 . . . . 50.51 108.027 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.463 0 N-CA-C 106.51 -2.636 . . . . 50.51 106.51 179.226 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 107.734 -1.21 . . . . 50.51 107.734 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -111.06 133.8 53.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 126.915 2.634 . . . . 50.55 105.701 178.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.73 162.13 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 115.921 -1.99 . . . . 50.51 108.41 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -113.0 123.55 50.57 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.518 4.886 . . . . 50.51 110.598 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.28 112.02 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 113.427 -3.178 . . . . 50.51 118.975 175.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.64 133.97 34.81 Favored 'General case' 0 N--CA 1.504 2.252 1 O-C-N 129.363 4.164 . . . . 50.51 105.515 -178.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -115.08 171.63 7.55 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 117.781 -1.104 . . . . 50.51 109.466 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -65.05 -31.81 73.22 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.159 0.912 . . . . 50.51 109.949 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -74.84 -1.95 24.56 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 115.72 -2.392 . . . . 50.51 114.656 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.28 2.52 87.7 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.917 -1.673 . . . . 50.51 108.917 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.01 143.8 41.24 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.507 -1.584 . . . . 50.51 107.443 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -113.93 112.02 22.63 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 126.693 2.495 . . . . 50.51 110.434 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -97.91 143.14 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.561 3.038 . . . . 50.51 113.765 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -108.18 144.73 35.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.267 -1.773 . . . . 50.51 111.923 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -140.7 129.27 22.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.466 -2.207 . . . . 50.51 109.002 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.83 144.12 41.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 128.947 3.904 . . . . 50.62 108.482 174.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -149.39 174.08 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 127.742 3.152 . . . . 50.51 112.14 -177.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 57.3 mm-40 -139.21 150.08 63.23 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.254 -2.248 . . . . 50.62 111.055 174.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -54.88 -24.6 39.64 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.634 2.223 . . . . 50.51 111.957 177.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.4 p -66.87 -38.74 86.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 105.985 -1.857 . . . . 50.51 105.985 -177.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 55' ' ' THR . 84.9 m-20 -44.92 155.21 0.11 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.981 2.215 . . . . 50.62 116.981 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 25' ' ' ASN . 33.1 p -119.01 138.18 53.01 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.252 -3.611 . . . . 50.51 101.252 175.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.664 HD12 HD21 ' A' ' 50' ' ' LEU . 25.5 mm -32.0 -42.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.123 2.764 . . . . 50.51 114.867 175.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -60.83 -34.15 74.11 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 50.62 111.08 176.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' THR . 91.3 m-20 -74.39 -28.93 61.32 Favored 'General case' 0 C--O 1.249 1.053 0 C-N-CA 124.321 1.048 . . . . 50.55 110.31 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -72.51 -51.88 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 125.039 1.462 . . . . 50.51 108.5 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.3 -36.66 84.77 Favored 'General case' 0 C--O 1.257 1.447 0 CA-C-N 115.717 -0.674 . . . . 50.51 109.342 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.61 79.44 Favored 'General case' 0 C--O 1.278 2.584 0 N-CA-C 121.133 3.753 . . . . 50.51 121.133 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -59.49 -41.63 90.3 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 120.404 -1.435 . . . . 50.51 107.679 176.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 60.4 mt -64.22 -20.7 27.41 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 113.375 0.88 . . . . 50.51 113.375 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.461 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 33.4 tt0 -50.19 -41.41 49.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.546 2.593 . . . . 50.55 107.228 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 33' ' ' LYS . 29.3 t70 -81.78 -46.05 14.75 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 116.683 2.105 . . . . 50.62 116.683 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 32' ' ' ASP . 48.5 mmtm -51.27 -64.15 0.9 Allowed 'General case' 0 C--O 1.279 2.631 0 C-N-CA 116.501 -2.079 . . . . 50.51 108.394 -175.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -93.09 -41.33 10.02 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.048 2.658 . . . . 50.62 117.926 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 119.34 17.25 4.91 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 111.083 -0.807 . . . . 50.51 111.083 176.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 24.7 mm -94.9 117.79 66.81 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 118.73 -1.188 . . . . 50.51 110.546 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.0 136.98 79.92 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.154 2.569 . . . . 50.51 110.909 178.341 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -57.26 -32.16 92.86 Favored 'Trans proline' 0 C--O 1.261 1.665 0 O-C-N 122.89 0.942 . . . . 50.51 113.371 -179.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -67.33 -14.44 62.92 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 120.002 -1.686 . . . . 50.62 111.758 -177.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.451 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 58.9 mt-30 -98.64 11.41 38.55 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.54 -1.35 . . . . 50.55 113.001 178.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -113.47 119.1 36.42 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 117.22 2.304 . . . . 50.55 117.22 -177.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.2 mtm180 -107.41 137.49 45.35 Favored 'General case' 0 C--O 1.296 3.543 0 CA-C-O 116.669 -1.634 . . . . 50.64 111.851 172.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.2 mt -120.94 115.23 22.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.522 1.056 . . . . 50.51 111.809 -177.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.44 114.95 35.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 O-C-N 125.218 1.574 . . . . 50.51 113.496 -177.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' A' ' 50' ' ' LEU . 39.9 t80 -140.76 117.05 10.67 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 114.555 -1.202 . . . . 50.51 109.983 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.36 23.97 13.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.16 -2.291 . . . . 50.51 113.03 177.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.59 0.27 89.87 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 128.379 2.895 . . . . 50.51 110.603 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -103.99 108.28 19.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 116.09 1.885 . . . . 50.51 116.09 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -45.75 129.17 9.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.222 -1.029 . . . . 50.55 108.222 174.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.664 HD21 HD12 ' A' ' 23' ' ' ILE . 5.8 mp -69.9 144.23 52.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 117.742 -1.123 . . . . 50.51 109.544 -175.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.435 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 42.6 mt-10 -94.47 145.44 24.79 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.886 1.366 . . . . 50.62 108.617 -177.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.6 -36.39 83.65 Favored 'General case' 0 C--O 1.263 1.805 0 N-CA-C 117.982 2.586 . . . . 50.62 117.982 -175.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.21 -26.05 49.52 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.411 1.005 . . . . 50.51 112.821 -177.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 22' ' ' THR . 25.6 mmm180 -59.71 173.76 0.53 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 119.957 -1.908 . . . . 50.64 111.275 176.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 21' ' ' ASP . 41.5 p -117.7 172.47 7.34 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 103.117 -2.92 . . . . 50.51 103.117 177.135 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.83 -26.84 64.42 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 106.117 -1.808 . . . . 50.51 106.117 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.1 p -67.3 -25.15 65.9 Favored 'General case' 0 C--O 1.268 2.062 0 C-N-CA 117.324 -1.751 . . . . 50.51 110.745 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 54' ' ' ARG . 47.0 m-20 -66.01 -36.8 84.27 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 118.883 2.92 . . . . 50.62 118.883 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.21 9.34 43.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 117.758 -1.115 . . . . 50.51 112.701 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 57.63 65.42 1.34 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 121.543 1.974 . . . . 50.55 115.113 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.19 93.35 4.21 Favored 'Isoleucine or valine' 0 C--O 1.266 1.967 0 CA-C-O 115.284 -2.293 . . . . 50.51 111.444 175.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.503 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 8.5 mm-40 -99.01 167.07 10.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 126.073 2.108 . . . . 50.55 111.963 -176.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 64.8 mttm -51.99 133.83 32.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 119.673 3.212 . . . . 50.51 119.673 -176.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 64.7 mm-40 77.35 23.48 0.88 Allowed 'General case' 0 C--O 1.256 1.427 0 CA-C-N 112.498 -2.137 . . . . 50.62 111.019 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.0 m -82.38 144.19 30.7 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.787 -1.097 . . . . 50.51 113.336 174.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 p -101.78 131.67 47.96 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 118.252 -0.88 . . . . 50.51 113.348 175.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.0 tp -100.96 139.11 37.11 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 114.647 -2.597 . . . . 50.51 105.642 175.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -100.06 117.84 35.18 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 127.463 2.977 . . . . 50.51 114.223 177.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.0 tp -91.26 106.18 18.32 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 115.187 1.551 . . . . 50.51 115.187 176.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 29.7 t -108.62 136.82 43.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 119.601 1.091 . . . . 50.51 112.155 175.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.2 mt -67.14 155.84 37.72 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 118.226 2.676 . . . . 50.51 118.226 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.451 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 29.2 tpt180 -136.4 77.79 1.67 Allowed 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.32 -3.229 . . . . 50.64 107.103 177.253 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -74.35 140.09 44.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.644 2.091 . . . . 50.51 116.644 -179.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.41 82.94 8.1 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.756 -1.566 . . . . 50.64 108.388 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.39 155.0 20.89 Favored Glycine 0 C--O 1.243 0.712 0 N-CA-C 116.527 1.371 . . . . 50.51 116.527 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 CA-C-O 116.294 -2.392 . . . . 50.51 107.282 179.258 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.51 104.333 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.55 104.738 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.51 102.29 173.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.51 112.145 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.51 111.786 175.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.51 109.252 -178.064 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.51 109.62 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.51 107.743 -178.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.51 114.468 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.51 111.28 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.51 116.256 174.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.51 110.602 176.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.465 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.51 109.027 179.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD21 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.51 113.571 178.077 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.51 114.99 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.62 109.559 173.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.51 121.09 -177.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.62 112.333 174.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.51 111.966 177.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.51 111.757 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.62 111.666 -179.019 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.51 101.444 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.51 119.584 175.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.62 112.675 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.55 114.628 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.51 109.898 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.51 115.72 -179.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.51 107.477 176.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 28' ' ' ALA . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.51 106.496 176.04 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.51 114.209 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.55 108.968 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.62 111.037 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.51 110.301 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.62 120.858 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.51 106.1 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.51 105.672 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.51 110.944 178.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.51 113.447 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.62 108.594 -177.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.55 115.056 178.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.55 109.719 -177.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.64 117.817 172.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.672 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.51 115.168 -177.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.51 112.637 -177.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.51 112.285 177.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.51 110.997 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.51 114.91 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.51 115.839 177.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.483 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.55 106.456 174.564 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.51 105.88 -175.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.62 110.154 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.62 111.365 -175.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.51 116.277 -177.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.64 116.133 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.51 113.461 177.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.51 117.407 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.51 109.337 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.62 110.015 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.51 107.531 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.55 112.093 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.51 107.161 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.55 114.939 -176.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.51 105.716 -176.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.62 117.312 179.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.51 112.232 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.51 108.905 175.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.51 107.573 175.074 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.51 103.336 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.51 105.765 176.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.51 109.836 175.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.51 116.358 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.64 107.244 177.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.51 116.283 -179.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.64 107.429 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.51 109.356 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.51 113.24 179.152 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.51 104.333 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.55 104.738 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.51 102.29 173.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.51 112.145 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.51 111.786 175.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.51 109.252 -178.064 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.51 109.62 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.51 107.743 -178.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.51 114.468 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.51 111.28 179.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.51 116.256 174.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.51 110.602 176.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.465 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.51 109.027 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD21 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.51 113.571 178.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.51 114.99 -179.243 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.62 109.559 173.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.51 121.09 -177.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.62 112.333 174.619 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.51 111.966 177.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.51 111.757 -177.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.62 111.666 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.51 101.444 175.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.51 119.584 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.62 112.675 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.55 114.628 -179.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.51 109.898 178.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.51 115.72 -179.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.51 107.477 176.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 28' ' ' ALA . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.51 106.496 176.04 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.51 114.209 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.55 108.968 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.62 111.037 179.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.51 110.301 -175.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.62 120.858 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.51 106.1 176.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.51 105.672 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.51 110.944 178.284 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.51 113.447 -179.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.62 108.594 -177.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.55 115.056 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.55 109.719 -177.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.64 117.817 172.109 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.672 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.51 115.168 -177.449 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.51 112.637 -177.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.51 112.285 177.562 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.51 110.997 177.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.51 114.91 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.51 115.839 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.483 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.55 106.456 174.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.51 105.88 -175.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.62 110.154 -177.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.62 111.365 -175.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.51 116.277 -177.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.64 116.133 176.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.51 113.461 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.51 117.407 177.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.51 109.337 -179.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.62 110.015 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.51 107.531 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.55 112.093 179.98 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.51 107.161 175.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.55 114.939 -176.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.51 105.716 -176.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.62 117.312 179.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.51 112.232 174.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.51 108.905 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.51 107.573 175.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.51 103.336 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.51 105.765 176.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.51 109.836 175.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.51 116.358 178.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.64 107.244 177.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.51 116.283 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.64 107.429 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.51 109.356 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.51 113.24 179.152 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.51 104.333 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.55 104.738 178.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.51 102.29 173.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.51 112.145 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.51 111.786 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.51 109.252 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.51 109.62 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.51 107.743 -178.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.51 114.468 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.51 111.28 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.51 116.256 174.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.51 110.602 176.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.465 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.51 109.027 179.705 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD21 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.51 113.571 178.077 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.51 114.99 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.62 109.559 173.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.51 121.09 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.62 112.333 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.51 111.966 177.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.51 111.757 -177.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.62 111.666 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.51 101.444 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.51 119.584 175.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.62 112.675 177.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.55 114.628 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.51 109.898 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.51 115.72 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.51 107.477 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 28' ' ' ALA . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.51 106.496 176.04 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.51 114.209 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.55 108.968 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.62 111.037 179.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.51 110.301 -175.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.62 120.858 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.51 106.1 176.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.51 105.672 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.51 110.944 178.284 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.51 113.447 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.62 108.594 -177.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.55 115.056 178.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.55 109.719 -177.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.64 117.817 172.109 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.672 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.51 115.168 -177.449 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.51 112.637 -177.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.472 ' HB3' HD22 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.51 112.285 177.562 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.51 110.997 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.51 114.91 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.51 115.839 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.483 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.55 106.456 174.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.51 105.88 -175.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.62 110.154 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.62 111.365 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.51 116.277 -177.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.64 116.133 176.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.51 113.461 177.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.51 117.407 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.51 109.337 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.62 110.015 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.51 107.531 179.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.55 112.093 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.51 107.161 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.55 114.939 -176.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.51 105.716 -176.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.62 117.312 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.51 112.232 174.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.51 108.905 175.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.51 107.573 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.51 103.336 177.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.51 105.765 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.51 109.836 175.091 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.51 116.358 178.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.64 107.244 177.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.51 116.283 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.64 107.429 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.51 109.356 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.51 113.24 179.152 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.51 110.493 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.55 104.893 178.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.51 102.837 173.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.41 ' HD2' HG22 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.51 117.134 179.556 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.51 116.317 175.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.51 112.121 -178.081 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.51 109.624 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.51 116.025 -177.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.51 106.536 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.51 112.921 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.51 113.028 175.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.41 HG22 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.51 111.926 176.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.51 102.234 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.51 107.977 178.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.51 113.269 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.62 114.947 174.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 1' ' ' MET . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.51 115.789 -177.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.62 107.53 174.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.51 111.949 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.51 109.308 -177.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.62 108.196 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.51 111.912 175.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 50' ' ' LEU . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.51 112.556 175.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.62 115.475 176.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 55.5 t-20 -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.55 106.23 -179.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.51 107.58 178.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.51 111.113 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.51 109.947 176.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.51 115.455 175.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.51 104.372 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.55 109.548 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.62 110.423 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.51 113.197 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.62 117.619 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.51 109.26 176.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.51 113.852 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.51 110.907 178.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.51 113.412 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.62 115.136 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.409 HE21 HD11 ' A' ' 71' ' ' LEU . 19.5 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.55 103.57 178.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.55 113.647 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.64 112.495 172.132 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.51 118.018 -177.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.51 117.708 -177.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.61 ' HB3' HD22 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.51 116.78 177.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.51 113.302 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.51 114.896 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.51 114.931 177.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.55 107.727 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.51 107.986 -175.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.62 112.944 -177.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.62 118.065 -175.824 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.51 108.537 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.64 104.693 176.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.51 107.733 177.174 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.51 103.779 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.51 109.455 -179.438 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.62 111.805 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.51 115.046 179.177 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.55 109.887 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.596 HD13 HD22 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.51 106.554 175.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.55 119.305 -176.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.51 112.625 -176.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.62 109.925 179.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.51 105.936 174.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.51 114.003 175.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD22 HD13 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.51 101.726 175.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.508 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 7.7 m170 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.51 105.529 177.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.51 108.662 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.51 109.301 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD11 HE21 ' A' ' 40' ' ' GLN . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.51 105.818 178.446 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.64 109.263 177.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.51 120.492 -179.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.64 113.699 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.51 105.703 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.51 108.344 179.318 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.51 110.493 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.55 104.893 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.51 102.837 173.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.41 ' HD2' HG22 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.51 117.134 179.556 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.51 116.317 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.51 112.121 -178.081 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.51 109.624 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.51 116.025 -177.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.51 106.536 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.51 112.921 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.51 113.028 175.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.41 HG22 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.51 111.926 176.101 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.51 102.234 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.51 107.977 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.51 113.269 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.62 114.947 174.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 1' ' ' MET . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.51 115.789 -177.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.62 107.53 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.51 111.949 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.51 109.308 -177.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.62 108.196 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.51 111.912 175.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 50' ' ' LEU . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.51 112.556 175.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.62 115.475 176.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 55.5 t-20 -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.55 106.23 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.51 107.58 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.51 111.113 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.51 109.947 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.51 115.455 175.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.51 104.372 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.55 109.548 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.62 110.423 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.51 113.197 -175.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.62 117.619 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.51 109.26 176.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.51 113.852 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.51 110.907 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.51 113.412 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.62 115.136 -177.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.409 HE21 HD11 ' A' ' 71' ' ' LEU . 19.5 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.55 103.57 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.55 113.647 -177.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.64 112.495 172.132 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.51 118.018 -177.498 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.51 117.708 -177.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.61 ' HB3' HD22 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.51 116.78 177.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.51 113.302 177.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.51 114.896 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.51 114.931 177.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.55 107.727 174.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.51 107.986 -175.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.62 112.944 -177.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.62 118.065 -175.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.51 108.537 -177.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.64 104.693 176.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.51 107.733 177.174 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.51 103.779 177.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.51 109.455 -179.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.62 111.805 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.51 115.046 179.177 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.55 109.887 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.596 HD13 HD22 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.51 106.554 175.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.55 119.305 -176.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.51 112.625 -176.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.62 109.925 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.51 105.936 174.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.51 114.003 175.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD22 HD13 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.51 101.726 175.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.508 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 7.7 m170 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.51 105.529 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.51 108.662 176.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.51 109.301 175.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD11 HE21 ' A' ' 40' ' ' GLN . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.51 105.818 178.446 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.64 109.263 177.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.51 120.492 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.64 113.699 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.51 105.703 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.51 108.344 179.318 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 107.349 -1.352 . . . . 50.51 107.349 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -87.51 137.75 32.07 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.946 2.654 . . . . 50.55 110.199 178.218 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -135.32 161.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.022 -1.942 . . . . 50.51 106.638 173.313 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -94.91 148.05 22.73 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.467 4.854 . . . . 50.51 119.097 179.532 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.44 116.74 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.395 -3.193 . . . . 50.51 106.384 175.822 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.19 106.45 17.68 Favored 'General case' 0 N--CA 1.504 2.253 1 O-C-N 129.388 4.18 . . . . 50.51 115.234 -178.118 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -82.79 178.88 7.97 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 117.759 -1.115 . . . . 50.51 109.653 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -70.56 -34.07 71.81 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 120.19 3.404 . . . . 50.51 120.19 -178.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 p -96.57 -9.09 30.21 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 115.706 -2.397 . . . . 50.51 116.356 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.64 38.41 0.72 Allowed Glycine 0 C--N 1.297 -1.617 0 N-CA-C 120.575 2.99 . . . . 50.51 120.575 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -94.61 135.64 35.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.848 -1.548 . . . . 50.51 111.047 175.018 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -109.51 117.76 34.83 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 126.702 2.501 . . . . 50.51 110.113 176.149 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.6 mt -117.72 132.05 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 127.609 3.068 . . . . 50.51 106.754 179.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.3 p -104.75 134.54 47.73 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.298 -1.761 . . . . 50.51 113.776 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.5 mt -118.39 155.87 29.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.435 -2.221 . . . . 50.51 116.029 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -93.7 119.16 32.35 Favored 'General case' 0 N--CA 1.501 2.084 1 O-C-N 129.227 4.08 . . . . 50.62 107.368 173.938 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.23 164.19 28.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 O-C-N 127.739 3.15 . . . . 50.51 111.114 -177.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.8 mt-10 -135.66 145.94 55.27 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 112.215 -2.266 . . . . 50.62 109.52 174.661 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.1 Cg_exo -54.94 -24.49 39.51 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.559 2.172 . . . . 50.51 111.956 177.732 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -78.58 -34.48 46.83 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.947 -1.501 . . . . 50.51 106.947 -177.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.1 145.63 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.37 -1.732 . . . . 50.62 114.434 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -96.83 156.41 16.36 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.874 -0.603 . . . . 50.51 109.555 175.657 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.647 HD11 ' HB3' ' A' ' 50' ' ' LEU . 55.5 mt -50.69 -40.13 19.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 O-C-N 127.094 2.746 . . . . 50.51 108.977 175.774 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 29.3 tt0 -47.65 -57.78 5.08 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.031 -1.1 . . . . 50.62 108.031 177.015 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -53.84 -40.87 66.83 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 115.74 1.756 . . . . 50.55 115.74 -179.633 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.71 -22.3 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 125.086 1.491 . . . . 50.51 110.299 178.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 94.9 mttt -82.78 -38.17 23.53 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 104.744 -2.317 . . . . 50.51 104.744 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.41 -28.45 61.08 Favored 'General case' 0 C--O 1.278 2.605 0 CA-C-N 117.982 0.355 . . . . 50.51 111.845 176.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -66.27 -36.51 83.17 Favored 'General case' 0 C--O 1.256 1.435 0 O-C-N 120.355 -1.466 . . . . 50.51 110.144 175.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.2 -29.29 27.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.529 -0.868 . . . . 50.51 108.661 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.24 -35.61 67.58 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 125.666 2.651 . . . . 50.55 111.019 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -63.75 -27.88 69.5 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 120.947 3.684 . . . . 50.62 120.947 179.132 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -108.83 -20.29 13.11 Favored 'General case' 0 C--O 1.279 2.65 0 O-C-N 119.27 -2.143 . . . . 50.51 113.539 -175.638 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -123.69 -26.57 4.13 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 123.061 2.664 . . . . 50.62 111.205 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.47 12.04 57.58 Favored Glycine 0 CA--C 1.477 -2.303 0 CA-C-O 120.049 -0.306 . . . . 50.51 113.122 176.55 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.8 mm -77.5 126.3 84.86 Favored Pre-proline 0 C--O 1.245 0.822 0 N-CA-C 104.66 -2.348 . . . . 50.51 104.66 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.97 136.95 79.69 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.166 2.578 . . . . 50.51 110.914 178.309 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.07 -32.3 92.8 Favored 'Trans proline' 0 C--O 1.262 1.688 0 C-N-CA 120.701 0.934 . . . . 50.51 113.436 -179.321 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -80.12 12.04 3.08 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.864 -1.772 . . . . 50.62 114.954 -177.406 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.23 9.14 11.0 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.467 -1.395 . . . . 50.55 107.358 178.663 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -103.05 125.13 49.65 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.407 2.051 . . . . 50.55 112.999 -177.583 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -111.79 114.54 27.58 Favored 'General case' 0 C--O 1.295 3.478 0 CA-C-O 116.711 -1.614 . . . . 50.64 114.898 172.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.557 HD12 HG23 ' A' ' 23' ' ' ILE . 23.1 mt -98.62 122.34 41.71 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 119.431 1.014 . . . . 50.51 111.832 -177.442 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.81 117.99 56.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 O-C-N 124.545 1.153 . . . . 50.51 111.016 -177.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.692 ' HB3' HD22 ' A' ' 50' ' ' LEU . 57.9 t80 -140.92 143.4 34.58 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.121 -1.437 . . . . 50.51 107.121 177.52 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 45.38 34.98 1.68 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.254 -2.248 . . . . 50.51 106.798 177.434 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.87 -7.39 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.445 2.926 . . . . 50.51 113.263 -179.499 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 46' ' ' ALA . 75.2 mmtt -77.04 148.07 36.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 118.099 0.949 . . . . 50.51 113.402 177.662 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.5 116.09 11.43 Favored 'General case' 0 C--O 1.259 1.573 0 O-C-N 123.953 0.783 . . . . 50.55 109.485 174.559 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.692 HD22 ' HB3' ' A' ' 45' ' ' PHE . 64.8 mt -78.84 145.68 34.1 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 101.394 -3.558 . . . . 50.51 101.394 -175.866 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' O ' HD13 ' A' ' 23' ' ' ILE . 4.2 mm-40 -116.72 148.66 40.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.975 1.472 . . . . 50.62 114.975 -177.661 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.25 -47.9 71.76 Favored 'General case' 0 C--O 1.264 1.838 0 C-N-CA 126.141 1.776 . . . . 50.62 114.572 -175.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 4.42 57.12 Favored Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 124.408 1.004 . . . . 50.51 112.921 -177.25 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.438 ' HD2' ' OH ' ' A' ' 59' ' ' TYR . 89.3 mtt-85 -93.01 143.52 26.15 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 119.997 -1.884 . . . . 50.64 112.3 176.451 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.2 p -86.25 162.05 18.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.036 0.935 . . . . 50.51 112.019 177.087 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.57 -27.31 65.95 Favored 'General case' 0 C--O 1.201 -1.495 0 N-CA-C 102.205 -3.257 . . . . 50.51 102.205 177.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -71.67 -36.03 70.52 Favored 'General case' 0 C--O 1.267 2.022 0 C-N-CA 117.326 -1.749 . . . . 50.51 113.078 -179.387 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -49.86 -38.64 36.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.501 1.143 . . . . 50.62 113.718 179.765 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.438 ' OH ' ' HD2' ' A' ' 54' ' ' ARG . 58.1 m-85 -91.58 -10.72 39.51 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.759 -1.115 . . . . 50.51 113.584 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 70.31 41.58 1.01 Allowed 'General case' 0 C--O 1.248 0.989 0 CA-C-N 121.52 1.964 . . . . 50.55 108.684 179.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.72 118.07 14.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.93 0 CA-C-O 115.184 -2.341 . . . . 50.51 107.126 175.872 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -97.3 177.86 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.556 1.785 . . . . 50.55 110.196 -176.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -58.15 146.94 31.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.198 1.475 . . . . 50.51 107.658 -176.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 39.74 61.31 1.46 Allowed 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.537 -2.12 . . . . 50.62 112.614 179.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 m -98.26 151.07 20.85 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 104.729 -2.323 . . . . 50.51 104.729 174.743 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 p -95.96 140.26 30.96 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 118.287 -0.863 . . . . 50.51 111.879 175.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -122.64 136.92 55.01 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 114.641 -2.599 . . . . 50.51 104.479 175.088 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.15 116.92 29.2 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 127.427 2.954 . . . . 50.51 108.517 177.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.25 130.92 34.96 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.623 -1.179 . . . . 50.51 111.098 176.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -128.56 141.78 45.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 104.004 -2.591 . . . . 50.51 104.004 174.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.4 ' HA ' HD21 ' A' ' 71' ' ' LEU . 35.5 mt -97.55 123.54 41.46 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.639 0.607 . . . . 50.51 112.639 178.438 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -104.28 86.76 2.59 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.336 -3.221 . . . . 50.64 112.841 177.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.7 mt -73.32 167.77 20.55 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.954 . . . . 50.51 107.815 -179.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -120.59 86.5 2.58 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.714 -1.585 . . . . 50.64 107.247 -179.624 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.23 131.74 3.36 Favored Glycine 0 C--O 1.244 0.743 0 O-C-N 124.645 1.216 . . . . 50.51 113.081 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.47 1 O-C-N 115.118 -4.754 . . . . 50.51 103.707 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.51 111.053 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.55 116.588 178.321 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.51 108.408 173.351 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.51 119.91 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.51 113.866 175.785 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.51 109.83 -178.037 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.51 114.27 179.956 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.51 106.823 -177.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.51 106.406 179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.51 115.847 179.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.51 113.185 174.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.51 106.82 176.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.51 110.632 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.51 110.788 178.084 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.51 115.167 -179.282 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.62 107.469 173.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.51 111.54 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.62 109.116 174.729 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.51 111.942 177.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.51 110.261 -177.489 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.62 110.438 -179.014 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.51 102.814 175.665 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.51 108.219 175.869 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.62 110.915 177.063 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.55 110.953 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.51 113.215 178.571 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.51 108.802 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.51 103.321 176.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.51 108.74 176.075 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.51 114.446 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.555 HE21 ' HA ' ' A' ' 37' ' ' PRO . 33.4 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.55 111.108 179.417 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.62 106.799 179.153 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.51 117.415 -175.737 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.62 108.973 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.51 108.229 176.498 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.51 107.149 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.555 ' HA ' HE21 ' A' ' 31' ' ' GLN . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.51 110.835 178.328 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.51 113.479 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.62 113.097 -177.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.55 107.358 178.748 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.55 116.575 -177.483 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.605 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.64 106.18 172.202 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' HB3' HD12 ' A' ' 50' ' ' LEU . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.51 109.103 -177.516 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.51 114.506 -177.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.494 ' HB3' HD22 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.51 114.578 177.624 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.51 108.335 177.409 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.51 113.694 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.51 108.927 177.678 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.55 107.079 174.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.51 107.602 -175.891 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.62 112.193 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.62 116.528 -175.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.51 116.292 -177.256 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.64 108.919 176.463 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.51 113.355 177.121 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.51 108.481 177.184 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.51 116.691 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.62 119.838 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.51 110.142 179.286 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.55 113.734 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.51 105.625 175.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.55 108.806 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.581 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.51 116.225 -176.896 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.62 117.221 179.545 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.51 103.824 174.726 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.51 115.599 175.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.51 106.66 175.091 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.51 108.183 177.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.51 108.516 176.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.51 105.118 175.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.51 116.356 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.605 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.64 113.39 177.176 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.51 111.184 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.64 111.505 -179.621 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.51 104.884 179.378 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.51 116.938 179.231 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.51 111.053 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.55 116.588 178.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.51 108.408 173.351 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.51 119.91 179.541 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.51 113.866 175.785 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.51 109.83 -178.037 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.51 114.27 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.51 106.823 -177.969 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.51 106.406 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.51 115.847 179.804 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.51 113.185 174.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.51 106.82 176.229 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.51 110.632 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.51 110.788 178.084 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.51 115.167 -179.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.62 107.469 173.999 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.51 111.54 -177.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.62 109.116 174.729 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.51 111.942 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.51 110.261 -177.489 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.62 110.438 -179.014 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.51 102.814 175.665 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.51 108.219 175.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.62 110.915 177.063 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.55 110.953 -179.579 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.51 113.215 178.571 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.51 108.802 -179.798 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.51 103.321 176.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.51 108.74 176.075 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.51 114.446 179.874 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.555 HE21 ' HA ' ' A' ' 37' ' ' PRO . 33.4 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.55 111.108 179.417 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.62 106.799 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.51 117.415 -175.737 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.62 108.973 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.51 108.229 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.51 107.149 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.555 ' HA ' HE21 ' A' ' 31' ' ' GLN . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.51 110.835 178.328 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.51 113.479 -179.365 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.62 113.097 -177.452 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.55 107.358 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.55 116.575 -177.483 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.605 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.64 106.18 172.202 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' HB3' HD12 ' A' ' 50' ' ' LEU . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.51 109.103 -177.516 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.51 114.506 -177.616 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.494 ' HB3' HD22 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.51 114.578 177.624 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.51 108.335 177.409 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.51 113.694 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.51 108.927 177.678 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.55 107.079 174.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.51 107.602 -175.891 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.62 112.193 -177.677 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.62 116.528 -175.761 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.51 116.292 -177.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.64 108.919 176.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.51 113.355 177.121 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.51 108.481 177.184 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.51 116.691 -179.453 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.62 119.838 179.741 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.51 110.142 179.286 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.55 113.734 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.51 105.625 175.863 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.55 108.806 -176.835 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.581 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.51 116.225 -176.896 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.62 117.221 179.545 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.51 103.824 174.726 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.51 115.599 175.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.51 106.66 175.091 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.51 108.183 177.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.51 108.516 176.581 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.51 105.118 175.096 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.51 116.356 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.605 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.64 113.39 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.51 111.184 -179.342 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.64 111.505 -179.621 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.51 104.884 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.51 116.938 179.231 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.51 110.518 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.55 111.931 178.254 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.51 109.629 173.36 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.51 110.788 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.51 109.267 175.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.51 112.054 -178.082 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.51 109.558 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.51 115.426 -177.96 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.51 110.359 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.51 109.262 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.51 111.702 175.031 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.51 120.495 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.51 104.467 179.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.51 119.511 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.51 111.182 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.62 105.523 173.97 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.51 120.87 -177.968 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.62 113.88 174.624 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.51 111.907 177.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.51 110.539 -177.503 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.62 116.041 -179.054 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.51 113.13 175.663 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.51 106.643 175.794 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.62 109.013 176.992 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.55 120.754 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.51 109.974 178.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.51 103.034 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.51 114.005 176.947 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.51 108.149 175.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.51 112.731 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.55 116.636 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.62 110.424 179.144 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.51 117.298 -175.651 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.62 114.698 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.51 108.03 176.505 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.51 103.399 179.696 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.51 110.927 178.325 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.51 113.487 -179.297 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.62 115.612 -177.478 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.55 108.548 178.699 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.55 111.184 -177.606 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.64 102.446 172.198 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.51 113.857 -177.541 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.51 112.916 -177.592 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.51 108.783 177.641 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 45' ' ' PHE . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.51 104.079 177.365 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.51 117.886 -179.581 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.51 111.909 177.62 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.55 106.814 174.54 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.51 110.278 -175.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.62 111.58 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.62 111.456 -175.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.51 112.985 -177.227 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.64 115.651 176.557 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.51 116.995 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD23 HD13 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.51 105.494 177.211 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.51 113.975 -179.481 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.62 113.595 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.51 108.268 179.243 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 57' ' ' SER . 17.4 m120 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.55 112.768 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.594 HD13 HD23 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.51 112.67 175.785 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.55 105.766 -176.791 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.51 107.365 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.62 116.2 179.519 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.51 107.156 174.815 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.51 106.777 175.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.51 107.127 175.12 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.51 114.104 177.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.51 109.856 176.533 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.51 106.088 175.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.51 118.655 178.372 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.64 107.592 177.293 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.51 112.686 -179.374 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.64 111.255 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.51 104.302 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.51 116.097 179.25 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.51 110.518 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.55 111.931 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.51 109.629 173.36 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.51 110.788 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.51 109.267 175.855 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.51 112.054 -178.082 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.51 109.558 179.941 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.51 115.426 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.51 110.359 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.51 109.262 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.51 111.702 175.031 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.51 120.495 176.137 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.51 104.467 179.69 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.51 119.511 178.086 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.51 111.182 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.62 105.523 173.97 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.51 120.87 -177.968 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.62 113.88 174.624 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.51 111.907 177.796 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.51 110.539 -177.503 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.62 116.041 -179.054 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.51 113.13 175.663 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.51 106.643 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.62 109.013 176.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.55 120.754 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.51 109.974 178.629 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.51 103.034 -179.722 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.51 114.005 176.947 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.51 108.149 175.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.51 112.731 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.55 116.636 179.47 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.62 110.424 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.51 117.298 -175.651 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.62 114.698 179.824 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.51 108.03 176.505 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.51 103.399 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.51 110.927 178.325 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.51 113.487 -179.297 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.62 115.612 -177.478 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.55 108.548 178.699 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.55 111.184 -177.606 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.64 102.446 172.198 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.51 113.857 -177.541 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.51 112.916 -177.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' O ' ' HB1' ' A' ' 46' ' ' ALA . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.51 108.783 177.641 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 45' ' ' PHE . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.51 104.079 177.365 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.51 117.886 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.51 111.909 177.62 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.55 106.814 174.54 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.51 110.278 -175.89 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.62 111.58 -177.608 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.62 111.456 -175.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.51 112.985 -177.227 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.64 115.651 176.557 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.51 116.995 177.093 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD23 HD13 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.51 105.494 177.211 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.51 113.975 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.62 113.595 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.51 108.268 179.243 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 57' ' ' SER . 17.4 m120 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.55 112.768 179.934 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.594 HD13 HD23 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.51 112.67 175.785 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.55 105.766 -176.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.51 107.365 -176.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.62 116.2 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.51 107.156 174.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.51 106.777 175.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.51 107.127 175.12 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.51 114.104 177.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.51 109.856 176.533 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.51 106.088 175.043 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.51 118.655 178.372 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.64 107.592 177.293 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.51 112.686 -179.374 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.64 111.255 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.51 104.302 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.51 116.097 179.25 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.51 109.216 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.55 103.603 178.265 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.51 102.846 173.404 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.51 110.328 179.525 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.51 108.503 175.797 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.51 111.281 -178.135 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.51 107.142 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.51 113.219 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.51 118.548 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.51 113.235 179.813 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.51 110.483 175.053 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.51 109.006 176.163 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.51 111.867 179.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.51 112.051 178.17 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.51 111.304 -179.259 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.62 111.542 173.996 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.51 113.859 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.62 109.383 174.688 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' CB ' ' HB3' ' A' ' 57' ' ' SER . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.51 111.93 177.744 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.51 109.656 -177.521 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.62 105.534 -178.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.51 104.641 175.636 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.51 102.724 175.8 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.62 112.597 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.55 113.205 -179.62 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.51 106.768 178.591 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.51 104.533 -179.657 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.51 115.722 176.905 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.51 109.212 176.022 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.51 108.658 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.55 111.06 179.442 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.62 114.416 179.161 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.51 113.454 -175.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.62 118.939 179.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.51 116.117 176.531 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.51 115.529 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.51 110.941 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.51 113.474 -179.286 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.62 110.618 -177.477 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.55 116.484 178.705 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.55 110.86 -177.585 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.64 113.393 172.104 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.51 110.243 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.51 110.981 -177.61 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD21 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.51 108.01 177.633 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.51 113.133 177.447 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.51 117.508 -179.574 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.51 101.956 177.664 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.55 110.798 174.602 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.51 119.732 -175.918 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.62 112.76 -177.687 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.62 106.458 -175.812 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.51 113.468 -177.236 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.64 110.824 176.396 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.51 113.774 177.098 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 26' ' ' VAL . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.51 108.835 177.218 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.51 111.441 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.62 112.841 179.711 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.51 112.857 179.26 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.55 107.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.51 106.658 175.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.55 117.509 -176.826 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.51 120.0 -176.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.62 112.075 179.492 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.51 105.232 174.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.51 116.272 175.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.51 110.944 175.058 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.51 108.741 177.914 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.51 111.13 176.573 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.51 106.129 175.073 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.51 117.402 178.462 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.64 102.12 177.214 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.51 112.404 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.64 110.368 -179.564 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.51 110.56 179.331 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.51 115.967 179.282 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.51 109.216 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.55 103.603 178.265 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.51 102.846 173.404 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.51 110.328 179.525 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.51 108.503 175.797 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.51 111.281 -178.135 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.51 107.142 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.51 113.219 -177.941 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.51 118.548 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.51 113.235 179.813 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.51 110.483 175.053 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.51 109.006 176.163 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.51 111.867 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.51 112.051 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.51 111.304 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.62 111.542 173.996 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.51 113.859 -177.904 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.62 109.383 174.688 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' CB ' ' HB3' ' A' ' 57' ' ' SER . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.51 111.93 177.744 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.51 109.656 -177.521 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.62 105.534 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.51 104.641 175.636 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.51 102.724 175.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.62 112.597 176.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.55 113.205 -179.62 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.51 106.768 178.591 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.51 104.533 -179.657 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.51 115.722 176.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.51 109.212 176.022 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.51 108.658 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.55 111.06 179.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.62 114.416 179.161 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.51 113.454 -175.681 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.62 118.939 179.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.51 116.117 176.531 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.51 115.529 179.717 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.51 110.941 178.286 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.51 113.474 -179.286 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.62 110.618 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.55 116.484 178.705 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.55 110.86 -177.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.64 113.393 172.104 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.51 110.243 -177.466 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.51 110.981 -177.61 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD21 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.51 108.01 177.633 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.51 113.133 177.447 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.51 117.508 -179.574 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.51 101.956 177.664 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.55 110.798 174.602 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.51 119.732 -175.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.62 112.76 -177.687 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.62 106.458 -175.812 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.51 113.468 -177.236 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.64 110.824 176.396 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.51 113.774 177.098 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 26' ' ' VAL . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.51 108.835 177.218 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.51 111.441 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.62 112.841 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.51 112.857 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.55 107.075 179.86 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.51 106.658 175.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.55 117.509 -176.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.51 120.0 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.62 112.075 179.492 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.51 105.232 174.788 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.51 116.272 175.958 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.51 110.944 175.058 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.51 108.741 177.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.51 111.13 176.573 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.51 106.129 175.073 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.51 117.402 178.462 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.64 102.12 177.214 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.51 112.404 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.64 110.368 -179.564 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.51 110.56 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.51 115.967 179.282 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.51 109.216 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.55 103.603 178.265 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.51 102.846 173.404 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.51 110.328 179.525 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.51 108.503 175.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.51 111.281 -178.135 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.51 107.142 179.927 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.51 113.219 -177.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.51 118.548 179.928 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.51 113.235 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.51 110.483 175.053 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.51 109.006 176.163 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.51 111.867 179.742 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.51 112.051 178.17 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.51 111.304 -179.259 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.62 111.542 173.996 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.51 113.859 -177.904 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.62 109.383 174.688 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' CB ' ' HB3' ' A' ' 57' ' ' SER . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.51 111.93 177.744 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.51 109.656 -177.521 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.62 105.534 -178.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.51 104.641 175.636 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.51 102.724 175.8 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.62 112.597 176.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.55 113.205 -179.62 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.51 106.768 178.591 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.51 104.533 -179.657 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.51 115.722 176.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.51 109.212 176.022 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.51 108.658 179.937 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.55 111.06 179.442 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.62 114.416 179.161 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.51 113.454 -175.681 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.62 118.939 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.51 116.117 176.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.51 115.529 179.717 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.51 110.941 178.286 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.51 113.474 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.62 110.618 -177.477 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.55 116.484 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.55 110.86 -177.585 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.64 113.393 172.104 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.51 110.243 -177.466 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.51 110.981 -177.61 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD21 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.51 108.01 177.633 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.51 113.133 177.447 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.51 117.508 -179.574 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.51 101.956 177.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.55 110.798 174.602 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.51 119.732 -175.918 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.62 112.76 -177.687 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.62 106.458 -175.812 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.51 113.468 -177.236 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.64 110.824 176.396 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.51 113.774 177.098 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 26' ' ' VAL . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.51 108.835 177.218 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.51 111.441 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.62 112.841 179.711 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.51 112.857 179.26 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.55 107.075 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.51 106.658 175.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.55 117.509 -176.826 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.51 120.0 -176.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.62 112.075 179.492 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.51 105.232 174.788 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.51 116.272 175.958 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.51 110.944 175.058 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.51 108.741 177.914 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.51 111.13 176.573 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.51 106.129 175.073 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.51 117.402 178.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.64 102.12 177.214 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.51 112.404 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.64 110.368 -179.564 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.51 110.56 179.331 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.51 115.967 179.282 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.51 109.216 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.55 103.603 178.265 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.51 102.846 173.404 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.51 110.328 179.525 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.51 108.503 175.797 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.51 111.281 -178.135 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.51 107.142 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.51 113.219 -177.941 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.51 118.548 179.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.51 113.235 179.813 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.51 110.483 175.053 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' VAL . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.51 109.006 176.163 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.51 111.867 179.742 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.51 112.051 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.51 111.304 -179.259 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.62 111.542 173.996 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.51 113.859 -177.904 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.62 109.383 174.688 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' CB ' ' HB3' ' A' ' 57' ' ' SER . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.51 111.93 177.744 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.51 109.656 -177.521 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.62 105.534 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.51 104.641 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.51 102.724 175.8 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.62 112.597 176.987 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.55 113.205 -179.62 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 HG22 HD22 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.51 106.768 178.591 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.51 104.533 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.51 115.722 176.905 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.51 109.212 176.022 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.51 108.658 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.55 111.06 179.442 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.62 114.416 179.161 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.51 113.454 -175.681 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.62 118.939 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.51 116.117 176.531 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.51 115.529 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.51 110.941 178.286 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.51 113.474 -179.286 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.62 110.618 -177.477 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.55 116.484 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.55 110.86 -177.585 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.64 113.393 172.104 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.51 110.243 -177.466 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.51 110.981 -177.61 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD21 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.51 108.01 177.633 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.51 113.133 177.447 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.51 117.508 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.51 101.956 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.55 110.798 174.602 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.51 119.732 -175.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.62 112.76 -177.687 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.62 106.458 -175.812 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.51 113.468 -177.236 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.64 110.824 176.396 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.51 113.774 177.098 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 26' ' ' VAL . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.51 108.835 177.218 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.51 111.441 -179.44 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.62 112.841 179.711 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.51 112.857 179.26 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.55 107.075 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.51 106.658 175.859 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.55 117.509 -176.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.51 120.0 -176.981 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.62 112.075 179.492 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.51 105.232 174.788 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.51 116.272 175.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.51 110.944 175.058 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.51 108.741 177.914 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.51 111.13 176.573 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.51 106.129 175.073 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.51 117.402 178.462 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.64 102.12 177.214 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.51 112.404 -179.306 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.64 110.368 -179.564 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.51 110.56 179.331 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.51 115.967 179.282 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.992 0.738 . . . . 50.51 112.992 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.58 106.94 9.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 126.973 2.671 . . . . 50.55 111.748 178.306 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -114.26 155.73 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 CA-C-O 115.983 -1.96 . . . . 50.51 113.24 173.276 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -119.93 132.41 55.51 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.523 4.889 . . . . 50.51 112.064 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 70.8 t -108.49 134.02 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 113.412 -3.185 . . . . 50.51 112.244 175.773 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -94.46 118.68 32.02 Favored 'General case' 0 N--CA 1.503 2.22 1 O-C-N 129.329 4.143 . . . . 50.51 106.07 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -98.48 161.28 13.76 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 117.753 -1.117 . . . . 50.51 110.633 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -54.82 -33.43 61.6 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.877 1.436 . . . . 50.51 114.877 -177.95 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 9' ' ' THR . 54.0 m -71.16 -20.77 62.26 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 115.689 -2.404 . . . . 50.51 113.117 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.56 -10.97 38.99 Favored Glycine 0 C--N 1.297 -1.602 0 O-C-N 120.144 -1.598 . . . . 50.51 116.312 179.843 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -69.22 117.6 11.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 116.868 -1.539 . . . . 50.51 110.608 174.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.2 m -73.51 126.55 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.659 2.475 . . . . 50.51 111.716 176.201 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.481 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 14.1 pt -104.58 142.4 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 127.432 2.958 . . . . 50.51 112.531 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -106.34 142.04 36.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 117.294 -1.763 . . . . 50.51 112.363 178.112 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -131.01 133.8 46.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 115.49 -2.195 . . . . 50.51 113.451 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -100.57 139.88 35.63 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 129.163 4.04 . . . . 50.62 106.417 173.974 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.94 170.76 18.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 O-C-N 127.728 3.143 . . . . 50.51 117.344 -177.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 28.4 mt-10 -115.27 138.13 23.43 Favored Pre-proline 0 C--N 1.315 -0.926 0 N-CA-C 103.36 -2.83 . . . . 50.62 103.36 174.642 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.6 Cg_exo -55.02 -24.46 40.01 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 122.535 2.157 . . . . 50.51 111.957 177.706 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -79.01 -6.42 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.128 -0.939 . . . . 50.51 109.326 -177.611 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -72.55 122.55 21.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.092 2.627 . . . . 50.62 118.092 -178.954 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.456 ' O ' HG21 ' A' ' 26' ' ' VAL . 66.8 p -67.66 155.54 38.95 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.423 -1.325 . . . . 50.51 107.423 175.71 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 54' ' ' ARG . 25.6 mm -58.12 -23.74 22.31 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 127.191 2.807 . . . . 50.51 107.383 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.34 -39.99 67.72 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.471 -0.768 . . . . 50.62 110.918 177.097 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -70.7 -20.67 62.65 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.292 1.037 . . . . 50.55 108.258 -179.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 22' ' ' THR . 90.6 t -71.35 -57.52 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 101.293 -3.595 . . . . 50.51 101.293 178.579 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HG2' ' OE1' ' A' ' 41' ' ' GLN . 93.6 mttt -52.14 -38.47 57.65 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 114.456 1.28 . . . . 50.51 114.456 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.08 90.84 Favored 'General case' 0 C--O 1.278 2.591 0 CA-C-N 118.007 0.367 . . . . 50.51 110.322 176.869 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -60.61 -13.47 14.53 Favored 'General case' 0 C--O 1.254 1.309 0 N-CA-C 118.576 2.806 . . . . 50.51 118.576 176.028 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -90.99 -40.41 12.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 C-N-CA 119.565 -0.854 . . . . 50.51 110.04 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.567 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 31.3 tt0 -54.15 -31.98 54.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 125.656 2.646 . . . . 50.55 116.229 179.474 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.04 -72.14 0.1 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.627 -1.624 . . . . 50.62 109.717 179.092 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.94 -39.99 33.09 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.404 -2.119 . . . . 50.51 114.829 -175.745 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -88.19 -22.14 24.18 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 123.037 2.653 . . . . 50.62 114.028 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 71.31 27.13 72.16 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 109.332 -1.507 . . . . 50.51 109.332 176.571 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.8 mt -96.66 118.62 64.99 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.856 -1.138 . . . . 50.51 107.968 179.711 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.8 Cg_exo -57.02 136.99 80.0 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 123.149 2.566 . . . . 50.51 110.865 178.296 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.5 Cg_exo -57.25 -32.16 92.81 Favored 'Trans proline' 0 C--O 1.261 1.657 0 O-C-N 122.873 0.933 . . . . 50.51 113.391 -179.268 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -69.76 -21.8 63.4 Favored 'General case' 0 C--O 1.262 1.736 0 O-C-N 119.985 -1.697 . . . . 50.62 110.39 -177.443 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -93.91 18.16 10.97 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.52 -1.363 . . . . 50.55 110.421 178.662 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 71.7 mt-30 -111.49 139.57 46.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.3 2.0 . . . . 50.55 112.116 -177.584 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.702 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 37.5 ttm180 -119.97 126.61 51.28 Favored 'General case' 0 C--O 1.296 3.529 0 CA-C-O 116.708 -1.615 . . . . 50.64 108.393 172.147 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.3 mt -118.91 89.25 3.09 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.452 1.024 . . . . 50.51 112.257 -177.553 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.539 HD12 ' HD3' ' A' ' 42' ' ' ARG . 60.5 mt -98.51 128.85 49.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 O-C-N 125.255 1.597 . . . . 50.51 107.084 -177.63 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.671 ' CE2' HG12 ' A' ' 61' ' ' ILE . 87.3 t80 -136.33 124.6 23.21 Favored 'General case' 0 C--N 1.36 1.025 0 CA-C-N 114.498 -1.228 . . . . 50.51 110.627 177.646 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 36.84 20.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 112.221 -2.263 . . . . 50.51 113.255 177.332 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 25.15 63.84 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 128.455 2.931 . . . . 50.51 115.916 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.17 136.55 40.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 118.036 0.918 . . . . 50.51 110.82 177.621 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -73.45 128.24 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.05 0.844 . . . . 50.55 112.456 174.624 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 43' ' ' LEU . 78.2 mt -77.4 149.15 35.19 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 105.514 -2.032 . . . . 50.51 105.514 -175.903 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 82.5 tt0 -105.72 144.53 32.34 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.929 1.393 . . . . 50.62 113.456 -177.693 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 37.5 p30 -61.19 -35.51 77.35 Favored 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.099 1.76 . . . . 50.62 109.198 -175.749 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.481 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -91.48 20.94 38.03 Favored Glycine 0 CA--C 1.492 -1.403 0 C-N-CA 124.383 0.992 . . . . 50.51 115.55 -177.296 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.6 ' O ' HG12 ' A' ' 23' ' ' ILE . 86.5 mmt-85 -128.69 168.3 16.0 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 101.878 -3.378 . . . . 50.64 101.878 176.488 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -108.57 152.67 24.44 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.003 0.921 . . . . 50.51 108.842 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.7 mt -47.36 -39.42 15.06 Favored 'General case' 0 C--O 1.201 -1.462 0 O-C-N 124.087 0.867 . . . . 50.51 108.791 177.239 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -70.79 -27.71 64.11 Favored 'General case' 0 C--O 1.268 2.051 0 N-CA-C 116.35 1.981 . . . . 50.51 116.35 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -57.46 -27.18 62.24 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.496 1.141 . . . . 50.62 109.733 179.789 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 59.0 m-85 -87.06 -5.73 58.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 118.284 2.698 . . . . 50.51 118.284 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 54.3 m-20 74.28 32.1 1.02 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.524 1.965 . . . . 50.55 111.521 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.671 HG12 ' CE2' ' A' ' 45' ' ' PHE . 69.5 mt -81.0 103.8 8.57 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.206 -2.33 . . . . 50.51 110.464 175.849 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 77.0 mt-30 -103.84 -171.1 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 119.241 3.052 . . . . 50.55 119.241 -176.853 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 65.5 tttm -52.72 138.36 29.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.245 -2.131 . . . . 50.51 105.245 -176.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 46.6 mt-10 61.95 68.15 0.71 Allowed 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.492 -2.14 . . . . 50.62 115.36 179.549 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.412 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 51.0 m -136.06 138.82 42.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.786 -1.097 . . . . 50.51 109.749 174.813 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -114.39 132.31 56.27 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 118.841 -2.412 . . . . 50.51 113.919 175.886 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.0 mt -90.06 145.96 24.68 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.64 -2.6 . . . . 50.51 111.595 175.091 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -96.78 140.64 31.06 Favored 'General case' 0 C--N 1.284 -2.258 0 O-C-N 127.295 2.872 . . . . 50.51 106.937 177.89 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -106.07 116.0 31.18 Favored 'General case' 0 C--O 1.282 2.81 0 CA-C-O 117.656 -1.164 . . . . 50.51 113.338 176.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -120.28 138.33 51.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 119.533 1.06 . . . . 50.51 112.217 175.072 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.36 114.53 28.71 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.405 0.52 . . . . 50.51 112.405 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -89.08 111.63 22.42 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 113.365 -3.207 . . . . 50.64 104.738 177.198 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.59 131.62 36.2 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.819 1.949 . . . . 50.51 112.438 -179.359 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -88.07 77.62 8.33 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 113.757 -1.565 . . . . 50.64 113.193 -179.544 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.67 -147.62 16.67 Favored Glycine 0 C--O 1.242 0.597 0 N-CA-C 106.325 -2.71 . . . . 50.51 106.325 179.372 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 CA-C-O 116.329 -2.373 . . . . 50.51 109.025 179.196 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 118.833 -0.603 . . . . 50.51 110.318 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -105.25 112.49 25.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 126.937 2.648 . . . . 50.55 112.805 178.264 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.9 pt -114.42 139.79 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-O 115.984 -1.96 . . . . 50.51 112.339 173.288 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.416 ' HB2' ' HG1' ' A' ' 66' ' ' THR . 75.7 m-85 -96.2 145.78 25.25 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 130.43 4.831 . . . . 50.51 111.845 179.503 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 70.6 t -133.87 105.18 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.328 -3.225 . . . . 50.51 113.923 175.748 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -91.08 139.72 30.49 Favored 'General case' 0 N--CA 1.504 2.265 1 O-C-N 129.388 4.18 . . . . 50.51 120.678 -178.121 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -113.79 -168.87 1.41 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 115.052 1.501 . . . . 50.51 115.052 179.956 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -107.9 7.98 28.31 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 124.109 0.88 . . . . 50.51 111.005 -177.925 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -92.24 -14.88 28.27 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 102.41 -3.181 . . . . 50.51 102.41 179.975 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.89 10.72 29.87 Favored Glycine 0 C--N 1.297 -1.603 0 O-C-N 120.188 -1.57 . . . . 50.51 110.048 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.649 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 43.0 mtpt -90.8 154.51 19.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.86 -1.543 . . . . 50.51 113.116 175.003 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -126.8 122.63 35.33 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.706 2.504 . . . . 50.51 107.466 176.19 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.521 HG22 ' HG ' ' A' ' 15' ' ' LEU . 62.5 mt -99.11 136.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 115.182 -2.607 . . . . 50.51 108.76 179.775 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.9 m -127.24 104.18 7.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 104.209 -2.515 . . . . 50.51 104.209 178.092 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.521 ' HG ' HG22 ' A' ' 13' ' ' ILE . 46.2 mt -106.75 175.23 5.57 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.536 -2.173 . . . . 50.51 110.936 -179.197 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -125.64 137.95 53.89 Favored 'General case' 0 N--CA 1.5 2.058 1 O-C-N 129.164 4.04 . . . . 50.62 108.038 173.961 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -139.69 165.9 21.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 O-C-N 126.599 2.437 . . . . 50.51 110.623 -177.891 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.29 158.65 31.58 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 119.381 3.104 . . . . 50.62 119.381 174.647 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.88 -24.56 39.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.629 2.219 . . . . 50.51 111.91 177.686 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -110.42 25.71 11.49 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 119.98 3.326 . . . . 50.51 119.98 -177.543 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -94.62 149.22 21.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 117.305 -1.758 . . . . 50.62 107.26 -179.038 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -92.97 148.46 21.98 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.799 -0.637 . . . . 50.51 109.688 175.752 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -44.94 -39.6 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.155 2.784 . . . . 50.51 115.021 175.785 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.87 -36.73 77.53 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.407 -0.808 . . . . 50.62 111.367 177.009 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -67.35 -34.07 76.56 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.358 1.063 . . . . 50.55 110.821 -179.589 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -71.16 -46.11 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 125.048 1.467 . . . . 50.51 112.878 178.571 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HG2' ' OE1' ' A' ' 41' ' ' GLN . 53.7 mtmt -62.84 -32.1 73.26 Favored 'General case' 0 C--O 1.255 1.352 0 N-CA-C 107.084 -1.45 . . . . 50.51 107.084 -179.753 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -56.75 17.61 Favored 'General case' 0 C--O 1.279 2.615 0 N-CA-C 114.575 1.324 . . . . 50.51 114.575 176.828 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -46.24 -49.18 17.58 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 120.387 -1.445 . . . . 50.51 109.911 176.054 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.84 -42.5 63.01 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 118.32 2.711 . . . . 50.51 118.32 179.896 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.406 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.8 tt0 -57.96 -45.51 86.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 125.662 2.648 . . . . 50.55 104.618 179.446 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.74 -25.13 61.93 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 116.353 1.982 . . . . 50.62 116.353 179.164 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -89.63 -58.61 2.46 Favored 'General case' 0 C--O 1.279 2.64 0 O-C-N 119.325 -2.109 . . . . 50.51 113.879 -175.683 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.649 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 74.2 mm-40 -103.93 -24.91 13.21 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 123.058 2.663 . . . . 50.62 110.631 179.868 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 105.52 20.11 9.85 Favored Glycine 0 CA--C 1.478 -2.274 0 N-CA-C 120.393 2.917 . . . . 50.51 120.393 176.52 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.9 mt -86.18 134.41 38.75 Favored Pre-proline 0 C--O 1.244 0.792 0 C-N-CA 118.854 -1.138 . . . . 50.51 110.05 179.738 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -57.07 136.99 79.88 Favored 'Trans proline' 0 C--O 1.26 1.603 0 C-N-CA 123.194 2.596 . . . . 50.51 110.877 178.361 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -57.13 -32.26 92.83 Favored 'Trans proline' 0 C--O 1.261 1.645 0 C-N-CA 120.731 0.954 . . . . 50.51 113.411 -179.306 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.79 -27.04 60.15 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 116.268 1.951 . . . . 50.62 116.268 -177.429 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 80.1 mt-30 -73.65 -21.59 60.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.567 -1.333 . . . . 50.55 109.995 178.686 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.615 ' HB3' HD11 ' A' ' 69' ' ' LEU . 71.8 mt-30 -70.56 118.28 13.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.36 2.028 . . . . 50.55 115.678 -177.613 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -113.81 121.4 43.92 Favored 'General case' 0 C--O 1.295 3.498 0 CA-C-O 116.621 -1.657 . . . . 50.64 109.303 172.098 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -96.49 127.49 42.53 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 119.447 1.021 . . . . 50.51 112.907 -177.422 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.51 119.3 57.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 115.056 1.502 . . . . 50.51 115.056 -177.623 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -145.35 121.44 10.76 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 104.741 -2.318 . . . . 50.51 104.741 177.608 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.0 39.8 3.12 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.208 -2.269 . . . . 50.51 107.961 177.41 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.47 11.24 4.99 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 128.417 2.913 . . . . 50.51 115.701 -179.606 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -115.92 126.67 54.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 119.27 3.063 . . . . 50.51 119.27 177.633 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -41.56 120.82 1.55 Allowed 'General case' 0 C--O 1.259 1.597 0 N-CA-C 120.047 3.351 . . . . 50.55 120.047 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 2.1 mp -82.35 123.59 29.24 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 117.751 -1.118 . . . . 50.51 109.737 -175.936 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.15 140.06 48.63 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.62 1.711 . . . . 50.62 115.62 -177.645 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -54.51 -53.02 59.94 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.148 1.779 . . . . 50.62 110.458 -175.776 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.17 -7.74 60.48 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 116.531 1.373 . . . . 50.51 116.531 -177.229 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -76.45 176.48 8.21 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 116.466 2.024 . . . . 50.64 116.466 176.538 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.6 p -112.44 164.83 12.81 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.055 -1.831 . . . . 50.51 106.055 177.148 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.414 HD23 ' CD1' ' A' ' 61' ' ' ILE . 65.5 mt -68.64 -36.17 78.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 106.573 -1.64 . . . . 50.51 106.573 177.279 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -65.51 -31.48 72.58 Favored 'General case' 0 C--O 1.267 1.995 0 C-N-CA 117.34 -1.744 . . . . 50.51 112.392 -179.491 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -47.37 -37.48 11.27 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.515 1.15 . . . . 50.62 111.902 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.501 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 92.5 m-85 -96.12 -11.32 26.42 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 117.757 -1.116 . . . . 50.51 113.147 179.216 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 32.5 t30 78.58 47.46 0.04 OUTLIER 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.464 1.938 . . . . 50.55 113.949 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CD1' HD23 ' A' ' 56' ' ' LEU . 73.8 mt -85.07 112.49 22.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.965 0 CA-C-O 115.243 -2.313 . . . . 50.51 109.183 175.873 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -114.69 -171.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 126.059 2.099 . . . . 50.55 108.661 -176.869 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.1 tttp -59.59 145.2 45.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.255 1.502 . . . . 50.51 110.307 -176.948 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 34.6 mt-10 66.36 10.22 7.07 Favored 'General case' 0 C--O 1.258 1.507 0 N-CA-C 118.578 2.807 . . . . 50.62 118.578 179.57 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -74.32 138.05 43.25 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.845 -1.071 . . . . 50.51 112.668 174.796 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.416 ' HG1' ' HB2' ' A' ' 4' ' ' PHE . 97.9 m -112.05 128.47 56.2 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 115.14 1.533 . . . . 50.51 115.14 175.934 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 94.5 mt -103.47 138.93 39.51 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 114.635 -2.602 . . . . 50.51 107.85 175.072 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -96.33 143.56 27.29 Favored 'General case' 0 C--N 1.284 -2.273 0 O-C-N 127.374 2.921 . . . . 50.51 106.491 177.885 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 41' ' ' GLN . 37.7 tp -110.86 115.86 30.25 Favored 'General case' 0 C--O 1.282 2.779 0 CA-C-O 117.733 -1.127 . . . . 50.51 112.625 176.572 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.62 143.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 119.541 1.064 . . . . 50.51 110.495 175.066 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 54.9 mt -101.61 102.85 13.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 117.019 2.229 . . . . 50.51 117.019 178.522 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -73.76 101.54 3.73 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 113.34 -3.219 . . . . 50.64 110.824 177.207 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.9 163.5 3.41 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.891 1.995 . . . . 50.51 112.581 -179.274 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.97 74.39 1.53 Allowed 'General case' 0 C--O 1.244 0.804 0 N-CA-C 105.945 -1.872 . . . . 50.64 105.945 -179.614 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.27 131.56 3.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 106.202 -2.759 . . . . 50.51 106.202 179.389 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.497 0 CA-C-O 116.331 -2.372 . . . . 50.51 116.984 179.311 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.51 111.006 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.55 116.688 178.266 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.51 111.74 173.324 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.51 115.113 179.52 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.51 107.106 175.824 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.51 103.747 -178.117 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.51 107.547 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.51 105.417 -177.96 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.51 110.637 179.919 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.51 119.029 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.51 114.413 174.998 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.51 113.052 176.185 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.534 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.51 114.549 179.78 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.51 111.59 178.086 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.51 110.023 -179.207 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.62 111.711 173.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.51 110.993 -177.951 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.62 108.19 174.632 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.51 111.964 177.711 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.51 113.164 -177.552 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.62 108.919 -179.0 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.51 108.06 175.711 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.51 117.251 175.811 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.62 111.876 176.964 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.55 110.173 -179.603 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.51 109.312 178.599 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.51 106.896 -179.77 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.51 114.569 176.92 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.51 103.094 176.011 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.419 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.51 104.805 179.898 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 40.0 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.55 111.202 179.415 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.62 113.082 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.51 116.338 -175.645 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.62 113.877 179.862 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.51 105.347 176.537 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.51 107.204 179.761 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.51 110.872 178.293 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.415 ' CG ' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.51 113.407 -179.303 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.62 115.506 -177.444 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.55 113.269 178.741 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.617 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.55 109.19 -177.64 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.561 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.64 104.765 172.138 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.635 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.51 109.582 -177.498 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.51 112.344 -177.583 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.51 107.281 177.627 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.51 104.493 177.379 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.51 118.709 -179.624 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.51 114.674 177.718 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.55 109.652 174.548 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.51 110.096 -175.862 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.62 111.682 -177.729 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.62 118.573 -175.763 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.51 109.54 -177.249 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.64 110.879 176.534 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.51 116.693 177.156 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.428 HD12 HD13 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.51 110.756 177.237 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.51 119.247 -179.485 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.62 116.794 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.51 117.56 179.269 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 59' ' ' TYR . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.55 116.376 179.895 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.44 HG23 ' HG ' ' A' ' 65' ' ' SER . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.51 115.487 175.861 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.55 107.756 -176.828 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.51 114.348 -176.929 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.62 107.384 179.576 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.44 ' HG ' HG23 ' A' ' 61' ' ' ILE . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.51 106.402 174.815 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.51 110.362 175.94 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.51 107.602 175.106 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.51 109.96 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.51 108.197 176.547 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.51 102.361 175.117 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.51 113.908 178.441 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.64 110.488 177.138 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.51 104.971 -179.332 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.64 109.517 -179.572 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.51 111.861 179.397 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.51 108.119 179.238 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.51 111.006 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.55 116.688 178.266 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.51 111.74 173.324 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.51 115.113 179.52 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.51 107.106 175.824 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.51 103.747 -178.117 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.51 107.547 179.921 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.51 105.417 -177.96 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.51 110.637 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.51 119.029 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.51 114.413 174.998 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.51 113.052 176.185 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.534 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.51 114.549 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.51 111.59 178.086 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.51 110.023 -179.207 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.62 111.711 173.943 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.51 110.993 -177.951 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.62 108.19 174.632 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.51 111.964 177.711 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.51 113.164 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.62 108.919 -179.0 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.51 108.06 175.711 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.51 117.251 175.811 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.62 111.876 176.964 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.55 110.173 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.51 109.312 178.599 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.51 106.896 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.51 114.569 176.92 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.51 103.094 176.011 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.419 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.51 104.805 179.898 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 40.0 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.55 111.202 179.415 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.62 113.082 179.182 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.51 116.338 -175.645 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.62 113.877 179.862 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.51 105.347 176.537 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.51 107.204 179.761 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.51 110.872 178.293 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.415 ' CG ' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.51 113.407 -179.303 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.62 115.506 -177.444 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.55 113.269 178.741 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.617 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.55 109.19 -177.64 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.561 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.64 104.765 172.138 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.635 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.51 109.582 -177.498 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.51 112.344 -177.583 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.51 107.281 177.627 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.51 104.493 177.379 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.51 118.709 -179.624 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.51 114.674 177.718 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.55 109.652 174.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.51 110.096 -175.862 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.62 111.682 -177.729 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.62 118.573 -175.763 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.51 109.54 -177.249 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.64 110.879 176.534 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.51 116.693 177.156 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.428 HD12 HD13 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.51 110.756 177.237 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.51 119.247 -179.485 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.62 116.794 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' A' ' 60' ' ' ASN . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.51 117.56 179.269 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 59' ' ' TYR . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.55 116.376 179.895 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.44 HG23 ' HG ' ' A' ' 65' ' ' SER . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.51 115.487 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.55 107.756 -176.828 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.51 114.348 -176.929 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.62 107.384 179.576 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.44 ' HG ' HG23 ' A' ' 61' ' ' ILE . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.51 106.402 174.815 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.51 110.362 175.94 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.51 107.602 175.106 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.51 109.96 177.938 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.51 108.197 176.547 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.51 102.361 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.51 113.908 178.441 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.64 110.488 177.138 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.51 104.971 -179.332 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.64 109.517 -179.572 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.51 111.861 179.397 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.51 108.119 179.238 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 108.426 -0.953 . . . . 50.51 108.426 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -94.3 140.95 29.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 126.951 2.657 . . . . 50.55 106.368 178.272 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -126.22 -179.35 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-O 116.017 -1.944 . . . . 50.51 109.918 173.348 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.91 101.28 5.78 Favored 'General case' 0 N--CA 1.512 2.626 1 O-C-N 130.414 4.821 . . . . 50.51 114.319 179.567 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.25 123.7 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.488 -3.149 . . . . 50.51 110.223 175.79 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -117.24 118.42 32.23 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.291 4.119 . . . . 50.51 112.111 -178.079 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.49 HG21 ' H ' ' A' ' 9' ' ' THR . 5.1 t -104.0 167.38 9.8 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 116.911 2.189 . . . . 50.51 116.911 179.982 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.97 -17.79 63.98 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.807 1.78 . . . . 50.51 115.807 -178.008 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.49 ' H ' HG21 ' A' ' 7' ' ' THR . 53.3 p -89.25 1.7 55.33 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 115.767 -2.373 . . . . 50.51 109.718 179.889 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 -4.28 85.63 Favored Glycine 0 C--N 1.296 -1.655 0 O-C-N 120.115 -1.616 . . . . 50.51 117.096 179.84 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -67.5 110.0 3.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.825 -1.56 . . . . 50.51 109.337 174.976 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -81.38 133.74 35.46 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.665 2.478 . . . . 50.51 114.41 176.175 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.87 138.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 127.38 2.925 . . . . 50.51 118.105 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.3 m -106.96 130.0 54.68 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.222 -1.791 . . . . 50.51 111.438 178.138 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.439 ' HG ' HG13 ' A' ' 17' ' ' VAL . 49.3 tp -115.74 152.19 33.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 115.479 -2.201 . . . . 50.51 114.636 -179.279 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -115.01 107.48 15.42 Favored 'General case' 0 N--CA 1.5 2.04 1 O-C-N 129.273 4.108 . . . . 50.62 114.466 173.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.439 HG13 ' HG ' ' A' ' 15' ' ' LEU . 21.0 m -126.55 150.58 32.38 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 127.849 3.218 . . . . 50.51 118.53 -177.869 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 76.3 mt-10 -87.31 152.12 52.13 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 117.776 2.51 . . . . 50.62 117.776 174.655 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.46 39.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.556 2.171 . . . . 50.51 111.946 177.715 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -107.6 37.77 2.33 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 116.229 1.937 . . . . 50.51 116.229 -177.54 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -105.01 148.54 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 117.321 -1.751 . . . . 50.62 109.822 -178.965 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -92.88 159.57 15.3 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.087 -1.449 . . . . 50.51 107.087 175.728 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.12 -40.58 74.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 O-C-N 127.234 2.834 . . . . 50.51 108.203 175.801 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -54.08 -13.49 0.82 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.301 1.222 . . . . 50.62 114.301 177.015 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.35 -18.87 10.37 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.062 1.505 . . . . 50.55 115.062 -179.608 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.85 -57.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 101.545 -3.502 . . . . 50.51 101.545 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -57.09 -24.68 55.72 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 115.77 -0.65 . . . . 50.51 111.547 -179.775 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.68 -6.61 57.52 Favored 'General case' 0 C--O 1.278 2.553 0 N-CA-C 117.612 2.449 . . . . 50.51 117.612 176.862 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.427 ' CB ' HD11 ' A' ' 15' ' ' LEU . 63.3 mttp -91.9 -30.25 16.24 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 102.818 -3.03 . . . . 50.51 102.818 176.037 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.97 -45.0 98.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 103.108 -2.923 . . . . 50.51 103.108 179.858 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -52.09 -50.84 60.81 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 125.608 2.623 . . . . 50.55 108.453 179.419 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -56.66 -14.46 3.27 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 113.612 -1.631 . . . . 50.62 115.384 179.062 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 31.2 mmmt -117.46 -50.09 2.55 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.465 -2.094 . . . . 50.51 111.468 -175.688 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -94.93 -8.46 37.0 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.62 111.17 179.853 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.05 29.25 69.16 Favored Glycine 0 CA--C 1.477 -2.313 0 N-CA-C 107.777 -2.129 . . . . 50.51 107.777 176.518 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.61 122.74 45.09 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 105.386 -2.079 . . . . 50.51 105.386 179.75 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -56.95 136.96 79.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 123.177 2.584 . . . . 50.51 110.913 178.328 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -57.14 -32.19 92.67 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 120.713 0.942 . . . . 50.51 113.428 -179.347 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.38 -14.42 27.57 Favored 'General case' 0 C--O 1.262 1.723 0 N-CA-C 115.691 1.737 . . . . 50.62 115.691 -177.383 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -100.66 13.38 34.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.416 1.636 . . . . 50.55 115.416 178.788 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -116.42 133.12 56.38 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.363 2.03 . . . . 50.55 114.944 -177.592 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -116.97 124.77 50.17 Favored 'General case' 0 C--O 1.296 3.516 0 N-CA-C 105.245 -2.132 . . . . 50.64 105.245 172.145 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.83 133.86 49.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.735 -1.95 . . . . 50.51 105.735 -177.582 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -121.55 123.47 69.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.159 1.537 . . . . 50.51 111.155 -177.615 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -134.58 127.78 31.95 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 114.477 -1.238 . . . . 50.51 111.214 177.625 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.28 20.31 5.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.292 -2.231 . . . . 50.51 114.468 177.354 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.2 -8.25 67.13 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 120.673 3.029 . . . . 50.51 120.673 -179.589 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -98.67 144.68 27.68 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 118.052 0.926 . . . . 50.51 109.91 177.61 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -80.12 129.87 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.346 -2.835 . . . . 50.55 103.346 174.587 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.71 157.96 31.34 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 117.701 -1.142 . . . . 50.51 113.902 -175.911 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -100.66 154.23 18.76 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.131 -1.433 . . . . 50.62 107.131 -177.603 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -72.02 -44.89 62.68 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 126.116 1.766 . . . . 50.62 111.718 -175.841 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.13 61.31 Favored Glycine 0 C--O 1.253 1.295 0 N-CA-C 120.191 2.836 . . . . 50.51 120.191 -177.249 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -95.87 169.05 10.26 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 120.066 -1.843 . . . . 50.64 112.669 176.524 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -100.41 153.92 18.94 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 114.167 1.173 . . . . 50.51 114.167 177.082 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.8 mt -55.28 -30.84 60.92 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.238 0.962 . . . . 50.51 112.059 177.254 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -75.23 -28.89 60.08 Favored 'General case' 0 C--O 1.268 2.039 0 C-N-CA 117.375 -1.73 . . . . 50.51 109.422 -179.434 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -53.44 -42.38 67.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.457 1.123 . . . . 50.62 112.401 179.836 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -91.18 20.15 5.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 117.779 -1.105 . . . . 50.51 113.266 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 m120 44.71 24.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 120.024 3.342 . . . . 50.55 120.024 179.976 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.19 127.92 34.63 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 N-CA-C 101.628 -3.471 . . . . 50.51 101.628 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' LYS . 44.8 mt-30 -132.37 159.98 37.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 125.946 2.029 . . . . 50.55 106.699 -176.795 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 62' ' ' GLN . 34.3 ttpt -43.09 146.61 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.707 -1.96 . . . . 50.51 105.707 -177.019 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 66.4 50.5 1.29 Allowed 'General case' 0 C--O 1.257 1.477 0 CA-C-N 112.5 -2.136 . . . . 50.62 114.734 179.558 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -124.91 142.97 51.11 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.827 -1.079 . . . . 50.51 108.436 174.847 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -91.91 135.52 33.87 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.276 -0.868 . . . . 50.51 109.119 175.87 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.77 136.76 53.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 114.669 -2.586 . . . . 50.51 105.323 175.11 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -95.23 128.3 41.96 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 127.453 2.971 . . . . 50.51 112.17 177.899 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.45 119.26 32.89 Favored 'General case' 0 C--O 1.282 2.764 0 CA-C-O 117.71 -1.138 . . . . 50.51 113.789 176.557 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.07 140.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.676 -2.713 . . . . 50.51 103.676 175.084 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -111.39 135.12 52.39 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.023 1.12 . . . . 50.51 114.023 178.462 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -116.29 115.97 26.91 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 113.324 -3.227 . . . . 50.64 107.894 177.265 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -99.75 168.17 10.09 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 117.876 2.547 . . . . 50.51 117.876 -179.334 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -77.26 123.36 26.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 113.739 -1.573 . . . . 50.64 109.597 -179.602 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 154.42 5.85 Favored Glycine 0 C--O 1.244 0.724 0 CA-C-N 114.605 -1.179 . . . . 50.51 114.458 179.37 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 CA-C-O 116.37 -2.35 . . . . 50.51 118.366 179.233 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtp . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 104.905 -2.257 . . . . 50.51 104.905 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -87.34 142.13 28.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.957 2.66 . . . . 50.55 109.191 178.32 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.86 174.03 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 116.012 -1.947 . . . . 50.51 105.937 173.324 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 66' ' ' THR . 77.5 m-85 -122.88 126.47 47.37 Favored 'General case' 0 N--CA 1.513 2.688 1 O-C-N 129.858 4.474 . . . . 50.51 113.505 179.558 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 114.86 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 113.373 -3.203 . . . . 50.51 115.835 175.753 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -79.76 121.1 24.93 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.346 4.154 . . . . 50.51 118.167 -178.045 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.68 HG23 HD21 ' A' ' 69' ' ' LEU . 24.7 p -96.64 177.16 5.75 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 120.831 3.641 . . . . 50.51 120.831 179.917 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.84 17.73 4.62 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.072 0.858 . . . . 50.51 109.674 -178.014 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -124.18 14.49 9.06 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 115.741 -2.384 . . . . 50.51 112.587 179.929 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.09 14.95 81.29 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 107.75 -2.14 . . . . 50.51 107.75 179.807 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -104.91 147.1 28.12 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 116.831 -1.557 . . . . 50.51 112.915 174.977 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -119.01 134.8 54.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 126.637 2.461 . . . . 50.51 106.354 176.113 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.1 mt -97.37 147.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.477 2.986 . . . . 50.51 112.74 179.706 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 m -109.99 125.13 52.56 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.287 -1.765 . . . . 50.51 106.692 178.136 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -126.12 141.89 51.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.875 -2.268 . . . . 50.51 104.875 -179.27 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -116.45 112.51 21.54 Favored 'General case' 0 N--CA 1.5 2.034 1 O-C-N 129.243 4.089 . . . . 50.62 109.392 173.962 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 56' ' ' LEU . 33.8 m -106.97 171.42 2.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.214 0 O-C-N 127.694 3.121 . . . . 50.51 114.6 -177.943 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 75.9 tt0 -111.3 143.15 27.84 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 112.21 -2.268 . . . . 50.62 106.057 174.556 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.2 Cg_exo -55.0 -24.44 39.78 Favored 'Trans proline' 0 C--N 1.32 -0.933 0 C-N-CA 122.564 2.176 . . . . 50.51 111.953 177.737 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -82.13 -17.8 45.14 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 114.348 1.24 . . . . 50.51 114.348 -177.537 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.93 163.42 27.49 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.451 -1.7 . . . . 50.62 112.123 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.597 ' O ' HG21 ' A' ' 26' ' ' VAL . 33.3 p -95.62 -165.48 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.876 -0.602 . . . . 50.51 111.085 175.7 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -87.01 -40.86 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 127.171 2.794 . . . . 50.51 108.181 175.716 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 16.8 tp10 -52.46 -42.56 64.31 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 107.534 -1.284 . . . . 50.62 107.534 177.021 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.17 -49.77 72.97 Favored 'General case' 0 C--O 1.249 1.038 0 C-N-CA 124.352 1.061 . . . . 50.55 113.405 -179.656 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 22' ' ' THR . 91.1 t -57.78 -42.65 82.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.999 1.437 . . . . 50.51 111.95 178.645 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 93.3 mttt -65.95 -37.06 85.03 Favored 'General case' 0 C--O 1.257 1.481 0 N-CA-C 106.535 -1.654 . . . . 50.51 106.535 -179.693 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 31' ' ' GLN . . . -63.88 -45.19 90.53 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 113.186 0.809 . . . . 50.51 113.186 176.911 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -44.18 -36.7 2.77 Favored 'General case' 0 C--O 1.255 1.348 0 O-C-N 120.375 -1.453 . . . . 50.51 108.8 175.973 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 HG21 HE22 ' A' ' 41' ' ' GLN . 58.8 mt -72.88 -33.44 43.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.487 -0.885 . . . . 50.51 110.492 179.895 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 28' ' ' ALA . 55.4 tt0 -54.95 -41.61 71.29 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.581 2.61 . . . . 50.55 108.434 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.73 -20.53 57.03 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 113.631 -1.622 . . . . 50.62 115.104 179.173 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 31.0 mmmt -110.37 -36.15 5.87 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.413 -2.115 . . . . 50.51 110.828 -175.703 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.55 -54.79 3.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 123.121 2.691 . . . . 50.62 108.627 179.861 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 18.77 4.06 Favored Glycine 0 CA--C 1.477 -2.288 0 N-CA-C 103.565 -3.814 . . . . 50.51 103.565 176.55 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.474 HG23 ' HD2' ' A' ' 37' ' ' PRO . 73.5 mt -103.74 135.89 19.29 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 116.785 2.143 . . . . 50.51 116.785 179.637 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 36' ' ' ILE . 78.2 Cg_exo -56.98 137.02 80.12 Favored 'Trans proline' 0 C--O 1.259 1.546 0 C-N-CA 123.084 2.523 . . . . 50.51 110.919 178.317 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -57.23 -32.14 92.72 Favored 'Trans proline' 0 C--O 1.262 1.687 0 O-C-N 122.914 0.955 . . . . 50.51 113.391 -179.298 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -64.71 -18.68 65.22 Favored 'General case' 0 C--O 1.263 1.767 0 N-CA-C 117.422 2.379 . . . . 50.62 117.422 -177.401 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -81.45 -15.61 54.55 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.573 -1.33 . . . . 50.55 109.072 178.719 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.44 HE22 HG21 ' A' ' 30' ' ' ILE . 61.9 mt-30 -100.71 130.09 46.7 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 124.48 2.086 . . . . 50.55 112.444 -177.6 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -111.65 137.61 49.29 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.648 -1.644 . . . . 50.64 110.507 172.14 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.603 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 35.2 mt -116.24 129.45 56.29 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.904 1.446 . . . . 50.51 114.904 -177.456 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -114.77 127.15 72.42 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 O-C-N 125.085 1.491 . . . . 50.51 111.278 -177.6 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -139.81 107.06 5.5 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 106.99 -1.485 . . . . 50.51 106.99 177.652 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.43 41.73 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.228 -2.26 . . . . 50.51 105.53 177.383 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.96 -51.51 2.0 Allowed Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 128.434 2.921 . . . . 50.51 116.588 -179.605 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -40.2 148.32 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 116.747 2.128 . . . . 50.51 116.747 177.718 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -82.42 146.08 29.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.042 -2.207 . . . . 50.55 105.042 174.598 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 43' ' ' LEU . 32.1 mt -100.03 142.35 31.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.102 -1.444 . . . . 50.51 107.102 -175.888 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.04 156.55 17.85 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.106 -1.442 . . . . 50.62 107.106 -177.72 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 74.8 m-20 -82.99 -39.1 21.75 Favored 'General case' 0 C--O 1.264 1.837 0 C-N-CA 126.159 1.784 . . . . 50.62 108.242 -175.8 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.41 2.07 87.74 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 116.288 1.275 . . . . 50.51 116.288 -177.201 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -95.73 161.01 14.21 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 119.91 -1.935 . . . . 50.64 106.027 176.515 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 22.8 p -98.37 170.29 8.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.403 -0.962 . . . . 50.51 108.403 177.129 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' CD2' HG22 ' A' ' 17' ' ' VAL . 4.1 mp -65.31 -16.91 64.07 Favored 'General case' 0 C--O 1.201 -1.498 0 N-CA-C 107.767 -1.198 . . . . 50.51 107.767 177.255 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 p -70.71 -23.66 62.51 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 116.47 2.026 . . . . 50.51 116.47 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.21 -37.66 80.96 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.107 2.262 . . . . 50.62 117.107 179.773 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -101.19 4.52 42.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 117.765 -1.112 . . . . 50.51 109.716 179.299 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 56.39 54.93 7.05 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 103.862 -2.644 . . . . 50.55 103.862 179.869 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.17 132.76 31.62 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 115.224 -2.322 . . . . 50.51 105.818 175.86 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -117.3 172.94 6.97 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.771 2.508 . . . . 50.55 117.771 -176.815 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -68.08 133.09 48.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 123.187 1.47 . . . . 50.51 113.737 -176.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.12 42.97 30.28 Favored 'General case' 0 C--O 1.256 1.436 0 N-CA-C 116.855 2.168 . . . . 50.62 116.855 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.6 p -85.46 166.27 16.48 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 104.315 -2.476 . . . . 50.51 104.315 174.796 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 46.9 p -114.94 132.72 56.47 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.816 -1.55 . . . . 50.51 106.816 175.975 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.6 mp -108.37 160.33 15.95 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 114.7 -2.572 . . . . 50.51 112.396 175.012 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.67 132.07 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.383 2.927 . . . . 50.51 109.765 177.947 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.68 HD21 HG23 ' A' ' 7' ' ' THR . 30.3 tp -112.78 125.37 54.26 Favored 'General case' 0 C--O 1.282 2.78 0 CA-C-O 117.657 -1.163 . . . . 50.51 109.467 176.525 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.84 139.97 39.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 105.165 -2.161 . . . . 50.51 105.165 175.087 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.2 mt -100.42 130.0 46.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.573 -2.01 . . . . 50.51 105.573 178.397 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -122.89 113.07 18.62 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 101.358 -3.571 . . . . 50.64 101.358 177.175 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.81 166.31 11.69 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.78 1.925 . . . . 50.51 111.032 -179.287 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.07 96.73 9.96 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 118.874 2.916 . . . . 50.64 118.874 -179.592 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.24 -168.62 12.63 Favored Glycine 0 C--O 1.243 0.679 0 N-CA-C 107.136 -2.385 . . . . 50.51 107.136 179.361 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.477 0 CA-C-O 116.31 -2.383 . . . . 50.51 110.028 179.212 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.495 ' CE ' ' HD2' ' A' ' 63' ' ' LYS . 81.4 mmm . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.081 0.771 . . . . 50.51 113.081 . . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -95.5 124.07 39.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.902 2.626 . . . . 50.55 115.59 178.29 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.39 152.72 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.984 -1.96 . . . . 50.51 109.264 173.317 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.557 ' CE2' ' OG1' ' A' ' 14' ' ' THR . 53.6 m-85 -106.52 141.71 37.36 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.386 4.804 . . . . 50.51 116.464 179.533 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' HB ' HG12 ' A' ' 13' ' ' ILE . 85.9 t -113.13 110.4 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 113.435 -3.174 . . . . 50.51 110.211 175.719 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -83.34 130.74 35.07 Favored 'General case' 0 N--CA 1.505 2.276 1 O-C-N 129.353 4.158 . . . . 50.51 106.732 -178.064 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.66 -173.65 2.52 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 117.846 -1.073 . . . . 50.51 108.973 179.928 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -90.34 -16.81 28.46 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.854 1.427 . . . . 50.51 114.854 -177.959 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -101.33 -3.14 29.38 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 115.695 -2.402 . . . . 50.51 116.879 179.962 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.41 1.38 Allowed Glycine 0 C--N 1.297 -1.614 0 N-CA-C 117.366 1.706 . . . . 50.51 117.366 179.781 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -54.9 143.02 27.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 116.069 1.877 . . . . 50.51 116.069 175.013 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -124.14 136.45 54.22 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 126.619 2.449 . . . . 50.51 112.919 176.11 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.47 HG12 ' HB ' ' A' ' 5' ' ' VAL . 17.3 pt -106.67 125.18 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.464 2.978 . . . . 50.51 107.182 179.774 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.557 ' OG1' ' CE2' ' A' ' 4' ' ' PHE . 43.7 m -98.65 134.98 40.81 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.294 -1.762 . . . . 50.51 112.953 178.123 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -117.01 154.73 30.42 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 115.492 -2.194 . . . . 50.51 114.072 -179.29 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.7 tt0 -114.94 99.3 7.37 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 129.172 4.045 . . . . 50.62 109.17 174.005 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.88 155.46 15.07 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.781 3.175 . . . . 50.51 116.308 -177.967 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -107.3 135.33 19.67 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 104.518 -2.401 . . . . 50.62 104.518 174.63 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 57' ' ' SER . 84.3 Cg_exo -54.95 -24.52 39.72 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 122.54 2.16 . . . . 50.51 111.931 177.765 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -76.99 -0.23 23.63 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 118.102 -0.952 . . . . 50.51 109.269 -177.585 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' O ' ' HB ' ' A' ' 55' ' ' THR . 92.1 m-20 -72.76 178.21 4.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 117.378 -1.729 . . . . 50.62 109.31 -179.01 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 26' ' ' VAL . 33.1 p -106.3 167.44 9.83 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 103.074 -2.936 . . . . 50.51 103.074 175.741 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -67.34 -45.99 84.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 O-C-N 126.975 2.672 . . . . 50.51 107.788 175.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -54.71 -48.41 72.52 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.42 -0.8 . . . . 50.62 112.376 177.017 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -48.61 -49.23 37.91 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.468 -1.308 . . . . 50.55 107.468 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 22' ' ' THR . 95.8 t -52.07 -52.65 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 125.069 1.481 . . . . 50.51 113.436 178.528 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -72.81 -23.05 60.73 Favored 'General case' 0 C--O 1.257 1.486 0 CA-C-N 115.755 -0.657 . . . . 50.51 109.356 -179.745 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.3 95.04 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.334 -2.099 . . . . 50.51 105.334 176.973 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.38 -48.81 60.04 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 114.995 1.48 . . . . 50.51 114.995 175.933 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -56.32 -52.6 49.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 103.796 -2.668 . . . . 50.51 103.796 179.871 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.501 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.6 tt0 -38.32 -73.56 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 125.567 2.603 . . . . 50.55 110.301 179.391 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -39.76 -59.13 1.22 Allowed 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.671 -1.604 . . . . 50.62 114.382 179.098 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -82.43 -42.66 18.28 Favored 'General case' 0 C--O 1.279 2.623 0 N-CA-C 119.941 3.312 . . . . 50.51 119.941 -175.677 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.18 -30.97 22.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 123.058 2.663 . . . . 50.62 105.776 179.828 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.63 22.76 23.08 Favored Glycine 0 CA--C 1.477 -2.31 0 N-CA-C 118.867 2.307 . . . . 50.51 118.867 176.564 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 59.2 mt -105.14 122.23 43.75 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 118.753 -1.179 . . . . 50.51 110.216 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.4 Cg_exo -56.97 136.94 79.64 Favored 'Trans proline' 0 C--O 1.259 1.537 0 C-N-CA 123.207 2.605 . . . . 50.51 110.879 178.348 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -57.15 -32.17 92.62 Favored 'Trans proline' 0 C--O 1.261 1.661 0 O-C-N 122.926 0.961 . . . . 50.51 113.486 -179.376 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.45 -0.33 1.88 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 119.973 -1.705 . . . . 50.62 115.303 -177.448 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -126.91 18.74 7.2 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.5 -1.375 . . . . 50.55 113.503 178.709 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -110.3 141.47 43.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.299 2.0 . . . . 50.55 110.246 -177.582 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -128.62 136.67 50.99 Favored 'General case' 0 C--O 1.297 3.557 0 CA-C-O 116.726 -1.607 . . . . 50.64 107.496 172.157 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 69' ' ' LEU . 60.3 mt -135.94 124.45 23.56 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.464 1.029 . . . . 50.51 110.586 -177.538 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -122.62 122.53 66.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.121 1.513 . . . . 50.51 108.685 -177.589 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -143.06 139.03 30.34 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 114.514 -1.221 . . . . 50.51 112.103 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 20.48 10.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 112.271 -2.24 . . . . 50.51 114.865 177.398 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -21.76 27.32 Favored Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 128.493 2.949 . . . . 50.51 109.173 -179.654 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.74 177.79 7.89 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 118.087 0.943 . . . . 50.51 111.707 177.65 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -109.59 149.59 29.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 123.99 0.806 . . . . 50.55 109.481 174.579 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.81 101.71 10.35 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 104.918 -2.253 . . . . 50.51 104.918 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -101.91 153.23 20.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.916 1.385 . . . . 50.62 113.765 -177.66 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.45 -44.55 96.15 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 115.969 1.84 . . . . 50.62 115.969 -175.795 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.99 -15.21 3.23 Favored Glycine 0 C--O 1.253 1.333 0 N-CA-C 116.118 1.207 . . . . 50.51 116.118 -177.226 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -131.37 145.78 51.99 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 118.838 2.903 . . . . 50.64 118.838 176.506 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 21' ' ' ASP . 70.7 p -68.94 172.35 6.74 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 115.279 1.585 . . . . 50.51 115.279 177.189 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.543 HD23 HG13 ' A' ' 61' ' ' ILE . 35.5 mt -59.47 -49.39 77.98 Favored 'General case' 0 C--O 1.201 -1.477 0 O-C-N 124.156 0.91 . . . . 50.51 108.789 177.188 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' PRO . 9.4 t -47.52 -47.87 27.66 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 117.298 -1.761 . . . . 50.51 112.454 -179.444 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -48.45 -26.36 2.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.236 1.569 . . . . 50.62 115.236 179.767 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CD2' ' O ' ' A' ' 55' ' ' THR . 66.9 m-85 -95.01 5.8 50.88 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 117.793 2.516 . . . . 50.51 117.793 179.222 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.518 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 63.4 m-20 68.81 9.71 7.52 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 121.534 1.97 . . . . 50.55 114.52 179.909 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.543 HG13 HD23 ' A' ' 56' ' ' LEU . 26.6 mm -50.97 117.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.99 0 CA-C-O 115.141 -2.361 . . . . 50.51 109.155 175.776 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 72.2 mt-30 -123.93 179.53 4.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 126.147 2.155 . . . . 50.55 105.837 -176.811 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.495 ' HD2' ' CE ' ' A' ' 1' ' ' MET . 82.9 tttt -68.2 146.52 53.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.202 1.477 . . . . 50.51 108.35 -176.921 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 46.8 67.4 0.79 Allowed 'General case' 0 C--O 1.256 1.429 0 N-CA-C 120.868 3.655 . . . . 50.62 120.868 179.538 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.5 p -121.04 172.07 8.21 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 106.966 -1.494 . . . . 50.51 106.966 174.798 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 p -111.96 118.17 34.73 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 115.604 1.705 . . . . 50.51 115.604 175.982 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.05 138.03 34.27 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 114.647 -2.596 . . . . 50.51 107.617 175.08 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -97.96 122.48 41.14 Favored 'General case' 0 C--N 1.285 -2.236 0 O-C-N 127.383 2.927 . . . . 50.51 112.859 177.886 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HA ' HD21 ' A' ' 43' ' ' LEU . 42.1 tp -90.14 131.91 35.73 Favored 'General case' 0 C--O 1.283 2.83 0 N-CA-C 115.551 1.686 . . . . 50.51 115.551 176.519 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -120.9 129.28 75.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 103.253 -2.869 . . . . 50.51 103.253 175.109 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.55 123.93 44.28 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.178 0.513 . . . . 50.51 110.13 178.424 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -112.19 91.44 3.66 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.41 -3.186 . . . . 50.64 110.839 177.247 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.87 163.0 28.61 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.811 1.945 . . . . 50.51 108.282 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.9 ttm105 -87.16 107.35 18.42 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 116.366 1.987 . . . . 50.64 116.366 -179.544 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.84 151.94 23.58 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 114.66 -1.154 . . . . 50.51 114.59 179.394 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.336 -2.369 . . . . 50.51 113.943 179.22 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 36.7 mmt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 105.584 -2.006 . . . . 50.51 105.584 . . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -100.73 135.85 41.53 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.965 2.666 . . . . 50.55 107.301 178.239 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.464 ' C ' HD13 ' A' ' 3' ' ' ILE . 2.8 pp -137.29 154.93 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 115.961 -1.971 . . . . 50.51 108.392 173.316 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.39 149.49 23.12 Favored 'General case' 0 N--CA 1.511 2.602 1 O-C-N 130.475 4.86 . . . . 50.51 115.331 179.558 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.52 122.11 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 101.949 -3.352 . . . . 50.51 101.949 175.73 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.503 2.198 1 O-C-N 129.322 4.139 . . . . 50.51 105.737 -178.074 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -87.31 -171.97 3.72 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 117.746 -1.121 . . . . 50.51 111.573 179.983 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.94 19.73 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.085 0.866 . . . . 50.51 112.175 -177.974 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -130.8 -14.49 3.56 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 115.706 -2.398 . . . . 50.51 115.874 179.921 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.83 29.21 4.45 Favored Glycine 0 C--N 1.296 -1.672 0 O-C-N 120.006 -1.684 . . . . 50.51 109.105 179.833 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.67 123.0 47.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 116.891 -1.528 . . . . 50.51 111.611 174.997 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p -109.21 131.94 54.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 118.001 2.593 . . . . 50.51 118.001 176.14 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -113.07 157.4 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 127.209 2.818 . . . . 50.51 106.143 179.741 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -112.83 140.13 47.88 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.274 -1.77 . . . . 50.51 109.73 178.131 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 mt -122.1 171.16 9.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 115.488 -2.196 . . . . 50.51 113.214 -179.293 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' H ' ' HE2' ' A' ' 29' ' ' LYS . 71.7 tt0 -128.94 109.85 11.59 Favored 'General case' 0 N--CA 1.5 2.032 1 O-C-N 129.104 4.003 . . . . 50.62 112.573 173.976 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.22 172.36 8.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.722 3.139 . . . . 50.51 114.387 -177.939 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 42.6 mt-10 -129.75 150.33 75.49 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 112.224 -2.262 . . . . 50.62 108.179 174.638 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.9 -24.53 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.562 2.174 . . . . 50.51 111.887 177.744 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -81.36 -19.96 41.63 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 118.154 -0.926 . . . . 50.51 109.737 -177.52 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.63 139.59 58.78 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.352 -1.739 . . . . 50.62 108.165 -179.053 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 156.03 18.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 105.125 -2.176 . . . . 50.51 105.125 175.691 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -49.24 -33.66 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 O-C-N 127.201 2.813 . . . . 50.51 112.734 175.787 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -72.37 -16.61 61.86 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 113.917 1.08 . . . . 50.62 113.917 177.034 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 25' ' ' ASN . 64.4 t-20 -98.7 -9.0 25.22 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.305 1.042 . . . . 50.55 109.217 -179.663 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -91.32 -43.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 104.981 -2.229 . . . . 50.51 104.981 178.588 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 30' ' ' ILE . 53.8 mtmt -64.38 -58.41 6.56 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 113.294 0.85 . . . . 50.51 113.294 -179.806 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.8 -34.11 3.51 Favored 'General case' 0 C--O 1.279 2.608 0 CA-C-N 117.984 0.356 . . . . 50.51 110.058 176.851 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' HE2' ' H ' ' A' ' 16' ' ' GLU . 66.1 tttp -62.84 -31.89 73.0 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.383 -1.448 . . . . 50.51 109.787 175.95 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' LYS . 70.0 mt -77.42 -35.03 21.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 105.709 -1.96 . . . . 50.51 105.709 179.903 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.444 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 17.8 tm0? -47.11 -36.72 8.69 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 125.564 2.602 . . . . 50.55 115.246 179.46 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -69.58 -32.24 70.89 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 113.664 -1.607 . . . . 50.62 113.743 179.131 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -99.77 -7.21 25.8 Favored 'General case' 0 C--O 1.279 2.641 0 C-N-CA 116.473 -2.091 . . . . 50.51 115.925 -175.671 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -121.97 -32.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 123.063 2.665 . . . . 50.62 110.136 179.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.55 12.57 60.88 Favored Glycine 0 CA--C 1.478 -2.222 0 N-CA-C 104.703 -3.359 . . . . 50.51 104.703 176.543 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 21.9 mm -98.3 125.64 42.63 Favored Pre-proline 0 C--O 1.245 0.818 0 N-CA-C 104.462 -2.422 . . . . 50.51 104.462 179.653 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.2 Cg_exo -57.04 136.94 79.66 Favored 'Trans proline' 0 C--O 1.259 1.528 0 C-N-CA 123.154 2.569 . . . . 50.51 110.922 178.353 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' CG ' ' A' ' 31' ' ' GLN . 87.4 Cg_exo -57.18 -32.17 92.7 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.918 0.957 . . . . 50.51 113.398 -179.268 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.45 -18.75 65.54 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 119.918 -1.739 . . . . 50.62 106.65 -177.489 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.36 -1.29 56.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.23 1.937 . . . . 50.55 116.23 178.724 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.415 HE22 ' HB ' ' A' ' 30' ' ' ILE . 57.6 mt-30 -86.74 151.48 23.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.363 2.03 . . . . 50.55 110.256 -177.575 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.583 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 75.3 ttt180 -133.54 106.96 7.72 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.671 -1.633 . . . . 50.64 109.224 172.151 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 50' ' ' LEU . 6.7 mp -98.05 136.33 38.46 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.483 1.038 . . . . 50.51 113.488 -177.472 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.75 124.97 57.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 O-C-N 125.111 1.507 . . . . 50.51 113.16 -177.608 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -138.35 118.08 13.15 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 114.472 1.286 . . . . 50.51 114.472 177.673 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 35.57 18.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.291 -2.232 . . . . 50.51 106.186 177.349 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 8.0 84.69 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 128.437 2.922 . . . . 50.51 116.237 -179.596 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -101.87 141.45 34.7 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 118.058 0.929 . . . . 50.51 113.213 177.665 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -84.46 120.73 26.65 Favored 'General case' 0 C--O 1.259 1.599 0 O-C-N 123.977 0.798 . . . . 50.55 109.235 174.599 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 43' ' ' LEU . 44.9 mt -60.98 126.23 26.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 117.726 -1.13 . . . . 50.51 110.757 -175.883 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.16 132.14 40.42 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.973 1.42 . . . . 50.62 114.002 -177.713 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.82 -58.31 5.01 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 103.631 -2.729 . . . . 50.62 103.631 -175.871 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.72 1.66 28.65 Favored Glycine 0 CA--C 1.493 -1.297 0 N-CA-C 118.34 2.096 . . . . 50.51 118.34 -177.174 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -109.81 144.96 37.52 Favored 'General case' 0 C--O 1.249 1.034 0 O-C-N 119.696 -2.061 . . . . 50.64 106.479 176.425 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -91.31 162.49 14.59 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 117.183 2.29 . . . . 50.51 117.183 177.109 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.732 ' HG ' ' HB ' ' A' ' 61' ' ' ILE . 2.7 mp -46.84 -25.92 0.86 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.14 0.9 . . . . 50.51 109.5 177.187 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.9 p -71.84 -36.91 70.3 Favored 'General case' 0 C--O 1.269 2.096 0 C-N-CA 117.314 -1.755 . . . . 50.51 114.309 -179.468 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.2 -25.29 67.71 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.472 1.13 . . . . 50.62 113.699 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.46 24.09 11.59 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 117.805 -1.093 . . . . 50.51 112.609 179.193 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 t30 37.16 54.18 1.25 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 118.865 2.913 . . . . 50.55 118.865 179.896 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.732 ' HB ' ' HG ' ' A' ' 56' ' ' LEU . 40.9 mm -88.82 100.15 10.2 Favored 'Isoleucine or valine' 0 C--O 1.267 2.017 0 CA-C-O 115.144 -2.36 . . . . 50.51 112.488 175.861 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -108.85 -178.58 3.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.155 2.16 . . . . 50.55 111.715 -176.864 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 64.0 tttm -67.63 144.62 55.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.094 -2.928 . . . . 50.51 103.094 -176.935 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 67.43 21.82 9.55 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 118.641 2.83 . . . . 50.62 118.641 179.559 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -73.96 174.24 8.85 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.15 1.907 . . . . 50.51 116.15 174.857 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -117.2 110.56 18.29 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.472 1.656 . . . . 50.51 115.472 175.981 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.7 113.83 27.04 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 114.655 -2.593 . . . . 50.51 115.949 175.042 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.35 136.89 37.12 Favored 'General case' 0 C--N 1.285 -2.216 0 O-C-N 127.457 2.973 . . . . 50.51 115.542 177.905 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -106.95 114.68 28.91 Favored 'General case' 0 C--O 1.281 2.763 0 N-CA-C 115.546 1.684 . . . . 50.51 115.546 176.578 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.583 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -111.75 137.91 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 104.908 -2.256 . . . . 50.51 104.908 175.121 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.92 157.57 28.21 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.403 0.89 . . . . 50.51 113.403 178.467 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 ttm105 -132.03 77.31 1.75 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 101.997 -3.335 . . . . 50.64 101.997 177.184 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -84.24 114.39 21.79 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 125.803 1.939 . . . . 50.51 111.716 -179.306 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -70.31 108.67 4.31 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.709 -1.587 . . . . 50.64 112.725 -179.635 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 -170.9 13.48 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 107.962 -2.055 . . . . 50.51 107.962 179.407 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 106.944 -2.462 . . . . 50.51 106.944 179.161 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 23.9 mmt . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 118.802 -0.618 . . . . 50.51 111.202 . . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -92.41 147.35 22.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.941 2.65 . . . . 50.55 106.999 178.287 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.528 HD11 HG22 ' A' ' 17' ' ' VAL . 35.1 pt -145.94 151.47 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.453 -2.054 . . . . 50.51 105.453 173.347 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 14' ' ' THR . 97.4 m-85 -103.19 143.52 32.52 Favored 'General case' 0 N--CA 1.512 2.671 1 O-C-N 130.502 4.876 . . . . 50.51 112.212 179.503 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.96 116.17 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 113.36 -3.21 . . . . 50.51 110.554 175.797 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HD3' HG23 ' A' ' 12' ' ' THR . 25.1 mmtp -73.39 160.74 31.34 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.363 4.165 . . . . 50.51 112.885 -178.08 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -134.49 -165.44 1.66 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.491 -1.3 . . . . 50.51 107.491 179.942 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.7 mt -94.73 -33.83 12.77 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.297 -2.112 . . . . 50.51 105.297 -177.965 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -75.68 -9.26 58.44 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 115.744 -2.383 . . . . 50.51 117.254 179.914 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.57 4.22 58.22 Favored Glycine 0 C--N 1.296 -1.642 0 O-C-N 120.194 -1.566 . . . . 50.51 116.153 179.748 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HE3' HG22 ' A' ' 13' ' ' ILE . 50.6 tptt -76.08 129.01 36.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 116.838 -1.553 . . . . 50.51 109.37 175.061 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.504 HG23 ' HD3' ' A' ' 6' ' ' LYS . 33.9 p -111.93 107.91 17.07 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 126.686 2.491 . . . . 50.51 107.119 176.215 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.459 HG22 ' HE3' ' A' ' 11' ' ' LYS . 26.9 pt -97.17 147.87 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 127.352 2.907 . . . . 50.51 114.29 179.643 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' CE1' ' A' ' 4' ' ' PHE . 20.7 p -94.13 153.75 17.94 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 101.438 -3.542 . . . . 50.51 101.438 178.164 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.33 149.27 49.69 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.64 -2.356 . . . . 50.51 104.64 -179.303 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -100.33 120.56 40.12 Favored 'General case' 0 N--CA 1.499 2.009 1 O-C-N 129.266 4.104 . . . . 50.62 109.741 173.955 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.528 HG22 HD11 ' A' ' 3' ' ' ILE . 18.8 m -131.7 166.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.673 3.108 . . . . 50.51 107.743 -177.987 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -125.86 143.49 45.46 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 112.185 -2.28 . . . . 50.62 106.18 174.733 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.94 -24.62 40.14 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.606 2.204 . . . . 50.51 111.905 177.702 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -69.87 -44.9 68.85 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 117.536 2.421 . . . . 50.51 117.536 -177.512 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.7 154.07 34.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 117.393 -1.723 . . . . 50.62 113.773 -178.992 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.416 ' C ' ' N ' ' A' ' 24' ' ' GLU . 44.9 p -84.5 157.79 21.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.834 1.05 . . . . 50.51 113.834 175.642 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -49.13 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 O-C-N 127.18 2.8 . . . . 50.51 105.858 175.793 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.507 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 41.2 tt0 -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 120.388 3.477 . . . . 50.62 120.388 177.05 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 73.1 m-80 -98.69 -38.02 9.27 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 102.963 -2.977 . . . . 50.55 102.963 -179.562 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.56 -59.0 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 125.069 1.481 . . . . 50.51 113.507 178.681 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 24' ' ' GLU . 54.8 pttt -53.11 -45.82 68.43 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 109.241 -0.652 . . . . 50.51 109.241 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.35 75.56 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 119.665 3.209 . . . . 50.51 119.665 176.797 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 94.1 mttt -52.92 -40.95 63.99 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.384 -1.447 . . . . 50.51 107.303 176.033 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . 87.1 mt -67.59 -21.94 28.0 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 N-CA-C 113.406 0.891 . . . . 50.51 113.406 179.882 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -58.57 -33.96 70.53 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.586 2.612 . . . . 50.55 106.395 179.473 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.06 -27.86 67.72 Favored 'General case' 0 C--O 1.253 1.271 0 N-CA-C 116.411 2.004 . . . . 50.62 116.411 179.16 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -107.08 -26.14 11.26 Favored 'General case' 0 C--O 1.279 2.643 0 C-N-CA 116.473 -2.091 . . . . 50.51 113.955 -175.669 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -109.22 -46.74 3.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.074 2.67 . . . . 50.62 110.337 179.869 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 10.1 20.56 Favored Glycine 0 CA--C 1.477 -2.292 0 N-CA-C 110.097 -1.201 . . . . 50.51 110.097 176.575 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 36.9 mm -83.42 124.21 75.98 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 106.671 -1.603 . . . . 50.51 106.671 179.693 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.4 Cg_exo -57.05 136.92 79.54 Favored 'Trans proline' 0 C--O 1.259 1.554 0 C-N-CA 123.159 2.573 . . . . 50.51 110.883 178.327 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -57.17 -32.19 92.71 Favored 'Trans proline' 0 C--O 1.261 1.64 0 O-C-N 122.886 0.94 . . . . 50.51 113.363 -179.265 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.99 -15.48 63.04 Favored 'General case' 0 C--O 1.262 1.722 0 O-C-N 119.92 -1.737 . . . . 50.62 108.114 -177.41 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.4 12.92 35.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.971 1.471 . . . . 50.55 114.971 178.758 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -114.94 119.67 37.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.428 2.061 . . . . 50.55 110.587 -177.705 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -119.92 116.9 26.74 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.694 -1.622 . . . . 50.64 107.394 172.178 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.02 133.4 44.47 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.153 1.538 . . . . 50.51 115.153 -177.548 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -115.83 124.87 72.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 N-CA-C 117.106 2.261 . . . . 50.51 117.106 -177.6 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -126.13 118.2 24.74 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.573 -1.194 . . . . 50.51 112.605 177.617 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.69 40.68 29.09 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.276 -2.238 . . . . 50.51 111.591 177.391 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 6.6 42.62 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 128.391 2.9 . . . . 50.51 112.91 -179.584 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -91.22 127.06 36.51 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.284 -1.376 . . . . 50.51 107.284 177.699 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -76.64 122.19 24.31 Favored 'General case' 0 C--O 1.26 1.611 0 O-C-N 123.971 0.794 . . . . 50.55 109.141 174.621 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 mt -81.03 155.51 26.32 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 116.588 2.07 . . . . 50.51 116.588 -175.884 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 41.3 tp10 -106.01 142.11 36.27 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 125.024 1.452 . . . . 50.62 113.709 -177.755 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -59.96 -32.2 70.59 Favored 'General case' 0 C--O 1.263 1.794 0 C-N-CA 126.131 1.772 . . . . 50.62 111.404 -175.75 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.438 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -101.06 38.25 3.23 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 124.334 0.969 . . . . 50.51 113.772 -177.235 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -134.2 159.04 42.12 Favored 'General case' 0 C--O 1.248 1.009 0 O-C-N 118.037 -3.037 . . . . 50.64 105.106 176.464 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -91.02 172.07 8.83 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.022 0.929 . . . . 50.51 112.063 177.091 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.98 -37.87 66.87 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.193 0.933 . . . . 50.51 108.486 177.225 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 t -64.11 -39.0 93.1 Favored 'General case' 0 C--O 1.268 2.04 0 N-CA-C 116.601 2.074 . . . . 50.51 116.601 -179.401 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -55.55 -23.84 28.94 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.418 1.104 . . . . 50.62 111.692 179.773 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -97.52 -0.18 46.43 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 117.722 -1.133 . . . . 50.51 113.931 179.234 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.5 t30 69.89 21.34 6.35 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.36 1.985 . . . . 50.55 116.36 179.892 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.73 96.86 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.976 0 CA-C-O 115.206 -2.33 . . . . 50.51 112.232 175.858 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.54 ' O ' ' OG ' ' A' ' 65' ' ' SER . 21.7 pt20 -88.18 160.34 17.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 126.074 2.109 . . . . 50.55 111.758 -176.813 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 88.4 tttt -43.23 149.36 0.24 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.426 -2.065 . . . . 50.51 105.426 -177.034 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 97.6 mt-10 52.64 74.28 0.29 Allowed 'General case' 0 C--O 1.257 1.493 0 CA-C-N 112.522 -2.127 . . . . 50.62 107.909 179.633 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.54 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 69.1 m -119.45 132.39 55.79 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.743 -1.117 . . . . 50.51 111.249 174.801 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.3 m -81.43 121.37 26.17 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 118.187 -0.911 . . . . 50.51 113.287 175.94 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -111.56 143.93 41.62 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.707 -2.568 . . . . 50.51 111.404 175.06 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -94.79 136.66 34.83 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 126.809 2.568 . . . . 50.51 108.367 177.914 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' CB ' ' O ' ' A' ' 6' ' ' LYS . 65.9 tp -93.09 118.96 31.8 Favored 'General case' 0 C--O 1.282 2.794 0 CA-C-O 117.609 -1.186 . . . . 50.51 110.624 176.517 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.9 121.96 66.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.558 -1.275 . . . . 50.51 107.558 175.071 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.8 mt -96.01 128.18 42.67 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.674 0.62 . . . . 50.51 112.674 178.403 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.564 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 60.8 ttt85 -113.69 69.62 0.71 Allowed 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 120.313 3.449 . . . . 50.64 120.313 177.305 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.57 142.23 28.6 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 125.872 1.982 . . . . 50.51 114.841 -179.382 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -91.21 85.94 6.02 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.773 -1.558 . . . . 50.64 111.801 -179.629 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.3 -161.7 28.35 Favored Glycine 0 C--O 1.243 0.699 0 N-CA-C 108.705 -1.758 . . . . 50.51 108.705 179.339 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 116.322 -2.376 . . . . 50.51 111.287 179.257 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mmt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 101.467 -3.531 . . . . 50.51 101.467 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -103.85 129.51 51.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 126.961 2.663 . . . . 50.55 107.932 178.256 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 pt -119.72 157.49 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 116.04 -1.933 . . . . 50.51 110.386 173.353 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -106.23 139.21 41.1 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.407 4.817 . . . . 50.51 112.035 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -113.86 101.58 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.359 -3.21 . . . . 50.51 108.884 175.81 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -66.76 147.0 53.84 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.463 4.227 . . . . 50.51 112.322 -178.097 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.512 HG23 HD21 ' A' ' 69' ' ' LEU . 41.6 p -135.64 170.39 16.03 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.768 -1.111 . . . . 50.51 108.494 179.959 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -91.4 29.96 1.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.967 0.792 . . . . 50.51 112.414 -177.966 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.3 p -130.55 18.67 5.25 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 115.677 -2.409 . . . . 50.51 117.199 179.904 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.92 51.15 25.47 Favored Glycine 0 C--N 1.297 -1.591 0 O-C-N 120.109 -1.619 . . . . 50.51 111.271 179.763 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -160.2 123.69 3.55 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 115.225 1.565 . . . . 50.51 115.225 175.02 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -83.89 135.15 34.6 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 126.666 2.479 . . . . 50.51 114.566 176.137 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 mm -108.51 133.79 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.562 3.039 . . . . 50.51 106.079 179.717 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.8 p -104.27 154.31 19.95 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.553 2.057 . . . . 50.51 116.553 178.073 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.5 mt -140.62 139.65 34.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.49 -2.195 . . . . 50.51 113.33 -179.261 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.61 113.52 25.6 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 128.66 3.725 . . . . 50.62 103.548 173.988 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.24 -166.26 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.271 0 O-C-N 127.518 3.011 . . . . 50.51 105.312 -177.911 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -150.56 156.87 36.66 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.256 -2.247 . . . . 50.62 109.062 174.621 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.96 -24.53 39.89 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.622 2.215 . . . . 50.51 111.953 177.754 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.5 p -93.52 -7.36 44.47 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 115.541 1.682 . . . . 50.51 115.541 -177.546 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.21 135.6 52.28 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.29 -1.764 . . . . 50.62 114.821 -179.017 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -77.43 160.34 28.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.851 -0.613 . . . . 50.51 110.904 175.78 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -55.3 -40.03 54.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.153 2.783 . . . . 50.51 109.387 175.808 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -61.64 -40.77 96.09 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.422 -0.798 . . . . 50.62 111.568 176.95 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -64.05 -45.44 88.79 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 124.377 1.071 . . . . 50.55 112.781 -179.613 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 56' ' ' LEU . 91.5 t -55.83 -55.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.344 -1.724 . . . . 50.51 106.344 178.613 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -48.2 -30.12 4.37 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 113.072 0.768 . . . . 50.51 113.072 -179.813 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -35.88 74.5 Favored 'General case' 0 C--O 1.278 2.6 0 N-CA-C 114.379 1.251 . . . . 50.51 114.379 176.846 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -58.38 -43.36 88.45 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 104.256 -2.498 . . . . 50.51 104.256 176.03 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.77 -35.05 53.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.287 0 N-CA-C 115.219 1.563 . . . . 50.51 115.219 179.93 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -60.64 -32.07 71.25 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 125.593 2.616 . . . . 50.55 112.391 179.427 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -71.7 -52.1 19.53 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-N 113.568 -1.651 . . . . 50.62 109.803 179.131 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -78.82 -47.44 16.67 Favored 'General case' 0 C--O 1.279 2.616 0 C-N-CA 116.465 -2.094 . . . . 50.51 116.073 -175.656 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.79 -14.26 40.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 123.079 2.672 . . . . 50.62 117.047 179.819 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 13.02 83.97 Favored Glycine 0 CA--C 1.477 -2.32 0 CA-C-O 120.065 -0.297 . . . . 50.51 112.612 176.539 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 68.0 mt -91.33 123.47 64.0 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 115.554 1.687 . . . . 50.51 115.554 179.7 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.9 Cg_exo -56.93 136.9 79.33 Favored 'Trans proline' 0 C--O 1.26 1.617 0 C-N-CA 123.109 2.539 . . . . 50.51 111.006 178.268 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -57.2 -32.07 92.45 Favored 'Trans proline' 0 C--O 1.261 1.651 0 O-C-N 122.83 0.911 . . . . 50.51 113.45 -179.249 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -59.61 -12.49 6.81 Favored 'General case' 0 C--O 1.262 1.729 0 N-CA-C 117.768 2.507 . . . . 50.62 117.768 -177.463 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.517 ' O ' HD21 ' A' ' 71' ' ' LEU . 79.2 mt-30 -112.23 14.71 20.57 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.519 -1.363 . . . . 50.55 113.661 178.718 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -107.46 131.67 54.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.4 2.048 . . . . 50.55 115.36 -177.612 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.589 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 33.1 ttm180 -115.58 113.85 24.15 Favored 'General case' 0 C--O 1.296 3.524 0 CA-C-O 116.592 -1.671 . . . . 50.64 112.565 172.148 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.92 130.08 46.06 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 104.507 -2.405 . . . . 50.51 104.507 -177.501 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.549 HD12 ' HD3' ' A' ' 42' ' ' ARG . 89.4 mt -125.95 130.97 72.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.078 1.486 . . . . 50.51 112.746 -177.565 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.89 103.38 8.02 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 114.505 -1.225 . . . . 50.51 111.211 177.572 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.09 48.39 22.4 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.211 -2.268 . . . . 50.51 108.317 177.368 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.37 72.16 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 128.445 2.926 . . . . 50.51 115.154 -179.539 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -99.28 138.32 36.54 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.328 -0.99 . . . . 50.51 108.328 177.6 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -88.78 114.78 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.02 0.825 . . . . 50.55 112.617 174.616 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.36 128.18 35.67 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 117.679 -1.153 . . . . 50.51 113.899 -175.919 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -92.88 137.46 32.34 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.956 1.41 . . . . 50.62 107.43 -177.593 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.04 -44.14 67.15 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 118.367 2.728 . . . . 50.62 118.367 -175.784 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.38 -22.32 77.62 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 119.54 2.576 . . . . 50.51 119.54 -177.225 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -82.99 158.99 22.31 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 119.716 -2.049 . . . . 50.64 112.849 176.485 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -88.03 160.7 17.74 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 117.629 2.455 . . . . 50.51 117.629 177.044 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.522 HD11 HG22 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -55.61 -31.01 61.91 Favored 'General case' 0 C--O 1.2 -1.526 0 CA-C-N 115.473 -0.785 . . . . 50.51 110.912 177.243 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -71.62 -27.2 62.95 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.301 -1.76 . . . . 50.51 112.059 -179.485 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.96 -13.95 62.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.461 1.282 . . . . 50.62 114.461 179.769 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.585 ' HB2' HG12 ' A' ' 61' ' ' ILE . 53.5 m-85 -103.19 14.39 31.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 115.497 1.665 . . . . 50.51 115.497 179.25 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.9 t30 64.78 19.81 11.94 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 121.48 1.946 . . . . 50.55 109.459 179.855 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 59' ' ' TYR . 34.8 mm -81.23 99.69 4.76 Favored 'Isoleucine or valine' 0 C--O 1.267 2.026 0 CA-C-O 115.209 -2.329 . . . . 50.51 113.777 175.847 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -124.27 -115.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.101 2.125 . . . . 50.55 112.77 -176.851 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.77 128.72 35.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.259 1.504 . . . . 50.51 111.915 -176.95 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 51.65 39.23 24.68 Favored 'General case' 0 C--O 1.257 1.47 0 CA-C-N 112.516 -2.129 . . . . 50.62 115.775 179.52 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -71.27 148.27 47.33 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.842 -1.072 . . . . 50.51 110.018 174.8 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.9 m -127.51 116.05 19.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 118.26 -0.876 . . . . 50.51 112.222 175.938 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.42 142.45 27.41 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.76 -2.543 . . . . 50.51 111.856 175.043 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -88.78 138.29 31.55 Favored 'General case' 0 C--N 1.286 -2.182 0 O-C-N 126.818 2.574 . . . . 50.51 107.324 177.925 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.512 HD21 HG23 ' A' ' 7' ' ' THR . 68.0 tp -106.98 123.55 48.35 Favored 'General case' 0 C--O 1.283 2.852 0 CA-C-O 117.632 -1.175 . . . . 50.51 109.246 176.544 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.589 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.6 t -135.22 126.99 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 119.596 1.089 . . . . 50.51 110.346 175.059 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 71.2 mt -70.21 139.9 52.36 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 120.417 3.488 . . . . 50.51 120.417 178.446 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -118.27 106.46 12.82 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.327 -3.225 . . . . 50.64 102.491 177.314 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' CD1' ' HB3' ' A' ' 71' ' ' LEU . 6.4 mp -104.75 127.81 52.66 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.955 . . . . 50.51 115.508 -179.314 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -90.02 84.37 6.16 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.751 -1.568 . . . . 50.64 107.806 -179.648 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.21 157.04 7.21 Favored Glycine 0 C--O 1.244 0.744 1 N-CA-C 102.525 -4.23 . . . . 50.51 102.525 179.367 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 N-CA-C 105.58 -3.008 . . . . 50.51 105.58 179.227 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 108.225 -1.028 . . . . 50.51 108.225 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -102.06 133.53 46.75 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 126.889 2.618 . . . . 50.55 107.185 178.29 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.35 169.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 N-CA-C 104.745 -2.317 . . . . 50.51 104.745 173.37 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.97 123.73 40.51 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.427 4.829 . . . . 50.51 111.603 179.588 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.18 110.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 113.349 -3.215 . . . . 50.51 109.404 175.788 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -99.18 146.85 25.72 Favored 'General case' 0 N--CA 1.504 2.271 1 O-C-N 129.367 4.167 . . . . 50.51 112.42 -178.085 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -112.87 178.97 4.1 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.046 -2.946 . . . . 50.51 103.046 179.993 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.6 mt -91.53 3.7 54.35 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.111 0.882 . . . . 50.51 111.028 -178.036 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -91.96 -24.83 19.13 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 115.673 -2.411 . . . . 50.51 114.467 179.956 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.76 14.65 2.28 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 106.022 -2.831 . . . . 50.51 106.022 179.735 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -95.33 120.12 35.01 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 115.247 1.573 . . . . 50.51 115.247 174.971 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -119.53 108.56 14.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 126.679 2.487 . . . . 50.51 105.48 176.143 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 tt -103.19 146.02 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.442 2.964 . . . . 50.51 114.156 179.721 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 15' ' ' LEU . 98.5 m -97.93 155.76 16.93 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 117.27 -1.772 . . . . 50.51 111.194 178.092 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' N ' HG23 ' A' ' 14' ' ' THR . 12.6 tp -138.11 140.02 39.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 115.485 -2.198 . . . . 50.51 111.804 -179.239 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -103.11 115.05 29.85 Favored 'General case' 0 N--CA 1.5 2.042 1 O-C-N 129.187 4.055 . . . . 50.62 111.421 173.972 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.58 178.09 2.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 O-C-N 127.888 3.243 . . . . 50.51 113.093 -177.93 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 25.7 tt0 -102.01 149.97 37.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 112.196 -2.274 . . . . 50.62 106.082 174.622 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.93 -24.5 39.52 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.6 2.2 . . . . 50.51 111.948 177.691 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.6 p -120.14 22.07 11.55 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 119.795 3.257 . . . . 50.51 119.795 -177.528 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.0 152.19 42.65 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.44 -1.704 . . . . 50.62 108.547 -179.026 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.407 HG23 HG23 ' A' ' 55' ' ' THR . 71.6 p -97.27 145.92 25.62 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.895 -0.593 . . . . 50.51 109.499 175.649 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.592 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 50.5 mm -42.64 -36.77 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 O-C-N 127.126 2.766 . . . . 50.51 113.586 175.789 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -44.53 -55.66 4.94 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.364 -0.835 . . . . 50.62 112.729 176.96 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -72.14 -46.02 58.19 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.361 1.064 . . . . 50.55 108.18 -179.645 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.509 ' HB ' ' HA ' ' A' ' 23' ' ' ILE . 90.8 t -40.69 -62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.003 1.439 . . . . 50.51 108.535 178.54 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 53.3 mtmt -67.7 -16.32 64.08 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 115.288 1.588 . . . . 50.51 115.288 -179.74 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.69 -33.08 25.25 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.84 -0.43 . . . . 50.51 109.84 176.87 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -69.0 -46.77 67.19 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 103.278 -2.86 . . . . 50.51 103.278 176.025 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -55.78 -28.69 24.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.491 -0.883 . . . . 50.51 111.724 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -63.56 -35.55 80.85 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 125.604 2.621 . . . . 50.55 108.384 179.465 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -68.93 -55.07 12.12 Favored 'General case' 0 C--O 1.254 1.303 0 N-CA-C 117.122 2.267 . . . . 50.62 117.122 179.08 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -80.47 -42.47 22.52 Favored 'General case' 0 C--O 1.28 2.71 0 C-N-CA 116.447 -2.101 . . . . 50.51 111.603 -175.687 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -86.82 -50.12 6.95 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 123.096 2.68 . . . . 50.62 115.667 179.881 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 18.59 7.84 Favored Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 107.886 -2.086 . . . . 50.51 107.886 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.455 HG21 ' HG2' ' A' ' 41' ' ' GLN . 31.0 mm -98.62 120.63 58.62 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.794 -1.162 . . . . 50.51 112.326 179.689 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.0 Cg_exo -56.99 136.9 79.49 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.202 2.601 . . . . 50.51 110.901 178.29 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HA ' HE21 ' A' ' 41' ' ' GLN . 86.5 Cg_exo -57.15 -32.14 92.54 Favored 'Trans proline' 0 C--O 1.262 1.697 0 C-N-CA 120.682 0.921 . . . . 50.51 113.449 -179.336 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.11 -11.7 59.85 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 119.931 -1.731 . . . . 50.62 109.084 -177.42 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -98.78 2.92 47.35 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.462 -1.399 . . . . 50.55 110.585 178.764 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 38' ' ' PRO . 54.8 mt-30 -102.27 118.77 37.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 124.348 2.023 . . . . 50.55 114.652 -177.588 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.548 ' HD2' ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp180 -102.17 118.5 37.02 Favored 'General case' 0 C--O 1.295 3.497 0 CA-C-O 116.732 -1.604 . . . . 50.64 107.566 172.165 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.555 ' HB3' HD12 ' A' ' 50' ' ' LEU . 51.5 mt -109.72 119.77 40.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 50.51 112.721 -177.425 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.41 132.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 O-C-N 125.046 1.467 . . . . 50.51 113.525 -177.65 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.14 100.71 7.0 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 103.543 -2.762 . . . . 50.51 103.543 177.556 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 33.63 11.68 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.152 -2.294 . . . . 50.51 114.779 177.448 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.62 10.27 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 128.513 2.959 . . . . 50.51 113.266 -179.546 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -124.55 112.24 16.61 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 115.11 1.522 . . . . 50.51 115.11 177.713 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -58.12 113.61 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.135 2.272 . . . . 50.55 117.135 174.574 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 43' ' ' LEU . 55.1 mt -65.15 150.05 48.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 117.802 -1.094 . . . . 50.51 112.936 -175.917 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.47 ' HB3' ' HH ' ' A' ' 59' ' ' TYR . 74.5 tt0 -108.04 135.09 49.99 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.544 1.153 . . . . 50.62 110.984 -177.684 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -53.02 -63.91 0.99 Allowed 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.115 1.766 . . . . 50.62 112.088 -175.806 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 -8.04 66.87 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 117.496 1.759 . . . . 50.51 117.496 -177.274 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.535 ' HB2' ' HH ' ' A' ' 59' ' ' TYR . 16.8 mmp_? -82.37 -173.1 4.37 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 120.037 -1.861 . . . . 50.64 107.531 176.492 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.407 HG23 HG23 ' A' ' 22' ' ' THR . 38.9 p -127.59 158.2 38.14 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.549 1.315 . . . . 50.51 114.549 177.07 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.87 -39.82 69.08 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 106.456 -1.683 . . . . 50.51 106.456 177.242 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' TYR . 73.3 m -61.49 -43.84 98.15 Favored 'General case' 0 C--O 1.269 2.086 0 C-N-CA 117.299 -1.76 . . . . 50.51 108.829 -179.493 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.29 -4.26 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.214 1.19 . . . . 50.62 114.214 179.685 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' HH ' ' HB2' ' A' ' 54' ' ' ARG . 83.7 m-85 -122.94 9.7 9.42 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 116.44 2.015 . . . . 50.51 116.44 179.26 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 61.22 23.25 13.48 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 121.446 1.93 . . . . 50.55 113.53 179.944 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 61' ' ' ILE . 73.4 mt -73.93 94.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.198 -2.335 . . . . 50.51 116.274 175.836 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -87.7 159.23 18.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 126.031 2.082 . . . . 50.55 112.994 -176.81 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 79.5 tttt -54.64 154.34 5.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 123.235 1.493 . . . . 50.51 108.135 -176.958 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' OE2' ' HE2' ' A' ' 63' ' ' LYS . 42.6 mm-40 57.8 69.31 0.75 Allowed 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.476 -2.147 . . . . 50.62 106.143 179.613 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -143.08 129.82 20.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.775 -1.102 . . . . 50.51 112.761 174.823 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -72.78 130.16 39.84 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 118.121 2.637 . . . . 50.51 118.121 175.92 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.3 138.02 45.29 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.673 -2.584 . . . . 50.51 107.445 175.079 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -91.95 123.07 35.04 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 127.389 2.93 . . . . 50.51 113.659 177.848 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -105.84 103.06 12.48 Favored 'General case' 0 C--O 1.282 2.792 0 CA-C-O 117.657 -1.163 . . . . 50.51 113.918 176.511 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.5 138.9 33.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 119.538 1.063 . . . . 50.51 109.262 175.174 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.26 148.11 39.71 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 117.33 2.344 . . . . 50.51 117.33 178.479 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.548 ' HD2' ' HD2' ' A' ' 42' ' ' ARG . 76.5 ttt-85 -132.41 87.36 2.42 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 113.375 -3.202 . . . . 50.64 104.574 177.22 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -79.2 167.47 20.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.814 1.946 . . . . 50.51 106.928 -179.344 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.39 63.58 1.12 Allowed 'General case' 0 C--O 1.244 0.772 0 N-CA-C 118.105 2.632 . . . . 50.64 118.105 -179.643 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.24 178.06 38.14 Favored Glycine 0 C--O 1.242 0.651 0 O-C-N 124.617 1.198 . . . . 50.51 112.85 179.403 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 CA-C-O 116.338 -2.368 . . . . 50.51 115.437 179.204 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.412 ' CE ' ' HB2' ' A' ' 63' ' ' LYS . 82.0 mtp . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.993 -1.114 . . . . 50.509999999999998 107.993 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -84.43 140.22 31.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 126.976 2.673 . . . . 50.549999999999997 109.692 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.4 pt -133.64 159.58 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-O 115.982 -1.961 . . . . 50.509999999999998 107.126 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -117.16 135.69 53.58 Favored 'General case' 0 N--CA 1.512 2.639 1 O-C-N 130.48 4.863 . . . . 50.509999999999998 110.963 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 69.9 t -114.87 108.28 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 113.436 -3.173 . . . . 50.509999999999998 110.719 175.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.473 ' CD ' HG22 ' A' ' 12' ' ' THR . 35.1 mmtp -88.2 122.94 32.33 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.303 4.127 . . . . 50.509999999999998 111.031 -178.082 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.9 p -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.354 -2.091 . . . . 50.509999999999998 105.354 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -112.64 6.62 18.38 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.067 0.854 . . . . 50.509999999999998 112.102 -177.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -106.67 -27.84 10.57 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.702 -2.399 . . . . 50.509999999999998 106.563 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.2 0.65 2.11 Favored Glycine 0 C--N 1.296 -1.641 0 O-C-N 119.78 -1.825 . . . . 50.509999999999998 115.343 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -73.92 152.29 40.17 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.852 -1.547 . . . . 50.509999999999998 115.111 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.473 HG22 ' CD ' ' A' ' 6' ' ' LYS . 44.3 p -121.26 156.72 31.88 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 126.654 2.471 . . . . 50.509999999999998 108.939 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 62.7 mt -127.96 142.09 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.396 2.935 . . . . 50.509999999999998 111.49 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -111.92 134.28 53.57 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.163 -1.792 . . . . 50.509999999999998 106.163 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.566 HD23 ' HE2' ' A' ' 33' ' ' LYS . 96.0 mt -127.15 134.06 50.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.412 2.375 . . . . 50.509999999999998 117.412 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.55 96.16 7.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 128.807 3.817 . . . . 50.619999999999997 111.345 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -121.86 -175.02 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.267 0 O-C-N 127.603 3.064 . . . . 50.509999999999998 115.619 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CD ' ' OG ' ' A' ' 20' ' ' SER . 14.7 pt-20 -151.91 154.73 33.12 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.227 -2.26 . . . . 50.619999999999997 108.206 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.94 -24.51 39.61 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.575 2.184 . . . . 50.509999999999998 111.985 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.46 ' OG ' ' CD ' ' A' ' 18' ' ' GLU . 92.8 p -63.79 -30.86 71.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.142 -0.932 . . . . 50.509999999999998 111.755 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -69.62 149.63 47.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.357 -1.737 . . . . 50.619999999999997 115.373 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 55' ' ' THR . 33.0 p -93.58 169.62 10.2 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.827 -0.624 . . . . 50.509999999999998 109.549 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 42.3 mm -58.99 -25.6 30.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 O-C-N 127.189 2.806 . . . . 50.509999999999998 112.352 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -70.89 -46.41 62.64 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.047 2.24 . . . . 50.619999999999997 117.047 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -66.6 -50.34 63.37 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 124.31 1.044 . . . . 50.549999999999997 110.626 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.41 -31.39 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.932 1.395 . . . . 50.509999999999998 112.353 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 92.1 mttt -81.65 -19.97 40.63 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 105.184 -2.154 . . . . 50.509999999999998 105.184 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.33 -14.97 34.5 Favored 'General case' 0 C--O 1.278 2.58 0 N-CA-C 112.47 0.544 . . . . 50.509999999999998 112.47 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.7 mmmt -90.15 -35.2 15.53 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.338 -1.476 . . . . 50.509999999999998 107.719 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 61.0 mt -60.41 -29.4 44.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.53 -0.868 . . . . 50.509999999999998 112.135 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' ILE . 61.9 tt0 -49.94 -51.94 37.32 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 125.627 2.632 . . . . 50.549999999999997 104.767 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.9 m-20 -46.96 -41.37 16.06 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.619 -1.628 . . . . 50.619999999999997 112.33 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HE2' HD23 ' A' ' 15' ' ' LEU . 12.3 mptt -73.68 -41.77 62.19 Favored 'General case' 0 C--O 1.279 2.645 0 C-N-CA 116.464 -2.094 . . . . 50.509999999999998 114.312 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' OE2' HD11 ' A' ' 13' ' ' ILE . 30.1 mt-10 -113.98 -62.79 1.54 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 123.06 2.664 . . . . 50.619999999999997 109.956 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.82 -16.68 1.98 Allowed Glycine 0 CA--C 1.477 -2.288 0 CA-C-O 120.017 -0.324 . . . . 50.509999999999998 112.919 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 21.9 mm -58.06 128.86 82.04 Favored Pre-proline 0 C--O 1.244 0.768 0 N-CA-C 117.582 2.438 . . . . 50.509999999999998 117.582 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 77.9 Cg_exo -56.98 136.97 79.83 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.147 2.565 . . . . 50.509999999999998 110.869 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 87.7 Cg_exo -57.21 -32.09 92.54 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.861 0.927 . . . . 50.509999999999998 113.45 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.33 -26.89 67.5 Favored 'General case' 0 C--O 1.262 1.743 0 O-C-N 119.981 -1.699 . . . . 50.619999999999997 108.101 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.0 3.5 55.1 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.555 -1.341 . . . . 50.549999999999997 113.535 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -101.49 140.5 35.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 124.355 2.026 . . . . 50.549999999999997 109.8 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -134.88 148.66 50.15 Favored 'General case' 0 C--O 1.296 3.506 0 CA-C-O 116.696 -1.621 . . . . 50.640000000000001 107.468 172.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 93.0 mt -129.83 125.13 34.96 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.638 -1.245 . . . . 50.509999999999998 107.638 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.6 133.68 61.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 125.08 1.488 . . . . 50.509999999999998 112.789 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.57 110.91 5.81 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 107.086 -1.45 . . . . 50.509999999999998 107.086 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.02 30.76 4.36 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.254 -2.248 . . . . 50.509999999999998 115.498 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.93 -7.46 82.07 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 128.424 2.916 . . . . 50.509999999999998 116.734 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -80.43 119.52 23.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.047 0.924 . . . . 50.509999999999998 112.719 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -81.6 106.18 13.34 Favored 'General case' 0 C--O 1.259 1.583 0 O-C-N 123.936 0.773 . . . . 50.549999999999997 111.918 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.07 154.23 4.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 114.268 1.21 . . . . 50.509999999999998 114.268 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.5 132.35 51.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.144 2.275 . . . . 50.619999999999997 117.144 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -56.31 -5.02 0.16 Allowed 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.927 2.936 . . . . 50.619999999999997 118.927 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 9.3 22.67 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 105.382 -3.087 . . . . 50.509999999999998 105.382 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.17 156.77 16.25 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 119.961 -1.905 . . . . 50.640000000000001 109.981 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 22' ' ' THR . 41.5 p -109.56 144.4 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.187 -1.412 . . . . 50.509999999999998 107.187 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -40.96 -25.47 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.145 0.903 . . . . 50.509999999999998 109.021 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' THR . 91.0 p -74.0 -27.41 60.95 Favored 'General case' 0 C--O 1.268 2.076 0 N-CA-C 115.809 1.781 . . . . 50.509999999999998 115.809 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -65.86 -26.95 67.88 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.461 1.124 . . . . 50.619999999999997 110.413 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.86 5.95 26.92 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 117.781 -1.104 . . . . 50.509999999999998 111.333 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 41.36 29.38 0.09 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.474 1.943 . . . . 50.549999999999997 113.378 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -51.44 107.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.267 1.975 0 N-CA-C 104.064 -2.569 . . . . 50.509999999999998 104.064 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -107.0 -169.04 1.48 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 126.092 2.12 . . . . 50.549999999999997 112.791 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 36.1 ttpt -73.32 136.06 44.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.184 1.469 . . . . 50.509999999999998 114.36 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 41.3 mt-10 71.85 8.9 6.13 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 117.217 2.302 . . . . 50.619999999999997 117.217 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 t -74.77 142.3 44.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 104.636 -2.357 . . . . 50.509999999999998 104.636 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -106.41 133.81 50.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.39 -0.967 . . . . 50.509999999999998 108.39 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.54 162.17 13.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.681 -2.581 . . . . 50.509999999999998 109.154 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -116.01 121.92 43.69 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 127.406 2.941 . . . . 50.509999999999998 111.196 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.1 tp -79.83 140.41 36.83 Favored 'General case' 0 C--O 1.283 2.822 0 N-CA-C 115.5 1.667 . . . . 50.509999999999998 115.5 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.74 138.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.634 1.106 . . . . 50.509999999999998 112.603 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.5 tp -103.91 107.78 18.81 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.47 0.915 . . . . 50.509999999999998 113.47 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.5 79.85 2.0 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 113.349 -3.215 . . . . 50.640000000000001 115.252 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -58.0 148.23 26.74 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 117.843 2.534 . . . . 50.509999999999998 117.843 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 70.6 ttp85 -95.34 55.03 1.69 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 115.389 1.625 . . . . 50.640000000000001 115.389 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.22 -170.86 39.59 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.594 -3.402 . . . . 50.509999999999998 104.594 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.453 0 CA-C-O 116.337 -2.369 . . . . 50.509999999999998 111.883 179.197 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 118.86 -0.591 . . . . 50.509999999999998 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -88.0 142.49 27.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 126.954 2.659 . . . . 50.549999999999997 109.499 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.45 HD13 HG21 ' A' ' 17' ' ' VAL . 24.3 pt -141.77 160.76 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 116.036 -1.935 . . . . 50.509999999999998 107.472 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' HB2' HG22 ' A' ' 66' ' ' THR . 83.1 m-85 -113.78 132.34 55.89 Favored 'General case' 0 N--CA 1.511 2.582 1 O-C-N 130.381 4.801 . . . . 50.509999999999998 113.364 179.564 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.99 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 106.321 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG2' ' OG1' ' A' ' 12' ' ' THR . 92.5 mttt -111.88 135.51 52.4 Favored 'General case' 0 N--CA 1.503 2.207 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 117.046 -178.112 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 154.78 31.92 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 107.609 -1.256 . . . . 50.509999999999998 107.609 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.26 -12.97 23.45 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.177 0.923 . . . . 50.509999999999998 110.549 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -66.06 -22.46 66.42 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 115.705 -2.398 . . . . 50.509999999999998 113.759 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.39 10.55 35.81 Favored Glycine 0 C--N 1.297 -1.598 0 O-C-N 120.106 -1.621 . . . . 50.509999999999998 112.437 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -101.28 134.84 43.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 116.82 -1.562 . . . . 50.509999999999998 112.252 174.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.46 ' OG1' ' HG2' ' A' ' 6' ' ' LYS . 52.4 m -127.51 149.29 50.2 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.707 2.505 . . . . 50.509999999999998 115.581 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -134.07 157.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 115.266 -2.574 . . . . 50.509999999999998 106.314 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -121.38 144.41 48.67 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.248 -1.781 . . . . 50.509999999999998 113.515 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.573 HD22 ' HB3' ' A' ' 29' ' ' LYS . 77.5 mt -120.1 167.37 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.445 -2.216 . . . . 50.509999999999998 109.959 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -129.47 92.96 3.44 Favored 'General case' 0 N--CA 1.5 2.041 1 O-C-N 129.131 4.019 . . . . 50.619999999999997 106.104 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.592 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 m -105.34 173.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.779 3.174 . . . . 50.509999999999998 111.764 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 84.0 mt-10 -106.44 145.13 30.4 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.164 -2.289 . . . . 50.619999999999997 111.14 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 85.3 Cg_exo -54.9 -24.57 39.62 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.637 2.224 . . . . 50.509999999999998 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 p -88.23 -9.0 54.4 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 115.2 1.556 . . . . 50.509999999999998 115.2 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 46.2 m-20 -65.27 148.79 51.07 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 117.412 -1.715 . . . . 50.619999999999997 110.448 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -78.94 170.94 15.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.865 -0.607 . . . . 50.509999999999998 110.503 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.24 -29.33 46.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 O-C-N 127.103 2.752 . . . . 50.509999999999998 108.04 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -70.93 -15.1 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 119.915 3.302 . . . . 50.619999999999997 119.915 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 23.0 t-20 -81.82 -50.63 9.0 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.366 1.066 . . . . 50.549999999999997 110.51 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -54.7 -44.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 125.045 1.466 . . . . 50.509999999999998 108.146 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.1 mttt -54.39 -35.46 62.87 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 107.989 -1.115 . . . . 50.509999999999998 107.989 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -67.2 -49.62 63.94 Favored 'General case' 0 C--O 1.278 2.597 0 N-CA-C 109.695 -0.483 . . . . 50.509999999999998 109.695 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HB3' HD22 ' A' ' 15' ' ' LEU . 46.8 mmtm -50.89 -37.09 41.66 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 120.374 -1.454 . . . . 50.509999999999998 114.823 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.82 -42.11 28.51 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 104.617 -2.364 . . . . 50.509999999999998 104.617 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -53.6 -42.36 67.6 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 125.628 2.632 . . . . 50.549999999999997 112.14 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.9 -41.73 78.62 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 120.716 3.599 . . . . 50.619999999999997 120.716 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -106.76 -15.08 14.83 Favored 'General case' 0 C--O 1.279 2.633 0 C-N-CA 116.434 -2.106 . . . . 50.509999999999998 113.39 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.18 -11.11 11.37 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 118.616 2.821 . . . . 50.619999999999997 118.616 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 28.74 45.78 Favored Glycine 0 CA--C 1.478 -2.25 0 N-CA-C 114.94 0.736 . . . . 50.509999999999998 114.94 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 71' ' ' LEU . 71.5 mt -107.46 119.64 50.05 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 114.984 1.476 . . . . 50.509999999999998 114.984 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.6 Cg_exo -57.07 137.0 79.94 Favored 'Trans proline' 0 C--O 1.258 1.515 0 C-N-CA 123.116 2.544 . . . . 50.509999999999998 110.883 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.6 Cg_exo -57.14 -32.28 92.9 Favored 'Trans proline' 0 C--O 1.261 1.663 0 C-N-CA 120.711 0.941 . . . . 50.509999999999998 113.379 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -73.27 0.15 12.76 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.948 -1.72 . . . . 50.619999999999997 110.64 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -112.4 1.69 16.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.572 -1.33 . . . . 50.549999999999997 109.356 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.04 128.55 47.03 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.419 2.057 . . . . 50.549999999999997 111.985 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.498 ' HD2' ' HB2' ' A' ' 72' ' ' ARG . 70.3 mtp180 -112.21 127.35 55.93 Favored 'General case' 0 C--O 1.297 3.555 0 N-CA-C 105.903 -1.888 . . . . 50.640000000000001 105.903 172.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -109.65 136.13 49.49 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 102.88 -3.007 . . . . 50.509999999999998 102.88 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -132.4 121.32 45.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 O-C-N 125.223 1.577 . . . . 50.509999999999998 111.755 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.53 90.81 3.4 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 106.998 -1.482 . . . . 50.509999999999998 106.998 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.07 76.54 0.33 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.219 -2.264 . . . . 50.509999999999998 112.337 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.03 32.07 0.35 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 128.405 2.907 . . . . 50.509999999999998 113.437 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -121.85 112.63 18.58 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 102.62 -3.104 . . . . 50.509999999999998 102.62 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -70.62 123.59 22.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.887 0.742 . . . . 50.549999999999997 111.637 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 mt -78.04 139.39 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 117.756 -1.116 . . . . 50.509999999999998 113.743 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -86.58 115.25 23.93 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.95 1.406 . . . . 50.619999999999997 114.529 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -40.42 -21.16 0.01 OUTLIER 'General case' 0 C--O 1.264 1.834 0 N-CA-C 117.809 2.522 . . . . 50.619999999999997 117.809 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.96 2.74 51.85 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 118.398 2.119 . . . . 50.509999999999998 118.398 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 mmp_? -96.99 -177.77 3.98 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 120.031 -1.864 . . . . 50.640000000000001 109.983 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -108.66 174.73 5.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.062 0.945 . . . . 50.509999999999998 110.315 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.5 mt -74.8 -13.95 60.64 Favored 'General case' 0 C--O 1.201 -1.482 0 CA-C-O 118.382 -0.818 . . . . 50.509999999999998 111.156 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -85.83 -40.85 15.56 Favored 'General case' 0 C--O 1.268 2.057 0 N-CA-C 117.598 2.444 . . . . 50.509999999999998 117.598 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -47.51 -37.27 11.67 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.497 1.141 . . . . 50.619999999999997 108.843 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 9.72 9.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 117.328 2.344 . . . . 50.509999999999998 117.328 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 62' ' ' GLN . 87.2 m-20 53.97 16.08 1.02 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-N 121.526 1.966 . . . . 50.549999999999997 115.744 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.2 mm -52.1 90.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.265 1.913 0 CA-C-O 115.207 -2.33 . . . . 50.509999999999998 110.741 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 60' ' ' ASN . 77.0 mt-30 -78.21 -175.73 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 125.588 1.805 . . . . 50.549999999999997 114.506 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -70.64 141.94 51.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.622 -1.992 . . . . 50.509999999999998 105.622 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 67.6 31.17 6.25 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.437 -2.165 . . . . 50.619999999999997 112.362 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 t -77.91 135.98 37.95 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.792 -1.094 . . . . 50.509999999999998 108.596 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.487 HG22 ' HB2' ' A' ' 4' ' ' PHE . 16.9 p -93.35 142.87 26.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 118.313 -0.851 . . . . 50.509999999999998 110.594 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.6 mt -122.09 122.58 39.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.78 -2.533 . . . . 50.509999999999998 105.6 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -83.64 151.25 25.4 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 102.87 -3.011 . . . . 50.509999999999998 102.87 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -123.3 109.76 14.34 Favored 'General case' 0 C--O 1.283 2.822 0 CA-C-O 117.608 -1.187 . . . . 50.509999999999998 110.481 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.09 133.01 49.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.502 -2.036 . . . . 50.509999999999998 105.502 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 36' ' ' ILE . 35.1 mt -82.67 152.09 25.99 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 118.77 2.878 . . . . 50.509999999999998 118.77 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.498 ' HB2' ' HD2' ' A' ' 42' ' ' ARG . 36.3 ttm180 -123.76 89.77 3.15 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 113.308 -3.234 . . . . 50.640000000000001 111.62 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.59 156.19 29.26 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 125.904 2.002 . . . . 50.509999999999998 111.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -106.16 77.61 1.24 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 115.821 1.785 . . . . 50.640000000000001 115.821 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.23 124.6 2.83 Favored Glycine 0 C--O 1.242 0.643 0 CA-C-N 114.646 -1.161 . . . . 50.509999999999998 113.593 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 N-CA-C 104.406 -3.478 . . . . 50.509999999999998 104.406 179.279 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' HE2' ' A' ' 63' ' ' LYS . 18.4 mmt . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 112.576 0.584 . . . . 50.509999999999998 112.576 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -88.21 150.95 23.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.907 2.629 . . . . 50.549999999999997 106.822 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -148.42 145.7 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 104.972 -2.232 . . . . 50.509999999999998 104.972 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.66 134.98 54.65 Favored 'General case' 0 N--CA 1.511 2.597 1 O-C-N 130.409 4.818 . . . . 50.509999999999998 110.476 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -119.55 128.01 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 113.399 -3.191 . . . . 50.509999999999998 116.944 175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -94.14 119.36 32.86 Favored 'General case' 0 N--CA 1.504 2.239 1 O-C-N 129.254 4.097 . . . . 50.509999999999998 113.065 -178.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.514 HG22 HD23 ' A' ' 69' ' ' LEU . 69.0 p -95.27 177.59 5.8 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.793 -1.098 . . . . 50.509999999999998 109.48 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 8' ' ' LEU . 42.6 mt -83.79 -12.85 55.09 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.138 0.899 . . . . 50.509999999999998 110.752 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -95.09 -17.46 21.82 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.76 -2.376 . . . . 50.509999999999998 113.426 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.16 -23.04 7.38 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 119.034 2.374 . . . . 50.509999999999998 119.034 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.66 107.09 0.76 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 117.134 2.272 . . . . 50.509999999999998 117.134 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -82.07 128.41 34.08 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.595 2.434 . . . . 50.509999999999998 107.848 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.01 144.92 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 127.591 3.057 . . . . 50.509999999999998 114.268 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -113.68 123.52 50.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.264 -1.774 . . . . 50.509999999999998 112.454 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.0 mt -116.92 145.92 43.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 120.933 3.679 . . . . 50.509999999999998 120.933 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.17 114.22 28.31 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 128.413 3.571 . . . . 50.619999999999997 112.676 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.51 163.05 35.8 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 O-C-N 127.831 3.207 . . . . 50.509999999999998 117.228 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 40.3 mt-10 -99.18 151.24 37.32 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 117.604 2.446 . . . . 50.619999999999997 117.604 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.1 Cg_exo -54.9 -24.52 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.586 2.191 . . . . 50.509999999999998 111.928 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -93.12 -19.48 21.46 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 116.547 2.054 . . . . 50.509999999999998 116.547 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.58 151.23 17.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.404 -1.718 . . . . 50.619999999999997 107.183 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -87.45 167.67 13.79 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.858 -0.61 . . . . 50.509999999999998 109.445 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.8 pt -61.58 -34.93 64.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 127.193 2.808 . . . . 50.509999999999998 103.875 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -56.55 -49.41 74.89 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 114.048 1.129 . . . . 50.619999999999997 114.048 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -55.97 -32.13 63.6 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.307 1.043 . . . . 50.549999999999997 111.959 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -41.94 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.975 1.422 . . . . 50.509999999999998 111.264 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.25 -40.31 45.25 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 116.391 1.997 . . . . 50.509999999999998 116.391 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.32 83.38 Favored 'General case' 0 C--O 1.278 2.576 0 CA-C-N 117.984 0.356 . . . . 50.509999999999998 111.524 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -55.15 -55.95 25.4 Favored 'General case' 0 C--O 1.255 1.351 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -54.77 -36.1 35.64 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.47 -0.892 . . . . 50.509999999999998 113.053 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.1 -32.85 16.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 125.625 2.631 . . . . 50.549999999999997 113.307 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.72 -44.71 20.27 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 113.592 -1.64 . . . . 50.619999999999997 113.123 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -87.72 -29.52 21.02 Favored 'General case' 0 C--O 1.279 2.637 0 N-CA-C 116.89 2.182 . . . . 50.509999999999998 116.89 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -115.58 -23.13 8.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 123.07 2.668 . . . . 50.619999999999997 109.5 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.21 -34.54 4.64 Favored Glycine 0 CA--C 1.477 -2.342 0 N-CA-C 116.477 1.351 . . . . 50.509999999999998 116.477 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.6 mt -40.69 113.7 1.03 Allowed Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 115.063 1.505 . . . . 50.509999999999998 115.063 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.182 2.588 . . . . 50.509999999999998 110.888 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.6 Cg_exo -57.18 -32.22 92.83 Favored 'Trans proline' 0 C--O 1.262 1.684 0 C-N-CA 120.671 0.914 . . . . 50.509999999999998 113.444 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.41 -12.79 15.87 Favored 'General case' 0 C--O 1.262 1.741 0 O-C-N 119.921 -1.737 . . . . 50.619999999999997 112.028 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.43 -12.42 17.19 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.515 -1.366 . . . . 50.549999999999997 111.808 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -93.11 125.27 37.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.345 2.021 . . . . 50.549999999999997 115.244 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -121.15 134.7 55.23 Favored 'General case' 0 C--O 1.295 3.458 0 CA-C-O 116.691 -1.623 . . . . 50.640000000000001 108.961 172.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.7 ' HB2' HD22 ' A' ' 50' ' ' LEU . 60.3 mt -119.17 120.33 36.78 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 102.08 -3.304 . . . . 50.509999999999998 102.08 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.34 129.47 71.54 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 O-C-N 125.15 1.531 . . . . 50.509999999999998 112.727 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.97 121.81 15.48 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 117.973 2.583 . . . . 50.509999999999998 117.973 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.38 9.53 6.51 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.206 -2.27 . . . . 50.509999999999998 108.435 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.62 37.35 8.09 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.481 2.943 . . . . 50.509999999999998 109.469 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' O ' ' C ' ' A' ' 49' ' ' GLN . 36.1 ttpt -126.63 85.39 2.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.098 0.949 . . . . 50.509999999999998 112.39 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.511 ' C ' ' O ' ' A' ' 48' ' ' LYS . 51.7 tt0 -36.93 128.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.926 -1.879 . . . . 50.549999999999997 105.926 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.7 HD22 ' HB2' ' A' ' 43' ' ' LEU . 2.1 mp -60.03 120.78 10.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 117.695 -1.145 . . . . 50.509999999999998 111.417 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -88.95 131.87 34.96 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.018 1.449 . . . . 50.619999999999997 109.345 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -50.82 -47.1 60.1 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.171 1.788 . . . . 50.619999999999997 111.497 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.82 21.44 2.56 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 119.051 2.38 . . . . 50.509999999999998 119.051 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -111.26 158.2 19.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.006 -1.879 . . . . 50.640000000000001 111.509 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 p -93.88 167.02 11.89 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.105 0.962 . . . . 50.509999999999998 110.491 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.53 -28.56 60.32 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 116.618 2.081 . . . . 50.509999999999998 116.618 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -87.82 -20.87 25.48 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.362 -1.735 . . . . 50.509999999999998 112.767 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.99 -36.46 62.95 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.225 -1.768 . . . . 50.619999999999997 106.225 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.658 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 77.8 m-85 -81.7 -31.91 31.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.777 -1.106 . . . . 50.509999999999998 109.354 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.658 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 84.9 m-20 76.54 36.74 0.36 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 121.451 1.932 . . . . 50.549999999999997 114.554 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.57 108.91 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.981 0 CA-C-O 115.165 -2.35 . . . . 50.509999999999998 113.679 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -104.88 -176.31 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.898 -2.63 . . . . 50.549999999999997 103.898 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 35.4 mmtp -67.07 162.4 22.33 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 102.841 -3.022 . . . . 50.509999999999998 102.841 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 51.34 44.75 28.72 Favored 'General case' 0 C--O 1.257 1.485 0 CA-C-N 112.443 -2.162 . . . . 50.619999999999997 114.696 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 t -109.23 137.78 46.58 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.23 1.196 . . . . 50.509999999999998 114.23 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 m -118.46 117.09 28.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 114.463 1.283 . . . . 50.509999999999998 114.463 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.34 153.04 20.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 114.738 -2.553 . . . . 50.509999999999998 110.766 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -95.57 146.54 24.38 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 127.371 2.919 . . . . 50.509999999999998 113.483 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.514 HD23 HG22 ' A' ' 7' ' ' THR . 29.3 tp -107.42 101.83 11.16 Favored 'General case' 0 C--O 1.283 2.827 0 CA-C-O 117.647 -1.168 . . . . 50.509999999999998 110.412 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.51 121.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 119.602 1.092 . . . . 50.509999999999998 111.027 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.5 mt -74.33 133.62 42.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.369 2.729 . . . . 50.509999999999998 118.369 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -113.59 131.43 56.11 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 113.368 -3.206 . . . . 50.640000000000001 105.614 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.94 -178.7 3.74 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.867 1.979 . . . . 50.509999999999998 111.226 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -126.04 67.89 1.19 Allowed 'General case' 0 C--O 1.245 0.831 0 N-CA-C 104.342 -2.466 . . . . 50.640000000000001 104.342 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.28 146.13 8.82 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 114.63 -1.168 . . . . 50.509999999999998 115.838 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.831 -3.307 . . . . 50.509999999999998 104.831 179.255 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 116.342 1.978 . . . . 50.509999999999998 116.342 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -82.88 149.76 26.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 126.882 2.613 . . . . 50.549999999999997 107.781 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 15' ' ' LEU . 18.5 tt -163.46 136.5 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 115.981 -1.961 . . . . 50.509999999999998 106.277 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' THR . 42.4 m-85 -104.39 143.52 32.89 Favored 'General case' 0 N--CA 1.512 2.634 1 O-C-N 130.259 4.724 . . . . 50.509999999999998 113.453 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 70.0 t -109.65 105.52 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 107.296 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -99.77 109.72 22.13 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.347 4.154 . . . . 50.509999999999998 110.385 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 9' ' ' THR . 9.7 t -89.78 -171.51 3.2 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 115.324 1.602 . . . . 50.509999999999998 115.324 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.488 ' N ' ' OG1' ' A' ' 7' ' ' THR . 65.6 mt -90.12 6.68 41.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.756 1.021 . . . . 50.509999999999998 113.756 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.548 ' H ' HG23 ' A' ' 7' ' ' THR . 55.5 p -104.55 0.53 28.79 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 115.715 -2.394 . . . . 50.509999999999998 114.853 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.88 37.04 7.46 Favored Glycine 0 C--N 1.298 -1.558 0 N-CA-C 103.411 -3.875 . . . . 50.509999999999998 103.411 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -113.59 159.14 19.93 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 119.455 3.131 . . . . 50.509999999999998 119.455 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.2 m -135.27 123.8 23.51 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 120.337 3.458 . . . . 50.509999999999998 120.337 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 96.7 mt -108.33 136.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.521 3.013 . . . . 50.509999999999998 107.483 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 m -117.16 117.54 29.86 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 117.329 -1.749 . . . . 50.509999999999998 112.395 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.479 ' O ' HG22 ' A' ' 3' ' ' ILE . 46.0 tp -128.69 135.49 49.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 120.168 3.395 . . . . 50.509999999999998 120.168 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -79.79 139.91 37.07 Favored 'General case' 0 N--CA 1.5 2.046 1 O-C-N 129.176 4.048 . . . . 50.619999999999997 114.764 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.76 175.18 6.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 O-C-N 127.758 3.161 . . . . 50.509999999999998 114.114 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.7 mt-10 -124.81 142.65 41.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 112.197 -2.274 . . . . 50.619999999999997 108.835 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.7 Cg_exo -54.97 -24.54 39.98 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 122.549 2.166 . . . . 50.509999999999998 111.943 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -86.35 -0.16 55.3 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.655 1.724 . . . . 50.509999999999998 115.655 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -79.13 160.08 27.17 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.421 -1.712 . . . . 50.619999999999997 107.471 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 52.3 p -107.62 153.68 22.54 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 103.753 -2.684 . . . . 50.509999999999998 103.753 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.438 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 25.6 mm -56.67 -23.03 16.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 O-C-N 127.011 2.694 . . . . 50.509999999999998 116.481 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 23.7 tt0 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 103.248 -2.871 . . . . 50.619999999999997 103.248 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 22' ' ' THR . 18.2 m120 -68.11 -43.17 79.04 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 124.383 1.073 . . . . 50.549999999999997 112.305 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.17 -38.57 77.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.046 1.466 . . . . 50.509999999999998 113.289 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.3 mttt -74.57 -30.31 61.67 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 106.784 -1.561 . . . . 50.509999999999998 106.784 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.13 82.73 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 114.364 1.246 . . . . 50.509999999999998 114.364 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.11 -31.99 73.47 Favored 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.373 -1.454 . . . . 50.509999999999998 114.549 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.452 HG21 HE22 ' A' ' 41' ' ' GLN . 97.3 mt -71.73 -45.08 67.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 119.551 -0.859 . . . . 50.509999999999998 113.077 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -52.08 -34.19 42.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.431 3.123 . . . . 50.549999999999997 119.431 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.05 -60.57 3.4 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 113.59 -1.641 . . . . 50.619999999999997 113.321 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.03 -55.97 4.24 Favored 'General case' 0 C--O 1.28 2.683 0 N-CA-C 119.806 3.262 . . . . 50.509999999999998 119.806 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.43 -60.11 4.01 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.143 2.702 . . . . 50.619999999999997 104.818 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.56 8.56 3.13 Favored Glycine 0 CA--C 1.478 -2.269 0 CA-C-O 120.033 -0.315 . . . . 50.509999999999998 113.398 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 84.8 mt -89.89 125.6 60.23 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 119.843 3.275 . . . . 50.509999999999998 119.843 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.0 136.97 79.9 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.111 2.541 . . . . 50.509999999999998 110.917 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.2 Cg_exo -57.17 -32.15 92.61 Favored 'Trans proline' 0 C--O 1.261 1.629 0 O-C-N 122.919 0.958 . . . . 50.509999999999998 113.442 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -56.72 -17.17 8.01 Favored 'General case' 0 C--O 1.263 1.781 0 O-C-N 120.045 -1.659 . . . . 50.619999999999997 114.713 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -91.8 -7.48 49.41 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.471 1.656 . . . . 50.549999999999997 115.471 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.452 HE22 HG21 ' A' ' 30' ' ' ILE . 36.6 mt-30 -90.66 137.56 32.26 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 116.787 2.144 . . . . 50.549999999999997 116.787 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -125.1 120.63 31.96 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 104.591 -2.374 . . . . 50.640000000000001 104.591 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 35.2 mt -102.89 138.07 40.26 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 103.596 -2.742 . . . . 50.509999999999998 103.596 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.31 129.23 36.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 119.972 3.323 . . . . 50.509999999999998 119.972 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -137.67 117.99 13.68 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 116.377 1.992 . . . . 50.509999999999998 116.377 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.83 16.25 4.58 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 103.752 -2.684 . . . . 50.509999999999998 103.752 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.41 44.68 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 107.135 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -108.85 114.7 28.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 104.653 -2.351 . . . . 50.509999999999998 104.653 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 43' ' ' LEU . 32.2 tt0 -68.98 129.77 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.325 0.861 . . . . 50.549999999999997 113.325 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.7 mp -78.2 150.39 33.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 109.67 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 73.7 mt-10 -115.98 158.98 22.25 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.959 1.412 . . . . 50.619999999999997 112.276 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -83.37 -9.71 58.88 Favored 'General case' 0 C--O 1.263 1.795 0 N-CA-C 117.204 2.298 . . . . 50.619999999999997 117.204 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.87 -2.68 34.35 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 110.178 -1.169 . . . . 50.509999999999998 110.178 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -107.5 143.32 36.04 Favored 'General case' 0 C--O 1.248 1.023 0 O-C-N 119.944 -1.915 . . . . 50.640000000000001 107.174 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -69.98 140.95 53.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 116.718 2.118 . . . . 50.509999999999998 116.718 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 61' ' ' ILE . 38.0 tp -48.19 -26.49 1.95 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.108 0.88 . . . . 50.509999999999998 112.08 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 p -90.47 -0.53 57.7 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.307 -1.757 . . . . 50.509999999999998 114.191 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -97.56 15.01 24.59 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 50.619999999999997 107.679 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 92.7 m-85 -113.85 -6.24 13.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 110.264 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.628 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 14.5 m120 73.42 18.67 3.6 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 121.457 1.935 . . . . 50.549999999999997 107.551 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.45 HD12 HD12 ' A' ' 56' ' ' LEU . 68.5 mt -75.22 108.59 7.19 Favored 'Isoleucine or valine' 0 C--O 1.267 2.007 0 CA-C-O 115.188 -2.339 . . . . 50.509999999999998 112.792 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -110.82 -175.68 2.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.117 2.135 . . . . 50.549999999999997 112.41 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -53.67 141.87 24.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 116.569 2.063 . . . . 50.509999999999998 116.569 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 52.71 42.93 31.82 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-N 112.554 -2.112 . . . . 50.619999999999997 114.585 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 152.59 18.98 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.494 2.035 . . . . 50.509999999999998 116.494 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 40.4 m -111.83 119.65 39.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 116.502 2.038 . . . . 50.509999999999998 116.502 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.88 140.02 32.05 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.723 -2.56 . . . . 50.509999999999998 108.086 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -89.96 132.38 35.37 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.199 2.812 . . . . 50.509999999999998 113.377 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' C ' HD23 ' A' ' 69' ' ' LEU . 10.2 tt -103.95 109.22 20.9 Favored 'General case' 0 C--O 1.282 2.768 0 N-CA-C 116.271 1.952 . . . . 50.509999999999998 116.271 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -94.1 145.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 119.604 1.093 . . . . 50.509999999999998 110.916 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 48.8 tp -99.29 86.78 3.48 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 119.437 3.125 . . . . 50.509999999999998 119.437 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 71' ' ' LEU . 59.8 ttt85 -53.36 130.98 36.94 Favored 'General case' 0 C--N 1.281 -2.383 1 O-C-N 110.816 -7.427 . . . . 50.640000000000001 113.779 177.166 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.49 147.44 24.24 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 120.858 1.663 . . . . 50.509999999999998 114.259 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -81.37 56.26 2.85 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.665 -1.605 . . . . 50.640000000000001 106.665 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.43 -155.71 16.87 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.586 -1.188 . . . . 50.509999999999998 113.999 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.682 -3.367 . . . . 50.509999999999998 104.682 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.814 -0.612 . . . . 50.509999999999998 109.802 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -101.27 131.68 47.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 126.973 2.671 . . . . 50.549999999999997 109.517 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 pt -132.19 149.8 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 N-CA-C 103.595 -2.743 . . . . 50.509999999999998 103.595 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -110.34 157.93 18.98 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.398 4.811 . . . . 50.509999999999998 112.095 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.6 t -141.36 121.02 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 113.383 -3.199 . . . . 50.509999999999998 112.24 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -90.59 136.05 33.31 Favored 'General case' 0 N--CA 1.504 2.261 1 O-C-N 129.37 4.169 . . . . 50.509999999999998 105.1 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -112.44 142.46 44.95 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 105.03 -2.211 . . . . 50.509999999999998 105.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -44.84 -35.97 3.04 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 109.198 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.6 m -52.3 -32.69 38.8 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 118.631 2.826 . . . . 50.509999999999998 118.631 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.11 4.79 11.05 Favored Glycine 0 C--N 1.296 -1.671 0 O-C-N 120.142 -1.599 . . . . 50.509999999999998 111.756 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -83.89 152.82 24.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.847 -1.549 . . . . 50.509999999999998 114.26 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -125.86 112.56 16.13 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.701 2.501 . . . . 50.509999999999998 106.849 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 pt -102.3 147.69 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 118.583 2.808 . . . . 50.509999999999998 118.583 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -104.32 123.72 47.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 117.263 -1.775 . . . . 50.509999999999998 113.436 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 29' ' ' LYS . 68.5 mt -109.73 132.31 54.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 117.591 2.441 . . . . 50.509999999999998 117.591 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.28 110.26 22.41 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 129.244 4.09 . . . . 50.619999999999997 109.888 174.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 56' ' ' LEU . 35.0 m -130.82 173.59 14.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 O-C-N 127.672 3.107 . . . . 50.509999999999998 108.589 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 68.8 mm-40 -116.87 141.95 29.04 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 112.157 -2.292 . . . . 50.619999999999997 108.862 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 85.4 Cg_exo -54.88 -24.58 39.54 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.617 2.211 . . . . 50.509999999999998 111.964 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -78.23 -23.13 47.54 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.818 -1.549 . . . . 50.509999999999998 106.818 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.39 139.18 58.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 104.308 -2.478 . . . . 50.619999999999997 104.308 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 48.1 p -78.23 165.17 24.22 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.326 -0.99 . . . . 50.509999999999998 108.326 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.542 HD12 HD23 ' A' ' 50' ' ' LEU . 24.5 mm -58.81 -35.21 54.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 O-C-N 127.244 2.84 . . . . 50.509999999999998 111.816 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.7 -45.34 81.88 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.211 -2.144 . . . . 50.619999999999997 105.211 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HB2' ' O ' ' A' ' 22' ' ' THR . 85.8 m-20 -56.56 -46.03 80.94 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.365 1.066 . . . . 50.549999999999997 112.181 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 56' ' ' LEU . 40.5 t -61.58 -41.38 90.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 125.168 1.543 . . . . 50.509999999999998 113.192 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.86 -22.71 60.73 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 106.824 -1.547 . . . . 50.509999999999998 106.824 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.35 -61.41 1.85 Allowed 'General case' 0 C--O 1.278 2.561 0 N-CA-C 105.049 -2.204 . . . . 50.509999999999998 105.049 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.677 ' CG ' HD22 ' A' ' 15' ' ' LEU . 17.0 tppt? -42.5 -41.6 3.03 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 115.679 1.733 . . . . 50.509999999999998 115.679 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.512 HG21 HD11 ' A' ' 69' ' ' LEU . 73.4 mt -68.19 -23.86 29.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 C-N-CA 119.493 -0.883 . . . . 50.509999999999998 108.68 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -82.25 -55.45 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 125.57 2.605 . . . . 50.549999999999997 105.565 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -35.32 -51.37 0.58 Allowed 'General case' 0 C--O 1.252 1.228 0 N-CA-C 118.513 2.782 . . . . 50.619999999999997 118.513 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.13 -59.99 1.62 Allowed 'General case' 0 C--O 1.28 2.677 0 C-N-CA 116.459 -2.096 . . . . 50.509999999999998 108.82 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -57.99 -43.76 86.75 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 123.158 2.708 . . . . 50.619999999999997 116.743 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.16 23.35 7.73 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 108.763 -1.735 . . . . 50.509999999999998 108.763 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.3 mt -100.58 117.31 63.06 Favored Pre-proline 0 C--O 1.243 0.73 0 C-N-CA 118.79 -1.164 . . . . 50.509999999999998 108.501 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.0 Cg_exo -56.93 136.93 79.52 Favored 'Trans proline' 0 C--O 1.261 1.634 0 C-N-CA 123.185 2.59 . . . . 50.509999999999998 110.916 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.0 Cg_exo -57.19 -32.15 92.66 Favored 'Trans proline' 0 C--O 1.262 1.691 0 C-N-CA 120.682 0.922 . . . . 50.509999999999998 113.429 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -62.56 -15.21 49.82 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.948 -1.72 . . . . 50.619999999999997 109.985 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -102.92 16.05 27.67 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.532 -1.355 . . . . 50.549999999999997 112.104 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -110.85 114.08 27.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 117.295 2.332 . . . . 50.549999999999997 117.295 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -111.39 108.49 18.09 Favored 'General case' 0 C--O 1.296 3.523 0 N-CA-C 105.502 -2.036 . . . . 50.640000000000001 105.502 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mt -101.99 132.76 47.63 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.501 1.046 . . . . 50.509999999999998 110.488 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.63 136.77 50.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 O-C-N 125.227 1.58 . . . . 50.509999999999998 115.167 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -133.75 112.06 11.06 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.543 -1.208 . . . . 50.509999999999998 110.483 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.45 49.7 6.2 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.268 -2.242 . . . . 50.509999999999998 113.311 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.47 1.71 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 120.894 3.118 . . . . 50.509999999999998 120.894 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -71.7 166.19 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 116.334 1.975 . . . . 50.509999999999998 116.334 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -102.26 140.86 35.98 Favored 'General case' 0 C--O 1.259 1.592 0 O-C-N 124.008 0.818 . . . . 50.549999999999997 112.008 174.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.542 HD23 HD12 ' A' ' 23' ' ' ILE . 2.1 mp -78.14 143.17 37.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.285 -1.746 . . . . 50.509999999999998 106.285 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -120.21 135.15 55.08 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.883 1.364 . . . . 50.619999999999997 109.464 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.56 -33.41 1.14 Allowed 'General case' 0 C--O 1.262 1.748 0 C-N-CA 126.165 1.786 . . . . 50.619999999999997 114.951 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.73 63.5 Favored Glycine 0 C--O 1.254 1.345 0 C-N-CA 124.339 0.971 . . . . 50.509999999999998 113.5 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -111.73 155.12 23.99 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 101.889 -3.374 . . . . 50.640000000000001 101.889 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -99.72 174.12 6.38 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.048 0.939 . . . . 50.509999999999998 111.483 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.561 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -67.54 -38.54 84.33 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 106.349 -1.723 . . . . 50.509999999999998 106.349 177.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -67.94 -22.61 65.04 Favored 'General case' 0 C--O 1.268 2.029 0 N-CA-C 117.75 2.5 . . . . 50.509999999999998 117.75 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -64.45 -40.17 95.22 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.664 2.098 . . . . 50.619999999999997 116.664 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -83.26 5.02 24.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 115.986 1.847 . . . . 50.509999999999998 115.986 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 59.08 38.44 23.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.493 1.951 . . . . 50.549999999999997 107.054 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -73.48 117.79 17.81 Favored 'Isoleucine or valine' 0 C--O 1.267 2.012 0 CA-C-O 115.223 -2.322 . . . . 50.509999999999998 108.388 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -94.15 -175.82 3.8 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.707 2.114 . . . . 50.549999999999997 116.707 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.03 142.72 49.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 123.144 1.449 . . . . 50.509999999999998 107.314 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 46.4 26.19 0.46 Allowed 'General case' 0 C--O 1.257 1.496 0 N-CA-C 117.592 2.441 . . . . 50.619999999999997 117.592 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -72.53 153.18 41.45 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.512 -1.662 . . . . 50.509999999999998 106.512 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.43 ' O ' HD23 ' A' ' 67' ' ' LEU . 40.6 m -108.16 146.09 33.22 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.225 -0.893 . . . . 50.509999999999998 111.084 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 66' ' ' THR . 26.8 mt -116.96 156.78 26.86 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 114.688 -2.577 . . . . 50.509999999999998 109.959 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -93.61 141.66 28.22 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 127.246 2.841 . . . . 50.509999999999998 106.202 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.512 HD11 HG21 ' A' ' 30' ' ' ILE . 5.3 tt -119.79 109.88 16.12 Favored 'General case' 0 C--O 1.282 2.8 0 N-CA-C 106.356 -1.72 . . . . 50.509999999999998 106.356 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -98.35 145.1 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.391 -2.078 . . . . 50.509999999999998 105.391 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.99 132.5 43.5 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.964 -0.754 . . . . 50.509999999999998 108.964 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -97.44 126.18 42.54 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-O 113.322 -3.228 . . . . 50.640000000000001 107.33 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.89 152.09 23.81 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.901 2.001 . . . . 50.509999999999998 111.862 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -83.15 55.42 3.12 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 113.726 -1.579 . . . . 50.640000000000001 108.051 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.15 156.33 18.08 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 109.56 -1.416 . . . . 50.509999999999998 109.56 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 1 N-CA-C 102.519 -4.233 . . . . 50.509999999999998 102.519 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 107.894 -1.151 . . . . 50.509999999999998 107.894 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -101.03 133.44 45.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.911 2.632 . . . . 50.549999999999997 110.278 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.35 159.89 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 117.083 -3.51 . . . . 50.509999999999998 107.703 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -114.67 137.31 52.06 Favored 'General case' 0 N--CA 1.512 2.648 1 O-C-N 130.429 4.831 . . . . 50.509999999999998 107.911 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 87.6 t -110.54 121.34 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 113.431 -3.176 . . . . 50.509999999999998 104.019 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -107.08 131.81 53.68 Favored 'General case' 0 N--CA 1.503 2.195 1 O-C-N 129.295 4.122 . . . . 50.509999999999998 113.336 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -91.38 -177.33 4.81 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.87 2.544 . . . . 50.509999999999998 117.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.26 -5.59 23.93 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.164 0.915 . . . . 50.509999999999998 109.792 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.7 p -114.69 9.01 16.36 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.726 2.862 . . . . 50.509999999999998 118.726 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.32 62.29 Favored Glycine 0 C--N 1.298 -1.565 0 O-C-N 120.072 -1.642 . . . . 50.509999999999998 115.164 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -65.23 140.22 58.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 116.888 -1.53 . . . . 50.509999999999998 113.033 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -131.53 164.46 25.76 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 126.613 2.446 . . . . 50.509999999999998 108.573 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.35 170.64 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 127.551 3.032 . . . . 50.509999999999998 110.215 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -111.41 128.33 55.95 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.266 -1.773 . . . . 50.509999999999998 110.41 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -126.53 135.71 51.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 115.488 -2.196 . . . . 50.509999999999998 116.567 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.27 100.41 7.16 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 128.315 3.509 . . . . 50.619999999999997 112.505 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -103.18 172.99 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.209 0 O-C-N 127.762 3.164 . . . . 50.509999999999998 116.324 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.65 153.45 43.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 112.157 -2.292 . . . . 50.619999999999997 112.521 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.89 -24.57 39.5 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.603 2.202 . . . . 50.509999999999998 111.909 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 m -82.92 -26.52 31.38 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 114.954 1.465 . . . . 50.509999999999998 114.954 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -53.34 138.95 31.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 117.398 -1.721 . . . . 50.619999999999997 114.311 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -95.1 172.46 8.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 102.156 -3.276 . . . . 50.509999999999998 102.156 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 54' ' ' ARG . 23.2 mm -53.89 -45.49 63.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 O-C-N 127.095 2.747 . . . . 50.509999999999998 110.439 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -54.11 -46.83 72.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.723 1.379 . . . . 50.619999999999997 114.723 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -57.54 -39.64 77.08 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.265 1.026 . . . . 50.549999999999997 111.757 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 -50.11 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 125.045 1.466 . . . . 50.509999999999998 111.73 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HE3' ' CG2' ' A' ' 23' ' ' ILE . 94.5 mttt -56.87 -29.93 63.38 Favored 'General case' 0 C--O 1.257 1.485 0 N-CA-C 104.583 -2.377 . . . . 50.509999999999998 104.583 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.06 -27.61 48.69 Favored 'General case' 0 C--O 1.278 2.599 0 CA-C-N 118.031 0.378 . . . . 50.509999999999998 111.567 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -71.76 -36.32 70.36 Favored 'General case' 0 C--O 1.255 1.342 0 N-CA-C 106.606 -1.627 . . . . 50.509999999999998 106.606 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.43 -34.55 65.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 106.863 -1.532 . . . . 50.509999999999998 106.863 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -51.49 -59.51 4.17 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.567 2.603 . . . . 50.549999999999997 112.225 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -51.76 -40.83 60.98 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 115.817 1.784 . . . . 50.619999999999997 115.817 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -76.65 -32.5 58.01 Favored 'General case' 0 C--O 1.279 2.647 0 C-N-CA 116.464 -2.095 . . . . 50.509999999999998 113.853 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -119.33 -39.47 2.89 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.018 2.644 . . . . 50.619999999999997 115.061 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.32 8.77 8.32 Favored Glycine 0 CA--C 1.478 -2.271 0 CA-C-O 119.947 -0.363 . . . . 50.509999999999998 112.46 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.491 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 93.5 mt -84.62 128.21 62.24 Favored Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 116.76 2.134 . . . . 50.509999999999998 116.76 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.94 136.99 79.85 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.116 2.544 . . . . 50.509999999999998 110.92 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.7 Cg_exo -57.2 -32.13 92.64 Favored 'Trans proline' 0 C--O 1.261 1.649 0 O-C-N 122.91 0.952 . . . . 50.509999999999998 113.405 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -75.29 -15.78 60.48 Favored 'General case' 0 C--O 1.262 1.745 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 112.375 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -97.34 9.0 43.46 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.568 -1.332 . . . . 50.549999999999997 110.692 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.97 132.98 53.57 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 103.437 -2.801 . . . . 50.549999999999997 103.437 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -119.48 108.52 14.63 Favored 'General case' 0 C--O 1.297 3.562 0 N-CA-C 105.462 -2.051 . . . . 50.640000000000001 105.462 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.78 121.97 44.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.49 1.041 . . . . 50.509999999999998 113.414 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 120.456 3.502 . . . . 50.509999999999998 120.456 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB3' HD21 ' A' ' 50' ' ' LEU . 17.8 t80 -110.18 130.17 55.59 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 114.811 1.411 . . . . 50.509999999999998 114.811 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.21 32.11 15.39 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.192 -2.276 . . . . 50.509999999999998 111.994 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.67 2.7 85.97 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 128.4 2.905 . . . . 50.509999999999998 113.269 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -94.51 115.77 27.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 116.32 1.97 . . . . 50.509999999999998 116.32 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 16.3 pt20 -50.53 120.24 4.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.94 0.775 . . . . 50.549999999999997 111.744 174.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 45' ' ' PHE . 56.1 mt -83.51 127.55 33.81 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.7 -1.143 . . . . 50.509999999999998 111.984 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 88.7 tt0 -77.0 145.23 38.17 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 119.173 3.027 . . . . 50.619999999999997 119.173 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -38.6 -48.08 1.4 Allowed 'General case' 0 C--O 1.264 1.833 0 N-CA-C 118.526 2.788 . . . . 50.619999999999997 118.526 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 23.01 32.27 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 116.384 1.314 . . . . 50.509999999999998 116.384 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 23' ' ' ILE . 37.1 mmt180 -93.34 155.53 17.34 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 119.892 -1.946 . . . . 50.640000000000001 111.151 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -108.53 176.93 4.94 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.979 0.912 . . . . 50.509999999999998 109.466 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.1 -32.69 70.04 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 119.177 3.028 . . . . 50.509999999999998 119.177 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -81.11 -23.34 38.45 Favored 'General case' 0 C--O 1.267 2.024 0 C-N-CA 117.325 -1.75 . . . . 50.509999999999998 112.258 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -53.54 -30.9 44.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.918 -2.253 . . . . 50.619999999999997 104.918 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.25 6.92 19.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 116.468 2.025 . . . . 50.509999999999998 116.468 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.37 32.49 20.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 111.036 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.438 HG12 ' CD2' ' A' ' 45' ' ' PHE . 93.2 mt -73.53 104.86 2.59 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.188 -2.339 . . . . 50.509999999999998 109.353 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -97.23 -165.86 1.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 126.137 2.148 . . . . 50.549999999999997 115.028 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 79.4 tttt -70.16 142.76 52.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.159 1.457 . . . . 50.509999999999998 110.688 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 23.1 mt-10 58.73 36.29 24.79 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.471 -2.15 . . . . 50.619999999999997 110.721 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -78.02 152.5 33.01 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.802 -1.09 . . . . 50.509999999999998 110.915 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.443 ' O ' HD23 ' A' ' 67' ' ' LEU . 60.4 p -103.64 140.13 37.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 118.216 -0.897 . . . . 50.509999999999998 110.182 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 59.5 mt -123.95 134.82 53.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 101.65 -3.463 . . . . 50.509999999999998 101.65 175.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -95.45 136.93 35.2 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 127.375 2.922 . . . . 50.509999999999998 108.264 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 tp -105.56 136.02 45.89 Favored 'General case' 0 C--O 1.282 2.802 0 CA-C-O 117.641 -1.171 . . . . 50.509999999999998 113.203 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -116.02 126.06 73.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 105.847 -1.909 . . . . 50.509999999999998 105.847 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -79.04 105.55 10.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.782 2.512 . . . . 50.509999999999998 117.782 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -92.96 102.21 14.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.279 -3.248 . . . . 50.640000000000001 114.666 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.64 177.58 7.01 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 125.715 1.884 . . . . 50.509999999999998 110.047 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -100.7 97.65 8.28 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 115.972 1.842 . . . . 50.640000000000001 115.972 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.46 158.67 6.18 Favored Glycine 0 C--O 1.243 0.668 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.562 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 1 N-CA-C 102.073 -4.411 . . . . 50.509999999999998 102.073 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 106.871 -1.529 . . . . 50.509999999999998 106.871 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -117.73 119.43 34.92 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.923 2.64 . . . . 50.549999999999997 104.846 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 tt -121.73 149.4 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 115.952 -1.975 . . . . 50.509999999999998 110.13 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.84 123.88 50.88 Favored 'General case' 0 N--CA 1.511 2.599 1 O-C-N 130.372 4.795 . . . . 50.509999999999998 114.524 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.34 104.86 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.42 -3.181 . . . . 50.509999999999998 109.571 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -85.02 121.2 27.45 Favored 'General case' 0 N--CA 1.504 2.237 1 O-C-N 129.394 4.184 . . . . 50.509999999999998 109.412 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 69' ' ' LEU . 69.7 p -85.95 -177.05 6.22 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 116.322 1.971 . . . . 50.509999999999998 116.322 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 70' ' ' VAL . 67.5 mt -82.01 -6.08 58.86 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.788 1.773 . . . . 50.509999999999998 115.788 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -90.07 -8.04 52.41 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 115.715 -2.394 . . . . 50.509999999999998 106.592 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 15.79 37.73 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 107.727 -2.149 . . . . 50.509999999999998 107.727 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.52 111.02 21.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 116.549 2.055 . . . . 50.509999999999998 116.549 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.9 m -87.37 125.44 34.26 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 126.65 2.469 . . . . 50.509999999999998 113.203 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -111.9 174.08 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 127.53 3.019 . . . . 50.509999999999998 113.725 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 m -124.37 140.97 52.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.011 -2.218 . . . . 50.509999999999998 105.011 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.7 mt -130.66 141.7 50.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 115.487 -2.197 . . . . 50.509999999999998 108.05 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.87 100.25 9.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 129.009 3.943 . . . . 50.619999999999997 109.281 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -100.27 171.12 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.253 0 O-C-N 127.796 3.185 . . . . 50.509999999999998 107.938 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -124.28 160.51 52.32 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 112.24 -2.254 . . . . 50.619999999999997 116.147 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.01 -24.45 39.92 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 122.586 2.191 . . . . 50.509999999999998 111.966 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -99.82 -28.82 12.95 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 116.031 1.863 . . . . 50.509999999999998 116.031 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -38.82 136.88 0.7 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.331 -1.748 . . . . 50.619999999999997 114.825 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' ASN . 70.7 p -88.7 138.17 31.66 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 103.109 -2.922 . . . . 50.509999999999998 103.109 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 52' ' ' ASP . 7.4 tp -47.52 -19.19 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.729 0 O-C-N 127.183 2.802 . . . . 50.509999999999998 114.02 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.57 -44.31 62.25 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 102.991 -2.966 . . . . 50.619999999999997 102.991 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' THR . 9.3 t-20 -70.78 -17.28 62.79 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 114.957 1.465 . . . . 50.549999999999997 114.957 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.12 -45.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.999 -1.482 . . . . 50.509999999999998 106.999 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 97.2 mttt -64.26 -42.87 96.28 Favored 'General case' 0 C--O 1.256 1.433 0 N-CA-C 108.04 -1.096 . . . . 50.509999999999998 108.04 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -59.14 -25.19 63.66 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 112.511 0.559 . . . . 50.509999999999998 112.511 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 58.2 mttm -64.75 -30.78 71.8 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 106.327 -1.731 . . . . 50.509999999999998 106.327 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.653 ' O ' HG22 ' A' ' 30' ' ' ILE . 95.7 mt -82.66 2.86 2.93 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 N-CA-C 105.535 -2.024 . . . . 50.509999999999998 105.535 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 50.7 tt0 -87.12 -57.43 2.97 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.592 2.615 . . . . 50.549999999999997 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -69.05 -36.23 77.45 Favored 'General case' 0 C--O 1.253 1.264 0 CA-C-N 113.616 -1.629 . . . . 50.619999999999997 113.278 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.2 -32.71 24.41 Favored 'General case' 0 C--O 1.279 2.623 0 C-N-CA 116.427 -2.109 . . . . 50.509999999999998 112.667 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -108.99 -17.04 14.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 119.315 3.08 . . . . 50.619999999999997 119.315 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.82 37.54 10.23 Favored Glycine 0 CA--C 1.479 -2.199 0 N-CA-C 107.607 -2.197 . . . . 50.509999999999998 107.607 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.4 117.74 30.21 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 106.939 -1.504 . . . . 50.509999999999998 106.939 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.97 136.89 79.36 Favored 'Trans proline' 0 C--O 1.259 1.562 0 C-N-CA 123.185 2.59 . . . . 50.509999999999998 110.924 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -57.11 -32.15 92.48 Favored 'Trans proline' 0 C--O 1.261 1.667 0 O-C-N 122.948 0.973 . . . . 50.509999999999998 113.471 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.96 -2.02 8.8 Favored 'General case' 0 C--O 1.262 1.731 0 O-C-N 119.976 -1.703 . . . . 50.619999999999997 111.592 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -114.77 15.58 17.48 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.617 -1.302 . . . . 50.549999999999997 114.13 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -115.76 122.26 44.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.366 2.031 . . . . 50.549999999999997 111.203 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -115.83 121.56 42.77 Favored 'General case' 0 C--O 1.296 3.507 0 CA-C-O 116.657 -1.639 . . . . 50.640000000000001 111.265 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 76.6 mt -104.59 139.93 38.74 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 119.397 0.999 . . . . 50.509999999999998 108.897 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.36 134.13 64.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 O-C-N 125.129 1.518 . . . . 50.509999999999998 108.377 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 50.5 t80 -160.17 113.15 2.1 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.561 -1.199 . . . . 50.509999999999998 110.926 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 78.39 28.62 0.46 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.259 -2.246 . . . . 50.509999999999998 116.087 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.14 -8.95 35.36 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 117.04 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -101.48 138.33 38.63 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 114.211 1.189 . . . . 50.509999999999998 114.211 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.06 121.01 15.23 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.994 0.809 . . . . 50.549999999999997 110.234 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.644 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 11.1 mp -78.58 150.26 32.8 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.096 -2.187 . . . . 50.509999999999998 105.096 -175.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -110.19 143.72 39.89 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.939 1.4 . . . . 50.619999999999997 113.769 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' CG2' ' A' ' 23' ' ' ILE . 34.9 m-20 -38.33 -46.22 1.08 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 120.332 3.456 . . . . 50.619999999999997 120.332 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.71 -3.68 73.76 Favored Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 121.177 3.231 . . . . 50.509999999999998 121.177 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -83.72 159.13 21.55 Favored 'General case' 0 C--O 1.249 1.046 0 O-C-N 117.464 -3.374 . . . . 50.640000000000001 115.453 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.3 p -99.99 172.18 7.37 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.018 0.927 . . . . 50.509999999999998 109.143 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -70.54 -23.78 62.68 Favored 'General case' 0 C--O 1.201 -1.46 0 O-C-N 124.164 0.915 . . . . 50.509999999999998 109.268 177.197 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.8 p -77.52 -30.44 52.88 Favored 'General case' 0 C--O 1.269 2.102 0 C-N-CA 117.338 -1.745 . . . . 50.509999999999998 111.28 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.17 -42.87 70.13 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.423 1.106 . . . . 50.619999999999997 111.21 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.644 ' CZ ' ' HG ' ' A' ' 50' ' ' LEU . 92.9 m-85 -93.48 17.75 11.0 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.773 -1.108 . . . . 50.509999999999998 113.765 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.68 40.34 31.83 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 121.516 1.962 . . . . 50.549999999999997 116.273 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.57 112.95 2.45 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-O 115.183 -2.341 . . . . 50.509999999999998 116.634 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -118.16 174.24 6.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 126.141 2.15 . . . . 50.549999999999997 112.497 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 79.4 tttt -57.61 138.6 55.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 123.193 1.473 . . . . 50.509999999999998 111.378 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.63 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 29.5 mt-10 65.31 43.27 3.58 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.458 -2.155 . . . . 50.619999999999997 115.755 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -82.91 137.9 34.06 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.664 -1.606 . . . . 50.509999999999998 106.664 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -113.59 123.22 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.253 -1.017 . . . . 50.509999999999998 108.253 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -117.84 153.52 33.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.188 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -109.35 133.07 53.51 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 127.451 2.97 . . . . 50.509999999999998 103.358 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.413 HD23 HG22 ' A' ' 7' ' ' THR . 44.4 tp -101.52 107.14 18.34 Favored 'General case' 0 C--O 1.282 2.806 0 N-CA-C 118.914 2.931 . . . . 50.509999999999998 118.914 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 8' ' ' LEU . 61.9 t -92.03 117.16 34.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 119.564 1.075 . . . . 50.509999999999998 112.995 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.99 159.81 33.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.146 0.498 . . . . 50.509999999999998 110.435 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -119.52 109.87 16.22 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 113.298 -3.239 . . . . 50.640000000000001 103.744 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 2.0 mp -86.08 140.82 29.9 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 125.826 1.953 . . . . 50.509999999999998 116.206 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -68.85 122.31 18.34 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.01 -1.848 . . . . 50.640000000000001 106.01 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.01 -176.82 52.0 Favored Glycine 0 C--O 1.243 0.695 0 CA-C-N 114.63 -1.168 . . . . 50.509999999999998 115.431 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.445 0 N-CA-C 119.479 2.552 . . . . 50.509999999999998 119.479 179.25 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.509999999999998 109.784 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.549999999999997 110.888 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.509999999999998 116.515 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 113.74 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.509999999999998 108.059 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 111.299 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 113.264 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.509999999999998 109.711 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.509999999999998 118.139 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.509999999999998 115.485 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 112.444 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.509999999999998 104.287 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.509999999999998 112.3 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.509999999999998 121.099 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.619999999999997 110.491 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.509999999999998 108.724 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.619999999999997 111.398 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.509999999999998 111.977 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.509999999999998 114.356 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.619999999999997 114.483 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.509999999999998 107.854 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.509999999999998 119.713 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.619999999999997 107.589 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.549999999999997 116.179 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.509999999999998 107.144 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.509999999999998 106.178 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.509999999999998 113.884 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.509999999999998 110.545 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.427 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.509999999999998 115.565 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 108.505 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.619999999999997 115.994 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.509999999999998 109.748 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.619999999999997 110.609 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.509999999999998 106.674 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.509999999999998 113.426 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.509999999999998 110.966 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.509999999999998 113.447 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.619999999999997 115.85 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.549999999999997 110.579 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.549999999999997 112.07 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.640000000000001 108.703 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.509999999999998 118.456 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.509999999999998 111.752 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 61' ' ' ILE . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.509999999999998 118.653 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.509999999999998 114.688 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.509999999999998 116.218 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.509999999999998 102.92 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.549999999999997 109.69 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 113.209 -175.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.619999999999997 106.192 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.619999999999997 118.695 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.509999999999998 114.117 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.640000000000001 110.918 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.509999999999998 113.601 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.509999999999998 119.947 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.509999999999998 115.529 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.619999999999997 114.759 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.509999999999998 110.366 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.549999999999997 113.715 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 45' ' ' PHE . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.509999999999998 106.035 175.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.549999999999997 104.072 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.509999999999998 118.355 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.619999999999997 118.736 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.509999999999998 106.228 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.509999999999998 112.755 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.509999999999998 109.784 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.509999999999998 108.847 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.509999999999998 104.275 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.509999999999998 102.101 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.509999999999998 111.016 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.640000000000001 109.31 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.509999999999998 112.756 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.640000000000001 102.16 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.509999999999998 109.351 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.509999999999998 108.526 179.194 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.509999999999998 109.784 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.549999999999997 110.888 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.509999999999998 116.515 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 113.74 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.509999999999998 108.059 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 111.299 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 113.264 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.509999999999998 109.711 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.509999999999998 118.139 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.509999999999998 115.485 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 112.444 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.509999999999998 104.287 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.509999999999998 112.3 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.509999999999998 121.099 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.619999999999997 110.491 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.509999999999998 108.724 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.619999999999997 111.398 174.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.509999999999998 111.977 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.509999999999998 114.356 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.619999999999997 114.483 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.509999999999998 107.854 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.509999999999998 119.713 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.619999999999997 107.589 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.549999999999997 116.179 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.509999999999998 107.144 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.509999999999998 106.178 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.509999999999998 113.884 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.509999999999998 110.545 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.427 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.509999999999998 115.565 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 108.505 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.619999999999997 115.994 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.509999999999998 109.748 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.619999999999997 110.609 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.509999999999998 106.674 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.509999999999998 113.426 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.509999999999998 110.966 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.509999999999998 113.447 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.619999999999997 115.85 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.549999999999997 110.579 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.549999999999997 112.07 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.640000000000001 108.703 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.509999999999998 118.456 -177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.509999999999998 111.752 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 61' ' ' ILE . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.509999999999998 118.653 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.509999999999998 114.688 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.509999999999998 116.218 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.509999999999998 102.92 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.549999999999997 109.69 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 113.209 -175.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.619999999999997 106.192 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.619999999999997 118.695 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.509999999999998 114.117 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.640000000000001 110.918 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.509999999999998 113.601 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.509999999999998 119.947 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.509999999999998 115.529 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.619999999999997 114.759 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.509999999999998 110.366 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.549999999999997 113.715 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 45' ' ' PHE . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.509999999999998 106.035 175.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.549999999999997 104.072 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.509999999999998 118.355 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.619999999999997 118.736 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.509999999999998 106.228 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.509999999999998 112.755 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.509999999999998 109.784 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.509999999999998 108.847 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.509999999999998 104.275 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.509999999999998 102.101 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.509999999999998 111.016 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.640000000000001 109.31 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.509999999999998 112.756 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.640000000000001 102.16 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.509999999999998 109.351 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.509999999999998 108.526 179.194 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.509999999999998 106.676 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.549999999999997 106.021 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.509999999999998 104.709 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' HB2' HG22 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.509999999999998 113.954 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.509999999999998 102.923 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.509999999999998 112.316 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.509999999999998 106.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.509999999999998 115.548 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.509999999999998 108.113 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.509999999999998 106.107 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.509999999999998 120.071 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.509999999999998 110.493 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.509999999999998 109.559 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.509999999999998 114.838 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.509999999999998 106.275 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.619999999999997 113.422 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.509999999999998 109.333 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.619999999999997 106.827 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.509999999999998 111.928 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.509999999999998 121.083 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.619999999999997 111.205 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.509999999999998 110.198 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.509999999999998 109.42 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.619999999999997 111.997 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.549999999999997 112.41 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.509999999999998 109.295 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.509999999999998 112.034 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.509999999999998 108.289 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.509999999999998 110.474 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.509999999999998 112.329 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.549999999999997 110.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 107.396 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.509999999999998 117.751 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.619999999999997 110.115 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.509999999999998 107.221 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.509999999999998 111.423 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.509999999999998 110.839 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.509999999999998 113.43 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.619999999999997 110.786 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.549999999999997 113.905 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.599 ' HG2' HD11 ' A' ' 69' ' ' LEU . 44.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.549999999999997 108.396 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.640000000000001 106.438 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.509999999999998 111.107 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.509999999999998 108.499 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.509999999999998 110.923 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.509999999999998 110.976 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 110.394 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.509999999999998 113.046 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.549999999999997 105.007 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.509999999999998 110.654 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.619999999999997 113.026 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.619999999999997 118.034 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.509999999999998 115.926 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.640000000000001 104.585 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.509999999999998 116.28 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.509999999999998 114.766 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.509999999999998 108.201 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.619999999999997 110.796 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 109.666 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.549999999999997 108.723 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.509999999999998 106.728 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.549999999999997 120.811 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.509999999999998 108.884 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.619999999999997 119.75 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.509999999999998 111.035 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.509999999999998 110.83 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.516 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.509999999999998 114.067 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 41' ' ' GLN . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.509999999999998 113.384 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.509999999999998 112.182 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.509999999999998 107.317 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.640000000000001 106.699 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.509999999999998 116.896 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.640000000000001 110.974 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.509999999999998 113.009 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 117.514 179.235 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.509999999999998 106.676 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.549999999999997 106.021 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.509999999999998 104.709 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' HB2' HG22 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.509999999999998 113.954 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.509999999999998 102.923 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.509999999999998 112.316 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.509999999999998 106.004 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.509999999999998 115.548 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.509999999999998 108.113 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.509999999999998 106.107 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.509999999999998 120.071 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.509999999999998 110.493 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.509999999999998 109.559 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.509999999999998 114.838 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.509999999999998 106.275 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.619999999999997 113.422 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.509999999999998 109.333 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.619999999999997 106.827 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.509999999999998 111.928 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.509999999999998 121.083 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.619999999999997 111.205 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.509999999999998 110.198 175.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.509999999999998 109.42 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.619999999999997 111.997 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.549999999999997 112.41 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.509999999999998 109.295 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.509999999999998 112.034 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.509999999999998 108.289 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.509999999999998 110.474 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.509999999999998 112.329 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.549999999999997 110.082 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 107.396 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.509999999999998 117.751 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.619999999999997 110.115 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.509999999999998 107.221 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.509999999999998 111.423 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.509999999999998 110.839 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.509999999999998 113.43 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.619999999999997 110.786 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.549999999999997 113.905 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.599 ' HG2' HD11 ' A' ' 69' ' ' LEU . 44.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.549999999999997 108.396 -177.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.640000000000001 106.438 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.509999999999998 111.107 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.509999999999998 108.499 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.509999999999998 110.923 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.509999999999998 110.976 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 110.394 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.509999999999998 113.046 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.549999999999997 105.007 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.509999999999998 110.654 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.619999999999997 113.026 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.619999999999997 118.034 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.509999999999998 115.926 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.640000000000001 104.585 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.509999999999998 116.28 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.509999999999998 114.766 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.509999999999998 108.201 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.619999999999997 110.796 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 109.666 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.549999999999997 108.723 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.509999999999998 106.728 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.549999999999997 120.811 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.509999999999998 108.884 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.619999999999997 119.75 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.509999999999998 111.035 174.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.509999999999998 110.83 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.516 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.509999999999998 114.067 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 41' ' ' GLN . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.509999999999998 113.384 176.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.509999999999998 112.182 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.509999999999998 107.317 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.640000000000001 106.699 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.509999999999998 116.896 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.640000000000001 110.974 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.509999999999998 113.009 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 117.514 179.235 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.868 0 N-CA-C 104.835 -2.283 . . . . 50.509999999999998 104.835 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -88.49 154.45 20.35 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 102.339 -3.208 . . . . 50.549999999999997 102.339 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 3' ' ' ILE . 19.7 tt -150.21 128.91 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 115.963 -1.97 . . . . 50.509999999999998 108.004 173.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 66' ' ' THR . 82.5 m-85 -92.92 141.96 27.84 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.328 4.767 . . . . 50.509999999999998 112.03 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.79 99.23 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 113.439 -3.172 . . . . 50.509999999999998 111.052 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -68.65 136.07 52.38 Favored 'General case' 0 N--CA 1.504 2.235 1 O-C-N 129.254 4.096 . . . . 50.509999999999998 114.159 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 p -112.87 149.23 33.43 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 104.91 -2.256 . . . . 50.509999999999998 104.91 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.44 -6.85 0.5 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.799 2.888 . . . . 50.509999999999998 118.799 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -115.91 19.46 15.1 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 120.312 3.449 . . . . 50.509999999999998 120.312 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.26 -13.69 66.4 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 117.483 1.753 . . . . 50.509999999999998 117.483 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.41 155.41 18.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 116.871 -1.538 . . . . 50.509999999999998 111.77 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -148.98 149.77 31.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 126.656 2.472 . . . . 50.509999999999998 109.639 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -143.62 146.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.497 2.998 . . . . 50.509999999999998 110.559 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.457 ' O ' HD23 ' A' ' 15' ' ' LEU . 20.9 p -102.87 130.4 49.89 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.315 -1.754 . . . . 50.509999999999998 112.746 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 14' ' ' THR . 48.0 mt -124.95 149.79 47.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 115.37 -2.253 . . . . 50.509999999999998 113.511 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -107.4 142.43 37.23 Favored 'General case' 0 N--CA 1.5 2.025 1 O-C-N 129.114 4.009 . . . . 50.619999999999997 104.294 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -144.08 167.18 12.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 O-C-N 126.091 2.119 . . . . 50.509999999999998 105.692 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 68.9 mm-40 -122.0 157.66 57.15 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 112.209 -2.269 . . . . 50.619999999999997 112.202 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.96 -24.47 39.58 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 122.662 2.241 . . . . 50.509999999999998 111.904 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -96.78 -8.78 30.31 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 118.158 -0.925 . . . . 50.509999999999998 112.674 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 30.4 m-20 -66.3 124.44 22.71 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.308 -1.757 . . . . 50.619999999999997 106.485 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -79.09 155.79 28.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.808 -0.633 . . . . 50.509999999999998 112.51 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.605 HD13 ' HB3' ' A' ' 50' ' ' LEU . 76.6 mt -52.18 -45.87 43.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 O-C-N 127.176 2.798 . . . . 50.509999999999998 108.374 175.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.05 -51.01 18.58 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.45 -0.781 . . . . 50.619999999999997 110.645 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -65.19 -43.05 92.87 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 118.735 2.865 . . . . 50.549999999999997 118.735 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.22 -42.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.123 -1.399 . . . . 50.509999999999998 110.285 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.26 -38.25 90.38 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 108.12 -1.066 . . . . 50.509999999999998 108.12 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.7 -40.02 63.94 Favored 'General case' 0 C--O 1.277 2.543 0 N-CA-C 114.709 1.374 . . . . 50.509999999999998 114.709 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -58.05 -29.19 65.17 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 120.398 -1.439 . . . . 50.509999999999998 112.966 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.436 HG12 HD11 ' A' ' 15' ' ' LEU . 74.6 mt -77.58 -29.86 16.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 N-CA-C 106.695 -1.595 . . . . 50.509999999999998 106.695 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -58.08 -41.71 84.0 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 125.614 2.626 . . . . 50.549999999999997 108.18 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -73.48 10.92 0.89 Allowed 'General case' 0 C--O 1.253 1.289 0 CA-C-N 113.6 -1.636 . . . . 50.619999999999997 113.765 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -139.26 -30.1 0.74 Allowed 'General case' 0 C--O 1.279 2.647 0 N-CA-C 104.592 -2.373 . . . . 50.509999999999998 104.592 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -110.18 -61.57 1.64 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 123.081 2.673 . . . . 50.619999999999997 109.578 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.51 20.29 0.9 Allowed Glycine 0 CA--C 1.477 -2.327 0 N-CA-C 108.891 -1.683 . . . . 50.509999999999998 108.891 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.2 mt -103.03 122.26 46.14 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 116.526 2.047 . . . . 50.509999999999998 116.526 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.0 Cg_exo -57.01 136.91 79.55 Favored 'Trans proline' 0 C--O 1.259 1.545 0 C-N-CA 123.104 2.536 . . . . 50.509999999999998 110.937 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.0 Cg_exo -57.18 -32.12 92.55 Favored 'Trans proline' 0 C--O 1.262 1.685 0 O-C-N 122.912 0.953 . . . . 50.509999999999998 113.388 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' A' ' 37' ' ' PRO . 42.1 p-10 -59.91 -27.91 67.14 Favored 'General case' 0 C--O 1.261 1.702 0 O-C-N 119.897 -1.752 . . . . 50.619999999999997 114.427 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -87.97 -15.63 35.97 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.593 -1.317 . . . . 50.549999999999997 113.857 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -87.3 117.7 26.25 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 118.3 2.704 . . . . 50.549999999999997 118.3 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.32 131.99 53.62 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 105.937 -1.875 . . . . 50.640000000000001 105.937 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 mt -107.67 133.38 52.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 101.965 -3.346 . . . . 50.509999999999998 101.965 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.42 HD13 HG23 ' A' ' 70' ' ' VAL . 3.3 mp -124.31 135.87 62.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 O-C-N 125.201 1.563 . . . . 50.509999999999998 114.334 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -140.14 113.03 8.14 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 105.719 -1.956 . . . . 50.509999999999998 105.719 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.93 41.42 31.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.26 -2.245 . . . . 50.509999999999998 108.716 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.66 3.54 59.15 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 128.432 2.92 . . . . 50.509999999999998 116.134 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.1 125.5 29.45 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.714 1.376 . . . . 50.509999999999998 114.714 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -75.24 127.91 34.24 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 107.68 -1.23 . . . . 50.549999999999997 107.68 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.605 ' HB3' HD13 ' A' ' 23' ' ' ILE . 2.9 mp -95.51 124.59 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 117.72 -1.133 . . . . 50.509999999999998 112.665 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -104.37 135.97 44.83 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.368 1.988 . . . . 50.619999999999997 116.368 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -42.62 -36.23 1.33 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 121.197 3.777 . . . . 50.619999999999997 121.197 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.56 -33.61 87.7 Favored Glycine 0 CA--C 1.493 -1.294 0 C-N-CA 124.438 1.018 . . . . 50.509999999999998 113.72 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -88.69 136.45 32.99 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 119.766 -2.02 . . . . 50.640000000000001 112.614 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 22' ' ' THR . 57.0 p -77.68 171.54 14.79 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.015 0.926 . . . . 50.509999999999998 111.465 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.69 -39.24 83.87 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 117.381 2.363 . . . . 50.509999999999998 117.381 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -64.41 -37.67 88.33 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.332 -1.747 . . . . 50.509999999999998 110.815 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -50.01 -43.57 50.68 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 116.888 2.181 . . . . 50.619999999999997 116.888 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.656 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 63.4 m-85 -74.57 -6.85 50.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 110.416 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.656 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 71.52 40.67 0.79 Allowed 'General case' 0 C--O 1.247 0.957 0 CA-C-N 121.429 1.922 . . . . 50.549999999999997 115.239 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mm -71.03 110.41 3.96 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.182 -2.342 . . . . 50.509999999999998 110.428 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 174.35 7.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.056 2.097 . . . . 50.549999999999997 114.79 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 26.7 ttpp -61.35 114.27 3.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 123.159 1.457 . . . . 50.509999999999998 112.848 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 45.6 mm-40 80.31 44.18 0.04 OUTLIER 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.575 -2.102 . . . . 50.619999999999997 111.989 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.2 t -82.64 140.71 33.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.785 -1.098 . . . . 50.509999999999998 108.832 174.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 45.7 m -109.28 146.65 33.94 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 102.454 -3.165 . . . . 50.509999999999998 102.454 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.2 147.28 41.59 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.739 -2.553 . . . . 50.509999999999998 109.193 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -88.89 137.98 31.83 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 127.149 2.78 . . . . 50.509999999999998 111.373 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.5 109.17 18.59 Favored 'General case' 0 C--O 1.283 2.86 0 CA-C-O 117.662 -1.161 . . . . 50.509999999999998 113.737 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG23 HD13 ' A' ' 44' ' ' ILE . 45.6 t -111.69 128.48 68.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 119.614 1.097 . . . . 50.509999999999998 108.452 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.07 139.05 32.73 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 116.296 1.962 . . . . 50.509999999999998 116.296 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -98.08 116.7 30.84 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.337 -3.22 . . . . 50.640000000000001 108.684 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mp -85.76 138.4 32.12 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.795 1.934 . . . . 50.509999999999998 106.421 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -99.56 73.93 1.86 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.763 -1.562 . . . . 50.640000000000001 109.118 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.55 145.04 6.7 Favored Glycine 0 C--O 1.244 0.735 0 N-CA-C 106.293 -2.723 . . . . 50.509999999999998 106.293 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.416 0 N-CA-C 106.551 -2.62 . . . . 50.509999999999998 106.551 179.239 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 97.6 mmm . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.819 -1.178 . . . . 50.509999999999998 107.819 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -113.54 139.66 48.8 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 103.575 -2.75 . . . . 50.549999999999997 103.575 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.521 HD12 ' C ' ' A' ' 3' ' ' ILE . 2.0 pp -144.78 162.55 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 104.75 -2.315 . . . . 50.509999999999998 104.75 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 148.02 40.27 Favored 'General case' 0 N--CA 1.511 2.604 1 O-C-N 130.46 4.85 . . . . 50.509999999999998 109.434 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 67' ' ' LEU . 42.9 t -130.22 100.05 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 113.406 -3.188 . . . . 50.509999999999998 105.245 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -65.4 131.11 45.61 Favored 'General case' 0 N--CA 1.504 2.275 1 O-C-N 129.266 4.103 . . . . 50.509999999999998 112.832 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 41.5 p -93.22 -169.39 2.14 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 107.672 -1.233 . . . . 50.509999999999998 107.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.06 34.87 4.75 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.851 -1.537 . . . . 50.509999999999998 106.851 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.1 p -134.13 -15.09 2.29 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 115.706 -2.398 . . . . 50.509999999999998 114.646 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.63 13.14 10.7 Favored Glycine 0 C--N 1.296 -1.645 0 O-C-N 120.227 -1.546 . . . . 50.509999999999998 112.654 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -119.87 120.31 36.08 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 116.834 -1.555 . . . . 50.509999999999998 111.126 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -85.77 144.75 27.58 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 126.647 2.467 . . . . 50.509999999999998 110.942 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -116.75 142.74 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 127.582 3.052 . . . . 50.509999999999998 110.391 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -122.33 128.92 51.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.249 -1.78 . . . . 50.509999999999998 113.007 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 30' ' ' ILE . 5.4 mp -118.64 151.7 37.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 115.39 -2.243 . . . . 50.509999999999998 107.28 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 1' ' ' MET . 40.1 mt-10 -117.22 126.18 52.35 Favored 'General case' 0 N--CA 1.5 2.028 1 O-C-N 129.176 4.048 . . . . 50.619999999999997 102.984 173.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.491 HG12 ' HE3' ' A' ' 29' ' ' LYS . 35.3 m -146.31 170.83 4.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 126.241 2.213 . . . . 50.509999999999998 108.46 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -108.52 154.84 41.33 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.163 -2.29 . . . . 50.619999999999997 114.645 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -55.03 -24.51 40.35 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 122.624 2.216 . . . . 50.509999999999998 111.918 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -75.08 -14.74 60.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 118.067 -0.968 . . . . 50.509999999999998 112.467 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.0 140.91 56.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 117.355 -1.738 . . . . 50.619999999999997 109.344 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.0 p -80.93 133.51 35.55 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 105.809 -1.923 . . . . 50.509999999999998 105.809 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 54' ' ' ARG . 24.4 mm -37.69 -35.64 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.212 2.82 . . . . 50.509999999999998 110.364 175.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -58.5 -45.17 89.29 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.543 2.423 . . . . 50.619999999999997 117.543 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.09 -26.59 66.79 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.874 2.175 . . . . 50.549999999999997 116.874 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.74 -43.08 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 125.118 1.511 . . . . 50.509999999999998 112.842 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.7 -34.34 71.19 Favored 'General case' 0 C--O 1.256 1.402 0 CA-C-N 115.767 -0.651 . . . . 50.509999999999998 110.009 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 31' ' ' GLN . . . -66.42 -44.82 81.88 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 117.872 2.545 . . . . 50.509999999999998 117.872 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HE3' HG12 ' A' ' 17' ' ' VAL . 62.0 mttm -46.65 -32.66 3.66 Favored 'General case' 0 C--O 1.255 1.395 0 O-C-N 120.422 -1.424 . . . . 50.509999999999998 108.56 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.463 HD11 HD11 ' A' ' 15' ' ' LEU . 22.6 mm -68.97 -40.69 81.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.199 0 N-CA-C 106.363 -1.717 . . . . 50.509999999999998 106.363 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 28' ' ' ALA . 26.0 tt0 -39.92 -38.62 0.72 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 118.359 2.726 . . . . 50.549999999999997 118.359 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.11 -12.4 61.48 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 115.605 1.706 . . . . 50.619999999999997 115.605 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -105.18 -43.47 5.01 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.459 -2.096 . . . . 50.509999999999998 115.246 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -110.57 -43.46 3.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 123.067 2.667 . . . . 50.619999999999997 108.205 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 35.39 1.88 Allowed Glycine 0 CA--C 1.477 -2.33 0 N-CA-C 108.188 -1.965 . . . . 50.509999999999998 108.188 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.9 mm -98.73 123.41 49.81 Favored Pre-proline 0 C--O 1.243 0.739 0 C-N-CA 118.851 -1.139 . . . . 50.509999999999998 108.703 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.92 136.98 79.77 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.1 2.533 . . . . 50.509999999999998 110.943 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.7 Cg_exo -57.18 -32.23 92.87 Favored 'Trans proline' 0 C--O 1.261 1.663 0 O-C-N 122.904 0.949 . . . . 50.509999999999998 113.436 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.45 -15.99 63.39 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 120.023 -1.673 . . . . 50.619999999999997 114.309 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -104.63 17.57 23.88 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.555 -1.341 . . . . 50.549999999999997 113.991 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -114.35 146.11 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 124.422 2.058 . . . . 50.549999999999997 106.636 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.635 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 21.5 mtp-105 -128.7 105.19 8.09 Favored 'General case' 0 C--O 1.295 3.488 0 CA-C-O 116.632 -1.651 . . . . 50.640000000000001 113.386 172.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.41 117.58 29.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.459 1.027 . . . . 50.509999999999998 110.701 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -107.8 122.07 61.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 N-CA-C 119.051 2.982 . . . . 50.509999999999998 119.051 -177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -128.38 128.92 45.42 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 106.791 -1.559 . . . . 50.509999999999998 106.791 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.11 25.91 15.88 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 108.701 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.57 16.52 61.06 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.438 2.923 . . . . 50.509999999999998 108.69 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.47 142.01 33.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 118.037 0.918 . . . . 50.509999999999998 110.062 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -75.92 156.7 34.0 Favored 'General case' 0 C--O 1.26 1.607 0 O-C-N 123.981 0.801 . . . . 50.549999999999997 111.969 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -107.9 146.81 31.85 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.344 -1.725 . . . . 50.509999999999998 106.344 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -92.01 140.15 29.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 103.767 -2.679 . . . . 50.619999999999997 103.767 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -53.52 -52.18 60.46 Favored 'General case' 0 C--O 1.264 1.836 0 C-N-CA 126.206 1.802 . . . . 50.619999999999997 113.646 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.72 28.46 5.91 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 119.658 2.623 . . . . 50.509999999999998 119.658 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 23' ' ' ILE . 20.7 mmm180 -117.35 169.49 9.45 Favored 'General case' 0 C--O 1.248 1.006 0 O-C-N 120.047 -1.854 . . . . 50.640000000000001 112.33 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.95 149.36 28.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.091 0.956 . . . . 50.509999999999998 113.485 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.444 ' HB3' HG13 ' A' ' 61' ' ' ILE . 65.8 mt -50.47 -36.0 31.57 Favored 'General case' 0 C--O 1.201 -1.475 0 O-C-N 124.196 0.935 . . . . 50.509999999999998 109.023 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -68.79 -15.01 63.38 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.319 -1.752 . . . . 50.509999999999998 112.086 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.391 1.091 . . . . 50.619999999999997 109.894 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -121.88 11.2 10.33 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.778 -1.106 . . . . 50.509999999999998 113.333 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t30 51.45 39.79 25.27 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 121.442 1.928 . . . . 50.549999999999997 110.203 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.444 HG13 ' HB3' ' A' ' 56' ' ' LEU . 25.9 mm -56.54 116.26 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.959 0 CA-C-O 115.215 -2.326 . . . . 50.509999999999998 109.473 175.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -79.98 -171.03 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.638 2.458 . . . . 50.549999999999997 117.638 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.27 143.68 48.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.229 1.49 . . . . 50.509999999999998 108.827 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 34.42 39.58 0.03 OUTLIER 'General case' 0 C--O 1.256 1.447 0 N-CA-C 117.905 2.557 . . . . 50.619999999999997 117.905 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -65.89 146.68 54.44 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.83 -1.077 . . . . 50.509999999999998 111.949 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 p -104.54 144.15 32.08 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 118.299 -0.857 . . . . 50.509999999999998 110.926 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 5' ' ' VAL . 60.0 mt -110.66 156.04 21.56 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 114.756 -2.545 . . . . 50.509999999999998 108.625 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -118.94 144.94 46.16 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 127.408 2.942 . . . . 50.509999999999998 110.475 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 49.2 tp -96.09 129.88 43.26 Favored 'General case' 0 C--O 1.282 2.803 0 CA-C-O 117.696 -1.145 . . . . 50.509999999999998 111.668 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 61.8 t -116.11 137.06 51.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 102.392 -3.188 . . . . 50.509999999999998 102.392 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.87 127.86 46.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.102 0.477 . . . . 50.509999999999998 110.42 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -114.27 111.83 22.14 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.374 -3.203 . . . . 50.640000000000001 112.494 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.05 143.9 28.12 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.837 1.961 . . . . 50.509999999999998 108.097 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -98.09 89.28 4.47 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 106.662 -1.607 . . . . 50.640000000000001 106.662 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.7 -162.65 26.99 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 104.643 -3.383 . . . . 50.509999999999998 104.643 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 CA-C-O 116.355 -2.358 . . . . 50.509999999999998 108.044 179.25 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 118.768 -0.634 . . . . 50.509999999999998 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.463 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 10.9 mm-40 -109.09 127.67 54.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 127.001 2.688 . . . . 50.549999999999997 109.026 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -133.16 146.55 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 116.024 -1.941 . . . . 50.509999999999998 107.717 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -106.56 135.89 47.28 Favored 'General case' 0 N--CA 1.512 2.645 1 O-C-N 130.446 4.841 . . . . 50.509999999999998 113.486 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.468 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.8 t -108.05 136.63 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.417 -3.182 . . . . 50.509999999999998 103.898 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -126.24 119.7 28.12 Favored 'General case' 0 N--CA 1.503 2.219 1 O-C-N 129.277 4.111 . . . . 50.509999999999998 114.834 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.565 HG22 HD23 ' A' ' 69' ' ' LEU . 43.9 p -67.44 -172.27 0.23 Allowed 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.869 -1.063 . . . . 50.509999999999998 110.337 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.89 -18.97 26.46 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.116 -0.698 . . . . 50.509999999999998 109.116 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -106.36 16.08 25.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 119.87 3.285 . . . . 50.509999999999998 119.87 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.86 55.67 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 120.952 3.141 . . . . 50.509999999999998 120.952 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -84.16 123.35 30.0 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.227 -1.768 . . . . 50.509999999999998 106.227 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -113.03 134.1 54.67 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 126.585 2.428 . . . . 50.509999999999998 111.872 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 5' ' ' VAL . 28.0 pt -115.92 153.81 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 127.533 3.02 . . . . 50.509999999999998 114.0 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -110.58 142.99 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 117.301 -1.76 . . . . 50.509999999999998 115.021 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' A' ' 30' ' ' ILE . 76.4 mt -135.46 139.78 44.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 115.459 -2.21 . . . . 50.509999999999998 113.54 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -101.85 107.19 18.3 Favored 'General case' 0 N--CA 1.5 2.069 1 O-C-N 129.128 4.018 . . . . 50.619999999999997 113.926 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -128.17 154.63 39.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.671 3.107 . . . . 50.509999999999998 114.443 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.67 159.02 30.65 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 118.256 2.688 . . . . 50.619999999999997 118.256 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.0 -24.49 40.0 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.581 2.187 . . . . 50.509999999999998 111.948 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -103.34 34.33 2.97 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 117.806 2.521 . . . . 50.509999999999998 117.806 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -114.15 130.75 56.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.374 -1.731 . . . . 50.619999999999997 112.166 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.3 p -57.93 155.54 10.5 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.598 1.332 . . . . 50.509999999999998 114.598 175.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 54' ' ' ARG . 15.3 mm -60.45 -42.06 89.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 127.205 2.816 . . . . 50.509999999999998 110.955 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.07 -59.05 5.88 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.941 . . . . 50.619999999999997 108.458 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 44.5 t30 -47.85 -43.54 28.36 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 124.399 1.08 . . . . 50.549999999999997 111.145 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 56' ' ' LEU . 42.1 t -63.38 -34.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.97 1.419 . . . . 50.509999999999998 109.707 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -76.16 -30.44 58.12 Favored 'General case' 0 C--O 1.257 1.451 0 N-CA-C 108.816 -0.809 . . . . 50.509999999999998 108.816 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.88 70.02 Favored 'General case' 0 C--O 1.279 2.616 0 N-CA-C 105.517 -2.031 . . . . 50.509999999999998 105.517 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 75.3 mmtt -58.93 -63.2 1.38 Allowed 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.397 -1.439 . . . . 50.509999999999998 107.994 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.499 ' CG1' HD11 ' A' ' 15' ' ' LEU . 70.3 mt -47.97 -37.75 6.8 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.486 -0.886 . . . . 50.509999999999998 109.105 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 46.1 tt0 -54.45 -50.73 66.99 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 125.568 2.604 . . . . 50.549999999999997 112.849 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -49.0 -60.99 2.3 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 113.644 -1.616 . . . . 50.619999999999997 110.273 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -84.13 -40.33 18.36 Favored 'General case' 0 C--O 1.279 2.654 0 N-CA-C 119.617 3.191 . . . . 50.509999999999998 119.617 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.606 ' HG3' HG13 ' A' ' 36' ' ' ILE . 42.5 tp10 -76.19 -31.37 58.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 123.082 2.674 . . . . 50.619999999999997 108.162 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.42 2.36 76.75 Favored Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.458 -1.057 . . . . 50.509999999999998 110.458 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.606 HG13 ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -87.81 136.39 32.67 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 118.812 -1.155 . . . . 50.509999999999998 110.999 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.0 Cg_exo -57.07 137.0 79.97 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.159 2.572 . . . . 50.509999999999998 110.875 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 86.8 Cg_exo -57.19 -32.16 92.68 Favored 'Trans proline' 0 C--O 1.262 1.709 0 O-C-N 122.89 0.942 . . . . 50.509999999999998 113.436 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.539 ' OD1' ' HG3' ' A' ' 40' ' ' GLN . 35.6 p30 -69.4 -14.1 62.72 Favored 'General case' 0 C--O 1.262 1.733 0 O-C-N 119.893 -1.754 . . . . 50.619999999999997 113.83 -177.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.539 ' HG3' ' OD1' ' A' ' 39' ' ' ASP . 88.2 mt-30 -102.81 6.84 39.49 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.544 -1.347 . . . . 50.549999999999997 109.891 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -103.41 130.94 50.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 124.362 2.029 . . . . 50.549999999999997 110.796 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -120.98 122.12 39.47 Favored 'General case' 0 C--O 1.296 3.544 0 CA-C-O 116.625 -1.655 . . . . 50.640000000000001 110.828 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CB ' HD12 ' A' ' 50' ' ' LEU . 60.2 mt -108.14 126.16 52.44 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.509 1.05 . . . . 50.509999999999998 109.839 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 67.5 mt -111.14 138.86 37.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 O-C-N 125.223 1.577 . . . . 50.509999999999998 108.147 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -150.55 120.63 7.2 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 114.488 -1.233 . . . . 50.509999999999998 110.913 177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.34 38.66 7.69 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.208 -2.269 . . . . 50.509999999999998 112.284 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 3.42 68.08 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.346 2.879 . . . . 50.509999999999998 115.863 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -113.76 146.78 39.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 114.978 1.473 . . . . 50.509999999999998 114.978 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -70.51 153.96 42.38 Favored 'General case' 0 C--O 1.259 1.58 0 N-CA-C 108.2 -1.037 . . . . 50.549999999999997 108.2 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.45 HD12 ' CB ' ' A' ' 43' ' ' LEU . 63.5 mt -96.94 135.01 39.55 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 117.666 -1.159 . . . . 50.509999999999998 110.312 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -99.06 128.1 45.13 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.933 1.395 . . . . 50.619999999999997 112.737 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.11 -57.82 3.63 Favored 'General case' 0 C--O 1.264 1.844 0 C-N-CA 126.133 1.773 . . . . 50.619999999999997 115.216 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.26 -26.68 29.85 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 124.415 1.007 . . . . 50.509999999999998 113.886 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 23' ' ' ILE . 29.5 mmt180 -83.6 161.04 21.27 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 120.025 -1.868 . . . . 50.640000000000001 112.109 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -103.93 172.68 6.67 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 124.065 0.946 . . . . 50.509999999999998 110.218 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD11 HG21 ' A' ' 26' ' ' VAL . 47.5 mt -58.07 -33.19 68.79 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 116.49 2.033 . . . . 50.509999999999998 116.49 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -86.38 -5.66 59.12 Favored 'General case' 0 C--O 1.267 2.0 0 C-N-CA 117.372 -1.731 . . . . 50.509999999999998 111.167 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -79.81 -0.79 36.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.809 -1.182 . . . . 50.619999999999997 107.809 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -123.95 11.98 9.01 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 117.755 -1.117 . . . . 50.509999999999998 110.542 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.61 28.61 12.2 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 121.545 1.975 . . . . 50.549999999999997 111.595 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.2 103.0 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.969 0 CA-C-O 115.17 -2.348 . . . . 50.509999999999998 108.827 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -98.84 164.62 12.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.112 2.133 . . . . 50.549999999999997 112.435 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -51.04 135.89 24.27 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.513 2.042 . . . . 50.509999999999998 116.513 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 73.09 37.93 0.73 Allowed 'General case' 0 C--O 1.255 1.393 0 CA-C-N 112.497 -2.138 . . . . 50.619999999999997 111.07 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 p -78.07 156.56 29.96 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 107.537 -1.283 . . . . 50.509999999999998 107.537 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.5 m -122.05 117.97 27.63 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.834 -3.024 . . . . 50.509999999999998 102.834 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.65 170.09 9.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 114.695 -2.574 . . . . 50.509999999999998 112.545 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -110.32 127.62 55.12 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.361 2.913 . . . . 50.509999999999998 108.73 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.565 HD23 HG22 ' A' ' 7' ' ' THR . 48.0 tp -103.07 101.87 11.87 Favored 'General case' 0 C--O 1.283 2.823 0 CA-C-O 117.649 -1.167 . . . . 50.509999999999998 113.194 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.38 137.11 25.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.583 1.083 . . . . 50.509999999999998 112.149 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 tp -96.03 115.73 27.88 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.318 -0.623 . . . . 50.509999999999998 109.318 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -109.04 108.18 18.79 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.305 -3.236 . . . . 50.640000000000001 114.166 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.86 165.16 15.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 125.859 1.974 . . . . 50.509999999999998 114.664 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -115.35 61.45 0.69 Allowed 'General case' 0 C--O 1.244 0.812 0 CA-C-N 113.742 -1.572 . . . . 50.640000000000001 108.472 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.75 138.82 2.55 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 107.298 -2.321 . . . . 50.509999999999998 107.298 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.444 0 CA-C-O 116.356 -2.358 . . . . 50.509999999999998 109.038 179.217 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 106.917 -1.512 . . . . 50.509999999999998 106.917 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -120.19 135.71 54.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 101.557 -3.498 . . . . 50.549999999999997 101.557 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -137.89 159.36 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.94 -1.981 . . . . 50.509999999999998 106.941 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -114.24 143.91 44.08 Favored 'General case' 0 N--CA 1.512 2.628 1 O-C-N 130.446 4.842 . . . . 50.509999999999998 111.395 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -118.97 109.87 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.404 -3.189 . . . . 50.509999999999998 106.121 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -84.3 150.37 25.46 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.306 4.129 . . . . 50.509999999999998 117.362 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -126.78 164.23 21.81 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 117.826 -1.083 . . . . 50.509999999999998 110.137 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.54 -43.36 65.12 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.999 2.592 . . . . 50.509999999999998 117.999 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.6 p -68.64 -26.52 65.37 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 115.726 -2.39 . . . . 50.509999999999998 107.455 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.73 -5.93 18.42 Favored Glycine 0 C--N 1.297 -1.6 0 O-C-N 120.258 -1.526 . . . . 50.509999999999998 115.438 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -54.66 130.88 41.96 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.88 -1.533 . . . . 50.509999999999998 109.889 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -112.86 119.58 38.47 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 126.624 2.453 . . . . 50.509999999999998 117.221 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -88.48 145.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.571 3.044 . . . . 50.509999999999998 108.329 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -104.58 141.93 35.53 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 117.287 -1.765 . . . . 50.509999999999998 110.584 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -134.13 137.48 44.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 118.195 2.665 . . . . 50.509999999999998 118.195 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -103.61 111.18 23.54 Favored 'General case' 0 N--CA 1.501 2.104 1 O-C-N 129.242 4.089 . . . . 50.619999999999997 112.35 174.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -98.24 166.74 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.197 0 O-C-N 127.508 3.005 . . . . 50.509999999999998 112.548 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 53.9 mm-40 -115.72 148.66 41.63 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.197 -2.274 . . . . 50.619999999999997 112.58 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.5 Cg_exo -54.95 -24.49 39.57 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.581 2.188 . . . . 50.509999999999998 112.003 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -103.14 13.75 33.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 118.043 2.608 . . . . 50.509999999999998 118.043 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -92.74 148.6 21.91 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 117.349 -1.74 . . . . 50.619999999999997 110.986 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -99.09 157.42 16.37 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.836 -0.62 . . . . 50.509999999999998 109.716 175.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 26.8 mm -45.01 -43.86 2.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 O-C-N 127.238 2.836 . . . . 50.509999999999998 113.015 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -57.39 -46.68 83.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.456 -0.778 . . . . 50.619999999999997 110.305 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -59.51 -39.88 85.3 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.287 1.035 . . . . 50.549999999999997 110.653 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.63 -46.73 95.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.022 -1.473 . . . . 50.509999999999998 107.022 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 93.4 mttt -55.0 -59.38 4.83 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-N 115.814 -0.63 . . . . 50.509999999999998 111.336 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 38' ' ' PRO . . . -57.02 -40.59 76.99 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 113.887 1.069 . . . . 50.509999999999998 113.887 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 55.8 tptt -50.8 -44.38 58.97 Favored 'General case' 0 C--O 1.255 1.39 0 N-CA-C 106.367 -1.716 . . . . 50.509999999999998 106.367 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 31' ' ' GLN . 72.3 mt -64.26 -42.2 94.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.281 0 C-N-CA 119.51 -0.876 . . . . 50.509999999999998 108.669 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' C ' ' A' ' 32' ' ' ASP . 35.4 tt0 -43.87 -58.34 2.8 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.623 2.63 . . . . 50.549999999999997 108.844 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 31' ' ' GLN . 98.1 m-20 -34.57 -35.79 0.04 OUTLIER 'General case' 0 C--O 1.253 1.26 0 CA-C-N 113.645 -1.616 . . . . 50.619999999999997 110.833 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 31' ' ' GLN . 33.7 mmtp -112.46 -1.22 15.05 Favored 'General case' 0 C--O 1.28 2.703 0 N-CA-C 120.15 3.389 . . . . 50.509999999999998 120.15 -175.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -129.81 -38.07 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 123.147 2.703 . . . . 50.619999999999997 108.399 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 11.98 31.98 Favored Glycine 0 CA--C 1.477 -2.333 0 N-CA-C 115.177 0.831 . . . . 50.509999999999998 115.177 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.501 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.6 mt -97.51 136.72 21.18 Favored Pre-proline 0 C--O 1.245 0.83 0 C-N-CA 118.836 -1.146 . . . . 50.509999999999998 112.149 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.565 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.88 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.596 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 Cg_exo -57.24 -32.18 92.86 Favored 'Trans proline' 0 C--O 1.26 1.621 0 O-C-N 122.903 0.949 . . . . 50.509999999999998 113.38 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -72.82 5.17 3.39 Favored 'General case' 0 C--O 1.262 1.757 0 O-C-N 120.022 -1.674 . . . . 50.619999999999997 113.573 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.592 HE21 ' HG3' ' A' ' 74' ' ' ARG . 62.8 mt-30 -111.2 -6.71 14.53 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.541 -1.349 . . . . 50.549999999999997 112.632 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.425 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 37.0 mt-30 -102.79 130.59 49.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.412 2.053 . . . . 50.549999999999997 112.686 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -111.54 119.68 39.57 Favored 'General case' 0 C--O 1.297 3.566 0 CA-C-O 116.672 -1.632 . . . . 50.640000000000001 108.368 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' A' ' 50' ' ' LEU . 94.4 mt -100.97 158.72 15.79 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 105.595 -2.002 . . . . 50.509999999999998 105.595 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.8 mt -137.35 135.78 46.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 118.835 2.902 . . . . 50.509999999999998 118.835 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -128.05 112.62 14.81 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 115.063 1.505 . . . . 50.509999999999998 115.063 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.92 30.92 20.42 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.19 -2.277 . . . . 50.509999999999998 109.525 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.09 19.34 72.63 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 128.486 2.945 . . . . 50.509999999999998 117.187 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -111.02 151.72 27.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 118.162 -0.923 . . . . 50.509999999999998 112.078 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.05 154.17 42.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.986 1.106 . . . . 50.549999999999997 113.986 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 43' ' ' LEU . 96.4 mt -117.09 140.22 49.77 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 117.796 -1.097 . . . . 50.509999999999998 109.169 -175.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -103.32 136.03 43.85 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.864 1.352 . . . . 50.619999999999997 114.31 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 75.4 m-20 -57.33 -55.73 31.01 Favored 'General case' 0 C--O 1.263 1.793 0 C-N-CA 126.177 1.791 . . . . 50.619999999999997 114.019 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.16 11.66 4.76 Favored Glycine 0 C--O 1.254 1.368 0 C-N-CA 124.464 1.03 . . . . 50.509999999999998 115.389 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -106.96 166.7 10.41 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 119.963 -1.904 . . . . 50.640000000000001 110.538 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -90.22 158.67 17.1 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 124.014 0.926 . . . . 50.509999999999998 113.308 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -70.62 -28.82 65.14 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 124.071 0.857 . . . . 50.509999999999998 110.085 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -69.31 -21.71 63.83 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.31 -1.756 . . . . 50.509999999999998 113.535 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.29 -5.35 51.78 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.63 2.085 . . . . 50.619999999999997 116.63 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -111.75 14.32 21.11 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 114.791 1.404 . . . . 50.509999999999998 114.791 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 51.4 28.1 4.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 121.571 1.987 . . . . 50.549999999999997 114.397 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.85 100.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.973 0 CA-C-O 115.192 -2.337 . . . . 50.509999999999998 106.878 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -98.9 162.76 12.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 126.159 2.162 . . . . 50.549999999999997 111.333 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 58.4 pttt -52.93 118.32 3.62 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 116.501 2.038 . . . . 50.509999999999998 116.501 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 71.69 46.87 0.36 Allowed 'General case' 0 C--O 1.257 1.453 0 CA-C-N 112.53 -2.123 . . . . 50.619999999999997 112.764 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.3 p -102.0 151.86 21.63 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 101.515 -3.513 . . . . 50.509999999999998 101.515 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.1 p -94.29 139.55 30.92 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 117.729 2.492 . . . . 50.509999999999998 117.729 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 46.6 mt -109.36 151.73 26.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 103.166 -2.902 . . . . 50.509999999999998 103.166 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 55.5 m80 -108.75 124.95 51.37 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 127.472 2.982 . . . . 50.509999999999998 104.565 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.4 tp -99.42 117.56 34.11 Favored 'General case' 0 C--O 1.283 2.841 0 CA-C-O 117.63 -1.176 . . . . 50.509999999999998 111.172 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -103.84 145.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 119.558 1.072 . . . . 50.509999999999998 108.765 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -115.23 120.55 40.08 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.859 2.17 . . . . 50.509999999999998 116.859 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -119.13 90.06 3.25 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 113.371 -3.204 . . . . 50.640000000000001 111.138 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.24 163.38 1.65 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.795 1.935 . . . . 50.509999999999998 109.209 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.592 ' HG3' HE21 ' A' ' 40' ' ' GLN . 93.8 mtt-85 -87.62 94.01 9.6 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 113.706 -1.588 . . . . 50.640000000000001 113.065 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.66 171.34 18.3 Favored Glycine 0 C--O 1.243 0.705 0 N-CA-C 109.663 -1.375 . . . . 50.509999999999998 109.663 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.472 0 N-CA-C 106.215 -2.754 . . . . 50.509999999999998 106.215 179.22 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 118.753 -0.641 . . . . 50.509999999999998 111.148 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.521 ' OE1' HG21 ' A' ' 14' ' ' THR . 48.9 mt-30 -86.22 125.11 33.31 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.96 2.663 . . . . 50.549999999999997 116.662 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.3 pt -119.87 162.65 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 115.983 -1.96 . . . . 50.509999999999998 109.392 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -112.02 136.28 51.58 Favored 'General case' 0 N--CA 1.513 2.69 1 O-C-N 130.504 4.877 . . . . 50.509999999999998 118.459 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -105.85 111.63 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.438 -3.172 . . . . 50.509999999999998 111.728 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -81.22 129.44 34.59 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.309 4.131 . . . . 50.509999999999998 109.318 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 69.2 p -97.67 -176.77 3.57 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 114.576 1.324 . . . . 50.509999999999998 114.576 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.2 mt -86.91 -28.68 22.64 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.784 1.031 . . . . 50.509999999999998 113.784 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 p -93.97 -22.37 18.61 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.713 -2.395 . . . . 50.509999999999998 111.12 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.2 3.9 2.39 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 117.726 1.85 . . . . 50.509999999999998 117.726 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' N ' ' OG1' ' A' ' 7' ' ' THR . 95.4 mttt -71.7 137.65 47.96 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 116.868 -1.539 . . . . 50.509999999999998 112.323 174.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.1 m -122.15 106.73 11.42 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.678 2.486 . . . . 50.509999999999998 110.809 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 15' ' ' LEU . 62.5 mt -84.87 153.09 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 127.244 2.84 . . . . 50.509999999999998 111.427 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.521 HG21 ' OE1' ' A' ' 2' ' ' GLN . 42.6 m -119.76 132.1 55.53 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 102.538 -3.134 . . . . 50.509999999999998 102.538 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 13' ' ' ILE . 1.5 mp -118.05 142.6 47.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 117.3 2.333 . . . . 50.509999999999998 117.3 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.71 107.39 19.87 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 128.944 3.902 . . . . 50.619999999999997 109.902 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.58 166.71 10.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 O-C-N 127.782 3.176 . . . . 50.509999999999998 106.046 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -132.67 157.77 77.46 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 112.234 -2.257 . . . . 50.619999999999997 106.446 174.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.92 -24.5 39.38 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.56 2.173 . . . . 50.509999999999998 112.014 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -75.81 -13.0 60.28 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 115.451 1.648 . . . . 50.509999999999998 115.451 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -84.65 131.27 34.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 118.379 2.733 . . . . 50.619999999999997 118.379 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -83.61 179.92 7.49 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 103.948 -2.612 . . . . 50.509999999999998 103.948 175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' GLU . 24.6 mm -65.41 -39.56 85.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 O-C-N 127.206 2.816 . . . . 50.509999999999998 110.824 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 29.7 tt0 -46.84 -59.23 3.2 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.275 -2.12 . . . . 50.619999999999997 105.275 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 24.6 m-80 -53.12 -46.37 68.73 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 118.123 2.638 . . . . 50.549999999999997 118.123 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.41 -39.6 81.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 117.777 2.51 . . . . 50.509999999999998 117.777 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -72.27 -30.08 64.5 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 103.231 -2.877 . . . . 50.509999999999998 103.231 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -30.86 71.18 Favored 'General case' 0 C--O 1.279 2.608 0 N-CA-C 109.146 -0.687 . . . . 50.509999999999998 109.146 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.6 mttt -71.79 -19.18 62.04 Favored 'General case' 0 C--O 1.256 1.422 0 O-C-N 120.316 -1.49 . . . . 50.509999999999998 111.058 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 30' ' ' ILE . 95.7 mt -88.94 -11.25 10.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 C-N-CA 119.538 -0.865 . . . . 50.509999999999998 109.491 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -91.67 -19.64 22.45 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 125.63 2.633 . . . . 50.549999999999997 113.161 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.26 -52.77 20.5 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.572 -1.649 . . . . 50.619999999999997 110.606 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -80.28 -75.93 0.24 Allowed 'General case' 0 C--O 1.278 2.598 0 C-N-CA 116.468 -2.093 . . . . 50.509999999999998 108.175 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -55.18 -70.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.05 2.659 . . . . 50.619999999999997 114.812 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.69 20.33 0.88 Allowed Glycine 0 CA--C 1.478 -2.27 0 CA-C-O 120.012 -0.327 . . . . 50.509999999999998 113.223 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -89.28 125.86 60.51 Favored Pre-proline 0 C--O 1.244 0.776 0 N-CA-C 116.77 2.137 . . . . 50.509999999999998 116.77 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -57.01 136.98 79.95 Favored 'Trans proline' 0 C--O 1.258 1.523 0 C-N-CA 123.159 2.572 . . . . 50.509999999999998 110.903 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.1 Cg_exo -57.17 -32.19 92.72 Favored 'Trans proline' 0 C--O 1.261 1.653 0 C-N-CA 120.671 0.914 . . . . 50.509999999999998 113.377 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.04 -9.71 58.9 Favored 'General case' 0 C--O 1.262 1.738 0 O-C-N 119.949 -1.719 . . . . 50.619999999999997 112.854 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.644 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 79.8 mt-30 -103.32 -1.89 27.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.488 -1.382 . . . . 50.549999999999997 107.656 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.22 138.1 31.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 124.447 2.07 . . . . 50.549999999999997 105.745 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.11 114.4 15.7 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.646 -1.645 . . . . 50.640000000000001 106.831 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' CB ' HD22 ' A' ' 50' ' ' LEU . 35.2 mt -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 119.537 1.062 . . . . 50.509999999999998 110.285 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -129.06 123.87 59.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 O-C-N 125.102 1.501 . . . . 50.509999999999998 111.849 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -140.1 117.19 11.16 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 114.539 -1.21 . . . . 50.509999999999998 109.948 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.7 29.0 13.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 112.241 -2.254 . . . . 50.509999999999998 114.706 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 37.54 45.29 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 114.393 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -133.95 150.23 51.28 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 118.317 2.71 . . . . 50.509999999999998 118.317 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.08 135.18 42.97 Favored 'General case' 0 C--O 1.26 1.635 0 O-C-N 123.953 0.783 . . . . 50.549999999999997 110.33 174.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD22 ' CB ' ' A' ' 43' ' ' LEU . 2.1 mp -87.79 129.18 35.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 114.637 1.347 . . . . 50.509999999999998 114.637 -175.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -89.5 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 120.377 3.473 . . . . 50.619999999999997 120.377 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -51.07 -55.97 14.95 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 119.74 3.237 . . . . 50.619999999999997 119.74 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.96 7.85 78.69 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.387 0.994 . . . . 50.509999999999998 114.189 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.51 144.55 28.48 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 119.951 -1.911 . . . . 50.640000000000001 109.276 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -87.4 155.84 19.85 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.062 0.945 . . . . 50.509999999999998 108.581 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -46.93 -32.26 3.71 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 113.869 1.063 . . . . 50.509999999999998 113.869 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.58 -20.38 65.38 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 115.759 1.763 . . . . 50.509999999999998 115.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -62.24 -43.84 97.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.452 1.12 . . . . 50.619999999999997 110.603 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -84.66 17.11 2.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 115.609 1.707 . . . . 50.509999999999998 115.609 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 t30 60.31 33.13 20.88 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 121.536 1.971 . . . . 50.549999999999997 113.59 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.533 HG23 ' OG ' ' A' ' 65' ' ' SER . 56.9 mt -85.47 83.71 2.08 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 CA-C-O 115.169 -2.348 . . . . 50.509999999999998 113.65 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -82.97 179.06 7.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 125.717 1.885 . . . . 50.549999999999997 116.027 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -53.2 124.21 13.91 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 123.179 1.466 . . . . 50.509999999999998 111.394 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 61.1 40.42 14.98 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 118.528 2.788 . . . . 50.619999999999997 118.528 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.533 ' OG ' HG23 ' A' ' 61' ' ' ILE . 94.2 p -86.91 152.35 22.51 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.164 -1.421 . . . . 50.509999999999998 107.164 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 m -91.47 123.3 34.78 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 116.667 2.099 . . . . 50.509999999999998 116.667 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.01 138.58 41.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 114.735 -2.555 . . . . 50.509999999999998 105.291 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 49.0 m80 -81.6 168.04 18.59 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 127.038 2.711 . . . . 50.509999999999998 106.612 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -131.24 120.47 23.28 Favored 'General case' 0 C--O 1.282 2.789 0 N-CA-C 104.664 -2.346 . . . . 50.509999999999998 104.664 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.5 t -118.8 149.93 21.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 102.585 -3.117 . . . . 50.509999999999998 102.585 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.11 152.33 18.64 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.536 0.569 . . . . 50.509999999999998 112.536 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.644 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 74.9 ttt180 -122.12 97.73 5.61 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 113.413 -3.184 . . . . 50.640000000000001 106.789 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.0 mt -85.83 134.6 33.91 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 125.757 1.911 . . . . 50.509999999999998 113.369 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.84 81.49 8.75 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.703 -1.59 . . . . 50.640000000000001 112.88 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.94 -175.34 16.6 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 107.596 -2.201 . . . . 50.509999999999998 107.596 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.464 0 N-CA-C 105.24 -3.144 . . . . 50.509999999999998 105.24 179.213 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtp . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 102.042 -3.318 . . . . 50.509999999999998 102.042 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -112.52 135.05 53.69 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 103.497 -2.779 . . . . 50.549999999999997 103.497 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -124.77 173.12 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 CA-C-O 116.074 -1.917 . . . . 50.509999999999998 107.004 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.8 141.98 38.55 Favored 'General case' 0 N--CA 1.511 2.609 1 O-C-N 130.343 4.777 . . . . 50.509999999999998 115.954 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.34 110.58 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.454 -3.165 . . . . 50.509999999999998 104.585 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -90.47 143.94 26.27 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.204 4.065 . . . . 50.509999999999998 105.472 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 24.8 p -117.39 177.2 4.82 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.8 -1.095 . . . . 50.509999999999998 112.878 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.05 -24.76 67.83 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.082 0.864 . . . . 50.509999999999998 112.65 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -101.23 25.79 7.83 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 115.748 -2.381 . . . . 50.509999999999998 110.799 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.56 31.34 74.44 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 107.559 -2.216 . . . . 50.509999999999998 107.559 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 29.3 ttpt -84.97 124.7 31.98 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 103.735 -2.691 . . . . 50.509999999999998 103.735 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 p -103.31 137.72 41.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.664 2.477 . . . . 50.509999999999998 105.851 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 13' ' ' ILE . 16.6 tt -144.74 112.13 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 101.735 -3.432 . . . . 50.509999999999998 101.735 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.9 p -81.52 155.07 25.94 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.302 -1.759 . . . . 50.509999999999998 114.975 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -114.22 167.63 10.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.446 -2.216 . . . . 50.509999999999998 110.928 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.6 104.06 12.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 129.025 3.953 . . . . 50.619999999999997 106.427 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.41 148.62 11.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 O-C-N 127.62 3.075 . . . . 50.509999999999998 114.912 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -116.0 149.47 43.4 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 112.131 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.87 -24.53 39.18 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.535 2.157 . . . . 50.509999999999998 111.971 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -87.31 -2.54 58.7 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 118.146 -0.931 . . . . 50.509999999999998 111.135 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.43 131.8 37.05 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 115.949 1.833 . . . . 50.619999999999997 115.949 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.98 148.58 24.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.808 -0.633 . . . . 50.509999999999998 111.04 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 51' ' ' GLU . 73.2 mt -48.6 -29.87 2.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.147 2.779 . . . . 50.509999999999998 114.907 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 78.5 tt0 -56.25 -63.82 1.06 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 105.021 -2.215 . . . . 50.619999999999997 105.021 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -50.42 -40.71 51.01 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 118.97 2.952 . . . . 50.549999999999997 118.97 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.13 -23.15 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.129 -1.396 . . . . 50.509999999999998 107.518 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 64.5 mttm -88.73 -26.68 21.65 Favored 'General case' 0 C--O 1.257 1.474 0 N-CA-C 118.272 2.693 . . . . 50.509999999999998 118.272 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -23.7 24.29 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.901 -0.407 . . . . 50.509999999999998 109.901 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.87 -49.69 73.84 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 120.333 -1.48 . . . . 50.509999999999998 111.41 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.42 -36.96 48.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 108.575 -0.898 . . . . 50.509999999999998 108.575 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.47 -45.19 73.13 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.578 2.608 . . . . 50.549999999999997 115.682 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -52.64 -29.55 26.83 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 106.387 -1.709 . . . . 50.619999999999997 106.387 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.72 -45.48 11.61 Favored 'General case' 0 C--O 1.279 2.656 0 C-N-CA 116.433 -2.107 . . . . 50.509999999999998 113.243 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -116.78 -36.67 3.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 123.107 2.685 . . . . 50.619999999999997 112.321 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.86 31.32 2.74 Favored Glycine 0 CA--C 1.477 -2.291 0 N-CA-C 110.512 -1.035 . . . . 50.509999999999998 110.512 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -83.09 122.92 77.89 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 105.273 -2.121 . . . . 50.509999999999998 105.273 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.4 Cg_exo -57.0 136.93 79.63 Favored 'Trans proline' 0 C--O 1.258 1.514 0 C-N-CA 123.228 2.618 . . . . 50.509999999999998 110.838 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.3 Cg_exo -57.18 -32.19 92.77 Favored 'Trans proline' 0 C--O 1.262 1.688 0 O-C-N 122.885 0.939 . . . . 50.509999999999998 113.418 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -89.25 27.57 1.39 Allowed 'General case' 0 C--O 1.262 1.75 0 O-C-N 119.981 -1.699 . . . . 50.619999999999997 115.06 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -137.8 14.03 2.91 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 104.384 -2.45 . . . . 50.549999999999997 104.384 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.513 ' HG2' HD11 ' A' ' 69' ' ' LEU . 58.7 mt-30 -110.39 137.79 47.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.948 -2.242 . . . . 50.549999999999997 104.948 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -131.62 108.88 9.82 Favored 'General case' 0 C--O 1.296 3.537 0 CA-C-O 116.676 -1.63 . . . . 50.640000000000001 112.564 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.0 mt -90.42 131.22 36.31 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 116.63 2.085 . . . . 50.509999999999998 116.63 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.713 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -107.0 137.9 35.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.509999999999998 113.524 -177.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -149.4 112.39 4.87 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 114.55 -1.204 . . . . 50.509999999999998 113.78 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 46.05 27.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.215 -2.266 . . . . 50.509999999999998 113.31 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.93 -6.07 56.63 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 128.384 2.897 . . . . 50.509999999999998 114.763 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -97.47 158.9 15.24 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 117.412 2.375 . . . . 50.509999999999998 117.412 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -96.17 139.96 31.57 Favored 'General case' 0 C--O 1.259 1.554 0 N-CA-C 105.644 -1.984 . . . . 50.549999999999997 105.644 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -95.84 127.79 42.16 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 117.72 -1.133 . . . . 50.509999999999998 112.554 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . 57.5 mt-10 -85.55 139.39 31.49 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.891 1.369 . . . . 50.619999999999997 113.79 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -53.88 -50.21 66.82 Favored 'General case' 0 C--O 1.264 1.86 0 C-N-CA 126.171 1.788 . . . . 50.619999999999997 114.38 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.3 -4.58 44.66 Favored Glycine 0 CA--C 1.493 -1.321 0 C-N-CA 124.457 1.027 . . . . 50.509999999999998 113.999 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.99 150.0 21.63 Favored 'General case' 0 C--O 1.249 1.072 0 O-C-N 119.858 -1.966 . . . . 50.640000000000001 108.92 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -83.47 -179.19 7.29 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.08 0.952 . . . . 50.509999999999998 110.398 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.38 -29.12 31.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.821 -1.548 . . . . 50.509999999999998 106.821 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 m -73.78 -37.37 65.0 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 106.904 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -46.92 -16.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.334 1.064 . . . . 50.619999999999997 112.88 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 91.1 m-85 -121.71 -6.12 9.14 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 113.613 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 66.31 41.65 3.29 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 117.569 2.433 . . . . 50.549999999999997 117.569 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -82.14 124.41 39.15 Favored 'Isoleucine or valine' 0 C--O 1.267 1.978 0 CA-C-O 115.287 -2.292 . . . . 50.509999999999998 110.174 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.67 168.68 9.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 126.018 2.073 . . . . 50.549999999999997 115.893 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -36.54 146.2 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 123.277 1.513 . . . . 50.509999999999998 113.569 -176.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 50.31 34.93 9.63 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-N 112.469 -2.15 . . . . 50.619999999999997 115.885 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 t -76.8 154.07 34.29 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.802 -1.09 . . . . 50.509999999999998 108.659 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 m -119.99 123.6 43.89 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.734 -1.209 . . . . 50.509999999999998 107.734 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.7 mt -94.85 147.88 22.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.696 -2.573 . . . . 50.509999999999998 111.47 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.713 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.0 m-70 -95.93 119.28 34.13 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 127.454 2.971 . . . . 50.509999999999998 108.781 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD11 ' HG2' ' A' ' 41' ' ' GLN . 33.1 tp -98.51 110.53 23.11 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 107.08 -1.452 . . . . 50.509999999999998 107.08 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 44' ' ' ILE . 45.6 t -93.81 165.17 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 101.499 -3.519 . . . . 50.509999999999998 101.499 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.3 mt -117.21 139.98 50.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.884 -0.784 . . . . 50.509999999999998 108.884 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -131.33 91.67 3.06 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-O 113.405 -3.188 . . . . 50.640000000000001 107.094 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -85.15 157.23 20.72 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 125.778 1.924 . . . . 50.509999999999998 110.066 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -90.53 113.2 25.13 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 105.543 -2.021 . . . . 50.640000000000001 105.543 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.65 155.81 14.52 Favored Glycine 0 C--O 1.243 0.682 0 CA-C-N 114.662 -1.154 . . . . 50.509999999999998 113.581 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.323 -2.376 . . . . 50.509999999999998 113.473 179.214 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 106.471 -1.678 . . . . 50.509999999999998 106.471 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.411 ' HG2' ' HG2' ' A' ' 16' ' ' GLU . 82.1 mt-30 -102.5 131.82 48.96 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 126.952 2.658 . . . . 50.549999999999997 108.424 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.73 163.95 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 CA-C-O 115.961 -1.971 . . . . 50.509999999999998 112.534 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.407 ' CD1' HG22 ' A' ' 14' ' ' THR . 79.0 m-85 -108.44 141.51 40.19 Favored 'General case' 0 N--CA 1.511 2.608 1 O-C-N 130.49 4.869 . . . . 50.509999999999998 116.756 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -116.72 120.16 64.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 113.356 -3.212 . . . . 50.509999999999998 106.065 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.32 117.38 34.0 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.326 4.141 . . . . 50.509999999999998 112.825 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 69.4 p -84.54 -174.46 5.28 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 117.774 -1.108 . . . . 50.509999999999998 108.723 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.74 -8.9 58.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.516 2.784 . . . . 50.509999999999998 118.516 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -122.65 22.86 9.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 115.74 -2.384 . . . . 50.509999999999998 116.791 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.03 22.16 21.03 Favored Glycine 0 C--N 1.297 -1.609 0 O-C-N 119.225 -2.172 . . . . 50.509999999999998 118.183 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 80.0 tttt -100.54 124.13 45.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 116.823 -1.56 . . . . 50.509999999999998 108.417 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.47 135.29 53.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 126.668 2.48 . . . . 50.509999999999998 106.369 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.3 pt -123.31 153.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 127.565 3.04 . . . . 50.509999999999998 103.594 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.407 HG22 ' CD1' ' A' ' 4' ' ' PHE . 70.2 p -117.1 139.04 51.2 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 117.266 -1.774 . . . . 50.509999999999998 107.862 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -126.3 137.96 53.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 115.454 -2.212 . . . . 50.509999999999998 107.446 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HG2' ' HG2' ' A' ' 2' ' ' GLN . 46.8 mt-10 -96.24 133.14 40.95 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.231 4.082 . . . . 50.619999999999997 109.407 173.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.42 170.62 19.03 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.631 3.082 . . . . 50.509999999999998 113.57 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -124.09 153.5 68.03 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.215 -2.266 . . . . 50.619999999999997 111.165 174.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.01 -24.5 40.1 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 122.623 2.215 . . . . 50.509999999999998 111.906 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.0 p -89.01 8.32 30.27 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 117.243 2.312 . . . . 50.509999999999998 117.243 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.84 137.73 32.99 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 118.648 2.833 . . . . 50.619999999999997 118.648 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 25' ' ' ASN . 32.8 p -86.89 137.17 32.61 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.834 -0.621 . . . . 50.509999999999998 111.95 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -42.6 -35.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.26 2.85 . . . . 50.509999999999998 112.932 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.47 -11.79 58.73 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.488 -0.757 . . . . 50.619999999999997 111.077 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' THR . 31.3 t30 -108.56 -14.48 14.63 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.251 1.02 . . . . 50.549999999999997 109.814 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.1 t -81.47 -44.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 103.701 -2.703 . . . . 50.509999999999998 103.701 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 50.9 mtmt -66.88 -33.54 75.81 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.769 -0.65 . . . . 50.509999999999998 110.203 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.04 73.88 Favored 'General case' 0 C--O 1.279 2.627 0 N-CA-C 108.324 -0.991 . . . . 50.509999999999998 108.324 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.1 mttt -47.16 -28.35 1.79 Allowed 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.368 -1.458 . . . . 50.509999999999998 113.826 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -80.23 -49.76 18.45 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 C-N-CA 119.496 -0.882 . . . . 50.509999999999998 109.861 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' ILE . 18.0 tm0? -38.63 -51.14 1.64 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 125.572 2.605 . . . . 50.549999999999997 112.061 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -54.69 -39.17 67.87 Favored 'General case' 0 C--O 1.253 1.24 0 N-CA-C 117.499 2.407 . . . . 50.619999999999997 117.499 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -109.59 -7.88 15.06 Favored 'General case' 0 C--O 1.279 2.653 0 C-N-CA 116.425 -2.11 . . . . 50.509999999999998 111.687 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' HG3' HG12 ' A' ' 36' ' ' ILE . 32.3 tp10 -108.6 -31.54 7.73 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 123.108 2.686 . . . . 50.619999999999997 107.77 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.99 7.4 85.52 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 109.488 -1.445 . . . . 50.509999999999998 109.488 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.559 HG12 ' HG3' ' A' ' 34' ' ' GLU . 30.4 mm -101.65 131.86 22.42 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 102.233 -3.247 . . . . 50.509999999999998 102.233 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.02 136.93 79.62 Favored 'Trans proline' 0 C--O 1.26 1.604 0 C-N-CA 123.192 2.595 . . . . 50.509999999999998 110.908 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.627 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.7 Cg_exo -57.15 -32.16 92.6 Favored 'Trans proline' 0 C--O 1.262 1.677 0 O-C-N 122.846 0.919 . . . . 50.509999999999998 113.44 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.09 2.82 3.22 Favored 'General case' 0 C--O 1.261 1.7 0 O-C-N 119.909 -1.744 . . . . 50.619999999999997 112.957 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -127.58 35.97 4.44 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.59 -1.319 . . . . 50.549999999999997 113.765 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.22 134.71 55.2 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 124.447 2.07 . . . . 50.549999999999997 111.514 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 54.8 ttm-85 -99.94 124.04 44.84 Favored 'General case' 0 C--O 1.298 3.613 0 CA-C-O 116.635 -1.65 . . . . 50.640000000000001 110.22 172.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.23 121.44 42.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.504 1.047 . . . . 50.509999999999998 110.749 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.13 123.39 60.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 125.174 1.546 . . . . 50.509999999999998 113.674 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.77 112.21 17.05 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 114.616 -1.175 . . . . 50.509999999999998 110.196 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.68 27.8 7.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 112.24 -2.254 . . . . 50.509999999999998 110.586 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.97 33.26 59.9 Favored Glycine 0 C--N 1.3 -1.453 0 C-N-CA 128.411 2.91 . . . . 50.509999999999998 117.476 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -119.03 148.88 42.53 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 104.741 -2.318 . . . . 50.509999999999998 104.741 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -88.04 135.75 33.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 119.797 3.258 . . . . 50.549999999999997 119.797 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.38 155.5 16.71 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 101.484 -3.525 . . . . 50.509999999999998 101.484 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -130.71 157.19 43.47 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 125.02 1.45 . . . . 50.619999999999997 108.242 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.01 -34.92 77.41 Favored 'General case' 0 C--O 1.264 1.833 0 C-N-CA 126.19 1.796 . . . . 50.619999999999997 109.38 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.39 9.21 4.58 Favored Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 124.426 1.013 . . . . 50.509999999999998 113.156 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -124.29 162.56 23.49 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 120.941 3.682 . . . . 50.640000000000001 120.941 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -80.43 173.76 12.28 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.028 0.931 . . . . 50.509999999999998 109.419 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 tp -88.85 -20.14 25.01 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.04 -1.096 . . . . 50.509999999999998 108.04 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 m -79.56 -36.69 37.87 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.362 -1.735 . . . . 50.509999999999998 112.665 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -53.13 -17.26 1.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 117.082 2.253 . . . . 50.619999999999997 117.082 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -93.38 12.0 26.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.823 -1.084 . . . . 50.509999999999998 110.836 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.37 33.08 3.59 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 116.533 2.049 . . . . 50.549999999999997 116.533 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -82.26 114.8 23.71 Favored 'Isoleucine or valine' 0 C--O 1.265 1.907 0 CA-C-O 115.268 -2.301 . . . . 50.509999999999998 112.346 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -110.33 -166.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.125 2.141 . . . . 50.549999999999997 111.126 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 78.7 tttt -74.16 134.65 42.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.177 1.465 . . . . 50.509999999999998 108.792 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 53.0 mt-10 67.55 44.23 1.75 Allowed 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.537 -2.12 . . . . 50.619999999999997 114.35 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -88.21 167.28 13.72 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 105.464 -2.05 . . . . 50.509999999999998 105.464 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -121.35 112.31 18.41 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 118.253 -0.879 . . . . 50.509999999999998 110.982 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.3 mt -99.7 141.68 32.18 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.729 -2.558 . . . . 50.509999999999998 109.56 175.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -95.1 134.81 37.4 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.347 2.905 . . . . 50.509999999999998 111.788 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -105.31 114.98 29.49 Favored 'General case' 0 C--O 1.283 2.861 0 CA-C-O 117.611 -1.185 . . . . 50.509999999999998 110.902 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.7 t -104.83 137.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.171 -1.788 . . . . 50.509999999999998 106.171 175.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.0 tp -79.86 128.68 33.74 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.252 0.549 . . . . 50.509999999999998 110.331 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 -103.28 107.41 18.22 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-O 113.428 -3.177 . . . . 50.640000000000001 110.041 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.92 143.1 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 125.791 1.932 . . . . 50.509999999999998 109.533 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -105.51 59.95 0.67 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.743 -1.571 . . . . 50.640000000000001 110.21 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.96 153.21 5.84 Favored Glycine 0 C--O 1.243 0.707 0 N-CA-C 107.926 -2.069 . . . . 50.509999999999998 107.926 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 CA-C-O 116.349 -2.362 . . . . 50.509999999999998 107.227 179.226 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 101.783 -3.414 . . . . 50.509999999999998 101.783 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -110.85 138.34 47.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 126.95 2.656 . . . . 50.549999999999997 105.433 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -133.07 155.69 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 115.928 -1.987 . . . . 50.509999999999998 113.867 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -93.63 144.41 25.41 Favored 'General case' 0 N--CA 1.512 2.663 1 O-C-N 130.442 4.839 . . . . 50.509999999999998 118.789 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.772 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.6 t -132.53 101.96 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.364 -3.208 . . . . 50.509999999999998 110.123 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.92 117.99 21.28 Favored 'General case' 0 N--CA 1.504 2.231 1 O-C-N 129.362 4.164 . . . . 50.509999999999998 117.225 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 11' ' ' LYS . 41.7 p -70.83 -172.72 0.69 Allowed 'General case' 0 C--N 1.351 0.673 0 N-CA-C 114.893 1.442 . . . . 50.509999999999998 114.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.78 11.78 38.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.854 -1.906 . . . . 50.509999999999998 105.854 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -122.45 -3.22 8.89 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 115.737 -2.385 . . . . 50.509999999999998 114.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 6.76 22.04 Favored Glycine 0 C--N 1.296 -1.665 0 O-C-N 120.103 -1.623 . . . . 50.509999999999998 113.617 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 45.0 mtmt -92.66 166.73 12.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 118.445 2.758 . . . . 50.509999999999998 118.445 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.0 p -125.15 158.69 33.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 126.658 2.474 . . . . 50.509999999999998 105.676 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.772 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 72.3 mt -131.27 111.18 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 127.415 2.947 . . . . 50.509999999999998 104.716 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -90.75 110.97 22.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.809 1.781 . . . . 50.509999999999998 115.809 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.3 mt -105.77 155.55 19.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 115.483 -2.198 . . . . 50.509999999999998 112.153 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.05 112.33 23.88 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 128.9 3.875 . . . . 50.619999999999997 112.23 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -117.25 169.45 7.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 O-C-N 127.743 3.152 . . . . 50.509999999999998 113.998 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -126.58 158.33 67.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 112.156 -2.293 . . . . 50.619999999999997 108.288 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 57' ' ' SER . 85.1 Cg_exo -54.93 -24.56 39.81 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.54 2.16 . . . . 50.509999999999998 111.969 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -87.09 -18.39 30.63 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 116.415 2.005 . . . . 50.509999999999998 116.415 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -70.86 135.73 48.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.898 1.814 . . . . 50.619999999999997 115.898 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.591 HG22 HG22 ' A' ' 55' ' ' THR . 72.3 p -78.85 168.42 19.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.947 1.832 . . . . 50.509999999999998 115.947 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 33.8 mm -62.69 -40.62 89.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 O-C-N 127.239 2.837 . . . . 50.509999999999998 109.34 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.94 -27.87 46.73 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 50.619999999999997 112.809 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.4 -27.85 20.15 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 114.84 1.422 . . . . 50.549999999999997 114.84 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.7 -41.63 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.024 1.453 . . . . 50.509999999999998 107.155 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -64.62 -28.0 69.32 Favored 'General case' 0 C--O 1.258 1.524 0 CA-C-N 115.845 -0.616 . . . . 50.509999999999998 111.524 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -29.6 59.73 Favored 'General case' 0 C--O 1.279 2.637 0 CA-C-N 118.088 0.404 . . . . 50.509999999999998 111.599 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.37 -31.34 69.67 Favored 'General case' 0 C--O 1.256 1.401 0 O-C-N 120.319 -1.488 . . . . 50.509999999999998 108.493 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.0 -34.67 71.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 107.091 -1.448 . . . . 50.509999999999998 107.091 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -56.36 -53.56 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 125.579 2.609 . . . . 50.549999999999997 117.578 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.28 -34.27 70.35 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 113.622 -1.626 . . . . 50.619999999999997 111.243 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.17 -28.57 21.13 Favored 'General case' 0 C--O 1.278 2.593 0 C-N-CA 116.434 -2.106 . . . . 50.509999999999998 109.737 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -117.22 -77.26 0.57 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 123.035 2.652 . . . . 50.619999999999997 109.059 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.09 23.51 0.48 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.572 -1.811 . . . . 50.509999999999998 108.572 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.7 mt -79.4 133.5 59.94 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.81 -1.156 . . . . 50.509999999999998 112.335 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.03 136.93 79.61 Favored 'Trans proline' 0 C--O 1.26 1.592 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.914 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.2 -32.1 92.53 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.857 0.925 . . . . 50.509999999999998 113.449 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 40' ' ' GLN . 6.9 p30 -76.71 -9.23 58.53 Favored 'General case' 0 C--O 1.262 1.746 0 O-C-N 119.94 -1.725 . . . . 50.619999999999997 109.297 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.427 ' HG3' ' OD1' ' A' ' 39' ' ' ASP . 79.9 mt-30 -103.01 19.06 20.22 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.422 1.638 . . . . 50.549999999999997 115.422 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -127.93 102.04 6.59 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 116.638 2.088 . . . . 50.549999999999997 116.638 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -99.35 132.51 44.63 Favored 'General case' 0 C--O 1.296 3.531 0 CA-C-O 116.742 -1.599 . . . . 50.640000000000001 109.381 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 mp -103.94 154.75 19.29 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.287 -2.486 . . . . 50.509999999999998 104.287 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.07 142.1 35.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.509999999999998 111.087 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -142.66 91.3 2.3 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 114.534 -1.212 . . . . 50.509999999999998 113.345 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.9 45.6 26.18 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 104.461 -2.422 . . . . 50.509999999999998 104.461 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 -18.13 6.99 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 128.386 2.898 . . . . 50.509999999999998 113.034 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -76.59 135.75 39.22 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 118.102 0.951 . . . . 50.509999999999998 111.418 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.85 129.22 35.14 Favored 'General case' 0 C--O 1.259 1.558 0 O-C-N 123.957 0.785 . . . . 50.549999999999997 110.968 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.8 mt -78.65 145.65 34.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 101.906 -3.368 . . . . 50.509999999999998 101.906 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -97.99 135.88 39.05 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.939 1.399 . . . . 50.619999999999997 108.538 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.5 m-20 -53.66 -49.59 67.63 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 126.151 1.78 . . . . 50.619999999999997 111.919 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.93 19.46 5.21 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.4 1.0 . . . . 50.509999999999998 113.9 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -113.0 156.69 22.61 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 103.069 -2.937 . . . . 50.640000000000001 103.069 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.591 HG22 HG22 ' A' ' 22' ' ' THR . 81.0 p -95.67 168.51 10.63 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.606 0.965 . . . . 50.509999999999998 113.606 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.16 -32.19 70.03 Favored 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.15 0.907 . . . . 50.509999999999998 109.358 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 90.9 p -74.13 -29.08 61.64 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.271 -1.772 . . . . 50.509999999999998 112.149 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.71 -29.33 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.431 1.11 . . . . 50.619999999999997 108.676 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -94.19 -5.21 47.54 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.809 -1.091 . . . . 50.509999999999998 112.291 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 53.93 51.33 14.94 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 121.552 1.978 . . . . 50.549999999999997 113.882 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -95.53 119.2 43.26 Favored 'Isoleucine or valine' 0 C--O 1.266 1.952 0 N-CA-C 102.218 -3.253 . . . . 50.509999999999998 102.218 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 -168.83 2.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.019 2.075 . . . . 50.549999999999997 111.213 -176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.635 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 84.2 tttt -79.07 143.76 35.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.185 1.469 . . . . 50.509999999999998 107.558 -176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.635 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 69.66 37.56 1.87 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.559 -2.109 . . . . 50.619999999999997 113.62 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -92.42 155.48 17.84 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.809 -1.087 . . . . 50.509999999999998 111.994 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -110.27 126.49 54.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 118.199 -0.905 . . . . 50.509999999999998 112.717 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.11 155.52 21.8 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 114.679 -2.581 . . . . 50.509999999999998 104.356 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -98.0 149.88 21.97 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 127.177 2.798 . . . . 50.509999999999998 112.998 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -102.2 126.68 49.25 Favored 'General case' 0 C--O 1.283 2.849 0 N-CA-C 104.9 -2.259 . . . . 50.509999999999998 104.9 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.63 146.24 28.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 105.861 -1.903 . . . . 50.509999999999998 105.861 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -114.09 107.57 15.83 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 119.869 3.285 . . . . 50.509999999999998 119.869 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -92.07 111.1 22.52 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.324 -3.227 . . . . 50.640000000000001 104.249 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.52 167.66 14.41 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 125.576 1.798 . . . . 50.509999999999998 110.907 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.0 mtm105 -102.85 86.42 2.73 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.72 -1.582 . . . . 50.640000000000001 108.321 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.95 147.51 22.78 Favored Glycine 0 C--O 1.244 0.726 0 CA-C-N 114.678 -1.146 . . . . 50.509999999999998 114.436 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.457 0 N-CA-C 106.023 -2.831 . . . . 50.509999999999998 106.023 179.232 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.458 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.547 0.86 0 CA-C-O 118.822 -0.609 . . . . 50.509999999999998 111.147 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -96.39 128.69 43.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 126.959 2.662 . . . . 50.549999999999997 113.368 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.67 152.44 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 115.972 -1.966 . . . . 50.509999999999998 107.561 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CD1' HG22 ' A' ' 14' ' ' THR . 97.3 m-85 -109.53 143.06 39.71 Favored 'General case' 0 N--CA 1.512 2.658 1 O-C-N 130.215 4.697 . . . . 50.509999999999998 115.202 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.12 98.18 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-O 113.425 -3.179 . . . . 50.509999999999998 113.771 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -72.86 114.92 11.54 Favored 'General case' 0 N--CA 1.503 2.224 1 O-C-N 129.297 4.123 . . . . 50.509999999999998 109.929 -178.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.44 ' HA ' HD23 ' A' ' 69' ' ' LEU . 68.7 p -72.04 -169.8 0.52 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-O 117.829 -1.081 . . . . 50.509999999999998 113.236 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.34 -47.1 7.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.756 -1.201 . . . . 50.509999999999998 107.756 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -70.59 2.17 4.37 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 115.732 -2.387 . . . . 50.509999999999998 115.586 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.81 -40.67 2.38 Favored Glycine 0 C--N 1.298 -1.541 0 N-CA-C 120.892 3.117 . . . . 50.509999999999998 120.892 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -42.09 131.33 3.48 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 116.902 -1.523 . . . . 50.509999999999998 108.125 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.0 p -101.59 138.15 38.97 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 126.623 2.452 . . . . 50.509999999999998 112.184 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 pt -120.16 146.79 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 127.507 3.004 . . . . 50.509999999999998 109.399 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.443 HG22 ' CD1' ' A' ' 4' ' ' PHE . 80.8 p -120.6 128.03 52.66 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.249 -1.78 . . . . 50.509999999999998 109.583 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 29' ' ' LYS . 50.0 mt -103.8 148.48 26.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 115.542 -2.171 . . . . 50.509999999999998 110.37 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -106.41 103.2 12.61 Favored 'General case' 0 N--CA 1.501 2.089 1 O-C-N 129.28 4.112 . . . . 50.619999999999997 104.954 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 1' ' ' MET . 33.7 m -101.65 164.54 2.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.69 3.119 . . . . 50.509999999999998 112.915 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.411 ' HG3' ' HB2' ' A' ' 21' ' ' ASP . 6.4 pt-20 -137.33 151.33 71.23 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.164 -2.289 . . . . 50.619999999999997 112.798 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.97 -24.5 39.77 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 122.587 2.191 . . . . 50.509999999999998 111.949 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -98.38 21.85 10.51 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 118.208 -0.901 . . . . 50.509999999999998 110.829 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 8.4 t70 -94.57 125.42 39.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 117.354 -1.738 . . . . 50.619999999999997 111.189 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.3 p -82.82 135.01 35.09 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.865 -0.607 . . . . 50.509999999999998 110.908 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.491 HG21 ' HA ' ' A' ' 52' ' ' ASP . 55.6 mt -37.56 -30.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.137 2.773 . . . . 50.509999999999998 117.552 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.21 -27.85 69.34 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.422 -0.798 . . . . 50.619999999999997 112.203 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.617 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 57.4 m-80 -86.08 -13.14 48.18 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.309 1.044 . . . . 50.549999999999997 112.4 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -78.18 -51.99 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.041 1.463 . . . . 50.509999999999998 110.256 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 91.5 mttt -58.04 -23.67 55.31 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.174 -0.676 . . . . 50.509999999999998 109.174 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.06 -34.79 17.84 Favored 'General case' 0 C--O 1.278 2.598 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 57.9 mttm -52.26 -38.62 58.72 Favored 'General case' 0 C--O 1.257 1.459 0 N-CA-C 106.291 -1.744 . . . . 50.509999999999998 106.291 175.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.9 -33.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 107.56 -1.274 . . . . 50.509999999999998 107.56 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 125.583 2.611 . . . . 50.549999999999997 113.525 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -58.36 -25.57 62.15 Favored 'General case' 0 C--O 1.254 1.322 0 N-CA-C 119.087 2.995 . . . . 50.619999999999997 119.087 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -108.81 -27.25 9.86 Favored 'General case' 0 C--O 1.28 2.659 0 C-N-CA 116.385 -2.126 . . . . 50.509999999999998 113.917 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -108.75 -29.15 8.83 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.056 2.662 . . . . 50.619999999999997 113.529 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.94 42.88 4.59 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 111.247 -0.741 . . . . 50.509999999999998 111.247 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 94.4 mt -117.95 125.2 28.15 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.597 -1.261 . . . . 50.509999999999998 107.597 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.05 136.97 79.82 Favored 'Trans proline' 0 C--O 1.259 1.559 0 C-N-CA 123.106 2.537 . . . . 50.509999999999998 110.95 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 85.9 Cg_exo -57.17 -32.07 92.37 Favored 'Trans proline' 0 C--O 1.26 1.619 0 O-C-N 122.828 0.909 . . . . 50.509999999999998 113.51 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.26 -20.35 64.16 Favored 'General case' 0 C--O 1.262 1.756 0 O-C-N 119.982 -1.699 . . . . 50.619999999999997 109.542 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -94.89 7.48 45.85 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.526 -1.358 . . . . 50.549999999999997 113.45 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -115.87 119.32 35.58 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 110.925 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.469 HH11 ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp85 -106.33 138.18 42.97 Favored 'General case' 0 C--O 1.295 3.486 0 CA-C-O 116.651 -1.642 . . . . 50.640000000000001 107.716 172.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.9 mt -115.2 105.97 13.53 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.987 1.847 . . . . 50.509999999999998 115.987 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 61.5 mt -110.55 130.37 63.98 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 O-C-N 125.254 1.596 . . . . 50.509999999999998 111.633 -177.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -145.83 126.01 13.82 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 115.293 1.59 . . . . 50.509999999999998 115.293 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.11 28.24 17.02 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.261 -2.245 . . . . 50.509999999999998 107.43 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.7 30.41 77.25 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 128.37 2.89 . . . . 50.509999999999998 111.595 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.48 135.6 53.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.455 -2.054 . . . . 50.509999999999998 105.455 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.35 113.9 9.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.946 0.779 . . . . 50.549999999999997 111.186 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.503 HD22 ' CE2' ' A' ' 59' ' ' TYR . 37.5 mt -75.49 113.84 13.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 117.722 -1.132 . . . . 50.509999999999998 112.296 -175.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -89.53 126.08 35.45 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.822 1.326 . . . . 50.619999999999997 109.598 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' HA ' HG21 ' A' ' 23' ' ' ILE . 27.7 p-10 -45.36 -38.93 6.28 Favored 'General case' 0 C--O 1.263 1.805 0 C-N-CA 126.14 1.776 . . . . 50.619999999999997 111.549 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.52 37.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 108.655 -1.778 . . . . 50.509999999999998 108.655 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -94.64 165.67 12.39 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 119.949 -1.912 . . . . 50.640000000000001 115.838 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -99.87 166.08 11.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.152 -1.055 . . . . 50.509999999999998 108.152 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -86.43 -39.72 16.07 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 104.193 -2.521 . . . . 50.509999999999998 104.193 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -52.64 -53.04 52.47 Favored 'General case' 0 C--O 1.268 2.058 0 C-N-CA 117.356 -1.738 . . . . 50.509999999999998 113.979 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.42 -28.28 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 120.635 3.568 . . . . 50.619999999999997 120.635 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.503 ' CE2' HD22 ' A' ' 50' ' ' LEU . 42.2 m-85 -82.1 13.1 3.61 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.764 -1.112 . . . . 50.509999999999998 109.511 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.57 32.26 20.38 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 121.442 1.928 . . . . 50.549999999999997 108.95 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.71 133.1 30.14 Favored 'Isoleucine or valine' 0 C--O 1.267 1.989 0 CA-C-O 115.146 -2.359 . . . . 50.509999999999998 113.362 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.406 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 57.7 mt-30 -134.81 -159.34 0.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 125.856 1.972 . . . . 50.549999999999997 110.636 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 63.2 tttm -69.15 149.88 48.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.257 1.503 . . . . 50.509999999999998 109.628 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.627 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 47.67 65.48 1.27 Allowed 'General case' 0 C--O 1.257 1.45 0 CA-C-N 112.42 -2.173 . . . . 50.619999999999997 113.981 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -122.97 125.57 45.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.921 -1.141 . . . . 50.509999999999998 107.921 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -81.67 133.68 35.39 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 117.186 2.291 . . . . 50.509999999999998 117.186 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.32 135.88 48.08 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 114.688 -2.577 . . . . 50.509999999999998 114.45 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.546 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -71.55 133.0 45.48 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 127.365 2.915 . . . . 50.509999999999998 115.619 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 7' ' ' THR . 30.6 tp -104.95 96.99 6.92 Favored 'General case' 0 C--O 1.282 2.809 0 N-CA-C 115.792 1.775 . . . . 50.509999999999998 115.792 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.53 123.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.857 -1.164 . . . . 50.509999999999998 107.857 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt -73.12 159.23 33.87 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.946 1.091 . . . . 50.509999999999998 113.946 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.469 ' HD2' HH11 ' A' ' 42' ' ' ARG . 77.8 ttt-85 -136.96 77.19 1.63 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 113.404 -3.188 . . . . 50.640000000000001 111.964 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.42 155.34 15.09 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 116.795 2.146 . . . . 50.509999999999998 116.795 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -110.39 85.53 2.13 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.714 -1.585 . . . . 50.640000000000001 107.073 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.26 160.9 13.61 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 107.691 -2.164 . . . . 50.509999999999998 107.691 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 CA-C-O 116.308 -2.385 . . . . 50.509999999999998 110.446 179.174 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.549999999999997 105.792 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.509999999999998 105.226 173.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.509999999999998 111.097 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.509999999999998 110.321 175.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.509999999999998 108.6 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 113.379 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.509999999999998 115.964 -177.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.509999999999998 111.276 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.509999999999998 114.048 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.509999999999998 102.065 174.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.509999999999998 107.975 176.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.509999999999998 108.441 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 110.2 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.447 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.509999999999998 118.562 -179.268 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.619999999999997 108.62 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.509999999999998 114.132 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.619999999999997 106.711 174.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.509999999999998 111.935 177.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.509999999999998 116.813 -177.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.619999999999997 109.138 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.509999999999998 107.045 175.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.509999999999998 110.561 175.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.619999999999997 113.229 177.002 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.549999999999997 110.044 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.509999999999998 107.759 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.509999999999998 106.412 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.509999999999998 109.249 176.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.509999999999998 111.346 176.077 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.447 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.509999999999998 110.973 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.549999999999997 112.509 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.619999999999997 116.389 179.097 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.509999999999998 111.864 -175.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 117.592 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.509999999999998 114.888 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.509999999999998 109.747 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.509999999999998 110.864 178.361 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.394 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.619999999999997 114.605 -177.389 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.637 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.549999999999997 107.838 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.549999999999997 119.467 -177.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.640000000000001 109.52 172.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.509999999999998 115.444 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.509999999999998 113.347 -177.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.509999999999998 111.83 177.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 113.518 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.509999999999998 115.209 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.509999999999998 114.25 177.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.549999999999997 117.72 174.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.509999999999998 119.412 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.619999999999997 106.675 -177.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.619999999999997 118.064 -175.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.509999999999998 112.981 -177.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.640000000000001 112.921 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.509999999999998 106.383 177.108 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.509999999999998 114.586 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.509999999999998 111.793 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.619999999999997 114.68 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.509999999999998 113.892 179.276 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.549999999999997 110.922 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.509999999999998 112.515 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.549999999999997 116.774 -176.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.509999999999998 113.522 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.619999999999997 110.901 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.509999999999998 110.249 174.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.509999999999998 101.589 175.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.509999999999998 106.251 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 71' ' ' LEU . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.509999999999998 111.961 176.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.509999999999998 104.421 175.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.509999999999998 115.767 178.435 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.640000000000001 106.516 177.224 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' HE21 ' A' ' 40' ' ' GLN . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.509999999999998 105.632 -179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.640000000000001 107.378 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.509999999999998 119.036 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.509999999999998 104.312 179.258 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.549999999999997 105.792 178.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.509999999999998 105.226 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.509999999999998 111.097 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.509999999999998 110.321 175.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.509999999999998 108.6 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 113.379 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.509999999999998 115.964 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.509999999999998 111.276 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.509999999999998 114.048 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.509999999999998 102.065 174.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.509999999999998 107.975 176.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.509999999999998 108.441 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 110.2 178.106 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.447 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.509999999999998 118.562 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.619999999999997 108.62 174.005 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.509999999999998 114.132 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.619999999999997 106.711 174.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.509999999999998 111.935 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.509999999999998 116.813 -177.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.619999999999997 109.138 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.509999999999998 107.045 175.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.509999999999998 110.561 175.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.619999999999997 113.229 177.002 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.549999999999997 110.044 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.509999999999998 107.759 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.509999999999998 106.412 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.509999999999998 109.249 176.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.509999999999998 111.346 176.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.447 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.509999999999998 110.973 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.549999999999997 112.509 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.619999999999997 116.389 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.509999999999998 111.864 -175.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 117.592 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.509999999999998 114.888 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.509999999999998 109.747 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.509999999999998 110.864 178.361 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.394 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.619999999999997 114.605 -177.389 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.637 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.549999999999997 107.838 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.549999999999997 119.467 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.640000000000001 109.52 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.509999999999998 115.444 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.509999999999998 113.347 -177.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.509999999999998 111.83 177.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 113.518 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.509999999999998 115.209 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.509999999999998 114.25 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.549999999999997 117.72 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.509999999999998 119.412 -175.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.619999999999997 106.675 -177.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.619999999999997 118.064 -175.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.509999999999998 112.981 -177.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.640000000000001 112.921 176.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.509999999999998 106.383 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.509999999999998 114.586 177.19 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.509999999999998 111.793 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.619999999999997 114.68 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.509999999999998 113.892 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.549999999999997 110.922 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.509999999999998 112.515 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.549999999999997 116.774 -176.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.509999999999998 113.522 -176.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.619999999999997 110.901 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.509999999999998 110.249 174.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 176.009 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.509999999999998 101.589 175.117 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.509999999999998 106.251 177.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 71' ' ' LEU . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.509999999999998 111.961 176.615 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.509999999999998 104.421 175.142 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.509999999999998 115.767 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.640000000000001 106.516 177.224 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' HE21 ' A' ' 40' ' ' GLN . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.509999999999998 105.632 -179.256 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.640000000000001 107.378 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.509999999999998 119.036 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.509999999999998 104.312 179.258 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.0 mtp . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 115.228 1.566 . . . . 50.509999999999998 115.228 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -88.72 118.09 28.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 126.99 2.681 . . . . 50.549999999999997 117.707 178.275 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.523 HD11 HD22 ' A' ' 67' ' ' LEU . 14.7 tt -122.01 161.57 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 115.935 -1.983 . . . . 50.509999999999998 109.47 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.421 ' N ' HG12 ' A' ' 3' ' ' ILE . 79.1 m-85 -130.3 128.98 42.63 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 129.667 4.354 . . . . 50.509999999999998 113.461 179.548 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -108.91 109.82 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 113.419 -3.182 . . . . 50.509999999999998 112.584 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -87.2 134.28 33.55 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.371 4.169 . . . . 50.509999999999998 106.23 -178.055 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.1 p -99.77 -168.47 1.61 Allowed 'General case' 0 C--N 1.351 0.651 0 N-CA-C 114.385 1.254 . . . . 50.509999999999998 114.385 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 mt -90.15 24.27 2.56 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.125 0.891 . . . . 50.509999999999998 111.979 -178.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -139.79 10.95 2.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 115.747 -2.381 . . . . 50.509999999999998 110.231 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.83 12.66 81.04 Favored Glycine 0 C--N 1.297 -1.604 0 O-C-N 119.303 -2.123 . . . . 50.509999999999998 114.738 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.64 139.47 30.66 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.533 -2.025 . . . . 50.509999999999998 105.533 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -120.9 119.62 33.14 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 126.586 2.429 . . . . 50.509999999999998 112.064 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.411 HD12 HD11 ' A' ' 15' ' ' LEU . 17.1 pt -94.75 144.3 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.346 2.904 . . . . 50.509999999999998 116.312 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -100.32 128.79 46.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.313 -1.755 . . . . 50.509999999999998 114.569 178.077 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD11 HD12 ' A' ' 13' ' ' ILE . 1.5 mp -114.24 145.23 42.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 115.463 -2.208 . . . . 50.509999999999998 116.629 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.15 89.58 3.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 129.065 3.978 . . . . 50.619999999999997 116.324 173.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.441 HG11 HG22 ' A' ' 26' ' ' VAL . 35.0 m -120.79 148.17 24.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 N-CA-C 120.095 3.368 . . . . 50.509999999999998 120.095 -177.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.65 151.47 37.46 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 112.198 -2.274 . . . . 50.619999999999997 111.017 174.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.89 -24.55 39.49 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.562 2.175 . . . . 50.509999999999998 111.962 177.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -73.23 -13.09 61.08 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.487 -2.042 . . . . 50.509999999999998 105.487 -177.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.531 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 75.6 m-20 -68.64 138.49 55.05 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 117.323 -1.751 . . . . 50.619999999999997 115.301 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -106.3 174.16 6.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.853 -0.612 . . . . 50.509999999999998 109.689 175.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -51.18 -46.66 32.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 O-C-N 127.138 2.774 . . . . 50.509999999999998 111.886 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -51.8 -38.13 54.43 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.802 -0.814 . . . . 50.619999999999997 108.802 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -79.53 -41.47 27.25 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 120.185 3.402 . . . . 50.549999999999997 120.185 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.441 HG22 HG11 ' A' ' 17' ' ' VAL . 40.6 t -72.71 -44.32 59.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.085 1.491 . . . . 50.509999999999998 114.531 178.549 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.87 -29.94 68.35 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 107.787 -1.19 . . . . 50.509999999999998 107.787 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -49.2 77.73 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 108.517 -0.919 . . . . 50.509999999999998 108.517 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -44.95 -53.77 7.28 Favored 'General case' 0 C--O 1.255 1.361 0 O-C-N 120.396 -1.44 . . . . 50.509999999999998 109.322 176.002 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -57.96 -25.23 25.4 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 116.219 1.933 . . . . 50.509999999999998 116.219 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.439 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.9 tt0 -75.47 -19.66 59.29 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 125.587 2.613 . . . . 50.549999999999997 111.862 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.51 -45.28 8.2 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 113.589 -1.641 . . . . 50.619999999999997 113.724 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.93 -51.04 10.19 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.476 -2.09 . . . . 50.509999999999998 107.665 -175.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -91.97 -56.33 3.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.131 2.696 . . . . 50.619999999999997 110.814 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 120.17 4.21 11.33 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 111.616 -0.594 . . . . 50.509999999999998 111.616 176.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mm -69.44 123.05 87.61 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 118.852 -1.139 . . . . 50.509999999999998 109.38 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -57.02 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.539 0 C-N-CA 123.203 2.602 . . . . 50.509999999999998 110.846 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_exo -57.21 -32.09 92.53 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.914 0.955 . . . . 50.509999999999998 113.422 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -73.67 2.26 8.53 Favored 'General case' 0 C--O 1.261 1.675 0 N-CA-C 118.375 2.731 . . . . 50.619999999999997 118.375 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -115.69 -9.23 11.98 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.536 -1.352 . . . . 50.549999999999997 108.153 178.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -81.25 143.28 32.4 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 124.384 2.04 . . . . 50.549999999999997 115.24 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -131.95 114.78 15.03 Favored 'General case' 0 C--O 1.296 3.506 0 N-CA-C 105.833 -1.914 . . . . 50.640000000000001 105.833 172.171 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 50' ' ' LEU . 95.5 mt -107.32 123.89 49.0 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.539 1.063 . . . . 50.509999999999998 111.324 -177.499 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.08 132.63 61.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 O-C-N 125.174 1.546 . . . . 50.509999999999998 112.57 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.56 ' CE2' HG12 ' A' ' 61' ' ' ILE . 45.2 t80 -142.33 112.61 7.1 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 114.575 -1.193 . . . . 50.509999999999998 108.987 177.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 75.64 18.64 2.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 112.227 -2.26 . . . . 50.509999999999998 108.501 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.3 -2.01 85.84 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.431 2.92 . . . . 50.509999999999998 110.513 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -85.66 121.55 28.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 118.045 0.923 . . . . 50.509999999999998 111.156 177.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -61.93 137.71 58.28 Favored 'General case' 0 C--O 1.26 1.61 0 N-CA-C 108.169 -1.049 . . . . 50.549999999999997 108.169 174.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 43' ' ' LEU . 37.5 mt -75.4 149.19 38.65 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.543 -1.28 . . . . 50.509999999999998 107.543 -175.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.15 150.89 28.83 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.996 1.435 . . . . 50.619999999999997 112.497 -177.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.99 -41.26 78.11 Favored 'General case' 0 C--O 1.264 1.826 0 N-CA-C 118.347 2.721 . . . . 50.619999999999997 118.347 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.41 5.0 67.34 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 120.212 2.845 . . . . 50.509999999999998 120.212 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.47 154.37 19.69 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 120.089 3.366 . . . . 50.640000000000001 120.089 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 41.5 p -93.09 151.9 19.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.39 -3.189 . . . . 50.509999999999998 102.39 177.103 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.4 mt -56.28 -36.58 68.77 Favored 'General case' 0 C--O 1.202 -1.425 0 O-C-N 124.19 0.931 . . . . 50.509999999999998 108.894 177.2 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -62.04 -31.07 71.44 Favored 'General case' 0 C--O 1.268 2.065 0 C-N-CA 117.331 -1.747 . . . . 50.509999999999998 109.04 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 55' ' ' THR . 88.7 m-20 -60.42 -10.17 4.54 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.405 1.098 . . . . 50.619999999999997 111.684 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -114.16 -14.9 12.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.094 -1.817 . . . . 50.509999999999998 106.094 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 48.44 56.77 7.03 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 121.522 1.965 . . . . 50.549999999999997 110.701 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.56 HG12 ' CE2' ' A' ' 45' ' ' PHE . 74.1 mt -78.33 105.95 8.25 Favored 'Isoleucine or valine' 0 C--O 1.267 1.997 0 N-CA-C 102.936 -2.987 . . . . 50.509999999999998 102.936 175.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.77 176.21 3.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 126.1 2.125 . . . . 50.549999999999997 107.713 -176.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -70.73 147.1 49.39 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 123.205 1.478 . . . . 50.509999999999998 110.572 -176.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 54.02 44.84 28.72 Favored 'General case' 0 C--O 1.258 1.526 0 CA-C-N 112.521 -2.127 . . . . 50.619999999999997 112.894 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -106.87 142.26 36.79 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.157 -1.794 . . . . 50.509999999999998 106.157 174.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.0 m -101.25 130.24 47.35 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 120.454 3.501 . . . . 50.509999999999998 120.454 175.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 3' ' ' ILE . 2.7 mp -95.38 149.7 21.08 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.68 -2.581 . . . . 50.509999999999998 114.761 175.08 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -102.31 132.93 47.97 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 126.969 2.668 . . . . 50.509999999999998 114.743 177.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -104.48 122.35 45.35 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.685 -1.15 . . . . 50.509999999999998 111.321 176.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -113.09 135.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.571 -1.641 . . . . 50.509999999999998 106.571 175.064 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.8 tp -93.83 100.11 12.36 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.497 1.666 . . . . 50.509999999999998 115.497 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -74.84 138.56 42.61 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 113.316 -3.231 . . . . 50.640000000000001 108.215 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 mt -111.86 139.2 47.54 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.804 1.94 . . . . 50.509999999999998 113.237 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -96.15 68.19 2.65 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 113.69 -1.596 . . . . 50.640000000000001 106.907 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.65 148.17 4.85 Favored Glycine 0 C--O 1.244 0.76 0 N-CA-C 107.145 -2.382 . . . . 50.509999999999998 107.145 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 116.361 -2.355 . . . . 50.509999999999998 110.4 179.246 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.877 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 61.2 mtm . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 105.248 -2.13 . . . . 50.509999999999998 105.248 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -70.42 144.62 51.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 127.003 2.689 . . . . 50.549999999999997 108.922 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.454 HD12 HD13 ' A' ' 67' ' ' LEU . 21.7 pt -132.24 164.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 N-CA-C 104.099 -2.556 . . . . 50.509999999999998 104.099 173.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.25 156.01 22.11 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.473 4.858 . . . . 50.509999999999998 109.296 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 67' ' ' LEU . 86.0 t -138.52 122.18 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.37 -3.205 . . . . 50.509999999999998 109.203 175.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 79.1 tttt -94.94 128.6 41.86 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.403 4.19 . . . . 50.509999999999998 114.904 -178.047 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.08 179.23 4.68 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-O 117.809 -1.091 . . . . 50.509999999999998 108.425 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.7 -12.19 58.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.93 2.937 . . . . 50.509999999999998 118.93 -177.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -90.48 -24.98 20.53 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 115.705 -2.398 . . . . 50.509999999999998 105.345 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.23 23.78 3.73 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 107.538 -2.225 . . . . 50.509999999999998 107.538 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -86.06 144.22 27.67 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.568 -2.012 . . . . 50.509999999999998 105.568 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.2 m -128.44 117.77 21.95 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 126.629 2.456 . . . . 50.509999999999998 110.992 176.16 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.7 pt -98.57 164.85 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 127.469 2.981 . . . . 50.509999999999998 113.557 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.6 p -121.59 144.1 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.256 -1.778 . . . . 50.509999999999998 108.483 178.137 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.441 HD22 ' HG3' ' A' ' 29' ' ' LYS . 78.4 mt -132.38 142.62 49.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 103.047 -2.946 . . . . 50.509999999999998 103.047 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.93 109.1 17.12 Favored 'General case' 0 N--CA 1.499 2.003 1 O-C-N 129.275 4.109 . . . . 50.619999999999997 102.972 173.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.74 156.22 31.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.74 3.15 . . . . 50.509999999999998 114.401 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 72.8 tt0 -88.37 139.81 30.18 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.175 -2.284 . . . . 50.619999999999997 107.746 174.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.759 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 85.5 Cg_exo -54.83 -24.57 39.11 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 122.552 2.168 . . . . 50.509999999999998 111.976 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -61.56 -26.06 67.71 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.241 -1.392 . . . . 50.509999999999998 107.241 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -59.76 136.52 58.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.353 -1.739 . . . . 50.619999999999997 114.831 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.6 p -79.11 171.59 14.99 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 117.834 -3.041 . . . . 50.509999999999998 110.062 175.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.19 -35.25 62.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 O-C-N 127.196 2.81 . . . . 50.509999999999998 109.281 175.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.3 -41.77 80.46 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.457 -0.777 . . . . 50.619999999999997 112.473 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -76.92 -50.23 13.77 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 115.099 1.518 . . . . 50.549999999999997 115.099 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 22' ' ' THR . 54.9 t -51.68 -39.31 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.958 1.411 . . . . 50.509999999999998 109.701 178.51 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 52.3 mtpt -61.71 -36.1 79.97 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 115.833 -0.621 . . . . 50.509999999999998 110.368 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.35 86.29 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 109.691 -0.485 . . . . 50.509999999999998 109.691 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HG3' HD22 ' A' ' 15' ' ' LEU . 50.9 tptt -57.97 -41.29 82.6 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.191 -1.781 . . . . 50.509999999999998 106.191 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.81 -49.17 81.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.54 -0.864 . . . . 50.509999999999998 111.674 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.767 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 22.0 tm0? -53.26 -56.83 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 117.944 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -46.32 -54.23 9.34 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 118.38 2.733 . . . . 50.619999999999997 118.38 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -81.16 -41.8 21.84 Favored 'General case' 0 C--O 1.279 2.638 0 C-N-CA 116.464 -2.095 . . . . 50.509999999999998 112.313 -175.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -86.75 -55.43 3.86 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.075 2.67 . . . . 50.619999999999997 110.958 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.88 -23.1 5.05 Favored Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 112.031 -0.428 . . . . 50.509999999999998 112.031 176.524 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 mm -53.68 113.86 5.48 Favored Pre-proline 0 C--O 1.245 0.854 0 C-N-CA 118.815 -1.154 . . . . 50.509999999999998 109.665 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.553 0 C-N-CA 123.181 2.588 . . . . 50.509999999999998 110.925 178.311 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.767 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 88.4 Cg_exo -57.32 -32.03 92.62 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -57.96 -18.12 21.49 Favored 'General case' 0 C--O 1.263 1.8 0 O-C-N 120.008 -1.683 . . . . 50.619999999999997 111.655 -177.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -113.53 11.34 18.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 120.631 3.567 . . . . 50.549999999999997 120.631 178.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -95.44 129.17 42.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 124.388 2.042 . . . . 50.549999999999997 111.987 -177.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 36.6 ttm180 -119.98 110.49 16.76 Favored 'General case' 0 C--O 1.295 3.477 0 N-CA-C 105.776 -1.935 . . . . 50.640000000000001 105.776 172.138 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.544 ' HB2' HD12 ' A' ' 50' ' ' LEU . 94.4 mt -101.62 129.7 47.8 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.441 1.019 . . . . 50.509999999999998 108.444 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.8 140.51 29.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.054 1.471 . . . . 50.509999999999998 111.994 -177.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -138.73 116.81 11.74 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.084 -2.191 . . . . 50.509999999999998 105.084 177.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.48 17.8 10.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.193 -2.276 . . . . 50.509999999999998 115.981 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.65 8.31 67.87 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 128.443 2.925 . . . . 50.509999999999998 109.279 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -100.36 112.81 25.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 118.071 0.936 . . . . 50.509999999999998 109.925 177.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -55.43 139.41 43.48 Favored 'General case' 0 C--O 1.259 1.581 0 N-CA-C 108.513 -0.921 . . . . 50.549999999999997 108.513 174.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 43' ' ' LEU . 80.9 mt -85.05 141.47 30.25 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.857 1.429 . . . . 50.509999999999998 114.857 -175.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.411 ' HB3' ' CG ' ' A' ' 54' ' ' ARG . 73.1 tt0 -84.65 126.8 33.68 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.923 1.389 . . . . 50.619999999999997 111.892 -177.644 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -50.9 -42.27 59.11 Favored 'General case' 0 C--O 1.264 1.818 0 C-N-CA 126.178 1.791 . . . . 50.619999999999997 109.743 -175.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.49 25.1 9.81 Favored Glycine 0 C--O 1.254 1.366 0 C-N-CA 124.442 1.02 . . . . 50.509999999999998 114.211 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CG ' ' HB3' ' A' ' 51' ' ' GLU . 29.3 mmt85 -116.33 164.69 14.15 Favored 'General case' 0 C--O 1.249 1.048 0 O-C-N 119.915 -1.932 . . . . 50.640000000000001 113.457 176.536 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 41.6 p -101.81 -178.74 3.81 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.111 0.965 . . . . 50.509999999999998 110.223 177.102 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.759 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 59.3 mt -79.94 -20.5 45.49 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.366 -0.975 . . . . 50.509999999999998 108.366 177.211 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.7 p -88.92 12.95 13.9 Favored 'General case' 0 C--O 1.268 2.077 0 C-N-CA 117.307 -1.757 . . . . 50.509999999999998 112.115 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -94.66 -36.24 11.85 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.449 1.119 . . . . 50.619999999999997 113.343 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.83 23.88 13.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 120.87 3.656 . . . . 50.509999999999998 120.87 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 56.08 46.64 21.26 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 111.377 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 61' ' ' ILE . 73.4 mt -101.01 85.54 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.009 0 CA-C-O 115.201 -2.333 . . . . 50.509999999999998 106.033 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 65' ' ' SER . 97.8 mm-40 -92.43 -177.07 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.099 2.124 . . . . 50.549999999999997 114.683 -176.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.877 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 60.3 pttt -57.76 143.55 41.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.18 1.467 . . . . 50.509999999999998 112.192 -176.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 65.78 31.55 9.47 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.502 -2.135 . . . . 50.619999999999997 109.887 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 95.7 p -80.23 164.34 23.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.813 -1.18 . . . . 50.509999999999998 107.813 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -123.58 131.9 53.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.268 -0.872 . . . . 50.509999999999998 108.791 175.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.1 mp -105.38 137.71 42.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.649 -2.595 . . . . 50.509999999999998 108.854 175.111 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -98.54 108.48 21.19 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 127.427 2.954 . . . . 50.509999999999998 107.195 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 33.2 tp -72.97 147.01 45.62 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.316 1.228 . . . . 50.509999999999998 114.316 176.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 63.4 t -138.42 142.85 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 102.787 -3.042 . . . . 50.509999999999998 102.787 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 mt -98.29 100.59 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.608 1.336 . . . . 50.509999999999998 114.608 178.364 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -69.95 104.1 2.43 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 113.338 -3.22 . . . . 50.640000000000001 112.11 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -83.56 165.07 19.38 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.767 1.917 . . . . 50.509999999999998 108.472 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -131.82 45.39 2.79 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.76 -1.564 . . . . 50.640000000000001 109.369 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.35 151.14 6.15 Favored Glycine 0 C--O 1.242 0.633 0 N-CA-C 108.027 -2.029 . . . . 50.509999999999998 108.027 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.463 0 N-CA-C 106.51 -2.636 . . . . 50.509999999999998 106.51 179.226 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 107.734 -1.21 . . . . 50.509999999999998 107.734 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -111.06 133.8 53.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 105.701 178.289 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.73 162.13 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 115.921 -1.99 . . . . 50.509999999999998 108.41 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -113.0 123.55 50.57 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.518 4.886 . . . . 50.509999999999998 110.598 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.28 112.02 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 113.427 -3.178 . . . . 50.509999999999998 118.975 175.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.64 133.97 34.81 Favored 'General case' 0 N--CA 1.504 2.252 1 O-C-N 129.363 4.164 . . . . 50.509999999999998 105.515 -178.104 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -115.08 171.63 7.55 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 117.781 -1.104 . . . . 50.509999999999998 109.466 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -65.05 -31.81 73.22 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.159 0.912 . . . . 50.509999999999998 109.949 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -74.84 -1.95 24.56 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 115.72 -2.392 . . . . 50.509999999999998 114.656 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.28 2.52 87.7 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.917 -1.673 . . . . 50.509999999999998 108.917 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.01 143.8 41.24 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.507 -1.584 . . . . 50.509999999999998 107.443 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -113.93 112.02 22.63 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 110.434 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -97.91 143.14 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.561 3.038 . . . . 50.509999999999998 113.765 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -108.18 144.73 35.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.267 -1.773 . . . . 50.509999999999998 111.923 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -140.7 129.27 22.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.466 -2.207 . . . . 50.509999999999998 109.002 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.83 144.12 41.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 128.947 3.904 . . . . 50.619999999999997 108.482 174.017 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -149.39 174.08 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 127.742 3.152 . . . . 50.509999999999998 112.14 -177.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 57.3 mm-40 -139.21 150.08 63.23 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.254 -2.248 . . . . 50.619999999999997 111.055 174.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -54.88 -24.6 39.64 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.634 2.223 . . . . 50.509999999999998 111.957 177.674 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.4 p -66.87 -38.74 86.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 105.985 -1.857 . . . . 50.509999999999998 105.985 -177.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 55' ' ' THR . 84.9 m-20 -44.92 155.21 0.11 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.981 2.215 . . . . 50.619999999999997 116.981 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 25' ' ' ASN . 33.1 p -119.01 138.18 53.01 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.252 -3.611 . . . . 50.509999999999998 101.252 175.73 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.664 HD11 HD23 ' A' ' 50' ' ' LEU . 25.5 mm -32.0 -42.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.123 2.764 . . . . 50.509999999999998 114.867 175.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -60.83 -34.15 74.11 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 50.619999999999997 111.08 176.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' THR . 91.3 m-20 -74.39 -28.93 61.32 Favored 'General case' 0 C--O 1.249 1.053 0 C-N-CA 124.321 1.048 . . . . 50.549999999999997 110.31 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -72.51 -51.88 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 125.039 1.462 . . . . 50.509999999999998 108.5 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.3 -36.66 84.77 Favored 'General case' 0 C--O 1.257 1.447 0 CA-C-N 115.717 -0.674 . . . . 50.509999999999998 109.342 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.61 79.44 Favored 'General case' 0 C--O 1.278 2.584 0 N-CA-C 121.133 3.753 . . . . 50.509999999999998 121.133 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -59.49 -41.63 90.3 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 120.404 -1.435 . . . . 50.509999999999998 107.679 176.002 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 30' ' ' ILE . 60.4 mt -64.22 -20.7 27.41 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 113.375 0.88 . . . . 50.509999999999998 113.375 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 33.4 tt0 -50.19 -41.41 49.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.546 2.593 . . . . 50.549999999999997 107.228 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 33' ' ' LYS . 29.3 t70 -81.78 -46.05 14.75 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 116.683 2.105 . . . . 50.619999999999997 116.683 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 32' ' ' ASP . 48.5 mmtm -51.27 -64.15 0.9 Allowed 'General case' 0 C--O 1.279 2.631 0 C-N-CA 116.501 -2.079 . . . . 50.509999999999998 108.394 -175.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -93.09 -41.33 10.02 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.048 2.658 . . . . 50.619999999999997 117.926 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 119.34 17.25 4.91 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 111.083 -0.807 . . . . 50.509999999999998 111.083 176.514 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 24.7 mm -94.9 117.79 66.81 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 118.73 -1.188 . . . . 50.509999999999998 110.546 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.0 136.98 79.92 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.154 2.569 . . . . 50.509999999999998 110.909 178.341 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.0 Cg_exo -57.26 -32.16 92.86 Favored 'Trans proline' 0 C--O 1.261 1.665 0 O-C-N 122.89 0.942 . . . . 50.509999999999998 113.371 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -67.33 -14.44 62.92 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 120.002 -1.686 . . . . 50.619999999999997 111.758 -177.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 58.9 mt-30 -98.64 11.41 38.55 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.54 -1.35 . . . . 50.549999999999997 113.001 178.733 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HG2' HD11 ' A' ' 69' ' ' LEU . 68.6 mt-30 -113.47 119.1 36.42 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 117.22 2.304 . . . . 50.549999999999997 117.22 -177.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.423 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.2 mtm180 -107.41 137.49 45.35 Favored 'General case' 0 C--O 1.296 3.543 0 CA-C-O 116.669 -1.634 . . . . 50.640000000000001 111.851 172.16 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 50' ' ' LEU . 23.2 mt -120.94 115.23 22.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.522 1.056 . . . . 50.509999999999998 111.809 -177.46 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.44 114.95 35.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 O-C-N 125.218 1.574 . . . . 50.509999999999998 113.496 -177.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 50' ' ' LEU . 39.9 t80 -140.76 117.05 10.67 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 114.555 -1.202 . . . . 50.509999999999998 109.983 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.36 23.97 13.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.16 -2.291 . . . . 50.509999999999998 113.03 177.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.59 0.27 89.87 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 110.603 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -103.99 108.28 19.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 116.09 1.885 . . . . 50.509999999999998 116.09 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -45.75 129.17 9.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.222 -1.029 . . . . 50.549999999999997 108.222 174.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 45' ' ' PHE . 5.8 mp -69.9 144.23 52.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 117.742 -1.123 . . . . 50.509999999999998 109.544 -175.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 42.6 mt-10 -94.47 145.44 24.79 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.886 1.366 . . . . 50.619999999999997 108.617 -177.613 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.6 -36.39 83.65 Favored 'General case' 0 C--O 1.263 1.805 0 N-CA-C 117.982 2.586 . . . . 50.619999999999997 117.982 -175.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.21 -26.05 49.52 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.411 1.005 . . . . 50.509999999999998 112.821 -177.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 25.6 mmm180 -59.71 173.76 0.53 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 119.957 -1.908 . . . . 50.640000000000001 111.275 176.433 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 21' ' ' ASP . 41.5 p -117.7 172.47 7.34 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 103.117 -2.92 . . . . 50.509999999999998 103.117 177.135 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.83 -26.84 64.42 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 106.117 -1.808 . . . . 50.509999999999998 106.117 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.1 p -67.3 -25.15 65.9 Favored 'General case' 0 C--O 1.268 2.062 0 C-N-CA 117.324 -1.751 . . . . 50.509999999999998 110.745 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 54' ' ' ARG . 47.0 m-20 -66.01 -36.8 84.27 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 118.883 2.92 . . . . 50.619999999999997 118.883 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.21 9.34 43.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 117.758 -1.115 . . . . 50.509999999999998 112.701 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 57.63 65.42 1.34 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 121.543 1.974 . . . . 50.549999999999997 115.113 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.19 93.35 4.21 Favored 'Isoleucine or valine' 0 C--O 1.266 1.967 0 CA-C-O 115.284 -2.293 . . . . 50.509999999999998 111.444 175.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 8.5 mm-40 -99.01 167.07 10.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 126.073 2.108 . . . . 50.549999999999997 111.963 -176.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 64.8 mttm -51.99 133.83 32.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 119.673 3.212 . . . . 50.509999999999998 119.673 -176.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 64.7 mm-40 77.35 23.48 0.88 Allowed 'General case' 0 C--O 1.256 1.427 0 CA-C-N 112.498 -2.137 . . . . 50.619999999999997 111.019 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.0 m -82.38 144.19 30.7 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.787 -1.097 . . . . 50.509999999999998 113.336 174.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 p -101.78 131.67 47.96 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 118.252 -0.88 . . . . 50.509999999999998 113.348 175.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.0 tp -100.96 139.11 37.11 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 114.647 -2.597 . . . . 50.509999999999998 105.642 175.06 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -100.06 117.84 35.18 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 127.463 2.977 . . . . 50.509999999999998 114.223 177.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.428 HD11 ' HG2' ' A' ' 41' ' ' GLN . 66.0 tp -91.26 106.18 18.32 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 115.187 1.551 . . . . 50.509999999999998 115.187 176.641 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 29.7 t -108.62 136.82 43.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 119.601 1.091 . . . . 50.509999999999998 112.155 175.095 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.2 mt -67.14 155.84 37.72 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 118.226 2.676 . . . . 50.509999999999998 118.226 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 29.2 tpt180 -136.4 77.79 1.67 Allowed 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.32 -3.229 . . . . 50.640000000000001 107.103 177.253 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -74.35 140.09 44.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.644 2.091 . . . . 50.509999999999998 116.644 -179.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.41 82.94 8.1 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.756 -1.566 . . . . 50.640000000000001 108.388 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.39 155.0 20.89 Favored Glycine 0 C--O 1.243 0.712 0 N-CA-C 116.527 1.371 . . . . 50.509999999999998 116.527 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 CA-C-O 116.294 -2.392 . . . . 50.509999999999998 107.282 179.258 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 t30 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 t30 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 t30 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.509999999999998 110.493 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 104.893 178.276 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.509999999999998 102.837 173.339 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.4 ' HD2' HG21 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.509999999999998 117.134 179.556 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.509999999999998 116.317 175.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.509999999999998 112.121 -178.081 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.509999999999998 109.624 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.509999999999998 116.025 -177.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.509999999999998 106.536 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.509999999999998 112.921 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.509999999999998 113.028 175.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.509999999999998 111.926 176.101 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.509999999999998 102.234 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.509999999999998 107.977 178.158 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.509999999999998 113.269 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.619999999999997 114.947 174.004 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.509999999999998 115.789 -177.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.619999999999997 107.53 174.655 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.509999999999998 111.949 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.509999999999998 109.308 -177.562 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.619999999999997 108.196 -179.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.509999999999998 111.912 175.706 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 23' ' ' ILE . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.509999999999998 112.556 175.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.619999999999997 115.475 176.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.549999999999997 106.23 -179.569 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.509999999999998 107.58 178.586 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.509999999999998 111.113 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.509999999999998 109.947 176.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.509999999999998 115.455 175.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.509999999999998 104.372 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.549999999999997 109.548 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.619999999999997 110.423 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.509999999999998 113.197 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.619999999999997 117.619 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.509999999999998 109.26 176.563 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.509999999999998 113.852 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.509999999999998 110.907 178.302 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.509999999999998 113.412 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.619999999999997 115.136 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 62.7 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.549999999999997 103.57 178.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.549999999999997 113.647 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.640000000000001 112.495 172.132 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.509999999999998 118.018 -177.498 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.509999999999998 117.708 -177.62 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.509999999999998 116.78 177.591 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.302 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.509999999999998 114.896 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.509999999999998 114.931 177.617 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.549999999999997 107.727 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.509999999999998 107.986 -175.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.619999999999997 112.944 -177.713 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.619999999999997 118.065 -175.824 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.509999999999998 108.537 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.640000000000001 104.693 176.538 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.509999999999998 107.733 177.174 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.509999999999998 103.779 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.509999999999998 109.455 -179.438 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.619999999999997 111.805 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.509999999999998 115.046 179.177 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.549999999999997 109.887 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.596 HD12 HD21 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 106.554 175.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.549999999999997 119.305 -176.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.509999999999998 112.625 -176.917 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.619999999999997 109.925 179.553 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.509999999999998 105.936 174.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.509999999999998 114.003 175.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.509999999999998 101.726 175.029 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 1.3 m80 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.509999999999998 105.529 177.945 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 108.662 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.509999999999998 109.301 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.509999999999998 105.818 178.446 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.640000000000001 109.263 177.155 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.509999999999998 120.492 -179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.640000000000001 113.699 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.509999999999998 105.703 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.509999999999998 108.344 179.318 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.509999999999998 110.493 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 104.893 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.509999999999998 102.837 173.339 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.4 ' HD2' HG21 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.509999999999998 117.134 179.556 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.509999999999998 116.317 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.509999999999998 112.121 -178.081 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.509999999999998 109.624 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.509999999999998 116.025 -177.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.509999999999998 106.536 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.509999999999998 112.921 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.509999999999998 113.028 175.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.509999999999998 111.926 176.101 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.509999999999998 102.234 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.509999999999998 107.977 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.509999999999998 113.269 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.619999999999997 114.947 174.004 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.509999999999998 115.789 -177.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.619999999999997 107.53 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.509999999999998 111.949 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.509999999999998 109.308 -177.562 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.619999999999997 108.196 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.509999999999998 111.912 175.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 23' ' ' ILE . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.509999999999998 112.556 175.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.619999999999997 115.475 176.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.549999999999997 106.23 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.509999999999998 107.58 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.509999999999998 111.113 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.509999999999998 109.947 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.509999999999998 115.455 175.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.509999999999998 104.372 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.549999999999997 109.548 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.619999999999997 110.423 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.509999999999998 113.197 -175.583 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.619999999999997 117.619 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.509999999999998 109.26 176.563 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.509999999999998 113.852 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.509999999999998 110.907 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.509999999999998 113.412 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.619999999999997 115.136 -177.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 62.7 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.549999999999997 103.57 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.549999999999997 113.647 -177.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.640000000000001 112.495 172.132 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.509999999999998 118.018 -177.498 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.509999999999998 117.708 -177.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.509999999999998 116.78 177.591 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.302 177.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.509999999999998 114.896 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.509999999999998 114.931 177.617 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.549999999999997 107.727 174.582 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.509999999999998 107.986 -175.892 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.619999999999997 112.944 -177.713 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.619999999999997 118.065 -175.824 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.509999999999998 108.537 -177.279 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.640000000000001 104.693 176.538 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.509999999999998 107.733 177.174 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.509999999999998 103.779 177.19 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.509999999999998 109.455 -179.438 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.619999999999997 111.805 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.509999999999998 115.046 179.177 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.549999999999997 109.887 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.596 HD12 HD21 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 106.554 175.897 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.549999999999997 119.305 -176.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.509999999999998 112.625 -176.917 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.619999999999997 109.925 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.509999999999998 105.936 174.787 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.509999999999998 114.003 175.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.509999999999998 101.726 175.029 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 1.3 m80 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.509999999999998 105.529 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 108.662 176.495 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.509999999999998 109.301 175.143 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.509999999999998 105.818 178.446 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.640000000000001 109.263 177.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.509999999999998 120.492 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.640000000000001 113.699 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.509999999999998 105.703 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.509999999999998 108.344 179.318 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 107.349 -1.352 . . . . 50.509999999999998 107.349 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 12.4 mm-40 -87.51 137.75 32.07 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.946 2.654 . . . . 50.549999999999997 110.199 178.218 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -135.32 161.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.022 -1.942 . . . . 50.509999999999998 106.638 173.313 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -94.91 148.05 22.73 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.467 4.854 . . . . 50.509999999999998 119.097 179.532 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.44 116.74 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.395 -3.193 . . . . 50.509999999999998 106.384 175.822 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.19 106.45 17.68 Favored 'General case' 0 N--CA 1.504 2.253 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 115.234 -178.118 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -82.79 178.88 7.97 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 117.759 -1.115 . . . . 50.509999999999998 109.653 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -70.56 -34.07 71.81 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 120.19 3.404 . . . . 50.509999999999998 120.19 -178.081 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 p -96.57 -9.09 30.21 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 115.706 -2.397 . . . . 50.509999999999998 116.356 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.64 38.41 0.72 Allowed Glycine 0 C--N 1.297 -1.617 0 N-CA-C 120.575 2.99 . . . . 50.509999999999998 120.575 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -94.61 135.64 35.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.848 -1.548 . . . . 50.509999999999998 111.047 175.018 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -109.51 117.76 34.83 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 126.702 2.501 . . . . 50.509999999999998 110.113 176.149 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.6 mt -117.72 132.05 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 127.609 3.068 . . . . 50.509999999999998 106.754 179.698 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.3 p -104.75 134.54 47.73 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.298 -1.761 . . . . 50.509999999999998 113.776 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.5 mt -118.39 155.87 29.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.435 -2.221 . . . . 50.509999999999998 116.029 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -93.7 119.16 32.35 Favored 'General case' 0 N--CA 1.501 2.084 1 O-C-N 129.227 4.08 . . . . 50.619999999999997 107.368 173.938 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.23 164.19 28.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 O-C-N 127.739 3.15 . . . . 50.509999999999998 111.114 -177.989 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.66 145.94 55.27 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 112.215 -2.266 . . . . 50.619999999999997 109.52 174.661 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.94 -24.49 39.51 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.559 2.172 . . . . 50.509999999999998 111.956 177.732 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -78.58 -34.48 46.83 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.947 -1.501 . . . . 50.509999999999998 106.947 -177.588 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.1 145.63 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.37 -1.732 . . . . 50.619999999999997 114.434 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -96.83 156.41 16.36 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.874 -0.603 . . . . 50.509999999999998 109.555 175.657 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' A' ' 50' ' ' LEU . 55.5 mt -50.69 -40.13 19.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 O-C-N 127.094 2.746 . . . . 50.509999999999998 108.977 175.774 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -47.65 -57.78 5.08 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.031 -1.1 . . . . 50.619999999999997 108.031 177.015 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -53.84 -40.87 66.83 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 115.74 1.756 . . . . 50.549999999999997 115.74 -179.633 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.71 -22.3 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 125.086 1.491 . . . . 50.509999999999998 110.299 178.519 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 94.9 mttt -82.78 -38.17 23.53 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 104.744 -2.317 . . . . 50.509999999999998 104.744 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.41 -28.45 61.08 Favored 'General case' 0 C--O 1.278 2.605 0 CA-C-N 117.982 0.355 . . . . 50.509999999999998 111.845 176.887 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -66.27 -36.51 83.17 Favored 'General case' 0 C--O 1.256 1.435 0 O-C-N 120.355 -1.466 . . . . 50.509999999999998 110.144 175.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.2 -29.29 27.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.529 -0.868 . . . . 50.509999999999998 108.661 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.24 -35.61 67.58 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 125.666 2.651 . . . . 50.549999999999997 111.019 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -63.75 -27.88 69.5 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 120.947 3.684 . . . . 50.619999999999997 120.947 179.132 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -108.83 -20.29 13.11 Favored 'General case' 0 C--O 1.279 2.65 0 O-C-N 119.27 -2.143 . . . . 50.509999999999998 113.539 -175.638 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' A' ' 36' ' ' ILE . 77.0 tt0 -123.69 -26.57 4.13 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 123.061 2.664 . . . . 50.619999999999997 111.205 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.47 12.04 57.58 Favored Glycine 0 CA--C 1.477 -2.303 0 CA-C-O 120.049 -0.306 . . . . 50.509999999999998 113.122 176.55 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.413 HG12 ' HG2' ' A' ' 34' ' ' GLU . 21.8 mm -77.5 126.3 84.86 Favored Pre-proline 0 C--O 1.245 0.822 0 N-CA-C 104.66 -2.348 . . . . 50.509999999999998 104.66 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.97 136.95 79.69 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.166 2.578 . . . . 50.509999999999998 110.914 178.309 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.07 -32.3 92.8 Favored 'Trans proline' 0 C--O 1.262 1.688 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.436 -179.321 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -80.12 12.04 3.08 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.864 -1.772 . . . . 50.619999999999997 114.954 -177.406 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.23 9.14 11.0 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.467 -1.395 . . . . 50.549999999999997 107.358 178.663 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -103.05 125.13 49.65 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.407 2.051 . . . . 50.549999999999997 112.999 -177.583 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -111.79 114.54 27.58 Favored 'General case' 0 C--O 1.295 3.478 0 CA-C-O 116.711 -1.614 . . . . 50.640000000000001 114.898 172.146 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.556 HD12 HG23 ' A' ' 23' ' ' ILE . 23.1 mt -98.62 122.34 41.71 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 119.431 1.014 . . . . 50.509999999999998 111.832 -177.442 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.81 117.99 56.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 O-C-N 124.545 1.153 . . . . 50.509999999999998 111.016 -177.609 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.707 ' HB3' HD21 ' A' ' 50' ' ' LEU . 57.9 t80 -140.92 143.4 34.58 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.121 -1.437 . . . . 50.509999999999998 107.121 177.52 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 45.38 34.98 1.68 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.254 -2.248 . . . . 50.509999999999998 106.798 177.434 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.87 -7.39 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.445 2.926 . . . . 50.509999999999998 113.263 -179.499 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 46' ' ' ALA . 75.2 mmtt -77.04 148.07 36.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 118.099 0.949 . . . . 50.509999999999998 113.402 177.662 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.5 116.09 11.43 Favored 'General case' 0 C--O 1.259 1.573 0 O-C-N 123.953 0.783 . . . . 50.549999999999997 109.485 174.559 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 45' ' ' PHE . 64.8 mt -78.84 145.68 34.1 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 101.394 -3.558 . . . . 50.509999999999998 101.394 -175.866 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' O ' HD12 ' A' ' 23' ' ' ILE . 4.2 mm-40 -116.72 148.66 40.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.975 1.472 . . . . 50.619999999999997 114.975 -177.661 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.25 -47.9 71.76 Favored 'General case' 0 C--O 1.264 1.838 0 C-N-CA 126.141 1.776 . . . . 50.619999999999997 114.572 -175.778 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 4.42 57.12 Favored Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 124.408 1.004 . . . . 50.509999999999998 112.921 -177.25 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.448 ' HD2' ' OH ' ' A' ' 59' ' ' TYR . 89.3 mtt-85 -93.01 143.52 26.15 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 119.997 -1.884 . . . . 50.640000000000001 112.3 176.451 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.2 p -86.25 162.05 18.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.036 0.935 . . . . 50.509999999999998 112.019 177.087 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.57 -27.31 65.95 Favored 'General case' 0 C--O 1.201 -1.495 0 N-CA-C 102.205 -3.257 . . . . 50.509999999999998 102.205 177.201 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -71.67 -36.03 70.52 Favored 'General case' 0 C--O 1.267 2.022 0 C-N-CA 117.326 -1.749 . . . . 50.509999999999998 113.078 -179.387 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -49.86 -38.64 36.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.501 1.143 . . . . 50.619999999999997 113.718 179.765 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 58.1 m-85 -91.58 -10.72 39.51 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.759 -1.115 . . . . 50.509999999999998 113.584 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 41.2 m-20 70.31 41.58 1.01 Allowed 'General case' 0 C--O 1.248 0.989 0 CA-C-N 121.52 1.964 . . . . 50.549999999999997 108.684 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.72 118.07 14.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.93 0 CA-C-O 115.184 -2.341 . . . . 50.509999999999998 107.126 175.872 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -97.3 177.86 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.556 1.785 . . . . 50.549999999999997 110.196 -176.854 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -58.15 146.94 31.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.198 1.475 . . . . 50.509999999999998 107.658 -176.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 39.74 61.31 1.46 Allowed 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.537 -2.12 . . . . 50.619999999999997 112.614 179.566 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 m -98.26 151.07 20.85 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 104.729 -2.323 . . . . 50.509999999999998 104.729 174.743 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 p -95.96 140.26 30.96 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 118.287 -0.863 . . . . 50.509999999999998 111.879 175.954 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -122.64 136.92 55.01 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 114.641 -2.599 . . . . 50.509999999999998 104.479 175.088 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.15 116.92 29.2 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 127.427 2.954 . . . . 50.509999999999998 108.517 177.897 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.25 130.92 34.96 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.623 -1.179 . . . . 50.509999999999998 111.098 176.57 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -128.56 141.78 45.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 104.004 -2.591 . . . . 50.509999999999998 104.004 174.989 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.5 mt -97.55 123.54 41.46 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.639 0.607 . . . . 50.509999999999998 112.639 178.438 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -104.28 86.76 2.59 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.336 -3.221 . . . . 50.640000000000001 112.841 177.187 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.7 mt -73.32 167.77 20.55 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.954 . . . . 50.509999999999998 107.815 -179.328 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -120.59 86.5 2.58 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.714 -1.585 . . . . 50.640000000000001 107.247 -179.624 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.23 131.74 3.36 Favored Glycine 0 C--O 1.244 0.743 0 O-C-N 124.645 1.216 . . . . 50.509999999999998 113.081 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.47 1 O-C-N 115.118 -4.754 . . . . 50.509999999999998 103.707 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.509999999999998 111.053 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.549999999999997 116.588 178.321 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.509999999999998 108.408 173.351 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.509999999999998 119.91 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.509999999999998 113.866 175.785 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.509999999999998 109.83 -178.037 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.509999999999998 114.27 179.956 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.509999999999998 106.823 -177.969 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.509999999999998 106.406 179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.509999999999998 115.847 179.804 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.509999999999998 113.185 174.982 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.509999999999998 106.82 176.229 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.509999999999998 110.632 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.509999999999998 110.788 178.084 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.509999999999998 115.167 -179.282 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.619999999999997 107.469 173.999 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.509999999999998 111.54 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.619999999999997 109.116 174.729 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.509999999999998 111.942 177.713 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.509999999999998 110.261 -177.489 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.619999999999997 110.438 -179.014 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.509999999999998 102.814 175.665 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.509999999999998 108.219 175.869 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.619999999999997 110.915 177.063 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.549999999999997 110.953 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.509999999999998 113.215 178.571 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.509999999999998 108.802 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.509999999999998 103.321 176.879 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.509999999999998 108.74 176.075 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.509999999999998 114.446 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.549999999999997 111.108 179.417 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.619999999999997 106.799 179.153 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.509999999999998 117.415 -175.737 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.619999999999997 108.973 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.509999999999998 108.229 176.498 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' A' ' 34' ' ' GLU . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.509999999999998 107.149 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.509999999999998 110.835 178.328 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.509999999999998 113.479 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.619999999999997 113.097 -177.452 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' A' ' 37' ' ' PRO . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.549999999999997 107.358 178.748 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.549999999999997 116.575 -177.483 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.640000000000001 106.18 172.202 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.509999999999998 109.103 -177.516 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.509999999999998 114.506 -177.616 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.509999999999998 114.578 177.624 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.509999999999998 108.335 177.409 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.509999999999998 113.694 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.509999999999998 108.927 177.678 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.549999999999997 107.079 174.615 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.509999999999998 107.602 -175.891 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.619999999999997 112.193 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.619999999999997 116.528 -175.761 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.509999999999998 116.292 -177.256 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.640000000000001 108.919 176.463 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.509999999999998 113.355 177.121 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.509999999999998 108.481 177.184 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.509999999999998 116.691 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.619999999999997 119.838 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.509999999999998 110.142 179.286 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 113.734 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.509999999999998 105.625 175.863 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.549999999999997 108.806 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.579 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.509999999999998 116.225 -176.896 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.619999999999997 117.221 179.545 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.509999999999998 103.824 174.726 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.509999999999998 115.599 175.963 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.509999999999998 106.66 175.091 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.509999999999998 108.183 177.947 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.509999999999998 108.516 176.581 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.509999999999998 105.118 175.096 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.509999999999998 116.356 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.640000000000001 113.39 177.176 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.509999999999998 111.184 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.505 -179.621 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.509999999999998 104.884 179.378 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.509999999999998 116.938 179.231 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.509999999999998 111.053 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.549999999999997 116.588 178.321 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.509999999999998 108.408 173.351 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.509999999999998 119.91 179.541 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.509999999999998 113.866 175.785 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.509999999999998 109.83 -178.037 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.509999999999998 114.27 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.509999999999998 106.823 -177.969 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.509999999999998 106.406 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.509999999999998 115.847 179.804 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.509999999999998 113.185 174.982 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.509999999999998 106.82 176.229 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.509999999999998 110.632 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.509999999999998 110.788 178.084 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.509999999999998 115.167 -179.282 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.619999999999997 107.469 173.999 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.509999999999998 111.54 -177.961 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.619999999999997 109.116 174.729 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.509999999999998 111.942 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.509999999999998 110.261 -177.489 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.619999999999997 110.438 -179.014 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.509999999999998 102.814 175.665 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.509999999999998 108.219 175.869 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.619999999999997 110.915 177.063 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.549999999999997 110.953 -179.579 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.509999999999998 113.215 178.571 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.509999999999998 108.802 -179.798 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.509999999999998 103.321 176.879 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.509999999999998 108.74 176.075 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.509999999999998 114.446 179.874 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.549999999999997 111.108 179.417 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.619999999999997 106.799 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.509999999999998 117.415 -175.737 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.619999999999997 108.973 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.509999999999998 108.229 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' A' ' 34' ' ' GLU . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.509999999999998 107.149 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.509999999999998 110.835 178.328 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.509999999999998 113.479 -179.365 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.619999999999997 113.097 -177.452 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' A' ' 37' ' ' PRO . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.549999999999997 107.358 178.748 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.549999999999997 116.575 -177.483 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.640000000000001 106.18 172.202 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.509999999999998 109.103 -177.516 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.509999999999998 114.506 -177.616 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.509999999999998 114.578 177.624 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.509999999999998 108.335 177.409 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.509999999999998 113.694 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.509999999999998 108.927 177.678 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.549999999999997 107.079 174.615 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.509999999999998 107.602 -175.891 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.619999999999997 112.193 -177.677 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.619999999999997 116.528 -175.761 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.509999999999998 116.292 -177.256 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.640000000000001 108.919 176.463 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.509999999999998 113.355 177.121 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.509999999999998 108.481 177.184 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.509999999999998 116.691 -179.453 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.619999999999997 119.838 179.741 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.509999999999998 110.142 179.286 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 113.734 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.509999999999998 105.625 175.863 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.549999999999997 108.806 -176.835 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.579 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.509999999999998 116.225 -176.896 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.619999999999997 117.221 179.545 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.509999999999998 103.824 174.726 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.509999999999998 115.599 175.963 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.509999999999998 106.66 175.091 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.509999999999998 108.183 177.947 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.509999999999998 108.516 176.581 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.509999999999998 105.118 175.096 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.509999999999998 116.356 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.640000000000001 113.39 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.509999999999998 111.184 -179.342 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.505 -179.621 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.509999999999998 104.884 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.509999999999998 116.938 179.231 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.509999999999998 110.518 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.549999999999997 111.931 178.254 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.509999999999998 109.629 173.36 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.509999999999998 110.788 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.509999999999998 109.267 175.855 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.509999999999998 112.054 -178.082 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.509999999999998 109.558 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.509999999999998 115.426 -177.96 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.509999999999998 110.359 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.509999999999998 109.262 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.509999999999998 111.702 175.031 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.509999999999998 120.495 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.509999999999998 104.467 179.69 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.509999999999998 119.511 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.509999999999998 111.182 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.619999999999997 105.523 173.97 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.509999999999998 120.87 -177.968 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.619999999999997 113.88 174.624 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.509999999999998 111.907 177.796 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.509999999999998 110.539 -177.503 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.619999999999997 116.041 -179.054 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.509999999999998 113.13 175.663 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.509999999999998 106.643 175.794 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.619999999999997 109.013 176.992 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.549999999999997 120.754 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.509999999999998 109.974 178.629 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.509999999999998 103.034 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.509999999999998 114.005 176.947 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.509999999999998 108.149 175.949 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.509999999999998 112.731 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.549999999999997 116.636 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 110.424 179.144 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.509999999999998 117.298 -175.651 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.619999999999997 114.698 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.509999999999998 108.03 176.505 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.509999999999998 103.399 179.696 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.509999999999998 110.927 178.325 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.599 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.509999999999998 113.487 -179.297 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.619999999999997 115.612 -177.478 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 108.548 178.699 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 111.184 -177.606 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.640000000000001 102.446 172.198 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.509999999999998 113.857 -177.541 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.509999999999998 112.916 -177.592 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.509999999999998 108.783 177.641 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.509999999999998 104.079 177.365 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.509999999999998 117.886 -179.581 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.509999999999998 111.909 177.62 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.549999999999997 106.814 174.54 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.509999999999998 110.278 -175.89 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.619999999999997 111.58 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.619999999999997 111.456 -175.849 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.509999999999998 112.985 -177.227 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.640000000000001 115.651 176.557 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.509999999999998 116.995 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.509999999999998 105.494 177.211 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.509999999999998 113.975 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.619999999999997 113.595 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 108.268 179.243 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 83.9 m-20 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.549999999999997 112.768 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.509999999999998 112.67 175.785 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.549999999999997 105.766 -176.791 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.509999999999998 107.365 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.619999999999997 116.2 179.519 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.509999999999998 107.156 174.815 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.509999999999998 106.777 175.972 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.509999999999998 107.127 175.12 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.509999999999998 114.104 177.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.509999999999998 109.856 176.533 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.509999999999998 106.088 175.043 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.509999999999998 118.655 178.372 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.640000000000001 107.592 177.293 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.509999999999998 112.686 -179.374 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.640000000000001 111.255 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.509999999999998 104.302 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 116.097 179.25 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.509999999999998 110.518 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.549999999999997 111.931 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.509999999999998 109.629 173.36 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.509999999999998 110.788 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.509999999999998 109.267 175.855 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.509999999999998 112.054 -178.082 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.509999999999998 109.558 179.941 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.509999999999998 115.426 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.509999999999998 110.359 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.509999999999998 109.262 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.509999999999998 111.702 175.031 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.509999999999998 120.495 176.137 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.509999999999998 104.467 179.69 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.509999999999998 119.511 178.086 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.509999999999998 111.182 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.619999999999997 105.523 173.97 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.509999999999998 120.87 -177.968 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.619999999999997 113.88 174.624 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.509999999999998 111.907 177.796 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.509999999999998 110.539 -177.503 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.619999999999997 116.041 -179.054 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.509999999999998 113.13 175.663 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.509999999999998 106.643 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.619999999999997 109.013 176.992 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.549999999999997 120.754 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.509999999999998 109.974 178.629 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.509999999999998 103.034 -179.722 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.509999999999998 114.005 176.947 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.509999999999998 108.149 175.949 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.509999999999998 112.731 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.549999999999997 116.636 179.47 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 110.424 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.509999999999998 117.298 -175.651 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.619999999999997 114.698 179.824 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.509999999999998 108.03 176.505 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.509999999999998 103.399 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.509999999999998 110.927 178.325 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.599 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.509999999999998 113.487 -179.297 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.619999999999997 115.612 -177.478 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 108.548 178.699 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 111.184 -177.606 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.640000000000001 102.446 172.198 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.509999999999998 113.857 -177.541 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.509999999999998 112.916 -177.592 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.509999999999998 108.783 177.641 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.509999999999998 104.079 177.365 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.509999999999998 117.886 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.509999999999998 111.909 177.62 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.549999999999997 106.814 174.54 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.509999999999998 110.278 -175.89 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.619999999999997 111.58 -177.608 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.619999999999997 111.456 -175.849 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.509999999999998 112.985 -177.227 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.640000000000001 115.651 176.557 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.509999999999998 116.995 177.093 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.509999999999998 105.494 177.211 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.509999999999998 113.975 -179.481 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.619999999999997 113.595 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 108.268 179.243 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 83.9 m-20 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.549999999999997 112.768 179.934 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.509999999999998 112.67 175.785 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.549999999999997 105.766 -176.791 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.509999999999998 107.365 -176.938 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.619999999999997 116.2 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.509999999999998 107.156 174.815 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.509999999999998 106.777 175.972 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.509999999999998 107.127 175.12 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.509999999999998 114.104 177.934 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.509999999999998 109.856 176.533 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.509999999999998 106.088 175.043 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.509999999999998 118.655 178.372 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.640000000000001 107.592 177.293 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.509999999999998 112.686 -179.374 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.640000000000001 111.255 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.509999999999998 104.302 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 116.097 179.25 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.992 0.738 . . . . 50.509999999999998 112.992 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.58 106.94 9.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 126.973 2.671 . . . . 50.549999999999997 111.748 178.306 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -114.26 155.73 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 CA-C-O 115.983 -1.96 . . . . 50.509999999999998 113.24 173.276 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -119.93 132.41 55.51 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.523 4.889 . . . . 50.509999999999998 112.064 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.486 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 70.8 t -108.49 134.02 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 113.412 -3.185 . . . . 50.509999999999998 112.244 175.773 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -94.46 118.68 32.02 Favored 'General case' 0 N--CA 1.503 2.22 1 O-C-N 129.329 4.143 . . . . 50.509999999999998 106.07 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -98.48 161.28 13.76 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 117.753 -1.117 . . . . 50.509999999999998 110.633 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -54.82 -33.43 61.6 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.877 1.436 . . . . 50.509999999999998 114.877 -177.95 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 9' ' ' THR . 54.0 m -71.16 -20.77 62.26 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 115.689 -2.404 . . . . 50.509999999999998 113.117 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.56 -10.97 38.99 Favored Glycine 0 C--N 1.297 -1.602 0 O-C-N 120.144 -1.598 . . . . 50.509999999999998 116.312 179.843 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -69.22 117.6 11.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 116.868 -1.539 . . . . 50.509999999999998 110.608 174.996 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.2 m -73.51 126.55 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.659 2.475 . . . . 50.509999999999998 111.716 176.201 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.486 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 14.1 pt -104.58 142.4 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 127.432 2.958 . . . . 50.509999999999998 112.531 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -106.34 142.04 36.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 117.294 -1.763 . . . . 50.509999999999998 112.363 178.112 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -131.01 133.8 46.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 115.49 -2.195 . . . . 50.509999999999998 113.451 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -100.57 139.88 35.63 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 129.163 4.04 . . . . 50.619999999999997 106.417 173.974 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.94 170.76 18.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 117.344 -177.958 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -115.27 138.13 23.43 Favored Pre-proline 0 C--N 1.315 -0.926 0 N-CA-C 103.36 -2.83 . . . . 50.619999999999997 103.36 174.642 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.02 -24.46 40.01 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 122.535 2.157 . . . . 50.509999999999998 111.957 177.706 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -79.01 -6.42 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.128 -0.939 . . . . 50.509999999999998 109.326 -177.611 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -72.55 122.55 21.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.092 2.627 . . . . 50.619999999999997 118.092 -178.954 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 26' ' ' VAL . 66.8 p -67.66 155.54 38.95 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.423 -1.325 . . . . 50.509999999999998 107.423 175.71 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 54' ' ' ARG . 25.6 mm -58.12 -23.74 22.31 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 127.191 2.807 . . . . 50.509999999999998 107.383 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.34 -39.99 67.72 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.471 -0.768 . . . . 50.619999999999997 110.918 177.097 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -70.7 -20.67 62.65 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.292 1.037 . . . . 50.549999999999997 108.258 -179.619 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 22' ' ' THR . 90.6 t -71.35 -57.52 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 101.293 -3.595 . . . . 50.509999999999998 101.293 178.579 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.6 mttt -52.14 -38.47 57.65 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 114.456 1.28 . . . . 50.509999999999998 114.456 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.08 90.84 Favored 'General case' 0 C--O 1.278 2.591 0 CA-C-N 118.007 0.367 . . . . 50.509999999999998 110.322 176.869 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -60.61 -13.47 14.53 Favored 'General case' 0 C--O 1.254 1.309 0 N-CA-C 118.576 2.806 . . . . 50.509999999999998 118.576 176.028 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -90.99 -40.41 12.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 C-N-CA 119.565 -0.854 . . . . 50.509999999999998 110.04 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.561 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 31.3 tt0 -54.15 -31.98 54.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 125.656 2.646 . . . . 50.549999999999997 116.229 179.474 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.04 -72.14 0.1 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.627 -1.624 . . . . 50.619999999999997 109.717 179.092 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.94 -39.99 33.09 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.404 -2.119 . . . . 50.509999999999998 114.829 -175.745 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -88.19 -22.14 24.18 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 114.028 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 71.31 27.13 72.16 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 109.332 -1.507 . . . . 50.509999999999998 109.332 176.571 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.8 mt -96.66 118.62 64.99 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.856 -1.138 . . . . 50.509999999999998 107.968 179.711 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.8 Cg_exo -57.02 136.99 80.0 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 123.149 2.566 . . . . 50.509999999999998 110.865 178.296 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.597 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.5 Cg_exo -57.25 -32.16 92.81 Favored 'Trans proline' 0 C--O 1.261 1.657 0 O-C-N 122.873 0.933 . . . . 50.509999999999998 113.391 -179.268 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -69.76 -21.8 63.4 Favored 'General case' 0 C--O 1.262 1.736 0 O-C-N 119.985 -1.697 . . . . 50.619999999999997 110.39 -177.443 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -93.91 18.16 10.97 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.52 -1.363 . . . . 50.549999999999997 110.421 178.662 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.495 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 71.7 mt-30 -111.49 139.57 46.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.3 2.0 . . . . 50.549999999999997 112.116 -177.584 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.73 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 37.5 ttm180 -119.97 126.61 51.28 Favored 'General case' 0 C--O 1.296 3.529 0 CA-C-O 116.708 -1.615 . . . . 50.640000000000001 108.393 172.147 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.3 mt -118.91 89.25 3.09 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.452 1.024 . . . . 50.509999999999998 112.257 -177.553 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.552 HD11 ' HD3' ' A' ' 42' ' ' ARG . 60.5 mt -98.51 128.85 49.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 O-C-N 125.255 1.597 . . . . 50.509999999999998 107.084 -177.63 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.682 ' CE2' HG12 ' A' ' 61' ' ' ILE . 87.3 t80 -136.33 124.6 23.21 Favored 'General case' 0 C--N 1.36 1.025 0 CA-C-N 114.498 -1.228 . . . . 50.509999999999998 110.627 177.646 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 36.84 20.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.255 177.332 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 25.15 63.84 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 128.455 2.931 . . . . 50.509999999999998 115.916 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.17 136.55 40.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 118.036 0.918 . . . . 50.509999999999998 110.82 177.621 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -73.45 128.24 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.05 0.844 . . . . 50.549999999999997 112.456 174.624 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.4 149.15 35.19 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 105.514 -2.032 . . . . 50.509999999999998 105.514 -175.903 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 82.5 tt0 -105.72 144.53 32.34 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.929 1.393 . . . . 50.619999999999997 113.456 -177.693 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 37.5 p30 -61.19 -35.51 77.35 Favored 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.099 1.76 . . . . 50.619999999999997 109.198 -175.749 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.496 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -91.48 20.94 38.03 Favored Glycine 0 CA--C 1.492 -1.403 0 C-N-CA 124.383 0.992 . . . . 50.509999999999998 115.55 -177.296 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.598 ' O ' HG12 ' A' ' 23' ' ' ILE . 86.5 mmt-85 -128.69 168.3 16.0 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 101.878 -3.378 . . . . 50.640000000000001 101.878 176.488 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -108.57 152.67 24.44 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.003 0.921 . . . . 50.509999999999998 108.842 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.7 mt -47.36 -39.42 15.06 Favored 'General case' 0 C--O 1.201 -1.462 0 O-C-N 124.087 0.867 . . . . 50.509999999999998 108.791 177.239 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -70.79 -27.71 64.11 Favored 'General case' 0 C--O 1.268 2.051 0 N-CA-C 116.35 1.981 . . . . 50.509999999999998 116.35 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -57.46 -27.18 62.24 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.496 1.141 . . . . 50.619999999999997 109.733 179.789 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.0 m-85 -87.06 -5.73 58.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 118.284 2.698 . . . . 50.509999999999998 118.284 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 54.3 m-20 74.28 32.1 1.02 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.524 1.965 . . . . 50.549999999999997 111.521 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.682 HG12 ' CE2' ' A' ' 45' ' ' PHE . 69.5 mt -81.0 103.8 8.57 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.206 -2.33 . . . . 50.509999999999998 110.464 175.849 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -103.84 -171.1 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 119.241 3.052 . . . . 50.549999999999997 119.241 -176.853 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 65.5 tttm -52.72 138.36 29.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.245 -2.131 . . . . 50.509999999999998 105.245 -176.975 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 46.6 mt-10 61.95 68.15 0.71 Allowed 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.492 -2.14 . . . . 50.619999999999997 115.36 179.549 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.408 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 51.0 m -136.06 138.82 42.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.786 -1.097 . . . . 50.509999999999998 109.749 174.813 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -114.39 132.31 56.27 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 118.841 -2.412 . . . . 50.509999999999998 113.919 175.886 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.0 mt -90.06 145.96 24.68 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.64 -2.6 . . . . 50.509999999999998 111.595 175.091 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -96.78 140.64 31.06 Favored 'General case' 0 C--N 1.284 -2.258 0 O-C-N 127.295 2.872 . . . . 50.509999999999998 106.937 177.89 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -106.07 116.0 31.18 Favored 'General case' 0 C--O 1.282 2.81 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 113.338 176.577 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -120.28 138.33 51.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 119.533 1.06 . . . . 50.509999999999998 112.217 175.072 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.36 114.53 28.71 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.405 0.52 . . . . 50.509999999999998 112.405 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -89.08 111.63 22.42 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 113.365 -3.207 . . . . 50.640000000000001 104.738 177.198 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.59 131.62 36.2 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.819 1.949 . . . . 50.509999999999998 112.438 -179.359 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -88.07 77.62 8.33 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 113.757 -1.565 . . . . 50.640000000000001 113.193 -179.544 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.67 -147.62 16.67 Favored Glycine 0 C--O 1.242 0.597 0 N-CA-C 106.325 -2.71 . . . . 50.509999999999998 106.325 179.372 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 CA-C-O 116.329 -2.373 . . . . 50.509999999999998 109.025 179.196 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 118.833 -0.603 . . . . 50.509999999999998 110.318 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -105.25 112.49 25.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 126.937 2.648 . . . . 50.549999999999997 112.805 178.264 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.9 pt -114.42 139.79 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-O 115.984 -1.96 . . . . 50.509999999999998 112.339 173.288 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -96.2 145.78 25.25 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 130.43 4.831 . . . . 50.509999999999998 111.845 179.503 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 70.6 t -133.87 105.18 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.328 -3.225 . . . . 50.509999999999998 113.923 175.748 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -91.08 139.72 30.49 Favored 'General case' 0 N--CA 1.504 2.265 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 120.678 -178.121 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -113.79 -168.87 1.41 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 115.052 1.501 . . . . 50.509999999999998 115.052 179.956 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -107.9 7.98 28.31 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 124.109 0.88 . . . . 50.509999999999998 111.005 -177.925 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -92.24 -14.88 28.27 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 102.41 -3.181 . . . . 50.509999999999998 102.41 179.975 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.89 10.72 29.87 Favored Glycine 0 C--N 1.297 -1.603 0 O-C-N 120.188 -1.57 . . . . 50.509999999999998 110.048 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.649 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 43.0 mtpt -90.8 154.51 19.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.86 -1.543 . . . . 50.509999999999998 113.116 175.003 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -126.8 122.63 35.33 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.706 2.504 . . . . 50.509999999999998 107.466 176.19 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.522 HG22 ' HG ' ' A' ' 15' ' ' LEU . 62.5 mt -99.11 136.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 115.182 -2.607 . . . . 50.509999999999998 108.76 179.775 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.9 m -127.24 104.18 7.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 104.209 -2.515 . . . . 50.509999999999998 104.209 178.092 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.522 ' HG ' HG22 ' A' ' 13' ' ' ILE . 46.2 mt -106.75 175.23 5.57 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.536 -2.173 . . . . 50.509999999999998 110.936 -179.197 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -125.64 137.95 53.89 Favored 'General case' 0 N--CA 1.5 2.058 1 O-C-N 129.164 4.04 . . . . 50.619999999999997 108.038 173.961 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -139.69 165.9 21.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 O-C-N 126.599 2.437 . . . . 50.509999999999998 110.623 -177.891 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.29 158.65 31.58 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 119.381 3.104 . . . . 50.619999999999997 119.381 174.647 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.88 -24.56 39.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.629 2.219 . . . . 50.509999999999998 111.91 177.686 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -110.42 25.71 11.49 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 119.98 3.326 . . . . 50.509999999999998 119.98 -177.543 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -94.62 149.22 21.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 117.305 -1.758 . . . . 50.619999999999997 107.26 -179.038 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -92.97 148.46 21.98 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.799 -0.637 . . . . 50.509999999999998 109.688 175.752 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -44.94 -39.6 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.155 2.784 . . . . 50.509999999999998 115.021 175.785 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.87 -36.73 77.53 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.407 -0.808 . . . . 50.619999999999997 111.367 177.009 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -67.35 -34.07 76.56 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.358 1.063 . . . . 50.549999999999997 110.821 -179.589 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -71.16 -46.11 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 125.048 1.467 . . . . 50.509999999999998 112.878 178.571 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HG2' ' OE1' ' A' ' 41' ' ' GLN . 53.7 mtmt -62.84 -32.1 73.26 Favored 'General case' 0 C--O 1.255 1.352 0 N-CA-C 107.084 -1.45 . . . . 50.509999999999998 107.084 -179.753 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -56.75 17.61 Favored 'General case' 0 C--O 1.279 2.615 0 N-CA-C 114.575 1.324 . . . . 50.509999999999998 114.575 176.828 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -46.24 -49.18 17.58 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 120.387 -1.445 . . . . 50.509999999999998 109.911 176.054 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.84 -42.5 63.01 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 118.32 2.711 . . . . 50.509999999999998 118.32 179.896 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.406 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.8 tt0 -57.96 -45.51 86.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 125.662 2.648 . . . . 50.549999999999997 104.618 179.446 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.74 -25.13 61.93 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 116.353 1.982 . . . . 50.619999999999997 116.353 179.164 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -89.63 -58.61 2.46 Favored 'General case' 0 C--O 1.279 2.64 0 O-C-N 119.325 -2.109 . . . . 50.509999999999998 113.879 -175.683 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.649 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 74.2 mm-40 -103.93 -24.91 13.21 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 123.058 2.663 . . . . 50.619999999999997 110.631 179.868 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 105.52 20.11 9.85 Favored Glycine 0 CA--C 1.478 -2.274 0 N-CA-C 120.393 2.917 . . . . 50.509999999999998 120.393 176.52 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.483 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.9 mt -86.18 134.41 38.75 Favored Pre-proline 0 C--O 1.244 0.792 0 C-N-CA 118.854 -1.138 . . . . 50.509999999999998 110.05 179.738 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -57.07 136.99 79.88 Favored 'Trans proline' 0 C--O 1.26 1.603 0 C-N-CA 123.194 2.596 . . . . 50.509999999999998 110.877 178.361 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.3 Cg_exo -57.13 -32.26 92.83 Favored 'Trans proline' 0 C--O 1.261 1.645 0 C-N-CA 120.731 0.954 . . . . 50.509999999999998 113.411 -179.306 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.79 -27.04 60.15 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 116.268 1.951 . . . . 50.619999999999997 116.268 -177.429 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 80.1 mt-30 -73.65 -21.59 60.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.567 -1.333 . . . . 50.549999999999997 109.995 178.686 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.602 ' HB3' HD11 ' A' ' 69' ' ' LEU . 71.8 mt-30 -70.56 118.28 13.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.36 2.028 . . . . 50.549999999999997 115.678 -177.613 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -113.81 121.4 43.92 Favored 'General case' 0 C--O 1.295 3.498 0 CA-C-O 116.621 -1.657 . . . . 50.640000000000001 109.303 172.098 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -96.49 127.49 42.53 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 119.447 1.021 . . . . 50.509999999999998 112.907 -177.422 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.51 119.3 57.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 115.056 1.502 . . . . 50.509999999999998 115.056 -177.623 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -145.35 121.44 10.76 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 104.741 -2.318 . . . . 50.509999999999998 104.741 177.608 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.0 39.8 3.12 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.208 -2.269 . . . . 50.509999999999998 107.961 177.41 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.47 11.24 4.99 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 128.417 2.913 . . . . 50.509999999999998 115.701 -179.606 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -115.92 126.67 54.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 119.27 3.063 . . . . 50.509999999999998 119.27 177.633 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -41.56 120.82 1.55 Allowed 'General case' 0 C--O 1.259 1.597 0 N-CA-C 120.047 3.351 . . . . 50.549999999999997 120.047 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 2.1 mp -82.35 123.59 29.24 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 117.751 -1.118 . . . . 50.509999999999998 109.737 -175.936 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.15 140.06 48.63 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.62 1.711 . . . . 50.619999999999997 115.62 -177.645 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -54.51 -53.02 59.94 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.148 1.779 . . . . 50.619999999999997 110.458 -175.776 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.17 -7.74 60.48 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 116.531 1.373 . . . . 50.509999999999998 116.531 -177.229 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -76.45 176.48 8.21 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 116.466 2.024 . . . . 50.640000000000001 116.466 176.538 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.6 p -112.44 164.83 12.81 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.055 -1.831 . . . . 50.509999999999998 106.055 177.148 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD22 ' CD1' ' A' ' 61' ' ' ILE . 65.5 mt -68.64 -36.17 78.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 106.573 -1.64 . . . . 50.509999999999998 106.573 177.279 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -65.51 -31.48 72.58 Favored 'General case' 0 C--O 1.267 1.995 0 C-N-CA 117.34 -1.744 . . . . 50.509999999999998 112.392 -179.491 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -47.37 -37.48 11.27 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.515 1.15 . . . . 50.619999999999997 111.902 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 92.5 m-85 -96.12 -11.32 26.42 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 117.757 -1.116 . . . . 50.509999999999998 113.147 179.216 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 32.5 t30 78.58 47.46 0.04 OUTLIER 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.464 1.938 . . . . 50.549999999999997 113.949 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.412 ' CD1' HD22 ' A' ' 56' ' ' LEU . 73.8 mt -85.07 112.49 22.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.965 0 CA-C-O 115.243 -2.313 . . . . 50.509999999999998 109.183 175.873 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -114.69 -171.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 126.059 2.099 . . . . 50.549999999999997 108.661 -176.869 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.1 tttp -59.59 145.2 45.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.255 1.502 . . . . 50.509999999999998 110.307 -176.948 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 34.6 mt-10 66.36 10.22 7.07 Favored 'General case' 0 C--O 1.258 1.507 0 N-CA-C 118.578 2.807 . . . . 50.619999999999997 118.578 179.57 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -74.32 138.05 43.25 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.845 -1.071 . . . . 50.509999999999998 112.668 174.796 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -112.05 128.47 56.2 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 115.14 1.533 . . . . 50.509999999999998 115.14 175.934 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 94.5 mt -103.47 138.93 39.51 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 114.635 -2.602 . . . . 50.509999999999998 107.85 175.072 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -96.33 143.56 27.29 Favored 'General case' 0 C--N 1.284 -2.273 0 O-C-N 127.374 2.921 . . . . 50.509999999999998 106.491 177.885 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.602 HD11 ' HB3' ' A' ' 41' ' ' GLN . 37.7 tp -110.86 115.86 30.25 Favored 'General case' 0 C--O 1.282 2.779 0 CA-C-O 117.733 -1.127 . . . . 50.509999999999998 112.625 176.572 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.62 143.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 119.541 1.064 . . . . 50.509999999999998 110.495 175.066 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 54.9 mt -101.61 102.85 13.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 117.019 2.229 . . . . 50.509999999999998 117.019 178.522 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -73.76 101.54 3.73 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 113.34 -3.219 . . . . 50.640000000000001 110.824 177.207 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.9 163.5 3.41 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.891 1.995 . . . . 50.509999999999998 112.581 -179.274 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.97 74.39 1.53 Allowed 'General case' 0 C--O 1.244 0.804 0 N-CA-C 105.945 -1.872 . . . . 50.640000000000001 105.945 -179.614 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.27 131.56 3.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 106.202 -2.759 . . . . 50.509999999999998 106.202 179.389 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.497 0 CA-C-O 116.331 -2.372 . . . . 50.509999999999998 116.984 179.311 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.509999999999998 111.006 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.549999999999997 116.688 178.266 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.509999999999998 111.74 173.324 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.509999999999998 115.113 179.52 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.509999999999998 107.106 175.824 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.509999999999998 103.747 -178.117 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.509999999999998 107.547 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.509999999999998 105.417 -177.96 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.509999999999998 110.637 179.919 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.509999999999998 119.029 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.509999999999998 114.413 174.998 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 113.052 176.185 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.509999999999998 114.549 179.78 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.509999999999998 111.59 178.086 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.509999999999998 110.023 -179.207 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.619999999999997 111.711 173.943 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 110.993 -177.951 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.619999999999997 108.19 174.632 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.509999999999998 111.964 177.711 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.509999999999998 113.164 -177.552 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.619999999999997 108.919 -179.0 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.509999999999998 108.06 175.711 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.509999999999998 117.251 175.811 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.619999999999997 111.876 176.964 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 110.173 -179.603 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.509999999999998 109.312 178.599 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.509999999999998 106.896 -179.77 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.509999999999998 114.569 176.92 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 176.011 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.423 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.509999999999998 104.805 179.898 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 21.8 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.549999999999997 111.202 179.415 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.619999999999997 113.082 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.509999999999998 116.338 -175.645 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.619999999999997 113.877 179.862 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.509999999999998 105.347 176.537 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.509999999999998 107.204 179.761 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.509999999999998 110.872 178.293 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.303 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.619999999999997 115.506 -177.444 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.549999999999997 113.269 178.741 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.608 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.549999999999997 109.19 -177.64 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.640000000000001 104.765 172.138 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.509999999999998 109.582 -177.498 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.509999999999998 112.344 -177.583 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.509999999999998 107.281 177.627 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.509999999999998 104.493 177.379 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 118.709 -179.624 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.509999999999998 114.674 177.718 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.549999999999997 109.652 174.548 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.509999999999998 110.096 -175.862 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.619999999999997 111.682 -177.729 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.619999999999997 118.573 -175.763 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.509999999999998 109.54 -177.249 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.640000000000001 110.879 176.534 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.509999999999998 116.693 177.156 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.509999999999998 110.756 177.237 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.509999999999998 119.247 -179.485 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.619999999999997 116.794 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.509999999999998 117.56 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.549999999999997 116.376 179.895 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 HD12 ' A' ' 56' ' ' LEU . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 115.487 175.861 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.549999999999997 107.756 -176.828 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.509999999999998 114.348 -176.929 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.619999999999997 107.384 179.576 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.509999999999998 106.402 174.815 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.509999999999998 110.362 175.94 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.509999999999998 107.602 175.106 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.509999999999998 109.96 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.509999999999998 108.197 176.547 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.509999999999998 102.361 175.117 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.509999999999998 113.908 178.441 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.640000000000001 110.488 177.138 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.509999999999998 104.971 -179.332 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.640000000000001 109.517 -179.572 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.509999999999998 111.861 179.397 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.509999999999998 108.119 179.238 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.509999999999998 111.006 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.549999999999997 116.688 178.266 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.509999999999998 111.74 173.324 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.509999999999998 115.113 179.52 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.509999999999998 107.106 175.824 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.509999999999998 103.747 -178.117 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.509999999999998 107.547 179.921 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.509999999999998 105.417 -177.96 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.509999999999998 110.637 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.509999999999998 119.029 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.509999999999998 114.413 174.998 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 113.052 176.185 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.509999999999998 114.549 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.509999999999998 111.59 178.086 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.509999999999998 110.023 -179.207 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.619999999999997 111.711 173.943 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 110.993 -177.951 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.619999999999997 108.19 174.632 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.509999999999998 111.964 177.711 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.509999999999998 113.164 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.619999999999997 108.919 -179.0 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.509999999999998 108.06 175.711 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.509999999999998 117.251 175.811 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.619999999999997 111.876 176.964 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 110.173 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.509999999999998 109.312 178.599 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.509999999999998 106.896 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.509999999999998 114.569 176.92 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 176.011 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.423 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.509999999999998 104.805 179.898 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 21.8 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.549999999999997 111.202 179.415 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.619999999999997 113.082 179.182 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.509999999999998 116.338 -175.645 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.619999999999997 113.877 179.862 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.509999999999998 105.347 176.537 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.509999999999998 107.204 179.761 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.509999999999998 110.872 178.293 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.303 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.619999999999997 115.506 -177.444 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.549999999999997 113.269 178.741 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.608 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.549999999999997 109.19 -177.64 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.640000000000001 104.765 172.138 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.509999999999998 109.582 -177.498 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.509999999999998 112.344 -177.583 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.509999999999998 107.281 177.627 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.509999999999998 104.493 177.379 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 118.709 -179.624 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.509999999999998 114.674 177.718 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.549999999999997 109.652 174.548 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.509999999999998 110.096 -175.862 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.619999999999997 111.682 -177.729 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.619999999999997 118.573 -175.763 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.509999999999998 109.54 -177.249 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.640000000000001 110.879 176.534 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.509999999999998 116.693 177.156 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.509999999999998 110.756 177.237 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.509999999999998 119.247 -179.485 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.619999999999997 116.794 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.509999999999998 117.56 179.269 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.549999999999997 116.376 179.895 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 HD12 ' A' ' 56' ' ' LEU . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 115.487 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.549999999999997 107.756 -176.828 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.509999999999998 114.348 -176.929 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.619999999999997 107.384 179.576 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.509999999999998 106.402 174.815 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.509999999999998 110.362 175.94 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.509999999999998 107.602 175.106 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.509999999999998 109.96 177.938 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.509999999999998 108.197 176.547 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.509999999999998 102.361 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.509999999999998 113.908 178.441 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.640000000000001 110.488 177.138 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.509999999999998 104.971 -179.332 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.640000000000001 109.517 -179.572 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.509999999999998 111.861 179.397 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.509999999999998 108.119 179.238 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 108.426 -0.953 . . . . 50.509999999999998 108.426 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -94.3 140.95 29.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 126.951 2.657 . . . . 50.549999999999997 106.368 178.272 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -126.22 -179.35 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-O 116.017 -1.944 . . . . 50.509999999999998 109.918 173.348 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.91 101.28 5.78 Favored 'General case' 0 N--CA 1.512 2.626 1 O-C-N 130.414 4.821 . . . . 50.509999999999998 114.319 179.567 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.25 123.7 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.488 -3.149 . . . . 50.509999999999998 110.223 175.79 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -117.24 118.42 32.23 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.291 4.119 . . . . 50.509999999999998 112.111 -178.079 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 9' ' ' THR . 5.1 t -104.0 167.38 9.8 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 116.911 2.189 . . . . 50.509999999999998 116.911 179.982 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.97 -17.79 63.98 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.807 1.78 . . . . 50.509999999999998 115.807 -178.008 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.511 ' H ' HG23 ' A' ' 7' ' ' THR . 53.3 p -89.25 1.7 55.33 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 115.767 -2.373 . . . . 50.509999999999998 109.718 179.889 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 -4.28 85.63 Favored Glycine 0 C--N 1.296 -1.655 0 O-C-N 120.115 -1.616 . . . . 50.509999999999998 117.096 179.84 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -67.5 110.0 3.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.825 -1.56 . . . . 50.509999999999998 109.337 174.976 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -81.38 133.74 35.46 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.665 2.478 . . . . 50.509999999999998 114.41 176.175 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.87 138.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 127.38 2.925 . . . . 50.509999999999998 118.105 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.3 m -106.96 130.0 54.68 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.222 -1.791 . . . . 50.509999999999998 111.438 178.138 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.428 HD11 ' CB ' ' A' ' 29' ' ' LYS . 49.3 tp -115.74 152.19 33.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 115.479 -2.201 . . . . 50.509999999999998 114.636 -179.279 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -115.01 107.48 15.42 Favored 'General case' 0 N--CA 1.5 2.04 1 O-C-N 129.273 4.108 . . . . 50.619999999999997 114.466 173.992 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG13 ' HG ' ' A' ' 15' ' ' LEU . 21.0 m -126.55 150.58 32.38 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 127.849 3.218 . . . . 50.509999999999998 118.53 -177.869 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 76.3 mt-10 -87.31 152.12 52.13 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 117.776 2.51 . . . . 50.619999999999997 117.776 174.655 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.46 39.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.556 2.171 . . . . 50.509999999999998 111.946 177.715 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -107.6 37.77 2.33 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 116.229 1.937 . . . . 50.509999999999998 116.229 -177.54 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -105.01 148.54 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 117.321 -1.751 . . . . 50.619999999999997 109.822 -178.965 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -92.88 159.57 15.3 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.087 -1.449 . . . . 50.509999999999998 107.087 175.728 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.12 -40.58 74.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 O-C-N 127.234 2.834 . . . . 50.509999999999998 108.203 175.801 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 52.0 mt-10 -54.08 -13.49 0.82 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.301 1.222 . . . . 50.619999999999997 114.301 177.015 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.35 -18.87 10.37 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.062 1.505 . . . . 50.549999999999997 115.062 -179.608 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.85 -57.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 101.545 -3.502 . . . . 50.509999999999998 101.545 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -57.09 -24.68 55.72 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 115.77 -0.65 . . . . 50.509999999999998 111.547 -179.775 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.68 -6.61 57.52 Favored 'General case' 0 C--O 1.278 2.553 0 N-CA-C 117.612 2.449 . . . . 50.509999999999998 117.612 176.862 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' CB ' HD11 ' A' ' 15' ' ' LEU . 63.3 mttp -91.9 -30.25 16.24 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 102.818 -3.03 . . . . 50.509999999999998 102.818 176.037 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.97 -45.0 98.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 103.108 -2.923 . . . . 50.509999999999998 103.108 179.858 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -52.09 -50.84 60.81 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 125.608 2.623 . . . . 50.549999999999997 108.453 179.419 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -56.66 -14.46 3.27 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 113.612 -1.631 . . . . 50.619999999999997 115.384 179.062 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 31.2 mmmt -117.46 -50.09 2.55 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.465 -2.094 . . . . 50.509999999999998 111.468 -175.688 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -94.93 -8.46 37.0 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 111.17 179.853 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.05 29.25 69.16 Favored Glycine 0 CA--C 1.477 -2.313 0 N-CA-C 107.777 -2.129 . . . . 50.509999999999998 107.777 176.518 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.61 122.74 45.09 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 105.386 -2.079 . . . . 50.509999999999998 105.386 179.75 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -56.95 136.96 79.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 123.177 2.584 . . . . 50.509999999999998 110.913 178.328 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.14 -32.19 92.67 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 120.713 0.942 . . . . 50.509999999999998 113.428 -179.347 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.38 -14.42 27.57 Favored 'General case' 0 C--O 1.262 1.723 0 N-CA-C 115.691 1.737 . . . . 50.619999999999997 115.691 -177.383 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -100.66 13.38 34.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.416 1.636 . . . . 50.549999999999997 115.416 178.788 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -116.42 133.12 56.38 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.363 2.03 . . . . 50.549999999999997 114.944 -177.592 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -116.97 124.77 50.17 Favored 'General case' 0 C--O 1.296 3.516 0 N-CA-C 105.245 -2.132 . . . . 50.640000000000001 105.245 172.145 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.83 133.86 49.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.735 -1.95 . . . . 50.509999999999998 105.735 -177.582 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -121.55 123.47 69.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.159 1.537 . . . . 50.509999999999998 111.155 -177.615 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -134.58 127.78 31.95 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 114.477 -1.238 . . . . 50.509999999999998 111.214 177.625 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.28 20.31 5.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.292 -2.231 . . . . 50.509999999999998 114.468 177.354 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.2 -8.25 67.13 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 120.673 3.029 . . . . 50.509999999999998 120.673 -179.589 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -98.67 144.68 27.68 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 118.052 0.926 . . . . 50.509999999999998 109.91 177.61 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -80.12 129.87 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.346 -2.835 . . . . 50.549999999999997 103.346 174.587 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.71 157.96 31.34 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 117.701 -1.142 . . . . 50.509999999999998 113.902 -175.911 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -100.66 154.23 18.76 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.131 -1.433 . . . . 50.619999999999997 107.131 -177.603 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 64.8 m-20 -72.02 -44.89 62.68 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 126.116 1.766 . . . . 50.619999999999997 111.718 -175.841 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.13 61.31 Favored Glycine 0 C--O 1.253 1.295 0 N-CA-C 120.191 2.836 . . . . 50.509999999999998 120.191 -177.249 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -95.87 169.05 10.26 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 120.066 -1.843 . . . . 50.640000000000001 112.669 176.524 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 70.7 p -100.41 153.92 18.94 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 114.167 1.173 . . . . 50.509999999999998 114.167 177.082 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.8 mt -55.28 -30.84 60.92 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.238 0.962 . . . . 50.509999999999998 112.059 177.254 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -75.23 -28.89 60.08 Favored 'General case' 0 C--O 1.268 2.039 0 C-N-CA 117.375 -1.73 . . . . 50.509999999999998 109.422 -179.434 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 55' ' ' THR . 90.8 m-20 -53.44 -42.38 67.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.457 1.123 . . . . 50.619999999999997 112.401 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -91.18 20.15 5.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 117.779 -1.105 . . . . 50.509999999999998 113.266 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 m120 44.71 24.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 120.024 3.342 . . . . 50.549999999999997 120.024 179.976 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.19 127.92 34.63 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 N-CA-C 101.628 -3.471 . . . . 50.509999999999998 101.628 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' LYS . 44.8 mt-30 -132.37 159.98 37.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 125.946 2.029 . . . . 50.549999999999997 106.699 -176.795 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 62' ' ' GLN . 34.3 ttpt -43.09 146.61 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.707 -1.96 . . . . 50.509999999999998 105.707 -177.019 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 66.4 50.5 1.29 Allowed 'General case' 0 C--O 1.257 1.477 0 CA-C-N 112.5 -2.136 . . . . 50.619999999999997 114.734 179.558 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -124.91 142.97 51.11 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.827 -1.079 . . . . 50.509999999999998 108.436 174.847 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -91.91 135.52 33.87 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.276 -0.868 . . . . 50.509999999999998 109.119 175.87 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.77 136.76 53.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 114.669 -2.586 . . . . 50.509999999999998 105.323 175.11 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -95.23 128.3 41.96 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 127.453 2.971 . . . . 50.509999999999998 112.17 177.899 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.45 119.26 32.89 Favored 'General case' 0 C--O 1.282 2.764 0 CA-C-O 117.71 -1.138 . . . . 50.509999999999998 113.789 176.557 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.07 140.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.676 -2.713 . . . . 50.509999999999998 103.676 175.084 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -111.39 135.12 52.39 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.023 1.12 . . . . 50.509999999999998 114.023 178.462 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -116.29 115.97 26.91 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 113.324 -3.227 . . . . 50.640000000000001 107.894 177.265 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -99.75 168.17 10.09 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 117.876 2.547 . . . . 50.509999999999998 117.876 -179.334 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -77.26 123.36 26.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 113.739 -1.573 . . . . 50.640000000000001 109.597 -179.602 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 154.42 5.85 Favored Glycine 0 C--O 1.244 0.724 0 CA-C-N 114.605 -1.179 . . . . 50.509999999999998 114.458 179.37 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 CA-C-O 116.37 -2.35 . . . . 50.509999999999998 118.366 179.233 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtp . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 104.905 -2.257 . . . . 50.509999999999998 104.905 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -87.34 142.13 28.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.957 2.66 . . . . 50.549999999999997 109.191 178.32 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.86 174.03 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 116.012 -1.947 . . . . 50.509999999999998 105.937 173.324 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -122.88 126.47 47.37 Favored 'General case' 0 N--CA 1.513 2.688 1 O-C-N 129.858 4.474 . . . . 50.509999999999998 113.505 179.558 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 114.86 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 113.373 -3.203 . . . . 50.509999999999998 115.835 175.753 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -79.76 121.1 24.93 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.346 4.154 . . . . 50.509999999999998 118.167 -178.045 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.68 HG22 HD23 ' A' ' 69' ' ' LEU . 24.7 p -96.64 177.16 5.75 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 120.831 3.641 . . . . 50.509999999999998 120.831 179.917 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.84 17.73 4.62 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.072 0.858 . . . . 50.509999999999998 109.674 -178.014 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -124.18 14.49 9.06 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 115.741 -2.384 . . . . 50.509999999999998 112.587 179.929 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.09 14.95 81.29 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 107.75 -2.14 . . . . 50.509999999999998 107.75 179.807 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -104.91 147.1 28.12 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 116.831 -1.557 . . . . 50.509999999999998 112.915 174.977 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -119.01 134.8 54.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 126.637 2.461 . . . . 50.509999999999998 106.354 176.113 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.1 mt -97.37 147.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.477 2.986 . . . . 50.509999999999998 112.74 179.706 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 m -109.99 125.13 52.56 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.287 -1.765 . . . . 50.509999999999998 106.692 178.136 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -126.12 141.89 51.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.875 -2.268 . . . . 50.509999999999998 104.875 -179.27 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -116.45 112.51 21.54 Favored 'General case' 0 N--CA 1.5 2.034 1 O-C-N 129.243 4.089 . . . . 50.619999999999997 109.392 173.962 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 56' ' ' LEU . 33.8 m -106.97 171.42 2.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.214 0 O-C-N 127.694 3.121 . . . . 50.509999999999998 114.6 -177.943 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 75.9 tt0 -111.3 143.15 27.84 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 112.21 -2.268 . . . . 50.619999999999997 106.057 174.556 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.2 Cg_exo -55.0 -24.44 39.78 Favored 'Trans proline' 0 C--N 1.32 -0.933 0 C-N-CA 122.564 2.176 . . . . 50.509999999999998 111.953 177.737 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -82.13 -17.8 45.14 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 114.348 1.24 . . . . 50.509999999999998 114.348 -177.537 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.93 163.42 27.49 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.451 -1.7 . . . . 50.619999999999997 112.123 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.3 p -95.62 -165.48 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.876 -0.602 . . . . 50.509999999999998 111.085 175.7 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -87.01 -40.86 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 127.171 2.794 . . . . 50.509999999999998 108.181 175.716 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 16.8 tp10 -52.46 -42.56 64.31 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 107.534 -1.284 . . . . 50.619999999999997 107.534 177.021 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.17 -49.77 72.97 Favored 'General case' 0 C--O 1.249 1.038 0 C-N-CA 124.352 1.061 . . . . 50.549999999999997 113.405 -179.656 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 22' ' ' THR . 91.1 t -57.78 -42.65 82.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.999 1.437 . . . . 50.509999999999998 111.95 178.645 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.615 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 93.3 mttt -65.95 -37.06 85.03 Favored 'General case' 0 C--O 1.257 1.481 0 N-CA-C 106.535 -1.654 . . . . 50.509999999999998 106.535 -179.693 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 31' ' ' GLN . . . -63.88 -45.19 90.53 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 113.186 0.809 . . . . 50.509999999999998 113.186 176.911 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -44.18 -36.7 2.77 Favored 'General case' 0 C--O 1.255 1.348 0 O-C-N 120.375 -1.453 . . . . 50.509999999999998 108.8 175.973 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.458 HG21 HE22 ' A' ' 41' ' ' GLN . 58.8 mt -72.88 -33.44 43.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.487 -0.885 . . . . 50.509999999999998 110.492 179.895 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 55.4 tt0 -54.95 -41.61 71.29 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.581 2.61 . . . . 50.549999999999997 108.434 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.73 -20.53 57.03 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 113.631 -1.622 . . . . 50.619999999999997 115.104 179.173 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 31.0 mmmt -110.37 -36.15 5.87 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.413 -2.115 . . . . 50.509999999999998 110.828 -175.703 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.55 -54.79 3.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 123.121 2.691 . . . . 50.619999999999997 108.627 179.861 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 18.77 4.06 Favored Glycine 0 CA--C 1.477 -2.288 0 N-CA-C 103.565 -3.814 . . . . 50.509999999999998 103.565 176.55 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.517 HG23 ' HD2' ' A' ' 37' ' ' PRO . 73.5 mt -103.74 135.89 19.29 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 116.785 2.143 . . . . 50.509999999999998 116.785 179.637 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HD2' HG23 ' A' ' 36' ' ' ILE . 78.2 Cg_exo -56.98 137.02 80.12 Favored 'Trans proline' 0 C--O 1.259 1.546 0 C-N-CA 123.084 2.523 . . . . 50.509999999999998 110.919 178.317 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 87.3 Cg_exo -57.23 -32.14 92.72 Favored 'Trans proline' 0 C--O 1.262 1.687 0 O-C-N 122.914 0.955 . . . . 50.509999999999998 113.391 -179.298 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -64.71 -18.68 65.22 Favored 'General case' 0 C--O 1.263 1.767 0 N-CA-C 117.422 2.379 . . . . 50.619999999999997 117.422 -177.401 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -81.45 -15.61 54.55 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.573 -1.33 . . . . 50.549999999999997 109.072 178.719 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.458 HE22 HG21 ' A' ' 30' ' ' ILE . 61.9 mt-30 -100.71 130.09 46.7 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 124.48 2.086 . . . . 50.549999999999997 112.444 -177.6 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -111.65 137.61 49.29 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.648 -1.644 . . . . 50.640000000000001 110.507 172.14 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.615 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 35.2 mt -116.24 129.45 56.29 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.904 1.446 . . . . 50.509999999999998 114.904 -177.456 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -114.77 127.15 72.42 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 O-C-N 125.085 1.491 . . . . 50.509999999999998 111.278 -177.6 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -139.81 107.06 5.5 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 106.99 -1.485 . . . . 50.509999999999998 106.99 177.652 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.43 41.73 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.228 -2.26 . . . . 50.509999999999998 105.53 177.383 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.96 -51.51 2.0 Allowed Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 116.588 -179.605 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -40.2 148.32 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 116.747 2.128 . . . . 50.509999999999998 116.747 177.718 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -82.42 146.08 29.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.042 -2.207 . . . . 50.549999999999997 105.042 174.598 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -100.03 142.35 31.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.102 -1.444 . . . . 50.509999999999998 107.102 -175.888 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.04 156.55 17.85 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.106 -1.442 . . . . 50.619999999999997 107.106 -177.72 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 74.8 m-20 -82.99 -39.1 21.75 Favored 'General case' 0 C--O 1.264 1.837 0 C-N-CA 126.159 1.784 . . . . 50.619999999999997 108.242 -175.8 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.41 2.07 87.74 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 116.288 1.275 . . . . 50.509999999999998 116.288 -177.201 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -95.73 161.01 14.21 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 119.91 -1.935 . . . . 50.640000000000001 106.027 176.515 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 22.8 p -98.37 170.29 8.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.403 -0.962 . . . . 50.509999999999998 108.403 177.129 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 17' ' ' VAL . 4.1 mp -65.31 -16.91 64.07 Favored 'General case' 0 C--O 1.201 -1.498 0 N-CA-C 107.767 -1.198 . . . . 50.509999999999998 107.767 177.255 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 p -70.71 -23.66 62.51 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 116.47 2.026 . . . . 50.509999999999998 116.47 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.21 -37.66 80.96 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.107 2.262 . . . . 50.619999999999997 117.107 179.773 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -101.19 4.52 42.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 117.765 -1.112 . . . . 50.509999999999998 109.716 179.299 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 56.39 54.93 7.05 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 103.862 -2.644 . . . . 50.549999999999997 103.862 179.869 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.17 132.76 31.62 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 115.224 -2.322 . . . . 50.509999999999998 105.818 175.86 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -117.3 172.94 6.97 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.771 2.508 . . . . 50.549999999999997 117.771 -176.815 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -68.08 133.09 48.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 123.187 1.47 . . . . 50.509999999999998 113.737 -176.967 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.12 42.97 30.28 Favored 'General case' 0 C--O 1.256 1.436 0 N-CA-C 116.855 2.168 . . . . 50.619999999999997 116.855 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.6 p -85.46 166.27 16.48 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 104.315 -2.476 . . . . 50.509999999999998 104.315 174.796 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.9 p -114.94 132.72 56.47 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.816 -1.55 . . . . 50.509999999999998 106.816 175.975 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.6 mp -108.37 160.33 15.95 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 114.7 -2.572 . . . . 50.509999999999998 112.396 175.012 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.67 132.07 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.383 2.927 . . . . 50.509999999999998 109.765 177.947 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.68 HD23 HG22 ' A' ' 7' ' ' THR . 30.3 tp -112.78 125.37 54.26 Favored 'General case' 0 C--O 1.282 2.78 0 CA-C-O 117.657 -1.163 . . . . 50.509999999999998 109.467 176.525 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.84 139.97 39.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 105.165 -2.161 . . . . 50.509999999999998 105.165 175.087 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.2 mt -100.42 130.0 46.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.573 -2.01 . . . . 50.509999999999998 105.573 178.397 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -122.89 113.07 18.62 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 101.358 -3.571 . . . . 50.640000000000001 101.358 177.175 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.81 166.31 11.69 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.78 1.925 . . . . 50.509999999999998 111.032 -179.287 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.07 96.73 9.96 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 118.874 2.916 . . . . 50.640000000000001 118.874 -179.592 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.24 -168.62 12.63 Favored Glycine 0 C--O 1.243 0.679 0 N-CA-C 107.136 -2.385 . . . . 50.509999999999998 107.136 179.361 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.477 0 CA-C-O 116.31 -2.383 . . . . 50.509999999999998 110.028 179.212 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.483 ' CE ' ' HD2' ' A' ' 63' ' ' LYS . 81.4 mmm . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.081 0.771 . . . . 50.509999999999998 113.081 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -95.5 124.07 39.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.902 2.626 . . . . 50.549999999999997 115.59 178.29 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.39 152.72 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.984 -1.96 . . . . 50.509999999999998 109.264 173.317 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.557 ' CE2' ' OG1' ' A' ' 14' ' ' THR . 53.6 m-85 -106.52 141.71 37.36 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.386 4.804 . . . . 50.509999999999998 116.464 179.533 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HB ' HG12 ' A' ' 13' ' ' ILE . 85.9 t -113.13 110.4 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 113.435 -3.174 . . . . 50.509999999999998 110.211 175.719 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -83.34 130.74 35.07 Favored 'General case' 0 N--CA 1.505 2.276 1 O-C-N 129.353 4.158 . . . . 50.509999999999998 106.732 -178.064 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.66 -173.65 2.52 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 117.846 -1.073 . . . . 50.509999999999998 108.973 179.928 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -90.34 -16.81 28.46 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.854 1.427 . . . . 50.509999999999998 114.854 -177.959 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -101.33 -3.14 29.38 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 115.695 -2.402 . . . . 50.509999999999998 116.879 179.962 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.41 1.38 Allowed Glycine 0 C--N 1.297 -1.614 0 N-CA-C 117.366 1.706 . . . . 50.509999999999998 117.366 179.781 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -54.9 143.02 27.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 116.069 1.877 . . . . 50.509999999999998 116.069 175.013 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -124.14 136.45 54.22 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 126.619 2.449 . . . . 50.509999999999998 112.919 176.11 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.5 HG12 ' HB ' ' A' ' 5' ' ' VAL . 17.3 pt -106.67 125.18 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.464 2.978 . . . . 50.509999999999998 107.182 179.774 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.557 ' OG1' ' CE2' ' A' ' 4' ' ' PHE . 43.7 m -98.65 134.98 40.81 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.294 -1.762 . . . . 50.509999999999998 112.953 178.123 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -117.01 154.73 30.42 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 115.492 -2.194 . . . . 50.509999999999998 114.072 -179.29 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.7 tt0 -114.94 99.3 7.37 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 129.172 4.045 . . . . 50.619999999999997 109.17 174.005 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.88 155.46 15.07 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.781 3.175 . . . . 50.509999999999998 116.308 -177.967 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -107.3 135.33 19.67 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 104.518 -2.401 . . . . 50.619999999999997 104.518 174.63 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 57' ' ' SER . 84.3 Cg_exo -54.95 -24.52 39.72 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 122.54 2.16 . . . . 50.509999999999998 111.931 177.765 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -76.99 -0.23 23.63 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 118.102 -0.952 . . . . 50.509999999999998 109.269 -177.585 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.545 ' O ' ' HB ' ' A' ' 55' ' ' THR . 92.1 m-20 -72.76 178.21 4.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 117.378 -1.729 . . . . 50.619999999999997 109.31 -179.01 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.1 p -106.3 167.44 9.83 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 103.074 -2.936 . . . . 50.509999999999998 103.074 175.741 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 23' ' ' ILE . 13.1 mm -67.34 -45.99 84.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 O-C-N 126.975 2.672 . . . . 50.509999999999998 107.788 175.809 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -54.71 -48.41 72.52 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.42 -0.8 . . . . 50.619999999999997 112.376 177.017 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -48.61 -49.23 37.91 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.468 -1.308 . . . . 50.549999999999997 107.468 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 22' ' ' THR . 95.8 t -52.07 -52.65 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 125.069 1.481 . . . . 50.509999999999998 113.436 178.528 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -72.81 -23.05 60.73 Favored 'General case' 0 C--O 1.257 1.486 0 CA-C-N 115.755 -0.657 . . . . 50.509999999999998 109.356 -179.745 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.3 95.04 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.334 -2.099 . . . . 50.509999999999998 105.334 176.973 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.38 -48.81 60.04 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 114.995 1.48 . . . . 50.509999999999998 114.995 175.933 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -56.32 -52.6 49.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 103.796 -2.668 . . . . 50.509999999999998 103.796 179.871 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.498 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.6 tt0 -38.32 -73.56 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 125.567 2.603 . . . . 50.549999999999997 110.301 179.391 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -39.76 -59.13 1.22 Allowed 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.671 -1.604 . . . . 50.619999999999997 114.382 179.098 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -82.43 -42.66 18.28 Favored 'General case' 0 C--O 1.279 2.623 0 N-CA-C 119.941 3.312 . . . . 50.509999999999998 119.941 -175.677 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.18 -30.97 22.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 123.058 2.663 . . . . 50.619999999999997 105.776 179.828 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.63 22.76 23.08 Favored Glycine 0 CA--C 1.477 -2.31 0 N-CA-C 118.867 2.307 . . . . 50.509999999999998 118.867 176.564 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 59.2 mt -105.14 122.23 43.75 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 118.753 -1.179 . . . . 50.509999999999998 110.216 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -56.97 136.94 79.64 Favored 'Trans proline' 0 C--O 1.259 1.537 0 C-N-CA 123.207 2.605 . . . . 50.509999999999998 110.879 178.348 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.4 Cg_exo -57.15 -32.17 92.62 Favored 'Trans proline' 0 C--O 1.261 1.661 0 O-C-N 122.926 0.961 . . . . 50.509999999999998 113.486 -179.376 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.45 -0.33 1.88 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 119.973 -1.705 . . . . 50.619999999999997 115.303 -177.448 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -126.91 18.74 7.2 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.5 -1.375 . . . . 50.549999999999997 113.503 178.709 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.425 ' HG2' HD11 ' A' ' 69' ' ' LEU . 69.8 mt-30 -110.3 141.47 43.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.299 2.0 . . . . 50.549999999999997 110.246 -177.582 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -128.62 136.67 50.99 Favored 'General case' 0 C--O 1.297 3.557 0 CA-C-O 116.726 -1.607 . . . . 50.640000000000001 107.496 172.157 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 69' ' ' LEU . 60.3 mt -135.94 124.45 23.56 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.464 1.029 . . . . 50.509999999999998 110.586 -177.538 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -122.62 122.53 66.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.121 1.513 . . . . 50.509999999999998 108.685 -177.589 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -143.06 139.03 30.34 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 114.514 -1.221 . . . . 50.509999999999998 112.103 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 20.48 10.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 112.271 -2.24 . . . . 50.509999999999998 114.865 177.398 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -21.76 27.32 Favored Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 128.493 2.949 . . . . 50.509999999999998 109.173 -179.654 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.74 177.79 7.89 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 118.087 0.943 . . . . 50.509999999999998 111.707 177.65 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -109.59 149.59 29.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 123.99 0.806 . . . . 50.549999999999997 109.481 174.579 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.81 101.71 10.35 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 104.918 -2.253 . . . . 50.509999999999998 104.918 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -101.91 153.23 20.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.916 1.385 . . . . 50.619999999999997 113.765 -177.66 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.45 -44.55 96.15 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 115.969 1.84 . . . . 50.619999999999997 115.969 -175.795 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.99 -15.21 3.23 Favored Glycine 0 C--O 1.253 1.333 0 N-CA-C 116.118 1.207 . . . . 50.509999999999998 116.118 -177.226 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -131.37 145.78 51.99 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 118.838 2.903 . . . . 50.640000000000001 118.838 176.506 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 21' ' ' ASP . 70.7 p -68.94 172.35 6.74 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 115.279 1.585 . . . . 50.509999999999998 115.279 177.189 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG13 ' A' ' 61' ' ' ILE . 35.5 mt -59.47 -49.39 77.98 Favored 'General case' 0 C--O 1.201 -1.477 0 O-C-N 124.156 0.91 . . . . 50.509999999999998 108.789 177.188 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' PRO . 9.4 t -47.52 -47.87 27.66 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 117.298 -1.761 . . . . 50.509999999999998 112.454 -179.444 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -48.45 -26.36 2.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.236 1.569 . . . . 50.619999999999997 115.236 179.767 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 66.9 m-85 -95.01 5.8 50.88 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 117.793 2.516 . . . . 50.509999999999998 117.793 179.222 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.684 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 63.4 m-20 68.81 9.71 7.52 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 121.534 1.97 . . . . 50.549999999999997 114.52 179.909 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.539 HG13 HD22 ' A' ' 56' ' ' LEU . 26.6 mm -50.97 117.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.99 0 CA-C-O 115.141 -2.361 . . . . 50.509999999999998 109.155 175.776 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.684 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 72.2 mt-30 -123.93 179.53 4.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 126.147 2.155 . . . . 50.549999999999997 105.837 -176.811 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HD2' ' CE ' ' A' ' 1' ' ' MET . 82.9 tttt -68.2 146.52 53.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.202 1.477 . . . . 50.509999999999998 108.35 -176.921 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 46.8 67.4 0.79 Allowed 'General case' 0 C--O 1.256 1.429 0 N-CA-C 120.868 3.655 . . . . 50.619999999999997 120.868 179.538 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.5 p -121.04 172.07 8.21 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 106.966 -1.494 . . . . 50.509999999999998 106.966 174.798 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 p -111.96 118.17 34.73 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 115.604 1.705 . . . . 50.509999999999998 115.604 175.982 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.05 138.03 34.27 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 114.647 -2.596 . . . . 50.509999999999998 107.617 175.08 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -97.96 122.48 41.14 Favored 'General case' 0 C--N 1.285 -2.236 0 O-C-N 127.383 2.927 . . . . 50.509999999999998 112.859 177.886 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 43' ' ' LEU . 42.1 tp -90.14 131.91 35.73 Favored 'General case' 0 C--O 1.283 2.83 0 N-CA-C 115.551 1.686 . . . . 50.509999999999998 115.551 176.519 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -120.9 129.28 75.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 103.253 -2.869 . . . . 50.509999999999998 103.253 175.109 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.55 123.93 44.28 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.178 0.513 . . . . 50.509999999999998 110.13 178.424 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -112.19 91.44 3.66 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.41 -3.186 . . . . 50.640000000000001 110.839 177.247 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.87 163.0 28.61 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.811 1.945 . . . . 50.509999999999998 108.282 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.9 ttm105 -87.16 107.35 18.42 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 116.366 1.987 . . . . 50.640000000000001 116.366 -179.544 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.84 151.94 23.58 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 114.66 -1.154 . . . . 50.509999999999998 114.59 179.394 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 113.943 179.22 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 36.7 mmt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 105.584 -2.006 . . . . 50.509999999999998 105.584 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -100.73 135.85 41.53 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.965 2.666 . . . . 50.549999999999997 107.301 178.239 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.465 HD12 ' C ' ' A' ' 3' ' ' ILE . 2.8 pp -137.29 154.93 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 115.961 -1.971 . . . . 50.509999999999998 108.392 173.316 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.39 149.49 23.12 Favored 'General case' 0 N--CA 1.511 2.602 1 O-C-N 130.475 4.86 . . . . 50.509999999999998 115.331 179.558 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.52 122.11 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 101.949 -3.352 . . . . 50.509999999999998 101.949 175.73 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.503 2.198 1 O-C-N 129.322 4.139 . . . . 50.509999999999998 105.737 -178.074 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -87.31 -171.97 3.72 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 117.746 -1.121 . . . . 50.509999999999998 111.573 179.983 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.94 19.73 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.085 0.866 . . . . 50.509999999999998 112.175 -177.974 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -130.8 -14.49 3.56 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 115.706 -2.398 . . . . 50.509999999999998 115.874 179.921 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.83 29.21 4.45 Favored Glycine 0 C--N 1.296 -1.672 0 O-C-N 120.006 -1.684 . . . . 50.509999999999998 109.105 179.833 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.67 123.0 47.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 116.891 -1.528 . . . . 50.509999999999998 111.611 174.997 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p -109.21 131.94 54.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 118.001 2.593 . . . . 50.509999999999998 118.001 176.14 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -113.07 157.4 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 127.209 2.818 . . . . 50.509999999999998 106.143 179.741 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -112.83 140.13 47.88 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.274 -1.77 . . . . 50.509999999999998 109.73 178.131 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 mt -122.1 171.16 9.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 115.488 -2.196 . . . . 50.509999999999998 113.214 -179.293 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' H ' ' HE2' ' A' ' 29' ' ' LYS . 71.7 tt0 -128.94 109.85 11.59 Favored 'General case' 0 N--CA 1.5 2.032 1 O-C-N 129.104 4.003 . . . . 50.619999999999997 112.573 173.976 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.22 172.36 8.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.722 3.139 . . . . 50.509999999999998 114.387 -177.939 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.75 150.33 75.49 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 112.224 -2.262 . . . . 50.619999999999997 108.179 174.638 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.9 -24.53 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.562 2.174 . . . . 50.509999999999998 111.887 177.744 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -81.36 -19.96 41.63 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 118.154 -0.926 . . . . 50.509999999999998 109.737 -177.52 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.63 139.59 58.78 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.352 -1.739 . . . . 50.619999999999997 108.165 -179.053 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 156.03 18.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 105.125 -2.176 . . . . 50.509999999999998 105.125 175.691 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -49.24 -33.66 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 O-C-N 127.201 2.813 . . . . 50.509999999999998 112.734 175.787 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -72.37 -16.61 61.86 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 113.917 1.08 . . . . 50.619999999999997 113.917 177.034 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 25' ' ' ASN . 64.4 t-20 -98.7 -9.0 25.22 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 109.217 -179.663 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -91.32 -43.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 104.981 -2.229 . . . . 50.509999999999998 104.981 178.588 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' ILE . 53.8 mtmt -64.38 -58.41 6.56 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 113.294 0.85 . . . . 50.509999999999998 113.294 -179.806 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.8 -34.11 3.51 Favored 'General case' 0 C--O 1.279 2.608 0 CA-C-N 117.984 0.356 . . . . 50.509999999999998 110.058 176.851 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' A' ' 16' ' ' GLU . 66.1 tttp -62.84 -31.89 73.0 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.383 -1.448 . . . . 50.509999999999998 109.787 175.95 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 27' ' ' LYS . 70.0 mt -77.42 -35.03 21.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 105.709 -1.96 . . . . 50.509999999999998 105.709 179.903 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.724 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 17.8 tm0? -47.11 -36.72 8.69 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 125.564 2.602 . . . . 50.549999999999997 115.246 179.46 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -69.58 -32.24 70.89 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 113.664 -1.607 . . . . 50.619999999999997 113.743 179.131 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -99.77 -7.21 25.8 Favored 'General case' 0 C--O 1.279 2.641 0 C-N-CA 116.473 -2.091 . . . . 50.509999999999998 115.925 -175.671 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -121.97 -32.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 123.063 2.665 . . . . 50.619999999999997 110.136 179.891 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.55 12.57 60.88 Favored Glycine 0 CA--C 1.478 -2.222 0 N-CA-C 104.703 -3.359 . . . . 50.509999999999998 104.703 176.543 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.9 mm -98.3 125.64 42.63 Favored Pre-proline 0 C--O 1.245 0.818 0 N-CA-C 104.462 -2.422 . . . . 50.509999999999998 104.462 179.653 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 78.2 Cg_exo -57.04 136.94 79.66 Favored 'Trans proline' 0 C--O 1.259 1.528 0 C-N-CA 123.154 2.569 . . . . 50.509999999999998 110.922 178.353 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.724 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.4 Cg_exo -57.18 -32.17 92.7 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.918 0.957 . . . . 50.509999999999998 113.398 -179.268 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.45 -18.75 65.54 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 119.918 -1.739 . . . . 50.619999999999997 106.65 -177.489 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.505 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 77.9 mt-30 -93.36 -1.29 56.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.23 1.937 . . . . 50.549999999999997 116.23 178.724 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 57.6 mt-30 -86.74 151.48 23.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.363 2.03 . . . . 50.549999999999997 110.256 -177.575 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.576 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 75.3 ttt180 -133.54 106.96 7.72 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.671 -1.633 . . . . 50.640000000000001 109.224 172.151 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -98.05 136.33 38.46 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.483 1.038 . . . . 50.509999999999998 113.488 -177.472 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.75 124.97 57.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 O-C-N 125.111 1.507 . . . . 50.509999999999998 113.16 -177.608 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -138.35 118.08 13.15 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 114.472 1.286 . . . . 50.509999999999998 114.472 177.673 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 35.57 18.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.291 -2.232 . . . . 50.509999999999998 106.186 177.349 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 8.0 84.69 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 128.437 2.922 . . . . 50.509999999999998 116.237 -179.596 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -101.87 141.45 34.7 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 118.058 0.929 . . . . 50.509999999999998 113.213 177.665 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -84.46 120.73 26.65 Favored 'General case' 0 C--O 1.259 1.599 0 O-C-N 123.977 0.798 . . . . 50.549999999999997 109.235 174.599 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -60.98 126.23 26.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 110.757 -175.883 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.16 132.14 40.42 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.973 1.42 . . . . 50.619999999999997 114.002 -177.713 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.82 -58.31 5.01 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 103.631 -2.729 . . . . 50.619999999999997 103.631 -175.871 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.72 1.66 28.65 Favored Glycine 0 CA--C 1.493 -1.297 0 N-CA-C 118.34 2.096 . . . . 50.509999999999998 118.34 -177.174 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 58' ' ' ASP . 52.8 mmm-85 -109.81 144.96 37.52 Favored 'General case' 0 C--O 1.249 1.034 0 O-C-N 119.696 -2.061 . . . . 50.640000000000001 106.479 176.425 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -91.31 162.49 14.59 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 117.183 2.29 . . . . 50.509999999999998 117.183 177.109 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.712 ' HG ' ' HB ' ' A' ' 61' ' ' ILE . 2.7 mp -46.84 -25.92 0.86 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.14 0.9 . . . . 50.509999999999998 109.5 177.187 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.9 p -71.84 -36.91 70.3 Favored 'General case' 0 C--O 1.269 2.096 0 C-N-CA 117.314 -1.755 . . . . 50.509999999999998 114.309 -179.468 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB3' ' NH2' ' A' ' 54' ' ' ARG . 1.4 m-20 -62.2 -25.29 67.71 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.472 1.13 . . . . 50.619999999999997 113.699 179.812 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.46 24.09 11.59 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 112.609 179.193 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 t30 37.16 54.18 1.25 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 118.865 2.913 . . . . 50.549999999999997 118.865 179.896 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.712 ' HB ' ' HG ' ' A' ' 56' ' ' LEU . 40.9 mm -88.82 100.15 10.2 Favored 'Isoleucine or valine' 0 C--O 1.267 2.017 0 CA-C-O 115.144 -2.36 . . . . 50.509999999999998 112.488 175.861 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -108.85 -178.58 3.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.155 2.16 . . . . 50.549999999999997 111.715 -176.864 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.451 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 64.0 tttm -67.63 144.62 55.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 -176.935 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 67.43 21.82 9.55 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 118.641 2.83 . . . . 50.619999999999997 118.641 179.559 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -73.96 174.24 8.85 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.15 1.907 . . . . 50.509999999999998 116.15 174.857 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -117.2 110.56 18.29 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.472 1.656 . . . . 50.509999999999998 115.472 175.981 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.7 113.83 27.04 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 114.655 -2.593 . . . . 50.509999999999998 115.949 175.042 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.35 136.89 37.12 Favored 'General case' 0 C--N 1.285 -2.216 0 O-C-N 127.457 2.973 . . . . 50.509999999999998 115.542 177.905 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -106.95 114.68 28.91 Favored 'General case' 0 C--O 1.281 2.763 0 N-CA-C 115.546 1.684 . . . . 50.509999999999998 115.546 176.578 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.576 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -111.75 137.91 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 104.908 -2.256 . . . . 50.509999999999998 104.908 175.121 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.92 157.57 28.21 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.403 0.89 . . . . 50.509999999999998 113.403 178.467 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 ttm105 -132.03 77.31 1.75 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 101.997 -3.335 . . . . 50.640000000000001 101.997 177.184 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -84.24 114.39 21.79 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 125.803 1.939 . . . . 50.509999999999998 111.716 -179.306 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -70.31 108.67 4.31 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.709 -1.587 . . . . 50.640000000000001 112.725 -179.635 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 -170.9 13.48 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 107.962 -2.055 . . . . 50.509999999999998 107.962 179.407 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 106.944 -2.462 . . . . 50.509999999999998 106.944 179.161 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.478 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 23.9 mmt . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 118.802 -0.618 . . . . 50.509999999999998 111.202 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -92.41 147.35 22.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.941 2.65 . . . . 50.549999999999997 106.999 178.287 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.528 HD13 HG21 ' A' ' 17' ' ' VAL . 35.1 pt -145.94 151.47 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.453 -2.054 . . . . 50.509999999999998 105.453 173.347 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.434 ' CE1' HG22 ' A' ' 14' ' ' THR . 97.4 m-85 -103.19 143.52 32.52 Favored 'General case' 0 N--CA 1.512 2.671 1 O-C-N 130.502 4.876 . . . . 50.509999999999998 112.212 179.503 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.96 116.17 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 113.36 -3.21 . . . . 50.509999999999998 110.554 175.797 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HD3' HG22 ' A' ' 12' ' ' THR . 25.1 mmtp -73.39 160.74 31.34 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.363 4.165 . . . . 50.509999999999998 112.885 -178.08 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -134.49 -165.44 1.66 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.491 -1.3 . . . . 50.509999999999998 107.491 179.942 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.7 mt -94.73 -33.83 12.77 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 -177.965 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -75.68 -9.26 58.44 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 115.744 -2.383 . . . . 50.509999999999998 117.254 179.914 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.57 4.22 58.22 Favored Glycine 0 C--N 1.296 -1.642 0 O-C-N 120.194 -1.566 . . . . 50.509999999999998 116.153 179.748 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE3' HG22 ' A' ' 13' ' ' ILE . 50.6 tptt -76.08 129.01 36.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 116.838 -1.553 . . . . 50.509999999999998 109.37 175.061 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.507 HG22 ' HD3' ' A' ' 6' ' ' LYS . 33.9 p -111.93 107.91 17.07 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 107.119 176.215 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.482 HG22 ' HE3' ' A' ' 11' ' ' LYS . 26.9 pt -97.17 147.87 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 127.352 2.907 . . . . 50.509999999999998 114.29 179.643 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.434 HG22 ' CE1' ' A' ' 4' ' ' PHE . 20.7 p -94.13 153.75 17.94 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 101.438 -3.542 . . . . 50.509999999999998 101.438 178.164 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.33 149.27 49.69 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.64 -2.356 . . . . 50.509999999999998 104.64 -179.303 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -100.33 120.56 40.12 Favored 'General case' 0 N--CA 1.499 2.009 1 O-C-N 129.266 4.104 . . . . 50.619999999999997 109.741 173.955 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 3' ' ' ILE . 18.8 m -131.7 166.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.673 3.108 . . . . 50.509999999999998 107.743 -177.987 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 38.3 mt-10 -125.86 143.49 45.46 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 112.185 -2.28 . . . . 50.619999999999997 106.18 174.733 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 84.2 Cg_exo -54.94 -24.62 40.14 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.606 2.204 . . . . 50.509999999999998 111.905 177.702 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -69.87 -44.9 68.85 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 117.536 2.421 . . . . 50.509999999999998 117.536 -177.512 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.7 154.07 34.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 117.393 -1.723 . . . . 50.619999999999997 113.773 -178.992 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.416 ' C ' ' N ' ' A' ' 24' ' ' GLU . 44.9 p -84.5 157.79 21.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.834 1.05 . . . . 50.509999999999998 113.834 175.642 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -49.13 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 O-C-N 127.18 2.8 . . . . 50.509999999999998 105.858 175.793 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 22' ' ' THR . 41.2 tt0 -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 120.388 3.477 . . . . 50.619999999999997 120.388 177.05 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.409 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 33.6 m120 -98.69 -38.02 9.27 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 102.963 -2.977 . . . . 50.549999999999997 102.963 -179.562 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.56 -59.0 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 125.069 1.481 . . . . 50.509999999999998 113.507 178.681 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 38' ' ' PRO . 54.8 pttt -53.11 -45.82 68.43 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 109.241 -0.652 . . . . 50.509999999999998 109.241 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.35 75.56 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 119.665 3.209 . . . . 50.509999999999998 119.665 176.797 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 94.1 mttt -52.92 -40.95 63.99 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.384 -1.447 . . . . 50.509999999999998 107.303 176.033 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . 87.1 mt -67.59 -21.94 28.0 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 N-CA-C 113.406 0.891 . . . . 50.509999999999998 113.406 179.882 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -58.57 -33.96 70.53 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.586 2.612 . . . . 50.549999999999997 106.395 179.473 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.06 -27.86 67.72 Favored 'General case' 0 C--O 1.253 1.271 0 N-CA-C 116.411 2.004 . . . . 50.619999999999997 116.411 179.16 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -107.08 -26.14 11.26 Favored 'General case' 0 C--O 1.279 2.643 0 C-N-CA 116.473 -2.091 . . . . 50.509999999999998 113.955 -175.669 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -109.22 -46.74 3.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.074 2.67 . . . . 50.619999999999997 110.337 179.869 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 10.1 20.56 Favored Glycine 0 CA--C 1.477 -2.292 0 N-CA-C 110.097 -1.201 . . . . 50.509999999999998 110.097 176.575 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 36.9 mm -83.42 124.21 75.98 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 106.671 -1.603 . . . . 50.509999999999998 106.671 179.693 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -57.05 136.92 79.54 Favored 'Trans proline' 0 C--O 1.259 1.554 0 C-N-CA 123.159 2.573 . . . . 50.509999999999998 110.883 178.327 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 88.3 Cg_exo -57.17 -32.19 92.71 Favored 'Trans proline' 0 C--O 1.261 1.64 0 O-C-N 122.886 0.94 . . . . 50.509999999999998 113.363 -179.265 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.99 -15.48 63.04 Favored 'General case' 0 C--O 1.262 1.722 0 O-C-N 119.92 -1.737 . . . . 50.619999999999997 108.114 -177.41 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.4 12.92 35.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.971 1.471 . . . . 50.549999999999997 114.971 178.758 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -114.94 119.67 37.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.428 2.061 . . . . 50.549999999999997 110.587 -177.705 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -119.92 116.9 26.74 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.694 -1.622 . . . . 50.640000000000001 107.394 172.178 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.02 133.4 44.47 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.153 1.538 . . . . 50.509999999999998 115.153 -177.548 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -115.83 124.87 72.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 N-CA-C 117.106 2.261 . . . . 50.509999999999998 117.106 -177.6 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -126.13 118.2 24.74 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.573 -1.194 . . . . 50.509999999999998 112.605 177.617 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.69 40.68 29.09 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.276 -2.238 . . . . 50.509999999999998 111.591 177.391 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 6.6 42.62 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 128.391 2.9 . . . . 50.509999999999998 112.91 -179.584 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -91.22 127.06 36.51 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.284 -1.376 . . . . 50.509999999999998 107.284 177.699 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -76.64 122.19 24.31 Favored 'General case' 0 C--O 1.26 1.611 0 O-C-N 123.971 0.794 . . . . 50.549999999999997 109.141 174.621 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 mt -81.03 155.51 26.32 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 116.588 2.07 . . . . 50.509999999999998 116.588 -175.884 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 41.3 tp10 -106.01 142.11 36.27 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 125.024 1.452 . . . . 50.619999999999997 113.709 -177.755 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -59.96 -32.2 70.59 Favored 'General case' 0 C--O 1.263 1.794 0 C-N-CA 126.131 1.772 . . . . 50.619999999999997 111.404 -175.75 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -101.06 38.25 3.23 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 124.334 0.969 . . . . 50.509999999999998 113.772 -177.235 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -134.2 159.04 42.12 Favored 'General case' 0 C--O 1.248 1.009 0 O-C-N 118.037 -3.037 . . . . 50.640000000000001 105.106 176.464 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -91.02 172.07 8.83 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.022 0.929 . . . . 50.509999999999998 112.063 177.091 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.98 -37.87 66.87 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.193 0.933 . . . . 50.509999999999998 108.486 177.225 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 19' ' ' PRO . 47.2 t -64.11 -39.0 93.1 Favored 'General case' 0 C--O 1.268 2.04 0 N-CA-C 116.601 2.074 . . . . 50.509999999999998 116.601 -179.401 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -55.55 -23.84 28.94 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.418 1.104 . . . . 50.619999999999997 111.692 179.773 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -97.52 -0.18 46.43 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 117.722 -1.133 . . . . 50.509999999999998 113.931 179.234 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.5 t30 69.89 21.34 6.35 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.36 1.985 . . . . 50.549999999999997 116.36 179.892 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.73 96.86 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.976 0 CA-C-O 115.206 -2.33 . . . . 50.509999999999998 112.232 175.858 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.442 ' O ' ' OG ' ' A' ' 65' ' ' SER . 21.7 pt20 -88.18 160.34 17.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 126.074 2.109 . . . . 50.549999999999997 111.758 -176.813 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 88.4 tttt -43.23 149.36 0.24 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.426 -2.065 . . . . 50.509999999999998 105.426 -177.034 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 97.6 mt-10 52.64 74.28 0.29 Allowed 'General case' 0 C--O 1.257 1.493 0 CA-C-N 112.522 -2.127 . . . . 50.619999999999997 107.909 179.633 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 69.1 m -119.45 132.39 55.79 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.743 -1.117 . . . . 50.509999999999998 111.249 174.801 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.3 m -81.43 121.37 26.17 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 118.187 -0.911 . . . . 50.509999999999998 113.287 175.94 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -111.56 143.93 41.62 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.707 -2.568 . . . . 50.509999999999998 111.404 175.06 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -94.79 136.66 34.83 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 126.809 2.568 . . . . 50.509999999999998 108.367 177.914 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 65.9 tp -93.09 118.96 31.8 Favored 'General case' 0 C--O 1.282 2.794 0 CA-C-O 117.609 -1.186 . . . . 50.509999999999998 110.624 176.517 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.9 121.96 66.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.558 -1.275 . . . . 50.509999999999998 107.558 175.071 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.8 mt -96.01 128.18 42.67 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.674 0.62 . . . . 50.509999999999998 112.674 178.403 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 60.8 ttt85 -113.69 69.62 0.71 Allowed 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 120.313 3.449 . . . . 50.640000000000001 120.313 177.305 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.57 142.23 28.6 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 125.872 1.982 . . . . 50.509999999999998 114.841 -179.382 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -91.21 85.94 6.02 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.801 -179.629 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.3 -161.7 28.35 Favored Glycine 0 C--O 1.243 0.699 0 N-CA-C 108.705 -1.758 . . . . 50.509999999999998 108.705 179.339 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 116.322 -2.376 . . . . 50.509999999999998 111.287 179.257 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mmt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 101.467 -3.531 . . . . 50.509999999999998 101.467 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -103.85 129.51 51.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 126.961 2.663 . . . . 50.549999999999997 107.932 178.256 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 pt -119.72 157.49 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 116.04 -1.933 . . . . 50.509999999999998 110.386 173.353 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -106.23 139.21 41.1 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.407 4.817 . . . . 50.509999999999998 112.035 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -113.86 101.58 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.359 -3.21 . . . . 50.509999999999998 108.884 175.81 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -66.76 147.0 53.84 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.463 4.227 . . . . 50.509999999999998 112.322 -178.097 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.513 HG22 HD23 ' A' ' 69' ' ' LEU . 41.6 p -135.64 170.39 16.03 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.768 -1.111 . . . . 50.509999999999998 108.494 179.959 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -91.4 29.96 1.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.967 0.792 . . . . 50.509999999999998 112.414 -177.966 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.3 p -130.55 18.67 5.25 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 115.677 -2.409 . . . . 50.509999999999998 117.199 179.904 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.92 51.15 25.47 Favored Glycine 0 C--N 1.297 -1.591 0 O-C-N 120.109 -1.619 . . . . 50.509999999999998 111.271 179.763 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -160.2 123.69 3.55 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 115.225 1.565 . . . . 50.509999999999998 115.225 175.02 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -83.89 135.15 34.6 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 126.666 2.479 . . . . 50.509999999999998 114.566 176.137 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 mm -108.51 133.79 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.562 3.039 . . . . 50.509999999999998 106.079 179.717 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.8 p -104.27 154.31 19.95 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.553 2.057 . . . . 50.509999999999998 116.553 178.073 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.5 mt -140.62 139.65 34.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.49 -2.195 . . . . 50.509999999999998 113.33 -179.261 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.61 113.52 25.6 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 128.66 3.725 . . . . 50.619999999999997 103.548 173.988 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.24 -166.26 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.271 0 O-C-N 127.518 3.011 . . . . 50.509999999999998 105.312 -177.911 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -150.56 156.87 36.66 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.256 -2.247 . . . . 50.619999999999997 109.062 174.621 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.96 -24.53 39.89 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.953 177.754 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.5 p -93.52 -7.36 44.47 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 115.541 1.682 . . . . 50.509999999999998 115.541 -177.546 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.21 135.6 52.28 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.29 -1.764 . . . . 50.619999999999997 114.821 -179.017 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -77.43 160.34 28.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.851 -0.613 . . . . 50.509999999999998 110.904 175.78 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 15.5 mm -55.3 -40.03 54.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.153 2.783 . . . . 50.509999999999998 109.387 175.808 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -61.64 -40.77 96.09 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.422 -0.798 . . . . 50.619999999999997 111.568 176.95 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -64.05 -45.44 88.79 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 124.377 1.071 . . . . 50.549999999999997 112.781 -179.613 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 56' ' ' LEU . 91.5 t -55.83 -55.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.344 -1.724 . . . . 50.509999999999998 106.344 178.613 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -48.2 -30.12 4.37 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 113.072 0.768 . . . . 50.509999999999998 113.072 -179.813 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -35.88 74.5 Favored 'General case' 0 C--O 1.278 2.6 0 N-CA-C 114.379 1.251 . . . . 50.509999999999998 114.379 176.846 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 29.3 mmtp -58.38 -43.36 88.45 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 104.256 -2.498 . . . . 50.509999999999998 104.256 176.03 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.77 -35.05 53.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.287 0 N-CA-C 115.219 1.563 . . . . 50.509999999999998 115.219 179.93 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -60.64 -32.07 71.25 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 125.593 2.616 . . . . 50.549999999999997 112.391 179.427 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -71.7 -52.1 19.53 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 109.803 179.131 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -78.82 -47.44 16.67 Favored 'General case' 0 C--O 1.279 2.616 0 C-N-CA 116.465 -2.094 . . . . 50.509999999999998 116.073 -175.656 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.79 -14.26 40.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 123.079 2.672 . . . . 50.619999999999997 117.047 179.819 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 13.02 83.97 Favored Glycine 0 CA--C 1.477 -2.32 0 CA-C-O 120.065 -0.297 . . . . 50.509999999999998 112.612 176.539 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.33 123.47 64.0 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 115.554 1.687 . . . . 50.509999999999998 115.554 179.7 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.9 Cg_exo -56.93 136.9 79.33 Favored 'Trans proline' 0 C--O 1.26 1.617 0 C-N-CA 123.109 2.539 . . . . 50.509999999999998 111.006 178.268 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.2 Cg_exo -57.2 -32.07 92.45 Favored 'Trans proline' 0 C--O 1.261 1.651 0 O-C-N 122.83 0.911 . . . . 50.509999999999998 113.45 -179.249 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -59.61 -12.49 6.81 Favored 'General case' 0 C--O 1.262 1.729 0 N-CA-C 117.768 2.507 . . . . 50.619999999999997 117.768 -177.463 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.517 ' O ' HD23 ' A' ' 71' ' ' LEU . 79.2 mt-30 -112.23 14.71 20.57 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.519 -1.363 . . . . 50.549999999999997 113.661 178.718 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -107.46 131.67 54.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.4 2.048 . . . . 50.549999999999997 115.36 -177.612 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.578 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 33.1 ttm180 -115.58 113.85 24.15 Favored 'General case' 0 C--O 1.296 3.524 0 CA-C-O 116.592 -1.671 . . . . 50.640000000000001 112.565 172.148 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.92 130.08 46.06 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 104.507 -2.405 . . . . 50.509999999999998 104.507 -177.501 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.574 HD11 ' HD3' ' A' ' 42' ' ' ARG . 89.4 mt -125.95 130.97 72.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.078 1.486 . . . . 50.509999999999998 112.746 -177.565 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.89 103.38 8.02 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 114.505 -1.225 . . . . 50.509999999999998 111.211 177.572 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.09 48.39 22.4 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.211 -2.268 . . . . 50.509999999999998 108.317 177.368 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.37 72.16 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 128.445 2.926 . . . . 50.509999999999998 115.154 -179.539 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -99.28 138.32 36.54 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.328 -0.99 . . . . 50.509999999999998 108.328 177.6 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -88.78 114.78 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.02 0.825 . . . . 50.549999999999997 112.617 174.616 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.36 128.18 35.67 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 117.679 -1.153 . . . . 50.509999999999998 113.899 -175.919 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -92.88 137.46 32.34 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.956 1.41 . . . . 50.619999999999997 107.43 -177.593 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.04 -44.14 67.15 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 118.367 2.728 . . . . 50.619999999999997 118.367 -175.784 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.38 -22.32 77.62 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 119.54 2.576 . . . . 50.509999999999998 119.54 -177.225 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -82.99 158.99 22.31 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 119.716 -2.049 . . . . 50.640000000000001 112.849 176.485 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -88.03 160.7 17.74 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 117.629 2.455 . . . . 50.509999999999998 117.629 177.044 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -55.61 -31.01 61.91 Favored 'General case' 0 C--O 1.2 -1.526 0 CA-C-N 115.473 -0.785 . . . . 50.509999999999998 110.912 177.243 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -71.62 -27.2 62.95 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.301 -1.76 . . . . 50.509999999999998 112.059 -179.485 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.96 -13.95 62.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.461 1.282 . . . . 50.619999999999997 114.461 179.769 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.602 ' HB2' HG12 ' A' ' 61' ' ' ILE . 53.5 m-85 -103.19 14.39 31.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 115.497 1.665 . . . . 50.509999999999998 115.497 179.25 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.9 t30 64.78 19.81 11.94 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 121.48 1.946 . . . . 50.549999999999997 109.459 179.855 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 59' ' ' TYR . 34.8 mm -81.23 99.69 4.76 Favored 'Isoleucine or valine' 0 C--O 1.267 2.026 0 CA-C-O 115.209 -2.329 . . . . 50.509999999999998 113.777 175.847 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -124.27 -115.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.101 2.125 . . . . 50.549999999999997 112.77 -176.851 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.77 128.72 35.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.259 1.504 . . . . 50.509999999999998 111.915 -176.95 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 51.65 39.23 24.68 Favored 'General case' 0 C--O 1.257 1.47 0 CA-C-N 112.516 -2.129 . . . . 50.619999999999997 115.775 179.52 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -71.27 148.27 47.33 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.842 -1.072 . . . . 50.509999999999998 110.018 174.8 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.9 m -127.51 116.05 19.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 118.26 -0.876 . . . . 50.509999999999998 112.222 175.938 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.42 142.45 27.41 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.76 -2.543 . . . . 50.509999999999998 111.856 175.043 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -88.78 138.29 31.55 Favored 'General case' 0 C--N 1.286 -2.182 0 O-C-N 126.818 2.574 . . . . 50.509999999999998 107.324 177.925 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 HG22 ' A' ' 7' ' ' THR . 68.0 tp -106.98 123.55 48.35 Favored 'General case' 0 C--O 1.283 2.852 0 CA-C-O 117.632 -1.175 . . . . 50.509999999999998 109.246 176.544 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.6 t -135.22 126.99 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 119.596 1.089 . . . . 50.509999999999998 110.346 175.059 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 40' ' ' GLN . 71.2 mt -70.21 139.9 52.36 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 120.417 3.488 . . . . 50.509999999999998 120.417 178.446 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -118.27 106.46 12.82 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.327 -3.225 . . . . 50.640000000000001 102.491 177.314 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' A' ' 71' ' ' LEU . 6.4 mp -104.75 127.81 52.66 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.955 . . . . 50.509999999999998 115.508 -179.314 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -90.02 84.37 6.16 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.751 -1.568 . . . . 50.640000000000001 107.806 -179.648 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.21 157.04 7.21 Favored Glycine 0 C--O 1.244 0.744 1 N-CA-C 102.525 -4.23 . . . . 50.509999999999998 102.525 179.367 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 N-CA-C 105.58 -3.008 . . . . 50.509999999999998 105.58 179.227 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 108.225 -1.028 . . . . 50.509999999999998 108.225 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -102.06 133.53 46.75 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 126.889 2.618 . . . . 50.549999999999997 107.185 178.29 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.35 169.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 N-CA-C 104.745 -2.317 . . . . 50.509999999999998 104.745 173.37 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.97 123.73 40.51 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.427 4.829 . . . . 50.509999999999998 111.603 179.588 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.18 110.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 113.349 -3.215 . . . . 50.509999999999998 109.404 175.788 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -99.18 146.85 25.72 Favored 'General case' 0 N--CA 1.504 2.271 1 O-C-N 129.367 4.167 . . . . 50.509999999999998 112.42 -178.085 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -112.87 178.97 4.1 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.046 -2.946 . . . . 50.509999999999998 103.046 179.993 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.6 mt -91.53 3.7 54.35 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.111 0.882 . . . . 50.509999999999998 111.028 -178.036 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -91.96 -24.83 19.13 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 115.673 -2.411 . . . . 50.509999999999998 114.467 179.956 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.76 14.65 2.28 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 106.022 -2.831 . . . . 50.509999999999998 106.022 179.735 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -95.33 120.12 35.01 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 115.247 1.573 . . . . 50.509999999999998 115.247 174.971 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -119.53 108.56 14.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 126.679 2.487 . . . . 50.509999999999998 105.48 176.143 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 tt -103.19 146.02 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.442 2.964 . . . . 50.509999999999998 114.156 179.721 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 15' ' ' LEU . 98.5 m -97.93 155.76 16.93 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 117.27 -1.772 . . . . 50.509999999999998 111.194 178.092 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' N ' HG22 ' A' ' 14' ' ' THR . 12.6 tp -138.11 140.02 39.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 115.485 -2.198 . . . . 50.509999999999998 111.804 -179.239 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -103.11 115.05 29.85 Favored 'General case' 0 N--CA 1.5 2.042 1 O-C-N 129.187 4.055 . . . . 50.619999999999997 111.421 173.972 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.58 178.09 2.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 O-C-N 127.888 3.243 . . . . 50.509999999999998 113.093 -177.93 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 25.7 tt0 -102.01 149.97 37.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 112.196 -2.274 . . . . 50.619999999999997 106.082 174.622 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.93 -24.5 39.52 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.6 2.2 . . . . 50.509999999999998 111.948 177.691 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.6 p -120.14 22.07 11.55 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 119.795 3.257 . . . . 50.509999999999998 119.795 -177.528 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.0 152.19 42.65 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.44 -1.704 . . . . 50.619999999999997 108.547 -179.026 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 55' ' ' THR . 71.6 p -97.27 145.92 25.62 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.895 -0.593 . . . . 50.509999999999998 109.499 175.649 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 50.5 mm -42.64 -36.77 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 O-C-N 127.126 2.766 . . . . 50.509999999999998 113.586 175.789 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -44.53 -55.66 4.94 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.364 -0.835 . . . . 50.619999999999997 112.729 176.96 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -72.14 -46.02 58.19 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.361 1.064 . . . . 50.549999999999997 108.18 -179.645 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 23' ' ' ILE . 90.8 t -40.69 -62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.003 1.439 . . . . 50.509999999999998 108.535 178.54 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 53.3 mtmt -67.7 -16.32 64.08 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 115.288 1.588 . . . . 50.509999999999998 115.288 -179.74 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.69 -33.08 25.25 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.84 -0.43 . . . . 50.509999999999998 109.84 176.87 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -69.0 -46.77 67.19 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 103.278 -2.86 . . . . 50.509999999999998 103.278 176.025 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -55.78 -28.69 24.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.491 -0.883 . . . . 50.509999999999998 111.724 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -63.56 -35.55 80.85 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 125.604 2.621 . . . . 50.549999999999997 108.384 179.465 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -68.93 -55.07 12.12 Favored 'General case' 0 C--O 1.254 1.303 0 N-CA-C 117.122 2.267 . . . . 50.619999999999997 117.122 179.08 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -80.47 -42.47 22.52 Favored 'General case' 0 C--O 1.28 2.71 0 C-N-CA 116.447 -2.101 . . . . 50.509999999999998 111.603 -175.687 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -86.82 -50.12 6.95 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 123.096 2.68 . . . . 50.619999999999997 115.667 179.881 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 18.59 7.84 Favored Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 107.886 -2.086 . . . . 50.509999999999998 107.886 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 31.0 mm -98.62 120.63 58.62 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.794 -1.162 . . . . 50.509999999999998 112.326 179.689 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -56.99 136.9 79.49 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.202 2.601 . . . . 50.509999999999998 110.901 178.29 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 86.5 Cg_exo -57.15 -32.14 92.54 Favored 'Trans proline' 0 C--O 1.262 1.697 0 C-N-CA 120.682 0.921 . . . . 50.509999999999998 113.449 -179.336 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.11 -11.7 59.85 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 119.931 -1.731 . . . . 50.619999999999997 109.084 -177.42 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -98.78 2.92 47.35 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 110.585 178.764 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.51 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 46.3 mt-30 -102.27 118.77 37.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 124.348 2.023 . . . . 50.549999999999997 114.652 -177.588 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.539 ' HD2' ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp180 -102.17 118.5 37.02 Favored 'General case' 0 C--O 1.295 3.497 0 CA-C-O 116.732 -1.604 . . . . 50.640000000000001 107.566 172.165 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 50' ' ' LEU . 51.5 mt -109.72 119.77 40.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 50.509999999999998 112.721 -177.425 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.41 132.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 O-C-N 125.046 1.467 . . . . 50.509999999999998 113.525 -177.65 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.14 100.71 7.0 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 103.543 -2.762 . . . . 50.509999999999998 103.543 177.556 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 33.63 11.68 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.152 -2.294 . . . . 50.509999999999998 114.779 177.448 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.62 10.27 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 128.513 2.959 . . . . 50.509999999999998 113.266 -179.546 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -124.55 112.24 16.61 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 115.11 1.522 . . . . 50.509999999999998 115.11 177.713 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -58.12 113.61 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.135 2.272 . . . . 50.549999999999997 117.135 174.574 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 55.1 mt -65.15 150.05 48.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 112.936 -175.917 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 74.5 tt0 -108.04 135.09 49.99 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.544 1.153 . . . . 50.619999999999997 110.984 -177.684 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.616 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -53.02 -63.91 0.99 Allowed 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.115 1.766 . . . . 50.619999999999997 112.088 -175.806 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 -8.04 66.87 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 117.496 1.759 . . . . 50.509999999999998 117.496 -177.274 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -82.37 -173.1 4.37 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 120.037 -1.861 . . . . 50.640000000000001 107.531 176.492 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 22' ' ' THR . 38.9 p -127.59 158.2 38.14 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.549 1.315 . . . . 50.509999999999998 114.549 177.07 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.87 -39.82 69.08 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 106.456 -1.683 . . . . 50.509999999999998 106.456 177.242 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 59' ' ' TYR . 73.3 m -61.49 -43.84 98.15 Favored 'General case' 0 C--O 1.269 2.086 0 C-N-CA 117.299 -1.76 . . . . 50.509999999999998 108.829 -179.493 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.29 -4.26 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.214 1.19 . . . . 50.619999999999997 114.214 179.685 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 57' ' ' SER . 83.7 m-85 -122.94 9.7 9.42 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 116.44 2.015 . . . . 50.509999999999998 116.44 179.26 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 61.22 23.25 13.48 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 121.446 1.93 . . . . 50.549999999999997 113.53 179.944 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 61' ' ' ILE . 73.4 mt -73.93 94.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.198 -2.335 . . . . 50.509999999999998 116.274 175.836 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -87.7 159.23 18.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 126.031 2.082 . . . . 50.549999999999997 112.994 -176.81 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.461 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 79.5 tttt -54.64 154.34 5.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 123.235 1.493 . . . . 50.509999999999998 108.135 -176.958 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' OE2' ' HE2' ' A' ' 63' ' ' LYS . 42.6 mm-40 57.8 69.31 0.75 Allowed 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.476 -2.147 . . . . 50.619999999999997 106.143 179.613 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -143.08 129.82 20.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.775 -1.102 . . . . 50.509999999999998 112.761 174.823 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -72.78 130.16 39.84 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 118.121 2.637 . . . . 50.509999999999998 118.121 175.92 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.3 138.02 45.29 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.673 -2.584 . . . . 50.509999999999998 107.445 175.079 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -91.95 123.07 35.04 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 127.389 2.93 . . . . 50.509999999999998 113.659 177.848 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -105.84 103.06 12.48 Favored 'General case' 0 C--O 1.282 2.792 0 CA-C-O 117.657 -1.163 . . . . 50.509999999999998 113.918 176.511 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.5 138.9 33.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 119.538 1.063 . . . . 50.509999999999998 109.262 175.174 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.26 148.11 39.71 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 117.33 2.344 . . . . 50.509999999999998 117.33 178.479 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HD2' ' HD2' ' A' ' 42' ' ' ARG . 76.5 ttt-85 -132.41 87.36 2.42 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 113.375 -3.202 . . . . 50.640000000000001 104.574 177.22 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -79.2 167.47 20.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.814 1.946 . . . . 50.509999999999998 106.928 -179.344 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.39 63.58 1.12 Allowed 'General case' 0 C--O 1.244 0.772 0 N-CA-C 118.105 2.632 . . . . 50.640000000000001 118.105 -179.643 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.24 178.06 38.14 Favored Glycine 0 C--O 1.242 0.651 0 O-C-N 124.617 1.198 . . . . 50.509999999999998 112.85 179.403 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 115.437 179.204 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' CE ' ' HB2' ' A' ' 63' ' ' LYS . 82.0 mtp . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.993 -1.114 . . . . 50.509999999999998 107.993 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -84.43 140.22 31.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 126.976 2.673 . . . . 50.549999999999997 109.692 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.4 pt -133.64 159.58 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-O 115.982 -1.961 . . . . 50.509999999999998 107.126 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -117.16 135.69 53.58 Favored 'General case' 0 N--CA 1.512 2.639 1 O-C-N 130.48 4.863 . . . . 50.509999999999998 110.963 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 69.9 t -114.87 108.28 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 113.436 -3.173 . . . . 50.509999999999998 110.719 175.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' CD ' HG22 ' A' ' 12' ' ' THR . 35.1 mmtp -88.2 122.94 32.33 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.303 4.127 . . . . 50.509999999999998 111.031 -178.082 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.9 p -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.354 -2.091 . . . . 50.509999999999998 105.354 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -112.64 6.62 18.38 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.067 0.854 . . . . 50.509999999999998 112.102 -177.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -106.67 -27.84 10.57 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.702 -2.399 . . . . 50.509999999999998 106.563 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.2 0.65 2.11 Favored Glycine 0 C--N 1.296 -1.641 0 O-C-N 119.78 -1.825 . . . . 50.509999999999998 115.343 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -73.92 152.29 40.17 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.852 -1.547 . . . . 50.509999999999998 115.111 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.473 HG22 ' CD ' ' A' ' 6' ' ' LYS . 44.3 p -121.26 156.72 31.88 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 126.654 2.471 . . . . 50.509999999999998 108.939 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 62.7 mt -127.96 142.09 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.396 2.935 . . . . 50.509999999999998 111.49 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -111.92 134.28 53.57 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.163 -1.792 . . . . 50.509999999999998 106.163 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.566 HD23 ' HE2' ' A' ' 33' ' ' LYS . 96.0 mt -127.15 134.06 50.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.412 2.375 . . . . 50.509999999999998 117.412 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.55 96.16 7.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 128.807 3.817 . . . . 50.619999999999997 111.345 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -121.86 -175.02 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.267 0 O-C-N 127.603 3.064 . . . . 50.509999999999998 115.619 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CD ' ' OG ' ' A' ' 20' ' ' SER . 14.7 pt-20 -151.91 154.73 33.12 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.227 -2.26 . . . . 50.619999999999997 108.206 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.94 -24.51 39.61 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.575 2.184 . . . . 50.509999999999998 111.985 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.46 ' OG ' ' CD ' ' A' ' 18' ' ' GLU . 92.8 p -63.79 -30.86 71.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.142 -0.932 . . . . 50.509999999999998 111.755 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -69.62 149.63 47.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.357 -1.737 . . . . 50.619999999999997 115.373 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 55' ' ' THR . 33.0 p -93.58 169.62 10.2 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.827 -0.624 . . . . 50.509999999999998 109.549 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 42.3 mm -58.99 -25.6 30.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 O-C-N 127.189 2.806 . . . . 50.509999999999998 112.352 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -70.89 -46.41 62.64 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.047 2.24 . . . . 50.619999999999997 117.047 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -66.6 -50.34 63.37 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 124.31 1.044 . . . . 50.549999999999997 110.626 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.41 -31.39 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.932 1.395 . . . . 50.509999999999998 112.353 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 92.1 mttt -81.65 -19.97 40.63 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 105.184 -2.154 . . . . 50.509999999999998 105.184 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.33 -14.97 34.5 Favored 'General case' 0 C--O 1.278 2.58 0 N-CA-C 112.47 0.544 . . . . 50.509999999999998 112.47 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.7 mmmt -90.15 -35.2 15.53 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.338 -1.476 . . . . 50.509999999999998 107.719 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 61.0 mt -60.41 -29.4 44.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.53 -0.868 . . . . 50.509999999999998 112.135 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' ILE . 61.9 tt0 -49.94 -51.94 37.32 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 125.627 2.632 . . . . 50.549999999999997 104.767 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.9 m-20 -46.96 -41.37 16.06 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.619 -1.628 . . . . 50.619999999999997 112.33 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HE2' HD23 ' A' ' 15' ' ' LEU . 12.3 mptt -73.68 -41.77 62.19 Favored 'General case' 0 C--O 1.279 2.645 0 C-N-CA 116.464 -2.094 . . . . 50.509999999999998 114.312 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' OE2' HD11 ' A' ' 13' ' ' ILE . 30.1 mt-10 -113.98 -62.79 1.54 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 123.06 2.664 . . . . 50.619999999999997 109.956 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.82 -16.68 1.98 Allowed Glycine 0 CA--C 1.477 -2.288 0 CA-C-O 120.017 -0.324 . . . . 50.509999999999998 112.919 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 21.9 mm -58.06 128.86 82.04 Favored Pre-proline 0 C--O 1.244 0.768 0 N-CA-C 117.582 2.438 . . . . 50.509999999999998 117.582 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 77.9 Cg_exo -56.98 136.97 79.83 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.147 2.565 . . . . 50.509999999999998 110.869 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 87.7 Cg_exo -57.21 -32.09 92.54 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.861 0.927 . . . . 50.509999999999998 113.45 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.33 -26.89 67.5 Favored 'General case' 0 C--O 1.262 1.743 0 O-C-N 119.981 -1.699 . . . . 50.619999999999997 108.101 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.0 3.5 55.1 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.555 -1.341 . . . . 50.549999999999997 113.535 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -101.49 140.5 35.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 124.355 2.026 . . . . 50.549999999999997 109.8 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -134.88 148.66 50.15 Favored 'General case' 0 C--O 1.296 3.506 0 CA-C-O 116.696 -1.621 . . . . 50.640000000000001 107.468 172.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 93.0 mt -129.83 125.13 34.96 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.638 -1.245 . . . . 50.509999999999998 107.638 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.6 133.68 61.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 125.08 1.488 . . . . 50.509999999999998 112.789 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.57 110.91 5.81 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 107.086 -1.45 . . . . 50.509999999999998 107.086 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.02 30.76 4.36 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.254 -2.248 . . . . 50.509999999999998 115.498 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.93 -7.46 82.07 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 128.424 2.916 . . . . 50.509999999999998 116.734 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -80.43 119.52 23.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.047 0.924 . . . . 50.509999999999998 112.719 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -81.6 106.18 13.34 Favored 'General case' 0 C--O 1.259 1.583 0 O-C-N 123.936 0.773 . . . . 50.549999999999997 111.918 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.07 154.23 4.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 114.268 1.21 . . . . 50.509999999999998 114.268 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.5 132.35 51.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.144 2.275 . . . . 50.619999999999997 117.144 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -56.31 -5.02 0.16 Allowed 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.927 2.936 . . . . 50.619999999999997 118.927 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 9.3 22.67 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 105.382 -3.087 . . . . 50.509999999999998 105.382 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.17 156.77 16.25 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 119.961 -1.905 . . . . 50.640000000000001 109.981 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 22' ' ' THR . 41.5 p -109.56 144.4 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.187 -1.412 . . . . 50.509999999999998 107.187 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -40.96 -25.47 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.145 0.903 . . . . 50.509999999999998 109.021 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' THR . 91.0 p -74.0 -27.41 60.95 Favored 'General case' 0 C--O 1.268 2.076 0 N-CA-C 115.809 1.781 . . . . 50.509999999999998 115.809 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -65.86 -26.95 67.88 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.461 1.124 . . . . 50.619999999999997 110.413 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.86 5.95 26.92 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 117.781 -1.104 . . . . 50.509999999999998 111.333 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 41.36 29.38 0.09 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.474 1.943 . . . . 50.549999999999997 113.378 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -51.44 107.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.267 1.975 0 N-CA-C 104.064 -2.569 . . . . 50.509999999999998 104.064 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -107.0 -169.04 1.48 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 126.092 2.12 . . . . 50.549999999999997 112.791 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 36.1 ttpt -73.32 136.06 44.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.184 1.469 . . . . 50.509999999999998 114.36 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 41.3 mt-10 71.85 8.9 6.13 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 117.217 2.302 . . . . 50.619999999999997 117.217 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 t -74.77 142.3 44.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 104.636 -2.357 . . . . 50.509999999999998 104.636 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -106.41 133.81 50.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.39 -0.967 . . . . 50.509999999999998 108.39 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.54 162.17 13.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.681 -2.581 . . . . 50.509999999999998 109.154 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -116.01 121.92 43.69 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 127.406 2.941 . . . . 50.509999999999998 111.196 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.1 tp -79.83 140.41 36.83 Favored 'General case' 0 C--O 1.283 2.822 0 N-CA-C 115.5 1.667 . . . . 50.509999999999998 115.5 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.74 138.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.634 1.106 . . . . 50.509999999999998 112.603 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.5 tp -103.91 107.78 18.81 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.47 0.915 . . . . 50.509999999999998 113.47 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.5 79.85 2.0 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 113.349 -3.215 . . . . 50.640000000000001 115.252 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -58.0 148.23 26.74 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 117.843 2.534 . . . . 50.509999999999998 117.843 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 70.6 ttp85 -95.34 55.03 1.69 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 115.389 1.625 . . . . 50.640000000000001 115.389 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.22 -170.86 39.59 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.594 -3.402 . . . . 50.509999999999998 104.594 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.453 0 CA-C-O 116.337 -2.369 . . . . 50.509999999999998 111.883 179.197 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 118.86 -0.591 . . . . 50.509999999999998 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -88.0 142.49 27.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 126.954 2.659 . . . . 50.549999999999997 109.499 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.45 HD13 HG21 ' A' ' 17' ' ' VAL . 24.3 pt -141.77 160.76 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 116.036 -1.935 . . . . 50.509999999999998 107.472 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' HB2' HG22 ' A' ' 66' ' ' THR . 83.1 m-85 -113.78 132.34 55.89 Favored 'General case' 0 N--CA 1.511 2.582 1 O-C-N 130.381 4.801 . . . . 50.509999999999998 113.364 179.564 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.99 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 106.321 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG2' ' OG1' ' A' ' 12' ' ' THR . 92.5 mttt -111.88 135.51 52.4 Favored 'General case' 0 N--CA 1.503 2.207 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 117.046 -178.112 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 154.78 31.92 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 107.609 -1.256 . . . . 50.509999999999998 107.609 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.26 -12.97 23.45 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.177 0.923 . . . . 50.509999999999998 110.549 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -66.06 -22.46 66.42 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 115.705 -2.398 . . . . 50.509999999999998 113.759 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.39 10.55 35.81 Favored Glycine 0 C--N 1.297 -1.598 0 O-C-N 120.106 -1.621 . . . . 50.509999999999998 112.437 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -101.28 134.84 43.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 116.82 -1.562 . . . . 50.509999999999998 112.252 174.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.46 ' OG1' ' HG2' ' A' ' 6' ' ' LYS . 52.4 m -127.51 149.29 50.2 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.707 2.505 . . . . 50.509999999999998 115.581 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -134.07 157.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 115.266 -2.574 . . . . 50.509999999999998 106.314 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -121.38 144.41 48.67 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.248 -1.781 . . . . 50.509999999999998 113.515 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.573 HD22 ' HB3' ' A' ' 29' ' ' LYS . 77.5 mt -120.1 167.37 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.445 -2.216 . . . . 50.509999999999998 109.959 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -129.47 92.96 3.44 Favored 'General case' 0 N--CA 1.5 2.041 1 O-C-N 129.131 4.019 . . . . 50.619999999999997 106.104 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.592 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 m -105.34 173.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.779 3.174 . . . . 50.509999999999998 111.764 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 84.0 mt-10 -106.44 145.13 30.4 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.164 -2.289 . . . . 50.619999999999997 111.14 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 85.3 Cg_exo -54.9 -24.57 39.62 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.637 2.224 . . . . 50.509999999999998 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 p -88.23 -9.0 54.4 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 115.2 1.556 . . . . 50.509999999999998 115.2 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 46.2 m-20 -65.27 148.79 51.07 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 117.412 -1.715 . . . . 50.619999999999997 110.448 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -78.94 170.94 15.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.865 -0.607 . . . . 50.509999999999998 110.503 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.24 -29.33 46.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 O-C-N 127.103 2.752 . . . . 50.509999999999998 108.04 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -70.93 -15.1 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 119.915 3.302 . . . . 50.619999999999997 119.915 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 23.0 t-20 -81.82 -50.63 9.0 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.366 1.066 . . . . 50.549999999999997 110.51 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -54.7 -44.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 125.045 1.466 . . . . 50.509999999999998 108.146 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.1 mttt -54.39 -35.46 62.87 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 107.989 -1.115 . . . . 50.509999999999998 107.989 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -67.2 -49.62 63.94 Favored 'General case' 0 C--O 1.278 2.597 0 N-CA-C 109.695 -0.483 . . . . 50.509999999999998 109.695 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HB3' HD22 ' A' ' 15' ' ' LEU . 46.8 mmtm -50.89 -37.09 41.66 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 120.374 -1.454 . . . . 50.509999999999998 114.823 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.82 -42.11 28.51 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 104.617 -2.364 . . . . 50.509999999999998 104.617 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -53.6 -42.36 67.6 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 125.628 2.632 . . . . 50.549999999999997 112.14 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.9 -41.73 78.62 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 120.716 3.599 . . . . 50.619999999999997 120.716 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -106.76 -15.08 14.83 Favored 'General case' 0 C--O 1.279 2.633 0 C-N-CA 116.434 -2.106 . . . . 50.509999999999998 113.39 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.18 -11.11 11.37 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 118.616 2.821 . . . . 50.619999999999997 118.616 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 28.74 45.78 Favored Glycine 0 CA--C 1.478 -2.25 0 N-CA-C 114.94 0.736 . . . . 50.509999999999998 114.94 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 71' ' ' LEU . 71.5 mt -107.46 119.64 50.05 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 114.984 1.476 . . . . 50.509999999999998 114.984 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.6 Cg_exo -57.07 137.0 79.94 Favored 'Trans proline' 0 C--O 1.258 1.515 0 C-N-CA 123.116 2.544 . . . . 50.509999999999998 110.883 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.6 Cg_exo -57.14 -32.28 92.9 Favored 'Trans proline' 0 C--O 1.261 1.663 0 C-N-CA 120.711 0.941 . . . . 50.509999999999998 113.379 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -73.27 0.15 12.76 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.948 -1.72 . . . . 50.619999999999997 110.64 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -112.4 1.69 16.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.572 -1.33 . . . . 50.549999999999997 109.356 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.04 128.55 47.03 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.419 2.057 . . . . 50.549999999999997 111.985 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.498 ' HD2' ' HB2' ' A' ' 72' ' ' ARG . 70.3 mtp180 -112.21 127.35 55.93 Favored 'General case' 0 C--O 1.297 3.555 0 N-CA-C 105.903 -1.888 . . . . 50.640000000000001 105.903 172.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -109.65 136.13 49.49 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 102.88 -3.007 . . . . 50.509999999999998 102.88 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -132.4 121.32 45.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 O-C-N 125.223 1.577 . . . . 50.509999999999998 111.755 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.53 90.81 3.4 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 106.998 -1.482 . . . . 50.509999999999998 106.998 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.07 76.54 0.33 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.219 -2.264 . . . . 50.509999999999998 112.337 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.03 32.07 0.35 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 128.405 2.907 . . . . 50.509999999999998 113.437 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -121.85 112.63 18.58 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 102.62 -3.104 . . . . 50.509999999999998 102.62 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -70.62 123.59 22.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.887 0.742 . . . . 50.549999999999997 111.637 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 mt -78.04 139.39 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 117.756 -1.116 . . . . 50.509999999999998 113.743 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -86.58 115.25 23.93 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.95 1.406 . . . . 50.619999999999997 114.529 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -40.42 -21.16 0.01 OUTLIER 'General case' 0 C--O 1.264 1.834 0 N-CA-C 117.809 2.522 . . . . 50.619999999999997 117.809 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.96 2.74 51.85 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 118.398 2.119 . . . . 50.509999999999998 118.398 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 mmp_? -96.99 -177.77 3.98 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 120.031 -1.864 . . . . 50.640000000000001 109.983 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -108.66 174.73 5.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.062 0.945 . . . . 50.509999999999998 110.315 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.5 mt -74.8 -13.95 60.64 Favored 'General case' 0 C--O 1.201 -1.482 0 CA-C-O 118.382 -0.818 . . . . 50.509999999999998 111.156 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -85.83 -40.85 15.56 Favored 'General case' 0 C--O 1.268 2.057 0 N-CA-C 117.598 2.444 . . . . 50.509999999999998 117.598 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -47.51 -37.27 11.67 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.497 1.141 . . . . 50.619999999999997 108.843 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 9.72 9.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 117.328 2.344 . . . . 50.509999999999998 117.328 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 62' ' ' GLN . 87.2 m-20 53.97 16.08 1.02 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-N 121.526 1.966 . . . . 50.549999999999997 115.744 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.2 mm -52.1 90.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.265 1.913 0 CA-C-O 115.207 -2.33 . . . . 50.509999999999998 110.741 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 60' ' ' ASN . 77.0 mt-30 -78.21 -175.73 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 125.588 1.805 . . . . 50.549999999999997 114.506 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -70.64 141.94 51.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.622 -1.992 . . . . 50.509999999999998 105.622 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 67.6 31.17 6.25 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.437 -2.165 . . . . 50.619999999999997 112.362 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 t -77.91 135.98 37.95 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.792 -1.094 . . . . 50.509999999999998 108.596 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.487 HG22 ' HB2' ' A' ' 4' ' ' PHE . 16.9 p -93.35 142.87 26.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 118.313 -0.851 . . . . 50.509999999999998 110.594 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.6 mt -122.09 122.58 39.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.78 -2.533 . . . . 50.509999999999998 105.6 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -83.64 151.25 25.4 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 102.87 -3.011 . . . . 50.509999999999998 102.87 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -123.3 109.76 14.34 Favored 'General case' 0 C--O 1.283 2.822 0 CA-C-O 117.608 -1.187 . . . . 50.509999999999998 110.481 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.09 133.01 49.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.502 -2.036 . . . . 50.509999999999998 105.502 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 36' ' ' ILE . 35.1 mt -82.67 152.09 25.99 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 118.77 2.878 . . . . 50.509999999999998 118.77 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.498 ' HB2' ' HD2' ' A' ' 42' ' ' ARG . 36.3 ttm180 -123.76 89.77 3.15 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 113.308 -3.234 . . . . 50.640000000000001 111.62 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.59 156.19 29.26 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 125.904 2.002 . . . . 50.509999999999998 111.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -106.16 77.61 1.24 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 115.821 1.785 . . . . 50.640000000000001 115.821 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.23 124.6 2.83 Favored Glycine 0 C--O 1.242 0.643 0 CA-C-N 114.646 -1.161 . . . . 50.509999999999998 113.593 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 N-CA-C 104.406 -3.478 . . . . 50.509999999999998 104.406 179.279 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' HE2' ' A' ' 63' ' ' LYS . 18.4 mmt . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 112.576 0.584 . . . . 50.509999999999998 112.576 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -88.21 150.95 23.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.907 2.629 . . . . 50.549999999999997 106.822 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -148.42 145.7 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 104.972 -2.232 . . . . 50.509999999999998 104.972 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.66 134.98 54.65 Favored 'General case' 0 N--CA 1.511 2.597 1 O-C-N 130.409 4.818 . . . . 50.509999999999998 110.476 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -119.55 128.01 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 113.399 -3.191 . . . . 50.509999999999998 116.944 175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -94.14 119.36 32.86 Favored 'General case' 0 N--CA 1.504 2.239 1 O-C-N 129.254 4.097 . . . . 50.509999999999998 113.065 -178.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.514 HG22 HD23 ' A' ' 69' ' ' LEU . 69.0 p -95.27 177.59 5.8 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.793 -1.098 . . . . 50.509999999999998 109.48 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 8' ' ' LEU . 42.6 mt -83.79 -12.85 55.09 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.138 0.899 . . . . 50.509999999999998 110.752 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -95.09 -17.46 21.82 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.76 -2.376 . . . . 50.509999999999998 113.426 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.16 -23.04 7.38 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 119.034 2.374 . . . . 50.509999999999998 119.034 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.66 107.09 0.76 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 117.134 2.272 . . . . 50.509999999999998 117.134 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -82.07 128.41 34.08 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.595 2.434 . . . . 50.509999999999998 107.848 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.01 144.92 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 127.591 3.057 . . . . 50.509999999999998 114.268 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -113.68 123.52 50.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.264 -1.774 . . . . 50.509999999999998 112.454 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.0 mt -116.92 145.92 43.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 120.933 3.679 . . . . 50.509999999999998 120.933 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.17 114.22 28.31 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 128.413 3.571 . . . . 50.619999999999997 112.676 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.51 163.05 35.8 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 O-C-N 127.831 3.207 . . . . 50.509999999999998 117.228 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 40.3 mt-10 -99.18 151.24 37.32 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 117.604 2.446 . . . . 50.619999999999997 117.604 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.1 Cg_exo -54.9 -24.52 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.586 2.191 . . . . 50.509999999999998 111.928 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -93.12 -19.48 21.46 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 116.547 2.054 . . . . 50.509999999999998 116.547 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.58 151.23 17.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.404 -1.718 . . . . 50.619999999999997 107.183 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -87.45 167.67 13.79 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.858 -0.61 . . . . 50.509999999999998 109.445 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.8 pt -61.58 -34.93 64.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 127.193 2.808 . . . . 50.509999999999998 103.875 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -56.55 -49.41 74.89 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 114.048 1.129 . . . . 50.619999999999997 114.048 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -55.97 -32.13 63.6 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.307 1.043 . . . . 50.549999999999997 111.959 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -41.94 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.975 1.422 . . . . 50.509999999999998 111.264 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.25 -40.31 45.25 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 116.391 1.997 . . . . 50.509999999999998 116.391 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.32 83.38 Favored 'General case' 0 C--O 1.278 2.576 0 CA-C-N 117.984 0.356 . . . . 50.509999999999998 111.524 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -55.15 -55.95 25.4 Favored 'General case' 0 C--O 1.255 1.351 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -54.77 -36.1 35.64 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.47 -0.892 . . . . 50.509999999999998 113.053 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.1 -32.85 16.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 125.625 2.631 . . . . 50.549999999999997 113.307 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.72 -44.71 20.27 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 113.592 -1.64 . . . . 50.619999999999997 113.123 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -87.72 -29.52 21.02 Favored 'General case' 0 C--O 1.279 2.637 0 N-CA-C 116.89 2.182 . . . . 50.509999999999998 116.89 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -115.58 -23.13 8.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 123.07 2.668 . . . . 50.619999999999997 109.5 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.21 -34.54 4.64 Favored Glycine 0 CA--C 1.477 -2.342 0 N-CA-C 116.477 1.351 . . . . 50.509999999999998 116.477 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.6 mt -40.69 113.7 1.03 Allowed Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 115.063 1.505 . . . . 50.509999999999998 115.063 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.182 2.588 . . . . 50.509999999999998 110.888 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.6 Cg_exo -57.18 -32.22 92.83 Favored 'Trans proline' 0 C--O 1.262 1.684 0 C-N-CA 120.671 0.914 . . . . 50.509999999999998 113.444 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.41 -12.79 15.87 Favored 'General case' 0 C--O 1.262 1.741 0 O-C-N 119.921 -1.737 . . . . 50.619999999999997 112.028 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.43 -12.42 17.19 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.515 -1.366 . . . . 50.549999999999997 111.808 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -93.11 125.27 37.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.345 2.021 . . . . 50.549999999999997 115.244 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -121.15 134.7 55.23 Favored 'General case' 0 C--O 1.295 3.458 0 CA-C-O 116.691 -1.623 . . . . 50.640000000000001 108.961 172.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.7 ' HB2' HD22 ' A' ' 50' ' ' LEU . 60.3 mt -119.17 120.33 36.78 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 102.08 -3.304 . . . . 50.509999999999998 102.08 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.34 129.47 71.54 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 O-C-N 125.15 1.531 . . . . 50.509999999999998 112.727 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.97 121.81 15.48 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 117.973 2.583 . . . . 50.509999999999998 117.973 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.38 9.53 6.51 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.206 -2.27 . . . . 50.509999999999998 108.435 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.62 37.35 8.09 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.481 2.943 . . . . 50.509999999999998 109.469 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' O ' ' C ' ' A' ' 49' ' ' GLN . 36.1 ttpt -126.63 85.39 2.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.098 0.949 . . . . 50.509999999999998 112.39 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.511 ' C ' ' O ' ' A' ' 48' ' ' LYS . 51.7 tt0 -36.93 128.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.926 -1.879 . . . . 50.549999999999997 105.926 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.7 HD22 ' HB2' ' A' ' 43' ' ' LEU . 2.1 mp -60.03 120.78 10.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 117.695 -1.145 . . . . 50.509999999999998 111.417 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -88.95 131.87 34.96 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.018 1.449 . . . . 50.619999999999997 109.345 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -50.82 -47.1 60.1 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.171 1.788 . . . . 50.619999999999997 111.497 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.82 21.44 2.56 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 119.051 2.38 . . . . 50.509999999999998 119.051 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -111.26 158.2 19.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.006 -1.879 . . . . 50.640000000000001 111.509 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 p -93.88 167.02 11.89 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.105 0.962 . . . . 50.509999999999998 110.491 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.53 -28.56 60.32 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 116.618 2.081 . . . . 50.509999999999998 116.618 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -87.82 -20.87 25.48 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.362 -1.735 . . . . 50.509999999999998 112.767 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.99 -36.46 62.95 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.225 -1.768 . . . . 50.619999999999997 106.225 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.658 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 77.8 m-85 -81.7 -31.91 31.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.777 -1.106 . . . . 50.509999999999998 109.354 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.658 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 84.9 m-20 76.54 36.74 0.36 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 121.451 1.932 . . . . 50.549999999999997 114.554 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.57 108.91 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.981 0 CA-C-O 115.165 -2.35 . . . . 50.509999999999998 113.679 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -104.88 -176.31 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.898 -2.63 . . . . 50.549999999999997 103.898 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 35.4 mmtp -67.07 162.4 22.33 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 102.841 -3.022 . . . . 50.509999999999998 102.841 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 51.34 44.75 28.72 Favored 'General case' 0 C--O 1.257 1.485 0 CA-C-N 112.443 -2.162 . . . . 50.619999999999997 114.696 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 t -109.23 137.78 46.58 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.23 1.196 . . . . 50.509999999999998 114.23 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 m -118.46 117.09 28.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 114.463 1.283 . . . . 50.509999999999998 114.463 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.34 153.04 20.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 114.738 -2.553 . . . . 50.509999999999998 110.766 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -95.57 146.54 24.38 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 127.371 2.919 . . . . 50.509999999999998 113.483 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.514 HD23 HG22 ' A' ' 7' ' ' THR . 29.3 tp -107.42 101.83 11.16 Favored 'General case' 0 C--O 1.283 2.827 0 CA-C-O 117.647 -1.168 . . . . 50.509999999999998 110.412 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.51 121.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 119.602 1.092 . . . . 50.509999999999998 111.027 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.5 mt -74.33 133.62 42.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.369 2.729 . . . . 50.509999999999998 118.369 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -113.59 131.43 56.11 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 113.368 -3.206 . . . . 50.640000000000001 105.614 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.94 -178.7 3.74 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.867 1.979 . . . . 50.509999999999998 111.226 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -126.04 67.89 1.19 Allowed 'General case' 0 C--O 1.245 0.831 0 N-CA-C 104.342 -2.466 . . . . 50.640000000000001 104.342 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.28 146.13 8.82 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 114.63 -1.168 . . . . 50.509999999999998 115.838 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.831 -3.307 . . . . 50.509999999999998 104.831 179.255 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 116.342 1.978 . . . . 50.509999999999998 116.342 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -82.88 149.76 26.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 126.882 2.613 . . . . 50.549999999999997 107.781 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 15' ' ' LEU . 18.5 tt -163.46 136.5 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 115.981 -1.961 . . . . 50.509999999999998 106.277 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' THR . 42.4 m-85 -104.39 143.52 32.89 Favored 'General case' 0 N--CA 1.512 2.634 1 O-C-N 130.259 4.724 . . . . 50.509999999999998 113.453 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 70.0 t -109.65 105.52 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 107.296 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -99.77 109.72 22.13 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.347 4.154 . . . . 50.509999999999998 110.385 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 9' ' ' THR . 9.7 t -89.78 -171.51 3.2 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 115.324 1.602 . . . . 50.509999999999998 115.324 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.488 ' N ' ' OG1' ' A' ' 7' ' ' THR . 65.6 mt -90.12 6.68 41.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.756 1.021 . . . . 50.509999999999998 113.756 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.548 ' H ' HG23 ' A' ' 7' ' ' THR . 55.5 p -104.55 0.53 28.79 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 115.715 -2.394 . . . . 50.509999999999998 114.853 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.88 37.04 7.46 Favored Glycine 0 C--N 1.298 -1.558 0 N-CA-C 103.411 -3.875 . . . . 50.509999999999998 103.411 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -113.59 159.14 19.93 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 119.455 3.131 . . . . 50.509999999999998 119.455 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.2 m -135.27 123.8 23.51 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 120.337 3.458 . . . . 50.509999999999998 120.337 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 96.7 mt -108.33 136.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.521 3.013 . . . . 50.509999999999998 107.483 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 m -117.16 117.54 29.86 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 117.329 -1.749 . . . . 50.509999999999998 112.395 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.479 ' O ' HG22 ' A' ' 3' ' ' ILE . 46.0 tp -128.69 135.49 49.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 120.168 3.395 . . . . 50.509999999999998 120.168 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -79.79 139.91 37.07 Favored 'General case' 0 N--CA 1.5 2.046 1 O-C-N 129.176 4.048 . . . . 50.619999999999997 114.764 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.76 175.18 6.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 O-C-N 127.758 3.161 . . . . 50.509999999999998 114.114 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.7 mt-10 -124.81 142.65 41.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 112.197 -2.274 . . . . 50.619999999999997 108.835 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.7 Cg_exo -54.97 -24.54 39.98 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 122.549 2.166 . . . . 50.509999999999998 111.943 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -86.35 -0.16 55.3 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.655 1.724 . . . . 50.509999999999998 115.655 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -79.13 160.08 27.17 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.421 -1.712 . . . . 50.619999999999997 107.471 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 52.3 p -107.62 153.68 22.54 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 103.753 -2.684 . . . . 50.509999999999998 103.753 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.438 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 25.6 mm -56.67 -23.03 16.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 O-C-N 127.011 2.694 . . . . 50.509999999999998 116.481 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 23.7 tt0 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 103.248 -2.871 . . . . 50.619999999999997 103.248 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 22' ' ' THR . 18.2 m120 -68.11 -43.17 79.04 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 124.383 1.073 . . . . 50.549999999999997 112.305 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.17 -38.57 77.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.046 1.466 . . . . 50.509999999999998 113.289 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.3 mttt -74.57 -30.31 61.67 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 106.784 -1.561 . . . . 50.509999999999998 106.784 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.13 82.73 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 114.364 1.246 . . . . 50.509999999999998 114.364 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.11 -31.99 73.47 Favored 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.373 -1.454 . . . . 50.509999999999998 114.549 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.452 HG21 HE22 ' A' ' 41' ' ' GLN . 97.3 mt -71.73 -45.08 67.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 119.551 -0.859 . . . . 50.509999999999998 113.077 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -52.08 -34.19 42.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.431 3.123 . . . . 50.549999999999997 119.431 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.05 -60.57 3.4 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 113.59 -1.641 . . . . 50.619999999999997 113.321 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.03 -55.97 4.24 Favored 'General case' 0 C--O 1.28 2.683 0 N-CA-C 119.806 3.262 . . . . 50.509999999999998 119.806 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.43 -60.11 4.01 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.143 2.702 . . . . 50.619999999999997 104.818 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.56 8.56 3.13 Favored Glycine 0 CA--C 1.478 -2.269 0 CA-C-O 120.033 -0.315 . . . . 50.509999999999998 113.398 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 84.8 mt -89.89 125.6 60.23 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 119.843 3.275 . . . . 50.509999999999998 119.843 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.0 136.97 79.9 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.111 2.541 . . . . 50.509999999999998 110.917 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.2 Cg_exo -57.17 -32.15 92.61 Favored 'Trans proline' 0 C--O 1.261 1.629 0 O-C-N 122.919 0.958 . . . . 50.509999999999998 113.442 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -56.72 -17.17 8.01 Favored 'General case' 0 C--O 1.263 1.781 0 O-C-N 120.045 -1.659 . . . . 50.619999999999997 114.713 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -91.8 -7.48 49.41 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.471 1.656 . . . . 50.549999999999997 115.471 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.452 HE22 HG21 ' A' ' 30' ' ' ILE . 36.6 mt-30 -90.66 137.56 32.26 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 116.787 2.144 . . . . 50.549999999999997 116.787 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -125.1 120.63 31.96 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 104.591 -2.374 . . . . 50.640000000000001 104.591 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 35.2 mt -102.89 138.07 40.26 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 103.596 -2.742 . . . . 50.509999999999998 103.596 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.31 129.23 36.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 119.972 3.323 . . . . 50.509999999999998 119.972 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -137.67 117.99 13.68 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 116.377 1.992 . . . . 50.509999999999998 116.377 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.83 16.25 4.58 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 103.752 -2.684 . . . . 50.509999999999998 103.752 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.41 44.68 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 107.135 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -108.85 114.7 28.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 104.653 -2.351 . . . . 50.509999999999998 104.653 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 43' ' ' LEU . 32.2 tt0 -68.98 129.77 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.325 0.861 . . . . 50.549999999999997 113.325 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.7 mp -78.2 150.39 33.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 109.67 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 73.7 mt-10 -115.98 158.98 22.25 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.959 1.412 . . . . 50.619999999999997 112.276 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -83.37 -9.71 58.88 Favored 'General case' 0 C--O 1.263 1.795 0 N-CA-C 117.204 2.298 . . . . 50.619999999999997 117.204 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.87 -2.68 34.35 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 110.178 -1.169 . . . . 50.509999999999998 110.178 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -107.5 143.32 36.04 Favored 'General case' 0 C--O 1.248 1.023 0 O-C-N 119.944 -1.915 . . . . 50.640000000000001 107.174 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -69.98 140.95 53.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 116.718 2.118 . . . . 50.509999999999998 116.718 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 61' ' ' ILE . 38.0 tp -48.19 -26.49 1.95 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.108 0.88 . . . . 50.509999999999998 112.08 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 p -90.47 -0.53 57.7 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.307 -1.757 . . . . 50.509999999999998 114.191 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -97.56 15.01 24.59 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 50.619999999999997 107.679 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 92.7 m-85 -113.85 -6.24 13.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 110.264 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.628 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 14.5 m120 73.42 18.67 3.6 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 121.457 1.935 . . . . 50.549999999999997 107.551 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.45 HD12 HD12 ' A' ' 56' ' ' LEU . 68.5 mt -75.22 108.59 7.19 Favored 'Isoleucine or valine' 0 C--O 1.267 2.007 0 CA-C-O 115.188 -2.339 . . . . 50.509999999999998 112.792 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -110.82 -175.68 2.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.117 2.135 . . . . 50.549999999999997 112.41 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -53.67 141.87 24.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 116.569 2.063 . . . . 50.509999999999998 116.569 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 52.71 42.93 31.82 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-N 112.554 -2.112 . . . . 50.619999999999997 114.585 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 152.59 18.98 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.494 2.035 . . . . 50.509999999999998 116.494 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 40.4 m -111.83 119.65 39.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 116.502 2.038 . . . . 50.509999999999998 116.502 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.88 140.02 32.05 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.723 -2.56 . . . . 50.509999999999998 108.086 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -89.96 132.38 35.37 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.199 2.812 . . . . 50.509999999999998 113.377 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' C ' HD23 ' A' ' 69' ' ' LEU . 10.2 tt -103.95 109.22 20.9 Favored 'General case' 0 C--O 1.282 2.768 0 N-CA-C 116.271 1.952 . . . . 50.509999999999998 116.271 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -94.1 145.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 119.604 1.093 . . . . 50.509999999999998 110.916 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 48.8 tp -99.29 86.78 3.48 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 119.437 3.125 . . . . 50.509999999999998 119.437 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 71' ' ' LEU . 59.8 ttt85 -53.36 130.98 36.94 Favored 'General case' 0 C--N 1.281 -2.383 1 O-C-N 110.816 -7.427 . . . . 50.640000000000001 113.779 177.166 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.49 147.44 24.24 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 120.858 1.663 . . . . 50.509999999999998 114.259 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -81.37 56.26 2.85 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.665 -1.605 . . . . 50.640000000000001 106.665 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.43 -155.71 16.87 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.586 -1.188 . . . . 50.509999999999998 113.999 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.682 -3.367 . . . . 50.509999999999998 104.682 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.814 -0.612 . . . . 50.509999999999998 109.802 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -101.27 131.68 47.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 126.973 2.671 . . . . 50.549999999999997 109.517 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 pt -132.19 149.8 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 N-CA-C 103.595 -2.743 . . . . 50.509999999999998 103.595 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -110.34 157.93 18.98 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.398 4.811 . . . . 50.509999999999998 112.095 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.6 t -141.36 121.02 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 113.383 -3.199 . . . . 50.509999999999998 112.24 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -90.59 136.05 33.31 Favored 'General case' 0 N--CA 1.504 2.261 1 O-C-N 129.37 4.169 . . . . 50.509999999999998 105.1 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -112.44 142.46 44.95 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 105.03 -2.211 . . . . 50.509999999999998 105.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -44.84 -35.97 3.04 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 109.198 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.6 m -52.3 -32.69 38.8 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 118.631 2.826 . . . . 50.509999999999998 118.631 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.11 4.79 11.05 Favored Glycine 0 C--N 1.296 -1.671 0 O-C-N 120.142 -1.599 . . . . 50.509999999999998 111.756 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -83.89 152.82 24.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.847 -1.549 . . . . 50.509999999999998 114.26 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -125.86 112.56 16.13 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.701 2.501 . . . . 50.509999999999998 106.849 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 pt -102.3 147.69 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 118.583 2.808 . . . . 50.509999999999998 118.583 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -104.32 123.72 47.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 117.263 -1.775 . . . . 50.509999999999998 113.436 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 29' ' ' LYS . 68.5 mt -109.73 132.31 54.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 117.591 2.441 . . . . 50.509999999999998 117.591 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.28 110.26 22.41 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 129.244 4.09 . . . . 50.619999999999997 109.888 174.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 56' ' ' LEU . 35.0 m -130.82 173.59 14.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 O-C-N 127.672 3.107 . . . . 50.509999999999998 108.589 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 68.8 mm-40 -116.87 141.95 29.04 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 112.157 -2.292 . . . . 50.619999999999997 108.862 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 85.4 Cg_exo -54.88 -24.58 39.54 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.617 2.211 . . . . 50.509999999999998 111.964 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -78.23 -23.13 47.54 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.818 -1.549 . . . . 50.509999999999998 106.818 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.39 139.18 58.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 104.308 -2.478 . . . . 50.619999999999997 104.308 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 48.1 p -78.23 165.17 24.22 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.326 -0.99 . . . . 50.509999999999998 108.326 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.542 HD12 HD23 ' A' ' 50' ' ' LEU . 24.5 mm -58.81 -35.21 54.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 O-C-N 127.244 2.84 . . . . 50.509999999999998 111.816 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.7 -45.34 81.88 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.211 -2.144 . . . . 50.619999999999997 105.211 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HB2' ' O ' ' A' ' 22' ' ' THR . 85.8 m-20 -56.56 -46.03 80.94 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.365 1.066 . . . . 50.549999999999997 112.181 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 56' ' ' LEU . 40.5 t -61.58 -41.38 90.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 125.168 1.543 . . . . 50.509999999999998 113.192 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.86 -22.71 60.73 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 106.824 -1.547 . . . . 50.509999999999998 106.824 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.35 -61.41 1.85 Allowed 'General case' 0 C--O 1.278 2.561 0 N-CA-C 105.049 -2.204 . . . . 50.509999999999998 105.049 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.677 ' CG ' HD22 ' A' ' 15' ' ' LEU . 17.0 tppt? -42.5 -41.6 3.03 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 115.679 1.733 . . . . 50.509999999999998 115.679 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.512 HG21 HD11 ' A' ' 69' ' ' LEU . 73.4 mt -68.19 -23.86 29.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 C-N-CA 119.493 -0.883 . . . . 50.509999999999998 108.68 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -82.25 -55.45 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 125.57 2.605 . . . . 50.549999999999997 105.565 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -35.32 -51.37 0.58 Allowed 'General case' 0 C--O 1.252 1.228 0 N-CA-C 118.513 2.782 . . . . 50.619999999999997 118.513 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.13 -59.99 1.62 Allowed 'General case' 0 C--O 1.28 2.677 0 C-N-CA 116.459 -2.096 . . . . 50.509999999999998 108.82 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -57.99 -43.76 86.75 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 123.158 2.708 . . . . 50.619999999999997 116.743 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.16 23.35 7.73 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 108.763 -1.735 . . . . 50.509999999999998 108.763 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.3 mt -100.58 117.31 63.06 Favored Pre-proline 0 C--O 1.243 0.73 0 C-N-CA 118.79 -1.164 . . . . 50.509999999999998 108.501 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.0 Cg_exo -56.93 136.93 79.52 Favored 'Trans proline' 0 C--O 1.261 1.634 0 C-N-CA 123.185 2.59 . . . . 50.509999999999998 110.916 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.0 Cg_exo -57.19 -32.15 92.66 Favored 'Trans proline' 0 C--O 1.262 1.691 0 C-N-CA 120.682 0.922 . . . . 50.509999999999998 113.429 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -62.56 -15.21 49.82 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.948 -1.72 . . . . 50.619999999999997 109.985 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -102.92 16.05 27.67 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.532 -1.355 . . . . 50.549999999999997 112.104 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -110.85 114.08 27.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 117.295 2.332 . . . . 50.549999999999997 117.295 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -111.39 108.49 18.09 Favored 'General case' 0 C--O 1.296 3.523 0 N-CA-C 105.502 -2.036 . . . . 50.640000000000001 105.502 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mt -101.99 132.76 47.63 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.501 1.046 . . . . 50.509999999999998 110.488 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.63 136.77 50.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 O-C-N 125.227 1.58 . . . . 50.509999999999998 115.167 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -133.75 112.06 11.06 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.543 -1.208 . . . . 50.509999999999998 110.483 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.45 49.7 6.2 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.268 -2.242 . . . . 50.509999999999998 113.311 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.47 1.71 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 120.894 3.118 . . . . 50.509999999999998 120.894 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -71.7 166.19 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 116.334 1.975 . . . . 50.509999999999998 116.334 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -102.26 140.86 35.98 Favored 'General case' 0 C--O 1.259 1.592 0 O-C-N 124.008 0.818 . . . . 50.549999999999997 112.008 174.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.542 HD23 HD12 ' A' ' 23' ' ' ILE . 2.1 mp -78.14 143.17 37.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.285 -1.746 . . . . 50.509999999999998 106.285 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -120.21 135.15 55.08 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.883 1.364 . . . . 50.619999999999997 109.464 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.56 -33.41 1.14 Allowed 'General case' 0 C--O 1.262 1.748 0 C-N-CA 126.165 1.786 . . . . 50.619999999999997 114.951 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.73 63.5 Favored Glycine 0 C--O 1.254 1.345 0 C-N-CA 124.339 0.971 . . . . 50.509999999999998 113.5 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -111.73 155.12 23.99 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 101.889 -3.374 . . . . 50.640000000000001 101.889 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -99.72 174.12 6.38 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.048 0.939 . . . . 50.509999999999998 111.483 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.561 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -67.54 -38.54 84.33 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 106.349 -1.723 . . . . 50.509999999999998 106.349 177.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -67.94 -22.61 65.04 Favored 'General case' 0 C--O 1.268 2.029 0 N-CA-C 117.75 2.5 . . . . 50.509999999999998 117.75 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -64.45 -40.17 95.22 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.664 2.098 . . . . 50.619999999999997 116.664 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -83.26 5.02 24.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 115.986 1.847 . . . . 50.509999999999998 115.986 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 59.08 38.44 23.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.493 1.951 . . . . 50.549999999999997 107.054 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -73.48 117.79 17.81 Favored 'Isoleucine or valine' 0 C--O 1.267 2.012 0 CA-C-O 115.223 -2.322 . . . . 50.509999999999998 108.388 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -94.15 -175.82 3.8 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.707 2.114 . . . . 50.549999999999997 116.707 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.03 142.72 49.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 123.144 1.449 . . . . 50.509999999999998 107.314 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 46.4 26.19 0.46 Allowed 'General case' 0 C--O 1.257 1.496 0 N-CA-C 117.592 2.441 . . . . 50.619999999999997 117.592 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -72.53 153.18 41.45 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.512 -1.662 . . . . 50.509999999999998 106.512 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.43 ' O ' HD23 ' A' ' 67' ' ' LEU . 40.6 m -108.16 146.09 33.22 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.225 -0.893 . . . . 50.509999999999998 111.084 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 66' ' ' THR . 26.8 mt -116.96 156.78 26.86 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 114.688 -2.577 . . . . 50.509999999999998 109.959 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -93.61 141.66 28.22 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 127.246 2.841 . . . . 50.509999999999998 106.202 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.512 HD11 HG21 ' A' ' 30' ' ' ILE . 5.3 tt -119.79 109.88 16.12 Favored 'General case' 0 C--O 1.282 2.8 0 N-CA-C 106.356 -1.72 . . . . 50.509999999999998 106.356 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -98.35 145.1 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.391 -2.078 . . . . 50.509999999999998 105.391 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.99 132.5 43.5 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.964 -0.754 . . . . 50.509999999999998 108.964 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -97.44 126.18 42.54 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-O 113.322 -3.228 . . . . 50.640000000000001 107.33 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.89 152.09 23.81 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.901 2.001 . . . . 50.509999999999998 111.862 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -83.15 55.42 3.12 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 113.726 -1.579 . . . . 50.640000000000001 108.051 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.15 156.33 18.08 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 109.56 -1.416 . . . . 50.509999999999998 109.56 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 1 N-CA-C 102.519 -4.233 . . . . 50.509999999999998 102.519 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 107.894 -1.151 . . . . 50.509999999999998 107.894 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -101.03 133.44 45.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.911 2.632 . . . . 50.549999999999997 110.278 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.35 159.89 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 117.083 -3.51 . . . . 50.509999999999998 107.703 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -114.67 137.31 52.06 Favored 'General case' 0 N--CA 1.512 2.648 1 O-C-N 130.429 4.831 . . . . 50.509999999999998 107.911 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 87.6 t -110.54 121.34 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 113.431 -3.176 . . . . 50.509999999999998 104.019 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -107.08 131.81 53.68 Favored 'General case' 0 N--CA 1.503 2.195 1 O-C-N 129.295 4.122 . . . . 50.509999999999998 113.336 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -91.38 -177.33 4.81 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.87 2.544 . . . . 50.509999999999998 117.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.26 -5.59 23.93 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.164 0.915 . . . . 50.509999999999998 109.792 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.7 p -114.69 9.01 16.36 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.726 2.862 . . . . 50.509999999999998 118.726 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.32 62.29 Favored Glycine 0 C--N 1.298 -1.565 0 O-C-N 120.072 -1.642 . . . . 50.509999999999998 115.164 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -65.23 140.22 58.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 116.888 -1.53 . . . . 50.509999999999998 113.033 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -131.53 164.46 25.76 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 126.613 2.446 . . . . 50.509999999999998 108.573 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.35 170.64 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 127.551 3.032 . . . . 50.509999999999998 110.215 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -111.41 128.33 55.95 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.266 -1.773 . . . . 50.509999999999998 110.41 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -126.53 135.71 51.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 115.488 -2.196 . . . . 50.509999999999998 116.567 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.27 100.41 7.16 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 128.315 3.509 . . . . 50.619999999999997 112.505 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -103.18 172.99 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.209 0 O-C-N 127.762 3.164 . . . . 50.509999999999998 116.324 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.65 153.45 43.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 112.157 -2.292 . . . . 50.619999999999997 112.521 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.89 -24.57 39.5 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.603 2.202 . . . . 50.509999999999998 111.909 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 m -82.92 -26.52 31.38 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 114.954 1.465 . . . . 50.509999999999998 114.954 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -53.34 138.95 31.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 117.398 -1.721 . . . . 50.619999999999997 114.311 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -95.1 172.46 8.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 102.156 -3.276 . . . . 50.509999999999998 102.156 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 54' ' ' ARG . 23.2 mm -53.89 -45.49 63.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 O-C-N 127.095 2.747 . . . . 50.509999999999998 110.439 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -54.11 -46.83 72.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.723 1.379 . . . . 50.619999999999997 114.723 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -57.54 -39.64 77.08 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.265 1.026 . . . . 50.549999999999997 111.757 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 -50.11 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 125.045 1.466 . . . . 50.509999999999998 111.73 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HE3' ' CG2' ' A' ' 23' ' ' ILE . 94.5 mttt -56.87 -29.93 63.38 Favored 'General case' 0 C--O 1.257 1.485 0 N-CA-C 104.583 -2.377 . . . . 50.509999999999998 104.583 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.06 -27.61 48.69 Favored 'General case' 0 C--O 1.278 2.599 0 CA-C-N 118.031 0.378 . . . . 50.509999999999998 111.567 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -71.76 -36.32 70.36 Favored 'General case' 0 C--O 1.255 1.342 0 N-CA-C 106.606 -1.627 . . . . 50.509999999999998 106.606 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.43 -34.55 65.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 106.863 -1.532 . . . . 50.509999999999998 106.863 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -51.49 -59.51 4.17 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.567 2.603 . . . . 50.549999999999997 112.225 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -51.76 -40.83 60.98 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 115.817 1.784 . . . . 50.619999999999997 115.817 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -76.65 -32.5 58.01 Favored 'General case' 0 C--O 1.279 2.647 0 C-N-CA 116.464 -2.095 . . . . 50.509999999999998 113.853 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -119.33 -39.47 2.89 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.018 2.644 . . . . 50.619999999999997 115.061 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.32 8.77 8.32 Favored Glycine 0 CA--C 1.478 -2.271 0 CA-C-O 119.947 -0.363 . . . . 50.509999999999998 112.46 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.491 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 93.5 mt -84.62 128.21 62.24 Favored Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 116.76 2.134 . . . . 50.509999999999998 116.76 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.94 136.99 79.85 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.116 2.544 . . . . 50.509999999999998 110.92 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.7 Cg_exo -57.2 -32.13 92.64 Favored 'Trans proline' 0 C--O 1.261 1.649 0 O-C-N 122.91 0.952 . . . . 50.509999999999998 113.405 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -75.29 -15.78 60.48 Favored 'General case' 0 C--O 1.262 1.745 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 112.375 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -97.34 9.0 43.46 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.568 -1.332 . . . . 50.549999999999997 110.692 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.97 132.98 53.57 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 103.437 -2.801 . . . . 50.549999999999997 103.437 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -119.48 108.52 14.63 Favored 'General case' 0 C--O 1.297 3.562 0 N-CA-C 105.462 -2.051 . . . . 50.640000000000001 105.462 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.78 121.97 44.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.49 1.041 . . . . 50.509999999999998 113.414 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 120.456 3.502 . . . . 50.509999999999998 120.456 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB3' HD21 ' A' ' 50' ' ' LEU . 17.8 t80 -110.18 130.17 55.59 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 114.811 1.411 . . . . 50.509999999999998 114.811 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.21 32.11 15.39 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.192 -2.276 . . . . 50.509999999999998 111.994 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.67 2.7 85.97 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 128.4 2.905 . . . . 50.509999999999998 113.269 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -94.51 115.77 27.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 116.32 1.97 . . . . 50.509999999999998 116.32 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 16.3 pt20 -50.53 120.24 4.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.94 0.775 . . . . 50.549999999999997 111.744 174.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 45' ' ' PHE . 56.1 mt -83.51 127.55 33.81 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.7 -1.143 . . . . 50.509999999999998 111.984 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 88.7 tt0 -77.0 145.23 38.17 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 119.173 3.027 . . . . 50.619999999999997 119.173 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -38.6 -48.08 1.4 Allowed 'General case' 0 C--O 1.264 1.833 0 N-CA-C 118.526 2.788 . . . . 50.619999999999997 118.526 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 23.01 32.27 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 116.384 1.314 . . . . 50.509999999999998 116.384 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 23' ' ' ILE . 37.1 mmt180 -93.34 155.53 17.34 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 119.892 -1.946 . . . . 50.640000000000001 111.151 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -108.53 176.93 4.94 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.979 0.912 . . . . 50.509999999999998 109.466 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.1 -32.69 70.04 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 119.177 3.028 . . . . 50.509999999999998 119.177 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -81.11 -23.34 38.45 Favored 'General case' 0 C--O 1.267 2.024 0 C-N-CA 117.325 -1.75 . . . . 50.509999999999998 112.258 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -53.54 -30.9 44.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.918 -2.253 . . . . 50.619999999999997 104.918 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.25 6.92 19.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 116.468 2.025 . . . . 50.509999999999998 116.468 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.37 32.49 20.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 111.036 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.438 HG12 ' CD2' ' A' ' 45' ' ' PHE . 93.2 mt -73.53 104.86 2.59 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.188 -2.339 . . . . 50.509999999999998 109.353 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -97.23 -165.86 1.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 126.137 2.148 . . . . 50.549999999999997 115.028 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 79.4 tttt -70.16 142.76 52.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.159 1.457 . . . . 50.509999999999998 110.688 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 23.1 mt-10 58.73 36.29 24.79 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.471 -2.15 . . . . 50.619999999999997 110.721 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -78.02 152.5 33.01 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.802 -1.09 . . . . 50.509999999999998 110.915 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.443 ' O ' HD23 ' A' ' 67' ' ' LEU . 60.4 p -103.64 140.13 37.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 118.216 -0.897 . . . . 50.509999999999998 110.182 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 59.5 mt -123.95 134.82 53.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 101.65 -3.463 . . . . 50.509999999999998 101.65 175.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -95.45 136.93 35.2 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 127.375 2.922 . . . . 50.509999999999998 108.264 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 tp -105.56 136.02 45.89 Favored 'General case' 0 C--O 1.282 2.802 0 CA-C-O 117.641 -1.171 . . . . 50.509999999999998 113.203 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -116.02 126.06 73.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 105.847 -1.909 . . . . 50.509999999999998 105.847 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -79.04 105.55 10.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.782 2.512 . . . . 50.509999999999998 117.782 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -92.96 102.21 14.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.279 -3.248 . . . . 50.640000000000001 114.666 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.64 177.58 7.01 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 125.715 1.884 . . . . 50.509999999999998 110.047 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -100.7 97.65 8.28 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 115.972 1.842 . . . . 50.640000000000001 115.972 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.46 158.67 6.18 Favored Glycine 0 C--O 1.243 0.668 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.562 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 1 N-CA-C 102.073 -4.411 . . . . 50.509999999999998 102.073 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 106.871 -1.529 . . . . 50.509999999999998 106.871 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -117.73 119.43 34.92 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.923 2.64 . . . . 50.549999999999997 104.846 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 tt -121.73 149.4 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 115.952 -1.975 . . . . 50.509999999999998 110.13 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.84 123.88 50.88 Favored 'General case' 0 N--CA 1.511 2.599 1 O-C-N 130.372 4.795 . . . . 50.509999999999998 114.524 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.34 104.86 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.42 -3.181 . . . . 50.509999999999998 109.571 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -85.02 121.2 27.45 Favored 'General case' 0 N--CA 1.504 2.237 1 O-C-N 129.394 4.184 . . . . 50.509999999999998 109.412 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 69' ' ' LEU . 69.7 p -85.95 -177.05 6.22 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 116.322 1.971 . . . . 50.509999999999998 116.322 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 70' ' ' VAL . 67.5 mt -82.01 -6.08 58.86 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.788 1.773 . . . . 50.509999999999998 115.788 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -90.07 -8.04 52.41 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 115.715 -2.394 . . . . 50.509999999999998 106.592 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 15.79 37.73 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 107.727 -2.149 . . . . 50.509999999999998 107.727 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.52 111.02 21.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 116.549 2.055 . . . . 50.509999999999998 116.549 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.9 m -87.37 125.44 34.26 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 126.65 2.469 . . . . 50.509999999999998 113.203 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -111.9 174.08 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 127.53 3.019 . . . . 50.509999999999998 113.725 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 m -124.37 140.97 52.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.011 -2.218 . . . . 50.509999999999998 105.011 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.7 mt -130.66 141.7 50.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 115.487 -2.197 . . . . 50.509999999999998 108.05 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.87 100.25 9.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 129.009 3.943 . . . . 50.619999999999997 109.281 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -100.27 171.12 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.253 0 O-C-N 127.796 3.185 . . . . 50.509999999999998 107.938 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -124.28 160.51 52.32 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 112.24 -2.254 . . . . 50.619999999999997 116.147 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.01 -24.45 39.92 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 122.586 2.191 . . . . 50.509999999999998 111.966 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -99.82 -28.82 12.95 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 116.031 1.863 . . . . 50.509999999999998 116.031 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -38.82 136.88 0.7 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.331 -1.748 . . . . 50.619999999999997 114.825 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' ASN . 70.7 p -88.7 138.17 31.66 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 103.109 -2.922 . . . . 50.509999999999998 103.109 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 52' ' ' ASP . 7.4 tp -47.52 -19.19 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.729 0 O-C-N 127.183 2.802 . . . . 50.509999999999998 114.02 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.57 -44.31 62.25 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 102.991 -2.966 . . . . 50.619999999999997 102.991 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' THR . 9.3 t-20 -70.78 -17.28 62.79 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 114.957 1.465 . . . . 50.549999999999997 114.957 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.12 -45.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.999 -1.482 . . . . 50.509999999999998 106.999 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 97.2 mttt -64.26 -42.87 96.28 Favored 'General case' 0 C--O 1.256 1.433 0 N-CA-C 108.04 -1.096 . . . . 50.509999999999998 108.04 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -59.14 -25.19 63.66 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 112.511 0.559 . . . . 50.509999999999998 112.511 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 58.2 mttm -64.75 -30.78 71.8 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 106.327 -1.731 . . . . 50.509999999999998 106.327 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.653 ' O ' HG22 ' A' ' 30' ' ' ILE . 95.7 mt -82.66 2.86 2.93 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 N-CA-C 105.535 -2.024 . . . . 50.509999999999998 105.535 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 50.7 tt0 -87.12 -57.43 2.97 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.592 2.615 . . . . 50.549999999999997 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -69.05 -36.23 77.45 Favored 'General case' 0 C--O 1.253 1.264 0 CA-C-N 113.616 -1.629 . . . . 50.619999999999997 113.278 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.2 -32.71 24.41 Favored 'General case' 0 C--O 1.279 2.623 0 C-N-CA 116.427 -2.109 . . . . 50.509999999999998 112.667 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -108.99 -17.04 14.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 119.315 3.08 . . . . 50.619999999999997 119.315 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.82 37.54 10.23 Favored Glycine 0 CA--C 1.479 -2.199 0 N-CA-C 107.607 -2.197 . . . . 50.509999999999998 107.607 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.4 117.74 30.21 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 106.939 -1.504 . . . . 50.509999999999998 106.939 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.97 136.89 79.36 Favored 'Trans proline' 0 C--O 1.259 1.562 0 C-N-CA 123.185 2.59 . . . . 50.509999999999998 110.924 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -57.11 -32.15 92.48 Favored 'Trans proline' 0 C--O 1.261 1.667 0 O-C-N 122.948 0.973 . . . . 50.509999999999998 113.471 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.96 -2.02 8.8 Favored 'General case' 0 C--O 1.262 1.731 0 O-C-N 119.976 -1.703 . . . . 50.619999999999997 111.592 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -114.77 15.58 17.48 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.617 -1.302 . . . . 50.549999999999997 114.13 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -115.76 122.26 44.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.366 2.031 . . . . 50.549999999999997 111.203 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -115.83 121.56 42.77 Favored 'General case' 0 C--O 1.296 3.507 0 CA-C-O 116.657 -1.639 . . . . 50.640000000000001 111.265 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 76.6 mt -104.59 139.93 38.74 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 119.397 0.999 . . . . 50.509999999999998 108.897 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.36 134.13 64.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 O-C-N 125.129 1.518 . . . . 50.509999999999998 108.377 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 50.5 t80 -160.17 113.15 2.1 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.561 -1.199 . . . . 50.509999999999998 110.926 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 78.39 28.62 0.46 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.259 -2.246 . . . . 50.509999999999998 116.087 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.14 -8.95 35.36 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 117.04 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -101.48 138.33 38.63 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 114.211 1.189 . . . . 50.509999999999998 114.211 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.06 121.01 15.23 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.994 0.809 . . . . 50.549999999999997 110.234 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.644 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 11.1 mp -78.58 150.26 32.8 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.096 -2.187 . . . . 50.509999999999998 105.096 -175.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -110.19 143.72 39.89 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.939 1.4 . . . . 50.619999999999997 113.769 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' CG2' ' A' ' 23' ' ' ILE . 34.9 m-20 -38.33 -46.22 1.08 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 120.332 3.456 . . . . 50.619999999999997 120.332 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.71 -3.68 73.76 Favored Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 121.177 3.231 . . . . 50.509999999999998 121.177 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -83.72 159.13 21.55 Favored 'General case' 0 C--O 1.249 1.046 0 O-C-N 117.464 -3.374 . . . . 50.640000000000001 115.453 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.3 p -99.99 172.18 7.37 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.018 0.927 . . . . 50.509999999999998 109.143 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -70.54 -23.78 62.68 Favored 'General case' 0 C--O 1.201 -1.46 0 O-C-N 124.164 0.915 . . . . 50.509999999999998 109.268 177.197 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.8 p -77.52 -30.44 52.88 Favored 'General case' 0 C--O 1.269 2.102 0 C-N-CA 117.338 -1.745 . . . . 50.509999999999998 111.28 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.17 -42.87 70.13 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.423 1.106 . . . . 50.619999999999997 111.21 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.644 ' CZ ' ' HG ' ' A' ' 50' ' ' LEU . 92.9 m-85 -93.48 17.75 11.0 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.773 -1.108 . . . . 50.509999999999998 113.765 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.68 40.34 31.83 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 121.516 1.962 . . . . 50.549999999999997 116.273 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.57 112.95 2.45 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-O 115.183 -2.341 . . . . 50.509999999999998 116.634 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -118.16 174.24 6.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 126.141 2.15 . . . . 50.549999999999997 112.497 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 79.4 tttt -57.61 138.6 55.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 123.193 1.473 . . . . 50.509999999999998 111.378 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.63 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 29.5 mt-10 65.31 43.27 3.58 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.458 -2.155 . . . . 50.619999999999997 115.755 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -82.91 137.9 34.06 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.664 -1.606 . . . . 50.509999999999998 106.664 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -113.59 123.22 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.253 -1.017 . . . . 50.509999999999998 108.253 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -117.84 153.52 33.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.188 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -109.35 133.07 53.51 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 127.451 2.97 . . . . 50.509999999999998 103.358 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.413 HD23 HG22 ' A' ' 7' ' ' THR . 44.4 tp -101.52 107.14 18.34 Favored 'General case' 0 C--O 1.282 2.806 0 N-CA-C 118.914 2.931 . . . . 50.509999999999998 118.914 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 8' ' ' LEU . 61.9 t -92.03 117.16 34.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 119.564 1.075 . . . . 50.509999999999998 112.995 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.99 159.81 33.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.146 0.498 . . . . 50.509999999999998 110.435 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -119.52 109.87 16.22 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 113.298 -3.239 . . . . 50.640000000000001 103.744 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 2.0 mp -86.08 140.82 29.9 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 125.826 1.953 . . . . 50.509999999999998 116.206 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -68.85 122.31 18.34 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.01 -1.848 . . . . 50.640000000000001 106.01 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.01 -176.82 52.0 Favored Glycine 0 C--O 1.243 0.695 0 CA-C-N 114.63 -1.168 . . . . 50.509999999999998 115.431 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.445 0 N-CA-C 119.479 2.552 . . . . 50.509999999999998 119.479 179.25 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.509999999999998 109.784 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.549999999999997 110.888 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.509999999999998 116.515 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 113.74 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.509999999999998 108.059 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 111.299 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 113.264 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.509999999999998 109.711 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.509999999999998 118.139 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.509999999999998 115.485 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 112.444 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.509999999999998 104.287 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.509999999999998 112.3 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.509999999999998 121.099 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.619999999999997 110.491 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.509999999999998 108.724 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.619999999999997 111.398 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.509999999999998 111.977 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.509999999999998 114.356 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.619999999999997 114.483 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.509999999999998 107.854 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.509999999999998 119.713 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.619999999999997 107.589 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.549999999999997 116.179 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.509999999999998 107.144 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.509999999999998 106.178 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.509999999999998 113.884 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.509999999999998 110.545 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.427 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.509999999999998 115.565 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 108.505 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.619999999999997 115.994 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.509999999999998 109.748 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.619999999999997 110.609 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.509999999999998 106.674 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.509999999999998 113.426 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.509999999999998 110.966 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.509999999999998 113.447 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.619999999999997 115.85 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.549999999999997 110.579 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.549999999999997 112.07 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.640000000000001 108.703 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.509999999999998 118.456 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.509999999999998 111.752 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 61' ' ' ILE . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.509999999999998 118.653 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.509999999999998 114.688 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.509999999999998 116.218 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.509999999999998 102.92 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.549999999999997 109.69 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 113.209 -175.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.619999999999997 106.192 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.619999999999997 118.695 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.509999999999998 114.117 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.640000000000001 110.918 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.509999999999998 113.601 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.509999999999998 119.947 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.509999999999998 115.529 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.619999999999997 114.759 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.509999999999998 110.366 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.549999999999997 113.715 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 45' ' ' PHE . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.509999999999998 106.035 175.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.549999999999997 104.072 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.509999999999998 118.355 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.619999999999997 118.736 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.509999999999998 106.228 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.509999999999998 112.755 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.509999999999998 109.784 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.509999999999998 108.847 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.509999999999998 104.275 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.509999999999998 102.101 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.509999999999998 111.016 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.640000000000001 109.31 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.509999999999998 112.756 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.640000000000001 102.16 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.509999999999998 109.351 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.509999999999998 108.526 179.194 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.509999999999998 109.784 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.549999999999997 110.888 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.509999999999998 116.515 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 113.74 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.509999999999998 108.059 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 111.299 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 113.264 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.509999999999998 109.711 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.509999999999998 118.139 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.509999999999998 115.485 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 112.444 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.509999999999998 104.287 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.509999999999998 112.3 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.509999999999998 121.099 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.619999999999997 110.491 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.509999999999998 108.724 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.619999999999997 111.398 174.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.509999999999998 111.977 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.509999999999998 114.356 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.619999999999997 114.483 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.509999999999998 107.854 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.509999999999998 119.713 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.619999999999997 107.589 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.549999999999997 116.179 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.509999999999998 107.144 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.509999999999998 106.178 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.509999999999998 113.884 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.509999999999998 110.545 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.427 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.509999999999998 115.565 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 108.505 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.619999999999997 115.994 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.509999999999998 109.748 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.619999999999997 110.609 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.509999999999998 106.674 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.509999999999998 113.426 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.509999999999998 110.966 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.509999999999998 113.447 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.619999999999997 115.85 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.549999999999997 110.579 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.549999999999997 112.07 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.640000000000001 108.703 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.509999999999998 118.456 -177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.509999999999998 111.752 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 61' ' ' ILE . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.509999999999998 118.653 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.509999999999998 114.688 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.509999999999998 116.218 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.509999999999998 102.92 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.549999999999997 109.69 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 113.209 -175.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.619999999999997 106.192 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.619999999999997 118.695 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.509999999999998 114.117 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.640000000000001 110.918 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.509999999999998 113.601 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.509999999999998 119.947 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.509999999999998 115.529 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.619999999999997 114.759 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.509999999999998 110.366 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.549999999999997 113.715 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 45' ' ' PHE . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.509999999999998 106.035 175.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.549999999999997 104.072 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.509999999999998 118.355 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.619999999999997 118.736 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.509999999999998 106.228 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.509999999999998 112.755 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.509999999999998 109.784 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.509999999999998 108.847 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.509999999999998 104.275 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.509999999999998 102.101 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.509999999999998 111.016 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.640000000000001 109.31 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.509999999999998 112.756 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.640000000000001 102.16 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.509999999999998 109.351 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.509999999999998 108.526 179.194 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.509999999999998 106.676 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.549999999999997 106.021 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.509999999999998 104.709 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' HB2' HG22 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.509999999999998 113.954 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.509999999999998 102.923 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.509999999999998 112.316 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.509999999999998 106.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.509999999999998 115.548 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.509999999999998 108.113 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.509999999999998 106.107 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.509999999999998 120.071 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.509999999999998 110.493 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.509999999999998 109.559 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.509999999999998 114.838 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.509999999999998 106.275 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.619999999999997 113.422 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.509999999999998 109.333 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.619999999999997 106.827 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.509999999999998 111.928 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.509999999999998 121.083 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.619999999999997 111.205 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.509999999999998 110.198 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.509999999999998 109.42 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.619999999999997 111.997 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.549999999999997 112.41 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.509999999999998 109.295 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.509999999999998 112.034 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.509999999999998 108.289 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.509999999999998 110.474 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.509999999999998 112.329 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.549999999999997 110.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 107.396 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.509999999999998 117.751 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.619999999999997 110.115 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.509999999999998 107.221 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.509999999999998 111.423 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.509999999999998 110.839 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.509999999999998 113.43 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.619999999999997 110.786 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.549999999999997 113.905 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.599 ' HG2' HD11 ' A' ' 69' ' ' LEU . 44.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.549999999999997 108.396 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.640000000000001 106.438 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.509999999999998 111.107 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.509999999999998 108.499 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.509999999999998 110.923 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.509999999999998 110.976 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 110.394 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.509999999999998 113.046 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.549999999999997 105.007 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.509999999999998 110.654 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.619999999999997 113.026 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.619999999999997 118.034 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.509999999999998 115.926 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.640000000000001 104.585 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.509999999999998 116.28 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.509999999999998 114.766 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.509999999999998 108.201 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.619999999999997 110.796 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 109.666 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.549999999999997 108.723 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.509999999999998 106.728 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.549999999999997 120.811 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.509999999999998 108.884 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.619999999999997 119.75 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.509999999999998 111.035 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.509999999999998 110.83 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.516 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.509999999999998 114.067 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 41' ' ' GLN . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.509999999999998 113.384 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.509999999999998 112.182 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.509999999999998 107.317 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.640000000000001 106.699 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.509999999999998 116.896 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.640000000000001 110.974 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.509999999999998 113.009 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 117.514 179.235 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.509999999999998 106.676 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.549999999999997 106.021 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.509999999999998 104.709 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' HB2' HG22 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.509999999999998 113.954 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.509999999999998 102.923 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.509999999999998 112.316 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.509999999999998 106.004 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.509999999999998 115.548 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.509999999999998 108.113 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.509999999999998 106.107 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.509999999999998 120.071 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.509999999999998 110.493 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.509999999999998 109.559 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.509999999999998 114.838 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.509999999999998 106.275 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.619999999999997 113.422 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.509999999999998 109.333 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.619999999999997 106.827 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.509999999999998 111.928 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.509999999999998 121.083 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.619999999999997 111.205 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.509999999999998 110.198 175.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.509999999999998 109.42 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.619999999999997 111.997 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.549999999999997 112.41 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.509999999999998 109.295 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.509999999999998 112.034 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.509999999999998 108.289 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.509999999999998 110.474 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.509999999999998 112.329 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.549999999999997 110.082 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 107.396 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.509999999999998 117.751 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.619999999999997 110.115 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.509999999999998 107.221 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.509999999999998 111.423 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.509999999999998 110.839 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.509999999999998 113.43 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.619999999999997 110.786 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.549999999999997 113.905 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.599 ' HG2' HD11 ' A' ' 69' ' ' LEU . 44.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.549999999999997 108.396 -177.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.640000000000001 106.438 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.509999999999998 111.107 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.509999999999998 108.499 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.509999999999998 110.923 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.509999999999998 110.976 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 110.394 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.509999999999998 113.046 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.549999999999997 105.007 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.509999999999998 110.654 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.619999999999997 113.026 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.619999999999997 118.034 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.509999999999998 115.926 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.640000000000001 104.585 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.509999999999998 116.28 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.509999999999998 114.766 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.509999999999998 108.201 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.619999999999997 110.796 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 109.666 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.549999999999997 108.723 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.509999999999998 106.728 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.549999999999997 120.811 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.509999999999998 108.884 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.619999999999997 119.75 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.509999999999998 111.035 174.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.509999999999998 110.83 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.516 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.509999999999998 114.067 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 41' ' ' GLN . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.509999999999998 113.384 176.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.509999999999998 112.182 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.509999999999998 107.317 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.640000000000001 106.699 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.509999999999998 116.896 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.640000000000001 110.974 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.509999999999998 113.009 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 117.514 179.235 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.868 0 N-CA-C 104.835 -2.283 . . . . 50.509999999999998 104.835 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -88.49 154.45 20.35 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 102.339 -3.208 . . . . 50.549999999999997 102.339 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 3' ' ' ILE . 19.7 tt -150.21 128.91 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 115.963 -1.97 . . . . 50.509999999999998 108.004 173.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 66' ' ' THR . 82.5 m-85 -92.92 141.96 27.84 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.328 4.767 . . . . 50.509999999999998 112.03 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.79 99.23 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 113.439 -3.172 . . . . 50.509999999999998 111.052 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -68.65 136.07 52.38 Favored 'General case' 0 N--CA 1.504 2.235 1 O-C-N 129.254 4.096 . . . . 50.509999999999998 114.159 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 p -112.87 149.23 33.43 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 104.91 -2.256 . . . . 50.509999999999998 104.91 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.44 -6.85 0.5 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.799 2.888 . . . . 50.509999999999998 118.799 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -115.91 19.46 15.1 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 120.312 3.449 . . . . 50.509999999999998 120.312 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.26 -13.69 66.4 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 117.483 1.753 . . . . 50.509999999999998 117.483 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.41 155.41 18.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 116.871 -1.538 . . . . 50.509999999999998 111.77 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -148.98 149.77 31.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 126.656 2.472 . . . . 50.509999999999998 109.639 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -143.62 146.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.497 2.998 . . . . 50.509999999999998 110.559 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.457 ' O ' HD23 ' A' ' 15' ' ' LEU . 20.9 p -102.87 130.4 49.89 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.315 -1.754 . . . . 50.509999999999998 112.746 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 14' ' ' THR . 48.0 mt -124.95 149.79 47.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 115.37 -2.253 . . . . 50.509999999999998 113.511 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -107.4 142.43 37.23 Favored 'General case' 0 N--CA 1.5 2.025 1 O-C-N 129.114 4.009 . . . . 50.619999999999997 104.294 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -144.08 167.18 12.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 O-C-N 126.091 2.119 . . . . 50.509999999999998 105.692 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 68.9 mm-40 -122.0 157.66 57.15 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 112.209 -2.269 . . . . 50.619999999999997 112.202 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.96 -24.47 39.58 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 122.662 2.241 . . . . 50.509999999999998 111.904 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -96.78 -8.78 30.31 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 118.158 -0.925 . . . . 50.509999999999998 112.674 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 30.4 m-20 -66.3 124.44 22.71 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.308 -1.757 . . . . 50.619999999999997 106.485 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -79.09 155.79 28.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.808 -0.633 . . . . 50.509999999999998 112.51 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.605 HD13 ' HB3' ' A' ' 50' ' ' LEU . 76.6 mt -52.18 -45.87 43.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 O-C-N 127.176 2.798 . . . . 50.509999999999998 108.374 175.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.05 -51.01 18.58 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.45 -0.781 . . . . 50.619999999999997 110.645 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -65.19 -43.05 92.87 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 118.735 2.865 . . . . 50.549999999999997 118.735 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.22 -42.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.123 -1.399 . . . . 50.509999999999998 110.285 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.26 -38.25 90.38 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 108.12 -1.066 . . . . 50.509999999999998 108.12 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.7 -40.02 63.94 Favored 'General case' 0 C--O 1.277 2.543 0 N-CA-C 114.709 1.374 . . . . 50.509999999999998 114.709 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -58.05 -29.19 65.17 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 120.398 -1.439 . . . . 50.509999999999998 112.966 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.436 HG12 HD11 ' A' ' 15' ' ' LEU . 74.6 mt -77.58 -29.86 16.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 N-CA-C 106.695 -1.595 . . . . 50.509999999999998 106.695 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -58.08 -41.71 84.0 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 125.614 2.626 . . . . 50.549999999999997 108.18 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -73.48 10.92 0.89 Allowed 'General case' 0 C--O 1.253 1.289 0 CA-C-N 113.6 -1.636 . . . . 50.619999999999997 113.765 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -139.26 -30.1 0.74 Allowed 'General case' 0 C--O 1.279 2.647 0 N-CA-C 104.592 -2.373 . . . . 50.509999999999998 104.592 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -110.18 -61.57 1.64 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 123.081 2.673 . . . . 50.619999999999997 109.578 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.51 20.29 0.9 Allowed Glycine 0 CA--C 1.477 -2.327 0 N-CA-C 108.891 -1.683 . . . . 50.509999999999998 108.891 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.2 mt -103.03 122.26 46.14 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 116.526 2.047 . . . . 50.509999999999998 116.526 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.0 Cg_exo -57.01 136.91 79.55 Favored 'Trans proline' 0 C--O 1.259 1.545 0 C-N-CA 123.104 2.536 . . . . 50.509999999999998 110.937 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.0 Cg_exo -57.18 -32.12 92.55 Favored 'Trans proline' 0 C--O 1.262 1.685 0 O-C-N 122.912 0.953 . . . . 50.509999999999998 113.388 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' A' ' 37' ' ' PRO . 42.1 p-10 -59.91 -27.91 67.14 Favored 'General case' 0 C--O 1.261 1.702 0 O-C-N 119.897 -1.752 . . . . 50.619999999999997 114.427 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -87.97 -15.63 35.97 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.593 -1.317 . . . . 50.549999999999997 113.857 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -87.3 117.7 26.25 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 118.3 2.704 . . . . 50.549999999999997 118.3 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.32 131.99 53.62 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 105.937 -1.875 . . . . 50.640000000000001 105.937 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 mt -107.67 133.38 52.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 101.965 -3.346 . . . . 50.509999999999998 101.965 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.42 HD13 HG23 ' A' ' 70' ' ' VAL . 3.3 mp -124.31 135.87 62.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 O-C-N 125.201 1.563 . . . . 50.509999999999998 114.334 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -140.14 113.03 8.14 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 105.719 -1.956 . . . . 50.509999999999998 105.719 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.93 41.42 31.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.26 -2.245 . . . . 50.509999999999998 108.716 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.66 3.54 59.15 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 128.432 2.92 . . . . 50.509999999999998 116.134 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.1 125.5 29.45 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.714 1.376 . . . . 50.509999999999998 114.714 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -75.24 127.91 34.24 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 107.68 -1.23 . . . . 50.549999999999997 107.68 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.605 ' HB3' HD13 ' A' ' 23' ' ' ILE . 2.9 mp -95.51 124.59 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 117.72 -1.133 . . . . 50.509999999999998 112.665 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -104.37 135.97 44.83 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.368 1.988 . . . . 50.619999999999997 116.368 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -42.62 -36.23 1.33 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 121.197 3.777 . . . . 50.619999999999997 121.197 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.56 -33.61 87.7 Favored Glycine 0 CA--C 1.493 -1.294 0 C-N-CA 124.438 1.018 . . . . 50.509999999999998 113.72 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -88.69 136.45 32.99 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 119.766 -2.02 . . . . 50.640000000000001 112.614 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 22' ' ' THR . 57.0 p -77.68 171.54 14.79 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.015 0.926 . . . . 50.509999999999998 111.465 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.69 -39.24 83.87 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 117.381 2.363 . . . . 50.509999999999998 117.381 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -64.41 -37.67 88.33 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.332 -1.747 . . . . 50.509999999999998 110.815 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -50.01 -43.57 50.68 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 116.888 2.181 . . . . 50.619999999999997 116.888 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.656 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 63.4 m-85 -74.57 -6.85 50.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 110.416 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.656 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 71.52 40.67 0.79 Allowed 'General case' 0 C--O 1.247 0.957 0 CA-C-N 121.429 1.922 . . . . 50.549999999999997 115.239 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mm -71.03 110.41 3.96 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.182 -2.342 . . . . 50.509999999999998 110.428 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 174.35 7.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.056 2.097 . . . . 50.549999999999997 114.79 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 26.7 ttpp -61.35 114.27 3.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 123.159 1.457 . . . . 50.509999999999998 112.848 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 45.6 mm-40 80.31 44.18 0.04 OUTLIER 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.575 -2.102 . . . . 50.619999999999997 111.989 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.2 t -82.64 140.71 33.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.785 -1.098 . . . . 50.509999999999998 108.832 174.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 45.7 m -109.28 146.65 33.94 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 102.454 -3.165 . . . . 50.509999999999998 102.454 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.2 147.28 41.59 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.739 -2.553 . . . . 50.509999999999998 109.193 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -88.89 137.98 31.83 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 127.149 2.78 . . . . 50.509999999999998 111.373 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.5 109.17 18.59 Favored 'General case' 0 C--O 1.283 2.86 0 CA-C-O 117.662 -1.161 . . . . 50.509999999999998 113.737 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG23 HD13 ' A' ' 44' ' ' ILE . 45.6 t -111.69 128.48 68.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 119.614 1.097 . . . . 50.509999999999998 108.452 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.07 139.05 32.73 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 116.296 1.962 . . . . 50.509999999999998 116.296 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -98.08 116.7 30.84 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.337 -3.22 . . . . 50.640000000000001 108.684 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mp -85.76 138.4 32.12 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.795 1.934 . . . . 50.509999999999998 106.421 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -99.56 73.93 1.86 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.763 -1.562 . . . . 50.640000000000001 109.118 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.55 145.04 6.7 Favored Glycine 0 C--O 1.244 0.735 0 N-CA-C 106.293 -2.723 . . . . 50.509999999999998 106.293 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.416 0 N-CA-C 106.551 -2.62 . . . . 50.509999999999998 106.551 179.239 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 97.6 mmm . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.819 -1.178 . . . . 50.509999999999998 107.819 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -113.54 139.66 48.8 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 103.575 -2.75 . . . . 50.549999999999997 103.575 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.521 HD12 ' C ' ' A' ' 3' ' ' ILE . 2.0 pp -144.78 162.55 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 104.75 -2.315 . . . . 50.509999999999998 104.75 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 148.02 40.27 Favored 'General case' 0 N--CA 1.511 2.604 1 O-C-N 130.46 4.85 . . . . 50.509999999999998 109.434 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 67' ' ' LEU . 42.9 t -130.22 100.05 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 113.406 -3.188 . . . . 50.509999999999998 105.245 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -65.4 131.11 45.61 Favored 'General case' 0 N--CA 1.504 2.275 1 O-C-N 129.266 4.103 . . . . 50.509999999999998 112.832 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 41.5 p -93.22 -169.39 2.14 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 107.672 -1.233 . . . . 50.509999999999998 107.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.06 34.87 4.75 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.851 -1.537 . . . . 50.509999999999998 106.851 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.1 p -134.13 -15.09 2.29 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 115.706 -2.398 . . . . 50.509999999999998 114.646 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.63 13.14 10.7 Favored Glycine 0 C--N 1.296 -1.645 0 O-C-N 120.227 -1.546 . . . . 50.509999999999998 112.654 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -119.87 120.31 36.08 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 116.834 -1.555 . . . . 50.509999999999998 111.126 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -85.77 144.75 27.58 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 126.647 2.467 . . . . 50.509999999999998 110.942 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -116.75 142.74 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 127.582 3.052 . . . . 50.509999999999998 110.391 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -122.33 128.92 51.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.249 -1.78 . . . . 50.509999999999998 113.007 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 30' ' ' ILE . 5.4 mp -118.64 151.7 37.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 115.39 -2.243 . . . . 50.509999999999998 107.28 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 1' ' ' MET . 40.1 mt-10 -117.22 126.18 52.35 Favored 'General case' 0 N--CA 1.5 2.028 1 O-C-N 129.176 4.048 . . . . 50.619999999999997 102.984 173.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.491 HG12 ' HE3' ' A' ' 29' ' ' LYS . 35.3 m -146.31 170.83 4.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 126.241 2.213 . . . . 50.509999999999998 108.46 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -108.52 154.84 41.33 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.163 -2.29 . . . . 50.619999999999997 114.645 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -55.03 -24.51 40.35 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 122.624 2.216 . . . . 50.509999999999998 111.918 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -75.08 -14.74 60.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 118.067 -0.968 . . . . 50.509999999999998 112.467 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.0 140.91 56.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 117.355 -1.738 . . . . 50.619999999999997 109.344 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.0 p -80.93 133.51 35.55 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 105.809 -1.923 . . . . 50.509999999999998 105.809 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 54' ' ' ARG . 24.4 mm -37.69 -35.64 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.212 2.82 . . . . 50.509999999999998 110.364 175.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -58.5 -45.17 89.29 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.543 2.423 . . . . 50.619999999999997 117.543 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.09 -26.59 66.79 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.874 2.175 . . . . 50.549999999999997 116.874 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.74 -43.08 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 125.118 1.511 . . . . 50.509999999999998 112.842 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.7 -34.34 71.19 Favored 'General case' 0 C--O 1.256 1.402 0 CA-C-N 115.767 -0.651 . . . . 50.509999999999998 110.009 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 31' ' ' GLN . . . -66.42 -44.82 81.88 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 117.872 2.545 . . . . 50.509999999999998 117.872 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HE3' HG12 ' A' ' 17' ' ' VAL . 62.0 mttm -46.65 -32.66 3.66 Favored 'General case' 0 C--O 1.255 1.395 0 O-C-N 120.422 -1.424 . . . . 50.509999999999998 108.56 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.463 HD11 HD11 ' A' ' 15' ' ' LEU . 22.6 mm -68.97 -40.69 81.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.199 0 N-CA-C 106.363 -1.717 . . . . 50.509999999999998 106.363 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 28' ' ' ALA . 26.0 tt0 -39.92 -38.62 0.72 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 118.359 2.726 . . . . 50.549999999999997 118.359 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.11 -12.4 61.48 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 115.605 1.706 . . . . 50.619999999999997 115.605 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -105.18 -43.47 5.01 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.459 -2.096 . . . . 50.509999999999998 115.246 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -110.57 -43.46 3.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 123.067 2.667 . . . . 50.619999999999997 108.205 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 35.39 1.88 Allowed Glycine 0 CA--C 1.477 -2.33 0 N-CA-C 108.188 -1.965 . . . . 50.509999999999998 108.188 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.9 mm -98.73 123.41 49.81 Favored Pre-proline 0 C--O 1.243 0.739 0 C-N-CA 118.851 -1.139 . . . . 50.509999999999998 108.703 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.92 136.98 79.77 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.1 2.533 . . . . 50.509999999999998 110.943 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.7 Cg_exo -57.18 -32.23 92.87 Favored 'Trans proline' 0 C--O 1.261 1.663 0 O-C-N 122.904 0.949 . . . . 50.509999999999998 113.436 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.45 -15.99 63.39 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 120.023 -1.673 . . . . 50.619999999999997 114.309 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -104.63 17.57 23.88 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.555 -1.341 . . . . 50.549999999999997 113.991 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -114.35 146.11 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 124.422 2.058 . . . . 50.549999999999997 106.636 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.635 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 21.5 mtp-105 -128.7 105.19 8.09 Favored 'General case' 0 C--O 1.295 3.488 0 CA-C-O 116.632 -1.651 . . . . 50.640000000000001 113.386 172.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.41 117.58 29.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.459 1.027 . . . . 50.509999999999998 110.701 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -107.8 122.07 61.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 N-CA-C 119.051 2.982 . . . . 50.509999999999998 119.051 -177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -128.38 128.92 45.42 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 106.791 -1.559 . . . . 50.509999999999998 106.791 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.11 25.91 15.88 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 108.701 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.57 16.52 61.06 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.438 2.923 . . . . 50.509999999999998 108.69 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.47 142.01 33.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 118.037 0.918 . . . . 50.509999999999998 110.062 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -75.92 156.7 34.0 Favored 'General case' 0 C--O 1.26 1.607 0 O-C-N 123.981 0.801 . . . . 50.549999999999997 111.969 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -107.9 146.81 31.85 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.344 -1.725 . . . . 50.509999999999998 106.344 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -92.01 140.15 29.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 103.767 -2.679 . . . . 50.619999999999997 103.767 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -53.52 -52.18 60.46 Favored 'General case' 0 C--O 1.264 1.836 0 C-N-CA 126.206 1.802 . . . . 50.619999999999997 113.646 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.72 28.46 5.91 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 119.658 2.623 . . . . 50.509999999999998 119.658 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 23' ' ' ILE . 20.7 mmm180 -117.35 169.49 9.45 Favored 'General case' 0 C--O 1.248 1.006 0 O-C-N 120.047 -1.854 . . . . 50.640000000000001 112.33 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.95 149.36 28.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.091 0.956 . . . . 50.509999999999998 113.485 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.444 ' HB3' HG13 ' A' ' 61' ' ' ILE . 65.8 mt -50.47 -36.0 31.57 Favored 'General case' 0 C--O 1.201 -1.475 0 O-C-N 124.196 0.935 . . . . 50.509999999999998 109.023 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -68.79 -15.01 63.38 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.319 -1.752 . . . . 50.509999999999998 112.086 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.391 1.091 . . . . 50.619999999999997 109.894 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -121.88 11.2 10.33 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.778 -1.106 . . . . 50.509999999999998 113.333 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t30 51.45 39.79 25.27 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 121.442 1.928 . . . . 50.549999999999997 110.203 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.444 HG13 ' HB3' ' A' ' 56' ' ' LEU . 25.9 mm -56.54 116.26 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.959 0 CA-C-O 115.215 -2.326 . . . . 50.509999999999998 109.473 175.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -79.98 -171.03 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.638 2.458 . . . . 50.549999999999997 117.638 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.27 143.68 48.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.229 1.49 . . . . 50.509999999999998 108.827 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 34.42 39.58 0.03 OUTLIER 'General case' 0 C--O 1.256 1.447 0 N-CA-C 117.905 2.557 . . . . 50.619999999999997 117.905 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -65.89 146.68 54.44 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.83 -1.077 . . . . 50.509999999999998 111.949 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 p -104.54 144.15 32.08 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 118.299 -0.857 . . . . 50.509999999999998 110.926 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 5' ' ' VAL . 60.0 mt -110.66 156.04 21.56 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 114.756 -2.545 . . . . 50.509999999999998 108.625 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -118.94 144.94 46.16 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 127.408 2.942 . . . . 50.509999999999998 110.475 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 49.2 tp -96.09 129.88 43.26 Favored 'General case' 0 C--O 1.282 2.803 0 CA-C-O 117.696 -1.145 . . . . 50.509999999999998 111.668 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 61.8 t -116.11 137.06 51.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 102.392 -3.188 . . . . 50.509999999999998 102.392 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.87 127.86 46.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.102 0.477 . . . . 50.509999999999998 110.42 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -114.27 111.83 22.14 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.374 -3.203 . . . . 50.640000000000001 112.494 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.05 143.9 28.12 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.837 1.961 . . . . 50.509999999999998 108.097 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -98.09 89.28 4.47 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 106.662 -1.607 . . . . 50.640000000000001 106.662 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.7 -162.65 26.99 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 104.643 -3.383 . . . . 50.509999999999998 104.643 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 CA-C-O 116.355 -2.358 . . . . 50.509999999999998 108.044 179.25 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 118.768 -0.634 . . . . 50.509999999999998 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 10.9 mm-40 -109.09 127.67 54.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 127.001 2.688 . . . . 50.549999999999997 109.026 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -133.16 146.55 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 116.024 -1.941 . . . . 50.509999999999998 107.717 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -106.56 135.89 47.28 Favored 'General case' 0 N--CA 1.512 2.645 1 O-C-N 130.446 4.841 . . . . 50.509999999999998 113.486 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.8 t -108.05 136.63 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.417 -3.182 . . . . 50.509999999999998 103.898 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -126.24 119.7 28.12 Favored 'General case' 0 N--CA 1.503 2.219 1 O-C-N 129.277 4.111 . . . . 50.509999999999998 114.834 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.565 HG22 HD23 ' A' ' 69' ' ' LEU . 43.9 p -67.44 -172.27 0.23 Allowed 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.869 -1.063 . . . . 50.509999999999998 110.337 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.89 -18.97 26.46 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.116 -0.698 . . . . 50.509999999999998 109.116 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -106.36 16.08 25.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 119.87 3.285 . . . . 50.509999999999998 119.87 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.86 55.67 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 120.952 3.141 . . . . 50.509999999999998 120.952 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -84.16 123.35 30.0 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.227 -1.768 . . . . 50.509999999999998 106.227 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -113.03 134.1 54.67 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 126.585 2.428 . . . . 50.509999999999998 111.872 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 5' ' ' VAL . 28.0 pt -115.92 153.81 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 127.533 3.02 . . . . 50.509999999999998 114.0 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -110.58 142.99 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 117.301 -1.76 . . . . 50.509999999999998 115.021 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' A' ' 30' ' ' ILE . 76.4 mt -135.46 139.78 44.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 115.459 -2.21 . . . . 50.509999999999998 113.54 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -101.85 107.19 18.3 Favored 'General case' 0 N--CA 1.5 2.069 1 O-C-N 129.128 4.018 . . . . 50.619999999999997 113.926 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -128.17 154.63 39.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.671 3.107 . . . . 50.509999999999998 114.443 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.67 159.02 30.65 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 118.256 2.688 . . . . 50.619999999999997 118.256 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.0 -24.49 40.0 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.581 2.187 . . . . 50.509999999999998 111.948 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -103.34 34.33 2.97 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 117.806 2.521 . . . . 50.509999999999998 117.806 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -114.15 130.75 56.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.374 -1.731 . . . . 50.619999999999997 112.166 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.3 p -57.93 155.54 10.5 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.598 1.332 . . . . 50.509999999999998 114.598 175.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 54' ' ' ARG . 15.3 mm -60.45 -42.06 89.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 127.205 2.816 . . . . 50.509999999999998 110.955 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.07 -59.05 5.88 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.941 . . . . 50.619999999999997 108.458 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 44.5 t30 -47.85 -43.54 28.36 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 124.399 1.08 . . . . 50.549999999999997 111.145 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 56' ' ' LEU . 42.1 t -63.38 -34.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.97 1.419 . . . . 50.509999999999998 109.707 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -76.16 -30.44 58.12 Favored 'General case' 0 C--O 1.257 1.451 0 N-CA-C 108.816 -0.809 . . . . 50.509999999999998 108.816 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.88 70.02 Favored 'General case' 0 C--O 1.279 2.616 0 N-CA-C 105.517 -2.031 . . . . 50.509999999999998 105.517 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 75.3 mmtt -58.93 -63.2 1.38 Allowed 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.397 -1.439 . . . . 50.509999999999998 107.994 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.499 ' CG1' HD11 ' A' ' 15' ' ' LEU . 70.3 mt -47.97 -37.75 6.8 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.486 -0.886 . . . . 50.509999999999998 109.105 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 46.1 tt0 -54.45 -50.73 66.99 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 125.568 2.604 . . . . 50.549999999999997 112.849 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -49.0 -60.99 2.3 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 113.644 -1.616 . . . . 50.619999999999997 110.273 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -84.13 -40.33 18.36 Favored 'General case' 0 C--O 1.279 2.654 0 N-CA-C 119.617 3.191 . . . . 50.509999999999998 119.617 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.606 ' HG3' HG13 ' A' ' 36' ' ' ILE . 42.5 tp10 -76.19 -31.37 58.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 123.082 2.674 . . . . 50.619999999999997 108.162 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.42 2.36 76.75 Favored Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.458 -1.057 . . . . 50.509999999999998 110.458 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.606 HG13 ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -87.81 136.39 32.67 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 118.812 -1.155 . . . . 50.509999999999998 110.999 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.0 Cg_exo -57.07 137.0 79.97 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.159 2.572 . . . . 50.509999999999998 110.875 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 86.8 Cg_exo -57.19 -32.16 92.68 Favored 'Trans proline' 0 C--O 1.262 1.709 0 O-C-N 122.89 0.942 . . . . 50.509999999999998 113.436 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.539 ' OD1' ' HG3' ' A' ' 40' ' ' GLN . 35.6 p30 -69.4 -14.1 62.72 Favored 'General case' 0 C--O 1.262 1.733 0 O-C-N 119.893 -1.754 . . . . 50.619999999999997 113.83 -177.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.539 ' HG3' ' OD1' ' A' ' 39' ' ' ASP . 88.2 mt-30 -102.81 6.84 39.49 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.544 -1.347 . . . . 50.549999999999997 109.891 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -103.41 130.94 50.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 124.362 2.029 . . . . 50.549999999999997 110.796 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -120.98 122.12 39.47 Favored 'General case' 0 C--O 1.296 3.544 0 CA-C-O 116.625 -1.655 . . . . 50.640000000000001 110.828 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CB ' HD12 ' A' ' 50' ' ' LEU . 60.2 mt -108.14 126.16 52.44 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.509 1.05 . . . . 50.509999999999998 109.839 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 67.5 mt -111.14 138.86 37.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 O-C-N 125.223 1.577 . . . . 50.509999999999998 108.147 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -150.55 120.63 7.2 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 114.488 -1.233 . . . . 50.509999999999998 110.913 177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.34 38.66 7.69 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.208 -2.269 . . . . 50.509999999999998 112.284 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 3.42 68.08 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.346 2.879 . . . . 50.509999999999998 115.863 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -113.76 146.78 39.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 114.978 1.473 . . . . 50.509999999999998 114.978 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -70.51 153.96 42.38 Favored 'General case' 0 C--O 1.259 1.58 0 N-CA-C 108.2 -1.037 . . . . 50.549999999999997 108.2 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.45 HD12 ' CB ' ' A' ' 43' ' ' LEU . 63.5 mt -96.94 135.01 39.55 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 117.666 -1.159 . . . . 50.509999999999998 110.312 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -99.06 128.1 45.13 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.933 1.395 . . . . 50.619999999999997 112.737 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.11 -57.82 3.63 Favored 'General case' 0 C--O 1.264 1.844 0 C-N-CA 126.133 1.773 . . . . 50.619999999999997 115.216 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.26 -26.68 29.85 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 124.415 1.007 . . . . 50.509999999999998 113.886 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 23' ' ' ILE . 29.5 mmt180 -83.6 161.04 21.27 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 120.025 -1.868 . . . . 50.640000000000001 112.109 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -103.93 172.68 6.67 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 124.065 0.946 . . . . 50.509999999999998 110.218 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD11 HG21 ' A' ' 26' ' ' VAL . 47.5 mt -58.07 -33.19 68.79 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 116.49 2.033 . . . . 50.509999999999998 116.49 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -86.38 -5.66 59.12 Favored 'General case' 0 C--O 1.267 2.0 0 C-N-CA 117.372 -1.731 . . . . 50.509999999999998 111.167 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -79.81 -0.79 36.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.809 -1.182 . . . . 50.619999999999997 107.809 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -123.95 11.98 9.01 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 117.755 -1.117 . . . . 50.509999999999998 110.542 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.61 28.61 12.2 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 121.545 1.975 . . . . 50.549999999999997 111.595 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.2 103.0 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.969 0 CA-C-O 115.17 -2.348 . . . . 50.509999999999998 108.827 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -98.84 164.62 12.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.112 2.133 . . . . 50.549999999999997 112.435 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -51.04 135.89 24.27 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.513 2.042 . . . . 50.509999999999998 116.513 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 73.09 37.93 0.73 Allowed 'General case' 0 C--O 1.255 1.393 0 CA-C-N 112.497 -2.138 . . . . 50.619999999999997 111.07 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 p -78.07 156.56 29.96 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 107.537 -1.283 . . . . 50.509999999999998 107.537 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.5 m -122.05 117.97 27.63 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.834 -3.024 . . . . 50.509999999999998 102.834 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.65 170.09 9.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 114.695 -2.574 . . . . 50.509999999999998 112.545 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -110.32 127.62 55.12 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.361 2.913 . . . . 50.509999999999998 108.73 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.565 HD23 HG22 ' A' ' 7' ' ' THR . 48.0 tp -103.07 101.87 11.87 Favored 'General case' 0 C--O 1.283 2.823 0 CA-C-O 117.649 -1.167 . . . . 50.509999999999998 113.194 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.38 137.11 25.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.583 1.083 . . . . 50.509999999999998 112.149 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 tp -96.03 115.73 27.88 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.318 -0.623 . . . . 50.509999999999998 109.318 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -109.04 108.18 18.79 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.305 -3.236 . . . . 50.640000000000001 114.166 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.86 165.16 15.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 125.859 1.974 . . . . 50.509999999999998 114.664 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -115.35 61.45 0.69 Allowed 'General case' 0 C--O 1.244 0.812 0 CA-C-N 113.742 -1.572 . . . . 50.640000000000001 108.472 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.75 138.82 2.55 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 107.298 -2.321 . . . . 50.509999999999998 107.298 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.444 0 CA-C-O 116.356 -2.358 . . . . 50.509999999999998 109.038 179.217 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 106.917 -1.512 . . . . 50.509999999999998 106.917 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -120.19 135.71 54.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 101.557 -3.498 . . . . 50.549999999999997 101.557 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -137.89 159.36 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.94 -1.981 . . . . 50.509999999999998 106.941 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -114.24 143.91 44.08 Favored 'General case' 0 N--CA 1.512 2.628 1 O-C-N 130.446 4.842 . . . . 50.509999999999998 111.395 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -118.97 109.87 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.404 -3.189 . . . . 50.509999999999998 106.121 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -84.3 150.37 25.46 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.306 4.129 . . . . 50.509999999999998 117.362 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -126.78 164.23 21.81 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 117.826 -1.083 . . . . 50.509999999999998 110.137 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.54 -43.36 65.12 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.999 2.592 . . . . 50.509999999999998 117.999 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.6 p -68.64 -26.52 65.37 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 115.726 -2.39 . . . . 50.509999999999998 107.455 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.73 -5.93 18.42 Favored Glycine 0 C--N 1.297 -1.6 0 O-C-N 120.258 -1.526 . . . . 50.509999999999998 115.438 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -54.66 130.88 41.96 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.88 -1.533 . . . . 50.509999999999998 109.889 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -112.86 119.58 38.47 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 126.624 2.453 . . . . 50.509999999999998 117.221 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -88.48 145.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.571 3.044 . . . . 50.509999999999998 108.329 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -104.58 141.93 35.53 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 117.287 -1.765 . . . . 50.509999999999998 110.584 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -134.13 137.48 44.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 118.195 2.665 . . . . 50.509999999999998 118.195 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -103.61 111.18 23.54 Favored 'General case' 0 N--CA 1.501 2.104 1 O-C-N 129.242 4.089 . . . . 50.619999999999997 112.35 174.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -98.24 166.74 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.197 0 O-C-N 127.508 3.005 . . . . 50.509999999999998 112.548 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 53.9 mm-40 -115.72 148.66 41.63 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.197 -2.274 . . . . 50.619999999999997 112.58 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.5 Cg_exo -54.95 -24.49 39.57 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.581 2.188 . . . . 50.509999999999998 112.003 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -103.14 13.75 33.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 118.043 2.608 . . . . 50.509999999999998 118.043 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -92.74 148.6 21.91 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 117.349 -1.74 . . . . 50.619999999999997 110.986 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -99.09 157.42 16.37 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.836 -0.62 . . . . 50.509999999999998 109.716 175.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 26.8 mm -45.01 -43.86 2.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 O-C-N 127.238 2.836 . . . . 50.509999999999998 113.015 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -57.39 -46.68 83.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.456 -0.778 . . . . 50.619999999999997 110.305 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -59.51 -39.88 85.3 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.287 1.035 . . . . 50.549999999999997 110.653 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.63 -46.73 95.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.022 -1.473 . . . . 50.509999999999998 107.022 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 93.4 mttt -55.0 -59.38 4.83 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-N 115.814 -0.63 . . . . 50.509999999999998 111.336 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 38' ' ' PRO . . . -57.02 -40.59 76.99 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 113.887 1.069 . . . . 50.509999999999998 113.887 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 55.8 tptt -50.8 -44.38 58.97 Favored 'General case' 0 C--O 1.255 1.39 0 N-CA-C 106.367 -1.716 . . . . 50.509999999999998 106.367 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 31' ' ' GLN . 72.3 mt -64.26 -42.2 94.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.281 0 C-N-CA 119.51 -0.876 . . . . 50.509999999999998 108.669 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' C ' ' A' ' 32' ' ' ASP . 35.4 tt0 -43.87 -58.34 2.8 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.623 2.63 . . . . 50.549999999999997 108.844 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 31' ' ' GLN . 98.1 m-20 -34.57 -35.79 0.04 OUTLIER 'General case' 0 C--O 1.253 1.26 0 CA-C-N 113.645 -1.616 . . . . 50.619999999999997 110.833 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 31' ' ' GLN . 33.7 mmtp -112.46 -1.22 15.05 Favored 'General case' 0 C--O 1.28 2.703 0 N-CA-C 120.15 3.389 . . . . 50.509999999999998 120.15 -175.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -129.81 -38.07 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 123.147 2.703 . . . . 50.619999999999997 108.399 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 11.98 31.98 Favored Glycine 0 CA--C 1.477 -2.333 0 N-CA-C 115.177 0.831 . . . . 50.509999999999998 115.177 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.501 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.6 mt -97.51 136.72 21.18 Favored Pre-proline 0 C--O 1.245 0.83 0 C-N-CA 118.836 -1.146 . . . . 50.509999999999998 112.149 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.565 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.88 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.596 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 Cg_exo -57.24 -32.18 92.86 Favored 'Trans proline' 0 C--O 1.26 1.621 0 O-C-N 122.903 0.949 . . . . 50.509999999999998 113.38 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -72.82 5.17 3.39 Favored 'General case' 0 C--O 1.262 1.757 0 O-C-N 120.022 -1.674 . . . . 50.619999999999997 113.573 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.592 HE21 ' HG3' ' A' ' 74' ' ' ARG . 62.8 mt-30 -111.2 -6.71 14.53 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.541 -1.349 . . . . 50.549999999999997 112.632 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.425 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 37.0 mt-30 -102.79 130.59 49.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.412 2.053 . . . . 50.549999999999997 112.686 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -111.54 119.68 39.57 Favored 'General case' 0 C--O 1.297 3.566 0 CA-C-O 116.672 -1.632 . . . . 50.640000000000001 108.368 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' A' ' 50' ' ' LEU . 94.4 mt -100.97 158.72 15.79 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 105.595 -2.002 . . . . 50.509999999999998 105.595 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.8 mt -137.35 135.78 46.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 118.835 2.902 . . . . 50.509999999999998 118.835 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -128.05 112.62 14.81 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 115.063 1.505 . . . . 50.509999999999998 115.063 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.92 30.92 20.42 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.19 -2.277 . . . . 50.509999999999998 109.525 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.09 19.34 72.63 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 128.486 2.945 . . . . 50.509999999999998 117.187 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -111.02 151.72 27.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 118.162 -0.923 . . . . 50.509999999999998 112.078 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.05 154.17 42.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.986 1.106 . . . . 50.549999999999997 113.986 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 43' ' ' LEU . 96.4 mt -117.09 140.22 49.77 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 117.796 -1.097 . . . . 50.509999999999998 109.169 -175.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -103.32 136.03 43.85 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.864 1.352 . . . . 50.619999999999997 114.31 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 75.4 m-20 -57.33 -55.73 31.01 Favored 'General case' 0 C--O 1.263 1.793 0 C-N-CA 126.177 1.791 . . . . 50.619999999999997 114.019 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.16 11.66 4.76 Favored Glycine 0 C--O 1.254 1.368 0 C-N-CA 124.464 1.03 . . . . 50.509999999999998 115.389 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -106.96 166.7 10.41 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 119.963 -1.904 . . . . 50.640000000000001 110.538 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -90.22 158.67 17.1 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 124.014 0.926 . . . . 50.509999999999998 113.308 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -70.62 -28.82 65.14 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 124.071 0.857 . . . . 50.509999999999998 110.085 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -69.31 -21.71 63.83 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.31 -1.756 . . . . 50.509999999999998 113.535 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.29 -5.35 51.78 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.63 2.085 . . . . 50.619999999999997 116.63 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -111.75 14.32 21.11 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 114.791 1.404 . . . . 50.509999999999998 114.791 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 51.4 28.1 4.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 121.571 1.987 . . . . 50.549999999999997 114.397 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.85 100.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.973 0 CA-C-O 115.192 -2.337 . . . . 50.509999999999998 106.878 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -98.9 162.76 12.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 126.159 2.162 . . . . 50.549999999999997 111.333 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 58.4 pttt -52.93 118.32 3.62 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 116.501 2.038 . . . . 50.509999999999998 116.501 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 71.69 46.87 0.36 Allowed 'General case' 0 C--O 1.257 1.453 0 CA-C-N 112.53 -2.123 . . . . 50.619999999999997 112.764 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.3 p -102.0 151.86 21.63 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 101.515 -3.513 . . . . 50.509999999999998 101.515 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.1 p -94.29 139.55 30.92 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 117.729 2.492 . . . . 50.509999999999998 117.729 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 46.6 mt -109.36 151.73 26.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 103.166 -2.902 . . . . 50.509999999999998 103.166 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 55.5 m80 -108.75 124.95 51.37 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 127.472 2.982 . . . . 50.509999999999998 104.565 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.4 tp -99.42 117.56 34.11 Favored 'General case' 0 C--O 1.283 2.841 0 CA-C-O 117.63 -1.176 . . . . 50.509999999999998 111.172 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -103.84 145.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 119.558 1.072 . . . . 50.509999999999998 108.765 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -115.23 120.55 40.08 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.859 2.17 . . . . 50.509999999999998 116.859 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -119.13 90.06 3.25 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 113.371 -3.204 . . . . 50.640000000000001 111.138 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.24 163.38 1.65 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.795 1.935 . . . . 50.509999999999998 109.209 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.592 ' HG3' HE21 ' A' ' 40' ' ' GLN . 93.8 mtt-85 -87.62 94.01 9.6 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 113.706 -1.588 . . . . 50.640000000000001 113.065 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.66 171.34 18.3 Favored Glycine 0 C--O 1.243 0.705 0 N-CA-C 109.663 -1.375 . . . . 50.509999999999998 109.663 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.472 0 N-CA-C 106.215 -2.754 . . . . 50.509999999999998 106.215 179.22 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 118.753 -0.641 . . . . 50.509999999999998 111.148 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.521 ' OE1' HG21 ' A' ' 14' ' ' THR . 48.9 mt-30 -86.22 125.11 33.31 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.96 2.663 . . . . 50.549999999999997 116.662 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.3 pt -119.87 162.65 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 115.983 -1.96 . . . . 50.509999999999998 109.392 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -112.02 136.28 51.58 Favored 'General case' 0 N--CA 1.513 2.69 1 O-C-N 130.504 4.877 . . . . 50.509999999999998 118.459 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -105.85 111.63 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.438 -3.172 . . . . 50.509999999999998 111.728 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -81.22 129.44 34.59 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.309 4.131 . . . . 50.509999999999998 109.318 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 69.2 p -97.67 -176.77 3.57 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 114.576 1.324 . . . . 50.509999999999998 114.576 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.2 mt -86.91 -28.68 22.64 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.784 1.031 . . . . 50.509999999999998 113.784 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 p -93.97 -22.37 18.61 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.713 -2.395 . . . . 50.509999999999998 111.12 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.2 3.9 2.39 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 117.726 1.85 . . . . 50.509999999999998 117.726 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' N ' ' OG1' ' A' ' 7' ' ' THR . 95.4 mttt -71.7 137.65 47.96 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 116.868 -1.539 . . . . 50.509999999999998 112.323 174.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.1 m -122.15 106.73 11.42 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.678 2.486 . . . . 50.509999999999998 110.809 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 15' ' ' LEU . 62.5 mt -84.87 153.09 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 127.244 2.84 . . . . 50.509999999999998 111.427 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.521 HG21 ' OE1' ' A' ' 2' ' ' GLN . 42.6 m -119.76 132.1 55.53 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 102.538 -3.134 . . . . 50.509999999999998 102.538 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 13' ' ' ILE . 1.5 mp -118.05 142.6 47.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 117.3 2.333 . . . . 50.509999999999998 117.3 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.71 107.39 19.87 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 128.944 3.902 . . . . 50.619999999999997 109.902 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.58 166.71 10.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 O-C-N 127.782 3.176 . . . . 50.509999999999998 106.046 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -132.67 157.77 77.46 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 112.234 -2.257 . . . . 50.619999999999997 106.446 174.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.92 -24.5 39.38 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.56 2.173 . . . . 50.509999999999998 112.014 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -75.81 -13.0 60.28 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 115.451 1.648 . . . . 50.509999999999998 115.451 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -84.65 131.27 34.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 118.379 2.733 . . . . 50.619999999999997 118.379 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -83.61 179.92 7.49 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 103.948 -2.612 . . . . 50.509999999999998 103.948 175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' GLU . 24.6 mm -65.41 -39.56 85.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 O-C-N 127.206 2.816 . . . . 50.509999999999998 110.824 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 29.7 tt0 -46.84 -59.23 3.2 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.275 -2.12 . . . . 50.619999999999997 105.275 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 24.6 m-80 -53.12 -46.37 68.73 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 118.123 2.638 . . . . 50.549999999999997 118.123 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.41 -39.6 81.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 117.777 2.51 . . . . 50.509999999999998 117.777 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -72.27 -30.08 64.5 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 103.231 -2.877 . . . . 50.509999999999998 103.231 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -30.86 71.18 Favored 'General case' 0 C--O 1.279 2.608 0 N-CA-C 109.146 -0.687 . . . . 50.509999999999998 109.146 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.6 mttt -71.79 -19.18 62.04 Favored 'General case' 0 C--O 1.256 1.422 0 O-C-N 120.316 -1.49 . . . . 50.509999999999998 111.058 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 30' ' ' ILE . 95.7 mt -88.94 -11.25 10.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 C-N-CA 119.538 -0.865 . . . . 50.509999999999998 109.491 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -91.67 -19.64 22.45 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 125.63 2.633 . . . . 50.549999999999997 113.161 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.26 -52.77 20.5 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.572 -1.649 . . . . 50.619999999999997 110.606 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -80.28 -75.93 0.24 Allowed 'General case' 0 C--O 1.278 2.598 0 C-N-CA 116.468 -2.093 . . . . 50.509999999999998 108.175 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -55.18 -70.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.05 2.659 . . . . 50.619999999999997 114.812 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.69 20.33 0.88 Allowed Glycine 0 CA--C 1.478 -2.27 0 CA-C-O 120.012 -0.327 . . . . 50.509999999999998 113.223 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -89.28 125.86 60.51 Favored Pre-proline 0 C--O 1.244 0.776 0 N-CA-C 116.77 2.137 . . . . 50.509999999999998 116.77 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -57.01 136.98 79.95 Favored 'Trans proline' 0 C--O 1.258 1.523 0 C-N-CA 123.159 2.572 . . . . 50.509999999999998 110.903 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.1 Cg_exo -57.17 -32.19 92.72 Favored 'Trans proline' 0 C--O 1.261 1.653 0 C-N-CA 120.671 0.914 . . . . 50.509999999999998 113.377 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.04 -9.71 58.9 Favored 'General case' 0 C--O 1.262 1.738 0 O-C-N 119.949 -1.719 . . . . 50.619999999999997 112.854 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.644 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 79.8 mt-30 -103.32 -1.89 27.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.488 -1.382 . . . . 50.549999999999997 107.656 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.22 138.1 31.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 124.447 2.07 . . . . 50.549999999999997 105.745 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.11 114.4 15.7 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.646 -1.645 . . . . 50.640000000000001 106.831 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' CB ' HD22 ' A' ' 50' ' ' LEU . 35.2 mt -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 119.537 1.062 . . . . 50.509999999999998 110.285 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -129.06 123.87 59.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 O-C-N 125.102 1.501 . . . . 50.509999999999998 111.849 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -140.1 117.19 11.16 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 114.539 -1.21 . . . . 50.509999999999998 109.948 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.7 29.0 13.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 112.241 -2.254 . . . . 50.509999999999998 114.706 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 37.54 45.29 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 114.393 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -133.95 150.23 51.28 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 118.317 2.71 . . . . 50.509999999999998 118.317 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.08 135.18 42.97 Favored 'General case' 0 C--O 1.26 1.635 0 O-C-N 123.953 0.783 . . . . 50.549999999999997 110.33 174.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD22 ' CB ' ' A' ' 43' ' ' LEU . 2.1 mp -87.79 129.18 35.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 114.637 1.347 . . . . 50.509999999999998 114.637 -175.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -89.5 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 120.377 3.473 . . . . 50.619999999999997 120.377 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -51.07 -55.97 14.95 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 119.74 3.237 . . . . 50.619999999999997 119.74 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.96 7.85 78.69 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.387 0.994 . . . . 50.509999999999998 114.189 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.51 144.55 28.48 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 119.951 -1.911 . . . . 50.640000000000001 109.276 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -87.4 155.84 19.85 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.062 0.945 . . . . 50.509999999999998 108.581 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -46.93 -32.26 3.71 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 113.869 1.063 . . . . 50.509999999999998 113.869 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.58 -20.38 65.38 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 115.759 1.763 . . . . 50.509999999999998 115.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -62.24 -43.84 97.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.452 1.12 . . . . 50.619999999999997 110.603 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -84.66 17.11 2.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 115.609 1.707 . . . . 50.509999999999998 115.609 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 t30 60.31 33.13 20.88 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 121.536 1.971 . . . . 50.549999999999997 113.59 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.533 HG23 ' OG ' ' A' ' 65' ' ' SER . 56.9 mt -85.47 83.71 2.08 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 CA-C-O 115.169 -2.348 . . . . 50.509999999999998 113.65 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -82.97 179.06 7.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 125.717 1.885 . . . . 50.549999999999997 116.027 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -53.2 124.21 13.91 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 123.179 1.466 . . . . 50.509999999999998 111.394 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 61.1 40.42 14.98 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 118.528 2.788 . . . . 50.619999999999997 118.528 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.533 ' OG ' HG23 ' A' ' 61' ' ' ILE . 94.2 p -86.91 152.35 22.51 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.164 -1.421 . . . . 50.509999999999998 107.164 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 m -91.47 123.3 34.78 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 116.667 2.099 . . . . 50.509999999999998 116.667 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.01 138.58 41.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 114.735 -2.555 . . . . 50.509999999999998 105.291 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 49.0 m80 -81.6 168.04 18.59 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 127.038 2.711 . . . . 50.509999999999998 106.612 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -131.24 120.47 23.28 Favored 'General case' 0 C--O 1.282 2.789 0 N-CA-C 104.664 -2.346 . . . . 50.509999999999998 104.664 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.5 t -118.8 149.93 21.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 102.585 -3.117 . . . . 50.509999999999998 102.585 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.11 152.33 18.64 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.536 0.569 . . . . 50.509999999999998 112.536 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.644 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 74.9 ttt180 -122.12 97.73 5.61 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 113.413 -3.184 . . . . 50.640000000000001 106.789 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.0 mt -85.83 134.6 33.91 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 125.757 1.911 . . . . 50.509999999999998 113.369 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.84 81.49 8.75 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.703 -1.59 . . . . 50.640000000000001 112.88 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.94 -175.34 16.6 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 107.596 -2.201 . . . . 50.509999999999998 107.596 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.464 0 N-CA-C 105.24 -3.144 . . . . 50.509999999999998 105.24 179.213 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtp . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 102.042 -3.318 . . . . 50.509999999999998 102.042 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -112.52 135.05 53.69 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 103.497 -2.779 . . . . 50.549999999999997 103.497 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -124.77 173.12 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 CA-C-O 116.074 -1.917 . . . . 50.509999999999998 107.004 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.8 141.98 38.55 Favored 'General case' 0 N--CA 1.511 2.609 1 O-C-N 130.343 4.777 . . . . 50.509999999999998 115.954 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.34 110.58 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.454 -3.165 . . . . 50.509999999999998 104.585 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -90.47 143.94 26.27 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.204 4.065 . . . . 50.509999999999998 105.472 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 24.8 p -117.39 177.2 4.82 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.8 -1.095 . . . . 50.509999999999998 112.878 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.05 -24.76 67.83 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.082 0.864 . . . . 50.509999999999998 112.65 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -101.23 25.79 7.83 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 115.748 -2.381 . . . . 50.509999999999998 110.799 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.56 31.34 74.44 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 107.559 -2.216 . . . . 50.509999999999998 107.559 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 29.3 ttpt -84.97 124.7 31.98 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 103.735 -2.691 . . . . 50.509999999999998 103.735 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 p -103.31 137.72 41.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.664 2.477 . . . . 50.509999999999998 105.851 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 13' ' ' ILE . 16.6 tt -144.74 112.13 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 101.735 -3.432 . . . . 50.509999999999998 101.735 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.9 p -81.52 155.07 25.94 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.302 -1.759 . . . . 50.509999999999998 114.975 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -114.22 167.63 10.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.446 -2.216 . . . . 50.509999999999998 110.928 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.6 104.06 12.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 129.025 3.953 . . . . 50.619999999999997 106.427 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.41 148.62 11.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 O-C-N 127.62 3.075 . . . . 50.509999999999998 114.912 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -116.0 149.47 43.4 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 112.131 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.87 -24.53 39.18 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.535 2.157 . . . . 50.509999999999998 111.971 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -87.31 -2.54 58.7 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 118.146 -0.931 . . . . 50.509999999999998 111.135 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.43 131.8 37.05 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 115.949 1.833 . . . . 50.619999999999997 115.949 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.98 148.58 24.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.808 -0.633 . . . . 50.509999999999998 111.04 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 51' ' ' GLU . 73.2 mt -48.6 -29.87 2.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.147 2.779 . . . . 50.509999999999998 114.907 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 78.5 tt0 -56.25 -63.82 1.06 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 105.021 -2.215 . . . . 50.619999999999997 105.021 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -50.42 -40.71 51.01 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 118.97 2.952 . . . . 50.549999999999997 118.97 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.13 -23.15 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.129 -1.396 . . . . 50.509999999999998 107.518 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 64.5 mttm -88.73 -26.68 21.65 Favored 'General case' 0 C--O 1.257 1.474 0 N-CA-C 118.272 2.693 . . . . 50.509999999999998 118.272 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -23.7 24.29 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.901 -0.407 . . . . 50.509999999999998 109.901 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.87 -49.69 73.84 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 120.333 -1.48 . . . . 50.509999999999998 111.41 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.42 -36.96 48.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 108.575 -0.898 . . . . 50.509999999999998 108.575 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.47 -45.19 73.13 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.578 2.608 . . . . 50.549999999999997 115.682 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -52.64 -29.55 26.83 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 106.387 -1.709 . . . . 50.619999999999997 106.387 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.72 -45.48 11.61 Favored 'General case' 0 C--O 1.279 2.656 0 C-N-CA 116.433 -2.107 . . . . 50.509999999999998 113.243 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -116.78 -36.67 3.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 123.107 2.685 . . . . 50.619999999999997 112.321 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.86 31.32 2.74 Favored Glycine 0 CA--C 1.477 -2.291 0 N-CA-C 110.512 -1.035 . . . . 50.509999999999998 110.512 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -83.09 122.92 77.89 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 105.273 -2.121 . . . . 50.509999999999998 105.273 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.4 Cg_exo -57.0 136.93 79.63 Favored 'Trans proline' 0 C--O 1.258 1.514 0 C-N-CA 123.228 2.618 . . . . 50.509999999999998 110.838 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.3 Cg_exo -57.18 -32.19 92.77 Favored 'Trans proline' 0 C--O 1.262 1.688 0 O-C-N 122.885 0.939 . . . . 50.509999999999998 113.418 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -89.25 27.57 1.39 Allowed 'General case' 0 C--O 1.262 1.75 0 O-C-N 119.981 -1.699 . . . . 50.619999999999997 115.06 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -137.8 14.03 2.91 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 104.384 -2.45 . . . . 50.549999999999997 104.384 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.513 ' HG2' HD11 ' A' ' 69' ' ' LEU . 58.7 mt-30 -110.39 137.79 47.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.948 -2.242 . . . . 50.549999999999997 104.948 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -131.62 108.88 9.82 Favored 'General case' 0 C--O 1.296 3.537 0 CA-C-O 116.676 -1.63 . . . . 50.640000000000001 112.564 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.0 mt -90.42 131.22 36.31 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 116.63 2.085 . . . . 50.509999999999998 116.63 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.713 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -107.0 137.9 35.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.509999999999998 113.524 -177.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -149.4 112.39 4.87 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 114.55 -1.204 . . . . 50.509999999999998 113.78 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 46.05 27.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.215 -2.266 . . . . 50.509999999999998 113.31 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.93 -6.07 56.63 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 128.384 2.897 . . . . 50.509999999999998 114.763 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -97.47 158.9 15.24 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 117.412 2.375 . . . . 50.509999999999998 117.412 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -96.17 139.96 31.57 Favored 'General case' 0 C--O 1.259 1.554 0 N-CA-C 105.644 -1.984 . . . . 50.549999999999997 105.644 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -95.84 127.79 42.16 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 117.72 -1.133 . . . . 50.509999999999998 112.554 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . 57.5 mt-10 -85.55 139.39 31.49 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.891 1.369 . . . . 50.619999999999997 113.79 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -53.88 -50.21 66.82 Favored 'General case' 0 C--O 1.264 1.86 0 C-N-CA 126.171 1.788 . . . . 50.619999999999997 114.38 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.3 -4.58 44.66 Favored Glycine 0 CA--C 1.493 -1.321 0 C-N-CA 124.457 1.027 . . . . 50.509999999999998 113.999 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.99 150.0 21.63 Favored 'General case' 0 C--O 1.249 1.072 0 O-C-N 119.858 -1.966 . . . . 50.640000000000001 108.92 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -83.47 -179.19 7.29 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.08 0.952 . . . . 50.509999999999998 110.398 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.38 -29.12 31.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.821 -1.548 . . . . 50.509999999999998 106.821 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 m -73.78 -37.37 65.0 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 106.904 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -46.92 -16.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.334 1.064 . . . . 50.619999999999997 112.88 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 91.1 m-85 -121.71 -6.12 9.14 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 113.613 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 66.31 41.65 3.29 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 117.569 2.433 . . . . 50.549999999999997 117.569 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -82.14 124.41 39.15 Favored 'Isoleucine or valine' 0 C--O 1.267 1.978 0 CA-C-O 115.287 -2.292 . . . . 50.509999999999998 110.174 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.67 168.68 9.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 126.018 2.073 . . . . 50.549999999999997 115.893 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -36.54 146.2 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 123.277 1.513 . . . . 50.509999999999998 113.569 -176.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 50.31 34.93 9.63 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-N 112.469 -2.15 . . . . 50.619999999999997 115.885 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 t -76.8 154.07 34.29 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.802 -1.09 . . . . 50.509999999999998 108.659 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 m -119.99 123.6 43.89 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.734 -1.209 . . . . 50.509999999999998 107.734 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.7 mt -94.85 147.88 22.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.696 -2.573 . . . . 50.509999999999998 111.47 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.713 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.0 m-70 -95.93 119.28 34.13 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 127.454 2.971 . . . . 50.509999999999998 108.781 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD11 ' HG2' ' A' ' 41' ' ' GLN . 33.1 tp -98.51 110.53 23.11 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 107.08 -1.452 . . . . 50.509999999999998 107.08 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 44' ' ' ILE . 45.6 t -93.81 165.17 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 101.499 -3.519 . . . . 50.509999999999998 101.499 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.3 mt -117.21 139.98 50.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.884 -0.784 . . . . 50.509999999999998 108.884 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -131.33 91.67 3.06 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-O 113.405 -3.188 . . . . 50.640000000000001 107.094 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -85.15 157.23 20.72 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 125.778 1.924 . . . . 50.509999999999998 110.066 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -90.53 113.2 25.13 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 105.543 -2.021 . . . . 50.640000000000001 105.543 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.65 155.81 14.52 Favored Glycine 0 C--O 1.243 0.682 0 CA-C-N 114.662 -1.154 . . . . 50.509999999999998 113.581 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.323 -2.376 . . . . 50.509999999999998 113.473 179.214 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 106.471 -1.678 . . . . 50.509999999999998 106.471 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.411 ' HG2' ' HG2' ' A' ' 16' ' ' GLU . 82.1 mt-30 -102.5 131.82 48.96 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 126.952 2.658 . . . . 50.549999999999997 108.424 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.73 163.95 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 CA-C-O 115.961 -1.971 . . . . 50.509999999999998 112.534 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.407 ' CD1' HG22 ' A' ' 14' ' ' THR . 79.0 m-85 -108.44 141.51 40.19 Favored 'General case' 0 N--CA 1.511 2.608 1 O-C-N 130.49 4.869 . . . . 50.509999999999998 116.756 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -116.72 120.16 64.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 113.356 -3.212 . . . . 50.509999999999998 106.065 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.32 117.38 34.0 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.326 4.141 . . . . 50.509999999999998 112.825 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 69.4 p -84.54 -174.46 5.28 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 117.774 -1.108 . . . . 50.509999999999998 108.723 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.74 -8.9 58.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.516 2.784 . . . . 50.509999999999998 118.516 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -122.65 22.86 9.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 115.74 -2.384 . . . . 50.509999999999998 116.791 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.03 22.16 21.03 Favored Glycine 0 C--N 1.297 -1.609 0 O-C-N 119.225 -2.172 . . . . 50.509999999999998 118.183 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 80.0 tttt -100.54 124.13 45.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 116.823 -1.56 . . . . 50.509999999999998 108.417 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.47 135.29 53.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 126.668 2.48 . . . . 50.509999999999998 106.369 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.3 pt -123.31 153.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 127.565 3.04 . . . . 50.509999999999998 103.594 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.407 HG22 ' CD1' ' A' ' 4' ' ' PHE . 70.2 p -117.1 139.04 51.2 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 117.266 -1.774 . . . . 50.509999999999998 107.862 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -126.3 137.96 53.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 115.454 -2.212 . . . . 50.509999999999998 107.446 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HG2' ' HG2' ' A' ' 2' ' ' GLN . 46.8 mt-10 -96.24 133.14 40.95 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.231 4.082 . . . . 50.619999999999997 109.407 173.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.42 170.62 19.03 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.631 3.082 . . . . 50.509999999999998 113.57 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -124.09 153.5 68.03 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.215 -2.266 . . . . 50.619999999999997 111.165 174.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.01 -24.5 40.1 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 122.623 2.215 . . . . 50.509999999999998 111.906 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.0 p -89.01 8.32 30.27 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 117.243 2.312 . . . . 50.509999999999998 117.243 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.84 137.73 32.99 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 118.648 2.833 . . . . 50.619999999999997 118.648 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 25' ' ' ASN . 32.8 p -86.89 137.17 32.61 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.834 -0.621 . . . . 50.509999999999998 111.95 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -42.6 -35.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.26 2.85 . . . . 50.509999999999998 112.932 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.47 -11.79 58.73 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.488 -0.757 . . . . 50.619999999999997 111.077 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' THR . 31.3 t30 -108.56 -14.48 14.63 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.251 1.02 . . . . 50.549999999999997 109.814 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.1 t -81.47 -44.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 103.701 -2.703 . . . . 50.509999999999998 103.701 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 50.9 mtmt -66.88 -33.54 75.81 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.769 -0.65 . . . . 50.509999999999998 110.203 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.04 73.88 Favored 'General case' 0 C--O 1.279 2.627 0 N-CA-C 108.324 -0.991 . . . . 50.509999999999998 108.324 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.1 mttt -47.16 -28.35 1.79 Allowed 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.368 -1.458 . . . . 50.509999999999998 113.826 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -80.23 -49.76 18.45 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 C-N-CA 119.496 -0.882 . . . . 50.509999999999998 109.861 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' ILE . 18.0 tm0? -38.63 -51.14 1.64 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 125.572 2.605 . . . . 50.549999999999997 112.061 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -54.69 -39.17 67.87 Favored 'General case' 0 C--O 1.253 1.24 0 N-CA-C 117.499 2.407 . . . . 50.619999999999997 117.499 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -109.59 -7.88 15.06 Favored 'General case' 0 C--O 1.279 2.653 0 C-N-CA 116.425 -2.11 . . . . 50.509999999999998 111.687 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' HG3' HG12 ' A' ' 36' ' ' ILE . 32.3 tp10 -108.6 -31.54 7.73 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 123.108 2.686 . . . . 50.619999999999997 107.77 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.99 7.4 85.52 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 109.488 -1.445 . . . . 50.509999999999998 109.488 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.559 HG12 ' HG3' ' A' ' 34' ' ' GLU . 30.4 mm -101.65 131.86 22.42 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 102.233 -3.247 . . . . 50.509999999999998 102.233 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.02 136.93 79.62 Favored 'Trans proline' 0 C--O 1.26 1.604 0 C-N-CA 123.192 2.595 . . . . 50.509999999999998 110.908 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.627 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.7 Cg_exo -57.15 -32.16 92.6 Favored 'Trans proline' 0 C--O 1.262 1.677 0 O-C-N 122.846 0.919 . . . . 50.509999999999998 113.44 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.09 2.82 3.22 Favored 'General case' 0 C--O 1.261 1.7 0 O-C-N 119.909 -1.744 . . . . 50.619999999999997 112.957 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -127.58 35.97 4.44 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.59 -1.319 . . . . 50.549999999999997 113.765 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.22 134.71 55.2 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 124.447 2.07 . . . . 50.549999999999997 111.514 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 54.8 ttm-85 -99.94 124.04 44.84 Favored 'General case' 0 C--O 1.298 3.613 0 CA-C-O 116.635 -1.65 . . . . 50.640000000000001 110.22 172.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.23 121.44 42.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.504 1.047 . . . . 50.509999999999998 110.749 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.13 123.39 60.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 125.174 1.546 . . . . 50.509999999999998 113.674 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.77 112.21 17.05 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 114.616 -1.175 . . . . 50.509999999999998 110.196 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.68 27.8 7.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 112.24 -2.254 . . . . 50.509999999999998 110.586 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.97 33.26 59.9 Favored Glycine 0 C--N 1.3 -1.453 0 C-N-CA 128.411 2.91 . . . . 50.509999999999998 117.476 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -119.03 148.88 42.53 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 104.741 -2.318 . . . . 50.509999999999998 104.741 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -88.04 135.75 33.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 119.797 3.258 . . . . 50.549999999999997 119.797 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.38 155.5 16.71 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 101.484 -3.525 . . . . 50.509999999999998 101.484 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -130.71 157.19 43.47 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 125.02 1.45 . . . . 50.619999999999997 108.242 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.01 -34.92 77.41 Favored 'General case' 0 C--O 1.264 1.833 0 C-N-CA 126.19 1.796 . . . . 50.619999999999997 109.38 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.39 9.21 4.58 Favored Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 124.426 1.013 . . . . 50.509999999999998 113.156 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -124.29 162.56 23.49 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 120.941 3.682 . . . . 50.640000000000001 120.941 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -80.43 173.76 12.28 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.028 0.931 . . . . 50.509999999999998 109.419 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 tp -88.85 -20.14 25.01 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.04 -1.096 . . . . 50.509999999999998 108.04 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 m -79.56 -36.69 37.87 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.362 -1.735 . . . . 50.509999999999998 112.665 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -53.13 -17.26 1.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 117.082 2.253 . . . . 50.619999999999997 117.082 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -93.38 12.0 26.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.823 -1.084 . . . . 50.509999999999998 110.836 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.37 33.08 3.59 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 116.533 2.049 . . . . 50.549999999999997 116.533 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -82.26 114.8 23.71 Favored 'Isoleucine or valine' 0 C--O 1.265 1.907 0 CA-C-O 115.268 -2.301 . . . . 50.509999999999998 112.346 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -110.33 -166.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.125 2.141 . . . . 50.549999999999997 111.126 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 78.7 tttt -74.16 134.65 42.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.177 1.465 . . . . 50.509999999999998 108.792 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 53.0 mt-10 67.55 44.23 1.75 Allowed 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.537 -2.12 . . . . 50.619999999999997 114.35 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -88.21 167.28 13.72 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 105.464 -2.05 . . . . 50.509999999999998 105.464 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -121.35 112.31 18.41 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 118.253 -0.879 . . . . 50.509999999999998 110.982 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.3 mt -99.7 141.68 32.18 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.729 -2.558 . . . . 50.509999999999998 109.56 175.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -95.1 134.81 37.4 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.347 2.905 . . . . 50.509999999999998 111.788 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -105.31 114.98 29.49 Favored 'General case' 0 C--O 1.283 2.861 0 CA-C-O 117.611 -1.185 . . . . 50.509999999999998 110.902 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.7 t -104.83 137.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.171 -1.788 . . . . 50.509999999999998 106.171 175.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.0 tp -79.86 128.68 33.74 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.252 0.549 . . . . 50.509999999999998 110.331 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 -103.28 107.41 18.22 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-O 113.428 -3.177 . . . . 50.640000000000001 110.041 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.92 143.1 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 125.791 1.932 . . . . 50.509999999999998 109.533 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -105.51 59.95 0.67 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.743 -1.571 . . . . 50.640000000000001 110.21 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.96 153.21 5.84 Favored Glycine 0 C--O 1.243 0.707 0 N-CA-C 107.926 -2.069 . . . . 50.509999999999998 107.926 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 CA-C-O 116.349 -2.362 . . . . 50.509999999999998 107.227 179.226 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 101.783 -3.414 . . . . 50.509999999999998 101.783 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -110.85 138.34 47.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 126.95 2.656 . . . . 50.549999999999997 105.433 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -133.07 155.69 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 115.928 -1.987 . . . . 50.509999999999998 113.867 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -93.63 144.41 25.41 Favored 'General case' 0 N--CA 1.512 2.663 1 O-C-N 130.442 4.839 . . . . 50.509999999999998 118.789 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.772 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.6 t -132.53 101.96 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.364 -3.208 . . . . 50.509999999999998 110.123 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.92 117.99 21.28 Favored 'General case' 0 N--CA 1.504 2.231 1 O-C-N 129.362 4.164 . . . . 50.509999999999998 117.225 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 11' ' ' LYS . 41.7 p -70.83 -172.72 0.69 Allowed 'General case' 0 C--N 1.351 0.673 0 N-CA-C 114.893 1.442 . . . . 50.509999999999998 114.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.78 11.78 38.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.854 -1.906 . . . . 50.509999999999998 105.854 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -122.45 -3.22 8.89 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 115.737 -2.385 . . . . 50.509999999999998 114.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 6.76 22.04 Favored Glycine 0 C--N 1.296 -1.665 0 O-C-N 120.103 -1.623 . . . . 50.509999999999998 113.617 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 45.0 mtmt -92.66 166.73 12.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 118.445 2.758 . . . . 50.509999999999998 118.445 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.0 p -125.15 158.69 33.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 126.658 2.474 . . . . 50.509999999999998 105.676 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.772 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 72.3 mt -131.27 111.18 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 127.415 2.947 . . . . 50.509999999999998 104.716 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -90.75 110.97 22.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.809 1.781 . . . . 50.509999999999998 115.809 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.3 mt -105.77 155.55 19.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 115.483 -2.198 . . . . 50.509999999999998 112.153 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.05 112.33 23.88 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 128.9 3.875 . . . . 50.619999999999997 112.23 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -117.25 169.45 7.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 O-C-N 127.743 3.152 . . . . 50.509999999999998 113.998 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -126.58 158.33 67.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 112.156 -2.293 . . . . 50.619999999999997 108.288 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 57' ' ' SER . 85.1 Cg_exo -54.93 -24.56 39.81 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.54 2.16 . . . . 50.509999999999998 111.969 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -87.09 -18.39 30.63 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 116.415 2.005 . . . . 50.509999999999998 116.415 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -70.86 135.73 48.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.898 1.814 . . . . 50.619999999999997 115.898 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.591 HG22 HG22 ' A' ' 55' ' ' THR . 72.3 p -78.85 168.42 19.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.947 1.832 . . . . 50.509999999999998 115.947 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 33.8 mm -62.69 -40.62 89.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 O-C-N 127.239 2.837 . . . . 50.509999999999998 109.34 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.94 -27.87 46.73 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 50.619999999999997 112.809 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.4 -27.85 20.15 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 114.84 1.422 . . . . 50.549999999999997 114.84 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.7 -41.63 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.024 1.453 . . . . 50.509999999999998 107.155 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -64.62 -28.0 69.32 Favored 'General case' 0 C--O 1.258 1.524 0 CA-C-N 115.845 -0.616 . . . . 50.509999999999998 111.524 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -29.6 59.73 Favored 'General case' 0 C--O 1.279 2.637 0 CA-C-N 118.088 0.404 . . . . 50.509999999999998 111.599 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.37 -31.34 69.67 Favored 'General case' 0 C--O 1.256 1.401 0 O-C-N 120.319 -1.488 . . . . 50.509999999999998 108.493 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.0 -34.67 71.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 107.091 -1.448 . . . . 50.509999999999998 107.091 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -56.36 -53.56 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 125.579 2.609 . . . . 50.549999999999997 117.578 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.28 -34.27 70.35 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 113.622 -1.626 . . . . 50.619999999999997 111.243 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.17 -28.57 21.13 Favored 'General case' 0 C--O 1.278 2.593 0 C-N-CA 116.434 -2.106 . . . . 50.509999999999998 109.737 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -117.22 -77.26 0.57 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 123.035 2.652 . . . . 50.619999999999997 109.059 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.09 23.51 0.48 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.572 -1.811 . . . . 50.509999999999998 108.572 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.7 mt -79.4 133.5 59.94 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.81 -1.156 . . . . 50.509999999999998 112.335 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.03 136.93 79.61 Favored 'Trans proline' 0 C--O 1.26 1.592 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.914 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.2 -32.1 92.53 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.857 0.925 . . . . 50.509999999999998 113.449 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 40' ' ' GLN . 6.9 p30 -76.71 -9.23 58.53 Favored 'General case' 0 C--O 1.262 1.746 0 O-C-N 119.94 -1.725 . . . . 50.619999999999997 109.297 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.427 ' HG3' ' OD1' ' A' ' 39' ' ' ASP . 79.9 mt-30 -103.01 19.06 20.22 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.422 1.638 . . . . 50.549999999999997 115.422 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -127.93 102.04 6.59 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 116.638 2.088 . . . . 50.549999999999997 116.638 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -99.35 132.51 44.63 Favored 'General case' 0 C--O 1.296 3.531 0 CA-C-O 116.742 -1.599 . . . . 50.640000000000001 109.381 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 mp -103.94 154.75 19.29 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.287 -2.486 . . . . 50.509999999999998 104.287 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.07 142.1 35.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.509999999999998 111.087 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -142.66 91.3 2.3 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 114.534 -1.212 . . . . 50.509999999999998 113.345 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.9 45.6 26.18 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 104.461 -2.422 . . . . 50.509999999999998 104.461 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 -18.13 6.99 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 128.386 2.898 . . . . 50.509999999999998 113.034 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -76.59 135.75 39.22 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 118.102 0.951 . . . . 50.509999999999998 111.418 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.85 129.22 35.14 Favored 'General case' 0 C--O 1.259 1.558 0 O-C-N 123.957 0.785 . . . . 50.549999999999997 110.968 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.8 mt -78.65 145.65 34.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 101.906 -3.368 . . . . 50.509999999999998 101.906 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -97.99 135.88 39.05 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.939 1.399 . . . . 50.619999999999997 108.538 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.5 m-20 -53.66 -49.59 67.63 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 126.151 1.78 . . . . 50.619999999999997 111.919 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.93 19.46 5.21 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.4 1.0 . . . . 50.509999999999998 113.9 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -113.0 156.69 22.61 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 103.069 -2.937 . . . . 50.640000000000001 103.069 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.591 HG22 HG22 ' A' ' 22' ' ' THR . 81.0 p -95.67 168.51 10.63 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.606 0.965 . . . . 50.509999999999998 113.606 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.16 -32.19 70.03 Favored 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.15 0.907 . . . . 50.509999999999998 109.358 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 90.9 p -74.13 -29.08 61.64 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.271 -1.772 . . . . 50.509999999999998 112.149 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.71 -29.33 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.431 1.11 . . . . 50.619999999999997 108.676 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -94.19 -5.21 47.54 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.809 -1.091 . . . . 50.509999999999998 112.291 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 53.93 51.33 14.94 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 121.552 1.978 . . . . 50.549999999999997 113.882 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -95.53 119.2 43.26 Favored 'Isoleucine or valine' 0 C--O 1.266 1.952 0 N-CA-C 102.218 -3.253 . . . . 50.509999999999998 102.218 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 -168.83 2.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.019 2.075 . . . . 50.549999999999997 111.213 -176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.635 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 84.2 tttt -79.07 143.76 35.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.185 1.469 . . . . 50.509999999999998 107.558 -176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.635 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 69.66 37.56 1.87 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.559 -2.109 . . . . 50.619999999999997 113.62 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -92.42 155.48 17.84 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.809 -1.087 . . . . 50.509999999999998 111.994 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -110.27 126.49 54.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 118.199 -0.905 . . . . 50.509999999999998 112.717 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.11 155.52 21.8 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 114.679 -2.581 . . . . 50.509999999999998 104.356 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -98.0 149.88 21.97 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 127.177 2.798 . . . . 50.509999999999998 112.998 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -102.2 126.68 49.25 Favored 'General case' 0 C--O 1.283 2.849 0 N-CA-C 104.9 -2.259 . . . . 50.509999999999998 104.9 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.63 146.24 28.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 105.861 -1.903 . . . . 50.509999999999998 105.861 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -114.09 107.57 15.83 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 119.869 3.285 . . . . 50.509999999999998 119.869 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -92.07 111.1 22.52 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.324 -3.227 . . . . 50.640000000000001 104.249 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.52 167.66 14.41 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 125.576 1.798 . . . . 50.509999999999998 110.907 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.0 mtm105 -102.85 86.42 2.73 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.72 -1.582 . . . . 50.640000000000001 108.321 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.95 147.51 22.78 Favored Glycine 0 C--O 1.244 0.726 0 CA-C-N 114.678 -1.146 . . . . 50.509999999999998 114.436 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.457 0 N-CA-C 106.023 -2.831 . . . . 50.509999999999998 106.023 179.232 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.458 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.547 0.86 0 CA-C-O 118.822 -0.609 . . . . 50.509999999999998 111.147 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -96.39 128.69 43.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 126.959 2.662 . . . . 50.549999999999997 113.368 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.67 152.44 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 115.972 -1.966 . . . . 50.509999999999998 107.561 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CD1' HG22 ' A' ' 14' ' ' THR . 97.3 m-85 -109.53 143.06 39.71 Favored 'General case' 0 N--CA 1.512 2.658 1 O-C-N 130.215 4.697 . . . . 50.509999999999998 115.202 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.12 98.18 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-O 113.425 -3.179 . . . . 50.509999999999998 113.771 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -72.86 114.92 11.54 Favored 'General case' 0 N--CA 1.503 2.224 1 O-C-N 129.297 4.123 . . . . 50.509999999999998 109.929 -178.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.44 ' HA ' HD23 ' A' ' 69' ' ' LEU . 68.7 p -72.04 -169.8 0.52 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-O 117.829 -1.081 . . . . 50.509999999999998 113.236 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.34 -47.1 7.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.756 -1.201 . . . . 50.509999999999998 107.756 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -70.59 2.17 4.37 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 115.732 -2.387 . . . . 50.509999999999998 115.586 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.81 -40.67 2.38 Favored Glycine 0 C--N 1.298 -1.541 0 N-CA-C 120.892 3.117 . . . . 50.509999999999998 120.892 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -42.09 131.33 3.48 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 116.902 -1.523 . . . . 50.509999999999998 108.125 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.0 p -101.59 138.15 38.97 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 126.623 2.452 . . . . 50.509999999999998 112.184 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 pt -120.16 146.79 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 127.507 3.004 . . . . 50.509999999999998 109.399 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.443 HG22 ' CD1' ' A' ' 4' ' ' PHE . 80.8 p -120.6 128.03 52.66 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.249 -1.78 . . . . 50.509999999999998 109.583 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 29' ' ' LYS . 50.0 mt -103.8 148.48 26.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 115.542 -2.171 . . . . 50.509999999999998 110.37 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -106.41 103.2 12.61 Favored 'General case' 0 N--CA 1.501 2.089 1 O-C-N 129.28 4.112 . . . . 50.619999999999997 104.954 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 1' ' ' MET . 33.7 m -101.65 164.54 2.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.69 3.119 . . . . 50.509999999999998 112.915 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' HG3' ' HB2' ' A' ' 21' ' ' ASP . 6.4 pt-20 -137.33 151.33 71.23 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.164 -2.289 . . . . 50.619999999999997 112.798 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.97 -24.5 39.77 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 122.587 2.191 . . . . 50.509999999999998 111.949 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -98.38 21.85 10.51 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 118.208 -0.901 . . . . 50.509999999999998 110.829 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 8.4 t70 -94.57 125.42 39.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 117.354 -1.738 . . . . 50.619999999999997 111.189 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.3 p -82.82 135.01 35.09 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.865 -0.607 . . . . 50.509999999999998 110.908 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.491 HG21 ' HA ' ' A' ' 52' ' ' ASP . 55.6 mt -37.56 -30.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.137 2.773 . . . . 50.509999999999998 117.552 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.21 -27.85 69.34 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.422 -0.798 . . . . 50.619999999999997 112.203 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.617 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 57.4 m-80 -86.08 -13.14 48.18 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.309 1.044 . . . . 50.549999999999997 112.4 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -78.18 -51.99 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.041 1.463 . . . . 50.509999999999998 110.256 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 91.5 mttt -58.04 -23.67 55.31 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.174 -0.676 . . . . 50.509999999999998 109.174 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.06 -34.79 17.84 Favored 'General case' 0 C--O 1.278 2.598 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 57.9 mttm -52.26 -38.62 58.72 Favored 'General case' 0 C--O 1.257 1.459 0 N-CA-C 106.291 -1.744 . . . . 50.509999999999998 106.291 175.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.9 -33.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 107.56 -1.274 . . . . 50.509999999999998 107.56 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 125.583 2.611 . . . . 50.549999999999997 113.525 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -58.36 -25.57 62.15 Favored 'General case' 0 C--O 1.254 1.322 0 N-CA-C 119.087 2.995 . . . . 50.619999999999997 119.087 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -108.81 -27.25 9.86 Favored 'General case' 0 C--O 1.28 2.659 0 C-N-CA 116.385 -2.126 . . . . 50.509999999999998 113.917 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -108.75 -29.15 8.83 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.056 2.662 . . . . 50.619999999999997 113.529 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.94 42.88 4.59 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 111.247 -0.741 . . . . 50.509999999999998 111.247 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 94.4 mt -117.95 125.2 28.15 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.597 -1.261 . . . . 50.509999999999998 107.597 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.05 136.97 79.82 Favored 'Trans proline' 0 C--O 1.259 1.559 0 C-N-CA 123.106 2.537 . . . . 50.509999999999998 110.95 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 85.9 Cg_exo -57.17 -32.07 92.37 Favored 'Trans proline' 0 C--O 1.26 1.619 0 O-C-N 122.828 0.909 . . . . 50.509999999999998 113.51 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.26 -20.35 64.16 Favored 'General case' 0 C--O 1.262 1.756 0 O-C-N 119.982 -1.699 . . . . 50.619999999999997 109.542 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -94.89 7.48 45.85 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.526 -1.358 . . . . 50.549999999999997 113.45 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -115.87 119.32 35.58 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 110.925 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.469 HH11 ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp85 -106.33 138.18 42.97 Favored 'General case' 0 C--O 1.295 3.486 0 CA-C-O 116.651 -1.642 . . . . 50.640000000000001 107.716 172.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.9 mt -115.2 105.97 13.53 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.987 1.847 . . . . 50.509999999999998 115.987 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 61.5 mt -110.55 130.37 63.98 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 O-C-N 125.254 1.596 . . . . 50.509999999999998 111.633 -177.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -145.83 126.01 13.82 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 115.293 1.59 . . . . 50.509999999999998 115.293 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.11 28.24 17.02 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.261 -2.245 . . . . 50.509999999999998 107.43 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.7 30.41 77.25 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 128.37 2.89 . . . . 50.509999999999998 111.595 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.48 135.6 53.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.455 -2.054 . . . . 50.509999999999998 105.455 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.35 113.9 9.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.946 0.779 . . . . 50.549999999999997 111.186 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.503 HD22 ' CE2' ' A' ' 59' ' ' TYR . 37.5 mt -75.49 113.84 13.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 117.722 -1.132 . . . . 50.509999999999998 112.296 -175.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -89.53 126.08 35.45 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.822 1.326 . . . . 50.619999999999997 109.598 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' HA ' HG21 ' A' ' 23' ' ' ILE . 27.7 p-10 -45.36 -38.93 6.28 Favored 'General case' 0 C--O 1.263 1.805 0 C-N-CA 126.14 1.776 . . . . 50.619999999999997 111.549 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.52 37.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 108.655 -1.778 . . . . 50.509999999999998 108.655 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -94.64 165.67 12.39 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 119.949 -1.912 . . . . 50.640000000000001 115.838 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -99.87 166.08 11.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.152 -1.055 . . . . 50.509999999999998 108.152 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -86.43 -39.72 16.07 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 104.193 -2.521 . . . . 50.509999999999998 104.193 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -52.64 -53.04 52.47 Favored 'General case' 0 C--O 1.268 2.058 0 C-N-CA 117.356 -1.738 . . . . 50.509999999999998 113.979 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.42 -28.28 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 120.635 3.568 . . . . 50.619999999999997 120.635 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.503 ' CE2' HD22 ' A' ' 50' ' ' LEU . 42.2 m-85 -82.1 13.1 3.61 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.764 -1.112 . . . . 50.509999999999998 109.511 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.57 32.26 20.38 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 121.442 1.928 . . . . 50.549999999999997 108.95 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.71 133.1 30.14 Favored 'Isoleucine or valine' 0 C--O 1.267 1.989 0 CA-C-O 115.146 -2.359 . . . . 50.509999999999998 113.362 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.406 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 57.7 mt-30 -134.81 -159.34 0.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 125.856 1.972 . . . . 50.549999999999997 110.636 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 63.2 tttm -69.15 149.88 48.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.257 1.503 . . . . 50.509999999999998 109.628 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.627 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 47.67 65.48 1.27 Allowed 'General case' 0 C--O 1.257 1.45 0 CA-C-N 112.42 -2.173 . . . . 50.619999999999997 113.981 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -122.97 125.57 45.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.921 -1.141 . . . . 50.509999999999998 107.921 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -81.67 133.68 35.39 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 117.186 2.291 . . . . 50.509999999999998 117.186 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.32 135.88 48.08 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 114.688 -2.577 . . . . 50.509999999999998 114.45 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.546 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -71.55 133.0 45.48 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 127.365 2.915 . . . . 50.509999999999998 115.619 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 7' ' ' THR . 30.6 tp -104.95 96.99 6.92 Favored 'General case' 0 C--O 1.282 2.809 0 N-CA-C 115.792 1.775 . . . . 50.509999999999998 115.792 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.53 123.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.857 -1.164 . . . . 50.509999999999998 107.857 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt -73.12 159.23 33.87 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.946 1.091 . . . . 50.509999999999998 113.946 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.469 ' HD2' HH11 ' A' ' 42' ' ' ARG . 77.8 ttt-85 -136.96 77.19 1.63 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 113.404 -3.188 . . . . 50.640000000000001 111.964 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.42 155.34 15.09 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 116.795 2.146 . . . . 50.509999999999998 116.795 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -110.39 85.53 2.13 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.714 -1.585 . . . . 50.640000000000001 107.073 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.26 160.9 13.61 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 107.691 -2.164 . . . . 50.509999999999998 107.691 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 CA-C-O 116.308 -2.385 . . . . 50.509999999999998 110.446 179.174 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.549999999999997 105.792 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.509999999999998 105.226 173.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.509999999999998 111.097 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.509999999999998 110.321 175.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.509999999999998 108.6 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 113.379 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.509999999999998 115.964 -177.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.509999999999998 111.276 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.509999999999998 114.048 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.509999999999998 102.065 174.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.509999999999998 107.975 176.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.509999999999998 108.441 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 110.2 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.447 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.509999999999998 118.562 -179.268 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.619999999999997 108.62 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.509999999999998 114.132 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.619999999999997 106.711 174.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.509999999999998 111.935 177.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.509999999999998 116.813 -177.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.619999999999997 109.138 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.509999999999998 107.045 175.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.509999999999998 110.561 175.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.619999999999997 113.229 177.002 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.549999999999997 110.044 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.509999999999998 107.759 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.509999999999998 106.412 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.509999999999998 109.249 176.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.509999999999998 111.346 176.077 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.447 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.509999999999998 110.973 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.549999999999997 112.509 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.619999999999997 116.389 179.097 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.509999999999998 111.864 -175.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 117.592 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.509999999999998 114.888 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.509999999999998 109.747 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.509999999999998 110.864 178.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.394 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.619999999999997 114.605 -177.389 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.637 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.549999999999997 107.838 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.549999999999997 119.467 -177.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.640000000000001 109.52 172.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.509999999999998 115.444 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.509999999999998 113.347 -177.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.509999999999998 111.83 177.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 113.518 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.509999999999998 115.209 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.509999999999998 114.25 177.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.549999999999997 117.72 174.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.509999999999998 119.412 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.619999999999997 106.675 -177.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.619999999999997 118.064 -175.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.509999999999998 112.981 -177.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.640000000000001 112.921 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.509999999999998 106.383 177.108 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.509999999999998 114.586 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.509999999999998 111.793 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.619999999999997 114.68 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.509999999999998 113.892 179.276 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.549999999999997 110.922 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.509999999999998 112.515 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.549999999999997 116.774 -176.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.509999999999998 113.522 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.619999999999997 110.901 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.509999999999998 110.249 174.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.509999999999998 101.589 175.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.509999999999998 106.251 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 71' ' ' LEU . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.509999999999998 111.961 176.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.509999999999998 104.421 175.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.509999999999998 115.767 178.435 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.640000000000001 106.516 177.224 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' HE21 ' A' ' 40' ' ' GLN . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.509999999999998 105.632 -179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.640000000000001 107.378 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.509999999999998 119.036 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.509999999999998 104.312 179.258 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.549999999999997 105.792 178.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.509999999999998 105.226 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.509999999999998 111.097 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.509999999999998 110.321 175.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.509999999999998 108.6 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 113.379 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.509999999999998 115.964 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.509999999999998 111.276 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.509999999999998 114.048 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.509999999999998 102.065 174.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.509999999999998 107.975 176.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.509999999999998 108.441 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 110.2 178.106 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.447 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.509999999999998 118.562 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.619999999999997 108.62 174.005 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.509999999999998 114.132 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.619999999999997 106.711 174.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.509999999999998 111.935 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.509999999999998 116.813 -177.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.619999999999997 109.138 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.509999999999998 107.045 175.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.509999999999998 110.561 175.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.619999999999997 113.229 177.002 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.549999999999997 110.044 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.509999999999998 107.759 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.509999999999998 106.412 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.509999999999998 109.249 176.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.509999999999998 111.346 176.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.447 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.509999999999998 110.973 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.549999999999997 112.509 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.619999999999997 116.389 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.509999999999998 111.864 -175.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 117.592 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.509999999999998 114.888 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.509999999999998 109.747 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.509999999999998 110.864 178.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.394 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.619999999999997 114.605 -177.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.637 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.549999999999997 107.838 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.549999999999997 119.467 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.640000000000001 109.52 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.509999999999998 115.444 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.509999999999998 113.347 -177.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.509999999999998 111.83 177.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 113.518 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.509999999999998 115.209 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.509999999999998 114.25 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.549999999999997 117.72 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.509999999999998 119.412 -175.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.619999999999997 106.675 -177.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.619999999999997 118.064 -175.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.509999999999998 112.981 -177.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.640000000000001 112.921 176.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.509999999999998 106.383 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.509999999999998 114.586 177.19 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.509999999999998 111.793 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.619999999999997 114.68 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.509999999999998 113.892 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.549999999999997 110.922 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.509999999999998 112.515 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.549999999999997 116.774 -176.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.509999999999998 113.522 -176.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.619999999999997 110.901 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.509999999999998 110.249 174.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 176.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.509999999999998 101.589 175.117 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.509999999999998 106.251 177.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 71' ' ' LEU . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.509999999999998 111.961 176.615 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.509999999999998 104.421 175.142 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.509999999999998 115.767 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.640000000000001 106.516 177.224 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' HE21 ' A' ' 40' ' ' GLN . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.509999999999998 105.632 -179.256 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.640000000000001 107.378 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.509999999999998 119.036 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.509999999999998 104.312 179.258 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.0 mtp . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 115.228 1.566 . . . . 50.509999999999998 115.228 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -88.72 118.09 28.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 126.99 2.681 . . . . 50.549999999999997 117.707 178.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.523 HD11 HD22 ' A' ' 67' ' ' LEU . 14.7 tt -122.01 161.57 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 115.935 -1.983 . . . . 50.509999999999998 109.47 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.421 ' N ' HG12 ' A' ' 3' ' ' ILE . 79.1 m-85 -130.3 128.98 42.63 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 129.667 4.354 . . . . 50.509999999999998 113.461 179.548 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -108.91 109.82 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 113.419 -3.182 . . . . 50.509999999999998 112.584 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -87.2 134.28 33.55 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.371 4.169 . . . . 50.509999999999998 106.23 -178.055 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.1 p -99.77 -168.47 1.61 Allowed 'General case' 0 C--N 1.351 0.651 0 N-CA-C 114.385 1.254 . . . . 50.509999999999998 114.385 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 mt -90.15 24.27 2.56 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.125 0.891 . . . . 50.509999999999998 111.979 -178.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -139.79 10.95 2.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 115.747 -2.381 . . . . 50.509999999999998 110.231 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.83 12.66 81.04 Favored Glycine 0 C--N 1.297 -1.604 0 O-C-N 119.303 -2.123 . . . . 50.509999999999998 114.738 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.64 139.47 30.66 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.533 -2.025 . . . . 50.509999999999998 105.533 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -120.9 119.62 33.14 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 126.586 2.429 . . . . 50.509999999999998 112.064 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.411 HD12 HD11 ' A' ' 15' ' ' LEU . 17.1 pt -94.75 144.3 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.346 2.904 . . . . 50.509999999999998 116.312 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -100.32 128.79 46.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.313 -1.755 . . . . 50.509999999999998 114.569 178.077 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD11 HD12 ' A' ' 13' ' ' ILE . 1.5 mp -114.24 145.23 42.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 115.463 -2.208 . . . . 50.509999999999998 116.629 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.15 89.58 3.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 129.065 3.978 . . . . 50.619999999999997 116.324 173.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.441 HG11 HG22 ' A' ' 26' ' ' VAL . 35.0 m -120.79 148.17 24.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 N-CA-C 120.095 3.368 . . . . 50.509999999999998 120.095 -177.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.65 151.47 37.46 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 112.198 -2.274 . . . . 50.619999999999997 111.017 174.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.89 -24.55 39.49 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.562 2.175 . . . . 50.509999999999998 111.962 177.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -73.23 -13.09 61.08 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.487 -2.042 . . . . 50.509999999999998 105.487 -177.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.531 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 75.6 m-20 -68.64 138.49 55.05 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 117.323 -1.751 . . . . 50.619999999999997 115.301 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -106.3 174.16 6.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.853 -0.612 . . . . 50.509999999999998 109.689 175.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -51.18 -46.66 32.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 O-C-N 127.138 2.774 . . . . 50.509999999999998 111.886 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -51.8 -38.13 54.43 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.802 -0.814 . . . . 50.619999999999997 108.802 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -79.53 -41.47 27.25 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 120.185 3.402 . . . . 50.549999999999997 120.185 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.441 HG22 HG11 ' A' ' 17' ' ' VAL . 40.6 t -72.71 -44.32 59.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.085 1.491 . . . . 50.509999999999998 114.531 178.549 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.87 -29.94 68.35 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 107.787 -1.19 . . . . 50.509999999999998 107.787 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -49.2 77.73 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 108.517 -0.919 . . . . 50.509999999999998 108.517 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -44.95 -53.77 7.28 Favored 'General case' 0 C--O 1.255 1.361 0 O-C-N 120.396 -1.44 . . . . 50.509999999999998 109.322 176.002 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -57.96 -25.23 25.4 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 116.219 1.933 . . . . 50.509999999999998 116.219 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.439 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.9 tt0 -75.47 -19.66 59.29 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 125.587 2.613 . . . . 50.549999999999997 111.862 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.51 -45.28 8.2 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 113.589 -1.641 . . . . 50.619999999999997 113.724 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.93 -51.04 10.19 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.476 -2.09 . . . . 50.509999999999998 107.665 -175.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -91.97 -56.33 3.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.131 2.696 . . . . 50.619999999999997 110.814 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 120.17 4.21 11.33 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 111.616 -0.594 . . . . 50.509999999999998 111.616 176.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mm -69.44 123.05 87.61 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 118.852 -1.139 . . . . 50.509999999999998 109.38 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -57.02 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.539 0 C-N-CA 123.203 2.602 . . . . 50.509999999999998 110.846 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_exo -57.21 -32.09 92.53 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.914 0.955 . . . . 50.509999999999998 113.422 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -73.67 2.26 8.53 Favored 'General case' 0 C--O 1.261 1.675 0 N-CA-C 118.375 2.731 . . . . 50.619999999999997 118.375 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -115.69 -9.23 11.98 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.536 -1.352 . . . . 50.549999999999997 108.153 178.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -81.25 143.28 32.4 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 124.384 2.04 . . . . 50.549999999999997 115.24 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -131.95 114.78 15.03 Favored 'General case' 0 C--O 1.296 3.506 0 N-CA-C 105.833 -1.914 . . . . 50.640000000000001 105.833 172.171 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 50' ' ' LEU . 95.5 mt -107.32 123.89 49.0 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.539 1.063 . . . . 50.509999999999998 111.324 -177.499 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.08 132.63 61.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 O-C-N 125.174 1.546 . . . . 50.509999999999998 112.57 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.56 ' CE2' HG12 ' A' ' 61' ' ' ILE . 45.2 t80 -142.33 112.61 7.1 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 114.575 -1.193 . . . . 50.509999999999998 108.987 177.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 75.64 18.64 2.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 112.227 -2.26 . . . . 50.509999999999998 108.501 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.3 -2.01 85.84 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.431 2.92 . . . . 50.509999999999998 110.513 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -85.66 121.55 28.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 118.045 0.923 . . . . 50.509999999999998 111.156 177.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -61.93 137.71 58.28 Favored 'General case' 0 C--O 1.26 1.61 0 N-CA-C 108.169 -1.049 . . . . 50.549999999999997 108.169 174.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 43' ' ' LEU . 37.5 mt -75.4 149.19 38.65 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.543 -1.28 . . . . 50.509999999999998 107.543 -175.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.15 150.89 28.83 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.996 1.435 . . . . 50.619999999999997 112.497 -177.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.99 -41.26 78.11 Favored 'General case' 0 C--O 1.264 1.826 0 N-CA-C 118.347 2.721 . . . . 50.619999999999997 118.347 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.41 5.0 67.34 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 120.212 2.845 . . . . 50.509999999999998 120.212 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.47 154.37 19.69 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 120.089 3.366 . . . . 50.640000000000001 120.089 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 41.5 p -93.09 151.9 19.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.39 -3.189 . . . . 50.509999999999998 102.39 177.103 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.4 mt -56.28 -36.58 68.77 Favored 'General case' 0 C--O 1.202 -1.425 0 O-C-N 124.19 0.931 . . . . 50.509999999999998 108.894 177.2 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -62.04 -31.07 71.44 Favored 'General case' 0 C--O 1.268 2.065 0 C-N-CA 117.331 -1.747 . . . . 50.509999999999998 109.04 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 55' ' ' THR . 88.7 m-20 -60.42 -10.17 4.54 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.405 1.098 . . . . 50.619999999999997 111.684 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -114.16 -14.9 12.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.094 -1.817 . . . . 50.509999999999998 106.094 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 48.44 56.77 7.03 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 121.522 1.965 . . . . 50.549999999999997 110.701 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.56 HG12 ' CE2' ' A' ' 45' ' ' PHE . 74.1 mt -78.33 105.95 8.25 Favored 'Isoleucine or valine' 0 C--O 1.267 1.997 0 N-CA-C 102.936 -2.987 . . . . 50.509999999999998 102.936 175.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.77 176.21 3.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 126.1 2.125 . . . . 50.549999999999997 107.713 -176.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -70.73 147.1 49.39 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 123.205 1.478 . . . . 50.509999999999998 110.572 -176.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 54.02 44.84 28.72 Favored 'General case' 0 C--O 1.258 1.526 0 CA-C-N 112.521 -2.127 . . . . 50.619999999999997 112.894 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -106.87 142.26 36.79 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.157 -1.794 . . . . 50.509999999999998 106.157 174.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.0 m -101.25 130.24 47.35 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 120.454 3.501 . . . . 50.509999999999998 120.454 175.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 3' ' ' ILE . 2.7 mp -95.38 149.7 21.08 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.68 -2.581 . . . . 50.509999999999998 114.761 175.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -102.31 132.93 47.97 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 126.969 2.668 . . . . 50.509999999999998 114.743 177.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -104.48 122.35 45.35 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.685 -1.15 . . . . 50.509999999999998 111.321 176.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -113.09 135.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.571 -1.641 . . . . 50.509999999999998 106.571 175.064 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.8 tp -93.83 100.11 12.36 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.497 1.666 . . . . 50.509999999999998 115.497 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -74.84 138.56 42.61 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 113.316 -3.231 . . . . 50.640000000000001 108.215 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 mt -111.86 139.2 47.54 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.804 1.94 . . . . 50.509999999999998 113.237 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -96.15 68.19 2.65 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 113.69 -1.596 . . . . 50.640000000000001 106.907 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.65 148.17 4.85 Favored Glycine 0 C--O 1.244 0.76 0 N-CA-C 107.145 -2.382 . . . . 50.509999999999998 107.145 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 116.361 -2.355 . . . . 50.509999999999998 110.4 179.246 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.877 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 61.2 mtm . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 105.248 -2.13 . . . . 50.509999999999998 105.248 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -70.42 144.62 51.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 127.003 2.689 . . . . 50.549999999999997 108.922 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.454 HD12 HD13 ' A' ' 67' ' ' LEU . 21.7 pt -132.24 164.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 N-CA-C 104.099 -2.556 . . . . 50.509999999999998 104.099 173.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.25 156.01 22.11 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.473 4.858 . . . . 50.509999999999998 109.296 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 67' ' ' LEU . 86.0 t -138.52 122.18 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.37 -3.205 . . . . 50.509999999999998 109.203 175.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 79.1 tttt -94.94 128.6 41.86 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.403 4.19 . . . . 50.509999999999998 114.904 -178.047 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.08 179.23 4.68 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-O 117.809 -1.091 . . . . 50.509999999999998 108.425 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.7 -12.19 58.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.93 2.937 . . . . 50.509999999999998 118.93 -177.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -90.48 -24.98 20.53 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 115.705 -2.398 . . . . 50.509999999999998 105.345 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.23 23.78 3.73 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 107.538 -2.225 . . . . 50.509999999999998 107.538 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -86.06 144.22 27.67 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.568 -2.012 . . . . 50.509999999999998 105.568 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.2 m -128.44 117.77 21.95 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 126.629 2.456 . . . . 50.509999999999998 110.992 176.16 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.7 pt -98.57 164.85 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 127.469 2.981 . . . . 50.509999999999998 113.557 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.6 p -121.59 144.1 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.256 -1.778 . . . . 50.509999999999998 108.483 178.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.441 HD22 ' HG3' ' A' ' 29' ' ' LYS . 78.4 mt -132.38 142.62 49.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 103.047 -2.946 . . . . 50.509999999999998 103.047 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.93 109.1 17.12 Favored 'General case' 0 N--CA 1.499 2.003 1 O-C-N 129.275 4.109 . . . . 50.619999999999997 102.972 173.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.74 156.22 31.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.74 3.15 . . . . 50.509999999999998 114.401 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 72.8 tt0 -88.37 139.81 30.18 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.175 -2.284 . . . . 50.619999999999997 107.746 174.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.759 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 85.5 Cg_exo -54.83 -24.57 39.11 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 122.552 2.168 . . . . 50.509999999999998 111.976 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -61.56 -26.06 67.71 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.241 -1.392 . . . . 50.509999999999998 107.241 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -59.76 136.52 58.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.353 -1.739 . . . . 50.619999999999997 114.831 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.6 p -79.11 171.59 14.99 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 117.834 -3.041 . . . . 50.509999999999998 110.062 175.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.19 -35.25 62.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 O-C-N 127.196 2.81 . . . . 50.509999999999998 109.281 175.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.3 -41.77 80.46 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.457 -0.777 . . . . 50.619999999999997 112.473 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -76.92 -50.23 13.77 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 115.099 1.518 . . . . 50.549999999999997 115.099 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 22' ' ' THR . 54.9 t -51.68 -39.31 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.958 1.411 . . . . 50.509999999999998 109.701 178.51 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 52.3 mtpt -61.71 -36.1 79.97 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 115.833 -0.621 . . . . 50.509999999999998 110.368 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.35 86.29 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 109.691 -0.485 . . . . 50.509999999999998 109.691 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HG3' HD22 ' A' ' 15' ' ' LEU . 50.9 tptt -57.97 -41.29 82.6 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.191 -1.781 . . . . 50.509999999999998 106.191 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.81 -49.17 81.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.54 -0.864 . . . . 50.509999999999998 111.674 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.767 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 22.0 tm0? -53.26 -56.83 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 117.944 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -46.32 -54.23 9.34 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 118.38 2.733 . . . . 50.619999999999997 118.38 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -81.16 -41.8 21.84 Favored 'General case' 0 C--O 1.279 2.638 0 C-N-CA 116.464 -2.095 . . . . 50.509999999999998 112.313 -175.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -86.75 -55.43 3.86 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.075 2.67 . . . . 50.619999999999997 110.958 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.88 -23.1 5.05 Favored Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 112.031 -0.428 . . . . 50.509999999999998 112.031 176.524 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 mm -53.68 113.86 5.48 Favored Pre-proline 0 C--O 1.245 0.854 0 C-N-CA 118.815 -1.154 . . . . 50.509999999999998 109.665 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.553 0 C-N-CA 123.181 2.588 . . . . 50.509999999999998 110.925 178.311 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.767 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 88.4 Cg_exo -57.32 -32.03 92.62 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -57.96 -18.12 21.49 Favored 'General case' 0 C--O 1.263 1.8 0 O-C-N 120.008 -1.683 . . . . 50.619999999999997 111.655 -177.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -113.53 11.34 18.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 120.631 3.567 . . . . 50.549999999999997 120.631 178.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -95.44 129.17 42.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 124.388 2.042 . . . . 50.549999999999997 111.987 -177.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 36.6 ttm180 -119.98 110.49 16.76 Favored 'General case' 0 C--O 1.295 3.477 0 N-CA-C 105.776 -1.935 . . . . 50.640000000000001 105.776 172.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.544 ' HB2' HD12 ' A' ' 50' ' ' LEU . 94.4 mt -101.62 129.7 47.8 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.441 1.019 . . . . 50.509999999999998 108.444 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.8 140.51 29.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.054 1.471 . . . . 50.509999999999998 111.994 -177.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -138.73 116.81 11.74 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.084 -2.191 . . . . 50.509999999999998 105.084 177.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.48 17.8 10.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.193 -2.276 . . . . 50.509999999999998 115.981 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.65 8.31 67.87 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 128.443 2.925 . . . . 50.509999999999998 109.279 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -100.36 112.81 25.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 118.071 0.936 . . . . 50.509999999999998 109.925 177.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -55.43 139.41 43.48 Favored 'General case' 0 C--O 1.259 1.581 0 N-CA-C 108.513 -0.921 . . . . 50.549999999999997 108.513 174.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 43' ' ' LEU . 80.9 mt -85.05 141.47 30.25 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.857 1.429 . . . . 50.509999999999998 114.857 -175.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.411 ' HB3' ' CG ' ' A' ' 54' ' ' ARG . 73.1 tt0 -84.65 126.8 33.68 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.923 1.389 . . . . 50.619999999999997 111.892 -177.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -50.9 -42.27 59.11 Favored 'General case' 0 C--O 1.264 1.818 0 C-N-CA 126.178 1.791 . . . . 50.619999999999997 109.743 -175.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.49 25.1 9.81 Favored Glycine 0 C--O 1.254 1.366 0 C-N-CA 124.442 1.02 . . . . 50.509999999999998 114.211 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CG ' ' HB3' ' A' ' 51' ' ' GLU . 29.3 mmt85 -116.33 164.69 14.15 Favored 'General case' 0 C--O 1.249 1.048 0 O-C-N 119.915 -1.932 . . . . 50.640000000000001 113.457 176.536 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 41.6 p -101.81 -178.74 3.81 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.111 0.965 . . . . 50.509999999999998 110.223 177.102 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.759 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 59.3 mt -79.94 -20.5 45.49 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.366 -0.975 . . . . 50.509999999999998 108.366 177.211 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.7 p -88.92 12.95 13.9 Favored 'General case' 0 C--O 1.268 2.077 0 C-N-CA 117.307 -1.757 . . . . 50.509999999999998 112.115 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -94.66 -36.24 11.85 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.449 1.119 . . . . 50.619999999999997 113.343 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.83 23.88 13.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 120.87 3.656 . . . . 50.509999999999998 120.87 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 56.08 46.64 21.26 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 111.377 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 61' ' ' ILE . 73.4 mt -101.01 85.54 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.009 0 CA-C-O 115.201 -2.333 . . . . 50.509999999999998 106.033 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 65' ' ' SER . 97.8 mm-40 -92.43 -177.07 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.099 2.124 . . . . 50.549999999999997 114.683 -176.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.877 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 60.3 pttt -57.76 143.55 41.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.18 1.467 . . . . 50.509999999999998 112.192 -176.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 65.78 31.55 9.47 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.502 -2.135 . . . . 50.619999999999997 109.887 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 95.7 p -80.23 164.34 23.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.813 -1.18 . . . . 50.509999999999998 107.813 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -123.58 131.9 53.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.268 -0.872 . . . . 50.509999999999998 108.791 175.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.1 mp -105.38 137.71 42.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.649 -2.595 . . . . 50.509999999999998 108.854 175.111 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -98.54 108.48 21.19 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 127.427 2.954 . . . . 50.509999999999998 107.195 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 33.2 tp -72.97 147.01 45.62 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.316 1.228 . . . . 50.509999999999998 114.316 176.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 63.4 t -138.42 142.85 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 102.787 -3.042 . . . . 50.509999999999998 102.787 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 mt -98.29 100.59 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.608 1.336 . . . . 50.509999999999998 114.608 178.364 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -69.95 104.1 2.43 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 113.338 -3.22 . . . . 50.640000000000001 112.11 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -83.56 165.07 19.38 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.767 1.917 . . . . 50.509999999999998 108.472 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -131.82 45.39 2.79 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.76 -1.564 . . . . 50.640000000000001 109.369 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.35 151.14 6.15 Favored Glycine 0 C--O 1.242 0.633 0 N-CA-C 108.027 -2.029 . . . . 50.509999999999998 108.027 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.463 0 N-CA-C 106.51 -2.636 . . . . 50.509999999999998 106.51 179.226 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 107.734 -1.21 . . . . 50.509999999999998 107.734 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -111.06 133.8 53.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 105.701 178.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.73 162.13 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 115.921 -1.99 . . . . 50.509999999999998 108.41 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -113.0 123.55 50.57 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.518 4.886 . . . . 50.509999999999998 110.598 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.28 112.02 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 113.427 -3.178 . . . . 50.509999999999998 118.975 175.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.64 133.97 34.81 Favored 'General case' 0 N--CA 1.504 2.252 1 O-C-N 129.363 4.164 . . . . 50.509999999999998 105.515 -178.104 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -115.08 171.63 7.55 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 117.781 -1.104 . . . . 50.509999999999998 109.466 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -65.05 -31.81 73.22 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.159 0.912 . . . . 50.509999999999998 109.949 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -74.84 -1.95 24.56 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 115.72 -2.392 . . . . 50.509999999999998 114.656 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.28 2.52 87.7 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.917 -1.673 . . . . 50.509999999999998 108.917 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.01 143.8 41.24 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.507 -1.584 . . . . 50.509999999999998 107.443 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -113.93 112.02 22.63 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 110.434 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -97.91 143.14 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.561 3.038 . . . . 50.509999999999998 113.765 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -108.18 144.73 35.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.267 -1.773 . . . . 50.509999999999998 111.923 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -140.7 129.27 22.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.466 -2.207 . . . . 50.509999999999998 109.002 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.83 144.12 41.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 128.947 3.904 . . . . 50.619999999999997 108.482 174.017 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -149.39 174.08 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 127.742 3.152 . . . . 50.509999999999998 112.14 -177.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 57.3 mm-40 -139.21 150.08 63.23 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.254 -2.248 . . . . 50.619999999999997 111.055 174.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -54.88 -24.6 39.64 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.634 2.223 . . . . 50.509999999999998 111.957 177.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.4 p -66.87 -38.74 86.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 105.985 -1.857 . . . . 50.509999999999998 105.985 -177.553 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 55' ' ' THR . 84.9 m-20 -44.92 155.21 0.11 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.981 2.215 . . . . 50.619999999999997 116.981 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 25' ' ' ASN . 33.1 p -119.01 138.18 53.01 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.252 -3.611 . . . . 50.509999999999998 101.252 175.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.664 HD11 HD23 ' A' ' 50' ' ' LEU . 25.5 mm -32.0 -42.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.123 2.764 . . . . 50.509999999999998 114.867 175.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -60.83 -34.15 74.11 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 50.619999999999997 111.08 176.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' THR . 91.3 m-20 -74.39 -28.93 61.32 Favored 'General case' 0 C--O 1.249 1.053 0 C-N-CA 124.321 1.048 . . . . 50.549999999999997 110.31 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -72.51 -51.88 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 125.039 1.462 . . . . 50.509999999999998 108.5 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.3 -36.66 84.77 Favored 'General case' 0 C--O 1.257 1.447 0 CA-C-N 115.717 -0.674 . . . . 50.509999999999998 109.342 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.61 79.44 Favored 'General case' 0 C--O 1.278 2.584 0 N-CA-C 121.133 3.753 . . . . 50.509999999999998 121.133 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -59.49 -41.63 90.3 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 120.404 -1.435 . . . . 50.509999999999998 107.679 176.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 30' ' ' ILE . 60.4 mt -64.22 -20.7 27.41 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 113.375 0.88 . . . . 50.509999999999998 113.375 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 33.4 tt0 -50.19 -41.41 49.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.546 2.593 . . . . 50.549999999999997 107.228 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 33' ' ' LYS . 29.3 t70 -81.78 -46.05 14.75 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 116.683 2.105 . . . . 50.619999999999997 116.683 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 32' ' ' ASP . 48.5 mmtm -51.27 -64.15 0.9 Allowed 'General case' 0 C--O 1.279 2.631 0 C-N-CA 116.501 -2.079 . . . . 50.509999999999998 108.394 -175.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -93.09 -41.33 10.02 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.048 2.658 . . . . 50.619999999999997 117.926 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 119.34 17.25 4.91 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 111.083 -0.807 . . . . 50.509999999999998 111.083 176.514 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 24.7 mm -94.9 117.79 66.81 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 118.73 -1.188 . . . . 50.509999999999998 110.546 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.0 136.98 79.92 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.154 2.569 . . . . 50.509999999999998 110.909 178.341 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.0 Cg_exo -57.26 -32.16 92.86 Favored 'Trans proline' 0 C--O 1.261 1.665 0 O-C-N 122.89 0.942 . . . . 50.509999999999998 113.371 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -67.33 -14.44 62.92 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 120.002 -1.686 . . . . 50.619999999999997 111.758 -177.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 58.9 mt-30 -98.64 11.41 38.55 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.54 -1.35 . . . . 50.549999999999997 113.001 178.733 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HG2' HD11 ' A' ' 69' ' ' LEU . 68.6 mt-30 -113.47 119.1 36.42 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 117.22 2.304 . . . . 50.549999999999997 117.22 -177.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.423 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.2 mtm180 -107.41 137.49 45.35 Favored 'General case' 0 C--O 1.296 3.543 0 CA-C-O 116.669 -1.634 . . . . 50.640000000000001 111.851 172.16 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 50' ' ' LEU . 23.2 mt -120.94 115.23 22.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.522 1.056 . . . . 50.509999999999998 111.809 -177.46 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.44 114.95 35.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 O-C-N 125.218 1.574 . . . . 50.509999999999998 113.496 -177.653 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 50' ' ' LEU . 39.9 t80 -140.76 117.05 10.67 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 114.555 -1.202 . . . . 50.509999999999998 109.983 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.36 23.97 13.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.16 -2.291 . . . . 50.509999999999998 113.03 177.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.59 0.27 89.87 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 110.603 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -103.99 108.28 19.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 116.09 1.885 . . . . 50.509999999999998 116.09 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -45.75 129.17 9.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.222 -1.029 . . . . 50.549999999999997 108.222 174.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 45' ' ' PHE . 5.8 mp -69.9 144.23 52.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 117.742 -1.123 . . . . 50.509999999999998 109.544 -175.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 42.6 mt-10 -94.47 145.44 24.79 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.886 1.366 . . . . 50.619999999999997 108.617 -177.613 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.6 -36.39 83.65 Favored 'General case' 0 C--O 1.263 1.805 0 N-CA-C 117.982 2.586 . . . . 50.619999999999997 117.982 -175.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.21 -26.05 49.52 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.411 1.005 . . . . 50.509999999999998 112.821 -177.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 25.6 mmm180 -59.71 173.76 0.53 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 119.957 -1.908 . . . . 50.640000000000001 111.275 176.433 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 21' ' ' ASP . 41.5 p -117.7 172.47 7.34 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 103.117 -2.92 . . . . 50.509999999999998 103.117 177.135 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.83 -26.84 64.42 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 106.117 -1.808 . . . . 50.509999999999998 106.117 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.1 p -67.3 -25.15 65.9 Favored 'General case' 0 C--O 1.268 2.062 0 C-N-CA 117.324 -1.751 . . . . 50.509999999999998 110.745 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 54' ' ' ARG . 47.0 m-20 -66.01 -36.8 84.27 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 118.883 2.92 . . . . 50.619999999999997 118.883 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.21 9.34 43.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 117.758 -1.115 . . . . 50.509999999999998 112.701 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 57.63 65.42 1.34 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 121.543 1.974 . . . . 50.549999999999997 115.113 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.19 93.35 4.21 Favored 'Isoleucine or valine' 0 C--O 1.266 1.967 0 CA-C-O 115.284 -2.293 . . . . 50.509999999999998 111.444 175.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 8.5 mm-40 -99.01 167.07 10.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 126.073 2.108 . . . . 50.549999999999997 111.963 -176.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 64.8 mttm -51.99 133.83 32.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 119.673 3.212 . . . . 50.509999999999998 119.673 -176.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 64.7 mm-40 77.35 23.48 0.88 Allowed 'General case' 0 C--O 1.256 1.427 0 CA-C-N 112.498 -2.137 . . . . 50.619999999999997 111.019 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.0 m -82.38 144.19 30.7 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.787 -1.097 . . . . 50.509999999999998 113.336 174.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 p -101.78 131.67 47.96 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 118.252 -0.88 . . . . 50.509999999999998 113.348 175.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.0 tp -100.96 139.11 37.11 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 114.647 -2.597 . . . . 50.509999999999998 105.642 175.06 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -100.06 117.84 35.18 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 127.463 2.977 . . . . 50.509999999999998 114.223 177.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.428 HD11 ' HG2' ' A' ' 41' ' ' GLN . 66.0 tp -91.26 106.18 18.32 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 115.187 1.551 . . . . 50.509999999999998 115.187 176.641 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 29.7 t -108.62 136.82 43.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 119.601 1.091 . . . . 50.509999999999998 112.155 175.095 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.2 mt -67.14 155.84 37.72 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 118.226 2.676 . . . . 50.509999999999998 118.226 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 29.2 tpt180 -136.4 77.79 1.67 Allowed 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.32 -3.229 . . . . 50.640000000000001 107.103 177.253 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -74.35 140.09 44.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.644 2.091 . . . . 50.509999999999998 116.644 -179.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.41 82.94 8.1 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.756 -1.566 . . . . 50.640000000000001 108.388 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.39 155.0 20.89 Favored Glycine 0 C--O 1.243 0.712 0 N-CA-C 116.527 1.371 . . . . 50.509999999999998 116.527 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 CA-C-O 116.294 -2.392 . . . . 50.509999999999998 107.282 179.258 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 t30 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 t30 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.8 t30 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.509999999999998 110.493 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 104.893 178.276 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.509999999999998 102.837 173.339 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' HD2' HG21 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.509999999999998 117.134 179.556 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.509999999999998 116.317 175.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.509999999999998 112.121 -178.081 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.509999999999998 109.624 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.509999999999998 116.025 -177.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.509999999999998 106.536 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.509999999999998 112.921 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.509999999999998 113.028 175.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.509999999999998 111.926 176.101 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.509999999999998 102.234 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.509999999999998 107.977 178.158 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.509999999999998 113.269 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.619999999999997 114.947 174.004 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.509999999999998 115.789 -177.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.619999999999997 107.53 174.655 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.509999999999998 111.949 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.509999999999998 109.308 -177.562 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.619999999999997 108.196 -179.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.509999999999998 111.912 175.706 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 23' ' ' ILE . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.509999999999998 112.556 175.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.619999999999997 115.475 176.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.549999999999997 106.23 -179.569 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.509999999999998 107.58 178.586 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.509999999999998 111.113 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.509999999999998 109.947 176.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.509999999999998 115.455 175.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.509999999999998 104.372 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.549999999999997 109.548 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.619999999999997 110.423 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.509999999999998 113.197 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.619999999999997 117.619 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.509999999999998 109.26 176.563 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.509999999999998 113.852 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.509999999999998 110.907 178.302 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.509999999999998 113.412 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.619999999999997 115.136 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 62.7 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.549999999999997 103.57 178.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.549999999999997 113.647 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.640000000000001 112.495 172.132 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.509999999999998 118.018 -177.498 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.509999999999998 117.708 -177.62 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.509999999999998 116.78 177.591 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.302 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.509999999999998 114.896 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.509999999999998 114.931 177.617 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.549999999999997 107.727 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.509999999999998 107.986 -175.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.619999999999997 112.944 -177.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.619999999999997 118.065 -175.824 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.509999999999998 108.537 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.640000000000001 104.693 176.538 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.509999999999998 107.733 177.174 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.509999999999998 103.779 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.509999999999998 109.455 -179.438 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.619999999999997 111.805 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.509999999999998 115.046 179.177 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.549999999999997 109.887 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.596 HD12 HD21 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 106.554 175.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.549999999999997 119.305 -176.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.509999999999998 112.625 -176.917 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.619999999999997 109.925 179.553 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.509999999999998 105.936 174.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.509999999999998 114.003 175.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.509999999999998 101.726 175.029 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 1.3 m80 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.509999999999998 105.529 177.945 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 108.662 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.509999999999998 109.301 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.509999999999998 105.818 178.446 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.640000000000001 109.263 177.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.509999999999998 120.492 -179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.640000000000001 113.699 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.509999999999998 105.703 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.509999999999998 108.344 179.318 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.509999999999998 110.493 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 104.893 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.509999999999998 102.837 173.339 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' HD2' HG21 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.509999999999998 117.134 179.556 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.509999999999998 116.317 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.509999999999998 112.121 -178.081 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.509999999999998 109.624 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.509999999999998 116.025 -177.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.509999999999998 106.536 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.509999999999998 112.921 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.509999999999998 113.028 175.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.509999999999998 111.926 176.101 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.509999999999998 102.234 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.509999999999998 107.977 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.509999999999998 113.269 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.619999999999997 114.947 174.004 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.509999999999998 115.789 -177.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.619999999999997 107.53 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.509999999999998 111.949 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.509999999999998 109.308 -177.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.619999999999997 108.196 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.509999999999998 111.912 175.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 23' ' ' ILE . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.509999999999998 112.556 175.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.619999999999997 115.475 176.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.549999999999997 106.23 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.509999999999998 107.58 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.509999999999998 111.113 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.509999999999998 109.947 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.509999999999998 115.455 175.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.509999999999998 104.372 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.549999999999997 109.548 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.619999999999997 110.423 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.509999999999998 113.197 -175.583 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.619999999999997 117.619 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.509999999999998 109.26 176.563 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.509999999999998 113.852 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.509999999999998 110.907 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.509999999999998 113.412 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.619999999999997 115.136 -177.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 62.7 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.549999999999997 103.57 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.549999999999997 113.647 -177.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.640000000000001 112.495 172.132 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.509999999999998 118.018 -177.498 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.509999999999998 117.708 -177.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.509999999999998 116.78 177.591 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.302 177.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.509999999999998 114.896 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.509999999999998 114.931 177.617 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.549999999999997 107.727 174.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.509999999999998 107.986 -175.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.619999999999997 112.944 -177.713 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.619999999999997 118.065 -175.824 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.509999999999998 108.537 -177.279 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.640000000000001 104.693 176.538 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.509999999999998 107.733 177.174 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.509999999999998 103.779 177.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.509999999999998 109.455 -179.438 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.619999999999997 111.805 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.509999999999998 115.046 179.177 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.549999999999997 109.887 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.596 HD12 HD21 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 106.554 175.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.549999999999997 119.305 -176.878 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.509999999999998 112.625 -176.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.619999999999997 109.925 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.509999999999998 105.936 174.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.509999999999998 114.003 175.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.509999999999998 101.726 175.029 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 1.3 m80 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.509999999999998 105.529 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 108.662 176.495 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.509999999999998 109.301 175.143 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.509999999999998 105.818 178.446 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.640000000000001 109.263 177.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.509999999999998 120.492 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.640000000000001 113.699 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.509999999999998 105.703 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.509999999999998 108.344 179.318 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 107.349 -1.352 . . . . 50.509999999999998 107.349 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 12.4 mm-40 -87.51 137.75 32.07 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.946 2.654 . . . . 50.549999999999997 110.199 178.218 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -135.32 161.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.022 -1.942 . . . . 50.509999999999998 106.638 173.313 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -94.91 148.05 22.73 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.467 4.854 . . . . 50.509999999999998 119.097 179.532 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.44 116.74 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.395 -3.193 . . . . 50.509999999999998 106.384 175.822 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.19 106.45 17.68 Favored 'General case' 0 N--CA 1.504 2.253 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 115.234 -178.118 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -82.79 178.88 7.97 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 117.759 -1.115 . . . . 50.509999999999998 109.653 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -70.56 -34.07 71.81 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 120.19 3.404 . . . . 50.509999999999998 120.19 -178.081 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 p -96.57 -9.09 30.21 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 115.706 -2.397 . . . . 50.509999999999998 116.356 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.64 38.41 0.72 Allowed Glycine 0 C--N 1.297 -1.617 0 N-CA-C 120.575 2.99 . . . . 50.509999999999998 120.575 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -94.61 135.64 35.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.848 -1.548 . . . . 50.509999999999998 111.047 175.018 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -109.51 117.76 34.83 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 126.702 2.501 . . . . 50.509999999999998 110.113 176.149 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.6 mt -117.72 132.05 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 127.609 3.068 . . . . 50.509999999999998 106.754 179.698 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.3 p -104.75 134.54 47.73 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.298 -1.761 . . . . 50.509999999999998 113.776 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.5 mt -118.39 155.87 29.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.435 -2.221 . . . . 50.509999999999998 116.029 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -93.7 119.16 32.35 Favored 'General case' 0 N--CA 1.501 2.084 1 O-C-N 129.227 4.08 . . . . 50.619999999999997 107.368 173.938 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.23 164.19 28.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 O-C-N 127.739 3.15 . . . . 50.509999999999998 111.114 -177.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.66 145.94 55.27 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 112.215 -2.266 . . . . 50.619999999999997 109.52 174.661 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.94 -24.49 39.51 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.559 2.172 . . . . 50.509999999999998 111.956 177.732 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -78.58 -34.48 46.83 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.947 -1.501 . . . . 50.509999999999998 106.947 -177.588 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.1 145.63 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.37 -1.732 . . . . 50.619999999999997 114.434 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -96.83 156.41 16.36 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.874 -0.603 . . . . 50.509999999999998 109.555 175.657 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' A' ' 50' ' ' LEU . 55.5 mt -50.69 -40.13 19.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 O-C-N 127.094 2.746 . . . . 50.509999999999998 108.977 175.774 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -47.65 -57.78 5.08 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.031 -1.1 . . . . 50.619999999999997 108.031 177.015 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -53.84 -40.87 66.83 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 115.74 1.756 . . . . 50.549999999999997 115.74 -179.633 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.71 -22.3 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 125.086 1.491 . . . . 50.509999999999998 110.299 178.519 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 94.9 mttt -82.78 -38.17 23.53 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 104.744 -2.317 . . . . 50.509999999999998 104.744 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.41 -28.45 61.08 Favored 'General case' 0 C--O 1.278 2.605 0 CA-C-N 117.982 0.355 . . . . 50.509999999999998 111.845 176.887 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -66.27 -36.51 83.17 Favored 'General case' 0 C--O 1.256 1.435 0 O-C-N 120.355 -1.466 . . . . 50.509999999999998 110.144 175.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.2 -29.29 27.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.529 -0.868 . . . . 50.509999999999998 108.661 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.24 -35.61 67.58 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 125.666 2.651 . . . . 50.549999999999997 111.019 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -63.75 -27.88 69.5 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 120.947 3.684 . . . . 50.619999999999997 120.947 179.132 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -108.83 -20.29 13.11 Favored 'General case' 0 C--O 1.279 2.65 0 O-C-N 119.27 -2.143 . . . . 50.509999999999998 113.539 -175.638 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' A' ' 36' ' ' ILE . 77.0 tt0 -123.69 -26.57 4.13 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 123.061 2.664 . . . . 50.619999999999997 111.205 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.47 12.04 57.58 Favored Glycine 0 CA--C 1.477 -2.303 0 CA-C-O 120.049 -0.306 . . . . 50.509999999999998 113.122 176.55 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.413 HG12 ' HG2' ' A' ' 34' ' ' GLU . 21.8 mm -77.5 126.3 84.86 Favored Pre-proline 0 C--O 1.245 0.822 0 N-CA-C 104.66 -2.348 . . . . 50.509999999999998 104.66 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.97 136.95 79.69 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.166 2.578 . . . . 50.509999999999998 110.914 178.309 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.07 -32.3 92.8 Favored 'Trans proline' 0 C--O 1.262 1.688 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.436 -179.321 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -80.12 12.04 3.08 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.864 -1.772 . . . . 50.619999999999997 114.954 -177.406 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.23 9.14 11.0 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.467 -1.395 . . . . 50.549999999999997 107.358 178.663 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -103.05 125.13 49.65 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.407 2.051 . . . . 50.549999999999997 112.999 -177.583 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -111.79 114.54 27.58 Favored 'General case' 0 C--O 1.295 3.478 0 CA-C-O 116.711 -1.614 . . . . 50.640000000000001 114.898 172.146 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.556 HD12 HG23 ' A' ' 23' ' ' ILE . 23.1 mt -98.62 122.34 41.71 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 119.431 1.014 . . . . 50.509999999999998 111.832 -177.442 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.81 117.99 56.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 O-C-N 124.545 1.153 . . . . 50.509999999999998 111.016 -177.609 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.707 ' HB3' HD21 ' A' ' 50' ' ' LEU . 57.9 t80 -140.92 143.4 34.58 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.121 -1.437 . . . . 50.509999999999998 107.121 177.52 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 45.38 34.98 1.68 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.254 -2.248 . . . . 50.509999999999998 106.798 177.434 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.87 -7.39 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.445 2.926 . . . . 50.509999999999998 113.263 -179.499 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 46' ' ' ALA . 75.2 mmtt -77.04 148.07 36.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 118.099 0.949 . . . . 50.509999999999998 113.402 177.662 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.5 116.09 11.43 Favored 'General case' 0 C--O 1.259 1.573 0 O-C-N 123.953 0.783 . . . . 50.549999999999997 109.485 174.559 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 45' ' ' PHE . 64.8 mt -78.84 145.68 34.1 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 101.394 -3.558 . . . . 50.509999999999998 101.394 -175.866 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.423 ' O ' HD12 ' A' ' 23' ' ' ILE . 4.2 mm-40 -116.72 148.66 40.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.975 1.472 . . . . 50.619999999999997 114.975 -177.661 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.25 -47.9 71.76 Favored 'General case' 0 C--O 1.264 1.838 0 C-N-CA 126.141 1.776 . . . . 50.619999999999997 114.572 -175.778 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 4.42 57.12 Favored Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 124.408 1.004 . . . . 50.509999999999998 112.921 -177.25 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.448 ' HD2' ' OH ' ' A' ' 59' ' ' TYR . 89.3 mtt-85 -93.01 143.52 26.15 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 119.997 -1.884 . . . . 50.640000000000001 112.3 176.451 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.2 p -86.25 162.05 18.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.036 0.935 . . . . 50.509999999999998 112.019 177.087 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.57 -27.31 65.95 Favored 'General case' 0 C--O 1.201 -1.495 0 N-CA-C 102.205 -3.257 . . . . 50.509999999999998 102.205 177.201 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -71.67 -36.03 70.52 Favored 'General case' 0 C--O 1.267 2.022 0 C-N-CA 117.326 -1.749 . . . . 50.509999999999998 113.078 -179.387 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -49.86 -38.64 36.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.501 1.143 . . . . 50.619999999999997 113.718 179.765 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 58.1 m-85 -91.58 -10.72 39.51 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.759 -1.115 . . . . 50.509999999999998 113.584 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 41.2 m-20 70.31 41.58 1.01 Allowed 'General case' 0 C--O 1.248 0.989 0 CA-C-N 121.52 1.964 . . . . 50.549999999999997 108.684 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.72 118.07 14.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.93 0 CA-C-O 115.184 -2.341 . . . . 50.509999999999998 107.126 175.872 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -97.3 177.86 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.556 1.785 . . . . 50.549999999999997 110.196 -176.854 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -58.15 146.94 31.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.198 1.475 . . . . 50.509999999999998 107.658 -176.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 39.74 61.31 1.46 Allowed 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.537 -2.12 . . . . 50.619999999999997 112.614 179.566 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 m -98.26 151.07 20.85 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 104.729 -2.323 . . . . 50.509999999999998 104.729 174.743 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 p -95.96 140.26 30.96 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 118.287 -0.863 . . . . 50.509999999999998 111.879 175.954 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -122.64 136.92 55.01 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 114.641 -2.599 . . . . 50.509999999999998 104.479 175.088 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.15 116.92 29.2 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 127.427 2.954 . . . . 50.509999999999998 108.517 177.897 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.25 130.92 34.96 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.623 -1.179 . . . . 50.509999999999998 111.098 176.57 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -128.56 141.78 45.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 104.004 -2.591 . . . . 50.509999999999998 104.004 174.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.5 mt -97.55 123.54 41.46 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.639 0.607 . . . . 50.509999999999998 112.639 178.438 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -104.28 86.76 2.59 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.336 -3.221 . . . . 50.640000000000001 112.841 177.187 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.7 mt -73.32 167.77 20.55 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.954 . . . . 50.509999999999998 107.815 -179.328 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -120.59 86.5 2.58 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.714 -1.585 . . . . 50.640000000000001 107.247 -179.624 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.23 131.74 3.36 Favored Glycine 0 C--O 1.244 0.743 0 O-C-N 124.645 1.216 . . . . 50.509999999999998 113.081 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.47 1 O-C-N 115.118 -4.754 . . . . 50.509999999999998 103.707 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.509999999999998 111.053 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.549999999999997 116.588 178.321 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.509999999999998 108.408 173.351 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.509999999999998 119.91 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.509999999999998 113.866 175.785 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.509999999999998 109.83 -178.037 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.509999999999998 114.27 179.956 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.509999999999998 106.823 -177.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.509999999999998 106.406 179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.509999999999998 115.847 179.804 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.509999999999998 113.185 174.982 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.509999999999998 106.82 176.229 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.509999999999998 110.632 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.509999999999998 110.788 178.084 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.509999999999998 115.167 -179.282 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.619999999999997 107.469 173.999 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.509999999999998 111.54 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.619999999999997 109.116 174.729 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.509999999999998 111.942 177.713 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.509999999999998 110.261 -177.489 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.619999999999997 110.438 -179.014 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.509999999999998 102.814 175.665 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.509999999999998 108.219 175.869 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.619999999999997 110.915 177.063 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.549999999999997 110.953 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.509999999999998 113.215 178.571 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.509999999999998 108.802 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.509999999999998 103.321 176.879 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.509999999999998 108.74 176.075 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.509999999999998 114.446 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.549999999999997 111.108 179.417 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.619999999999997 106.799 179.153 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.509999999999998 117.415 -175.737 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.619999999999997 108.973 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.509999999999998 108.229 176.498 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' A' ' 34' ' ' GLU . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.509999999999998 107.149 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.509999999999998 110.835 178.328 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.509999999999998 113.479 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.619999999999997 113.097 -177.452 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' A' ' 37' ' ' PRO . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.549999999999997 107.358 178.748 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.549999999999997 116.575 -177.483 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.640000000000001 106.18 172.202 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.509999999999998 109.103 -177.516 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.509999999999998 114.506 -177.616 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.509999999999998 114.578 177.624 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.509999999999998 108.335 177.409 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.509999999999998 113.694 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.509999999999998 108.927 177.678 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.549999999999997 107.079 174.615 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.509999999999998 107.602 -175.891 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.619999999999997 112.193 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.619999999999997 116.528 -175.761 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.509999999999998 116.292 -177.256 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.640000000000001 108.919 176.463 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.509999999999998 113.355 177.121 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.509999999999998 108.481 177.184 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.509999999999998 116.691 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.619999999999997 119.838 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.509999999999998 110.142 179.286 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 113.734 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.509999999999998 105.625 175.863 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.549999999999997 108.806 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.579 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.509999999999998 116.225 -176.896 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.619999999999997 117.221 179.545 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.509999999999998 103.824 174.726 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.509999999999998 115.599 175.963 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.509999999999998 106.66 175.091 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.509999999999998 108.183 177.947 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.509999999999998 108.516 176.581 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.509999999999998 105.118 175.096 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.509999999999998 116.356 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.640000000000001 113.39 177.176 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.509999999999998 111.184 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.505 -179.621 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.509999999999998 104.884 179.378 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.509999999999998 116.938 179.231 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.509999999999998 111.053 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.549999999999997 116.588 178.321 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.509999999999998 108.408 173.351 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.509999999999998 119.91 179.541 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.509999999999998 113.866 175.785 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.509999999999998 109.83 -178.037 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.509999999999998 114.27 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.509999999999998 106.823 -177.969 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.509999999999998 106.406 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.509999999999998 115.847 179.804 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.509999999999998 113.185 174.982 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.509999999999998 106.82 176.229 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.509999999999998 110.632 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.509999999999998 110.788 178.084 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.509999999999998 115.167 -179.282 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.619999999999997 107.469 173.999 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.509999999999998 111.54 -177.961 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.619999999999997 109.116 174.729 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.509999999999998 111.942 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.509999999999998 110.261 -177.489 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.619999999999997 110.438 -179.014 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.509999999999998 102.814 175.665 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.509999999999998 108.219 175.869 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.619999999999997 110.915 177.063 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.549999999999997 110.953 -179.579 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.509999999999998 113.215 178.571 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.509999999999998 108.802 -179.798 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.509999999999998 103.321 176.879 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.509999999999998 108.74 176.075 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.509999999999998 114.446 179.874 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.549999999999997 111.108 179.417 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.619999999999997 106.799 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.509999999999998 117.415 -175.737 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.619999999999997 108.973 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.509999999999998 108.229 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' A' ' 34' ' ' GLU . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.509999999999998 107.149 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.509999999999998 110.835 178.328 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.509999999999998 113.479 -179.365 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.619999999999997 113.097 -177.452 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' A' ' 37' ' ' PRO . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.549999999999997 107.358 178.748 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.549999999999997 116.575 -177.483 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.640000000000001 106.18 172.202 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.509999999999998 109.103 -177.516 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.509999999999998 114.506 -177.616 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.509999999999998 114.578 177.624 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.509999999999998 108.335 177.409 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.509999999999998 113.694 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.509999999999998 108.927 177.678 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.549999999999997 107.079 174.615 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.509999999999998 107.602 -175.891 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.619999999999997 112.193 -177.677 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.619999999999997 116.528 -175.761 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.509999999999998 116.292 -177.256 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.640000000000001 108.919 176.463 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.509999999999998 113.355 177.121 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.509999999999998 108.481 177.184 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.509999999999998 116.691 -179.453 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.619999999999997 119.838 179.741 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.509999999999998 110.142 179.286 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 113.734 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.509999999999998 105.625 175.863 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.549999999999997 108.806 -176.835 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.579 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.509999999999998 116.225 -176.896 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.619999999999997 117.221 179.545 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.509999999999998 103.824 174.726 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.509999999999998 115.599 175.963 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.509999999999998 106.66 175.091 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.509999999999998 108.183 177.947 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.509999999999998 108.516 176.581 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.509999999999998 105.118 175.096 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.509999999999998 116.356 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.640000000000001 113.39 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.509999999999998 111.184 -179.342 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.505 -179.621 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.509999999999998 104.884 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.509999999999998 116.938 179.231 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.509999999999998 110.518 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.549999999999997 111.931 178.254 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.509999999999998 109.629 173.36 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.509999999999998 110.788 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.509999999999998 109.267 175.855 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.509999999999998 112.054 -178.082 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.509999999999998 109.558 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.509999999999998 115.426 -177.96 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.509999999999998 110.359 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.509999999999998 109.262 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.509999999999998 111.702 175.031 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.509999999999998 120.495 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.509999999999998 104.467 179.69 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.509999999999998 119.511 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.509999999999998 111.182 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.619999999999997 105.523 173.97 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.509999999999998 120.87 -177.968 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.619999999999997 113.88 174.624 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.509999999999998 111.907 177.796 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.509999999999998 110.539 -177.503 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.619999999999997 116.041 -179.054 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.509999999999998 113.13 175.663 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.509999999999998 106.643 175.794 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.619999999999997 109.013 176.992 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.549999999999997 120.754 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.509999999999998 109.974 178.629 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.509999999999998 103.034 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.509999999999998 114.005 176.947 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.509999999999998 108.149 175.949 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.509999999999998 112.731 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.549999999999997 116.636 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 110.424 179.144 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.509999999999998 117.298 -175.651 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.619999999999997 114.698 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.509999999999998 108.03 176.505 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.509999999999998 103.399 179.696 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.509999999999998 110.927 178.325 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.599 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.509999999999998 113.487 -179.297 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.619999999999997 115.612 -177.478 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 108.548 178.699 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 111.184 -177.606 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.640000000000001 102.446 172.198 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.509999999999998 113.857 -177.541 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.509999999999998 112.916 -177.592 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.509999999999998 108.783 177.641 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.509999999999998 104.079 177.365 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.509999999999998 117.886 -179.581 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.509999999999998 111.909 177.62 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.549999999999997 106.814 174.54 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.509999999999998 110.278 -175.89 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.619999999999997 111.58 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.619999999999997 111.456 -175.849 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.509999999999998 112.985 -177.227 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.640000000000001 115.651 176.557 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.509999999999998 116.995 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.509999999999998 105.494 177.211 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.509999999999998 113.975 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.619999999999997 113.595 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 108.268 179.243 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 83.9 m-20 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.549999999999997 112.768 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.509999999999998 112.67 175.785 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.549999999999997 105.766 -176.791 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.509999999999998 107.365 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.619999999999997 116.2 179.519 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.509999999999998 107.156 174.815 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.509999999999998 106.777 175.972 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.509999999999998 107.127 175.12 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.509999999999998 114.104 177.934 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.509999999999998 109.856 176.533 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.509999999999998 106.088 175.043 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.509999999999998 118.655 178.372 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.640000000000001 107.592 177.293 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.509999999999998 112.686 -179.374 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.640000000000001 111.255 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.509999999999998 104.302 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 116.097 179.25 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.509999999999998 110.518 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.549999999999997 111.931 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.509999999999998 109.629 173.36 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.509999999999998 110.788 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.509999999999998 109.267 175.855 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.509999999999998 112.054 -178.082 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.509999999999998 109.558 179.941 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.509999999999998 115.426 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.509999999999998 110.359 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.509999999999998 109.262 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.509999999999998 111.702 175.031 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.509999999999998 120.495 176.137 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.509999999999998 104.467 179.69 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.509999999999998 119.511 178.086 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.509999999999998 111.182 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.619999999999997 105.523 173.97 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.509999999999998 120.87 -177.968 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.619999999999997 113.88 174.624 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.509999999999998 111.907 177.796 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.509999999999998 110.539 -177.503 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.619999999999997 116.041 -179.054 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.509999999999998 113.13 175.663 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.509999999999998 106.643 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.619999999999997 109.013 176.992 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.549999999999997 120.754 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.509999999999998 109.974 178.629 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.509999999999998 103.034 -179.722 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.509999999999998 114.005 176.947 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.509999999999998 108.149 175.949 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.509999999999998 112.731 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.549999999999997 116.636 179.47 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 110.424 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.509999999999998 117.298 -175.651 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.619999999999997 114.698 179.824 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.509999999999998 108.03 176.505 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.509999999999998 103.399 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.509999999999998 110.927 178.325 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.599 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.509999999999998 113.487 -179.297 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.619999999999997 115.612 -177.478 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 108.548 178.699 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 111.184 -177.606 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.640000000000001 102.446 172.198 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.509999999999998 113.857 -177.541 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.509999999999998 112.916 -177.592 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.509999999999998 108.783 177.641 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.509999999999998 104.079 177.365 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.509999999999998 117.886 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.509999999999998 111.909 177.62 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.549999999999997 106.814 174.54 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.509999999999998 110.278 -175.89 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.619999999999997 111.58 -177.608 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.619999999999997 111.456 -175.849 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.509999999999998 112.985 -177.227 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.640000000000001 115.651 176.557 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.509999999999998 116.995 177.093 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.509999999999998 105.494 177.211 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.509999999999998 113.975 -179.481 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.619999999999997 113.595 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 108.268 179.243 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 83.9 m-20 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.549999999999997 112.768 179.934 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.509999999999998 112.67 175.785 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.549999999999997 105.766 -176.791 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.509999999999998 107.365 -176.938 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.619999999999997 116.2 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.509999999999998 107.156 174.815 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.509999999999998 106.777 175.972 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.509999999999998 107.127 175.12 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.509999999999998 114.104 177.934 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.509999999999998 109.856 176.533 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.509999999999998 106.088 175.043 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.509999999999998 118.655 178.372 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.640000000000001 107.592 177.293 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.509999999999998 112.686 -179.374 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.640000000000001 111.255 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.509999999999998 104.302 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 116.097 179.25 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.992 0.738 . . . . 50.509999999999998 112.992 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.58 106.94 9.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 126.973 2.671 . . . . 50.549999999999997 111.748 178.306 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -114.26 155.73 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 CA-C-O 115.983 -1.96 . . . . 50.509999999999998 113.24 173.276 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -119.93 132.41 55.51 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.523 4.889 . . . . 50.509999999999998 112.064 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 70.8 t -108.49 134.02 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 113.412 -3.185 . . . . 50.509999999999998 112.244 175.773 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -94.46 118.68 32.02 Favored 'General case' 0 N--CA 1.503 2.22 1 O-C-N 129.329 4.143 . . . . 50.509999999999998 106.07 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -98.48 161.28 13.76 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 117.753 -1.117 . . . . 50.509999999999998 110.633 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -54.82 -33.43 61.6 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.877 1.436 . . . . 50.509999999999998 114.877 -177.95 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 9' ' ' THR . 54.0 m -71.16 -20.77 62.26 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 115.689 -2.404 . . . . 50.509999999999998 113.117 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.56 -10.97 38.99 Favored Glycine 0 C--N 1.297 -1.602 0 O-C-N 120.144 -1.598 . . . . 50.509999999999998 116.312 179.843 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -69.22 117.6 11.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 116.868 -1.539 . . . . 50.509999999999998 110.608 174.996 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.2 m -73.51 126.55 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.659 2.475 . . . . 50.509999999999998 111.716 176.201 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.486 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 14.1 pt -104.58 142.4 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 127.432 2.958 . . . . 50.509999999999998 112.531 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -106.34 142.04 36.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 117.294 -1.763 . . . . 50.509999999999998 112.363 178.112 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -131.01 133.8 46.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 115.49 -2.195 . . . . 50.509999999999998 113.451 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -100.57 139.88 35.63 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 129.163 4.04 . . . . 50.619999999999997 106.417 173.974 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.94 170.76 18.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 117.344 -177.958 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -115.27 138.13 23.43 Favored Pre-proline 0 C--N 1.315 -0.926 0 N-CA-C 103.36 -2.83 . . . . 50.619999999999997 103.36 174.642 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.02 -24.46 40.01 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 122.535 2.157 . . . . 50.509999999999998 111.957 177.706 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -79.01 -6.42 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.128 -0.939 . . . . 50.509999999999998 109.326 -177.611 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -72.55 122.55 21.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.092 2.627 . . . . 50.619999999999997 118.092 -178.954 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 26' ' ' VAL . 66.8 p -67.66 155.54 38.95 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.423 -1.325 . . . . 50.509999999999998 107.423 175.71 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 54' ' ' ARG . 25.6 mm -58.12 -23.74 22.31 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 127.191 2.807 . . . . 50.509999999999998 107.383 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.34 -39.99 67.72 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.471 -0.768 . . . . 50.619999999999997 110.918 177.097 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -70.7 -20.67 62.65 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.292 1.037 . . . . 50.549999999999997 108.258 -179.619 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 22' ' ' THR . 90.6 t -71.35 -57.52 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 101.293 -3.595 . . . . 50.509999999999998 101.293 178.579 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.6 mttt -52.14 -38.47 57.65 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 114.456 1.28 . . . . 50.509999999999998 114.456 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.08 90.84 Favored 'General case' 0 C--O 1.278 2.591 0 CA-C-N 118.007 0.367 . . . . 50.509999999999998 110.322 176.869 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -60.61 -13.47 14.53 Favored 'General case' 0 C--O 1.254 1.309 0 N-CA-C 118.576 2.806 . . . . 50.509999999999998 118.576 176.028 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -90.99 -40.41 12.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 C-N-CA 119.565 -0.854 . . . . 50.509999999999998 110.04 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.561 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 31.3 tt0 -54.15 -31.98 54.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 125.656 2.646 . . . . 50.549999999999997 116.229 179.474 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.04 -72.14 0.1 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.627 -1.624 . . . . 50.619999999999997 109.717 179.092 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.94 -39.99 33.09 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.404 -2.119 . . . . 50.509999999999998 114.829 -175.745 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -88.19 -22.14 24.18 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 114.028 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 71.31 27.13 72.16 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 109.332 -1.507 . . . . 50.509999999999998 109.332 176.571 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.8 mt -96.66 118.62 64.99 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.856 -1.138 . . . . 50.509999999999998 107.968 179.711 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.8 Cg_exo -57.02 136.99 80.0 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 123.149 2.566 . . . . 50.509999999999998 110.865 178.296 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.597 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.5 Cg_exo -57.25 -32.16 92.81 Favored 'Trans proline' 0 C--O 1.261 1.657 0 O-C-N 122.873 0.933 . . . . 50.509999999999998 113.391 -179.268 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -69.76 -21.8 63.4 Favored 'General case' 0 C--O 1.262 1.736 0 O-C-N 119.985 -1.697 . . . . 50.619999999999997 110.39 -177.443 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -93.91 18.16 10.97 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.52 -1.363 . . . . 50.549999999999997 110.421 178.662 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.495 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 71.7 mt-30 -111.49 139.57 46.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.3 2.0 . . . . 50.549999999999997 112.116 -177.584 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.73 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 37.5 ttm180 -119.97 126.61 51.28 Favored 'General case' 0 C--O 1.296 3.529 0 CA-C-O 116.708 -1.615 . . . . 50.640000000000001 108.393 172.147 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.3 mt -118.91 89.25 3.09 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.452 1.024 . . . . 50.509999999999998 112.257 -177.553 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.552 HD11 ' HD3' ' A' ' 42' ' ' ARG . 60.5 mt -98.51 128.85 49.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 O-C-N 125.255 1.597 . . . . 50.509999999999998 107.084 -177.63 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.682 ' CE2' HG12 ' A' ' 61' ' ' ILE . 87.3 t80 -136.33 124.6 23.21 Favored 'General case' 0 C--N 1.36 1.025 0 CA-C-N 114.498 -1.228 . . . . 50.509999999999998 110.627 177.646 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 36.84 20.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.255 177.332 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 25.15 63.84 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 128.455 2.931 . . . . 50.509999999999998 115.916 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.17 136.55 40.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 118.036 0.918 . . . . 50.509999999999998 110.82 177.621 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -73.45 128.24 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.05 0.844 . . . . 50.549999999999997 112.456 174.624 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.4 149.15 35.19 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 105.514 -2.032 . . . . 50.509999999999998 105.514 -175.903 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 82.5 tt0 -105.72 144.53 32.34 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.929 1.393 . . . . 50.619999999999997 113.456 -177.693 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 37.5 p30 -61.19 -35.51 77.35 Favored 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.099 1.76 . . . . 50.619999999999997 109.198 -175.749 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.496 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -91.48 20.94 38.03 Favored Glycine 0 CA--C 1.492 -1.403 0 C-N-CA 124.383 0.992 . . . . 50.509999999999998 115.55 -177.296 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.598 ' O ' HG12 ' A' ' 23' ' ' ILE . 86.5 mmt-85 -128.69 168.3 16.0 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 101.878 -3.378 . . . . 50.640000000000001 101.878 176.488 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -108.57 152.67 24.44 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.003 0.921 . . . . 50.509999999999998 108.842 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.7 mt -47.36 -39.42 15.06 Favored 'General case' 0 C--O 1.201 -1.462 0 O-C-N 124.087 0.867 . . . . 50.509999999999998 108.791 177.239 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -70.79 -27.71 64.11 Favored 'General case' 0 C--O 1.268 2.051 0 N-CA-C 116.35 1.981 . . . . 50.509999999999998 116.35 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -57.46 -27.18 62.24 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.496 1.141 . . . . 50.619999999999997 109.733 179.789 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.0 m-85 -87.06 -5.73 58.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 118.284 2.698 . . . . 50.509999999999998 118.284 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 54.3 m-20 74.28 32.1 1.02 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.524 1.965 . . . . 50.549999999999997 111.521 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.682 HG12 ' CE2' ' A' ' 45' ' ' PHE . 69.5 mt -81.0 103.8 8.57 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.206 -2.33 . . . . 50.509999999999998 110.464 175.849 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -103.84 -171.1 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 119.241 3.052 . . . . 50.549999999999997 119.241 -176.853 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 65.5 tttm -52.72 138.36 29.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.245 -2.131 . . . . 50.509999999999998 105.245 -176.975 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 46.6 mt-10 61.95 68.15 0.71 Allowed 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.492 -2.14 . . . . 50.619999999999997 115.36 179.549 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.408 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 51.0 m -136.06 138.82 42.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.786 -1.097 . . . . 50.509999999999998 109.749 174.813 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -114.39 132.31 56.27 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 118.841 -2.412 . . . . 50.509999999999998 113.919 175.886 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.0 mt -90.06 145.96 24.68 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.64 -2.6 . . . . 50.509999999999998 111.595 175.091 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -96.78 140.64 31.06 Favored 'General case' 0 C--N 1.284 -2.258 0 O-C-N 127.295 2.872 . . . . 50.509999999999998 106.937 177.89 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -106.07 116.0 31.18 Favored 'General case' 0 C--O 1.282 2.81 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 113.338 176.577 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -120.28 138.33 51.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 119.533 1.06 . . . . 50.509999999999998 112.217 175.072 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.36 114.53 28.71 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.405 0.52 . . . . 50.509999999999998 112.405 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -89.08 111.63 22.42 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 113.365 -3.207 . . . . 50.640000000000001 104.738 177.198 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.59 131.62 36.2 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.819 1.949 . . . . 50.509999999999998 112.438 -179.359 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -88.07 77.62 8.33 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 113.757 -1.565 . . . . 50.640000000000001 113.193 -179.544 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.67 -147.62 16.67 Favored Glycine 0 C--O 1.242 0.597 0 N-CA-C 106.325 -2.71 . . . . 50.509999999999998 106.325 179.372 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 CA-C-O 116.329 -2.373 . . . . 50.509999999999998 109.025 179.196 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 118.833 -0.603 . . . . 50.509999999999998 110.318 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -105.25 112.49 25.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 126.937 2.648 . . . . 50.549999999999997 112.805 178.264 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.9 pt -114.42 139.79 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-O 115.984 -1.96 . . . . 50.509999999999998 112.339 173.288 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -96.2 145.78 25.25 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 130.43 4.831 . . . . 50.509999999999998 111.845 179.503 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 70.6 t -133.87 105.18 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.328 -3.225 . . . . 50.509999999999998 113.923 175.748 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -91.08 139.72 30.49 Favored 'General case' 0 N--CA 1.504 2.265 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 120.678 -178.121 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -113.79 -168.87 1.41 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 115.052 1.501 . . . . 50.509999999999998 115.052 179.956 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -107.9 7.98 28.31 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 124.109 0.88 . . . . 50.509999999999998 111.005 -177.925 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -92.24 -14.88 28.27 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 102.41 -3.181 . . . . 50.509999999999998 102.41 179.975 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.89 10.72 29.87 Favored Glycine 0 C--N 1.297 -1.603 0 O-C-N 120.188 -1.57 . . . . 50.509999999999998 110.048 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.649 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 43.0 mtpt -90.8 154.51 19.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.86 -1.543 . . . . 50.509999999999998 113.116 175.003 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -126.8 122.63 35.33 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.706 2.504 . . . . 50.509999999999998 107.466 176.19 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.522 HG22 ' HG ' ' A' ' 15' ' ' LEU . 62.5 mt -99.11 136.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 115.182 -2.607 . . . . 50.509999999999998 108.76 179.775 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.9 m -127.24 104.18 7.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 104.209 -2.515 . . . . 50.509999999999998 104.209 178.092 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.522 ' HG ' HG22 ' A' ' 13' ' ' ILE . 46.2 mt -106.75 175.23 5.57 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.536 -2.173 . . . . 50.509999999999998 110.936 -179.197 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -125.64 137.95 53.89 Favored 'General case' 0 N--CA 1.5 2.058 1 O-C-N 129.164 4.04 . . . . 50.619999999999997 108.038 173.961 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -139.69 165.9 21.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 O-C-N 126.599 2.437 . . . . 50.509999999999998 110.623 -177.891 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.29 158.65 31.58 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 119.381 3.104 . . . . 50.619999999999997 119.381 174.647 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.88 -24.56 39.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.629 2.219 . . . . 50.509999999999998 111.91 177.686 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -110.42 25.71 11.49 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 119.98 3.326 . . . . 50.509999999999998 119.98 -177.543 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -94.62 149.22 21.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 117.305 -1.758 . . . . 50.619999999999997 107.26 -179.038 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -92.97 148.46 21.98 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.799 -0.637 . . . . 50.509999999999998 109.688 175.752 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -44.94 -39.6 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.155 2.784 . . . . 50.509999999999998 115.021 175.785 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.87 -36.73 77.53 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.407 -0.808 . . . . 50.619999999999997 111.367 177.009 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -67.35 -34.07 76.56 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.358 1.063 . . . . 50.549999999999997 110.821 -179.589 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -71.16 -46.11 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 125.048 1.467 . . . . 50.509999999999998 112.878 178.571 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HG2' ' OE1' ' A' ' 41' ' ' GLN . 53.7 mtmt -62.84 -32.1 73.26 Favored 'General case' 0 C--O 1.255 1.352 0 N-CA-C 107.084 -1.45 . . . . 50.509999999999998 107.084 -179.753 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -56.75 17.61 Favored 'General case' 0 C--O 1.279 2.615 0 N-CA-C 114.575 1.324 . . . . 50.509999999999998 114.575 176.828 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -46.24 -49.18 17.58 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 120.387 -1.445 . . . . 50.509999999999998 109.911 176.054 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.84 -42.5 63.01 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 118.32 2.711 . . . . 50.509999999999998 118.32 179.896 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.406 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.8 tt0 -57.96 -45.51 86.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 125.662 2.648 . . . . 50.549999999999997 104.618 179.446 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.74 -25.13 61.93 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 116.353 1.982 . . . . 50.619999999999997 116.353 179.164 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -89.63 -58.61 2.46 Favored 'General case' 0 C--O 1.279 2.64 0 O-C-N 119.325 -2.109 . . . . 50.509999999999998 113.879 -175.683 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.649 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 74.2 mm-40 -103.93 -24.91 13.21 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 123.058 2.663 . . . . 50.619999999999997 110.631 179.868 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 105.52 20.11 9.85 Favored Glycine 0 CA--C 1.478 -2.274 0 N-CA-C 120.393 2.917 . . . . 50.509999999999998 120.393 176.52 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.483 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.9 mt -86.18 134.41 38.75 Favored Pre-proline 0 C--O 1.244 0.792 0 C-N-CA 118.854 -1.138 . . . . 50.509999999999998 110.05 179.738 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -57.07 136.99 79.88 Favored 'Trans proline' 0 C--O 1.26 1.603 0 C-N-CA 123.194 2.596 . . . . 50.509999999999998 110.877 178.361 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.3 Cg_exo -57.13 -32.26 92.83 Favored 'Trans proline' 0 C--O 1.261 1.645 0 C-N-CA 120.731 0.954 . . . . 50.509999999999998 113.411 -179.306 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.79 -27.04 60.15 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 116.268 1.951 . . . . 50.619999999999997 116.268 -177.429 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 80.1 mt-30 -73.65 -21.59 60.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.567 -1.333 . . . . 50.549999999999997 109.995 178.686 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.602 ' HB3' HD11 ' A' ' 69' ' ' LEU . 71.8 mt-30 -70.56 118.28 13.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.36 2.028 . . . . 50.549999999999997 115.678 -177.613 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -113.81 121.4 43.92 Favored 'General case' 0 C--O 1.295 3.498 0 CA-C-O 116.621 -1.657 . . . . 50.640000000000001 109.303 172.098 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -96.49 127.49 42.53 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 119.447 1.021 . . . . 50.509999999999998 112.907 -177.422 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.51 119.3 57.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 115.056 1.502 . . . . 50.509999999999998 115.056 -177.623 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -145.35 121.44 10.76 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 104.741 -2.318 . . . . 50.509999999999998 104.741 177.608 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.0 39.8 3.12 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.208 -2.269 . . . . 50.509999999999998 107.961 177.41 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.47 11.24 4.99 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 128.417 2.913 . . . . 50.509999999999998 115.701 -179.606 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -115.92 126.67 54.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 119.27 3.063 . . . . 50.509999999999998 119.27 177.633 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -41.56 120.82 1.55 Allowed 'General case' 0 C--O 1.259 1.597 0 N-CA-C 120.047 3.351 . . . . 50.549999999999997 120.047 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 2.1 mp -82.35 123.59 29.24 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 117.751 -1.118 . . . . 50.509999999999998 109.737 -175.936 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.15 140.06 48.63 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.62 1.711 . . . . 50.619999999999997 115.62 -177.645 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -54.51 -53.02 59.94 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.148 1.779 . . . . 50.619999999999997 110.458 -175.776 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.17 -7.74 60.48 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 116.531 1.373 . . . . 50.509999999999998 116.531 -177.229 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -76.45 176.48 8.21 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 116.466 2.024 . . . . 50.640000000000001 116.466 176.538 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.6 p -112.44 164.83 12.81 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.055 -1.831 . . . . 50.509999999999998 106.055 177.148 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD22 ' CD1' ' A' ' 61' ' ' ILE . 65.5 mt -68.64 -36.17 78.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 106.573 -1.64 . . . . 50.509999999999998 106.573 177.279 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -65.51 -31.48 72.58 Favored 'General case' 0 C--O 1.267 1.995 0 C-N-CA 117.34 -1.744 . . . . 50.509999999999998 112.392 -179.491 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -47.37 -37.48 11.27 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.515 1.15 . . . . 50.619999999999997 111.902 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 92.5 m-85 -96.12 -11.32 26.42 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 117.757 -1.116 . . . . 50.509999999999998 113.147 179.216 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 32.5 t30 78.58 47.46 0.04 OUTLIER 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.464 1.938 . . . . 50.549999999999997 113.949 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.412 ' CD1' HD22 ' A' ' 56' ' ' LEU . 73.8 mt -85.07 112.49 22.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.965 0 CA-C-O 115.243 -2.313 . . . . 50.509999999999998 109.183 175.873 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -114.69 -171.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 126.059 2.099 . . . . 50.549999999999997 108.661 -176.869 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.1 tttp -59.59 145.2 45.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.255 1.502 . . . . 50.509999999999998 110.307 -176.948 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 34.6 mt-10 66.36 10.22 7.07 Favored 'General case' 0 C--O 1.258 1.507 0 N-CA-C 118.578 2.807 . . . . 50.619999999999997 118.578 179.57 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -74.32 138.05 43.25 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.845 -1.071 . . . . 50.509999999999998 112.668 174.796 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -112.05 128.47 56.2 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 115.14 1.533 . . . . 50.509999999999998 115.14 175.934 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 94.5 mt -103.47 138.93 39.51 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 114.635 -2.602 . . . . 50.509999999999998 107.85 175.072 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -96.33 143.56 27.29 Favored 'General case' 0 C--N 1.284 -2.273 0 O-C-N 127.374 2.921 . . . . 50.509999999999998 106.491 177.885 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.602 HD11 ' HB3' ' A' ' 41' ' ' GLN . 37.7 tp -110.86 115.86 30.25 Favored 'General case' 0 C--O 1.282 2.779 0 CA-C-O 117.733 -1.127 . . . . 50.509999999999998 112.625 176.572 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.62 143.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 119.541 1.064 . . . . 50.509999999999998 110.495 175.066 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 54.9 mt -101.61 102.85 13.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 117.019 2.229 . . . . 50.509999999999998 117.019 178.522 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -73.76 101.54 3.73 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 113.34 -3.219 . . . . 50.640000000000001 110.824 177.207 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.9 163.5 3.41 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.891 1.995 . . . . 50.509999999999998 112.581 -179.274 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.97 74.39 1.53 Allowed 'General case' 0 C--O 1.244 0.804 0 N-CA-C 105.945 -1.872 . . . . 50.640000000000001 105.945 -179.614 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.27 131.56 3.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 106.202 -2.759 . . . . 50.509999999999998 106.202 179.389 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.497 0 CA-C-O 116.331 -2.372 . . . . 50.509999999999998 116.984 179.311 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.509999999999998 111.006 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.549999999999997 116.688 178.266 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.509999999999998 111.74 173.324 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.509999999999998 115.113 179.52 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.509999999999998 107.106 175.824 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.509999999999998 103.747 -178.117 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.509999999999998 107.547 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.509999999999998 105.417 -177.96 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.509999999999998 110.637 179.919 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.509999999999998 119.029 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.509999999999998 114.413 174.998 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 113.052 176.185 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.509999999999998 114.549 179.78 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.509999999999998 111.59 178.086 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.509999999999998 110.023 -179.207 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.619999999999997 111.711 173.943 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 110.993 -177.951 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.619999999999997 108.19 174.632 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.509999999999998 111.964 177.711 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.509999999999998 113.164 -177.552 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.619999999999997 108.919 -179.0 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.509999999999998 108.06 175.711 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.509999999999998 117.251 175.811 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.619999999999997 111.876 176.964 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 110.173 -179.603 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.509999999999998 109.312 178.599 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.509999999999998 106.896 -179.77 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.509999999999998 114.569 176.92 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 176.011 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.423 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.509999999999998 104.805 179.898 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 21.8 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.549999999999997 111.202 179.415 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.619999999999997 113.082 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.509999999999998 116.338 -175.645 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.619999999999997 113.877 179.862 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.509999999999998 105.347 176.537 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.509999999999998 107.204 179.761 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.509999999999998 110.872 178.293 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.303 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.619999999999997 115.506 -177.444 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.549999999999997 113.269 178.741 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.608 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.549999999999997 109.19 -177.64 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.640000000000001 104.765 172.138 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.509999999999998 109.582 -177.498 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.509999999999998 112.344 -177.583 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.509999999999998 107.281 177.627 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.509999999999998 104.493 177.379 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 118.709 -179.624 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.509999999999998 114.674 177.718 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.549999999999997 109.652 174.548 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.509999999999998 110.096 -175.862 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.619999999999997 111.682 -177.729 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.619999999999997 118.573 -175.763 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.509999999999998 109.54 -177.249 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.640000000000001 110.879 176.534 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.509999999999998 116.693 177.156 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.509999999999998 110.756 177.237 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.509999999999998 119.247 -179.485 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.619999999999997 116.794 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.509999999999998 117.56 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.549999999999997 116.376 179.895 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 HD12 ' A' ' 56' ' ' LEU . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 115.487 175.861 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.549999999999997 107.756 -176.828 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.509999999999998 114.348 -176.929 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.619999999999997 107.384 179.576 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.509999999999998 106.402 174.815 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.509999999999998 110.362 175.94 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.509999999999998 107.602 175.106 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.509999999999998 109.96 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.509999999999998 108.197 176.547 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.509999999999998 102.361 175.117 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.509999999999998 113.908 178.441 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.640000000000001 110.488 177.138 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.509999999999998 104.971 -179.332 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.640000000000001 109.517 -179.572 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.509999999999998 111.861 179.397 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.509999999999998 108.119 179.238 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.509999999999998 111.006 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.549999999999997 116.688 178.266 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.509999999999998 111.74 173.324 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.509999999999998 115.113 179.52 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.509999999999998 107.106 175.824 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.509999999999998 103.747 -178.117 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.509999999999998 107.547 179.921 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.509999999999998 105.417 -177.96 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.509999999999998 110.637 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.509999999999998 119.029 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.509999999999998 114.413 174.998 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 113.052 176.185 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.509999999999998 114.549 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.509999999999998 111.59 178.086 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.509999999999998 110.023 -179.207 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.619999999999997 111.711 173.943 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 110.993 -177.951 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.619999999999997 108.19 174.632 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.509999999999998 111.964 177.711 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.509999999999998 113.164 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.619999999999997 108.919 -179.0 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.509999999999998 108.06 175.711 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.509999999999998 117.251 175.811 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.619999999999997 111.876 176.964 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 110.173 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.509999999999998 109.312 178.599 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.509999999999998 106.896 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.509999999999998 114.569 176.92 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 176.011 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.423 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.509999999999998 104.805 179.898 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 21.8 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.549999999999997 111.202 179.415 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.619999999999997 113.082 179.182 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.509999999999998 116.338 -175.645 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.619999999999997 113.877 179.862 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.509999999999998 105.347 176.537 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.509999999999998 107.204 179.761 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.509999999999998 110.872 178.293 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.303 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.619999999999997 115.506 -177.444 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.549999999999997 113.269 178.741 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.608 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.549999999999997 109.19 -177.64 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.640000000000001 104.765 172.138 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.509999999999998 109.582 -177.498 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.509999999999998 112.344 -177.583 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.509999999999998 107.281 177.627 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.509999999999998 104.493 177.379 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 118.709 -179.624 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.509999999999998 114.674 177.718 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.549999999999997 109.652 174.548 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.509999999999998 110.096 -175.862 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.619999999999997 111.682 -177.729 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.619999999999997 118.573 -175.763 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.509999999999998 109.54 -177.249 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.640000000000001 110.879 176.534 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.509999999999998 116.693 177.156 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.509999999999998 110.756 177.237 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.509999999999998 119.247 -179.485 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.619999999999997 116.794 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.509999999999998 117.56 179.269 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.549999999999997 116.376 179.895 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 HD12 ' A' ' 56' ' ' LEU . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 115.487 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.549999999999997 107.756 -176.828 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.509999999999998 114.348 -176.929 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.619999999999997 107.384 179.576 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.509999999999998 106.402 174.815 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.509999999999998 110.362 175.94 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.509999999999998 107.602 175.106 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.509999999999998 109.96 177.938 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.509999999999998 108.197 176.547 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.509999999999998 102.361 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.509999999999998 113.908 178.441 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.640000000000001 110.488 177.138 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.509999999999998 104.971 -179.332 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.640000000000001 109.517 -179.572 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.509999999999998 111.861 179.397 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.509999999999998 108.119 179.238 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 108.426 -0.953 . . . . 50.509999999999998 108.426 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -94.3 140.95 29.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 126.951 2.657 . . . . 50.549999999999997 106.368 178.272 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -126.22 -179.35 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-O 116.017 -1.944 . . . . 50.509999999999998 109.918 173.348 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.91 101.28 5.78 Favored 'General case' 0 N--CA 1.512 2.626 1 O-C-N 130.414 4.821 . . . . 50.509999999999998 114.319 179.567 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.25 123.7 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.488 -3.149 . . . . 50.509999999999998 110.223 175.79 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -117.24 118.42 32.23 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.291 4.119 . . . . 50.509999999999998 112.111 -178.079 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 9' ' ' THR . 5.1 t -104.0 167.38 9.8 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 116.911 2.189 . . . . 50.509999999999998 116.911 179.982 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.97 -17.79 63.98 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.807 1.78 . . . . 50.509999999999998 115.807 -178.008 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.511 ' H ' HG23 ' A' ' 7' ' ' THR . 53.3 p -89.25 1.7 55.33 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 115.767 -2.373 . . . . 50.509999999999998 109.718 179.889 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 -4.28 85.63 Favored Glycine 0 C--N 1.296 -1.655 0 O-C-N 120.115 -1.616 . . . . 50.509999999999998 117.096 179.84 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -67.5 110.0 3.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.825 -1.56 . . . . 50.509999999999998 109.337 174.976 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -81.38 133.74 35.46 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.665 2.478 . . . . 50.509999999999998 114.41 176.175 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.87 138.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 127.38 2.925 . . . . 50.509999999999998 118.105 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.3 m -106.96 130.0 54.68 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.222 -1.791 . . . . 50.509999999999998 111.438 178.138 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.428 HD11 ' CB ' ' A' ' 29' ' ' LYS . 49.3 tp -115.74 152.19 33.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 115.479 -2.201 . . . . 50.509999999999998 114.636 -179.279 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -115.01 107.48 15.42 Favored 'General case' 0 N--CA 1.5 2.04 1 O-C-N 129.273 4.108 . . . . 50.619999999999997 114.466 173.992 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.427 HG13 ' HG ' ' A' ' 15' ' ' LEU . 21.0 m -126.55 150.58 32.38 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 127.849 3.218 . . . . 50.509999999999998 118.53 -177.869 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 76.3 mt-10 -87.31 152.12 52.13 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 117.776 2.51 . . . . 50.619999999999997 117.776 174.655 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.46 39.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.556 2.171 . . . . 50.509999999999998 111.946 177.715 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -107.6 37.77 2.33 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 116.229 1.937 . . . . 50.509999999999998 116.229 -177.54 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -105.01 148.54 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 117.321 -1.751 . . . . 50.619999999999997 109.822 -178.965 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -92.88 159.57 15.3 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.087 -1.449 . . . . 50.509999999999998 107.087 175.728 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.12 -40.58 74.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 O-C-N 127.234 2.834 . . . . 50.509999999999998 108.203 175.801 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 52.0 mt-10 -54.08 -13.49 0.82 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.301 1.222 . . . . 50.619999999999997 114.301 177.015 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.35 -18.87 10.37 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.062 1.505 . . . . 50.549999999999997 115.062 -179.608 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.85 -57.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 101.545 -3.502 . . . . 50.509999999999998 101.545 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -57.09 -24.68 55.72 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 115.77 -0.65 . . . . 50.509999999999998 111.547 -179.775 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.68 -6.61 57.52 Favored 'General case' 0 C--O 1.278 2.553 0 N-CA-C 117.612 2.449 . . . . 50.509999999999998 117.612 176.862 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' CB ' HD11 ' A' ' 15' ' ' LEU . 63.3 mttp -91.9 -30.25 16.24 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 102.818 -3.03 . . . . 50.509999999999998 102.818 176.037 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.97 -45.0 98.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 103.108 -2.923 . . . . 50.509999999999998 103.108 179.858 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -52.09 -50.84 60.81 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 125.608 2.623 . . . . 50.549999999999997 108.453 179.419 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -56.66 -14.46 3.27 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 113.612 -1.631 . . . . 50.619999999999997 115.384 179.062 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 31.2 mmmt -117.46 -50.09 2.55 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.465 -2.094 . . . . 50.509999999999998 111.468 -175.688 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -94.93 -8.46 37.0 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 111.17 179.853 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.05 29.25 69.16 Favored Glycine 0 CA--C 1.477 -2.313 0 N-CA-C 107.777 -2.129 . . . . 50.509999999999998 107.777 176.518 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.61 122.74 45.09 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 105.386 -2.079 . . . . 50.509999999999998 105.386 179.75 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -56.95 136.96 79.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 123.177 2.584 . . . . 50.509999999999998 110.913 178.328 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.14 -32.19 92.67 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 120.713 0.942 . . . . 50.509999999999998 113.428 -179.347 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.38 -14.42 27.57 Favored 'General case' 0 C--O 1.262 1.723 0 N-CA-C 115.691 1.737 . . . . 50.619999999999997 115.691 -177.383 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -100.66 13.38 34.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.416 1.636 . . . . 50.549999999999997 115.416 178.788 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -116.42 133.12 56.38 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.363 2.03 . . . . 50.549999999999997 114.944 -177.592 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -116.97 124.77 50.17 Favored 'General case' 0 C--O 1.296 3.516 0 N-CA-C 105.245 -2.132 . . . . 50.640000000000001 105.245 172.145 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.83 133.86 49.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.735 -1.95 . . . . 50.509999999999998 105.735 -177.582 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -121.55 123.47 69.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.159 1.537 . . . . 50.509999999999998 111.155 -177.615 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -134.58 127.78 31.95 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 114.477 -1.238 . . . . 50.509999999999998 111.214 177.625 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.28 20.31 5.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.292 -2.231 . . . . 50.509999999999998 114.468 177.354 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.2 -8.25 67.13 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 120.673 3.029 . . . . 50.509999999999998 120.673 -179.589 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -98.67 144.68 27.68 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 118.052 0.926 . . . . 50.509999999999998 109.91 177.61 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -80.12 129.87 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.346 -2.835 . . . . 50.549999999999997 103.346 174.587 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.71 157.96 31.34 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 117.701 -1.142 . . . . 50.509999999999998 113.902 -175.911 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -100.66 154.23 18.76 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.131 -1.433 . . . . 50.619999999999997 107.131 -177.603 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 64.8 m-20 -72.02 -44.89 62.68 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 126.116 1.766 . . . . 50.619999999999997 111.718 -175.841 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.13 61.31 Favored Glycine 0 C--O 1.253 1.295 0 N-CA-C 120.191 2.836 . . . . 50.509999999999998 120.191 -177.249 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -95.87 169.05 10.26 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 120.066 -1.843 . . . . 50.640000000000001 112.669 176.524 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 70.7 p -100.41 153.92 18.94 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 114.167 1.173 . . . . 50.509999999999998 114.167 177.082 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.8 mt -55.28 -30.84 60.92 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.238 0.962 . . . . 50.509999999999998 112.059 177.254 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -75.23 -28.89 60.08 Favored 'General case' 0 C--O 1.268 2.039 0 C-N-CA 117.375 -1.73 . . . . 50.509999999999998 109.422 -179.434 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 55' ' ' THR . 90.8 m-20 -53.44 -42.38 67.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.457 1.123 . . . . 50.619999999999997 112.401 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -91.18 20.15 5.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 117.779 -1.105 . . . . 50.509999999999998 113.266 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 m120 44.71 24.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 120.024 3.342 . . . . 50.549999999999997 120.024 179.976 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.19 127.92 34.63 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 N-CA-C 101.628 -3.471 . . . . 50.509999999999998 101.628 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' LYS . 44.8 mt-30 -132.37 159.98 37.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 125.946 2.029 . . . . 50.549999999999997 106.699 -176.795 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 62' ' ' GLN . 34.3 ttpt -43.09 146.61 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.707 -1.96 . . . . 50.509999999999998 105.707 -177.019 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 66.4 50.5 1.29 Allowed 'General case' 0 C--O 1.257 1.477 0 CA-C-N 112.5 -2.136 . . . . 50.619999999999997 114.734 179.558 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -124.91 142.97 51.11 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.827 -1.079 . . . . 50.509999999999998 108.436 174.847 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -91.91 135.52 33.87 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.276 -0.868 . . . . 50.509999999999998 109.119 175.87 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.77 136.76 53.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 114.669 -2.586 . . . . 50.509999999999998 105.323 175.11 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -95.23 128.3 41.96 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 127.453 2.971 . . . . 50.509999999999998 112.17 177.899 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.45 119.26 32.89 Favored 'General case' 0 C--O 1.282 2.764 0 CA-C-O 117.71 -1.138 . . . . 50.509999999999998 113.789 176.557 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.07 140.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.676 -2.713 . . . . 50.509999999999998 103.676 175.084 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -111.39 135.12 52.39 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.023 1.12 . . . . 50.509999999999998 114.023 178.462 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -116.29 115.97 26.91 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 113.324 -3.227 . . . . 50.640000000000001 107.894 177.265 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -99.75 168.17 10.09 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 117.876 2.547 . . . . 50.509999999999998 117.876 -179.334 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -77.26 123.36 26.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 113.739 -1.573 . . . . 50.640000000000001 109.597 -179.602 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 154.42 5.85 Favored Glycine 0 C--O 1.244 0.724 0 CA-C-N 114.605 -1.179 . . . . 50.509999999999998 114.458 179.37 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 CA-C-O 116.37 -2.35 . . . . 50.509999999999998 118.366 179.233 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtp . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 104.905 -2.257 . . . . 50.509999999999998 104.905 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -87.34 142.13 28.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.957 2.66 . . . . 50.549999999999997 109.191 178.32 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.86 174.03 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 116.012 -1.947 . . . . 50.509999999999998 105.937 173.324 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -122.88 126.47 47.37 Favored 'General case' 0 N--CA 1.513 2.688 1 O-C-N 129.858 4.474 . . . . 50.509999999999998 113.505 179.558 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 114.86 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 113.373 -3.203 . . . . 50.509999999999998 115.835 175.753 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -79.76 121.1 24.93 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.346 4.154 . . . . 50.509999999999998 118.167 -178.045 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.68 HG22 HD23 ' A' ' 69' ' ' LEU . 24.7 p -96.64 177.16 5.75 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 120.831 3.641 . . . . 50.509999999999998 120.831 179.917 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.84 17.73 4.62 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.072 0.858 . . . . 50.509999999999998 109.674 -178.014 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -124.18 14.49 9.06 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 115.741 -2.384 . . . . 50.509999999999998 112.587 179.929 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.09 14.95 81.29 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 107.75 -2.14 . . . . 50.509999999999998 107.75 179.807 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -104.91 147.1 28.12 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 116.831 -1.557 . . . . 50.509999999999998 112.915 174.977 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -119.01 134.8 54.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 126.637 2.461 . . . . 50.509999999999998 106.354 176.113 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.1 mt -97.37 147.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.477 2.986 . . . . 50.509999999999998 112.74 179.706 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 m -109.99 125.13 52.56 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.287 -1.765 . . . . 50.509999999999998 106.692 178.136 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -126.12 141.89 51.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.875 -2.268 . . . . 50.509999999999998 104.875 -179.27 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -116.45 112.51 21.54 Favored 'General case' 0 N--CA 1.5 2.034 1 O-C-N 129.243 4.089 . . . . 50.619999999999997 109.392 173.962 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 56' ' ' LEU . 33.8 m -106.97 171.42 2.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.214 0 O-C-N 127.694 3.121 . . . . 50.509999999999998 114.6 -177.943 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 75.9 tt0 -111.3 143.15 27.84 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 112.21 -2.268 . . . . 50.619999999999997 106.057 174.556 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.2 Cg_exo -55.0 -24.44 39.78 Favored 'Trans proline' 0 C--N 1.32 -0.933 0 C-N-CA 122.564 2.176 . . . . 50.509999999999998 111.953 177.737 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -82.13 -17.8 45.14 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 114.348 1.24 . . . . 50.509999999999998 114.348 -177.537 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.93 163.42 27.49 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.451 -1.7 . . . . 50.619999999999997 112.123 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.3 p -95.62 -165.48 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.876 -0.602 . . . . 50.509999999999998 111.085 175.7 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -87.01 -40.86 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 127.171 2.794 . . . . 50.509999999999998 108.181 175.716 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 16.8 tp10 -52.46 -42.56 64.31 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 107.534 -1.284 . . . . 50.619999999999997 107.534 177.021 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.17 -49.77 72.97 Favored 'General case' 0 C--O 1.249 1.038 0 C-N-CA 124.352 1.061 . . . . 50.549999999999997 113.405 -179.656 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 22' ' ' THR . 91.1 t -57.78 -42.65 82.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.999 1.437 . . . . 50.509999999999998 111.95 178.645 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.615 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 93.3 mttt -65.95 -37.06 85.03 Favored 'General case' 0 C--O 1.257 1.481 0 N-CA-C 106.535 -1.654 . . . . 50.509999999999998 106.535 -179.693 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 31' ' ' GLN . . . -63.88 -45.19 90.53 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 113.186 0.809 . . . . 50.509999999999998 113.186 176.911 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -44.18 -36.7 2.77 Favored 'General case' 0 C--O 1.255 1.348 0 O-C-N 120.375 -1.453 . . . . 50.509999999999998 108.8 175.973 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.458 HG21 HE22 ' A' ' 41' ' ' GLN . 58.8 mt -72.88 -33.44 43.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.487 -0.885 . . . . 50.509999999999998 110.492 179.895 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 55.4 tt0 -54.95 -41.61 71.29 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.581 2.61 . . . . 50.549999999999997 108.434 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.73 -20.53 57.03 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 113.631 -1.622 . . . . 50.619999999999997 115.104 179.173 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 31.0 mmmt -110.37 -36.15 5.87 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.413 -2.115 . . . . 50.509999999999998 110.828 -175.703 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.55 -54.79 3.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 123.121 2.691 . . . . 50.619999999999997 108.627 179.861 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 18.77 4.06 Favored Glycine 0 CA--C 1.477 -2.288 0 N-CA-C 103.565 -3.814 . . . . 50.509999999999998 103.565 176.55 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.517 HG23 ' HD2' ' A' ' 37' ' ' PRO . 73.5 mt -103.74 135.89 19.29 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 116.785 2.143 . . . . 50.509999999999998 116.785 179.637 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HD2' HG23 ' A' ' 36' ' ' ILE . 78.2 Cg_exo -56.98 137.02 80.12 Favored 'Trans proline' 0 C--O 1.259 1.546 0 C-N-CA 123.084 2.523 . . . . 50.509999999999998 110.919 178.317 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 87.3 Cg_exo -57.23 -32.14 92.72 Favored 'Trans proline' 0 C--O 1.262 1.687 0 O-C-N 122.914 0.955 . . . . 50.509999999999998 113.391 -179.298 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -64.71 -18.68 65.22 Favored 'General case' 0 C--O 1.263 1.767 0 N-CA-C 117.422 2.379 . . . . 50.619999999999997 117.422 -177.401 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -81.45 -15.61 54.55 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.573 -1.33 . . . . 50.549999999999997 109.072 178.719 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.458 HE22 HG21 ' A' ' 30' ' ' ILE . 61.9 mt-30 -100.71 130.09 46.7 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 124.48 2.086 . . . . 50.549999999999997 112.444 -177.6 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -111.65 137.61 49.29 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.648 -1.644 . . . . 50.640000000000001 110.507 172.14 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.615 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 35.2 mt -116.24 129.45 56.29 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.904 1.446 . . . . 50.509999999999998 114.904 -177.456 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -114.77 127.15 72.42 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 O-C-N 125.085 1.491 . . . . 50.509999999999998 111.278 -177.6 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -139.81 107.06 5.5 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 106.99 -1.485 . . . . 50.509999999999998 106.99 177.652 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.43 41.73 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.228 -2.26 . . . . 50.509999999999998 105.53 177.383 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.96 -51.51 2.0 Allowed Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 116.588 -179.605 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -40.2 148.32 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 116.747 2.128 . . . . 50.509999999999998 116.747 177.718 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -82.42 146.08 29.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.042 -2.207 . . . . 50.549999999999997 105.042 174.598 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -100.03 142.35 31.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.102 -1.444 . . . . 50.509999999999998 107.102 -175.888 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.04 156.55 17.85 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.106 -1.442 . . . . 50.619999999999997 107.106 -177.72 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 74.8 m-20 -82.99 -39.1 21.75 Favored 'General case' 0 C--O 1.264 1.837 0 C-N-CA 126.159 1.784 . . . . 50.619999999999997 108.242 -175.8 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.41 2.07 87.74 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 116.288 1.275 . . . . 50.509999999999998 116.288 -177.201 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -95.73 161.01 14.21 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 119.91 -1.935 . . . . 50.640000000000001 106.027 176.515 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 22.8 p -98.37 170.29 8.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.403 -0.962 . . . . 50.509999999999998 108.403 177.129 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 17' ' ' VAL . 4.1 mp -65.31 -16.91 64.07 Favored 'General case' 0 C--O 1.201 -1.498 0 N-CA-C 107.767 -1.198 . . . . 50.509999999999998 107.767 177.255 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 p -70.71 -23.66 62.51 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 116.47 2.026 . . . . 50.509999999999998 116.47 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.21 -37.66 80.96 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.107 2.262 . . . . 50.619999999999997 117.107 179.773 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -101.19 4.52 42.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 117.765 -1.112 . . . . 50.509999999999998 109.716 179.299 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 56.39 54.93 7.05 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 103.862 -2.644 . . . . 50.549999999999997 103.862 179.869 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.17 132.76 31.62 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 115.224 -2.322 . . . . 50.509999999999998 105.818 175.86 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -117.3 172.94 6.97 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.771 2.508 . . . . 50.549999999999997 117.771 -176.815 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -68.08 133.09 48.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 123.187 1.47 . . . . 50.509999999999998 113.737 -176.967 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.12 42.97 30.28 Favored 'General case' 0 C--O 1.256 1.436 0 N-CA-C 116.855 2.168 . . . . 50.619999999999997 116.855 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.6 p -85.46 166.27 16.48 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 104.315 -2.476 . . . . 50.509999999999998 104.315 174.796 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.9 p -114.94 132.72 56.47 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.816 -1.55 . . . . 50.509999999999998 106.816 175.975 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.6 mp -108.37 160.33 15.95 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 114.7 -2.572 . . . . 50.509999999999998 112.396 175.012 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.67 132.07 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.383 2.927 . . . . 50.509999999999998 109.765 177.947 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.68 HD23 HG22 ' A' ' 7' ' ' THR . 30.3 tp -112.78 125.37 54.26 Favored 'General case' 0 C--O 1.282 2.78 0 CA-C-O 117.657 -1.163 . . . . 50.509999999999998 109.467 176.525 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.84 139.97 39.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 105.165 -2.161 . . . . 50.509999999999998 105.165 175.087 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.2 mt -100.42 130.0 46.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.573 -2.01 . . . . 50.509999999999998 105.573 178.397 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -122.89 113.07 18.62 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 101.358 -3.571 . . . . 50.640000000000001 101.358 177.175 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.81 166.31 11.69 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.78 1.925 . . . . 50.509999999999998 111.032 -179.287 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.07 96.73 9.96 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 118.874 2.916 . . . . 50.640000000000001 118.874 -179.592 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.24 -168.62 12.63 Favored Glycine 0 C--O 1.243 0.679 0 N-CA-C 107.136 -2.385 . . . . 50.509999999999998 107.136 179.361 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.477 0 CA-C-O 116.31 -2.383 . . . . 50.509999999999998 110.028 179.212 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.483 ' CE ' ' HD2' ' A' ' 63' ' ' LYS . 81.4 mmm . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.081 0.771 . . . . 50.509999999999998 113.081 . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -95.5 124.07 39.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.902 2.626 . . . . 50.549999999999997 115.59 178.29 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.39 152.72 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.984 -1.96 . . . . 50.509999999999998 109.264 173.317 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.557 ' CE2' ' OG1' ' A' ' 14' ' ' THR . 53.6 m-85 -106.52 141.71 37.36 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.386 4.804 . . . . 50.509999999999998 116.464 179.533 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HB ' HG12 ' A' ' 13' ' ' ILE . 85.9 t -113.13 110.4 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 113.435 -3.174 . . . . 50.509999999999998 110.211 175.719 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -83.34 130.74 35.07 Favored 'General case' 0 N--CA 1.505 2.276 1 O-C-N 129.353 4.158 . . . . 50.509999999999998 106.732 -178.064 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.66 -173.65 2.52 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 117.846 -1.073 . . . . 50.509999999999998 108.973 179.928 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -90.34 -16.81 28.46 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.854 1.427 . . . . 50.509999999999998 114.854 -177.959 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -101.33 -3.14 29.38 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 115.695 -2.402 . . . . 50.509999999999998 116.879 179.962 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.41 1.38 Allowed Glycine 0 C--N 1.297 -1.614 0 N-CA-C 117.366 1.706 . . . . 50.509999999999998 117.366 179.781 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -54.9 143.02 27.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 116.069 1.877 . . . . 50.509999999999998 116.069 175.013 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -124.14 136.45 54.22 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 126.619 2.449 . . . . 50.509999999999998 112.919 176.11 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.5 HG12 ' HB ' ' A' ' 5' ' ' VAL . 17.3 pt -106.67 125.18 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.464 2.978 . . . . 50.509999999999998 107.182 179.774 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.557 ' OG1' ' CE2' ' A' ' 4' ' ' PHE . 43.7 m -98.65 134.98 40.81 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.294 -1.762 . . . . 50.509999999999998 112.953 178.123 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -117.01 154.73 30.42 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 115.492 -2.194 . . . . 50.509999999999998 114.072 -179.29 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.7 tt0 -114.94 99.3 7.37 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 129.172 4.045 . . . . 50.619999999999997 109.17 174.005 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.88 155.46 15.07 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.781 3.175 . . . . 50.509999999999998 116.308 -177.967 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -107.3 135.33 19.67 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 104.518 -2.401 . . . . 50.619999999999997 104.518 174.63 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 57' ' ' SER . 84.3 Cg_exo -54.95 -24.52 39.72 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 122.54 2.16 . . . . 50.509999999999998 111.931 177.765 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -76.99 -0.23 23.63 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 118.102 -0.952 . . . . 50.509999999999998 109.269 -177.585 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.545 ' O ' ' HB ' ' A' ' 55' ' ' THR . 92.1 m-20 -72.76 178.21 4.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 117.378 -1.729 . . . . 50.619999999999997 109.31 -179.01 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.1 p -106.3 167.44 9.83 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 103.074 -2.936 . . . . 50.509999999999998 103.074 175.741 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 23' ' ' ILE . 13.1 mm -67.34 -45.99 84.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 O-C-N 126.975 2.672 . . . . 50.509999999999998 107.788 175.809 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -54.71 -48.41 72.52 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.42 -0.8 . . . . 50.619999999999997 112.376 177.017 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -48.61 -49.23 37.91 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.468 -1.308 . . . . 50.549999999999997 107.468 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 22' ' ' THR . 95.8 t -52.07 -52.65 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 125.069 1.481 . . . . 50.509999999999998 113.436 178.528 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -72.81 -23.05 60.73 Favored 'General case' 0 C--O 1.257 1.486 0 CA-C-N 115.755 -0.657 . . . . 50.509999999999998 109.356 -179.745 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.3 95.04 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.334 -2.099 . . . . 50.509999999999998 105.334 176.973 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.38 -48.81 60.04 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 114.995 1.48 . . . . 50.509999999999998 114.995 175.933 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -56.32 -52.6 49.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 103.796 -2.668 . . . . 50.509999999999998 103.796 179.871 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.498 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.6 tt0 -38.32 -73.56 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 125.567 2.603 . . . . 50.549999999999997 110.301 179.391 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -39.76 -59.13 1.22 Allowed 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.671 -1.604 . . . . 50.619999999999997 114.382 179.098 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -82.43 -42.66 18.28 Favored 'General case' 0 C--O 1.279 2.623 0 N-CA-C 119.941 3.312 . . . . 50.509999999999998 119.941 -175.677 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.18 -30.97 22.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 123.058 2.663 . . . . 50.619999999999997 105.776 179.828 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.63 22.76 23.08 Favored Glycine 0 CA--C 1.477 -2.31 0 N-CA-C 118.867 2.307 . . . . 50.509999999999998 118.867 176.564 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 59.2 mt -105.14 122.23 43.75 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 118.753 -1.179 . . . . 50.509999999999998 110.216 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -56.97 136.94 79.64 Favored 'Trans proline' 0 C--O 1.259 1.537 0 C-N-CA 123.207 2.605 . . . . 50.509999999999998 110.879 178.348 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.4 Cg_exo -57.15 -32.17 92.62 Favored 'Trans proline' 0 C--O 1.261 1.661 0 O-C-N 122.926 0.961 . . . . 50.509999999999998 113.486 -179.376 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.45 -0.33 1.88 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 119.973 -1.705 . . . . 50.619999999999997 115.303 -177.448 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -126.91 18.74 7.2 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.5 -1.375 . . . . 50.549999999999997 113.503 178.709 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.425 ' HG2' HD11 ' A' ' 69' ' ' LEU . 69.8 mt-30 -110.3 141.47 43.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.299 2.0 . . . . 50.549999999999997 110.246 -177.582 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -128.62 136.67 50.99 Favored 'General case' 0 C--O 1.297 3.557 0 CA-C-O 116.726 -1.607 . . . . 50.640000000000001 107.496 172.157 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 69' ' ' LEU . 60.3 mt -135.94 124.45 23.56 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.464 1.029 . . . . 50.509999999999998 110.586 -177.538 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -122.62 122.53 66.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.121 1.513 . . . . 50.509999999999998 108.685 -177.589 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -143.06 139.03 30.34 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 114.514 -1.221 . . . . 50.509999999999998 112.103 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 20.48 10.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 112.271 -2.24 . . . . 50.509999999999998 114.865 177.398 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -21.76 27.32 Favored Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 128.493 2.949 . . . . 50.509999999999998 109.173 -179.654 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.74 177.79 7.89 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 118.087 0.943 . . . . 50.509999999999998 111.707 177.65 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -109.59 149.59 29.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 123.99 0.806 . . . . 50.549999999999997 109.481 174.579 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.81 101.71 10.35 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 104.918 -2.253 . . . . 50.509999999999998 104.918 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -101.91 153.23 20.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.916 1.385 . . . . 50.619999999999997 113.765 -177.66 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.45 -44.55 96.15 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 115.969 1.84 . . . . 50.619999999999997 115.969 -175.795 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.99 -15.21 3.23 Favored Glycine 0 C--O 1.253 1.333 0 N-CA-C 116.118 1.207 . . . . 50.509999999999998 116.118 -177.226 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -131.37 145.78 51.99 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 118.838 2.903 . . . . 50.640000000000001 118.838 176.506 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 21' ' ' ASP . 70.7 p -68.94 172.35 6.74 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 115.279 1.585 . . . . 50.509999999999998 115.279 177.189 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG13 ' A' ' 61' ' ' ILE . 35.5 mt -59.47 -49.39 77.98 Favored 'General case' 0 C--O 1.201 -1.477 0 O-C-N 124.156 0.91 . . . . 50.509999999999998 108.789 177.188 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' PRO . 9.4 t -47.52 -47.87 27.66 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 117.298 -1.761 . . . . 50.509999999999998 112.454 -179.444 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -48.45 -26.36 2.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.236 1.569 . . . . 50.619999999999997 115.236 179.767 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 66.9 m-85 -95.01 5.8 50.88 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 117.793 2.516 . . . . 50.509999999999998 117.793 179.222 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.684 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 63.4 m-20 68.81 9.71 7.52 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 121.534 1.97 . . . . 50.549999999999997 114.52 179.909 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.539 HG13 HD22 ' A' ' 56' ' ' LEU . 26.6 mm -50.97 117.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.99 0 CA-C-O 115.141 -2.361 . . . . 50.509999999999998 109.155 175.776 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.684 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 72.2 mt-30 -123.93 179.53 4.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 126.147 2.155 . . . . 50.549999999999997 105.837 -176.811 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HD2' ' CE ' ' A' ' 1' ' ' MET . 82.9 tttt -68.2 146.52 53.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.202 1.477 . . . . 50.509999999999998 108.35 -176.921 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 46.8 67.4 0.79 Allowed 'General case' 0 C--O 1.256 1.429 0 N-CA-C 120.868 3.655 . . . . 50.619999999999997 120.868 179.538 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.5 p -121.04 172.07 8.21 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 106.966 -1.494 . . . . 50.509999999999998 106.966 174.798 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 p -111.96 118.17 34.73 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 115.604 1.705 . . . . 50.509999999999998 115.604 175.982 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.05 138.03 34.27 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 114.647 -2.596 . . . . 50.509999999999998 107.617 175.08 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -97.96 122.48 41.14 Favored 'General case' 0 C--N 1.285 -2.236 0 O-C-N 127.383 2.927 . . . . 50.509999999999998 112.859 177.886 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 43' ' ' LEU . 42.1 tp -90.14 131.91 35.73 Favored 'General case' 0 C--O 1.283 2.83 0 N-CA-C 115.551 1.686 . . . . 50.509999999999998 115.551 176.519 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -120.9 129.28 75.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 103.253 -2.869 . . . . 50.509999999999998 103.253 175.109 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.55 123.93 44.28 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.178 0.513 . . . . 50.509999999999998 110.13 178.424 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -112.19 91.44 3.66 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.41 -3.186 . . . . 50.640000000000001 110.839 177.247 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.87 163.0 28.61 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.811 1.945 . . . . 50.509999999999998 108.282 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.9 ttm105 -87.16 107.35 18.42 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 116.366 1.987 . . . . 50.640000000000001 116.366 -179.544 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.84 151.94 23.58 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 114.66 -1.154 . . . . 50.509999999999998 114.59 179.394 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 113.943 179.22 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 36.7 mmt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 105.584 -2.006 . . . . 50.509999999999998 105.584 . . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -100.73 135.85 41.53 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.965 2.666 . . . . 50.549999999999997 107.301 178.239 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.465 HD12 ' C ' ' A' ' 3' ' ' ILE . 2.8 pp -137.29 154.93 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 115.961 -1.971 . . . . 50.509999999999998 108.392 173.316 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.39 149.49 23.12 Favored 'General case' 0 N--CA 1.511 2.602 1 O-C-N 130.475 4.86 . . . . 50.509999999999998 115.331 179.558 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.52 122.11 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 101.949 -3.352 . . . . 50.509999999999998 101.949 175.73 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.503 2.198 1 O-C-N 129.322 4.139 . . . . 50.509999999999998 105.737 -178.074 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -87.31 -171.97 3.72 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 117.746 -1.121 . . . . 50.509999999999998 111.573 179.983 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.94 19.73 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.085 0.866 . . . . 50.509999999999998 112.175 -177.974 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -130.8 -14.49 3.56 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 115.706 -2.398 . . . . 50.509999999999998 115.874 179.921 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.83 29.21 4.45 Favored Glycine 0 C--N 1.296 -1.672 0 O-C-N 120.006 -1.684 . . . . 50.509999999999998 109.105 179.833 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.67 123.0 47.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 116.891 -1.528 . . . . 50.509999999999998 111.611 174.997 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p -109.21 131.94 54.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 118.001 2.593 . . . . 50.509999999999998 118.001 176.14 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -113.07 157.4 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 127.209 2.818 . . . . 50.509999999999998 106.143 179.741 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -112.83 140.13 47.88 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.274 -1.77 . . . . 50.509999999999998 109.73 178.131 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 mt -122.1 171.16 9.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 115.488 -2.196 . . . . 50.509999999999998 113.214 -179.293 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' H ' ' HE2' ' A' ' 29' ' ' LYS . 71.7 tt0 -128.94 109.85 11.59 Favored 'General case' 0 N--CA 1.5 2.032 1 O-C-N 129.104 4.003 . . . . 50.619999999999997 112.573 173.976 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.22 172.36 8.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.722 3.139 . . . . 50.509999999999998 114.387 -177.939 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.75 150.33 75.49 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 112.224 -2.262 . . . . 50.619999999999997 108.179 174.638 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.9 -24.53 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.562 2.174 . . . . 50.509999999999998 111.887 177.744 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -81.36 -19.96 41.63 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 118.154 -0.926 . . . . 50.509999999999998 109.737 -177.52 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.63 139.59 58.78 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.352 -1.739 . . . . 50.619999999999997 108.165 -179.053 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 156.03 18.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 105.125 -2.176 . . . . 50.509999999999998 105.125 175.691 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -49.24 -33.66 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 O-C-N 127.201 2.813 . . . . 50.509999999999998 112.734 175.787 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -72.37 -16.61 61.86 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 113.917 1.08 . . . . 50.619999999999997 113.917 177.034 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 25' ' ' ASN . 64.4 t-20 -98.7 -9.0 25.22 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 109.217 -179.663 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -91.32 -43.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 104.981 -2.229 . . . . 50.509999999999998 104.981 178.588 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' ILE . 53.8 mtmt -64.38 -58.41 6.56 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 113.294 0.85 . . . . 50.509999999999998 113.294 -179.806 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.8 -34.11 3.51 Favored 'General case' 0 C--O 1.279 2.608 0 CA-C-N 117.984 0.356 . . . . 50.509999999999998 110.058 176.851 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' A' ' 16' ' ' GLU . 66.1 tttp -62.84 -31.89 73.0 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.383 -1.448 . . . . 50.509999999999998 109.787 175.95 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 27' ' ' LYS . 70.0 mt -77.42 -35.03 21.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 105.709 -1.96 . . . . 50.509999999999998 105.709 179.903 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.724 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 17.8 tm0? -47.11 -36.72 8.69 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 125.564 2.602 . . . . 50.549999999999997 115.246 179.46 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -69.58 -32.24 70.89 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 113.664 -1.607 . . . . 50.619999999999997 113.743 179.131 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -99.77 -7.21 25.8 Favored 'General case' 0 C--O 1.279 2.641 0 C-N-CA 116.473 -2.091 . . . . 50.509999999999998 115.925 -175.671 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -121.97 -32.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 123.063 2.665 . . . . 50.619999999999997 110.136 179.891 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.55 12.57 60.88 Favored Glycine 0 CA--C 1.478 -2.222 0 N-CA-C 104.703 -3.359 . . . . 50.509999999999998 104.703 176.543 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.9 mm -98.3 125.64 42.63 Favored Pre-proline 0 C--O 1.245 0.818 0 N-CA-C 104.462 -2.422 . . . . 50.509999999999998 104.462 179.653 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 78.2 Cg_exo -57.04 136.94 79.66 Favored 'Trans proline' 0 C--O 1.259 1.528 0 C-N-CA 123.154 2.569 . . . . 50.509999999999998 110.922 178.353 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.724 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.4 Cg_exo -57.18 -32.17 92.7 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.918 0.957 . . . . 50.509999999999998 113.398 -179.268 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.45 -18.75 65.54 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 119.918 -1.739 . . . . 50.619999999999997 106.65 -177.489 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.505 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 77.9 mt-30 -93.36 -1.29 56.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.23 1.937 . . . . 50.549999999999997 116.23 178.724 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 57.6 mt-30 -86.74 151.48 23.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.363 2.03 . . . . 50.549999999999997 110.256 -177.575 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.576 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 75.3 ttt180 -133.54 106.96 7.72 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.671 -1.633 . . . . 50.640000000000001 109.224 172.151 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -98.05 136.33 38.46 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.483 1.038 . . . . 50.509999999999998 113.488 -177.472 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.75 124.97 57.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 O-C-N 125.111 1.507 . . . . 50.509999999999998 113.16 -177.608 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -138.35 118.08 13.15 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 114.472 1.286 . . . . 50.509999999999998 114.472 177.673 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 35.57 18.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.291 -2.232 . . . . 50.509999999999998 106.186 177.349 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 8.0 84.69 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 128.437 2.922 . . . . 50.509999999999998 116.237 -179.596 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -101.87 141.45 34.7 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 118.058 0.929 . . . . 50.509999999999998 113.213 177.665 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -84.46 120.73 26.65 Favored 'General case' 0 C--O 1.259 1.599 0 O-C-N 123.977 0.798 . . . . 50.549999999999997 109.235 174.599 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -60.98 126.23 26.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 110.757 -175.883 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.16 132.14 40.42 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.973 1.42 . . . . 50.619999999999997 114.002 -177.713 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.82 -58.31 5.01 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 103.631 -2.729 . . . . 50.619999999999997 103.631 -175.871 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.72 1.66 28.65 Favored Glycine 0 CA--C 1.493 -1.297 0 N-CA-C 118.34 2.096 . . . . 50.509999999999998 118.34 -177.174 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 58' ' ' ASP . 52.8 mmm-85 -109.81 144.96 37.52 Favored 'General case' 0 C--O 1.249 1.034 0 O-C-N 119.696 -2.061 . . . . 50.640000000000001 106.479 176.425 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -91.31 162.49 14.59 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 117.183 2.29 . . . . 50.509999999999998 117.183 177.109 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.712 ' HG ' ' HB ' ' A' ' 61' ' ' ILE . 2.7 mp -46.84 -25.92 0.86 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.14 0.9 . . . . 50.509999999999998 109.5 177.187 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.9 p -71.84 -36.91 70.3 Favored 'General case' 0 C--O 1.269 2.096 0 C-N-CA 117.314 -1.755 . . . . 50.509999999999998 114.309 -179.468 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB3' ' NH2' ' A' ' 54' ' ' ARG . 1.4 m-20 -62.2 -25.29 67.71 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.472 1.13 . . . . 50.619999999999997 113.699 179.812 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.46 24.09 11.59 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 112.609 179.193 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 t30 37.16 54.18 1.25 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 118.865 2.913 . . . . 50.549999999999997 118.865 179.896 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.712 ' HB ' ' HG ' ' A' ' 56' ' ' LEU . 40.9 mm -88.82 100.15 10.2 Favored 'Isoleucine or valine' 0 C--O 1.267 2.017 0 CA-C-O 115.144 -2.36 . . . . 50.509999999999998 112.488 175.861 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -108.85 -178.58 3.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.155 2.16 . . . . 50.549999999999997 111.715 -176.864 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.451 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 64.0 tttm -67.63 144.62 55.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 -176.935 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 67.43 21.82 9.55 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 118.641 2.83 . . . . 50.619999999999997 118.641 179.559 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -73.96 174.24 8.85 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.15 1.907 . . . . 50.509999999999998 116.15 174.857 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -117.2 110.56 18.29 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.472 1.656 . . . . 50.509999999999998 115.472 175.981 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.7 113.83 27.04 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 114.655 -2.593 . . . . 50.509999999999998 115.949 175.042 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.35 136.89 37.12 Favored 'General case' 0 C--N 1.285 -2.216 0 O-C-N 127.457 2.973 . . . . 50.509999999999998 115.542 177.905 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -106.95 114.68 28.91 Favored 'General case' 0 C--O 1.281 2.763 0 N-CA-C 115.546 1.684 . . . . 50.509999999999998 115.546 176.578 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.576 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -111.75 137.91 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 104.908 -2.256 . . . . 50.509999999999998 104.908 175.121 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.92 157.57 28.21 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.403 0.89 . . . . 50.509999999999998 113.403 178.467 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 ttm105 -132.03 77.31 1.75 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 101.997 -3.335 . . . . 50.640000000000001 101.997 177.184 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -84.24 114.39 21.79 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 125.803 1.939 . . . . 50.509999999999998 111.716 -179.306 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -70.31 108.67 4.31 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.709 -1.587 . . . . 50.640000000000001 112.725 -179.635 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 -170.9 13.48 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 107.962 -2.055 . . . . 50.509999999999998 107.962 179.407 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 106.944 -2.462 . . . . 50.509999999999998 106.944 179.161 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 23.9 mmt . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 118.802 -0.618 . . . . 50.509999999999998 111.202 . . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -92.41 147.35 22.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.941 2.65 . . . . 50.549999999999997 106.999 178.287 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.528 HD13 HG21 ' A' ' 17' ' ' VAL . 35.1 pt -145.94 151.47 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.453 -2.054 . . . . 50.509999999999998 105.453 173.347 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.434 ' CE1' HG22 ' A' ' 14' ' ' THR . 97.4 m-85 -103.19 143.52 32.52 Favored 'General case' 0 N--CA 1.512 2.671 1 O-C-N 130.502 4.876 . . . . 50.509999999999998 112.212 179.503 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.96 116.17 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 113.36 -3.21 . . . . 50.509999999999998 110.554 175.797 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HD3' HG22 ' A' ' 12' ' ' THR . 25.1 mmtp -73.39 160.74 31.34 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.363 4.165 . . . . 50.509999999999998 112.885 -178.08 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -134.49 -165.44 1.66 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.491 -1.3 . . . . 50.509999999999998 107.491 179.942 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.7 mt -94.73 -33.83 12.77 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 -177.965 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -75.68 -9.26 58.44 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 115.744 -2.383 . . . . 50.509999999999998 117.254 179.914 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.57 4.22 58.22 Favored Glycine 0 C--N 1.296 -1.642 0 O-C-N 120.194 -1.566 . . . . 50.509999999999998 116.153 179.748 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE3' HG22 ' A' ' 13' ' ' ILE . 50.6 tptt -76.08 129.01 36.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 116.838 -1.553 . . . . 50.509999999999998 109.37 175.061 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.507 HG22 ' HD3' ' A' ' 6' ' ' LYS . 33.9 p -111.93 107.91 17.07 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 107.119 176.215 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.482 HG22 ' HE3' ' A' ' 11' ' ' LYS . 26.9 pt -97.17 147.87 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 127.352 2.907 . . . . 50.509999999999998 114.29 179.643 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.434 HG22 ' CE1' ' A' ' 4' ' ' PHE . 20.7 p -94.13 153.75 17.94 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 101.438 -3.542 . . . . 50.509999999999998 101.438 178.164 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.33 149.27 49.69 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.64 -2.356 . . . . 50.509999999999998 104.64 -179.303 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -100.33 120.56 40.12 Favored 'General case' 0 N--CA 1.499 2.009 1 O-C-N 129.266 4.104 . . . . 50.619999999999997 109.741 173.955 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 3' ' ' ILE . 18.8 m -131.7 166.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.673 3.108 . . . . 50.509999999999998 107.743 -177.987 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 38.3 mt-10 -125.86 143.49 45.46 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 112.185 -2.28 . . . . 50.619999999999997 106.18 174.733 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 84.2 Cg_exo -54.94 -24.62 40.14 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.606 2.204 . . . . 50.509999999999998 111.905 177.702 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -69.87 -44.9 68.85 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 117.536 2.421 . . . . 50.509999999999998 117.536 -177.512 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.7 154.07 34.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 117.393 -1.723 . . . . 50.619999999999997 113.773 -178.992 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.416 ' C ' ' N ' ' A' ' 24' ' ' GLU . 44.9 p -84.5 157.79 21.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.834 1.05 . . . . 50.509999999999998 113.834 175.642 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -49.13 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 O-C-N 127.18 2.8 . . . . 50.509999999999998 105.858 175.793 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 22' ' ' THR . 41.2 tt0 -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 120.388 3.477 . . . . 50.619999999999997 120.388 177.05 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.409 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 33.6 m120 -98.69 -38.02 9.27 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 102.963 -2.977 . . . . 50.549999999999997 102.963 -179.562 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.56 -59.0 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 125.069 1.481 . . . . 50.509999999999998 113.507 178.681 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 38' ' ' PRO . 54.8 pttt -53.11 -45.82 68.43 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 109.241 -0.652 . . . . 50.509999999999998 109.241 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.35 75.56 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 119.665 3.209 . . . . 50.509999999999998 119.665 176.797 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 94.1 mttt -52.92 -40.95 63.99 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.384 -1.447 . . . . 50.509999999999998 107.303 176.033 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . 87.1 mt -67.59 -21.94 28.0 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 N-CA-C 113.406 0.891 . . . . 50.509999999999998 113.406 179.882 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -58.57 -33.96 70.53 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.586 2.612 . . . . 50.549999999999997 106.395 179.473 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.06 -27.86 67.72 Favored 'General case' 0 C--O 1.253 1.271 0 N-CA-C 116.411 2.004 . . . . 50.619999999999997 116.411 179.16 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -107.08 -26.14 11.26 Favored 'General case' 0 C--O 1.279 2.643 0 C-N-CA 116.473 -2.091 . . . . 50.509999999999998 113.955 -175.669 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -109.22 -46.74 3.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.074 2.67 . . . . 50.619999999999997 110.337 179.869 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 10.1 20.56 Favored Glycine 0 CA--C 1.477 -2.292 0 N-CA-C 110.097 -1.201 . . . . 50.509999999999998 110.097 176.575 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 36.9 mm -83.42 124.21 75.98 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 106.671 -1.603 . . . . 50.509999999999998 106.671 179.693 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -57.05 136.92 79.54 Favored 'Trans proline' 0 C--O 1.259 1.554 0 C-N-CA 123.159 2.573 . . . . 50.509999999999998 110.883 178.327 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 88.3 Cg_exo -57.17 -32.19 92.71 Favored 'Trans proline' 0 C--O 1.261 1.64 0 O-C-N 122.886 0.94 . . . . 50.509999999999998 113.363 -179.265 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.99 -15.48 63.04 Favored 'General case' 0 C--O 1.262 1.722 0 O-C-N 119.92 -1.737 . . . . 50.619999999999997 108.114 -177.41 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.4 12.92 35.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.971 1.471 . . . . 50.549999999999997 114.971 178.758 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -114.94 119.67 37.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.428 2.061 . . . . 50.549999999999997 110.587 -177.705 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -119.92 116.9 26.74 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.694 -1.622 . . . . 50.640000000000001 107.394 172.178 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.02 133.4 44.47 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.153 1.538 . . . . 50.509999999999998 115.153 -177.548 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -115.83 124.87 72.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 N-CA-C 117.106 2.261 . . . . 50.509999999999998 117.106 -177.6 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -126.13 118.2 24.74 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.573 -1.194 . . . . 50.509999999999998 112.605 177.617 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.69 40.68 29.09 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.276 -2.238 . . . . 50.509999999999998 111.591 177.391 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 6.6 42.62 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 128.391 2.9 . . . . 50.509999999999998 112.91 -179.584 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -91.22 127.06 36.51 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.284 -1.376 . . . . 50.509999999999998 107.284 177.699 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -76.64 122.19 24.31 Favored 'General case' 0 C--O 1.26 1.611 0 O-C-N 123.971 0.794 . . . . 50.549999999999997 109.141 174.621 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 mt -81.03 155.51 26.32 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 116.588 2.07 . . . . 50.509999999999998 116.588 -175.884 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 41.3 tp10 -106.01 142.11 36.27 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 125.024 1.452 . . . . 50.619999999999997 113.709 -177.755 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -59.96 -32.2 70.59 Favored 'General case' 0 C--O 1.263 1.794 0 C-N-CA 126.131 1.772 . . . . 50.619999999999997 111.404 -175.75 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -101.06 38.25 3.23 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 124.334 0.969 . . . . 50.509999999999998 113.772 -177.235 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -134.2 159.04 42.12 Favored 'General case' 0 C--O 1.248 1.009 0 O-C-N 118.037 -3.037 . . . . 50.640000000000001 105.106 176.464 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -91.02 172.07 8.83 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.022 0.929 . . . . 50.509999999999998 112.063 177.091 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.98 -37.87 66.87 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.193 0.933 . . . . 50.509999999999998 108.486 177.225 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 19' ' ' PRO . 47.2 t -64.11 -39.0 93.1 Favored 'General case' 0 C--O 1.268 2.04 0 N-CA-C 116.601 2.074 . . . . 50.509999999999998 116.601 -179.401 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -55.55 -23.84 28.94 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.418 1.104 . . . . 50.619999999999997 111.692 179.773 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -97.52 -0.18 46.43 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 117.722 -1.133 . . . . 50.509999999999998 113.931 179.234 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.5 t30 69.89 21.34 6.35 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.36 1.985 . . . . 50.549999999999997 116.36 179.892 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.73 96.86 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.976 0 CA-C-O 115.206 -2.33 . . . . 50.509999999999998 112.232 175.858 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.442 ' O ' ' OG ' ' A' ' 65' ' ' SER . 21.7 pt20 -88.18 160.34 17.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 126.074 2.109 . . . . 50.549999999999997 111.758 -176.813 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 88.4 tttt -43.23 149.36 0.24 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.426 -2.065 . . . . 50.509999999999998 105.426 -177.034 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 97.6 mt-10 52.64 74.28 0.29 Allowed 'General case' 0 C--O 1.257 1.493 0 CA-C-N 112.522 -2.127 . . . . 50.619999999999997 107.909 179.633 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 69.1 m -119.45 132.39 55.79 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.743 -1.117 . . . . 50.509999999999998 111.249 174.801 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.3 m -81.43 121.37 26.17 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 118.187 -0.911 . . . . 50.509999999999998 113.287 175.94 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -111.56 143.93 41.62 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.707 -2.568 . . . . 50.509999999999998 111.404 175.06 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -94.79 136.66 34.83 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 126.809 2.568 . . . . 50.509999999999998 108.367 177.914 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 65.9 tp -93.09 118.96 31.8 Favored 'General case' 0 C--O 1.282 2.794 0 CA-C-O 117.609 -1.186 . . . . 50.509999999999998 110.624 176.517 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.9 121.96 66.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.558 -1.275 . . . . 50.509999999999998 107.558 175.071 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.8 mt -96.01 128.18 42.67 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.674 0.62 . . . . 50.509999999999998 112.674 178.403 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 60.8 ttt85 -113.69 69.62 0.71 Allowed 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 120.313 3.449 . . . . 50.640000000000001 120.313 177.305 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.57 142.23 28.6 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 125.872 1.982 . . . . 50.509999999999998 114.841 -179.382 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -91.21 85.94 6.02 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.801 -179.629 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.3 -161.7 28.35 Favored Glycine 0 C--O 1.243 0.699 0 N-CA-C 108.705 -1.758 . . . . 50.509999999999998 108.705 179.339 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 116.322 -2.376 . . . . 50.509999999999998 111.287 179.257 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mmt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 101.467 -3.531 . . . . 50.509999999999998 101.467 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -103.85 129.51 51.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 126.961 2.663 . . . . 50.549999999999997 107.932 178.256 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 pt -119.72 157.49 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 116.04 -1.933 . . . . 50.509999999999998 110.386 173.353 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -106.23 139.21 41.1 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.407 4.817 . . . . 50.509999999999998 112.035 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -113.86 101.58 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.359 -3.21 . . . . 50.509999999999998 108.884 175.81 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -66.76 147.0 53.84 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.463 4.227 . . . . 50.509999999999998 112.322 -178.097 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.513 HG22 HD23 ' A' ' 69' ' ' LEU . 41.6 p -135.64 170.39 16.03 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.768 -1.111 . . . . 50.509999999999998 108.494 179.959 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -91.4 29.96 1.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.967 0.792 . . . . 50.509999999999998 112.414 -177.966 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.3 p -130.55 18.67 5.25 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 115.677 -2.409 . . . . 50.509999999999998 117.199 179.904 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.92 51.15 25.47 Favored Glycine 0 C--N 1.297 -1.591 0 O-C-N 120.109 -1.619 . . . . 50.509999999999998 111.271 179.763 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -160.2 123.69 3.55 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 115.225 1.565 . . . . 50.509999999999998 115.225 175.02 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -83.89 135.15 34.6 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 126.666 2.479 . . . . 50.509999999999998 114.566 176.137 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 mm -108.51 133.79 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.562 3.039 . . . . 50.509999999999998 106.079 179.717 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.8 p -104.27 154.31 19.95 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.553 2.057 . . . . 50.509999999999998 116.553 178.073 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.5 mt -140.62 139.65 34.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.49 -2.195 . . . . 50.509999999999998 113.33 -179.261 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.61 113.52 25.6 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 128.66 3.725 . . . . 50.619999999999997 103.548 173.988 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.24 -166.26 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.271 0 O-C-N 127.518 3.011 . . . . 50.509999999999998 105.312 -177.911 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -150.56 156.87 36.66 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.256 -2.247 . . . . 50.619999999999997 109.062 174.621 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.96 -24.53 39.89 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.953 177.754 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.5 p -93.52 -7.36 44.47 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 115.541 1.682 . . . . 50.509999999999998 115.541 -177.546 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.21 135.6 52.28 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.29 -1.764 . . . . 50.619999999999997 114.821 -179.017 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -77.43 160.34 28.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.851 -0.613 . . . . 50.509999999999998 110.904 175.78 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 15.5 mm -55.3 -40.03 54.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.153 2.783 . . . . 50.509999999999998 109.387 175.808 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -61.64 -40.77 96.09 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.422 -0.798 . . . . 50.619999999999997 111.568 176.95 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -64.05 -45.44 88.79 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 124.377 1.071 . . . . 50.549999999999997 112.781 -179.613 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 56' ' ' LEU . 91.5 t -55.83 -55.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.344 -1.724 . . . . 50.509999999999998 106.344 178.613 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -48.2 -30.12 4.37 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 113.072 0.768 . . . . 50.509999999999998 113.072 -179.813 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -35.88 74.5 Favored 'General case' 0 C--O 1.278 2.6 0 N-CA-C 114.379 1.251 . . . . 50.509999999999998 114.379 176.846 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 29.3 mmtp -58.38 -43.36 88.45 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 104.256 -2.498 . . . . 50.509999999999998 104.256 176.03 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.77 -35.05 53.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.287 0 N-CA-C 115.219 1.563 . . . . 50.509999999999998 115.219 179.93 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -60.64 -32.07 71.25 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 125.593 2.616 . . . . 50.549999999999997 112.391 179.427 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -71.7 -52.1 19.53 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 109.803 179.131 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -78.82 -47.44 16.67 Favored 'General case' 0 C--O 1.279 2.616 0 C-N-CA 116.465 -2.094 . . . . 50.509999999999998 116.073 -175.656 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.79 -14.26 40.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 123.079 2.672 . . . . 50.619999999999997 117.047 179.819 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 13.02 83.97 Favored Glycine 0 CA--C 1.477 -2.32 0 CA-C-O 120.065 -0.297 . . . . 50.509999999999998 112.612 176.539 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.33 123.47 64.0 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 115.554 1.687 . . . . 50.509999999999998 115.554 179.7 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.9 Cg_exo -56.93 136.9 79.33 Favored 'Trans proline' 0 C--O 1.26 1.617 0 C-N-CA 123.109 2.539 . . . . 50.509999999999998 111.006 178.268 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.2 Cg_exo -57.2 -32.07 92.45 Favored 'Trans proline' 0 C--O 1.261 1.651 0 O-C-N 122.83 0.911 . . . . 50.509999999999998 113.45 -179.249 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -59.61 -12.49 6.81 Favored 'General case' 0 C--O 1.262 1.729 0 N-CA-C 117.768 2.507 . . . . 50.619999999999997 117.768 -177.463 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.517 ' O ' HD23 ' A' ' 71' ' ' LEU . 79.2 mt-30 -112.23 14.71 20.57 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.519 -1.363 . . . . 50.549999999999997 113.661 178.718 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -107.46 131.67 54.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.4 2.048 . . . . 50.549999999999997 115.36 -177.612 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.578 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 33.1 ttm180 -115.58 113.85 24.15 Favored 'General case' 0 C--O 1.296 3.524 0 CA-C-O 116.592 -1.671 . . . . 50.640000000000001 112.565 172.148 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.92 130.08 46.06 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 104.507 -2.405 . . . . 50.509999999999998 104.507 -177.501 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.574 HD11 ' HD3' ' A' ' 42' ' ' ARG . 89.4 mt -125.95 130.97 72.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.078 1.486 . . . . 50.509999999999998 112.746 -177.565 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.89 103.38 8.02 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 114.505 -1.225 . . . . 50.509999999999998 111.211 177.572 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.09 48.39 22.4 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.211 -2.268 . . . . 50.509999999999998 108.317 177.368 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.37 72.16 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 128.445 2.926 . . . . 50.509999999999998 115.154 -179.539 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -99.28 138.32 36.54 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.328 -0.99 . . . . 50.509999999999998 108.328 177.6 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -88.78 114.78 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.02 0.825 . . . . 50.549999999999997 112.617 174.616 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.36 128.18 35.67 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 117.679 -1.153 . . . . 50.509999999999998 113.899 -175.919 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -92.88 137.46 32.34 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.956 1.41 . . . . 50.619999999999997 107.43 -177.593 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.04 -44.14 67.15 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 118.367 2.728 . . . . 50.619999999999997 118.367 -175.784 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.38 -22.32 77.62 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 119.54 2.576 . . . . 50.509999999999998 119.54 -177.225 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -82.99 158.99 22.31 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 119.716 -2.049 . . . . 50.640000000000001 112.849 176.485 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -88.03 160.7 17.74 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 117.629 2.455 . . . . 50.509999999999998 117.629 177.044 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -55.61 -31.01 61.91 Favored 'General case' 0 C--O 1.2 -1.526 0 CA-C-N 115.473 -0.785 . . . . 50.509999999999998 110.912 177.243 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -71.62 -27.2 62.95 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.301 -1.76 . . . . 50.509999999999998 112.059 -179.485 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.96 -13.95 62.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.461 1.282 . . . . 50.619999999999997 114.461 179.769 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.602 ' HB2' HG12 ' A' ' 61' ' ' ILE . 53.5 m-85 -103.19 14.39 31.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 115.497 1.665 . . . . 50.509999999999998 115.497 179.25 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.9 t30 64.78 19.81 11.94 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 121.48 1.946 . . . . 50.549999999999997 109.459 179.855 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 59' ' ' TYR . 34.8 mm -81.23 99.69 4.76 Favored 'Isoleucine or valine' 0 C--O 1.267 2.026 0 CA-C-O 115.209 -2.329 . . . . 50.509999999999998 113.777 175.847 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -124.27 -115.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.101 2.125 . . . . 50.549999999999997 112.77 -176.851 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.77 128.72 35.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.259 1.504 . . . . 50.509999999999998 111.915 -176.95 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 51.65 39.23 24.68 Favored 'General case' 0 C--O 1.257 1.47 0 CA-C-N 112.516 -2.129 . . . . 50.619999999999997 115.775 179.52 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -71.27 148.27 47.33 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.842 -1.072 . . . . 50.509999999999998 110.018 174.8 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.9 m -127.51 116.05 19.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 118.26 -0.876 . . . . 50.509999999999998 112.222 175.938 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.42 142.45 27.41 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.76 -2.543 . . . . 50.509999999999998 111.856 175.043 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -88.78 138.29 31.55 Favored 'General case' 0 C--N 1.286 -2.182 0 O-C-N 126.818 2.574 . . . . 50.509999999999998 107.324 177.925 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 HG22 ' A' ' 7' ' ' THR . 68.0 tp -106.98 123.55 48.35 Favored 'General case' 0 C--O 1.283 2.852 0 CA-C-O 117.632 -1.175 . . . . 50.509999999999998 109.246 176.544 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.6 t -135.22 126.99 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 119.596 1.089 . . . . 50.509999999999998 110.346 175.059 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 40' ' ' GLN . 71.2 mt -70.21 139.9 52.36 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 120.417 3.488 . . . . 50.509999999999998 120.417 178.446 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -118.27 106.46 12.82 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.327 -3.225 . . . . 50.640000000000001 102.491 177.314 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' A' ' 71' ' ' LEU . 6.4 mp -104.75 127.81 52.66 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.955 . . . . 50.509999999999998 115.508 -179.314 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -90.02 84.37 6.16 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.751 -1.568 . . . . 50.640000000000001 107.806 -179.648 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.21 157.04 7.21 Favored Glycine 0 C--O 1.244 0.744 1 N-CA-C 102.525 -4.23 . . . . 50.509999999999998 102.525 179.367 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 N-CA-C 105.58 -3.008 . . . . 50.509999999999998 105.58 179.227 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 108.225 -1.028 . . . . 50.509999999999998 108.225 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -102.06 133.53 46.75 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 126.889 2.618 . . . . 50.549999999999997 107.185 178.29 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.35 169.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 N-CA-C 104.745 -2.317 . . . . 50.509999999999998 104.745 173.37 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.97 123.73 40.51 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.427 4.829 . . . . 50.509999999999998 111.603 179.588 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.18 110.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 113.349 -3.215 . . . . 50.509999999999998 109.404 175.788 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -99.18 146.85 25.72 Favored 'General case' 0 N--CA 1.504 2.271 1 O-C-N 129.367 4.167 . . . . 50.509999999999998 112.42 -178.085 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -112.87 178.97 4.1 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.046 -2.946 . . . . 50.509999999999998 103.046 179.993 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.6 mt -91.53 3.7 54.35 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.111 0.882 . . . . 50.509999999999998 111.028 -178.036 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -91.96 -24.83 19.13 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 115.673 -2.411 . . . . 50.509999999999998 114.467 179.956 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.76 14.65 2.28 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 106.022 -2.831 . . . . 50.509999999999998 106.022 179.735 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -95.33 120.12 35.01 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 115.247 1.573 . . . . 50.509999999999998 115.247 174.971 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -119.53 108.56 14.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 126.679 2.487 . . . . 50.509999999999998 105.48 176.143 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 tt -103.19 146.02 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.442 2.964 . . . . 50.509999999999998 114.156 179.721 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 15' ' ' LEU . 98.5 m -97.93 155.76 16.93 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 117.27 -1.772 . . . . 50.509999999999998 111.194 178.092 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' N ' HG22 ' A' ' 14' ' ' THR . 12.6 tp -138.11 140.02 39.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 115.485 -2.198 . . . . 50.509999999999998 111.804 -179.239 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -103.11 115.05 29.85 Favored 'General case' 0 N--CA 1.5 2.042 1 O-C-N 129.187 4.055 . . . . 50.619999999999997 111.421 173.972 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.58 178.09 2.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 O-C-N 127.888 3.243 . . . . 50.509999999999998 113.093 -177.93 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 25.7 tt0 -102.01 149.97 37.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 112.196 -2.274 . . . . 50.619999999999997 106.082 174.622 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.93 -24.5 39.52 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.6 2.2 . . . . 50.509999999999998 111.948 177.691 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.6 p -120.14 22.07 11.55 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 119.795 3.257 . . . . 50.509999999999998 119.795 -177.528 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.0 152.19 42.65 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.44 -1.704 . . . . 50.619999999999997 108.547 -179.026 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 55' ' ' THR . 71.6 p -97.27 145.92 25.62 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.895 -0.593 . . . . 50.509999999999998 109.499 175.649 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 50.5 mm -42.64 -36.77 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 O-C-N 127.126 2.766 . . . . 50.509999999999998 113.586 175.789 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -44.53 -55.66 4.94 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.364 -0.835 . . . . 50.619999999999997 112.729 176.96 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -72.14 -46.02 58.19 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.361 1.064 . . . . 50.549999999999997 108.18 -179.645 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 23' ' ' ILE . 90.8 t -40.69 -62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.003 1.439 . . . . 50.509999999999998 108.535 178.54 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 53.3 mtmt -67.7 -16.32 64.08 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 115.288 1.588 . . . . 50.509999999999998 115.288 -179.74 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.69 -33.08 25.25 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.84 -0.43 . . . . 50.509999999999998 109.84 176.87 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -69.0 -46.77 67.19 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 103.278 -2.86 . . . . 50.509999999999998 103.278 176.025 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -55.78 -28.69 24.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.491 -0.883 . . . . 50.509999999999998 111.724 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -63.56 -35.55 80.85 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 125.604 2.621 . . . . 50.549999999999997 108.384 179.465 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -68.93 -55.07 12.12 Favored 'General case' 0 C--O 1.254 1.303 0 N-CA-C 117.122 2.267 . . . . 50.619999999999997 117.122 179.08 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -80.47 -42.47 22.52 Favored 'General case' 0 C--O 1.28 2.71 0 C-N-CA 116.447 -2.101 . . . . 50.509999999999998 111.603 -175.687 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -86.82 -50.12 6.95 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 123.096 2.68 . . . . 50.619999999999997 115.667 179.881 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 18.59 7.84 Favored Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 107.886 -2.086 . . . . 50.509999999999998 107.886 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 31.0 mm -98.62 120.63 58.62 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.794 -1.162 . . . . 50.509999999999998 112.326 179.689 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -56.99 136.9 79.49 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.202 2.601 . . . . 50.509999999999998 110.901 178.29 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 86.5 Cg_exo -57.15 -32.14 92.54 Favored 'Trans proline' 0 C--O 1.262 1.697 0 C-N-CA 120.682 0.921 . . . . 50.509999999999998 113.449 -179.336 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.11 -11.7 59.85 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 119.931 -1.731 . . . . 50.619999999999997 109.084 -177.42 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -98.78 2.92 47.35 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 110.585 178.764 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.51 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 46.3 mt-30 -102.27 118.77 37.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 124.348 2.023 . . . . 50.549999999999997 114.652 -177.588 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.539 ' HD2' ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp180 -102.17 118.5 37.02 Favored 'General case' 0 C--O 1.295 3.497 0 CA-C-O 116.732 -1.604 . . . . 50.640000000000001 107.566 172.165 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 50' ' ' LEU . 51.5 mt -109.72 119.77 40.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 50.509999999999998 112.721 -177.425 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.41 132.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 O-C-N 125.046 1.467 . . . . 50.509999999999998 113.525 -177.65 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.14 100.71 7.0 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 103.543 -2.762 . . . . 50.509999999999998 103.543 177.556 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 33.63 11.68 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.152 -2.294 . . . . 50.509999999999998 114.779 177.448 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.62 10.27 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 128.513 2.959 . . . . 50.509999999999998 113.266 -179.546 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -124.55 112.24 16.61 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 115.11 1.522 . . . . 50.509999999999998 115.11 177.713 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -58.12 113.61 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.135 2.272 . . . . 50.549999999999997 117.135 174.574 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 55.1 mt -65.15 150.05 48.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 112.936 -175.917 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 74.5 tt0 -108.04 135.09 49.99 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.544 1.153 . . . . 50.619999999999997 110.984 -177.684 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.616 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -53.02 -63.91 0.99 Allowed 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.115 1.766 . . . . 50.619999999999997 112.088 -175.806 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 -8.04 66.87 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 117.496 1.759 . . . . 50.509999999999998 117.496 -177.274 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -82.37 -173.1 4.37 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 120.037 -1.861 . . . . 50.640000000000001 107.531 176.492 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 22' ' ' THR . 38.9 p -127.59 158.2 38.14 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.549 1.315 . . . . 50.509999999999998 114.549 177.07 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.87 -39.82 69.08 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 106.456 -1.683 . . . . 50.509999999999998 106.456 177.242 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 59' ' ' TYR . 73.3 m -61.49 -43.84 98.15 Favored 'General case' 0 C--O 1.269 2.086 0 C-N-CA 117.299 -1.76 . . . . 50.509999999999998 108.829 -179.493 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.29 -4.26 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.214 1.19 . . . . 50.619999999999997 114.214 179.685 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 57' ' ' SER . 83.7 m-85 -122.94 9.7 9.42 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 116.44 2.015 . . . . 50.509999999999998 116.44 179.26 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 61.22 23.25 13.48 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 121.446 1.93 . . . . 50.549999999999997 113.53 179.944 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 61' ' ' ILE . 73.4 mt -73.93 94.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.198 -2.335 . . . . 50.509999999999998 116.274 175.836 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -87.7 159.23 18.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 126.031 2.082 . . . . 50.549999999999997 112.994 -176.81 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.461 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 79.5 tttt -54.64 154.34 5.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 123.235 1.493 . . . . 50.509999999999998 108.135 -176.958 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' OE2' ' HE2' ' A' ' 63' ' ' LYS . 42.6 mm-40 57.8 69.31 0.75 Allowed 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.476 -2.147 . . . . 50.619999999999997 106.143 179.613 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -143.08 129.82 20.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.775 -1.102 . . . . 50.509999999999998 112.761 174.823 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -72.78 130.16 39.84 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 118.121 2.637 . . . . 50.509999999999998 118.121 175.92 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.3 138.02 45.29 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.673 -2.584 . . . . 50.509999999999998 107.445 175.079 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -91.95 123.07 35.04 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 127.389 2.93 . . . . 50.509999999999998 113.659 177.848 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -105.84 103.06 12.48 Favored 'General case' 0 C--O 1.282 2.792 0 CA-C-O 117.657 -1.163 . . . . 50.509999999999998 113.918 176.511 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.5 138.9 33.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 119.538 1.063 . . . . 50.509999999999998 109.262 175.174 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.26 148.11 39.71 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 117.33 2.344 . . . . 50.509999999999998 117.33 178.479 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HD2' ' HD2' ' A' ' 42' ' ' ARG . 76.5 ttt-85 -132.41 87.36 2.42 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 113.375 -3.202 . . . . 50.640000000000001 104.574 177.22 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -79.2 167.47 20.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.814 1.946 . . . . 50.509999999999998 106.928 -179.344 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.39 63.58 1.12 Allowed 'General case' 0 C--O 1.244 0.772 0 N-CA-C 118.105 2.632 . . . . 50.640000000000001 118.105 -179.643 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.24 178.06 38.14 Favored Glycine 0 C--O 1.242 0.651 0 O-C-N 124.617 1.198 . . . . 50.509999999999998 112.85 179.403 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 115.437 179.204 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.412 ' CE ' ' HB2' ' A' ' 63' ' ' LYS . 82.0 mtp . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.993 -1.114 . . . . 50.509999999999998 107.993 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -84.43 140.22 31.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 126.976 2.673 . . . . 50.549999999999997 109.692 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.4 pt -133.64 159.58 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-O 115.982 -1.961 . . . . 50.509999999999998 107.126 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -117.16 135.69 53.58 Favored 'General case' 0 N--CA 1.512 2.639 1 O-C-N 130.48 4.863 . . . . 50.509999999999998 110.963 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 69.9 t -114.87 108.28 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 113.436 -3.173 . . . . 50.509999999999998 110.719 175.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.473 ' CD ' HG22 ' A' ' 12' ' ' THR . 35.1 mmtp -88.2 122.94 32.33 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.303 4.127 . . . . 50.509999999999998 111.031 -178.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.9 p -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.354 -2.091 . . . . 50.509999999999998 105.354 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -112.64 6.62 18.38 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.067 0.854 . . . . 50.509999999999998 112.102 -177.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -106.67 -27.84 10.57 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.702 -2.399 . . . . 50.509999999999998 106.563 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.2 0.65 2.11 Favored Glycine 0 C--N 1.296 -1.641 0 O-C-N 119.78 -1.825 . . . . 50.509999999999998 115.343 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -73.92 152.29 40.17 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.852 -1.547 . . . . 50.509999999999998 115.111 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.473 HG22 ' CD ' ' A' ' 6' ' ' LYS . 44.3 p -121.26 156.72 31.88 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 126.654 2.471 . . . . 50.509999999999998 108.939 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 62.7 mt -127.96 142.09 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.396 2.935 . . . . 50.509999999999998 111.49 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -111.92 134.28 53.57 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.163 -1.792 . . . . 50.509999999999998 106.163 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.566 HD23 ' HE2' ' A' ' 33' ' ' LYS . 96.0 mt -127.15 134.06 50.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.412 2.375 . . . . 50.509999999999998 117.412 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.55 96.16 7.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 128.807 3.817 . . . . 50.619999999999997 111.345 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -121.86 -175.02 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.267 0 O-C-N 127.603 3.064 . . . . 50.509999999999998 115.619 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CD ' ' OG ' ' A' ' 20' ' ' SER . 14.7 pt-20 -151.91 154.73 33.12 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.227 -2.26 . . . . 50.619999999999997 108.206 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.94 -24.51 39.61 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.575 2.184 . . . . 50.509999999999998 111.985 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.46 ' OG ' ' CD ' ' A' ' 18' ' ' GLU . 92.8 p -63.79 -30.86 71.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.142 -0.932 . . . . 50.509999999999998 111.755 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -69.62 149.63 47.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.357 -1.737 . . . . 50.619999999999997 115.373 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 55' ' ' THR . 33.0 p -93.58 169.62 10.2 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.827 -0.624 . . . . 50.509999999999998 109.549 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 42.3 mm -58.99 -25.6 30.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 O-C-N 127.189 2.806 . . . . 50.509999999999998 112.352 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -70.89 -46.41 62.64 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.047 2.24 . . . . 50.619999999999997 117.047 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -66.6 -50.34 63.37 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 124.31 1.044 . . . . 50.549999999999997 110.626 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.41 -31.39 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.932 1.395 . . . . 50.509999999999998 112.353 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 92.1 mttt -81.65 -19.97 40.63 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 105.184 -2.154 . . . . 50.509999999999998 105.184 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.33 -14.97 34.5 Favored 'General case' 0 C--O 1.278 2.58 0 N-CA-C 112.47 0.544 . . . . 50.509999999999998 112.47 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.7 mmmt -90.15 -35.2 15.53 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.338 -1.476 . . . . 50.509999999999998 107.719 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 61.0 mt -60.41 -29.4 44.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.53 -0.868 . . . . 50.509999999999998 112.135 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' ILE . 61.9 tt0 -49.94 -51.94 37.32 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 125.627 2.632 . . . . 50.549999999999997 104.767 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.9 m-20 -46.96 -41.37 16.06 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.619 -1.628 . . . . 50.619999999999997 112.33 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HE2' HD23 ' A' ' 15' ' ' LEU . 12.3 mptt -73.68 -41.77 62.19 Favored 'General case' 0 C--O 1.279 2.645 0 C-N-CA 116.464 -2.094 . . . . 50.509999999999998 114.312 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' OE2' HD11 ' A' ' 13' ' ' ILE . 30.1 mt-10 -113.98 -62.79 1.54 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 123.06 2.664 . . . . 50.619999999999997 109.956 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.82 -16.68 1.98 Allowed Glycine 0 CA--C 1.477 -2.288 0 CA-C-O 120.017 -0.324 . . . . 50.509999999999998 112.919 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.502 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.9 mm -58.06 128.86 82.04 Favored Pre-proline 0 C--O 1.244 0.768 0 N-CA-C 117.582 2.438 . . . . 50.509999999999998 117.582 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 77.9 Cg_exo -56.98 136.97 79.83 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.147 2.565 . . . . 50.509999999999998 110.869 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 87.7 Cg_exo -57.21 -32.09 92.54 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.861 0.927 . . . . 50.509999999999998 113.45 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.33 -26.89 67.5 Favored 'General case' 0 C--O 1.262 1.743 0 O-C-N 119.981 -1.699 . . . . 50.619999999999997 108.101 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.0 3.5 55.1 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.555 -1.341 . . . . 50.549999999999997 113.535 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 86.7 mt-30 -101.49 140.5 35.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 124.355 2.026 . . . . 50.549999999999997 109.8 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -134.88 148.66 50.15 Favored 'General case' 0 C--O 1.296 3.506 0 CA-C-O 116.696 -1.621 . . . . 50.640000000000001 107.468 172.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 93.0 mt -129.83 125.13 34.96 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.638 -1.245 . . . . 50.509999999999998 107.638 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.6 133.68 61.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 125.08 1.488 . . . . 50.509999999999998 112.789 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.57 110.91 5.81 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 107.086 -1.45 . . . . 50.509999999999998 107.086 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.02 30.76 4.36 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.254 -2.248 . . . . 50.509999999999998 115.498 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.93 -7.46 82.07 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 128.424 2.916 . . . . 50.509999999999998 116.734 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -80.43 119.52 23.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.047 0.924 . . . . 50.509999999999998 112.719 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -81.6 106.18 13.34 Favored 'General case' 0 C--O 1.259 1.583 0 O-C-N 123.936 0.773 . . . . 50.549999999999997 111.918 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.07 154.23 4.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 114.268 1.21 . . . . 50.509999999999998 114.268 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.5 132.35 51.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.144 2.275 . . . . 50.619999999999997 117.144 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -56.31 -5.02 0.16 Allowed 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.927 2.936 . . . . 50.619999999999997 118.927 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 9.3 22.67 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 105.382 -3.087 . . . . 50.509999999999998 105.382 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.17 156.77 16.25 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 119.961 -1.905 . . . . 50.640000000000001 109.981 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 22' ' ' THR . 41.5 p -109.56 144.4 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.187 -1.412 . . . . 50.509999999999998 107.187 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -40.96 -25.47 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.145 0.903 . . . . 50.509999999999998 109.021 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' THR . 91.0 p -74.0 -27.41 60.95 Favored 'General case' 0 C--O 1.268 2.076 0 N-CA-C 115.809 1.781 . . . . 50.509999999999998 115.809 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -65.86 -26.95 67.88 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.461 1.124 . . . . 50.619999999999997 110.413 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.86 5.95 26.92 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 117.781 -1.104 . . . . 50.509999999999998 111.333 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 41.36 29.38 0.09 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.474 1.943 . . . . 50.549999999999997 113.378 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -51.44 107.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.267 1.975 0 N-CA-C 104.064 -2.569 . . . . 50.509999999999998 104.064 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -107.0 -169.04 1.48 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 126.092 2.12 . . . . 50.549999999999997 112.791 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 36.1 ttpt -73.32 136.06 44.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.184 1.469 . . . . 50.509999999999998 114.36 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 41.3 mt-10 71.85 8.9 6.13 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 117.217 2.302 . . . . 50.619999999999997 117.217 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 t -74.77 142.3 44.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 104.636 -2.357 . . . . 50.509999999999998 104.636 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -106.41 133.81 50.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.39 -0.967 . . . . 50.509999999999998 108.39 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.54 162.17 13.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.681 -2.581 . . . . 50.509999999999998 109.154 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -116.01 121.92 43.69 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 127.406 2.941 . . . . 50.509999999999998 111.196 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.1 tp -79.83 140.41 36.83 Favored 'General case' 0 C--O 1.283 2.822 0 N-CA-C 115.5 1.667 . . . . 50.509999999999998 115.5 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.74 138.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.634 1.106 . . . . 50.509999999999998 112.603 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.5 tp -103.91 107.78 18.81 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.47 0.915 . . . . 50.509999999999998 113.47 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.5 79.85 2.0 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 113.349 -3.215 . . . . 50.640000000000001 115.252 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -58.0 148.23 26.74 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 117.843 2.534 . . . . 50.509999999999998 117.843 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 70.6 ttp85 -95.34 55.03 1.69 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 115.389 1.625 . . . . 50.640000000000001 115.389 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.22 -170.86 39.59 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.594 -3.402 . . . . 50.509999999999998 104.594 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.453 0 CA-C-O 116.337 -2.369 . . . . 50.509999999999998 111.883 179.197 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 118.86 -0.591 . . . . 50.509999999999998 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -88.0 142.49 27.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 126.954 2.659 . . . . 50.549999999999997 109.499 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.45 HD13 HG21 ' A' ' 17' ' ' VAL . 24.3 pt -141.77 160.76 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 116.036 -1.935 . . . . 50.509999999999998 107.472 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' HB2' HG22 ' A' ' 66' ' ' THR . 83.1 m-85 -113.78 132.34 55.89 Favored 'General case' 0 N--CA 1.511 2.582 1 O-C-N 130.381 4.801 . . . . 50.509999999999998 113.364 179.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.99 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 106.321 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG2' ' OG1' ' A' ' 12' ' ' THR . 92.5 mttt -111.88 135.51 52.4 Favored 'General case' 0 N--CA 1.503 2.207 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 117.046 -178.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 154.78 31.92 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 107.609 -1.256 . . . . 50.509999999999998 107.609 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.26 -12.97 23.45 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.177 0.923 . . . . 50.509999999999998 110.549 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -66.06 -22.46 66.42 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 115.705 -2.398 . . . . 50.509999999999998 113.759 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.39 10.55 35.81 Favored Glycine 0 C--N 1.297 -1.598 0 O-C-N 120.106 -1.621 . . . . 50.509999999999998 112.437 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -101.28 134.84 43.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 116.82 -1.562 . . . . 50.509999999999998 112.252 174.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.46 ' OG1' ' HG2' ' A' ' 6' ' ' LYS . 52.4 m -127.51 149.29 50.2 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.707 2.505 . . . . 50.509999999999998 115.581 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -134.07 157.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 115.266 -2.574 . . . . 50.509999999999998 106.314 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -121.38 144.41 48.67 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.248 -1.781 . . . . 50.509999999999998 113.515 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.573 HD22 ' HB3' ' A' ' 29' ' ' LYS . 77.5 mt -120.1 167.37 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.445 -2.216 . . . . 50.509999999999998 109.959 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -129.47 92.96 3.44 Favored 'General case' 0 N--CA 1.5 2.041 1 O-C-N 129.131 4.019 . . . . 50.619999999999997 106.104 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.592 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 m -105.34 173.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.779 3.174 . . . . 50.509999999999998 111.764 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 84.0 mt-10 -106.44 145.13 30.4 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.164 -2.289 . . . . 50.619999999999997 111.14 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 85.3 Cg_exo -54.9 -24.57 39.62 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.637 2.224 . . . . 50.509999999999998 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 p -88.23 -9.0 54.4 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 115.2 1.556 . . . . 50.509999999999998 115.2 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 46.2 m-20 -65.27 148.79 51.07 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 117.412 -1.715 . . . . 50.619999999999997 110.448 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -78.94 170.94 15.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.865 -0.607 . . . . 50.509999999999998 110.503 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.24 -29.33 46.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 O-C-N 127.103 2.752 . . . . 50.509999999999998 108.04 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -70.93 -15.1 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 119.915 3.302 . . . . 50.619999999999997 119.915 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 23.0 t-20 -81.82 -50.63 9.0 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.366 1.066 . . . . 50.549999999999997 110.51 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -54.7 -44.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 125.045 1.466 . . . . 50.509999999999998 108.146 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.1 mttt -54.39 -35.46 62.87 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 107.989 -1.115 . . . . 50.509999999999998 107.989 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -67.2 -49.62 63.94 Favored 'General case' 0 C--O 1.278 2.597 0 N-CA-C 109.695 -0.483 . . . . 50.509999999999998 109.695 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HB3' HD22 ' A' ' 15' ' ' LEU . 46.8 mmtm -50.89 -37.09 41.66 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 120.374 -1.454 . . . . 50.509999999999998 114.823 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.82 -42.11 28.51 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 104.617 -2.364 . . . . 50.509999999999998 104.617 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -53.6 -42.36 67.6 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 125.628 2.632 . . . . 50.549999999999997 112.14 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.9 -41.73 78.62 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 120.716 3.599 . . . . 50.619999999999997 120.716 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -106.76 -15.08 14.83 Favored 'General case' 0 C--O 1.279 2.633 0 C-N-CA 116.434 -2.106 . . . . 50.509999999999998 113.39 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.18 -11.11 11.37 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 118.616 2.821 . . . . 50.619999999999997 118.616 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 28.74 45.78 Favored Glycine 0 CA--C 1.478 -2.25 0 N-CA-C 114.94 0.736 . . . . 50.509999999999998 114.94 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 71' ' ' LEU . 71.5 mt -107.46 119.64 50.05 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 114.984 1.476 . . . . 50.509999999999998 114.984 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.6 Cg_exo -57.07 137.0 79.94 Favored 'Trans proline' 0 C--O 1.258 1.515 0 C-N-CA 123.116 2.544 . . . . 50.509999999999998 110.883 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.6 Cg_exo -57.14 -32.28 92.9 Favored 'Trans proline' 0 C--O 1.261 1.663 0 C-N-CA 120.711 0.941 . . . . 50.509999999999998 113.379 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -73.27 0.15 12.76 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.948 -1.72 . . . . 50.619999999999997 110.64 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -112.4 1.69 16.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.572 -1.33 . . . . 50.549999999999997 109.356 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.04 128.55 47.03 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.419 2.057 . . . . 50.549999999999997 111.985 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.498 ' HD2' ' HB2' ' A' ' 72' ' ' ARG . 70.3 mtp180 -112.21 127.35 55.93 Favored 'General case' 0 C--O 1.297 3.555 0 N-CA-C 105.903 -1.888 . . . . 50.640000000000001 105.903 172.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -109.65 136.13 49.49 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 102.88 -3.007 . . . . 50.509999999999998 102.88 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -132.4 121.32 45.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 O-C-N 125.223 1.577 . . . . 50.509999999999998 111.755 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.53 90.81 3.4 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 106.998 -1.482 . . . . 50.509999999999998 106.998 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.07 76.54 0.33 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.219 -2.264 . . . . 50.509999999999998 112.337 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.03 32.07 0.35 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 128.405 2.907 . . . . 50.509999999999998 113.437 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -121.85 112.63 18.58 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 102.62 -3.104 . . . . 50.509999999999998 102.62 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -70.62 123.59 22.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.887 0.742 . . . . 50.549999999999997 111.637 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 mt -78.04 139.39 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 117.756 -1.116 . . . . 50.509999999999998 113.743 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -86.58 115.25 23.93 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.95 1.406 . . . . 50.619999999999997 114.529 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -40.42 -21.16 0.01 OUTLIER 'General case' 0 C--O 1.264 1.834 0 N-CA-C 117.809 2.522 . . . . 50.619999999999997 117.809 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.96 2.74 51.85 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 118.398 2.119 . . . . 50.509999999999998 118.398 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 mmp_? -96.99 -177.77 3.98 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 120.031 -1.864 . . . . 50.640000000000001 109.983 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -108.66 174.73 5.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.062 0.945 . . . . 50.509999999999998 110.315 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.5 mt -74.8 -13.95 60.64 Favored 'General case' 0 C--O 1.201 -1.482 0 CA-C-O 118.382 -0.818 . . . . 50.509999999999998 111.156 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -85.83 -40.85 15.56 Favored 'General case' 0 C--O 1.268 2.057 0 N-CA-C 117.598 2.444 . . . . 50.509999999999998 117.598 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -47.51 -37.27 11.67 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.497 1.141 . . . . 50.619999999999997 108.843 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 9.72 9.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 117.328 2.344 . . . . 50.509999999999998 117.328 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 62' ' ' GLN . 87.2 m-20 53.97 16.08 1.02 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-N 121.526 1.966 . . . . 50.549999999999997 115.744 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.2 mm -52.1 90.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.265 1.913 0 CA-C-O 115.207 -2.33 . . . . 50.509999999999998 110.741 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 60' ' ' ASN . 77.0 mt-30 -78.21 -175.73 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 125.588 1.805 . . . . 50.549999999999997 114.506 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -70.64 141.94 51.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.622 -1.992 . . . . 50.509999999999998 105.622 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 67.6 31.17 6.25 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.437 -2.165 . . . . 50.619999999999997 112.362 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 t -77.91 135.98 37.95 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.792 -1.094 . . . . 50.509999999999998 108.596 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.487 HG22 ' HB2' ' A' ' 4' ' ' PHE . 16.9 p -93.35 142.87 26.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 118.313 -0.851 . . . . 50.509999999999998 110.594 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.6 mt -122.09 122.58 39.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.78 -2.533 . . . . 50.509999999999998 105.6 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -83.64 151.25 25.4 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 102.87 -3.011 . . . . 50.509999999999998 102.87 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -123.3 109.76 14.34 Favored 'General case' 0 C--O 1.283 2.822 0 CA-C-O 117.608 -1.187 . . . . 50.509999999999998 110.481 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.09 133.01 49.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.502 -2.036 . . . . 50.509999999999998 105.502 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 36' ' ' ILE . 35.1 mt -82.67 152.09 25.99 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 118.77 2.878 . . . . 50.509999999999998 118.77 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.498 ' HB2' ' HD2' ' A' ' 42' ' ' ARG . 36.3 ttm180 -123.76 89.77 3.15 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 113.308 -3.234 . . . . 50.640000000000001 111.62 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.59 156.19 29.26 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 125.904 2.002 . . . . 50.509999999999998 111.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -106.16 77.61 1.24 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 115.821 1.785 . . . . 50.640000000000001 115.821 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.23 124.6 2.83 Favored Glycine 0 C--O 1.242 0.643 0 CA-C-N 114.646 -1.161 . . . . 50.509999999999998 113.593 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 N-CA-C 104.406 -3.478 . . . . 50.509999999999998 104.406 179.279 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' HE2' ' A' ' 63' ' ' LYS . 18.4 mmt . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 112.576 0.584 . . . . 50.509999999999998 112.576 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -88.21 150.95 23.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.907 2.629 . . . . 50.549999999999997 106.822 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -148.42 145.7 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 104.972 -2.232 . . . . 50.509999999999998 104.972 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.66 134.98 54.65 Favored 'General case' 0 N--CA 1.511 2.597 1 O-C-N 130.409 4.818 . . . . 50.509999999999998 110.476 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -119.55 128.01 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 113.399 -3.191 . . . . 50.509999999999998 116.944 175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -94.14 119.36 32.86 Favored 'General case' 0 N--CA 1.504 2.239 1 O-C-N 129.254 4.097 . . . . 50.509999999999998 113.065 -178.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.514 HG22 HD23 ' A' ' 69' ' ' LEU . 69.0 p -95.27 177.59 5.8 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.793 -1.098 . . . . 50.509999999999998 109.48 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 8' ' ' LEU . 42.6 mt -83.79 -12.85 55.09 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.138 0.899 . . . . 50.509999999999998 110.752 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -95.09 -17.46 21.82 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.76 -2.376 . . . . 50.509999999999998 113.426 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.16 -23.04 7.38 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 119.034 2.374 . . . . 50.509999999999998 119.034 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.66 107.09 0.76 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 117.134 2.272 . . . . 50.509999999999998 117.134 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -82.07 128.41 34.08 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.595 2.434 . . . . 50.509999999999998 107.848 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.01 144.92 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 127.591 3.057 . . . . 50.509999999999998 114.268 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -113.68 123.52 50.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.264 -1.774 . . . . 50.509999999999998 112.454 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.0 mt -116.92 145.92 43.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 120.933 3.679 . . . . 50.509999999999998 120.933 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.17 114.22 28.31 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 128.413 3.571 . . . . 50.619999999999997 112.676 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.51 163.05 35.8 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 O-C-N 127.831 3.207 . . . . 50.509999999999998 117.228 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 40.3 mt-10 -99.18 151.24 37.32 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 117.604 2.446 . . . . 50.619999999999997 117.604 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.1 Cg_exo -54.9 -24.52 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.586 2.191 . . . . 50.509999999999998 111.928 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -93.12 -19.48 21.46 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 116.547 2.054 . . . . 50.509999999999998 116.547 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.58 151.23 17.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.404 -1.718 . . . . 50.619999999999997 107.183 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -87.45 167.67 13.79 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.858 -0.61 . . . . 50.509999999999998 109.445 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.8 pt -61.58 -34.93 64.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 127.193 2.808 . . . . 50.509999999999998 103.875 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -56.55 -49.41 74.89 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 114.048 1.129 . . . . 50.619999999999997 114.048 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -55.97 -32.13 63.6 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.307 1.043 . . . . 50.549999999999997 111.959 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -41.94 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.975 1.422 . . . . 50.509999999999998 111.264 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.25 -40.31 45.25 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 116.391 1.997 . . . . 50.509999999999998 116.391 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.32 83.38 Favored 'General case' 0 C--O 1.278 2.576 0 CA-C-N 117.984 0.356 . . . . 50.509999999999998 111.524 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -55.15 -55.95 25.4 Favored 'General case' 0 C--O 1.255 1.351 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -54.77 -36.1 35.64 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.47 -0.892 . . . . 50.509999999999998 113.053 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.1 -32.85 16.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 125.625 2.631 . . . . 50.549999999999997 113.307 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.72 -44.71 20.27 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 113.592 -1.64 . . . . 50.619999999999997 113.123 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -87.72 -29.52 21.02 Favored 'General case' 0 C--O 1.279 2.637 0 N-CA-C 116.89 2.182 . . . . 50.509999999999998 116.89 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -115.58 -23.13 8.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 123.07 2.668 . . . . 50.619999999999997 109.5 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.21 -34.54 4.64 Favored Glycine 0 CA--C 1.477 -2.342 0 N-CA-C 116.477 1.351 . . . . 50.509999999999998 116.477 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.6 mt -40.69 113.7 1.03 Allowed Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 115.063 1.505 . . . . 50.509999999999998 115.063 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.182 2.588 . . . . 50.509999999999998 110.888 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.6 Cg_exo -57.18 -32.22 92.83 Favored 'Trans proline' 0 C--O 1.262 1.684 0 C-N-CA 120.671 0.914 . . . . 50.509999999999998 113.444 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.41 -12.79 15.87 Favored 'General case' 0 C--O 1.262 1.741 0 O-C-N 119.921 -1.737 . . . . 50.619999999999997 112.028 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.43 -12.42 17.19 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.515 -1.366 . . . . 50.549999999999997 111.808 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -93.11 125.27 37.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.345 2.021 . . . . 50.549999999999997 115.244 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -121.15 134.7 55.23 Favored 'General case' 0 C--O 1.295 3.458 0 CA-C-O 116.691 -1.623 . . . . 50.640000000000001 108.961 172.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.7 ' HB2' HD22 ' A' ' 50' ' ' LEU . 60.3 mt -119.17 120.33 36.78 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 102.08 -3.304 . . . . 50.509999999999998 102.08 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.34 129.47 71.54 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 O-C-N 125.15 1.531 . . . . 50.509999999999998 112.727 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.97 121.81 15.48 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 117.973 2.583 . . . . 50.509999999999998 117.973 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.38 9.53 6.51 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.206 -2.27 . . . . 50.509999999999998 108.435 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.62 37.35 8.09 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.481 2.943 . . . . 50.509999999999998 109.469 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' O ' ' C ' ' A' ' 49' ' ' GLN . 36.1 ttpt -126.63 85.39 2.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.098 0.949 . . . . 50.509999999999998 112.39 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.511 ' C ' ' O ' ' A' ' 48' ' ' LYS . 6.9 tt0 -36.93 128.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.926 -1.879 . . . . 50.549999999999997 105.926 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.7 HD22 ' HB2' ' A' ' 43' ' ' LEU . 2.1 mp -60.03 120.78 10.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 117.695 -1.145 . . . . 50.509999999999998 111.417 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -88.95 131.87 34.96 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.018 1.449 . . . . 50.619999999999997 109.345 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -50.82 -47.1 60.1 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.171 1.788 . . . . 50.619999999999997 111.497 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.82 21.44 2.56 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 119.051 2.38 . . . . 50.509999999999998 119.051 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -111.26 158.2 19.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.006 -1.879 . . . . 50.640000000000001 111.509 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 p -93.88 167.02 11.89 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.105 0.962 . . . . 50.509999999999998 110.491 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.53 -28.56 60.32 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 116.618 2.081 . . . . 50.509999999999998 116.618 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -87.82 -20.87 25.48 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.362 -1.735 . . . . 50.509999999999998 112.767 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.99 -36.46 62.95 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.225 -1.768 . . . . 50.619999999999997 106.225 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.658 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 77.8 m-85 -81.7 -31.91 31.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.777 -1.106 . . . . 50.509999999999998 109.354 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.658 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 26.2 m120 76.54 36.74 0.36 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 121.451 1.932 . . . . 50.549999999999997 114.554 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.57 108.91 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.981 0 CA-C-O 115.165 -2.35 . . . . 50.509999999999998 113.679 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -104.88 -176.31 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.898 -2.63 . . . . 50.549999999999997 103.898 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 35.4 mmtp -67.07 162.4 22.33 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 102.841 -3.022 . . . . 50.509999999999998 102.841 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 51.34 44.75 28.72 Favored 'General case' 0 C--O 1.257 1.485 0 CA-C-N 112.443 -2.162 . . . . 50.619999999999997 114.696 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 t -109.23 137.78 46.58 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.23 1.196 . . . . 50.509999999999998 114.23 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 m -118.46 117.09 28.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 114.463 1.283 . . . . 50.509999999999998 114.463 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.34 153.04 20.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 114.738 -2.553 . . . . 50.509999999999998 110.766 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -95.57 146.54 24.38 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 127.371 2.919 . . . . 50.509999999999998 113.483 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.514 HD23 HG22 ' A' ' 7' ' ' THR . 29.3 tp -107.42 101.83 11.16 Favored 'General case' 0 C--O 1.283 2.827 0 CA-C-O 117.647 -1.168 . . . . 50.509999999999998 110.412 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.51 121.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 119.602 1.092 . . . . 50.509999999999998 111.027 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.5 mt -74.33 133.62 42.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.369 2.729 . . . . 50.509999999999998 118.369 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -113.59 131.43 56.11 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 113.368 -3.206 . . . . 50.640000000000001 105.614 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.94 -178.7 3.74 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.867 1.979 . . . . 50.509999999999998 111.226 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -126.04 67.89 1.19 Allowed 'General case' 0 C--O 1.245 0.831 0 N-CA-C 104.342 -2.466 . . . . 50.640000000000001 104.342 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.28 146.13 8.82 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 114.63 -1.168 . . . . 50.509999999999998 115.838 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.831 -3.307 . . . . 50.509999999999998 104.831 179.255 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 116.342 1.978 . . . . 50.509999999999998 116.342 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -82.88 149.76 26.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 126.882 2.613 . . . . 50.549999999999997 107.781 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 15' ' ' LEU . 18.5 tt -163.46 136.5 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 115.981 -1.961 . . . . 50.509999999999998 106.277 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' THR . 42.4 m-85 -104.39 143.52 32.89 Favored 'General case' 0 N--CA 1.512 2.634 1 O-C-N 130.259 4.724 . . . . 50.509999999999998 113.453 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 70.0 t -109.65 105.52 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 107.296 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -99.77 109.72 22.13 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.347 4.154 . . . . 50.509999999999998 110.385 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 9' ' ' THR . 9.7 t -89.78 -171.51 3.2 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 115.324 1.602 . . . . 50.509999999999998 115.324 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.488 ' N ' ' OG1' ' A' ' 7' ' ' THR . 65.6 mt -90.12 6.68 41.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.756 1.021 . . . . 50.509999999999998 113.756 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.548 ' H ' HG23 ' A' ' 7' ' ' THR . 55.5 p -104.55 0.53 28.79 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 115.715 -2.394 . . . . 50.509999999999998 114.853 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.88 37.04 7.46 Favored Glycine 0 C--N 1.298 -1.558 0 N-CA-C 103.411 -3.875 . . . . 50.509999999999998 103.411 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -113.59 159.14 19.93 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 119.455 3.131 . . . . 50.509999999999998 119.455 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.2 m -135.27 123.8 23.51 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 120.337 3.458 . . . . 50.509999999999998 120.337 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 96.7 mt -108.33 136.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.521 3.013 . . . . 50.509999999999998 107.483 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 m -117.16 117.54 29.86 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 117.329 -1.749 . . . . 50.509999999999998 112.395 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.479 ' O ' HG22 ' A' ' 3' ' ' ILE . 46.0 tp -128.69 135.49 49.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 120.168 3.395 . . . . 50.509999999999998 120.168 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -79.79 139.91 37.07 Favored 'General case' 0 N--CA 1.5 2.046 1 O-C-N 129.176 4.048 . . . . 50.619999999999997 114.764 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.76 175.18 6.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 O-C-N 127.758 3.161 . . . . 50.509999999999998 114.114 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.7 mt-10 -124.81 142.65 41.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 112.197 -2.274 . . . . 50.619999999999997 108.835 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.7 Cg_exo -54.97 -24.54 39.98 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 122.549 2.166 . . . . 50.509999999999998 111.943 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -86.35 -0.16 55.3 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.655 1.724 . . . . 50.509999999999998 115.655 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -79.13 160.08 27.17 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.421 -1.712 . . . . 50.619999999999997 107.471 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 52.3 p -107.62 153.68 22.54 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 103.753 -2.684 . . . . 50.509999999999998 103.753 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.438 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 25.6 mm -56.67 -23.03 16.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 O-C-N 127.011 2.694 . . . . 50.509999999999998 116.481 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 23.7 tt0 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 103.248 -2.871 . . . . 50.619999999999997 103.248 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 22' ' ' THR . 57.8 m-80 -68.11 -43.17 79.04 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 124.383 1.073 . . . . 50.549999999999997 112.305 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.17 -38.57 77.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.046 1.466 . . . . 50.509999999999998 113.289 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.3 mttt -74.57 -30.31 61.67 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 106.784 -1.561 . . . . 50.509999999999998 106.784 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.13 82.73 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 114.364 1.246 . . . . 50.509999999999998 114.364 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.11 -31.99 73.47 Favored 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.373 -1.454 . . . . 50.509999999999998 114.549 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.73 -45.08 67.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 119.551 -0.859 . . . . 50.509999999999998 113.077 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.555 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 6.1 tt0 -52.08 -34.19 42.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.431 3.123 . . . . 50.549999999999997 119.431 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.05 -60.57 3.4 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 113.59 -1.641 . . . . 50.619999999999997 113.321 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.03 -55.97 4.24 Favored 'General case' 0 C--O 1.28 2.683 0 N-CA-C 119.806 3.262 . . . . 50.509999999999998 119.806 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.43 -60.11 4.01 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.143 2.702 . . . . 50.619999999999997 104.818 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.56 8.56 3.13 Favored Glycine 0 CA--C 1.478 -2.269 0 CA-C-O 120.033 -0.315 . . . . 50.509999999999998 113.398 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 84.8 mt -89.89 125.6 60.23 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 119.843 3.275 . . . . 50.509999999999998 119.843 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.0 136.97 79.9 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.111 2.541 . . . . 50.509999999999998 110.917 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 87.2 Cg_exo -57.17 -32.15 92.61 Favored 'Trans proline' 0 C--O 1.261 1.629 0 O-C-N 122.919 0.958 . . . . 50.509999999999998 113.442 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -56.72 -17.17 8.01 Favored 'General case' 0 C--O 1.263 1.781 0 O-C-N 120.045 -1.659 . . . . 50.619999999999997 114.713 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -91.8 -7.48 49.41 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.471 1.656 . . . . 50.549999999999997 115.471 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -90.66 137.56 32.26 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 116.787 2.144 . . . . 50.549999999999997 116.787 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -125.1 120.63 31.96 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 104.591 -2.374 . . . . 50.640000000000001 104.591 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 35.2 mt -102.89 138.07 40.26 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 103.596 -2.742 . . . . 50.509999999999998 103.596 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.31 129.23 36.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 119.972 3.323 . . . . 50.509999999999998 119.972 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -137.67 117.99 13.68 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 116.377 1.992 . . . . 50.509999999999998 116.377 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.83 16.25 4.58 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 103.752 -2.684 . . . . 50.509999999999998 103.752 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.41 44.68 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 107.135 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -108.85 114.7 28.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 104.653 -2.351 . . . . 50.509999999999998 104.653 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 43' ' ' LEU . 32.2 tt0 -68.98 129.77 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.325 0.861 . . . . 50.549999999999997 113.325 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.7 mp -78.2 150.39 33.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 109.67 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 73.7 mt-10 -115.98 158.98 22.25 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.959 1.412 . . . . 50.619999999999997 112.276 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -83.37 -9.71 58.88 Favored 'General case' 0 C--O 1.263 1.795 0 N-CA-C 117.204 2.298 . . . . 50.619999999999997 117.204 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.87 -2.68 34.35 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 110.178 -1.169 . . . . 50.509999999999998 110.178 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -107.5 143.32 36.04 Favored 'General case' 0 C--O 1.248 1.023 0 O-C-N 119.944 -1.915 . . . . 50.640000000000001 107.174 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -69.98 140.95 53.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 116.718 2.118 . . . . 50.509999999999998 116.718 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 61' ' ' ILE . 38.0 tp -48.19 -26.49 1.95 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.108 0.88 . . . . 50.509999999999998 112.08 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 p -90.47 -0.53 57.7 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.307 -1.757 . . . . 50.509999999999998 114.191 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -97.56 15.01 24.59 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 50.619999999999997 107.679 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 92.7 m-85 -113.85 -6.24 13.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 110.264 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.628 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 14.5 m120 73.42 18.67 3.6 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 121.457 1.935 . . . . 50.549999999999997 107.551 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.45 HD12 HD12 ' A' ' 56' ' ' LEU . 68.5 mt -75.22 108.59 7.19 Favored 'Isoleucine or valine' 0 C--O 1.267 2.007 0 CA-C-O 115.188 -2.339 . . . . 50.509999999999998 112.792 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -110.82 -175.68 2.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.117 2.135 . . . . 50.549999999999997 112.41 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -53.67 141.87 24.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 116.569 2.063 . . . . 50.509999999999998 116.569 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 52.71 42.93 31.82 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-N 112.554 -2.112 . . . . 50.619999999999997 114.585 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 152.59 18.98 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.494 2.035 . . . . 50.509999999999998 116.494 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 40.4 m -111.83 119.65 39.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 116.502 2.038 . . . . 50.509999999999998 116.502 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.88 140.02 32.05 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.723 -2.56 . . . . 50.509999999999998 108.086 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -89.96 132.38 35.37 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.199 2.812 . . . . 50.509999999999998 113.377 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' C ' HD23 ' A' ' 69' ' ' LEU . 10.2 tt -103.95 109.22 20.9 Favored 'General case' 0 C--O 1.282 2.768 0 N-CA-C 116.271 1.952 . . . . 50.509999999999998 116.271 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -94.1 145.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 119.604 1.093 . . . . 50.509999999999998 110.916 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 48.8 tp -99.29 86.78 3.48 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 119.437 3.125 . . . . 50.509999999999998 119.437 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 71' ' ' LEU . 59.8 ttt85 -53.36 130.98 36.94 Favored 'General case' 0 C--N 1.281 -2.383 1 O-C-N 110.816 -7.427 . . . . 50.640000000000001 113.779 177.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.49 147.44 24.24 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 120.858 1.663 . . . . 50.509999999999998 114.259 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -81.37 56.26 2.85 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.665 -1.605 . . . . 50.640000000000001 106.665 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.43 -155.71 16.87 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.586 -1.188 . . . . 50.509999999999998 113.999 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.682 -3.367 . . . . 50.509999999999998 104.682 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.814 -0.612 . . . . 50.509999999999998 109.802 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -101.27 131.68 47.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 126.973 2.671 . . . . 50.549999999999997 109.517 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 pt -132.19 149.8 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 N-CA-C 103.595 -2.743 . . . . 50.509999999999998 103.595 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -110.34 157.93 18.98 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.398 4.811 . . . . 50.509999999999998 112.095 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.6 t -141.36 121.02 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 113.383 -3.199 . . . . 50.509999999999998 112.24 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -90.59 136.05 33.31 Favored 'General case' 0 N--CA 1.504 2.261 1 O-C-N 129.37 4.169 . . . . 50.509999999999998 105.1 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -112.44 142.46 44.95 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 105.03 -2.211 . . . . 50.509999999999998 105.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -44.84 -35.97 3.04 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 109.198 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.6 m -52.3 -32.69 38.8 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 118.631 2.826 . . . . 50.509999999999998 118.631 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.11 4.79 11.05 Favored Glycine 0 C--N 1.296 -1.671 0 O-C-N 120.142 -1.599 . . . . 50.509999999999998 111.756 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -83.89 152.82 24.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.847 -1.549 . . . . 50.509999999999998 114.26 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -125.86 112.56 16.13 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.701 2.501 . . . . 50.509999999999998 106.849 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 pt -102.3 147.69 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 118.583 2.808 . . . . 50.509999999999998 118.583 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -104.32 123.72 47.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 117.263 -1.775 . . . . 50.509999999999998 113.436 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 29' ' ' LYS . 68.5 mt -109.73 132.31 54.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 117.591 2.441 . . . . 50.509999999999998 117.591 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.28 110.26 22.41 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 129.244 4.09 . . . . 50.619999999999997 109.888 174.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 56' ' ' LEU . 35.0 m -130.82 173.59 14.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 O-C-N 127.672 3.107 . . . . 50.509999999999998 108.589 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 68.8 mm-40 -116.87 141.95 29.04 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 112.157 -2.292 . . . . 50.619999999999997 108.862 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 85.4 Cg_exo -54.88 -24.58 39.54 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.617 2.211 . . . . 50.509999999999998 111.964 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -78.23 -23.13 47.54 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.818 -1.549 . . . . 50.509999999999998 106.818 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.39 139.18 58.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 104.308 -2.478 . . . . 50.619999999999997 104.308 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 48.1 p -78.23 165.17 24.22 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.326 -0.99 . . . . 50.509999999999998 108.326 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.542 HD12 HD23 ' A' ' 50' ' ' LEU . 24.5 mm -58.81 -35.21 54.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 O-C-N 127.244 2.84 . . . . 50.509999999999998 111.816 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.7 -45.34 81.88 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.211 -2.144 . . . . 50.619999999999997 105.211 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HB2' ' O ' ' A' ' 22' ' ' THR . 85.8 m-20 -56.56 -46.03 80.94 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.365 1.066 . . . . 50.549999999999997 112.181 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 56' ' ' LEU . 40.5 t -61.58 -41.38 90.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 125.168 1.543 . . . . 50.509999999999998 113.192 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.86 -22.71 60.73 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 106.824 -1.547 . . . . 50.509999999999998 106.824 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.35 -61.41 1.85 Allowed 'General case' 0 C--O 1.278 2.561 0 N-CA-C 105.049 -2.204 . . . . 50.509999999999998 105.049 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.677 ' CG ' HD22 ' A' ' 15' ' ' LEU . 17.0 tppt? -42.5 -41.6 3.03 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 115.679 1.733 . . . . 50.509999999999998 115.679 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.512 HG21 HD11 ' A' ' 69' ' ' LEU . 73.4 mt -68.19 -23.86 29.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 C-N-CA 119.493 -0.883 . . . . 50.509999999999998 108.68 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -82.25 -55.45 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 125.57 2.605 . . . . 50.549999999999997 105.565 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -35.32 -51.37 0.58 Allowed 'General case' 0 C--O 1.252 1.228 0 N-CA-C 118.513 2.782 . . . . 50.619999999999997 118.513 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.13 -59.99 1.62 Allowed 'General case' 0 C--O 1.28 2.677 0 C-N-CA 116.459 -2.096 . . . . 50.509999999999998 108.82 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -57.99 -43.76 86.75 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 123.158 2.708 . . . . 50.619999999999997 116.743 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.16 23.35 7.73 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 108.763 -1.735 . . . . 50.509999999999998 108.763 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.3 mt -100.58 117.31 63.06 Favored Pre-proline 0 C--O 1.243 0.73 0 C-N-CA 118.79 -1.164 . . . . 50.509999999999998 108.501 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.0 Cg_exo -56.93 136.93 79.52 Favored 'Trans proline' 0 C--O 1.261 1.634 0 C-N-CA 123.185 2.59 . . . . 50.509999999999998 110.916 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.0 Cg_exo -57.19 -32.15 92.66 Favored 'Trans proline' 0 C--O 1.262 1.691 0 C-N-CA 120.682 0.922 . . . . 50.509999999999998 113.429 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -62.56 -15.21 49.82 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.948 -1.72 . . . . 50.619999999999997 109.985 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -102.92 16.05 27.67 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.532 -1.355 . . . . 50.549999999999997 112.104 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -110.85 114.08 27.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 117.295 2.332 . . . . 50.549999999999997 117.295 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -111.39 108.49 18.09 Favored 'General case' 0 C--O 1.296 3.523 0 N-CA-C 105.502 -2.036 . . . . 50.640000000000001 105.502 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mt -101.99 132.76 47.63 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.501 1.046 . . . . 50.509999999999998 110.488 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.63 136.77 50.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 O-C-N 125.227 1.58 . . . . 50.509999999999998 115.167 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -133.75 112.06 11.06 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.543 -1.208 . . . . 50.509999999999998 110.483 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.45 49.7 6.2 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.268 -2.242 . . . . 50.509999999999998 113.311 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.47 1.71 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 120.894 3.118 . . . . 50.509999999999998 120.894 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -71.7 166.19 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 116.334 1.975 . . . . 50.509999999999998 116.334 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -102.26 140.86 35.98 Favored 'General case' 0 C--O 1.259 1.592 0 O-C-N 124.008 0.818 . . . . 50.549999999999997 112.008 174.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.542 HD23 HD12 ' A' ' 23' ' ' ILE . 2.1 mp -78.14 143.17 37.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.285 -1.746 . . . . 50.509999999999998 106.285 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -120.21 135.15 55.08 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.883 1.364 . . . . 50.619999999999997 109.464 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.56 -33.41 1.14 Allowed 'General case' 0 C--O 1.262 1.748 0 C-N-CA 126.165 1.786 . . . . 50.619999999999997 114.951 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.73 63.5 Favored Glycine 0 C--O 1.254 1.345 0 C-N-CA 124.339 0.971 . . . . 50.509999999999998 113.5 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -111.73 155.12 23.99 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 101.889 -3.374 . . . . 50.640000000000001 101.889 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -99.72 174.12 6.38 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.048 0.939 . . . . 50.509999999999998 111.483 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.561 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -67.54 -38.54 84.33 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 106.349 -1.723 . . . . 50.509999999999998 106.349 177.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -67.94 -22.61 65.04 Favored 'General case' 0 C--O 1.268 2.029 0 N-CA-C 117.75 2.5 . . . . 50.509999999999998 117.75 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -64.45 -40.17 95.22 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.664 2.098 . . . . 50.619999999999997 116.664 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -83.26 5.02 24.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 115.986 1.847 . . . . 50.509999999999998 115.986 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 59.08 38.44 23.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.493 1.951 . . . . 50.549999999999997 107.054 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -73.48 117.79 17.81 Favored 'Isoleucine or valine' 0 C--O 1.267 2.012 0 CA-C-O 115.223 -2.322 . . . . 50.509999999999998 108.388 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -94.15 -175.82 3.8 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.707 2.114 . . . . 50.549999999999997 116.707 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.03 142.72 49.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 123.144 1.449 . . . . 50.509999999999998 107.314 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 46.4 26.19 0.46 Allowed 'General case' 0 C--O 1.257 1.496 0 N-CA-C 117.592 2.441 . . . . 50.619999999999997 117.592 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -72.53 153.18 41.45 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.512 -1.662 . . . . 50.509999999999998 106.512 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.43 ' O ' HD23 ' A' ' 67' ' ' LEU . 40.6 m -108.16 146.09 33.22 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.225 -0.893 . . . . 50.509999999999998 111.084 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 66' ' ' THR . 26.8 mt -116.96 156.78 26.86 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 114.688 -2.577 . . . . 50.509999999999998 109.959 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -93.61 141.66 28.22 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 127.246 2.841 . . . . 50.509999999999998 106.202 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.512 HD11 HG21 ' A' ' 30' ' ' ILE . 5.3 tt -119.79 109.88 16.12 Favored 'General case' 0 C--O 1.282 2.8 0 N-CA-C 106.356 -1.72 . . . . 50.509999999999998 106.356 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -98.35 145.1 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.391 -2.078 . . . . 50.509999999999998 105.391 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.99 132.5 43.5 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.964 -0.754 . . . . 50.509999999999998 108.964 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -97.44 126.18 42.54 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-O 113.322 -3.228 . . . . 50.640000000000001 107.33 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.89 152.09 23.81 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.901 2.001 . . . . 50.509999999999998 111.862 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -83.15 55.42 3.12 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 113.726 -1.579 . . . . 50.640000000000001 108.051 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.15 156.33 18.08 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 109.56 -1.416 . . . . 50.509999999999998 109.56 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 1 N-CA-C 102.519 -4.233 . . . . 50.509999999999998 102.519 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 107.894 -1.151 . . . . 50.509999999999998 107.894 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -101.03 133.44 45.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.911 2.632 . . . . 50.549999999999997 110.278 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.35 159.89 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 117.083 -3.51 . . . . 50.509999999999998 107.703 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -114.67 137.31 52.06 Favored 'General case' 0 N--CA 1.512 2.648 1 O-C-N 130.429 4.831 . . . . 50.509999999999998 107.911 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 87.6 t -110.54 121.34 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 113.431 -3.176 . . . . 50.509999999999998 104.019 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -107.08 131.81 53.68 Favored 'General case' 0 N--CA 1.503 2.195 1 O-C-N 129.295 4.122 . . . . 50.509999999999998 113.336 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -91.38 -177.33 4.81 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.87 2.544 . . . . 50.509999999999998 117.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.26 -5.59 23.93 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.164 0.915 . . . . 50.509999999999998 109.792 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.7 p -114.69 9.01 16.36 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.726 2.862 . . . . 50.509999999999998 118.726 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.32 62.29 Favored Glycine 0 C--N 1.298 -1.565 0 O-C-N 120.072 -1.642 . . . . 50.509999999999998 115.164 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -65.23 140.22 58.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 116.888 -1.53 . . . . 50.509999999999998 113.033 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -131.53 164.46 25.76 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 126.613 2.446 . . . . 50.509999999999998 108.573 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.35 170.64 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 127.551 3.032 . . . . 50.509999999999998 110.215 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -111.41 128.33 55.95 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.266 -1.773 . . . . 50.509999999999998 110.41 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -126.53 135.71 51.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 115.488 -2.196 . . . . 50.509999999999998 116.567 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.27 100.41 7.16 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 128.315 3.509 . . . . 50.619999999999997 112.505 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -103.18 172.99 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.209 0 O-C-N 127.762 3.164 . . . . 50.509999999999998 116.324 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.65 153.45 43.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 112.157 -2.292 . . . . 50.619999999999997 112.521 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.89 -24.57 39.5 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.603 2.202 . . . . 50.509999999999998 111.909 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 m -82.92 -26.52 31.38 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 114.954 1.465 . . . . 50.509999999999998 114.954 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -53.34 138.95 31.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 117.398 -1.721 . . . . 50.619999999999997 114.311 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -95.1 172.46 8.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 102.156 -3.276 . . . . 50.509999999999998 102.156 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 54' ' ' ARG . 23.2 mm -53.89 -45.49 63.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 O-C-N 127.095 2.747 . . . . 50.509999999999998 110.439 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -54.11 -46.83 72.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.723 1.379 . . . . 50.619999999999997 114.723 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -57.54 -39.64 77.08 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.265 1.026 . . . . 50.549999999999997 111.757 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 -50.11 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 125.045 1.466 . . . . 50.509999999999998 111.73 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HE3' ' CG2' ' A' ' 23' ' ' ILE . 94.5 mttt -56.87 -29.93 63.38 Favored 'General case' 0 C--O 1.257 1.485 0 N-CA-C 104.583 -2.377 . . . . 50.509999999999998 104.583 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.06 -27.61 48.69 Favored 'General case' 0 C--O 1.278 2.599 0 CA-C-N 118.031 0.378 . . . . 50.509999999999998 111.567 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -71.76 -36.32 70.36 Favored 'General case' 0 C--O 1.255 1.342 0 N-CA-C 106.606 -1.627 . . . . 50.509999999999998 106.606 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.43 -34.55 65.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 106.863 -1.532 . . . . 50.509999999999998 106.863 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -51.49 -59.51 4.17 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.567 2.603 . . . . 50.549999999999997 112.225 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -51.76 -40.83 60.98 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 115.817 1.784 . . . . 50.619999999999997 115.817 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -76.65 -32.5 58.01 Favored 'General case' 0 C--O 1.279 2.647 0 C-N-CA 116.464 -2.095 . . . . 50.509999999999998 113.853 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -119.33 -39.47 2.89 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.018 2.644 . . . . 50.619999999999997 115.061 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.32 8.77 8.32 Favored Glycine 0 CA--C 1.478 -2.271 0 CA-C-O 119.947 -0.363 . . . . 50.509999999999998 112.46 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.491 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 93.5 mt -84.62 128.21 62.24 Favored Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 116.76 2.134 . . . . 50.509999999999998 116.76 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.94 136.99 79.85 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.116 2.544 . . . . 50.509999999999998 110.92 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.7 Cg_exo -57.2 -32.13 92.64 Favored 'Trans proline' 0 C--O 1.261 1.649 0 O-C-N 122.91 0.952 . . . . 50.509999999999998 113.405 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -75.29 -15.78 60.48 Favored 'General case' 0 C--O 1.262 1.745 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 112.375 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -97.34 9.0 43.46 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.568 -1.332 . . . . 50.549999999999997 110.692 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.97 132.98 53.57 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 103.437 -2.801 . . . . 50.549999999999997 103.437 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -119.48 108.52 14.63 Favored 'General case' 0 C--O 1.297 3.562 0 N-CA-C 105.462 -2.051 . . . . 50.640000000000001 105.462 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.78 121.97 44.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.49 1.041 . . . . 50.509999999999998 113.414 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 120.456 3.502 . . . . 50.509999999999998 120.456 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB3' HD21 ' A' ' 50' ' ' LEU . 17.8 t80 -110.18 130.17 55.59 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 114.811 1.411 . . . . 50.509999999999998 114.811 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.21 32.11 15.39 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.192 -2.276 . . . . 50.509999999999998 111.994 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.67 2.7 85.97 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 128.4 2.905 . . . . 50.509999999999998 113.269 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -94.51 115.77 27.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 116.32 1.97 . . . . 50.509999999999998 116.32 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 16.3 pt20 -50.53 120.24 4.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.94 0.775 . . . . 50.549999999999997 111.744 174.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 45' ' ' PHE . 56.1 mt -83.51 127.55 33.81 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.7 -1.143 . . . . 50.509999999999998 111.984 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 88.7 tt0 -77.0 145.23 38.17 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 119.173 3.027 . . . . 50.619999999999997 119.173 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -38.6 -48.08 1.4 Allowed 'General case' 0 C--O 1.264 1.833 0 N-CA-C 118.526 2.788 . . . . 50.619999999999997 118.526 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 23.01 32.27 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 116.384 1.314 . . . . 50.509999999999998 116.384 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 23' ' ' ILE . 37.1 mmt180 -93.34 155.53 17.34 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 119.892 -1.946 . . . . 50.640000000000001 111.151 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -108.53 176.93 4.94 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.979 0.912 . . . . 50.509999999999998 109.466 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.1 -32.69 70.04 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 119.177 3.028 . . . . 50.509999999999998 119.177 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -81.11 -23.34 38.45 Favored 'General case' 0 C--O 1.267 2.024 0 C-N-CA 117.325 -1.75 . . . . 50.509999999999998 112.258 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -53.54 -30.9 44.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.918 -2.253 . . . . 50.619999999999997 104.918 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.25 6.92 19.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 116.468 2.025 . . . . 50.509999999999998 116.468 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.37 32.49 20.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 111.036 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.438 HG12 ' CD2' ' A' ' 45' ' ' PHE . 93.2 mt -73.53 104.86 2.59 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.188 -2.339 . . . . 50.509999999999998 109.353 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -97.23 -165.86 1.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 126.137 2.148 . . . . 50.549999999999997 115.028 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 79.4 tttt -70.16 142.76 52.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.159 1.457 . . . . 50.509999999999998 110.688 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 23.1 mt-10 58.73 36.29 24.79 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.471 -2.15 . . . . 50.619999999999997 110.721 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -78.02 152.5 33.01 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.802 -1.09 . . . . 50.509999999999998 110.915 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.443 ' O ' HD23 ' A' ' 67' ' ' LEU . 60.4 p -103.64 140.13 37.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 118.216 -0.897 . . . . 50.509999999999998 110.182 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 59.5 mt -123.95 134.82 53.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 101.65 -3.463 . . . . 50.509999999999998 101.65 175.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -95.45 136.93 35.2 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 127.375 2.922 . . . . 50.509999999999998 108.264 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 tp -105.56 136.02 45.89 Favored 'General case' 0 C--O 1.282 2.802 0 CA-C-O 117.641 -1.171 . . . . 50.509999999999998 113.203 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -116.02 126.06 73.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 105.847 -1.909 . . . . 50.509999999999998 105.847 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -79.04 105.55 10.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.782 2.512 . . . . 50.509999999999998 117.782 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -92.96 102.21 14.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.279 -3.248 . . . . 50.640000000000001 114.666 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.64 177.58 7.01 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 125.715 1.884 . . . . 50.509999999999998 110.047 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -100.7 97.65 8.28 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 115.972 1.842 . . . . 50.640000000000001 115.972 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.46 158.67 6.18 Favored Glycine 0 C--O 1.243 0.668 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.562 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 1 N-CA-C 102.073 -4.411 . . . . 50.509999999999998 102.073 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 106.871 -1.529 . . . . 50.509999999999998 106.871 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -117.73 119.43 34.92 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.923 2.64 . . . . 50.549999999999997 104.846 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 tt -121.73 149.4 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 115.952 -1.975 . . . . 50.509999999999998 110.13 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.84 123.88 50.88 Favored 'General case' 0 N--CA 1.511 2.599 1 O-C-N 130.372 4.795 . . . . 50.509999999999998 114.524 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.34 104.86 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.42 -3.181 . . . . 50.509999999999998 109.571 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -85.02 121.2 27.45 Favored 'General case' 0 N--CA 1.504 2.237 1 O-C-N 129.394 4.184 . . . . 50.509999999999998 109.412 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 69' ' ' LEU . 69.7 p -85.95 -177.05 6.22 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 116.322 1.971 . . . . 50.509999999999998 116.322 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 70' ' ' VAL . 67.5 mt -82.01 -6.08 58.86 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.788 1.773 . . . . 50.509999999999998 115.788 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -90.07 -8.04 52.41 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 115.715 -2.394 . . . . 50.509999999999998 106.592 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 15.79 37.73 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 107.727 -2.149 . . . . 50.509999999999998 107.727 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.52 111.02 21.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 116.549 2.055 . . . . 50.509999999999998 116.549 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.9 m -87.37 125.44 34.26 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 126.65 2.469 . . . . 50.509999999999998 113.203 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -111.9 174.08 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 127.53 3.019 . . . . 50.509999999999998 113.725 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 m -124.37 140.97 52.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.011 -2.218 . . . . 50.509999999999998 105.011 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.7 mt -130.66 141.7 50.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 115.487 -2.197 . . . . 50.509999999999998 108.05 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.87 100.25 9.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 129.009 3.943 . . . . 50.619999999999997 109.281 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -100.27 171.12 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.253 0 O-C-N 127.796 3.185 . . . . 50.509999999999998 107.938 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -124.28 160.51 52.32 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 112.24 -2.254 . . . . 50.619999999999997 116.147 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.01 -24.45 39.92 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 122.586 2.191 . . . . 50.509999999999998 111.966 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -99.82 -28.82 12.95 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 116.031 1.863 . . . . 50.509999999999998 116.031 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -38.82 136.88 0.7 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.331 -1.748 . . . . 50.619999999999997 114.825 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' ASN . 70.7 p -88.7 138.17 31.66 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 103.109 -2.922 . . . . 50.509999999999998 103.109 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 52' ' ' ASP . 7.4 tp -47.52 -19.19 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.729 0 O-C-N 127.183 2.802 . . . . 50.509999999999998 114.02 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.57 -44.31 62.25 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 102.991 -2.966 . . . . 50.619999999999997 102.991 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' THR . 9.3 t-20 -70.78 -17.28 62.79 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 114.957 1.465 . . . . 50.549999999999997 114.957 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.12 -45.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.999 -1.482 . . . . 50.509999999999998 106.999 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 97.2 mttt -64.26 -42.87 96.28 Favored 'General case' 0 C--O 1.256 1.433 0 N-CA-C 108.04 -1.096 . . . . 50.509999999999998 108.04 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -59.14 -25.19 63.66 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 112.511 0.559 . . . . 50.509999999999998 112.511 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 58.2 mttm -64.75 -30.78 71.8 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 106.327 -1.731 . . . . 50.509999999999998 106.327 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.653 ' O ' HG22 ' A' ' 30' ' ' ILE . 95.7 mt -82.66 2.86 2.93 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 N-CA-C 105.535 -2.024 . . . . 50.509999999999998 105.535 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 50.7 tt0 -87.12 -57.43 2.97 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.592 2.615 . . . . 50.549999999999997 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -69.05 -36.23 77.45 Favored 'General case' 0 C--O 1.253 1.264 0 CA-C-N 113.616 -1.629 . . . . 50.619999999999997 113.278 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.2 -32.71 24.41 Favored 'General case' 0 C--O 1.279 2.623 0 C-N-CA 116.427 -2.109 . . . . 50.509999999999998 112.667 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -108.99 -17.04 14.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 119.315 3.08 . . . . 50.619999999999997 119.315 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.82 37.54 10.23 Favored Glycine 0 CA--C 1.479 -2.199 0 N-CA-C 107.607 -2.197 . . . . 50.509999999999998 107.607 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.4 117.74 30.21 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 106.939 -1.504 . . . . 50.509999999999998 106.939 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.97 136.89 79.36 Favored 'Trans proline' 0 C--O 1.259 1.562 0 C-N-CA 123.185 2.59 . . . . 50.509999999999998 110.924 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -57.11 -32.15 92.48 Favored 'Trans proline' 0 C--O 1.261 1.667 0 O-C-N 122.948 0.973 . . . . 50.509999999999998 113.471 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.96 -2.02 8.8 Favored 'General case' 0 C--O 1.262 1.731 0 O-C-N 119.976 -1.703 . . . . 50.619999999999997 111.592 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -114.77 15.58 17.48 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.617 -1.302 . . . . 50.549999999999997 114.13 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -115.76 122.26 44.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.366 2.031 . . . . 50.549999999999997 111.203 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -115.83 121.56 42.77 Favored 'General case' 0 C--O 1.296 3.507 0 CA-C-O 116.657 -1.639 . . . . 50.640000000000001 111.265 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 76.6 mt -104.59 139.93 38.74 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 119.397 0.999 . . . . 50.509999999999998 108.897 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.36 134.13 64.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 O-C-N 125.129 1.518 . . . . 50.509999999999998 108.377 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 50.5 t80 -160.17 113.15 2.1 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.561 -1.199 . . . . 50.509999999999998 110.926 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 78.39 28.62 0.46 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.259 -2.246 . . . . 50.509999999999998 116.087 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.14 -8.95 35.36 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 117.04 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -101.48 138.33 38.63 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 114.211 1.189 . . . . 50.509999999999998 114.211 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.06 121.01 15.23 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.994 0.809 . . . . 50.549999999999997 110.234 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.644 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 11.1 mp -78.58 150.26 32.8 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.096 -2.187 . . . . 50.509999999999998 105.096 -175.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -110.19 143.72 39.89 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.939 1.4 . . . . 50.619999999999997 113.769 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' CG2' ' A' ' 23' ' ' ILE . 34.9 m-20 -38.33 -46.22 1.08 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 120.332 3.456 . . . . 50.619999999999997 120.332 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.71 -3.68 73.76 Favored Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 121.177 3.231 . . . . 50.509999999999998 121.177 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -83.72 159.13 21.55 Favored 'General case' 0 C--O 1.249 1.046 0 O-C-N 117.464 -3.374 . . . . 50.640000000000001 115.453 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.3 p -99.99 172.18 7.37 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.018 0.927 . . . . 50.509999999999998 109.143 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -70.54 -23.78 62.68 Favored 'General case' 0 C--O 1.201 -1.46 0 O-C-N 124.164 0.915 . . . . 50.509999999999998 109.268 177.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.8 p -77.52 -30.44 52.88 Favored 'General case' 0 C--O 1.269 2.102 0 C-N-CA 117.338 -1.745 . . . . 50.509999999999998 111.28 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.17 -42.87 70.13 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.423 1.106 . . . . 50.619999999999997 111.21 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.644 ' CZ ' ' HG ' ' A' ' 50' ' ' LEU . 92.9 m-85 -93.48 17.75 11.0 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.773 -1.108 . . . . 50.509999999999998 113.765 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.68 40.34 31.83 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 121.516 1.962 . . . . 50.549999999999997 116.273 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.57 112.95 2.45 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-O 115.183 -2.341 . . . . 50.509999999999998 116.634 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -118.16 174.24 6.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 126.141 2.15 . . . . 50.549999999999997 112.497 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 79.4 tttt -57.61 138.6 55.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 123.193 1.473 . . . . 50.509999999999998 111.378 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.63 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 29.5 mt-10 65.31 43.27 3.58 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.458 -2.155 . . . . 50.619999999999997 115.755 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -82.91 137.9 34.06 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.664 -1.606 . . . . 50.509999999999998 106.664 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -113.59 123.22 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.253 -1.017 . . . . 50.509999999999998 108.253 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -117.84 153.52 33.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.188 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -109.35 133.07 53.51 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 127.451 2.97 . . . . 50.509999999999998 103.358 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.413 HD23 HG22 ' A' ' 7' ' ' THR . 44.4 tp -101.52 107.14 18.34 Favored 'General case' 0 C--O 1.282 2.806 0 N-CA-C 118.914 2.931 . . . . 50.509999999999998 118.914 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 8' ' ' LEU . 61.9 t -92.03 117.16 34.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 119.564 1.075 . . . . 50.509999999999998 112.995 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.99 159.81 33.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.146 0.498 . . . . 50.509999999999998 110.435 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -119.52 109.87 16.22 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 113.298 -3.239 . . . . 50.640000000000001 103.744 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 2.0 mp -86.08 140.82 29.9 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 125.826 1.953 . . . . 50.509999999999998 116.206 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -68.85 122.31 18.34 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.01 -1.848 . . . . 50.640000000000001 106.01 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.01 -176.82 52.0 Favored Glycine 0 C--O 1.243 0.695 0 CA-C-N 114.63 -1.168 . . . . 50.509999999999998 115.431 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.445 0 N-CA-C 119.479 2.552 . . . . 50.509999999999998 119.479 179.25 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.509999999999998 109.784 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.549999999999997 110.888 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.509999999999998 116.515 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 113.74 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.509999999999998 108.059 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 111.299 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 113.264 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.509999999999998 109.711 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.509999999999998 118.139 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.509999999999998 115.485 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 112.444 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.509999999999998 104.287 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.509999999999998 112.3 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.509999999999998 121.099 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.619999999999997 110.491 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.509999999999998 108.724 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.619999999999997 111.398 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.509999999999998 111.977 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.509999999999998 114.356 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.619999999999997 114.483 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.509999999999998 107.854 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.509999999999998 119.713 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.619999999999997 107.589 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.549999999999997 116.179 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.509999999999998 107.144 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.509999999999998 106.178 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.509999999999998 113.884 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.509999999999998 110.545 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.427 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.509999999999998 115.565 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 108.505 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.619999999999997 115.994 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.509999999999998 109.748 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.619999999999997 110.609 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.509999999999998 106.674 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.509999999999998 113.426 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.509999999999998 110.966 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.509999999999998 113.447 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.619999999999997 115.85 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.549999999999997 110.579 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.549999999999997 112.07 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.640000000000001 108.703 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.509999999999998 118.456 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.509999999999998 111.752 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 61' ' ' ILE . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.509999999999998 118.653 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.509999999999998 114.688 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.509999999999998 116.218 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.509999999999998 102.92 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.549999999999997 109.69 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 113.209 -175.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.619999999999997 106.192 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.619999999999997 118.695 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.509999999999998 114.117 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.640000000000001 110.918 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.509999999999998 113.601 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.509999999999998 119.947 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.509999999999998 115.529 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.619999999999997 114.759 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.509999999999998 110.366 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.549999999999997 113.715 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 45' ' ' PHE . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.509999999999998 106.035 175.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.549999999999997 104.072 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.509999999999998 118.355 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.619999999999997 118.736 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.509999999999998 106.228 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.509999999999998 112.755 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.509999999999998 109.784 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.509999999999998 108.847 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.509999999999998 104.275 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.509999999999998 102.101 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.509999999999998 111.016 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.640000000000001 109.31 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.509999999999998 112.756 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.640000000000001 102.16 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.509999999999998 109.351 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.509999999999998 108.526 179.194 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.509999999999998 109.784 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.549999999999997 110.888 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.509999999999998 116.515 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 113.74 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.509999999999998 108.059 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 111.299 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 113.264 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.509999999999998 109.711 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.509999999999998 118.139 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.509999999999998 115.485 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 112.444 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.509999999999998 104.287 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.509999999999998 112.3 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.509999999999998 121.099 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.619999999999997 110.491 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.509999999999998 108.724 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.619999999999997 111.398 174.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.509999999999998 111.977 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.509999999999998 114.356 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.619999999999997 114.483 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.509999999999998 107.854 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.509999999999998 119.713 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.619999999999997 107.589 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.549999999999997 116.179 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.509999999999998 107.144 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.509999999999998 106.178 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.509999999999998 113.884 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.509999999999998 110.545 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.427 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.509999999999998 115.565 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 108.505 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.619999999999997 115.994 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.509999999999998 109.748 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.619999999999997 110.609 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.509999999999998 106.674 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.509999999999998 113.426 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.509999999999998 110.966 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.509999999999998 113.447 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.619999999999997 115.85 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.549999999999997 110.579 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.549999999999997 112.07 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.640000000000001 108.703 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.509999999999998 118.456 -177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.509999999999998 111.752 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 61' ' ' ILE . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.509999999999998 118.653 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.509999999999998 114.688 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.509999999999998 116.218 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.509999999999998 102.92 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.549999999999997 109.69 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 113.209 -175.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.619999999999997 106.192 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.619999999999997 118.695 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.509999999999998 114.117 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.640000000000001 110.918 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.509999999999998 113.601 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.509999999999998 119.947 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.509999999999998 115.529 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.619999999999997 114.759 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.509999999999998 110.366 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.549999999999997 113.715 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 45' ' ' PHE . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.509999999999998 106.035 175.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.549999999999997 104.072 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.509999999999998 118.355 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.619999999999997 118.736 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.509999999999998 106.228 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.509999999999998 112.755 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.509999999999998 109.784 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.509999999999998 108.847 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.509999999999998 104.275 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.509999999999998 102.101 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.509999999999998 111.016 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.640000000000001 109.31 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.509999999999998 112.756 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.640000000000001 102.16 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.509999999999998 109.351 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.509999999999998 108.526 179.194 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.509999999999998 106.676 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.549999999999997 106.021 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.509999999999998 104.709 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' HB2' HG22 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.509999999999998 113.954 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.509999999999998 102.923 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.509999999999998 112.316 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.509999999999998 106.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.509999999999998 115.548 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.509999999999998 108.113 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.509999999999998 106.107 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.509999999999998 120.071 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.509999999999998 110.493 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.509999999999998 109.559 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.509999999999998 114.838 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.509999999999998 106.275 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.619999999999997 113.422 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.509999999999998 109.333 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.619999999999997 106.827 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.509999999999998 111.928 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.509999999999998 121.083 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.619999999999997 111.205 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.509999999999998 110.198 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.509999999999998 109.42 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.619999999999997 111.997 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.549999999999997 112.41 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.509999999999998 109.295 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.509999999999998 112.034 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.509999999999998 108.289 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.509999999999998 110.474 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.509999999999998 112.329 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.549999999999997 110.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 107.396 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.509999999999998 117.751 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.619999999999997 110.115 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.509999999999998 107.221 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.509999999999998 111.423 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.509999999999998 110.839 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.509999999999998 113.43 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.619999999999997 110.786 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.549999999999997 113.905 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.599 ' HG2' HD11 ' A' ' 69' ' ' LEU . 50.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.549999999999997 108.396 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.640000000000001 106.438 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.509999999999998 111.107 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.509999999999998 108.499 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.509999999999998 110.923 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.509999999999998 110.976 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 110.394 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.509999999999998 113.046 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.549999999999997 105.007 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.509999999999998 110.654 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.619999999999997 113.026 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.619999999999997 118.034 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.509999999999998 115.926 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.640000000000001 104.585 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.509999999999998 116.28 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.509999999999998 114.766 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.509999999999998 108.201 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.619999999999997 110.796 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 109.666 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.549999999999997 108.723 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.509999999999998 106.728 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.549999999999997 120.811 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.509999999999998 108.884 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.619999999999997 119.75 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.509999999999998 111.035 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.509999999999998 110.83 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.516 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.509999999999998 114.067 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 41' ' ' GLN . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.509999999999998 113.384 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.509999999999998 112.182 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.509999999999998 107.317 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.640000000000001 106.699 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.509999999999998 116.896 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.640000000000001 110.974 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.509999999999998 113.009 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 117.514 179.235 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.509999999999998 106.676 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.549999999999997 106.021 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.509999999999998 104.709 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' HB2' HG22 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.509999999999998 113.954 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.509999999999998 102.923 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.509999999999998 112.316 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.509999999999998 106.004 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.509999999999998 115.548 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.509999999999998 108.113 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.509999999999998 106.107 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.509999999999998 120.071 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.509999999999998 110.493 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.509999999999998 109.559 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.509999999999998 114.838 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.509999999999998 106.275 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.619999999999997 113.422 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.509999999999998 109.333 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.619999999999997 106.827 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.509999999999998 111.928 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.509999999999998 121.083 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.619999999999997 111.205 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.509999999999998 110.198 175.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.509999999999998 109.42 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.619999999999997 111.997 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.549999999999997 112.41 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.509999999999998 109.295 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.509999999999998 112.034 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.509999999999998 108.289 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.509999999999998 110.474 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.509999999999998 112.329 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.549999999999997 110.082 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 107.396 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.509999999999998 117.751 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.619999999999997 110.115 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.509999999999998 107.221 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.509999999999998 111.423 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.509999999999998 110.839 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.509999999999998 113.43 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.619999999999997 110.786 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.549999999999997 113.905 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.599 ' HG2' HD11 ' A' ' 69' ' ' LEU . 50.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.549999999999997 108.396 -177.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.640000000000001 106.438 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.509999999999998 111.107 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.509999999999998 108.499 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.509999999999998 110.923 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.509999999999998 110.976 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 110.394 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.509999999999998 113.046 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.549999999999997 105.007 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.509999999999998 110.654 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.619999999999997 113.026 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.619999999999997 118.034 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.509999999999998 115.926 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.640000000000001 104.585 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.509999999999998 116.28 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.509999999999998 114.766 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.509999999999998 108.201 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.619999999999997 110.796 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 109.666 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.549999999999997 108.723 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.509999999999998 106.728 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.549999999999997 120.811 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.509999999999998 108.884 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.619999999999997 119.75 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.509999999999998 111.035 174.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.509999999999998 110.83 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.516 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.509999999999998 114.067 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 41' ' ' GLN . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.509999999999998 113.384 176.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.509999999999998 112.182 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.509999999999998 107.317 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.640000000000001 106.699 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.509999999999998 116.896 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.640000000000001 110.974 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.509999999999998 113.009 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 117.514 179.235 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.868 0 N-CA-C 104.835 -2.283 . . . . 50.509999999999998 104.835 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -88.49 154.45 20.35 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 102.339 -3.208 . . . . 50.549999999999997 102.339 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 3' ' ' ILE . 19.7 tt -150.21 128.91 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 115.963 -1.97 . . . . 50.509999999999998 108.004 173.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 66' ' ' THR . 82.5 m-85 -92.92 141.96 27.84 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.328 4.767 . . . . 50.509999999999998 112.03 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.79 99.23 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 113.439 -3.172 . . . . 50.509999999999998 111.052 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -68.65 136.07 52.38 Favored 'General case' 0 N--CA 1.504 2.235 1 O-C-N 129.254 4.096 . . . . 50.509999999999998 114.159 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 p -112.87 149.23 33.43 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 104.91 -2.256 . . . . 50.509999999999998 104.91 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.44 -6.85 0.5 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.799 2.888 . . . . 50.509999999999998 118.799 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -115.91 19.46 15.1 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 120.312 3.449 . . . . 50.509999999999998 120.312 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.26 -13.69 66.4 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 117.483 1.753 . . . . 50.509999999999998 117.483 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.41 155.41 18.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 116.871 -1.538 . . . . 50.509999999999998 111.77 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -148.98 149.77 31.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 126.656 2.472 . . . . 50.509999999999998 109.639 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -143.62 146.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.497 2.998 . . . . 50.509999999999998 110.559 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.457 ' O ' HD23 ' A' ' 15' ' ' LEU . 20.9 p -102.87 130.4 49.89 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.315 -1.754 . . . . 50.509999999999998 112.746 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 14' ' ' THR . 48.0 mt -124.95 149.79 47.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 115.37 -2.253 . . . . 50.509999999999998 113.511 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -107.4 142.43 37.23 Favored 'General case' 0 N--CA 1.5 2.025 1 O-C-N 129.114 4.009 . . . . 50.619999999999997 104.294 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -144.08 167.18 12.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 O-C-N 126.091 2.119 . . . . 50.509999999999998 105.692 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 68.9 mm-40 -122.0 157.66 57.15 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 112.209 -2.269 . . . . 50.619999999999997 112.202 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.96 -24.47 39.58 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 122.662 2.241 . . . . 50.509999999999998 111.904 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -96.78 -8.78 30.31 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 118.158 -0.925 . . . . 50.509999999999998 112.674 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 30.4 m-20 -66.3 124.44 22.71 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.308 -1.757 . . . . 50.619999999999997 106.485 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -79.09 155.79 28.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.808 -0.633 . . . . 50.509999999999998 112.51 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.605 HD13 ' HB3' ' A' ' 50' ' ' LEU . 76.6 mt -52.18 -45.87 43.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 O-C-N 127.176 2.798 . . . . 50.509999999999998 108.374 175.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.05 -51.01 18.58 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.45 -0.781 . . . . 50.619999999999997 110.645 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -65.19 -43.05 92.87 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 118.735 2.865 . . . . 50.549999999999997 118.735 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.22 -42.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.123 -1.399 . . . . 50.509999999999998 110.285 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.26 -38.25 90.38 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 108.12 -1.066 . . . . 50.509999999999998 108.12 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.7 -40.02 63.94 Favored 'General case' 0 C--O 1.277 2.543 0 N-CA-C 114.709 1.374 . . . . 50.509999999999998 114.709 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -58.05 -29.19 65.17 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 120.398 -1.439 . . . . 50.509999999999998 112.966 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.436 HG12 HD11 ' A' ' 15' ' ' LEU . 74.6 mt -77.58 -29.86 16.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 N-CA-C 106.695 -1.595 . . . . 50.509999999999998 106.695 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -58.08 -41.71 84.0 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 125.614 2.626 . . . . 50.549999999999997 108.18 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -73.48 10.92 0.89 Allowed 'General case' 0 C--O 1.253 1.289 0 CA-C-N 113.6 -1.636 . . . . 50.619999999999997 113.765 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -139.26 -30.1 0.74 Allowed 'General case' 0 C--O 1.279 2.647 0 N-CA-C 104.592 -2.373 . . . . 50.509999999999998 104.592 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -110.18 -61.57 1.64 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 123.081 2.673 . . . . 50.619999999999997 109.578 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.51 20.29 0.9 Allowed Glycine 0 CA--C 1.477 -2.327 0 N-CA-C 108.891 -1.683 . . . . 50.509999999999998 108.891 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.2 mt -103.03 122.26 46.14 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 116.526 2.047 . . . . 50.509999999999998 116.526 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.0 Cg_exo -57.01 136.91 79.55 Favored 'Trans proline' 0 C--O 1.259 1.545 0 C-N-CA 123.104 2.536 . . . . 50.509999999999998 110.937 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.0 Cg_exo -57.18 -32.12 92.55 Favored 'Trans proline' 0 C--O 1.262 1.685 0 O-C-N 122.912 0.953 . . . . 50.509999999999998 113.388 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' A' ' 37' ' ' PRO . 42.1 p-10 -59.91 -27.91 67.14 Favored 'General case' 0 C--O 1.261 1.702 0 O-C-N 119.897 -1.752 . . . . 50.619999999999997 114.427 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -87.97 -15.63 35.97 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.593 -1.317 . . . . 50.549999999999997 113.857 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -87.3 117.7 26.25 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 118.3 2.704 . . . . 50.549999999999997 118.3 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.32 131.99 53.62 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 105.937 -1.875 . . . . 50.640000000000001 105.937 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 mt -107.67 133.38 52.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 101.965 -3.346 . . . . 50.509999999999998 101.965 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.42 HD13 HG23 ' A' ' 70' ' ' VAL . 3.3 mp -124.31 135.87 62.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 O-C-N 125.201 1.563 . . . . 50.509999999999998 114.334 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -140.14 113.03 8.14 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 105.719 -1.956 . . . . 50.509999999999998 105.719 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.93 41.42 31.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.26 -2.245 . . . . 50.509999999999998 108.716 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.66 3.54 59.15 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 128.432 2.92 . . . . 50.509999999999998 116.134 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.1 125.5 29.45 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.714 1.376 . . . . 50.509999999999998 114.714 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -75.24 127.91 34.24 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 107.68 -1.23 . . . . 50.549999999999997 107.68 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.605 ' HB3' HD13 ' A' ' 23' ' ' ILE . 2.9 mp -95.51 124.59 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 117.72 -1.133 . . . . 50.509999999999998 112.665 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -104.37 135.97 44.83 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.368 1.988 . . . . 50.619999999999997 116.368 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -42.62 -36.23 1.33 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 121.197 3.777 . . . . 50.619999999999997 121.197 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.56 -33.61 87.7 Favored Glycine 0 CA--C 1.493 -1.294 0 C-N-CA 124.438 1.018 . . . . 50.509999999999998 113.72 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -88.69 136.45 32.99 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 119.766 -2.02 . . . . 50.640000000000001 112.614 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 22' ' ' THR . 57.0 p -77.68 171.54 14.79 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.015 0.926 . . . . 50.509999999999998 111.465 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.69 -39.24 83.87 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 117.381 2.363 . . . . 50.509999999999998 117.381 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -64.41 -37.67 88.33 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.332 -1.747 . . . . 50.509999999999998 110.815 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -50.01 -43.57 50.68 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 116.888 2.181 . . . . 50.619999999999997 116.888 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.656 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 63.4 m-85 -74.57 -6.85 50.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 110.416 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.656 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 71.52 40.67 0.79 Allowed 'General case' 0 C--O 1.247 0.957 0 CA-C-N 121.429 1.922 . . . . 50.549999999999997 115.239 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mm -71.03 110.41 3.96 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.182 -2.342 . . . . 50.509999999999998 110.428 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 174.35 7.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.056 2.097 . . . . 50.549999999999997 114.79 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 26.7 ttpp -61.35 114.27 3.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 123.159 1.457 . . . . 50.509999999999998 112.848 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 45.6 mm-40 80.31 44.18 0.04 OUTLIER 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.575 -2.102 . . . . 50.619999999999997 111.989 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.2 t -82.64 140.71 33.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.785 -1.098 . . . . 50.509999999999998 108.832 174.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 45.7 m -109.28 146.65 33.94 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 102.454 -3.165 . . . . 50.509999999999998 102.454 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.2 147.28 41.59 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.739 -2.553 . . . . 50.509999999999998 109.193 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -88.89 137.98 31.83 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 127.149 2.78 . . . . 50.509999999999998 111.373 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.5 109.17 18.59 Favored 'General case' 0 C--O 1.283 2.86 0 CA-C-O 117.662 -1.161 . . . . 50.509999999999998 113.737 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG23 HD13 ' A' ' 44' ' ' ILE . 45.6 t -111.69 128.48 68.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 119.614 1.097 . . . . 50.509999999999998 108.452 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.07 139.05 32.73 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 116.296 1.962 . . . . 50.509999999999998 116.296 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -98.08 116.7 30.84 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.337 -3.22 . . . . 50.640000000000001 108.684 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mp -85.76 138.4 32.12 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.795 1.934 . . . . 50.509999999999998 106.421 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -99.56 73.93 1.86 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.763 -1.562 . . . . 50.640000000000001 109.118 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.55 145.04 6.7 Favored Glycine 0 C--O 1.244 0.735 0 N-CA-C 106.293 -2.723 . . . . 50.509999999999998 106.293 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.416 0 N-CA-C 106.551 -2.62 . . . . 50.509999999999998 106.551 179.239 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 97.6 mmm . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.819 -1.178 . . . . 50.509999999999998 107.819 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -113.54 139.66 48.8 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 103.575 -2.75 . . . . 50.549999999999997 103.575 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.521 HD12 ' C ' ' A' ' 3' ' ' ILE . 2.0 pp -144.78 162.55 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 104.75 -2.315 . . . . 50.509999999999998 104.75 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 148.02 40.27 Favored 'General case' 0 N--CA 1.511 2.604 1 O-C-N 130.46 4.85 . . . . 50.509999999999998 109.434 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 67' ' ' LEU . 42.9 t -130.22 100.05 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 113.406 -3.188 . . . . 50.509999999999998 105.245 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -65.4 131.11 45.61 Favored 'General case' 0 N--CA 1.504 2.275 1 O-C-N 129.266 4.103 . . . . 50.509999999999998 112.832 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 41.5 p -93.22 -169.39 2.14 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 107.672 -1.233 . . . . 50.509999999999998 107.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.06 34.87 4.75 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.851 -1.537 . . . . 50.509999999999998 106.851 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.1 p -134.13 -15.09 2.29 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 115.706 -2.398 . . . . 50.509999999999998 114.646 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.63 13.14 10.7 Favored Glycine 0 C--N 1.296 -1.645 0 O-C-N 120.227 -1.546 . . . . 50.509999999999998 112.654 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -119.87 120.31 36.08 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 116.834 -1.555 . . . . 50.509999999999998 111.126 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -85.77 144.75 27.58 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 126.647 2.467 . . . . 50.509999999999998 110.942 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -116.75 142.74 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 127.582 3.052 . . . . 50.509999999999998 110.391 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -122.33 128.92 51.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.249 -1.78 . . . . 50.509999999999998 113.007 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 30' ' ' ILE . 5.4 mp -118.64 151.7 37.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 115.39 -2.243 . . . . 50.509999999999998 107.28 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 1' ' ' MET . 40.1 mt-10 -117.22 126.18 52.35 Favored 'General case' 0 N--CA 1.5 2.028 1 O-C-N 129.176 4.048 . . . . 50.619999999999997 102.984 173.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.491 HG12 ' HE3' ' A' ' 29' ' ' LYS . 35.3 m -146.31 170.83 4.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 126.241 2.213 . . . . 50.509999999999998 108.46 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -108.52 154.84 41.33 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.163 -2.29 . . . . 50.619999999999997 114.645 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -55.03 -24.51 40.35 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 122.624 2.216 . . . . 50.509999999999998 111.918 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -75.08 -14.74 60.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 118.067 -0.968 . . . . 50.509999999999998 112.467 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.0 140.91 56.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 117.355 -1.738 . . . . 50.619999999999997 109.344 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.0 p -80.93 133.51 35.55 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 105.809 -1.923 . . . . 50.509999999999998 105.809 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 54' ' ' ARG . 24.4 mm -37.69 -35.64 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.212 2.82 . . . . 50.509999999999998 110.364 175.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -58.5 -45.17 89.29 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.543 2.423 . . . . 50.619999999999997 117.543 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.09 -26.59 66.79 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.874 2.175 . . . . 50.549999999999997 116.874 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.74 -43.08 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 125.118 1.511 . . . . 50.509999999999998 112.842 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.7 -34.34 71.19 Favored 'General case' 0 C--O 1.256 1.402 0 CA-C-N 115.767 -0.651 . . . . 50.509999999999998 110.009 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 31' ' ' GLN . . . -66.42 -44.82 81.88 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 117.872 2.545 . . . . 50.509999999999998 117.872 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HE3' HG12 ' A' ' 17' ' ' VAL . 62.0 mttm -46.65 -32.66 3.66 Favored 'General case' 0 C--O 1.255 1.395 0 O-C-N 120.422 -1.424 . . . . 50.509999999999998 108.56 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.463 HD11 HD11 ' A' ' 15' ' ' LEU . 22.6 mm -68.97 -40.69 81.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.199 0 N-CA-C 106.363 -1.717 . . . . 50.509999999999998 106.363 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 28' ' ' ALA . 26.0 tt0 -39.92 -38.62 0.72 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 118.359 2.726 . . . . 50.549999999999997 118.359 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.11 -12.4 61.48 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 115.605 1.706 . . . . 50.619999999999997 115.605 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -105.18 -43.47 5.01 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.459 -2.096 . . . . 50.509999999999998 115.246 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -110.57 -43.46 3.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 123.067 2.667 . . . . 50.619999999999997 108.205 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 35.39 1.88 Allowed Glycine 0 CA--C 1.477 -2.33 0 N-CA-C 108.188 -1.965 . . . . 50.509999999999998 108.188 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.9 mm -98.73 123.41 49.81 Favored Pre-proline 0 C--O 1.243 0.739 0 C-N-CA 118.851 -1.139 . . . . 50.509999999999998 108.703 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.92 136.98 79.77 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.1 2.533 . . . . 50.509999999999998 110.943 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.516 ' HA ' HE21 ' A' ' 41' ' ' GLN . 86.7 Cg_exo -57.18 -32.23 92.87 Favored 'Trans proline' 0 C--O 1.261 1.663 0 O-C-N 122.904 0.949 . . . . 50.509999999999998 113.436 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.45 -15.99 63.39 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 120.023 -1.673 . . . . 50.619999999999997 114.309 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -104.63 17.57 23.88 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.555 -1.341 . . . . 50.549999999999997 113.991 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.516 HE21 ' HA ' ' A' ' 38' ' ' PRO . 54.7 mt-30 -114.35 146.11 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 124.422 2.058 . . . . 50.549999999999997 106.636 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.635 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 21.5 mtp-105 -128.7 105.19 8.09 Favored 'General case' 0 C--O 1.295 3.488 0 CA-C-O 116.632 -1.651 . . . . 50.640000000000001 113.386 172.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.41 117.58 29.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.459 1.027 . . . . 50.509999999999998 110.701 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -107.8 122.07 61.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 N-CA-C 119.051 2.982 . . . . 50.509999999999998 119.051 -177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -128.38 128.92 45.42 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 106.791 -1.559 . . . . 50.509999999999998 106.791 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.11 25.91 15.88 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 108.701 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.57 16.52 61.06 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.438 2.923 . . . . 50.509999999999998 108.69 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.47 142.01 33.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 118.037 0.918 . . . . 50.509999999999998 110.062 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -75.92 156.7 34.0 Favored 'General case' 0 C--O 1.26 1.607 0 O-C-N 123.981 0.801 . . . . 50.549999999999997 111.969 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -107.9 146.81 31.85 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.344 -1.725 . . . . 50.509999999999998 106.344 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -92.01 140.15 29.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 103.767 -2.679 . . . . 50.619999999999997 103.767 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -53.52 -52.18 60.46 Favored 'General case' 0 C--O 1.264 1.836 0 C-N-CA 126.206 1.802 . . . . 50.619999999999997 113.646 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.72 28.46 5.91 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 119.658 2.623 . . . . 50.509999999999998 119.658 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 23' ' ' ILE . 20.7 mmm180 -117.35 169.49 9.45 Favored 'General case' 0 C--O 1.248 1.006 0 O-C-N 120.047 -1.854 . . . . 50.640000000000001 112.33 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.95 149.36 28.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.091 0.956 . . . . 50.509999999999998 113.485 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.444 ' HB3' HG13 ' A' ' 61' ' ' ILE . 65.8 mt -50.47 -36.0 31.57 Favored 'General case' 0 C--O 1.201 -1.475 0 O-C-N 124.196 0.935 . . . . 50.509999999999998 109.023 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -68.79 -15.01 63.38 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.319 -1.752 . . . . 50.509999999999998 112.086 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.391 1.091 . . . . 50.619999999999997 109.894 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -121.88 11.2 10.33 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.778 -1.106 . . . . 50.509999999999998 113.333 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t30 51.45 39.79 25.27 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 121.442 1.928 . . . . 50.549999999999997 110.203 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.444 HG13 ' HB3' ' A' ' 56' ' ' LEU . 25.9 mm -56.54 116.26 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.959 0 CA-C-O 115.215 -2.326 . . . . 50.509999999999998 109.473 175.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -79.98 -171.03 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.638 2.458 . . . . 50.549999999999997 117.638 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.27 143.68 48.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.229 1.49 . . . . 50.509999999999998 108.827 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 34.42 39.58 0.03 OUTLIER 'General case' 0 C--O 1.256 1.447 0 N-CA-C 117.905 2.557 . . . . 50.619999999999997 117.905 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -65.89 146.68 54.44 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.83 -1.077 . . . . 50.509999999999998 111.949 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 p -104.54 144.15 32.08 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 118.299 -0.857 . . . . 50.509999999999998 110.926 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 5' ' ' VAL . 60.0 mt -110.66 156.04 21.56 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 114.756 -2.545 . . . . 50.509999999999998 108.625 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -118.94 144.94 46.16 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 127.408 2.942 . . . . 50.509999999999998 110.475 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 49.2 tp -96.09 129.88 43.26 Favored 'General case' 0 C--O 1.282 2.803 0 CA-C-O 117.696 -1.145 . . . . 50.509999999999998 111.668 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 61.8 t -116.11 137.06 51.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 102.392 -3.188 . . . . 50.509999999999998 102.392 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.87 127.86 46.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.102 0.477 . . . . 50.509999999999998 110.42 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -114.27 111.83 22.14 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.374 -3.203 . . . . 50.640000000000001 112.494 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.05 143.9 28.12 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.837 1.961 . . . . 50.509999999999998 108.097 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -98.09 89.28 4.47 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 106.662 -1.607 . . . . 50.640000000000001 106.662 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.7 -162.65 26.99 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 104.643 -3.383 . . . . 50.509999999999998 104.643 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 CA-C-O 116.355 -2.358 . . . . 50.509999999999998 108.044 179.25 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 118.768 -0.634 . . . . 50.509999999999998 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.463 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 10.9 mm-40 -109.09 127.67 54.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 127.001 2.688 . . . . 50.549999999999997 109.026 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -133.16 146.55 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 116.024 -1.941 . . . . 50.509999999999998 107.717 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -106.56 135.89 47.28 Favored 'General case' 0 N--CA 1.512 2.645 1 O-C-N 130.446 4.841 . . . . 50.509999999999998 113.486 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.468 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.8 t -108.05 136.63 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.417 -3.182 . . . . 50.509999999999998 103.898 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -126.24 119.7 28.12 Favored 'General case' 0 N--CA 1.503 2.219 1 O-C-N 129.277 4.111 . . . . 50.509999999999998 114.834 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.565 HG22 HD23 ' A' ' 69' ' ' LEU . 43.9 p -67.44 -172.27 0.23 Allowed 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.869 -1.063 . . . . 50.509999999999998 110.337 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.89 -18.97 26.46 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.116 -0.698 . . . . 50.509999999999998 109.116 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -106.36 16.08 25.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 119.87 3.285 . . . . 50.509999999999998 119.87 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.86 55.67 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 120.952 3.141 . . . . 50.509999999999998 120.952 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -84.16 123.35 30.0 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.227 -1.768 . . . . 50.509999999999998 106.227 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -113.03 134.1 54.67 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 126.585 2.428 . . . . 50.509999999999998 111.872 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 5' ' ' VAL . 28.0 pt -115.92 153.81 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 127.533 3.02 . . . . 50.509999999999998 114.0 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -110.58 142.99 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 117.301 -1.76 . . . . 50.509999999999998 115.021 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' A' ' 30' ' ' ILE . 76.4 mt -135.46 139.78 44.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 115.459 -2.21 . . . . 50.509999999999998 113.54 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -101.85 107.19 18.3 Favored 'General case' 0 N--CA 1.5 2.069 1 O-C-N 129.128 4.018 . . . . 50.619999999999997 113.926 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -128.17 154.63 39.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.671 3.107 . . . . 50.509999999999998 114.443 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.67 159.02 30.65 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 118.256 2.688 . . . . 50.619999999999997 118.256 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.0 -24.49 40.0 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.581 2.187 . . . . 50.509999999999998 111.948 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -103.34 34.33 2.97 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 117.806 2.521 . . . . 50.509999999999998 117.806 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -114.15 130.75 56.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.374 -1.731 . . . . 50.619999999999997 112.166 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.3 p -57.93 155.54 10.5 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.598 1.332 . . . . 50.509999999999998 114.598 175.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 54' ' ' ARG . 15.3 mm -60.45 -42.06 89.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 127.205 2.816 . . . . 50.509999999999998 110.955 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.07 -59.05 5.88 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.941 . . . . 50.619999999999997 108.458 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 44.5 t30 -47.85 -43.54 28.36 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 124.399 1.08 . . . . 50.549999999999997 111.145 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 56' ' ' LEU . 42.1 t -63.38 -34.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.97 1.419 . . . . 50.509999999999998 109.707 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -76.16 -30.44 58.12 Favored 'General case' 0 C--O 1.257 1.451 0 N-CA-C 108.816 -0.809 . . . . 50.509999999999998 108.816 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.88 70.02 Favored 'General case' 0 C--O 1.279 2.616 0 N-CA-C 105.517 -2.031 . . . . 50.509999999999998 105.517 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 75.3 mmtt -58.93 -63.2 1.38 Allowed 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.397 -1.439 . . . . 50.509999999999998 107.994 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.499 ' CG1' HD11 ' A' ' 15' ' ' LEU . 70.3 mt -47.97 -37.75 6.8 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.486 -0.886 . . . . 50.509999999999998 109.105 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 46.1 tt0 -54.45 -50.73 66.99 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 125.568 2.604 . . . . 50.549999999999997 112.849 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -49.0 -60.99 2.3 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 113.644 -1.616 . . . . 50.619999999999997 110.273 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -84.13 -40.33 18.36 Favored 'General case' 0 C--O 1.279 2.654 0 N-CA-C 119.617 3.191 . . . . 50.509999999999998 119.617 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.606 ' HG3' HG13 ' A' ' 36' ' ' ILE . 42.5 tp10 -76.19 -31.37 58.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 123.082 2.674 . . . . 50.619999999999997 108.162 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.42 2.36 76.75 Favored Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.458 -1.057 . . . . 50.509999999999998 110.458 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.606 HG13 ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -87.81 136.39 32.67 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 118.812 -1.155 . . . . 50.509999999999998 110.999 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.0 Cg_exo -57.07 137.0 79.97 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.159 2.572 . . . . 50.509999999999998 110.875 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 86.8 Cg_exo -57.19 -32.16 92.68 Favored 'Trans proline' 0 C--O 1.262 1.709 0 O-C-N 122.89 0.942 . . . . 50.509999999999998 113.436 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.539 ' OD1' ' HG3' ' A' ' 40' ' ' GLN . 35.6 p30 -69.4 -14.1 62.72 Favored 'General case' 0 C--O 1.262 1.733 0 O-C-N 119.893 -1.754 . . . . 50.619999999999997 113.83 -177.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.539 ' HG3' ' OD1' ' A' ' 39' ' ' ASP . 88.2 mt-30 -102.81 6.84 39.49 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.544 -1.347 . . . . 50.549999999999997 109.891 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -103.41 130.94 50.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 124.362 2.029 . . . . 50.549999999999997 110.796 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -120.98 122.12 39.47 Favored 'General case' 0 C--O 1.296 3.544 0 CA-C-O 116.625 -1.655 . . . . 50.640000000000001 110.828 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CB ' HD12 ' A' ' 50' ' ' LEU . 60.2 mt -108.14 126.16 52.44 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.509 1.05 . . . . 50.509999999999998 109.839 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 67.5 mt -111.14 138.86 37.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 O-C-N 125.223 1.577 . . . . 50.509999999999998 108.147 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -150.55 120.63 7.2 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 114.488 -1.233 . . . . 50.509999999999998 110.913 177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.34 38.66 7.69 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.208 -2.269 . . . . 50.509999999999998 112.284 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 3.42 68.08 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.346 2.879 . . . . 50.509999999999998 115.863 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -113.76 146.78 39.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 114.978 1.473 . . . . 50.509999999999998 114.978 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -70.51 153.96 42.38 Favored 'General case' 0 C--O 1.259 1.58 0 N-CA-C 108.2 -1.037 . . . . 50.549999999999997 108.2 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.45 HD12 ' CB ' ' A' ' 43' ' ' LEU . 63.5 mt -96.94 135.01 39.55 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 117.666 -1.159 . . . . 50.509999999999998 110.312 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -99.06 128.1 45.13 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.933 1.395 . . . . 50.619999999999997 112.737 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.11 -57.82 3.63 Favored 'General case' 0 C--O 1.264 1.844 0 C-N-CA 126.133 1.773 . . . . 50.619999999999997 115.216 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.26 -26.68 29.85 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 124.415 1.007 . . . . 50.509999999999998 113.886 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 23' ' ' ILE . 29.5 mmt180 -83.6 161.04 21.27 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 120.025 -1.868 . . . . 50.640000000000001 112.109 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -103.93 172.68 6.67 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 124.065 0.946 . . . . 50.509999999999998 110.218 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD11 HG21 ' A' ' 26' ' ' VAL . 47.5 mt -58.07 -33.19 68.79 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 116.49 2.033 . . . . 50.509999999999998 116.49 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -86.38 -5.66 59.12 Favored 'General case' 0 C--O 1.267 2.0 0 C-N-CA 117.372 -1.731 . . . . 50.509999999999998 111.167 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -79.81 -0.79 36.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.809 -1.182 . . . . 50.619999999999997 107.809 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -123.95 11.98 9.01 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 117.755 -1.117 . . . . 50.509999999999998 110.542 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.61 28.61 12.2 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 121.545 1.975 . . . . 50.549999999999997 111.595 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.2 103.0 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.969 0 CA-C-O 115.17 -2.348 . . . . 50.509999999999998 108.827 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -98.84 164.62 12.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.112 2.133 . . . . 50.549999999999997 112.435 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -51.04 135.89 24.27 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.513 2.042 . . . . 50.509999999999998 116.513 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 73.09 37.93 0.73 Allowed 'General case' 0 C--O 1.255 1.393 0 CA-C-N 112.497 -2.138 . . . . 50.619999999999997 111.07 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 p -78.07 156.56 29.96 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 107.537 -1.283 . . . . 50.509999999999998 107.537 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.5 m -122.05 117.97 27.63 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.834 -3.024 . . . . 50.509999999999998 102.834 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.65 170.09 9.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 114.695 -2.574 . . . . 50.509999999999998 112.545 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -110.32 127.62 55.12 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.361 2.913 . . . . 50.509999999999998 108.73 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.565 HD23 HG22 ' A' ' 7' ' ' THR . 48.0 tp -103.07 101.87 11.87 Favored 'General case' 0 C--O 1.283 2.823 0 CA-C-O 117.649 -1.167 . . . . 50.509999999999998 113.194 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.38 137.11 25.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.583 1.083 . . . . 50.509999999999998 112.149 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 tp -96.03 115.73 27.88 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.318 -0.623 . . . . 50.509999999999998 109.318 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -109.04 108.18 18.79 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.305 -3.236 . . . . 50.640000000000001 114.166 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.86 165.16 15.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 125.859 1.974 . . . . 50.509999999999998 114.664 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -115.35 61.45 0.69 Allowed 'General case' 0 C--O 1.244 0.812 0 CA-C-N 113.742 -1.572 . . . . 50.640000000000001 108.472 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.75 138.82 2.55 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 107.298 -2.321 . . . . 50.509999999999998 107.298 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.444 0 CA-C-O 116.356 -2.358 . . . . 50.509999999999998 109.038 179.217 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 106.917 -1.512 . . . . 50.509999999999998 106.917 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -120.19 135.71 54.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 101.557 -3.498 . . . . 50.549999999999997 101.557 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -137.89 159.36 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.94 -1.981 . . . . 50.509999999999998 106.941 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -114.24 143.91 44.08 Favored 'General case' 0 N--CA 1.512 2.628 1 O-C-N 130.446 4.842 . . . . 50.509999999999998 111.395 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -118.97 109.87 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.404 -3.189 . . . . 50.509999999999998 106.121 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -84.3 150.37 25.46 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.306 4.129 . . . . 50.509999999999998 117.362 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -126.78 164.23 21.81 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 117.826 -1.083 . . . . 50.509999999999998 110.137 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.54 -43.36 65.12 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.999 2.592 . . . . 50.509999999999998 117.999 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.6 p -68.64 -26.52 65.37 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 115.726 -2.39 . . . . 50.509999999999998 107.455 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.73 -5.93 18.42 Favored Glycine 0 C--N 1.297 -1.6 0 O-C-N 120.258 -1.526 . . . . 50.509999999999998 115.438 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -54.66 130.88 41.96 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.88 -1.533 . . . . 50.509999999999998 109.889 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -112.86 119.58 38.47 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 126.624 2.453 . . . . 50.509999999999998 117.221 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -88.48 145.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.571 3.044 . . . . 50.509999999999998 108.329 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -104.58 141.93 35.53 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 117.287 -1.765 . . . . 50.509999999999998 110.584 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -134.13 137.48 44.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 118.195 2.665 . . . . 50.509999999999998 118.195 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -103.61 111.18 23.54 Favored 'General case' 0 N--CA 1.501 2.104 1 O-C-N 129.242 4.089 . . . . 50.619999999999997 112.35 174.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -98.24 166.74 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.197 0 O-C-N 127.508 3.005 . . . . 50.509999999999998 112.548 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 53.9 mm-40 -115.72 148.66 41.63 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.197 -2.274 . . . . 50.619999999999997 112.58 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.5 Cg_exo -54.95 -24.49 39.57 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.581 2.188 . . . . 50.509999999999998 112.003 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -103.14 13.75 33.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 118.043 2.608 . . . . 50.509999999999998 118.043 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -92.74 148.6 21.91 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 117.349 -1.74 . . . . 50.619999999999997 110.986 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -99.09 157.42 16.37 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.836 -0.62 . . . . 50.509999999999998 109.716 175.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 26.8 mm -45.01 -43.86 2.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 O-C-N 127.238 2.836 . . . . 50.509999999999998 113.015 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -57.39 -46.68 83.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.456 -0.778 . . . . 50.619999999999997 110.305 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -59.51 -39.88 85.3 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.287 1.035 . . . . 50.549999999999997 110.653 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.63 -46.73 95.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.022 -1.473 . . . . 50.509999999999998 107.022 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 93.4 mttt -55.0 -59.38 4.83 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-N 115.814 -0.63 . . . . 50.509999999999998 111.336 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 38' ' ' PRO . . . -57.02 -40.59 76.99 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 113.887 1.069 . . . . 50.509999999999998 113.887 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 55.8 tptt -50.8 -44.38 58.97 Favored 'General case' 0 C--O 1.255 1.39 0 N-CA-C 106.367 -1.716 . . . . 50.509999999999998 106.367 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 31' ' ' GLN . 72.3 mt -64.26 -42.2 94.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.281 0 C-N-CA 119.51 -0.876 . . . . 50.509999999999998 108.669 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' C ' ' A' ' 32' ' ' ASP . 35.4 tt0 -43.87 -58.34 2.8 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.623 2.63 . . . . 50.549999999999997 108.844 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 31' ' ' GLN . 98.1 m-20 -34.57 -35.79 0.04 OUTLIER 'General case' 0 C--O 1.253 1.26 0 CA-C-N 113.645 -1.616 . . . . 50.619999999999997 110.833 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 31' ' ' GLN . 33.7 mmtp -112.46 -1.22 15.05 Favored 'General case' 0 C--O 1.28 2.703 0 N-CA-C 120.15 3.389 . . . . 50.509999999999998 120.15 -175.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -129.81 -38.07 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 123.147 2.703 . . . . 50.619999999999997 108.399 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 11.98 31.98 Favored Glycine 0 CA--C 1.477 -2.333 0 N-CA-C 115.177 0.831 . . . . 50.509999999999998 115.177 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.501 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.6 mt -97.51 136.72 21.18 Favored Pre-proline 0 C--O 1.245 0.83 0 C-N-CA 118.836 -1.146 . . . . 50.509999999999998 112.149 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.565 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.88 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.596 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 Cg_exo -57.24 -32.18 92.86 Favored 'Trans proline' 0 C--O 1.26 1.621 0 O-C-N 122.903 0.949 . . . . 50.509999999999998 113.38 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -72.82 5.17 3.39 Favored 'General case' 0 C--O 1.262 1.757 0 O-C-N 120.022 -1.674 . . . . 50.619999999999997 113.573 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.592 HE21 ' HG3' ' A' ' 74' ' ' ARG . 62.8 mt-30 -111.2 -6.71 14.53 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.541 -1.349 . . . . 50.549999999999997 112.632 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.425 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 8.8 mt-30 -102.79 130.59 49.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.412 2.053 . . . . 50.549999999999997 112.686 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -111.54 119.68 39.57 Favored 'General case' 0 C--O 1.297 3.566 0 CA-C-O 116.672 -1.632 . . . . 50.640000000000001 108.368 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' A' ' 50' ' ' LEU . 94.4 mt -100.97 158.72 15.79 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 105.595 -2.002 . . . . 50.509999999999998 105.595 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.8 mt -137.35 135.78 46.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 118.835 2.902 . . . . 50.509999999999998 118.835 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -128.05 112.62 14.81 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 115.063 1.505 . . . . 50.509999999999998 115.063 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.92 30.92 20.42 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.19 -2.277 . . . . 50.509999999999998 109.525 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.09 19.34 72.63 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 128.486 2.945 . . . . 50.509999999999998 117.187 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -111.02 151.72 27.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 118.162 -0.923 . . . . 50.509999999999998 112.078 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.05 154.17 42.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.986 1.106 . . . . 50.549999999999997 113.986 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 43' ' ' LEU . 96.4 mt -117.09 140.22 49.77 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 117.796 -1.097 . . . . 50.509999999999998 109.169 -175.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -103.32 136.03 43.85 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.864 1.352 . . . . 50.619999999999997 114.31 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 75.4 m-20 -57.33 -55.73 31.01 Favored 'General case' 0 C--O 1.263 1.793 0 C-N-CA 126.177 1.791 . . . . 50.619999999999997 114.019 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.16 11.66 4.76 Favored Glycine 0 C--O 1.254 1.368 0 C-N-CA 124.464 1.03 . . . . 50.509999999999998 115.389 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -106.96 166.7 10.41 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 119.963 -1.904 . . . . 50.640000000000001 110.538 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -90.22 158.67 17.1 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 124.014 0.926 . . . . 50.509999999999998 113.308 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -70.62 -28.82 65.14 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 124.071 0.857 . . . . 50.509999999999998 110.085 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -69.31 -21.71 63.83 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.31 -1.756 . . . . 50.509999999999998 113.535 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.29 -5.35 51.78 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.63 2.085 . . . . 50.619999999999997 116.63 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -111.75 14.32 21.11 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 114.791 1.404 . . . . 50.509999999999998 114.791 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 51.4 28.1 4.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 121.571 1.987 . . . . 50.549999999999997 114.397 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.85 100.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.973 0 CA-C-O 115.192 -2.337 . . . . 50.509999999999998 106.878 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -98.9 162.76 12.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 126.159 2.162 . . . . 50.549999999999997 111.333 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 58.4 pttt -52.93 118.32 3.62 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 116.501 2.038 . . . . 50.509999999999998 116.501 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 71.69 46.87 0.36 Allowed 'General case' 0 C--O 1.257 1.453 0 CA-C-N 112.53 -2.123 . . . . 50.619999999999997 112.764 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.3 p -102.0 151.86 21.63 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 101.515 -3.513 . . . . 50.509999999999998 101.515 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.1 p -94.29 139.55 30.92 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 117.729 2.492 . . . . 50.509999999999998 117.729 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 46.6 mt -109.36 151.73 26.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 103.166 -2.902 . . . . 50.509999999999998 103.166 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 55.5 m80 -108.75 124.95 51.37 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 127.472 2.982 . . . . 50.509999999999998 104.565 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.4 tp -99.42 117.56 34.11 Favored 'General case' 0 C--O 1.283 2.841 0 CA-C-O 117.63 -1.176 . . . . 50.509999999999998 111.172 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -103.84 145.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 119.558 1.072 . . . . 50.509999999999998 108.765 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -115.23 120.55 40.08 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.859 2.17 . . . . 50.509999999999998 116.859 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -119.13 90.06 3.25 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 113.371 -3.204 . . . . 50.640000000000001 111.138 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.24 163.38 1.65 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.795 1.935 . . . . 50.509999999999998 109.209 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.592 ' HG3' HE21 ' A' ' 40' ' ' GLN . 93.8 mtt-85 -87.62 94.01 9.6 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 113.706 -1.588 . . . . 50.640000000000001 113.065 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.66 171.34 18.3 Favored Glycine 0 C--O 1.243 0.705 0 N-CA-C 109.663 -1.375 . . . . 50.509999999999998 109.663 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.472 0 N-CA-C 106.215 -2.754 . . . . 50.509999999999998 106.215 179.22 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 118.753 -0.641 . . . . 50.509999999999998 111.148 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.521 ' OE1' HG21 ' A' ' 14' ' ' THR . 48.9 mt-30 -86.22 125.11 33.31 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.96 2.663 . . . . 50.549999999999997 116.662 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.3 pt -119.87 162.65 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 115.983 -1.96 . . . . 50.509999999999998 109.392 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -112.02 136.28 51.58 Favored 'General case' 0 N--CA 1.513 2.69 1 O-C-N 130.504 4.877 . . . . 50.509999999999998 118.459 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -105.85 111.63 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.438 -3.172 . . . . 50.509999999999998 111.728 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -81.22 129.44 34.59 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.309 4.131 . . . . 50.509999999999998 109.318 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 69.2 p -97.67 -176.77 3.57 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 114.576 1.324 . . . . 50.509999999999998 114.576 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.2 mt -86.91 -28.68 22.64 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.784 1.031 . . . . 50.509999999999998 113.784 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 p -93.97 -22.37 18.61 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.713 -2.395 . . . . 50.509999999999998 111.12 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.2 3.9 2.39 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 117.726 1.85 . . . . 50.509999999999998 117.726 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' N ' ' OG1' ' A' ' 7' ' ' THR . 95.4 mttt -71.7 137.65 47.96 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 116.868 -1.539 . . . . 50.509999999999998 112.323 174.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.1 m -122.15 106.73 11.42 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.678 2.486 . . . . 50.509999999999998 110.809 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 15' ' ' LEU . 62.5 mt -84.87 153.09 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 127.244 2.84 . . . . 50.509999999999998 111.427 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.521 HG21 ' OE1' ' A' ' 2' ' ' GLN . 42.6 m -119.76 132.1 55.53 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 102.538 -3.134 . . . . 50.509999999999998 102.538 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 13' ' ' ILE . 1.5 mp -118.05 142.6 47.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 117.3 2.333 . . . . 50.509999999999998 117.3 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.71 107.39 19.87 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 128.944 3.902 . . . . 50.619999999999997 109.902 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.58 166.71 10.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 O-C-N 127.782 3.176 . . . . 50.509999999999998 106.046 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -132.67 157.77 77.46 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 112.234 -2.257 . . . . 50.619999999999997 106.446 174.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.92 -24.5 39.38 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.56 2.173 . . . . 50.509999999999998 112.014 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -75.81 -13.0 60.28 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 115.451 1.648 . . . . 50.509999999999998 115.451 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -84.65 131.27 34.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 118.379 2.733 . . . . 50.619999999999997 118.379 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -83.61 179.92 7.49 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 103.948 -2.612 . . . . 50.509999999999998 103.948 175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' GLU . 24.6 mm -65.41 -39.56 85.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 O-C-N 127.206 2.816 . . . . 50.509999999999998 110.824 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 29.7 tt0 -46.84 -59.23 3.2 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.275 -2.12 . . . . 50.619999999999997 105.275 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 24.6 m-80 -53.12 -46.37 68.73 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 118.123 2.638 . . . . 50.549999999999997 118.123 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.41 -39.6 81.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 117.777 2.51 . . . . 50.509999999999998 117.777 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -72.27 -30.08 64.5 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 103.231 -2.877 . . . . 50.509999999999998 103.231 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -30.86 71.18 Favored 'General case' 0 C--O 1.279 2.608 0 N-CA-C 109.146 -0.687 . . . . 50.509999999999998 109.146 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.6 mttt -71.79 -19.18 62.04 Favored 'General case' 0 C--O 1.256 1.422 0 O-C-N 120.316 -1.49 . . . . 50.509999999999998 111.058 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 30' ' ' ILE . 95.7 mt -88.94 -11.25 10.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 C-N-CA 119.538 -0.865 . . . . 50.509999999999998 109.491 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -91.67 -19.64 22.45 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 125.63 2.633 . . . . 50.549999999999997 113.161 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.26 -52.77 20.5 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.572 -1.649 . . . . 50.619999999999997 110.606 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -80.28 -75.93 0.24 Allowed 'General case' 0 C--O 1.278 2.598 0 C-N-CA 116.468 -2.093 . . . . 50.509999999999998 108.175 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -55.18 -70.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.05 2.659 . . . . 50.619999999999997 114.812 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.69 20.33 0.88 Allowed Glycine 0 CA--C 1.478 -2.27 0 CA-C-O 120.012 -0.327 . . . . 50.509999999999998 113.223 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -89.28 125.86 60.51 Favored Pre-proline 0 C--O 1.244 0.776 0 N-CA-C 116.77 2.137 . . . . 50.509999999999998 116.77 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -57.01 136.98 79.95 Favored 'Trans proline' 0 C--O 1.258 1.523 0 C-N-CA 123.159 2.572 . . . . 50.509999999999998 110.903 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.1 Cg_exo -57.17 -32.19 92.72 Favored 'Trans proline' 0 C--O 1.261 1.653 0 C-N-CA 120.671 0.914 . . . . 50.509999999999998 113.377 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.04 -9.71 58.9 Favored 'General case' 0 C--O 1.262 1.738 0 O-C-N 119.949 -1.719 . . . . 50.619999999999997 112.854 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.644 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 79.8 mt-30 -103.32 -1.89 27.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.488 -1.382 . . . . 50.549999999999997 107.656 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.22 138.1 31.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 124.447 2.07 . . . . 50.549999999999997 105.745 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.11 114.4 15.7 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.646 -1.645 . . . . 50.640000000000001 106.831 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' CB ' HD22 ' A' ' 50' ' ' LEU . 35.2 mt -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 119.537 1.062 . . . . 50.509999999999998 110.285 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -129.06 123.87 59.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 O-C-N 125.102 1.501 . . . . 50.509999999999998 111.849 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -140.1 117.19 11.16 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 114.539 -1.21 . . . . 50.509999999999998 109.948 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.7 29.0 13.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 112.241 -2.254 . . . . 50.509999999999998 114.706 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 37.54 45.29 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 114.393 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -133.95 150.23 51.28 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 118.317 2.71 . . . . 50.509999999999998 118.317 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.08 135.18 42.97 Favored 'General case' 0 C--O 1.26 1.635 0 O-C-N 123.953 0.783 . . . . 50.549999999999997 110.33 174.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD22 ' CB ' ' A' ' 43' ' ' LEU . 2.1 mp -87.79 129.18 35.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 114.637 1.347 . . . . 50.509999999999998 114.637 -175.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -89.5 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 120.377 3.473 . . . . 50.619999999999997 120.377 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -51.07 -55.97 14.95 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 119.74 3.237 . . . . 50.619999999999997 119.74 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.96 7.85 78.69 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.387 0.994 . . . . 50.509999999999998 114.189 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.51 144.55 28.48 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 119.951 -1.911 . . . . 50.640000000000001 109.276 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -87.4 155.84 19.85 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.062 0.945 . . . . 50.509999999999998 108.581 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -46.93 -32.26 3.71 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 113.869 1.063 . . . . 50.509999999999998 113.869 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.58 -20.38 65.38 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 115.759 1.763 . . . . 50.509999999999998 115.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -62.24 -43.84 97.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.452 1.12 . . . . 50.619999999999997 110.603 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -84.66 17.11 2.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 115.609 1.707 . . . . 50.509999999999998 115.609 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 t30 60.31 33.13 20.88 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 121.536 1.971 . . . . 50.549999999999997 113.59 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.533 HG23 ' OG ' ' A' ' 65' ' ' SER . 56.9 mt -85.47 83.71 2.08 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 CA-C-O 115.169 -2.348 . . . . 50.509999999999998 113.65 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -82.97 179.06 7.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 125.717 1.885 . . . . 50.549999999999997 116.027 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -53.2 124.21 13.91 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 123.179 1.466 . . . . 50.509999999999998 111.394 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 61.1 40.42 14.98 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 118.528 2.788 . . . . 50.619999999999997 118.528 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.533 ' OG ' HG23 ' A' ' 61' ' ' ILE . 94.2 p -86.91 152.35 22.51 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.164 -1.421 . . . . 50.509999999999998 107.164 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 m -91.47 123.3 34.78 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 116.667 2.099 . . . . 50.509999999999998 116.667 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.01 138.58 41.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 114.735 -2.555 . . . . 50.509999999999998 105.291 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 49.0 m80 -81.6 168.04 18.59 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 127.038 2.711 . . . . 50.509999999999998 106.612 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -131.24 120.47 23.28 Favored 'General case' 0 C--O 1.282 2.789 0 N-CA-C 104.664 -2.346 . . . . 50.509999999999998 104.664 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.5 t -118.8 149.93 21.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 102.585 -3.117 . . . . 50.509999999999998 102.585 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.11 152.33 18.64 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.536 0.569 . . . . 50.509999999999998 112.536 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.644 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 74.9 ttt180 -122.12 97.73 5.61 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 113.413 -3.184 . . . . 50.640000000000001 106.789 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.0 mt -85.83 134.6 33.91 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 125.757 1.911 . . . . 50.509999999999998 113.369 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.84 81.49 8.75 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.703 -1.59 . . . . 50.640000000000001 112.88 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.94 -175.34 16.6 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 107.596 -2.201 . . . . 50.509999999999998 107.596 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.464 0 N-CA-C 105.24 -3.144 . . . . 50.509999999999998 105.24 179.213 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtp . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 102.042 -3.318 . . . . 50.509999999999998 102.042 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -112.52 135.05 53.69 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 103.497 -2.779 . . . . 50.549999999999997 103.497 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -124.77 173.12 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 CA-C-O 116.074 -1.917 . . . . 50.509999999999998 107.004 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.8 141.98 38.55 Favored 'General case' 0 N--CA 1.511 2.609 1 O-C-N 130.343 4.777 . . . . 50.509999999999998 115.954 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.34 110.58 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.454 -3.165 . . . . 50.509999999999998 104.585 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -90.47 143.94 26.27 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.204 4.065 . . . . 50.509999999999998 105.472 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 24.8 p -117.39 177.2 4.82 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.8 -1.095 . . . . 50.509999999999998 112.878 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.05 -24.76 67.83 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.082 0.864 . . . . 50.509999999999998 112.65 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -101.23 25.79 7.83 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 115.748 -2.381 . . . . 50.509999999999998 110.799 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.56 31.34 74.44 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 107.559 -2.216 . . . . 50.509999999999998 107.559 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 29.3 ttpt -84.97 124.7 31.98 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 103.735 -2.691 . . . . 50.509999999999998 103.735 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 p -103.31 137.72 41.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.664 2.477 . . . . 50.509999999999998 105.851 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 13' ' ' ILE . 16.6 tt -144.74 112.13 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 101.735 -3.432 . . . . 50.509999999999998 101.735 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.9 p -81.52 155.07 25.94 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.302 -1.759 . . . . 50.509999999999998 114.975 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -114.22 167.63 10.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.446 -2.216 . . . . 50.509999999999998 110.928 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.6 104.06 12.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 129.025 3.953 . . . . 50.619999999999997 106.427 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.41 148.62 11.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 O-C-N 127.62 3.075 . . . . 50.509999999999998 114.912 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -116.0 149.47 43.4 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 112.131 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.87 -24.53 39.18 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.535 2.157 . . . . 50.509999999999998 111.971 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -87.31 -2.54 58.7 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 118.146 -0.931 . . . . 50.509999999999998 111.135 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.43 131.8 37.05 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 115.949 1.833 . . . . 50.619999999999997 115.949 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.98 148.58 24.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.808 -0.633 . . . . 50.509999999999998 111.04 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 51' ' ' GLU . 73.2 mt -48.6 -29.87 2.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.147 2.779 . . . . 50.509999999999998 114.907 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 78.5 tt0 -56.25 -63.82 1.06 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 105.021 -2.215 . . . . 50.619999999999997 105.021 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -50.42 -40.71 51.01 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 118.97 2.952 . . . . 50.549999999999997 118.97 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.13 -23.15 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.129 -1.396 . . . . 50.509999999999998 107.518 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 64.5 mttm -88.73 -26.68 21.65 Favored 'General case' 0 C--O 1.257 1.474 0 N-CA-C 118.272 2.693 . . . . 50.509999999999998 118.272 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -23.7 24.29 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.901 -0.407 . . . . 50.509999999999998 109.901 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.87 -49.69 73.84 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 120.333 -1.48 . . . . 50.509999999999998 111.41 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.42 -36.96 48.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 108.575 -0.898 . . . . 50.509999999999998 108.575 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.47 -45.19 73.13 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.578 2.608 . . . . 50.549999999999997 115.682 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -52.64 -29.55 26.83 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 106.387 -1.709 . . . . 50.619999999999997 106.387 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.72 -45.48 11.61 Favored 'General case' 0 C--O 1.279 2.656 0 C-N-CA 116.433 -2.107 . . . . 50.509999999999998 113.243 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -116.78 -36.67 3.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 123.107 2.685 . . . . 50.619999999999997 112.321 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.86 31.32 2.74 Favored Glycine 0 CA--C 1.477 -2.291 0 N-CA-C 110.512 -1.035 . . . . 50.509999999999998 110.512 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -83.09 122.92 77.89 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 105.273 -2.121 . . . . 50.509999999999998 105.273 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.4 Cg_exo -57.0 136.93 79.63 Favored 'Trans proline' 0 C--O 1.258 1.514 0 C-N-CA 123.228 2.618 . . . . 50.509999999999998 110.838 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.3 Cg_exo -57.18 -32.19 92.77 Favored 'Trans proline' 0 C--O 1.262 1.688 0 O-C-N 122.885 0.939 . . . . 50.509999999999998 113.418 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -89.25 27.57 1.39 Allowed 'General case' 0 C--O 1.262 1.75 0 O-C-N 119.981 -1.699 . . . . 50.619999999999997 115.06 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -137.8 14.03 2.91 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 104.384 -2.45 . . . . 50.549999999999997 104.384 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.513 ' HG2' HD11 ' A' ' 69' ' ' LEU . 58.7 mt-30 -110.39 137.79 47.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.948 -2.242 . . . . 50.549999999999997 104.948 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -131.62 108.88 9.82 Favored 'General case' 0 C--O 1.296 3.537 0 CA-C-O 116.676 -1.63 . . . . 50.640000000000001 112.564 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.0 mt -90.42 131.22 36.31 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 116.63 2.085 . . . . 50.509999999999998 116.63 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.713 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -107.0 137.9 35.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.509999999999998 113.524 -177.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -149.4 112.39 4.87 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 114.55 -1.204 . . . . 50.509999999999998 113.78 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 46.05 27.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.215 -2.266 . . . . 50.509999999999998 113.31 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.93 -6.07 56.63 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 128.384 2.897 . . . . 50.509999999999998 114.763 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -97.47 158.9 15.24 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 117.412 2.375 . . . . 50.509999999999998 117.412 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -96.17 139.96 31.57 Favored 'General case' 0 C--O 1.259 1.554 0 N-CA-C 105.644 -1.984 . . . . 50.549999999999997 105.644 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -95.84 127.79 42.16 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 117.72 -1.133 . . . . 50.509999999999998 112.554 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . 57.5 mt-10 -85.55 139.39 31.49 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.891 1.369 . . . . 50.619999999999997 113.79 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -53.88 -50.21 66.82 Favored 'General case' 0 C--O 1.264 1.86 0 C-N-CA 126.171 1.788 . . . . 50.619999999999997 114.38 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.3 -4.58 44.66 Favored Glycine 0 CA--C 1.493 -1.321 0 C-N-CA 124.457 1.027 . . . . 50.509999999999998 113.999 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.99 150.0 21.63 Favored 'General case' 0 C--O 1.249 1.072 0 O-C-N 119.858 -1.966 . . . . 50.640000000000001 108.92 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -83.47 -179.19 7.29 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.08 0.952 . . . . 50.509999999999998 110.398 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.38 -29.12 31.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.821 -1.548 . . . . 50.509999999999998 106.821 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 m -73.78 -37.37 65.0 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 106.904 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -46.92 -16.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.334 1.064 . . . . 50.619999999999997 112.88 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 91.1 m-85 -121.71 -6.12 9.14 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 113.613 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 66.31 41.65 3.29 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 117.569 2.433 . . . . 50.549999999999997 117.569 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -82.14 124.41 39.15 Favored 'Isoleucine or valine' 0 C--O 1.267 1.978 0 CA-C-O 115.287 -2.292 . . . . 50.509999999999998 110.174 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.67 168.68 9.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 126.018 2.073 . . . . 50.549999999999997 115.893 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -36.54 146.2 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 123.277 1.513 . . . . 50.509999999999998 113.569 -176.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 50.31 34.93 9.63 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-N 112.469 -2.15 . . . . 50.619999999999997 115.885 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 t -76.8 154.07 34.29 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.802 -1.09 . . . . 50.509999999999998 108.659 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 m -119.99 123.6 43.89 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.734 -1.209 . . . . 50.509999999999998 107.734 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.7 mt -94.85 147.88 22.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.696 -2.573 . . . . 50.509999999999998 111.47 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.713 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.0 m-70 -95.93 119.28 34.13 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 127.454 2.971 . . . . 50.509999999999998 108.781 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD11 ' HG2' ' A' ' 41' ' ' GLN . 33.1 tp -98.51 110.53 23.11 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 107.08 -1.452 . . . . 50.509999999999998 107.08 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 44' ' ' ILE . 45.6 t -93.81 165.17 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 101.499 -3.519 . . . . 50.509999999999998 101.499 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.3 mt -117.21 139.98 50.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.884 -0.784 . . . . 50.509999999999998 108.884 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -131.33 91.67 3.06 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-O 113.405 -3.188 . . . . 50.640000000000001 107.094 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -85.15 157.23 20.72 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 125.778 1.924 . . . . 50.509999999999998 110.066 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -90.53 113.2 25.13 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 105.543 -2.021 . . . . 50.640000000000001 105.543 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.65 155.81 14.52 Favored Glycine 0 C--O 1.243 0.682 0 CA-C-N 114.662 -1.154 . . . . 50.509999999999998 113.581 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.323 -2.376 . . . . 50.509999999999998 113.473 179.214 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 106.471 -1.678 . . . . 50.509999999999998 106.471 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.411 ' HG2' ' HG2' ' A' ' 16' ' ' GLU . 82.1 mt-30 -102.5 131.82 48.96 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 126.952 2.658 . . . . 50.549999999999997 108.424 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.73 163.95 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 CA-C-O 115.961 -1.971 . . . . 50.509999999999998 112.534 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.407 ' CD1' HG22 ' A' ' 14' ' ' THR . 79.0 m-85 -108.44 141.51 40.19 Favored 'General case' 0 N--CA 1.511 2.608 1 O-C-N 130.49 4.869 . . . . 50.509999999999998 116.756 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -116.72 120.16 64.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 113.356 -3.212 . . . . 50.509999999999998 106.065 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.32 117.38 34.0 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.326 4.141 . . . . 50.509999999999998 112.825 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 69.4 p -84.54 -174.46 5.28 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 117.774 -1.108 . . . . 50.509999999999998 108.723 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.74 -8.9 58.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.516 2.784 . . . . 50.509999999999998 118.516 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -122.65 22.86 9.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 115.74 -2.384 . . . . 50.509999999999998 116.791 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.03 22.16 21.03 Favored Glycine 0 C--N 1.297 -1.609 0 O-C-N 119.225 -2.172 . . . . 50.509999999999998 118.183 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 80.0 tttt -100.54 124.13 45.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 116.823 -1.56 . . . . 50.509999999999998 108.417 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.47 135.29 53.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 126.668 2.48 . . . . 50.509999999999998 106.369 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.3 pt -123.31 153.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 127.565 3.04 . . . . 50.509999999999998 103.594 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.407 HG22 ' CD1' ' A' ' 4' ' ' PHE . 70.2 p -117.1 139.04 51.2 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 117.266 -1.774 . . . . 50.509999999999998 107.862 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -126.3 137.96 53.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 115.454 -2.212 . . . . 50.509999999999998 107.446 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HG2' ' HG2' ' A' ' 2' ' ' GLN . 46.8 mt-10 -96.24 133.14 40.95 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.231 4.082 . . . . 50.619999999999997 109.407 173.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.42 170.62 19.03 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.631 3.082 . . . . 50.509999999999998 113.57 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -124.09 153.5 68.03 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.215 -2.266 . . . . 50.619999999999997 111.165 174.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.01 -24.5 40.1 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 122.623 2.215 . . . . 50.509999999999998 111.906 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.0 p -89.01 8.32 30.27 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 117.243 2.312 . . . . 50.509999999999998 117.243 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.84 137.73 32.99 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 118.648 2.833 . . . . 50.619999999999997 118.648 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 25' ' ' ASN . 32.8 p -86.89 137.17 32.61 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.834 -0.621 . . . . 50.509999999999998 111.95 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -42.6 -35.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.26 2.85 . . . . 50.509999999999998 112.932 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.47 -11.79 58.73 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.488 -0.757 . . . . 50.619999999999997 111.077 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' THR . 31.3 t30 -108.56 -14.48 14.63 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.251 1.02 . . . . 50.549999999999997 109.814 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.1 t -81.47 -44.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 103.701 -2.703 . . . . 50.509999999999998 103.701 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 50.9 mtmt -66.88 -33.54 75.81 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.769 -0.65 . . . . 50.509999999999998 110.203 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.04 73.88 Favored 'General case' 0 C--O 1.279 2.627 0 N-CA-C 108.324 -0.991 . . . . 50.509999999999998 108.324 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.1 mttt -47.16 -28.35 1.79 Allowed 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.368 -1.458 . . . . 50.509999999999998 113.826 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -80.23 -49.76 18.45 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 C-N-CA 119.496 -0.882 . . . . 50.509999999999998 109.861 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' ILE . 18.0 tm0? -38.63 -51.14 1.64 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 125.572 2.605 . . . . 50.549999999999997 112.061 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -54.69 -39.17 67.87 Favored 'General case' 0 C--O 1.253 1.24 0 N-CA-C 117.499 2.407 . . . . 50.619999999999997 117.499 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -109.59 -7.88 15.06 Favored 'General case' 0 C--O 1.279 2.653 0 C-N-CA 116.425 -2.11 . . . . 50.509999999999998 111.687 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.559 ' HG3' HG12 ' A' ' 36' ' ' ILE . 32.3 tp10 -108.6 -31.54 7.73 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 123.108 2.686 . . . . 50.619999999999997 107.77 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.99 7.4 85.52 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 109.488 -1.445 . . . . 50.509999999999998 109.488 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.559 HG12 ' HG3' ' A' ' 34' ' ' GLU . 30.4 mm -101.65 131.86 22.42 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 102.233 -3.247 . . . . 50.509999999999998 102.233 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.02 136.93 79.62 Favored 'Trans proline' 0 C--O 1.26 1.604 0 C-N-CA 123.192 2.595 . . . . 50.509999999999998 110.908 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.627 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.7 Cg_exo -57.15 -32.16 92.6 Favored 'Trans proline' 0 C--O 1.262 1.677 0 O-C-N 122.846 0.919 . . . . 50.509999999999998 113.44 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.09 2.82 3.22 Favored 'General case' 0 C--O 1.261 1.7 0 O-C-N 119.909 -1.744 . . . . 50.619999999999997 112.957 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -127.58 35.97 4.44 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.59 -1.319 . . . . 50.549999999999997 113.765 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.22 134.71 55.2 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 124.447 2.07 . . . . 50.549999999999997 111.514 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 54.8 ttm-85 -99.94 124.04 44.84 Favored 'General case' 0 C--O 1.298 3.613 0 CA-C-O 116.635 -1.65 . . . . 50.640000000000001 110.22 172.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.23 121.44 42.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.504 1.047 . . . . 50.509999999999998 110.749 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.13 123.39 60.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 125.174 1.546 . . . . 50.509999999999998 113.674 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.77 112.21 17.05 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 114.616 -1.175 . . . . 50.509999999999998 110.196 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.68 27.8 7.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 112.24 -2.254 . . . . 50.509999999999998 110.586 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.97 33.26 59.9 Favored Glycine 0 C--N 1.3 -1.453 0 C-N-CA 128.411 2.91 . . . . 50.509999999999998 117.476 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -119.03 148.88 42.53 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 104.741 -2.318 . . . . 50.509999999999998 104.741 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -88.04 135.75 33.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 119.797 3.258 . . . . 50.549999999999997 119.797 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.38 155.5 16.71 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 101.484 -3.525 . . . . 50.509999999999998 101.484 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -130.71 157.19 43.47 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 125.02 1.45 . . . . 50.619999999999997 108.242 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.01 -34.92 77.41 Favored 'General case' 0 C--O 1.264 1.833 0 C-N-CA 126.19 1.796 . . . . 50.619999999999997 109.38 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.39 9.21 4.58 Favored Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 124.426 1.013 . . . . 50.509999999999998 113.156 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -124.29 162.56 23.49 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 120.941 3.682 . . . . 50.640000000000001 120.941 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -80.43 173.76 12.28 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.028 0.931 . . . . 50.509999999999998 109.419 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 tp -88.85 -20.14 25.01 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.04 -1.096 . . . . 50.509999999999998 108.04 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 m -79.56 -36.69 37.87 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.362 -1.735 . . . . 50.509999999999998 112.665 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -53.13 -17.26 1.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 117.082 2.253 . . . . 50.619999999999997 117.082 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -93.38 12.0 26.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.823 -1.084 . . . . 50.509999999999998 110.836 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.37 33.08 3.59 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 116.533 2.049 . . . . 50.549999999999997 116.533 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -82.26 114.8 23.71 Favored 'Isoleucine or valine' 0 C--O 1.265 1.907 0 CA-C-O 115.268 -2.301 . . . . 50.509999999999998 112.346 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -110.33 -166.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.125 2.141 . . . . 50.549999999999997 111.126 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 78.7 tttt -74.16 134.65 42.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.177 1.465 . . . . 50.509999999999998 108.792 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 53.0 mt-10 67.55 44.23 1.75 Allowed 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.537 -2.12 . . . . 50.619999999999997 114.35 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -88.21 167.28 13.72 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 105.464 -2.05 . . . . 50.509999999999998 105.464 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -121.35 112.31 18.41 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 118.253 -0.879 . . . . 50.509999999999998 110.982 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.3 mt -99.7 141.68 32.18 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.729 -2.558 . . . . 50.509999999999998 109.56 175.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -95.1 134.81 37.4 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.347 2.905 . . . . 50.509999999999998 111.788 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -105.31 114.98 29.49 Favored 'General case' 0 C--O 1.283 2.861 0 CA-C-O 117.611 -1.185 . . . . 50.509999999999998 110.902 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.7 t -104.83 137.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.171 -1.788 . . . . 50.509999999999998 106.171 175.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.0 tp -79.86 128.68 33.74 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.252 0.549 . . . . 50.509999999999998 110.331 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 -103.28 107.41 18.22 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-O 113.428 -3.177 . . . . 50.640000000000001 110.041 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.92 143.1 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 125.791 1.932 . . . . 50.509999999999998 109.533 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -105.51 59.95 0.67 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.743 -1.571 . . . . 50.640000000000001 110.21 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.96 153.21 5.84 Favored Glycine 0 C--O 1.243 0.707 0 N-CA-C 107.926 -2.069 . . . . 50.509999999999998 107.926 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 CA-C-O 116.349 -2.362 . . . . 50.509999999999998 107.227 179.226 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 101.783 -3.414 . . . . 50.509999999999998 101.783 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -110.85 138.34 47.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 126.95 2.656 . . . . 50.549999999999997 105.433 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -133.07 155.69 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 115.928 -1.987 . . . . 50.509999999999998 113.867 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -93.63 144.41 25.41 Favored 'General case' 0 N--CA 1.512 2.663 1 O-C-N 130.442 4.839 . . . . 50.509999999999998 118.789 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.772 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.6 t -132.53 101.96 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.364 -3.208 . . . . 50.509999999999998 110.123 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.92 117.99 21.28 Favored 'General case' 0 N--CA 1.504 2.231 1 O-C-N 129.362 4.164 . . . . 50.509999999999998 117.225 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 11' ' ' LYS . 41.7 p -70.83 -172.72 0.69 Allowed 'General case' 0 C--N 1.351 0.673 0 N-CA-C 114.893 1.442 . . . . 50.509999999999998 114.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.78 11.78 38.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.854 -1.906 . . . . 50.509999999999998 105.854 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -122.45 -3.22 8.89 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 115.737 -2.385 . . . . 50.509999999999998 114.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 6.76 22.04 Favored Glycine 0 C--N 1.296 -1.665 0 O-C-N 120.103 -1.623 . . . . 50.509999999999998 113.617 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 45.0 mtmt -92.66 166.73 12.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 118.445 2.758 . . . . 50.509999999999998 118.445 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.0 p -125.15 158.69 33.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 126.658 2.474 . . . . 50.509999999999998 105.676 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.772 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 72.3 mt -131.27 111.18 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 127.415 2.947 . . . . 50.509999999999998 104.716 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -90.75 110.97 22.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.809 1.781 . . . . 50.509999999999998 115.809 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.3 mt -105.77 155.55 19.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 115.483 -2.198 . . . . 50.509999999999998 112.153 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.05 112.33 23.88 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 128.9 3.875 . . . . 50.619999999999997 112.23 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -117.25 169.45 7.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 O-C-N 127.743 3.152 . . . . 50.509999999999998 113.998 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -126.58 158.33 67.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 112.156 -2.293 . . . . 50.619999999999997 108.288 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 57' ' ' SER . 85.1 Cg_exo -54.93 -24.56 39.81 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.54 2.16 . . . . 50.509999999999998 111.969 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -87.09 -18.39 30.63 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 116.415 2.005 . . . . 50.509999999999998 116.415 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -70.86 135.73 48.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.898 1.814 . . . . 50.619999999999997 115.898 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.591 HG22 HG22 ' A' ' 55' ' ' THR . 72.3 p -78.85 168.42 19.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.947 1.832 . . . . 50.509999999999998 115.947 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 33.8 mm -62.69 -40.62 89.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 O-C-N 127.239 2.837 . . . . 50.509999999999998 109.34 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.94 -27.87 46.73 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 50.619999999999997 112.809 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.4 -27.85 20.15 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 114.84 1.422 . . . . 50.549999999999997 114.84 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.7 -41.63 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.024 1.453 . . . . 50.509999999999998 107.155 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -64.62 -28.0 69.32 Favored 'General case' 0 C--O 1.258 1.524 0 CA-C-N 115.845 -0.616 . . . . 50.509999999999998 111.524 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -29.6 59.73 Favored 'General case' 0 C--O 1.279 2.637 0 CA-C-N 118.088 0.404 . . . . 50.509999999999998 111.599 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.37 -31.34 69.67 Favored 'General case' 0 C--O 1.256 1.401 0 O-C-N 120.319 -1.488 . . . . 50.509999999999998 108.493 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.0 -34.67 71.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 107.091 -1.448 . . . . 50.509999999999998 107.091 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -56.36 -53.56 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 125.579 2.609 . . . . 50.549999999999997 117.578 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.28 -34.27 70.35 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 113.622 -1.626 . . . . 50.619999999999997 111.243 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.17 -28.57 21.13 Favored 'General case' 0 C--O 1.278 2.593 0 C-N-CA 116.434 -2.106 . . . . 50.509999999999998 109.737 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -117.22 -77.26 0.57 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 123.035 2.652 . . . . 50.619999999999997 109.059 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.09 23.51 0.48 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.572 -1.811 . . . . 50.509999999999998 108.572 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.7 mt -79.4 133.5 59.94 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.81 -1.156 . . . . 50.509999999999998 112.335 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.03 136.93 79.61 Favored 'Trans proline' 0 C--O 1.26 1.592 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.914 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.2 -32.1 92.53 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.857 0.925 . . . . 50.509999999999998 113.449 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 40' ' ' GLN . 6.9 p30 -76.71 -9.23 58.53 Favored 'General case' 0 C--O 1.262 1.746 0 O-C-N 119.94 -1.725 . . . . 50.619999999999997 109.297 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.427 ' HG3' ' OD1' ' A' ' 39' ' ' ASP . 79.9 mt-30 -103.01 19.06 20.22 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.422 1.638 . . . . 50.549999999999997 115.422 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -127.93 102.04 6.59 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 116.638 2.088 . . . . 50.549999999999997 116.638 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -99.35 132.51 44.63 Favored 'General case' 0 C--O 1.296 3.531 0 CA-C-O 116.742 -1.599 . . . . 50.640000000000001 109.381 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 mp -103.94 154.75 19.29 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.287 -2.486 . . . . 50.509999999999998 104.287 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.07 142.1 35.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.509999999999998 111.087 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -142.66 91.3 2.3 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 114.534 -1.212 . . . . 50.509999999999998 113.345 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.9 45.6 26.18 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 104.461 -2.422 . . . . 50.509999999999998 104.461 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 -18.13 6.99 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 128.386 2.898 . . . . 50.509999999999998 113.034 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -76.59 135.75 39.22 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 118.102 0.951 . . . . 50.509999999999998 111.418 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.85 129.22 35.14 Favored 'General case' 0 C--O 1.259 1.558 0 O-C-N 123.957 0.785 . . . . 50.549999999999997 110.968 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.8 mt -78.65 145.65 34.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 101.906 -3.368 . . . . 50.509999999999998 101.906 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -97.99 135.88 39.05 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.939 1.399 . . . . 50.619999999999997 108.538 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.5 m-20 -53.66 -49.59 67.63 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 126.151 1.78 . . . . 50.619999999999997 111.919 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.93 19.46 5.21 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.4 1.0 . . . . 50.509999999999998 113.9 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -113.0 156.69 22.61 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 103.069 -2.937 . . . . 50.640000000000001 103.069 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.591 HG22 HG22 ' A' ' 22' ' ' THR . 81.0 p -95.67 168.51 10.63 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.606 0.965 . . . . 50.509999999999998 113.606 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.16 -32.19 70.03 Favored 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.15 0.907 . . . . 50.509999999999998 109.358 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 90.9 p -74.13 -29.08 61.64 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.271 -1.772 . . . . 50.509999999999998 112.149 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.71 -29.33 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.431 1.11 . . . . 50.619999999999997 108.676 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -94.19 -5.21 47.54 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.809 -1.091 . . . . 50.509999999999998 112.291 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 53.93 51.33 14.94 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 121.552 1.978 . . . . 50.549999999999997 113.882 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -95.53 119.2 43.26 Favored 'Isoleucine or valine' 0 C--O 1.266 1.952 0 N-CA-C 102.218 -3.253 . . . . 50.509999999999998 102.218 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 -168.83 2.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.019 2.075 . . . . 50.549999999999997 111.213 -176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.635 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 84.2 tttt -79.07 143.76 35.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.185 1.469 . . . . 50.509999999999998 107.558 -176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.635 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 69.66 37.56 1.87 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.559 -2.109 . . . . 50.619999999999997 113.62 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -92.42 155.48 17.84 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.809 -1.087 . . . . 50.509999999999998 111.994 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -110.27 126.49 54.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 118.199 -0.905 . . . . 50.509999999999998 112.717 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.11 155.52 21.8 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 114.679 -2.581 . . . . 50.509999999999998 104.356 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -98.0 149.88 21.97 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 127.177 2.798 . . . . 50.509999999999998 112.998 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -102.2 126.68 49.25 Favored 'General case' 0 C--O 1.283 2.849 0 N-CA-C 104.9 -2.259 . . . . 50.509999999999998 104.9 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.63 146.24 28.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 105.861 -1.903 . . . . 50.509999999999998 105.861 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -114.09 107.57 15.83 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 119.869 3.285 . . . . 50.509999999999998 119.869 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -92.07 111.1 22.52 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.324 -3.227 . . . . 50.640000000000001 104.249 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.52 167.66 14.41 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 125.576 1.798 . . . . 50.509999999999998 110.907 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.0 mtm105 -102.85 86.42 2.73 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.72 -1.582 . . . . 50.640000000000001 108.321 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.95 147.51 22.78 Favored Glycine 0 C--O 1.244 0.726 0 CA-C-N 114.678 -1.146 . . . . 50.509999999999998 114.436 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.457 0 N-CA-C 106.023 -2.831 . . . . 50.509999999999998 106.023 179.232 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.458 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.547 0.86 0 CA-C-O 118.822 -0.609 . . . . 50.509999999999998 111.147 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -96.39 128.69 43.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 126.959 2.662 . . . . 50.549999999999997 113.368 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.67 152.44 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 115.972 -1.966 . . . . 50.509999999999998 107.561 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CD1' HG22 ' A' ' 14' ' ' THR . 97.3 m-85 -109.53 143.06 39.71 Favored 'General case' 0 N--CA 1.512 2.658 1 O-C-N 130.215 4.697 . . . . 50.509999999999998 115.202 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.12 98.18 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-O 113.425 -3.179 . . . . 50.509999999999998 113.771 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -72.86 114.92 11.54 Favored 'General case' 0 N--CA 1.503 2.224 1 O-C-N 129.297 4.123 . . . . 50.509999999999998 109.929 -178.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.44 ' HA ' HD23 ' A' ' 69' ' ' LEU . 68.7 p -72.04 -169.8 0.52 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-O 117.829 -1.081 . . . . 50.509999999999998 113.236 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.34 -47.1 7.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.756 -1.201 . . . . 50.509999999999998 107.756 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -70.59 2.17 4.37 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 115.732 -2.387 . . . . 50.509999999999998 115.586 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.81 -40.67 2.38 Favored Glycine 0 C--N 1.298 -1.541 0 N-CA-C 120.892 3.117 . . . . 50.509999999999998 120.892 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -42.09 131.33 3.48 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 116.902 -1.523 . . . . 50.509999999999998 108.125 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.0 p -101.59 138.15 38.97 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 126.623 2.452 . . . . 50.509999999999998 112.184 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 pt -120.16 146.79 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 127.507 3.004 . . . . 50.509999999999998 109.399 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.443 HG22 ' CD1' ' A' ' 4' ' ' PHE . 80.8 p -120.6 128.03 52.66 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.249 -1.78 . . . . 50.509999999999998 109.583 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 29' ' ' LYS . 50.0 mt -103.8 148.48 26.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 115.542 -2.171 . . . . 50.509999999999998 110.37 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -106.41 103.2 12.61 Favored 'General case' 0 N--CA 1.501 2.089 1 O-C-N 129.28 4.112 . . . . 50.619999999999997 104.954 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 1' ' ' MET . 33.7 m -101.65 164.54 2.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.69 3.119 . . . . 50.509999999999998 112.915 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.411 ' HG3' ' HB2' ' A' ' 21' ' ' ASP . 6.4 pt-20 -137.33 151.33 71.23 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.164 -2.289 . . . . 50.619999999999997 112.798 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.97 -24.5 39.77 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 122.587 2.191 . . . . 50.509999999999998 111.949 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -98.38 21.85 10.51 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 118.208 -0.901 . . . . 50.509999999999998 110.829 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 8.4 t70 -94.57 125.42 39.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 117.354 -1.738 . . . . 50.619999999999997 111.189 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.3 p -82.82 135.01 35.09 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.865 -0.607 . . . . 50.509999999999998 110.908 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.491 HG21 ' HA ' ' A' ' 52' ' ' ASP . 55.6 mt -37.56 -30.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.137 2.773 . . . . 50.509999999999998 117.552 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.21 -27.85 69.34 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.422 -0.798 . . . . 50.619999999999997 112.203 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.617 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 57.4 m-80 -86.08 -13.14 48.18 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.309 1.044 . . . . 50.549999999999997 112.4 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -78.18 -51.99 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.041 1.463 . . . . 50.509999999999998 110.256 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 91.5 mttt -58.04 -23.67 55.31 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.174 -0.676 . . . . 50.509999999999998 109.174 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.06 -34.79 17.84 Favored 'General case' 0 C--O 1.278 2.598 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 57.9 mttm -52.26 -38.62 58.72 Favored 'General case' 0 C--O 1.257 1.459 0 N-CA-C 106.291 -1.744 . . . . 50.509999999999998 106.291 175.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.9 -33.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 107.56 -1.274 . . . . 50.509999999999998 107.56 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 125.583 2.611 . . . . 50.549999999999997 113.525 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -58.36 -25.57 62.15 Favored 'General case' 0 C--O 1.254 1.322 0 N-CA-C 119.087 2.995 . . . . 50.619999999999997 119.087 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -108.81 -27.25 9.86 Favored 'General case' 0 C--O 1.28 2.659 0 C-N-CA 116.385 -2.126 . . . . 50.509999999999998 113.917 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -108.75 -29.15 8.83 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.056 2.662 . . . . 50.619999999999997 113.529 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.94 42.88 4.59 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 111.247 -0.741 . . . . 50.509999999999998 111.247 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 94.4 mt -117.95 125.2 28.15 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.597 -1.261 . . . . 50.509999999999998 107.597 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.05 136.97 79.82 Favored 'Trans proline' 0 C--O 1.259 1.559 0 C-N-CA 123.106 2.537 . . . . 50.509999999999998 110.95 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 85.9 Cg_exo -57.17 -32.07 92.37 Favored 'Trans proline' 0 C--O 1.26 1.619 0 O-C-N 122.828 0.909 . . . . 50.509999999999998 113.51 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.26 -20.35 64.16 Favored 'General case' 0 C--O 1.262 1.756 0 O-C-N 119.982 -1.699 . . . . 50.619999999999997 109.542 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -94.89 7.48 45.85 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.526 -1.358 . . . . 50.549999999999997 113.45 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -115.87 119.32 35.58 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 110.925 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.469 HH11 ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp85 -106.33 138.18 42.97 Favored 'General case' 0 C--O 1.295 3.486 0 CA-C-O 116.651 -1.642 . . . . 50.640000000000001 107.716 172.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.9 mt -115.2 105.97 13.53 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.987 1.847 . . . . 50.509999999999998 115.987 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 61.5 mt -110.55 130.37 63.98 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 O-C-N 125.254 1.596 . . . . 50.509999999999998 111.633 -177.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -145.83 126.01 13.82 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 115.293 1.59 . . . . 50.509999999999998 115.293 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.11 28.24 17.02 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.261 -2.245 . . . . 50.509999999999998 107.43 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.7 30.41 77.25 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 128.37 2.89 . . . . 50.509999999999998 111.595 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.48 135.6 53.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.455 -2.054 . . . . 50.509999999999998 105.455 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.35 113.9 9.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.946 0.779 . . . . 50.549999999999997 111.186 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.503 HD22 ' CE2' ' A' ' 59' ' ' TYR . 37.5 mt -75.49 113.84 13.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 117.722 -1.132 . . . . 50.509999999999998 112.296 -175.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -89.53 126.08 35.45 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.822 1.326 . . . . 50.619999999999997 109.598 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' HA ' HG21 ' A' ' 23' ' ' ILE . 27.7 p-10 -45.36 -38.93 6.28 Favored 'General case' 0 C--O 1.263 1.805 0 C-N-CA 126.14 1.776 . . . . 50.619999999999997 111.549 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.52 37.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 108.655 -1.778 . . . . 50.509999999999998 108.655 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -94.64 165.67 12.39 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 119.949 -1.912 . . . . 50.640000000000001 115.838 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -99.87 166.08 11.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.152 -1.055 . . . . 50.509999999999998 108.152 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -86.43 -39.72 16.07 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 104.193 -2.521 . . . . 50.509999999999998 104.193 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -52.64 -53.04 52.47 Favored 'General case' 0 C--O 1.268 2.058 0 C-N-CA 117.356 -1.738 . . . . 50.509999999999998 113.979 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.42 -28.28 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 120.635 3.568 . . . . 50.619999999999997 120.635 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.503 ' CE2' HD22 ' A' ' 50' ' ' LEU . 42.2 m-85 -82.1 13.1 3.61 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.764 -1.112 . . . . 50.509999999999998 109.511 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.57 32.26 20.38 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 121.442 1.928 . . . . 50.549999999999997 108.95 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.71 133.1 30.14 Favored 'Isoleucine or valine' 0 C--O 1.267 1.989 0 CA-C-O 115.146 -2.359 . . . . 50.509999999999998 113.362 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.406 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 57.7 mt-30 -134.81 -159.34 0.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 125.856 1.972 . . . . 50.549999999999997 110.636 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 63.2 tttm -69.15 149.88 48.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.257 1.503 . . . . 50.509999999999998 109.628 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.627 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 47.67 65.48 1.27 Allowed 'General case' 0 C--O 1.257 1.45 0 CA-C-N 112.42 -2.173 . . . . 50.619999999999997 113.981 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -122.97 125.57 45.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.921 -1.141 . . . . 50.509999999999998 107.921 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -81.67 133.68 35.39 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 117.186 2.291 . . . . 50.509999999999998 117.186 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.32 135.88 48.08 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 114.688 -2.577 . . . . 50.509999999999998 114.45 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.546 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -71.55 133.0 45.48 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 127.365 2.915 . . . . 50.509999999999998 115.619 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 7' ' ' THR . 30.6 tp -104.95 96.99 6.92 Favored 'General case' 0 C--O 1.282 2.809 0 N-CA-C 115.792 1.775 . . . . 50.509999999999998 115.792 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.53 123.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.857 -1.164 . . . . 50.509999999999998 107.857 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt -73.12 159.23 33.87 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.946 1.091 . . . . 50.509999999999998 113.946 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.469 ' HD2' HH11 ' A' ' 42' ' ' ARG . 77.8 ttt-85 -136.96 77.19 1.63 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 113.404 -3.188 . . . . 50.640000000000001 111.964 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.42 155.34 15.09 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 116.795 2.146 . . . . 50.509999999999998 116.795 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -110.39 85.53 2.13 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.714 -1.585 . . . . 50.640000000000001 107.073 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.26 160.9 13.61 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 107.691 -2.164 . . . . 50.509999999999998 107.691 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 CA-C-O 116.308 -2.385 . . . . 50.509999999999998 110.446 179.174 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.549999999999997 105.792 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.509999999999998 105.226 173.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.509999999999998 111.097 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.509999999999998 110.321 175.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.509999999999998 108.6 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 113.379 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.509999999999998 115.964 -177.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.509999999999998 111.276 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.509999999999998 114.048 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.509999999999998 102.065 174.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.509999999999998 107.975 176.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.509999999999998 108.441 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 110.2 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.447 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.509999999999998 118.562 -179.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.619999999999997 108.62 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.509999999999998 114.132 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.619999999999997 106.711 174.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.509999999999998 111.935 177.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.509999999999998 116.813 -177.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.619999999999997 109.138 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.509999999999998 107.045 175.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.509999999999998 110.561 175.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.619999999999997 113.229 177.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.549999999999997 110.044 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.509999999999998 107.759 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.509999999999998 106.412 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.509999999999998 109.249 176.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.509999999999998 111.346 176.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.447 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.509999999999998 110.973 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.549999999999997 112.509 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.619999999999997 116.389 179.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.509999999999998 111.864 -175.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 117.592 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.509999999999998 114.888 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.509999999999998 109.747 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.509999999999998 110.864 178.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.394 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.619999999999997 114.605 -177.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.637 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.549999999999997 107.838 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.549999999999997 119.467 -177.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.640000000000001 109.52 172.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.509999999999998 115.444 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.509999999999998 113.347 -177.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.509999999999998 111.83 177.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 113.518 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.509999999999998 115.209 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.509999999999998 114.25 177.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.549999999999997 117.72 174.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.509999999999998 119.412 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.619999999999997 106.675 -177.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.619999999999997 118.064 -175.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.509999999999998 112.981 -177.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.640000000000001 112.921 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.509999999999998 106.383 177.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.509999999999998 114.586 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.509999999999998 111.793 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.619999999999997 114.68 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.509999999999998 113.892 179.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.549999999999997 110.922 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.509999999999998 112.515 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.549999999999997 116.774 -176.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.509999999999998 113.522 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.619999999999997 110.901 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.509999999999998 110.249 174.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.509999999999998 101.589 175.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.509999999999998 106.251 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 71' ' ' LEU . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.509999999999998 111.961 176.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.509999999999998 104.421 175.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.509999999999998 115.767 178.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.640000000000001 106.516 177.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' HE21 ' A' ' 40' ' ' GLN . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.509999999999998 105.632 -179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.640000000000001 107.378 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.509999999999998 119.036 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.509999999999998 104.312 179.258 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.549999999999997 105.792 178.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.509999999999998 105.226 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.509999999999998 111.097 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.509999999999998 110.321 175.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.509999999999998 108.6 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 113.379 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.509999999999998 115.964 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.509999999999998 111.276 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.509999999999998 114.048 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.509999999999998 102.065 174.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.509999999999998 107.975 176.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.509999999999998 108.441 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 110.2 178.106 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.447 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.509999999999998 118.562 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.619999999999997 108.62 174.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.509999999999998 114.132 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.619999999999997 106.711 174.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.509999999999998 111.935 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.509999999999998 116.813 -177.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.619999999999997 109.138 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.509999999999998 107.045 175.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.509999999999998 110.561 175.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.619999999999997 113.229 177.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.549999999999997 110.044 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.509999999999998 107.759 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.509999999999998 106.412 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.509999999999998 109.249 176.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.509999999999998 111.346 176.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.447 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.509999999999998 110.973 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.549999999999997 112.509 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.619999999999997 116.389 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.509999999999998 111.864 -175.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 117.592 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.509999999999998 114.888 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.509999999999998 109.747 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.509999999999998 110.864 178.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.394 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.619999999999997 114.605 -177.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.637 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.549999999999997 107.838 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.549999999999997 119.467 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.640000000000001 109.52 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.509999999999998 115.444 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.509999999999998 113.347 -177.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.509999999999998 111.83 177.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 113.518 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.509999999999998 115.209 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.509999999999998 114.25 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.549999999999997 117.72 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.509999999999998 119.412 -175.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.619999999999997 106.675 -177.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.619999999999997 118.064 -175.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.509999999999998 112.981 -177.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.640000000000001 112.921 176.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.509999999999998 106.383 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.509999999999998 114.586 177.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.509999999999998 111.793 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.619999999999997 114.68 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.509999999999998 113.892 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.549999999999997 110.922 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.509999999999998 112.515 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.549999999999997 116.774 -176.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.509999999999998 113.522 -176.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.619999999999997 110.901 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.509999999999998 110.249 174.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 176.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.509999999999998 101.589 175.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.509999999999998 106.251 177.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 71' ' ' LEU . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.509999999999998 111.961 176.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.509999999999998 104.421 175.142 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.509999999999998 115.767 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.640000000000001 106.516 177.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' HE21 ' A' ' 40' ' ' GLN . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.509999999999998 105.632 -179.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.640000000000001 107.378 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.509999999999998 119.036 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.509999999999998 104.312 179.258 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.0 mtp . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 115.228 1.566 . . . . 50.509999999999998 115.228 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -88.72 118.09 28.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 126.99 2.681 . . . . 50.549999999999997 117.707 178.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.523 HD11 HD22 ' A' ' 67' ' ' LEU . 14.7 tt -122.01 161.57 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 115.935 -1.983 . . . . 50.509999999999998 109.47 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.421 ' N ' HG12 ' A' ' 3' ' ' ILE . 79.1 m-85 -130.3 128.98 42.63 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 129.667 4.354 . . . . 50.509999999999998 113.461 179.548 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -108.91 109.82 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 113.419 -3.182 . . . . 50.509999999999998 112.584 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -87.2 134.28 33.55 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.371 4.169 . . . . 50.509999999999998 106.23 -178.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.1 p -99.77 -168.47 1.61 Allowed 'General case' 0 C--N 1.351 0.651 0 N-CA-C 114.385 1.254 . . . . 50.509999999999998 114.385 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 mt -90.15 24.27 2.56 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.125 0.891 . . . . 50.509999999999998 111.979 -178.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -139.79 10.95 2.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 115.747 -2.381 . . . . 50.509999999999998 110.231 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.83 12.66 81.04 Favored Glycine 0 C--N 1.297 -1.604 0 O-C-N 119.303 -2.123 . . . . 50.509999999999998 114.738 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.64 139.47 30.66 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.533 -2.025 . . . . 50.509999999999998 105.533 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -120.9 119.62 33.14 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 126.586 2.429 . . . . 50.509999999999998 112.064 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.411 HD12 HD11 ' A' ' 15' ' ' LEU . 17.1 pt -94.75 144.3 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.346 2.904 . . . . 50.509999999999998 116.312 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -100.32 128.79 46.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.313 -1.755 . . . . 50.509999999999998 114.569 178.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD11 HD12 ' A' ' 13' ' ' ILE . 1.5 mp -114.24 145.23 42.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 115.463 -2.208 . . . . 50.509999999999998 116.629 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.15 89.58 3.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 129.065 3.978 . . . . 50.619999999999997 116.324 173.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.441 HG11 HG22 ' A' ' 26' ' ' VAL . 35.0 m -120.79 148.17 24.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 N-CA-C 120.095 3.368 . . . . 50.509999999999998 120.095 -177.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.65 151.47 37.46 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 112.198 -2.274 . . . . 50.619999999999997 111.017 174.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.89 -24.55 39.49 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.562 2.175 . . . . 50.509999999999998 111.962 177.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -73.23 -13.09 61.08 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.487 -2.042 . . . . 50.509999999999998 105.487 -177.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.531 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 75.6 m-20 -68.64 138.49 55.05 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 117.323 -1.751 . . . . 50.619999999999997 115.301 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -106.3 174.16 6.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.853 -0.612 . . . . 50.509999999999998 109.689 175.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -51.18 -46.66 32.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 O-C-N 127.138 2.774 . . . . 50.509999999999998 111.886 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -51.8 -38.13 54.43 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.802 -0.814 . . . . 50.619999999999997 108.802 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -79.53 -41.47 27.25 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 120.185 3.402 . . . . 50.549999999999997 120.185 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.441 HG22 HG11 ' A' ' 17' ' ' VAL . 40.6 t -72.71 -44.32 59.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.085 1.491 . . . . 50.509999999999998 114.531 178.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.87 -29.94 68.35 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 107.787 -1.19 . . . . 50.509999999999998 107.787 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -49.2 77.73 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 108.517 -0.919 . . . . 50.509999999999998 108.517 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -44.95 -53.77 7.28 Favored 'General case' 0 C--O 1.255 1.361 0 O-C-N 120.396 -1.44 . . . . 50.509999999999998 109.322 176.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -57.96 -25.23 25.4 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 116.219 1.933 . . . . 50.509999999999998 116.219 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.439 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.9 tt0 -75.47 -19.66 59.29 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 125.587 2.613 . . . . 50.549999999999997 111.862 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.51 -45.28 8.2 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 113.589 -1.641 . . . . 50.619999999999997 113.724 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.93 -51.04 10.19 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.476 -2.09 . . . . 50.509999999999998 107.665 -175.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -91.97 -56.33 3.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.131 2.696 . . . . 50.619999999999997 110.814 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 120.17 4.21 11.33 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 111.616 -0.594 . . . . 50.509999999999998 111.616 176.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mm -69.44 123.05 87.61 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 118.852 -1.139 . . . . 50.509999999999998 109.38 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -57.02 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.539 0 C-N-CA 123.203 2.602 . . . . 50.509999999999998 110.846 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_exo -57.21 -32.09 92.53 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.914 0.955 . . . . 50.509999999999998 113.422 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -73.67 2.26 8.53 Favored 'General case' 0 C--O 1.261 1.675 0 N-CA-C 118.375 2.731 . . . . 50.619999999999997 118.375 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -115.69 -9.23 11.98 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.536 -1.352 . . . . 50.549999999999997 108.153 178.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -81.25 143.28 32.4 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 124.384 2.04 . . . . 50.549999999999997 115.24 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -131.95 114.78 15.03 Favored 'General case' 0 C--O 1.296 3.506 0 N-CA-C 105.833 -1.914 . . . . 50.640000000000001 105.833 172.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 50' ' ' LEU . 95.5 mt -107.32 123.89 49.0 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.539 1.063 . . . . 50.509999999999998 111.324 -177.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.08 132.63 61.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 O-C-N 125.174 1.546 . . . . 50.509999999999998 112.57 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.56 ' CE2' HG12 ' A' ' 61' ' ' ILE . 45.2 t80 -142.33 112.61 7.1 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 114.575 -1.193 . . . . 50.509999999999998 108.987 177.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 75.64 18.64 2.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 112.227 -2.26 . . . . 50.509999999999998 108.501 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.3 -2.01 85.84 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.431 2.92 . . . . 50.509999999999998 110.513 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -85.66 121.55 28.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 118.045 0.923 . . . . 50.509999999999998 111.156 177.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -61.93 137.71 58.28 Favored 'General case' 0 C--O 1.26 1.61 0 N-CA-C 108.169 -1.049 . . . . 50.549999999999997 108.169 174.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 43' ' ' LEU . 37.5 mt -75.4 149.19 38.65 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.543 -1.28 . . . . 50.509999999999998 107.543 -175.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.15 150.89 28.83 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.996 1.435 . . . . 50.619999999999997 112.497 -177.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.99 -41.26 78.11 Favored 'General case' 0 C--O 1.264 1.826 0 N-CA-C 118.347 2.721 . . . . 50.619999999999997 118.347 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.41 5.0 67.34 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 120.212 2.845 . . . . 50.509999999999998 120.212 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.47 154.37 19.69 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 120.089 3.366 . . . . 50.640000000000001 120.089 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 41.5 p -93.09 151.9 19.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.39 -3.189 . . . . 50.509999999999998 102.39 177.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.4 mt -56.28 -36.58 68.77 Favored 'General case' 0 C--O 1.202 -1.425 0 O-C-N 124.19 0.931 . . . . 50.509999999999998 108.894 177.2 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -62.04 -31.07 71.44 Favored 'General case' 0 C--O 1.268 2.065 0 C-N-CA 117.331 -1.747 . . . . 50.509999999999998 109.04 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 55' ' ' THR . 88.7 m-20 -60.42 -10.17 4.54 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.405 1.098 . . . . 50.619999999999997 111.684 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -114.16 -14.9 12.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.094 -1.817 . . . . 50.509999999999998 106.094 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 48.44 56.77 7.03 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 121.522 1.965 . . . . 50.549999999999997 110.701 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.56 HG12 ' CE2' ' A' ' 45' ' ' PHE . 74.1 mt -78.33 105.95 8.25 Favored 'Isoleucine or valine' 0 C--O 1.267 1.997 0 N-CA-C 102.936 -2.987 . . . . 50.509999999999998 102.936 175.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.77 176.21 3.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 126.1 2.125 . . . . 50.549999999999997 107.713 -176.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -70.73 147.1 49.39 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 123.205 1.478 . . . . 50.509999999999998 110.572 -176.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 54.02 44.84 28.72 Favored 'General case' 0 C--O 1.258 1.526 0 CA-C-N 112.521 -2.127 . . . . 50.619999999999997 112.894 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -106.87 142.26 36.79 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.157 -1.794 . . . . 50.509999999999998 106.157 174.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.0 m -101.25 130.24 47.35 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 120.454 3.501 . . . . 50.509999999999998 120.454 175.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 3' ' ' ILE . 2.7 mp -95.38 149.7 21.08 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.68 -2.581 . . . . 50.509999999999998 114.761 175.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -102.31 132.93 47.97 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 126.969 2.668 . . . . 50.509999999999998 114.743 177.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -104.48 122.35 45.35 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.685 -1.15 . . . . 50.509999999999998 111.321 176.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -113.09 135.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.571 -1.641 . . . . 50.509999999999998 106.571 175.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.8 tp -93.83 100.11 12.36 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.497 1.666 . . . . 50.509999999999998 115.497 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -74.84 138.56 42.61 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 113.316 -3.231 . . . . 50.640000000000001 108.215 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 mt -111.86 139.2 47.54 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.804 1.94 . . . . 50.509999999999998 113.237 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -96.15 68.19 2.65 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 113.69 -1.596 . . . . 50.640000000000001 106.907 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.65 148.17 4.85 Favored Glycine 0 C--O 1.244 0.76 0 N-CA-C 107.145 -2.382 . . . . 50.509999999999998 107.145 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 116.361 -2.355 . . . . 50.509999999999998 110.4 179.246 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.877 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 61.2 mtm . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 105.248 -2.13 . . . . 50.509999999999998 105.248 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -70.42 144.62 51.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 127.003 2.689 . . . . 50.549999999999997 108.922 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.454 HD12 HD13 ' A' ' 67' ' ' LEU . 21.7 pt -132.24 164.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 N-CA-C 104.099 -2.556 . . . . 50.509999999999998 104.099 173.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.25 156.01 22.11 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.473 4.858 . . . . 50.509999999999998 109.296 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 67' ' ' LEU . 86.0 t -138.52 122.18 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.37 -3.205 . . . . 50.509999999999998 109.203 175.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 79.1 tttt -94.94 128.6 41.86 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.403 4.19 . . . . 50.509999999999998 114.904 -178.047 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.08 179.23 4.68 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-O 117.809 -1.091 . . . . 50.509999999999998 108.425 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.7 -12.19 58.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.93 2.937 . . . . 50.509999999999998 118.93 -177.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -90.48 -24.98 20.53 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 115.705 -2.398 . . . . 50.509999999999998 105.345 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.23 23.78 3.73 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 107.538 -2.225 . . . . 50.509999999999998 107.538 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -86.06 144.22 27.67 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.568 -2.012 . . . . 50.509999999999998 105.568 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.2 m -128.44 117.77 21.95 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 126.629 2.456 . . . . 50.509999999999998 110.992 176.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.7 pt -98.57 164.85 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 127.469 2.981 . . . . 50.509999999999998 113.557 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.6 p -121.59 144.1 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.256 -1.778 . . . . 50.509999999999998 108.483 178.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.441 HD22 ' HG3' ' A' ' 29' ' ' LYS . 78.4 mt -132.38 142.62 49.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 103.047 -2.946 . . . . 50.509999999999998 103.047 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.93 109.1 17.12 Favored 'General case' 0 N--CA 1.499 2.003 1 O-C-N 129.275 4.109 . . . . 50.619999999999997 102.972 173.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.74 156.22 31.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.74 3.15 . . . . 50.509999999999998 114.401 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 72.8 tt0 -88.37 139.81 30.18 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.175 -2.284 . . . . 50.619999999999997 107.746 174.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.759 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 85.5 Cg_exo -54.83 -24.57 39.11 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 122.552 2.168 . . . . 50.509999999999998 111.976 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -61.56 -26.06 67.71 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.241 -1.392 . . . . 50.509999999999998 107.241 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -59.76 136.52 58.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.353 -1.739 . . . . 50.619999999999997 114.831 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.6 p -79.11 171.59 14.99 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 117.834 -3.041 . . . . 50.509999999999998 110.062 175.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.19 -35.25 62.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 O-C-N 127.196 2.81 . . . . 50.509999999999998 109.281 175.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.3 -41.77 80.46 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.457 -0.777 . . . . 50.619999999999997 112.473 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -76.92 -50.23 13.77 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 115.099 1.518 . . . . 50.549999999999997 115.099 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 22' ' ' THR . 54.9 t -51.68 -39.31 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.958 1.411 . . . . 50.509999999999998 109.701 178.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 52.3 mtpt -61.71 -36.1 79.97 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 115.833 -0.621 . . . . 50.509999999999998 110.368 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.35 86.29 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 109.691 -0.485 . . . . 50.509999999999998 109.691 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HG3' HD22 ' A' ' 15' ' ' LEU . 50.9 tptt -57.97 -41.29 82.6 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.191 -1.781 . . . . 50.509999999999998 106.191 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.81 -49.17 81.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.54 -0.864 . . . . 50.509999999999998 111.674 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.767 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 22.0 tm0? -53.26 -56.83 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 117.944 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -46.32 -54.23 9.34 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 118.38 2.733 . . . . 50.619999999999997 118.38 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -81.16 -41.8 21.84 Favored 'General case' 0 C--O 1.279 2.638 0 C-N-CA 116.464 -2.095 . . . . 50.509999999999998 112.313 -175.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -86.75 -55.43 3.86 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.075 2.67 . . . . 50.619999999999997 110.958 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.88 -23.1 5.05 Favored Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 112.031 -0.428 . . . . 50.509999999999998 112.031 176.524 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 mm -53.68 113.86 5.48 Favored Pre-proline 0 C--O 1.245 0.854 0 C-N-CA 118.815 -1.154 . . . . 50.509999999999998 109.665 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.553 0 C-N-CA 123.181 2.588 . . . . 50.509999999999998 110.925 178.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.767 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 88.4 Cg_exo -57.32 -32.03 92.62 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -57.96 -18.12 21.49 Favored 'General case' 0 C--O 1.263 1.8 0 O-C-N 120.008 -1.683 . . . . 50.619999999999997 111.655 -177.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -113.53 11.34 18.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 120.631 3.567 . . . . 50.549999999999997 120.631 178.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -95.44 129.17 42.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 124.388 2.042 . . . . 50.549999999999997 111.987 -177.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 36.6 ttm180 -119.98 110.49 16.76 Favored 'General case' 0 C--O 1.295 3.477 0 N-CA-C 105.776 -1.935 . . . . 50.640000000000001 105.776 172.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.544 ' HB2' HD12 ' A' ' 50' ' ' LEU . 94.4 mt -101.62 129.7 47.8 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.441 1.019 . . . . 50.509999999999998 108.444 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.8 140.51 29.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.054 1.471 . . . . 50.509999999999998 111.994 -177.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -138.73 116.81 11.74 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.084 -2.191 . . . . 50.509999999999998 105.084 177.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.48 17.8 10.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.193 -2.276 . . . . 50.509999999999998 115.981 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.65 8.31 67.87 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 128.443 2.925 . . . . 50.509999999999998 109.279 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -100.36 112.81 25.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 118.071 0.936 . . . . 50.509999999999998 109.925 177.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -55.43 139.41 43.48 Favored 'General case' 0 C--O 1.259 1.581 0 N-CA-C 108.513 -0.921 . . . . 50.549999999999997 108.513 174.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 43' ' ' LEU . 80.9 mt -85.05 141.47 30.25 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.857 1.429 . . . . 50.509999999999998 114.857 -175.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.411 ' HB3' ' CG ' ' A' ' 54' ' ' ARG . 73.1 tt0 -84.65 126.8 33.68 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.923 1.389 . . . . 50.619999999999997 111.892 -177.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -50.9 -42.27 59.11 Favored 'General case' 0 C--O 1.264 1.818 0 C-N-CA 126.178 1.791 . . . . 50.619999999999997 109.743 -175.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.49 25.1 9.81 Favored Glycine 0 C--O 1.254 1.366 0 C-N-CA 124.442 1.02 . . . . 50.509999999999998 114.211 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CG ' ' HB3' ' A' ' 51' ' ' GLU . 29.3 mmt85 -116.33 164.69 14.15 Favored 'General case' 0 C--O 1.249 1.048 0 O-C-N 119.915 -1.932 . . . . 50.640000000000001 113.457 176.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 41.6 p -101.81 -178.74 3.81 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.111 0.965 . . . . 50.509999999999998 110.223 177.102 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.759 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 59.3 mt -79.94 -20.5 45.49 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.366 -0.975 . . . . 50.509999999999998 108.366 177.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.7 p -88.92 12.95 13.9 Favored 'General case' 0 C--O 1.268 2.077 0 C-N-CA 117.307 -1.757 . . . . 50.509999999999998 112.115 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -94.66 -36.24 11.85 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.449 1.119 . . . . 50.619999999999997 113.343 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.83 23.88 13.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 120.87 3.656 . . . . 50.509999999999998 120.87 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 56.08 46.64 21.26 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 111.377 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 61' ' ' ILE . 73.4 mt -101.01 85.54 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.009 0 CA-C-O 115.201 -2.333 . . . . 50.509999999999998 106.033 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 65' ' ' SER . 97.8 mm-40 -92.43 -177.07 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.099 2.124 . . . . 50.549999999999997 114.683 -176.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.877 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 60.3 pttt -57.76 143.55 41.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.18 1.467 . . . . 50.509999999999998 112.192 -176.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 65.78 31.55 9.47 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.502 -2.135 . . . . 50.619999999999997 109.887 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 95.7 p -80.23 164.34 23.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.813 -1.18 . . . . 50.509999999999998 107.813 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -123.58 131.9 53.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.268 -0.872 . . . . 50.509999999999998 108.791 175.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.1 mp -105.38 137.71 42.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.649 -2.595 . . . . 50.509999999999998 108.854 175.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -98.54 108.48 21.19 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 127.427 2.954 . . . . 50.509999999999998 107.195 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 33.2 tp -72.97 147.01 45.62 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.316 1.228 . . . . 50.509999999999998 114.316 176.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 63.4 t -138.42 142.85 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 102.787 -3.042 . . . . 50.509999999999998 102.787 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 mt -98.29 100.59 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.608 1.336 . . . . 50.509999999999998 114.608 178.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -69.95 104.1 2.43 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 113.338 -3.22 . . . . 50.640000000000001 112.11 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -83.56 165.07 19.38 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.767 1.917 . . . . 50.509999999999998 108.472 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -131.82 45.39 2.79 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.76 -1.564 . . . . 50.640000000000001 109.369 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.35 151.14 6.15 Favored Glycine 0 C--O 1.242 0.633 0 N-CA-C 108.027 -2.029 . . . . 50.509999999999998 108.027 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.463 0 N-CA-C 106.51 -2.636 . . . . 50.509999999999998 106.51 179.226 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 107.734 -1.21 . . . . 50.509999999999998 107.734 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -111.06 133.8 53.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 105.701 178.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.73 162.13 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 115.921 -1.99 . . . . 50.509999999999998 108.41 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -113.0 123.55 50.57 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.518 4.886 . . . . 50.509999999999998 110.598 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.28 112.02 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 113.427 -3.178 . . . . 50.509999999999998 118.975 175.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.64 133.97 34.81 Favored 'General case' 0 N--CA 1.504 2.252 1 O-C-N 129.363 4.164 . . . . 50.509999999999998 105.515 -178.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -115.08 171.63 7.55 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 117.781 -1.104 . . . . 50.509999999999998 109.466 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -65.05 -31.81 73.22 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.159 0.912 . . . . 50.509999999999998 109.949 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -74.84 -1.95 24.56 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 115.72 -2.392 . . . . 50.509999999999998 114.656 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.28 2.52 87.7 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.917 -1.673 . . . . 50.509999999999998 108.917 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.01 143.8 41.24 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.507 -1.584 . . . . 50.509999999999998 107.443 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -113.93 112.02 22.63 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 110.434 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -97.91 143.14 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.561 3.038 . . . . 50.509999999999998 113.765 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -108.18 144.73 35.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.267 -1.773 . . . . 50.509999999999998 111.923 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -140.7 129.27 22.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.466 -2.207 . . . . 50.509999999999998 109.002 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.83 144.12 41.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 128.947 3.904 . . . . 50.619999999999997 108.482 174.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -149.39 174.08 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 127.742 3.152 . . . . 50.509999999999998 112.14 -177.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 57.3 mm-40 -139.21 150.08 63.23 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.254 -2.248 . . . . 50.619999999999997 111.055 174.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -54.88 -24.6 39.64 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.634 2.223 . . . . 50.509999999999998 111.957 177.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.4 p -66.87 -38.74 86.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 105.985 -1.857 . . . . 50.509999999999998 105.985 -177.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 55' ' ' THR . 84.9 m-20 -44.92 155.21 0.11 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.981 2.215 . . . . 50.619999999999997 116.981 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 25' ' ' ASN . 33.1 p -119.01 138.18 53.01 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.252 -3.611 . . . . 50.509999999999998 101.252 175.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.664 HD11 HD23 ' A' ' 50' ' ' LEU . 25.5 mm -32.0 -42.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.123 2.764 . . . . 50.509999999999998 114.867 175.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -60.83 -34.15 74.11 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 50.619999999999997 111.08 176.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' THR . 91.3 m-20 -74.39 -28.93 61.32 Favored 'General case' 0 C--O 1.249 1.053 0 C-N-CA 124.321 1.048 . . . . 50.549999999999997 110.31 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -72.51 -51.88 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 125.039 1.462 . . . . 50.509999999999998 108.5 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.3 -36.66 84.77 Favored 'General case' 0 C--O 1.257 1.447 0 CA-C-N 115.717 -0.674 . . . . 50.509999999999998 109.342 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.61 79.44 Favored 'General case' 0 C--O 1.278 2.584 0 N-CA-C 121.133 3.753 . . . . 50.509999999999998 121.133 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -59.49 -41.63 90.3 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 120.404 -1.435 . . . . 50.509999999999998 107.679 176.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 30' ' ' ILE . 60.4 mt -64.22 -20.7 27.41 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 113.375 0.88 . . . . 50.509999999999998 113.375 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 33.4 tt0 -50.19 -41.41 49.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.546 2.593 . . . . 50.549999999999997 107.228 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 33' ' ' LYS . 29.3 t70 -81.78 -46.05 14.75 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 116.683 2.105 . . . . 50.619999999999997 116.683 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 32' ' ' ASP . 48.5 mmtm -51.27 -64.15 0.9 Allowed 'General case' 0 C--O 1.279 2.631 0 C-N-CA 116.501 -2.079 . . . . 50.509999999999998 108.394 -175.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -93.09 -41.33 10.02 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.048 2.658 . . . . 50.619999999999997 117.926 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 119.34 17.25 4.91 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 111.083 -0.807 . . . . 50.509999999999998 111.083 176.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 24.7 mm -94.9 117.79 66.81 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 118.73 -1.188 . . . . 50.509999999999998 110.546 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.0 136.98 79.92 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.154 2.569 . . . . 50.509999999999998 110.909 178.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.0 Cg_exo -57.26 -32.16 92.86 Favored 'Trans proline' 0 C--O 1.261 1.665 0 O-C-N 122.89 0.942 . . . . 50.509999999999998 113.371 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -67.33 -14.44 62.92 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 120.002 -1.686 . . . . 50.619999999999997 111.758 -177.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 58.9 mt-30 -98.64 11.41 38.55 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.54 -1.35 . . . . 50.549999999999997 113.001 178.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HG2' HD11 ' A' ' 69' ' ' LEU . 68.6 mt-30 -113.47 119.1 36.42 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 117.22 2.304 . . . . 50.549999999999997 117.22 -177.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.423 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.2 mtm180 -107.41 137.49 45.35 Favored 'General case' 0 C--O 1.296 3.543 0 CA-C-O 116.669 -1.634 . . . . 50.640000000000001 111.851 172.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 50' ' ' LEU . 23.2 mt -120.94 115.23 22.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.522 1.056 . . . . 50.509999999999998 111.809 -177.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.44 114.95 35.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 O-C-N 125.218 1.574 . . . . 50.509999999999998 113.496 -177.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 50' ' ' LEU . 39.9 t80 -140.76 117.05 10.67 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 114.555 -1.202 . . . . 50.509999999999998 109.983 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.36 23.97 13.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.16 -2.291 . . . . 50.509999999999998 113.03 177.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.59 0.27 89.87 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 110.603 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -103.99 108.28 19.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 116.09 1.885 . . . . 50.509999999999998 116.09 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -45.75 129.17 9.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.222 -1.029 . . . . 50.549999999999997 108.222 174.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 45' ' ' PHE . 5.8 mp -69.9 144.23 52.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 117.742 -1.123 . . . . 50.509999999999998 109.544 -175.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 42.6 mt-10 -94.47 145.44 24.79 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.886 1.366 . . . . 50.619999999999997 108.617 -177.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.6 -36.39 83.65 Favored 'General case' 0 C--O 1.263 1.805 0 N-CA-C 117.982 2.586 . . . . 50.619999999999997 117.982 -175.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.21 -26.05 49.52 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.411 1.005 . . . . 50.509999999999998 112.821 -177.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 25.6 mmm180 -59.71 173.76 0.53 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 119.957 -1.908 . . . . 50.640000000000001 111.275 176.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 21' ' ' ASP . 41.5 p -117.7 172.47 7.34 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 103.117 -2.92 . . . . 50.509999999999998 103.117 177.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.83 -26.84 64.42 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 106.117 -1.808 . . . . 50.509999999999998 106.117 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.1 p -67.3 -25.15 65.9 Favored 'General case' 0 C--O 1.268 2.062 0 C-N-CA 117.324 -1.751 . . . . 50.509999999999998 110.745 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 54' ' ' ARG . 47.0 m-20 -66.01 -36.8 84.27 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 118.883 2.92 . . . . 50.619999999999997 118.883 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.21 9.34 43.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 117.758 -1.115 . . . . 50.509999999999998 112.701 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 57.63 65.42 1.34 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 121.543 1.974 . . . . 50.549999999999997 115.113 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.19 93.35 4.21 Favored 'Isoleucine or valine' 0 C--O 1.266 1.967 0 CA-C-O 115.284 -2.293 . . . . 50.509999999999998 111.444 175.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 8.5 mm-40 -99.01 167.07 10.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 126.073 2.108 . . . . 50.549999999999997 111.963 -176.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 64.8 mttm -51.99 133.83 32.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 119.673 3.212 . . . . 50.509999999999998 119.673 -176.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 64.7 mm-40 77.35 23.48 0.88 Allowed 'General case' 0 C--O 1.256 1.427 0 CA-C-N 112.498 -2.137 . . . . 50.619999999999997 111.019 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.0 m -82.38 144.19 30.7 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.787 -1.097 . . . . 50.509999999999998 113.336 174.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 p -101.78 131.67 47.96 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 118.252 -0.88 . . . . 50.509999999999998 113.348 175.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.0 tp -100.96 139.11 37.11 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 114.647 -2.597 . . . . 50.509999999999998 105.642 175.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -100.06 117.84 35.18 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 127.463 2.977 . . . . 50.509999999999998 114.223 177.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.428 HD11 ' HG2' ' A' ' 41' ' ' GLN . 66.0 tp -91.26 106.18 18.32 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 115.187 1.551 . . . . 50.509999999999998 115.187 176.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 29.7 t -108.62 136.82 43.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 119.601 1.091 . . . . 50.509999999999998 112.155 175.095 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.2 mt -67.14 155.84 37.72 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 118.226 2.676 . . . . 50.509999999999998 118.226 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 29.2 tpt180 -136.4 77.79 1.67 Allowed 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.32 -3.229 . . . . 50.640000000000001 107.103 177.253 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -74.35 140.09 44.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.644 2.091 . . . . 50.509999999999998 116.644 -179.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.41 82.94 8.1 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.756 -1.566 . . . . 50.640000000000001 108.388 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.39 155.0 20.89 Favored Glycine 0 C--O 1.243 0.712 0 N-CA-C 116.527 1.371 . . . . 50.509999999999998 116.527 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 CA-C-O 116.294 -2.392 . . . . 50.509999999999998 107.282 179.258 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.52 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.52 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.46 HD22 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.52 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.52 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.46 HD22 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.52 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.52 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.46 HD22 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.509999999999998 110.493 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 104.893 178.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.509999999999998 102.837 173.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.4 ' HD2' HG21 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.509999999999998 117.134 179.556 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.509999999999998 116.317 175.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.509999999999998 112.121 -178.081 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.509999999999998 109.624 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.509999999999998 116.025 -177.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.509999999999998 106.536 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.509999999999998 112.921 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.509999999999998 113.028 175.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.509999999999998 111.926 176.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.509999999999998 102.234 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.509999999999998 107.977 178.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.509999999999998 113.269 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.619999999999997 114.947 174.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.509999999999998 115.789 -177.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.619999999999997 107.53 174.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.509999999999998 111.949 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.509999999999998 109.308 -177.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.619999999999997 108.196 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.509999999999998 111.912 175.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 23' ' ' ILE . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.509999999999998 112.556 175.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.619999999999997 115.475 176.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 55.5 t-20 -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.549999999999997 106.23 -179.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.509999999999998 107.58 178.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.509999999999998 111.113 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.509999999999998 109.947 176.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.509999999999998 115.455 175.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.509999999999998 104.372 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.549999999999997 109.548 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.619999999999997 110.423 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.509999999999998 113.197 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.619999999999997 117.619 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.509999999999998 109.26 176.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.509999999999998 113.852 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.509999999999998 110.907 178.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.509999999999998 113.412 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.619999999999997 115.136 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 19.5 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.549999999999997 103.57 178.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.549999999999997 113.647 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.640000000000001 112.495 172.132 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.509999999999998 118.018 -177.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.509999999999998 117.708 -177.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.509999999999998 116.78 177.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.302 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.509999999999998 114.896 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.509999999999998 114.931 177.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.549999999999997 107.727 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.509999999999998 107.986 -175.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.619999999999997 112.944 -177.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.619999999999997 118.065 -175.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.509999999999998 108.537 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.640000000000001 104.693 176.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.509999999999998 107.733 177.174 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.509999999999998 103.779 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.509999999999998 109.455 -179.438 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.619999999999997 111.805 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.509999999999998 115.046 179.177 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.549999999999997 109.887 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.596 HD12 HD21 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 106.554 175.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.549999999999997 119.305 -176.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.509999999999998 112.625 -176.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.619999999999997 109.925 179.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.509999999999998 105.936 174.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.509999999999998 114.003 175.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.509999999999998 101.726 175.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 7.7 m170 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.509999999999998 105.529 177.945 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 108.662 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.509999999999998 109.301 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.423 HD11 HE21 ' A' ' 40' ' ' GLN . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.509999999999998 105.818 178.446 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.640000000000001 109.263 177.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.509999999999998 120.492 -179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.640000000000001 113.699 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.509999999999998 105.703 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.509999999999998 108.344 179.318 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.509999999999998 110.493 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 104.893 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.509999999999998 102.837 173.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.4 ' HD2' HG21 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.509999999999998 117.134 179.556 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.509999999999998 116.317 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.509999999999998 112.121 -178.081 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.509999999999998 109.624 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.509999999999998 116.025 -177.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.509999999999998 106.536 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.509999999999998 112.921 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.509999999999998 113.028 175.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.509999999999998 111.926 176.101 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.509999999999998 102.234 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.509999999999998 107.977 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.509999999999998 113.269 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.619999999999997 114.947 174.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.509999999999998 115.789 -177.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.619999999999997 107.53 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.509999999999998 111.949 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.509999999999998 109.308 -177.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.619999999999997 108.196 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.509999999999998 111.912 175.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 23' ' ' ILE . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.509999999999998 112.556 175.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.619999999999997 115.475 176.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 55.5 t-20 -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.549999999999997 106.23 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.509999999999998 107.58 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.509999999999998 111.113 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.509999999999998 109.947 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.509999999999998 115.455 175.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.509999999999998 104.372 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.549999999999997 109.548 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.619999999999997 110.423 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.509999999999998 113.197 -175.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.619999999999997 117.619 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.509999999999998 109.26 176.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.509999999999998 113.852 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.509999999999998 110.907 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.509999999999998 113.412 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.619999999999997 115.136 -177.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 19.5 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.549999999999997 103.57 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.549999999999997 113.647 -177.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.640000000000001 112.495 172.132 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.509999999999998 118.018 -177.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.509999999999998 117.708 -177.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.509999999999998 116.78 177.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.302 177.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.509999999999998 114.896 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.509999999999998 114.931 177.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.549999999999997 107.727 174.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.509999999999998 107.986 -175.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.619999999999997 112.944 -177.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.619999999999997 118.065 -175.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.509999999999998 108.537 -177.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.640000000000001 104.693 176.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.509999999999998 107.733 177.174 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.509999999999998 103.779 177.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.509999999999998 109.455 -179.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.619999999999997 111.805 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.509999999999998 115.046 179.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.549999999999997 109.887 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.596 HD12 HD21 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 106.554 175.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.549999999999997 119.305 -176.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.509999999999998 112.625 -176.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.619999999999997 109.925 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.509999999999998 105.936 174.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.509999999999998 114.003 175.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.509999999999998 101.726 175.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 7.7 m170 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.509999999999998 105.529 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 108.662 176.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.509999999999998 109.301 175.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.423 HD11 HE21 ' A' ' 40' ' ' GLN . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.509999999999998 105.818 178.446 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.640000000000001 109.263 177.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.509999999999998 120.492 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.640000000000001 113.699 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.509999999999998 105.703 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.509999999999998 108.344 179.318 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 107.349 -1.352 . . . . 50.509999999999998 107.349 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 12.4 mm-40 -87.51 137.75 32.07 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.946 2.654 . . . . 50.549999999999997 110.199 178.218 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -135.32 161.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.022 -1.942 . . . . 50.509999999999998 106.638 173.313 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -94.91 148.05 22.73 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.467 4.854 . . . . 50.509999999999998 119.097 179.532 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.44 116.74 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.395 -3.193 . . . . 50.509999999999998 106.384 175.822 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.19 106.45 17.68 Favored 'General case' 0 N--CA 1.504 2.253 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 115.234 -178.118 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -82.79 178.88 7.97 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 117.759 -1.115 . . . . 50.509999999999998 109.653 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -70.56 -34.07 71.81 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 120.19 3.404 . . . . 50.509999999999998 120.19 -178.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 p -96.57 -9.09 30.21 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 115.706 -2.397 . . . . 50.509999999999998 116.356 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.64 38.41 0.72 Allowed Glycine 0 C--N 1.297 -1.617 0 N-CA-C 120.575 2.99 . . . . 50.509999999999998 120.575 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -94.61 135.64 35.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.848 -1.548 . . . . 50.509999999999998 111.047 175.018 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -109.51 117.76 34.83 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 126.702 2.501 . . . . 50.509999999999998 110.113 176.149 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.6 mt -117.72 132.05 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 127.609 3.068 . . . . 50.509999999999998 106.754 179.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.3 p -104.75 134.54 47.73 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.298 -1.761 . . . . 50.509999999999998 113.776 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.5 mt -118.39 155.87 29.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.435 -2.221 . . . . 50.509999999999998 116.029 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -93.7 119.16 32.35 Favored 'General case' 0 N--CA 1.501 2.084 1 O-C-N 129.227 4.08 . . . . 50.619999999999997 107.368 173.938 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.23 164.19 28.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 O-C-N 127.739 3.15 . . . . 50.509999999999998 111.114 -177.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.66 145.94 55.27 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 112.215 -2.266 . . . . 50.619999999999997 109.52 174.661 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.94 -24.49 39.51 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.559 2.172 . . . . 50.509999999999998 111.956 177.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -78.58 -34.48 46.83 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.947 -1.501 . . . . 50.509999999999998 106.947 -177.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.1 145.63 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.37 -1.732 . . . . 50.619999999999997 114.434 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -96.83 156.41 16.36 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.874 -0.603 . . . . 50.509999999999998 109.555 175.657 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' A' ' 50' ' ' LEU . 55.5 mt -50.69 -40.13 19.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 O-C-N 127.094 2.746 . . . . 50.509999999999998 108.977 175.774 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -47.65 -57.78 5.08 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.031 -1.1 . . . . 50.619999999999997 108.031 177.015 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -53.84 -40.87 66.83 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 115.74 1.756 . . . . 50.549999999999997 115.74 -179.633 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.71 -22.3 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 125.086 1.491 . . . . 50.509999999999998 110.299 178.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 94.9 mttt -82.78 -38.17 23.53 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 104.744 -2.317 . . . . 50.509999999999998 104.744 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.41 -28.45 61.08 Favored 'General case' 0 C--O 1.278 2.605 0 CA-C-N 117.982 0.355 . . . . 50.509999999999998 111.845 176.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -66.27 -36.51 83.17 Favored 'General case' 0 C--O 1.256 1.435 0 O-C-N 120.355 -1.466 . . . . 50.509999999999998 110.144 175.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.2 -29.29 27.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.529 -0.868 . . . . 50.509999999999998 108.661 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.24 -35.61 67.58 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 125.666 2.651 . . . . 50.549999999999997 111.019 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -63.75 -27.88 69.5 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 120.947 3.684 . . . . 50.619999999999997 120.947 179.132 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -108.83 -20.29 13.11 Favored 'General case' 0 C--O 1.279 2.65 0 O-C-N 119.27 -2.143 . . . . 50.509999999999998 113.539 -175.638 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' A' ' 36' ' ' ILE . 77.0 tt0 -123.69 -26.57 4.13 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 123.061 2.664 . . . . 50.619999999999997 111.205 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.47 12.04 57.58 Favored Glycine 0 CA--C 1.477 -2.303 0 CA-C-O 120.049 -0.306 . . . . 50.509999999999998 113.122 176.55 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.413 HG12 ' HG2' ' A' ' 34' ' ' GLU . 21.8 mm -77.5 126.3 84.86 Favored Pre-proline 0 C--O 1.245 0.822 0 N-CA-C 104.66 -2.348 . . . . 50.509999999999998 104.66 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.97 136.95 79.69 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.166 2.578 . . . . 50.509999999999998 110.914 178.309 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.07 -32.3 92.8 Favored 'Trans proline' 0 C--O 1.262 1.688 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.436 -179.321 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -80.12 12.04 3.08 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.864 -1.772 . . . . 50.619999999999997 114.954 -177.406 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.23 9.14 11.0 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.467 -1.395 . . . . 50.549999999999997 107.358 178.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -103.05 125.13 49.65 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.407 2.051 . . . . 50.549999999999997 112.999 -177.583 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -111.79 114.54 27.58 Favored 'General case' 0 C--O 1.295 3.478 0 CA-C-O 116.711 -1.614 . . . . 50.640000000000001 114.898 172.146 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.556 HD12 HG23 ' A' ' 23' ' ' ILE . 23.1 mt -98.62 122.34 41.71 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 119.431 1.014 . . . . 50.509999999999998 111.832 -177.442 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.81 117.99 56.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 O-C-N 124.545 1.153 . . . . 50.509999999999998 111.016 -177.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.707 ' HB3' HD21 ' A' ' 50' ' ' LEU . 57.9 t80 -140.92 143.4 34.58 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.121 -1.437 . . . . 50.509999999999998 107.121 177.52 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 45.38 34.98 1.68 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.254 -2.248 . . . . 50.509999999999998 106.798 177.434 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.87 -7.39 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.445 2.926 . . . . 50.509999999999998 113.263 -179.499 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 46' ' ' ALA . 75.2 mmtt -77.04 148.07 36.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 118.099 0.949 . . . . 50.509999999999998 113.402 177.662 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.5 116.09 11.43 Favored 'General case' 0 C--O 1.259 1.573 0 O-C-N 123.953 0.783 . . . . 50.549999999999997 109.485 174.559 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 45' ' ' PHE . 64.8 mt -78.84 145.68 34.1 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 101.394 -3.558 . . . . 50.509999999999998 101.394 -175.866 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' O ' HD12 ' A' ' 23' ' ' ILE . 4.2 mm-40 -116.72 148.66 40.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.975 1.472 . . . . 50.619999999999997 114.975 -177.661 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.25 -47.9 71.76 Favored 'General case' 0 C--O 1.264 1.838 0 C-N-CA 126.141 1.776 . . . . 50.619999999999997 114.572 -175.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 4.42 57.12 Favored Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 124.408 1.004 . . . . 50.509999999999998 112.921 -177.25 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.448 ' HD2' ' OH ' ' A' ' 59' ' ' TYR . 89.3 mtt-85 -93.01 143.52 26.15 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 119.997 -1.884 . . . . 50.640000000000001 112.3 176.451 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.2 p -86.25 162.05 18.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.036 0.935 . . . . 50.509999999999998 112.019 177.087 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.57 -27.31 65.95 Favored 'General case' 0 C--O 1.201 -1.495 0 N-CA-C 102.205 -3.257 . . . . 50.509999999999998 102.205 177.201 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -71.67 -36.03 70.52 Favored 'General case' 0 C--O 1.267 2.022 0 C-N-CA 117.326 -1.749 . . . . 50.509999999999998 113.078 -179.387 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -49.86 -38.64 36.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.501 1.143 . . . . 50.619999999999997 113.718 179.765 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 58.1 m-85 -91.58 -10.72 39.51 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.759 -1.115 . . . . 50.509999999999998 113.584 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 41.2 m-20 70.31 41.58 1.01 Allowed 'General case' 0 C--O 1.248 0.989 0 CA-C-N 121.52 1.964 . . . . 50.549999999999997 108.684 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.72 118.07 14.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.93 0 CA-C-O 115.184 -2.341 . . . . 50.509999999999998 107.126 175.872 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -97.3 177.86 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.556 1.785 . . . . 50.549999999999997 110.196 -176.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -58.15 146.94 31.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.198 1.475 . . . . 50.509999999999998 107.658 -176.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 39.74 61.31 1.46 Allowed 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.537 -2.12 . . . . 50.619999999999997 112.614 179.566 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 m -98.26 151.07 20.85 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 104.729 -2.323 . . . . 50.509999999999998 104.729 174.743 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 p -95.96 140.26 30.96 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 118.287 -0.863 . . . . 50.509999999999998 111.879 175.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -122.64 136.92 55.01 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 114.641 -2.599 . . . . 50.509999999999998 104.479 175.088 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.15 116.92 29.2 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 127.427 2.954 . . . . 50.509999999999998 108.517 177.897 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.25 130.92 34.96 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.623 -1.179 . . . . 50.509999999999998 111.098 176.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -128.56 141.78 45.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 104.004 -2.591 . . . . 50.509999999999998 104.004 174.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.5 mt -97.55 123.54 41.46 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.639 0.607 . . . . 50.509999999999998 112.639 178.438 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -104.28 86.76 2.59 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.336 -3.221 . . . . 50.640000000000001 112.841 177.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.7 mt -73.32 167.77 20.55 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.954 . . . . 50.509999999999998 107.815 -179.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -120.59 86.5 2.58 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.714 -1.585 . . . . 50.640000000000001 107.247 -179.624 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.23 131.74 3.36 Favored Glycine 0 C--O 1.244 0.743 0 O-C-N 124.645 1.216 . . . . 50.509999999999998 113.081 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.47 1 O-C-N 115.118 -4.754 . . . . 50.509999999999998 103.707 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.509999999999998 111.053 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.549999999999997 116.588 178.321 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.509999999999998 108.408 173.351 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.509999999999998 119.91 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.509999999999998 113.866 175.785 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.509999999999998 109.83 -178.037 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.509999999999998 114.27 179.956 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.509999999999998 106.823 -177.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.509999999999998 106.406 179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.509999999999998 115.847 179.804 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.509999999999998 113.185 174.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.509999999999998 106.82 176.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.509999999999998 110.632 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.509999999999998 110.788 178.084 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.509999999999998 115.167 -179.282 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.619999999999997 107.469 173.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.509999999999998 111.54 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.619999999999997 109.116 174.729 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.509999999999998 111.942 177.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.509999999999998 110.261 -177.489 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.619999999999997 110.438 -179.014 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.509999999999998 102.814 175.665 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.509999999999998 108.219 175.869 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.619999999999997 110.915 177.063 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.549999999999997 110.953 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.509999999999998 113.215 178.571 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.509999999999998 108.802 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.509999999999998 103.321 176.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.509999999999998 108.74 176.075 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.509999999999998 114.446 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.643 HE21 ' HA ' ' A' ' 37' ' ' PRO . 33.4 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.549999999999997 111.108 179.417 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.619999999999997 106.799 179.153 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.509999999999998 117.415 -175.737 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.619999999999997 108.973 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.509999999999998 108.229 176.498 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' A' ' 34' ' ' GLU . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.509999999999998 107.149 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.643 ' HA ' HE21 ' A' ' 31' ' ' GLN . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.509999999999998 110.835 178.328 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.509999999999998 113.479 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.619999999999997 113.097 -177.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' A' ' 37' ' ' PRO . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.549999999999997 107.358 178.748 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.549999999999997 116.575 -177.483 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.640000000000001 106.18 172.202 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.509999999999998 109.103 -177.516 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.509999999999998 114.506 -177.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.509999999999998 114.578 177.624 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.509999999999998 108.335 177.409 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.509999999999998 113.694 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.509999999999998 108.927 177.678 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.549999999999997 107.079 174.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.509999999999998 107.602 -175.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.619999999999997 112.193 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.619999999999997 116.528 -175.761 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.509999999999998 116.292 -177.256 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.640000000000001 108.919 176.463 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.509999999999998 113.355 177.121 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.509999999999998 108.481 177.184 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.509999999999998 116.691 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.619999999999997 119.838 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.509999999999998 110.142 179.286 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 113.734 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.509999999999998 105.625 175.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.549999999999997 108.806 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.579 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.509999999999998 116.225 -176.896 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.619999999999997 117.221 179.545 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.509999999999998 103.824 174.726 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.509999999999998 115.599 175.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.509999999999998 106.66 175.091 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.509999999999998 108.183 177.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.509999999999998 108.516 176.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.509999999999998 105.118 175.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.509999999999998 116.356 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.640000000000001 113.39 177.176 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.509999999999998 111.184 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.505 -179.621 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.509999999999998 104.884 179.378 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.509999999999998 116.938 179.231 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.509999999999998 111.053 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.549999999999997 116.588 178.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.509999999999998 108.408 173.351 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.509999999999998 119.91 179.541 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.509999999999998 113.866 175.785 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.509999999999998 109.83 -178.037 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.509999999999998 114.27 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.509999999999998 106.823 -177.969 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.509999999999998 106.406 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.509999999999998 115.847 179.804 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.509999999999998 113.185 174.982 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.509999999999998 106.82 176.229 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.509999999999998 110.632 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.509999999999998 110.788 178.084 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.509999999999998 115.167 -179.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.619999999999997 107.469 173.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.509999999999998 111.54 -177.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.619999999999997 109.116 174.729 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.509999999999998 111.942 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.509999999999998 110.261 -177.489 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.619999999999997 110.438 -179.014 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.509999999999998 102.814 175.665 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.509999999999998 108.219 175.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.619999999999997 110.915 177.063 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.549999999999997 110.953 -179.579 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.509999999999998 113.215 178.571 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.509999999999998 108.802 -179.798 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.509999999999998 103.321 176.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.509999999999998 108.74 176.075 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.509999999999998 114.446 179.874 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.643 HE21 ' HA ' ' A' ' 37' ' ' PRO . 33.4 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.549999999999997 111.108 179.417 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.619999999999997 106.799 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.509999999999998 117.415 -175.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.619999999999997 108.973 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.509999999999998 108.229 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' A' ' 34' ' ' GLU . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.509999999999998 107.149 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.643 ' HA ' HE21 ' A' ' 31' ' ' GLN . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.509999999999998 110.835 178.328 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.509999999999998 113.479 -179.365 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.619999999999997 113.097 -177.452 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' A' ' 37' ' ' PRO . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.549999999999997 107.358 178.748 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.549999999999997 116.575 -177.483 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.640000000000001 106.18 172.202 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.509999999999998 109.103 -177.516 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.509999999999998 114.506 -177.616 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.509999999999998 114.578 177.624 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.509999999999998 108.335 177.409 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.509999999999998 113.694 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.509999999999998 108.927 177.678 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.549999999999997 107.079 174.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.509999999999998 107.602 -175.891 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.619999999999997 112.193 -177.677 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.619999999999997 116.528 -175.761 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.509999999999998 116.292 -177.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.640000000000001 108.919 176.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.509999999999998 113.355 177.121 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.509999999999998 108.481 177.184 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.509999999999998 116.691 -179.453 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.619999999999997 119.838 179.741 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.509999999999998 110.142 179.286 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 113.734 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.509999999999998 105.625 175.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.549999999999997 108.806 -176.835 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.579 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.509999999999998 116.225 -176.896 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.619999999999997 117.221 179.545 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.509999999999998 103.824 174.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.509999999999998 115.599 175.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.509999999999998 106.66 175.091 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.509999999999998 108.183 177.947 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.509999999999998 108.516 176.581 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.509999999999998 105.118 175.096 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.509999999999998 116.356 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.640000000000001 113.39 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.509999999999998 111.184 -179.342 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.505 -179.621 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.509999999999998 104.884 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.509999999999998 116.938 179.231 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.509999999999998 110.518 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.549999999999997 111.931 178.254 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.509999999999998 109.629 173.36 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.509999999999998 110.788 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.509999999999998 109.267 175.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.509999999999998 112.054 -178.082 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.509999999999998 109.558 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.509999999999998 115.426 -177.96 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.509999999999998 110.359 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.509999999999998 109.262 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.509999999999998 111.702 175.031 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.509999999999998 120.495 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.509999999999998 104.467 179.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.509999999999998 119.511 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.509999999999998 111.182 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.619999999999997 105.523 173.97 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.509999999999998 120.87 -177.968 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.619999999999997 113.88 174.624 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.509999999999998 111.907 177.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.509999999999998 110.539 -177.503 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.619999999999997 116.041 -179.054 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.509999999999998 113.13 175.663 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.509999999999998 106.643 175.794 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.619999999999997 109.013 176.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.549999999999997 120.754 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.509999999999998 109.974 178.629 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.509999999999998 103.034 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.509999999999998 114.005 176.947 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.509999999999998 108.149 175.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.509999999999998 112.731 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.549999999999997 116.636 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 110.424 179.144 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.509999999999998 117.298 -175.651 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.619999999999997 114.698 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.509999999999998 108.03 176.505 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.509999999999998 103.399 179.696 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.509999999999998 110.927 178.325 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.599 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.509999999999998 113.487 -179.297 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.619999999999997 115.612 -177.478 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 108.548 178.699 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 111.184 -177.606 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.640000000000001 102.446 172.198 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.509999999999998 113.857 -177.541 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.509999999999998 112.916 -177.592 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.509999999999998 108.783 177.641 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.509999999999998 104.079 177.365 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.509999999999998 117.886 -179.581 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.509999999999998 111.909 177.62 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.549999999999997 106.814 174.54 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.509999999999998 110.278 -175.89 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.619999999999997 111.58 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.619999999999997 111.456 -175.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.509999999999998 112.985 -177.227 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.640000000000001 115.651 176.557 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.509999999999998 116.995 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.509999999999998 105.494 177.211 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.509999999999998 113.975 -179.481 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.619999999999997 113.595 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 108.268 179.243 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 57' ' ' SER . 17.4 m120 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.549999999999997 112.768 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.509999999999998 112.67 175.785 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.549999999999997 105.766 -176.791 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.509999999999998 107.365 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.619999999999997 116.2 179.519 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.509999999999998 107.156 174.815 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.509999999999998 106.777 175.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.509999999999998 107.127 175.12 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.509999999999998 114.104 177.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.509999999999998 109.856 176.533 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.509999999999998 106.088 175.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.509999999999998 118.655 178.372 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.640000000000001 107.592 177.293 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.509999999999998 112.686 -179.374 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.640000000000001 111.255 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.509999999999998 104.302 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 116.097 179.25 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.509999999999998 110.518 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.549999999999997 111.931 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.509999999999998 109.629 173.36 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.509999999999998 110.788 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.509999999999998 109.267 175.855 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.509999999999998 112.054 -178.082 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.509999999999998 109.558 179.941 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.509999999999998 115.426 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.509999999999998 110.359 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.509999999999998 109.262 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.509999999999998 111.702 175.031 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.509999999999998 120.495 176.137 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.509999999999998 104.467 179.69 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.509999999999998 119.511 178.086 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.509999999999998 111.182 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.619999999999997 105.523 173.97 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.509999999999998 120.87 -177.968 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.619999999999997 113.88 174.624 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.509999999999998 111.907 177.796 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.509999999999998 110.539 -177.503 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.619999999999997 116.041 -179.054 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.509999999999998 113.13 175.663 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.509999999999998 106.643 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.619999999999997 109.013 176.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.549999999999997 120.754 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.509999999999998 109.974 178.629 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.509999999999998 103.034 -179.722 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.509999999999998 114.005 176.947 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.509999999999998 108.149 175.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.509999999999998 112.731 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.549999999999997 116.636 179.47 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 110.424 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.509999999999998 117.298 -175.651 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.619999999999997 114.698 179.824 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.509999999999998 108.03 176.505 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.509999999999998 103.399 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.509999999999998 110.927 178.325 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.599 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.509999999999998 113.487 -179.297 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.619999999999997 115.612 -177.478 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 108.548 178.699 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 111.184 -177.606 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.640000000000001 102.446 172.198 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.509999999999998 113.857 -177.541 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.509999999999998 112.916 -177.592 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.509999999999998 108.783 177.641 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.509999999999998 104.079 177.365 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.509999999999998 117.886 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.509999999999998 111.909 177.62 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.549999999999997 106.814 174.54 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.509999999999998 110.278 -175.89 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.619999999999997 111.58 -177.608 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.619999999999997 111.456 -175.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.509999999999998 112.985 -177.227 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.640000000000001 115.651 176.557 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.509999999999998 116.995 177.093 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.509999999999998 105.494 177.211 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.509999999999998 113.975 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.619999999999997 113.595 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 108.268 179.243 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 57' ' ' SER . 17.4 m120 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.549999999999997 112.768 179.934 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.509999999999998 112.67 175.785 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.549999999999997 105.766 -176.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.509999999999998 107.365 -176.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.619999999999997 116.2 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.509999999999998 107.156 174.815 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.509999999999998 106.777 175.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.509999999999998 107.127 175.12 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.509999999999998 114.104 177.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.509999999999998 109.856 176.533 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.509999999999998 106.088 175.043 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.509999999999998 118.655 178.372 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.640000000000001 107.592 177.293 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.509999999999998 112.686 -179.374 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.640000000000001 111.255 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.509999999999998 104.302 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 116.097 179.25 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.992 0.738 . . . . 50.509999999999998 112.992 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.58 106.94 9.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 126.973 2.671 . . . . 50.549999999999997 111.748 178.306 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -114.26 155.73 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 CA-C-O 115.983 -1.96 . . . . 50.509999999999998 113.24 173.276 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -119.93 132.41 55.51 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.523 4.889 . . . . 50.509999999999998 112.064 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.486 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 70.8 t -108.49 134.02 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 113.412 -3.185 . . . . 50.509999999999998 112.244 175.773 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -94.46 118.68 32.02 Favored 'General case' 0 N--CA 1.503 2.22 1 O-C-N 129.329 4.143 . . . . 50.509999999999998 106.07 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -98.48 161.28 13.76 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 117.753 -1.117 . . . . 50.509999999999998 110.633 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -54.82 -33.43 61.6 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.877 1.436 . . . . 50.509999999999998 114.877 -177.95 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 9' ' ' THR . 54.0 m -71.16 -20.77 62.26 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 115.689 -2.404 . . . . 50.509999999999998 113.117 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.56 -10.97 38.99 Favored Glycine 0 C--N 1.297 -1.602 0 O-C-N 120.144 -1.598 . . . . 50.509999999999998 116.312 179.843 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -69.22 117.6 11.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 116.868 -1.539 . . . . 50.509999999999998 110.608 174.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.2 m -73.51 126.55 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.659 2.475 . . . . 50.509999999999998 111.716 176.201 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.486 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 14.1 pt -104.58 142.4 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 127.432 2.958 . . . . 50.509999999999998 112.531 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -106.34 142.04 36.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 117.294 -1.763 . . . . 50.509999999999998 112.363 178.112 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -131.01 133.8 46.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 115.49 -2.195 . . . . 50.509999999999998 113.451 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -100.57 139.88 35.63 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 129.163 4.04 . . . . 50.619999999999997 106.417 173.974 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.94 170.76 18.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 117.344 -177.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -115.27 138.13 23.43 Favored Pre-proline 0 C--N 1.315 -0.926 0 N-CA-C 103.36 -2.83 . . . . 50.619999999999997 103.36 174.642 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.02 -24.46 40.01 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 122.535 2.157 . . . . 50.509999999999998 111.957 177.706 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -79.01 -6.42 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.128 -0.939 . . . . 50.509999999999998 109.326 -177.611 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -72.55 122.55 21.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.092 2.627 . . . . 50.619999999999997 118.092 -178.954 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 26' ' ' VAL . 66.8 p -67.66 155.54 38.95 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.423 -1.325 . . . . 50.509999999999998 107.423 175.71 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 54' ' ' ARG . 25.6 mm -58.12 -23.74 22.31 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 127.191 2.807 . . . . 50.509999999999998 107.383 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.34 -39.99 67.72 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.471 -0.768 . . . . 50.619999999999997 110.918 177.097 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -70.7 -20.67 62.65 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.292 1.037 . . . . 50.549999999999997 108.258 -179.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 22' ' ' THR . 90.6 t -71.35 -57.52 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 101.293 -3.595 . . . . 50.509999999999998 101.293 178.579 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.6 mttt -52.14 -38.47 57.65 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 114.456 1.28 . . . . 50.509999999999998 114.456 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.08 90.84 Favored 'General case' 0 C--O 1.278 2.591 0 CA-C-N 118.007 0.367 . . . . 50.509999999999998 110.322 176.869 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -60.61 -13.47 14.53 Favored 'General case' 0 C--O 1.254 1.309 0 N-CA-C 118.576 2.806 . . . . 50.509999999999998 118.576 176.028 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -90.99 -40.41 12.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 C-N-CA 119.565 -0.854 . . . . 50.509999999999998 110.04 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.561 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 31.3 tt0 -54.15 -31.98 54.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 125.656 2.646 . . . . 50.549999999999997 116.229 179.474 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.04 -72.14 0.1 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.627 -1.624 . . . . 50.619999999999997 109.717 179.092 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.94 -39.99 33.09 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.404 -2.119 . . . . 50.509999999999998 114.829 -175.745 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -88.19 -22.14 24.18 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 114.028 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 71.31 27.13 72.16 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 109.332 -1.507 . . . . 50.509999999999998 109.332 176.571 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.8 mt -96.66 118.62 64.99 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.856 -1.138 . . . . 50.509999999999998 107.968 179.711 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.8 Cg_exo -57.02 136.99 80.0 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 123.149 2.566 . . . . 50.509999999999998 110.865 178.296 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.597 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.5 Cg_exo -57.25 -32.16 92.81 Favored 'Trans proline' 0 C--O 1.261 1.657 0 O-C-N 122.873 0.933 . . . . 50.509999999999998 113.391 -179.268 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -69.76 -21.8 63.4 Favored 'General case' 0 C--O 1.262 1.736 0 O-C-N 119.985 -1.697 . . . . 50.619999999999997 110.39 -177.443 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -93.91 18.16 10.97 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.52 -1.363 . . . . 50.549999999999997 110.421 178.662 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.495 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 71.7 mt-30 -111.49 139.57 46.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.3 2.0 . . . . 50.549999999999997 112.116 -177.584 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.73 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 37.5 ttm180 -119.97 126.61 51.28 Favored 'General case' 0 C--O 1.296 3.529 0 CA-C-O 116.708 -1.615 . . . . 50.640000000000001 108.393 172.147 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.3 mt -118.91 89.25 3.09 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.452 1.024 . . . . 50.509999999999998 112.257 -177.553 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.552 HD11 ' HD3' ' A' ' 42' ' ' ARG . 60.5 mt -98.51 128.85 49.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 O-C-N 125.255 1.597 . . . . 50.509999999999998 107.084 -177.63 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.682 ' CE2' HG12 ' A' ' 61' ' ' ILE . 87.3 t80 -136.33 124.6 23.21 Favored 'General case' 0 C--N 1.36 1.025 0 CA-C-N 114.498 -1.228 . . . . 50.509999999999998 110.627 177.646 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 36.84 20.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.255 177.332 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 25.15 63.84 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 128.455 2.931 . . . . 50.509999999999998 115.916 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.17 136.55 40.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 118.036 0.918 . . . . 50.509999999999998 110.82 177.621 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -73.45 128.24 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.05 0.844 . . . . 50.549999999999997 112.456 174.624 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.4 149.15 35.19 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 105.514 -2.032 . . . . 50.509999999999998 105.514 -175.903 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 82.5 tt0 -105.72 144.53 32.34 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.929 1.393 . . . . 50.619999999999997 113.456 -177.693 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 37.5 p30 -61.19 -35.51 77.35 Favored 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.099 1.76 . . . . 50.619999999999997 109.198 -175.749 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.496 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -91.48 20.94 38.03 Favored Glycine 0 CA--C 1.492 -1.403 0 C-N-CA 124.383 0.992 . . . . 50.509999999999998 115.55 -177.296 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.598 ' O ' HG12 ' A' ' 23' ' ' ILE . 86.5 mmt-85 -128.69 168.3 16.0 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 101.878 -3.378 . . . . 50.640000000000001 101.878 176.488 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -108.57 152.67 24.44 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.003 0.921 . . . . 50.509999999999998 108.842 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.7 mt -47.36 -39.42 15.06 Favored 'General case' 0 C--O 1.201 -1.462 0 O-C-N 124.087 0.867 . . . . 50.509999999999998 108.791 177.239 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -70.79 -27.71 64.11 Favored 'General case' 0 C--O 1.268 2.051 0 N-CA-C 116.35 1.981 . . . . 50.509999999999998 116.35 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -57.46 -27.18 62.24 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.496 1.141 . . . . 50.619999999999997 109.733 179.789 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.0 m-85 -87.06 -5.73 58.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 118.284 2.698 . . . . 50.509999999999998 118.284 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 54.3 m-20 74.28 32.1 1.02 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.524 1.965 . . . . 50.549999999999997 111.521 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.682 HG12 ' CE2' ' A' ' 45' ' ' PHE . 69.5 mt -81.0 103.8 8.57 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.206 -2.33 . . . . 50.509999999999998 110.464 175.849 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -103.84 -171.1 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 119.241 3.052 . . . . 50.549999999999997 119.241 -176.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 65.5 tttm -52.72 138.36 29.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.245 -2.131 . . . . 50.509999999999998 105.245 -176.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 46.6 mt-10 61.95 68.15 0.71 Allowed 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.492 -2.14 . . . . 50.619999999999997 115.36 179.549 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.408 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 51.0 m -136.06 138.82 42.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.786 -1.097 . . . . 50.509999999999998 109.749 174.813 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -114.39 132.31 56.27 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 118.841 -2.412 . . . . 50.509999999999998 113.919 175.886 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.0 mt -90.06 145.96 24.68 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.64 -2.6 . . . . 50.509999999999998 111.595 175.091 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -96.78 140.64 31.06 Favored 'General case' 0 C--N 1.284 -2.258 0 O-C-N 127.295 2.872 . . . . 50.509999999999998 106.937 177.89 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -106.07 116.0 31.18 Favored 'General case' 0 C--O 1.282 2.81 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 113.338 176.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -120.28 138.33 51.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 119.533 1.06 . . . . 50.509999999999998 112.217 175.072 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.36 114.53 28.71 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.405 0.52 . . . . 50.509999999999998 112.405 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -89.08 111.63 22.42 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 113.365 -3.207 . . . . 50.640000000000001 104.738 177.198 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.59 131.62 36.2 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.819 1.949 . . . . 50.509999999999998 112.438 -179.359 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -88.07 77.62 8.33 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 113.757 -1.565 . . . . 50.640000000000001 113.193 -179.544 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.67 -147.62 16.67 Favored Glycine 0 C--O 1.242 0.597 0 N-CA-C 106.325 -2.71 . . . . 50.509999999999998 106.325 179.372 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 CA-C-O 116.329 -2.373 . . . . 50.509999999999998 109.025 179.196 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 118.833 -0.603 . . . . 50.509999999999998 110.318 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -105.25 112.49 25.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 126.937 2.648 . . . . 50.549999999999997 112.805 178.264 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.9 pt -114.42 139.79 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-O 115.984 -1.96 . . . . 50.509999999999998 112.339 173.288 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -96.2 145.78 25.25 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 130.43 4.831 . . . . 50.509999999999998 111.845 179.503 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 70.6 t -133.87 105.18 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.328 -3.225 . . . . 50.509999999999998 113.923 175.748 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -91.08 139.72 30.49 Favored 'General case' 0 N--CA 1.504 2.265 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 120.678 -178.121 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -113.79 -168.87 1.41 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 115.052 1.501 . . . . 50.509999999999998 115.052 179.956 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -107.9 7.98 28.31 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 124.109 0.88 . . . . 50.509999999999998 111.005 -177.925 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -92.24 -14.88 28.27 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 102.41 -3.181 . . . . 50.509999999999998 102.41 179.975 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.89 10.72 29.87 Favored Glycine 0 C--N 1.297 -1.603 0 O-C-N 120.188 -1.57 . . . . 50.509999999999998 110.048 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.649 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 43.0 mtpt -90.8 154.51 19.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.86 -1.543 . . . . 50.509999999999998 113.116 175.003 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -126.8 122.63 35.33 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.706 2.504 . . . . 50.509999999999998 107.466 176.19 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.522 HG22 ' HG ' ' A' ' 15' ' ' LEU . 62.5 mt -99.11 136.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 115.182 -2.607 . . . . 50.509999999999998 108.76 179.775 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.9 m -127.24 104.18 7.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 104.209 -2.515 . . . . 50.509999999999998 104.209 178.092 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.522 ' HG ' HG22 ' A' ' 13' ' ' ILE . 46.2 mt -106.75 175.23 5.57 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.536 -2.173 . . . . 50.509999999999998 110.936 -179.197 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -125.64 137.95 53.89 Favored 'General case' 0 N--CA 1.5 2.058 1 O-C-N 129.164 4.04 . . . . 50.619999999999997 108.038 173.961 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -139.69 165.9 21.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 O-C-N 126.599 2.437 . . . . 50.509999999999998 110.623 -177.891 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.29 158.65 31.58 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 119.381 3.104 . . . . 50.619999999999997 119.381 174.647 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.88 -24.56 39.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.629 2.219 . . . . 50.509999999999998 111.91 177.686 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -110.42 25.71 11.49 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 119.98 3.326 . . . . 50.509999999999998 119.98 -177.543 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -94.62 149.22 21.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 117.305 -1.758 . . . . 50.619999999999997 107.26 -179.038 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -92.97 148.46 21.98 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.799 -0.637 . . . . 50.509999999999998 109.688 175.752 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -44.94 -39.6 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.155 2.784 . . . . 50.509999999999998 115.021 175.785 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.87 -36.73 77.53 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.407 -0.808 . . . . 50.619999999999997 111.367 177.009 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -67.35 -34.07 76.56 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.358 1.063 . . . . 50.549999999999997 110.821 -179.589 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -71.16 -46.11 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 125.048 1.467 . . . . 50.509999999999998 112.878 178.571 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HG2' ' OE1' ' A' ' 41' ' ' GLN . 53.7 mtmt -62.84 -32.1 73.26 Favored 'General case' 0 C--O 1.255 1.352 0 N-CA-C 107.084 -1.45 . . . . 50.509999999999998 107.084 -179.753 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -56.75 17.61 Favored 'General case' 0 C--O 1.279 2.615 0 N-CA-C 114.575 1.324 . . . . 50.509999999999998 114.575 176.828 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -46.24 -49.18 17.58 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 120.387 -1.445 . . . . 50.509999999999998 109.911 176.054 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.84 -42.5 63.01 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 118.32 2.711 . . . . 50.509999999999998 118.32 179.896 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.406 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.8 tt0 -57.96 -45.51 86.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 125.662 2.648 . . . . 50.549999999999997 104.618 179.446 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.74 -25.13 61.93 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 116.353 1.982 . . . . 50.619999999999997 116.353 179.164 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -89.63 -58.61 2.46 Favored 'General case' 0 C--O 1.279 2.64 0 O-C-N 119.325 -2.109 . . . . 50.509999999999998 113.879 -175.683 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.649 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 74.2 mm-40 -103.93 -24.91 13.21 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 123.058 2.663 . . . . 50.619999999999997 110.631 179.868 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 105.52 20.11 9.85 Favored Glycine 0 CA--C 1.478 -2.274 0 N-CA-C 120.393 2.917 . . . . 50.509999999999998 120.393 176.52 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.483 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.9 mt -86.18 134.41 38.75 Favored Pre-proline 0 C--O 1.244 0.792 0 C-N-CA 118.854 -1.138 . . . . 50.509999999999998 110.05 179.738 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -57.07 136.99 79.88 Favored 'Trans proline' 0 C--O 1.26 1.603 0 C-N-CA 123.194 2.596 . . . . 50.509999999999998 110.877 178.361 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.3 Cg_exo -57.13 -32.26 92.83 Favored 'Trans proline' 0 C--O 1.261 1.645 0 C-N-CA 120.731 0.954 . . . . 50.509999999999998 113.411 -179.306 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.79 -27.04 60.15 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 116.268 1.951 . . . . 50.619999999999997 116.268 -177.429 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 80.1 mt-30 -73.65 -21.59 60.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.567 -1.333 . . . . 50.549999999999997 109.995 178.686 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.602 ' HB3' HD11 ' A' ' 69' ' ' LEU . 71.8 mt-30 -70.56 118.28 13.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.36 2.028 . . . . 50.549999999999997 115.678 -177.613 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -113.81 121.4 43.92 Favored 'General case' 0 C--O 1.295 3.498 0 CA-C-O 116.621 -1.657 . . . . 50.640000000000001 109.303 172.098 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -96.49 127.49 42.53 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 119.447 1.021 . . . . 50.509999999999998 112.907 -177.422 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.51 119.3 57.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 115.056 1.502 . . . . 50.509999999999998 115.056 -177.623 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -145.35 121.44 10.76 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 104.741 -2.318 . . . . 50.509999999999998 104.741 177.608 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.0 39.8 3.12 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.208 -2.269 . . . . 50.509999999999998 107.961 177.41 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.47 11.24 4.99 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 128.417 2.913 . . . . 50.509999999999998 115.701 -179.606 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -115.92 126.67 54.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 119.27 3.063 . . . . 50.509999999999998 119.27 177.633 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -41.56 120.82 1.55 Allowed 'General case' 0 C--O 1.259 1.597 0 N-CA-C 120.047 3.351 . . . . 50.549999999999997 120.047 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 2.1 mp -82.35 123.59 29.24 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 117.751 -1.118 . . . . 50.509999999999998 109.737 -175.936 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.15 140.06 48.63 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.62 1.711 . . . . 50.619999999999997 115.62 -177.645 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -54.51 -53.02 59.94 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.148 1.779 . . . . 50.619999999999997 110.458 -175.776 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.17 -7.74 60.48 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 116.531 1.373 . . . . 50.509999999999998 116.531 -177.229 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -76.45 176.48 8.21 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 116.466 2.024 . . . . 50.640000000000001 116.466 176.538 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.6 p -112.44 164.83 12.81 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.055 -1.831 . . . . 50.509999999999998 106.055 177.148 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD22 ' CD1' ' A' ' 61' ' ' ILE . 65.5 mt -68.64 -36.17 78.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 106.573 -1.64 . . . . 50.509999999999998 106.573 177.279 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -65.51 -31.48 72.58 Favored 'General case' 0 C--O 1.267 1.995 0 C-N-CA 117.34 -1.744 . . . . 50.509999999999998 112.392 -179.491 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -47.37 -37.48 11.27 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.515 1.15 . . . . 50.619999999999997 111.902 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 92.5 m-85 -96.12 -11.32 26.42 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 117.757 -1.116 . . . . 50.509999999999998 113.147 179.216 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 32.5 t30 78.58 47.46 0.04 OUTLIER 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.464 1.938 . . . . 50.549999999999997 113.949 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.412 ' CD1' HD22 ' A' ' 56' ' ' LEU . 73.8 mt -85.07 112.49 22.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.965 0 CA-C-O 115.243 -2.313 . . . . 50.509999999999998 109.183 175.873 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -114.69 -171.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 126.059 2.099 . . . . 50.549999999999997 108.661 -176.869 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.1 tttp -59.59 145.2 45.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.255 1.502 . . . . 50.509999999999998 110.307 -176.948 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 34.6 mt-10 66.36 10.22 7.07 Favored 'General case' 0 C--O 1.258 1.507 0 N-CA-C 118.578 2.807 . . . . 50.619999999999997 118.578 179.57 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -74.32 138.05 43.25 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.845 -1.071 . . . . 50.509999999999998 112.668 174.796 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -112.05 128.47 56.2 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 115.14 1.533 . . . . 50.509999999999998 115.14 175.934 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 94.5 mt -103.47 138.93 39.51 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 114.635 -2.602 . . . . 50.509999999999998 107.85 175.072 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -96.33 143.56 27.29 Favored 'General case' 0 C--N 1.284 -2.273 0 O-C-N 127.374 2.921 . . . . 50.509999999999998 106.491 177.885 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.602 HD11 ' HB3' ' A' ' 41' ' ' GLN . 37.7 tp -110.86 115.86 30.25 Favored 'General case' 0 C--O 1.282 2.779 0 CA-C-O 117.733 -1.127 . . . . 50.509999999999998 112.625 176.572 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.62 143.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 119.541 1.064 . . . . 50.509999999999998 110.495 175.066 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 54.9 mt -101.61 102.85 13.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 117.019 2.229 . . . . 50.509999999999998 117.019 178.522 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -73.76 101.54 3.73 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 113.34 -3.219 . . . . 50.640000000000001 110.824 177.207 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.9 163.5 3.41 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.891 1.995 . . . . 50.509999999999998 112.581 -179.274 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.97 74.39 1.53 Allowed 'General case' 0 C--O 1.244 0.804 0 N-CA-C 105.945 -1.872 . . . . 50.640000000000001 105.945 -179.614 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.27 131.56 3.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 106.202 -2.759 . . . . 50.509999999999998 106.202 179.389 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.497 0 CA-C-O 116.331 -2.372 . . . . 50.509999999999998 116.984 179.311 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.509999999999998 111.006 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.549999999999997 116.688 178.266 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.509999999999998 111.74 173.324 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.509999999999998 115.113 179.52 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.509999999999998 107.106 175.824 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.509999999999998 103.747 -178.117 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.509999999999998 107.547 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.509999999999998 105.417 -177.96 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.509999999999998 110.637 179.919 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.509999999999998 119.029 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.509999999999998 114.413 174.998 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 113.052 176.185 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.509999999999998 114.549 179.78 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.509999999999998 111.59 178.086 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.509999999999998 110.023 -179.207 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.619999999999997 111.711 173.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 110.993 -177.951 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.619999999999997 108.19 174.632 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.509999999999998 111.964 177.711 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.509999999999998 113.164 -177.552 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.619999999999997 108.919 -179.0 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.509999999999998 108.06 175.711 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.509999999999998 117.251 175.811 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.619999999999997 111.876 176.964 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 110.173 -179.603 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.509999999999998 109.312 178.599 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.509999999999998 106.896 -179.77 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.509999999999998 114.569 176.92 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 176.011 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.423 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.509999999999998 104.805 179.898 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 40.0 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.549999999999997 111.202 179.415 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.619999999999997 113.082 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.509999999999998 116.338 -175.645 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.619999999999997 113.877 179.862 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.509999999999998 105.347 176.537 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.509999999999998 107.204 179.761 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.509999999999998 110.872 178.293 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.303 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.619999999999997 115.506 -177.444 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.549999999999997 113.269 178.741 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.608 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.549999999999997 109.19 -177.64 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.640000000000001 104.765 172.138 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.509999999999998 109.582 -177.498 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.509999999999998 112.344 -177.583 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.509999999999998 107.281 177.627 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.509999999999998 104.493 177.379 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 118.709 -179.624 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.509999999999998 114.674 177.718 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.549999999999997 109.652 174.548 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.509999999999998 110.096 -175.862 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.619999999999997 111.682 -177.729 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.619999999999997 118.573 -175.763 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.509999999999998 109.54 -177.249 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.640000000000001 110.879 176.534 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.509999999999998 116.693 177.156 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.509999999999998 110.756 177.237 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.509999999999998 119.247 -179.485 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.619999999999997 116.794 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.509999999999998 117.56 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.549999999999997 116.376 179.895 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 HD12 ' A' ' 56' ' ' LEU . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 115.487 175.861 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.549999999999997 107.756 -176.828 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.509999999999998 114.348 -176.929 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.619999999999997 107.384 179.576 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.509999999999998 106.402 174.815 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.509999999999998 110.362 175.94 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.509999999999998 107.602 175.106 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.509999999999998 109.96 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.509999999999998 108.197 176.547 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.509999999999998 102.361 175.117 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.509999999999998 113.908 178.441 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.640000000000001 110.488 177.138 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.509999999999998 104.971 -179.332 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.640000000000001 109.517 -179.572 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.509999999999998 111.861 179.397 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.509999999999998 108.119 179.238 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.509999999999998 111.006 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.549999999999997 116.688 178.266 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.509999999999998 111.74 173.324 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.509999999999998 115.113 179.52 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.509999999999998 107.106 175.824 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.509999999999998 103.747 -178.117 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.509999999999998 107.547 179.921 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.509999999999998 105.417 -177.96 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.509999999999998 110.637 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.509999999999998 119.029 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.509999999999998 114.413 174.998 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 113.052 176.185 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.509999999999998 114.549 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.509999999999998 111.59 178.086 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.509999999999998 110.023 -179.207 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.619999999999997 111.711 173.943 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 110.993 -177.951 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.619999999999997 108.19 174.632 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.509999999999998 111.964 177.711 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.509999999999998 113.164 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.619999999999997 108.919 -179.0 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.509999999999998 108.06 175.711 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.509999999999998 117.251 175.811 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.619999999999997 111.876 176.964 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 110.173 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.509999999999998 109.312 178.599 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.509999999999998 106.896 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.509999999999998 114.569 176.92 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 176.011 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.423 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.509999999999998 104.805 179.898 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 40.0 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.549999999999997 111.202 179.415 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.619999999999997 113.082 179.182 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.509999999999998 116.338 -175.645 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.619999999999997 113.877 179.862 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.509999999999998 105.347 176.537 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.509999999999998 107.204 179.761 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.509999999999998 110.872 178.293 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.303 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.619999999999997 115.506 -177.444 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.549999999999997 113.269 178.741 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.608 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.549999999999997 109.19 -177.64 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.640000000000001 104.765 172.138 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.509999999999998 109.582 -177.498 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.509999999999998 112.344 -177.583 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.509999999999998 107.281 177.627 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.509999999999998 104.493 177.379 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 118.709 -179.624 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.509999999999998 114.674 177.718 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.549999999999997 109.652 174.548 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.509999999999998 110.096 -175.862 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.619999999999997 111.682 -177.729 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.619999999999997 118.573 -175.763 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.509999999999998 109.54 -177.249 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.640000000000001 110.879 176.534 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.509999999999998 116.693 177.156 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.509999999999998 110.756 177.237 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.509999999999998 119.247 -179.485 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.619999999999997 116.794 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.509999999999998 117.56 179.269 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.549999999999997 116.376 179.895 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 HD12 ' A' ' 56' ' ' LEU . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 115.487 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.549999999999997 107.756 -176.828 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.509999999999998 114.348 -176.929 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.619999999999997 107.384 179.576 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.509999999999998 106.402 174.815 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.509999999999998 110.362 175.94 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.509999999999998 107.602 175.106 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.509999999999998 109.96 177.938 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.509999999999998 108.197 176.547 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.509999999999998 102.361 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.509999999999998 113.908 178.441 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.640000000000001 110.488 177.138 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.509999999999998 104.971 -179.332 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.640000000000001 109.517 -179.572 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.509999999999998 111.861 179.397 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.509999999999998 108.119 179.238 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 108.426 -0.953 . . . . 50.509999999999998 108.426 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -94.3 140.95 29.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 126.951 2.657 . . . . 50.549999999999997 106.368 178.272 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -126.22 -179.35 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-O 116.017 -1.944 . . . . 50.509999999999998 109.918 173.348 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.91 101.28 5.78 Favored 'General case' 0 N--CA 1.512 2.626 1 O-C-N 130.414 4.821 . . . . 50.509999999999998 114.319 179.567 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.25 123.7 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.488 -3.149 . . . . 50.509999999999998 110.223 175.79 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -117.24 118.42 32.23 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.291 4.119 . . . . 50.509999999999998 112.111 -178.079 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 9' ' ' THR . 5.1 t -104.0 167.38 9.8 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 116.911 2.189 . . . . 50.509999999999998 116.911 179.982 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.97 -17.79 63.98 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.807 1.78 . . . . 50.509999999999998 115.807 -178.008 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.511 ' H ' HG23 ' A' ' 7' ' ' THR . 53.3 p -89.25 1.7 55.33 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 115.767 -2.373 . . . . 50.509999999999998 109.718 179.889 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 -4.28 85.63 Favored Glycine 0 C--N 1.296 -1.655 0 O-C-N 120.115 -1.616 . . . . 50.509999999999998 117.096 179.84 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -67.5 110.0 3.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.825 -1.56 . . . . 50.509999999999998 109.337 174.976 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -81.38 133.74 35.46 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.665 2.478 . . . . 50.509999999999998 114.41 176.175 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.87 138.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 127.38 2.925 . . . . 50.509999999999998 118.105 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.3 m -106.96 130.0 54.68 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.222 -1.791 . . . . 50.509999999999998 111.438 178.138 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.428 HD11 ' CB ' ' A' ' 29' ' ' LYS . 49.3 tp -115.74 152.19 33.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 115.479 -2.201 . . . . 50.509999999999998 114.636 -179.279 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -115.01 107.48 15.42 Favored 'General case' 0 N--CA 1.5 2.04 1 O-C-N 129.273 4.108 . . . . 50.619999999999997 114.466 173.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG13 ' HG ' ' A' ' 15' ' ' LEU . 21.0 m -126.55 150.58 32.38 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 127.849 3.218 . . . . 50.509999999999998 118.53 -177.869 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 76.3 mt-10 -87.31 152.12 52.13 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 117.776 2.51 . . . . 50.619999999999997 117.776 174.655 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.46 39.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.556 2.171 . . . . 50.509999999999998 111.946 177.715 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -107.6 37.77 2.33 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 116.229 1.937 . . . . 50.509999999999998 116.229 -177.54 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -105.01 148.54 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 117.321 -1.751 . . . . 50.619999999999997 109.822 -178.965 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -92.88 159.57 15.3 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.087 -1.449 . . . . 50.509999999999998 107.087 175.728 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.12 -40.58 74.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 O-C-N 127.234 2.834 . . . . 50.509999999999998 108.203 175.801 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 52.0 mt-10 -54.08 -13.49 0.82 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.301 1.222 . . . . 50.619999999999997 114.301 177.015 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.35 -18.87 10.37 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.062 1.505 . . . . 50.549999999999997 115.062 -179.608 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.85 -57.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 101.545 -3.502 . . . . 50.509999999999998 101.545 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -57.09 -24.68 55.72 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 115.77 -0.65 . . . . 50.509999999999998 111.547 -179.775 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.68 -6.61 57.52 Favored 'General case' 0 C--O 1.278 2.553 0 N-CA-C 117.612 2.449 . . . . 50.509999999999998 117.612 176.862 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' CB ' HD11 ' A' ' 15' ' ' LEU . 63.3 mttp -91.9 -30.25 16.24 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 102.818 -3.03 . . . . 50.509999999999998 102.818 176.037 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.97 -45.0 98.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 103.108 -2.923 . . . . 50.509999999999998 103.108 179.858 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -52.09 -50.84 60.81 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 125.608 2.623 . . . . 50.549999999999997 108.453 179.419 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -56.66 -14.46 3.27 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 113.612 -1.631 . . . . 50.619999999999997 115.384 179.062 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 31.2 mmmt -117.46 -50.09 2.55 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.465 -2.094 . . . . 50.509999999999998 111.468 -175.688 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -94.93 -8.46 37.0 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 111.17 179.853 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.05 29.25 69.16 Favored Glycine 0 CA--C 1.477 -2.313 0 N-CA-C 107.777 -2.129 . . . . 50.509999999999998 107.777 176.518 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.61 122.74 45.09 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 105.386 -2.079 . . . . 50.509999999999998 105.386 179.75 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -56.95 136.96 79.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 123.177 2.584 . . . . 50.509999999999998 110.913 178.328 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.14 -32.19 92.67 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 120.713 0.942 . . . . 50.509999999999998 113.428 -179.347 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.38 -14.42 27.57 Favored 'General case' 0 C--O 1.262 1.723 0 N-CA-C 115.691 1.737 . . . . 50.619999999999997 115.691 -177.383 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -100.66 13.38 34.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.416 1.636 . . . . 50.549999999999997 115.416 178.788 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -116.42 133.12 56.38 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.363 2.03 . . . . 50.549999999999997 114.944 -177.592 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -116.97 124.77 50.17 Favored 'General case' 0 C--O 1.296 3.516 0 N-CA-C 105.245 -2.132 . . . . 50.640000000000001 105.245 172.145 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.83 133.86 49.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.735 -1.95 . . . . 50.509999999999998 105.735 -177.582 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -121.55 123.47 69.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.159 1.537 . . . . 50.509999999999998 111.155 -177.615 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -134.58 127.78 31.95 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 114.477 -1.238 . . . . 50.509999999999998 111.214 177.625 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.28 20.31 5.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.292 -2.231 . . . . 50.509999999999998 114.468 177.354 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.2 -8.25 67.13 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 120.673 3.029 . . . . 50.509999999999998 120.673 -179.589 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -98.67 144.68 27.68 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 118.052 0.926 . . . . 50.509999999999998 109.91 177.61 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -80.12 129.87 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.346 -2.835 . . . . 50.549999999999997 103.346 174.587 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.71 157.96 31.34 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 117.701 -1.142 . . . . 50.509999999999998 113.902 -175.911 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -100.66 154.23 18.76 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.131 -1.433 . . . . 50.619999999999997 107.131 -177.603 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 64.8 m-20 -72.02 -44.89 62.68 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 126.116 1.766 . . . . 50.619999999999997 111.718 -175.841 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.13 61.31 Favored Glycine 0 C--O 1.253 1.295 0 N-CA-C 120.191 2.836 . . . . 50.509999999999998 120.191 -177.249 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -95.87 169.05 10.26 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 120.066 -1.843 . . . . 50.640000000000001 112.669 176.524 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 70.7 p -100.41 153.92 18.94 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 114.167 1.173 . . . . 50.509999999999998 114.167 177.082 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.8 mt -55.28 -30.84 60.92 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.238 0.962 . . . . 50.509999999999998 112.059 177.254 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -75.23 -28.89 60.08 Favored 'General case' 0 C--O 1.268 2.039 0 C-N-CA 117.375 -1.73 . . . . 50.509999999999998 109.422 -179.434 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 55' ' ' THR . 90.8 m-20 -53.44 -42.38 67.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.457 1.123 . . . . 50.619999999999997 112.401 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -91.18 20.15 5.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 117.779 -1.105 . . . . 50.509999999999998 113.266 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 m120 44.71 24.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 120.024 3.342 . . . . 50.549999999999997 120.024 179.976 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.19 127.92 34.63 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 N-CA-C 101.628 -3.471 . . . . 50.509999999999998 101.628 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' LYS . 44.8 mt-30 -132.37 159.98 37.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 125.946 2.029 . . . . 50.549999999999997 106.699 -176.795 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 62' ' ' GLN . 34.3 ttpt -43.09 146.61 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.707 -1.96 . . . . 50.509999999999998 105.707 -177.019 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 66.4 50.5 1.29 Allowed 'General case' 0 C--O 1.257 1.477 0 CA-C-N 112.5 -2.136 . . . . 50.619999999999997 114.734 179.558 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -124.91 142.97 51.11 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.827 -1.079 . . . . 50.509999999999998 108.436 174.847 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -91.91 135.52 33.87 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.276 -0.868 . . . . 50.509999999999998 109.119 175.87 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.77 136.76 53.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 114.669 -2.586 . . . . 50.509999999999998 105.323 175.11 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -95.23 128.3 41.96 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 127.453 2.971 . . . . 50.509999999999998 112.17 177.899 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.45 119.26 32.89 Favored 'General case' 0 C--O 1.282 2.764 0 CA-C-O 117.71 -1.138 . . . . 50.509999999999998 113.789 176.557 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.07 140.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.676 -2.713 . . . . 50.509999999999998 103.676 175.084 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -111.39 135.12 52.39 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.023 1.12 . . . . 50.509999999999998 114.023 178.462 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -116.29 115.97 26.91 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 113.324 -3.227 . . . . 50.640000000000001 107.894 177.265 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -99.75 168.17 10.09 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 117.876 2.547 . . . . 50.509999999999998 117.876 -179.334 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -77.26 123.36 26.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 113.739 -1.573 . . . . 50.640000000000001 109.597 -179.602 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 154.42 5.85 Favored Glycine 0 C--O 1.244 0.724 0 CA-C-N 114.605 -1.179 . . . . 50.509999999999998 114.458 179.37 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 CA-C-O 116.37 -2.35 . . . . 50.509999999999998 118.366 179.233 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtp . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 104.905 -2.257 . . . . 50.509999999999998 104.905 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -87.34 142.13 28.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.957 2.66 . . . . 50.549999999999997 109.191 178.32 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.86 174.03 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 116.012 -1.947 . . . . 50.509999999999998 105.937 173.324 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -122.88 126.47 47.37 Favored 'General case' 0 N--CA 1.513 2.688 1 O-C-N 129.858 4.474 . . . . 50.509999999999998 113.505 179.558 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 114.86 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 113.373 -3.203 . . . . 50.509999999999998 115.835 175.753 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -79.76 121.1 24.93 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.346 4.154 . . . . 50.509999999999998 118.167 -178.045 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.68 HG22 HD23 ' A' ' 69' ' ' LEU . 24.7 p -96.64 177.16 5.75 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 120.831 3.641 . . . . 50.509999999999998 120.831 179.917 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.84 17.73 4.62 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.072 0.858 . . . . 50.509999999999998 109.674 -178.014 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -124.18 14.49 9.06 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 115.741 -2.384 . . . . 50.509999999999998 112.587 179.929 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.09 14.95 81.29 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 107.75 -2.14 . . . . 50.509999999999998 107.75 179.807 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -104.91 147.1 28.12 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 116.831 -1.557 . . . . 50.509999999999998 112.915 174.977 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -119.01 134.8 54.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 126.637 2.461 . . . . 50.509999999999998 106.354 176.113 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.1 mt -97.37 147.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.477 2.986 . . . . 50.509999999999998 112.74 179.706 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 m -109.99 125.13 52.56 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.287 -1.765 . . . . 50.509999999999998 106.692 178.136 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -126.12 141.89 51.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.875 -2.268 . . . . 50.509999999999998 104.875 -179.27 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -116.45 112.51 21.54 Favored 'General case' 0 N--CA 1.5 2.034 1 O-C-N 129.243 4.089 . . . . 50.619999999999997 109.392 173.962 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 56' ' ' LEU . 33.8 m -106.97 171.42 2.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.214 0 O-C-N 127.694 3.121 . . . . 50.509999999999998 114.6 -177.943 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 75.9 tt0 -111.3 143.15 27.84 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 112.21 -2.268 . . . . 50.619999999999997 106.057 174.556 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.2 Cg_exo -55.0 -24.44 39.78 Favored 'Trans proline' 0 C--N 1.32 -0.933 0 C-N-CA 122.564 2.176 . . . . 50.509999999999998 111.953 177.737 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -82.13 -17.8 45.14 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 114.348 1.24 . . . . 50.509999999999998 114.348 -177.537 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.93 163.42 27.49 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.451 -1.7 . . . . 50.619999999999997 112.123 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.3 p -95.62 -165.48 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.876 -0.602 . . . . 50.509999999999998 111.085 175.7 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -87.01 -40.86 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 127.171 2.794 . . . . 50.509999999999998 108.181 175.716 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 16.8 tp10 -52.46 -42.56 64.31 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 107.534 -1.284 . . . . 50.619999999999997 107.534 177.021 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.17 -49.77 72.97 Favored 'General case' 0 C--O 1.249 1.038 0 C-N-CA 124.352 1.061 . . . . 50.549999999999997 113.405 -179.656 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 22' ' ' THR . 91.1 t -57.78 -42.65 82.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.999 1.437 . . . . 50.509999999999998 111.95 178.645 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.615 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 93.3 mttt -65.95 -37.06 85.03 Favored 'General case' 0 C--O 1.257 1.481 0 N-CA-C 106.535 -1.654 . . . . 50.509999999999998 106.535 -179.693 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 31' ' ' GLN . . . -63.88 -45.19 90.53 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 113.186 0.809 . . . . 50.509999999999998 113.186 176.911 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -44.18 -36.7 2.77 Favored 'General case' 0 C--O 1.255 1.348 0 O-C-N 120.375 -1.453 . . . . 50.509999999999998 108.8 175.973 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.458 HG21 HE22 ' A' ' 41' ' ' GLN . 58.8 mt -72.88 -33.44 43.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.487 -0.885 . . . . 50.509999999999998 110.492 179.895 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 55.4 tt0 -54.95 -41.61 71.29 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.581 2.61 . . . . 50.549999999999997 108.434 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.73 -20.53 57.03 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 113.631 -1.622 . . . . 50.619999999999997 115.104 179.173 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 31.0 mmmt -110.37 -36.15 5.87 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.413 -2.115 . . . . 50.509999999999998 110.828 -175.703 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.55 -54.79 3.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 123.121 2.691 . . . . 50.619999999999997 108.627 179.861 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 18.77 4.06 Favored Glycine 0 CA--C 1.477 -2.288 0 N-CA-C 103.565 -3.814 . . . . 50.509999999999998 103.565 176.55 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.517 HG23 ' HD2' ' A' ' 37' ' ' PRO . 73.5 mt -103.74 135.89 19.29 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 116.785 2.143 . . . . 50.509999999999998 116.785 179.637 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HD2' HG23 ' A' ' 36' ' ' ILE . 78.2 Cg_exo -56.98 137.02 80.12 Favored 'Trans proline' 0 C--O 1.259 1.546 0 C-N-CA 123.084 2.523 . . . . 50.509999999999998 110.919 178.317 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 87.3 Cg_exo -57.23 -32.14 92.72 Favored 'Trans proline' 0 C--O 1.262 1.687 0 O-C-N 122.914 0.955 . . . . 50.509999999999998 113.391 -179.298 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -64.71 -18.68 65.22 Favored 'General case' 0 C--O 1.263 1.767 0 N-CA-C 117.422 2.379 . . . . 50.619999999999997 117.422 -177.401 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -81.45 -15.61 54.55 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.573 -1.33 . . . . 50.549999999999997 109.072 178.719 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.458 HE22 HG21 ' A' ' 30' ' ' ILE . 61.9 mt-30 -100.71 130.09 46.7 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 124.48 2.086 . . . . 50.549999999999997 112.444 -177.6 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -111.65 137.61 49.29 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.648 -1.644 . . . . 50.640000000000001 110.507 172.14 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.615 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 35.2 mt -116.24 129.45 56.29 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.904 1.446 . . . . 50.509999999999998 114.904 -177.456 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -114.77 127.15 72.42 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 O-C-N 125.085 1.491 . . . . 50.509999999999998 111.278 -177.6 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -139.81 107.06 5.5 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 106.99 -1.485 . . . . 50.509999999999998 106.99 177.652 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.43 41.73 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.228 -2.26 . . . . 50.509999999999998 105.53 177.383 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.96 -51.51 2.0 Allowed Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 116.588 -179.605 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -40.2 148.32 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 116.747 2.128 . . . . 50.509999999999998 116.747 177.718 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -82.42 146.08 29.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.042 -2.207 . . . . 50.549999999999997 105.042 174.598 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -100.03 142.35 31.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.102 -1.444 . . . . 50.509999999999998 107.102 -175.888 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.04 156.55 17.85 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.106 -1.442 . . . . 50.619999999999997 107.106 -177.72 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 74.8 m-20 -82.99 -39.1 21.75 Favored 'General case' 0 C--O 1.264 1.837 0 C-N-CA 126.159 1.784 . . . . 50.619999999999997 108.242 -175.8 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.41 2.07 87.74 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 116.288 1.275 . . . . 50.509999999999998 116.288 -177.201 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -95.73 161.01 14.21 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 119.91 -1.935 . . . . 50.640000000000001 106.027 176.515 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 22.8 p -98.37 170.29 8.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.403 -0.962 . . . . 50.509999999999998 108.403 177.129 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 17' ' ' VAL . 4.1 mp -65.31 -16.91 64.07 Favored 'General case' 0 C--O 1.201 -1.498 0 N-CA-C 107.767 -1.198 . . . . 50.509999999999998 107.767 177.255 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 p -70.71 -23.66 62.51 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 116.47 2.026 . . . . 50.509999999999998 116.47 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.21 -37.66 80.96 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.107 2.262 . . . . 50.619999999999997 117.107 179.773 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -101.19 4.52 42.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 117.765 -1.112 . . . . 50.509999999999998 109.716 179.299 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 56.39 54.93 7.05 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 103.862 -2.644 . . . . 50.549999999999997 103.862 179.869 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.17 132.76 31.62 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 115.224 -2.322 . . . . 50.509999999999998 105.818 175.86 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -117.3 172.94 6.97 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.771 2.508 . . . . 50.549999999999997 117.771 -176.815 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -68.08 133.09 48.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 123.187 1.47 . . . . 50.509999999999998 113.737 -176.967 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.12 42.97 30.28 Favored 'General case' 0 C--O 1.256 1.436 0 N-CA-C 116.855 2.168 . . . . 50.619999999999997 116.855 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.6 p -85.46 166.27 16.48 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 104.315 -2.476 . . . . 50.509999999999998 104.315 174.796 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.9 p -114.94 132.72 56.47 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.816 -1.55 . . . . 50.509999999999998 106.816 175.975 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.6 mp -108.37 160.33 15.95 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 114.7 -2.572 . . . . 50.509999999999998 112.396 175.012 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.67 132.07 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.383 2.927 . . . . 50.509999999999998 109.765 177.947 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.68 HD23 HG22 ' A' ' 7' ' ' THR . 30.3 tp -112.78 125.37 54.26 Favored 'General case' 0 C--O 1.282 2.78 0 CA-C-O 117.657 -1.163 . . . . 50.509999999999998 109.467 176.525 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.84 139.97 39.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 105.165 -2.161 . . . . 50.509999999999998 105.165 175.087 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.2 mt -100.42 130.0 46.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.573 -2.01 . . . . 50.509999999999998 105.573 178.397 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -122.89 113.07 18.62 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 101.358 -3.571 . . . . 50.640000000000001 101.358 177.175 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.81 166.31 11.69 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.78 1.925 . . . . 50.509999999999998 111.032 -179.287 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.07 96.73 9.96 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 118.874 2.916 . . . . 50.640000000000001 118.874 -179.592 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.24 -168.62 12.63 Favored Glycine 0 C--O 1.243 0.679 0 N-CA-C 107.136 -2.385 . . . . 50.509999999999998 107.136 179.361 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.477 0 CA-C-O 116.31 -2.383 . . . . 50.509999999999998 110.028 179.212 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.483 ' CE ' ' HD2' ' A' ' 63' ' ' LYS . 81.4 mmm . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.081 0.771 . . . . 50.509999999999998 113.081 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -95.5 124.07 39.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.902 2.626 . . . . 50.549999999999997 115.59 178.29 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.39 152.72 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.984 -1.96 . . . . 50.509999999999998 109.264 173.317 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.557 ' CE2' ' OG1' ' A' ' 14' ' ' THR . 53.6 m-85 -106.52 141.71 37.36 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.386 4.804 . . . . 50.509999999999998 116.464 179.533 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HB ' HG12 ' A' ' 13' ' ' ILE . 85.9 t -113.13 110.4 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 113.435 -3.174 . . . . 50.509999999999998 110.211 175.719 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -83.34 130.74 35.07 Favored 'General case' 0 N--CA 1.505 2.276 1 O-C-N 129.353 4.158 . . . . 50.509999999999998 106.732 -178.064 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.66 -173.65 2.52 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 117.846 -1.073 . . . . 50.509999999999998 108.973 179.928 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -90.34 -16.81 28.46 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.854 1.427 . . . . 50.509999999999998 114.854 -177.959 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -101.33 -3.14 29.38 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 115.695 -2.402 . . . . 50.509999999999998 116.879 179.962 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.41 1.38 Allowed Glycine 0 C--N 1.297 -1.614 0 N-CA-C 117.366 1.706 . . . . 50.509999999999998 117.366 179.781 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -54.9 143.02 27.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 116.069 1.877 . . . . 50.509999999999998 116.069 175.013 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -124.14 136.45 54.22 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 126.619 2.449 . . . . 50.509999999999998 112.919 176.11 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.5 HG12 ' HB ' ' A' ' 5' ' ' VAL . 17.3 pt -106.67 125.18 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.464 2.978 . . . . 50.509999999999998 107.182 179.774 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.557 ' OG1' ' CE2' ' A' ' 4' ' ' PHE . 43.7 m -98.65 134.98 40.81 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.294 -1.762 . . . . 50.509999999999998 112.953 178.123 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -117.01 154.73 30.42 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 115.492 -2.194 . . . . 50.509999999999998 114.072 -179.29 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.7 tt0 -114.94 99.3 7.37 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 129.172 4.045 . . . . 50.619999999999997 109.17 174.005 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.88 155.46 15.07 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.781 3.175 . . . . 50.509999999999998 116.308 -177.967 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -107.3 135.33 19.67 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 104.518 -2.401 . . . . 50.619999999999997 104.518 174.63 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 57' ' ' SER . 84.3 Cg_exo -54.95 -24.52 39.72 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 122.54 2.16 . . . . 50.509999999999998 111.931 177.765 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -76.99 -0.23 23.63 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 118.102 -0.952 . . . . 50.509999999999998 109.269 -177.585 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.545 ' O ' ' HB ' ' A' ' 55' ' ' THR . 92.1 m-20 -72.76 178.21 4.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 117.378 -1.729 . . . . 50.619999999999997 109.31 -179.01 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.1 p -106.3 167.44 9.83 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 103.074 -2.936 . . . . 50.509999999999998 103.074 175.741 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 23' ' ' ILE . 13.1 mm -67.34 -45.99 84.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 O-C-N 126.975 2.672 . . . . 50.509999999999998 107.788 175.809 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -54.71 -48.41 72.52 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.42 -0.8 . . . . 50.619999999999997 112.376 177.017 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -48.61 -49.23 37.91 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.468 -1.308 . . . . 50.549999999999997 107.468 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 22' ' ' THR . 95.8 t -52.07 -52.65 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 125.069 1.481 . . . . 50.509999999999998 113.436 178.528 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -72.81 -23.05 60.73 Favored 'General case' 0 C--O 1.257 1.486 0 CA-C-N 115.755 -0.657 . . . . 50.509999999999998 109.356 -179.745 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.3 95.04 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.334 -2.099 . . . . 50.509999999999998 105.334 176.973 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.38 -48.81 60.04 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 114.995 1.48 . . . . 50.509999999999998 114.995 175.933 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -56.32 -52.6 49.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 103.796 -2.668 . . . . 50.509999999999998 103.796 179.871 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.498 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.6 tt0 -38.32 -73.56 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 125.567 2.603 . . . . 50.549999999999997 110.301 179.391 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -39.76 -59.13 1.22 Allowed 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.671 -1.604 . . . . 50.619999999999997 114.382 179.098 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -82.43 -42.66 18.28 Favored 'General case' 0 C--O 1.279 2.623 0 N-CA-C 119.941 3.312 . . . . 50.509999999999998 119.941 -175.677 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.18 -30.97 22.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 123.058 2.663 . . . . 50.619999999999997 105.776 179.828 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.63 22.76 23.08 Favored Glycine 0 CA--C 1.477 -2.31 0 N-CA-C 118.867 2.307 . . . . 50.509999999999998 118.867 176.564 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 59.2 mt -105.14 122.23 43.75 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 118.753 -1.179 . . . . 50.509999999999998 110.216 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -56.97 136.94 79.64 Favored 'Trans proline' 0 C--O 1.259 1.537 0 C-N-CA 123.207 2.605 . . . . 50.509999999999998 110.879 178.348 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.4 Cg_exo -57.15 -32.17 92.62 Favored 'Trans proline' 0 C--O 1.261 1.661 0 O-C-N 122.926 0.961 . . . . 50.509999999999998 113.486 -179.376 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.45 -0.33 1.88 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 119.973 -1.705 . . . . 50.619999999999997 115.303 -177.448 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -126.91 18.74 7.2 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.5 -1.375 . . . . 50.549999999999997 113.503 178.709 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.425 ' HG2' HD11 ' A' ' 69' ' ' LEU . 69.8 mt-30 -110.3 141.47 43.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.299 2.0 . . . . 50.549999999999997 110.246 -177.582 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -128.62 136.67 50.99 Favored 'General case' 0 C--O 1.297 3.557 0 CA-C-O 116.726 -1.607 . . . . 50.640000000000001 107.496 172.157 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 69' ' ' LEU . 60.3 mt -135.94 124.45 23.56 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.464 1.029 . . . . 50.509999999999998 110.586 -177.538 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -122.62 122.53 66.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.121 1.513 . . . . 50.509999999999998 108.685 -177.589 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -143.06 139.03 30.34 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 114.514 -1.221 . . . . 50.509999999999998 112.103 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 20.48 10.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 112.271 -2.24 . . . . 50.509999999999998 114.865 177.398 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -21.76 27.32 Favored Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 128.493 2.949 . . . . 50.509999999999998 109.173 -179.654 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.74 177.79 7.89 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 118.087 0.943 . . . . 50.509999999999998 111.707 177.65 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -109.59 149.59 29.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 123.99 0.806 . . . . 50.549999999999997 109.481 174.579 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.81 101.71 10.35 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 104.918 -2.253 . . . . 50.509999999999998 104.918 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -101.91 153.23 20.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.916 1.385 . . . . 50.619999999999997 113.765 -177.66 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.45 -44.55 96.15 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 115.969 1.84 . . . . 50.619999999999997 115.969 -175.795 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.99 -15.21 3.23 Favored Glycine 0 C--O 1.253 1.333 0 N-CA-C 116.118 1.207 . . . . 50.509999999999998 116.118 -177.226 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -131.37 145.78 51.99 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 118.838 2.903 . . . . 50.640000000000001 118.838 176.506 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 21' ' ' ASP . 70.7 p -68.94 172.35 6.74 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 115.279 1.585 . . . . 50.509999999999998 115.279 177.189 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG13 ' A' ' 61' ' ' ILE . 35.5 mt -59.47 -49.39 77.98 Favored 'General case' 0 C--O 1.201 -1.477 0 O-C-N 124.156 0.91 . . . . 50.509999999999998 108.789 177.188 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' PRO . 9.4 t -47.52 -47.87 27.66 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 117.298 -1.761 . . . . 50.509999999999998 112.454 -179.444 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -48.45 -26.36 2.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.236 1.569 . . . . 50.619999999999997 115.236 179.767 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 66.9 m-85 -95.01 5.8 50.88 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 117.793 2.516 . . . . 50.509999999999998 117.793 179.222 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.684 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 63.4 m-20 68.81 9.71 7.52 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 121.534 1.97 . . . . 50.549999999999997 114.52 179.909 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.539 HG13 HD22 ' A' ' 56' ' ' LEU . 26.6 mm -50.97 117.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.99 0 CA-C-O 115.141 -2.361 . . . . 50.509999999999998 109.155 175.776 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.684 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 72.2 mt-30 -123.93 179.53 4.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 126.147 2.155 . . . . 50.549999999999997 105.837 -176.811 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HD2' ' CE ' ' A' ' 1' ' ' MET . 82.9 tttt -68.2 146.52 53.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.202 1.477 . . . . 50.509999999999998 108.35 -176.921 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 46.8 67.4 0.79 Allowed 'General case' 0 C--O 1.256 1.429 0 N-CA-C 120.868 3.655 . . . . 50.619999999999997 120.868 179.538 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.5 p -121.04 172.07 8.21 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 106.966 -1.494 . . . . 50.509999999999998 106.966 174.798 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 p -111.96 118.17 34.73 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 115.604 1.705 . . . . 50.509999999999998 115.604 175.982 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.05 138.03 34.27 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 114.647 -2.596 . . . . 50.509999999999998 107.617 175.08 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -97.96 122.48 41.14 Favored 'General case' 0 C--N 1.285 -2.236 0 O-C-N 127.383 2.927 . . . . 50.509999999999998 112.859 177.886 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 43' ' ' LEU . 42.1 tp -90.14 131.91 35.73 Favored 'General case' 0 C--O 1.283 2.83 0 N-CA-C 115.551 1.686 . . . . 50.509999999999998 115.551 176.519 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -120.9 129.28 75.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 103.253 -2.869 . . . . 50.509999999999998 103.253 175.109 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.55 123.93 44.28 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.178 0.513 . . . . 50.509999999999998 110.13 178.424 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -112.19 91.44 3.66 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.41 -3.186 . . . . 50.640000000000001 110.839 177.247 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.87 163.0 28.61 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.811 1.945 . . . . 50.509999999999998 108.282 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.9 ttm105 -87.16 107.35 18.42 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 116.366 1.987 . . . . 50.640000000000001 116.366 -179.544 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.84 151.94 23.58 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 114.66 -1.154 . . . . 50.509999999999998 114.59 179.394 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 113.943 179.22 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 36.7 mmt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 105.584 -2.006 . . . . 50.509999999999998 105.584 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -100.73 135.85 41.53 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.965 2.666 . . . . 50.549999999999997 107.301 178.239 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.465 HD12 ' C ' ' A' ' 3' ' ' ILE . 2.8 pp -137.29 154.93 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 115.961 -1.971 . . . . 50.509999999999998 108.392 173.316 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.39 149.49 23.12 Favored 'General case' 0 N--CA 1.511 2.602 1 O-C-N 130.475 4.86 . . . . 50.509999999999998 115.331 179.558 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.52 122.11 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 101.949 -3.352 . . . . 50.509999999999998 101.949 175.73 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.503 2.198 1 O-C-N 129.322 4.139 . . . . 50.509999999999998 105.737 -178.074 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -87.31 -171.97 3.72 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 117.746 -1.121 . . . . 50.509999999999998 111.573 179.983 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.94 19.73 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.085 0.866 . . . . 50.509999999999998 112.175 -177.974 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -130.8 -14.49 3.56 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 115.706 -2.398 . . . . 50.509999999999998 115.874 179.921 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.83 29.21 4.45 Favored Glycine 0 C--N 1.296 -1.672 0 O-C-N 120.006 -1.684 . . . . 50.509999999999998 109.105 179.833 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.67 123.0 47.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 116.891 -1.528 . . . . 50.509999999999998 111.611 174.997 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p -109.21 131.94 54.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 118.001 2.593 . . . . 50.509999999999998 118.001 176.14 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -113.07 157.4 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 127.209 2.818 . . . . 50.509999999999998 106.143 179.741 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -112.83 140.13 47.88 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.274 -1.77 . . . . 50.509999999999998 109.73 178.131 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 mt -122.1 171.16 9.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 115.488 -2.196 . . . . 50.509999999999998 113.214 -179.293 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' H ' ' HE2' ' A' ' 29' ' ' LYS . 71.7 tt0 -128.94 109.85 11.59 Favored 'General case' 0 N--CA 1.5 2.032 1 O-C-N 129.104 4.003 . . . . 50.619999999999997 112.573 173.976 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.22 172.36 8.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.722 3.139 . . . . 50.509999999999998 114.387 -177.939 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.75 150.33 75.49 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 112.224 -2.262 . . . . 50.619999999999997 108.179 174.638 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.9 -24.53 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.562 2.174 . . . . 50.509999999999998 111.887 177.744 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -81.36 -19.96 41.63 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 118.154 -0.926 . . . . 50.509999999999998 109.737 -177.52 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.63 139.59 58.78 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.352 -1.739 . . . . 50.619999999999997 108.165 -179.053 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 156.03 18.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 105.125 -2.176 . . . . 50.509999999999998 105.125 175.691 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -49.24 -33.66 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 O-C-N 127.201 2.813 . . . . 50.509999999999998 112.734 175.787 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -72.37 -16.61 61.86 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 113.917 1.08 . . . . 50.619999999999997 113.917 177.034 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 25' ' ' ASN . 64.4 t-20 -98.7 -9.0 25.22 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 109.217 -179.663 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -91.32 -43.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 104.981 -2.229 . . . . 50.509999999999998 104.981 178.588 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' ILE . 53.8 mtmt -64.38 -58.41 6.56 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 113.294 0.85 . . . . 50.509999999999998 113.294 -179.806 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.8 -34.11 3.51 Favored 'General case' 0 C--O 1.279 2.608 0 CA-C-N 117.984 0.356 . . . . 50.509999999999998 110.058 176.851 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' A' ' 16' ' ' GLU . 66.1 tttp -62.84 -31.89 73.0 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.383 -1.448 . . . . 50.509999999999998 109.787 175.95 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 27' ' ' LYS . 70.0 mt -77.42 -35.03 21.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 105.709 -1.96 . . . . 50.509999999999998 105.709 179.903 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.724 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 17.8 tm0? -47.11 -36.72 8.69 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 125.564 2.602 . . . . 50.549999999999997 115.246 179.46 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -69.58 -32.24 70.89 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 113.664 -1.607 . . . . 50.619999999999997 113.743 179.131 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -99.77 -7.21 25.8 Favored 'General case' 0 C--O 1.279 2.641 0 C-N-CA 116.473 -2.091 . . . . 50.509999999999998 115.925 -175.671 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -121.97 -32.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 123.063 2.665 . . . . 50.619999999999997 110.136 179.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.55 12.57 60.88 Favored Glycine 0 CA--C 1.478 -2.222 0 N-CA-C 104.703 -3.359 . . . . 50.509999999999998 104.703 176.543 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.9 mm -98.3 125.64 42.63 Favored Pre-proline 0 C--O 1.245 0.818 0 N-CA-C 104.462 -2.422 . . . . 50.509999999999998 104.462 179.653 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 78.2 Cg_exo -57.04 136.94 79.66 Favored 'Trans proline' 0 C--O 1.259 1.528 0 C-N-CA 123.154 2.569 . . . . 50.509999999999998 110.922 178.353 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.724 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.4 Cg_exo -57.18 -32.17 92.7 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.918 0.957 . . . . 50.509999999999998 113.398 -179.268 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.45 -18.75 65.54 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 119.918 -1.739 . . . . 50.619999999999997 106.65 -177.489 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.505 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 77.9 mt-30 -93.36 -1.29 56.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.23 1.937 . . . . 50.549999999999997 116.23 178.724 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 57.6 mt-30 -86.74 151.48 23.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.363 2.03 . . . . 50.549999999999997 110.256 -177.575 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.576 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 75.3 ttt180 -133.54 106.96 7.72 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.671 -1.633 . . . . 50.640000000000001 109.224 172.151 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -98.05 136.33 38.46 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.483 1.038 . . . . 50.509999999999998 113.488 -177.472 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.75 124.97 57.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 O-C-N 125.111 1.507 . . . . 50.509999999999998 113.16 -177.608 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -138.35 118.08 13.15 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 114.472 1.286 . . . . 50.509999999999998 114.472 177.673 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 35.57 18.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.291 -2.232 . . . . 50.509999999999998 106.186 177.349 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 8.0 84.69 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 128.437 2.922 . . . . 50.509999999999998 116.237 -179.596 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -101.87 141.45 34.7 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 118.058 0.929 . . . . 50.509999999999998 113.213 177.665 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -84.46 120.73 26.65 Favored 'General case' 0 C--O 1.259 1.599 0 O-C-N 123.977 0.798 . . . . 50.549999999999997 109.235 174.599 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -60.98 126.23 26.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 110.757 -175.883 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.16 132.14 40.42 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.973 1.42 . . . . 50.619999999999997 114.002 -177.713 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.82 -58.31 5.01 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 103.631 -2.729 . . . . 50.619999999999997 103.631 -175.871 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.72 1.66 28.65 Favored Glycine 0 CA--C 1.493 -1.297 0 N-CA-C 118.34 2.096 . . . . 50.509999999999998 118.34 -177.174 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 58' ' ' ASP . 52.8 mmm-85 -109.81 144.96 37.52 Favored 'General case' 0 C--O 1.249 1.034 0 O-C-N 119.696 -2.061 . . . . 50.640000000000001 106.479 176.425 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -91.31 162.49 14.59 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 117.183 2.29 . . . . 50.509999999999998 117.183 177.109 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.712 ' HG ' ' HB ' ' A' ' 61' ' ' ILE . 2.7 mp -46.84 -25.92 0.86 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.14 0.9 . . . . 50.509999999999998 109.5 177.187 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.9 p -71.84 -36.91 70.3 Favored 'General case' 0 C--O 1.269 2.096 0 C-N-CA 117.314 -1.755 . . . . 50.509999999999998 114.309 -179.468 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB3' ' NH2' ' A' ' 54' ' ' ARG . 1.4 m-20 -62.2 -25.29 67.71 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.472 1.13 . . . . 50.619999999999997 113.699 179.812 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.46 24.09 11.59 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 112.609 179.193 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 t30 37.16 54.18 1.25 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 118.865 2.913 . . . . 50.549999999999997 118.865 179.896 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.712 ' HB ' ' HG ' ' A' ' 56' ' ' LEU . 40.9 mm -88.82 100.15 10.2 Favored 'Isoleucine or valine' 0 C--O 1.267 2.017 0 CA-C-O 115.144 -2.36 . . . . 50.509999999999998 112.488 175.861 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -108.85 -178.58 3.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.155 2.16 . . . . 50.549999999999997 111.715 -176.864 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.451 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 64.0 tttm -67.63 144.62 55.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 -176.935 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 67.43 21.82 9.55 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 118.641 2.83 . . . . 50.619999999999997 118.641 179.559 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -73.96 174.24 8.85 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.15 1.907 . . . . 50.509999999999998 116.15 174.857 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -117.2 110.56 18.29 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.472 1.656 . . . . 50.509999999999998 115.472 175.981 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.7 113.83 27.04 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 114.655 -2.593 . . . . 50.509999999999998 115.949 175.042 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.35 136.89 37.12 Favored 'General case' 0 C--N 1.285 -2.216 0 O-C-N 127.457 2.973 . . . . 50.509999999999998 115.542 177.905 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -106.95 114.68 28.91 Favored 'General case' 0 C--O 1.281 2.763 0 N-CA-C 115.546 1.684 . . . . 50.509999999999998 115.546 176.578 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.576 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -111.75 137.91 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 104.908 -2.256 . . . . 50.509999999999998 104.908 175.121 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.92 157.57 28.21 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.403 0.89 . . . . 50.509999999999998 113.403 178.467 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 ttm105 -132.03 77.31 1.75 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 101.997 -3.335 . . . . 50.640000000000001 101.997 177.184 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -84.24 114.39 21.79 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 125.803 1.939 . . . . 50.509999999999998 111.716 -179.306 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -70.31 108.67 4.31 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.709 -1.587 . . . . 50.640000000000001 112.725 -179.635 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 -170.9 13.48 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 107.962 -2.055 . . . . 50.509999999999998 107.962 179.407 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 106.944 -2.462 . . . . 50.509999999999998 106.944 179.161 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.478 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 23.9 mmt . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 118.802 -0.618 . . . . 50.509999999999998 111.202 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -92.41 147.35 22.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.941 2.65 . . . . 50.549999999999997 106.999 178.287 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.528 HD13 HG21 ' A' ' 17' ' ' VAL . 35.1 pt -145.94 151.47 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.453 -2.054 . . . . 50.509999999999998 105.453 173.347 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.434 ' CE1' HG22 ' A' ' 14' ' ' THR . 97.4 m-85 -103.19 143.52 32.52 Favored 'General case' 0 N--CA 1.512 2.671 1 O-C-N 130.502 4.876 . . . . 50.509999999999998 112.212 179.503 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.96 116.17 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 113.36 -3.21 . . . . 50.509999999999998 110.554 175.797 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HD3' HG22 ' A' ' 12' ' ' THR . 25.1 mmtp -73.39 160.74 31.34 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.363 4.165 . . . . 50.509999999999998 112.885 -178.08 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -134.49 -165.44 1.66 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.491 -1.3 . . . . 50.509999999999998 107.491 179.942 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.7 mt -94.73 -33.83 12.77 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 -177.965 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -75.68 -9.26 58.44 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 115.744 -2.383 . . . . 50.509999999999998 117.254 179.914 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.57 4.22 58.22 Favored Glycine 0 C--N 1.296 -1.642 0 O-C-N 120.194 -1.566 . . . . 50.509999999999998 116.153 179.748 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE3' HG22 ' A' ' 13' ' ' ILE . 50.6 tptt -76.08 129.01 36.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 116.838 -1.553 . . . . 50.509999999999998 109.37 175.061 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.507 HG22 ' HD3' ' A' ' 6' ' ' LYS . 33.9 p -111.93 107.91 17.07 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 107.119 176.215 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.482 HG22 ' HE3' ' A' ' 11' ' ' LYS . 26.9 pt -97.17 147.87 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 127.352 2.907 . . . . 50.509999999999998 114.29 179.643 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.434 HG22 ' CE1' ' A' ' 4' ' ' PHE . 20.7 p -94.13 153.75 17.94 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 101.438 -3.542 . . . . 50.509999999999998 101.438 178.164 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.33 149.27 49.69 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.64 -2.356 . . . . 50.509999999999998 104.64 -179.303 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -100.33 120.56 40.12 Favored 'General case' 0 N--CA 1.499 2.009 1 O-C-N 129.266 4.104 . . . . 50.619999999999997 109.741 173.955 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 3' ' ' ILE . 18.8 m -131.7 166.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.673 3.108 . . . . 50.509999999999998 107.743 -177.987 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 38.3 mt-10 -125.86 143.49 45.46 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 112.185 -2.28 . . . . 50.619999999999997 106.18 174.733 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 84.2 Cg_exo -54.94 -24.62 40.14 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.606 2.204 . . . . 50.509999999999998 111.905 177.702 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -69.87 -44.9 68.85 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 117.536 2.421 . . . . 50.509999999999998 117.536 -177.512 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.7 154.07 34.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 117.393 -1.723 . . . . 50.619999999999997 113.773 -178.992 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.416 ' C ' ' N ' ' A' ' 24' ' ' GLU . 44.9 p -84.5 157.79 21.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.834 1.05 . . . . 50.509999999999998 113.834 175.642 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -49.13 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 O-C-N 127.18 2.8 . . . . 50.509999999999998 105.858 175.793 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 22' ' ' THR . 41.2 tt0 -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 120.388 3.477 . . . . 50.619999999999997 120.388 177.05 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.409 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 73.1 m-80 -98.69 -38.02 9.27 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 102.963 -2.977 . . . . 50.549999999999997 102.963 -179.562 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.56 -59.0 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 125.069 1.481 . . . . 50.509999999999998 113.507 178.681 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 38' ' ' PRO . 54.8 pttt -53.11 -45.82 68.43 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 109.241 -0.652 . . . . 50.509999999999998 109.241 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.35 75.56 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 119.665 3.209 . . . . 50.509999999999998 119.665 176.797 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 94.1 mttt -52.92 -40.95 63.99 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.384 -1.447 . . . . 50.509999999999998 107.303 176.033 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . 87.1 mt -67.59 -21.94 28.0 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 N-CA-C 113.406 0.891 . . . . 50.509999999999998 113.406 179.882 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -58.57 -33.96 70.53 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.586 2.612 . . . . 50.549999999999997 106.395 179.473 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.06 -27.86 67.72 Favored 'General case' 0 C--O 1.253 1.271 0 N-CA-C 116.411 2.004 . . . . 50.619999999999997 116.411 179.16 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -107.08 -26.14 11.26 Favored 'General case' 0 C--O 1.279 2.643 0 C-N-CA 116.473 -2.091 . . . . 50.509999999999998 113.955 -175.669 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -109.22 -46.74 3.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.074 2.67 . . . . 50.619999999999997 110.337 179.869 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 10.1 20.56 Favored Glycine 0 CA--C 1.477 -2.292 0 N-CA-C 110.097 -1.201 . . . . 50.509999999999998 110.097 176.575 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 36.9 mm -83.42 124.21 75.98 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 106.671 -1.603 . . . . 50.509999999999998 106.671 179.693 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -57.05 136.92 79.54 Favored 'Trans proline' 0 C--O 1.259 1.554 0 C-N-CA 123.159 2.573 . . . . 50.509999999999998 110.883 178.327 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 88.3 Cg_exo -57.17 -32.19 92.71 Favored 'Trans proline' 0 C--O 1.261 1.64 0 O-C-N 122.886 0.94 . . . . 50.509999999999998 113.363 -179.265 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.99 -15.48 63.04 Favored 'General case' 0 C--O 1.262 1.722 0 O-C-N 119.92 -1.737 . . . . 50.619999999999997 108.114 -177.41 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.4 12.92 35.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.971 1.471 . . . . 50.549999999999997 114.971 178.758 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -114.94 119.67 37.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.428 2.061 . . . . 50.549999999999997 110.587 -177.705 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -119.92 116.9 26.74 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.694 -1.622 . . . . 50.640000000000001 107.394 172.178 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.02 133.4 44.47 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.153 1.538 . . . . 50.509999999999998 115.153 -177.548 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -115.83 124.87 72.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 N-CA-C 117.106 2.261 . . . . 50.509999999999998 117.106 -177.6 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -126.13 118.2 24.74 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.573 -1.194 . . . . 50.509999999999998 112.605 177.617 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.69 40.68 29.09 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.276 -2.238 . . . . 50.509999999999998 111.591 177.391 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 6.6 42.62 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 128.391 2.9 . . . . 50.509999999999998 112.91 -179.584 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -91.22 127.06 36.51 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.284 -1.376 . . . . 50.509999999999998 107.284 177.699 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -76.64 122.19 24.31 Favored 'General case' 0 C--O 1.26 1.611 0 O-C-N 123.971 0.794 . . . . 50.549999999999997 109.141 174.621 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 mt -81.03 155.51 26.32 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 116.588 2.07 . . . . 50.509999999999998 116.588 -175.884 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 41.3 tp10 -106.01 142.11 36.27 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 125.024 1.452 . . . . 50.619999999999997 113.709 -177.755 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -59.96 -32.2 70.59 Favored 'General case' 0 C--O 1.263 1.794 0 C-N-CA 126.131 1.772 . . . . 50.619999999999997 111.404 -175.75 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -101.06 38.25 3.23 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 124.334 0.969 . . . . 50.509999999999998 113.772 -177.235 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -134.2 159.04 42.12 Favored 'General case' 0 C--O 1.248 1.009 0 O-C-N 118.037 -3.037 . . . . 50.640000000000001 105.106 176.464 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -91.02 172.07 8.83 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.022 0.929 . . . . 50.509999999999998 112.063 177.091 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.98 -37.87 66.87 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.193 0.933 . . . . 50.509999999999998 108.486 177.225 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 19' ' ' PRO . 47.2 t -64.11 -39.0 93.1 Favored 'General case' 0 C--O 1.268 2.04 0 N-CA-C 116.601 2.074 . . . . 50.509999999999998 116.601 -179.401 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -55.55 -23.84 28.94 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.418 1.104 . . . . 50.619999999999997 111.692 179.773 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -97.52 -0.18 46.43 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 117.722 -1.133 . . . . 50.509999999999998 113.931 179.234 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.5 t30 69.89 21.34 6.35 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.36 1.985 . . . . 50.549999999999997 116.36 179.892 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.73 96.86 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.976 0 CA-C-O 115.206 -2.33 . . . . 50.509999999999998 112.232 175.858 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.442 ' O ' ' OG ' ' A' ' 65' ' ' SER . 21.7 pt20 -88.18 160.34 17.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 126.074 2.109 . . . . 50.549999999999997 111.758 -176.813 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 88.4 tttt -43.23 149.36 0.24 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.426 -2.065 . . . . 50.509999999999998 105.426 -177.034 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 97.6 mt-10 52.64 74.28 0.29 Allowed 'General case' 0 C--O 1.257 1.493 0 CA-C-N 112.522 -2.127 . . . . 50.619999999999997 107.909 179.633 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 69.1 m -119.45 132.39 55.79 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.743 -1.117 . . . . 50.509999999999998 111.249 174.801 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.3 m -81.43 121.37 26.17 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 118.187 -0.911 . . . . 50.509999999999998 113.287 175.94 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -111.56 143.93 41.62 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.707 -2.568 . . . . 50.509999999999998 111.404 175.06 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -94.79 136.66 34.83 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 126.809 2.568 . . . . 50.509999999999998 108.367 177.914 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 65.9 tp -93.09 118.96 31.8 Favored 'General case' 0 C--O 1.282 2.794 0 CA-C-O 117.609 -1.186 . . . . 50.509999999999998 110.624 176.517 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.9 121.96 66.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.558 -1.275 . . . . 50.509999999999998 107.558 175.071 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.8 mt -96.01 128.18 42.67 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.674 0.62 . . . . 50.509999999999998 112.674 178.403 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 60.8 ttt85 -113.69 69.62 0.71 Allowed 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 120.313 3.449 . . . . 50.640000000000001 120.313 177.305 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.57 142.23 28.6 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 125.872 1.982 . . . . 50.509999999999998 114.841 -179.382 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -91.21 85.94 6.02 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.801 -179.629 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.3 -161.7 28.35 Favored Glycine 0 C--O 1.243 0.699 0 N-CA-C 108.705 -1.758 . . . . 50.509999999999998 108.705 179.339 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 116.322 -2.376 . . . . 50.509999999999998 111.287 179.257 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mmt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 101.467 -3.531 . . . . 50.509999999999998 101.467 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -103.85 129.51 51.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 126.961 2.663 . . . . 50.549999999999997 107.932 178.256 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 pt -119.72 157.49 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 116.04 -1.933 . . . . 50.509999999999998 110.386 173.353 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -106.23 139.21 41.1 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.407 4.817 . . . . 50.509999999999998 112.035 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -113.86 101.58 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.359 -3.21 . . . . 50.509999999999998 108.884 175.81 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -66.76 147.0 53.84 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.463 4.227 . . . . 50.509999999999998 112.322 -178.097 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.513 HG22 HD23 ' A' ' 69' ' ' LEU . 41.6 p -135.64 170.39 16.03 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.768 -1.111 . . . . 50.509999999999998 108.494 179.959 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -91.4 29.96 1.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.967 0.792 . . . . 50.509999999999998 112.414 -177.966 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.3 p -130.55 18.67 5.25 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 115.677 -2.409 . . . . 50.509999999999998 117.199 179.904 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.92 51.15 25.47 Favored Glycine 0 C--N 1.297 -1.591 0 O-C-N 120.109 -1.619 . . . . 50.509999999999998 111.271 179.763 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -160.2 123.69 3.55 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 115.225 1.565 . . . . 50.509999999999998 115.225 175.02 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -83.89 135.15 34.6 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 126.666 2.479 . . . . 50.509999999999998 114.566 176.137 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 mm -108.51 133.79 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.562 3.039 . . . . 50.509999999999998 106.079 179.717 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.8 p -104.27 154.31 19.95 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.553 2.057 . . . . 50.509999999999998 116.553 178.073 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.5 mt -140.62 139.65 34.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.49 -2.195 . . . . 50.509999999999998 113.33 -179.261 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.61 113.52 25.6 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 128.66 3.725 . . . . 50.619999999999997 103.548 173.988 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.24 -166.26 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.271 0 O-C-N 127.518 3.011 . . . . 50.509999999999998 105.312 -177.911 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -150.56 156.87 36.66 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.256 -2.247 . . . . 50.619999999999997 109.062 174.621 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.96 -24.53 39.89 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.953 177.754 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.5 p -93.52 -7.36 44.47 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 115.541 1.682 . . . . 50.509999999999998 115.541 -177.546 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.21 135.6 52.28 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.29 -1.764 . . . . 50.619999999999997 114.821 -179.017 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -77.43 160.34 28.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.851 -0.613 . . . . 50.509999999999998 110.904 175.78 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 15.5 mm -55.3 -40.03 54.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.153 2.783 . . . . 50.509999999999998 109.387 175.808 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -61.64 -40.77 96.09 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.422 -0.798 . . . . 50.619999999999997 111.568 176.95 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -64.05 -45.44 88.79 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 124.377 1.071 . . . . 50.549999999999997 112.781 -179.613 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 56' ' ' LEU . 91.5 t -55.83 -55.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.344 -1.724 . . . . 50.509999999999998 106.344 178.613 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -48.2 -30.12 4.37 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 113.072 0.768 . . . . 50.509999999999998 113.072 -179.813 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -35.88 74.5 Favored 'General case' 0 C--O 1.278 2.6 0 N-CA-C 114.379 1.251 . . . . 50.509999999999998 114.379 176.846 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 29.3 mmtp -58.38 -43.36 88.45 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 104.256 -2.498 . . . . 50.509999999999998 104.256 176.03 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.77 -35.05 53.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.287 0 N-CA-C 115.219 1.563 . . . . 50.509999999999998 115.219 179.93 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -60.64 -32.07 71.25 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 125.593 2.616 . . . . 50.549999999999997 112.391 179.427 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -71.7 -52.1 19.53 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 109.803 179.131 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -78.82 -47.44 16.67 Favored 'General case' 0 C--O 1.279 2.616 0 C-N-CA 116.465 -2.094 . . . . 50.509999999999998 116.073 -175.656 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.79 -14.26 40.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 123.079 2.672 . . . . 50.619999999999997 117.047 179.819 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 13.02 83.97 Favored Glycine 0 CA--C 1.477 -2.32 0 CA-C-O 120.065 -0.297 . . . . 50.509999999999998 112.612 176.539 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.414 HG22 HE21 ' A' ' 41' ' ' GLN . 68.0 mt -91.33 123.47 64.0 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 115.554 1.687 . . . . 50.509999999999998 115.554 179.7 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.9 Cg_exo -56.93 136.9 79.33 Favored 'Trans proline' 0 C--O 1.26 1.617 0 C-N-CA 123.109 2.539 . . . . 50.509999999999998 111.006 178.268 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.2 Cg_exo -57.2 -32.07 92.45 Favored 'Trans proline' 0 C--O 1.261 1.651 0 O-C-N 122.83 0.911 . . . . 50.509999999999998 113.45 -179.249 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -59.61 -12.49 6.81 Favored 'General case' 0 C--O 1.262 1.729 0 N-CA-C 117.768 2.507 . . . . 50.619999999999997 117.768 -177.463 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.517 ' O ' HD23 ' A' ' 71' ' ' LEU . 79.2 mt-30 -112.23 14.71 20.57 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.519 -1.363 . . . . 50.549999999999997 113.661 178.718 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.414 HE21 HG22 ' A' ' 36' ' ' ILE . 63.0 mt-30 -107.46 131.67 54.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.4 2.048 . . . . 50.549999999999997 115.36 -177.612 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.578 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 33.1 ttm180 -115.58 113.85 24.15 Favored 'General case' 0 C--O 1.296 3.524 0 CA-C-O 116.592 -1.671 . . . . 50.640000000000001 112.565 172.148 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.92 130.08 46.06 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 104.507 -2.405 . . . . 50.509999999999998 104.507 -177.501 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.574 HD11 ' HD3' ' A' ' 42' ' ' ARG . 89.4 mt -125.95 130.97 72.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.078 1.486 . . . . 50.509999999999998 112.746 -177.565 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.89 103.38 8.02 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 114.505 -1.225 . . . . 50.509999999999998 111.211 177.572 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.09 48.39 22.4 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.211 -2.268 . . . . 50.509999999999998 108.317 177.368 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.37 72.16 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 128.445 2.926 . . . . 50.509999999999998 115.154 -179.539 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -99.28 138.32 36.54 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.328 -0.99 . . . . 50.509999999999998 108.328 177.6 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -88.78 114.78 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.02 0.825 . . . . 50.549999999999997 112.617 174.616 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.36 128.18 35.67 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 117.679 -1.153 . . . . 50.509999999999998 113.899 -175.919 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -92.88 137.46 32.34 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.956 1.41 . . . . 50.619999999999997 107.43 -177.593 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.04 -44.14 67.15 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 118.367 2.728 . . . . 50.619999999999997 118.367 -175.784 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.38 -22.32 77.62 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 119.54 2.576 . . . . 50.509999999999998 119.54 -177.225 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -82.99 158.99 22.31 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 119.716 -2.049 . . . . 50.640000000000001 112.849 176.485 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -88.03 160.7 17.74 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 117.629 2.455 . . . . 50.509999999999998 117.629 177.044 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -55.61 -31.01 61.91 Favored 'General case' 0 C--O 1.2 -1.526 0 CA-C-N 115.473 -0.785 . . . . 50.509999999999998 110.912 177.243 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -71.62 -27.2 62.95 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.301 -1.76 . . . . 50.509999999999998 112.059 -179.485 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.96 -13.95 62.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.461 1.282 . . . . 50.619999999999997 114.461 179.769 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.602 ' HB2' HG12 ' A' ' 61' ' ' ILE . 53.5 m-85 -103.19 14.39 31.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 115.497 1.665 . . . . 50.509999999999998 115.497 179.25 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.9 t30 64.78 19.81 11.94 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 121.48 1.946 . . . . 50.549999999999997 109.459 179.855 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 59' ' ' TYR . 34.8 mm -81.23 99.69 4.76 Favored 'Isoleucine or valine' 0 C--O 1.267 2.026 0 CA-C-O 115.209 -2.329 . . . . 50.509999999999998 113.777 175.847 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -124.27 -115.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.101 2.125 . . . . 50.549999999999997 112.77 -176.851 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.77 128.72 35.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.259 1.504 . . . . 50.509999999999998 111.915 -176.95 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 51.65 39.23 24.68 Favored 'General case' 0 C--O 1.257 1.47 0 CA-C-N 112.516 -2.129 . . . . 50.619999999999997 115.775 179.52 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -71.27 148.27 47.33 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.842 -1.072 . . . . 50.509999999999998 110.018 174.8 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.9 m -127.51 116.05 19.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 118.26 -0.876 . . . . 50.509999999999998 112.222 175.938 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.42 142.45 27.41 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.76 -2.543 . . . . 50.509999999999998 111.856 175.043 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -88.78 138.29 31.55 Favored 'General case' 0 C--N 1.286 -2.182 0 O-C-N 126.818 2.574 . . . . 50.509999999999998 107.324 177.925 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 HG22 ' A' ' 7' ' ' THR . 68.0 tp -106.98 123.55 48.35 Favored 'General case' 0 C--O 1.283 2.852 0 CA-C-O 117.632 -1.175 . . . . 50.509999999999998 109.246 176.544 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.6 t -135.22 126.99 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 119.596 1.089 . . . . 50.509999999999998 110.346 175.059 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 40' ' ' GLN . 71.2 mt -70.21 139.9 52.36 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 120.417 3.488 . . . . 50.509999999999998 120.417 178.446 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -118.27 106.46 12.82 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.327 -3.225 . . . . 50.640000000000001 102.491 177.314 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' A' ' 71' ' ' LEU . 6.4 mp -104.75 127.81 52.66 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.955 . . . . 50.509999999999998 115.508 -179.314 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -90.02 84.37 6.16 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.751 -1.568 . . . . 50.640000000000001 107.806 -179.648 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.21 157.04 7.21 Favored Glycine 0 C--O 1.244 0.744 1 N-CA-C 102.525 -4.23 . . . . 50.509999999999998 102.525 179.367 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 N-CA-C 105.58 -3.008 . . . . 50.509999999999998 105.58 179.227 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 108.225 -1.028 . . . . 50.509999999999998 108.225 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -102.06 133.53 46.75 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 126.889 2.618 . . . . 50.549999999999997 107.185 178.29 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.35 169.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 N-CA-C 104.745 -2.317 . . . . 50.509999999999998 104.745 173.37 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.97 123.73 40.51 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.427 4.829 . . . . 50.509999999999998 111.603 179.588 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.18 110.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 113.349 -3.215 . . . . 50.509999999999998 109.404 175.788 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -99.18 146.85 25.72 Favored 'General case' 0 N--CA 1.504 2.271 1 O-C-N 129.367 4.167 . . . . 50.509999999999998 112.42 -178.085 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -112.87 178.97 4.1 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.046 -2.946 . . . . 50.509999999999998 103.046 179.993 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.6 mt -91.53 3.7 54.35 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.111 0.882 . . . . 50.509999999999998 111.028 -178.036 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -91.96 -24.83 19.13 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 115.673 -2.411 . . . . 50.509999999999998 114.467 179.956 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.76 14.65 2.28 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 106.022 -2.831 . . . . 50.509999999999998 106.022 179.735 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -95.33 120.12 35.01 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 115.247 1.573 . . . . 50.509999999999998 115.247 174.971 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -119.53 108.56 14.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 126.679 2.487 . . . . 50.509999999999998 105.48 176.143 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 tt -103.19 146.02 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.442 2.964 . . . . 50.509999999999998 114.156 179.721 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 15' ' ' LEU . 98.5 m -97.93 155.76 16.93 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 117.27 -1.772 . . . . 50.509999999999998 111.194 178.092 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' N ' HG22 ' A' ' 14' ' ' THR . 12.6 tp -138.11 140.02 39.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 115.485 -2.198 . . . . 50.509999999999998 111.804 -179.239 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -103.11 115.05 29.85 Favored 'General case' 0 N--CA 1.5 2.042 1 O-C-N 129.187 4.055 . . . . 50.619999999999997 111.421 173.972 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.58 178.09 2.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 O-C-N 127.888 3.243 . . . . 50.509999999999998 113.093 -177.93 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 25.7 tt0 -102.01 149.97 37.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 112.196 -2.274 . . . . 50.619999999999997 106.082 174.622 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.93 -24.5 39.52 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.6 2.2 . . . . 50.509999999999998 111.948 177.691 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.6 p -120.14 22.07 11.55 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 119.795 3.257 . . . . 50.509999999999998 119.795 -177.528 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.0 152.19 42.65 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.44 -1.704 . . . . 50.619999999999997 108.547 -179.026 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 55' ' ' THR . 71.6 p -97.27 145.92 25.62 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.895 -0.593 . . . . 50.509999999999998 109.499 175.649 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 50.5 mm -42.64 -36.77 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 O-C-N 127.126 2.766 . . . . 50.509999999999998 113.586 175.789 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -44.53 -55.66 4.94 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.364 -0.835 . . . . 50.619999999999997 112.729 176.96 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -72.14 -46.02 58.19 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.361 1.064 . . . . 50.549999999999997 108.18 -179.645 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 23' ' ' ILE . 90.8 t -40.69 -62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.003 1.439 . . . . 50.509999999999998 108.535 178.54 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 53.3 mtmt -67.7 -16.32 64.08 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 115.288 1.588 . . . . 50.509999999999998 115.288 -179.74 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.69 -33.08 25.25 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.84 -0.43 . . . . 50.509999999999998 109.84 176.87 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -69.0 -46.77 67.19 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 103.278 -2.86 . . . . 50.509999999999998 103.278 176.025 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -55.78 -28.69 24.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.491 -0.883 . . . . 50.509999999999998 111.724 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -63.56 -35.55 80.85 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 125.604 2.621 . . . . 50.549999999999997 108.384 179.465 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -68.93 -55.07 12.12 Favored 'General case' 0 C--O 1.254 1.303 0 N-CA-C 117.122 2.267 . . . . 50.619999999999997 117.122 179.08 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -80.47 -42.47 22.52 Favored 'General case' 0 C--O 1.28 2.71 0 C-N-CA 116.447 -2.101 . . . . 50.509999999999998 111.603 -175.687 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -86.82 -50.12 6.95 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 123.096 2.68 . . . . 50.619999999999997 115.667 179.881 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 18.59 7.84 Favored Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 107.886 -2.086 . . . . 50.509999999999998 107.886 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 31.0 mm -98.62 120.63 58.62 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.794 -1.162 . . . . 50.509999999999998 112.326 179.689 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -56.99 136.9 79.49 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.202 2.601 . . . . 50.509999999999998 110.901 178.29 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.588 ' HA ' HE21 ' A' ' 41' ' ' GLN . 86.5 Cg_exo -57.15 -32.14 92.54 Favored 'Trans proline' 0 C--O 1.262 1.697 0 C-N-CA 120.682 0.921 . . . . 50.509999999999998 113.449 -179.336 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.11 -11.7 59.85 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 119.931 -1.731 . . . . 50.619999999999997 109.084 -177.42 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -98.78 2.92 47.35 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 110.585 178.764 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.588 HE21 ' HA ' ' A' ' 38' ' ' PRO . 54.8 mt-30 -102.27 118.77 37.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 124.348 2.023 . . . . 50.549999999999997 114.652 -177.588 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.539 ' HD2' ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp180 -102.17 118.5 37.02 Favored 'General case' 0 C--O 1.295 3.497 0 CA-C-O 116.732 -1.604 . . . . 50.640000000000001 107.566 172.165 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 50' ' ' LEU . 51.5 mt -109.72 119.77 40.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 50.509999999999998 112.721 -177.425 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.41 132.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 O-C-N 125.046 1.467 . . . . 50.509999999999998 113.525 -177.65 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.14 100.71 7.0 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 103.543 -2.762 . . . . 50.509999999999998 103.543 177.556 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 33.63 11.68 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.152 -2.294 . . . . 50.509999999999998 114.779 177.448 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.62 10.27 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 128.513 2.959 . . . . 50.509999999999998 113.266 -179.546 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -124.55 112.24 16.61 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 115.11 1.522 . . . . 50.509999999999998 115.11 177.713 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -58.12 113.61 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.135 2.272 . . . . 50.549999999999997 117.135 174.574 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 55.1 mt -65.15 150.05 48.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 112.936 -175.917 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 74.5 tt0 -108.04 135.09 49.99 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.544 1.153 . . . . 50.619999999999997 110.984 -177.684 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.616 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -53.02 -63.91 0.99 Allowed 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.115 1.766 . . . . 50.619999999999997 112.088 -175.806 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 -8.04 66.87 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 117.496 1.759 . . . . 50.509999999999998 117.496 -177.274 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -82.37 -173.1 4.37 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 120.037 -1.861 . . . . 50.640000000000001 107.531 176.492 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 22' ' ' THR . 38.9 p -127.59 158.2 38.14 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.549 1.315 . . . . 50.509999999999998 114.549 177.07 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.87 -39.82 69.08 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 106.456 -1.683 . . . . 50.509999999999998 106.456 177.242 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 59' ' ' TYR . 73.3 m -61.49 -43.84 98.15 Favored 'General case' 0 C--O 1.269 2.086 0 C-N-CA 117.299 -1.76 . . . . 50.509999999999998 108.829 -179.493 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.29 -4.26 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.214 1.19 . . . . 50.619999999999997 114.214 179.685 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 57' ' ' SER . 83.7 m-85 -122.94 9.7 9.42 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 116.44 2.015 . . . . 50.509999999999998 116.44 179.26 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 61.22 23.25 13.48 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 121.446 1.93 . . . . 50.549999999999997 113.53 179.944 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 61' ' ' ILE . 73.4 mt -73.93 94.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.198 -2.335 . . . . 50.509999999999998 116.274 175.836 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -87.7 159.23 18.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 126.031 2.082 . . . . 50.549999999999997 112.994 -176.81 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.461 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 79.5 tttt -54.64 154.34 5.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 123.235 1.493 . . . . 50.509999999999998 108.135 -176.958 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' OE2' ' HE2' ' A' ' 63' ' ' LYS . 42.6 mm-40 57.8 69.31 0.75 Allowed 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.476 -2.147 . . . . 50.619999999999997 106.143 179.613 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -143.08 129.82 20.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.775 -1.102 . . . . 50.509999999999998 112.761 174.823 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -72.78 130.16 39.84 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 118.121 2.637 . . . . 50.509999999999998 118.121 175.92 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.3 138.02 45.29 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.673 -2.584 . . . . 50.509999999999998 107.445 175.079 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -91.95 123.07 35.04 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 127.389 2.93 . . . . 50.509999999999998 113.659 177.848 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -105.84 103.06 12.48 Favored 'General case' 0 C--O 1.282 2.792 0 CA-C-O 117.657 -1.163 . . . . 50.509999999999998 113.918 176.511 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.5 138.9 33.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 119.538 1.063 . . . . 50.509999999999998 109.262 175.174 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.26 148.11 39.71 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 117.33 2.344 . . . . 50.509999999999998 117.33 178.479 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HD2' ' HD2' ' A' ' 42' ' ' ARG . 76.5 ttt-85 -132.41 87.36 2.42 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 113.375 -3.202 . . . . 50.640000000000001 104.574 177.22 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -79.2 167.47 20.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.814 1.946 . . . . 50.509999999999998 106.928 -179.344 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.39 63.58 1.12 Allowed 'General case' 0 C--O 1.244 0.772 0 N-CA-C 118.105 2.632 . . . . 50.640000000000001 118.105 -179.643 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.24 178.06 38.14 Favored Glycine 0 C--O 1.242 0.651 0 O-C-N 124.617 1.198 . . . . 50.509999999999998 112.85 179.403 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 115.437 179.204 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' CE ' ' HB2' ' A' ' 63' ' ' LYS . 82.0 mtp . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.993 -1.114 . . . . 50.509999999999998 107.993 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -84.43 140.22 31.67 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 126.976 2.673 . . . . 50.549999999999997 109.692 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.4 pt -133.64 159.58 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-O 115.982 -1.961 . . . . 50.509999999999998 107.126 173.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -117.16 135.69 53.58 Favored 'General case' 0 N--CA 1.512 2.639 1 O-C-N 130.48 4.863 . . . . 50.509999999999998 110.963 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 69.9 t -114.87 108.28 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 113.436 -3.173 . . . . 50.509999999999998 110.719 175.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' CD ' HG22 ' A' ' 12' ' ' THR . 35.1 mmtp -88.2 122.94 32.33 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.303 4.127 . . . . 50.509999999999998 111.031 -178.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.9 p -79.0 -162.49 0.39 Allowed 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.354 -2.091 . . . . 50.509999999999998 105.354 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -112.64 6.62 18.38 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.067 0.854 . . . . 50.509999999999998 112.102 -177.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -106.67 -27.84 10.57 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 115.702 -2.399 . . . . 50.509999999999998 106.563 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.2 0.65 2.11 Favored Glycine 0 C--N 1.296 -1.641 0 O-C-N 119.78 -1.825 . . . . 50.509999999999998 115.343 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -73.92 152.29 40.17 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.852 -1.547 . . . . 50.509999999999998 115.111 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.473 HG22 ' CD ' ' A' ' 6' ' ' LYS . 44.3 p -121.26 156.72 31.88 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 126.654 2.471 . . . . 50.509999999999998 108.939 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 62.7 mt -127.96 142.09 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.396 2.935 . . . . 50.509999999999998 111.49 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -111.92 134.28 53.57 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.163 -1.792 . . . . 50.509999999999998 106.163 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.566 HD23 ' HE2' ' A' ' 33' ' ' LYS . 96.0 mt -127.15 134.06 50.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.412 2.375 . . . . 50.509999999999998 117.412 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -99.55 96.16 7.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 128.807 3.817 . . . . 50.619999999999997 111.345 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -121.86 -175.02 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.267 0 O-C-N 127.603 3.064 . . . . 50.509999999999998 115.619 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CD ' ' OG ' ' A' ' 20' ' ' SER . 14.7 pt-20 -151.91 154.73 33.12 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.227 -2.26 . . . . 50.619999999999997 108.206 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.94 -24.51 39.61 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.575 2.184 . . . . 50.509999999999998 111.985 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.46 ' OG ' ' CD ' ' A' ' 18' ' ' GLU . 92.8 p -63.79 -30.86 71.91 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.142 -0.932 . . . . 50.509999999999998 111.755 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -69.62 149.63 47.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.357 -1.737 . . . . 50.619999999999997 115.373 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 55' ' ' THR . 33.0 p -93.58 169.62 10.2 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.827 -0.624 . . . . 50.509999999999998 109.549 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 42.3 mm -58.99 -25.6 30.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 O-C-N 127.189 2.806 . . . . 50.509999999999998 112.352 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -70.89 -46.41 62.64 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.047 2.24 . . . . 50.619999999999997 117.047 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -66.6 -50.34 63.37 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 124.31 1.044 . . . . 50.549999999999997 110.626 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.41 -31.39 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.932 1.395 . . . . 50.509999999999998 112.353 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 92.1 mttt -81.65 -19.97 40.63 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 105.184 -2.154 . . . . 50.509999999999998 105.184 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.33 -14.97 34.5 Favored 'General case' 0 C--O 1.278 2.58 0 N-CA-C 112.47 0.544 . . . . 50.509999999999998 112.47 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.7 mmmt -90.15 -35.2 15.53 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.338 -1.476 . . . . 50.509999999999998 107.719 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 61.0 mt -60.41 -29.4 44.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.53 -0.868 . . . . 50.509999999999998 112.135 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' ILE . 61.9 tt0 -49.94 -51.94 37.32 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 125.627 2.632 . . . . 50.549999999999997 104.767 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.9 m-20 -46.96 -41.37 16.06 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.619 -1.628 . . . . 50.619999999999997 112.33 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HE2' HD23 ' A' ' 15' ' ' LEU . 12.3 mptt -73.68 -41.77 62.19 Favored 'General case' 0 C--O 1.279 2.645 0 C-N-CA 116.464 -2.094 . . . . 50.509999999999998 114.312 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' OE2' HD11 ' A' ' 13' ' ' ILE . 30.1 mt-10 -113.98 -62.79 1.54 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 123.06 2.664 . . . . 50.619999999999997 109.956 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.82 -16.68 1.98 Allowed Glycine 0 CA--C 1.477 -2.288 0 CA-C-O 120.017 -0.324 . . . . 50.509999999999998 112.919 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.502 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.9 mm -58.06 128.86 82.04 Favored Pre-proline 0 C--O 1.244 0.768 0 N-CA-C 117.582 2.438 . . . . 50.509999999999998 117.582 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 77.9 Cg_exo -56.98 136.97 79.83 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.147 2.565 . . . . 50.509999999999998 110.869 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 87.7 Cg_exo -57.21 -32.09 92.54 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.861 0.927 . . . . 50.509999999999998 113.45 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.33 -26.89 67.5 Favored 'General case' 0 C--O 1.262 1.743 0 O-C-N 119.981 -1.699 . . . . 50.619999999999997 108.101 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -92.0 3.5 55.1 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.555 -1.341 . . . . 50.549999999999997 113.535 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 86.7 mt-30 -101.49 140.5 35.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 124.355 2.026 . . . . 50.549999999999997 109.8 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -134.88 148.66 50.15 Favored 'General case' 0 C--O 1.296 3.506 0 CA-C-O 116.696 -1.621 . . . . 50.640000000000001 107.468 172.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 93.0 mt -129.83 125.13 34.96 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.638 -1.245 . . . . 50.509999999999998 107.638 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.6 133.68 61.38 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 125.08 1.488 . . . . 50.509999999999998 112.789 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.57 110.91 5.81 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 107.086 -1.45 . . . . 50.509999999999998 107.086 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.02 30.76 4.36 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.254 -2.248 . . . . 50.509999999999998 115.498 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.93 -7.46 82.07 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 128.424 2.916 . . . . 50.509999999999998 116.734 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -80.43 119.52 23.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.047 0.924 . . . . 50.509999999999998 112.719 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -81.6 106.18 13.34 Favored 'General case' 0 C--O 1.259 1.583 0 O-C-N 123.936 0.773 . . . . 50.549999999999997 111.918 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.07 154.23 4.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 114.268 1.21 . . . . 50.509999999999998 114.268 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.5 132.35 51.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.144 2.275 . . . . 50.619999999999997 117.144 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -56.31 -5.02 0.16 Allowed 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.927 2.936 . . . . 50.619999999999997 118.927 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 9.3 22.67 Favored Glycine 0 CA--C 1.492 -1.354 0 N-CA-C 105.382 -3.087 . . . . 50.509999999999998 105.382 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -97.17 156.77 16.25 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 119.961 -1.905 . . . . 50.640000000000001 109.981 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 22' ' ' THR . 41.5 p -109.56 144.4 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.187 -1.412 . . . . 50.509999999999998 107.187 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -40.96 -25.47 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.145 0.903 . . . . 50.509999999999998 109.021 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' THR . 91.0 p -74.0 -27.41 60.95 Favored 'General case' 0 C--O 1.268 2.076 0 N-CA-C 115.809 1.781 . . . . 50.509999999999998 115.809 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -65.86 -26.95 67.88 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.461 1.124 . . . . 50.619999999999997 110.413 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -107.86 5.95 26.92 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 117.781 -1.104 . . . . 50.509999999999998 111.333 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 41.36 29.38 0.09 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.474 1.943 . . . . 50.549999999999997 113.378 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -51.44 107.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.267 1.975 0 N-CA-C 104.064 -2.569 . . . . 50.509999999999998 104.064 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -107.0 -169.04 1.48 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 126.092 2.12 . . . . 50.549999999999997 112.791 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 36.1 ttpt -73.32 136.06 44.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.184 1.469 . . . . 50.509999999999998 114.36 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 41.3 mt-10 71.85 8.9 6.13 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 117.217 2.302 . . . . 50.619999999999997 117.217 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 t -74.77 142.3 44.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 104.636 -2.357 . . . . 50.509999999999998 104.636 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.5 p -106.41 133.81 50.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.39 -0.967 . . . . 50.509999999999998 108.39 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.54 162.17 13.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.681 -2.581 . . . . 50.509999999999998 109.154 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -116.01 121.92 43.69 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 127.406 2.941 . . . . 50.509999999999998 111.196 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.1 tp -79.83 140.41 36.83 Favored 'General case' 0 C--O 1.283 2.822 0 N-CA-C 115.5 1.667 . . . . 50.509999999999998 115.5 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.74 138.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.634 1.106 . . . . 50.509999999999998 112.603 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.5 tp -103.91 107.78 18.81 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.47 0.915 . . . . 50.509999999999998 113.47 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.5 79.85 2.0 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 113.349 -3.215 . . . . 50.640000000000001 115.252 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -58.0 148.23 26.74 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 117.843 2.534 . . . . 50.509999999999998 117.843 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 70.6 ttp85 -95.34 55.03 1.69 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 115.389 1.625 . . . . 50.640000000000001 115.389 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.22 -170.86 39.59 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.594 -3.402 . . . . 50.509999999999998 104.594 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.453 0 CA-C-O 116.337 -2.369 . . . . 50.509999999999998 111.883 179.197 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 118.86 -0.591 . . . . 50.509999999999998 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -88.0 142.49 27.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 126.954 2.659 . . . . 50.549999999999997 109.499 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.45 HD13 HG21 ' A' ' 17' ' ' VAL . 24.3 pt -141.77 160.76 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 116.036 -1.935 . . . . 50.509999999999998 107.472 173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' HB2' HG22 ' A' ' 66' ' ' THR . 83.1 m-85 -113.78 132.34 55.89 Favored 'General case' 0 N--CA 1.511 2.582 1 O-C-N 130.381 4.801 . . . . 50.509999999999998 113.364 179.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.99 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 106.321 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG2' ' OG1' ' A' ' 12' ' ' THR . 92.5 mttt -111.88 135.51 52.4 Favored 'General case' 0 N--CA 1.503 2.207 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 117.046 -178.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 154.78 31.92 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 107.609 -1.256 . . . . 50.509999999999998 107.609 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.26 -12.97 23.45 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.177 0.923 . . . . 50.509999999999998 110.549 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -66.06 -22.46 66.42 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 115.705 -2.398 . . . . 50.509999999999998 113.759 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.39 10.55 35.81 Favored Glycine 0 C--N 1.297 -1.598 0 O-C-N 120.106 -1.621 . . . . 50.509999999999998 112.437 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -101.28 134.84 43.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 116.82 -1.562 . . . . 50.509999999999998 112.252 174.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.46 ' OG1' ' HG2' ' A' ' 6' ' ' LYS . 52.4 m -127.51 149.29 50.2 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.707 2.505 . . . . 50.509999999999998 115.581 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -134.07 157.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 115.266 -2.574 . . . . 50.509999999999998 106.314 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -121.38 144.41 48.67 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 117.248 -1.781 . . . . 50.509999999999998 113.515 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.573 HD22 ' HB3' ' A' ' 29' ' ' LYS . 77.5 mt -120.1 167.37 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 115.445 -2.216 . . . . 50.509999999999998 109.959 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -129.47 92.96 3.44 Favored 'General case' 0 N--CA 1.5 2.041 1 O-C-N 129.131 4.019 . . . . 50.619999999999997 106.104 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.592 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 m -105.34 173.45 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.779 3.174 . . . . 50.509999999999998 111.764 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 84.0 mt-10 -106.44 145.13 30.4 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.164 -2.289 . . . . 50.619999999999997 111.14 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 85.3 Cg_exo -54.9 -24.57 39.62 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.637 2.224 . . . . 50.509999999999998 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 p -88.23 -9.0 54.4 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 115.2 1.556 . . . . 50.509999999999998 115.2 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 46.2 m-20 -65.27 148.79 51.07 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 117.412 -1.715 . . . . 50.619999999999997 110.448 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -78.94 170.94 15.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.865 -0.607 . . . . 50.509999999999998 110.503 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.24 -29.33 46.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 O-C-N 127.103 2.752 . . . . 50.509999999999998 108.04 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -70.93 -15.1 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 119.915 3.302 . . . . 50.619999999999997 119.915 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 23.0 t-20 -81.82 -50.63 9.0 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.366 1.066 . . . . 50.549999999999997 110.51 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -54.7 -44.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 125.045 1.466 . . . . 50.509999999999998 108.146 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.1 mttt -54.39 -35.46 62.87 Favored 'General case' 0 C--O 1.257 1.47 0 N-CA-C 107.989 -1.115 . . . . 50.509999999999998 107.989 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -67.2 -49.62 63.94 Favored 'General case' 0 C--O 1.278 2.597 0 N-CA-C 109.695 -0.483 . . . . 50.509999999999998 109.695 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HB3' HD22 ' A' ' 15' ' ' LEU . 46.8 mmtm -50.89 -37.09 41.66 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 120.374 -1.454 . . . . 50.509999999999998 114.823 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.82 -42.11 28.51 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 104.617 -2.364 . . . . 50.509999999999998 104.617 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -53.6 -42.36 67.6 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 125.628 2.632 . . . . 50.549999999999997 112.14 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.9 -41.73 78.62 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 120.716 3.599 . . . . 50.619999999999997 120.716 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -106.76 -15.08 14.83 Favored 'General case' 0 C--O 1.279 2.633 0 C-N-CA 116.434 -2.106 . . . . 50.509999999999998 113.39 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.18 -11.11 11.37 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 118.616 2.821 . . . . 50.619999999999997 118.616 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 28.74 45.78 Favored Glycine 0 CA--C 1.478 -2.25 0 N-CA-C 114.94 0.736 . . . . 50.509999999999998 114.94 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 71' ' ' LEU . 71.5 mt -107.46 119.64 50.05 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 114.984 1.476 . . . . 50.509999999999998 114.984 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.6 Cg_exo -57.07 137.0 79.94 Favored 'Trans proline' 0 C--O 1.258 1.515 0 C-N-CA 123.116 2.544 . . . . 50.509999999999998 110.883 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.6 Cg_exo -57.14 -32.28 92.9 Favored 'Trans proline' 0 C--O 1.261 1.663 0 C-N-CA 120.711 0.941 . . . . 50.509999999999998 113.379 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -73.27 0.15 12.76 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.948 -1.72 . . . . 50.619999999999997 110.64 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -112.4 1.69 16.1 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.572 -1.33 . . . . 50.549999999999997 109.356 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.04 128.55 47.03 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.419 2.057 . . . . 50.549999999999997 111.985 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.498 ' HD2' ' HB2' ' A' ' 72' ' ' ARG . 70.3 mtp180 -112.21 127.35 55.93 Favored 'General case' 0 C--O 1.297 3.555 0 N-CA-C 105.903 -1.888 . . . . 50.640000000000001 105.903 172.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -109.65 136.13 49.49 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 102.88 -3.007 . . . . 50.509999999999998 102.88 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -132.4 121.32 45.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 O-C-N 125.223 1.577 . . . . 50.509999999999998 111.755 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.53 90.81 3.4 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 106.998 -1.482 . . . . 50.509999999999998 106.998 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.07 76.54 0.33 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 112.219 -2.264 . . . . 50.509999999999998 112.337 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 40.03 32.07 0.35 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 128.405 2.907 . . . . 50.509999999999998 113.437 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -121.85 112.63 18.58 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 102.62 -3.104 . . . . 50.509999999999998 102.62 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -70.62 123.59 22.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.887 0.742 . . . . 50.549999999999997 111.637 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 mt -78.04 139.39 39.1 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 117.756 -1.116 . . . . 50.509999999999998 113.743 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -86.58 115.25 23.93 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.95 1.406 . . . . 50.619999999999997 114.529 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -40.42 -21.16 0.01 OUTLIER 'General case' 0 C--O 1.264 1.834 0 N-CA-C 117.809 2.522 . . . . 50.619999999999997 117.809 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.96 2.74 51.85 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 118.398 2.119 . . . . 50.509999999999998 118.398 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 mmp_? -96.99 -177.77 3.98 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 120.031 -1.864 . . . . 50.640000000000001 109.983 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.9 p -108.66 174.73 5.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.062 0.945 . . . . 50.509999999999998 110.315 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.5 mt -74.8 -13.95 60.64 Favored 'General case' 0 C--O 1.201 -1.482 0 CA-C-O 118.382 -0.818 . . . . 50.509999999999998 111.156 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -85.83 -40.85 15.56 Favored 'General case' 0 C--O 1.268 2.057 0 N-CA-C 117.598 2.444 . . . . 50.509999999999998 117.598 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -47.51 -37.27 11.67 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.497 1.141 . . . . 50.619999999999997 108.843 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 9.72 9.8 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 117.328 2.344 . . . . 50.509999999999998 117.328 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 62' ' ' GLN . 87.2 m-20 53.97 16.08 1.02 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-N 121.526 1.966 . . . . 50.549999999999997 115.744 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.2 mm -52.1 90.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.265 1.913 0 CA-C-O 115.207 -2.33 . . . . 50.509999999999998 110.741 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 60' ' ' ASN . 77.0 mt-30 -78.21 -175.73 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 125.588 1.805 . . . . 50.549999999999997 114.506 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -70.64 141.94 51.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.622 -1.992 . . . . 50.509999999999998 105.622 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 67.6 31.17 6.25 Favored 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.437 -2.165 . . . . 50.619999999999997 112.362 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 t -77.91 135.98 37.95 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.792 -1.094 . . . . 50.509999999999998 108.596 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.487 HG22 ' HB2' ' A' ' 4' ' ' PHE . 16.9 p -93.35 142.87 26.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 118.313 -0.851 . . . . 50.509999999999998 110.594 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.6 mt -122.09 122.58 39.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.78 -2.533 . . . . 50.509999999999998 105.6 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -83.64 151.25 25.4 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 102.87 -3.011 . . . . 50.509999999999998 102.87 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -123.3 109.76 14.34 Favored 'General case' 0 C--O 1.283 2.822 0 CA-C-O 117.608 -1.187 . . . . 50.509999999999998 110.481 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.09 133.01 49.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.502 -2.036 . . . . 50.509999999999998 105.502 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 36' ' ' ILE . 35.1 mt -82.67 152.09 25.99 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 118.77 2.878 . . . . 50.509999999999998 118.77 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.498 ' HB2' ' HD2' ' A' ' 42' ' ' ARG . 36.3 ttm180 -123.76 89.77 3.15 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 113.308 -3.234 . . . . 50.640000000000001 111.62 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.59 156.19 29.26 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 125.904 2.002 . . . . 50.509999999999998 111.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -106.16 77.61 1.24 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 115.821 1.785 . . . . 50.640000000000001 115.821 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.23 124.6 2.83 Favored Glycine 0 C--O 1.242 0.643 0 CA-C-N 114.646 -1.161 . . . . 50.509999999999998 113.593 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 N-CA-C 104.406 -3.478 . . . . 50.509999999999998 104.406 179.279 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' HE2' ' A' ' 63' ' ' LYS . 18.4 mmt . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 112.576 0.584 . . . . 50.509999999999998 112.576 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -88.21 150.95 23.01 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.907 2.629 . . . . 50.549999999999997 106.822 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.9 tt -148.42 145.7 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 104.972 -2.232 . . . . 50.509999999999998 104.972 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -114.66 134.98 54.65 Favored 'General case' 0 N--CA 1.511 2.597 1 O-C-N 130.409 4.818 . . . . 50.509999999999998 110.476 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -119.55 128.01 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 113.399 -3.191 . . . . 50.509999999999998 116.944 175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -94.14 119.36 32.86 Favored 'General case' 0 N--CA 1.504 2.239 1 O-C-N 129.254 4.097 . . . . 50.509999999999998 113.065 -178.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.514 HG22 HD23 ' A' ' 69' ' ' LEU . 69.0 p -95.27 177.59 5.8 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.793 -1.098 . . . . 50.509999999999998 109.48 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 8' ' ' LEU . 42.6 mt -83.79 -12.85 55.09 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 124.138 0.899 . . . . 50.509999999999998 110.752 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -95.09 -17.46 21.82 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.76 -2.376 . . . . 50.509999999999998 113.426 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.16 -23.04 7.38 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 119.034 2.374 . . . . 50.509999999999998 119.034 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.66 107.09 0.76 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 117.134 2.272 . . . . 50.509999999999998 117.134 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -82.07 128.41 34.08 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.595 2.434 . . . . 50.509999999999998 107.848 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.01 144.92 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 127.591 3.057 . . . . 50.509999999999998 114.268 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -113.68 123.52 50.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.264 -1.774 . . . . 50.509999999999998 112.454 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.0 mt -116.92 145.92 43.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 120.933 3.679 . . . . 50.509999999999998 120.933 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.17 114.22 28.31 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 128.413 3.571 . . . . 50.619999999999997 112.676 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.51 163.05 35.8 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 O-C-N 127.831 3.207 . . . . 50.509999999999998 117.228 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 40.3 mt-10 -99.18 151.24 37.32 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 117.604 2.446 . . . . 50.619999999999997 117.604 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.1 Cg_exo -54.9 -24.52 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.586 2.191 . . . . 50.509999999999998 111.928 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -93.12 -19.48 21.46 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 116.547 2.054 . . . . 50.509999999999998 116.547 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.58 151.23 17.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.404 -1.718 . . . . 50.619999999999997 107.183 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -87.45 167.67 13.79 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.858 -0.61 . . . . 50.509999999999998 109.445 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.8 pt -61.58 -34.93 64.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 127.193 2.808 . . . . 50.509999999999998 103.875 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -56.55 -49.41 74.89 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 114.048 1.129 . . . . 50.619999999999997 114.048 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -55.97 -32.13 63.6 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.307 1.043 . . . . 50.549999999999997 111.959 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -41.94 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.975 1.422 . . . . 50.509999999999998 111.264 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.25 -40.31 45.25 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 116.391 1.997 . . . . 50.509999999999998 116.391 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.32 83.38 Favored 'General case' 0 C--O 1.278 2.576 0 CA-C-N 117.984 0.356 . . . . 50.509999999999998 111.524 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -55.15 -55.95 25.4 Favored 'General case' 0 C--O 1.255 1.351 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -54.77 -36.1 35.64 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.47 -0.892 . . . . 50.509999999999998 113.053 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.1 -32.85 16.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 125.625 2.631 . . . . 50.549999999999997 113.307 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.72 -44.71 20.27 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 113.592 -1.64 . . . . 50.619999999999997 113.123 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -87.72 -29.52 21.02 Favored 'General case' 0 C--O 1.279 2.637 0 N-CA-C 116.89 2.182 . . . . 50.509999999999998 116.89 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -115.58 -23.13 8.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 123.07 2.668 . . . . 50.619999999999997 109.5 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.21 -34.54 4.64 Favored Glycine 0 CA--C 1.477 -2.342 0 N-CA-C 116.477 1.351 . . . . 50.509999999999998 116.477 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.6 mt -40.69 113.7 1.03 Allowed Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 115.063 1.505 . . . . 50.509999999999998 115.063 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.182 2.588 . . . . 50.509999999999998 110.888 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.6 Cg_exo -57.18 -32.22 92.83 Favored 'Trans proline' 0 C--O 1.262 1.684 0 C-N-CA 120.671 0.914 . . . . 50.509999999999998 113.444 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.41 -12.79 15.87 Favored 'General case' 0 C--O 1.262 1.741 0 O-C-N 119.921 -1.737 . . . . 50.619999999999997 112.028 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.43 -12.42 17.19 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.515 -1.366 . . . . 50.549999999999997 111.808 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -93.11 125.27 37.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.345 2.021 . . . . 50.549999999999997 115.244 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -121.15 134.7 55.23 Favored 'General case' 0 C--O 1.295 3.458 0 CA-C-O 116.691 -1.623 . . . . 50.640000000000001 108.961 172.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.7 ' HB2' HD22 ' A' ' 50' ' ' LEU . 60.3 mt -119.17 120.33 36.78 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 102.08 -3.304 . . . . 50.509999999999998 102.08 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.34 129.47 71.54 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 O-C-N 125.15 1.531 . . . . 50.509999999999998 112.727 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -139.97 121.81 15.48 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 117.973 2.583 . . . . 50.509999999999998 117.973 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.38 9.53 6.51 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.206 -2.27 . . . . 50.509999999999998 108.435 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.62 37.35 8.09 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.481 2.943 . . . . 50.509999999999998 109.469 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' O ' ' C ' ' A' ' 49' ' ' GLN . 36.1 ttpt -126.63 85.39 2.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.098 0.949 . . . . 50.509999999999998 112.39 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.511 ' C ' ' O ' ' A' ' 48' ' ' LYS . 6.9 tt0 -36.93 128.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.926 -1.879 . . . . 50.549999999999997 105.926 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.7 HD22 ' HB2' ' A' ' 43' ' ' LEU . 2.1 mp -60.03 120.78 10.33 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 117.695 -1.145 . . . . 50.509999999999998 111.417 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -88.95 131.87 34.96 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.018 1.449 . . . . 50.619999999999997 109.345 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -50.82 -47.1 60.1 Favored 'General case' 0 C--O 1.263 1.813 0 C-N-CA 126.171 1.788 . . . . 50.619999999999997 111.497 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.82 21.44 2.56 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 119.051 2.38 . . . . 50.509999999999998 119.051 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -111.26 158.2 19.26 Favored 'General case' 0 C--O 1.249 1.073 0 O-C-N 120.006 -1.879 . . . . 50.640000000000001 111.509 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 p -93.88 167.02 11.89 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.105 0.962 . . . . 50.509999999999998 110.491 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.53 -28.56 60.32 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 116.618 2.081 . . . . 50.509999999999998 116.618 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -87.82 -20.87 25.48 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.362 -1.735 . . . . 50.509999999999998 112.767 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.99 -36.46 62.95 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.225 -1.768 . . . . 50.619999999999997 106.225 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.658 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 77.8 m-85 -81.7 -31.91 31.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.777 -1.106 . . . . 50.509999999999998 109.354 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.658 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 26.2 m120 76.54 36.74 0.36 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 121.451 1.932 . . . . 50.549999999999997 114.554 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.57 108.91 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.981 0 CA-C-O 115.165 -2.35 . . . . 50.509999999999998 113.679 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -104.88 -176.31 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.898 -2.63 . . . . 50.549999999999997 103.898 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 35.4 mmtp -67.07 162.4 22.33 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 102.841 -3.022 . . . . 50.509999999999998 102.841 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 51.34 44.75 28.72 Favored 'General case' 0 C--O 1.257 1.485 0 CA-C-N 112.443 -2.162 . . . . 50.619999999999997 114.696 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 t -109.23 137.78 46.58 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.23 1.196 . . . . 50.509999999999998 114.23 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 m -118.46 117.09 28.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 114.463 1.283 . . . . 50.509999999999998 114.463 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.34 153.04 20.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 114.738 -2.553 . . . . 50.509999999999998 110.766 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -95.57 146.54 24.38 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 127.371 2.919 . . . . 50.509999999999998 113.483 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.514 HD23 HG22 ' A' ' 7' ' ' THR . 29.3 tp -107.42 101.83 11.16 Favored 'General case' 0 C--O 1.283 2.827 0 CA-C-O 117.647 -1.168 . . . . 50.509999999999998 110.412 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.51 121.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 119.602 1.092 . . . . 50.509999999999998 111.027 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.5 mt -74.33 133.62 42.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.369 2.729 . . . . 50.509999999999998 118.369 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -113.59 131.43 56.11 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 113.368 -3.206 . . . . 50.640000000000001 105.614 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.94 -178.7 3.74 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.867 1.979 . . . . 50.509999999999998 111.226 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -126.04 67.89 1.19 Allowed 'General case' 0 C--O 1.245 0.831 0 N-CA-C 104.342 -2.466 . . . . 50.640000000000001 104.342 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.28 146.13 8.82 Favored Glycine 0 C--O 1.243 0.691 0 CA-C-N 114.63 -1.168 . . . . 50.509999999999998 115.838 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.831 -3.307 . . . . 50.509999999999998 104.831 179.255 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 116.342 1.978 . . . . 50.509999999999998 116.342 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -82.88 149.76 26.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 126.882 2.613 . . . . 50.549999999999997 107.781 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 15' ' ' LEU . 18.5 tt -163.46 136.5 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 115.981 -1.961 . . . . 50.509999999999998 106.277 173.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' THR . 42.4 m-85 -104.39 143.52 32.89 Favored 'General case' 0 N--CA 1.512 2.634 1 O-C-N 130.259 4.724 . . . . 50.509999999999998 113.453 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 70.0 t -109.65 105.52 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 107.296 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -99.77 109.72 22.13 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.347 4.154 . . . . 50.509999999999998 110.385 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 9' ' ' THR . 9.7 t -89.78 -171.51 3.2 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 115.324 1.602 . . . . 50.509999999999998 115.324 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.488 ' N ' ' OG1' ' A' ' 7' ' ' THR . 65.6 mt -90.12 6.68 41.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.756 1.021 . . . . 50.509999999999998 113.756 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.548 ' H ' HG23 ' A' ' 7' ' ' THR . 55.5 p -104.55 0.53 28.79 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 115.715 -2.394 . . . . 50.509999999999998 114.853 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.88 37.04 7.46 Favored Glycine 0 C--N 1.298 -1.558 0 N-CA-C 103.411 -3.875 . . . . 50.509999999999998 103.411 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -113.59 159.14 19.93 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 119.455 3.131 . . . . 50.509999999999998 119.455 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.2 m -135.27 123.8 23.51 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 120.337 3.458 . . . . 50.509999999999998 120.337 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 96.7 mt -108.33 136.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.521 3.013 . . . . 50.509999999999998 107.483 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 m -117.16 117.54 29.86 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 117.329 -1.749 . . . . 50.509999999999998 112.395 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.479 ' O ' HG22 ' A' ' 3' ' ' ILE . 46.0 tp -128.69 135.49 49.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 120.168 3.395 . . . . 50.509999999999998 120.168 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -79.79 139.91 37.07 Favored 'General case' 0 N--CA 1.5 2.046 1 O-C-N 129.176 4.048 . . . . 50.619999999999997 114.764 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.76 175.18 6.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 O-C-N 127.758 3.161 . . . . 50.509999999999998 114.114 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.7 mt-10 -124.81 142.65 41.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 112.197 -2.274 . . . . 50.619999999999997 108.835 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.7 Cg_exo -54.97 -24.54 39.98 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 122.549 2.166 . . . . 50.509999999999998 111.943 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -86.35 -0.16 55.3 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.655 1.724 . . . . 50.509999999999998 115.655 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -79.13 160.08 27.17 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.421 -1.712 . . . . 50.619999999999997 107.471 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 52.3 p -107.62 153.68 22.54 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 103.753 -2.684 . . . . 50.509999999999998 103.753 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.438 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 25.6 mm -56.67 -23.03 16.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 O-C-N 127.011 2.694 . . . . 50.509999999999998 116.481 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 23.7 tt0 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 103.248 -2.871 . . . . 50.619999999999997 103.248 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 22' ' ' THR . 57.8 m-80 -68.11 -43.17 79.04 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 124.383 1.073 . . . . 50.549999999999997 112.305 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.17 -38.57 77.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.046 1.466 . . . . 50.509999999999998 113.289 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.3 mttt -74.57 -30.31 61.67 Favored 'General case' 0 C--O 1.257 1.471 0 N-CA-C 106.784 -1.561 . . . . 50.509999999999998 106.784 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.13 82.73 Favored 'General case' 0 C--O 1.278 2.578 0 N-CA-C 114.364 1.246 . . . . 50.509999999999998 114.364 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.11 -31.99 73.47 Favored 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.373 -1.454 . . . . 50.509999999999998 114.549 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.73 -45.08 67.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 119.551 -0.859 . . . . 50.509999999999998 113.077 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.555 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 6.1 tt0 -52.08 -34.19 42.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.431 3.123 . . . . 50.549999999999997 119.431 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.05 -60.57 3.4 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 113.59 -1.641 . . . . 50.619999999999997 113.321 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.03 -55.97 4.24 Favored 'General case' 0 C--O 1.28 2.683 0 N-CA-C 119.806 3.262 . . . . 50.509999999999998 119.806 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.43 -60.11 4.01 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.143 2.702 . . . . 50.619999999999997 104.818 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.56 8.56 3.13 Favored Glycine 0 CA--C 1.478 -2.269 0 CA-C-O 120.033 -0.315 . . . . 50.509999999999998 113.398 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 84.8 mt -89.89 125.6 60.23 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 119.843 3.275 . . . . 50.509999999999998 119.843 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.6 Cg_exo -57.0 136.97 79.9 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.111 2.541 . . . . 50.509999999999998 110.917 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 87.2 Cg_exo -57.17 -32.15 92.61 Favored 'Trans proline' 0 C--O 1.261 1.629 0 O-C-N 122.919 0.958 . . . . 50.509999999999998 113.442 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -56.72 -17.17 8.01 Favored 'General case' 0 C--O 1.263 1.781 0 O-C-N 120.045 -1.659 . . . . 50.619999999999997 114.713 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -91.8 -7.48 49.41 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.471 1.656 . . . . 50.549999999999997 115.471 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -90.66 137.56 32.26 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 116.787 2.144 . . . . 50.549999999999997 116.787 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -125.1 120.63 31.96 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 104.591 -2.374 . . . . 50.640000000000001 104.591 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 35.2 mt -102.89 138.07 40.26 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 103.596 -2.742 . . . . 50.509999999999998 103.596 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.31 129.23 36.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 119.972 3.323 . . . . 50.509999999999998 119.972 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -137.67 117.99 13.68 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 116.377 1.992 . . . . 50.509999999999998 116.377 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.83 16.25 4.58 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 103.752 -2.684 . . . . 50.509999999999998 103.752 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.09 25.41 44.68 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 107.135 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -108.85 114.7 28.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 104.653 -2.351 . . . . 50.509999999999998 104.653 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 43' ' ' LEU . 32.2 tt0 -68.98 129.77 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.325 0.861 . . . . 50.549999999999997 113.325 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.7 mp -78.2 150.39 33.51 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 109.67 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 73.7 mt-10 -115.98 158.98 22.25 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.959 1.412 . . . . 50.619999999999997 112.276 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -83.37 -9.71 58.88 Favored 'General case' 0 C--O 1.263 1.795 0 N-CA-C 117.204 2.298 . . . . 50.619999999999997 117.204 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.87 -2.68 34.35 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 110.178 -1.169 . . . . 50.509999999999998 110.178 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -107.5 143.32 36.04 Favored 'General case' 0 C--O 1.248 1.023 0 O-C-N 119.944 -1.915 . . . . 50.640000000000001 107.174 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.7 p -69.98 140.95 53.04 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 116.718 2.118 . . . . 50.509999999999998 116.718 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 61' ' ' ILE . 38.0 tp -48.19 -26.49 1.95 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.108 0.88 . . . . 50.509999999999998 112.08 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 p -90.47 -0.53 57.7 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.307 -1.757 . . . . 50.509999999999998 114.191 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -97.56 15.01 24.59 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 50.619999999999997 107.679 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 92.7 m-85 -113.85 -6.24 13.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 110.264 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.628 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 14.5 m120 73.42 18.67 3.6 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 121.457 1.935 . . . . 50.549999999999997 107.551 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.45 HD12 HD12 ' A' ' 56' ' ' LEU . 68.5 mt -75.22 108.59 7.19 Favored 'Isoleucine or valine' 0 C--O 1.267 2.007 0 CA-C-O 115.188 -2.339 . . . . 50.509999999999998 112.792 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -110.82 -175.68 2.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.117 2.135 . . . . 50.549999999999997 112.41 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -53.67 141.87 24.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 116.569 2.063 . . . . 50.509999999999998 116.569 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 52.71 42.93 31.82 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-N 112.554 -2.112 . . . . 50.619999999999997 114.585 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 152.59 18.98 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.494 2.035 . . . . 50.509999999999998 116.494 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 40.4 m -111.83 119.65 39.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 116.502 2.038 . . . . 50.509999999999998 116.502 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.88 140.02 32.05 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.723 -2.56 . . . . 50.509999999999998 108.086 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -89.96 132.38 35.37 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.199 2.812 . . . . 50.509999999999998 113.377 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' C ' HD23 ' A' ' 69' ' ' LEU . 10.2 tt -103.95 109.22 20.9 Favored 'General case' 0 C--O 1.282 2.768 0 N-CA-C 116.271 1.952 . . . . 50.509999999999998 116.271 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -94.1 145.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 119.604 1.093 . . . . 50.509999999999998 110.916 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 48.8 tp -99.29 86.78 3.48 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 119.437 3.125 . . . . 50.509999999999998 119.437 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 71' ' ' LEU . 59.8 ttt85 -53.36 130.98 36.94 Favored 'General case' 0 C--N 1.281 -2.383 1 O-C-N 110.816 -7.427 . . . . 50.640000000000001 113.779 177.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.49 147.44 24.24 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 120.858 1.663 . . . . 50.509999999999998 114.259 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -81.37 56.26 2.85 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 106.665 -1.605 . . . . 50.640000000000001 106.665 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.43 -155.71 16.87 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.586 -1.188 . . . . 50.509999999999998 113.999 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 N-CA-C 104.682 -3.367 . . . . 50.509999999999998 104.682 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.814 -0.612 . . . . 50.509999999999998 109.802 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -101.27 131.68 47.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 126.973 2.671 . . . . 50.549999999999997 109.517 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 pt -132.19 149.8 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 N-CA-C 103.595 -2.743 . . . . 50.509999999999998 103.595 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -110.34 157.93 18.98 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.398 4.811 . . . . 50.509999999999998 112.095 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.6 t -141.36 121.02 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-O 113.383 -3.199 . . . . 50.509999999999998 112.24 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -90.59 136.05 33.31 Favored 'General case' 0 N--CA 1.504 2.261 1 O-C-N 129.37 4.169 . . . . 50.509999999999998 105.1 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -112.44 142.46 44.95 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 105.03 -2.211 . . . . 50.509999999999998 105.03 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -44.84 -35.97 3.04 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 109.198 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.6 m -52.3 -32.69 38.8 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 118.631 2.826 . . . . 50.509999999999998 118.631 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.11 4.79 11.05 Favored Glycine 0 C--N 1.296 -1.671 0 O-C-N 120.142 -1.599 . . . . 50.509999999999998 111.756 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -83.89 152.82 24.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.847 -1.549 . . . . 50.509999999999998 114.26 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -125.86 112.56 16.13 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.701 2.501 . . . . 50.509999999999998 106.849 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 pt -102.3 147.69 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 118.583 2.808 . . . . 50.509999999999998 118.583 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -104.32 123.72 47.9 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 117.263 -1.775 . . . . 50.509999999999998 113.436 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 29' ' ' LYS . 68.5 mt -109.73 132.31 54.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 117.591 2.441 . . . . 50.509999999999998 117.591 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.28 110.26 22.41 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 129.244 4.09 . . . . 50.619999999999997 109.888 174.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 56' ' ' LEU . 35.0 m -130.82 173.59 14.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.196 0 O-C-N 127.672 3.107 . . . . 50.509999999999998 108.589 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 68.8 mm-40 -116.87 141.95 29.04 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 112.157 -2.292 . . . . 50.619999999999997 108.862 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HA ' ' CB ' ' A' ' 56' ' ' LEU . 85.4 Cg_exo -54.88 -24.58 39.54 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.617 2.211 . . . . 50.509999999999998 111.964 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.9 m -78.23 -23.13 47.54 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.818 -1.549 . . . . 50.509999999999998 106.818 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.39 139.18 58.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 104.308 -2.478 . . . . 50.619999999999997 104.308 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 48.1 p -78.23 165.17 24.22 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.326 -0.99 . . . . 50.509999999999998 108.326 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.542 HD12 HD23 ' A' ' 50' ' ' LEU . 24.5 mm -58.81 -35.21 54.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 O-C-N 127.244 2.84 . . . . 50.509999999999998 111.816 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.7 -45.34 81.88 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 105.211 -2.144 . . . . 50.619999999999997 105.211 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.624 ' HB2' ' O ' ' A' ' 22' ' ' THR . 85.8 m-20 -56.56 -46.03 80.94 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.365 1.066 . . . . 50.549999999999997 112.181 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 56' ' ' LEU . 40.5 t -61.58 -41.38 90.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 125.168 1.543 . . . . 50.509999999999998 113.192 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.86 -22.71 60.73 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 106.824 -1.547 . . . . 50.509999999999998 106.824 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.35 -61.41 1.85 Allowed 'General case' 0 C--O 1.278 2.561 0 N-CA-C 105.049 -2.204 . . . . 50.509999999999998 105.049 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.677 ' CG ' HD22 ' A' ' 15' ' ' LEU . 17.0 tppt? -42.5 -41.6 3.03 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 115.679 1.733 . . . . 50.509999999999998 115.679 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.512 HG21 HD11 ' A' ' 69' ' ' LEU . 73.4 mt -68.19 -23.86 29.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 C-N-CA 119.493 -0.883 . . . . 50.509999999999998 108.68 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -82.25 -55.45 4.52 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 125.57 2.605 . . . . 50.549999999999997 105.565 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -35.32 -51.37 0.58 Allowed 'General case' 0 C--O 1.252 1.228 0 N-CA-C 118.513 2.782 . . . . 50.619999999999997 118.513 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.13 -59.99 1.62 Allowed 'General case' 0 C--O 1.28 2.677 0 C-N-CA 116.459 -2.096 . . . . 50.509999999999998 108.82 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -57.99 -43.76 86.75 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 123.158 2.708 . . . . 50.619999999999997 116.743 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.16 23.35 7.73 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 108.763 -1.735 . . . . 50.509999999999998 108.763 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.3 mt -100.58 117.31 63.06 Favored Pre-proline 0 C--O 1.243 0.73 0 C-N-CA 118.79 -1.164 . . . . 50.509999999999998 108.501 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.0 Cg_exo -56.93 136.93 79.52 Favored 'Trans proline' 0 C--O 1.261 1.634 0 C-N-CA 123.185 2.59 . . . . 50.509999999999998 110.916 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.0 Cg_exo -57.19 -32.15 92.66 Favored 'Trans proline' 0 C--O 1.262 1.691 0 C-N-CA 120.682 0.922 . . . . 50.509999999999998 113.429 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -62.56 -15.21 49.82 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.948 -1.72 . . . . 50.619999999999997 109.985 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -102.92 16.05 27.67 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.532 -1.355 . . . . 50.549999999999997 112.104 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -110.85 114.08 27.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 117.295 2.332 . . . . 50.549999999999997 117.295 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -111.39 108.49 18.09 Favored 'General case' 0 C--O 1.296 3.523 0 N-CA-C 105.502 -2.036 . . . . 50.640000000000001 105.502 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mt -101.99 132.76 47.63 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.501 1.046 . . . . 50.509999999999998 110.488 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.63 136.77 50.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 O-C-N 125.227 1.58 . . . . 50.509999999999998 115.167 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -133.75 112.06 11.06 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.543 -1.208 . . . . 50.509999999999998 110.483 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.45 49.7 6.2 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.268 -2.242 . . . . 50.509999999999998 113.311 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.47 1.71 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 120.894 3.118 . . . . 50.509999999999998 120.894 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -71.7 166.19 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 116.334 1.975 . . . . 50.509999999999998 116.334 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -102.26 140.86 35.98 Favored 'General case' 0 C--O 1.259 1.592 0 O-C-N 124.008 0.818 . . . . 50.549999999999997 112.008 174.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.542 HD23 HD12 ' A' ' 23' ' ' ILE . 2.1 mp -78.14 143.17 37.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.285 -1.746 . . . . 50.509999999999998 106.285 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -120.21 135.15 55.08 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.883 1.364 . . . . 50.619999999999997 109.464 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.56 -33.41 1.14 Allowed 'General case' 0 C--O 1.262 1.748 0 C-N-CA 126.165 1.786 . . . . 50.619999999999997 114.951 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.88 14.73 63.5 Favored Glycine 0 C--O 1.254 1.345 0 C-N-CA 124.339 0.971 . . . . 50.509999999999998 113.5 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -111.73 155.12 23.99 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 101.889 -3.374 . . . . 50.640000000000001 101.889 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -99.72 174.12 6.38 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.048 0.939 . . . . 50.509999999999998 111.483 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.561 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -67.54 -38.54 84.33 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 106.349 -1.723 . . . . 50.509999999999998 106.349 177.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -67.94 -22.61 65.04 Favored 'General case' 0 C--O 1.268 2.029 0 N-CA-C 117.75 2.5 . . . . 50.509999999999998 117.75 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -64.45 -40.17 95.22 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.664 2.098 . . . . 50.619999999999997 116.664 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -83.26 5.02 24.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 115.986 1.847 . . . . 50.509999999999998 115.986 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 59.08 38.44 23.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.493 1.951 . . . . 50.549999999999997 107.054 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -73.48 117.79 17.81 Favored 'Isoleucine or valine' 0 C--O 1.267 2.012 0 CA-C-O 115.223 -2.322 . . . . 50.509999999999998 108.388 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -94.15 -175.82 3.8 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.707 2.114 . . . . 50.549999999999997 116.707 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.03 142.72 49.29 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 123.144 1.449 . . . . 50.509999999999998 107.314 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 46.4 26.19 0.46 Allowed 'General case' 0 C--O 1.257 1.496 0 N-CA-C 117.592 2.441 . . . . 50.619999999999997 117.592 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.0 m -72.53 153.18 41.45 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.512 -1.662 . . . . 50.509999999999998 106.512 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.43 ' O ' HD23 ' A' ' 67' ' ' LEU . 40.6 m -108.16 146.09 33.22 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.225 -0.893 . . . . 50.509999999999998 111.084 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 66' ' ' THR . 26.8 mt -116.96 156.78 26.86 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 114.688 -2.577 . . . . 50.509999999999998 109.959 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -93.61 141.66 28.22 Favored 'General case' 0 C--N 1.285 -2.207 0 O-C-N 127.246 2.841 . . . . 50.509999999999998 106.202 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.512 HD11 HG21 ' A' ' 30' ' ' ILE . 5.3 tt -119.79 109.88 16.12 Favored 'General case' 0 C--O 1.282 2.8 0 N-CA-C 106.356 -1.72 . . . . 50.509999999999998 106.356 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -98.35 145.1 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.391 -2.078 . . . . 50.509999999999998 105.391 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.99 132.5 43.5 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.964 -0.754 . . . . 50.509999999999998 108.964 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -97.44 126.18 42.54 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-O 113.322 -3.228 . . . . 50.640000000000001 107.33 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.89 152.09 23.81 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.901 2.001 . . . . 50.509999999999998 111.862 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -83.15 55.42 3.12 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 113.726 -1.579 . . . . 50.640000000000001 108.051 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.15 156.33 18.08 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 109.56 -1.416 . . . . 50.509999999999998 109.56 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 1 N-CA-C 102.519 -4.233 . . . . 50.509999999999998 102.519 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 107.894 -1.151 . . . . 50.509999999999998 107.894 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -101.03 133.44 45.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.911 2.632 . . . . 50.549999999999997 110.278 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.35 159.89 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 117.083 -3.51 . . . . 50.509999999999998 107.703 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -114.67 137.31 52.06 Favored 'General case' 0 N--CA 1.512 2.648 1 O-C-N 130.429 4.831 . . . . 50.509999999999998 107.911 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 87.6 t -110.54 121.34 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 113.431 -3.176 . . . . 50.509999999999998 104.019 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -107.08 131.81 53.68 Favored 'General case' 0 N--CA 1.503 2.195 1 O-C-N 129.295 4.122 . . . . 50.509999999999998 113.336 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -91.38 -177.33 4.81 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.87 2.544 . . . . 50.509999999999998 117.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.26 -5.59 23.93 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 124.164 0.915 . . . . 50.509999999999998 109.792 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.7 p -114.69 9.01 16.36 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.726 2.862 . . . . 50.509999999999998 118.726 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.32 62.29 Favored Glycine 0 C--N 1.298 -1.565 0 O-C-N 120.072 -1.642 . . . . 50.509999999999998 115.164 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -65.23 140.22 58.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 116.888 -1.53 . . . . 50.509999999999998 113.033 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -131.53 164.46 25.76 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 126.613 2.446 . . . . 50.509999999999998 108.573 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.35 170.64 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 127.551 3.032 . . . . 50.509999999999998 110.215 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -111.41 128.33 55.95 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.266 -1.773 . . . . 50.509999999999998 110.41 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.2 mt -126.53 135.71 51.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 115.488 -2.196 . . . . 50.509999999999998 116.567 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.27 100.41 7.16 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 128.315 3.509 . . . . 50.619999999999997 112.505 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -103.18 172.99 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.209 0 O-C-N 127.762 3.164 . . . . 50.509999999999998 116.324 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.65 153.45 43.6 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 112.157 -2.292 . . . . 50.619999999999997 112.521 174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.89 -24.57 39.5 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.603 2.202 . . . . 50.509999999999998 111.909 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 m -82.92 -26.52 31.38 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 114.954 1.465 . . . . 50.509999999999998 114.954 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -53.34 138.95 31.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 117.398 -1.721 . . . . 50.619999999999997 114.311 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -95.1 172.46 8.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 102.156 -3.276 . . . . 50.509999999999998 102.156 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 54' ' ' ARG . 23.2 mm -53.89 -45.49 63.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 O-C-N 127.095 2.747 . . . . 50.509999999999998 110.439 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -54.11 -46.83 72.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.723 1.379 . . . . 50.619999999999997 114.723 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -57.54 -39.64 77.08 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 124.265 1.026 . . . . 50.549999999999997 111.757 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 -50.11 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 125.045 1.466 . . . . 50.509999999999998 111.73 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HE3' ' CG2' ' A' ' 23' ' ' ILE . 94.5 mttt -56.87 -29.93 63.38 Favored 'General case' 0 C--O 1.257 1.485 0 N-CA-C 104.583 -2.377 . . . . 50.509999999999998 104.583 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.06 -27.61 48.69 Favored 'General case' 0 C--O 1.278 2.599 0 CA-C-N 118.031 0.378 . . . . 50.509999999999998 111.567 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -71.76 -36.32 70.36 Favored 'General case' 0 C--O 1.255 1.342 0 N-CA-C 106.606 -1.627 . . . . 50.509999999999998 106.606 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.43 -34.55 65.19 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 106.863 -1.532 . . . . 50.509999999999998 106.863 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -51.49 -59.51 4.17 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.567 2.603 . . . . 50.549999999999997 112.225 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -51.76 -40.83 60.98 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 115.817 1.784 . . . . 50.619999999999997 115.817 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -76.65 -32.5 58.01 Favored 'General case' 0 C--O 1.279 2.647 0 C-N-CA 116.464 -2.095 . . . . 50.509999999999998 113.853 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -119.33 -39.47 2.89 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.018 2.644 . . . . 50.619999999999997 115.061 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.32 8.77 8.32 Favored Glycine 0 CA--C 1.478 -2.271 0 CA-C-O 119.947 -0.363 . . . . 50.509999999999998 112.46 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.491 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 93.5 mt -84.62 128.21 62.24 Favored Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 116.76 2.134 . . . . 50.509999999999998 116.76 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.94 136.99 79.85 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.116 2.544 . . . . 50.509999999999998 110.92 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.7 Cg_exo -57.2 -32.13 92.64 Favored 'Trans proline' 0 C--O 1.261 1.649 0 O-C-N 122.91 0.952 . . . . 50.509999999999998 113.405 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -75.29 -15.78 60.48 Favored 'General case' 0 C--O 1.262 1.745 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 112.375 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -97.34 9.0 43.46 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 120.568 -1.332 . . . . 50.549999999999997 110.692 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.97 132.98 53.57 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 103.437 -2.801 . . . . 50.549999999999997 103.437 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -119.48 108.52 14.63 Favored 'General case' 0 C--O 1.297 3.562 0 N-CA-C 105.462 -2.051 . . . . 50.640000000000001 105.462 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.5 mt -103.78 121.97 44.13 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.49 1.041 . . . . 50.509999999999998 113.414 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 N-CA-C 120.456 3.502 . . . . 50.509999999999998 120.456 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB3' HD21 ' A' ' 50' ' ' LEU . 17.8 t80 -110.18 130.17 55.59 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 114.811 1.411 . . . . 50.509999999999998 114.811 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.21 32.11 15.39 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.192 -2.276 . . . . 50.509999999999998 111.994 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.67 2.7 85.97 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 128.4 2.905 . . . . 50.509999999999998 113.269 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -94.51 115.77 27.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 116.32 1.97 . . . . 50.509999999999998 116.32 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 16.3 pt20 -50.53 120.24 4.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 123.94 0.775 . . . . 50.549999999999997 111.744 174.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 45' ' ' PHE . 56.1 mt -83.51 127.55 33.81 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.7 -1.143 . . . . 50.509999999999998 111.984 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 88.7 tt0 -77.0 145.23 38.17 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 119.173 3.027 . . . . 50.619999999999997 119.173 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -38.6 -48.08 1.4 Allowed 'General case' 0 C--O 1.264 1.833 0 N-CA-C 118.526 2.788 . . . . 50.619999999999997 118.526 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 23.01 32.27 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 116.384 1.314 . . . . 50.509999999999998 116.384 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 23' ' ' ILE . 37.1 mmt180 -93.34 155.53 17.34 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 119.892 -1.946 . . . . 50.640000000000001 111.151 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -108.53 176.93 4.94 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.979 0.912 . . . . 50.509999999999998 109.466 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.1 -32.69 70.04 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 119.177 3.028 . . . . 50.509999999999998 119.177 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -81.11 -23.34 38.45 Favored 'General case' 0 C--O 1.267 2.024 0 C-N-CA 117.325 -1.75 . . . . 50.509999999999998 112.258 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -53.54 -30.9 44.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 104.918 -2.253 . . . . 50.619999999999997 104.918 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.25 6.92 19.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 116.468 2.025 . . . . 50.509999999999998 116.468 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.37 32.49 20.66 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 111.036 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.438 HG12 ' CD2' ' A' ' 45' ' ' PHE . 93.2 mt -73.53 104.86 2.59 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.188 -2.339 . . . . 50.509999999999998 109.353 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -97.23 -165.86 1.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 126.137 2.148 . . . . 50.549999999999997 115.028 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 79.4 tttt -70.16 142.76 52.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.159 1.457 . . . . 50.509999999999998 110.688 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 23.1 mt-10 58.73 36.29 24.79 Favored 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.471 -2.15 . . . . 50.619999999999997 110.721 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -78.02 152.5 33.01 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.802 -1.09 . . . . 50.509999999999998 110.915 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.443 ' O ' HD23 ' A' ' 67' ' ' LEU . 60.4 p -103.64 140.13 37.98 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 118.216 -0.897 . . . . 50.509999999999998 110.182 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 59.5 mt -123.95 134.82 53.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 101.65 -3.463 . . . . 50.509999999999998 101.65 175.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -95.45 136.93 35.2 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 127.375 2.922 . . . . 50.509999999999998 108.264 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.2 tp -105.56 136.02 45.89 Favored 'General case' 0 C--O 1.282 2.802 0 CA-C-O 117.641 -1.171 . . . . 50.509999999999998 113.203 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -116.02 126.06 73.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 105.847 -1.909 . . . . 50.509999999999998 105.847 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.9 tp -79.04 105.55 10.45 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.782 2.512 . . . . 50.509999999999998 117.782 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -92.96 102.21 14.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.279 -3.248 . . . . 50.640000000000001 114.666 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.64 177.58 7.01 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 125.715 1.884 . . . . 50.509999999999998 110.047 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -100.7 97.65 8.28 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 115.972 1.842 . . . . 50.640000000000001 115.972 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.46 158.67 6.18 Favored Glycine 0 C--O 1.243 0.668 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.562 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 1 N-CA-C 102.073 -4.411 . . . . 50.509999999999998 102.073 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 106.871 -1.529 . . . . 50.509999999999998 106.871 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -117.73 119.43 34.92 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.923 2.64 . . . . 50.549999999999997 104.846 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 tt -121.73 149.4 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 CA-C-O 115.952 -1.975 . . . . 50.509999999999998 110.13 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.84 123.88 50.88 Favored 'General case' 0 N--CA 1.511 2.599 1 O-C-N 130.372 4.795 . . . . 50.509999999999998 114.524 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.34 104.86 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.42 -3.181 . . . . 50.509999999999998 109.571 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -85.02 121.2 27.45 Favored 'General case' 0 N--CA 1.504 2.237 1 O-C-N 129.394 4.184 . . . . 50.509999999999998 109.412 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 69' ' ' LEU . 69.7 p -85.95 -177.05 6.22 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 116.322 1.971 . . . . 50.509999999999998 116.322 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 70' ' ' VAL . 67.5 mt -82.01 -6.08 58.86 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.788 1.773 . . . . 50.509999999999998 115.788 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.5 p -90.07 -8.04 52.41 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 115.715 -2.394 . . . . 50.509999999999998 106.592 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 15.79 37.73 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 107.727 -2.149 . . . . 50.509999999999998 107.727 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -89.52 111.02 21.82 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 116.549 2.055 . . . . 50.509999999999998 116.549 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.9 m -87.37 125.44 34.26 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 126.65 2.469 . . . . 50.509999999999998 113.203 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -111.9 174.08 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 127.53 3.019 . . . . 50.509999999999998 113.725 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 m -124.37 140.97 52.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.011 -2.218 . . . . 50.509999999999998 105.011 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.7 mt -130.66 141.7 50.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 115.487 -2.197 . . . . 50.509999999999998 108.05 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.87 100.25 9.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 129.009 3.943 . . . . 50.619999999999997 109.281 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -100.27 171.12 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.253 0 O-C-N 127.796 3.185 . . . . 50.509999999999998 107.938 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -124.28 160.51 52.32 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 112.24 -2.254 . . . . 50.619999999999997 116.147 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.01 -24.45 39.92 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 122.586 2.191 . . . . 50.509999999999998 111.966 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -99.82 -28.82 12.95 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 116.031 1.863 . . . . 50.509999999999998 116.031 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -38.82 136.88 0.7 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.331 -1.748 . . . . 50.619999999999997 114.825 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' ASN . 70.7 p -88.7 138.17 31.66 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 103.109 -2.922 . . . . 50.509999999999998 103.109 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 52' ' ' ASP . 7.4 tp -47.52 -19.19 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.729 0 O-C-N 127.183 2.802 . . . . 50.509999999999998 114.02 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.57 -44.31 62.25 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 102.991 -2.966 . . . . 50.619999999999997 102.991 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 22' ' ' THR . 9.3 t-20 -70.78 -17.28 62.79 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 114.957 1.465 . . . . 50.549999999999997 114.957 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.12 -45.92 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.999 -1.482 . . . . 50.509999999999998 106.999 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 97.2 mttt -64.26 -42.87 96.28 Favored 'General case' 0 C--O 1.256 1.433 0 N-CA-C 108.04 -1.096 . . . . 50.509999999999998 108.04 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -59.14 -25.19 63.66 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 112.511 0.559 . . . . 50.509999999999998 112.511 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 58.2 mttm -64.75 -30.78 71.8 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 106.327 -1.731 . . . . 50.509999999999998 106.327 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.653 ' O ' HG22 ' A' ' 30' ' ' ILE . 95.7 mt -82.66 2.86 2.93 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 N-CA-C 105.535 -2.024 . . . . 50.509999999999998 105.535 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 50.7 tt0 -87.12 -57.43 2.97 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.592 2.615 . . . . 50.549999999999997 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -69.05 -36.23 77.45 Favored 'General case' 0 C--O 1.253 1.264 0 CA-C-N 113.616 -1.629 . . . . 50.619999999999997 113.278 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.2 -32.71 24.41 Favored 'General case' 0 C--O 1.279 2.623 0 C-N-CA 116.427 -2.109 . . . . 50.509999999999998 112.667 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -108.99 -17.04 14.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 119.315 3.08 . . . . 50.619999999999997 119.315 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.82 37.54 10.23 Favored Glycine 0 CA--C 1.479 -2.199 0 N-CA-C 107.607 -2.197 . . . . 50.509999999999998 107.607 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.4 117.74 30.21 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 106.939 -1.504 . . . . 50.509999999999998 106.939 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.97 136.89 79.36 Favored 'Trans proline' 0 C--O 1.259 1.562 0 C-N-CA 123.185 2.59 . . . . 50.509999999999998 110.924 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -57.11 -32.15 92.48 Favored 'Trans proline' 0 C--O 1.261 1.667 0 O-C-N 122.948 0.973 . . . . 50.509999999999998 113.471 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.96 -2.02 8.8 Favored 'General case' 0 C--O 1.262 1.731 0 O-C-N 119.976 -1.703 . . . . 50.619999999999997 111.592 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -114.77 15.58 17.48 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.617 -1.302 . . . . 50.549999999999997 114.13 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -115.76 122.26 44.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.366 2.031 . . . . 50.549999999999997 111.203 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -115.83 121.56 42.77 Favored 'General case' 0 C--O 1.296 3.507 0 CA-C-O 116.657 -1.639 . . . . 50.640000000000001 111.265 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 76.6 mt -104.59 139.93 38.74 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 119.397 0.999 . . . . 50.509999999999998 108.897 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.36 134.13 64.82 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 O-C-N 125.129 1.518 . . . . 50.509999999999998 108.377 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 50.5 t80 -160.17 113.15 2.1 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.561 -1.199 . . . . 50.509999999999998 110.926 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 78.39 28.62 0.46 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.259 -2.246 . . . . 50.509999999999998 116.087 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.14 -8.95 35.36 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 117.04 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -101.48 138.33 38.63 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 114.211 1.189 . . . . 50.509999999999998 114.211 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.06 121.01 15.23 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.994 0.809 . . . . 50.549999999999997 110.234 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.644 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 11.1 mp -78.58 150.26 32.8 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.096 -2.187 . . . . 50.509999999999998 105.096 -175.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -110.19 143.72 39.89 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 124.939 1.4 . . . . 50.619999999999997 113.769 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' CG2' ' A' ' 23' ' ' ILE . 34.9 m-20 -38.33 -46.22 1.08 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 120.332 3.456 . . . . 50.619999999999997 120.332 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.71 -3.68 73.76 Favored Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 121.177 3.231 . . . . 50.509999999999998 121.177 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 -83.72 159.13 21.55 Favored 'General case' 0 C--O 1.249 1.046 0 O-C-N 117.464 -3.374 . . . . 50.640000000000001 115.453 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.3 p -99.99 172.18 7.37 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.018 0.927 . . . . 50.509999999999998 109.143 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -70.54 -23.78 62.68 Favored 'General case' 0 C--O 1.201 -1.46 0 O-C-N 124.164 0.915 . . . . 50.509999999999998 109.268 177.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.8 p -77.52 -30.44 52.88 Favored 'General case' 0 C--O 1.269 2.102 0 C-N-CA 117.338 -1.745 . . . . 50.509999999999998 111.28 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -54.17 -42.87 70.13 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.423 1.106 . . . . 50.619999999999997 111.21 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.644 ' CZ ' ' HG ' ' A' ' 50' ' ' LEU . 92.9 m-85 -93.48 17.75 11.0 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.773 -1.108 . . . . 50.509999999999998 113.765 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.68 40.34 31.83 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 121.516 1.962 . . . . 50.549999999999997 116.273 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.57 112.95 2.45 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-O 115.183 -2.341 . . . . 50.509999999999998 116.634 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -118.16 174.24 6.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 126.141 2.15 . . . . 50.549999999999997 112.497 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 79.4 tttt -57.61 138.6 55.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 123.193 1.473 . . . . 50.509999999999998 111.378 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.63 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 29.5 mt-10 65.31 43.27 3.58 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.458 -2.155 . . . . 50.619999999999997 115.755 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -82.91 137.9 34.06 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 106.664 -1.606 . . . . 50.509999999999998 106.664 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -113.59 123.22 49.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.253 -1.017 . . . . 50.509999999999998 108.253 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -117.84 153.52 33.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.188 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -109.35 133.07 53.51 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 127.451 2.97 . . . . 50.509999999999998 103.358 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.413 HD23 HG22 ' A' ' 7' ' ' THR . 44.4 tp -101.52 107.14 18.34 Favored 'General case' 0 C--O 1.282 2.806 0 N-CA-C 118.914 2.931 . . . . 50.509999999999998 118.914 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 8' ' ' LEU . 61.9 t -92.03 117.16 34.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 119.564 1.075 . . . . 50.509999999999998 112.995 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.99 159.81 33.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.146 0.498 . . . . 50.509999999999998 110.435 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -119.52 109.87 16.22 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 113.298 -3.239 . . . . 50.640000000000001 103.744 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 2.0 mp -86.08 140.82 29.9 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 125.826 1.953 . . . . 50.509999999999998 116.206 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -68.85 122.31 18.34 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.01 -1.848 . . . . 50.640000000000001 106.01 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.01 -176.82 52.0 Favored Glycine 0 C--O 1.243 0.695 0 CA-C-N 114.63 -1.168 . . . . 50.509999999999998 115.431 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.445 0 N-CA-C 119.479 2.552 . . . . 50.509999999999998 119.479 179.25 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.509999999999998 109.784 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.549999999999997 110.888 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.509999999999998 116.515 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 113.74 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.509999999999998 108.059 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 111.299 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 113.264 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.509999999999998 109.711 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.509999999999998 118.139 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.509999999999998 115.485 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 112.444 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.509999999999998 104.287 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.509999999999998 112.3 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.509999999999998 121.099 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.619999999999997 110.491 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.509999999999998 108.724 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.619999999999997 111.398 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.509999999999998 111.977 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.509999999999998 114.356 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.619999999999997 114.483 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.509999999999998 107.854 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.509999999999998 119.713 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.619999999999997 107.589 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.549999999999997 116.179 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.509999999999998 107.144 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.509999999999998 106.178 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.509999999999998 113.884 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.509999999999998 110.545 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.427 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.509999999999998 115.565 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 108.505 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.619999999999997 115.994 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.509999999999998 109.748 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.619999999999997 110.609 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.509999999999998 106.674 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.509999999999998 113.426 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.509999999999998 110.966 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.509999999999998 113.447 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.619999999999997 115.85 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.549999999999997 110.579 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.549999999999997 112.07 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.640000000000001 108.703 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.509999999999998 118.456 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.509999999999998 111.752 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 61' ' ' ILE . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.509999999999998 118.653 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.509999999999998 114.688 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.509999999999998 116.218 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.509999999999998 102.92 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.549999999999997 109.69 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 113.209 -175.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.619999999999997 106.192 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.619999999999997 118.695 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.509999999999998 114.117 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.640000000000001 110.918 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.509999999999998 113.601 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.509999999999998 119.947 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.509999999999998 115.529 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.619999999999997 114.759 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.509999999999998 110.366 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.549999999999997 113.715 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 45' ' ' PHE . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.509999999999998 106.035 175.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.549999999999997 104.072 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.509999999999998 118.355 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.619999999999997 118.736 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.509999999999998 106.228 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.509999999999998 112.755 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.509999999999998 109.784 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.509999999999998 108.847 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.509999999999998 104.275 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.509999999999998 102.101 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.509999999999998 111.016 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.640000000000001 109.31 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.509999999999998 112.756 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.640000000000001 102.16 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.509999999999998 109.351 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.509999999999998 108.526 179.194 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.548 0.896 0 CA-C-O 118.786 -0.626 . . . . 50.509999999999998 109.784 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -73.92 139.62 45.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 127.017 2.698 . . . . 50.549999999999997 110.888 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.4 pt -136.14 148.76 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 N-CA-C 104.776 -2.305 . . . . 50.509999999999998 104.776 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -98.07 146.12 25.86 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.484 4.865 . . . . 50.509999999999998 116.515 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.89 109.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 113.391 -3.195 . . . . 50.509999999999998 113.74 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -87.91 130.92 34.77 Favored 'General case' 0 N--CA 1.503 2.181 1 O-C-N 129.267 4.104 . . . . 50.509999999999998 108.059 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -101.55 -168.95 1.62 Allowed 'General case' 0 C--N 1.351 0.651 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 111.299 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.4 mt -87.55 -9.54 54.13 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.052 0.845 . . . . 50.509999999999998 113.264 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -111.52 12.48 21.36 Favored 'General case' 0 N--CA 1.503 2.178 1 O-C-N 113.514 -5.741 . . . . 50.509999999999998 109.711 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.83 -4.22 81.63 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 118.139 2.016 . . . . 50.509999999999998 118.139 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -72.62 142.27 48.34 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 115.485 1.661 . . . . 50.509999999999998 115.485 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -127.6 142.47 51.35 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 112.444 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 pt -111.94 168.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 127.56 3.038 . . . . 50.509999999999998 104.287 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.3 m -126.62 116.83 21.62 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 117.296 -1.762 . . . . 50.509999999999998 112.3 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 151.28 30.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 121.099 3.74 . . . . 50.509999999999998 121.099 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -123.5 111.24 16.06 Favored 'General case' 0 N--CA 1.499 2.012 1 O-C-N 129.169 4.043 . . . . 50.619999999999997 110.491 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.96 173.02 4.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 O-C-N 127.861 3.226 . . . . 50.509999999999998 108.724 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -90.83 140.89 26.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.152 -2.295 . . . . 50.619999999999997 111.398 174.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.4 Cg_exo -54.9 -24.57 39.63 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.647 2.231 . . . . 50.509999999999998 111.977 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -92.49 17.31 10.21 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 114.356 1.243 . . . . 50.509999999999998 114.356 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -83.29 128.88 34.87 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.388 -1.725 . . . . 50.619999999999997 114.483 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -76.63 151.26 36.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.854 -1.165 . . . . 50.509999999999998 107.854 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -48.33 -32.99 4.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 119.713 3.227 . . . . 50.509999999999998 119.713 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 107.589 -1.263 . . . . 50.619999999999997 107.589 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.47 -37.53 75.68 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 116.179 1.918 . . . . 50.549999999999997 116.179 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.28 -43.34 89.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 125.034 1.459 . . . . 50.509999999999998 107.144 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtmt -70.14 -44.55 68.63 Favored 'General case' 0 C--O 1.256 1.426 0 N-CA-C 106.178 -1.786 . . . . 50.509999999999998 106.178 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -3.28 0.2 Allowed 'General case' 0 C--O 1.278 2.602 0 N-CA-C 113.884 1.068 . . . . 50.509999999999998 113.884 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.71 -46.9 4.79 Favored 'General case' 0 C--O 1.255 1.36 0 O-C-N 120.392 -1.443 . . . . 50.509999999999998 110.545 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.427 HG23 ' OE1' ' A' ' 34' ' ' GLU . 68.8 mt -56.5 -34.85 42.44 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 N-CA-C 115.565 1.691 . . . . 50.509999999999998 115.565 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' ASP . 50.4 tt0 -56.37 -50.64 70.96 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 108.505 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' GLN . 79.9 m-20 -25.98 -60.9 0.08 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 115.994 1.85 . . . . 50.619999999999997 115.994 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -101.07 -54.19 2.86 Favored 'General case' 0 C--O 1.28 2.68 0 C-N-CA 116.432 -2.107 . . . . 50.509999999999998 109.748 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' HG23 ' A' ' 30' ' ' ILE . 38.7 mt-10 -55.65 -34.57 65.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 123.026 2.648 . . . . 50.619999999999997 110.609 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.92 5.96 67.68 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 106.674 -2.571 . . . . 50.509999999999998 106.674 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 65.9 mt -82.63 119.73 75.16 Favored Pre-proline 0 C--O 1.244 0.796 0 C-N-CA 118.781 -1.167 . . . . 50.509999999999998 113.426 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 79.7 Cg_exo -56.91 136.93 79.44 Favored 'Trans proline' 0 C--O 1.259 1.538 0 C-N-CA 123.166 2.577 . . . . 50.509999999999998 110.966 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 86.2 Cg_exo -57.15 -32.17 92.64 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.929 0.963 . . . . 50.509999999999998 113.447 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.26 -22.91 60.28 Favored 'General case' 0 C--O 1.262 1.754 0 N-CA-C 115.85 1.796 . . . . 50.619999999999997 115.85 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.36 27.39 2.95 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.538 -1.351 . . . . 50.549999999999997 110.579 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mt-30 -103.9 143.97 32.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 124.46 2.076 . . . . 50.549999999999997 112.07 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.06 104.05 7.11 Favored 'General case' 0 C--O 1.296 3.53 0 CA-C-O 116.628 -1.653 . . . . 50.640000000000001 108.703 172.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HD12 ' A' ' 50' ' ' LEU . 94.6 mt -98.11 120.27 38.22 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.456 2.762 . . . . 50.509999999999998 118.456 -177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.69 127.62 73.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 125.095 1.497 . . . . 50.509999999999998 111.752 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.406 ' CE2' HG12 ' A' ' 61' ' ' ILE . 82.8 t80 -151.03 112.07 4.32 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 118.653 2.834 . . . . 50.509999999999998 118.653 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.37 20.8 12.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 112.22 -2.264 . . . . 50.509999999999998 114.688 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 2.73 75.99 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 128.365 2.888 . . . . 50.509999999999998 116.218 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -108.95 115.85 30.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 102.92 -2.993 . . . . 50.509999999999998 102.92 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -72.5 124.39 25.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 123.925 0.765 . . . . 50.549999999999997 109.69 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 43' ' ' LEU . 31.9 mt -62.75 124.44 21.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 113.209 -175.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -86.6 152.32 22.7 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 106.192 -1.781 . . . . 50.619999999999997 106.192 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.9 -38.27 75.53 Favored 'General case' 0 C--O 1.264 1.844 0 N-CA-C 118.695 2.85 . . . . 50.619999999999997 118.695 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.47 33.19 6.78 Favored Glycine 0 CA--C 1.492 -1.36 0 C-N-CA 124.417 1.008 . . . . 50.509999999999998 114.117 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -109.96 160.84 16.06 Favored 'General case' 0 C--O 1.249 1.063 0 O-C-N 120.053 -1.851 . . . . 50.640000000000001 110.918 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -93.21 -174.95 3.69 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.601 0.963 . . . . 50.509999999999998 113.601 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 18' ' ' GLU . 49.1 mt -83.68 -22.77 31.99 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 119.947 3.314 . . . . 50.509999999999998 119.947 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -89.11 -26.97 21.06 Favored 'General case' 0 C--O 1.268 2.032 0 C-N-CA 117.354 -1.739 . . . . 50.509999999999998 115.529 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.75 -36.31 71.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.759 1.392 . . . . 50.619999999999997 114.759 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -89.42 17.32 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 117.718 -1.134 . . . . 50.509999999999998 110.366 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.35 35.62 5.94 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 121.596 1.998 . . . . 50.549999999999997 113.715 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG12 ' CE2' ' A' ' 45' ' ' PHE . 89.2 mt -85.24 91.74 3.18 Favored 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.186 -2.34 . . . . 50.509999999999998 106.035 175.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -94.94 -176.65 3.91 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.072 -2.566 . . . . 50.549999999999997 104.072 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -57.56 142.08 45.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.355 2.724 . . . . 50.509999999999998 118.355 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 53.45 44.7 29.6 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 118.736 2.865 . . . . 50.619999999999997 118.736 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -92.65 161.76 14.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.228 -1.767 . . . . 50.509999999999998 106.228 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -107.73 122.82 47.52 Favored 'General case' 0 C--N 1.307 -1.267 1 O-C-N 112.583 -6.323 . . . . 50.509999999999998 112.755 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.56 143.5 26.8 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 114.698 -2.573 . . . . 50.509999999999998 109.784 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -91.84 140.57 29.55 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 127.385 2.928 . . . . 50.509999999999998 108.847 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -111.38 140.12 46.22 Favored 'General case' 0 C--O 1.282 2.815 0 N-CA-C 104.275 -2.491 . . . . 50.509999999999998 104.275 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.4 t -136.94 133.58 47.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 102.101 -3.296 . . . . 50.509999999999998 102.101 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -76.19 127.53 33.1 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.186 0.517 . . . . 50.509999999999998 111.016 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -109.39 98.22 7.66 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.325 -3.226 . . . . 50.640000000000001 109.31 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.8 mt -94.02 134.69 36.16 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.815 1.947 . . . . 50.509999999999998 112.756 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -95.21 96.36 9.14 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 102.16 -3.274 . . . . 50.640000000000001 102.16 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 160.29 10.2 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 109.351 -1.5 . . . . 50.509999999999998 109.351 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-O 116.328 -2.373 . . . . 50.509999999999998 108.526 179.194 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.509999999999998 106.676 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.549999999999997 106.021 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.509999999999998 104.709 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' HB2' HG22 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.509999999999998 113.954 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.509999999999998 102.923 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.509999999999998 112.316 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.509999999999998 106.004 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.509999999999998 115.548 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.509999999999998 108.113 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.509999999999998 106.107 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.509999999999998 120.071 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.509999999999998 110.493 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.509999999999998 109.559 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.509999999999998 114.838 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.509999999999998 106.275 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.619999999999997 113.422 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.509999999999998 109.333 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.619999999999997 106.827 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.509999999999998 111.928 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.509999999999998 121.083 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.619999999999997 111.205 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.509999999999998 110.198 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.509999999999998 109.42 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.619999999999997 111.997 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.549999999999997 112.41 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.509999999999998 109.295 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.509999999999998 112.034 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.509999999999998 108.289 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.509999999999998 110.474 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.509999999999998 112.329 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.549999999999997 110.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 107.396 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.509999999999998 117.751 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.619999999999997 110.115 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.509999999999998 107.221 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.509999999999998 111.423 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.509999999999998 110.839 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.509999999999998 113.43 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.619999999999997 110.786 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.549999999999997 113.905 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.599 ' HG2' HD11 ' A' ' 69' ' ' LEU . 50.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.549999999999997 108.396 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.640000000000001 106.438 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.509999999999998 111.107 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.509999999999998 108.499 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.509999999999998 110.923 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.509999999999998 110.976 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 110.394 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.509999999999998 113.046 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.549999999999997 105.007 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.509999999999998 110.654 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.619999999999997 113.026 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.619999999999997 118.034 -175.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.509999999999998 115.926 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.640000000000001 104.585 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.509999999999998 116.28 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.509999999999998 114.766 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.509999999999998 108.201 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.619999999999997 110.796 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 109.666 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.549999999999997 108.723 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.509999999999998 106.728 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.549999999999997 120.811 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.509999999999998 108.884 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.619999999999997 119.75 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.509999999999998 111.035 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.509999999999998 110.83 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.516 175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.509999999999998 114.067 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 41' ' ' GLN . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.509999999999998 113.384 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.509999999999998 112.182 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.509999999999998 107.317 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.640000000000001 106.699 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.509999999999998 116.896 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.640000000000001 110.974 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.509999999999998 113.009 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 117.514 179.235 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 106.676 -1.601 . . . . 50.509999999999998 106.676 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.09 149.26 23.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 126.885 2.615 . . . . 50.549999999999997 106.021 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -147.8 160.03 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 104.709 -2.33 . . . . 50.509999999999998 104.709 173.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' HB2' HG22 ' A' ' 66' ' ' THR . 81.1 m-85 -106.05 149.87 26.29 Favored 'General case' 0 N--CA 1.51 2.555 1 O-C-N 130.29 4.744 . . . . 50.509999999999998 113.954 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 15' ' ' LEU . 42.7 t -129.22 139.86 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 113.368 -3.206 . . . . 50.509999999999998 102.923 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -108.06 138.1 44.91 Favored 'General case' 0 N--CA 1.504 2.257 1 O-C-N 129.384 4.177 . . . . 50.509999999999998 112.316 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.8 p -117.88 158.95 23.92 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.004 -1.85 . . . . 50.509999999999998 106.004 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.4 mt -54.16 -10.48 0.36 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.548 1.684 . . . . 50.509999999999998 115.548 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 80.5 m -83.17 -1.59 53.34 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 115.708 -2.397 . . . . 50.509999999999998 108.113 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.0 82.47 Favored Glycine 0 C--N 1.296 -1.654 0 N-CA-C 106.107 -2.797 . . . . 50.509999999999998 106.107 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.25 141.96 58.58 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 120.071 3.36 . . . . 50.509999999999998 120.071 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -112.37 157.97 20.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.652 2.47 . . . . 50.509999999999998 110.493 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 pt -144.0 142.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 127.416 2.948 . . . . 50.509999999999998 109.559 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.7 p -92.4 123.07 35.45 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.272 -1.771 . . . . 50.509999999999998 114.838 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD11 HG21 ' A' ' 5' ' ' VAL . 61.0 mt -98.51 164.83 12.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 115.423 -2.227 . . . . 50.509999999999998 106.275 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -122.84 98.82 6.08 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 129.249 4.093 . . . . 50.619999999999997 113.422 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.93 167.12 7.04 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 O-C-N 127.712 3.132 . . . . 50.509999999999998 109.333 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -122.16 161.03 45.03 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 112.125 -2.307 . . . . 50.619999999999997 106.827 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -54.96 -24.58 40.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 122.584 2.19 . . . . 50.509999999999998 111.928 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -91.12 -12.27 36.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 121.083 3.734 . . . . 50.509999999999998 121.083 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -72.5 146.84 46.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 117.334 -1.746 . . . . 50.619999999999997 111.205 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -86.65 173.35 9.58 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.821 -0.627 . . . . 50.509999999999998 110.198 175.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.9 -48.9 85.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 126.95 2.656 . . . . 50.509999999999998 109.42 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -47.0 -39.64 12.95 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.46 -0.775 . . . . 50.619999999999997 111.997 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -71.51 -49.28 42.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.288 1.035 . . . . 50.549999999999997 112.41 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 22' ' ' THR . 70.6 t -54.11 -34.35 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 125.072 1.482 . . . . 50.509999999999998 109.295 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -75.76 -31.72 59.66 Favored 'General case' 0 C--O 1.256 1.43 0 CA-C-N 115.751 -0.659 . . . . 50.509999999999998 112.034 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.51 -40.55 70.06 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 108.289 -1.004 . . . . 50.509999999999998 108.289 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 27.4 tptp -55.02 -39.22 68.88 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 120.431 -1.418 . . . . 50.509999999999998 110.474 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.1 -48.44 62.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.262 0 C-N-CA 119.466 -0.894 . . . . 50.509999999999998 112.329 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 32' ' ' ASP . 66.0 tt0 -46.94 -37.81 9.58 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 125.6 2.619 . . . . 50.549999999999997 110.082 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 96.3 m-20 -42.29 -65.94 0.41 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 107.396 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -92.01 -44.49 8.84 Favored 'General case' 0 C--O 1.279 2.644 0 N-CA-C 117.751 2.5 . . . . 50.509999999999998 117.751 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -72.33 -17.95 61.8 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 123.088 2.676 . . . . 50.619999999999997 110.115 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.0 32.28 80.41 Favored Glycine 0 CA--C 1.477 -2.329 0 N-CA-C 107.221 -2.352 . . . . 50.509999999999998 107.221 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.67 120.33 48.68 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 118.862 -1.135 . . . . 50.509999999999998 111.423 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.02 136.95 79.76 Favored 'Trans proline' 0 C--O 1.259 1.527 0 C-N-CA 123.187 2.592 . . . . 50.509999999999998 110.839 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.07 -32.28 92.76 Favored 'Trans proline' 0 C--O 1.261 1.646 0 O-C-N 122.889 0.941 . . . . 50.509999999999998 113.43 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.94 -12.21 53.14 Favored 'General case' 0 C--O 1.263 1.794 0 O-C-N 119.942 -1.724 . . . . 50.619999999999997 110.786 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -103.82 8.46 37.08 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.495 -1.378 . . . . 50.549999999999997 113.905 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.599 ' HG2' HD11 ' A' ' 69' ' ' LEU . 50.1 mt-30 -111.02 138.9 46.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.4 2.047 . . . . 50.549999999999997 108.396 -177.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -125.18 128.24 48.06 Favored 'General case' 0 C--O 1.296 3.514 0 N-CA-C 106.438 -1.69 . . . . 50.640000000000001 106.438 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -97.79 112.99 24.67 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 119.382 0.992 . . . . 50.509999999999998 111.107 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.21 125.84 63.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 O-C-N 125.122 1.514 . . . . 50.509999999999998 108.499 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -158.98 119.58 3.23 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 114.506 -1.225 . . . . 50.509999999999998 110.923 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.2 44.53 18.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 112.182 -2.281 . . . . 50.509999999999998 110.976 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.99 9.28 13.46 Favored Glycine 0 N--CA 1.432 -1.574 0 C-N-CA 128.44 2.924 . . . . 50.509999999999998 110.394 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -105.55 139.14 40.61 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 118.086 0.943 . . . . 50.509999999999998 113.046 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 49' ' ' GLN . 15.1 pt20 -93.87 125.81 38.71 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 105.007 -2.22 . . . . 50.549999999999997 105.007 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.46 162.52 28.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 117.735 -1.126 . . . . 50.509999999999998 110.654 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -100.02 144.64 28.83 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.909 1.381 . . . . 50.619999999999997 113.026 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -52.98 -55.9 20.09 Favored 'General case' 0 C--O 1.264 1.849 0 N-CA-C 118.034 2.605 . . . . 50.619999999999997 118.034 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.97 6.2 79.11 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 115.926 1.13 . . . . 50.509999999999998 115.926 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.57 161.33 14.25 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.585 -2.376 . . . . 50.640000000000001 104.585 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.7 p -96.61 178.09 5.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 116.28 1.956 . . . . 50.509999999999998 116.28 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.4 mt -79.4 -21.49 45.58 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 114.766 1.395 . . . . 50.509999999999998 114.766 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 59' ' ' TYR . 26.8 m -79.17 -26.29 42.71 Favored 'General case' 0 C--O 1.268 2.074 0 C-N-CA 117.286 -1.766 . . . . 50.509999999999998 108.201 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.67 5.59 1.04 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.481 1.134 . . . . 50.619999999999997 110.796 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 57' ' ' SER . 93.0 m-85 -128.49 7.08 5.77 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 109.666 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 t30 51.13 36.79 16.49 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 121.528 1.967 . . . . 50.549999999999997 108.723 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.06 109.51 23.29 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.23 -2.319 . . . . 50.509999999999998 106.728 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -109.78 174.21 5.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 120.811 3.634 . . . . 50.549999999999997 120.811 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -44.44 133.16 5.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 123.223 1.487 . . . . 50.509999999999998 108.884 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 64' ' ' GLU . 10.9 tt0 80.02 32.86 0.19 Allowed 'General case' 0 C--O 1.257 1.5 0 N-CA-C 119.75 3.241 . . . . 50.619999999999997 119.75 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -102.24 155.36 18.27 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.84 -1.073 . . . . 50.509999999999998 111.035 174.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 4' ' ' PHE . 44.8 p -110.88 131.48 55.01 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 118.256 -0.878 . . . . 50.509999999999998 110.83 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -112.2 133.61 54.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 114.663 -2.589 . . . . 50.509999999999998 107.516 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -83.66 122.76 29.04 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 127.446 2.966 . . . . 50.509999999999998 114.067 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 41' ' ' GLN . 48.6 tp -92.15 115.18 27.85 Favored 'General case' 0 C--O 1.283 2.83 0 CA-C-O 117.61 -1.186 . . . . 50.509999999999998 113.384 176.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.01 133.5 44.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 CA-C-N 119.586 1.085 . . . . 50.509999999999998 112.182 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.13 138.49 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.317 -1.364 . . . . 50.509999999999998 107.317 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.97 60.8 1.58 Allowed 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 113.394 -3.194 . . . . 50.640000000000001 106.699 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.39 170.29 0.54 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 116.896 2.184 . . . . 50.509999999999998 116.896 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -99.33 105.0 16.94 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 113.8 -1.545 . . . . 50.640000000000001 110.974 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.08 152.47 8.4 Favored Glycine 0 C--O 1.243 0.713 0 CA-C-N 114.635 -1.166 . . . . 50.509999999999998 113.009 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 117.514 179.235 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.868 0 N-CA-C 104.835 -2.283 . . . . 50.509999999999998 104.835 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -88.49 154.45 20.35 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 102.339 -3.208 . . . . 50.549999999999997 102.339 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 3' ' ' ILE . 19.7 tt -150.21 128.91 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 115.963 -1.97 . . . . 50.509999999999998 108.004 173.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 66' ' ' THR . 82.5 m-85 -92.92 141.96 27.84 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.328 4.767 . . . . 50.509999999999998 112.03 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.79 99.23 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 113.439 -3.172 . . . . 50.509999999999998 111.052 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -68.65 136.07 52.38 Favored 'General case' 0 N--CA 1.504 2.235 1 O-C-N 129.254 4.096 . . . . 50.509999999999998 114.159 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 p -112.87 149.23 33.43 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 104.91 -2.256 . . . . 50.509999999999998 104.91 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.44 -6.85 0.5 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 118.799 2.888 . . . . 50.509999999999998 118.799 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -115.91 19.46 15.1 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 120.312 3.449 . . . . 50.509999999999998 120.312 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.26 -13.69 66.4 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 117.483 1.753 . . . . 50.509999999999998 117.483 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.41 155.41 18.21 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 116.871 -1.538 . . . . 50.509999999999998 111.77 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -148.98 149.77 31.72 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 126.656 2.472 . . . . 50.509999999999998 109.639 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -143.62 146.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.497 2.998 . . . . 50.509999999999998 110.559 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.457 ' O ' HD23 ' A' ' 15' ' ' LEU . 20.9 p -102.87 130.4 49.89 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.315 -1.754 . . . . 50.509999999999998 112.746 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 14' ' ' THR . 48.0 mt -124.95 149.79 47.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 115.37 -2.253 . . . . 50.509999999999998 113.511 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -107.4 142.43 37.23 Favored 'General case' 0 N--CA 1.5 2.025 1 O-C-N 129.114 4.009 . . . . 50.619999999999997 104.294 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -144.08 167.18 12.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 O-C-N 126.091 2.119 . . . . 50.509999999999998 105.692 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 68.9 mm-40 -122.0 157.66 57.15 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 112.209 -2.269 . . . . 50.619999999999997 112.202 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.96 -24.47 39.58 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 122.662 2.241 . . . . 50.509999999999998 111.904 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -96.78 -8.78 30.31 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 118.158 -0.925 . . . . 50.509999999999998 112.674 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 30.4 m-20 -66.3 124.44 22.71 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.308 -1.757 . . . . 50.619999999999997 106.485 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -79.09 155.79 28.6 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.808 -0.633 . . . . 50.509999999999998 112.51 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.605 HD13 ' HB3' ' A' ' 50' ' ' LEU . 76.6 mt -52.18 -45.87 43.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 O-C-N 127.176 2.798 . . . . 50.509999999999998 108.374 175.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -47.05 -51.01 18.58 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.45 -0.781 . . . . 50.619999999999997 110.645 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -65.19 -43.05 92.87 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 118.735 2.865 . . . . 50.549999999999997 118.735 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.22 -42.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.123 -1.399 . . . . 50.509999999999998 110.285 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.26 -38.25 90.38 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 108.12 -1.066 . . . . 50.509999999999998 108.12 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.7 -40.02 63.94 Favored 'General case' 0 C--O 1.277 2.543 0 N-CA-C 114.709 1.374 . . . . 50.509999999999998 114.709 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -58.05 -29.19 65.17 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 120.398 -1.439 . . . . 50.509999999999998 112.966 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.436 HG12 HD11 ' A' ' 15' ' ' LEU . 74.6 mt -77.58 -29.86 16.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.216 0 N-CA-C 106.695 -1.595 . . . . 50.509999999999998 106.695 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -58.08 -41.71 84.0 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 125.614 2.626 . . . . 50.549999999999997 108.18 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -73.48 10.92 0.89 Allowed 'General case' 0 C--O 1.253 1.289 0 CA-C-N 113.6 -1.636 . . . . 50.619999999999997 113.765 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -139.26 -30.1 0.74 Allowed 'General case' 0 C--O 1.279 2.647 0 N-CA-C 104.592 -2.373 . . . . 50.509999999999998 104.592 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -110.18 -61.57 1.64 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 123.081 2.673 . . . . 50.619999999999997 109.578 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.51 20.29 0.9 Allowed Glycine 0 CA--C 1.477 -2.327 0 N-CA-C 108.891 -1.683 . . . . 50.509999999999998 108.891 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.2 mt -103.03 122.26 46.14 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 116.526 2.047 . . . . 50.509999999999998 116.526 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.0 Cg_exo -57.01 136.91 79.55 Favored 'Trans proline' 0 C--O 1.259 1.545 0 C-N-CA 123.104 2.536 . . . . 50.509999999999998 110.937 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.0 Cg_exo -57.18 -32.12 92.55 Favored 'Trans proline' 0 C--O 1.262 1.685 0 O-C-N 122.912 0.953 . . . . 50.509999999999998 113.388 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' A' ' 37' ' ' PRO . 42.1 p-10 -59.91 -27.91 67.14 Favored 'General case' 0 C--O 1.261 1.702 0 O-C-N 119.897 -1.752 . . . . 50.619999999999997 114.427 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -87.97 -15.63 35.97 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.593 -1.317 . . . . 50.549999999999997 113.857 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -87.3 117.7 26.25 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 118.3 2.704 . . . . 50.549999999999997 118.3 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.32 131.99 53.62 Favored 'General case' 0 C--O 1.296 3.511 0 N-CA-C 105.937 -1.875 . . . . 50.640000000000001 105.937 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 mt -107.67 133.38 52.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 101.965 -3.346 . . . . 50.509999999999998 101.965 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.42 HD13 HG23 ' A' ' 70' ' ' VAL . 3.3 mp -124.31 135.87 62.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 O-C-N 125.201 1.563 . . . . 50.509999999999998 114.334 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -140.14 113.03 8.14 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 105.719 -1.956 . . . . 50.509999999999998 105.719 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.93 41.42 31.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.26 -2.245 . . . . 50.509999999999998 108.716 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.66 3.54 59.15 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 128.432 2.92 . . . . 50.509999999999998 116.134 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -78.1 125.5 29.45 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.714 1.376 . . . . 50.509999999999998 114.714 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -75.24 127.91 34.24 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 107.68 -1.23 . . . . 50.549999999999997 107.68 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.605 ' HB3' HD13 ' A' ' 23' ' ' ILE . 2.9 mp -95.51 124.59 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 117.72 -1.133 . . . . 50.509999999999998 112.665 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -104.37 135.97 44.83 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.368 1.988 . . . . 50.619999999999997 116.368 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -42.62 -36.23 1.33 Allowed 'General case' 0 C--O 1.264 1.821 0 N-CA-C 121.197 3.777 . . . . 50.619999999999997 121.197 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.56 -33.61 87.7 Favored Glycine 0 CA--C 1.493 -1.294 0 C-N-CA 124.438 1.018 . . . . 50.509999999999998 113.72 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -88.69 136.45 32.99 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 119.766 -2.02 . . . . 50.640000000000001 112.614 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 22' ' ' THR . 57.0 p -77.68 171.54 14.79 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.015 0.926 . . . . 50.509999999999998 111.465 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.69 -39.24 83.87 Favored 'General case' 0 C--O 1.2 -1.502 0 N-CA-C 117.381 2.363 . . . . 50.509999999999998 117.381 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -64.41 -37.67 88.33 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.332 -1.747 . . . . 50.509999999999998 110.815 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -50.01 -43.57 50.68 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 116.888 2.181 . . . . 50.619999999999997 116.888 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.656 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 63.4 m-85 -74.57 -6.85 50.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 110.416 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.656 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 71.52 40.67 0.79 Allowed 'General case' 0 C--O 1.247 0.957 0 CA-C-N 121.429 1.922 . . . . 50.549999999999997 115.239 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mm -71.03 110.41 3.96 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.182 -2.342 . . . . 50.509999999999998 110.428 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 174.35 7.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.056 2.097 . . . . 50.549999999999997 114.79 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HG2' ' HG2' ' A' ' 64' ' ' GLU . 26.7 ttpp -61.35 114.27 3.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 123.159 1.457 . . . . 50.509999999999998 112.848 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 45.6 mm-40 80.31 44.18 0.04 OUTLIER 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.575 -2.102 . . . . 50.619999999999997 111.989 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.2 t -82.64 140.71 33.02 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.785 -1.098 . . . . 50.509999999999998 108.832 174.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 45.7 m -109.28 146.65 33.94 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 102.454 -3.165 . . . . 50.509999999999998 102.454 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.2 147.28 41.59 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.739 -2.553 . . . . 50.509999999999998 109.193 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -88.89 137.98 31.83 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 127.149 2.78 . . . . 50.509999999999998 111.373 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.3 tp -112.5 109.17 18.59 Favored 'General case' 0 C--O 1.283 2.86 0 CA-C-O 117.662 -1.161 . . . . 50.509999999999998 113.737 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG23 HD13 ' A' ' 44' ' ' ILE . 45.6 t -111.69 128.48 68.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 119.614 1.097 . . . . 50.509999999999998 108.452 175.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.07 139.05 32.73 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 116.296 1.962 . . . . 50.509999999999998 116.296 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -98.08 116.7 30.84 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 113.337 -3.22 . . . . 50.640000000000001 108.684 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mp -85.76 138.4 32.12 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 125.795 1.934 . . . . 50.509999999999998 106.421 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -99.56 73.93 1.86 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.763 -1.562 . . . . 50.640000000000001 109.118 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.55 145.04 6.7 Favored Glycine 0 C--O 1.244 0.735 0 N-CA-C 106.293 -2.723 . . . . 50.509999999999998 106.293 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.416 0 N-CA-C 106.551 -2.62 . . . . 50.509999999999998 106.551 179.239 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 97.6 mmm . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 107.819 -1.178 . . . . 50.509999999999998 107.819 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -113.54 139.66 48.8 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 103.575 -2.75 . . . . 50.549999999999997 103.575 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.521 HD12 ' C ' ' A' ' 3' ' ' ILE . 2.0 pp -144.78 162.55 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 N-CA-C 104.75 -2.315 . . . . 50.509999999999998 104.75 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 148.02 40.27 Favored 'General case' 0 N--CA 1.511 2.604 1 O-C-N 130.46 4.85 . . . . 50.509999999999998 109.434 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 67' ' ' LEU . 42.9 t -130.22 100.05 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 113.406 -3.188 . . . . 50.509999999999998 105.245 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -65.4 131.11 45.61 Favored 'General case' 0 N--CA 1.504 2.275 1 O-C-N 129.266 4.103 . . . . 50.509999999999998 112.832 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 41.5 p -93.22 -169.39 2.14 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 107.672 -1.233 . . . . 50.509999999999998 107.672 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.06 34.87 4.75 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 106.851 -1.537 . . . . 50.509999999999998 106.851 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.1 p -134.13 -15.09 2.29 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 115.706 -2.398 . . . . 50.509999999999998 114.646 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.63 13.14 10.7 Favored Glycine 0 C--N 1.296 -1.645 0 O-C-N 120.227 -1.546 . . . . 50.509999999999998 112.654 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -119.87 120.31 36.08 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 116.834 -1.555 . . . . 50.509999999999998 111.126 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 p -85.77 144.75 27.58 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 126.647 2.467 . . . . 50.509999999999998 110.942 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.6 mt -116.75 142.74 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 127.582 3.052 . . . . 50.509999999999998 110.391 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -122.33 128.92 51.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.249 -1.78 . . . . 50.509999999999998 113.007 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 30' ' ' ILE . 5.4 mp -118.64 151.7 37.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 115.39 -2.243 . . . . 50.509999999999998 107.28 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 1' ' ' MET . 40.1 mt-10 -117.22 126.18 52.35 Favored 'General case' 0 N--CA 1.5 2.028 1 O-C-N 129.176 4.048 . . . . 50.619999999999997 102.984 173.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.491 HG12 ' HE3' ' A' ' 29' ' ' LYS . 35.3 m -146.31 170.83 4.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 126.241 2.213 . . . . 50.509999999999998 108.46 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -108.52 154.84 41.33 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.163 -2.29 . . . . 50.619999999999997 114.645 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -55.03 -24.51 40.35 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 122.624 2.216 . . . . 50.509999999999998 111.918 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -75.08 -14.74 60.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 118.067 -0.968 . . . . 50.509999999999998 112.467 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.0 140.91 56.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 117.355 -1.738 . . . . 50.619999999999997 109.344 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.0 p -80.93 133.51 35.55 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 105.809 -1.923 . . . . 50.509999999999998 105.809 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 54' ' ' ARG . 24.4 mm -37.69 -35.64 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.212 2.82 . . . . 50.509999999999998 110.364 175.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -58.5 -45.17 89.29 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.543 2.423 . . . . 50.619999999999997 117.543 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -67.09 -26.59 66.79 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.874 2.175 . . . . 50.549999999999997 116.874 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.74 -43.08 93.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 125.118 1.511 . . . . 50.509999999999998 112.842 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.7 -34.34 71.19 Favored 'General case' 0 C--O 1.256 1.402 0 CA-C-N 115.767 -0.651 . . . . 50.509999999999998 110.009 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 31' ' ' GLN . . . -66.42 -44.82 81.88 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 117.872 2.545 . . . . 50.509999999999998 117.872 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HE3' HG12 ' A' ' 17' ' ' VAL . 62.0 mttm -46.65 -32.66 3.66 Favored 'General case' 0 C--O 1.255 1.395 0 O-C-N 120.422 -1.424 . . . . 50.509999999999998 108.56 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.463 HD11 HD11 ' A' ' 15' ' ' LEU . 22.6 mm -68.97 -40.69 81.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.199 0 N-CA-C 106.363 -1.717 . . . . 50.509999999999998 106.363 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 28' ' ' ALA . 26.0 tt0 -39.92 -38.62 0.72 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 118.359 2.726 . . . . 50.549999999999997 118.359 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.11 -12.4 61.48 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 115.605 1.706 . . . . 50.619999999999997 115.605 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -105.18 -43.47 5.01 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.459 -2.096 . . . . 50.509999999999998 115.246 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -110.57 -43.46 3.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 123.067 2.667 . . . . 50.619999999999997 108.205 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 35.39 1.88 Allowed Glycine 0 CA--C 1.477 -2.33 0 N-CA-C 108.188 -1.965 . . . . 50.509999999999998 108.188 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.9 mm -98.73 123.41 49.81 Favored Pre-proline 0 C--O 1.243 0.739 0 C-N-CA 118.851 -1.139 . . . . 50.509999999999998 108.703 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.5 Cg_exo -56.92 136.98 79.77 Favored 'Trans proline' 0 C--O 1.258 1.516 0 C-N-CA 123.1 2.533 . . . . 50.509999999999998 110.943 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.516 ' HA ' HE21 ' A' ' 41' ' ' GLN . 86.7 Cg_exo -57.18 -32.23 92.87 Favored 'Trans proline' 0 C--O 1.261 1.663 0 O-C-N 122.904 0.949 . . . . 50.509999999999998 113.436 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.45 -15.99 63.39 Favored 'General case' 0 C--O 1.262 1.711 0 O-C-N 120.023 -1.673 . . . . 50.619999999999997 114.309 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -104.63 17.57 23.88 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.555 -1.341 . . . . 50.549999999999997 113.991 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.516 HE21 ' HA ' ' A' ' 38' ' ' PRO . 54.7 mt-30 -114.35 146.11 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 124.422 2.058 . . . . 50.549999999999997 106.636 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.635 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 21.5 mtp-105 -128.7 105.19 8.09 Favored 'General case' 0 C--O 1.295 3.488 0 CA-C-O 116.632 -1.651 . . . . 50.640000000000001 113.386 172.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.41 117.58 29.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.459 1.027 . . . . 50.509999999999998 110.701 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -107.8 122.07 61.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 N-CA-C 119.051 2.982 . . . . 50.509999999999998 119.051 -177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -128.38 128.92 45.42 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 106.791 -1.559 . . . . 50.509999999999998 106.791 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.11 25.91 15.88 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 108.701 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.57 16.52 61.06 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.438 2.923 . . . . 50.509999999999998 108.69 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.47 142.01 33.49 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 118.037 0.918 . . . . 50.509999999999998 110.062 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -75.92 156.7 34.0 Favored 'General case' 0 C--O 1.26 1.607 0 O-C-N 123.981 0.801 . . . . 50.549999999999997 111.969 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.5 mt -107.9 146.81 31.85 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.344 -1.725 . . . . 50.509999999999998 106.344 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -92.01 140.15 29.94 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 103.767 -2.679 . . . . 50.619999999999997 103.767 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -53.52 -52.18 60.46 Favored 'General case' 0 C--O 1.264 1.836 0 C-N-CA 126.206 1.802 . . . . 50.619999999999997 113.646 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.72 28.46 5.91 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 119.658 2.623 . . . . 50.509999999999998 119.658 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 23' ' ' ILE . 20.7 mmm180 -117.35 169.49 9.45 Favored 'General case' 0 C--O 1.248 1.006 0 O-C-N 120.047 -1.854 . . . . 50.640000000000001 112.33 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.95 149.36 28.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.091 0.956 . . . . 50.509999999999998 113.485 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.444 ' HB3' HG13 ' A' ' 61' ' ' ILE . 65.8 mt -50.47 -36.0 31.57 Favored 'General case' 0 C--O 1.201 -1.475 0 O-C-N 124.196 0.935 . . . . 50.509999999999998 109.023 177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -68.79 -15.01 63.38 Favored 'General case' 0 C--O 1.268 2.059 0 C-N-CA 117.319 -1.752 . . . . 50.509999999999998 112.086 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.391 1.091 . . . . 50.619999999999997 109.894 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -121.88 11.2 10.33 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.778 -1.106 . . . . 50.509999999999998 113.333 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t30 51.45 39.79 25.27 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 121.442 1.928 . . . . 50.549999999999997 110.203 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.444 HG13 ' HB3' ' A' ' 56' ' ' LEU . 25.9 mm -56.54 116.26 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.959 0 CA-C-O 115.215 -2.326 . . . . 50.509999999999998 109.473 175.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -79.98 -171.03 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.638 2.458 . . . . 50.549999999999997 117.638 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.27 143.68 48.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.229 1.49 . . . . 50.509999999999998 108.827 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 34.42 39.58 0.03 OUTLIER 'General case' 0 C--O 1.256 1.447 0 N-CA-C 117.905 2.557 . . . . 50.619999999999997 117.905 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -65.89 146.68 54.44 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.83 -1.077 . . . . 50.509999999999998 111.949 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 p -104.54 144.15 32.08 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 118.299 -0.857 . . . . 50.509999999999998 110.926 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 5' ' ' VAL . 60.0 mt -110.66 156.04 21.56 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 114.756 -2.545 . . . . 50.509999999999998 108.625 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -118.94 144.94 46.16 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 127.408 2.942 . . . . 50.509999999999998 110.475 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 49.2 tp -96.09 129.88 43.26 Favored 'General case' 0 C--O 1.282 2.803 0 CA-C-O 117.696 -1.145 . . . . 50.509999999999998 111.668 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 61.8 t -116.11 137.06 51.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 102.392 -3.188 . . . . 50.509999999999998 102.392 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.87 127.86 46.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.102 0.477 . . . . 50.509999999999998 110.42 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -114.27 111.83 22.14 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.374 -3.203 . . . . 50.640000000000001 112.494 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.05 143.9 28.12 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 125.837 1.961 . . . . 50.509999999999998 108.097 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -98.09 89.28 4.47 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 106.662 -1.607 . . . . 50.640000000000001 106.662 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.7 -162.65 26.99 Favored Glycine 0 C--O 1.242 0.655 0 N-CA-C 104.643 -3.383 . . . . 50.509999999999998 104.643 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.397 0 CA-C-O 116.355 -2.358 . . . . 50.509999999999998 108.044 179.25 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 CA--C 1.548 0.874 0 CA-C-O 118.768 -0.634 . . . . 50.509999999999998 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 10.9 mm-40 -109.09 127.67 54.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 127.001 2.688 . . . . 50.549999999999997 109.026 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -133.16 146.55 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 116.024 -1.941 . . . . 50.509999999999998 107.717 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -106.56 135.89 47.28 Favored 'General case' 0 N--CA 1.512 2.645 1 O-C-N 130.446 4.841 . . . . 50.509999999999998 113.486 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.8 t -108.05 136.63 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.417 -3.182 . . . . 50.509999999999998 103.898 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -126.24 119.7 28.12 Favored 'General case' 0 N--CA 1.503 2.219 1 O-C-N 129.277 4.111 . . . . 50.509999999999998 114.834 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.565 HG22 HD23 ' A' ' 69' ' ' LEU . 43.9 p -67.44 -172.27 0.23 Allowed 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.869 -1.063 . . . . 50.509999999999998 110.337 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.89 -18.97 26.46 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.116 -0.698 . . . . 50.509999999999998 109.116 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -106.36 16.08 25.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 119.87 3.285 . . . . 50.509999999999998 119.87 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.86 55.67 Favored Glycine 0 C--N 1.296 -1.679 0 N-CA-C 120.952 3.141 . . . . 50.509999999999998 120.952 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -84.16 123.35 30.0 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.227 -1.768 . . . . 50.509999999999998 106.227 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -113.03 134.1 54.67 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 126.585 2.428 . . . . 50.509999999999998 111.872 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 5' ' ' VAL . 28.0 pt -115.92 153.81 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 127.533 3.02 . . . . 50.509999999999998 114.0 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -110.58 142.99 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 117.301 -1.76 . . . . 50.509999999999998 115.021 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' A' ' 30' ' ' ILE . 76.4 mt -135.46 139.78 44.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 115.459 -2.21 . . . . 50.509999999999998 113.54 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -101.85 107.19 18.3 Favored 'General case' 0 N--CA 1.5 2.069 1 O-C-N 129.128 4.018 . . . . 50.619999999999997 113.926 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -128.17 154.63 39.08 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.671 3.107 . . . . 50.509999999999998 114.443 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -101.67 159.02 30.65 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 118.256 2.688 . . . . 50.619999999999997 118.256 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.0 -24.49 40.0 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.581 2.187 . . . . 50.509999999999998 111.948 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -103.34 34.33 2.97 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 117.806 2.521 . . . . 50.509999999999998 117.806 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -114.15 130.75 56.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.374 -1.731 . . . . 50.619999999999997 112.166 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.3 p -57.93 155.54 10.5 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.598 1.332 . . . . 50.509999999999998 114.598 175.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 54' ' ' ARG . 15.3 mm -60.45 -42.06 89.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 127.205 2.816 . . . . 50.509999999999998 110.955 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -58.07 -59.05 5.88 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.941 . . . . 50.619999999999997 108.458 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 44.5 t30 -47.85 -43.54 28.36 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 124.399 1.08 . . . . 50.549999999999997 111.145 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 56' ' ' LEU . 42.1 t -63.38 -34.05 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.97 1.419 . . . . 50.509999999999998 109.707 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -76.16 -30.44 58.12 Favored 'General case' 0 C--O 1.257 1.451 0 N-CA-C 108.816 -0.809 . . . . 50.509999999999998 108.816 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.88 70.02 Favored 'General case' 0 C--O 1.279 2.616 0 N-CA-C 105.517 -2.031 . . . . 50.509999999999998 105.517 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 75.3 mmtt -58.93 -63.2 1.38 Allowed 'General case' 0 C--O 1.255 1.359 0 O-C-N 120.397 -1.439 . . . . 50.509999999999998 107.994 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.499 ' CG1' HD11 ' A' ' 15' ' ' LEU . 70.3 mt -47.97 -37.75 6.8 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.486 -0.886 . . . . 50.509999999999998 109.105 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 46.1 tt0 -54.45 -50.73 66.99 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 125.568 2.604 . . . . 50.549999999999997 112.849 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -49.0 -60.99 2.3 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 113.644 -1.616 . . . . 50.619999999999997 110.273 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -84.13 -40.33 18.36 Favored 'General case' 0 C--O 1.279 2.654 0 N-CA-C 119.617 3.191 . . . . 50.509999999999998 119.617 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.606 ' HG3' HG13 ' A' ' 36' ' ' ILE . 42.5 tp10 -76.19 -31.37 58.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 123.082 2.674 . . . . 50.619999999999997 108.162 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.42 2.36 76.75 Favored Glycine 0 CA--C 1.479 -2.202 0 N-CA-C 110.458 -1.057 . . . . 50.509999999999998 110.458 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.606 HG13 ' HG3' ' A' ' 34' ' ' GLU . 94.0 mt -87.81 136.39 32.67 Favored Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 118.812 -1.155 . . . . 50.509999999999998 110.999 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.0 Cg_exo -57.07 137.0 79.97 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.159 2.572 . . . . 50.509999999999998 110.875 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 86.8 Cg_exo -57.19 -32.16 92.68 Favored 'Trans proline' 0 C--O 1.262 1.709 0 O-C-N 122.89 0.942 . . . . 50.509999999999998 113.436 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.539 ' OD1' ' HG3' ' A' ' 40' ' ' GLN . 35.6 p30 -69.4 -14.1 62.72 Favored 'General case' 0 C--O 1.262 1.733 0 O-C-N 119.893 -1.754 . . . . 50.619999999999997 113.83 -177.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.539 ' HG3' ' OD1' ' A' ' 39' ' ' ASP . 88.2 mt-30 -102.81 6.84 39.49 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.544 -1.347 . . . . 50.549999999999997 109.891 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -103.41 130.94 50.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 124.362 2.029 . . . . 50.549999999999997 110.796 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -120.98 122.12 39.47 Favored 'General case' 0 C--O 1.296 3.544 0 CA-C-O 116.625 -1.655 . . . . 50.640000000000001 110.828 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CB ' HD12 ' A' ' 50' ' ' LEU . 60.2 mt -108.14 126.16 52.44 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.509 1.05 . . . . 50.509999999999998 109.839 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 67.5 mt -111.14 138.86 37.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 O-C-N 125.223 1.577 . . . . 50.509999999999998 108.147 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -150.55 120.63 7.2 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 114.488 -1.233 . . . . 50.509999999999998 110.913 177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.34 38.66 7.69 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.208 -2.269 . . . . 50.509999999999998 112.284 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 3.42 68.08 Favored Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.346 2.879 . . . . 50.509999999999998 115.863 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -113.76 146.78 39.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 114.978 1.473 . . . . 50.509999999999998 114.978 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -70.51 153.96 42.38 Favored 'General case' 0 C--O 1.259 1.58 0 N-CA-C 108.2 -1.037 . . . . 50.549999999999997 108.2 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.45 HD12 ' CB ' ' A' ' 43' ' ' LEU . 63.5 mt -96.94 135.01 39.55 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 117.666 -1.159 . . . . 50.509999999999998 110.312 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -99.06 128.1 45.13 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.933 1.395 . . . . 50.619999999999997 112.737 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.11 -57.82 3.63 Favored 'General case' 0 C--O 1.264 1.844 0 C-N-CA 126.133 1.773 . . . . 50.619999999999997 115.216 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.26 -26.68 29.85 Favored Glycine 0 CA--C 1.492 -1.389 0 C-N-CA 124.415 1.007 . . . . 50.509999999999998 113.886 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 23' ' ' ILE . 29.5 mmt180 -83.6 161.04 21.27 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 120.025 -1.868 . . . . 50.640000000000001 112.109 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -103.93 172.68 6.67 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 124.065 0.946 . . . . 50.509999999999998 110.218 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD11 HG21 ' A' ' 26' ' ' VAL . 47.5 mt -58.07 -33.19 68.79 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 116.49 2.033 . . . . 50.509999999999998 116.49 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -86.38 -5.66 59.12 Favored 'General case' 0 C--O 1.267 2.0 0 C-N-CA 117.372 -1.731 . . . . 50.509999999999998 111.167 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -79.81 -0.79 36.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.809 -1.182 . . . . 50.619999999999997 107.809 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -123.95 11.98 9.01 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 117.755 -1.117 . . . . 50.509999999999998 110.542 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.61 28.61 12.2 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 121.545 1.975 . . . . 50.549999999999997 111.595 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.2 103.0 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.969 0 CA-C-O 115.17 -2.348 . . . . 50.509999999999998 108.827 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -98.84 164.62 12.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.112 2.133 . . . . 50.549999999999997 112.435 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -51.04 135.89 24.27 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.513 2.042 . . . . 50.509999999999998 116.513 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 73.09 37.93 0.73 Allowed 'General case' 0 C--O 1.255 1.393 0 CA-C-N 112.497 -2.138 . . . . 50.619999999999997 111.07 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 p -78.07 156.56 29.96 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 107.537 -1.283 . . . . 50.509999999999998 107.537 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.5 m -122.05 117.97 27.63 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.834 -3.024 . . . . 50.509999999999998 102.834 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.65 170.09 9.04 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 114.695 -2.574 . . . . 50.509999999999998 112.545 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -110.32 127.62 55.12 Favored 'General case' 0 C--N 1.285 -2.215 0 O-C-N 127.361 2.913 . . . . 50.509999999999998 108.73 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.565 HD23 HG22 ' A' ' 7' ' ' THR . 48.0 tp -103.07 101.87 11.87 Favored 'General case' 0 C--O 1.283 2.823 0 CA-C-O 117.649 -1.167 . . . . 50.509999999999998 113.194 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.0 t -96.38 137.11 25.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.583 1.083 . . . . 50.509999999999998 112.149 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 tp -96.03 115.73 27.88 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.318 -0.623 . . . . 50.509999999999998 109.318 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -109.04 108.18 18.79 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.305 -3.236 . . . . 50.640000000000001 114.166 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -87.86 165.16 15.48 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 125.859 1.974 . . . . 50.509999999999998 114.664 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -115.35 61.45 0.69 Allowed 'General case' 0 C--O 1.244 0.812 0 CA-C-N 113.742 -1.572 . . . . 50.640000000000001 108.472 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.75 138.82 2.55 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 107.298 -2.321 . . . . 50.509999999999998 107.298 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.444 0 CA-C-O 116.356 -2.358 . . . . 50.509999999999998 109.038 179.217 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 106.917 -1.512 . . . . 50.509999999999998 106.917 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -120.19 135.71 54.88 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 101.557 -3.498 . . . . 50.549999999999997 101.557 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -137.89 159.36 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.94 -1.981 . . . . 50.509999999999998 106.941 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -114.24 143.91 44.08 Favored 'General case' 0 N--CA 1.512 2.628 1 O-C-N 130.446 4.842 . . . . 50.509999999999998 111.395 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -118.97 109.87 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.404 -3.189 . . . . 50.509999999999998 106.121 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -84.3 150.37 25.46 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.306 4.129 . . . . 50.509999999999998 117.362 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.4 p -126.78 164.23 21.81 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 117.826 -1.083 . . . . 50.509999999999998 110.137 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.54 -43.36 65.12 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.999 2.592 . . . . 50.509999999999998 117.999 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.6 p -68.64 -26.52 65.37 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 115.726 -2.39 . . . . 50.509999999999998 107.455 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.73 -5.93 18.42 Favored Glycine 0 C--N 1.297 -1.6 0 O-C-N 120.258 -1.526 . . . . 50.509999999999998 115.438 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -54.66 130.88 41.96 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.88 -1.533 . . . . 50.509999999999998 109.889 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -112.86 119.58 38.47 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 126.624 2.453 . . . . 50.509999999999998 117.221 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -88.48 145.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.571 3.044 . . . . 50.509999999999998 108.329 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -104.58 141.93 35.53 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 117.287 -1.765 . . . . 50.509999999999998 110.584 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 mt -134.13 137.48 44.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 118.195 2.665 . . . . 50.509999999999998 118.195 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -103.61 111.18 23.54 Favored 'General case' 0 N--CA 1.501 2.104 1 O-C-N 129.242 4.089 . . . . 50.619999999999997 112.35 174.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -98.24 166.74 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.197 0 O-C-N 127.508 3.005 . . . . 50.509999999999998 112.548 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 53.9 mm-40 -115.72 148.66 41.63 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.197 -2.274 . . . . 50.619999999999997 112.58 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.5 Cg_exo -54.95 -24.49 39.57 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.581 2.188 . . . . 50.509999999999998 112.003 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -103.14 13.75 33.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 118.043 2.608 . . . . 50.509999999999998 118.043 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -92.74 148.6 21.91 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 117.349 -1.74 . . . . 50.619999999999997 110.986 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -99.09 157.42 16.37 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.836 -0.62 . . . . 50.509999999999998 109.716 175.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 26.8 mm -45.01 -43.86 2.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 O-C-N 127.238 2.836 . . . . 50.509999999999998 113.015 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -57.39 -46.68 83.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.456 -0.778 . . . . 50.619999999999997 110.305 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -59.51 -39.88 85.3 Favored 'General case' 0 C--O 1.248 1.012 0 C-N-CA 124.287 1.035 . . . . 50.549999999999997 110.653 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.63 -46.73 95.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.022 -1.473 . . . . 50.509999999999998 107.022 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 93.4 mttt -55.0 -59.38 4.83 Favored 'General case' 0 C--O 1.257 1.467 0 CA-C-N 115.814 -0.63 . . . . 50.509999999999998 111.336 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 38' ' ' PRO . . . -57.02 -40.59 76.99 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 113.887 1.069 . . . . 50.509999999999998 113.887 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 55.8 tptt -50.8 -44.38 58.97 Favored 'General case' 0 C--O 1.255 1.39 0 N-CA-C 106.367 -1.716 . . . . 50.509999999999998 106.367 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 31' ' ' GLN . 72.3 mt -64.26 -42.2 94.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.281 0 C-N-CA 119.51 -0.876 . . . . 50.509999999999998 108.669 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' O ' ' C ' ' A' ' 32' ' ' ASP . 35.4 tt0 -43.87 -58.34 2.8 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.623 2.63 . . . . 50.549999999999997 108.844 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 31' ' ' GLN . 98.1 m-20 -34.57 -35.79 0.04 OUTLIER 'General case' 0 C--O 1.253 1.26 0 CA-C-N 113.645 -1.616 . . . . 50.619999999999997 110.833 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 31' ' ' GLN . 33.7 mmtp -112.46 -1.22 15.05 Favored 'General case' 0 C--O 1.28 2.703 0 N-CA-C 120.15 3.389 . . . . 50.509999999999998 120.15 -175.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -129.81 -38.07 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 123.147 2.703 . . . . 50.619999999999997 108.399 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 11.98 31.98 Favored Glycine 0 CA--C 1.477 -2.333 0 N-CA-C 115.177 0.831 . . . . 50.509999999999998 115.177 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.501 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.6 mt -97.51 136.72 21.18 Favored Pre-proline 0 C--O 1.245 0.83 0 C-N-CA 118.836 -1.146 . . . . 50.509999999999998 112.149 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.565 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.88 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.596 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 Cg_exo -57.24 -32.18 92.86 Favored 'Trans proline' 0 C--O 1.26 1.621 0 O-C-N 122.903 0.949 . . . . 50.509999999999998 113.38 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -72.82 5.17 3.39 Favored 'General case' 0 C--O 1.262 1.757 0 O-C-N 120.022 -1.674 . . . . 50.619999999999997 113.573 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.592 HE21 ' HG3' ' A' ' 74' ' ' ARG . 62.8 mt-30 -111.2 -6.71 14.53 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.541 -1.349 . . . . 50.549999999999997 112.632 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.425 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 8.8 mt-30 -102.79 130.59 49.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.412 2.053 . . . . 50.549999999999997 112.686 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -111.54 119.68 39.57 Favored 'General case' 0 C--O 1.297 3.566 0 CA-C-O 116.672 -1.632 . . . . 50.640000000000001 108.368 172.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' A' ' 50' ' ' LEU . 94.4 mt -100.97 158.72 15.79 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 105.595 -2.002 . . . . 50.509999999999998 105.595 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.8 mt -137.35 135.78 46.91 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 118.835 2.902 . . . . 50.509999999999998 118.835 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -128.05 112.62 14.81 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 115.063 1.505 . . . . 50.509999999999998 115.063 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.92 30.92 20.42 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.19 -2.277 . . . . 50.509999999999998 109.525 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.09 19.34 72.63 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 128.486 2.945 . . . . 50.509999999999998 117.187 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -111.02 151.72 27.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 118.162 -0.923 . . . . 50.509999999999998 112.078 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.05 154.17 42.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.986 1.106 . . . . 50.549999999999997 113.986 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' A' ' 43' ' ' LEU . 96.4 mt -117.09 140.22 49.77 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 117.796 -1.097 . . . . 50.509999999999998 109.169 -175.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -103.32 136.03 43.85 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.864 1.352 . . . . 50.619999999999997 114.31 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 75.4 m-20 -57.33 -55.73 31.01 Favored 'General case' 0 C--O 1.263 1.793 0 C-N-CA 126.177 1.791 . . . . 50.619999999999997 114.019 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.16 11.66 4.76 Favored Glycine 0 C--O 1.254 1.368 0 C-N-CA 124.464 1.03 . . . . 50.509999999999998 115.389 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -106.96 166.7 10.41 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 119.963 -1.904 . . . . 50.640000000000001 110.538 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -90.22 158.67 17.1 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 124.014 0.926 . . . . 50.509999999999998 113.308 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -70.62 -28.82 65.14 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 124.071 0.857 . . . . 50.509999999999998 110.085 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 p -69.31 -21.71 63.83 Favored 'General case' 0 C--O 1.268 2.042 0 C-N-CA 117.31 -1.756 . . . . 50.509999999999998 113.535 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -78.29 -5.35 51.78 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.63 2.085 . . . . 50.619999999999997 116.63 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -111.75 14.32 21.11 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 114.791 1.404 . . . . 50.509999999999998 114.791 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 51.4 28.1 4.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 121.571 1.987 . . . . 50.549999999999997 114.397 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.85 100.48 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.973 0 CA-C-O 115.192 -2.337 . . . . 50.509999999999998 106.878 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -98.9 162.76 12.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 126.159 2.162 . . . . 50.549999999999997 111.333 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 58.4 pttt -52.93 118.32 3.62 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 116.501 2.038 . . . . 50.509999999999998 116.501 -176.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 71.69 46.87 0.36 Allowed 'General case' 0 C--O 1.257 1.453 0 CA-C-N 112.53 -2.123 . . . . 50.619999999999997 112.764 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.3 p -102.0 151.86 21.63 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 101.515 -3.513 . . . . 50.509999999999998 101.515 174.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.1 p -94.29 139.55 30.92 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 117.729 2.492 . . . . 50.509999999999998 117.729 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 46.6 mt -109.36 151.73 26.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 103.166 -2.902 . . . . 50.509999999999998 103.166 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 55.5 m80 -108.75 124.95 51.37 Favored 'General case' 0 C--N 1.284 -2.278 0 O-C-N 127.472 2.982 . . . . 50.509999999999998 104.565 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.4 tp -99.42 117.56 34.11 Favored 'General case' 0 C--O 1.283 2.841 0 CA-C-O 117.63 -1.176 . . . . 50.509999999999998 111.172 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -103.84 145.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 119.558 1.072 . . . . 50.509999999999998 108.765 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -115.23 120.55 40.08 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.859 2.17 . . . . 50.509999999999998 116.859 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -119.13 90.06 3.25 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 113.371 -3.204 . . . . 50.640000000000001 111.138 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.24 163.38 1.65 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 125.795 1.935 . . . . 50.509999999999998 109.209 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.592 ' HG3' HE21 ' A' ' 40' ' ' GLN . 93.8 mtt-85 -87.62 94.01 9.6 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 113.706 -1.588 . . . . 50.640000000000001 113.065 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.66 171.34 18.3 Favored Glycine 0 C--O 1.243 0.705 0 N-CA-C 109.663 -1.375 . . . . 50.509999999999998 109.663 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.472 0 N-CA-C 106.215 -2.754 . . . . 50.509999999999998 106.215 179.22 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 CA--C 1.547 0.862 0 CA-C-O 118.753 -0.641 . . . . 50.509999999999998 111.148 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.521 ' OE1' HG21 ' A' ' 14' ' ' THR . 48.9 mt-30 -86.22 125.11 33.31 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.96 2.663 . . . . 50.549999999999997 116.662 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.3 pt -119.87 162.65 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 115.983 -1.96 . . . . 50.509999999999998 109.392 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -112.02 136.28 51.58 Favored 'General case' 0 N--CA 1.513 2.69 1 O-C-N 130.504 4.877 . . . . 50.509999999999998 118.459 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -105.85 111.63 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 113.438 -3.172 . . . . 50.509999999999998 111.728 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -81.22 129.44 34.59 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.309 4.131 . . . . 50.509999999999998 109.318 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 69.2 p -97.67 -176.77 3.57 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 114.576 1.324 . . . . 50.509999999999998 114.576 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.2 mt -86.91 -28.68 22.64 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.784 1.031 . . . . 50.509999999999998 113.784 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 p -93.97 -22.37 18.61 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.713 -2.395 . . . . 50.509999999999998 111.12 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.2 3.9 2.39 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 117.726 1.85 . . . . 50.509999999999998 117.726 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' N ' ' OG1' ' A' ' 7' ' ' THR . 95.4 mttt -71.7 137.65 47.96 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 116.868 -1.539 . . . . 50.509999999999998 112.323 174.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.1 m -122.15 106.73 11.42 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.678 2.486 . . . . 50.509999999999998 110.809 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 15' ' ' LEU . 62.5 mt -84.87 153.09 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 127.244 2.84 . . . . 50.509999999999998 111.427 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.521 HG21 ' OE1' ' A' ' 2' ' ' GLN . 42.6 m -119.76 132.1 55.53 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 102.538 -3.134 . . . . 50.509999999999998 102.538 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 13' ' ' ILE . 1.5 mp -118.05 142.6 47.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 117.3 2.333 . . . . 50.509999999999998 117.3 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -97.71 107.39 19.87 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 128.944 3.902 . . . . 50.619999999999997 109.902 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.58 166.71 10.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 O-C-N 127.782 3.176 . . . . 50.509999999999998 106.046 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -132.67 157.77 77.46 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 112.234 -2.257 . . . . 50.619999999999997 106.446 174.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.92 -24.5 39.38 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.56 2.173 . . . . 50.509999999999998 112.014 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -75.81 -13.0 60.28 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 115.451 1.648 . . . . 50.509999999999998 115.451 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -84.65 131.27 34.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 118.379 2.733 . . . . 50.619999999999997 118.379 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -83.61 179.92 7.49 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 103.948 -2.612 . . . . 50.509999999999998 103.948 175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' GLU . 24.6 mm -65.41 -39.56 85.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 O-C-N 127.206 2.816 . . . . 50.509999999999998 110.824 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ILE . 29.7 tt0 -46.84 -59.23 3.2 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.275 -2.12 . . . . 50.619999999999997 105.275 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 24.6 m-80 -53.12 -46.37 68.73 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 118.123 2.638 . . . . 50.549999999999997 118.123 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.41 -39.6 81.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 117.777 2.51 . . . . 50.509999999999998 117.777 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -72.27 -30.08 64.5 Favored 'General case' 0 C--O 1.256 1.439 0 N-CA-C 103.231 -2.877 . . . . 50.509999999999998 103.231 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -30.86 71.18 Favored 'General case' 0 C--O 1.279 2.608 0 N-CA-C 109.146 -0.687 . . . . 50.509999999999998 109.146 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.6 mttt -71.79 -19.18 62.04 Favored 'General case' 0 C--O 1.256 1.422 0 O-C-N 120.316 -1.49 . . . . 50.509999999999998 111.058 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 30' ' ' ILE . 95.7 mt -88.94 -11.25 10.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 C-N-CA 119.538 -0.865 . . . . 50.509999999999998 109.491 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -91.67 -19.64 22.45 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 125.63 2.633 . . . . 50.549999999999997 113.161 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.26 -52.77 20.5 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.572 -1.649 . . . . 50.619999999999997 110.606 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -80.28 -75.93 0.24 Allowed 'General case' 0 C--O 1.278 2.598 0 C-N-CA 116.468 -2.093 . . . . 50.509999999999998 108.175 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -55.18 -70.02 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.05 2.659 . . . . 50.619999999999997 114.812 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.69 20.33 0.88 Allowed Glycine 0 CA--C 1.478 -2.27 0 CA-C-O 120.012 -0.327 . . . . 50.509999999999998 113.223 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -89.28 125.86 60.51 Favored Pre-proline 0 C--O 1.244 0.776 0 N-CA-C 116.77 2.137 . . . . 50.509999999999998 116.77 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -57.01 136.98 79.95 Favored 'Trans proline' 0 C--O 1.258 1.523 0 C-N-CA 123.159 2.572 . . . . 50.509999999999998 110.903 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.1 Cg_exo -57.17 -32.19 92.72 Favored 'Trans proline' 0 C--O 1.261 1.653 0 C-N-CA 120.671 0.914 . . . . 50.509999999999998 113.377 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.04 -9.71 58.9 Favored 'General case' 0 C--O 1.262 1.738 0 O-C-N 119.949 -1.719 . . . . 50.619999999999997 112.854 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.644 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 79.8 mt-30 -103.32 -1.89 27.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.488 -1.382 . . . . 50.549999999999997 107.656 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -92.22 138.1 31.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 124.447 2.07 . . . . 50.549999999999997 105.745 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -130.11 114.4 15.7 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.646 -1.645 . . . . 50.640000000000001 106.831 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' CB ' HD22 ' A' ' 50' ' ' LEU . 35.2 mt -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 119.537 1.062 . . . . 50.509999999999998 110.285 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -129.06 123.87 59.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 O-C-N 125.102 1.501 . . . . 50.509999999999998 111.849 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -140.1 117.19 11.16 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 114.539 -1.21 . . . . 50.509999999999998 109.948 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.7 29.0 13.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 112.241 -2.254 . . . . 50.509999999999998 114.706 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 37.54 45.29 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 114.393 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -133.95 150.23 51.28 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 118.317 2.71 . . . . 50.509999999999998 118.317 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.08 135.18 42.97 Favored 'General case' 0 C--O 1.26 1.635 0 O-C-N 123.953 0.783 . . . . 50.549999999999997 110.33 174.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD22 ' CB ' ' A' ' 43' ' ' LEU . 2.1 mp -87.79 129.18 35.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 114.637 1.347 . . . . 50.509999999999998 114.637 -175.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -89.5 141.42 28.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 120.377 3.473 . . . . 50.619999999999997 120.377 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -51.07 -55.97 14.95 Favored 'General case' 0 C--O 1.264 1.821 0 N-CA-C 119.74 3.237 . . . . 50.619999999999997 119.74 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.96 7.85 78.69 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 124.387 0.994 . . . . 50.509999999999998 114.189 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.51 144.55 28.48 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 119.951 -1.911 . . . . 50.640000000000001 109.276 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -87.4 155.84 19.85 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.062 0.945 . . . . 50.509999999999998 108.581 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -46.93 -32.26 3.71 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 113.869 1.063 . . . . 50.509999999999998 113.869 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.58 -20.38 65.38 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 115.759 1.763 . . . . 50.509999999999998 115.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -62.24 -43.84 97.91 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.452 1.12 . . . . 50.619999999999997 110.603 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -84.66 17.11 2.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 115.609 1.707 . . . . 50.509999999999998 115.609 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.7 t30 60.31 33.13 20.88 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 121.536 1.971 . . . . 50.549999999999997 113.59 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.533 HG23 ' OG ' ' A' ' 65' ' ' SER . 56.9 mt -85.47 83.71 2.08 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 CA-C-O 115.169 -2.348 . . . . 50.509999999999998 113.65 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -82.97 179.06 7.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 125.717 1.885 . . . . 50.549999999999997 116.027 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -53.2 124.21 13.91 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 123.179 1.466 . . . . 50.509999999999998 111.394 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 61.1 40.42 14.98 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 118.528 2.788 . . . . 50.619999999999997 118.528 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.533 ' OG ' HG23 ' A' ' 61' ' ' ILE . 94.2 p -86.91 152.35 22.51 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.164 -1.421 . . . . 50.509999999999998 107.164 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 m -91.47 123.3 34.78 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 116.667 2.099 . . . . 50.509999999999998 116.667 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.01 138.58 41.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 114.735 -2.555 . . . . 50.509999999999998 105.291 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 49.0 m80 -81.6 168.04 18.59 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 127.038 2.711 . . . . 50.509999999999998 106.612 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.8 tp -131.24 120.47 23.28 Favored 'General case' 0 C--O 1.282 2.789 0 N-CA-C 104.664 -2.346 . . . . 50.509999999999998 104.664 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 85.5 t -118.8 149.93 21.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 102.585 -3.117 . . . . 50.509999999999998 102.585 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.11 152.33 18.64 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.536 0.569 . . . . 50.509999999999998 112.536 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.644 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 74.9 ttt180 -122.12 97.73 5.61 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 113.413 -3.184 . . . . 50.640000000000001 106.789 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.0 mt -85.83 134.6 33.91 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 125.757 1.911 . . . . 50.509999999999998 113.369 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -83.84 81.49 8.75 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 113.703 -1.59 . . . . 50.640000000000001 112.88 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.94 -175.34 16.6 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 107.596 -2.201 . . . . 50.509999999999998 107.596 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.464 0 N-CA-C 105.24 -3.144 . . . . 50.509999999999998 105.24 179.213 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtp . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 102.042 -3.318 . . . . 50.509999999999998 102.042 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -112.52 135.05 53.69 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 103.497 -2.779 . . . . 50.549999999999997 103.497 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -124.77 173.12 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 CA-C-O 116.074 -1.917 . . . . 50.509999999999998 107.004 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.8 141.98 38.55 Favored 'General case' 0 N--CA 1.511 2.609 1 O-C-N 130.343 4.777 . . . . 50.509999999999998 115.954 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.34 110.58 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 113.454 -3.165 . . . . 50.509999999999998 104.585 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -90.47 143.94 26.27 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.204 4.065 . . . . 50.509999999999998 105.472 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 24.8 p -117.39 177.2 4.82 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 117.8 -1.095 . . . . 50.509999999999998 112.878 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.05 -24.76 67.83 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.082 0.864 . . . . 50.509999999999998 112.65 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -101.23 25.79 7.83 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 115.748 -2.381 . . . . 50.509999999999998 110.799 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.56 31.34 74.44 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 107.559 -2.216 . . . . 50.509999999999998 107.559 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 29.3 ttpt -84.97 124.7 31.98 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 103.735 -2.691 . . . . 50.509999999999998 103.735 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 p -103.31 137.72 41.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 126.664 2.477 . . . . 50.509999999999998 105.851 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 13' ' ' ILE . 16.6 tt -144.74 112.13 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 101.735 -3.432 . . . . 50.509999999999998 101.735 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.9 p -81.52 155.07 25.94 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.302 -1.759 . . . . 50.509999999999998 114.975 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -114.22 167.63 10.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.446 -2.216 . . . . 50.509999999999998 110.928 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.6 104.06 12.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 129.025 3.953 . . . . 50.619999999999997 106.427 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.41 148.62 11.49 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 O-C-N 127.62 3.075 . . . . 50.509999999999998 114.912 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -116.0 149.47 43.4 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 112.131 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.87 -24.53 39.18 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.535 2.157 . . . . 50.509999999999998 111.971 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -87.31 -2.54 58.7 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 118.146 -0.931 . . . . 50.509999999999998 111.135 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.43 131.8 37.05 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 115.949 1.833 . . . . 50.619999999999997 115.949 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.98 148.58 24.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.808 -0.633 . . . . 50.509999999999998 111.04 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 51' ' ' GLU . 73.2 mt -48.6 -29.87 2.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.147 2.779 . . . . 50.509999999999998 114.907 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 78.5 tt0 -56.25 -63.82 1.06 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 105.021 -2.215 . . . . 50.619999999999997 105.021 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -50.42 -40.71 51.01 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 118.97 2.952 . . . . 50.549999999999997 118.97 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.13 -23.15 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.129 -1.396 . . . . 50.509999999999998 107.518 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 64.5 mttm -88.73 -26.68 21.65 Favored 'General case' 0 C--O 1.257 1.474 0 N-CA-C 118.272 2.693 . . . . 50.509999999999998 118.272 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.54 -23.7 24.29 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.901 -0.407 . . . . 50.509999999999998 109.901 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.87 -49.69 73.84 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 120.333 -1.48 . . . . 50.509999999999998 111.41 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -56.42 -36.96 48.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 108.575 -0.898 . . . . 50.509999999999998 108.575 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -54.47 -45.19 73.13 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.578 2.608 . . . . 50.549999999999997 115.682 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -52.64 -29.55 26.83 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 106.387 -1.709 . . . . 50.619999999999997 106.387 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.72 -45.48 11.61 Favored 'General case' 0 C--O 1.279 2.656 0 C-N-CA 116.433 -2.107 . . . . 50.509999999999998 113.243 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -116.78 -36.67 3.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 123.107 2.685 . . . . 50.619999999999997 112.321 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.86 31.32 2.74 Favored Glycine 0 CA--C 1.477 -2.291 0 N-CA-C 110.512 -1.035 . . . . 50.509999999999998 110.512 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -83.09 122.92 77.89 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 105.273 -2.121 . . . . 50.509999999999998 105.273 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.4 Cg_exo -57.0 136.93 79.63 Favored 'Trans proline' 0 C--O 1.258 1.514 0 C-N-CA 123.228 2.618 . . . . 50.509999999999998 110.838 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.3 Cg_exo -57.18 -32.19 92.77 Favored 'Trans proline' 0 C--O 1.262 1.688 0 O-C-N 122.885 0.939 . . . . 50.509999999999998 113.418 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -89.25 27.57 1.39 Allowed 'General case' 0 C--O 1.262 1.75 0 O-C-N 119.981 -1.699 . . . . 50.619999999999997 115.06 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -137.8 14.03 2.91 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 104.384 -2.45 . . . . 50.549999999999997 104.384 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.513 ' HG2' HD11 ' A' ' 69' ' ' LEU . 58.7 mt-30 -110.39 137.79 47.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.948 -2.242 . . . . 50.549999999999997 104.948 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -131.62 108.88 9.82 Favored 'General case' 0 C--O 1.296 3.537 0 CA-C-O 116.676 -1.63 . . . . 50.640000000000001 112.564 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.0 mt -90.42 131.22 36.31 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 116.63 2.085 . . . . 50.509999999999998 116.63 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.713 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.7 mt -107.0 137.9 35.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.509999999999998 113.524 -177.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -149.4 112.39 4.87 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 114.55 -1.204 . . . . 50.509999999999998 113.78 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 46.05 27.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.215 -2.266 . . . . 50.509999999999998 113.31 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.93 -6.07 56.63 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 128.384 2.897 . . . . 50.509999999999998 114.763 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -97.47 158.9 15.24 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 117.412 2.375 . . . . 50.509999999999998 117.412 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -96.17 139.96 31.57 Favored 'General case' 0 C--O 1.259 1.554 0 N-CA-C 105.644 -1.984 . . . . 50.549999999999997 105.644 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -95.84 127.79 42.16 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 117.72 -1.133 . . . . 50.509999999999998 112.554 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . 57.5 mt-10 -85.55 139.39 31.49 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.891 1.369 . . . . 50.619999999999997 113.79 -177.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -53.88 -50.21 66.82 Favored 'General case' 0 C--O 1.264 1.86 0 C-N-CA 126.171 1.788 . . . . 50.619999999999997 114.38 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.3 -4.58 44.66 Favored Glycine 0 CA--C 1.493 -1.321 0 C-N-CA 124.457 1.027 . . . . 50.509999999999998 113.999 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -90.99 150.0 21.63 Favored 'General case' 0 C--O 1.249 1.072 0 O-C-N 119.858 -1.966 . . . . 50.640000000000001 108.92 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -83.47 -179.19 7.29 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.08 0.952 . . . . 50.509999999999998 110.398 177.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.38 -29.12 31.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.821 -1.548 . . . . 50.509999999999998 106.821 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.3 m -73.78 -37.37 65.0 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 106.904 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -46.92 -16.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.334 1.064 . . . . 50.619999999999997 112.88 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 91.1 m-85 -121.71 -6.12 9.14 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 113.613 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 66.31 41.65 3.29 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 117.569 2.433 . . . . 50.549999999999997 117.569 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -82.14 124.41 39.15 Favored 'Isoleucine or valine' 0 C--O 1.267 1.978 0 CA-C-O 115.287 -2.292 . . . . 50.509999999999998 110.174 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -112.67 168.68 9.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 126.018 2.073 . . . . 50.549999999999997 115.893 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -36.54 146.2 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 123.277 1.513 . . . . 50.509999999999998 113.569 -176.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 50.31 34.93 9.63 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-N 112.469 -2.15 . . . . 50.619999999999997 115.885 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 t -76.8 154.07 34.29 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.802 -1.09 . . . . 50.509999999999998 108.659 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 m -119.99 123.6 43.89 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.734 -1.209 . . . . 50.509999999999998 107.734 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.7 mt -94.85 147.88 22.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.696 -2.573 . . . . 50.509999999999998 111.47 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.713 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.0 m-70 -95.93 119.28 34.13 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 127.454 2.971 . . . . 50.509999999999998 108.781 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD11 ' HG2' ' A' ' 41' ' ' GLN . 33.1 tp -98.51 110.53 23.11 Favored 'General case' 0 C--O 1.282 2.779 0 N-CA-C 107.08 -1.452 . . . . 50.509999999999998 107.08 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 44' ' ' ILE . 45.6 t -93.81 165.17 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 101.499 -3.519 . . . . 50.509999999999998 101.499 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.3 mt -117.21 139.98 50.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.884 -0.784 . . . . 50.509999999999998 108.884 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -131.33 91.67 3.06 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-O 113.405 -3.188 . . . . 50.640000000000001 107.094 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -85.15 157.23 20.72 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 125.778 1.924 . . . . 50.509999999999998 110.066 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -90.53 113.2 25.13 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 105.543 -2.021 . . . . 50.640000000000001 105.543 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.65 155.81 14.52 Favored Glycine 0 C--O 1.243 0.682 0 CA-C-N 114.662 -1.154 . . . . 50.509999999999998 113.581 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.323 -2.376 . . . . 50.509999999999998 113.473 179.214 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 106.471 -1.678 . . . . 50.509999999999998 106.471 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.411 ' HG2' ' HG2' ' A' ' 16' ' ' GLU . 82.1 mt-30 -102.5 131.82 48.96 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 126.952 2.658 . . . . 50.549999999999997 108.424 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.73 163.95 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 CA-C-O 115.961 -1.971 . . . . 50.509999999999998 112.534 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.407 ' CD1' HG22 ' A' ' 14' ' ' THR . 79.0 m-85 -108.44 141.51 40.19 Favored 'General case' 0 N--CA 1.511 2.608 1 O-C-N 130.49 4.869 . . . . 50.509999999999998 116.756 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -116.72 120.16 64.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-O 113.356 -3.212 . . . . 50.509999999999998 106.065 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.32 117.38 34.0 Favored 'General case' 0 N--CA 1.504 2.245 1 O-C-N 129.326 4.141 . . . . 50.509999999999998 112.825 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 69.4 p -84.54 -174.46 5.28 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 117.774 -1.108 . . . . 50.509999999999998 108.723 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.9 mt -84.74 -8.9 58.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 118.516 2.784 . . . . 50.509999999999998 118.516 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -122.65 22.86 9.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 115.74 -2.384 . . . . 50.509999999999998 116.791 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.03 22.16 21.03 Favored Glycine 0 C--N 1.297 -1.609 0 O-C-N 119.225 -2.172 . . . . 50.509999999999998 118.183 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 80.0 tttt -100.54 124.13 45.68 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 116.823 -1.56 . . . . 50.509999999999998 108.417 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 m -124.47 135.29 53.11 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 126.668 2.48 . . . . 50.509999999999998 106.369 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.3 pt -123.31 153.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 127.565 3.04 . . . . 50.509999999999998 103.594 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.407 HG22 ' CD1' ' A' ' 4' ' ' PHE . 70.2 p -117.1 139.04 51.2 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 117.266 -1.774 . . . . 50.509999999999998 107.862 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -126.3 137.96 53.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 115.454 -2.212 . . . . 50.509999999999998 107.446 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HG2' ' HG2' ' A' ' 2' ' ' GLN . 46.8 mt-10 -96.24 133.14 40.95 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.231 4.082 . . . . 50.619999999999997 109.407 173.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.42 170.62 19.03 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 O-C-N 127.631 3.082 . . . . 50.509999999999998 113.57 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -124.09 153.5 68.03 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.215 -2.266 . . . . 50.619999999999997 111.165 174.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.01 -24.5 40.1 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 122.623 2.215 . . . . 50.509999999999998 111.906 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.0 p -89.01 8.32 30.27 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 117.243 2.312 . . . . 50.509999999999998 117.243 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.84 137.73 32.99 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 118.648 2.833 . . . . 50.619999999999997 118.648 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 25' ' ' ASN . 32.8 p -86.89 137.17 32.61 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.834 -0.621 . . . . 50.509999999999998 111.95 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -42.6 -35.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.26 2.85 . . . . 50.509999999999998 112.932 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.47 -11.79 58.73 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.488 -0.757 . . . . 50.619999999999997 111.077 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' THR . 31.3 t30 -108.56 -14.48 14.63 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.251 1.02 . . . . 50.549999999999997 109.814 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.1 t -81.47 -44.79 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 103.701 -2.703 . . . . 50.509999999999998 103.701 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 50.9 mtmt -66.88 -33.54 75.81 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-N 115.769 -0.65 . . . . 50.509999999999998 110.203 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.04 73.88 Favored 'General case' 0 C--O 1.279 2.627 0 N-CA-C 108.324 -0.991 . . . . 50.509999999999998 108.324 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 98.1 mttt -47.16 -28.35 1.79 Allowed 'General case' 0 C--O 1.256 1.399 0 O-C-N 120.368 -1.458 . . . . 50.509999999999998 113.826 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -80.23 -49.76 18.45 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 C-N-CA 119.496 -0.882 . . . . 50.509999999999998 109.861 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' ILE . 18.0 tm0? -38.63 -51.14 1.64 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 125.572 2.605 . . . . 50.549999999999997 112.061 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -54.69 -39.17 67.87 Favored 'General case' 0 C--O 1.253 1.24 0 N-CA-C 117.499 2.407 . . . . 50.619999999999997 117.499 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -109.59 -7.88 15.06 Favored 'General case' 0 C--O 1.279 2.653 0 C-N-CA 116.425 -2.11 . . . . 50.509999999999998 111.687 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.559 ' HG3' HG12 ' A' ' 36' ' ' ILE . 32.3 tp10 -108.6 -31.54 7.73 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 123.108 2.686 . . . . 50.619999999999997 107.77 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.99 7.4 85.52 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 109.488 -1.445 . . . . 50.509999999999998 109.488 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.559 HG12 ' HG3' ' A' ' 34' ' ' GLU . 30.4 mm -101.65 131.86 22.42 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 102.233 -3.247 . . . . 50.509999999999998 102.233 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.02 136.93 79.62 Favored 'Trans proline' 0 C--O 1.26 1.604 0 C-N-CA 123.192 2.595 . . . . 50.509999999999998 110.908 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.627 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.7 Cg_exo -57.15 -32.16 92.6 Favored 'Trans proline' 0 C--O 1.262 1.677 0 O-C-N 122.846 0.919 . . . . 50.509999999999998 113.44 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.09 2.82 3.22 Favored 'General case' 0 C--O 1.261 1.7 0 O-C-N 119.909 -1.744 . . . . 50.619999999999997 112.957 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -127.58 35.97 4.44 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.59 -1.319 . . . . 50.549999999999997 113.765 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.22 134.71 55.2 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 124.447 2.07 . . . . 50.549999999999997 111.514 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 54.8 ttm-85 -99.94 124.04 44.84 Favored 'General case' 0 C--O 1.298 3.613 0 CA-C-O 116.635 -1.65 . . . . 50.640000000000001 110.22 172.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.23 121.44 42.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.504 1.047 . . . . 50.509999999999998 110.749 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.13 123.39 60.31 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 125.174 1.546 . . . . 50.509999999999998 113.674 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.77 112.21 17.05 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 114.616 -1.175 . . . . 50.509999999999998 110.196 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.68 27.8 7.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 112.24 -2.254 . . . . 50.509999999999998 110.586 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.97 33.26 59.9 Favored Glycine 0 C--N 1.3 -1.453 0 C-N-CA 128.411 2.91 . . . . 50.509999999999998 117.476 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -119.03 148.88 42.53 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 104.741 -2.318 . . . . 50.509999999999998 104.741 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -88.04 135.75 33.28 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 119.797 3.258 . . . . 50.549999999999997 119.797 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.38 155.5 16.71 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 101.484 -3.525 . . . . 50.509999999999998 101.484 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -130.71 157.19 43.47 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 125.02 1.45 . . . . 50.619999999999997 108.242 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.01 -34.92 77.41 Favored 'General case' 0 C--O 1.264 1.833 0 C-N-CA 126.19 1.796 . . . . 50.619999999999997 109.38 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.39 9.21 4.58 Favored Glycine 0 CA--C 1.492 -1.354 0 C-N-CA 124.426 1.013 . . . . 50.509999999999998 113.156 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -124.29 162.56 23.49 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 120.941 3.682 . . . . 50.640000000000001 120.941 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.4 p -80.43 173.76 12.28 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.028 0.931 . . . . 50.509999999999998 109.419 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 tp -88.85 -20.14 25.01 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.04 -1.096 . . . . 50.509999999999998 108.04 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 m -79.56 -36.69 37.87 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.362 -1.735 . . . . 50.509999999999998 112.665 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -53.13 -17.26 1.5 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 117.082 2.253 . . . . 50.619999999999997 117.082 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -93.38 12.0 26.37 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 117.823 -1.084 . . . . 50.509999999999998 110.836 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.37 33.08 3.59 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 116.533 2.049 . . . . 50.549999999999997 116.533 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -82.26 114.8 23.71 Favored 'Isoleucine or valine' 0 C--O 1.265 1.907 0 CA-C-O 115.268 -2.301 . . . . 50.509999999999998 112.346 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -110.33 -166.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.125 2.141 . . . . 50.549999999999997 111.126 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 78.7 tttt -74.16 134.65 42.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.177 1.465 . . . . 50.509999999999998 108.792 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 53.0 mt-10 67.55 44.23 1.75 Allowed 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.537 -2.12 . . . . 50.619999999999997 114.35 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -88.21 167.28 13.72 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 105.464 -2.05 . . . . 50.509999999999998 105.464 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.6 m -121.35 112.31 18.41 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 118.253 -0.879 . . . . 50.509999999999998 110.982 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.3 mt -99.7 141.68 32.18 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 114.729 -2.558 . . . . 50.509999999999998 109.56 175.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -95.1 134.81 37.4 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.347 2.905 . . . . 50.509999999999998 111.788 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -105.31 114.98 29.49 Favored 'General case' 0 C--O 1.283 2.861 0 CA-C-O 117.611 -1.185 . . . . 50.509999999999998 110.902 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.7 t -104.83 137.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.171 -1.788 . . . . 50.509999999999998 106.171 175.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.0 tp -79.86 128.68 33.74 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.252 0.549 . . . . 50.509999999999998 110.331 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 -103.28 107.41 18.22 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-O 113.428 -3.177 . . . . 50.640000000000001 110.041 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.92 143.1 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 125.791 1.932 . . . . 50.509999999999998 109.533 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -105.51 59.95 0.67 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.743 -1.571 . . . . 50.640000000000001 110.21 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.96 153.21 5.84 Favored Glycine 0 C--O 1.243 0.707 0 N-CA-C 107.926 -2.069 . . . . 50.509999999999998 107.926 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 CA-C-O 116.349 -2.362 . . . . 50.509999999999998 107.227 179.226 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 101.783 -3.414 . . . . 50.509999999999998 101.783 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -110.85 138.34 47.36 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 126.95 2.656 . . . . 50.549999999999997 105.433 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -133.07 155.69 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 115.928 -1.987 . . . . 50.509999999999998 113.867 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -93.63 144.41 25.41 Favored 'General case' 0 N--CA 1.512 2.663 1 O-C-N 130.442 4.839 . . . . 50.509999999999998 118.789 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.772 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.6 t -132.53 101.96 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 113.364 -3.208 . . . . 50.509999999999998 110.123 175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.92 117.99 21.28 Favored 'General case' 0 N--CA 1.504 2.231 1 O-C-N 129.362 4.164 . . . . 50.509999999999998 117.225 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 11' ' ' LYS . 41.7 p -70.83 -172.72 0.69 Allowed 'General case' 0 C--N 1.351 0.673 0 N-CA-C 114.893 1.442 . . . . 50.509999999999998 114.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.78 11.78 38.85 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 105.854 -1.906 . . . . 50.509999999999998 105.854 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -122.45 -3.22 8.89 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 115.737 -2.385 . . . . 50.509999999999998 114.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 6.76 22.04 Favored Glycine 0 C--N 1.296 -1.665 0 O-C-N 120.103 -1.623 . . . . 50.509999999999998 113.617 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 45.0 mtmt -92.66 166.73 12.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 118.445 2.758 . . . . 50.509999999999998 118.445 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.0 p -125.15 158.69 33.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 126.658 2.474 . . . . 50.509999999999998 105.676 176.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.772 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 72.3 mt -131.27 111.18 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 127.415 2.947 . . . . 50.509999999999998 104.716 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -90.75 110.97 22.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.809 1.781 . . . . 50.509999999999998 115.809 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.3 mt -105.77 155.55 19.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 115.483 -2.198 . . . . 50.509999999999998 112.153 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.05 112.33 23.88 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 128.9 3.875 . . . . 50.619999999999997 112.23 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -117.25 169.45 7.66 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 O-C-N 127.743 3.152 . . . . 50.509999999999998 113.998 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -126.58 158.33 67.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 112.156 -2.293 . . . . 50.619999999999997 108.288 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 57' ' ' SER . 85.1 Cg_exo -54.93 -24.56 39.81 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.54 2.16 . . . . 50.509999999999998 111.969 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.8 p -87.09 -18.39 30.63 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 116.415 2.005 . . . . 50.509999999999998 116.415 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -70.86 135.73 48.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.898 1.814 . . . . 50.619999999999997 115.898 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.591 HG22 HG22 ' A' ' 55' ' ' THR . 72.3 p -78.85 168.42 19.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.947 1.832 . . . . 50.509999999999998 115.947 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 33.8 mm -62.69 -40.62 89.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 O-C-N 127.239 2.837 . . . . 50.509999999999998 109.34 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -54.94 -27.87 46.73 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 50.619999999999997 112.809 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.4 -27.85 20.15 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 114.84 1.422 . . . . 50.549999999999997 114.84 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.7 -41.63 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.024 1.453 . . . . 50.509999999999998 107.155 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -64.62 -28.0 69.32 Favored 'General case' 0 C--O 1.258 1.524 0 CA-C-N 115.845 -0.616 . . . . 50.509999999999998 111.524 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -29.6 59.73 Favored 'General case' 0 C--O 1.279 2.637 0 CA-C-N 118.088 0.404 . . . . 50.509999999999998 111.599 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.37 -31.34 69.67 Favored 'General case' 0 C--O 1.256 1.401 0 O-C-N 120.319 -1.488 . . . . 50.509999999999998 108.493 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.0 -34.67 71.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 107.091 -1.448 . . . . 50.509999999999998 107.091 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -56.36 -53.56 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 125.579 2.609 . . . . 50.549999999999997 117.578 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.28 -34.27 70.35 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 113.622 -1.626 . . . . 50.619999999999997 111.243 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.17 -28.57 21.13 Favored 'General case' 0 C--O 1.278 2.593 0 C-N-CA 116.434 -2.106 . . . . 50.509999999999998 109.737 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -117.22 -77.26 0.57 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 123.035 2.652 . . . . 50.619999999999997 109.059 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.09 23.51 0.48 Allowed Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.572 -1.811 . . . . 50.509999999999998 108.572 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 45.7 mt -79.4 133.5 59.94 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.81 -1.156 . . . . 50.509999999999998 112.335 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.03 136.93 79.61 Favored 'Trans proline' 0 C--O 1.26 1.592 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.914 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.2 -32.1 92.53 Favored 'Trans proline' 0 C--O 1.262 1.71 0 O-C-N 122.857 0.925 . . . . 50.509999999999998 113.449 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 40' ' ' GLN . 6.9 p30 -76.71 -9.23 58.53 Favored 'General case' 0 C--O 1.262 1.746 0 O-C-N 119.94 -1.725 . . . . 50.619999999999997 109.297 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.427 ' HG3' ' OD1' ' A' ' 39' ' ' ASP . 79.9 mt-30 -103.01 19.06 20.22 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.422 1.638 . . . . 50.549999999999997 115.422 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -127.93 102.04 6.59 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 116.638 2.088 . . . . 50.549999999999997 116.638 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -99.35 132.51 44.63 Favored 'General case' 0 C--O 1.296 3.531 0 CA-C-O 116.742 -1.599 . . . . 50.640000000000001 109.381 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 mp -103.94 154.75 19.29 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 104.287 -2.486 . . . . 50.509999999999998 104.287 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.07 142.1 35.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 O-C-N 125.138 1.524 . . . . 50.509999999999998 111.087 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -142.66 91.3 2.3 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 114.534 -1.212 . . . . 50.509999999999998 113.345 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.9 45.6 26.18 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 104.461 -2.422 . . . . 50.509999999999998 104.461 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.28 -18.13 6.99 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 128.386 2.898 . . . . 50.509999999999998 113.034 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -76.59 135.75 39.22 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 118.102 0.951 . . . . 50.509999999999998 111.418 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.85 129.22 35.14 Favored 'General case' 0 C--O 1.259 1.558 0 O-C-N 123.957 0.785 . . . . 50.549999999999997 110.968 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.8 mt -78.65 145.65 34.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 101.906 -3.368 . . . . 50.509999999999998 101.906 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -97.99 135.88 39.05 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.939 1.399 . . . . 50.619999999999997 108.538 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.5 m-20 -53.66 -49.59 67.63 Favored 'General case' 0 C--O 1.264 1.834 0 C-N-CA 126.151 1.78 . . . . 50.619999999999997 111.919 -175.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.93 19.46 5.21 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.4 1.0 . . . . 50.509999999999998 113.9 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -113.0 156.69 22.61 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 103.069 -2.937 . . . . 50.640000000000001 103.069 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.591 HG22 HG22 ' A' ' 22' ' ' THR . 81.0 p -95.67 168.51 10.63 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.606 0.965 . . . . 50.509999999999998 113.606 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.7 mt -70.16 -32.19 70.03 Favored 'General case' 0 C--O 1.201 -1.467 0 O-C-N 124.15 0.907 . . . . 50.509999999999998 109.358 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 90.9 p -74.13 -29.08 61.64 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.271 -1.772 . . . . 50.509999999999998 112.149 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.71 -29.33 70.03 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.431 1.11 . . . . 50.619999999999997 108.676 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -94.19 -5.21 47.54 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 117.809 -1.091 . . . . 50.509999999999998 112.291 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 53.93 51.33 14.94 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 121.552 1.978 . . . . 50.549999999999997 113.882 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.8 mt -95.53 119.2 43.26 Favored 'Isoleucine or valine' 0 C--O 1.266 1.952 0 N-CA-C 102.218 -3.253 . . . . 50.509999999999998 102.218 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -90.06 -168.83 2.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 126.019 2.075 . . . . 50.549999999999997 111.213 -176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.635 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 84.2 tttt -79.07 143.76 35.26 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.185 1.469 . . . . 50.509999999999998 107.558 -176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.635 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 69.66 37.56 1.87 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 112.559 -2.109 . . . . 50.619999999999997 113.62 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -92.42 155.48 17.84 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.809 -1.087 . . . . 50.509999999999998 111.994 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.8 m -110.27 126.49 54.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 118.199 -0.905 . . . . 50.509999999999998 112.717 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -110.11 155.52 21.8 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 114.679 -2.581 . . . . 50.509999999999998 104.356 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -98.0 149.88 21.97 Favored 'General case' 0 C--N 1.284 -2.27 0 O-C-N 127.177 2.798 . . . . 50.509999999999998 112.998 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -102.2 126.68 49.25 Favored 'General case' 0 C--O 1.283 2.849 0 N-CA-C 104.9 -2.259 . . . . 50.509999999999998 104.9 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.63 146.24 28.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 105.861 -1.903 . . . . 50.509999999999998 105.861 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.2 mt -114.09 107.57 15.83 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 119.869 3.285 . . . . 50.509999999999998 119.869 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -92.07 111.1 22.52 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.324 -3.227 . . . . 50.640000000000001 104.249 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.52 167.66 14.41 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 125.576 1.798 . . . . 50.509999999999998 110.907 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.0 mtm105 -102.85 86.42 2.73 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.72 -1.582 . . . . 50.640000000000001 108.321 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.95 147.51 22.78 Favored Glycine 0 C--O 1.244 0.726 0 CA-C-N 114.678 -1.146 . . . . 50.509999999999998 114.436 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.457 0 N-CA-C 106.023 -2.831 . . . . 50.509999999999998 106.023 179.232 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.458 ' N ' ' O ' ' A' ' 17' ' ' VAL . 67.5 mtt . . . . . 0 CA--C 1.547 0.86 0 CA-C-O 118.822 -0.609 . . . . 50.509999999999998 111.147 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -96.39 128.69 43.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 126.959 2.662 . . . . 50.549999999999997 113.368 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -131.67 152.44 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 115.972 -1.966 . . . . 50.509999999999998 107.561 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CD1' HG22 ' A' ' 14' ' ' THR . 97.3 m-85 -109.53 143.06 39.71 Favored 'General case' 0 N--CA 1.512 2.658 1 O-C-N 130.215 4.697 . . . . 50.509999999999998 115.202 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.12 98.18 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-O 113.425 -3.179 . . . . 50.509999999999998 113.771 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -72.86 114.92 11.54 Favored 'General case' 0 N--CA 1.503 2.224 1 O-C-N 129.297 4.123 . . . . 50.509999999999998 109.929 -178.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.44 ' HA ' HD23 ' A' ' 69' ' ' LEU . 68.7 p -72.04 -169.8 0.52 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-O 117.829 -1.081 . . . . 50.509999999999998 113.236 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.34 -47.1 7.06 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.756 -1.201 . . . . 50.509999999999998 107.756 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -70.59 2.17 4.37 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 115.732 -2.387 . . . . 50.509999999999998 115.586 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.81 -40.67 2.38 Favored Glycine 0 C--N 1.298 -1.541 0 N-CA-C 120.892 3.117 . . . . 50.509999999999998 120.892 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -42.09 131.33 3.48 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 116.902 -1.523 . . . . 50.509999999999998 108.125 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.0 p -101.59 138.15 38.97 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 126.623 2.452 . . . . 50.509999999999998 112.184 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 pt -120.16 146.79 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 127.507 3.004 . . . . 50.509999999999998 109.399 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.443 HG22 ' CD1' ' A' ' 4' ' ' PHE . 80.8 p -120.6 128.03 52.66 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 117.249 -1.78 . . . . 50.509999999999998 109.583 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 29' ' ' LYS . 50.0 mt -103.8 148.48 26.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 115.542 -2.171 . . . . 50.509999999999998 110.37 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -106.41 103.2 12.61 Favored 'General case' 0 N--CA 1.501 2.089 1 O-C-N 129.28 4.112 . . . . 50.619999999999997 104.954 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 1' ' ' MET . 33.7 m -101.65 164.54 2.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.69 3.119 . . . . 50.509999999999998 112.915 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' HG3' ' HB2' ' A' ' 21' ' ' ASP . 6.4 pt-20 -137.33 151.33 71.23 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.164 -2.289 . . . . 50.619999999999997 112.798 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.97 -24.5 39.77 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 122.587 2.191 . . . . 50.509999999999998 111.949 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -98.38 21.85 10.51 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 118.208 -0.901 . . . . 50.509999999999998 110.829 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 8.4 t70 -94.57 125.42 39.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 117.354 -1.738 . . . . 50.619999999999997 111.189 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.3 p -82.82 135.01 35.09 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.865 -0.607 . . . . 50.509999999999998 110.908 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.491 HG21 ' HA ' ' A' ' 52' ' ' ASP . 55.6 mt -37.56 -30.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.137 2.773 . . . . 50.509999999999998 117.552 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.21 -27.85 69.34 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.422 -0.798 . . . . 50.619999999999997 112.203 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.617 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 57.4 m-80 -86.08 -13.14 48.18 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.309 1.044 . . . . 50.549999999999997 112.4 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -78.18 -51.99 16.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 125.041 1.463 . . . . 50.509999999999998 110.256 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 91.5 mttt -58.04 -23.67 55.31 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.174 -0.676 . . . . 50.509999999999998 109.174 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.06 -34.79 17.84 Favored 'General case' 0 C--O 1.278 2.598 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 57.9 mttm -52.26 -38.62 58.72 Favored 'General case' 0 C--O 1.257 1.459 0 N-CA-C 106.291 -1.744 . . . . 50.509999999999998 106.291 175.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.9 -33.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.293 0 N-CA-C 107.56 -1.274 . . . . 50.509999999999998 107.56 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 125.583 2.611 . . . . 50.549999999999997 113.525 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -58.36 -25.57 62.15 Favored 'General case' 0 C--O 1.254 1.322 0 N-CA-C 119.087 2.995 . . . . 50.619999999999997 119.087 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -108.81 -27.25 9.86 Favored 'General case' 0 C--O 1.28 2.659 0 C-N-CA 116.385 -2.126 . . . . 50.509999999999998 113.917 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -108.75 -29.15 8.83 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.056 2.662 . . . . 50.619999999999997 113.529 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.94 42.88 4.59 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 111.247 -0.741 . . . . 50.509999999999998 111.247 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 94.4 mt -117.95 125.2 28.15 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.597 -1.261 . . . . 50.509999999999998 107.597 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 77.9 Cg_exo -57.05 136.97 79.82 Favored 'Trans proline' 0 C--O 1.259 1.559 0 C-N-CA 123.106 2.537 . . . . 50.509999999999998 110.95 178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 85.9 Cg_exo -57.17 -32.07 92.37 Favored 'Trans proline' 0 C--O 1.26 1.619 0 O-C-N 122.828 0.909 . . . . 50.509999999999998 113.51 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.26 -20.35 64.16 Favored 'General case' 0 C--O 1.262 1.756 0 O-C-N 119.982 -1.699 . . . . 50.619999999999997 109.542 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -94.89 7.48 45.85 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.526 -1.358 . . . . 50.549999999999997 113.45 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -115.87 119.32 35.58 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 110.925 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.469 HH11 ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp85 -106.33 138.18 42.97 Favored 'General case' 0 C--O 1.295 3.486 0 CA-C-O 116.651 -1.642 . . . . 50.640000000000001 107.716 172.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.9 mt -115.2 105.97 13.53 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.987 1.847 . . . . 50.509999999999998 115.987 -177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 61.5 mt -110.55 130.37 63.98 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 O-C-N 125.254 1.596 . . . . 50.509999999999998 111.633 -177.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -145.83 126.01 13.82 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 115.293 1.59 . . . . 50.509999999999998 115.293 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.11 28.24 17.02 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.261 -2.245 . . . . 50.509999999999998 107.43 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.7 30.41 77.25 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 128.37 2.89 . . . . 50.509999999999998 111.595 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.48 135.6 53.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 105.455 -2.054 . . . . 50.509999999999998 105.455 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.35 113.9 9.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.946 0.779 . . . . 50.549999999999997 111.186 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.503 HD22 ' CE2' ' A' ' 59' ' ' TYR . 37.5 mt -75.49 113.84 13.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 117.722 -1.132 . . . . 50.509999999999998 112.296 -175.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -89.53 126.08 35.45 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.822 1.326 . . . . 50.619999999999997 109.598 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' HA ' HG21 ' A' ' 23' ' ' ILE . 27.7 p-10 -45.36 -38.93 6.28 Favored 'General case' 0 C--O 1.263 1.805 0 C-N-CA 126.14 1.776 . . . . 50.619999999999997 111.549 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.52 37.93 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 108.655 -1.778 . . . . 50.509999999999998 108.655 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -94.64 165.67 12.39 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 119.949 -1.912 . . . . 50.640000000000001 115.838 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -99.87 166.08 11.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.152 -1.055 . . . . 50.509999999999998 108.152 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -86.43 -39.72 16.07 Favored 'General case' 0 C--O 1.201 -1.485 0 N-CA-C 104.193 -2.521 . . . . 50.509999999999998 104.193 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 p -52.64 -53.04 52.47 Favored 'General case' 0 C--O 1.268 2.058 0 C-N-CA 117.356 -1.738 . . . . 50.509999999999998 113.979 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.42 -28.28 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 120.635 3.568 . . . . 50.619999999999997 120.635 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.503 ' CE2' HD22 ' A' ' 50' ' ' LEU . 42.2 m-85 -82.1 13.1 3.61 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.764 -1.112 . . . . 50.509999999999998 109.511 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.57 32.26 20.38 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 121.442 1.928 . . . . 50.549999999999997 108.95 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -80.71 133.1 30.14 Favored 'Isoleucine or valine' 0 C--O 1.267 1.989 0 CA-C-O 115.146 -2.359 . . . . 50.509999999999998 113.362 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.406 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 57.7 mt-30 -134.81 -159.34 0.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 125.856 1.972 . . . . 50.549999999999997 110.636 -176.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 63.2 tttm -69.15 149.88 48.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.257 1.503 . . . . 50.509999999999998 109.628 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.627 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 47.67 65.48 1.27 Allowed 'General case' 0 C--O 1.257 1.45 0 CA-C-N 112.42 -2.173 . . . . 50.619999999999997 113.981 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -122.97 125.57 45.52 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.921 -1.141 . . . . 50.509999999999998 107.921 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -81.67 133.68 35.39 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 117.186 2.291 . . . . 50.509999999999998 117.186 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.32 135.88 48.08 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 114.688 -2.577 . . . . 50.509999999999998 114.45 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.546 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 48.0 m170 -71.55 133.0 45.48 Favored 'General case' 0 C--N 1.284 -2.254 0 O-C-N 127.365 2.915 . . . . 50.509999999999998 115.619 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 7' ' ' THR . 30.6 tp -104.95 96.99 6.92 Favored 'General case' 0 C--O 1.282 2.809 0 N-CA-C 115.792 1.775 . . . . 50.509999999999998 115.792 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.53 123.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 107.857 -1.164 . . . . 50.509999999999998 107.857 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt -73.12 159.23 33.87 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.946 1.091 . . . . 50.509999999999998 113.946 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.469 ' HD2' HH11 ' A' ' 42' ' ' ARG . 77.8 ttt-85 -136.96 77.19 1.63 Allowed 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 113.404 -3.188 . . . . 50.640000000000001 111.964 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.42 155.34 15.09 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 116.795 2.146 . . . . 50.509999999999998 116.795 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -110.39 85.53 2.13 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.714 -1.585 . . . . 50.640000000000001 107.073 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.26 160.9 13.61 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 107.691 -2.164 . . . . 50.509999999999998 107.691 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 CA-C-O 116.308 -2.385 . . . . 50.509999999999998 110.446 179.174 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.549999999999997 105.792 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.509999999999998 105.226 173.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.509999999999998 111.097 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.509999999999998 110.321 175.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.509999999999998 108.6 -178.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 113.379 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.509999999999998 115.964 -177.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.509999999999998 111.276 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.509999999999998 114.048 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.509999999999998 102.065 174.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.509999999999998 107.975 176.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.509999999999998 108.441 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 110.2 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.447 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.509999999999998 118.562 -179.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.619999999999997 108.62 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.509999999999998 114.132 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.619999999999997 106.711 174.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.509999999999998 111.935 177.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.509999999999998 116.813 -177.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.619999999999997 109.138 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.509999999999998 107.045 175.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.509999999999998 110.561 175.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.619999999999997 113.229 177.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.549999999999997 110.044 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.509999999999998 107.759 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.509999999999998 106.412 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.509999999999998 109.249 176.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.509999999999998 111.346 176.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.447 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.509999999999998 110.973 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.549999999999997 112.509 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.619999999999997 116.389 179.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.509999999999998 111.864 -175.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 117.592 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.509999999999998 114.888 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.509999999999998 109.747 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.509999999999998 110.864 178.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.394 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.619999999999997 114.605 -177.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.637 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.549999999999997 107.838 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.549999999999997 119.467 -177.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.640000000000001 109.52 172.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.509999999999998 115.444 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.509999999999998 113.347 -177.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.509999999999998 111.83 177.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 113.518 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.509999999999998 115.209 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.509999999999998 114.25 177.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.549999999999997 117.72 174.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.509999999999998 119.412 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.619999999999997 106.675 -177.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.619999999999997 118.064 -175.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.509999999999998 112.981 -177.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.640000000000001 112.921 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.509999999999998 106.383 177.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.509999999999998 114.586 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.509999999999998 111.793 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.619999999999997 114.68 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.509999999999998 113.892 179.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.549999999999997 110.922 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.509999999999998 112.515 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.549999999999997 116.774 -176.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.509999999999998 113.522 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.619999999999997 110.901 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.509999999999998 110.249 174.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 176.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.509999999999998 101.589 175.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.509999999999998 106.251 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 71' ' ' LEU . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.509999999999998 111.961 176.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.509999999999998 104.421 175.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.509999999999998 115.767 178.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.640000000000001 106.516 177.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' HE21 ' A' ' 40' ' ' GLN . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.509999999999998 105.632 -179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.640000000000001 107.378 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.509999999999998 119.036 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.509999999999998 104.312 179.258 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 107.478 -1.305 . . . . 50.509999999999998 107.478 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -115.44 128.64 56.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.933 2.645 . . . . 50.549999999999997 105.792 178.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -128.96 165.51 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 N-CA-C 105.226 -2.139 . . . . 50.509999999999998 105.226 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.48 150.52 40.7 Favored 'General case' 0 N--CA 1.511 2.59 1 O-C-N 130.461 4.851 . . . . 50.509999999999998 111.097 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.57 141.8 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 113.384 -3.198 . . . . 50.509999999999998 110.321 175.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.47 132.24 44.94 Favored 'General case' 0 N--CA 1.504 2.273 1 O-C-N 129.307 4.129 . . . . 50.509999999999998 108.6 -178.018 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.1 p -108.75 175.54 5.43 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.812 -1.09 . . . . 50.509999999999998 113.379 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.85 8.01 7.67 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.964 1.839 . . . . 50.509999999999998 115.964 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 9' ' ' THR . 6.5 m -136.43 13.22 3.24 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 115.75 -2.38 . . . . 50.509999999999998 111.276 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.56 8.32 80.64 Favored Glycine 0 C--N 1.298 -1.582 0 O-C-N 120.116 -1.615 . . . . 50.509999999999998 114.048 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -81.28 130.55 35.08 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 102.065 -3.309 . . . . 50.509999999999998 102.065 174.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.8 137.89 41.9 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 126.64 2.463 . . . . 50.509999999999998 107.975 176.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -105.05 147.96 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 127.736 3.147 . . . . 50.509999999999998 108.441 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.8 p -114.07 126.55 55.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 117.282 -1.767 . . . . 50.509999999999998 110.2 178.106 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.447 HD11 HG12 ' A' ' 30' ' ' ILE . 86.0 mt -112.05 134.52 53.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 118.562 2.801 . . . . 50.509999999999998 118.562 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -114.07 119.46 37.24 Favored 'General case' 0 N--CA 1.499 1.981 1 O-C-N 129.115 4.009 . . . . 50.619999999999997 108.62 174.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.67 171.2 8.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.242 0 O-C-N 127.51 3.006 . . . . 50.509999999999998 114.132 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 51.4 mt-10 -114.09 148.44 40.03 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 112.193 -2.276 . . . . 50.619999999999997 106.711 174.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.56 39.91 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.573 2.182 . . . . 50.509999999999998 111.935 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -68.63 -34.64 76.09 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 116.813 2.153 . . . . 50.509999999999998 116.813 -177.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -58.52 156.25 10.85 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 117.364 -1.734 . . . . 50.619999999999997 109.138 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 26' ' ' VAL . 42.8 p -94.5 167.59 11.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.045 -1.465 . . . . 50.509999999999998 107.045 175.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.3 mm -61.44 -20.91 23.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 127.226 2.829 . . . . 50.509999999999998 110.561 175.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 88.2 mt-10 -69.0 -50.33 49.8 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.229 0.825 . . . . 50.619999999999997 113.229 177.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.6 -28.96 66.39 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 124.343 1.057 . . . . 50.549999999999997 110.044 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 22' ' ' THR . 70.4 t -68.83 -27.15 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 125.094 1.496 . . . . 50.509999999999998 107.759 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 54.4 mtpt -72.9 -38.98 66.73 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.412 -1.699 . . . . 50.509999999999998 106.412 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.76 -5.25 50.06 Favored 'General case' 0 C--O 1.278 2.582 0 N-CA-C 109.249 -0.649 . . . . 50.509999999999998 109.249 176.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -88.33 -36.28 16.72 Favored 'General case' 0 C--O 1.256 1.408 0 O-C-N 120.395 -1.441 . . . . 50.509999999999998 111.346 176.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.447 HG12 HD11 ' A' ' 15' ' ' LEU . 60.4 mt -74.68 -41.55 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 C-N-CA 119.495 -0.882 . . . . 50.509999999999998 110.973 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -43.84 -51.73 7.24 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 125.643 2.64 . . . . 50.549999999999997 112.509 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -46.56 -32.34 3.36 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 116.389 1.996 . . . . 50.619999999999997 116.389 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -86.61 -24.59 25.3 Favored 'General case' 0 C--O 1.279 2.619 0 C-N-CA 116.483 -2.087 . . . . 50.509999999999998 111.864 -175.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -127.26 -36.9 2.09 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 117.592 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.81 18.66 8.72 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 114.888 0.715 . . . . 50.509999999999998 114.888 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mm -90.65 132.4 35.15 Favored Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 118.889 -1.125 . . . . 50.509999999999998 109.747 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 77.9 Cg_exo -56.95 136.99 79.87 Favored 'Trans proline' 0 C--O 1.259 1.561 0 C-N-CA 123.212 2.608 . . . . 50.509999999999998 110.864 178.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.17 -32.21 92.81 Favored 'Trans proline' 0 C--O 1.263 1.752 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.394 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.3 -16.32 63.94 Favored 'General case' 0 C--O 1.262 1.726 0 O-C-N 119.946 -1.721 . . . . 50.619999999999997 114.605 -177.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.637 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 61.1 mt-30 -90.68 -30.02 17.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.533 -1.355 . . . . 50.549999999999997 107.838 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -62.16 120.29 10.63 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 119.467 3.136 . . . . 50.549999999999997 119.467 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -107.65 123.94 49.25 Favored 'General case' 0 C--O 1.295 3.483 0 CA-C-O 116.668 -1.634 . . . . 50.640000000000001 109.52 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.4 mt -104.57 116.37 31.96 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.444 1.646 . . . . 50.509999999999998 115.444 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.0 mm -104.72 130.97 54.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 O-C-N 125.123 1.514 . . . . 50.509999999999998 113.347 -177.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -144.21 116.58 8.53 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 114.576 -1.193 . . . . 50.509999999999998 111.83 177.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.93 28.77 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 113.518 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 14.12 68.93 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 128.415 2.912 . . . . 50.509999999999998 115.209 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -113.83 129.56 56.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 114.25 1.204 . . . . 50.509999999999998 114.25 177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.846 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 4.5 mp0 -71.16 104.46 3.08 Favored 'General case' 0 C--O 1.259 1.575 0 N-CA-C 117.72 2.489 . . . . 50.549999999999997 117.72 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.8 mt -55.46 143.39 29.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 119.412 3.115 . . . . 50.509999999999998 119.412 -175.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -103.06 141.4 35.89 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 106.675 -1.602 . . . . 50.619999999999997 106.675 -177.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -60.83 -48.65 80.85 Favored 'General case' 0 C--O 1.263 1.812 0 N-CA-C 118.064 2.616 . . . . 50.619999999999997 118.064 -175.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.77 10.58 6.87 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 124.361 0.981 . . . . 50.509999999999998 112.981 -177.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -99.75 157.68 16.32 Favored 'General case' 0 C--O 1.249 1.068 0 O-C-N 120.073 -1.839 . . . . 50.640000000000001 112.921 176.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.8 p -92.6 168.71 11.05 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.383 -1.71 . . . . 50.509999999999998 106.383 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.57 -48.17 61.14 Favored 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 114.586 1.328 . . . . 50.509999999999998 114.586 177.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 p -57.89 -32.74 68.02 Favored 'General case' 0 C--O 1.268 2.036 0 C-N-CA 117.322 -1.751 . . . . 50.509999999999998 111.793 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -41.82 -41.19 2.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.68 1.363 . . . . 50.619999999999997 114.68 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.1 m-85 -94.08 1.2 56.2 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 117.768 -1.11 . . . . 50.509999999999998 113.892 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 92.6 m-20 67.85 54.03 0.65 Allowed 'General case' 0 C--O 1.248 0.983 0 CA-C-N 121.511 1.96 . . . . 50.549999999999997 110.922 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.2 mt -85.07 104.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.266 1.962 0 CA-C-O 115.155 -2.355 . . . . 50.509999999999998 112.515 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -91.63 -175.64 4.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.774 2.139 . . . . 50.549999999999997 116.774 -176.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 48.6 tttp -54.22 153.23 5.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 123.288 1.518 . . . . 50.509999999999998 113.522 -176.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.2 mt-10 27.22 58.17 0.08 Allowed 'General case' 0 C--O 1.257 1.496 0 CA-C-N 112.478 -2.146 . . . . 50.619999999999997 110.901 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -75.38 169.16 18.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.854 -1.066 . . . . 50.509999999999998 110.249 174.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.9 m -118.54 119.0 33.23 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 176.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.8 tp -107.81 144.99 34.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 101.589 -3.486 . . . . 50.509999999999998 101.589 175.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -104.98 152.42 22.72 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 126.861 2.601 . . . . 50.509999999999998 106.251 177.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 71' ' ' LEU . 42.8 tp -121.56 103.02 8.61 Favored 'General case' 0 C--O 1.282 2.775 0 CA-C-O 117.689 -1.148 . . . . 50.509999999999998 111.961 176.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -105.91 126.58 61.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 104.421 -2.437 . . . . 50.509999999999998 104.421 175.142 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.4 mp -86.53 138.74 31.48 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.767 1.765 . . . . 50.509999999999998 115.767 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 58.3 ttp180 -104.75 128.16 52.78 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.391 -3.195 . . . . 50.640000000000001 106.516 177.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' HE21 ' A' ' 40' ' ' GLN . 6.4 mp -109.36 141.98 40.94 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 105.632 -1.988 . . . . 50.509999999999998 105.632 -179.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -84.0 79.55 9.46 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 113.733 -1.576 . . . . 50.640000000000001 107.378 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.44 -165.07 18.76 Favored Glycine 0 C--O 1.244 0.72 0 N-CA-C 119.036 2.374 . . . . 50.509999999999998 119.036 179.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.41 0 N-CA-C 104.312 -3.515 . . . . 50.509999999999998 104.312 179.258 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.0 mtp . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 115.228 1.566 . . . . 50.509999999999998 115.228 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -88.72 118.09 28.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 126.99 2.681 . . . . 50.549999999999997 117.707 178.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.523 HD11 HD22 ' A' ' 67' ' ' LEU . 14.7 tt -122.01 161.57 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 115.935 -1.983 . . . . 50.509999999999998 109.47 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.421 ' N ' HG12 ' A' ' 3' ' ' ILE . 79.1 m-85 -130.3 128.98 42.63 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 129.667 4.354 . . . . 50.509999999999998 113.461 179.548 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -108.91 109.82 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 113.419 -3.182 . . . . 50.509999999999998 112.584 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -87.2 134.28 33.55 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.371 4.169 . . . . 50.509999999999998 106.23 -178.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.1 p -99.77 -168.47 1.61 Allowed 'General case' 0 C--N 1.351 0.651 0 N-CA-C 114.385 1.254 . . . . 50.509999999999998 114.385 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 mt -90.15 24.27 2.56 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.125 0.891 . . . . 50.509999999999998 111.979 -178.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.8 p -139.79 10.95 2.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 115.747 -2.381 . . . . 50.509999999999998 110.231 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.83 12.66 81.04 Favored Glycine 0 C--N 1.297 -1.604 0 O-C-N 119.303 -2.123 . . . . 50.509999999999998 114.738 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.64 139.47 30.66 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.533 -2.025 . . . . 50.509999999999998 105.533 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -120.9 119.62 33.14 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 126.586 2.429 . . . . 50.509999999999998 112.064 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.411 HD12 HD11 ' A' ' 15' ' ' LEU . 17.1 pt -94.75 144.3 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.346 2.904 . . . . 50.509999999999998 116.312 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -100.32 128.79 46.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 117.313 -1.755 . . . . 50.509999999999998 114.569 178.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD11 HD12 ' A' ' 13' ' ' ILE . 1.5 mp -114.24 145.23 42.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 115.463 -2.208 . . . . 50.509999999999998 116.629 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.15 89.58 3.09 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 129.065 3.978 . . . . 50.619999999999997 116.324 173.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.441 HG11 HG22 ' A' ' 26' ' ' VAL . 35.0 m -120.79 148.17 24.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.259 0 N-CA-C 120.095 3.368 . . . . 50.509999999999998 120.095 -177.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.65 151.47 37.46 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 112.198 -2.274 . . . . 50.619999999999997 111.017 174.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.89 -24.55 39.49 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.562 2.175 . . . . 50.509999999999998 111.962 177.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -73.23 -13.09 61.08 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 105.487 -2.042 . . . . 50.509999999999998 105.487 -177.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.531 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 75.6 m-20 -68.64 138.49 55.05 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 117.323 -1.751 . . . . 50.619999999999997 115.301 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.3 p -106.3 174.16 6.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.853 -0.612 . . . . 50.509999999999998 109.689 175.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -51.18 -46.66 32.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 O-C-N 127.138 2.774 . . . . 50.509999999999998 111.886 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -51.8 -38.13 54.43 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.802 -0.814 . . . . 50.619999999999997 108.802 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -79.53 -41.47 27.25 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 120.185 3.402 . . . . 50.549999999999997 120.185 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.441 HG22 HG11 ' A' ' 17' ' ' VAL . 40.6 t -72.71 -44.32 59.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.085 1.491 . . . . 50.509999999999998 114.531 178.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -68.87 -29.94 68.35 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 107.787 -1.19 . . . . 50.509999999999998 107.787 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -49.2 77.73 Favored 'General case' 0 C--O 1.278 2.581 0 N-CA-C 108.517 -0.919 . . . . 50.509999999999998 108.517 176.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -44.95 -53.77 7.28 Favored 'General case' 0 C--O 1.255 1.361 0 O-C-N 120.396 -1.44 . . . . 50.509999999999998 109.322 176.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -57.96 -25.23 25.4 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 116.219 1.933 . . . . 50.509999999999998 116.219 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.439 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.9 tt0 -75.47 -19.66 59.29 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 125.587 2.613 . . . . 50.549999999999997 111.862 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.51 -45.28 8.2 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 113.589 -1.641 . . . . 50.619999999999997 113.724 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -78.93 -51.04 10.19 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.476 -2.09 . . . . 50.509999999999998 107.665 -175.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -91.97 -56.33 3.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 123.131 2.696 . . . . 50.619999999999997 110.814 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 120.17 4.21 11.33 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 111.616 -0.594 . . . . 50.509999999999998 111.616 176.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 35.8 mm -69.44 123.05 87.61 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 118.852 -1.139 . . . . 50.509999999999998 109.38 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.1 Cg_exo -57.02 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.539 0 C-N-CA 123.203 2.602 . . . . 50.509999999999998 110.846 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_exo -57.21 -32.09 92.53 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.914 0.955 . . . . 50.509999999999998 113.422 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -73.67 2.26 8.53 Favored 'General case' 0 C--O 1.261 1.675 0 N-CA-C 118.375 2.731 . . . . 50.619999999999997 118.375 -177.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -115.69 -9.23 11.98 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 120.536 -1.352 . . . . 50.549999999999997 108.153 178.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -81.25 143.28 32.4 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 124.384 2.04 . . . . 50.549999999999997 115.24 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -131.95 114.78 15.03 Favored 'General case' 0 C--O 1.296 3.506 0 N-CA-C 105.833 -1.914 . . . . 50.640000000000001 105.833 172.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 50' ' ' LEU . 95.5 mt -107.32 123.89 49.0 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.539 1.063 . . . . 50.509999999999998 111.324 -177.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.08 132.63 61.38 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 O-C-N 125.174 1.546 . . . . 50.509999999999998 112.57 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.56 ' CE2' HG12 ' A' ' 61' ' ' ILE . 45.2 t80 -142.33 112.61 7.1 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 114.575 -1.193 . . . . 50.509999999999998 108.987 177.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 75.64 18.64 2.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 112.227 -2.26 . . . . 50.509999999999998 108.501 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.3 -2.01 85.84 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.431 2.92 . . . . 50.509999999999998 110.513 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -85.66 121.55 28.49 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 118.045 0.923 . . . . 50.509999999999998 111.156 177.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -61.93 137.71 58.28 Favored 'General case' 0 C--O 1.26 1.61 0 N-CA-C 108.169 -1.049 . . . . 50.549999999999997 108.169 174.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 43' ' ' LEU . 37.5 mt -75.4 149.19 38.65 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.543 -1.28 . . . . 50.509999999999998 107.543 -175.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.15 150.89 28.83 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.996 1.435 . . . . 50.619999999999997 112.497 -177.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.99 -41.26 78.11 Favored 'General case' 0 C--O 1.264 1.826 0 N-CA-C 118.347 2.721 . . . . 50.619999999999997 118.347 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.41 5.0 67.34 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 120.212 2.845 . . . . 50.509999999999998 120.212 -177.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -90.47 154.37 19.69 Favored 'General case' 0 C--O 1.249 1.071 0 N-CA-C 120.089 3.366 . . . . 50.640000000000001 120.089 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 41.5 p -93.09 151.9 19.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.39 -3.189 . . . . 50.509999999999998 102.39 177.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 21' ' ' ASP . 89.4 mt -56.28 -36.58 68.77 Favored 'General case' 0 C--O 1.202 -1.425 0 O-C-N 124.19 0.931 . . . . 50.509999999999998 108.894 177.2 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -62.04 -31.07 71.44 Favored 'General case' 0 C--O 1.268 2.065 0 C-N-CA 117.331 -1.747 . . . . 50.509999999999998 109.04 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 55' ' ' THR . 88.7 m-20 -60.42 -10.17 4.54 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.405 1.098 . . . . 50.619999999999997 111.684 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -114.16 -14.9 12.29 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.094 -1.817 . . . . 50.509999999999998 106.094 179.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 48.44 56.77 7.03 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 121.522 1.965 . . . . 50.549999999999997 110.701 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.56 HG12 ' CE2' ' A' ' 45' ' ' PHE . 74.1 mt -78.33 105.95 8.25 Favored 'Isoleucine or valine' 0 C--O 1.267 1.997 0 N-CA-C 102.936 -2.987 . . . . 50.509999999999998 102.936 175.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -68.77 176.21 3.16 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 126.1 2.125 . . . . 50.549999999999997 107.713 -176.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -70.73 147.1 49.39 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 123.205 1.478 . . . . 50.509999999999998 110.572 -176.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 54.02 44.84 28.72 Favored 'General case' 0 C--O 1.258 1.526 0 CA-C-N 112.521 -2.127 . . . . 50.619999999999997 112.894 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -106.87 142.26 36.79 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 106.157 -1.794 . . . . 50.509999999999998 106.157 174.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.0 m -101.25 130.24 47.35 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 120.454 3.501 . . . . 50.509999999999998 120.454 175.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 3' ' ' ILE . 2.7 mp -95.38 149.7 21.08 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 114.68 -2.581 . . . . 50.509999999999998 114.761 175.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -102.31 132.93 47.97 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 126.969 2.668 . . . . 50.509999999999998 114.743 177.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.6 tp -104.48 122.35 45.35 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.685 -1.15 . . . . 50.509999999999998 111.321 176.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -113.09 135.97 50.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.571 -1.641 . . . . 50.509999999999998 106.571 175.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.8 tp -93.83 100.11 12.36 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.497 1.666 . . . . 50.509999999999998 115.497 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -74.84 138.56 42.61 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 113.316 -3.231 . . . . 50.640000000000001 108.215 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.9 mt -111.86 139.2 47.54 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.804 1.94 . . . . 50.509999999999998 113.237 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -96.15 68.19 2.65 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 113.69 -1.596 . . . . 50.640000000000001 106.907 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.65 148.17 4.85 Favored Glycine 0 C--O 1.244 0.76 0 N-CA-C 107.145 -2.382 . . . . 50.509999999999998 107.145 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.469 0 CA-C-O 116.361 -2.355 . . . . 50.509999999999998 110.4 179.246 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.877 ' SD ' ' HB3' ' A' ' 63' ' ' LYS . 61.2 mtm . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 105.248 -2.13 . . . . 50.509999999999998 105.248 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -70.42 144.62 51.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 127.003 2.689 . . . . 50.549999999999997 108.922 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.454 HD12 HD13 ' A' ' 67' ' ' LEU . 21.7 pt -132.24 164.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 N-CA-C 104.099 -2.556 . . . . 50.509999999999998 104.099 173.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -111.25 156.01 22.11 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.473 4.858 . . . . 50.509999999999998 109.296 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 67' ' ' LEU . 86.0 t -138.52 122.18 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.37 -3.205 . . . . 50.509999999999998 109.203 175.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 79.1 tttt -94.94 128.6 41.86 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.403 4.19 . . . . 50.509999999999998 114.904 -178.047 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.08 179.23 4.68 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-O 117.809 -1.091 . . . . 50.509999999999998 108.425 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.7 -12.19 58.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.93 2.937 . . . . 50.509999999999998 118.93 -177.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -90.48 -24.98 20.53 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 115.705 -2.398 . . . . 50.509999999999998 105.345 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.23 23.78 3.73 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 107.538 -2.225 . . . . 50.509999999999998 107.538 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -86.06 144.22 27.67 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.568 -2.012 . . . . 50.509999999999998 105.568 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.2 m -128.44 117.77 21.95 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 126.629 2.456 . . . . 50.509999999999998 110.992 176.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.7 pt -98.57 164.85 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 127.469 2.981 . . . . 50.509999999999998 113.557 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.6 p -121.59 144.1 48.93 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.256 -1.778 . . . . 50.509999999999998 108.483 178.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.441 HD22 ' HG3' ' A' ' 29' ' ' LYS . 78.4 mt -132.38 142.62 49.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 103.047 -2.946 . . . . 50.509999999999998 103.047 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.93 109.1 17.12 Favored 'General case' 0 N--CA 1.499 2.003 1 O-C-N 129.275 4.109 . . . . 50.619999999999997 102.972 173.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.74 156.22 31.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.74 3.15 . . . . 50.509999999999998 114.401 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 72.8 tt0 -88.37 139.81 30.18 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 112.175 -2.284 . . . . 50.619999999999997 107.746 174.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.759 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 85.5 Cg_exo -54.83 -24.57 39.11 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 122.552 2.168 . . . . 50.509999999999998 111.976 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -61.56 -26.06 67.71 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.241 -1.392 . . . . 50.509999999999998 107.241 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -59.76 136.52 58.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.353 -1.739 . . . . 50.619999999999997 114.831 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.6 p -79.11 171.59 14.99 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 117.834 -3.041 . . . . 50.509999999999998 110.062 175.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.19 -35.25 62.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 O-C-N 127.196 2.81 . . . . 50.509999999999998 109.281 175.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.3 -41.77 80.46 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.457 -0.777 . . . . 50.619999999999997 112.473 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -76.92 -50.23 13.77 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 115.099 1.518 . . . . 50.549999999999997 115.099 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 22' ' ' THR . 54.9 t -51.68 -39.31 23.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.958 1.411 . . . . 50.509999999999998 109.701 178.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 52.3 mtpt -61.71 -36.1 79.97 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 115.833 -0.621 . . . . 50.509999999999998 110.368 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.35 86.29 Favored 'General case' 0 C--O 1.279 2.621 0 N-CA-C 109.691 -0.485 . . . . 50.509999999999998 109.691 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HG3' HD22 ' A' ' 15' ' ' LEU . 50.9 tptt -57.97 -41.29 82.6 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 106.191 -1.781 . . . . 50.509999999999998 106.191 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.81 -49.17 81.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 C-N-CA 119.54 -0.864 . . . . 50.509999999999998 111.674 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.767 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 22.0 tm0? -53.26 -56.83 13.42 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 125.554 2.597 . . . . 50.549999999999997 117.944 179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -46.32 -54.23 9.34 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 118.38 2.733 . . . . 50.619999999999997 118.38 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -81.16 -41.8 21.84 Favored 'General case' 0 C--O 1.279 2.638 0 C-N-CA 116.464 -2.095 . . . . 50.509999999999998 112.313 -175.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -86.75 -55.43 3.86 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 123.075 2.67 . . . . 50.619999999999997 110.958 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.88 -23.1 5.05 Favored Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 112.031 -0.428 . . . . 50.509999999999998 112.031 176.524 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.4 mm -53.68 113.86 5.48 Favored Pre-proline 0 C--O 1.245 0.854 0 C-N-CA 118.815 -1.154 . . . . 50.509999999999998 109.665 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -56.93 136.99 79.85 Favored 'Trans proline' 0 C--O 1.259 1.553 0 C-N-CA 123.181 2.588 . . . . 50.509999999999998 110.925 178.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.767 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 88.4 Cg_exo -57.32 -32.03 92.62 Favored 'Trans proline' 0 C--O 1.261 1.631 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -57.96 -18.12 21.49 Favored 'General case' 0 C--O 1.263 1.8 0 O-C-N 120.008 -1.683 . . . . 50.619999999999997 111.655 -177.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -113.53 11.34 18.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 120.631 3.567 . . . . 50.549999999999997 120.631 178.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -95.44 129.17 42.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 124.388 2.042 . . . . 50.549999999999997 111.987 -177.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 36.6 ttm180 -119.98 110.49 16.76 Favored 'General case' 0 C--O 1.295 3.477 0 N-CA-C 105.776 -1.935 . . . . 50.640000000000001 105.776 172.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.544 ' HB2' HD12 ' A' ' 50' ' ' LEU . 94.4 mt -101.62 129.7 47.8 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.441 1.019 . . . . 50.509999999999998 108.444 -177.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.8 140.51 29.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.054 1.471 . . . . 50.509999999999998 111.994 -177.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -138.73 116.81 11.74 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.084 -2.191 . . . . 50.509999999999998 105.084 177.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.48 17.8 10.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.193 -2.276 . . . . 50.509999999999998 115.981 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.65 8.31 67.87 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 128.443 2.925 . . . . 50.509999999999998 109.279 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -100.36 112.81 25.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 118.071 0.936 . . . . 50.509999999999998 109.925 177.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -55.43 139.41 43.48 Favored 'General case' 0 C--O 1.259 1.581 0 N-CA-C 108.513 -0.921 . . . . 50.549999999999997 108.513 174.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 43' ' ' LEU . 80.9 mt -85.05 141.47 30.25 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.857 1.429 . . . . 50.509999999999998 114.857 -175.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.411 ' HB3' ' CG ' ' A' ' 54' ' ' ARG . 73.1 tt0 -84.65 126.8 33.68 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.923 1.389 . . . . 50.619999999999997 111.892 -177.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -50.9 -42.27 59.11 Favored 'General case' 0 C--O 1.264 1.818 0 C-N-CA 126.178 1.791 . . . . 50.619999999999997 109.743 -175.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.49 25.1 9.81 Favored Glycine 0 C--O 1.254 1.366 0 C-N-CA 124.442 1.02 . . . . 50.509999999999998 114.211 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CG ' ' HB3' ' A' ' 51' ' ' GLU . 29.3 mmt85 -116.33 164.69 14.15 Favored 'General case' 0 C--O 1.249 1.048 0 O-C-N 119.915 -1.932 . . . . 50.640000000000001 113.457 176.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 41.6 p -101.81 -178.74 3.81 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.111 0.965 . . . . 50.509999999999998 110.223 177.102 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.759 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 59.3 mt -79.94 -20.5 45.49 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.366 -0.975 . . . . 50.509999999999998 108.366 177.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.7 p -88.92 12.95 13.9 Favored 'General case' 0 C--O 1.268 2.077 0 C-N-CA 117.307 -1.757 . . . . 50.509999999999998 112.115 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -94.66 -36.24 11.85 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.449 1.119 . . . . 50.619999999999997 113.343 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -107.83 23.88 13.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 120.87 3.656 . . . . 50.509999999999998 120.87 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 56.08 46.64 21.26 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 111.377 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 61' ' ' ILE . 73.4 mt -101.01 85.54 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.267 2.009 0 CA-C-O 115.201 -2.333 . . . . 50.509999999999998 106.033 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 65' ' ' SER . 97.8 mm-40 -92.43 -177.07 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.099 2.124 . . . . 50.549999999999997 114.683 -176.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.877 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 60.3 pttt -57.76 143.55 41.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.18 1.467 . . . . 50.509999999999998 112.192 -176.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 65.78 31.55 9.47 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 112.502 -2.135 . . . . 50.619999999999997 109.887 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 95.7 p -80.23 164.34 23.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.813 -1.18 . . . . 50.509999999999998 107.813 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -123.58 131.9 53.74 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.268 -0.872 . . . . 50.509999999999998 108.791 175.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.1 mp -105.38 137.71 42.76 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 114.649 -2.595 . . . . 50.509999999999998 108.854 175.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -98.54 108.48 21.19 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 127.427 2.954 . . . . 50.509999999999998 107.195 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 33.2 tp -72.97 147.01 45.62 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.316 1.228 . . . . 50.509999999999998 114.316 176.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 63.4 t -138.42 142.85 34.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 102.787 -3.042 . . . . 50.509999999999998 102.787 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 mt -98.29 100.59 11.88 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.608 1.336 . . . . 50.509999999999998 114.608 178.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -69.95 104.1 2.43 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 113.338 -3.22 . . . . 50.640000000000001 112.11 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -83.56 165.07 19.38 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.767 1.917 . . . . 50.509999999999998 108.472 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -131.82 45.39 2.79 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.76 -1.564 . . . . 50.640000000000001 109.369 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.35 151.14 6.15 Favored Glycine 0 C--O 1.242 0.633 0 N-CA-C 108.027 -2.029 . . . . 50.509999999999998 108.027 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.463 0 N-CA-C 106.51 -2.636 . . . . 50.509999999999998 106.51 179.226 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 107.734 -1.21 . . . . 50.509999999999998 107.734 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -111.06 133.8 53.16 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 105.701 178.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.73 162.13 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 115.921 -1.99 . . . . 50.509999999999998 108.41 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -113.0 123.55 50.57 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.518 4.886 . . . . 50.509999999999998 110.598 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.28 112.02 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 113.427 -3.178 . . . . 50.509999999999998 118.975 175.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.64 133.97 34.81 Favored 'General case' 0 N--CA 1.504 2.252 1 O-C-N 129.363 4.164 . . . . 50.509999999999998 105.515 -178.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -115.08 171.63 7.55 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 117.781 -1.104 . . . . 50.509999999999998 109.466 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.2 mt -65.05 -31.81 73.22 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.159 0.912 . . . . 50.509999999999998 109.949 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -74.84 -1.95 24.56 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 115.72 -2.392 . . . . 50.509999999999998 114.656 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.28 2.52 87.7 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 108.917 -1.673 . . . . 50.509999999999998 108.917 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.01 143.8 41.24 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.507 -1.584 . . . . 50.509999999999998 107.443 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -113.93 112.02 22.63 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 126.693 2.495 . . . . 50.509999999999998 110.434 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -97.91 143.14 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 127.561 3.038 . . . . 50.509999999999998 113.765 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.4 m -108.18 144.73 35.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.267 -1.773 . . . . 50.509999999999998 111.923 178.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -140.7 129.27 22.76 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.466 -2.207 . . . . 50.509999999999998 109.002 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -75.83 144.12 41.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 128.947 3.904 . . . . 50.619999999999997 108.482 174.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -149.39 174.08 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 127.742 3.152 . . . . 50.509999999999998 112.14 -177.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 57.3 mm-40 -139.21 150.08 63.23 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 112.254 -2.248 . . . . 50.619999999999997 111.055 174.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -54.88 -24.6 39.64 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.634 2.223 . . . . 50.509999999999998 111.957 177.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.4 p -66.87 -38.74 86.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 105.985 -1.857 . . . . 50.509999999999998 105.985 -177.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 55' ' ' THR . 84.9 m-20 -44.92 155.21 0.11 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.981 2.215 . . . . 50.619999999999997 116.981 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 25' ' ' ASN . 33.1 p -119.01 138.18 53.01 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.252 -3.611 . . . . 50.509999999999998 101.252 175.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.664 HD11 HD23 ' A' ' 50' ' ' LEU . 25.5 mm -32.0 -42.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.123 2.764 . . . . 50.509999999999998 114.867 175.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -60.83 -34.15 74.11 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 50.619999999999997 111.08 176.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' THR . 91.3 m-20 -74.39 -28.93 61.32 Favored 'General case' 0 C--O 1.249 1.053 0 C-N-CA 124.321 1.048 . . . . 50.549999999999997 110.31 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -72.51 -51.88 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 125.039 1.462 . . . . 50.509999999999998 108.5 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.3 -36.66 84.77 Favored 'General case' 0 C--O 1.257 1.447 0 CA-C-N 115.717 -0.674 . . . . 50.509999999999998 109.342 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.61 79.44 Favored 'General case' 0 C--O 1.278 2.584 0 N-CA-C 121.133 3.753 . . . . 50.509999999999998 121.133 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -59.49 -41.63 90.3 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 120.404 -1.435 . . . . 50.509999999999998 107.679 176.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 30' ' ' ILE . 60.4 mt -64.22 -20.7 27.41 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 113.375 0.88 . . . . 50.509999999999998 113.375 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 33.4 tt0 -50.19 -41.41 49.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 125.546 2.593 . . . . 50.549999999999997 107.228 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 33' ' ' LYS . 29.3 t70 -81.78 -46.05 14.75 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 116.683 2.105 . . . . 50.619999999999997 116.683 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 32' ' ' ASP . 48.5 mmtm -51.27 -64.15 0.9 Allowed 'General case' 0 C--O 1.279 2.631 0 C-N-CA 116.501 -2.079 . . . . 50.509999999999998 108.394 -175.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -93.09 -41.33 10.02 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.048 2.658 . . . . 50.619999999999997 117.926 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 119.34 17.25 4.91 Favored Glycine 0 CA--C 1.478 -2.263 0 N-CA-C 111.083 -0.807 . . . . 50.509999999999998 111.083 176.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 24.7 mm -94.9 117.79 66.81 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 118.73 -1.188 . . . . 50.509999999999998 110.546 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -57.0 136.98 79.92 Favored 'Trans proline' 0 C--O 1.259 1.532 0 C-N-CA 123.154 2.569 . . . . 50.509999999999998 110.909 178.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.0 Cg_exo -57.26 -32.16 92.86 Favored 'Trans proline' 0 C--O 1.261 1.665 0 O-C-N 122.89 0.942 . . . . 50.509999999999998 113.371 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -67.33 -14.44 62.92 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 120.002 -1.686 . . . . 50.619999999999997 111.758 -177.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 58.9 mt-30 -98.64 11.41 38.55 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.54 -1.35 . . . . 50.549999999999997 113.001 178.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HG2' HD11 ' A' ' 69' ' ' LEU . 68.6 mt-30 -113.47 119.1 36.42 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 117.22 2.304 . . . . 50.549999999999997 117.22 -177.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.423 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.2 mtm180 -107.41 137.49 45.35 Favored 'General case' 0 C--O 1.296 3.543 0 CA-C-O 116.669 -1.634 . . . . 50.640000000000001 111.851 172.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 50' ' ' LEU . 23.2 mt -120.94 115.23 22.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.522 1.056 . . . . 50.509999999999998 111.809 -177.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.44 114.95 35.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 O-C-N 125.218 1.574 . . . . 50.509999999999998 113.496 -177.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 50' ' ' LEU . 39.9 t80 -140.76 117.05 10.67 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 114.555 -1.202 . . . . 50.509999999999998 109.983 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.36 23.97 13.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.16 -2.291 . . . . 50.509999999999998 113.03 177.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.59 0.27 89.87 Favored Glycine 0 N--CA 1.433 -1.506 0 C-N-CA 128.379 2.895 . . . . 50.509999999999998 110.603 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -103.99 108.28 19.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 116.09 1.885 . . . . 50.509999999999998 116.09 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -45.75 129.17 9.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.222 -1.029 . . . . 50.549999999999997 108.222 174.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 45' ' ' PHE . 5.8 mp -69.9 144.23 52.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 117.742 -1.123 . . . . 50.509999999999998 109.544 -175.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 42.6 mt-10 -94.47 145.44 24.79 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.886 1.366 . . . . 50.619999999999997 108.617 -177.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.6 -36.39 83.65 Favored 'General case' 0 C--O 1.263 1.805 0 N-CA-C 117.982 2.586 . . . . 50.619999999999997 117.982 -175.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.21 -26.05 49.52 Favored Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 124.411 1.005 . . . . 50.509999999999998 112.821 -177.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 25.6 mmm180 -59.71 173.76 0.53 Allowed 'General case' 0 C--O 1.249 1.052 0 O-C-N 119.957 -1.908 . . . . 50.640000000000001 111.275 176.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 21' ' ' ASP . 41.5 p -117.7 172.47 7.34 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 103.117 -2.92 . . . . 50.509999999999998 103.117 177.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.83 -26.84 64.42 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 106.117 -1.808 . . . . 50.509999999999998 106.117 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.1 p -67.3 -25.15 65.9 Favored 'General case' 0 C--O 1.268 2.062 0 C-N-CA 117.324 -1.751 . . . . 50.509999999999998 110.745 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 54' ' ' ARG . 47.0 m-20 -66.01 -36.8 84.27 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 118.883 2.92 . . . . 50.619999999999997 118.883 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.21 9.34 43.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 117.758 -1.115 . . . . 50.509999999999998 112.701 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.3 t30 57.63 65.42 1.34 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 121.543 1.974 . . . . 50.549999999999997 115.113 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mm -92.19 93.35 4.21 Favored 'Isoleucine or valine' 0 C--O 1.266 1.967 0 CA-C-O 115.284 -2.293 . . . . 50.509999999999998 111.444 175.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 8.5 mm-40 -99.01 167.07 10.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 126.073 2.108 . . . . 50.549999999999997 111.963 -176.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 64.8 mttm -51.99 133.83 32.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 119.673 3.212 . . . . 50.509999999999998 119.673 -176.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 64.7 mm-40 77.35 23.48 0.88 Allowed 'General case' 0 C--O 1.256 1.427 0 CA-C-N 112.498 -2.137 . . . . 50.619999999999997 111.019 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.0 m -82.38 144.19 30.7 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.787 -1.097 . . . . 50.509999999999998 113.336 174.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 p -101.78 131.67 47.96 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 118.252 -0.88 . . . . 50.509999999999998 113.348 175.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.0 tp -100.96 139.11 37.11 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 114.647 -2.597 . . . . 50.509999999999998 105.642 175.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -100.06 117.84 35.18 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 127.463 2.977 . . . . 50.509999999999998 114.223 177.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.428 HD11 ' HG2' ' A' ' 41' ' ' GLN . 66.0 tp -91.26 106.18 18.32 Favored 'General case' 0 C--O 1.283 2.846 0 N-CA-C 115.187 1.551 . . . . 50.509999999999998 115.187 176.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 29.7 t -108.62 136.82 43.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 119.601 1.091 . . . . 50.509999999999998 112.155 175.095 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.2 mt -67.14 155.84 37.72 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 118.226 2.676 . . . . 50.509999999999998 118.226 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 40' ' ' GLN . 29.2 tpt180 -136.4 77.79 1.67 Allowed 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 113.32 -3.229 . . . . 50.640000000000001 107.103 177.253 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -74.35 140.09 44.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.644 2.091 . . . . 50.509999999999998 116.644 -179.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.41 82.94 8.1 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.756 -1.566 . . . . 50.640000000000001 108.388 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.39 155.0 20.89 Favored Glycine 0 C--O 1.243 0.712 0 N-CA-C 116.527 1.371 . . . . 50.509999999999998 116.527 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.476 0 CA-C-O 116.294 -2.392 . . . . 50.509999999999998 107.282 179.258 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.52 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.52 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.46 HD22 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.52 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.52 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.46 HD22 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 mmt . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 104.333 -2.469 . . . . 50.509999999999998 104.333 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -102.52 144.7 30.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 127.026 2.704 . . . . 50.549999999999997 104.738 178.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -137.74 165.17 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 N-CA-C 102.29 -3.226 . . . . 50.509999999999998 102.29 173.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -121.18 134.84 55.23 Favored 'General case' 0 N--CA 1.511 2.606 1 O-C-N 130.449 4.843 . . . . 50.509999999999998 112.145 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.98 141.26 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 113.437 -3.173 . . . . 50.509999999999998 111.786 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.6 121.69 45.52 Favored 'General case' 0 N--CA 1.504 2.27 1 O-C-N 129.372 4.17 . . . . 50.509999999999998 109.252 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -110.97 160.48 16.77 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 117.82 -1.086 . . . . 50.509999999999998 109.62 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.7 mt -88.18 18.54 4.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.743 -1.206 . . . . 50.509999999999998 107.743 -178.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.5 p -107.14 -37.6 6.24 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 115.682 -2.407 . . . . 50.509999999999998 114.468 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.13 -8.06 4.76 Favored Glycine 0 C--N 1.298 -1.574 0 O-C-N 119.929 -1.732 . . . . 50.509999999999998 111.28 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' NZ ' HG12 ' A' ' 13' ' ' ILE . 62.1 tttm -81.36 157.91 24.86 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 116.256 1.947 . . . . 50.509999999999998 116.256 174.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -125.06 129.32 50.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.66 2.475 . . . . 50.509999999999998 110.602 176.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.478 HG12 ' NZ ' ' A' ' 11' ' ' LYS . 62.5 mt -114.41 122.31 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 115.228 -2.589 . . . . 50.509999999999998 109.027 179.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 15' ' ' LEU . 75.2 p -95.05 159.28 15.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.293 -1.763 . . . . 50.509999999999998 113.571 178.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 14' ' ' THR . 60.7 mt -140.93 143.03 34.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 115.428 -2.225 . . . . 50.509999999999998 114.99 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -108.87 95.23 5.5 Favored 'General case' 0 N--CA 1.5 2.036 1 O-C-N 129.262 4.101 . . . . 50.619999999999997 109.559 173.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.7 155.58 25.97 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 N-CA-C 121.09 3.737 . . . . 50.509999999999998 121.09 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 mt-10 -99.83 135.09 20.58 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 112.169 -2.287 . . . . 50.619999999999997 112.333 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.0 Cg_exo -55.01 -24.49 40.1 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.621 2.214 . . . . 50.509999999999998 111.966 177.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -77.65 -21.97 51.36 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 118.133 -0.937 . . . . 50.509999999999998 111.757 -177.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -51.07 166.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 117.399 -1.72 . . . . 50.619999999999997 111.666 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -112.47 143.59 43.36 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 101.444 -3.539 . . . . 50.509999999999998 101.444 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -34.06 -43.28 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 119.584 3.179 . . . . 50.509999999999998 119.584 175.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.9 -35.53 66.66 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.403 -0.811 . . . . 50.619999999999997 112.675 177.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -77.97 -11.7 59.92 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 114.628 1.344 . . . . 50.549999999999997 114.628 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.17 -38.1 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 125.058 1.474 . . . . 50.509999999999998 109.898 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.8 -41.42 60.0 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 115.72 1.748 . . . . 50.509999999999998 115.72 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 29' ' ' LYS . . . -61.05 -43.43 98.89 Favored 'General case' 0 C--O 1.278 2.599 0 N-CA-C 107.477 -1.305 . . . . 50.509999999999998 107.477 176.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 23.7 mtpp -43.53 -49.0 7.52 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 106.496 -1.668 . . . . 50.509999999999998 106.496 176.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.19 -29.73 47.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.25 0 N-CA-C 114.209 1.188 . . . . 50.509999999999998 114.209 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.3 -26.94 68.13 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 125.609 2.623 . . . . 50.549999999999997 108.968 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 49.8 m-20 -62.58 -31.89 72.78 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 113.581 -1.645 . . . . 50.619999999999997 111.037 179.139 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -111.12 -13.36 14.04 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.46 -2.096 . . . . 50.509999999999998 110.301 -175.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -120.22 -30.11 4.7 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 120.858 3.651 . . . . 50.619999999999997 120.858 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.42 8.29 77.89 Favored Glycine 0 CA--C 1.477 -2.331 0 N-CA-C 106.1 -2.8 . . . . 50.509999999999998 106.1 176.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 63.6 mt -86.54 123.0 71.69 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 105.672 -1.973 . . . . 50.509999999999998 105.672 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 79.3 Cg_exo -56.98 136.98 79.89 Favored 'Trans proline' 0 C--O 1.26 1.583 0 C-N-CA 123.152 2.568 . . . . 50.509999999999998 110.944 178.284 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.5 Cg_exo -57.19 -32.12 92.57 Favored 'Trans proline' 0 C--O 1.262 1.718 0 C-N-CA 120.694 0.929 . . . . 50.509999999999998 113.447 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -70.03 -14.09 62.52 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.915 -1.74 . . . . 50.619999999999997 108.594 -177.404 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -98.79 3.38 47.46 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.056 1.502 . . . . 50.549999999999997 115.056 178.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -102.31 142.74 33.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 124.374 2.035 . . . . 50.549999999999997 109.719 -177.596 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.52 ' HD2' HE21 ' A' ' 49' ' ' GLN . 49.3 ttp180 -120.96 114.89 22.18 Favored 'General case' 0 C--O 1.296 3.534 0 N-CA-C 117.817 2.525 . . . . 50.640000000000001 117.817 172.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 50' ' ' LEU . 75.4 mt -107.1 123.72 48.64 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 115.168 1.544 . . . . 50.509999999999998 115.168 -177.449 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.62 136.44 50.02 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 O-C-N 125.154 1.534 . . . . 50.509999999999998 112.637 -177.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 50' ' ' LEU . 55.3 t80 -160.57 131.14 5.38 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.485 -1.234 . . . . 50.509999999999998 112.285 177.562 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.63 38.5 1.27 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.234 -2.257 . . . . 50.509999999999998 110.997 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.77 21.29 67.19 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 128.439 2.923 . . . . 50.509999999999998 114.91 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -129.63 161.9 29.51 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 115.839 1.792 . . . . 50.509999999999998 115.839 177.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.52 HE21 ' HD2' ' A' ' 42' ' ' ARG . 35.9 tt0 -85.2 131.34 34.44 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 106.456 -1.683 . . . . 50.549999999999997 106.456 174.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 43' ' ' LEU . 61.0 mt -78.89 151.22 31.9 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 105.88 -1.896 . . . . 50.509999999999998 105.88 -175.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -117.9 139.79 50.63 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.834 1.334 . . . . 50.619999999999997 110.154 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.27 -14.25 10.61 Favored 'General case' 0 C--O 1.263 1.808 0 C-N-CA 126.197 1.799 . . . . 50.619999999999997 111.365 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.25 9.36 72.24 Favored Glycine 0 C--O 1.252 1.257 0 N-CA-C 116.277 1.271 . . . . 50.509999999999998 116.277 -177.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -123.41 177.85 5.43 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 116.133 1.901 . . . . 50.640000000000001 116.133 176.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.3 p -105.9 162.55 13.48 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.044 0.938 . . . . 50.509999999999998 113.461 177.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.81 -21.37 64.55 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 117.407 2.373 . . . . 50.509999999999998 117.407 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -92.17 -14.67 28.73 Favored 'General case' 0 C--O 1.268 2.068 0 C-N-CA 117.317 -1.753 . . . . 50.509999999999998 109.337 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.19 -32.26 70.1 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.438 1.113 . . . . 50.619999999999997 110.015 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -96.62 15.37 21.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.531 -1.285 . . . . 50.509999999999998 107.531 179.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.46 HD22 ' HA ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 51.35 42.04 28.72 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 121.512 1.96 . . . . 50.549999999999997 112.093 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 45' ' ' PHE . 66.6 mt -80.75 99.89 4.58 Favored 'Isoleucine or valine' 0 C--O 1.266 1.943 0 CA-C-O 115.315 -2.278 . . . . 50.509999999999998 107.161 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -93.12 -173.07 3.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.055 2.097 . . . . 50.549999999999997 114.939 -176.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -67.44 146.46 53.98 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.716 -1.957 . . . . 50.509999999999998 105.716 -176.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 42.97 40.78 2.33 Favored 'General case' 0 C--O 1.257 1.461 0 N-CA-C 117.312 2.338 . . . . 50.619999999999997 117.312 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.2 p -74.31 163.35 27.91 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.803 -1.09 . . . . 50.509999999999998 112.232 174.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.3 m -109.96 120.84 43.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 118.249 -0.882 . . . . 50.509999999999998 108.905 175.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 45' ' ' PHE . 59.8 mt -106.57 147.61 29.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 114.694 -2.575 . . . . 50.509999999999998 107.573 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -98.49 139.84 33.62 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.392 2.932 . . . . 50.509999999999998 103.336 177.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.17 127.1 55.48 Favored 'General case' 0 C--O 1.282 2.798 0 N-CA-C 105.765 -1.939 . . . . 50.509999999999998 105.765 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.04 121.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 119.571 1.078 . . . . 50.509999999999998 109.836 175.091 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.4 mt -68.29 111.43 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 116.358 1.985 . . . . 50.509999999999998 116.358 178.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.03 122.7 23.06 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-O 113.339 -3.22 . . . . 50.640000000000001 107.244 177.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 148.0 44.5 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 116.283 1.957 . . . . 50.509999999999998 116.283 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.83 -38.49 28.2 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.728 -1.578 . . . . 50.640000000000001 107.429 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.85 -155.61 7.52 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 109.356 -1.498 . . . . 50.509999999999998 109.356 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.496 0 CA-C-O 116.322 -2.377 . . . . 50.509999999999998 113.24 179.152 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.509999999999998 110.493 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 104.893 178.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.509999999999998 102.837 173.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' HD2' HG21 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.509999999999998 117.134 179.556 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.509999999999998 116.317 175.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.509999999999998 112.121 -178.081 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.509999999999998 109.624 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.509999999999998 116.025 -177.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.509999999999998 106.536 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.509999999999998 112.921 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.509999999999998 113.028 175.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.509999999999998 111.926 176.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.509999999999998 102.234 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.509999999999998 107.977 178.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.509999999999998 113.269 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.619999999999997 114.947 174.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.509999999999998 115.789 -177.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.619999999999997 107.53 174.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.509999999999998 111.949 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.509999999999998 109.308 -177.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.619999999999997 108.196 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.509999999999998 111.912 175.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 23' ' ' ILE . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.509999999999998 112.556 175.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.619999999999997 115.475 176.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 55.5 t-20 -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.549999999999997 106.23 -179.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.509999999999998 107.58 178.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.509999999999998 111.113 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.509999999999998 109.947 176.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.509999999999998 115.455 175.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.509999999999998 104.372 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.549999999999997 109.548 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.619999999999997 110.423 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.509999999999998 113.197 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.619999999999997 117.619 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.509999999999998 109.26 176.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.509999999999998 113.852 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.509999999999998 110.907 178.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.509999999999998 113.412 -179.288 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.619999999999997 115.136 -177.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 19.5 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.549999999999997 103.57 178.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.549999999999997 113.647 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.640000000000001 112.495 172.132 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.509999999999998 118.018 -177.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.509999999999998 117.708 -177.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.509999999999998 116.78 177.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.302 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.509999999999998 114.896 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.509999999999998 114.931 177.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.549999999999997 107.727 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.509999999999998 107.986 -175.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.619999999999997 112.944 -177.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.619999999999997 118.065 -175.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.509999999999998 108.537 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.640000000000001 104.693 176.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.509999999999998 107.733 177.174 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.509999999999998 103.779 177.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.509999999999998 109.455 -179.438 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.619999999999997 111.805 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.509999999999998 115.046 179.177 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.549999999999997 109.887 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.596 HD12 HD21 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 106.554 175.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.549999999999997 119.305 -176.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.509999999999998 112.625 -176.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.619999999999997 109.925 179.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.509999999999998 105.936 174.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.509999999999998 114.003 175.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.509999999999998 101.726 175.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 7.7 m170 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.509999999999998 105.529 177.945 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 108.662 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.509999999999998 109.301 175.143 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.423 HD11 HE21 ' A' ' 40' ' ' GLN . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.509999999999998 105.818 178.446 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.640000000000001 109.263 177.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.509999999999998 120.492 -179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.640000000000001 113.699 -179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.509999999999998 105.703 179.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.509999999999998 108.344 179.318 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 118.879 -0.582 . . . . 50.509999999999998 110.493 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -84.42 156.13 21.93 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.915 2.634 . . . . 50.549999999999997 104.893 178.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.5 tt -154.76 148.24 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 N-CA-C 102.837 -3.023 . . . . 50.509999999999998 102.837 173.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' HD2' HG21 ' A' ' 12' ' ' THR . 63.4 m-85 -105.75 118.23 36.06 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.359 4.787 . . . . 50.509999999999998 117.134 179.556 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.46 134.43 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.409 -3.186 . . . . 50.509999999999998 116.317 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 34.5 mmtp -90.95 143.76 26.38 Favored 'General case' 0 N--CA 1.503 2.203 1 O-C-N 129.292 4.12 . . . . 50.509999999999998 112.121 -178.081 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -136.3 154.91 50.74 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 117.837 -1.078 . . . . 50.509999999999998 109.624 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.02 -8.53 45.81 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.025 1.861 . . . . 50.509999999999998 116.025 -177.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 9' ' ' THR . 55.0 m -87.52 1.68 52.83 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 115.707 -2.397 . . . . 50.509999999999998 106.536 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.35 17.71 80.12 Favored Glycine 0 C--N 1.298 -1.58 0 O-C-N 120.012 -1.68 . . . . 50.509999999999998 112.921 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -105.18 106.98 17.73 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 116.919 -1.515 . . . . 50.509999999999998 113.028 175.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 4' ' ' PHE . 96.4 m -61.92 143.83 55.87 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 126.624 2.452 . . . . 50.509999999999998 111.926 176.101 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.6 mt -122.21 141.32 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 102.234 -3.247 . . . . 50.509999999999998 102.234 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.5 m -117.61 125.13 50.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.363 -1.735 . . . . 50.509999999999998 107.977 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -114.48 140.87 48.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.416 -2.23 . . . . 50.509999999999998 113.269 -179.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -95.23 129.89 42.18 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 128.873 3.858 . . . . 50.619999999999997 114.947 174.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.04 162.9 21.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.286 2.866 . . . . 50.509999999999998 115.789 -177.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.25 136.13 26.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.189 -2.278 . . . . 50.619999999999997 107.53 174.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.94 -24.5 39.56 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.538 2.159 . . . . 50.509999999999998 111.949 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.4 p -82.39 9.32 9.29 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 118.084 -0.96 . . . . 50.509999999999998 109.308 -177.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 30.5 m-20 -84.57 151.76 24.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 117.363 -1.735 . . . . 50.619999999999997 108.196 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' THR . 33.3 p -94.97 161.04 14.31 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.856 -0.611 . . . . 50.509999999999998 111.912 175.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 23' ' ' ILE . 15.7 mm -47.67 -45.49 10.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 127.232 2.833 . . . . 50.509999999999998 112.556 175.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.25 -17.06 57.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.475 1.657 . . . . 50.619999999999997 115.475 176.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.518 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 55.5 t-20 -90.71 -0.45 57.7 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 106.23 -1.767 . . . . 50.549999999999997 106.23 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 96.0 t -95.85 -32.54 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.105 -1.407 . . . . 50.509999999999998 107.58 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 99.4 mttt -79.62 -20.98 45.5 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 115.806 -0.634 . . . . 50.509999999999998 111.113 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -56.98 4.15 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 109.947 -0.39 . . . . 50.509999999999998 109.947 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -46.53 -29.63 1.87 Allowed 'General case' 0 C--O 1.254 1.339 0 N-CA-C 115.455 1.65 . . . . 50.509999999999998 115.455 175.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -77.37 -48.34 24.71 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 N-CA-C 104.372 -2.455 . . . . 50.509999999999998 104.372 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -55.11 -31.26 61.11 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 125.652 2.644 . . . . 50.549999999999997 109.548 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -65.48 -15.64 62.85 Favored 'General case' 0 C--O 1.254 1.291 0 CA-C-N 113.614 -1.63 . . . . 50.619999999999997 110.423 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -121.78 -52.35 2.01 Favored 'General case' 0 C--O 1.28 2.662 0 O-C-N 119.368 -2.083 . . . . 50.509999999999998 113.197 -175.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.77 -41.02 15.45 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 123.098 2.681 . . . . 50.619999999999997 117.619 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.12 6.89 17.9 Favored Glycine 0 CA--C 1.477 -2.309 0 N-CA-C 109.26 -1.536 . . . . 50.509999999999998 109.26 176.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 41.4 mm -82.61 128.95 64.52 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 118.806 -1.157 . . . . 50.509999999999998 113.852 179.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.1 Cg_exo -56.99 136.94 79.67 Favored 'Trans proline' 0 C--O 1.26 1.581 0 C-N-CA 123.188 2.592 . . . . 50.509999999999998 110.907 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.5 Cg_exo -57.19 -32.2 92.79 Favored 'Trans proline' 0 C--O 1.262 1.724 0 C-N-CA 120.696 0.931 . . . . 50.509999999999998 113.412 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -83.1 6.04 20.41 Favored 'General case' 0 C--O 1.263 1.776 0 O-C-N 119.896 -1.752 . . . . 50.619999999999997 115.136 -177.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 19.5 mt-30 -109.7 2.61 20.24 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 103.57 -2.752 . . . . 50.549999999999997 103.57 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -95.52 139.88 31.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 124.337 2.018 . . . . 50.549999999999997 113.647 -177.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 70.8 mtp85 -128.16 100.07 5.71 Favored 'General case' 0 C--O 1.295 3.491 0 CA-C-O 116.684 -1.627 . . . . 50.640000000000001 112.495 172.132 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 68' ' ' HIS . 6.6 mp -93.94 124.46 37.96 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 118.018 2.599 . . . . 50.509999999999998 118.018 -177.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.49 129.24 68.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 117.708 2.484 . . . . 50.509999999999998 117.708 -177.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.5 t80 -140.06 126.77 20.5 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 116.78 2.141 . . . . 50.509999999999998 116.78 177.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.88 33.75 22.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.302 177.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -34.88 4.4 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 128.525 2.964 . . . . 50.509999999999998 114.896 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.51 164.58 21.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.931 1.456 . . . . 50.509999999999998 114.931 177.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -95.73 158.42 15.46 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 107.727 -1.212 . . . . 50.549999999999997 107.727 174.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 45' ' ' PHE . 59.7 mt -98.0 136.95 37.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 117.664 -1.16 . . . . 50.509999999999998 107.986 -175.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.75 152.63 24.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.984 1.427 . . . . 50.619999999999997 112.944 -177.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.76 -40.67 76.22 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 118.065 2.617 . . . . 50.619999999999997 118.065 -175.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.11 -16.0 65.85 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.537 -1.825 . . . . 50.509999999999998 108.537 -177.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -77.06 161.28 28.43 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 104.693 -2.336 . . . . 50.640000000000001 104.693 176.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 22' ' ' THR . 44.7 p -119.6 174.83 6.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.733 -1.21 . . . . 50.509999999999998 107.733 177.174 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.99 -25.62 67.94 Favored 'General case' 0 C--O 1.202 -1.439 0 N-CA-C 103.779 -2.674 . . . . 50.509999999999998 103.779 177.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -75.96 -46.26 30.64 Favored 'General case' 0 C--O 1.267 1.99 0 C-N-CA 117.373 -1.731 . . . . 50.509999999999998 109.455 -179.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -52.21 -34.17 44.39 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.526 1.155 . . . . 50.619999999999997 111.805 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 45.7 m-85 -92.85 5.82 49.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 115.046 1.498 . . . . 50.509999999999998 115.046 179.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 54.99 32.98 19.21 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-N 121.399 1.909 . . . . 50.549999999999997 109.887 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.596 HD12 HD21 ' A' ' 67' ' ' LEU . 27.3 mm -68.64 118.01 11.97 Favored 'Isoleucine or valine' 0 C--O 1.265 1.917 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 106.554 175.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -111.7 -167.17 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 119.305 3.076 . . . . 50.549999999999997 119.305 -176.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 88.6 tttt -70.74 123.15 21.25 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.237 1.494 . . . . 50.509999999999998 112.625 -176.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 95.1 mt-10 60.45 49.97 6.36 Favored 'General case' 0 C--O 1.256 1.425 0 CA-C-N 112.495 -2.139 . . . . 50.619999999999997 109.925 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.7 m -95.73 149.15 21.81 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.936 -1.876 . . . . 50.509999999999998 105.936 174.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.5 m -102.04 139.24 37.93 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.003 1.112 . . . . 50.509999999999998 114.003 175.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -118.95 139.13 52.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 101.726 -3.435 . . . . 50.509999999999998 101.726 175.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 7.7 m170 -91.4 143.11 26.96 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 127.36 2.913 . . . . 50.509999999999998 105.529 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' LYS . 48.8 tp -111.34 104.18 12.63 Favored 'General case' 0 C--O 1.283 2.839 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 108.662 176.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.4 t -93.16 143.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 119.619 1.1 . . . . 50.509999999999998 109.301 175.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.423 HD11 HE21 ' A' ' 40' ' ' GLN . 23.1 tp -106.52 106.47 17.01 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.818 -1.919 . . . . 50.509999999999998 105.818 178.446 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -72.71 133.81 44.74 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 113.303 -3.236 . . . . 50.640000000000001 109.263 177.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.66 104.78 16.8 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 120.492 3.515 . . . . 50.509999999999998 120.492 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -69.6 71.95 0.34 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-N 113.688 -1.596 . . . . 50.640000000000001 113.699 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.66 158.43 9.63 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 105.703 -2.959 . . . . 50.509999999999998 105.703 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 CA-C-O 116.314 -2.381 . . . . 50.509999999999998 108.344 179.318 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 107.349 -1.352 . . . . 50.509999999999998 107.349 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 12.4 mm-40 -87.51 137.75 32.07 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 126.946 2.654 . . . . 50.549999999999997 110.199 178.218 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.6 pt -135.32 161.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.022 -1.942 . . . . 50.509999999999998 106.638 173.313 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -94.91 148.05 22.73 Favored 'General case' 0 N--CA 1.512 2.637 1 O-C-N 130.467 4.854 . . . . 50.509999999999998 119.097 179.532 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.44 116.74 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.395 -3.193 . . . . 50.509999999999998 106.384 175.822 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.19 106.45 17.68 Favored 'General case' 0 N--CA 1.504 2.253 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 115.234 -178.118 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -82.79 178.88 7.97 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 117.759 -1.115 . . . . 50.509999999999998 109.653 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -70.56 -34.07 71.81 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 120.19 3.404 . . . . 50.509999999999998 120.19 -178.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 p -96.57 -9.09 30.21 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 115.706 -2.397 . . . . 50.509999999999998 116.356 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.64 38.41 0.72 Allowed Glycine 0 C--N 1.297 -1.617 0 N-CA-C 120.575 2.99 . . . . 50.509999999999998 120.575 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -94.61 135.64 35.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 116.848 -1.548 . . . . 50.509999999999998 111.047 175.018 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -109.51 117.76 34.83 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 126.702 2.501 . . . . 50.509999999999998 110.113 176.149 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.6 mt -117.72 132.05 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 127.609 3.068 . . . . 50.509999999999998 106.754 179.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.3 p -104.75 134.54 47.73 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.298 -1.761 . . . . 50.509999999999998 113.776 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.5 mt -118.39 155.87 29.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 115.435 -2.221 . . . . 50.509999999999998 116.029 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -93.7 119.16 32.35 Favored 'General case' 0 N--CA 1.501 2.084 1 O-C-N 129.227 4.08 . . . . 50.619999999999997 107.368 173.938 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.23 164.19 28.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.274 0 O-C-N 127.739 3.15 . . . . 50.509999999999998 111.114 -177.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.66 145.94 55.27 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 112.215 -2.266 . . . . 50.619999999999997 109.52 174.661 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.94 -24.49 39.51 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.559 2.172 . . . . 50.509999999999998 111.956 177.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -78.58 -34.48 46.83 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.947 -1.501 . . . . 50.509999999999998 106.947 -177.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.1 145.63 10.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.37 -1.732 . . . . 50.619999999999997 114.434 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 32.8 p -96.83 156.41 16.36 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.874 -0.603 . . . . 50.509999999999998 109.555 175.657 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.615 HD13 ' HB3' ' A' ' 50' ' ' LEU . 55.5 mt -50.69 -40.13 19.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 O-C-N 127.094 2.746 . . . . 50.509999999999998 108.977 175.774 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -47.65 -57.78 5.08 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.031 -1.1 . . . . 50.619999999999997 108.031 177.015 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -53.84 -40.87 66.83 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 115.74 1.756 . . . . 50.549999999999997 115.74 -179.633 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.71 -22.3 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 125.086 1.491 . . . . 50.509999999999998 110.299 178.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 94.9 mttt -82.78 -38.17 23.53 Favored 'General case' 0 C--O 1.255 1.372 0 N-CA-C 104.744 -2.317 . . . . 50.509999999999998 104.744 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.41 -28.45 61.08 Favored 'General case' 0 C--O 1.278 2.605 0 CA-C-N 117.982 0.355 . . . . 50.509999999999998 111.845 176.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -66.27 -36.51 83.17 Favored 'General case' 0 C--O 1.256 1.435 0 O-C-N 120.355 -1.466 . . . . 50.509999999999998 110.144 175.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.2 -29.29 27.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.529 -0.868 . . . . 50.509999999999998 108.661 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -56.24 -35.61 67.58 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 125.666 2.651 . . . . 50.549999999999997 111.019 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -63.75 -27.88 69.5 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 120.947 3.684 . . . . 50.619999999999997 120.947 179.132 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -108.83 -20.29 13.11 Favored 'General case' 0 C--O 1.279 2.65 0 O-C-N 119.27 -2.143 . . . . 50.509999999999998 113.539 -175.638 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' A' ' 36' ' ' ILE . 77.0 tt0 -123.69 -26.57 4.13 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 123.061 2.664 . . . . 50.619999999999997 111.205 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.47 12.04 57.58 Favored Glycine 0 CA--C 1.477 -2.303 0 CA-C-O 120.049 -0.306 . . . . 50.509999999999998 113.122 176.55 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.413 HG12 ' HG2' ' A' ' 34' ' ' GLU . 21.8 mm -77.5 126.3 84.86 Favored Pre-proline 0 C--O 1.245 0.822 0 N-CA-C 104.66 -2.348 . . . . 50.509999999999998 104.66 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.97 136.95 79.69 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.166 2.578 . . . . 50.509999999999998 110.914 178.309 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 87.0 Cg_exo -57.07 -32.3 92.8 Favored 'Trans proline' 0 C--O 1.262 1.688 0 C-N-CA 120.701 0.934 . . . . 50.509999999999998 113.436 -179.321 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -80.12 12.04 3.08 Favored 'General case' 0 C--O 1.263 1.777 0 O-C-N 119.864 -1.772 . . . . 50.619999999999997 114.954 -177.406 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.23 9.14 11.0 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.467 -1.395 . . . . 50.549999999999997 107.358 178.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -103.05 125.13 49.65 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.407 2.051 . . . . 50.549999999999997 112.999 -177.583 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -111.79 114.54 27.58 Favored 'General case' 0 C--O 1.295 3.478 0 CA-C-O 116.711 -1.614 . . . . 50.640000000000001 114.898 172.146 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.556 HD12 HG23 ' A' ' 23' ' ' ILE . 23.1 mt -98.62 122.34 41.71 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 119.431 1.014 . . . . 50.509999999999998 111.832 -177.442 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.81 117.99 56.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 O-C-N 124.545 1.153 . . . . 50.509999999999998 111.016 -177.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.707 ' HB3' HD21 ' A' ' 50' ' ' LEU . 57.9 t80 -140.92 143.4 34.58 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.121 -1.437 . . . . 50.509999999999998 107.121 177.52 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 45.38 34.98 1.68 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 112.254 -2.248 . . . . 50.509999999999998 106.798 177.434 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.87 -7.39 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 128.445 2.926 . . . . 50.509999999999998 113.263 -179.499 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 46' ' ' ALA . 75.2 mmtt -77.04 148.07 36.37 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 118.099 0.949 . . . . 50.509999999999998 113.402 177.662 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.5 116.09 11.43 Favored 'General case' 0 C--O 1.259 1.573 0 O-C-N 123.953 0.783 . . . . 50.549999999999997 109.485 174.559 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 45' ' ' PHE . 64.8 mt -78.84 145.68 34.1 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 101.394 -3.558 . . . . 50.509999999999998 101.394 -175.866 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.423 ' O ' HD12 ' A' ' 23' ' ' ILE . 4.2 mm-40 -116.72 148.66 40.88 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.975 1.472 . . . . 50.619999999999997 114.975 -177.661 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.25 -47.9 71.76 Favored 'General case' 0 C--O 1.264 1.838 0 C-N-CA 126.141 1.776 . . . . 50.619999999999997 114.572 -175.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 4.42 57.12 Favored Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 124.408 1.004 . . . . 50.509999999999998 112.921 -177.25 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.448 ' HD2' ' OH ' ' A' ' 59' ' ' TYR . 89.3 mtt-85 -93.01 143.52 26.15 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 119.997 -1.884 . . . . 50.640000000000001 112.3 176.451 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.2 p -86.25 162.05 18.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.036 0.935 . . . . 50.509999999999998 112.019 177.087 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.57 -27.31 65.95 Favored 'General case' 0 C--O 1.201 -1.495 0 N-CA-C 102.205 -3.257 . . . . 50.509999999999998 102.205 177.201 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -71.67 -36.03 70.52 Favored 'General case' 0 C--O 1.267 2.022 0 C-N-CA 117.326 -1.749 . . . . 50.509999999999998 113.078 -179.387 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -49.86 -38.64 36.19 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.501 1.143 . . . . 50.619999999999997 113.718 179.765 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 58.1 m-85 -91.58 -10.72 39.51 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 117.759 -1.115 . . . . 50.509999999999998 113.584 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 41.2 m-20 70.31 41.58 1.01 Allowed 'General case' 0 C--O 1.248 0.989 0 CA-C-N 121.52 1.964 . . . . 50.549999999999997 108.684 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.6 mt -70.72 118.07 14.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.93 0 CA-C-O 115.184 -2.341 . . . . 50.509999999999998 107.126 175.872 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -97.3 177.86 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 125.556 1.785 . . . . 50.549999999999997 110.196 -176.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -58.15 146.94 31.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.198 1.475 . . . . 50.509999999999998 107.658 -176.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 39.74 61.31 1.46 Allowed 'General case' 0 C--O 1.256 1.415 0 CA-C-N 112.537 -2.12 . . . . 50.619999999999997 112.614 179.566 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 m -98.26 151.07 20.85 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 104.729 -2.323 . . . . 50.509999999999998 104.729 174.743 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 p -95.96 140.26 30.96 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 118.287 -0.863 . . . . 50.509999999999998 111.879 175.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -122.64 136.92 55.01 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 114.641 -2.599 . . . . 50.509999999999998 104.479 175.088 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.15 116.92 29.2 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 127.427 2.954 . . . . 50.509999999999998 108.517 177.897 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.25 130.92 34.96 Favored 'General case' 0 C--O 1.283 2.818 0 CA-C-O 117.623 -1.179 . . . . 50.509999999999998 111.098 176.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.9 t -128.56 141.78 45.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 104.004 -2.591 . . . . 50.509999999999998 104.004 174.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.5 mt -97.55 123.54 41.46 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.639 0.607 . . . . 50.509999999999998 112.639 178.438 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -104.28 86.76 2.59 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 113.336 -3.221 . . . . 50.640000000000001 112.841 177.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.7 mt -73.32 167.77 20.55 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.954 . . . . 50.509999999999998 107.815 -179.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -120.59 86.5 2.58 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.714 -1.585 . . . . 50.640000000000001 107.247 -179.624 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.23 131.74 3.36 Favored Glycine 0 C--O 1.244 0.743 0 O-C-N 124.645 1.216 . . . . 50.509999999999998 113.081 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.47 1 O-C-N 115.118 -4.754 . . . . 50.509999999999998 103.707 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.509999999999998 111.053 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.549999999999997 116.588 178.321 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.509999999999998 108.408 173.351 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.509999999999998 119.91 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.509999999999998 113.866 175.785 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.509999999999998 109.83 -178.037 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.509999999999998 114.27 179.956 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.509999999999998 106.823 -177.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.509999999999998 106.406 179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.509999999999998 115.847 179.804 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.509999999999998 113.185 174.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.509999999999998 106.82 176.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.509999999999998 110.632 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.509999999999998 110.788 178.084 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.509999999999998 115.167 -179.282 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.619999999999997 107.469 173.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.509999999999998 111.54 -177.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.619999999999997 109.116 174.729 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.509999999999998 111.942 177.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.509999999999998 110.261 -177.489 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.619999999999997 110.438 -179.014 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.509999999999998 102.814 175.665 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.509999999999998 108.219 175.869 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.619999999999997 110.915 177.063 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.549999999999997 110.953 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.509999999999998 113.215 178.571 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.509999999999998 108.802 -179.798 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.509999999999998 103.321 176.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.509999999999998 108.74 176.075 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.509999999999998 114.446 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.643 HE21 ' HA ' ' A' ' 37' ' ' PRO . 33.4 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.549999999999997 111.108 179.417 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.619999999999997 106.799 179.153 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.509999999999998 117.415 -175.737 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.619999999999997 108.973 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.509999999999998 108.229 176.498 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' A' ' 34' ' ' GLU . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.509999999999998 107.149 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.643 ' HA ' HE21 ' A' ' 31' ' ' GLN . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.509999999999998 110.835 178.328 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.509999999999998 113.479 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.619999999999997 113.097 -177.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' A' ' 37' ' ' PRO . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.549999999999997 107.358 178.748 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.549999999999997 116.575 -177.483 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.640000000000001 106.18 172.202 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.509999999999998 109.103 -177.516 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.509999999999998 114.506 -177.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.509999999999998 114.578 177.624 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.509999999999998 108.335 177.409 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.509999999999998 113.694 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.509999999999998 108.927 177.678 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.549999999999997 107.079 174.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.509999999999998 107.602 -175.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.619999999999997 112.193 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.619999999999997 116.528 -175.761 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.509999999999998 116.292 -177.256 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.640000000000001 108.919 176.463 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.509999999999998 113.355 177.121 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.509999999999998 108.481 177.184 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.509999999999998 116.691 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.619999999999997 119.838 179.741 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.509999999999998 110.142 179.286 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 113.734 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.509999999999998 105.625 175.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.549999999999997 108.806 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.579 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.509999999999998 116.225 -176.896 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.619999999999997 117.221 179.545 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.509999999999998 103.824 174.726 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.509999999999998 115.599 175.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.509999999999998 106.66 175.091 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.509999999999998 108.183 177.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.509999999999998 108.516 176.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.509999999999998 105.118 175.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.509999999999998 116.356 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.640000000000001 113.39 177.176 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.509999999999998 111.184 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.505 -179.621 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.509999999999998 104.884 179.378 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.509999999999998 116.938 179.231 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 63' ' ' LYS . 47.0 tpp . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 118.86 -0.59 . . . . 50.509999999999998 111.053 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -71.1 132.79 45.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 126.922 2.639 . . . . 50.549999999999997 116.588 178.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.88 149.67 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 116.002 -1.951 . . . . 50.509999999999998 108.408 173.351 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -108.73 134.84 50.91 Favored 'General case' 0 N--CA 1.513 2.687 1 O-C-N 130.401 4.813 . . . . 50.509999999999998 119.91 179.541 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.09 122.5 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 113.397 -3.192 . . . . 50.509999999999998 113.866 175.785 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -87.83 128.98 35.34 Favored 'General case' 0 N--CA 1.504 2.254 1 O-C-N 129.338 4.149 . . . . 50.509999999999998 109.83 -178.037 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -108.16 164.47 12.27 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 114.27 1.211 . . . . 50.509999999999998 114.27 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.82 4.66 40.22 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 106.823 -1.547 . . . . 50.509999999999998 106.823 -177.969 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -98.68 3.44 47.75 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 115.762 -2.375 . . . . 50.509999999999998 106.406 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.1 36.53 45.81 Favored Glycine 0 C--N 1.296 -1.64 0 O-C-N 120.049 -1.657 . . . . 50.509999999999998 115.847 179.804 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -121.41 144.92 48.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 116.862 -1.542 . . . . 50.509999999999998 113.185 174.982 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -99.13 128.75 45.31 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 126.651 2.469 . . . . 50.509999999999998 106.82 176.229 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.94 128.78 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 127.555 3.034 . . . . 50.509999999999998 110.632 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -101.68 108.32 19.82 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 117.305 -1.758 . . . . 50.509999999999998 110.788 178.084 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -90.93 154.46 19.45 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 115.434 -2.222 . . . . 50.509999999999998 115.167 -179.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -116.54 117.52 30.11 Favored 'General case' 0 N--CA 1.499 2.008 1 O-C-N 129.261 4.101 . . . . 50.619999999999997 107.469 173.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -135.99 177.74 6.04 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 O-C-N 126.424 2.328 . . . . 50.509999999999998 111.54 -177.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.62 149.1 67.17 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 112.179 -2.282 . . . . 50.619999999999997 109.116 174.729 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.84 -24.55 39.06 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.596 2.198 . . . . 50.509999999999998 111.942 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -85.59 -2.02 57.73 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 118.098 -0.953 . . . . 50.509999999999998 110.261 -177.489 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.88 145.72 48.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 117.362 -1.735 . . . . 50.619999999999997 110.438 -179.014 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 p -89.25 164.75 14.82 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 102.814 -3.032 . . . . 50.509999999999998 102.814 175.665 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.1 mm -64.77 -32.82 59.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 O-C-N 127.13 2.769 . . . . 50.509999999999998 108.219 175.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.78 -50.58 70.06 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.515 -0.741 . . . . 50.619999999999997 110.915 177.063 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -57.56 -47.22 82.66 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.335 1.054 . . . . 50.549999999999997 110.953 -179.579 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.4 t -57.29 -42.54 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 125.021 1.451 . . . . 50.509999999999998 113.215 178.571 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 38' ' ' PRO . 54.5 mtpt -79.98 -17.69 52.27 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 108.802 -0.814 . . . . 50.509999999999998 108.802 -179.798 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.03 -18.75 38.65 Favored 'General case' 0 C--O 1.278 2.56 0 N-CA-C 103.321 -2.844 . . . . 50.509999999999998 103.321 176.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -86.36 -36.35 19.27 Favored 'General case' 0 C--O 1.255 1.392 0 O-C-N 120.347 -1.47 . . . . 50.509999999999998 108.74 176.075 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.24 -34.33 65.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.246 0 N-CA-C 114.446 1.276 . . . . 50.509999999999998 114.446 179.874 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.643 HE21 ' HA ' ' A' ' 37' ' ' PRO . 33.4 tt0 -71.61 -23.55 61.73 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 125.61 2.624 . . . . 50.549999999999997 111.108 179.417 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.59 -22.55 50.72 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.642 -1.617 . . . . 50.619999999999997 106.799 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -115.78 -20.48 10.04 Favored 'General case' 0 C--O 1.28 2.674 0 N-CA-C 117.415 2.376 . . . . 50.509999999999998 117.415 -175.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' A' ' 36' ' ' ILE . 71.8 tt0 -120.98 -21.91 6.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 123.103 2.683 . . . . 50.619999999999997 108.973 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.5 39.32 9.84 Favored Glycine 0 CA--C 1.477 -2.339 0 N-CA-C 108.229 -1.949 . . . . 50.509999999999998 108.229 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' A' ' 34' ' ' GLU . 36.0 mm -115.17 123.04 32.3 Favored Pre-proline 0 C--O 1.245 0.845 0 N-CA-C 107.149 -1.426 . . . . 50.509999999999998 107.149 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.643 ' HA ' HE21 ' A' ' 31' ' ' GLN . 78.8 Cg_exo -56.99 136.92 79.58 Favored 'Trans proline' 0 C--O 1.259 1.535 0 C-N-CA 123.253 2.635 . . . . 50.509999999999998 110.835 178.328 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 86.9 Cg_exo -57.13 -32.15 92.52 Favored 'Trans proline' 0 C--O 1.261 1.628 0 O-C-N 122.882 0.938 . . . . 50.509999999999998 113.479 -179.365 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.62 -4.82 53.33 Favored 'General case' 0 C--O 1.262 1.721 0 O-C-N 119.97 -1.706 . . . . 50.619999999999997 113.097 -177.452 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' A' ' 37' ' ' PRO . 14.7 mm-40 -98.88 -13.12 20.18 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.508 -1.37 . . . . 50.549999999999997 107.358 178.748 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.61 129.0 35.03 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 116.575 2.065 . . . . 50.549999999999997 116.575 -177.483 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HD2' ' HD3' ' A' ' 72' ' ' ARG . 75.3 mtp180 -103.72 132.75 49.69 Favored 'General case' 0 C--O 1.296 3.507 0 N-CA-C 106.18 -1.785 . . . . 50.640000000000001 106.18 172.202 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 mt -133.7 104.34 6.29 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.423 1.01 . . . . 50.509999999999998 109.103 -177.516 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.29 139.58 25.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 O-C-N 125.099 1.499 . . . . 50.509999999999998 114.506 -177.616 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HB3' HD21 ' A' ' 50' ' ' LEU . 87.3 t80 -137.06 125.95 24.16 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 114.578 1.325 . . . . 50.509999999999998 114.578 177.624 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.9 24.1 1.68 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.252 -2.249 . . . . 50.509999999999998 108.335 177.409 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.68 -18.65 49.12 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 128.48 2.943 . . . . 50.509999999999998 113.694 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 99.4 mttt -74.96 132.78 41.65 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.044 0.922 . . . . 50.509999999999998 108.927 177.678 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.05 130.36 41.34 Favored 'General case' 0 C--O 1.259 1.598 0 N-CA-C 107.079 -1.452 . . . . 50.549999999999997 107.079 174.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 45' ' ' PHE . 67.6 mt -75.53 126.16 30.46 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.602 -1.259 . . . . 50.509999999999998 107.602 -175.891 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -89.67 132.98 34.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.976 1.423 . . . . 50.619999999999997 112.193 -177.677 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -55.98 -34.85 66.13 Favored 'General case' 0 C--O 1.263 1.806 0 N-CA-C 116.528 2.047 . . . . 50.619999999999997 116.528 -175.761 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.62 16.95 52.35 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 116.292 1.277 . . . . 50.509999999999998 116.292 -177.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -122.13 152.17 40.18 Favored 'General case' 0 C--O 1.249 1.047 0 O-C-N 120.002 -1.881 . . . . 50.640000000000001 108.919 176.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.5 p -81.09 165.15 21.89 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 124.039 0.936 . . . . 50.509999999999998 113.355 177.121 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HA ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.41 -18.79 65.25 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 108.481 -0.933 . . . . 50.509999999999998 108.481 177.184 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.94 -29.86 50.14 Favored 'General case' 0 C--O 1.267 2.003 0 N-CA-C 116.691 2.108 . . . . 50.509999999999998 116.691 -179.453 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.24 -9.34 55.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 119.838 3.273 . . . . 50.619999999999997 119.838 179.741 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.449 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 42.2 m-85 -114.73 -5.47 12.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 117.816 -1.087 . . . . 50.509999999999998 110.142 179.286 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 47.1 t30 75.35 39.89 0.34 Allowed 'General case' 0 C--O 1.247 0.933 0 CA-C-N 121.515 1.961 . . . . 50.549999999999997 113.734 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -84.66 116.73 28.78 Favored 'Isoleucine or valine' 0 C--O 1.267 2.004 0 CA-C-O 115.233 -2.318 . . . . 50.509999999999998 105.625 175.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -128.22 -176.55 3.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.069 2.105 . . . . 50.549999999999997 108.806 -176.835 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.579 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 26.7 ttpp -41.51 134.27 2.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 116.225 1.935 . . . . 50.509999999999998 116.225 -176.896 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 51.2 41.29 27.63 Favored 'General case' 0 C--O 1.256 1.438 0 N-CA-C 117.221 2.304 . . . . 50.619999999999997 117.221 179.545 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.7 t -84.98 135.44 34.03 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.824 -2.658 . . . . 50.509999999999998 103.824 174.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -93.7 116.1 28.57 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 115.599 1.703 . . . . 50.509999999999998 115.599 175.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.69 134.91 34.29 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 114.712 -2.566 . . . . 50.509999999999998 106.66 175.091 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -91.42 139.85 30.33 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 126.893 2.62 . . . . 50.509999999999998 108.183 177.947 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.29 123.03 46.65 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 117.686 -1.149 . . . . 50.509999999999998 108.516 176.581 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.23 118.37 55.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 105.118 -2.178 . . . . 50.509999999999998 105.118 175.096 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.16 135.17 56.08 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 116.356 1.984 . . . . 50.509999999999998 116.356 178.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HD3' ' HD2' ' A' ' 42' ' ' ARG . 53.1 ttp180 -135.39 92.06 2.8 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 113.376 -3.202 . . . . 50.640000000000001 113.39 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -65.24 -176.66 0.32 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 125.637 1.836 . . . . 50.509999999999998 111.184 -179.342 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -123.29 49.21 1.71 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.505 -179.621 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.68 -171.31 35.14 Favored Glycine 0 C--O 1.243 0.665 0 N-CA-C 104.884 -3.286 . . . . 50.509999999999998 104.884 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.478 0 CA-C-O 116.372 -2.349 . . . . 50.509999999999998 116.938 179.231 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.509999999999998 110.518 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.549999999999997 111.931 178.254 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.509999999999998 109.629 173.36 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.509999999999998 110.788 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.509999999999998 109.267 175.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.509999999999998 112.054 -178.082 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.509999999999998 109.558 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.509999999999998 115.426 -177.96 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.509999999999998 110.359 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.509999999999998 109.262 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.509999999999998 111.702 175.031 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.509999999999998 120.495 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.509999999999998 104.467 179.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.509999999999998 119.511 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.509999999999998 111.182 -179.269 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.619999999999997 105.523 173.97 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.509999999999998 120.87 -177.968 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.619999999999997 113.88 174.624 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.509999999999998 111.907 177.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.509999999999998 110.539 -177.503 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.619999999999997 116.041 -179.054 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.509999999999998 113.13 175.663 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.509999999999998 106.643 175.794 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.619999999999997 109.013 176.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.549999999999997 120.754 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.509999999999998 109.974 178.629 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.509999999999998 103.034 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.509999999999998 114.005 176.947 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.509999999999998 108.149 175.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.509999999999998 112.731 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.549999999999997 116.636 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 110.424 179.144 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.509999999999998 117.298 -175.651 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.619999999999997 114.698 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.509999999999998 108.03 176.505 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.509999999999998 103.399 179.696 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.509999999999998 110.927 178.325 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.599 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.509999999999998 113.487 -179.297 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.619999999999997 115.612 -177.478 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 108.548 178.699 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 111.184 -177.606 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.640000000000001 102.446 172.198 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.509999999999998 113.857 -177.541 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.509999999999998 112.916 -177.592 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.509999999999998 108.783 177.641 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.509999999999998 104.079 177.365 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.509999999999998 117.886 -179.581 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.509999999999998 111.909 177.62 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.549999999999997 106.814 174.54 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.509999999999998 110.278 -175.89 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.619999999999997 111.58 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.619999999999997 111.456 -175.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.509999999999998 112.985 -177.227 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.640000000000001 115.651 176.557 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.509999999999998 116.995 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.509999999999998 105.494 177.211 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.509999999999998 113.975 -179.481 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.619999999999997 113.595 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 108.268 179.243 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 57' ' ' SER . 17.4 m120 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.549999999999997 112.768 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.509999999999998 112.67 175.785 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.549999999999997 105.766 -176.791 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.509999999999998 107.365 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.619999999999997 116.2 179.519 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.509999999999998 107.156 174.815 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.509999999999998 106.777 175.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.509999999999998 107.127 175.12 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.509999999999998 114.104 177.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.509999999999998 109.856 176.533 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.509999999999998 106.088 175.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.509999999999998 118.655 178.372 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.640000000000001 107.592 177.293 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.509999999999998 112.686 -179.374 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.640000000000001 111.255 -179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.509999999999998 104.302 179.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 116.097 179.25 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 17' ' ' VAL . 21.0 mmt . . . . . 0 CA--C 1.547 0.859 0 CA-C-O 118.835 -0.603 . . . . 50.509999999999998 110.518 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -89.75 133.72 34.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 126.924 2.64 . . . . 50.549999999999997 111.931 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -135.32 150.71 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-O 116.037 -1.935 . . . . 50.509999999999998 109.629 173.36 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -114.87 147.82 39.39 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.292 4.745 . . . . 50.509999999999998 110.788 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.1 120.89 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 113.307 -3.235 . . . . 50.509999999999998 109.267 175.855 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -92.03 123.93 35.75 Favored 'General case' 0 N--CA 1.503 2.188 1 O-C-N 129.337 4.148 . . . . 50.509999999999998 112.054 -178.082 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -104.37 -171.98 2.02 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 117.798 -1.096 . . . . 50.509999999999998 109.558 179.941 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.57 -13.06 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.426 1.639 . . . . 50.509999999999998 115.426 -177.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.7 p -91.52 -25.01 19.46 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 115.691 -2.404 . . . . 50.509999999999998 110.359 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.51 17.13 14.08 Favored Glycine 0 C--N 1.297 -1.601 0 O-C-N 120.171 -1.581 . . . . 50.509999999999998 109.262 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -96.24 90.14 5.37 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 116.861 -1.542 . . . . 50.509999999999998 111.702 175.031 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -52.13 129.07 26.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 120.495 3.517 . . . . 50.509999999999998 120.495 176.137 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.4 mm -99.66 139.61 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 127.597 3.061 . . . . 50.509999999999998 104.467 179.69 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.1 p -112.42 121.59 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 119.511 3.152 . . . . 50.509999999999998 119.511 178.086 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.99 141.7 50.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 115.482 -2.199 . . . . 50.509999999999998 111.182 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.85 139.47 40.37 Favored 'General case' 0 N--CA 1.499 2.007 1 O-C-N 129.186 4.054 . . . . 50.619999999999997 105.523 173.97 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -129.62 165.36 29.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 120.87 3.655 . . . . 50.509999999999998 120.87 -177.968 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 mp0 -122.4 147.16 49.2 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 112.186 -2.279 . . . . 50.619999999999997 113.88 174.624 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.1 Cg_exo -54.98 -24.48 39.75 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 122.558 2.172 . . . . 50.509999999999998 111.907 177.796 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.2 p -81.66 -12.85 58.52 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 118.136 -0.935 . . . . 50.509999999999998 110.539 -177.503 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 134.05 37.74 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.041 1.867 . . . . 50.619999999999997 116.041 -179.054 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.28 138.52 31.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.13 0.789 . . . . 50.509999999999998 113.13 175.663 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' GLU . 25.8 mm -38.36 -43.04 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.744 0 O-C-N 127.141 2.776 . . . . 50.509999999999998 106.643 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 23' ' ' ILE . 47.4 tp10 -36.01 -60.05 0.57 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.3 -0.875 . . . . 50.619999999999997 109.013 176.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.99 -33.03 71.51 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 120.754 3.612 . . . . 50.549999999999997 120.754 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.45 -30.54 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.063 1.477 . . . . 50.509999999999998 109.974 178.629 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -80.13 -31.3 39.07 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 103.034 -2.95 . . . . 50.509999999999998 103.034 -179.722 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.34 Favored 'General case' 0 C--O 1.277 2.551 0 N-CA-C 114.005 1.113 . . . . 50.509999999999998 114.005 176.947 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -54.88 -35.77 64.43 Favored 'General case' 0 C--O 1.255 1.375 0 O-C-N 120.315 -1.491 . . . . 50.509999999999998 108.149 175.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.1 -35.95 71.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.291 0 C-N-CA 119.59 -0.844 . . . . 50.509999999999998 112.731 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 10.6 tm0? -67.2 -36.32 81.49 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 125.66 2.647 . . . . 50.549999999999997 116.636 179.47 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.15 -49.62 66.22 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 110.424 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -102.64 -30.36 10.98 Favored 'General case' 0 C--O 1.28 2.679 0 N-CA-C 117.298 2.333 . . . . 50.509999999999998 117.298 -175.651 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -94.29 -18.71 21.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 123.141 2.701 . . . . 50.619999999999997 114.698 179.824 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.49 35.05 30.28 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 108.03 -2.028 . . . . 50.509999999999998 108.03 176.505 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mm -103.22 121.8 47.51 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 103.399 -2.815 . . . . 50.509999999999998 103.399 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -57.05 136.87 79.21 Favored 'Trans proline' 0 C--O 1.259 1.574 0 C-N-CA 123.255 2.636 . . . . 50.509999999999998 110.927 178.325 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.599 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.08 -32.22 92.6 Favored 'Trans proline' 0 C--O 1.26 1.618 0 O-C-N 122.865 0.929 . . . . 50.509999999999998 113.487 -179.297 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.11 -2.53 52.32 Favored 'General case' 0 C--O 1.264 1.824 0 N-CA-C 115.612 1.708 . . . . 50.619999999999997 115.612 -177.478 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -101.9 6.64 41.49 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 108.548 178.699 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -111.86 127.69 55.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 124.42 2.057 . . . . 50.549999999999997 111.184 -177.606 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mmm-85 -121.17 136.74 54.92 Favored 'General case' 0 C--O 1.297 3.556 0 N-CA-C 102.446 -3.168 . . . . 50.640000000000001 102.446 172.198 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.3 130.87 57.0 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.857 1.058 . . . . 50.509999999999998 113.857 -177.541 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.5 mt -115.6 125.95 72.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-O 122.312 1.054 . . . . 50.509999999999998 112.916 -177.592 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -143.41 127.09 17.06 Favored 'General case' 0 C--N 1.359 1.006 0 CA-C-N 114.551 -1.204 . . . . 50.509999999999998 108.783 177.641 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.76 31.19 1.66 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 104.079 -2.563 . . . . 50.509999999999998 104.079 177.365 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.73 1.52 17.68 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 128.469 2.938 . . . . 50.509999999999998 117.886 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -102.16 138.08 39.58 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.107 0.953 . . . . 50.509999999999998 111.909 177.62 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.85 137.1 53.63 Favored 'General case' 0 C--O 1.259 1.6 0 N-CA-C 106.814 -1.55 . . . . 50.549999999999997 106.814 174.54 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.94 158.01 18.2 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 117.712 -1.137 . . . . 50.509999999999998 110.278 -175.89 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -95.99 155.67 16.66 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.997 1.436 . . . . 50.619999999999997 111.58 -177.608 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.34 44.61 1.21 Allowed 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.228 1.811 . . . . 50.619999999999997 111.456 -175.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 26.72 0.17 Allowed Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 124.404 1.002 . . . . 50.509999999999998 112.985 -177.227 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' OH ' ' A' ' 59' ' ' TYR . 88.8 mtt180 -131.05 162.23 30.27 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 119.186 -2.361 . . . . 50.640000000000001 115.651 176.557 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.19 152.27 18.71 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.995 2.22 . . . . 50.509999999999998 116.995 177.093 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.593 HD22 HD12 ' A' ' 61' ' ' ILE . 84.1 mt -46.78 -33.23 4.23 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 105.494 -2.039 . . . . 50.509999999999998 105.494 177.211 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 26.5 m -62.23 -30.64 71.24 Favored 'General case' 0 C--O 1.269 2.081 0 C-N-CA 117.334 -1.746 . . . . 50.509999999999998 113.975 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.15 -29.74 68.7 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.451 1.119 . . . . 50.619999999999997 113.595 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 54' ' ' ARG . 12.4 m-85 -99.48 -26.98 13.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 117.815 -1.088 . . . . 50.509999999999998 108.268 179.243 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 57' ' ' SER . 17.4 m120 63.71 68.01 0.6 Allowed 'General case' 0 C--O 1.248 0.994 0 CA-C-N 121.467 1.94 . . . . 50.549999999999997 112.768 179.934 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.593 HD12 HD22 ' A' ' 56' ' ' LEU . 76.6 mt -88.46 118.59 34.25 Favored 'Isoleucine or valine' 0 C--O 1.266 1.941 0 CA-C-O 115.312 -2.28 . . . . 50.509999999999998 112.67 175.785 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -86.5 162.44 18.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 126.072 2.108 . . . . 50.549999999999997 105.766 -176.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -64.71 144.85 56.95 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 123.208 1.48 . . . . 50.509999999999998 107.365 -176.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 66.06 51.76 1.27 Allowed 'General case' 0 C--O 1.256 1.403 0 CA-C-N 112.526 -2.125 . . . . 50.619999999999997 116.2 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m -113.86 146.29 40.22 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 107.156 -1.424 . . . . 50.509999999999998 107.156 174.815 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 p -95.25 141.48 28.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.777 -1.564 . . . . 50.509999999999998 106.777 175.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.6 mt -106.63 164.11 12.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.805 -2.521 . . . . 50.509999999999998 107.127 175.12 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -116.54 113.13 22.33 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 127.306 2.879 . . . . 50.509999999999998 114.104 177.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.61 131.48 34.41 Favored 'General case' 0 C--O 1.282 2.787 0 CA-C-O 117.616 -1.183 . . . . 50.509999999999998 109.856 176.533 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.01 141.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.088 -1.819 . . . . 50.509999999999998 106.088 175.043 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.4 mt -82.23 129.49 34.86 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 118.655 2.835 . . . . 50.509999999999998 118.655 178.372 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -126.47 94.83 4.17 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-O 113.356 -3.211 . . . . 50.640000000000001 107.592 177.293 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.5 mt -98.19 163.74 12.61 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 125.798 1.936 . . . . 50.509999999999998 112.686 -179.374 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -109.27 86.25 2.25 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 113.703 -1.589 . . . . 50.640000000000001 111.255 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.59 139.89 3.52 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 104.302 -3.519 . . . . 50.509999999999998 104.302 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 116.097 179.25 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' CE ' ' HG3' ' A' ' 19' ' ' PRO . 66.1 mtm . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 50.509999999999998 109.216 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -108.89 144.62 36.55 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 103.603 -2.74 . . . . 50.549999999999997 103.603 178.265 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 65' ' ' SER . 20.9 tt -151.74 153.85 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 N-CA-C 102.846 -3.02 . . . . 50.509999999999998 102.846 173.404 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 62.7 m-85 -111.74 153.94 25.76 Favored 'General case' 0 N--CA 1.512 2.647 1 O-C-N 130.347 4.78 . . . . 50.509999999999998 110.328 179.525 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' THR . 73.5 t -123.7 106.24 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 113.348 -3.215 . . . . 50.509999999999998 108.503 175.797 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -85.23 126.31 33.57 Favored 'General case' 0 N--CA 1.504 2.247 1 O-C-N 129.422 4.201 . . . . 50.509999999999998 111.281 -178.135 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -103.06 173.45 6.3 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 107.142 -1.429 . . . . 50.509999999999998 107.142 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -50.88 -29.49 12.07 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.102 0.876 . . . . 50.509999999999998 113.219 -177.941 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -88.72 13.4 12.48 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 118.548 2.796 . . . . 50.509999999999998 118.548 179.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.97 62.53 Favored Glycine 0 C--N 1.298 -1.579 0 O-C-N 120.094 -1.629 . . . . 50.509999999999998 113.235 179.813 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -61.92 124.49 20.91 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 116.921 -1.514 . . . . 50.509999999999998 110.483 175.053 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 4' ' ' PHE . 4.4 p -115.72 131.57 56.9 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 126.604 2.44 . . . . 50.509999999999998 109.006 176.163 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.41 135.26 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 127.344 2.903 . . . . 50.509999999999998 111.867 179.742 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -92.7 128.12 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.311 -1.756 . . . . 50.509999999999998 112.051 178.17 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.64 144.78 42.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 115.473 -2.203 . . . . 50.509999999999998 111.304 -179.259 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -100.84 86.01 3.0 Favored 'General case' 0 N--CA 1.5 2.049 1 O-C-N 129.222 4.076 . . . . 50.619999999999997 111.542 173.996 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.86 174.52 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.247 0 O-C-N 127.649 3.093 . . . . 50.509999999999998 113.859 -177.904 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 56' ' ' LEU . 94.2 mt-10 -130.11 151.17 77.91 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 112.208 -2.269 . . . . 50.619999999999997 109.383 174.688 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 84.8 Cg_exo -54.85 -24.6 39.36 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.93 177.744 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.4 m -78.41 -15.31 58.8 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.074 -0.965 . . . . 50.509999999999998 109.656 -177.521 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.99 140.58 52.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 105.534 -2.024 . . . . 50.619999999999997 105.534 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 55' ' ' THR . 69.7 p -78.83 156.58 28.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 104.641 -2.355 . . . . 50.509999999999998 104.641 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.9 mm -57.11 -38.39 60.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 102.724 -3.065 . . . . 50.509999999999998 102.724 175.8 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -55.06 -25.07 28.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.359 -0.838 . . . . 50.619999999999997 112.597 176.987 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 79.7 m-20 -93.88 -20.3 20.17 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.35 1.06 . . . . 50.549999999999997 113.205 -179.62 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 56' ' ' LEU . 91.4 t -73.41 -62.17 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.768 -1.567 . . . . 50.509999999999998 106.768 178.591 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 54.3 mtmt -53.02 -30.99 38.7 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 104.533 -2.395 . . . . 50.509999999999998 104.533 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.5 -41.28 85.01 Favored 'General case' 0 C--O 1.279 2.633 0 N-CA-C 115.722 1.749 . . . . 50.509999999999998 115.722 176.905 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -61.05 -49.4 77.51 Favored 'General case' 0 C--O 1.255 1.377 0 O-C-N 120.344 -1.472 . . . . 50.509999999999998 109.212 176.022 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.25 -40.93 79.63 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 N-CA-C 108.658 -0.867 . . . . 50.509999999999998 108.658 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 58.3 tt0 -50.26 -51.75 42.06 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.607 2.622 . . . . 50.549999999999997 111.06 179.442 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.74 -37.49 82.23 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-N 113.598 -1.637 . . . . 50.619999999999997 114.416 179.161 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -80.9 -28.73 35.79 Favored 'General case' 0 C--O 1.28 2.675 0 C-N-CA 116.499 -2.08 . . . . 50.509999999999998 113.454 -175.681 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -117.42 -57.35 2.15 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 118.939 2.941 . . . . 50.619999999999997 118.939 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.04 16.18 0.35 Allowed Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 116.117 1.207 . . . . 50.509999999999998 116.117 176.531 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.0 mt -104.17 121.72 46.61 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 115.529 1.677 . . . . 50.509999999999998 115.529 179.717 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.7 Cg_exo -56.97 136.97 79.85 Favored 'Trans proline' 0 C--O 1.259 1.567 0 C-N-CA 123.167 2.578 . . . . 50.509999999999998 110.941 178.286 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.8 Cg_exo -57.21 -32.13 92.65 Favored 'Trans proline' 0 C--O 1.261 1.642 0 O-C-N 122.862 0.927 . . . . 50.509999999999998 113.474 -179.286 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' O ' ' NH2' ' A' ' 72' ' ' ARG . 70.5 m-20 -61.61 -38.73 88.68 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 119.974 -1.704 . . . . 50.619999999999997 110.618 -177.477 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -79.29 -6.86 57.64 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.484 2.031 . . . . 50.549999999999997 116.484 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 55.8 mt-30 -91.72 142.62 27.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 124.345 2.022 . . . . 50.549999999999997 110.86 -177.585 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -122.41 123.94 42.5 Favored 'General case' 0 C--O 1.296 3.533 0 CA-C-O 116.674 -1.632 . . . . 50.640000000000001 113.393 172.104 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 27' ' ' LYS . 52.4 mt -109.01 117.22 33.63 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 119.455 1.025 . . . . 50.509999999999998 110.243 -177.466 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 30.0 mm -118.57 116.55 51.65 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 125.116 1.51 . . . . 50.509999999999998 110.981 -177.61 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 39.8 t80 -138.71 123.05 18.25 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.536 -1.211 . . . . 50.509999999999998 108.01 177.633 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 23.8 6.07 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.195 -2.275 . . . . 50.509999999999998 113.133 177.447 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.78 13.7 78.42 Favored Glycine 0 N--CA 1.433 -1.534 0 C-N-CA 128.414 2.912 . . . . 50.509999999999998 117.508 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -109.6 162.98 13.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 101.956 -3.35 . . . . 50.509999999999998 101.956 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -101.25 126.46 47.99 Favored 'General case' 0 C--O 1.259 1.597 0 O-C-N 123.964 0.79 . . . . 50.549999999999997 110.798 174.602 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.2 112.53 5.18 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 119.732 3.234 . . . . 50.509999999999998 119.732 -175.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 16.4 tp10 -65.6 134.75 53.97 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.428 1.08 . . . . 50.619999999999997 112.76 -177.687 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 66.2 m-20 -68.66 -37.93 80.02 Favored 'General case' 0 C--O 1.265 1.869 0 C-N-CA 126.205 1.802 . . . . 50.619999999999997 106.458 -175.812 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -69.68 -23.6 76.66 Favored Glycine 0 CA--C 1.493 -1.291 0 C-N-CA 124.397 0.999 . . . . 50.509999999999998 113.468 -177.236 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -85.69 169.81 13.09 Favored 'General case' 0 C--O 1.25 1.086 0 O-C-N 119.923 -1.928 . . . . 50.640000000000001 110.824 176.396 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 22' ' ' THR . 21.0 p -109.84 159.0 17.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.774 1.027 . . . . 50.509999999999998 113.774 177.098 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 47.5 mt -53.02 -33.73 53.09 Favored 'General case' 0 C--O 1.202 -1.444 0 O-C-N 124.095 0.872 . . . . 50.509999999999998 108.835 177.218 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 19' ' ' PRO . 57.9 p -71.41 -28.75 64.22 Favored 'General case' 0 C--O 1.269 2.09 0 C-N-CA 117.341 -1.743 . . . . 50.509999999999998 111.441 -179.44 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -61.29 -20.51 62.98 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.456 1.122 . . . . 50.619999999999997 112.841 179.711 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 93.0 m-85 -106.76 -13.23 15.32 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 117.795 -1.098 . . . . 50.509999999999998 112.857 179.26 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.755 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 95.9 m-20 79.66 25.16 0.41 Allowed 'General case' 0 C--O 1.247 0.959 0 CA-C-N 121.461 1.937 . . . . 50.549999999999997 107.075 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 59' ' ' TYR . 27.3 mm -58.58 118.61 2.53 Favored 'Isoleucine or valine' 0 C--O 1.266 1.974 0 CA-C-O 115.185 -2.341 . . . . 50.509999999999998 106.658 175.859 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 60' ' ' ASN . 24.5 mm100 -110.99 -169.24 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.509 2.411 . . . . 50.549999999999997 117.509 -176.826 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -72.2 127.21 31.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 120.0 3.333 . . . . 50.509999999999998 120.0 -176.981 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 55.77 57.17 5.42 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 112.51 -2.132 . . . . 50.619999999999997 112.075 179.492 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 3' ' ' ILE . 26.3 m -104.51 165.49 11.02 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 105.232 -2.136 . . . . 50.509999999999998 105.232 174.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.8 m -115.99 112.7 22.2 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 116.272 1.953 . . . . 50.509999999999998 116.272 175.958 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 56.1 mt -81.7 156.73 24.89 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.652 -2.594 . . . . 50.509999999999998 110.944 175.058 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 21.4 t-160 -102.66 129.56 49.29 Favored 'General case' 0 C--N 1.284 -2.267 0 O-C-N 127.303 2.877 . . . . 50.509999999999998 108.741 177.914 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -102.22 123.01 45.31 Favored 'General case' 0 C--O 1.283 2.838 0 CA-C-O 117.607 -1.187 . . . . 50.509999999999998 111.13 176.573 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.94 140.01 45.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 106.129 -1.804 . . . . 50.509999999999998 106.129 175.073 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -87.42 131.13 34.41 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.402 2.371 . . . . 50.509999999999998 117.402 178.462 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.488 ' NH2' ' O ' ' A' ' 39' ' ' ASP . 63.9 ttp85 -103.25 93.0 4.75 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 102.12 -3.289 . . . . 50.640000000000001 102.12 177.214 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.0 mt -76.29 151.15 36.83 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 125.877 1.986 . . . . 50.509999999999998 112.404 -179.306 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -98.22 90.91 5.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 113.767 -1.561 . . . . 50.640000000000001 110.368 -179.564 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.01 174.03 18.02 Favored Glycine 0 C--O 1.243 0.716 0 CA-C-N 114.619 -1.173 . . . . 50.509999999999998 110.56 179.331 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 CA-C-O 116.364 -2.353 . . . . 50.509999999999998 115.967 179.282 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.992 0.738 . . . . 50.509999999999998 112.992 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.58 106.94 9.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 126.973 2.671 . . . . 50.549999999999997 111.748 178.306 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.5 pt -114.26 155.73 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 CA-C-O 115.983 -1.96 . . . . 50.509999999999998 113.24 173.276 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -119.93 132.41 55.51 Favored 'General case' 0 N--CA 1.511 2.62 1 O-C-N 130.523 4.889 . . . . 50.509999999999998 112.064 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' HB ' ' CG1' ' A' ' 13' ' ' ILE . 70.8 t -108.49 134.02 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 113.412 -3.185 . . . . 50.509999999999998 112.244 175.773 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -94.46 118.68 32.02 Favored 'General case' 0 N--CA 1.503 2.22 1 O-C-N 129.329 4.143 . . . . 50.509999999999998 106.07 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -98.48 161.28 13.76 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 117.753 -1.117 . . . . 50.509999999999998 110.633 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -54.82 -33.43 61.6 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.877 1.436 . . . . 50.509999999999998 114.877 -177.95 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 9' ' ' THR . 54.0 m -71.16 -20.77 62.26 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 115.689 -2.404 . . . . 50.509999999999998 113.117 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.56 -10.97 38.99 Favored Glycine 0 C--N 1.297 -1.602 0 O-C-N 120.144 -1.598 . . . . 50.509999999999998 116.312 179.843 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -69.22 117.6 11.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 116.868 -1.539 . . . . 50.509999999999998 110.608 174.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.2 m -73.51 126.55 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 126.659 2.475 . . . . 50.509999999999998 111.716 176.201 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.486 ' CG1' ' HB ' ' A' ' 5' ' ' VAL . 14.1 pt -104.58 142.4 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 127.432 2.958 . . . . 50.509999999999998 112.531 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.8 m -106.34 142.04 36.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 117.294 -1.763 . . . . 50.509999999999998 112.363 178.112 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -131.01 133.8 46.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 115.49 -2.195 . . . . 50.509999999999998 113.451 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -100.57 139.88 35.63 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 129.163 4.04 . . . . 50.619999999999997 106.417 173.974 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.94 170.76 18.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 117.344 -177.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -115.27 138.13 23.43 Favored Pre-proline 0 C--N 1.315 -0.926 0 N-CA-C 103.36 -2.83 . . . . 50.619999999999997 103.36 174.642 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -55.02 -24.46 40.01 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 122.535 2.157 . . . . 50.509999999999998 111.957 177.706 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -79.01 -6.42 56.3 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 118.128 -0.939 . . . . 50.509999999999998 109.326 -177.611 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -72.55 122.55 21.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.092 2.627 . . . . 50.619999999999997 118.092 -178.954 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 26' ' ' VAL . 66.8 p -67.66 155.54 38.95 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.423 -1.325 . . . . 50.509999999999998 107.423 175.71 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 54' ' ' ARG . 25.6 mm -58.12 -23.74 22.31 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 127.191 2.807 . . . . 50.509999999999998 107.383 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.34 -39.99 67.72 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.471 -0.768 . . . . 50.619999999999997 110.918 177.097 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -70.7 -20.67 62.65 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.292 1.037 . . . . 50.549999999999997 108.258 -179.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 22' ' ' THR . 90.6 t -71.35 -57.52 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 101.293 -3.595 . . . . 50.509999999999998 101.293 178.579 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 93.6 mttt -52.14 -38.47 57.65 Favored 'General case' 0 C--O 1.256 1.423 0 N-CA-C 114.456 1.28 . . . . 50.509999999999998 114.456 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.08 90.84 Favored 'General case' 0 C--O 1.278 2.591 0 CA-C-N 118.007 0.367 . . . . 50.509999999999998 110.322 176.869 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -60.61 -13.47 14.53 Favored 'General case' 0 C--O 1.254 1.309 0 N-CA-C 118.576 2.806 . . . . 50.509999999999998 118.576 176.028 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -90.99 -40.41 12.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 C-N-CA 119.565 -0.854 . . . . 50.509999999999998 110.04 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.561 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 31.3 tt0 -54.15 -31.98 54.01 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 125.656 2.646 . . . . 50.549999999999997 116.229 179.474 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.04 -72.14 0.1 Allowed 'General case' 0 C--O 1.253 1.261 0 CA-C-N 113.627 -1.624 . . . . 50.619999999999997 109.717 179.092 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -78.94 -39.99 33.09 Favored 'General case' 0 C--O 1.279 2.632 0 C-N-CA 116.404 -2.119 . . . . 50.509999999999998 114.829 -175.745 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -88.19 -22.14 24.18 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 114.028 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 71.31 27.13 72.16 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 109.332 -1.507 . . . . 50.509999999999998 109.332 176.571 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.8 mt -96.66 118.62 64.99 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.856 -1.138 . . . . 50.509999999999998 107.968 179.711 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.8 Cg_exo -57.02 136.99 80.0 Favored 'Trans proline' 0 C--O 1.259 1.544 0 C-N-CA 123.149 2.566 . . . . 50.509999999999998 110.865 178.296 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.597 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.5 Cg_exo -57.25 -32.16 92.81 Favored 'Trans proline' 0 C--O 1.261 1.657 0 O-C-N 122.873 0.933 . . . . 50.509999999999998 113.391 -179.268 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -69.76 -21.8 63.4 Favored 'General case' 0 C--O 1.262 1.736 0 O-C-N 119.985 -1.697 . . . . 50.619999999999997 110.39 -177.443 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -93.91 18.16 10.97 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.52 -1.363 . . . . 50.549999999999997 110.421 178.662 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.495 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 71.7 mt-30 -111.49 139.57 46.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.3 2.0 . . . . 50.549999999999997 112.116 -177.584 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.73 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 37.5 ttm180 -119.97 126.61 51.28 Favored 'General case' 0 C--O 1.296 3.529 0 CA-C-O 116.708 -1.615 . . . . 50.640000000000001 108.393 172.147 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.3 mt -118.91 89.25 3.09 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 119.452 1.024 . . . . 50.509999999999998 112.257 -177.553 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.552 HD11 ' HD3' ' A' ' 42' ' ' ARG . 60.5 mt -98.51 128.85 49.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 O-C-N 125.255 1.597 . . . . 50.509999999999998 107.084 -177.63 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.682 ' CE2' HG12 ' A' ' 61' ' ' ILE . 87.3 t80 -136.33 124.6 23.21 Favored 'General case' 0 C--N 1.36 1.025 0 CA-C-N 114.498 -1.228 . . . . 50.509999999999998 110.627 177.646 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.38 36.84 20.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 112.221 -2.263 . . . . 50.509999999999998 113.255 177.332 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.47 25.15 63.84 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 128.455 2.931 . . . . 50.509999999999998 115.916 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.17 136.55 40.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 118.036 0.918 . . . . 50.509999999999998 110.82 177.621 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -73.45 128.24 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.05 0.844 . . . . 50.549999999999997 112.456 174.624 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.4 149.15 35.19 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 105.514 -2.032 . . . . 50.509999999999998 105.514 -175.903 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 82.5 tt0 -105.72 144.53 32.34 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.929 1.393 . . . . 50.619999999999997 113.456 -177.693 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 37.5 p30 -61.19 -35.51 77.35 Favored 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.099 1.76 . . . . 50.619999999999997 109.198 -175.749 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.496 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -91.48 20.94 38.03 Favored Glycine 0 CA--C 1.492 -1.403 0 C-N-CA 124.383 0.992 . . . . 50.509999999999998 115.55 -177.296 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.598 ' O ' HG12 ' A' ' 23' ' ' ILE . 86.5 mmt-85 -128.69 168.3 16.0 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 101.878 -3.378 . . . . 50.640000000000001 101.878 176.488 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -108.57 152.67 24.44 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 124.003 0.921 . . . . 50.509999999999998 108.842 177.085 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.7 mt -47.36 -39.42 15.06 Favored 'General case' 0 C--O 1.201 -1.462 0 O-C-N 124.087 0.867 . . . . 50.509999999999998 108.791 177.239 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -70.79 -27.71 64.11 Favored 'General case' 0 C--O 1.268 2.051 0 N-CA-C 116.35 1.981 . . . . 50.509999999999998 116.35 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -57.46 -27.18 62.24 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.496 1.141 . . . . 50.619999999999997 109.733 179.789 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 59.0 m-85 -87.06 -5.73 58.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 118.284 2.698 . . . . 50.509999999999998 118.284 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 59' ' ' TYR . 54.3 m-20 74.28 32.1 1.02 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.524 1.965 . . . . 50.549999999999997 111.521 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.682 HG12 ' CE2' ' A' ' 45' ' ' PHE . 69.5 mt -81.0 103.8 8.57 Favored 'Isoleucine or valine' 0 C--O 1.266 1.956 0 CA-C-O 115.206 -2.33 . . . . 50.509999999999998 110.464 175.849 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -103.84 -171.1 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 119.241 3.052 . . . . 50.549999999999997 119.241 -176.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 65.5 tttm -52.72 138.36 29.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.245 -2.131 . . . . 50.509999999999998 105.245 -176.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 46.6 mt-10 61.95 68.15 0.71 Allowed 'General case' 0 C--O 1.256 1.44 0 CA-C-N 112.492 -2.14 . . . . 50.619999999999997 115.36 179.549 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.408 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 51.0 m -136.06 138.82 42.54 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.786 -1.097 . . . . 50.509999999999998 109.749 174.813 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -114.39 132.31 56.27 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 118.841 -2.412 . . . . 50.509999999999998 113.919 175.886 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.0 mt -90.06 145.96 24.68 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.64 -2.6 . . . . 50.509999999999998 111.595 175.091 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -96.78 140.64 31.06 Favored 'General case' 0 C--N 1.284 -2.258 0 O-C-N 127.295 2.872 . . . . 50.509999999999998 106.937 177.89 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -106.07 116.0 31.18 Favored 'General case' 0 C--O 1.282 2.81 0 CA-C-O 117.656 -1.164 . . . . 50.509999999999998 113.338 176.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -120.28 138.33 51.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 119.533 1.06 . . . . 50.509999999999998 112.217 175.072 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.36 114.53 28.71 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.405 0.52 . . . . 50.509999999999998 112.405 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -89.08 111.63 22.42 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 113.365 -3.207 . . . . 50.640000000000001 104.738 177.198 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.59 131.62 36.2 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 125.819 1.949 . . . . 50.509999999999998 112.438 -179.359 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -88.07 77.62 8.33 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 113.757 -1.565 . . . . 50.640000000000001 113.193 -179.544 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.67 -147.62 16.67 Favored Glycine 0 C--O 1.242 0.597 0 N-CA-C 106.325 -2.71 . . . . 50.509999999999998 106.325 179.372 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 CA-C-O 116.329 -2.373 . . . . 50.509999999999998 109.025 179.196 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 mtt . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 118.833 -0.603 . . . . 50.509999999999998 110.318 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -105.25 112.49 25.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 126.937 2.648 . . . . 50.549999999999997 112.805 178.264 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.9 pt -114.42 139.79 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-O 115.984 -1.96 . . . . 50.509999999999998 112.339 173.288 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -96.2 145.78 25.25 Favored 'General case' 0 N--CA 1.512 2.66 1 O-C-N 130.43 4.831 . . . . 50.509999999999998 111.845 179.503 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 70.6 t -133.87 105.18 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.328 -3.225 . . . . 50.509999999999998 113.923 175.748 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -91.08 139.72 30.49 Favored 'General case' 0 N--CA 1.504 2.265 1 O-C-N 129.388 4.18 . . . . 50.509999999999998 120.678 -178.121 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -113.79 -168.87 1.41 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 115.052 1.501 . . . . 50.509999999999998 115.052 179.956 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -107.9 7.98 28.31 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 124.109 0.88 . . . . 50.509999999999998 111.005 -177.925 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -92.24 -14.88 28.27 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 102.41 -3.181 . . . . 50.509999999999998 102.41 179.975 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.89 10.72 29.87 Favored Glycine 0 C--N 1.297 -1.603 0 O-C-N 120.188 -1.57 . . . . 50.509999999999998 110.048 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.649 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 43.0 mtpt -90.8 154.51 19.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.86 -1.543 . . . . 50.509999999999998 113.116 175.003 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -126.8 122.63 35.33 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.706 2.504 . . . . 50.509999999999998 107.466 176.19 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.522 HG22 ' HG ' ' A' ' 15' ' ' LEU . 62.5 mt -99.11 136.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 115.182 -2.607 . . . . 50.509999999999998 108.76 179.775 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.9 m -127.24 104.18 7.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 104.209 -2.515 . . . . 50.509999999999998 104.209 178.092 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.522 ' HG ' HG22 ' A' ' 13' ' ' ILE . 46.2 mt -106.75 175.23 5.57 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.536 -2.173 . . . . 50.509999999999998 110.936 -179.197 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -125.64 137.95 53.89 Favored 'General case' 0 N--CA 1.5 2.058 1 O-C-N 129.164 4.04 . . . . 50.619999999999997 108.038 173.961 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -139.69 165.9 21.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 O-C-N 126.599 2.437 . . . . 50.509999999999998 110.623 -177.891 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.29 158.65 31.58 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 119.381 3.104 . . . . 50.619999999999997 119.381 174.647 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.88 -24.56 39.37 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.629 2.219 . . . . 50.509999999999998 111.91 177.686 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.8 m -110.42 25.71 11.49 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 119.98 3.326 . . . . 50.509999999999998 119.98 -177.543 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -94.62 149.22 21.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 117.305 -1.758 . . . . 50.619999999999997 107.26 -179.038 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -92.97 148.46 21.98 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.799 -0.637 . . . . 50.509999999999998 109.688 175.752 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.6 mm -44.94 -39.6 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 O-C-N 127.155 2.784 . . . . 50.509999999999998 115.021 175.785 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.87 -36.73 77.53 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.407 -0.808 . . . . 50.619999999999997 111.367 177.009 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -67.35 -34.07 76.56 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.358 1.063 . . . . 50.549999999999997 110.821 -179.589 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -71.16 -46.11 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 125.048 1.467 . . . . 50.509999999999998 112.878 178.571 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HG2' ' OE1' ' A' ' 41' ' ' GLN . 53.7 mtmt -62.84 -32.1 73.26 Favored 'General case' 0 C--O 1.255 1.352 0 N-CA-C 107.084 -1.45 . . . . 50.509999999999998 107.084 -179.753 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -56.75 17.61 Favored 'General case' 0 C--O 1.279 2.615 0 N-CA-C 114.575 1.324 . . . . 50.509999999999998 114.575 176.828 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -46.24 -49.18 17.58 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 120.387 -1.445 . . . . 50.509999999999998 109.911 176.054 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.84 -42.5 63.01 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 118.32 2.711 . . . . 50.509999999999998 118.32 179.896 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.406 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 61.8 tt0 -57.96 -45.51 86.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 125.662 2.648 . . . . 50.549999999999997 104.618 179.446 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.74 -25.13 61.93 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 116.353 1.982 . . . . 50.619999999999997 116.353 179.164 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -89.63 -58.61 2.46 Favored 'General case' 0 C--O 1.279 2.64 0 O-C-N 119.325 -2.109 . . . . 50.509999999999998 113.879 -175.683 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.649 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 74.2 mm-40 -103.93 -24.91 13.21 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 123.058 2.663 . . . . 50.619999999999997 110.631 179.868 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 105.52 20.11 9.85 Favored Glycine 0 CA--C 1.478 -2.274 0 N-CA-C 120.393 2.917 . . . . 50.509999999999998 120.393 176.52 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.483 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 72.9 mt -86.18 134.41 38.75 Favored Pre-proline 0 C--O 1.244 0.792 0 C-N-CA 118.854 -1.138 . . . . 50.509999999999998 110.05 179.738 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -57.07 136.99 79.88 Favored 'Trans proline' 0 C--O 1.26 1.603 0 C-N-CA 123.194 2.596 . . . . 50.509999999999998 110.877 178.361 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.3 Cg_exo -57.13 -32.26 92.83 Favored 'Trans proline' 0 C--O 1.261 1.645 0 C-N-CA 120.731 0.954 . . . . 50.509999999999998 113.411 -179.306 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.79 -27.04 60.15 Favored 'General case' 0 C--O 1.261 1.698 0 N-CA-C 116.268 1.951 . . . . 50.619999999999997 116.268 -177.429 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.545 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 80.1 mt-30 -73.65 -21.59 60.24 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.567 -1.333 . . . . 50.549999999999997 109.995 178.686 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.602 ' HB3' HD11 ' A' ' 69' ' ' LEU . 71.8 mt-30 -70.56 118.28 13.16 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 124.36 2.028 . . . . 50.549999999999997 115.678 -177.613 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -113.81 121.4 43.92 Favored 'General case' 0 C--O 1.295 3.498 0 CA-C-O 116.621 -1.657 . . . . 50.640000000000001 109.303 172.098 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 mt -96.49 127.49 42.53 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 119.447 1.021 . . . . 50.509999999999998 112.907 -177.422 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.51 119.3 57.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 N-CA-C 115.056 1.502 . . . . 50.509999999999998 115.056 -177.623 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -145.35 121.44 10.76 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 104.741 -2.318 . . . . 50.509999999999998 104.741 177.608 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.0 39.8 3.12 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.208 -2.269 . . . . 50.509999999999998 107.961 177.41 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.47 11.24 4.99 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 128.417 2.913 . . . . 50.509999999999998 115.701 -179.606 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -115.92 126.67 54.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 119.27 3.063 . . . . 50.509999999999998 119.27 177.633 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -41.56 120.82 1.55 Allowed 'General case' 0 C--O 1.259 1.597 0 N-CA-C 120.047 3.351 . . . . 50.549999999999997 120.047 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 2.1 mp -82.35 123.59 29.24 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 117.751 -1.118 . . . . 50.509999999999998 109.737 -175.936 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.15 140.06 48.63 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.62 1.711 . . . . 50.619999999999997 115.62 -177.645 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -54.51 -53.02 59.94 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 126.148 1.779 . . . . 50.619999999999997 110.458 -175.776 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.17 -7.74 60.48 Favored Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 116.531 1.373 . . . . 50.509999999999998 116.531 -177.229 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -76.45 176.48 8.21 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 116.466 2.024 . . . . 50.640000000000001 116.466 176.538 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.6 p -112.44 164.83 12.81 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.055 -1.831 . . . . 50.509999999999998 106.055 177.148 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD22 ' CD1' ' A' ' 61' ' ' ILE . 65.5 mt -68.64 -36.17 78.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 106.573 -1.64 . . . . 50.509999999999998 106.573 177.279 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -65.51 -31.48 72.58 Favored 'General case' 0 C--O 1.267 1.995 0 C-N-CA 117.34 -1.744 . . . . 50.509999999999998 112.392 -179.491 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -47.37 -37.48 11.27 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.515 1.15 . . . . 50.619999999999997 111.902 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 92.5 m-85 -96.12 -11.32 26.42 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 117.757 -1.116 . . . . 50.509999999999998 113.147 179.216 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 32.5 t30 78.58 47.46 0.04 OUTLIER 'General case' 0 C--O 1.248 1.0 0 CA-C-N 121.464 1.938 . . . . 50.549999999999997 113.949 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.412 ' CD1' HD22 ' A' ' 56' ' ' LEU . 73.8 mt -85.07 112.49 22.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.965 0 CA-C-O 115.243 -2.313 . . . . 50.509999999999998 109.183 175.873 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -114.69 -171.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 126.059 2.099 . . . . 50.549999999999997 108.661 -176.869 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.1 tttp -59.59 145.2 45.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.255 1.502 . . . . 50.509999999999998 110.307 -176.948 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 34.6 mt-10 66.36 10.22 7.07 Favored 'General case' 0 C--O 1.258 1.507 0 N-CA-C 118.578 2.807 . . . . 50.619999999999997 118.578 179.57 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -74.32 138.05 43.25 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.845 -1.071 . . . . 50.509999999999998 112.668 174.796 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -112.05 128.47 56.2 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 115.14 1.533 . . . . 50.509999999999998 115.14 175.934 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 94.5 mt -103.47 138.93 39.51 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 114.635 -2.602 . . . . 50.509999999999998 107.85 175.072 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -96.33 143.56 27.29 Favored 'General case' 0 C--N 1.284 -2.273 0 O-C-N 127.374 2.921 . . . . 50.509999999999998 106.491 177.885 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.602 HD11 ' HB3' ' A' ' 41' ' ' GLN . 37.7 tp -110.86 115.86 30.25 Favored 'General case' 0 C--O 1.282 2.779 0 CA-C-O 117.733 -1.127 . . . . 50.509999999999998 112.625 176.572 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.62 143.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 119.541 1.064 . . . . 50.509999999999998 110.495 175.066 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 54.9 mt -101.61 102.85 13.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 117.019 2.229 . . . . 50.509999999999998 117.019 178.522 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -73.76 101.54 3.73 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-O 113.34 -3.219 . . . . 50.640000000000001 110.824 177.207 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.9 163.5 3.41 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.891 1.995 . . . . 50.509999999999998 112.581 -179.274 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.97 74.39 1.53 Allowed 'General case' 0 C--O 1.244 0.804 0 N-CA-C 105.945 -1.872 . . . . 50.640000000000001 105.945 -179.614 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.27 131.56 3.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 106.202 -2.759 . . . . 50.509999999999998 106.202 179.389 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.497 0 CA-C-O 116.331 -2.372 . . . . 50.509999999999998 116.984 179.311 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.509999999999998 111.006 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.549999999999997 116.688 178.266 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.509999999999998 111.74 173.324 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.509999999999998 115.113 179.52 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.509999999999998 107.106 175.824 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.509999999999998 103.747 -178.117 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.509999999999998 107.547 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.509999999999998 105.417 -177.96 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.509999999999998 110.637 179.919 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.509999999999998 119.029 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.509999999999998 114.413 174.998 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 113.052 176.185 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.509999999999998 114.549 179.78 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.509999999999998 111.59 178.086 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.509999999999998 110.023 -179.207 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.619999999999997 111.711 173.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 110.993 -177.951 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.619999999999997 108.19 174.632 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.509999999999998 111.964 177.711 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.509999999999998 113.164 -177.552 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.619999999999997 108.919 -179.0 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.509999999999998 108.06 175.711 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.509999999999998 117.251 175.811 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.619999999999997 111.876 176.964 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 110.173 -179.603 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.509999999999998 109.312 178.599 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.509999999999998 106.896 -179.77 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.509999999999998 114.569 176.92 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 176.011 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.423 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.509999999999998 104.805 179.898 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 40.0 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.549999999999997 111.202 179.415 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.619999999999997 113.082 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.509999999999998 116.338 -175.645 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.619999999999997 113.877 179.862 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.509999999999998 105.347 176.537 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.509999999999998 107.204 179.761 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.509999999999998 110.872 178.293 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.303 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.619999999999997 115.506 -177.444 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.549999999999997 113.269 178.741 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.608 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.549999999999997 109.19 -177.64 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.640000000000001 104.765 172.138 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.509999999999998 109.582 -177.498 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.509999999999998 112.344 -177.583 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.509999999999998 107.281 177.627 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.509999999999998 104.493 177.379 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 118.709 -179.624 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.509999999999998 114.674 177.718 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.549999999999997 109.652 174.548 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.509999999999998 110.096 -175.862 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.619999999999997 111.682 -177.729 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.619999999999997 118.573 -175.763 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.509999999999998 109.54 -177.249 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.640000000000001 110.879 176.534 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.509999999999998 116.693 177.156 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.509999999999998 110.756 177.237 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.509999999999998 119.247 -179.485 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.619999999999997 116.794 179.805 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.509999999999998 117.56 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.549999999999997 116.376 179.895 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 HD12 ' A' ' 56' ' ' LEU . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 115.487 175.861 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.549999999999997 107.756 -176.828 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.509999999999998 114.348 -176.929 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.619999999999997 107.384 179.576 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.509999999999998 106.402 174.815 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.509999999999998 110.362 175.94 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.509999999999998 107.602 175.106 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.509999999999998 109.96 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.509999999999998 108.197 176.547 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.509999999999998 102.361 175.117 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.509999999999998 113.908 178.441 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.640000000000001 110.488 177.138 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.509999999999998 104.971 -179.332 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.640000000000001 109.517 -179.572 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.509999999999998 111.861 179.397 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.509999999999998 108.119 179.238 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.547 0.857 0 CA-C-O 118.772 -0.632 . . . . 50.509999999999998 111.006 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -94.62 115.62 27.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 126.925 2.64 . . . . 50.549999999999997 116.688 178.266 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.52 172.18 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-O 115.956 -1.973 . . . . 50.509999999999998 111.74 173.324 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.5 148.18 38.27 Favored 'General case' 0 N--CA 1.511 2.622 1 O-C-N 130.461 4.85 . . . . 50.509999999999998 115.113 179.52 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.7 t -122.21 77.43 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 113.445 -3.169 . . . . 50.509999999999998 107.106 175.824 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -73.09 128.48 35.61 Favored 'General case' 0 N--CA 1.505 2.281 1 O-C-N 129.358 4.161 . . . . 50.509999999999998 103.747 -178.117 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -98.4 175.48 6.03 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.547 -1.279 . . . . 50.509999999999998 107.547 179.921 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -92.57 29.05 1.82 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 105.417 -2.068 . . . . 50.509999999999998 105.417 -177.96 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -126.83 -11.97 5.99 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 115.739 -2.384 . . . . 50.509999999999998 110.637 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.2 -15.13 18.43 Favored Glycine 0 C--N 1.296 -1.644 0 N-CA-C 119.029 2.372 . . . . 50.509999999999998 119.029 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -82.33 137.11 34.87 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 116.881 -1.533 . . . . 50.509999999999998 114.413 174.998 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -119.33 127.48 53.22 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 113.052 176.185 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.52 HG23 ' HB ' ' A' ' 5' ' ' VAL . 2.7 tt -122.73 125.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 127.493 2.996 . . . . 50.509999999999998 114.549 179.78 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -81.24 146.38 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.247 -1.781 . . . . 50.509999999999998 111.59 178.086 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.93 136.95 42.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 115.469 -2.205 . . . . 50.509999999999998 110.023 -179.207 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.69 131.35 35.26 Favored 'General case' 0 N--CA 1.499 1.999 1 O-C-N 129.296 4.123 . . . . 50.619999999999997 111.711 173.943 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.05 131.64 6.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.227 0 O-C-N 127.728 3.143 . . . . 50.509999999999998 110.993 -177.951 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.04 146.94 37.48 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 112.188 -2.278 . . . . 50.619999999999997 108.19 174.632 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.9 -24.49 39.22 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.645 2.23 . . . . 50.509999999999998 111.964 177.711 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -83.92 4.32 30.12 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 118.153 -0.927 . . . . 50.509999999999998 113.164 -177.552 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -90.88 124.0 34.84 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.459 -1.697 . . . . 50.619999999999997 108.919 -179.0 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 p -66.94 150.7 48.85 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.06 -1.089 . . . . 50.509999999999998 108.06 175.711 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 23' ' ' ILE . 30.0 mm -54.64 -19.12 3.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 127.139 2.774 . . . . 50.509999999999998 117.251 175.811 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -78.32 -38.52 42.08 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.517 -0.739 . . . . 50.619999999999997 111.876 176.964 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.41 -42.13 75.46 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 110.173 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.95 -48.77 86.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 125.076 1.485 . . . . 50.509999999999998 109.312 178.599 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 88.7 mttt -55.74 -36.8 67.66 Favored 'General case' 0 C--O 1.257 1.473 0 N-CA-C 106.896 -1.52 . . . . 50.509999999999998 106.896 -179.77 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 -16.34 61.07 Favored 'General case' 0 C--O 1.278 2.566 0 N-CA-C 114.569 1.322 . . . . 50.509999999999998 114.569 176.92 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -75.53 -37.35 60.11 Favored 'General case' 0 C--O 1.254 1.333 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 176.011 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.423 ' CG2' HE22 ' A' ' 41' ' ' GLN . 60.3 mt -64.88 -38.07 81.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 N-CA-C 104.805 -2.294 . . . . 50.509999999999998 104.805 179.898 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 38' ' ' PRO . 40.0 tt0 -50.55 -50.18 54.09 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 125.68 2.657 . . . . 50.549999999999997 111.202 179.415 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.29 -44.45 97.2 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-N 113.629 -1.623 . . . . 50.619999999999997 113.082 179.182 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 11.3 mmpt? -81.8 -40.65 22.26 Favored 'General case' 0 C--O 1.278 2.596 0 C-N-CA 116.491 -2.083 . . . . 50.509999999999998 116.338 -175.645 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.33 -42.93 10.67 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 123.059 2.663 . . . . 50.619999999999997 113.877 179.862 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.83 -2.09 33.87 Favored Glycine 0 CA--C 1.478 -2.273 0 N-CA-C 105.347 -3.101 . . . . 50.509999999999998 105.347 176.537 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 57.3 mt -85.33 130.92 49.77 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 107.204 -1.406 . . . . 50.509999999999998 107.204 179.761 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.5 Cg_exo -56.99 137.01 80.07 Favored 'Trans proline' 0 C--O 1.259 1.54 0 C-N-CA 123.179 2.586 . . . . 50.509999999999998 110.872 178.293 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 31' ' ' GLN . 87.0 Cg_exo -57.23 -32.19 92.88 Favored 'Trans proline' 0 C--O 1.262 1.697 0 O-C-N 122.9 0.947 . . . . 50.509999999999998 113.407 -179.303 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -62.14 -11.9 16.81 Favored 'General case' 0 C--O 1.263 1.814 0 O-C-N 119.966 -1.709 . . . . 50.619999999999997 115.506 -177.444 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -105.53 10.9 32.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.499 -1.375 . . . . 50.549999999999997 113.269 178.741 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.608 ' HB3' HD11 ' A' ' 69' ' ' LEU . 72.0 mt-30 -106.61 129.25 54.56 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 124.39 2.043 . . . . 50.549999999999997 109.19 -177.64 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 75.5 mtp180 -107.32 135.28 49.09 Favored 'General case' 0 C--O 1.296 3.551 0 N-CA-C 104.765 -2.309 . . . . 50.640000000000001 104.765 172.138 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' A' ' 50' ' ' LEU . 35.2 mt -113.32 115.17 27.72 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 119.476 1.035 . . . . 50.509999999999998 109.582 -177.498 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.2 mm -111.74 127.91 68.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.714 0 O-C-N 125.136 1.522 . . . . 50.509999999999998 112.344 -177.583 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -135.59 118.93 16.73 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.281 -1.377 . . . . 50.509999999999998 107.281 177.627 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 43.78 29.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.493 -2.41 . . . . 50.509999999999998 104.493 177.379 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.48 48.25 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 118.709 -179.624 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -104.07 145.63 29.89 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.674 1.361 . . . . 50.509999999999998 114.674 177.718 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.23 132.41 44.05 Favored 'General case' 0 C--O 1.259 1.602 0 O-C-N 123.958 0.786 . . . . 50.549999999999997 109.652 174.548 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 43' ' ' LEU . 76.0 mt -98.4 125.26 43.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 117.763 -1.113 . . . . 50.509999999999998 110.096 -175.862 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -83.39 143.02 30.58 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.79 1.306 . . . . 50.619999999999997 111.682 -177.729 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -64.37 -35.74 81.86 Favored 'General case' 0 C--O 1.264 1.864 0 N-CA-C 118.573 2.805 . . . . 50.619999999999997 118.573 -175.763 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.14 33.07 5.07 Favored Glycine 0 CA--C 1.493 -1.331 0 N-CA-C 109.54 -1.424 . . . . 50.509999999999998 109.54 -177.249 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -120.41 167.84 11.92 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.026 -1.867 . . . . 50.640000000000001 110.879 176.534 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.6 p -102.33 171.11 7.66 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 116.693 2.109 . . . . 50.509999999999998 116.693 177.156 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 61' ' ' ILE . 18.0 tp -63.1 -46.33 87.85 Favored 'General case' 0 C--O 1.202 -1.397 0 O-C-N 124.154 0.909 . . . . 50.509999999999998 110.756 177.237 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -66.89 -29.28 69.14 Favored 'General case' 0 C--O 1.268 2.041 0 N-CA-C 119.247 3.054 . . . . 50.509999999999998 119.247 -179.485 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -53.92 -33.66 57.34 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 116.794 2.146 . . . . 50.619999999999997 116.794 179.805 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -90.2 9.68 27.56 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 117.56 2.43 . . . . 50.509999999999998 117.56 179.269 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.29 25.43 8.8 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 116.376 1.991 . . . . 50.549999999999997 116.376 179.895 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 HD12 ' A' ' 56' ' ' LEU . 69.2 mt -74.14 110.29 7.94 Favored 'Isoleucine or valine' 0 C--O 1.266 1.928 0 CA-C-O 115.275 -2.298 . . . . 50.509999999999998 115.487 175.861 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -94.96 -175.28 3.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 126.094 2.121 . . . . 50.549999999999997 107.756 -176.828 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.42 143.23 57.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 123.17 1.462 . . . . 50.509999999999998 114.348 -176.929 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 45.16 74.35 0.13 Allowed 'General case' 0 C--O 1.256 1.399 0 CA-C-N 112.506 -2.134 . . . . 50.619999999999997 107.384 179.576 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -106.55 153.34 22.47 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.402 -1.703 . . . . 50.509999999999998 106.402 174.815 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.1 m -101.1 131.65 46.93 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 118.285 -0.864 . . . . 50.509999999999998 110.362 175.94 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 tp -110.93 137.76 48.16 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 114.764 -2.541 . . . . 50.509999999999998 107.602 175.106 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -96.88 129.99 44.24 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 127.381 2.926 . . . . 50.509999999999998 109.96 177.938 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 41' ' ' GLN . 39.2 tp -95.86 140.14 31.06 Favored 'General case' 0 C--O 1.283 2.819 0 CA-C-O 117.673 -1.156 . . . . 50.509999999999998 108.197 176.547 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 85.2 t -118.61 145.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 102.361 -3.2 . . . . 50.509999999999998 102.361 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -107.48 98.96 8.51 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.908 1.077 . . . . 50.509999999999998 113.908 178.441 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -90.49 101.41 14.15 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 113.417 -3.182 . . . . 50.640000000000001 110.488 177.138 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -78.85 173.89 12.04 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.971 -2.233 . . . . 50.509999999999998 104.971 -179.332 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -97.62 118.02 33.21 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 113.718 -1.583 . . . . 50.640000000000001 109.517 -179.572 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.15 -155.24 28.45 Favored Glycine 0 C--O 1.243 0.698 0 CA-C-N 114.626 -1.17 . . . . 50.509999999999998 111.861 179.397 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 CA-C-O 116.346 -2.363 . . . . 50.509999999999998 108.119 179.238 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 108.426 -0.953 . . . . 50.509999999999998 108.426 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -94.3 140.95 29.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 126.951 2.657 . . . . 50.549999999999997 106.368 178.272 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -126.22 -179.35 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-O 116.017 -1.944 . . . . 50.509999999999998 109.918 173.348 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -129.91 101.28 5.78 Favored 'General case' 0 N--CA 1.512 2.626 1 O-C-N 130.414 4.821 . . . . 50.509999999999998 114.319 179.567 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.25 123.7 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 113.488 -3.149 . . . . 50.509999999999998 110.223 175.79 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -117.24 118.42 32.23 Favored 'General case' 0 N--CA 1.504 2.255 1 O-C-N 129.291 4.119 . . . . 50.509999999999998 112.111 -178.079 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 9' ' ' THR . 5.1 t -104.0 167.38 9.8 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 116.911 2.189 . . . . 50.509999999999998 116.911 179.982 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.97 -17.79 63.98 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.807 1.78 . . . . 50.509999999999998 115.807 -178.008 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.511 ' H ' HG23 ' A' ' 7' ' ' THR . 53.3 p -89.25 1.7 55.33 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 115.767 -2.373 . . . . 50.509999999999998 109.718 179.889 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.95 -4.28 85.63 Favored Glycine 0 C--N 1.296 -1.655 0 O-C-N 120.115 -1.616 . . . . 50.509999999999998 117.096 179.84 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -67.5 110.0 3.46 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 116.825 -1.56 . . . . 50.509999999999998 109.337 174.976 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -81.38 133.74 35.46 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 126.665 2.478 . . . . 50.509999999999998 114.41 176.175 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.87 138.24 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 127.38 2.925 . . . . 50.509999999999998 118.105 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.3 m -106.96 130.0 54.68 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.222 -1.791 . . . . 50.509999999999998 111.438 178.138 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.428 HD11 ' CB ' ' A' ' 29' ' ' LYS . 49.3 tp -115.74 152.19 33.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 115.479 -2.201 . . . . 50.509999999999998 114.636 -179.279 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -115.01 107.48 15.42 Favored 'General case' 0 N--CA 1.5 2.04 1 O-C-N 129.273 4.108 . . . . 50.619999999999997 114.466 173.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.427 HG13 ' HG ' ' A' ' 15' ' ' LEU . 21.0 m -126.55 150.58 32.38 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 O-C-N 127.849 3.218 . . . . 50.509999999999998 118.53 -177.869 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 76.3 mt-10 -87.31 152.12 52.13 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 117.776 2.51 . . . . 50.619999999999997 117.776 174.655 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.95 -24.46 39.44 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.556 2.171 . . . . 50.509999999999998 111.946 177.715 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 p -107.6 37.77 2.33 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 116.229 1.937 . . . . 50.509999999999998 116.229 -177.54 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -105.01 148.54 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 117.321 -1.751 . . . . 50.619999999999997 109.822 -178.965 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -92.88 159.57 15.3 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.087 -1.449 . . . . 50.509999999999998 107.087 175.728 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.12 -40.58 74.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 O-C-N 127.234 2.834 . . . . 50.509999999999998 108.203 175.801 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 52.0 mt-10 -54.08 -13.49 0.82 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.301 1.222 . . . . 50.619999999999997 114.301 177.015 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.35 -18.87 10.37 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 115.062 1.505 . . . . 50.549999999999997 115.062 -179.608 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.85 -57.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 101.545 -3.502 . . . . 50.509999999999998 101.545 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -57.09 -24.68 55.72 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 115.77 -0.65 . . . . 50.509999999999998 111.547 -179.775 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.68 -6.61 57.52 Favored 'General case' 0 C--O 1.278 2.553 0 N-CA-C 117.612 2.449 . . . . 50.509999999999998 117.612 176.862 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' CB ' HD11 ' A' ' 15' ' ' LEU . 63.3 mttp -91.9 -30.25 16.24 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 102.818 -3.03 . . . . 50.509999999999998 102.818 176.037 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.97 -45.0 98.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 103.108 -2.923 . . . . 50.509999999999998 103.108 179.858 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -52.09 -50.84 60.81 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 125.608 2.623 . . . . 50.549999999999997 108.453 179.419 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -56.66 -14.46 3.27 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 113.612 -1.631 . . . . 50.619999999999997 115.384 179.062 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 33' ' ' LYS . 31.2 mmmt -117.46 -50.09 2.55 Favored 'General case' 0 C--O 1.279 2.64 0 C-N-CA 116.465 -2.094 . . . . 50.509999999999998 111.468 -175.688 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -94.93 -8.46 37.0 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 123.037 2.653 . . . . 50.619999999999997 111.17 179.853 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.05 29.25 69.16 Favored Glycine 0 CA--C 1.477 -2.313 0 N-CA-C 107.777 -2.129 . . . . 50.509999999999998 107.777 176.518 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.61 122.74 45.09 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 105.386 -2.079 . . . . 50.509999999999998 105.386 179.75 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.6 Cg_exo -56.95 136.96 79.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 123.177 2.584 . . . . 50.509999999999998 110.913 178.328 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.9 Cg_exo -57.14 -32.19 92.67 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 120.713 0.942 . . . . 50.509999999999998 113.428 -179.347 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.38 -14.42 27.57 Favored 'General case' 0 C--O 1.262 1.723 0 N-CA-C 115.691 1.737 . . . . 50.619999999999997 115.691 -177.383 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -100.66 13.38 34.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.416 1.636 . . . . 50.549999999999997 115.416 178.788 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -116.42 133.12 56.38 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 124.363 2.03 . . . . 50.549999999999997 114.944 -177.592 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -116.97 124.77 50.17 Favored 'General case' 0 C--O 1.296 3.516 0 N-CA-C 105.245 -2.132 . . . . 50.640000000000001 105.245 172.145 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.83 133.86 49.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 105.735 -1.95 . . . . 50.509999999999998 105.735 -177.582 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.3 mt -121.55 123.47 69.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.159 1.537 . . . . 50.509999999999998 111.155 -177.615 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -134.58 127.78 31.95 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 114.477 -1.238 . . . . 50.509999999999998 111.214 177.625 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.28 20.31 5.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.292 -2.231 . . . . 50.509999999999998 114.468 177.354 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.2 -8.25 67.13 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 120.673 3.029 . . . . 50.509999999999998 120.673 -179.589 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -98.67 144.68 27.68 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 118.052 0.926 . . . . 50.509999999999998 109.91 177.61 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -80.12 129.87 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.346 -2.835 . . . . 50.549999999999997 103.346 174.587 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.71 157.96 31.34 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 117.701 -1.142 . . . . 50.509999999999998 113.902 -175.911 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -100.66 154.23 18.76 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.131 -1.433 . . . . 50.619999999999997 107.131 -177.603 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 64.8 m-20 -72.02 -44.89 62.68 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 126.116 1.766 . . . . 50.619999999999997 111.718 -175.841 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.13 61.31 Favored Glycine 0 C--O 1.253 1.295 0 N-CA-C 120.191 2.836 . . . . 50.509999999999998 120.191 -177.249 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -95.87 169.05 10.26 Favored 'General case' 0 C--O 1.249 1.051 0 O-C-N 120.066 -1.843 . . . . 50.640000000000001 112.669 176.524 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 70.7 p -100.41 153.92 18.94 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 114.167 1.173 . . . . 50.509999999999998 114.167 177.082 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.8 mt -55.28 -30.84 60.92 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.238 0.962 . . . . 50.509999999999998 112.059 177.254 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -75.23 -28.89 60.08 Favored 'General case' 0 C--O 1.268 2.039 0 C-N-CA 117.375 -1.73 . . . . 50.509999999999998 109.422 -179.434 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 55' ' ' THR . 90.8 m-20 -53.44 -42.38 67.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.457 1.123 . . . . 50.619999999999997 112.401 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -91.18 20.15 5.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 117.779 -1.105 . . . . 50.509999999999998 113.266 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 m120 44.71 24.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 120.024 3.342 . . . . 50.549999999999997 120.024 179.976 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.19 127.92 34.63 Favored 'Isoleucine or valine' 0 C--O 1.266 1.939 0 N-CA-C 101.628 -3.471 . . . . 50.509999999999998 101.628 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' LYS . 44.8 mt-30 -132.37 159.98 37.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 125.946 2.029 . . . . 50.549999999999997 106.699 -176.795 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 62' ' ' GLN . 34.3 ttpt -43.09 146.61 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.707 -1.96 . . . . 50.509999999999998 105.707 -177.019 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 66.4 50.5 1.29 Allowed 'General case' 0 C--O 1.257 1.477 0 CA-C-N 112.5 -2.136 . . . . 50.619999999999997 114.734 179.558 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -124.91 142.97 51.11 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.827 -1.079 . . . . 50.509999999999998 108.436 174.847 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -91.91 135.52 33.87 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 118.276 -0.868 . . . . 50.509999999999998 109.119 175.87 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.2 mt -118.77 136.76 53.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 114.669 -2.586 . . . . 50.509999999999998 105.323 175.11 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -95.23 128.3 41.96 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 127.453 2.971 . . . . 50.509999999999998 112.17 177.899 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -94.45 119.26 32.89 Favored 'General case' 0 C--O 1.282 2.764 0 CA-C-O 117.71 -1.138 . . . . 50.509999999999998 113.789 176.557 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.07 140.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 103.676 -2.713 . . . . 50.509999999999998 103.676 175.084 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -111.39 135.12 52.39 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.023 1.12 . . . . 50.509999999999998 114.023 178.462 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -116.29 115.97 26.91 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 113.324 -3.227 . . . . 50.640000000000001 107.894 177.265 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.2 mt -99.75 168.17 10.09 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 117.876 2.547 . . . . 50.509999999999998 117.876 -179.334 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -77.26 123.36 26.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 113.739 -1.573 . . . . 50.640000000000001 109.597 -179.602 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 154.42 5.85 Favored Glycine 0 C--O 1.244 0.724 0 CA-C-N 114.605 -1.179 . . . . 50.509999999999998 114.458 179.37 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 CA-C-O 116.37 -2.35 . . . . 50.509999999999998 118.366 179.233 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtp . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 104.905 -2.257 . . . . 50.509999999999998 104.905 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -87.34 142.13 28.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 126.957 2.66 . . . . 50.549999999999997 109.191 178.32 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.86 174.03 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 116.012 -1.947 . . . . 50.509999999999998 105.937 173.324 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -122.88 126.47 47.37 Favored 'General case' 0 N--CA 1.513 2.688 1 O-C-N 129.858 4.474 . . . . 50.509999999999998 113.505 179.558 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 114.86 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 113.373 -3.203 . . . . 50.509999999999998 115.835 175.753 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -79.76 121.1 24.93 Favored 'General case' 0 N--CA 1.503 2.211 1 O-C-N 129.346 4.154 . . . . 50.509999999999998 118.167 -178.045 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.68 HG22 HD23 ' A' ' 69' ' ' LEU . 24.7 p -96.64 177.16 5.75 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 120.831 3.641 . . . . 50.509999999999998 120.831 179.917 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.84 17.73 4.62 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 124.072 0.858 . . . . 50.509999999999998 109.674 -178.014 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -124.18 14.49 9.06 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 115.741 -2.384 . . . . 50.509999999999998 112.587 179.929 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.09 14.95 81.29 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 107.75 -2.14 . . . . 50.509999999999998 107.75 179.807 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -104.91 147.1 28.12 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 116.831 -1.557 . . . . 50.509999999999998 112.915 174.977 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -119.01 134.8 54.97 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 126.637 2.461 . . . . 50.509999999999998 106.354 176.113 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.1 mt -97.37 147.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.477 2.986 . . . . 50.509999999999998 112.74 179.706 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 m -109.99 125.13 52.56 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.287 -1.765 . . . . 50.509999999999998 106.692 178.136 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -126.12 141.89 51.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.875 -2.268 . . . . 50.509999999999998 104.875 -179.27 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -116.45 112.51 21.54 Favored 'General case' 0 N--CA 1.5 2.034 1 O-C-N 129.243 4.089 . . . . 50.619999999999997 109.392 173.962 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 56' ' ' LEU . 33.8 m -106.97 171.42 2.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.214 0 O-C-N 127.694 3.121 . . . . 50.509999999999998 114.6 -177.943 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 75.9 tt0 -111.3 143.15 27.84 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 112.21 -2.268 . . . . 50.619999999999997 106.057 174.556 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 85.2 Cg_exo -55.0 -24.44 39.78 Favored 'Trans proline' 0 C--N 1.32 -0.933 0 C-N-CA 122.564 2.176 . . . . 50.509999999999998 111.953 177.737 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -82.13 -17.8 45.14 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 114.348 1.24 . . . . 50.509999999999998 114.348 -177.537 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.93 163.42 27.49 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.451 -1.7 . . . . 50.619999999999997 112.123 -179.04 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.3 p -95.62 -165.48 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.876 -0.602 . . . . 50.509999999999998 111.085 175.7 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -87.01 -40.86 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 O-C-N 127.171 2.794 . . . . 50.509999999999998 108.181 175.716 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 16.8 tp10 -52.46 -42.56 64.31 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 107.534 -1.284 . . . . 50.619999999999997 107.534 177.021 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.17 -49.77 72.97 Favored 'General case' 0 C--O 1.249 1.038 0 C-N-CA 124.352 1.061 . . . . 50.549999999999997 113.405 -179.656 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 22' ' ' THR . 91.1 t -57.78 -42.65 82.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.999 1.437 . . . . 50.509999999999998 111.95 178.645 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.615 ' HE2' ' HG ' ' A' ' 43' ' ' LEU . 93.3 mttt -65.95 -37.06 85.03 Favored 'General case' 0 C--O 1.257 1.481 0 N-CA-C 106.535 -1.654 . . . . 50.509999999999998 106.535 -179.693 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 31' ' ' GLN . . . -63.88 -45.19 90.53 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 113.186 0.809 . . . . 50.509999999999998 113.186 176.911 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -44.18 -36.7 2.77 Favored 'General case' 0 C--O 1.255 1.348 0 O-C-N 120.375 -1.453 . . . . 50.509999999999998 108.8 175.973 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.458 HG21 HE22 ' A' ' 41' ' ' GLN . 58.8 mt -72.88 -33.44 43.58 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 C-N-CA 119.487 -0.885 . . . . 50.509999999999998 110.492 179.895 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 55.4 tt0 -54.95 -41.61 71.29 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 125.581 2.61 . . . . 50.549999999999997 108.434 179.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.73 -20.53 57.03 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 113.631 -1.622 . . . . 50.619999999999997 115.104 179.173 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 31.0 mmmt -110.37 -36.15 5.87 Favored 'General case' 0 C--O 1.279 2.646 0 C-N-CA 116.413 -2.115 . . . . 50.509999999999998 110.828 -175.703 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -92.55 -54.79 3.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 123.121 2.691 . . . . 50.619999999999997 108.627 179.861 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 18.77 4.06 Favored Glycine 0 CA--C 1.477 -2.288 0 N-CA-C 103.565 -3.814 . . . . 50.509999999999998 103.565 176.55 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.517 HG23 ' HD2' ' A' ' 37' ' ' PRO . 73.5 mt -103.74 135.89 19.29 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 116.785 2.143 . . . . 50.509999999999998 116.785 179.637 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HD2' HG23 ' A' ' 36' ' ' ILE . 78.2 Cg_exo -56.98 137.02 80.12 Favored 'Trans proline' 0 C--O 1.259 1.546 0 C-N-CA 123.084 2.523 . . . . 50.509999999999998 110.919 178.317 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 87.3 Cg_exo -57.23 -32.14 92.72 Favored 'Trans proline' 0 C--O 1.262 1.687 0 O-C-N 122.914 0.955 . . . . 50.509999999999998 113.391 -179.298 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -64.71 -18.68 65.22 Favored 'General case' 0 C--O 1.263 1.767 0 N-CA-C 117.422 2.379 . . . . 50.619999999999997 117.422 -177.401 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -81.45 -15.61 54.55 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.573 -1.33 . . . . 50.549999999999997 109.072 178.719 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.458 HE22 HG21 ' A' ' 30' ' ' ILE . 61.9 mt-30 -100.71 130.09 46.7 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 124.48 2.086 . . . . 50.549999999999997 112.444 -177.6 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -111.65 137.61 49.29 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.648 -1.644 . . . . 50.640000000000001 110.507 172.14 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.615 ' HG ' ' HE2' ' A' ' 27' ' ' LYS . 35.2 mt -116.24 129.45 56.29 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.904 1.446 . . . . 50.509999999999998 114.904 -177.456 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -114.77 127.15 72.42 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 O-C-N 125.085 1.491 . . . . 50.509999999999998 111.278 -177.6 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -139.81 107.06 5.5 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 106.99 -1.485 . . . . 50.509999999999998 106.99 177.652 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.43 41.73 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.228 -2.26 . . . . 50.509999999999998 105.53 177.383 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.96 -51.51 2.0 Allowed Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 128.434 2.921 . . . . 50.509999999999998 116.588 -179.605 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -40.2 148.32 0.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 116.747 2.128 . . . . 50.509999999999998 116.747 177.718 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -82.42 146.08 29.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.042 -2.207 . . . . 50.549999999999997 105.042 174.598 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -100.03 142.35 31.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.102 -1.444 . . . . 50.509999999999998 107.102 -175.888 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.04 156.55 17.85 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.106 -1.442 . . . . 50.619999999999997 107.106 -177.72 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 74.8 m-20 -82.99 -39.1 21.75 Favored 'General case' 0 C--O 1.264 1.837 0 C-N-CA 126.159 1.784 . . . . 50.619999999999997 108.242 -175.8 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.41 2.07 87.74 Favored Glycine 0 CA--C 1.493 -1.33 0 N-CA-C 116.288 1.275 . . . . 50.509999999999998 116.288 -177.201 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -95.73 161.01 14.21 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 119.91 -1.935 . . . . 50.640000000000001 106.027 176.515 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 22.8 p -98.37 170.29 8.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.403 -0.962 . . . . 50.509999999999998 108.403 177.129 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 17' ' ' VAL . 4.1 mp -65.31 -16.91 64.07 Favored 'General case' 0 C--O 1.201 -1.498 0 N-CA-C 107.767 -1.198 . . . . 50.509999999999998 107.767 177.255 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.9 p -70.71 -23.66 62.51 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 116.47 2.026 . . . . 50.509999999999998 116.47 -179.461 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.21 -37.66 80.96 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.107 2.262 . . . . 50.619999999999997 117.107 179.773 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -101.19 4.52 42.01 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 117.765 -1.112 . . . . 50.509999999999998 109.716 179.299 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 56.39 54.93 7.05 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 103.862 -2.644 . . . . 50.549999999999997 103.862 179.869 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.17 132.76 31.62 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 115.224 -2.322 . . . . 50.509999999999998 105.818 175.86 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -117.3 172.94 6.97 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.771 2.508 . . . . 50.549999999999997 117.771 -176.815 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -68.08 133.09 48.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 123.187 1.47 . . . . 50.509999999999998 113.737 -176.967 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.12 42.97 30.28 Favored 'General case' 0 C--O 1.256 1.436 0 N-CA-C 116.855 2.168 . . . . 50.619999999999997 116.855 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.6 p -85.46 166.27 16.48 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 104.315 -2.476 . . . . 50.509999999999998 104.315 174.796 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.9 p -114.94 132.72 56.47 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.816 -1.55 . . . . 50.509999999999998 106.816 175.975 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.6 mp -108.37 160.33 15.95 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 114.7 -2.572 . . . . 50.509999999999998 112.396 175.012 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.67 132.07 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 O-C-N 127.383 2.927 . . . . 50.509999999999998 109.765 177.947 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.68 HD23 HG22 ' A' ' 7' ' ' THR . 30.3 tp -112.78 125.37 54.26 Favored 'General case' 0 C--O 1.282 2.78 0 CA-C-O 117.657 -1.163 . . . . 50.509999999999998 109.467 176.525 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.84 139.97 39.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 105.165 -2.161 . . . . 50.509999999999998 105.165 175.087 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.2 mt -100.42 130.0 46.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.573 -2.01 . . . . 50.509999999999998 105.573 178.397 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -122.89 113.07 18.62 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 101.358 -3.571 . . . . 50.640000000000001 101.358 177.175 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.81 166.31 11.69 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 125.78 1.925 . . . . 50.509999999999998 111.032 -179.287 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.07 96.73 9.96 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 118.874 2.916 . . . . 50.640000000000001 118.874 -179.592 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.24 -168.62 12.63 Favored Glycine 0 C--O 1.243 0.679 0 N-CA-C 107.136 -2.385 . . . . 50.509999999999998 107.136 179.361 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.477 0 CA-C-O 116.31 -2.383 . . . . 50.509999999999998 110.028 179.212 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.483 ' CE ' ' HD2' ' A' ' 63' ' ' LYS . 81.4 mmm . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.081 0.771 . . . . 50.509999999999998 113.081 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -95.5 124.07 39.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 126.902 2.626 . . . . 50.549999999999997 115.59 178.29 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -127.39 152.72 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 115.984 -1.96 . . . . 50.509999999999998 109.264 173.317 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.557 ' CE2' ' OG1' ' A' ' 14' ' ' THR . 53.6 m-85 -106.52 141.71 37.36 Favored 'General case' 0 N--CA 1.512 2.636 1 O-C-N 130.386 4.804 . . . . 50.509999999999998 116.464 179.533 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HB ' HG12 ' A' ' 13' ' ' ILE . 85.9 t -113.13 110.4 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 113.435 -3.174 . . . . 50.509999999999998 110.211 175.719 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -83.34 130.74 35.07 Favored 'General case' 0 N--CA 1.505 2.276 1 O-C-N 129.353 4.158 . . . . 50.509999999999998 106.732 -178.064 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 p -99.66 -173.65 2.52 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-O 117.846 -1.073 . . . . 50.509999999999998 108.973 179.928 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -90.34 -16.81 28.46 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.854 1.427 . . . . 50.509999999999998 114.854 -177.959 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -101.33 -3.14 29.38 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 115.695 -2.402 . . . . 50.509999999999998 116.879 179.962 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.41 1.38 Allowed Glycine 0 C--N 1.297 -1.614 0 N-CA-C 117.366 1.706 . . . . 50.509999999999998 117.366 179.781 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -54.9 143.02 27.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 116.069 1.877 . . . . 50.509999999999998 116.069 175.013 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.7 p -124.14 136.45 54.22 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 126.619 2.449 . . . . 50.509999999999998 112.919 176.11 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.5 HG12 ' HB ' ' A' ' 5' ' ' VAL . 17.3 pt -106.67 125.18 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 127.464 2.978 . . . . 50.509999999999998 107.182 179.774 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.557 ' OG1' ' CE2' ' A' ' 4' ' ' PHE . 43.7 m -98.65 134.98 40.81 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 117.294 -1.762 . . . . 50.509999999999998 112.953 178.123 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mp -117.01 154.73 30.42 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 115.492 -2.194 . . . . 50.509999999999998 114.072 -179.29 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.7 tt0 -114.94 99.3 7.37 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 129.172 4.045 . . . . 50.619999999999997 109.17 174.005 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.88 155.46 15.07 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 O-C-N 127.781 3.175 . . . . 50.509999999999998 116.308 -177.967 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -107.3 135.33 19.67 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 104.518 -2.401 . . . . 50.619999999999997 104.518 174.63 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 57' ' ' SER . 84.3 Cg_exo -54.95 -24.52 39.72 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 122.54 2.16 . . . . 50.509999999999998 111.931 177.765 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.5 m -76.99 -0.23 23.63 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 118.102 -0.952 . . . . 50.509999999999998 109.269 -177.585 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.545 ' O ' ' HB ' ' A' ' 55' ' ' THR . 92.1 m-20 -72.76 178.21 4.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 117.378 -1.729 . . . . 50.619999999999997 109.31 -179.01 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.1 p -106.3 167.44 9.83 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 103.074 -2.936 . . . . 50.509999999999998 103.074 175.741 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 23' ' ' ILE . 13.1 mm -67.34 -45.99 84.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 O-C-N 126.975 2.672 . . . . 50.509999999999998 107.788 175.809 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -54.71 -48.41 72.52 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.42 -0.8 . . . . 50.619999999999997 112.376 177.017 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -48.61 -49.23 37.91 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.468 -1.308 . . . . 50.549999999999997 107.468 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 22' ' ' THR . 95.8 t -52.07 -52.65 22.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 125.069 1.481 . . . . 50.509999999999998 113.436 178.528 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -72.81 -23.05 60.73 Favored 'General case' 0 C--O 1.257 1.486 0 CA-C-N 115.755 -0.657 . . . . 50.509999999999998 109.356 -179.745 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.3 95.04 Favored 'General case' 0 C--O 1.279 2.618 0 N-CA-C 105.334 -2.099 . . . . 50.509999999999998 105.334 176.973 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.38 -48.81 60.04 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 114.995 1.48 . . . . 50.509999999999998 114.995 175.933 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 31' ' ' GLN . 70.3 mt -56.32 -52.6 49.94 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 103.796 -2.668 . . . . 50.509999999999998 103.796 179.871 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.498 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.6 tt0 -38.32 -73.56 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 125.567 2.603 . . . . 50.549999999999997 110.301 179.391 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -39.76 -59.13 1.22 Allowed 'General case' 0 C--O 1.253 1.27 0 CA-C-N 113.671 -1.604 . . . . 50.619999999999997 114.382 179.098 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -82.43 -42.66 18.28 Favored 'General case' 0 C--O 1.279 2.623 0 N-CA-C 119.941 3.312 . . . . 50.509999999999998 119.941 -175.677 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -86.18 -30.97 22.03 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 123.058 2.663 . . . . 50.619999999999997 105.776 179.828 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.63 22.76 23.08 Favored Glycine 0 CA--C 1.477 -2.31 0 N-CA-C 118.867 2.307 . . . . 50.509999999999998 118.867 176.564 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 59.2 mt -105.14 122.23 43.75 Favored Pre-proline 0 C--O 1.244 0.807 0 C-N-CA 118.753 -1.179 . . . . 50.509999999999998 110.216 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -56.97 136.94 79.64 Favored 'Trans proline' 0 C--O 1.259 1.537 0 C-N-CA 123.207 2.605 . . . . 50.509999999999998 110.879 178.348 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 86.4 Cg_exo -57.15 -32.17 92.62 Favored 'Trans proline' 0 C--O 1.261 1.661 0 O-C-N 122.926 0.961 . . . . 50.509999999999998 113.486 -179.376 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -65.45 -0.33 1.88 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 119.973 -1.705 . . . . 50.619999999999997 115.303 -177.448 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -126.91 18.74 7.2 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 120.5 -1.375 . . . . 50.549999999999997 113.503 178.709 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.425 ' HG2' HD11 ' A' ' 69' ' ' LEU . 69.8 mt-30 -110.3 141.47 43.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 124.299 2.0 . . . . 50.549999999999997 110.246 -177.582 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -128.62 136.67 50.99 Favored 'General case' 0 C--O 1.297 3.557 0 CA-C-O 116.726 -1.607 . . . . 50.640000000000001 107.496 172.157 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 69' ' ' LEU . 60.3 mt -135.94 124.45 23.56 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.464 1.029 . . . . 50.509999999999998 110.586 -177.538 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -122.62 122.53 66.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 O-C-N 125.121 1.513 . . . . 50.509999999999998 108.685 -177.589 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -143.06 139.03 30.34 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 114.514 -1.221 . . . . 50.509999999999998 112.103 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 20.48 10.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 112.271 -2.24 . . . . 50.509999999999998 114.865 177.398 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -21.76 27.32 Favored Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 128.493 2.949 . . . . 50.509999999999998 109.173 -179.654 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.74 177.79 7.89 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 118.087 0.943 . . . . 50.509999999999998 111.707 177.65 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -109.59 149.59 29.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 123.99 0.806 . . . . 50.549999999999997 109.481 174.579 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.81 101.71 10.35 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 104.918 -2.253 . . . . 50.509999999999998 104.918 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -101.91 153.23 20.05 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.916 1.385 . . . . 50.619999999999997 113.765 -177.66 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.45 -44.55 96.15 Favored 'General case' 0 C--O 1.265 1.88 0 N-CA-C 115.969 1.84 . . . . 50.619999999999997 115.969 -175.795 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.99 -15.21 3.23 Favored Glycine 0 C--O 1.253 1.333 0 N-CA-C 116.118 1.207 . . . . 50.509999999999998 116.118 -177.226 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -131.37 145.78 51.99 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 118.838 2.903 . . . . 50.640000000000001 118.838 176.506 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 21' ' ' ASP . 70.7 p -68.94 172.35 6.74 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 115.279 1.585 . . . . 50.509999999999998 115.279 177.189 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 HG13 ' A' ' 61' ' ' ILE . 35.5 mt -59.47 -49.39 77.98 Favored 'General case' 0 C--O 1.201 -1.477 0 O-C-N 124.156 0.91 . . . . 50.509999999999998 108.789 177.188 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 19' ' ' PRO . 9.4 t -47.52 -47.87 27.66 Favored 'General case' 0 C--O 1.267 1.986 0 C-N-CA 117.298 -1.761 . . . . 50.509999999999998 112.454 -179.444 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -48.45 -26.36 2.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 115.236 1.569 . . . . 50.619999999999997 115.236 179.767 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 66.9 m-85 -95.01 5.8 50.88 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 117.793 2.516 . . . . 50.509999999999998 117.793 179.222 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.684 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 63.4 m-20 68.81 9.71 7.52 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 121.534 1.97 . . . . 50.549999999999997 114.52 179.909 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.539 HG13 HD22 ' A' ' 56' ' ' LEU . 26.6 mm -50.97 117.95 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.99 0 CA-C-O 115.141 -2.361 . . . . 50.509999999999998 109.155 175.776 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.684 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 72.2 mt-30 -123.93 179.53 4.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 126.147 2.155 . . . . 50.549999999999997 105.837 -176.811 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HD2' ' CE ' ' A' ' 1' ' ' MET . 82.9 tttt -68.2 146.52 53.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.202 1.477 . . . . 50.509999999999998 108.35 -176.921 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 46.8 67.4 0.79 Allowed 'General case' 0 C--O 1.256 1.429 0 N-CA-C 120.868 3.655 . . . . 50.619999999999997 120.868 179.538 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.5 p -121.04 172.07 8.21 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 106.966 -1.494 . . . . 50.509999999999998 106.966 174.798 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 p -111.96 118.17 34.73 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 115.604 1.705 . . . . 50.509999999999998 115.604 175.982 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.05 138.03 34.27 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 114.647 -2.596 . . . . 50.509999999999998 107.617 175.08 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -97.96 122.48 41.14 Favored 'General case' 0 C--N 1.285 -2.236 0 O-C-N 127.383 2.927 . . . . 50.509999999999998 112.859 177.886 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 43' ' ' LEU . 42.1 tp -90.14 131.91 35.73 Favored 'General case' 0 C--O 1.283 2.83 0 N-CA-C 115.551 1.686 . . . . 50.509999999999998 115.551 176.519 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.6 t -120.9 129.28 75.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 103.253 -2.869 . . . . 50.509999999999998 103.253 175.109 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.55 123.93 44.28 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.178 0.513 . . . . 50.509999999999998 110.13 178.424 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -112.19 91.44 3.66 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 113.41 -3.186 . . . . 50.640000000000001 110.839 177.247 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.87 163.0 28.61 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.811 1.945 . . . . 50.509999999999998 108.282 -179.328 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.9 ttm105 -87.16 107.35 18.42 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 116.366 1.987 . . . . 50.640000000000001 116.366 -179.544 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.84 151.94 23.58 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 114.66 -1.154 . . . . 50.509999999999998 114.59 179.394 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-O 116.336 -2.369 . . . . 50.509999999999998 113.943 179.22 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 36.7 mmt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 105.584 -2.006 . . . . 50.509999999999998 105.584 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -100.73 135.85 41.53 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.965 2.666 . . . . 50.549999999999997 107.301 178.239 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.465 HD12 ' C ' ' A' ' 3' ' ' ILE . 2.8 pp -137.29 154.93 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 115.961 -1.971 . . . . 50.509999999999998 108.392 173.316 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.39 149.49 23.12 Favored 'General case' 0 N--CA 1.511 2.602 1 O-C-N 130.475 4.86 . . . . 50.509999999999998 115.331 179.558 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.52 122.11 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 101.949 -3.352 . . . . 50.509999999999998 101.949 175.73 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.503 2.198 1 O-C-N 129.322 4.139 . . . . 50.509999999999998 105.737 -178.074 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -87.31 -171.97 3.72 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 117.746 -1.121 . . . . 50.509999999999998 111.573 179.983 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.8 mt -78.94 19.73 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.085 0.866 . . . . 50.509999999999998 112.175 -177.974 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -130.8 -14.49 3.56 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 115.706 -2.398 . . . . 50.509999999999998 115.874 179.921 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.83 29.21 4.45 Favored Glycine 0 C--N 1.296 -1.672 0 O-C-N 120.006 -1.684 . . . . 50.509999999999998 109.105 179.833 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.67 123.0 47.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 116.891 -1.528 . . . . 50.509999999999998 111.611 174.997 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p -109.21 131.94 54.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 118.001 2.593 . . . . 50.509999999999998 118.001 176.14 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.6 pt -113.07 157.4 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 127.209 2.818 . . . . 50.509999999999998 106.143 179.741 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -112.83 140.13 47.88 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.274 -1.77 . . . . 50.509999999999998 109.73 178.131 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 mt -122.1 171.16 9.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 115.488 -2.196 . . . . 50.509999999999998 113.214 -179.293 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' H ' ' HE2' ' A' ' 29' ' ' LYS . 71.7 tt0 -128.94 109.85 11.59 Favored 'General case' 0 N--CA 1.5 2.032 1 O-C-N 129.104 4.003 . . . . 50.619999999999997 112.573 173.976 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.22 172.36 8.42 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 O-C-N 127.722 3.139 . . . . 50.509999999999998 114.387 -177.939 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.75 150.33 75.49 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 112.224 -2.262 . . . . 50.619999999999997 108.179 174.638 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.9 -24.53 39.39 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.562 2.174 . . . . 50.509999999999998 111.887 177.744 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -81.36 -19.96 41.63 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 118.154 -0.926 . . . . 50.509999999999998 109.737 -177.52 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.63 139.59 58.78 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.352 -1.739 . . . . 50.619999999999997 108.165 -179.053 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 156.03 18.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 105.125 -2.176 . . . . 50.509999999999998 105.125 175.691 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.9 mm -49.24 -33.66 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 O-C-N 127.201 2.813 . . . . 50.509999999999998 112.734 175.787 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -72.37 -16.61 61.86 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 113.917 1.08 . . . . 50.619999999999997 113.917 177.034 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 25' ' ' ASN . 64.4 t-20 -98.7 -9.0 25.22 Favored 'General case' 0 C--O 1.249 1.036 0 C-N-CA 124.305 1.042 . . . . 50.549999999999997 109.217 -179.663 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -91.32 -43.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 104.981 -2.229 . . . . 50.509999999999998 104.981 178.588 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' ILE . 53.8 mtmt -64.38 -58.41 6.56 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 113.294 0.85 . . . . 50.509999999999998 113.294 -179.806 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.8 -34.11 3.51 Favored 'General case' 0 C--O 1.279 2.608 0 CA-C-N 117.984 0.356 . . . . 50.509999999999998 110.058 176.851 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' A' ' 16' ' ' GLU . 66.1 tttp -62.84 -31.89 73.0 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.383 -1.448 . . . . 50.509999999999998 109.787 175.95 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 27' ' ' LYS . 70.0 mt -77.42 -35.03 21.49 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 105.709 -1.96 . . . . 50.509999999999998 105.709 179.903 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.724 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 17.8 tm0? -47.11 -36.72 8.69 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 125.564 2.602 . . . . 50.549999999999997 115.246 179.46 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -69.58 -32.24 70.89 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 113.664 -1.607 . . . . 50.619999999999997 113.743 179.131 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -99.77 -7.21 25.8 Favored 'General case' 0 C--O 1.279 2.641 0 C-N-CA 116.473 -2.091 . . . . 50.509999999999998 115.925 -175.671 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -121.97 -32.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 123.063 2.665 . . . . 50.619999999999997 110.136 179.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.55 12.57 60.88 Favored Glycine 0 CA--C 1.478 -2.222 0 N-CA-C 104.703 -3.359 . . . . 50.509999999999998 104.703 176.543 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.9 mm -98.3 125.64 42.63 Favored Pre-proline 0 C--O 1.245 0.818 0 N-CA-C 104.462 -2.422 . . . . 50.509999999999998 104.462 179.653 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 78.2 Cg_exo -57.04 136.94 79.66 Favored 'Trans proline' 0 C--O 1.259 1.528 0 C-N-CA 123.154 2.569 . . . . 50.509999999999998 110.922 178.353 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.724 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 87.4 Cg_exo -57.18 -32.17 92.7 Favored 'Trans proline' 0 C--O 1.262 1.681 0 O-C-N 122.918 0.957 . . . . 50.509999999999998 113.398 -179.268 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -66.45 -18.75 65.54 Favored 'General case' 0 C--O 1.263 1.778 0 O-C-N 119.918 -1.739 . . . . 50.619999999999997 106.65 -177.489 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.505 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 77.9 mt-30 -93.36 -1.29 56.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 116.23 1.937 . . . . 50.549999999999997 116.23 178.724 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 57.6 mt-30 -86.74 151.48 23.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 124.363 2.03 . . . . 50.549999999999997 110.256 -177.575 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.576 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 75.3 ttt180 -133.54 106.96 7.72 Favored 'General case' 0 C--O 1.296 3.517 0 CA-C-O 116.671 -1.633 . . . . 50.640000000000001 109.224 172.151 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 mp -98.05 136.33 38.46 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.483 1.038 . . . . 50.509999999999998 113.488 -177.472 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.75 124.97 57.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.852 0 O-C-N 125.111 1.507 . . . . 50.509999999999998 113.16 -177.608 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -138.35 118.08 13.15 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 114.472 1.286 . . . . 50.509999999999998 114.472 177.673 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 35.57 18.34 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.291 -2.232 . . . . 50.509999999999998 106.186 177.349 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 8.0 84.69 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 128.437 2.922 . . . . 50.509999999999998 116.237 -179.596 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -101.87 141.45 34.7 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 118.058 0.929 . . . . 50.509999999999998 113.213 177.665 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -84.46 120.73 26.65 Favored 'General case' 0 C--O 1.259 1.599 0 O-C-N 123.977 0.798 . . . . 50.549999999999997 109.235 174.599 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -60.98 126.23 26.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 117.726 -1.13 . . . . 50.509999999999998 110.757 -175.883 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.16 132.14 40.42 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.973 1.42 . . . . 50.619999999999997 114.002 -177.713 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.82 -58.31 5.01 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 103.631 -2.729 . . . . 50.619999999999997 103.631 -175.871 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.72 1.66 28.65 Favored Glycine 0 CA--C 1.493 -1.297 0 N-CA-C 118.34 2.096 . . . . 50.509999999999998 118.34 -177.174 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 58' ' ' ASP . 52.8 mmm-85 -109.81 144.96 37.52 Favored 'General case' 0 C--O 1.249 1.034 0 O-C-N 119.696 -2.061 . . . . 50.640000000000001 106.479 176.425 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.9 p -91.31 162.49 14.59 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 117.183 2.29 . . . . 50.509999999999998 117.183 177.109 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.712 ' HG ' ' HB ' ' A' ' 61' ' ' ILE . 2.7 mp -46.84 -25.92 0.86 Allowed 'General case' 0 C--O 1.201 -1.45 0 O-C-N 124.14 0.9 . . . . 50.509999999999998 109.5 177.187 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.9 p -71.84 -36.91 70.3 Favored 'General case' 0 C--O 1.269 2.096 0 C-N-CA 117.314 -1.755 . . . . 50.509999999999998 114.309 -179.468 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB3' ' NH2' ' A' ' 54' ' ' ARG . 1.4 m-20 -62.2 -25.29 67.71 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.472 1.13 . . . . 50.619999999999997 113.699 179.812 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.46 24.09 11.59 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 117.805 -1.093 . . . . 50.509999999999998 112.609 179.193 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 t30 37.16 54.18 1.25 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 118.865 2.913 . . . . 50.549999999999997 118.865 179.896 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.712 ' HB ' ' HG ' ' A' ' 56' ' ' LEU . 40.9 mm -88.82 100.15 10.2 Favored 'Isoleucine or valine' 0 C--O 1.267 2.017 0 CA-C-O 115.144 -2.36 . . . . 50.509999999999998 112.488 175.861 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -108.85 -178.58 3.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 126.155 2.16 . . . . 50.549999999999997 111.715 -176.864 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.451 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 64.0 tttm -67.63 144.62 55.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 103.094 -2.928 . . . . 50.509999999999998 103.094 -176.935 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 67.43 21.82 9.55 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 118.641 2.83 . . . . 50.619999999999997 118.641 179.559 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -73.96 174.24 8.85 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.15 1.907 . . . . 50.509999999999998 116.15 174.857 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -117.2 110.56 18.29 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 115.472 1.656 . . . . 50.509999999999998 115.472 175.981 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.7 113.83 27.04 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 114.655 -2.593 . . . . 50.509999999999998 115.949 175.042 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.35 136.89 37.12 Favored 'General case' 0 C--N 1.285 -2.216 0 O-C-N 127.457 2.973 . . . . 50.509999999999998 115.542 177.905 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -106.95 114.68 28.91 Favored 'General case' 0 C--O 1.281 2.763 0 N-CA-C 115.546 1.684 . . . . 50.509999999999998 115.546 176.578 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.576 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.7 t -111.75 137.91 42.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 104.908 -2.256 . . . . 50.509999999999998 104.908 175.121 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.92 157.57 28.21 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.403 0.89 . . . . 50.509999999999998 113.403 178.467 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 ttm105 -132.03 77.31 1.75 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 101.997 -3.335 . . . . 50.640000000000001 101.997 177.184 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -84.24 114.39 21.79 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 125.803 1.939 . . . . 50.509999999999998 111.716 -179.306 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -70.31 108.67 4.31 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 113.709 -1.587 . . . . 50.640000000000001 112.725 -179.635 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.72 -170.9 13.48 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 107.962 -2.055 . . . . 50.509999999999998 107.962 179.407 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 106.944 -2.462 . . . . 50.509999999999998 106.944 179.161 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' SD ' ' HD2' ' A' ' 63' ' ' LYS . 23.9 mmt . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 118.802 -0.618 . . . . 50.509999999999998 111.202 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -92.41 147.35 22.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 126.941 2.65 . . . . 50.549999999999997 106.999 178.287 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.528 HD13 HG21 ' A' ' 17' ' ' VAL . 35.1 pt -145.94 151.47 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 105.453 -2.054 . . . . 50.509999999999998 105.453 173.347 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.434 ' CE1' HG22 ' A' ' 14' ' ' THR . 97.4 m-85 -103.19 143.52 32.52 Favored 'General case' 0 N--CA 1.512 2.671 1 O-C-N 130.502 4.876 . . . . 50.509999999999998 112.212 179.503 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.96 116.17 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 113.36 -3.21 . . . . 50.509999999999998 110.554 175.797 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HD3' HG22 ' A' ' 12' ' ' THR . 25.1 mmtp -73.39 160.74 31.34 Favored 'General case' 0 N--CA 1.504 2.251 1 O-C-N 129.363 4.165 . . . . 50.509999999999998 112.885 -178.08 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -134.49 -165.44 1.66 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.491 -1.3 . . . . 50.509999999999998 107.491 179.942 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.7 mt -94.73 -33.83 12.77 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.297 -2.112 . . . . 50.509999999999998 105.297 -177.965 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 p -75.68 -9.26 58.44 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 115.744 -2.383 . . . . 50.509999999999998 117.254 179.914 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.57 4.22 58.22 Favored Glycine 0 C--N 1.296 -1.642 0 O-C-N 120.194 -1.566 . . . . 50.509999999999998 116.153 179.748 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE3' HG22 ' A' ' 13' ' ' ILE . 50.6 tptt -76.08 129.01 36.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 116.838 -1.553 . . . . 50.509999999999998 109.37 175.061 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.507 HG22 ' HD3' ' A' ' 6' ' ' LYS . 33.9 p -111.93 107.91 17.07 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 126.686 2.491 . . . . 50.509999999999998 107.119 176.215 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.482 HG22 ' HE3' ' A' ' 11' ' ' LYS . 26.9 pt -97.17 147.87 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 127.352 2.907 . . . . 50.509999999999998 114.29 179.643 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.434 HG22 ' CE1' ' A' ' 4' ' ' PHE . 20.7 p -94.13 153.75 17.94 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 101.438 -3.542 . . . . 50.509999999999998 101.438 178.164 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.33 149.27 49.69 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.64 -2.356 . . . . 50.509999999999998 104.64 -179.303 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -100.33 120.56 40.12 Favored 'General case' 0 N--CA 1.499 2.009 1 O-C-N 129.266 4.104 . . . . 50.619999999999997 109.741 173.955 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 3' ' ' ILE . 18.8 m -131.7 166.43 28.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 O-C-N 127.673 3.108 . . . . 50.509999999999998 107.743 -177.987 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 38.3 mt-10 -125.86 143.49 45.46 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 112.185 -2.28 . . . . 50.619999999999997 106.18 174.733 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 84.2 Cg_exo -54.94 -24.62 40.14 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 122.606 2.204 . . . . 50.509999999999998 111.905 177.702 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 p -69.87 -44.9 68.85 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 117.536 2.421 . . . . 50.509999999999998 117.536 -177.512 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.7 154.07 34.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 117.393 -1.723 . . . . 50.619999999999997 113.773 -178.992 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.416 ' C ' ' N ' ' A' ' 24' ' ' GLU . 44.9 p -84.5 157.79 21.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.834 1.05 . . . . 50.509999999999998 113.834 175.642 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -49.13 -28.06 2.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 O-C-N 127.18 2.8 . . . . 50.509999999999998 105.858 175.793 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' N ' ' C ' ' A' ' 22' ' ' THR . 41.2 tt0 -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 120.388 3.477 . . . . 50.619999999999997 120.388 177.05 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.409 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 73.1 m-80 -98.69 -38.02 9.27 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 102.963 -2.977 . . . . 50.549999999999997 102.963 -179.562 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.56 -59.0 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 125.069 1.481 . . . . 50.509999999999998 113.507 178.681 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 38' ' ' PRO . 54.8 pttt -53.11 -45.82 68.43 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 109.241 -0.652 . . . . 50.509999999999998 109.241 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.35 75.56 Favored 'General case' 0 C--O 1.278 2.59 0 N-CA-C 119.665 3.209 . . . . 50.509999999999998 119.665 176.797 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 94.1 mttt -52.92 -40.95 63.99 Favored 'General case' 0 C--O 1.256 1.395 0 O-C-N 120.384 -1.447 . . . . 50.509999999999998 107.303 176.033 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . 87.1 mt -67.59 -21.94 28.0 Favored 'Isoleucine or valine' 0 C--O 1.253 1.26 0 N-CA-C 113.406 0.891 . . . . 50.509999999999998 113.406 179.882 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -58.57 -33.96 70.53 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 125.586 2.612 . . . . 50.549999999999997 106.395 179.473 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.06 -27.86 67.72 Favored 'General case' 0 C--O 1.253 1.271 0 N-CA-C 116.411 2.004 . . . . 50.619999999999997 116.411 179.16 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -107.08 -26.14 11.26 Favored 'General case' 0 C--O 1.279 2.643 0 C-N-CA 116.473 -2.091 . . . . 50.509999999999998 113.955 -175.669 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -109.22 -46.74 3.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 123.074 2.67 . . . . 50.619999999999997 110.337 179.869 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 10.1 20.56 Favored Glycine 0 CA--C 1.477 -2.292 0 N-CA-C 110.097 -1.201 . . . . 50.509999999999998 110.097 176.575 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 36.9 mm -83.42 124.21 75.98 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 106.671 -1.603 . . . . 50.509999999999998 106.671 179.693 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.484 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -57.05 136.92 79.54 Favored 'Trans proline' 0 C--O 1.259 1.554 0 C-N-CA 123.159 2.573 . . . . 50.509999999999998 110.883 178.327 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 88.3 Cg_exo -57.17 -32.19 92.71 Favored 'Trans proline' 0 C--O 1.261 1.64 0 O-C-N 122.886 0.94 . . . . 50.509999999999998 113.363 -179.265 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.99 -15.48 63.04 Favored 'General case' 0 C--O 1.262 1.722 0 O-C-N 119.92 -1.737 . . . . 50.619999999999997 108.114 -177.41 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.4 12.92 35.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.971 1.471 . . . . 50.549999999999997 114.971 178.758 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -114.94 119.67 37.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 124.428 2.061 . . . . 50.549999999999997 110.587 -177.705 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -119.92 116.9 26.74 Favored 'General case' 0 C--O 1.296 3.539 0 CA-C-O 116.694 -1.622 . . . . 50.640000000000001 107.394 172.178 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.02 133.4 44.47 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.153 1.538 . . . . 50.509999999999998 115.153 -177.548 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mm -115.83 124.87 72.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 N-CA-C 117.106 2.261 . . . . 50.509999999999998 117.106 -177.6 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -126.13 118.2 24.74 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-N 114.573 -1.194 . . . . 50.509999999999998 112.605 177.617 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.69 40.68 29.09 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.276 -2.238 . . . . 50.509999999999998 111.591 177.391 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 6.6 42.62 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 128.391 2.9 . . . . 50.509999999999998 112.91 -179.584 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -91.22 127.06 36.51 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.284 -1.376 . . . . 50.509999999999998 107.284 177.699 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -76.64 122.19 24.31 Favored 'General case' 0 C--O 1.26 1.611 0 O-C-N 123.971 0.794 . . . . 50.549999999999997 109.141 174.621 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 mt -81.03 155.51 26.32 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 116.588 2.07 . . . . 50.509999999999998 116.588 -175.884 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 53' ' ' GLY . 41.3 tp10 -106.01 142.11 36.27 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 125.024 1.452 . . . . 50.619999999999997 113.709 -177.755 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -59.96 -32.2 70.59 Favored 'General case' 0 C--O 1.263 1.794 0 C-N-CA 126.131 1.772 . . . . 50.619999999999997 111.404 -175.75 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' H ' ' HG3' ' A' ' 51' ' ' GLU . . . -101.06 38.25 3.23 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 124.334 0.969 . . . . 50.509999999999998 113.772 -177.235 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -134.2 159.04 42.12 Favored 'General case' 0 C--O 1.248 1.009 0 O-C-N 118.037 -3.037 . . . . 50.640000000000001 105.106 176.464 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -91.02 172.07 8.83 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.022 0.929 . . . . 50.509999999999998 112.063 177.091 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.98 -37.87 66.87 Favored 'General case' 0 C--O 1.202 -1.433 0 O-C-N 124.193 0.933 . . . . 50.509999999999998 108.486 177.225 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 19' ' ' PRO . 47.2 t -64.11 -39.0 93.1 Favored 'General case' 0 C--O 1.268 2.04 0 N-CA-C 116.601 2.074 . . . . 50.509999999999998 116.601 -179.401 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -55.55 -23.84 28.94 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.418 1.104 . . . . 50.619999999999997 111.692 179.773 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -97.52 -0.18 46.43 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 117.722 -1.133 . . . . 50.509999999999998 113.931 179.234 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.5 t30 69.89 21.34 6.35 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.36 1.985 . . . . 50.549999999999997 116.36 179.892 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.73 96.86 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.267 1.976 0 CA-C-O 115.206 -2.33 . . . . 50.509999999999998 112.232 175.858 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.442 ' O ' ' OG ' ' A' ' 65' ' ' SER . 21.7 pt20 -88.18 160.34 17.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 126.074 2.109 . . . . 50.549999999999997 111.758 -176.813 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 88.4 tttt -43.23 149.36 0.24 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.426 -2.065 . . . . 50.509999999999998 105.426 -177.034 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 97.6 mt-10 52.64 74.28 0.29 Allowed 'General case' 0 C--O 1.257 1.493 0 CA-C-N 112.522 -2.127 . . . . 50.619999999999997 107.909 179.633 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 69.1 m -119.45 132.39 55.79 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.743 -1.117 . . . . 50.509999999999998 111.249 174.801 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.3 m -81.43 121.37 26.17 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 118.187 -0.911 . . . . 50.509999999999998 113.287 175.94 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -111.56 143.93 41.62 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 114.707 -2.568 . . . . 50.509999999999998 111.404 175.06 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -94.79 136.66 34.83 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 126.809 2.568 . . . . 50.509999999999998 108.367 177.914 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 65.9 tp -93.09 118.96 31.8 Favored 'General case' 0 C--O 1.282 2.794 0 CA-C-O 117.609 -1.186 . . . . 50.509999999999998 110.624 176.517 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.9 121.96 66.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.558 -1.275 . . . . 50.509999999999998 107.558 175.071 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.8 mt -96.01 128.18 42.67 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.674 0.62 . . . . 50.509999999999998 112.674 178.403 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 60.8 ttt85 -113.69 69.62 0.71 Allowed 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 120.313 3.449 . . . . 50.640000000000001 120.313 177.305 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.57 142.23 28.6 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 125.872 1.982 . . . . 50.509999999999998 114.841 -179.382 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -91.21 85.94 6.02 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.773 -1.558 . . . . 50.640000000000001 111.801 -179.629 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.3 -161.7 28.35 Favored Glycine 0 C--O 1.243 0.699 0 N-CA-C 108.705 -1.758 . . . . 50.509999999999998 108.705 179.339 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 116.322 -2.376 . . . . 50.509999999999998 111.287 179.257 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mmt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 101.467 -3.531 . . . . 50.509999999999998 101.467 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -103.85 129.51 51.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 126.961 2.663 . . . . 50.549999999999997 107.932 178.256 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 pt -119.72 157.49 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-O 116.04 -1.933 . . . . 50.509999999999998 110.386 173.353 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -106.23 139.21 41.1 Favored 'General case' 0 N--CA 1.512 2.635 1 O-C-N 130.407 4.817 . . . . 50.509999999999998 112.035 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -113.86 101.58 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 113.359 -3.21 . . . . 50.509999999999998 108.884 175.81 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -66.76 147.0 53.84 Favored 'General case' 0 N--CA 1.504 2.246 1 O-C-N 129.463 4.227 . . . . 50.509999999999998 112.322 -178.097 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.513 HG22 HD23 ' A' ' 69' ' ' LEU . 41.6 p -135.64 170.39 16.03 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 117.768 -1.111 . . . . 50.509999999999998 108.494 179.959 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -91.4 29.96 1.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.967 0.792 . . . . 50.509999999999998 112.414 -177.966 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.3 p -130.55 18.67 5.25 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 115.677 -2.409 . . . . 50.509999999999998 117.199 179.904 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.92 51.15 25.47 Favored Glycine 0 C--N 1.297 -1.591 0 O-C-N 120.109 -1.619 . . . . 50.509999999999998 111.271 179.763 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -160.2 123.69 3.55 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 115.225 1.565 . . . . 50.509999999999998 115.225 175.02 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 p -83.89 135.15 34.6 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 126.666 2.479 . . . . 50.509999999999998 114.566 176.137 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 mm -108.51 133.79 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 127.562 3.039 . . . . 50.509999999999998 106.079 179.717 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.8 p -104.27 154.31 19.95 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.553 2.057 . . . . 50.509999999999998 116.553 178.073 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.5 mt -140.62 139.65 34.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.49 -2.195 . . . . 50.509999999999998 113.33 -179.261 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.61 113.52 25.6 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 128.66 3.725 . . . . 50.619999999999997 103.548 173.988 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.24 -166.26 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.271 0 O-C-N 127.518 3.011 . . . . 50.509999999999998 105.312 -177.911 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -150.56 156.87 36.66 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.256 -2.247 . . . . 50.619999999999997 109.062 174.621 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.96 -24.53 39.89 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.622 2.215 . . . . 50.509999999999998 111.953 177.754 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.5 p -93.52 -7.36 44.47 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 115.541 1.682 . . . . 50.509999999999998 115.541 -177.546 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.21 135.6 52.28 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 117.29 -1.764 . . . . 50.619999999999997 114.821 -179.017 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -77.43 160.34 28.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.851 -0.613 . . . . 50.509999999999998 110.904 175.78 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 15.5 mm -55.3 -40.03 54.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 O-C-N 127.153 2.783 . . . . 50.509999999999998 109.387 175.808 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -61.64 -40.77 96.09 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.422 -0.798 . . . . 50.619999999999997 111.568 176.95 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -64.05 -45.44 88.79 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 124.377 1.071 . . . . 50.549999999999997 112.781 -179.613 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 56' ' ' LEU . 91.5 t -55.83 -55.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.344 -1.724 . . . . 50.509999999999998 106.344 178.613 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -48.2 -30.12 4.37 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 113.072 0.768 . . . . 50.509999999999998 113.072 -179.813 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -35.88 74.5 Favored 'General case' 0 C--O 1.278 2.6 0 N-CA-C 114.379 1.251 . . . . 50.509999999999998 114.379 176.846 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 29.3 mmtp -58.38 -43.36 88.45 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 104.256 -2.498 . . . . 50.509999999999998 104.256 176.03 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.77 -35.05 53.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.287 0 N-CA-C 115.219 1.563 . . . . 50.509999999999998 115.219 179.93 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -60.64 -32.07 71.25 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 125.593 2.616 . . . . 50.549999999999997 112.391 179.427 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -71.7 -52.1 19.53 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-N 113.568 -1.651 . . . . 50.619999999999997 109.803 179.131 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -78.82 -47.44 16.67 Favored 'General case' 0 C--O 1.279 2.616 0 C-N-CA 116.465 -2.094 . . . . 50.509999999999998 116.073 -175.656 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.79 -14.26 40.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 123.079 2.672 . . . . 50.619999999999997 117.047 179.819 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.72 13.02 83.97 Favored Glycine 0 CA--C 1.477 -2.32 0 CA-C-O 120.065 -0.297 . . . . 50.509999999999998 112.612 176.539 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.414 HG22 HE21 ' A' ' 41' ' ' GLN . 68.0 mt -91.33 123.47 64.0 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 115.554 1.687 . . . . 50.509999999999998 115.554 179.7 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.9 Cg_exo -56.93 136.9 79.33 Favored 'Trans proline' 0 C--O 1.26 1.617 0 C-N-CA 123.109 2.539 . . . . 50.509999999999998 111.006 178.268 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.2 Cg_exo -57.2 -32.07 92.45 Favored 'Trans proline' 0 C--O 1.261 1.651 0 O-C-N 122.83 0.911 . . . . 50.509999999999998 113.45 -179.249 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -59.61 -12.49 6.81 Favored 'General case' 0 C--O 1.262 1.729 0 N-CA-C 117.768 2.507 . . . . 50.619999999999997 117.768 -177.463 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.517 ' O ' HD23 ' A' ' 71' ' ' LEU . 79.2 mt-30 -112.23 14.71 20.57 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.519 -1.363 . . . . 50.549999999999997 113.661 178.718 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.414 HE21 HG22 ' A' ' 36' ' ' ILE . 63.0 mt-30 -107.46 131.67 54.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 124.4 2.048 . . . . 50.549999999999997 115.36 -177.612 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.578 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 33.1 ttm180 -115.58 113.85 24.15 Favored 'General case' 0 C--O 1.296 3.524 0 CA-C-O 116.592 -1.671 . . . . 50.640000000000001 112.565 172.148 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.92 130.08 46.06 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 104.507 -2.405 . . . . 50.509999999999998 104.507 -177.501 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.574 HD11 ' HD3' ' A' ' 42' ' ' ARG . 89.4 mt -125.95 130.97 72.28 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 O-C-N 125.078 1.486 . . . . 50.509999999999998 112.746 -177.565 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.89 103.38 8.02 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 114.505 -1.225 . . . . 50.509999999999998 111.211 177.572 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.09 48.39 22.4 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.211 -2.268 . . . . 50.509999999999998 108.317 177.368 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.37 72.16 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 128.445 2.926 . . . . 50.509999999999998 115.154 -179.539 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -99.28 138.32 36.54 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.328 -0.99 . . . . 50.509999999999998 108.328 177.6 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -88.78 114.78 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.02 0.825 . . . . 50.549999999999997 112.617 174.616 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.36 128.18 35.67 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 117.679 -1.153 . . . . 50.509999999999998 113.899 -175.919 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -92.88 137.46 32.34 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.956 1.41 . . . . 50.619999999999997 107.43 -177.593 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.04 -44.14 67.15 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 118.367 2.728 . . . . 50.619999999999997 118.367 -175.784 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.38 -22.32 77.62 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 119.54 2.576 . . . . 50.509999999999998 119.54 -177.225 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -82.99 158.99 22.31 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 119.716 -2.049 . . . . 50.640000000000001 112.849 176.485 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -88.03 160.7 17.74 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 117.629 2.455 . . . . 50.509999999999998 117.629 177.044 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -55.61 -31.01 61.91 Favored 'General case' 0 C--O 1.2 -1.526 0 CA-C-N 115.473 -0.785 . . . . 50.509999999999998 110.912 177.243 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.8 p -71.62 -27.2 62.95 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 117.301 -1.76 . . . . 50.509999999999998 112.059 -179.485 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -67.96 -13.95 62.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.461 1.282 . . . . 50.619999999999997 114.461 179.769 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.602 ' HB2' HG12 ' A' ' 61' ' ' ILE . 53.5 m-85 -103.19 14.39 31.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 115.497 1.665 . . . . 50.509999999999998 115.497 179.25 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.9 t30 64.78 19.81 11.94 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 121.48 1.946 . . . . 50.549999999999997 109.459 179.855 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 59' ' ' TYR . 34.8 mm -81.23 99.69 4.76 Favored 'Isoleucine or valine' 0 C--O 1.267 2.026 0 CA-C-O 115.209 -2.329 . . . . 50.509999999999998 113.777 175.847 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -124.27 -115.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 126.101 2.125 . . . . 50.549999999999997 112.77 -176.851 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.77 128.72 35.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.259 1.504 . . . . 50.509999999999998 111.915 -176.95 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 51.65 39.23 24.68 Favored 'General case' 0 C--O 1.257 1.47 0 CA-C-N 112.516 -2.129 . . . . 50.619999999999997 115.775 179.52 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -71.27 148.27 47.33 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.842 -1.072 . . . . 50.509999999999998 110.018 174.8 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.9 m -127.51 116.05 19.79 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 118.26 -0.876 . . . . 50.509999999999998 112.222 175.938 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.42 142.45 27.41 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 114.76 -2.543 . . . . 50.509999999999998 111.856 175.043 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -88.78 138.29 31.55 Favored 'General case' 0 C--N 1.286 -2.182 0 O-C-N 126.818 2.574 . . . . 50.509999999999998 107.324 177.925 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 HG22 ' A' ' 7' ' ' THR . 68.0 tp -106.98 123.55 48.35 Favored 'General case' 0 C--O 1.283 2.852 0 CA-C-O 117.632 -1.175 . . . . 50.509999999999998 109.246 176.544 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 45.6 t -135.22 126.99 46.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 119.596 1.089 . . . . 50.509999999999998 110.346 175.059 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 40' ' ' GLN . 71.2 mt -70.21 139.9 52.36 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 120.417 3.488 . . . . 50.509999999999998 120.417 178.446 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -118.27 106.46 12.82 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 113.327 -3.225 . . . . 50.640000000000001 102.491 177.314 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' A' ' 71' ' ' LEU . 6.4 mp -104.75 127.81 52.66 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 125.827 1.955 . . . . 50.509999999999998 115.508 -179.314 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -90.02 84.37 6.16 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.751 -1.568 . . . . 50.640000000000001 107.806 -179.648 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.21 157.04 7.21 Favored Glycine 0 C--O 1.244 0.744 1 N-CA-C 102.525 -4.23 . . . . 50.509999999999998 102.525 179.367 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 N-CA-C 105.58 -3.008 . . . . 50.509999999999998 105.58 179.227 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 108.225 -1.028 . . . . 50.509999999999998 108.225 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -102.06 133.53 46.75 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 126.889 2.618 . . . . 50.549999999999997 107.185 178.29 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.35 169.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 N-CA-C 104.745 -2.317 . . . . 50.509999999999998 104.745 173.37 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.97 123.73 40.51 Favored 'General case' 0 N--CA 1.51 2.568 1 O-C-N 130.427 4.829 . . . . 50.509999999999998 111.603 179.588 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.18 110.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 113.349 -3.215 . . . . 50.509999999999998 109.404 175.788 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -99.18 146.85 25.72 Favored 'General case' 0 N--CA 1.504 2.271 1 O-C-N 129.367 4.167 . . . . 50.509999999999998 112.42 -178.085 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.2 p -112.87 178.97 4.1 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.046 -2.946 . . . . 50.509999999999998 103.046 179.993 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.6 mt -91.53 3.7 54.35 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 124.111 0.882 . . . . 50.509999999999998 111.028 -178.036 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -91.96 -24.83 19.13 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 115.673 -2.411 . . . . 50.509999999999998 114.467 179.956 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.76 14.65 2.28 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 106.022 -2.831 . . . . 50.509999999999998 106.022 179.735 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -95.33 120.12 35.01 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 115.247 1.573 . . . . 50.509999999999998 115.247 174.971 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -119.53 108.56 14.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 126.679 2.487 . . . . 50.509999999999998 105.48 176.143 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 tt -103.19 146.02 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 127.442 2.964 . . . . 50.509999999999998 114.156 179.721 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 15' ' ' LEU . 98.5 m -97.93 155.76 16.93 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 117.27 -1.772 . . . . 50.509999999999998 111.194 178.092 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' N ' HG22 ' A' ' 14' ' ' THR . 12.6 tp -138.11 140.02 39.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 115.485 -2.198 . . . . 50.509999999999998 111.804 -179.239 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -103.11 115.05 29.85 Favored 'General case' 0 N--CA 1.5 2.042 1 O-C-N 129.187 4.055 . . . . 50.619999999999997 111.421 173.972 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.58 178.09 2.56 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 O-C-N 127.888 3.243 . . . . 50.509999999999998 113.093 -177.93 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 25.7 tt0 -102.01 149.97 37.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 112.196 -2.274 . . . . 50.619999999999997 106.082 174.622 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' CG ' ' A' ' 18' ' ' GLU . 84.8 Cg_exo -54.93 -24.5 39.52 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.6 2.2 . . . . 50.509999999999998 111.948 177.691 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.6 p -120.14 22.07 11.55 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 119.795 3.257 . . . . 50.509999999999998 119.795 -177.528 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.0 152.19 42.65 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.44 -1.704 . . . . 50.619999999999997 108.547 -179.026 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 55' ' ' THR . 71.6 p -97.27 145.92 25.62 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.895 -0.593 . . . . 50.509999999999998 109.499 175.649 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 50.5 mm -42.64 -36.77 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 O-C-N 127.126 2.766 . . . . 50.509999999999998 113.586 175.789 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -44.53 -55.66 4.94 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.364 -0.835 . . . . 50.619999999999997 112.729 176.96 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -72.14 -46.02 58.19 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.361 1.064 . . . . 50.549999999999997 108.18 -179.645 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 23' ' ' ILE . 90.8 t -40.69 -62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 125.003 1.439 . . . . 50.509999999999998 108.535 178.54 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 38' ' ' PRO . 53.3 mtmt -67.7 -16.32 64.08 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 115.288 1.588 . . . . 50.509999999999998 115.288 -179.74 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.69 -33.08 25.25 Favored 'General case' 0 C--O 1.279 2.607 0 N-CA-C 109.84 -0.43 . . . . 50.509999999999998 109.84 176.87 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -69.0 -46.77 67.19 Favored 'General case' 0 C--O 1.256 1.397 0 N-CA-C 103.278 -2.86 . . . . 50.509999999999998 103.278 176.025 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -55.78 -28.69 24.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.252 0 C-N-CA 119.491 -0.883 . . . . 50.509999999999998 111.724 179.921 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -63.56 -35.55 80.85 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 125.604 2.621 . . . . 50.549999999999997 108.384 179.465 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -68.93 -55.07 12.12 Favored 'General case' 0 C--O 1.254 1.303 0 N-CA-C 117.122 2.267 . . . . 50.619999999999997 117.122 179.08 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -80.47 -42.47 22.52 Favored 'General case' 0 C--O 1.28 2.71 0 C-N-CA 116.447 -2.101 . . . . 50.509999999999998 111.603 -175.687 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -86.82 -50.12 6.95 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 123.096 2.68 . . . . 50.619999999999997 115.667 179.881 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.73 18.59 7.84 Favored Glycine 0 CA--C 1.477 -2.284 0 N-CA-C 107.886 -2.086 . . . . 50.509999999999998 107.886 176.504 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 31.0 mm -98.62 120.63 58.62 Favored Pre-proline 0 C--O 1.244 0.785 0 C-N-CA 118.794 -1.162 . . . . 50.509999999999998 112.326 179.689 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.0 Cg_exo -56.99 136.9 79.49 Favored 'Trans proline' 0 C--O 1.26 1.578 0 C-N-CA 123.202 2.601 . . . . 50.509999999999998 110.901 178.29 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.588 ' HA ' HE21 ' A' ' 41' ' ' GLN . 86.5 Cg_exo -57.15 -32.14 92.54 Favored 'Trans proline' 0 C--O 1.262 1.697 0 C-N-CA 120.682 0.921 . . . . 50.509999999999998 113.449 -179.336 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.11 -11.7 59.85 Favored 'General case' 0 C--O 1.263 1.764 0 O-C-N 119.931 -1.731 . . . . 50.619999999999997 109.084 -177.42 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -98.78 2.92 47.35 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.462 -1.399 . . . . 50.549999999999997 110.585 178.764 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.588 HE21 ' HA ' ' A' ' 38' ' ' PRO . 54.8 mt-30 -102.27 118.77 37.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 124.348 2.023 . . . . 50.549999999999997 114.652 -177.588 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.539 ' HD2' ' HD2' ' A' ' 72' ' ' ARG . 70.4 mtp180 -102.17 118.5 37.02 Favored 'General case' 0 C--O 1.295 3.497 0 CA-C-O 116.732 -1.604 . . . . 50.640000000000001 107.566 172.165 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 50' ' ' LEU . 51.5 mt -109.72 119.77 40.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 50.509999999999998 112.721 -177.425 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.41 132.23 61.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 O-C-N 125.046 1.467 . . . . 50.509999999999998 113.525 -177.65 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.14 100.71 7.0 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 103.543 -2.762 . . . . 50.509999999999998 103.543 177.556 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.81 33.63 11.68 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.152 -2.294 . . . . 50.509999999999998 114.779 177.448 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.62 10.27 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 128.513 2.959 . . . . 50.509999999999998 113.266 -179.546 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -124.55 112.24 16.61 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 115.11 1.522 . . . . 50.509999999999998 115.11 177.713 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -58.12 113.61 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.135 2.272 . . . . 50.549999999999997 117.135 174.574 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 55.1 mt -65.15 150.05 48.84 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 117.802 -1.094 . . . . 50.509999999999998 112.936 -175.917 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 74.5 tt0 -108.04 135.09 49.99 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 124.544 1.153 . . . . 50.619999999999997 110.984 -177.684 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.616 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -53.02 -63.91 0.99 Allowed 'General case' 0 C--O 1.263 1.814 0 C-N-CA 126.115 1.766 . . . . 50.619999999999997 112.088 -175.806 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 -8.04 66.87 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 117.496 1.759 . . . . 50.509999999999998 117.496 -177.274 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -82.37 -173.1 4.37 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 120.037 -1.861 . . . . 50.640000000000001 107.531 176.492 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 22' ' ' THR . 38.9 p -127.59 158.2 38.14 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.549 1.315 . . . . 50.509999999999998 114.549 177.07 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.87 -39.82 69.08 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 106.456 -1.683 . . . . 50.509999999999998 106.456 177.242 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 59' ' ' TYR . 73.3 m -61.49 -43.84 98.15 Favored 'General case' 0 C--O 1.269 2.086 0 C-N-CA 117.299 -1.76 . . . . 50.509999999999998 108.829 -179.493 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.29 -4.26 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.214 1.19 . . . . 50.619999999999997 114.214 179.685 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 57' ' ' SER . 83.7 m-85 -122.94 9.7 9.42 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 116.44 2.015 . . . . 50.509999999999998 116.44 179.26 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 61.22 23.25 13.48 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 121.446 1.93 . . . . 50.549999999999997 113.53 179.944 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 61' ' ' ILE . 73.4 mt -73.93 94.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.266 1.966 0 CA-C-O 115.198 -2.335 . . . . 50.509999999999998 116.274 175.836 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -87.7 159.23 18.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 126.031 2.082 . . . . 50.549999999999997 112.994 -176.81 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.461 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 79.5 tttt -54.64 154.34 5.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 123.235 1.493 . . . . 50.509999999999998 108.135 -176.958 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' OE2' ' HE2' ' A' ' 63' ' ' LYS . 42.6 mm-40 57.8 69.31 0.75 Allowed 'General case' 0 C--O 1.257 1.462 0 CA-C-N 112.476 -2.147 . . . . 50.619999999999997 106.143 179.613 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 93.9 p -143.08 129.82 20.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.775 -1.102 . . . . 50.509999999999998 112.761 174.823 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -72.78 130.16 39.84 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 118.121 2.637 . . . . 50.509999999999998 118.121 175.92 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.3 138.02 45.29 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 114.673 -2.584 . . . . 50.509999999999998 107.445 175.079 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -91.95 123.07 35.04 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 127.389 2.93 . . . . 50.509999999999998 113.659 177.848 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -105.84 103.06 12.48 Favored 'General case' 0 C--O 1.282 2.792 0 CA-C-O 117.657 -1.163 . . . . 50.509999999999998 113.918 176.511 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -108.5 138.9 33.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 119.538 1.063 . . . . 50.509999999999998 109.262 175.174 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.26 148.11 39.71 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 117.33 2.344 . . . . 50.509999999999998 117.33 178.479 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HD2' ' HD2' ' A' ' 42' ' ' ARG . 76.5 ttt-85 -132.41 87.36 2.42 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 113.375 -3.202 . . . . 50.640000000000001 104.574 177.22 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 60.4 mt -79.2 167.47 20.94 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 125.814 1.946 . . . . 50.509999999999998 106.928 -179.344 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -100.39 63.58 1.12 Allowed 'General case' 0 C--O 1.244 0.772 0 N-CA-C 118.105 2.632 . . . . 50.640000000000001 118.105 -179.643 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.24 178.06 38.14 Favored Glycine 0 C--O 1.242 0.651 0 O-C-N 124.617 1.198 . . . . 50.509999999999998 112.85 179.403 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.458 0 CA-C-O 116.338 -2.368 . . . . 50.509999999999998 115.437 179.204 . . . . . . . . 0 0 . 1 stop_ save_